FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yan, LP
   Silva-Correia, J
   Correia, C
   Caridade, SG
   Fernandes, EM
   Sousa, RA
   Mano, JF
   Oliveira, JM
   Oliveira, AL
   Reis, RL
AF Yan, Le-Ping
   Silva-Correia, Joana
   Correia, Cristina
   Caridade, Sofia G.
   Fernandes, Emanuel M.
   Sousa, Rui A.
   Mano, Joao F.
   Oliveira, Joaquim M.
   Oliveira, Ana L.
   Reis, Rui L.
TI Bioactive macro/micro porous silk fibroin/nano-sized calcium phosphate
   scaffolds with potential for bone-tissue-engineering applications
SO NANOMEDICINE
LA English
DT Article
DE bone tissue engineering; nano-sized calcium phosphate; nanocomposite;
   porous scaffold; silk fibroin
ID CARBOXYMETHYLCHITOSAN/POLY(AMIDOAMINE) DENDRIMER NANOPARTICLES; MARROW
   STROMAL CELLS; COMPOSITE SCAFFOLDS; ARTICULAR-CARTILAGE; BIOMATERIAL
AB Aim: The development of novel silk/nano-sized calcium phosphate (silk/nano-CaP) scaffolds with highly dispersed CaP nanoparticles in the silk fibroin (SF) matrix for bone tissue engineering. Materials&methods: Nano-CaP was incorporated in a concentrated aqueous SF solution (16 wt.%) by using an in situ synthesis method. The silk/nano-CaP scaffolds were then prepared through a combination of salt-leaching/Iyophilization approaches. Results: The CaP particles presented good affinity to SF and their size was inferior to 200 nm when theoretical CaP/silk ratios were between 4 and 16 wt.%, as determined by scanning electron microscopy. The CaP particles displayed a uniform distribution in the scaffolds at both microscopic and macroscopic scales as observed by backscattered scanning electron microscopy and micro-computed tomography, respectively. The prepared scaffolds presented self-mineralization capability and no cytotoxicity confirmed by in vitro bioactivity tests and cell viability assays, respectively. Conclusion: These results indicated that the produced silk/nano-CaP scaffolds could be suitable candidates for bone-tissue-engineering applications. Original submitted 21 December 2011; Revised submitted 10 July 2012; Published online 24 December 2012
C1 [Yan, Le-Ping; Silva-Correia, Joana; Correia, Cristina; Caridade, Sofia G.; Fernandes, Emanuel M.; Sousa, Rui A.; Mano, Joao F.; Oliveira, Joaquim M.; Oliveira, Ana L.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Yan, Le-Ping; Silva-Correia, Joana; Correia, Cristina; Caridade, Sofia G.; Fernandes, Emanuel M.; Sousa, Rui A.; Mano, Joao F.; Oliveira, Joaquim M.; Oliveira, Ana L.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Oliveira, Ana L.] Portuguese Catholic Univ, Dept Hlth Sci, P-3504505 Viseu, Portugal.
RP Reis, RL (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Caridade,
   Sofia/P-1925-2015; Silva-Correia, Joana/D-4980-2012; Fernandes,
   Emanuel/A-4464-2013; Oliveira, Ana/J-3404-2013; Oliveira, Joaquim
   Miguel/H-8636-2012; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129;
   Caridade, Sofia/0000-0002-0448-1871; Silva-Correia,
   Joana/0000-0003-1312-3109; Fernandes, Emanuel/0000-0002-4296-2529;
   Oliveira, Ana/0000-0001-8012-4203; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Mano, Joao/0000-0002-2342-3765; Yan,
   Leping/0000-0002-4806-5052; Correia, Cristina/0000-0002-4979-3254;
   Sousa, Rui/0000-0003-0362-7418
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/105703/2008, PTDC/CTM-BPC/115977/2009]; Foundation
   Luso-Americana; FCT [SFRHIBD/64717/2009]
FX This study was funded by the Portuguese Foundation for Science and
   Technology (FCT) through the projects Tissue2Tissue
   (PTDC/CTM/105703/2008) and Osteo Cart (PTDC/CTM-BPC/115977/2009). The
   funding from Foundation Luso-Americana is greatly acknowledged. L-P Yan
   gives thanks for his PhD scholarship from FCT (SFRHIBD/64717/2009). The
   authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript. This includes employment, consultancies, honoraria, stock
   ownership or potions, expert testimony, grants or patents received or
   pending, or royalties.
CR Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Oliveira AL, 2007, J MATER SCI-MATER M, V18, P211, DOI 10.1007/s10856-006-0683-8
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Oliveira AL, 2004, BIODEGRADABLE SYSTEM, P205
   Oliveira AL, 2006, 20 EUR C BIOM NANT F
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira JM, 2009, J BIOMED MATER RES A, V91A, P175, DOI 10.1002/jbm.a.32213
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 33
TC 25
Z9 25
U1 2
U2 65
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD MAR
PY 2013
VL 8
IS 3
BP 359
EP 378
DI 10.2217/NNM.12.118
PG 20
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 104EG
UT WOS:000315973900014
PM 23259755
DA 2018-10-20
ER

PT J
AU Fitzpatrick, S
AF Fitzpatrick, Sean
TI Tissue engineers report knee cartilage repair success with new
   biomaterial
SO REGENERATIVE MEDICINE
LA English
DT News Item
CR Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
NR 1
TC 0
Z9 0
U1 1
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD MAR
PY 2013
VL 8
IS 2
BP 106
EP 107
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 102GE
UT WOS:000315832100008
DA 2018-10-20
ER

PT J
AU Gopi, D
   Bhuvaneshwari, N
   Indira, J
   Kavitha, L
AF Gopi, D.
   Bhuvaneshwari, N.
   Indira, J.
   Kavitha, L.
TI Synthesis and spectroscopic investigations of hydroxyapatite using a
   green chelating agent as template
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Hydroxyapatite; Biomaterial; Green chelating agent; Sucrose
ID SOL-GEL SYNTHESIS; CELLS IN-VITRO; NANOHYDROXYAPATITE; NANOPARTICLES;
   MORPHOLOGY; MICROEMULSION; TEMPERATURE; EMULSION; POWDERS; PH
AB Hydroxyapatite [Ca-10(PO4)(6)(OH)(2), HAP] particles have been successfully synthesized by a cost-effective, eco-friendly green template method using natural and commercially available sucrose as a chelating agent. The sucrose used in this method has been extracted from various sources, three from natural and one from commercially available sources are exploited in our study to achieve a controlled crystallinity, particle size as well as uniform morphology. Spectral characterizations involving Fourier transform infrared spectroscopy (FT-IR) for the functional group analysis of sucrose and HAP; carbon-13 nuclear magnetic resonance spectroscopy (C-13 NMR) for the identification of the carbon atoms in sucrose and in HAP; liquid chromatography/mass spectrometry (LC-MS) for the determination of the hydrolyzed products of sucrose; and X-ray diffraction (XRD) techniques for the phase identification of the HAP particles were performed. The morphology of the HAP particles were assessed thoroughly using a scanning electron microscope (SEM) equipped with energy dispersive X-ray analysis (EDAX). The experimental results indicate that the obtained HAP using the natural sucrose as a chelating agent is of phase pure, with a well defined morphology having discrete particles without any agglomeration than the HAP from commercially available sucrose. Further, the reduced particle size can be achieved from the stem sugarcane extract as the source of the chelating agent. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Gopi, D.; Bhuvaneshwari, N.; Indira, J.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Gopi, D.; Kavitha, L.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Bhuvaneshwari, N.] Chikkaiah Naicker Coll, Dept Chem, Erode 638004, Tamil Nadu, India.
   [Kavitha, L.] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com; louiskavitha@yahoo.co.in
RI Gopi, Dhanaraj/A-9163-2012; Louis, Kavitha/B-9313-2017
OI Gopi, Dhanaraj/0000-0001-6662-1238; Louis, Kavitha/0000-0002-8893-2050
FU Indian Council of Medical Research (ICMR, IRIS ID) [2010-08660,
   5/20/11(Bio)/10-NCD-I]; Department of Science and Technology (DST-SERC)
   [SR/FTP/ETA-04/2009]; DST-TSD [DST/TSG/NTS/2011/73]; Council of
   Scientific and Industrial Research (CSIR), New Delhi, India [01
   (2547)/11/EMR-II]
FX One of the author D. Gopi acknowledges the major functional support from
   the Indian Council of Medical Research (ICMR, IRIS ID No. 2010-08660,
   Ref. No.: 5/20/11(Bio)/10-NCD-I), Department of Science and Technology
   (DST-SERC, Ref. No.: SR/FTP/ETA-04/2009 and DST-TSD, Ref. No.:
   DST/TSG/NTS/2011/73) and Council of Scientific and Industrial Research
   (CSIR, Ref. No.: 01 (2547)/11/EMR-II, Dated: 12.12.2011) New Delhi,
   India in the form of major research projects. Another author (J. Indira)
   wishes to thank the Council of Scientific and Industrial Research
   (CSIR), New Delhi, India for the award of Senior Research Fellowship
   (CSIR-SRF).
CR [Anonymous], 1985, SADTL STAND CARB 13
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Bax A., 1981, J MAGN RESON, V43, P483
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Brizuela A.B., 2012, CARBOHYD RES, DOI org/10.1016/j.carres.2012.07.009
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Elliot J.C., 1994, STUDIES INORGANIC CH, P4
   Fu N. Zhou, 2005, J BIOMED MATER RES A, V74 A, P156
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Gopi D, 2010, SPECTROCHIM ACTA A, V77, P545, DOI 10.1016/j.saa.2010.06.013
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P590
   Guo GS, 2005, CERAM INT, V31, P869, DOI 10.1016/j.ceramint.2004.10.003
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hulbert S. F., 1987, CERAMICS CLIN APPL P, P189
   Karkacier M, 2003, J CHROMATOGR SCI, V41, P331, DOI 10.1093/chromsci/41.6.331
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Li B, 2008, APPL SURF SCI, V255, P357, DOI 10.1016/j.apsusc.2008.06.114
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu DM, 2002, BIOMATERIALS, V23, P1227, DOI 10.1016/S0142-9612(01)00242-3
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Popov KI, 2006, FOOD CHEM, V96, P248, DOI 10.1016/j.foodchem.2005.02.025
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Roveri Norberto, 2009, Recent Patents on Biomedical Engineering, V2, P197, DOI 10.2174/1874764710902030197
   Sonoda K, 2002, SOLID STATE IONICS, V151, P321, DOI 10.1016/S0167-2738(02)00730-0
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   Yin MZ, 2006, BIOMED MATER, V1, P38, DOI 10.1088/1748-6041/1/1/006
   Yingjun W., 2006, MATER LETT, V60, P3227
   Yoshimura M, 2004, MAT SCI ENG C-BIO S, V24, P521, DOI 10.1016/j.msec.2004.01.005
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
NR 37
TC 16
Z9 16
U1 0
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAR
PY 2013
VL 104
BP 292
EP 299
DI 10.1016/j.saa.2012.11.092
PG 8
WC Spectroscopy
SC Spectroscopy
GA 098OE
UT WOS:000315557800038
PM 23270888
DA 2018-10-20
ER

PT J
AU Rahmany, MB
   Van Dyke, M
AF Rahmany, Maria B.
   Van Dyke, Mark
TI Biomimetic approaches to modulate cellular adhesion in biomaterials: A
   review
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterial functionalization; Integrin adhesion; Biomimetic; Surface
   modification
ID INTEGRIN ACTIVATION; RGD-PEPTIDES; IN-VITRO; EXTRACELLULAR SEGMENT;
   KERATIN BIOMATERIALS; OSTEOBLAST ADHESION; CRYSTAL-STRUCTURE; MIGRATION
   SPEED; TALIN BINDING; SURFACES
AB Natural extracellular matrix (ECM) proteins possess critical biological characteristics that provide a platform for cellular adhesion and activation of highly regulated signaling pathways. However, ECM-based biomaterials can have several limitations, including poor mechanical properties and risk of immunogenicity. Synthetic biomaterials alleviate the risks associated with natural biomaterials but often lack the robust biological activity necessary to direct cell function beyond initial adhesion. A thorough understanding of receptor-mediated cellular adhesion to the ECM and subsequent signaling activation has facilitated development of techniques that functionalize inert biomaterials to provide a biologically active surface. Here we review a range of approaches used to modify biomaterial surfaces for optimal receptor-mediated cell interactions, as well as provide insights into specific mechanisms of downstream signaling activation. In addition to a brief overview of integrin receptor-mediated cell function, so-called "biomimetic" techniques reviewed here include (i) surface modification of biomaterials with bioadhesive ECM macromolecules or specific binding motifs, (ii) nanoscale patterning of the materials and (iii) the use of "natural-like" biomaterials. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rahmany, Maria B.] Wake Forest Sch Med, Winston Salem, NC 27157 USA.
   [Van Dyke, Mark] Virginia Polytech Inst & State Univ, Blacksburg, VA 24060 USA.
RP Van Dyke, M (reprint author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24060 USA.
EM mvandyk5@vt.edu
CR Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   BALE MD, 1989, BLOOD, V74, P2698
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434
   Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Glass R, 2003, ADV FUNCT MATER, V13, P569, DOI 10.1002/adfm.200304331
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Haubner R, 2003, BIOCONJUGATE CHEM, V14, P274, DOI 10.1021/bc020084w
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Kaufmann D, 2008, MACROMOL BIOSCI, V8, P577, DOI 10.1002/mabi.200700234
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kim DH, 2010, ADV MATER, V22, P4551, DOI 10.1002/adma.201000468
   Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   KUHN K, 1986, BIOL CHEM H-S, V367, P88
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Mofrad MRK, 2005, ACTA BIOMATER, V1, P281, DOI 10.1016/j.actbio.2005.02.008
   Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0
   Sanz-Herrera JA, 2011, INT J MOL SCI, V12, P8217, DOI 10.3390/ijms12118217
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Seitz TL, 1982, J BIOMED MATER RES, V16, P11
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200
   Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8
NR 85
TC 81
Z9 83
U1 6
U2 221
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2013
VL 9
IS 3
BP 5431
EP 5437
DI 10.1016/j.actbio.2012.11.019
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GH
UT WOS:000315536000002
PM 23178862
DA 2018-10-20
ER

PT J
AU Lampe, KJ
   Antaris, AL
   Heilshorn, SC
AF Lampe, Kyle J.
   Antaris, Alexander L.
   Heilshorn, Sarah C.
TI Design of three-dimensional engineered protein hydrogels for tailored
   control of neurite growth
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Neuron; Neurite; Stiffness; Three-dimensional
ID NEURAL STEM-CELLS; FIBRIN GELS; MECHANICAL-PROPERTIES; NERVE
   REGENERATION; EXTENSION; MATRICES; TISSUE; OUTGROWTH; DIFFERENTIATION;
   SCAFFOLDS
AB The design of bioactive materials allows tailored studies probing cell-biomaterial interactions, however, relatively few studies have examined the effects of ligand density and material stiffness on neurite growth in three-dimensions. Elastin-like proteins (ELPs) have been designed with modular bioactive and structural regions to enable the systematic characterization of design parameters within three-dimensional (3-D) materials. To promote neurite out-growth and better understand the effects of common biomaterial design parameters on neuronal cultures we here focused on the cell-adhesive ligand density and hydrogel stiffness as design variables for ELP hydrogels. With the inherent design freedom of engineered proteins these 3-D ELP hydrogels enabled decoupled investigations into the effects of biomechanics and biochemistry on neurite out-growth from dorsal root ganglia. Increasing the cell-adhesive RGD ligand density from 0 to 1.9 x 10(7) ligands mu m(-3) led to a significant increase in the rate, length, and density of neurite out-growth, as quantified by a high throughput algorithm developed for dense neurite analysis. An approximately two-fold improvement in total neurite out-growth was observed in materials with the higher ligand density at all time points up to 7 days. ELP hydrogels with initial elastic moduli of 0.5, 1.5, or 2.1 kPa and identical RGD ligand densities revealed that the most compliant materials led to the greatest out-growth, with some neurites extending over 1800 mu m by day 7. Given the ability of ELP hydrogels to efficiently promote neurite out-growth within defined and tunable 3-D microenvironments these materials may be useful in developing therapeutic nerve guides and the further study of basic neuron-biomaterial interactions. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lampe, Kyle J.; Antaris, Alexander L.; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU NIH NRSA [F32NS076222]; NSF Graduate Research Fellowship [DGE 1147470];
   NSF [DMR-0846363]; NIH [DP2-OD0006477]; CIRM [RT2-01938]
FX The authors acknowledge support from NIH NRSA F32NS076222 (K.J.L.), NSF
   Graduate Research Fellowship DGE 1147470 (A.L.A.), and NSF DMR-0846363,
   NIH DP2-OD0006477, and CIRM RT2-01938 (S.C.H.). The authors thank
   Branden Cord for training in DRG isolation, Ruby Dewi for
   immunocytochemical staining advice, and Cindy Chung and Widya
   Mulyasasmita for helpful scientific discussion.
CR Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Buxboim A., 2010, J PHYS CONDENS MATT, V22, P1
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Curley JL, 2011, J BIOMED MATER RES A, V99A, P532, DOI 10.1002/jbm.a.33195
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Fraley SI, 2011, NAT CELL BIOL, V13, pU254
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gelain F., 2006, PLOS ONE, Ve119, P1
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Kofron CM, 2009, J NEURAL ENG, V6, P1
   Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042
   Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Macaya D., 2012, BIOMED MATER, V7, P1
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895
   Ribeiro A, 2012, TISSUE ENG PT A, V18, P93, DOI 10.1089/ten.tea.2011.0221
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sang-Nadir O, 2010, BIOMATERIALS, V31, P6411, DOI 10.1016/j.biomaterials.2010.04.052
   Sarig-Nadir O, 2008, TISSUE ENG PT A, V14, P401, DOI 10.1089/tea.2007.0029
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Straley K. S., 2009, FRONT NEUROENG, V2, P1
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5
   Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
NR 59
TC 73
Z9 73
U1 3
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2013
VL 9
IS 3
BP 5590
EP 5599
DI 10.1016/j.actbio.2012.10.033
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GH
UT WOS:000315536000019
PM 23128159
OA Other Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Franz, S
   Allenstein, F
   Kajahn, J
   Forstreuter, I
   Hintze, V
   Moller, S
   Simon, JC
AF Franz, Sandra
   Allenstein, Francie
   Kajahn, Jennifer
   Forstreuter, Inka
   Hintze, Vera
   Moeller, Stephanie
   Simon, Jan C.
TI Artificial extracellular matrices composed of collagen I and
   high-sulfated hyaluronan promote phenotypic and functional modulation of
   human pro-inflammatory M1 macrophages
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Biomaterial coatings; Wound healing;
   Immunomodulation; Inflammatory M1 macrophages
ID NF-KAPPA-B; ACTIVATION; POLARIZATION; MICE; GLYCOSAMINOGLYCANS;
   BIOMATERIALS; RESPONSES; INHIBITION; PATTERNS; SYSTEM
AB The sequential phases of biomaterial integration and wound healing require different macrophage functions mediated by distinct macrophage subsets. During the initial phase of healing, pro-inflammatory M1 macrophages (M Phi 1) are required to clear the wound from microbes and debris; however, their unopposed, persistent activation often leads to disturbed integration of biomaterials and perturbed wound healing. Here we investigated whether pro-inflammatory macrophage functions are affected by immunomodulatory biomaterials based on artificial extracellular matrices (aECM). To address this issue, we tested the capacity of two-dimensional aECM consisting of collagen I and hyaluronan or sulfated derivatives of hyaluronan to affect functions of in vitro polarized human pro-inflammatory M Phi 1. The aECM containing high-sulfated hyaluronan substantially decreased inflammatory macrophage functions, including pathogen uptake and release of the pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-12 due to impaired activation of nuclear factor "kappa-light-chain-enhancer" of activated B-cells. Moreover, these macrophages secreted immunregulatory IL-10 and showed reduced activity of the transcription factors signal transducer and activator of transcription 1 and interferon-regulating factor 5, both controlling macrophage polarization to M Phi 1 subsets. Our data reveal that the collagen I matrix containing high-sulfated hyaluronan possesses immunomodulating properties and dampens inflammatory macrophage activities by impeding signaling pathways crucial for polarization of pro-inflammatory M Phi 1 We therefore suggest this aECM as a promising coating for biomaterials to modulate inflammatory macrophage functions during the healing response and recommend its further testing as a three-dimensional construct and in in vivo models. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Franz, Sandra; Allenstein, Francie; Kajahn, Jennifer; Forstreuter, Inka; Simon, Jan C.] Univ Leipzig, Dept Dermatol Venerol & Allergol, D-04103 Leipzig, Germany.
   [Hintze, Vera] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Moeller, Stephanie] INNOVENT eV, Biomat Dept, Jena, Germany.
   [Franz, Sandra; Allenstein, Francie; Kajahn, Jennifer; Forstreuter, Inka; Hintze, Vera; Moeller, Stephanie; Simon, Jan C.] Matrixengn Leipzig & Dresden, Collaborat Res Ctr SFB TR67, Leipzig, Germany.
RP Franz, S (reprint author), Univ Leipzig, Dept Dermatol Venerol & Allergol, D-04103 Leipzig, Germany.
EM sandra.franz@medizin.uni-leipzig.de
OI Franz, Sandra/0000-0002-3449-2723
FU German Research Council [DFG SFB-TR67]
FX This work was funded by the German Research Council (DFG SFB-TR67,
   projects A2, A3, B3). We thank Tobias Polte and Saskia Trump for their
   help with the BD Pathway (TM) 855 High-Content Bioimager and data
   analysis with the attovision software. We also acknowledge excellent
   technical assistance by Aline Katzschner and Heike Zimmermann in
   preparing aECM.
CR Adamson R, 2009, J Wound Care, V18, P349
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   DOUKAS M, 1995, CANCER RES, V55, P5161
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245
   Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Franz S, 2009, AUTOIMMUNITY, V42, P275, DOI 10.1080/08916930902828080
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2012, J TISSUE EN IN PRESS
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598
   Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Matias MAT, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-39
   Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Saalbach A, 2010, J INVEST DERMATOL, V130, P444, DOI 10.1038/jid.2009.253
   Salek-Ardakani S, 2000, BLOOD, V96, P1879
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev
   van der SA, 2011, BIOMATERIALS, V32, P8938
   Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 43
TC 40
Z9 42
U1 4
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2013
VL 9
IS 3
BP 5621
EP 5629
DI 10.1016/j.actbio.2012.11.016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GH
UT WOS:000315536000022
PM 23168224
DA 2018-10-20
ER

PT J
AU Drevet, R
   Lemelle, A
   Untereiner, V
   Manfait, M
   Sockalingum, GD
   Benhayoune, H
AF Drevet, R.
   Lemelle, A.
   Untereiner, V.
   Manfait, M.
   Sockalingum, G. D.
   Benhayoune, H.
TI Morphological modifications of electrodeposited calcium phosphate
   coatings under amino acids effect
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Calcium phosphate; Electrodeposition; Electron microscopy; Corrosion;
   Biomaterial; Titanium alloy
ID CORROSION BEHAVIOR; PULSED-LASER; HYDROXYAPATITE; ALLOY; BONE;
   DEPOSITION; PARTICLES; RAMAN
AB Calcium phosphate coatings are synthesized on titanium alloy (Ti6Al4V) substrates by pulsed electrode-position. This work aims to observe the morphological modifications of the coating when an amino acid is added to the electrolytic solution used in the process. The effects of two amino acids (glutamic acid and aspartic acid) are studied at a low and a high concentration. The coating morphology is observed at a nanometer scale by field emission gun-scanning electron microscopy (FEG-SEM). The structural characterization of the coating is performed by Fourier transformed infrared spectroscopy (FT-IR), Raman spectroscopy and X-ray diffraction (XRD). Moreover, corrosion measurements of the prosthetic surfaces are carried out by potentiodynamic polarization experiments in a physiological solution named Dulbecco's modified eagle medium (DMEM). The results show that the addition of an amino acid to the electrolytic solution leads to the decrease of the size of the crystallites which compose the prosthetic calcium phosphate coating that becomes denser and less porous than the coatings obtained without amino acid. Consequently, the corrosion behavior of the prosthetic material immersed in DMEM is improved. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Drevet, R.; Lemelle, A.; Benhayoune, H.] Univ Reims, LISM EA 4695, F-51685 Reims 02, France.
   [Untereiner, V.; Manfait, M.; Sockalingum, G. D.] Univ Reims, UFR Pharm, Unite MEDyC FRE CNRS3481, Equipe MeDIAN Biophoton & Technol Sante, F-51096 Reims, France.
RP Drevet, R (reprint author), Univ Reims, LISM EA 4695, 21 Rue Clement Ader,BP 138, F-51685 Reims 02, France.
EM richard.drevet@univ-reims.fr
RI DREVET, Richard/A-8878-2016
OI DREVET, Richard/0000-0002-7425-4885
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Arias JL, 1998, BIOMATERIALS, V19, P883, DOI 10.1016/S0142-9612(97)00168-3
   Benhayoune H, 2010, ADV ENG MATER, V12, pB192, DOI 10.1002/adem.200980058
   Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105
   Boanini E, 2006, EUR J INORG CHEM, P4821, DOI 10.1002/ejic.200600423
   Chu XB, 2011, J PHYS CHEM B, V115, P1151, DOI 10.1021/jp106863q
   deAza PN, 1997, CHEM MATER, V9, P916, DOI 10.1021/cm9604266
   Diegmueller J.J., 2009, CRYSTAL GROWTH DESIG, V9, P5520
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Drevet R, 2012, J SOLID STATE ELECTR, V16, P3069, DOI 10.1007/s10008-012-1742-3
   Drevet R, 2011, J MATER SCI-MATER M, V22, P753, DOI 10.1007/s10856-011-4251-5
   Drevet R, 2010, MATER CHARACT, V61, P786, DOI 10.1016/j.matchar.2010.04.016
   Drevet R, 2011, J BIOMATER TISS ENG, V1, P68, DOI 10.1166/jbt.2011.1007
   Drevet R, 2012, ADV ENG MATER, V14, P377, DOI 10.1002/adem.201100331
   Dyshlovenko S, 2004, SURF COAT TECH, V179, P110, DOI 10.1016/S0257-8972(03)00799-0
   Eliaz N, 2008, CRYST GROWTH DES, V8, P3965, DOI 10.1021/cg800016h
   Faure J, 2012, KEY ENG MATER, V507, P135, DOI 10.4028/www.scientific.net/KEM.507.135
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gil FJ, 2012, J MATER SCI-MATER M, V23, P885, DOI 10.1007/s10856-012-4572-z
   Hashimoto Y, 2008, J MATER SCI-MATER M, V19, P327, DOI 10.1007/s10856-006-0107-9
   Hsu RWW, 2004, MATER CHEM PHYS, V86, P269, DOI 10.1016/j.matchemphys.2004.02.025
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   Ikawa N, 2009, J MATER CHEM, V19, P4906, DOI 10.1039/b815154g
   Koseoglu NC, 2009, ADV ENG MATER, V11, pB194, DOI 10.1002/adem.200900034
   Koutsopoulos S, 2000, J CRYST GROWTH, V217, P410, DOI 10.1016/S0022-0248(00)00502-9
   Kumar S, 2011, J APPL ELECTROCHEM, V41, P123, DOI 10.1007/s10800-010-0210-y
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Matsumoto T, 2006, DENT MATER J, V25, P360, DOI 10.4012/dmj.25.360
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Moorthi A, 2012, J BIOMATER TISS ENG, V2, P197, DOI 10.1166/jbt.2012.1045
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   SMITH R, 1994, J MATER SCI-MATER M, V5, P775, DOI 10.1007/BF00120375
   Zhang GD, 2011, MATER LETT, V65, P572, DOI 10.1016/j.matlet.2010.10.078
NR 35
TC 16
Z9 16
U1 0
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2013
VL 268
BP 343
EP 348
DI 10.1016/j.apsusc.2012.12.093
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 095JK
UT WOS:000315330300054
DA 2018-10-20
ER

PT J
AU Tutak, W
   Sarkar, S
   Lin-Gibson, S
   Farooque, TM
   Jyotsnendu, G
   Wang, DB
   Kohn, J
   Bolikal, D
   Simon, CG
AF Tutak, Wojtek
   Sarkar, Sumona
   Lin-Gibson, Sheng
   Farooque, Tanya M.
   Jyotsnendu, Giri
   Wang, Dongbo
   Kohn, Joachim
   Bolikal, Durgadas
   Simon, Carl G., Jr.
TI The support of bone marrow stromal cell differentiation by airbrushed
   nanofiber scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Airbrushing; Bone marrow stromal cell; Cell differentiation;
   Electrospinning; Nanofiber; Stem cell
ID EMBRYONIC STEM-CELLS; OSTEOGENIC DIFFERENTIATION; SHAPE;
   POLY(EPSILON-CAPROLACTONE); 3D; PROLIFERATION; REGENERATION; BIOMATERIAL
AB Nanofiber scaffolds are effective for tissue engineering since they emulate the fibrous nanostructure of native extracellular matrix (ECM). Although electrospinning has been the most common approach for fabricating nanofiber scaffolds, airbrushing approaches have also been advanced for making nanofibers. For airbrushing, compressed gas is used to blow polymer solution through a small nozzle which shears the polymer solution into fibers. Our goals were 1) to assess the versatility of airbrushing, 2) to compare the properties of airbrushed and electrospun nanofiber scaffolds and 3) to test the ability of airbrushed nanofibers to support stem cell differentiation. The results demonstrated that airbrushing could produce nanofibers from a wide range of polymers and onto a wide range of targets. Airbrushing was safer, 10-fold faster, 100-fold less expensive to set-up and able to deposit nanofibers onto a broader range of targets than electrospinning. Airbrushing yielded nanofibers that formed loosely packed bundles of aligned nanofibers, while electrospinning produced un-aligned, single nanofibers that were tightly packed and highly entangled. Airbrushed nanofiber mats had larger pores, higher porosity and lower modulus than electrospun mats, results that were likely caused by the differences in morphology (nanofiber packing and entanglement). Airbrushed nanofiber scaffolds fabricated from 4 different polymers were each able to support osteogenic differentiation of primary human bone marrow stromal cells (hBMSCs). Finally, the differences in airbrushed versus electrospun nanofiber morphology caused differences in hBMSC shape where cells had a smaller spread area and a smaller volume on airbrushed nanofiber scaffolds. These results highlight the advantages and disadvantages of airbrushing versus electrospinning nanofiber scaffolds and demonstrate that airbrushed nanofiber scaffolds can support stem cell differentiation. Published by Elsevier Ltd.
C1 [Tutak, Wojtek; Sarkar, Sumona; Lin-Gibson, Sheng; Farooque, Tanya M.; Jyotsnendu, Giri; Wang, Dongbo; Simon, Carl G., Jr.] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.
   [Tutak, Wojtek; Jyotsnendu, Giri] NIST, Amer Dent Assoc Fdn, Gaithersburg, MD 20899 USA.
   [Kohn, Joachim; Bolikal, Durgadas] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Simon, CG (reprint author), NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
OI Sarkar, Sumona/0000-0002-3192-843X
FU NRC-NIST; NRC-NIH/NIBIB-NIST
FX W.T., T.M.F., D.W. and S.S. were supported by NRC-NIST postdoctoral
   fellowships. G.J. was supported by an NRC-NIH/NIBIB-NIST postdoctoral
   fellowship. We thank Kathy Flynn (NIST) for gel permeation
   chromatography measurements. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of
   NIST. This article, a contribution of NIST, is not subject to US
   copyright. Certain equipment and instruments or materials are identified
   in the paper to adequately specify the experimental details. Such
   identification does not imply recommendation by NIST, nor does it imply
   the materials are necessarily the best available for the purpose. The
   authors declare no conflicts of interest.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Chatterjee Kaushik, 2012, J Funct Biomater, V3, P372, DOI 10.3390/jfb3020372
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Cordelires F, 2006, 3D OBJECT COUNTER IM
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorsey SM, 2009, BIOMATERIALS, V30, P2967, DOI 10.1016/j.biomaterials.2009.02.032
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Grafahrend D, 2008, BIOTECHNOL BIOENG, V101, P609, DOI 10.1002/bit.21928
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong S, 2010, J BIOMED MATER RES B, V94B, P421, DOI 10.1002/jbm.b.31670
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Medeiros ES, 2011, J APPL POLYM SCI, V113, P2322
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Nguyen LTH, 2012, NANOMEDICINE-UK, V7, P1561, DOI [10.2217/NNM.12.41, 10.2217/nnm.12.41]
   Norton CL, 1933, US Patent No, Patent No. 2048651
   Parekh SH, 2011, BIOMATERIALS, V32, P2256, DOI 10.1016/j.biomaterials.2010.11.065
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Robey PG, 2011, TISSUE ENG PART B-RE, V17, P423, DOI 10.1089/ten.teb.2011.0199
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   SHARP DG, 1950, J BIOL CHEM, V185, P247
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Srinivasan S, 2011, POLYMER, V52, P3209, DOI 10.1016/j.polymer.2011.05.008
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Uyar T, 2010, ACS NANO, V4, P5121, DOI 10.1021/nn100954z
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
NR 42
TC 58
Z9 60
U1 2
U2 120
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2013
VL 34
IS 10
BP 2389
EP 2398
DI 10.1016/j.biomaterials.2012.12.020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098JL
UT WOS:000315545500001
PM 23312903
DA 2018-10-20
ER

PT J
AU Culpepper, BK
   Morris, DS
   Prevelige, PE
   Bellis, SL
AF Culpepper, Bonnie K.
   Morris, David S.
   Prevelige, Peter E.
   Bellis, Susan L.
TI Engineering nanocages with polyglutamate domains for coupling to
   hydroxyapatite biomaterials and allograft bone
SO BIOMATERIALS
LA English
DT Article
DE Bone graft; Drug delivery; Nanoparticle; Hydroxyapatite
ID BACTERIOPHAGE P22; COAT PROTEIN; MORPHOGENETIC PROTEIN; CELL-ADHESION;
   IN-VITRO; NANOPARTICLES; DELIVERY; MATURATION; PEPTIDES; IDENTIFICATION
AB Hydroxyapatite (HA) is the principal constituent of bone mineral, and synthetic HA is widely used as a biomaterial for bone repair. Previous work has shown that polyglutamate domains bind selectively to HA and that these domains can be utilized to couple bioactive peptides onto many different HA-containing materials. In the current study we have adapted this technology to engineer polyglutamate domains into cargo-loaded nanocage structures derived from the P22 bacteriophage. P22 nanocages have demonstrated significant potential as a drug delivery system due to their stability, large capacity for loading with a diversity of proteins and other types of cargo, and ability to resist degradation by proteases. Site-directed mutagenesis was used to modify the primary coding sequence of the P22 coat protein to incorporate glutamate-rich regions. Relative to wild-type P22, the polyglutamate-modified nanocages (E2-P22) exhibited increased binding to ceramic HA disks, particulate HA and allograft bone. Furthermore, E2-P22 binding was HA selective, as evidenced by negligible binding of the nanocages to non-HA materials including polystyrene, agarose, and polycaprolactone (PCL). Taken together these results establish a new mechanism for the directed coupling of nanocage drug delivery systems to a variety of HA-containing materials commonly used in diverse bone therapies. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Culpepper, Bonnie K.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Morris, David S.; Prevelige, Peter E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.
   [Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.
RP Prevelige, PE (reprint author), 416 BBRB,845 19th St South, Birmingham, AL 35233 USA.
EM prevelig@uab.edu; bellis@uab.edu
FU NIH [R01AR51539]; Osseointegration Foundation; UAB BioMatrix Engineering
   and Regenerative Medicine Center; NIH/NIDCR [1F31DE021613]
FX This research was supported by NIH grant R01AR51539 (SLB), as well as
   grants from the Osseointegration Foundation (SLB), and the UAB BioMatrix
   Engineering and Regenerative Medicine Center (PEP). BKC was supported by
   NIH/NIDCR predoctoral fellowship 1F31DE021613 (BKC). We are grateful for
   technical support provided by Kuni J. Scissum.
CR Aljabali A.A., 2012, MOL PHARM
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022
   Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108
   Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005
   Culpepper BK, 2013, BIOMATERIALS, V34, P1506, DOI 10.1016/j.biomaterials.2012.10.046
   Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   GALISTEO ML, 1995, J BIOL CHEM, V270, P16595, DOI 10.1074/jbc.270.28.16595
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0
   Hengst V, 2007, INT J PHARM, V331, P224, DOI 10.1016/j.ijpharm.2006.11.024
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hosain F, 1996, J NUCL MED, V37, P105
   Huang L, 2011, ANNU REV BIOMED ENG, V13, P507, DOI 10.1146/annurev-bioeng-071910-124709
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891
   Kang S, 2008, CHEMBIOCHEM, V9, P514, DOI 10.1002/cbic.200700555
   Kang S, 2010, BIOMACROMOLECULES, V11, P2804, DOI 10.1021/bm100877q
   Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936
   Koudelka KJ, 2010, CURR OPIN CHEM BIOL, V14, P810, DOI 10.1016/j.cbpa.2010.10.005
   Lanman J, 1999, BIOCHEMISTRY-US, V38, P14614, DOI 10.1021/bi9915420
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Low SA, 2012, ADV DRUG DELIVER REV, V64, P1189, DOI 10.1016/j.addr.2012.01.012
   Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]
   Morioka M, 2010, BIOORGAN MED CHEM, V18, P1143, DOI 10.1016/j.bmc.2009.12.041
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   O'Neil A, 2011, ANGEW CHEM INT EDIT, V50, P7425, DOI 10.1002/anie.201102036
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   ONO I, 1995, J CRANIOFAC SURG, V6, P238, DOI 10.1097/00001665-199505000-00011
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Qazi S, 2012, MOL PHARM
   Salerno M, 2010, CURR CANCER DRUG TAR, V10, P649, DOI 10.2174/156800910793605767
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   Teschke CM, 2003, BIOPHYS J, V84, P2585, DOI 10.1016/S0006-3495(03)75063-2
   Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026
   Uchida M, 2012, LANGMUIR, V28, P1998, DOI 10.1021/la203866c
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P258, DOI 10.1021/bp990154m
   Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011
   Wang GL, 2012, J BIOMED MATER RES A, V100A, P684, DOI 10.1002/jbm.a.34002
   Wang GL, 2010, J DRUG TARGET, V18, P611, DOI 10.3109/10611861003622560
   Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]
   Yasuda H, 2012, J ORTHOP SCI, V17, P299, DOI 10.1007/s00776-012-0196-x
   Ziebart T, 2011, CLIN ORAL INVEST, V15, P105, DOI 10.1007/s00784-009-0365-2
NR 47
TC 12
Z9 12
U1 0
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2013
VL 34
IS 10
BP 2455
EP 2462
DI 10.1016/j.biomaterials.2012.12.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098JL
UT WOS:000315545500007
PM 23312905
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Srivastava, S
   Raj, KR
   Kardam, A
AF Srivastava, Shalini
   Raj, Kumar Rohit
   Kardam, Abhishek
TI Efficient arsenic depollution in water using modified maize powder
SO ENVIRONMENTAL CHEMISTRY LETTERS
LA English
DT Article
DE Modifications; Sorption efficiency; Zea mays cob powder (maize powder);
   Arsenic; Reusability of biomaterial
ID DRINKING-WATER; REMOVAL; GROUNDWATER
AB This article reports the synthesis of an efficient, low-cost material from maize powder to depollute arsenic-contaminated water. Arsenic is toxic for humans and other organisms even at low concentrations. The most well-known and severe case of arsenic poisoning through drinking water has been found in India and Bangladesh. Numerous inorganic materials have been tested for the removal of arsenic from water bodies over the last two decades. However, all such materials have several disadvantages such as unpredictable arsenic ion removal, high cost and the generation of toxic sludge that is often more difficult to manage. Alternatively, organic material from agricultural waste may be modified to enrich functional groups responsible for As sorption and, in turn, used to depollute contaminated waters. Here, Zea mays cob powder has been modified to remove arsenic species from water. Two modified materials were produced: an aminated maize powder and a thiolated maize powder. Amination was done using epichlorohydrin and dimethylamine. Thiolation was done using thioglycolic acids. Amination increased As (III) sorption from 70 to 75.8 % and As (V) sorption from 85 to 94.42 %, compared with unmodified maize powder. Thiolation increased As (III) sorption from 70 to 81.7 % and As (V) sorption from 85 to 90 %. Amination increased usability cycles from 3 to 5. Thiolation increased usability cycles from 3 to 6. The novel modified maize biosorbent has enough potential for the development of a low-cost technological pre-treatment step, prior to high-tech chemical treatments.
C1 [Srivastava, Shalini; Raj, Kumar Rohit; Kardam, Abhishek] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
RP Srivastava, S (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM dei.smohanm@gmail.com
FU UGC
FX The authors gratefully acknowledge Prof. V. G. Das, Director, and Prof.
   L. D. Khemani, Head, Department of Chemistry, Dayalbagh Educational
   Institute, Dayalbagh, Agra. Authors also gratefully acknowledge UGC for
   providing financial assistance.
CR Anirudhan TS, 2007, CHEMOSPHERE, V66, P60, DOI 10.1016/j.chemosphere.2006.05.031
   Egila J. N., 2011, International Journal of Physical Sciences, V6, P2152
   Ferella F, 2007, DESALINATION, V207, P125, DOI 10.1016/j.desal.2006.07.007
   Ghimire KN, 2002, SEPAR SCI TECHNOL, V37, P2785, DOI 10.1081/SS-120005466
   Goyal P, 2009, J HAZARD MATER, V172, P1206, DOI 10.1016/j.jhazmat.2009.07.125
   Kanel SR, 2005, ENVIRON SCI TECHNOL, V39, P1291, DOI 10.1021/es048991u
   Kardam A, 2009, NATL ACAD SCI LETT, V32, P179
   Kumaresan M, 2001, CURR SCI INDIA, V80, P837
   Raj Kumar Rohit, 2010, Journal of Water Resource and Protection, V2, P331, DOI 10.4236/jwarp.2010.24038
   Raj KR, 2012, BOOK CHEM PHYTOPOTEN, P243, DOI [10.1007/978-3-642-23394-4_51, DOI 10.1007/978-3-642-23394-4_51]
   Ranjan D, 2009, IND ENG CHEM RES, V48, P10180, DOI 10.1021/ie9008771
   Rivas BL, 2007, J APPL POLYM SCI, V106, P1889, DOI 10.1002/app.26737
   Rivas BL, 2010, WATER RES, V44, P5730, DOI 10.1016/j.watres.2010.06.031
   Netzahuatl-Munoz AR, 2012, WATER AIR SOIL POLL, V223, P625, DOI 10.1007/s11270-011-0888-4
   Samuel D, 2002, AMINO ACIDS PROTEINS
   Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec
   Song S, 2006, WATER RES, V40, P364, DOI 10.1016/j.watres.2005.09.046
   Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q
   Srivastava S., 2010, DECONTAMINATION TOXI
   Walker M, 2008, SCI TOTAL ENVIRON, V389, P245, DOI 10.1016/j.scitotenv.2007.08.061
   Wang JS, 2004, J CHEM EDUC, V81, P207, DOI 10.1021/ed081p207
   Yeneneh M. A., 2011, J APPL SCI, V11, P3555
NR 22
TC 4
Z9 4
U1 4
U2 35
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1610-3653
J9 ENVIRON CHEM LETT
JI Environ. Chem. Lett.
PD MAR
PY 2013
VL 11
IS 1
BP 47
EP 53
DI 10.1007/s10311-012-0376-0
PG 7
WC Chemistry, Multidisciplinary; Engineering, Environmental; Environmental
   Sciences
SC Chemistry; Engineering; Environmental Sciences & Ecology
GA 097RT
UT WOS:000315491900007
DA 2018-10-20
ER

PT J
AU Miller, DL
   Force, SD
   Pickens, A
   Fernandez, FG
   Luu, T
   Mansour, KA
AF Miller, Daniel L.
   Force, Seth D.
   Pickens, Allan
   Fernandez, Felix G.
   Luu, Theresa
   Mansour, Kamal A.
TI Chest Wall Reconstruction Using Biomaterials
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT Basic Science Forum of the 58th Annual Meeting of the
   Southern-Thoracic-Surgical-Association
CY NOV 09-12, 2011
CL San Antonio, TX
SP So Thorac Surg Assoc
ID RESECTION; REPAIR; PROSTHESIS; MESH
AB Background. Skeletal chest wall reconstruction can be a challenge, depending on the indication, location, and health of the patient; various materials are available. Recently, biomaterials that are remodelable (bovine pericardium patch; Veritas, Synovis Life Technologies Inc, St Paul, MN) or absorbable (polylactic acid [PLA] bar; BioBridge, Acute Innovations, Hillsboro, OR) have been introduced for reconstruction procedures.
   Methods. We performed a retrospective review of all patients who underwent chest wall stabilization or reconstruction between July 1, 2009, and March 31, 2011.
   Results. Biomaterials were used in 25 of 112 patients (22%) who underwent chest wall stabilization or reconstruction, and they form the basis of this review. Indication for reconstruction was malignant disease in 17 patients (68%). Overall, 10 (40%) resection sites were infected preoperatively. Reconstruction was performed with a combination of bovine pericardium and PLA bars in 11 patients (44%), bovine pericardium alone in 10, and PLA bars alone in 4; muscle flaps were interposed in 7 patients (28%). There were no operative deaths. Complications occurred in 6 patients (24%). Median follow-up was 12 months (range, 6 to 27 months). Three patients required removal of their biomaterials. Two bovine pericardial patches were removed prophylactically at the time of debridement of a partially necrotic muscle flap, and 1 PLA bar was removed because of an inflammatory reaction. None of the patients with an infected resection site required removal of their biomaterial.
   Conclusions. Chest wall reconstruction with biomaterials is a valuable option in the management of patients with chest wall abnormalities. Early results are promising. Biomaterials may be the preferred method of reconstruction for infected chest wall sites. (Ann Thorac Surg 2013;95:1050-6) (C) 2013 by The Society of Thoracic Surgeons
C1 [Miller, Daniel L.; Force, Seth D.; Pickens, Allan; Fernandez, Felix G.; Luu, Theresa; Mansour, Kamal A.] Emory Univ, Sch Med, Sect Gen Thorac Surg, Atlanta, GA USA.
RP Miller, DL (reprint author), Emory Univ Clin, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.
EM daniel.miller@emoryhealthcare.org
CR Alaedeen D I, 2007, Hernia, V11, P41, DOI 10.1007/s10029-006-0164-5
   [Anonymous], 1947, J THORAC SURG
   Arnold PG, 1996, PLAST RECONSTR SURG, V98, P804, DOI 10.1097/00006534-199610000-00008
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   BISGARD JD, 1948, ARCH SURG-CHICAGO, V56, P570, DOI 10.1001/archsurg.1948.01240010580002
   CAMPBELL DA, 1950, J THORAC SURG, V19, P456
   Deschamps C, 1999, J THORAC CARDIOV SUR, V117, P588, DOI 10.1016/S0022-5223(99)70339-9
   Ge PS, 2010, ANN THORAC SURG, V90, P1799, DOI 10.1016/j.athoracsur.2010.07.080
   le Roux B T, 1983, Curr Probl Surg, V20, P345, DOI 10.1016/S0011-3840(83)80007-0
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Losken A, 2004, BRIT J PLAST SURG, V57, P295, DOI 10.1016/j.bjps.2004.02.004
   MAIER HC, 1947, SURGERY, V22, P169
   Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0
   MCCORMACK P, 1981, ANN THORAC SURG, V31, P45, DOI 10.1016/S0003-4975(10)61315-X
   Miller DL, 2009, GEN THORACIC SURG, V1, P679
   Peacock O, 2011, INT J COLORECTAL DIS, V10, P1325
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Steinau G, 2000, PEDIATR SURG INT, V16, P19, DOI 10.1007/s003830050005
   Weyant MJ, 2006, ANN THORAC SURG, V81, P279, DOI 10.1016/j.athoracsur.2005.07.001
   Wiegmann B, 2010, EUR J CARDIO-THORAC, V37, P602, DOI 10.1016/j.ejcts.2009.07.012
NR 20
TC 26
Z9 28
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAR
PY 2013
VL 95
IS 3
BP 1050
EP 1056
DI 10.1016/j.athoracsur.2012.11.024
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 095KI
UT WOS:000315332800050
PM 23333060
DA 2018-10-20
ER

PT J
AU Song, GD
   Habibovic, P
   Bao, CY
   Hu, J
   van Blitterswijk, CA
   Yuan, HP
   Chen, WC
   Xu, HHK
AF Song, Guodong
   Habibovic, Pamela
   Bao, Chongyun
   Hu, Jing
   van Blitterswijk, Clemens A.
   Yuan, Huipin
   Chen, Wenchuan
   Xu, Hockin H. K.
TI The homing of bone marrow MSCs to non-osseous sites for ectopic bone
   formation induced by osteoinductive calcium phosphate
SO BIOMATERIALS
LA English
DT Article
DE Bone repair; Osteoinductive; Calcium phosphate ceramic; Bone marrow
   mesenchymal stem cells; Y chromosomes; Canine model
ID BETA-TRICALCIUM PHOSPHATE; MESENCHYMAL STEM-CELLS; IN-VITRO
   CHARACTERIZATION; STROMAL CELLS; MECHANICAL-PROPERTIES; CANINE MODEL;
   SCAFFOLDS; TRANSPLANTATION; CERAMICS; IMPLANTS
AB Osteoinductive biomaterials are promising for bone repair. There is no direct proof that bone marrow mesenchymal stem cells (BMSCs) home to non-osseous sites and participate in ectopic bone formation induced by osteoinductive bioceramics. The objective of this study was to use a sex-mismatched beagle dog model to investigate BMSC homing via blood circulation to participate in ectopic bone formation via osteoinductive biomaterial. BMSCs of male dogs were injected into female femoral marrow cavity. The survival and stable chimerism of donor BMSCs in recipients were confirmed with polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH). Biphasic calcium phosphate (BCP) granules were implanted in dorsal muscles of female dogs. Y chromosomes were detected in samples harvested from female dogs which had received male BMSCs. At 4 weeks, cells with Y-chromosomes were distributed in the new bone matrix throughout the BCP granule implant. At 6 weeks, cells with Y chromosomes were present in newly mineralized woven bone. TRAP positive osteoclast-like cells were observed in 4-week implants, and the number of such cells decreased from 4 to 6 weeks. These results show that osteoprogenitors were recruited from bone marrow and homed to ectopic site to serve as a cell source for calcium phosphate-induced bone formation. In conclusion, BMSCs were demonstrated to migrate from bone marrow through blood circulation to non-osseous bioceramic implant site to contribute to ectopic bone formation in a canine model. BCP induced new bone in muscles without growth factor delivery, showing excellent osteoinductivity that could be useful for bone tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Song, Guodong; Bao, Chongyun; Hu, Jing; Chen, Wenchuan] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Habibovic, Pamela; van Blitterswijk, Clemens A.; Yuan, Huipin] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Chen, Wenchuan; Xu, Hockin H. K.] Univ Maryland, Sch Dent, Dept Endodont Prosthodont & Operat Dent, Biomat & Tissue Engn Div, Baltimore, MD 21201 USA.
RP Bao, CY (reprint author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
EM cybao9933@scu.edu.cn; hxu@umaryland.edu
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU National Science foundation of China [NSFC-30672337, NSFC-30970728]; NIH
   [R01 DE14190]
FX The authors would like to thank Dr. Jan de Bore in Department of Tissue
   Regeneration, BMTI, University of Twente, The Netherlands, for his help
   in design the experiment. We thank Xiaoyu Li, Min Zhou, Yurong Liu,
   Xiaoqin Yang, and Yunfeng Li for experimental assistance. We also thank
   the technical assistance from the Key Laboratory of Transplant
   Engineering and Immunology of Ministry of Health, West China Hospital,
   Sichuan University. This work was funded by the National Science
   foundation of China (NSFC-30672337 and NSFC-30970728 to CB) and NIH R01
   DE14190 (to HX).
CR Bao CY, 2011, ACTA BIOMATER, V7, P4037, DOI 10.1016/j.actbio.2011.06.046
   Barou O, 2002, BONE, V30, P604, DOI 10.1016/S8756-3282(02)00677-4
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   BURNETT RC, 1995, MAMM GENOME, V6, P684, DOI 10.1007/BF00352386
   Chen WC, 2012, TISSUE ENG PT A, V18, P816, DOI [10.1089/ten.TEA.2011.0267, 10.1089/ten.tea.2011.0267]
   Chow LC, 2000, MATER RES SOC SYMP P, V599, P27
   De Groot J, 1998, Tissue Eng, V4, P337
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Feng Q, 2008, EXP HEMATOL, V36, P1556, DOI 10.1016/j.exphem.2008.06.010
   Fiegler H, 2002, VET IMMUNOL IMMUNOP, V84, P61, DOI 10.1016/S0165-2427(01)00390-7
   Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260
   Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5
   Guille MMG, 2005, MICRON, V36, P602, DOI 10.1016/j.micron.2005.07.005
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kruyt MC, 2007, BIOMATERIALS, V28, P1798, DOI 10.1016/j.biomaterials.2006.11.038
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Luk KDK, 2003, BIOCHEM BIOPH RES CO, V308, P636, DOI 10.1016/S0006-291X(03)01429-3
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Mao JJ, 2007, REGENERATIVE MED TRA
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meyers WVN, 1999, MOL REPROD DEV, V53, P266
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Niemeyer GP, 2005, TRANSPLANT P, V37, P4579, DOI 10.1016/j.transproceed.2005.10.034
   Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164
   Russias J, 2007, J BIOMED MATER RES A, V83A, P434, DOI 10.1002/jbm.a.31237
   Service RF, 2005, SCIENCE, V309, P683
   Shirley D, 2005, J ORTHOP RES, V23, P1013, DOI 10.1016/j.orthres.2005.01.013
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Storb R, 1999, BLOOD, V94, P1131
   Tang H, 2009, BIOMATERIALS, V30, P3224, DOI 10.1016/j.biomaterials.2009.02.007
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   United States Bone and Joint Decade (USBJD), 2008, US BON JOINT DEC USB
   Wagner JL, 1996, TRANSPLANTATION, V62, P876, DOI 10.1097/00007890-199609270-00032
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yao JF, 2009, J BIOMED MATER RES B, V91B, P805, DOI 10.1002/jbm.b.31459
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
NR 59
TC 47
Z9 53
U1 6
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2013
VL 34
IS 9
BP 2167
EP 2176
DI 10.1016/j.biomaterials.2012.12.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093GH
UT WOS:000315179200002
PM 23298780
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Koppolu, B
   Zaharoff, DA
AF Koppolu, Bhanuprasanth
   Zaharoff, David A.
TI The effect of antigen encapsulation in chitosan particles on uptake,
   activation and presentation by antigen presenting cells
SO BIOMATERIALS
LA English
DT Article
DE Chitosan particles; Antigen delivery; Antigen presentation; Adjuvant;
   Co-stimulation
ID VACCINE-DELIVERY-SYSTEMS; DENDRITIC CELLS; IMMUNE-RESPONSE;
   NANOPARTICLES; ADJUVANTS; DRUG; MICROPARTICLES; IMMUNOTHERAPY;
   MICROSPHERES; DERIVATIVES
AB Particle-based vaccine delivery systems are under exploration to enhance antigen-specific immunity against safe but poorly immunogenic polypeptide antigens. Chitosan is a promising biomaterial for antigen encapsulation and delivery due to its ability to form nano- and microparticles in mild aqueous conditions thus preserving the antigenicity of loaded polypeptides. In this study, the influence of chitosan encapsulation on antigen uptake, activation and presentation by antigen presenting cells (APCs) is explored. Fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA) and ovalbumin (OVA) were used as model protein antigens and encapsulated in chitosan particles via precipitation coacervation at loading efficiencies >89%. Formulation conditions were manipulated to create antigen-encapsulated chitosan particles (AgCPs) with discrete nominal sizes (300 nm, 1 mu m, and 3 mu m). Uptake of AgCPs by dendritic cells and macrophages was found to be dependent on particle size, antigen concentration and exposure time. Flow cytometry analysis revealed that uptake of AgCPs enhanced upregulation of surface activation markers on APCs and increased the release of pro-inflammatory cytokines. Lastly, antigen-specific T cells exhibited higher proliferative responses when stimulated with APCs activated with AgCPs versus soluble antigen. These data suggest that encapsulation of antigens in chitosan particles enhances uptake, activation and presentation by APCs. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Koppolu, Bhanuprasanth; Zaharoff, David A.] Univ Arkansas, Dept Biomed Engn, Bell Engn Ctr 4188B, Fayetteville, AR 72701 USA.
RP Zaharoff, DA (reprint author), Univ Arkansas, Dept Biomed Engn, Bell Engn Ctr 4188B, Fayetteville, AR 72701 USA.
EM zaharoff@uark.edu
RI Koppolu, Bhanu prasanth/H-1313-2016
OI Koppolu, Bhanu prasanth/0000-0001-9570-3902; Zaharoff,
   David/0000-0001-6885-6727
FU National Cancer Institute [K22CA131567]
FX This work was supported by the National Cancer Institute (K22CA131567 to
   D.A.Z.).
CR Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI 10.1586/ERV.09.47
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bernkop-Schnurch A, 2000, INT J PHARM, V194, P1, DOI 10.1016/S0378-5173(99)00365-8
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   Chang KL, 2010, BIOCONJUGATE CHEM, V21, P1087, DOI 10.1021/bc1000609
   Clark TG, 2005, DEV BIOLOGICALS, V121, P153
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009
   Gordon S, 2008, J PHARM PHARMACOL, V60, P1591, DOI 10.1211/jpp/60.12.0004
   Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86
   Kreuter J, 1996, J ANAT, V189, P503
   Morein B, 1996, VET IMMUNOL IMMUNOP, V54, P373, DOI 10.1016/S0165-2427(96)05697-8
   Nagamoto T, 2004, PHARM RES, V21, P671, DOI 10.1023/B:PHAM.0000022414.17183.58
   O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017
   O'Hagan DT, 2004, PHARM RES, V21, P1519, DOI 10.1023/B:PHAM.0000041443.17935.33
   O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176
   Ozbas-Turan S, 2002, J PHARM SCI, V91, P1245, DOI 10.1002/jps.10122
   Pan Y, 2002, INT J PHARM, V249, P139, DOI 10.1016/S0378-5173(02)00486-6
   Pearse MJ, 2005, ADV DRUG DELIVER REV, V57, P465, DOI 10.1016/j.addr.2004.09.006
   Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036
   Qu BX, 2004, ARCH NEUROL-CHICAGO, V61, P1859, DOI 10.1001/archneur.61.12.1859
   SCHEICHER C, 1995, EUR J IMMUNOL, V25, P1566, DOI 10.1002/eji.1830250615
   Scheicher C, 1995, ADV EXP MED BIOL, V378, P253
   Schlom J, 2007, Curr Oncol, V14, P238, DOI 10.3747/co.2007.158
   Schlom J, 2008, EXP BIOL MED, V233, P522, DOI 10.3181/0708-MR-226
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1
   Zaharoff DA, 2007, VACCINE, V25, P8673, DOI 10.1016/j.vaccine.2007.10.037
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
   Zaharoff DA, 2010, J IMMUNOTHER, V33, P697, DOI 10.1097/CJI.0b013e3181eb826d
   Zaharoff DA, 2009, CANCER RES, V69, P6192, DOI 10.1158/0008-5472.CAN-09-1114
NR 38
TC 38
Z9 41
U1 1
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2013
VL 34
IS 9
BP 2359
EP 2369
DI 10.1016/j.biomaterials.2012.11.066
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093GH
UT WOS:000315179200021
PM 23274070
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Asgary, S
   Eghbal, MJ
   Ghoddusi, J
   Yazdani, S
AF Asgary, Saeed
   Eghbal, Mohammad Jafar
   Ghoddusi, Jamileh
   Yazdani, Shahram
TI One-year results of vital pulp therapy in permanent molars with
   irreversible pulpitis: an ongoing multicenter, randomized,
   non-inferiority clinical trial
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Biomaterial; Calcium-enriched mixture; CEM cement; Endodontics; Human;
   Molar; Pulpitis; Pulpotomy; Vital pulp therapy
ID MINERAL TRIOXIDE AGGREGATE; CALCIUM-ENRICHED MIXTURE; END FILLING
   MATERIAL; ROOT-FILLED TEETH; HUMAN DENTAL-PULP; ENDODONTIC TREATMENT;
   APICAL PERIODONTITIS; TREATMENT OUTCOMES; CEMENT; PULPOTOMY
AB Root canal therapy (RCT) and tooth extraction have been conventional treatment options for management of human mature teeth with irreversible pulpitis. Excellent short-term treatment outcomes of vital pulp therapy with calcium-enriched mixture cement (VPT/CEM), as a new treatment option, on postoperative pain relief was demonstrated; if intermediate- and long-term treatment outcomes of the new treatment are also non-inferior compared to RCT, then VPT/CEM may become a viable treatment option for management of mature teeth with irreversible pulpitis.
   In 23 healthcare centers, 407 9- to 65-year-old patients were randomly allocated into two study arms including one-visit RCT (reference treatment; n = 202) and VPT/CEM (alternative treatment; n = 205). Six- and twelve-month clinical and radiographic successes were assessed.
   Mean follow-up times at 6- and 12-month follow-ups were "6.70 +/- 0.68 and 6.72 +/- 0.71 months" and "12.96 +/- 0.67 and 12.90 +/- 0.66 months" in the available cases of RCT and VPT/CEM arms, respectively. Favorable clinical success rates in the two study arms did not show statistical difference; however, the radiographic success rate in the VPT/CEM was significantly greater than RCT arm at the two follow-ups (P < 0.001). The patients' age had no effect on the treatment outcomes (P = 0.231).
   Treatment outcomes of VPT/CEM may be superior to RCT in mature molars with irreversible pulpitis. The performance of biomaterials such CEM cement may assist in the shift towards more biologic treatments.
   VPT/CEM may be a realistic alternative treatment for human mature molar teeth with symptoms of irreversible pulpitis; the use of VPT/CEM is highly beneficial for patients as well as general dentists.
C1 [Asgary, Saeed] Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Tehran 1983963113, Iran.
   [Eghbal, Mohammad Jafar] Shahid Beheshti Univ Med Sci, Dent Res Ctr, Tehran, Iran.
   [Ghoddusi, Jamileh] Mashad Univ Med Sci, Endodont Dept, Sch Dent, Mashhad, Iran.
   [Yazdani, Shahram] Shahid Beheshti Univ Med Sci, EDC, Tehran, Iran.
RP Asgary, S (reprint author), Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Tehran 1983963113, Iran.
EM saasgary@yahoo.com
FU Iranian Ministry of Health and Medical Education (Health Deputy, Oral
   Health Office); Shahid Beheshti University of Medical Sciences
   [p/25/17/1/tm/103]
FX This work was supported by the Iranian Ministry of Health and Medical
   Education (Health Deputy, Oral Health Office) and Shahid Beheshti
   University of Medical Sciences [grant number p/25/17/1/tm/103].
CR Aguilar P, 2011, J ENDODONT, V37, P581, DOI 10.1016/j.joen.2010.12.004
   Alongi DJ, 2010, REGEN MED, V5, P617, DOI 10.2217/RME.10.30
   Asgary S, 2011, USA, Patent No. [7,942,961, 7942961]
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary S, 2013, ACTA ODONTOL SCAND, V71, P130, DOI 10.3109/00016357.2011.654251
   Asgary Saeed, 2010, Iran Endod J, V5, P74
   Asgary Saeed, 2011, J Conserv Dent, V14, P90, DOI 10.4103/0972-0707.80733
   Asgary S, 2011, J ENDODONT, V37, P411, DOI 10.1016/j.joen.2010.11.015
   Asgary Saeed, 2010, J Conserv Dent, V13, P156, DOI 10.4103/0972-0707.71650
   Asgary S, 2010, ODONTOLOGY, V98, P126, DOI 10.1007/s10266-010-0127-2
   Asgary Saeed, 2009, J Conserv Dent, V12, P31, DOI 10.4103/0972-0707.53340
   Asgary S, 2010, J ENDODONT, V36, P837, DOI 10.1016/j.joen.2010.03.005
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Bjorndal L, 2006, INT ENDOD J, V39, P785, DOI 10.1111/j.1365-2591.2006.01149.x
   Bjorndal L, 2008, PEDIATR DENT, V30, P225
   Bogen G, 2008, INGLES ENDODONTICS, P1310
   Bohay RN, 2000, ORAL SURG ORAL MED O, V89, P639, DOI 10.1067/moe.2000.105908
   CALISKAN MK, 1995, INT ENDOD J, V28, P172, DOI 10.1111/j.1365-2591.1995.tb00293.x
   Caplan DJ, 2005, J PUBLIC HEALTH DENT, V65, P90, DOI 10.1111/j.1752-7325.2005.tb02792.x
   Dammaschke T, 2010, CLIN ORAL INVEST, V14, P559, DOI 10.1007/s00784-009-0326-9
   Dugas NN, 2003, INT ENDOD J, V36, P181, DOI 10.1046/j.1365-2591.2003.00640.x
   Dugas NN, 2002, J ENDODONT, V28, P819, DOI 10.1097/00004770-200212000-00007
   Eghbal MJ, 2009, AUST ENDOD J, V35, P4, DOI 10.1111/j.1747-4477.2009.00166.x
   Friedman Shimon, 2004, J Calif Dent Assoc, V32, P493
   Fristad I, 2004, INT ENDOD J, V37, P12, DOI 10.1111/j.1365-2591.2004.00743.x
   Geurtsen W, 2001, Aust Endod J, V27, P12
   Goldberg M, 2011, CLIN ORAL INVEST, V15, P1, DOI 10.1007/s00784-010-0503-x
   Hasan Zarrabi M, 2009, J ORAL SCI, V51, P437
   Kojima K, 2004, ORAL SURG ORAL MED O, V97, P95, DOI 10.1016/j.tripleo.2003.07.006
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levin LG, 2009, J ENDODONT, V35, P1645, DOI 10.1016/j.joen.2009.09.032
   LZ S, 1965, ACTA ODONTOL SCA S21, V14
   Malekafzali B, 2011, EUR J PAEDIATR DENT, V12, P189
   Massler M, 1978, J Pedod, V2, P217
   Matsuo T, 1996, J ENDODONT, V22, P551, DOI 10.1016/S0099-2399(96)80017-3
   McDougal RA, 2004, J AM DENT ASSOC, V135, P1707, DOI 10.14219/jada.archive.2004.0123
   Mente J, 2010, J ENDODONT, V36, P806, DOI 10.1016/j.joen.2010.02.024
   Nosrat A, 2010, INT ENDOD J, V43, P940, DOI 10.1111/j.1365-2591.2010.01777.x
   Nosrat A, 2013, INT J PAEDIATR DENT, V23, P56, DOI 10.1111/j.1365-263X.2012.01224.x
   Nosrat A, 2011, J ENDODONT, V37, P562, DOI 10.1016/j.joen.2011.01.011
   Nosrat A, 2010, J ENDODONT, V36, P912, DOI 10.1016/j.joen.2009.11.025
   Orstavik D, 1996, INT ENDOD J, V29, P150, DOI 10.1111/j.1365-2591.1996.tb01361.x
   Parirokh M, 2011, INT ENDOD J, V44, P283, DOI 10.1111/j.1365-2591.2010.01808.x
   Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152
   Ranly DM, 2000, J DENT, V28, P153, DOI 10.1016/S0300-5712(99)00065-2
   Salehrabi R, 2004, J ENDODONT, V30, P846, DOI 10.1097/01.don.0000145031.04236.ca
   Samiee MEM, 2009, CLIN ORAL INVEST, V14, P653
   Schmalz G., 2009, BIOCOMPATIBILITY DEN, P13
   SELTZER SAMUEL, 1963, ORAL SURG ORAL MED AND ORAL PATHOL, V16, P969, DOI 10.1016/0030-4220(63)90201-9
   Siqueira JF, 2008, ORAL SURG ORAL MED O, V106, P757, DOI 10.1016/j.tripleo.2008.06.007
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   Wang ZY, 2010, J ENDODONT, V36, P820, DOI 10.1016/j.joen.2010.02.003
   Ward Jeff, 2002, Aust Endod J, V28, P29
   Zarrabi MH, 2010, J ENDODONT, V36, P1778, DOI 10.1016/j.joen.2010.08.024
NR 58
TC 16
Z9 17
U1 0
U2 32
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2013
VL 17
IS 2
BP 431
EP 439
DI 10.1007/s00784-012-0712-6
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 095TD
UT WOS:000315356700009
PM 22431145
DA 2018-10-20
ER

PT J
AU He, FP
   Li, JY
   Ye, JD
AF He, Fupo
   Li, Jiyan
   Ye, Jiandong
TI Improvement of cell response of the poly(lactic-co-glycolic
   acid)/calcium phosphate cement composite scaffold with unidirectional
   pore structure by the surface immobilization of collagen via plasma
   treatment
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Calcium phosphate cement; PLGA; Collagen; Scaffold; Cell response;
   Plasma treatment; Unidirectional lamellar pore
ID MESENCHYMAL STEM-CELLS; HYDROXYAPATITE CEMENT; TRABECULAR BONE;
   IN-VITRO; OSTEOGENESIS; ADHESION; BIOCOMPATIBILITY; BIOMATERIAL;
   ANCHORAGE; POLYMERS
AB In this study, calcium phosphate cement (CPC)-based scaffold with unidirectional lamellar pore structure was fabricated by unidirectional freeze casting. Poly(lactic-co-glycolic acid) (PLGA) was infiltrated into the CPC scaffold to improve its strength and toughness, which compromised the bioactivity and osteoconductivity of CPC. Collagen (Col) was immobilized on the pore surface of the PLGA/CPC scaffold to enhance the bioactivity of the scaffold using plasma treatment under the ammonia (NH3) atmosphere. The immobilization of collagen was characterized by infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM). Compared to the PLGA/CPC composite scaffold, the Col/PLGA/CPC composite scaffold had higher contact angle, porosity and water absorption, while the compressive strength of both scaffolds was comparable. Rat bone marrow mesenchymal stem cells (rMSCs) seeded on the Col/PLGA/CPC scaffold showed markedly improved cell seeding, attachment, proliferation and differentiation than those on the PLGA/CPC scaffold. These results suggest that the surface immobilization of collagen by plasma treatment can improve the bioactivity of the PLGA/CPC scaffold and the Col/PLGA/CPC composite scaffold is a promising candidate for bone tissue engineering. (c) 2012 Elsevier B.V. All rights reserved.
C1 [He, Fupo; Li, Jiyan; Ye, Jiandong] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Peoples R China.
   [Ye, Jiandong] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
RP Ye, JD (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Peoples R China.
EM jdye@scut.edu.cn
FU National Natural Science Foundation of China (NSFC) [51172074]; National
   Basic Research Program of China [2012CB619100]; Program for Changjiang
   Scholars and Innovative Research Team in University [IRT0919]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) under Grant No. 51172074 and the National Basic Research
   Program of China under Grant No. 2012CB619100 as well as the Program for
   Changjiang Scholars and Innovative Research Team in University under
   Grant No. IRT0919.
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Chen GP, 2009, J BIOMED MATER RES B, V90B, P864, DOI 10.1002/jbm.b.31356
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Comuzzi L, 2002, CLIN ORAL IMPLAN RES, V13, P304, DOI 10.1034/j.1600-0501.2002.130311.x
   Feng ZQ, 2010, BIOMATERIALS, V31, P3604, DOI 10.1016/j.biomaterials.2010.01.080
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   He LR, 2011, INT J BIOL MACROMOL, V48, P354, DOI 10.1016/j.ijbiomac.2010.12.012
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319
   Miao XG, 2008, ACTA BIOMATER, V4, P638, DOI 10.1016/j.actbio.2007.10.006
   Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c
   Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Qi XP, 2009, J BIOMED MATER RES A, V89A, P980, DOI 10.1002/jbm.a.32054
   Rube P.Q., 2005, J BIOMED MATER RES A, V74, P533
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Seyedjafari E, 2011, J MATER SCI-MATER M, V22, P165, DOI 10.1007/s10856-010-4174-6
   Shen H., 1998, SURF COAT TECH, V98, P1102
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shi XT, 2010, EUR J PHARM SCI, V39, P59, DOI 10.1016/j.ejps.2009.10.012
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   TAKAGI S, 1995, J DENT RES, V74, P559
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Wang XP, 2007, J BIOMED MATER RES A, V81A, P781, DOI 10.1002/jbm.a.31059
   Wang XP, 2008, J MATER SCI-MATER M, V19, P813, DOI 10.1007/s10856-006-0029-6
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yoshikawa T, 1996, BIO-MED MATER ENG, V6, P345
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhao J, 2008, APPL SURF SCI, V255, P2942, DOI 10.1016/j.apsusc.2008.08.056
NR 38
TC 28
Z9 30
U1 1
U2 96
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2013
VL 103
BP 209
EP 216
DI 10.1016/j.colsurfb.2012.10.018
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 092MP
UT WOS:000315127000028
PM 23201739
DA 2018-10-20
ER

PT J
AU Salim, N
   Moore, C
   Silikas, N
   Satterthwaite, J
   Rautemaa, R
AF Salim, N.
   Moore, C.
   Silikas, N.
   Satterthwaite, J.
   Rautemaa, R.
TI Candidacidal effect of fluconazole and chlorhexidine released from
   acrylic polymer
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE Candida; leachates; biomaterial infection; antimicrobials; poly(ethyl
   methacrylate); tetrahydrofurfuryl methacrylate
ID ALBICANS BIOFILMS; STOMATITIS; GLABRATA; ANTIMICROBIALS; CANDIDIASIS;
   RESISTANCE; EFFICACY; WATER
AB To investigate the efficacy and rate of killing of a fluconazole- or chlorhexidine-impregnated polymeric delivery system against fluconazole-susceptible and -resistant Candida albicans and fluconazole-resistant Candida glabrata.
   Poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate (PEM/THFM) discs impregnated with chlorhexidine, pure fluconazole (FLCp) or fluconazole from capsules (FLCc) were prepared by substituting a portion of PEM powder with an equivalent amount of each drug. Discs were incubated in sterile water for 1, 3, 7, 14, 21 and 28 days. The amounts of drugs in the leachates were measured spectrophotometrically and their antifungal activity against fluconazole-susceptible (n1) and fluconazole-resistant (n2) candidal isolates was determined using a timekill method and by comparing the released concentrations with the corresponding MICs.
   Fluconazole and chlorhexidine leached from PEM/THFM polymer for up to 28 days and the released concentrations were fungicidal against all three Candida isolates for at least the first 7 days. Chlorhexidine leachates killed all Candida isolates more rapidly than the two fluconazole formulation leachates throughout the study period. FLCc leachates required longer incubation for 100 killing than FLCp leachates. The proportion of viable C. glabrata dropped more slowly than that of C. albicans with the same MIC.
   The concentrations of chlorhexidine and fluconazole leached from the PEM/THFM polymer were fungicidal against all Candida isolates, including those resistant to fluconazole, for the first 7 days. Chlorhexidine leachates showed a rapid fungicidal activity for up to 4 weeks, which can be of use in cases with poor response to conventional antifungals.
C1 [Salim, N.; Silikas, N.; Satterthwaite, J.] Univ Manchester, Sch Dent, Manchester M15 6FH, Lancs, England.
   [Salim, N.] Univ Jordan, Sch Dent, Amman, Jordan.
   [Moore, C.; Rautemaa, R.] Mycol Reference Ctr, Manchester M23 9LT, Lancs, England.
   [Moore, C.; Rautemaa, R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Manchester M23 9LT, Lancs, England.
   [Rautemaa, R.] Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.
RP Rautemaa, R (reprint author), Wythenshawe Hosp, Educ & Res Ctr, 2nd Floor,Southmoor Rd, Manchester M23 9LT, Lancs, England.
EM riina.richardson@manchester.ac.uk
RI Silikas, Nick/B-2990-2009
OI Silikas, Nick/0000-0003-4576-4584; Richardson,
   Riina/0000-0002-1071-6040; Salim, Nesreen/0000-0002-5355-2269
FU University of Jordan; University of Manchester Research Funds; NHS
   National Commissioning Group Chronic Pulmonary Aspergillosis National
   Service, UK
FX This work was supported in part by the University of Jordan (to N.
   Salim), The University of Manchester Research Funds (to all) and the NHS
   National Commissioning Group Chronic Pulmonary Aspergillosis National
   Service, UK (to R. R.).
CR Amin Wala M, 2009, Eur J Dent, V3, P257
   *CLIN LAB STAND I, 2008, M27S3 CLSI
   Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI
   Coco BJ, 2008, ORAL MICROBIOL IMMUN, V23, P377, DOI 10.1111/j.1399-302X.2008.00439.x
   Darwish RM, 2011, J MATER SCI-MATER M, V22, P1885, DOI 10.1007/s10856-009-3893-z
   Douglas WH, 1977, DENT UPDATE, V4, P395
   Figueiral MH, 2007, J ORAL REHABIL, V34, P448, DOI 10.1111/j.1365-2842.2007.01709.x
   FORCE RW, 1995, ANN PHARMACOTHER, V29, P10, DOI 10.1177/106002809502900102
   HIOM SJ, 1995, LETT APPL MICROBIOL, V21, P20, DOI 10.1111/j.1472-765X.1995.tb00997.x
   Klepser ME, 1998, ANTIMICROB AGENTS CH, V42, P1207, DOI 10.1128/AAC.42.5.1207
   Lamfon H, 2004, J ANTIMICROB CHEMOTH, V53, P383, DOI 10.1093/jac/dkh071
   Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304
   Meiller TF, 2001, ORAL SURG ORAL MED O, V91, P663, DOI 10.1067/moe.2001.113550
   Patel MP, 2001, BIOMATERIALS, V22, P2319, DOI 10.1016/S0142-9612(00)00367-7
   Postic SD, 2011, SERBIAN DENT J, V58, P209
   Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI [10.1093/jac/dkf049, 10.1093/jac.dkf049]
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ramage G, 2011, ORAL SURG ORAL MED O, V111, P456, DOI 10.1016/j.tripleo.2010.10.043
   Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606
   Redding S, 2009, ORAL SURG ORAL MED O, V107, P669, DOI 10.1016/j.tripleo.2009.01.021
   RUSHTON A, 1977, J CLIN PERIODONTOL, V4, P73, DOI 10.1111/j.1600-051X.1977.tb00053.x
   Ryalat S, 2011, THER CLIN RISK MANAG, V7, P219, DOI 10.2147/TCRM.S18297
   Salim N, 2013, INT J ANTIMICROB AG, V41, P193, DOI 10.1016/j.ijantimicag.2012.09.006
   Salim N, 2012, DENT MAT J IN PRESS
   Salim N, 2012, J DENT, V40, P693, DOI 10.1016/j.jdent.2012.04.027
   Salim N, 2012, J DENT, V40, P506, DOI 10.1016/j.jdent.2012.02.016
   Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x
   Schneid T R, 1992, Spec Care Dentist, V12, P245, DOI 10.1111/j.1754-4505.1992.tb00458.x
   Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354
   WILSON SJ, 1993, J ORAL REHABIL, V20, P225, DOI 10.1111/j.1365-2842.1993.tb01604.x
NR 30
TC 2
Z9 3
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAR
PY 2013
VL 68
IS 3
BP 587
EP 592
DI 10.1093/jac/dks452
PG 6
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 089EU
UT WOS:000314893700019
PM 23171950
OA Bronze
DA 2018-10-20
ER

PT J
AU Gomes, FS
   Procopio, TF
   Napoleao, TH
   Coelho, LCBB
   Paiva, PMG
AF Gomes, F. S.
   Procopio, T. F.
   Napoleao, T. H.
   Coelho, L. C. B. B.
   Paiva, P. M. G.
TI Antimicrobial lectin from Schinus terebinthifolius leaf
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antibacterial activity; antifungal activity; leaves; lectin; Schinus
   terebinthifolius
ID ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; HEVEA-BRASILIENSIS;
   CELL-WALL; PURIFICATION; PROTEINS; MICROORGANISMS; POLYPHENOLS;
   CHARCOAL; REMOVAL
AB Aims Schinus terebinthifolius leaves are used for treating human diseases caused by micro-organisms. This work reports the isolation, characterization and antimicrobial activity of S.terebinthifolius leaf lectin (SteLL). Methods and Results The isolation procedure involved protein extraction with 0 center dot 15moll1 NaCl, filtration through activated charcoal and chromatography of the filtrate on a chitin column. SteLL is a 14-kDa glycopeptide with haemagglutinating activity that is inhibited by N-acetyl-glucosamine, not affected by ions (Ca2+ and Mg2+) and stable upon heating (30100 degrees C) as well as over the pH 5 center dot 08 center dot 0. The antimicrobial effect of SteLL was evaluated by determining the minimal inhibitory (MIC), bactericide (MBC) and fungicide (MFC) concentrations. Lectin was active against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enteritidis and Staphylococcus aureus. Highest bacteriostatic and bactericide effects were detected for Salm.enteritidis (MIC: 0 center dot 45gml1) and Staph.aureus (MBC: 7 center dot 18gml1), respectively. SteLL impaired the growth (MIC: 6 center dot 5gml1) and survival (MFC: 26gml1) of Candida albicans. Conclusions SteLL, a chitin-binding lectin, purified in milligram quantities, showed antimicrobial activity against medically important bacteria and fungi. Significance and Impact of the Study SteLL can be considered as a new biomaterial for potential antimicrobial applications.
C1 [Gomes, F. S.; Procopio, T. F.; Napoleao, T. H.; Coelho, L. C. B. B.; Paiva, P. M. G.] Univ Fed Pernambuco, Dept Bioquim, CCB, BR-50670420 Recife, PE, Brazil.
RP Paiva, PMG (reprint author), Univ Fed Pernambuco, Dept Bioquim, CCB, Ave Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM ppaivaufpe@yahoo.com.br
RI Gomes, Francis/H-5615-2015
OI Paiva, Patricia/0000-0003-3467-708X; Napoleao,
   Thiago/0000-0002-0065-2602
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)
FX The authors express their gratitude to the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for research grants and
   fellowships (LCBBC and PMGP). We are also grateful to the Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for
   financial support. F. S. Gomes would like to thank CAPES for graduate
   scholarship. We thank Maria Barbosa Reis da Silva for technical
   assistance and Dra. Rita de Cassia Pereira, from Instituto Agronomico de
   Pernambuco (IPA), for the identification of the botanical material.
CR Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0
   Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6
   Amsterdam D, 1996, ANTIBIOT LAB MED, V4, P52
   BING DH, 1967, P SOC EXP BIOL MED, V124, P1166
   Boleti APD, 2007, J AGR FOOD CHEM, V55, P2653, DOI 10.1021/jf0636317
   BOURNE Y, 1994, J BIOL CHEM, V269, P9429
   Charungchitrak S, 2011, FOOD CHEM, V126, P1025, DOI 10.1016/j.foodchem.2010.11.114
   Cordeiro RA, 2006, BRAZ ARCH BIOL TECHN, V49, P915, DOI 10.1590/S1516-89132006000700008
   Costa RMPB, 2010, PROCESS BIOCHEM, V45, P526, DOI 10.1016/j.procbio.2009.11.013
   Dziarski R, 2000, BBA-GEN SUBJECTS, V1524, P17, DOI 10.1016/S0304-4165(00)00137-9
   El-Massry KF, 2009, J AGR FOOD CHEM, V57, P5265, DOI 10.1021/jf900638c
   Gostinar G., 2011, FUNGAL BIOL, V115, P1008
   Guerra MJM, 2000, REV CUB PLANT MED, V5, P23
   HAGERMAN AE, 1992, ACS SYM SER, V506, P236
   Hill C, 1995, INT J FOOD MICROBIOL, V28, P245, DOI 10.1016/0168-1605(95)00060-7
   Kanokwiroon K, 2008, MYCOSES, V51, P301, DOI 10.1111/j.1439-0507.2008.01490.x
   Kaushik S, 2011, PROTEIN SCI, V20, P465, DOI 10.1002/pro.578
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012
   LIMA MRF, 2006, J ETHNOPHARMACOL, V105, P137, DOI DOI 10.1016/J.JEP.2005.10.026
   Lindenmaier DS, 2008, ETNOBOTANICA COMUNID
   Lis H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 6. Proteins and nucleic acids., P371
   LLOYD HA, 1977, PHYTOCHEMISTRY, V16, P1301, DOI 10.1016/S0031-9422(00)94384-X
   Loman V, 1980, LAB TECHNIQUES, P54
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martinez MJ, 1996, J ETHNOPHARMACOL, V52, P171, DOI 10.1016/0378-8741(96)01405-5
   Mohan SV, 1997, ENVIRON POLLUT, V97, P183, DOI 10.1016/S0269-7491(97)00025-0
   Morais SAL, 1999, J BRAZIL CHEM SOC, V10, P447, DOI 10.1590/S0103-50531999000600005
   Mukherjee S, 2007, CHEM ENG J, V129, P133, DOI 10.1016/j.cej.2006.10.030
   Napoleao TH, 2011, INT BIODETER BIODEGR, V65, P52, DOI 10.1016/j.ibiod.2010.05.015
   Nunes ED, 2011, COMP BIOCHEM PHYS B, V159, P57, DOI 10.1016/j.cbpb.2011.02.001
   Oliveira MDL, 2008, LETT APPL MICROBIOL, V46, P371, DOI 10.1111/j.1472-765X.2007.02319.x
   PAIVA PMG, 1992, APPL BIOCHEM BIOTECH, V36, P113, DOI 10.1007/BF02929691
   Pajic I, 2002, COMP BIOCHEM PHYS C, V132, P213, DOI 10.1016/S1532-0456(02)00068-6
   Petnual P, 2010, FOOD SCI BIOTECHNOL, V19, P907, DOI 10.1007/s10068-010-0128-5
   Ribas MdO, 2006, REV ODONTO CIENC, V21, P245
   Sa RA, 2009, WOOD SCI TECHNOL, V43, P85, DOI 10.1007/s00226-008-0220-7
   Santana GMS, 2009, ACTA HORTIC, V811, P281
   Santi-Gadelha T, 2006, BIOCHEM BIOPH RES CO, V350, P1050, DOI 10.1016/j.bbrc.2006.09.149
   Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001
   Silva AB, 2010, BRAZ J MICROBIOL, V41, P158, DOI [10.1590/S1517-83822010000100023, 10.1590/S1517-838220100001000023]
   SUZUKI T, 1989, COMP BIOCHEM PHYS B, V92, P455, DOI 10.1016/0305-0491(89)90116-8
   Trindade MB, 2006, BBA-PROTEINS PROTEOM, V1764, P146, DOI 10.1016/j.bbapap.2005.09.011
   VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797
   Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11
   Yao Q, 2010, PROCESS BIOCHEM, V45, P1477, DOI 10.1016/j.procbio.2010.05.026
NR 46
TC 21
Z9 23
U1 2
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD MAR
PY 2013
VL 114
IS 3
BP 672
EP 679
DI 10.1111/jam.12086
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 093JG
UT WOS:000315187400008
PM 23190078
OA Bronze
DA 2018-10-20
ER

PT J
AU Konofaos, P
   Halen, JPV
AF Konofaos, P.
   Halen, J. P. Ver
TI Nerve Repair by Means of Tubulization: Past, Present, Future
SO JOURNAL OF RECONSTRUCTIVE MICROSURGERY
LA English
DT Review
DE nerve gap; nerve repair; nerve guides; neurotrophic factors
ID DENATURED MUSCLE-TISSUE; PROSPECTIVE CLINICAL-EVALUATION; CILIARY
   NEUROTROPHIC FACTOR; ENHANCE NEURONAL SURVIVAL;
   FIBROBLAST-GROWTH-FACTOR; CULTURED SCHWANN-CELLS; AUTOGENOUS VEIN GRAFT;
   LONG-TERM EVALUATION; ACID-COLLAGEN TUBE; RAT SPINAL-CORD
AB Peripheral nerve injury may result in injury without gaps or injury with gaps between nerve stumps. In the presence of a nerve defect, the placement of an autologous nerve graft is the current gold standard for nerve restoration. The clinical employment of tubes as an alternative to autogenous nerve grafts is mainly justified by the limited availability of donor tissue for nerve autografts and their related morbidity. The purpose of this review is to present an overview of the literature on the applications of nerve conduits in peripheral nerve repair. Moreover, the different steps that are involved in the design of an ideal nerve conduit for peripheral nerve repair, including the choice of biomaterial, fabrication technique, and the various potential modifications to the common hollow nerve tube, are also discussed.
C1 [Konofaos, P.; Halen, J. P. Ver] Univ Tennessee, Dept Plast Surg, Germantown, TN 38103 USA.
RP Halen, JPV (reprint author), Univ Tennessee, Dept Plast Surg, 7945 Wolf River Blvd,Suite 290, Germantown, TN 38103 USA.
EM jpverhalen@gmail.com
CR AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   Aegineta Paulus, 1528, RE MED PAULOU AIGINE, P1528
   AGUAYO AJ, 1985, NEURAL GRAFTING MAMM, P61
   Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812
   Albert E., 1885, EINIGE OPERATIONEN N, V26, P1285
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Atchabahian A, 1998, RESTOR NEUROL NEUROS, V13, P129
   BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356
   BALL RA, 1992, J UROLOGY, V148, P211, DOI 10.1016/S0022-5347(17)36555-2
   Battiston B, 2000, MICROSURG, V20, P37, DOI 10.1002/(SICI)1098-2752(2000)20:1<37::AID-MICR7>3.0.CO;2-5
   Battiston B, 2000, MICROSURG, V20, P32, DOI 10.1002/(SICI)1098-2752(2000)20:1<32::AID-MICR6>3.0.CO;2-D
   Bennett DLH, 1998, J NEUROSCI, V18, P3059
   Berry M, 2001, CURR OPIN MOL THER, V3, P338
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   BORA FW, 1987, J HAND SURG-AM, V12A, P685
   Braga-Silva J, 1999, J HAND SURG-BRIT EUR, V24B, P703, DOI 10.1054/jhsb.1999.0276
   Brandt J, 2002, SCAND J PLAST RECONS, V36, P2, DOI 10.1080/028443102753478309
   Brandt J, 1999, EXP NEUROL, V160, P386, DOI 10.1006/exnr.1999.7210
   Brandt J, 1999, J HAND SURG-BRIT EUR, V24B, P284, DOI 10.1054/jhsb.1999.0074
   Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S
   Braun S, 1996, J NEUROL SCI, V144, P233
   BRAY GM, 1987, J EXP BIOL, V132, P5
   Brenner MJ, 2002, J BONE JOINT SURG AM, V84A, P1861, DOI 10.2106/00004623-200210000-00020
   Brown RE, 1996, J RECONSTR MICROSURG, V12, P149, DOI 10.1055/s-2007-1006468
   BRUNELLI GA, 1993, MICROSURG, V14, P247, DOI 10.1002/micr.1920140407
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Bunger O, 1891, BEITR PATHOL ANAL, V10, P312
   BUSSCHER HJ, 1983, J COLLOID INTERF SCI, V95, P23, DOI 10.1016/0021-9797(83)90067-X
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Chavez-Delgado ME, 2003, J BIOMED MATER RES B, V67B, P702, DOI 10.1002/jbm.b.10059
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   CHIU DTW, 1990, PLAST RECONSTR SURG, V86, P928, DOI 10.1097/00006534-199011000-00015
   Chiu DTW, 1999, HAND CLIN, V15, P667
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Den Dunnen WFA, 1998, J MATER SCI-MATER M, V9, P811, DOI 10.1023/A:1008987910224
   den Dunnen WFA, 2001, BIOMATERIALS, V22, P1171, DOI 10.1016/S0142-9612(00)00339-2
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   DUCKER TB, 1968, J NEUROSURG, V28, P582, DOI 10.3171/jns.1968.28.6.0582
   EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x
   Elkwood AI, 2011, J SPINAL CORD MED, V34, P241, DOI 10.1179/107902611X12972448729521
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Fansa H, 2002, MUSCLE NERVE, V26, P87, DOI 10.1002/mus.10165
   FENELEY MR, 1991, EXP NEUROL, V114, P275, DOI 10.1016/0014-4886(91)90153-4
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   FORAMETTI C, 1904, ARCH KLIN CHIR, V73, P643
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   GARRITY R W, 1956, Surg Forum, V6, P517
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GLASBY MA, 1986, J HAND SURG-BRIT EUR, V11B, P347, DOI 10.1016/0266-7681(86)90155-5
   GLUCK T, 1880, ARCH KLIN CHIR, V25, P606
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hart AM, 2003, BRIT J PLAST SURG, V56, P444, DOI 10.1016/S0007-1226(03)00134-6
   HE CL, 1992, MICROSURG, V13, P151, DOI 10.1002/micr.1920130310
   Helgren ME, 1997, J NEUROSCI, V17, P372
   Hermens WTJMC, 1998, PROG NEUROBIOL, V55, P399, DOI 10.1016/S0301-0082(98)00007-0
   Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x
   Hsu SH, 2007, BIOMED MICRODEVICES, V9, P665, DOI 10.1007/s10544-007-9068-0
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Inada Y, 2004, NEUROSURGERY, V55, P646
   Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x
   Kakinoki R, 1997, INT ORTHOP, V21, P332, DOI 10.1007/s002640050179
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   Kitahara AK, 1999, SCAND J PLAST RECONS, V33, P187
   Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   Lad Shivanand P, 2009, Neurosurg Focus, V26, P1, DOI 10.3171/FOC.2009.26.1.E10
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   Lundborg G, 1997, J HAND SURG-AM, V22A, P99, DOI 10.1016/S0363-5023(05)80188-1
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   LUNDBORG G, 1982, BRAIN RES, V232, P157, DOI 10.1016/0006-8993(82)90618-7
   LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P273, DOI 10.1016/0266-7681(94)90068-X
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   MACKINNON S, 1982, NEUROSURGERY, V10, P61, DOI 10.1227/00006123-198201000-00011
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Madison RD, 1999, J NEUROSCI, V19, P11007
   Mahanthappa NK, 1996, J NEUROSCI, V16, P4673
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056
   MCCAIG CD, 1990, J CELL SCI, V95, P605
   Meek MF, 1996, MICROSURG, V17, P555, DOI 10.1002/(SICI)1098-2752(1996)17:10<555::AID-MICR5>3.0.CO;2-P
   Meek MF, 2004, TISSUE ENG, V10, P1027, DOI 10.1089/ten.2004.10.1027
   Meek MF, 2001, MUSCLE NERVE, V24, P753, DOI 10.1002/mus.1066
   Meek MF, 1999, BIOMATERIALS, V20, P401, DOI 10.1016/S0142-9612(98)00178-1
   Meek MF, 2001, BIOMATERIALS, V22, P1177, DOI 10.1016/S0142-9612(00)00340-9
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MIDHA R, 1994, RESTOR NEUROL NEUROS, V7, P45, DOI 10.3233/RNN-1994-7107
   MIDHA R, 1994, J NEUROPATH EXP NEUR, V53, P316, DOI 10.1097/00005072-199405000-00013
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Midha R, 1997, J NEUROPATH EXP NEUR, V56, P421, DOI 10.1097/00005072-199704000-00011
   MIDHA R, 1993, TRANSPLANT P, V25, P532
   Mikos AG, 2000, ELEC J BIOTECHN, V3, P115
   Mohanna PN, 2005, SCAND J PLAST RECONS, V39, P129, DOI 10.1080/02844310510006295
   Mohanna PN, 2003, J ANAT, V203, P553, DOI 10.1046/j.1469-7580.2003.00243.x
   MOLANDER H, 1983, BIOMATERIALS, V4, P276, DOI 10.1016/0142-9612(83)90027-3
   Munson JB, 1997, EUR J NEUROSCI, V9, P1126, DOI 10.1111/j.1460-9568.1997.tb01465.x
   Myckatyn TM, 2004, NEUROL RES, V26, P124, DOI 10.1179/016164104225013743
   Nageotte J, 1915, CR SOC BIOL, V78, P249
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Narakas A., 1977, RECONSTRUCTIVE MICRO, V1
   Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x
   Nishiura Y, 2004, TISSUE ENG, V10, P157, DOI 10.1089/107632704322791808
   NORRIS RW, 1988, J BONE JOINT SURG BR, V70, P530
   NOTTHAFT V, 1893, Z WISS ZOOL, V1, P134
   Oakley RA, 1997, J NEUROSCI, V17, P4262
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   PEREIRA JH, 1991, LANCET, V338, P1239, DOI 10.1016/0140-6736(91)92105-B
   PEREIRA JH, 1991, J HAND SURG-BRIT EUR, V16B, P519, DOI 10.1016/0266-7681(91)90107-Y
   Pitta MC, 2001, J ORAL MAXIL SURG, V59, P493, DOI 10.1053/joms.2001.22671
   PORAYKO MK, 1994, MAYO CLIN PROC, V69, P105, DOI 10.1016/S0025-6196(12)61034-9
   PURVES D, 1986, TRENDS NEUROSCI, V9, P486, DOI 10.1016/0166-2236(86)90155-4
   Ramasamy I, 2003, LANCET INFECT DIS, V3, P214, DOI 10.1016/S1473-3099(03)00578-4
   Reisner H., 1940, ARCH KLIN CHIR, V199, P318
   RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5
   Richardson P M, 1991, Curr Opin Neurobiol, V1, P401, DOI 10.1016/0959-4388(91)90061-B
   RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   SAIKA T, 1991, MOL BRAIN RES, V9, P157, DOI 10.1016/0169-328X(91)90142-K
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   Schlosshauer B, 2006, NEUROSURGERY, V59, P747, DOI doi: 10.1227/01.neu.0000235197.36789.42
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Sinis N, 2007, RESTOR NEUROL NEUROS, V25, P131
   Smith GM, 1999, J NEUROSCI RES, V55, P147, DOI 10.1002/(SICI)1097-4547(19990115)55:2<147::AID-JNR2>3.3.CO;2-#
   SPECTOR JG, 1995, ANN OTO RHINOL LARYN, V104, P875, DOI 10.1177/000348949510401110
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x
   Sterne GD, 1997, J CELL BIOL, V139, P709, DOI 10.1083/jcb.139.3.709
   Strauch B, 1996, J RECONSTR MICROSURG, V12, P521, DOI 10.1055/s-2007-1006624
   Strauch B, 2001, J RECONSTR MICROSURG, V17, P589, DOI 10.1055/s-2001-18812
   STRAUCH B, 2001, J RECONSTR MICROSURG, V17, P596, DOI DOI 10.1055/S-2001-18812
   Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0
   TANG JB, 1995, J RECONSTR MICROSURG, V11, P21, DOI 10.1055/s-2007-1006506
   TANG JB, 1993, MICROSURG, V14, P404, DOI 10.1002/micr.1920140611
   TANG JB, 1993, J HAND SURG-BRIT EUR, V18B, P449, DOI 10.1016/0266-7681(93)90144-5
   Tatard VM, 2005, BIOMATERIALS, V26, P3727, DOI 10.1016/j.biomaterials.2004.09.042
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   TERZIS J, 1975, PLAST RECONSTR SURG, V56, P166, DOI 10.1097/00006534-197508000-00008
   Terzis JK, 2011, PLAST RECONSTR SURG, V127, P739, DOI 10.1097/PRS.0b013e3181fed7de
   Terzis JK, 2010, ANN PLAS SURG, V64, P622, DOI 10.1097/SAP.0b013e3181b6aae1
   Thanos PK, 1998, J RECONSTR MICROSURG, V14, P423, DOI 10.1055/s-2007-1000203
   Trumble TE, 2000, HAND CLIN, V16, P105
   Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331
   Vanlair C, 1882, ARCH BIOL PARIS, V3, P379
   VANLAIR C, 1885, ARCH BIOL PARIS, V6, P127
   Waller A., 1850, PHILOS T R SOC LOND, V140, P423, DOI [10.1098/rstl.1850.0021, DOI 10.1098/RSTL.1850.0021]
   WALTER MA, 1993, LYMPHOKINE CYTOK RES, V12, P135
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P950
   Wang SG, 2003, J BIOMED MATER RES A, V66A, P522, DOI 10.1002/jbm.a.10008
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1046
   Weiss P, 1944, J EXP ZOOL, V95, P233, DOI 10.1002/jez.1400950205
   WEISS P, 1946, J NEUROSURG, V3, P375, DOI 10.3171/jns.1946.3.5.0375
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Willard M., 1894, MED NEWS
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WREDE L, 1909, DEUT MED WOCHENSCHR, V35, P1125
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yannas IV, 1995, ADV POLYM SCI, V122, P219
   Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219
   Zhang F, 2002, J RECONSTR MICROSURG, V18, P295, DOI 10.1055/s-2002-30186
   Zhang J, 2004, J RECONSTR MICROSURG, V20, P323, DOI 10.1055/s-2004-824891
   Zhang PX, 2008, ARTIF CELL BLOOD SUB, V36, P360, DOI 10.1080/10731190802239040
NR 200
TC 70
Z9 73
U1 3
U2 65
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0743-684X
J9 J RECONSTR MICROSURG
JI J. Reconstr. Microsurg.
PD MAR
PY 2013
VL 29
IS 3
BP 149
EP 163
DI 10.1055/s-0032-1333316
PG 15
WC Surgery
SC Surgery
GA 092GE
UT WOS:000315107000002
PM 23303520
OA Bronze
DA 2018-10-20
ER

PT J
AU Torres, FG
   Troncoso, OP
   Montes, MR
AF Torres, Fernando G.
   Troncoso, Omar P.
   Montes, Maribella R.
TI The effect of temperature on the mechanical properties of a
   protein-based biopolymer network The eggshell membrane
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Eggshell membrane; Collagen; Thermal transition
ID DIFFERENTIAL SCANNING CALORIMETRY; RAT TAIL TENDON; THERMAL
   STABILIZATION; COLLAGEN MOLECULES; MODEL; DENATURATION; DEPENDENCE;
   FIBERS; WATER; BONE
AB Several studies have shown that eggshell membrane (ESM) is a suitable biomaterial with potential applications in biomedicine such as wound repair and cell culture. In order to control and improve the use of ESM for biomedical applications their physical and structural properties must be known. In this paper, we have studied the effect of temperature on the mechanical properties of the ESM. Atomic force microscopy was used to assess the morphology of the ESM. The mechanical properties of the membranes were studied by means of uniaxial tensile tests carried out at four different temperatures. Differential scanning calorimetry and thermo-gravimetrical analysis were used to assess the thermal transitions of the ESM and the influence of the water content on its thermal behavior. The Young's modulus showed a linear inverse dependence with regard to the temperature of the sample. A peak associated to the thermal denaturation of collagen was observed in the DSC tests of the membrane. These peaks showed a dependence on the water content of the specimens.
C1 [Torres, Fernando G.; Troncoso, Omar P.; Montes, Maribella R.] Catholic Univ Peru, Dept Mech Engn, Lima 32, Peru.
RP Torres, FG (reprint author), Catholic Univ Peru, Dept Mech Engn, Av Univ 1801, Lima 32, Peru.
EM fgtorres@pucp.edu.pe
RI Troncoso, Omar/G-6469-2013
OI Troncoso, Omar/0000-0001-9621-2435; Torres, Fernando
   G./0000-0002-3123-266X
FU Catholic University of Peru (VRI-PUCP)
FX The authors would like to thank the Vice-Rectorate for Research of the
   Catholic University of Peru (VRI-PUCP) for financial support.
CR BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BIGI A, 1987, INT J BIOL MACROMOL, V9, P363, DOI 10.1016/0141-8130(87)90010-9
   BONSER RHC, 1995, J EXP BIOL, V198, P1029
   Buehler MJ, 2007, BIOPHYS J, V93, P37, DOI 10.1529/biophysj.106.102616
   Chae Y, 2003, LASER SURG MED, V32, P271, DOI 10.1002/lsm.10167
   Choi MMF, 2001, ANALYST, V126, P1558, DOI 10.1039/b103205b
   Durmus E, 2003, J INT MED RES, V31, P223, DOI 10.1177/147323000303100309
   Feughelman M, 2002, J APPL POLYM SCI, V83, P489, DOI 10.1002/app.2255
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Freed AD, 2005, J BIOMECH ENG-T ASME, V127, P587, DOI 10.1115/1.1934145
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   KOPP J, 1990, MATRIX, V9, P443, DOI 10.1016/S0934-8832(11)80013-2
   LAGAKOS N, 1986, J APPL PHYS, V59, P4017, DOI 10.1063/1.336707
   Maeda K, 1981, BURNS, V8, P313
   Miculescu F, 2012, DIG J NANOMATER BIOS, V7, P1667
   Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   Misof K, 1997, BIOPHYS J, V72, P1376, DOI 10.1016/S0006-3495(97)78783-6
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   TAVASSOLI M, 1983, EXPERIENTIA, V39, P411, DOI 10.1007/BF01963153
   Torres FG, 2012, MAT SCI ENG C-MATER, V32, P2212, DOI 10.1016/j.msec.2012.06.003
   Torres FG, 2010, ACTA BIOMATER, V6, P3687, DOI 10.1016/j.actbio.2010.03.014
   Trebacz H, 2005, INT J BIOL MACROMOL, V37, P257, DOI 10.1016/j.ijbiomac.2005.04.007
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   WATTS DC, 1987, J DENT RES, V66, P29, DOI 10.1177/00220345870660010601
   Wiegand N, 2010, J THERM ANAL CALORIM, V101, P487, DOI 10.1007/s10973-010-0820-y
   Willett TL, 2007, ANN BIOMED ENG, V35, P1961, DOI 10.1007/s10439-007-9375-x
   Yang D, 2003, J MATER CHEM, V13, P1119, DOI 10.1039/b301077e
   Yang Jui-Yung, 2003, Chang Gung Med J, V26, P153
   Zhao Y.-H, 2009, BIOTECHNOLOGY, V8, P254
NR 35
TC 9
Z9 10
U1 3
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD MAR
PY 2013
VL 111
IS 3
BP 1921
EP 1925
DI 10.1007/s10973-012-2915-0
PG 5
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 094XO
UT WOS:000315298800034
DA 2018-10-20
ER

PT J
AU Gu, JH
   Zhang, W
   Yang, XL
AF Gu, Junheng
   Zhang, Wei
   Yang, Xinlin
TI Preparation of a superparamagnetic MRI contrast agent with a tumor
   targeting function
SO MATERIALS LETTERS
LA English
DT Article
DE Fe3O4 magnetic nanoparticles; Tumor targeting biomaterials; Functional
   MRI contrast agents; Composite nanoparticles
ID MAGNETIC NANOPARTICLES; NANOSTRUCTURES; HYPERTHERMIA; FABRICATION;
   DELIVERY
AB The folic acid (FA) conjugated superparamagnetic Fe3O4-SiO2 composite particles were prepared and their properties including saturate magnetization and relaxivity value were investigated. The Fe3O4-SiO2-FA conjugate biomaterials were prepared by the amide reaction between the carboxyl of FA molecule and the surface amino of 3-aminopropyltriethoxysilane (APS)-modified Fe3O4-SiO2 composite, which was synthesized via direct silica coating using Tween-80 modified Fe3O4 nano-aggregates. The morphology and structure of Fe3O4-SiO2-FA conjugate were characterized. The saturation magnetic intensity was measured by a magnetometer and contrast effect in solution of the Fe3O4-SiO2-FA composites as magnetic contrast biomaterial was determined by a clinical MRI instrument. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Gu, Junheng] Tianjin Chest Hosp, Tianjin 300051, Peoples R China.
   [Zhang, Wei; Yang, Xinlin] Nankai Univ, Inst Polymer Chem, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China.
RP Yang, XL (reprint author), Nankai Univ, Inst Polymer Chem, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China.
EM xlyang88@nankai.edu.cn
FU NSFC [21174065]; Tianjin Science Technology Research Funds of China
   [11JCYBJC02100]
FX This work was supported by the NSFC (Project no: 21174065), and Tianjin
   Science Technology Research Funds of China (11JCYBJC02100).
CR Baio G, 2010, MOL IMAGING BIOL, V12, P305, DOI 10.1007/s11307-009-0264-6
   Chen Y, 2010, ACS NANO, V4, P529, DOI 10.1021/nn901398j
   Chen YX, 2012, MATER LETT, V67, P49, DOI 10.1016/j.matlet.2011.09.042
   Fu R, 2011, J MATER CHEM, V21, P15352, DOI 10.1039/c1jm11883h
   Hayashi K, 2010, ACS APPL MATER INTER, V2, P1903, DOI 10.1021/am100237p
   Hayashi K, 2009, CHEM MATER, V21, P1318, DOI 10.1021/cm803113e
   Kamat M, 2010, BIOCONJUGATE CHEM, V21, P2128, DOI 10.1021/bc100354m
   Lee JE, 2010, J AM CHEM SOC, V132, P552, DOI 10.1021/ja905793q
   Lu CW, 2007, NANO LETT, V7, P149, DOI 10.1021/nl0624263
   Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u
   Peng XC, 2012, MATER LETT, V81, P102, DOI 10.1016/j.matlet.2012.04.127
   Shi DL, 2009, ADV MATER, V21, P2170, DOI 10.1002/adma.200803159
   Wunderbaldinger P, 2002, BIOCONJUGATE CHEM, V13, P264, DOI 10.1021/bc015563u
   Zhang SJ, 2012, MATER LETT, V68, P243, DOI 10.1016/j.matlet.2011.10.070
   Zhao WR, 2005, J AM CHEM SOC, V127, P8916, DOI 10.1021/ja051113r
NR 15
TC 7
Z9 9
U1 2
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAR 1
PY 2013
VL 94
BP 8
EP 10
DI 10.1016/j.matlet.2012.12.030
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 094HU
UT WOS:000315254400003
DA 2018-10-20
ER

PT J
AU Irwin, NJ
   McCoy, CP
   Jones, DS
   Gorman, SP
AF Irwin, Nicola J.
   McCoy, Colin P.
   Jones, David S.
   Gorman, Sean P.
TI Infection-Responsive Drug Delivery from Urinary Biomaterials Controlled
   by a Novel Kinetic and Thermodynamic Approach
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE anti-infective; nalidixic acid; pH-responsive; solubility; urinary
   catheter
ID TRACT-INFECTION; RELEASE; CATHETERS; HYDROGELS; POLYMERS; TEMPERATURE;
   STORAGE; ACID
AB The pH-dependent physicochemical properties of the antimicrobial quinolone, nalidixic acid, were exploited to achieve 'intelligent' drug release from a potential urinary catheter coating, poly(2-hydroxyethylmethacrylate) (p(HEMA)), in direct response to the elevated pH which occurs at the onset of catheter infection.
   p(HEMA) hydrogels, and reduced-hydrophilicity copolymers incorporating methyl methacrylate, were loaded with nalidixic acid by a novel, surface particulate localization method, and characterized in terms of pH-dependent drug release and microbiological activity against the common urease-producing urinary pathogen Proteus mirabilis.
   The pH-dependent release kinetics of surface-localized nalidixic acid were 50- and 10-fold faster at pH 9, representing the alkaline conditions induced by urease-producing urinary pathogens, compared to release at pH 5 and pH 7 respectively. Furthermore, microbiological activity against P. mirabilis was significantly enhanced after loading surface particulate nalidixic acid in comparison to p(HEMA) hydrogels conventionally loaded with dispersed drug. The more hydrophobic methyl methacrylate-containing copolymers also demonstrated this pH-responsive behavior, but additionally exhibited a sustained period of zero-order release.
   The paradigm presented here provides a system with latent, immediate infection-responsive drug release followed by prolonged zero-order antimicrobial delivery, and represents an 'intelligent', infection-responsive, self-sterilizing biomaterial.
C1 [Irwin, Nicola J.; McCoy, Colin P.; Jones, David S.; Gorman, Sean P.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
RP McCoy, CP (reprint author), Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM c.mccoy@qub.ac.uk
OI McCoy, Colin/0000-0002-6468-2018
FU Department for Employment and Learning, Northern Ireland
FX This study was supported by the Department for Employment and Learning,
   Northern Ireland.
CR Andersen TE, 2010, J MICROBIOL METH, V81, P135, DOI 10.1016/j.mimet.2010.02.009
   Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212
   Babic S, 2007, TRAC-TREND ANAL CHEM, V26, P1043, DOI 10.1016/j.trac.2007.09.004
   Basak P, 2009, J MATER SCI-MATER M, V20, P213, DOI 10.1007/s10856-008-3521-3
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Donahoe G, 2011, ESTIMATES MED DEVICE
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Fuertes I, 2010, INT J PHARMACEUT, V383, P138, DOI 10.1016/j.ijpharm.2009.09.019
   GARIBALDI RA, 1974, NEW ENGL J MED, V291, P215, DOI 10.1056/NEJM197408012910501
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Huynh TTN, 2010, EUR J PHARM BIOPHARM, V74, P255, DOI 10.1016/j.ejpb.2009.11.002
   Jahren SL, 2010, MACROMOL CHEM PHYS, V211, P644, DOI 10.1002/macp.200900560
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   Jones DS, 2008, J BIOMED MATER RES B, V85B, P417, DOI 10.1002/jbm.b.30960
   KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Lauridsen M, 2007, ANAL CHEM, V79, P1181, DOI 10.1021/ac061354x
   Lendlein A, 2011, MACROMOL BIOSCI, V11, P1621, DOI 10.1002/mabi.201100375
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin HR, 2010, J APPL POLYM SCI, V118, P1878, DOI 10.1002/app.32574
   McCoy CP, 2010, EXPERT OPIN DRUG DEL, V7, P605, DOI 10.1517/17425241003677731
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   MOORE WE, 1965, J PHARM SCI-US, V54, P36, DOI 10.1002/jps.2600540109
   Nicolle LE, 2010, INFECT CONT HOSP EP, V31, P327, DOI 10.1086/651092
   Nowatzki PJ, 2012, ACTA BIOMATER, V8, P1869, DOI 10.1016/j.actbio.2012.01.032
   OSBERG I, 1990, CLIN CHEM, V36, P1428
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   ROSS DL, 1990, INT J PHARM, V63, P237, DOI 10.1016/0378-5173(90)90130-V
   Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013
   Scott R. D., 2009, DIRECT MED COSTS HEA
   Stickler DJ, 2010, SPINAL CORD, V48, P784, DOI 10.1038/sc.2010.32
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0
   Tiwari MM, 2012, AM J INFECT CONTROL, V40, P51, DOI 10.1016/j.ajic.2011.03.032
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zobell CE, 1943, J BACTERIOL, V46, P39
NR 38
TC 9
Z9 9
U1 0
U2 47
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES-DORDR
JI Pharm. Res.
PD MAR
PY 2013
VL 30
IS 3
BP 857
EP 865
DI 10.1007/s11095-012-0927-x
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 094WF
UT WOS:000315294800021
PM 23229857
DA 2018-10-20
ER

PT J
AU Sanders, DL
   Kingsnorth, AN
   Lambie, J
   Bond, P
   Moate, R
   Steer, JA
AF Sanders, David L.
   Kingsnorth, Andrew N.
   Lambie, Jaynnie
   Bond, Peter
   Moate, Roy
   Steer, Jane A.
TI An experimental study exploring the relationship between the size of
   bacterial inoculum and bacterial adherence to prosthetic mesh
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Inoculum; Bacterial colonization; Hernia; Mesh
ID INCISIONAL HERNIA REPAIR; EXPANDED POLYTETRAFLUOROETHYLENE PATCH;
   PERIOPERATIVE ANTIBIOTIC-PROPHYLAXIS; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   ABDOMINAL-WALL RECONSTRUCTION; FREE INGUINAL HERNIOPLASTY; POLYPROPYLENE
   MESH; WOUND-INFECTION; BIOLOGIC MESH; SURFACES
AB Infection is a major concern with medical implants. Surgical meshes used for the repair of abdominal wall hernias are associated with wound infection rates ranging from 7 to 18 %. Although mesh infection is relatively rare, once a patient shows clinical signs of mesh infection, the surgeon may be required to remove the mesh, resulting in additional surgery, morbidity, and cost. The usual causative organisms associated with cases of mesh infection are Staphylococcus species. The first stage of implant infection is bacterial adherence to the biomaterial. An accurate assessment of adherent bacteria to medical prosthetics is therefore important in order to determine the infection risk associated with surgical implants.
   This experimental study evaluated the relationship between the size of the bacterial inoculum and bacterial adherence to three commonly used hernia prosthetics (polypropylene, polyester, and ePTFE). Tenfold dilutions of S. epidermidis (Evans-ATCC 12228) and S. aureus (Rosenbach-ATCC 25923), created with phosphate-buffered saline, were used to inoculate each of the meshes in 3 ml of tryptone soya broth for 18 h at 37 A degrees C, 95 % air/5 % CO2. The number of viable bacteria in each dilution was calculated using a spot plate technique. The number of adherent bacteria to the meshes was counted using direct imaging analysis with scanning electron microscopy and expressed as a mean.
   One hundred eight mesh samples were analysed. The size of the bacterial inoculum of S. epidermidis significantly influenced the number of adherent bacteria to the mesh, and lower rates of adhesion were observed with smaller inoculums for all three meshes (polypropylene, p = 0.02; ePTFE p = 0.03; polyester p = 0.02). A similar, albeit less profound, pattern of results was observed with S. aureus. Bacterial adherence was observed with inoculum sizes as small as < 10 bacteria.
   The results demonstrate that even a very low number of bacterial inoculums can result in adherence to hernia biomaterials and that the level of adherence is directly related to the size of the inoculum. These in vitro results provide evidence that the size of the inoculum is important in the colonization of hernia biomaterials and demonstrate the importance of minimising the bacterial inoculum in the clinical setting.
C1 [Sanders, David L.; Kingsnorth, Andrew N.] Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England.
   [Sanders, David L.] Royal Cornwall Hosp, Dept Upper GI Surg, Truro TR1 3LJ, Cornwall, England.
   [Kingsnorth, Andrew N.] Derriford Hosp, Dept Upper GI Surg, Plymouth PL6 8DH, Devon, England.
   [Lambie, Jaynnie; Bond, Peter; Moate, Roy] Univ Plymouth, Plymouth Elect Microscopy Ctr, Plymouth PL4 8AA, Devon, England.
   [Steer, Jane A.] Derriford Hosp, Dept Microbiol, Plymouth PL6 8DH, Devon, England.
RP Sanders, DL (reprint author), Royal Cornwall Hosp, Dept Upper GI Surg, Truro TR1 3LJ, Cornwall, England.
EM dsanders@doctors.org.uk
CR Abramov D, 1996, EUR J SURG, V162, P945
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P16
   Anderson DJ, 2011, INFECT DIS CLIN N AM, V25, P135, DOI 10.1016/j.idc.2010.11.004
   ARBEIT RD, 1987, J INFECT DIS, V156, P947, DOI 10.1093/infdis/156.6.947
   Be'er A, 2009, P NATL ACAD SCI USA, V106, P428, DOI 10.1073/pnas.0811816106
   Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451
   Bellon JM, 2001, BIOMATERIALS, V22, P2021, DOI 10.1016/S0142-9612(00)00390-2
   Bellon JM, 2000, WORLD J SURG, V24, P528, DOI 10.1007/s002689910085
   Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4
   Carbonell AM, 2005, SURG ENDOSC, V19, P1670, DOI 10.1007/s00464-005-0103-z
   Carlson MA, 2008, HERNIA, V12, P9, DOI 10.1007/s10029-007-0286-4
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Chavarriaga LF, 2010, AM SURGEON, V76, P96
   Collins CH, 2004, COLLINS LYNES MICROB, P6
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x
   FROMAN G, 1987, J BIOL CHEM, V262, P6564
   GAUDY AF, 1963, APPL MICROBIOL, V11, P305
   Geesey GG, 2001, CURR OPIN MICROBIOL, V4, P296, DOI 10.1016/S1369-5274(00)00206-X
   Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0
   Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609
   HOUANG ET, 1991, J HOSP INFECT, V19, P181, DOI 10.1016/0195-6701(91)90222-T
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   KAISER AB, 1990, PRINCIPLES PRACTICE, P2245
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   KRIZEK TJ, 1975, AM J SURG, V130, P579, DOI 10.1016/0002-9610(75)90516-4
   Kumar S, 1999, BRIT J SURG, V86, P1482
   LAW NW, 1990, ACTA CHIR SCAND, V156, P759
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LeBlanc K A, 2004, Hernia, V8, P323, DOI 10.1007/s10029-004-0250-5
   McGreevy JM, 2003, SURG ENDOSC, V17, P1778, DOI 10.1007/s00464-002-8851-5
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Park A, 1998, SURGERY, V124, P816, DOI 10.1067/msy.1998.92102
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   PLATT R, 1990, NEW ENGL J MED, V322, P153, DOI 10.1056/NEJM199001183220303
   Rios A, 2001, Hernia, V5, P148
   Sanchez VM, 2011, SURG INFECT, V12, P205, DOI 10.1089/sur.2011.033
   Sanders DL, 2012, EXPERT REV MED DEVIC, V9, P159, DOI [10.1586/ERD.11.65, 10.1586/erd.11.65]
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7
   STOPPA RE, 1989, WORLD J SURG, V13, P545, DOI 10.1007/BF01658869
   Taylor SG, 1999, BRIT J SURG, V86, P562
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   WALDVOGEL FA, 1991, REV INFECT DIS, V13, pS782
   Woodward J, 2010, SURG INFECT, V11, P405, DOI 10.1089/sur.2009.016
   Yerdel MA, 2001, ANN SURG, V233, P26, DOI 10.1097/00000658-200101000-00005
NR 52
TC 14
Z9 15
U1 0
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD MAR
PY 2013
VL 27
IS 3
BP 978
EP 985
DI 10.1007/s00464-012-2545-4
PG 8
WC Surgery
SC Surgery
GA 092TN
UT WOS:000315145500038
PM 23052522
DA 2018-10-20
ER

PT J
AU Chen, TM
   Tzeng, YS
   Tsai, JC
   Burnouf, T
AF Chen, Tim-Mo
   Tzeng, Yuan-Sheng
   Tsai, Jui-Che
   Burnouf, Thierry
TI Single-Donor Allogeneic Platelet Fibrin Glue and Osteoconductive
   Scaffold in Orbital Floor Fracture Reconstruction
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE orbital reconstruction; platelet fibrin glue; cryoprecipitate; biphasic
   calcium phosphate
ID RICH PLASMA; HUMAN THROMBIN; BONE-GRAFTS; SEALANT; TRAUMA; GEL;
   REGENERATION; PHOSPHATE; PROTEINS; DEFECTS
AB Background: Commonly used materials for orbital floor fracture reconstruction include autologous cranial bone graft and titanium mesh. We have evaluated here a biomaterial combining biphasic calcium phosphate (hydroxyapatite [HA]/beta-tricalcium phosphate [TCP]) osteoconductive scaffold with single-donor allogeneic platelet fibrin glue.
   Methods: The study was conducted on 10 consecutive patients with a follow-up of up to 4 years. Platelet fibrin glue was prepared by mixing equal volumes of single-donor platelet-rich plasma and cryoprecipitate with HA/beta-TCP followed by activation with human thrombin prepared by plasma activation. Postoperative evaluations included serial photographs, repeated physical examination, and 3-dimensional computed tomography scan performed 2 years after surgery.
   Results: The fibrin-rich platelet biomaterial was easy to mold and to apply on the surgical site allowing the surgeon to sculpt accurately the bone defect, providing mechanical stability while avoiding spillage of the scaffold. No infection of the orbit or extrusion of HA/beta-TCP was observed. Ocular motility was normal, and no diplopia or enophthalmos of the injured orbit was noted. Coronal computed tomography scans of the reconstructed orbits revealed good restoration of the orbital floor defect in all 10 patients.
   Conclusions: The use of single-donor platelet fibrin glue combined with an osteoconductive scaffold offers a valuable alternative to autologous cranial bone graft or titanium mesh in the reconstruction of orbital floor bone defect.
C1 [Chen, Tim-Mo; Tzeng, Yuan-Sheng] Tri Serv Gen Hosp, Dept Surg, Natl Def Med Ctr, Div Plast Surg, Taipei, Taiwan.
   [Tsai, Jui-Che] I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
   [Burnouf, Thierry] Human Prot Proc Sci, F-59000 Lille, France.
   [Burnouf, Thierry] Taipei Med Univ, Coll Oral Med, Taipei, Taiwan.
RP Burnouf, T (reprint author), Human Prot Proc Sci, 18 Rue St Jacques, F-59000 Lille, France.
EM tburnou@attglobal.net
FU National Science Council (NSC) R.O.C. [NSC 98-2314-B-016-029];
   Tri-Service-General Hospital, Taipei, Taiwan [TSGH-C98-92]; National
   Defense Medical Center, Taipei, Taiwan [DOD-98-13-02]
FX This study was supported in part by the National Science Council (NSC)
   R.O.C. (NSC 98-2314-B-016-029 grant), the Tri-Service-General Hospital,
   Taipei, Taiwan (TSGH-C98-92 grant) and the National Defense Medical
   Center, Taipei, Taiwan (DOD-98-13-02 grant). The authors have no
   conflicts of interest to declare.
CR Aizawa P, 2008, THROMB RES, V122, P560, DOI 10.1016/j.thromres.2007.12.027
   Anderson CD, 2009, EXPERT OPIN BIOL TH, V9, P133, DOI 10.1517/14712590802588773 
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Asamura S, 2010, ANN PLAS SURG, V64, P496, DOI 10.1097/SAP.0b013e31819b6c52
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   Borzini P, 2005, CURR OPIN HEMATOL, V12, P473, DOI 10.1097/01.moh.0000177831.70657.e8
   Burnouf T, 2011, VOX SANG, V100, P68, DOI 10.1111/j.1423-0410.2010.01384.x
   Burnouf T, 2009, ISBT SCI SER, V4, P136, DOI 10.1111/j.1751-2824.2009.01222.x
   Chapman WC, 2007, J AM COLL SURGEONS, V205, P256
   Chen TM, 2010, DERMATOL SURG, V36, P453, DOI 10.1111/j.1524-4725.2010.01480.x
   Chen TM, 2008, J TRAUMA, V65, P1321, DOI 10.1097/TA.0b013e3181574edf
   Cole P, 2009, J CRANIOFAC SURG, V20, P101, DOI 10.1097/SCS.0b013e318190e1b6
   El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2
   Gilhotra JS, 2002, CLIN EXP OPHTHALMOL, V30, P352, DOI 10.1046/j.1442-9071.2002.t01-1-00555.x
   Jacono A A, 2000, Facial Plast Surg, V16, P63, DOI 10.1055/s-2000-7327
   Klein HG, 2005, J INTERN MED, V257, P224, DOI 10.1111/j.1365-2796.2005.01451.x
   KNORINGER P, 1989, NEUROSURG REV, V12, P31, DOI 10.1007/BF01787124
   Kovacs K, 2005, J CRANIOFAC SURG, V16, P150
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Matras H, 1985, Facial Plast Surg, V2, P297, DOI 10.1055/s-0028-1085289
   OBERG S, 1993, SWED DENT J, V17, P147
   Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Schwartz C, 1999, J MATER SCI-MATER M, V10, P821, DOI 10.1023/A:1008944227417
   Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137
   Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x
   Su CY, 2004, TRANSFUSION, V44, P945, DOI 10.1111/j.1537-2995.2004.00382.x
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Yazer MH, 2010, TRANSFUSION, V50, P1014, DOI 10.1111/j.1537-2995.2009.02535.x
   ZEHNDER JL, 1990, BLOOD, V76, P2011
NR 32
TC 7
Z9 8
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD MAR
PY 2013
VL 70
IS 3
BP 370
EP 374
DI 10.1097/SAP.0b013e31823b6880
PG 5
WC Surgery
SC Surgery
GA 092BI
UT WOS:000315093400025
PM 23038145
DA 2018-10-20
ER

PT J
AU Zeng, W
   Lin, YS
   Qi, ZX
   He, YY
   Wang, DY
   Chen, GG
   Liang, ZQ
AF Zeng, Wei
   Lin, Yuanshan
   Qi, Zongxian
   He, Yangyang
   Wang, Dayun
   Chen, Guiguang
   Liang, Zhiqun
TI An integrated high-throughput strategy for rapid screening of
   poly(gamma-glutamic acid)-producing bacteria
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Poly(gamma-glutamic acid); Neutral red; High-throughput screening;
   Bacteria
ID GAMMA-POLYGLUTAMIC ACID; BACILLUS-SUBTILIS NX-2; GLUTAMIC-ACID;
   POLY-(GAMMA-GLUTAMIC ACID); INDEPENDENT PRODUCTION; EFFICIENT
   PRODUCTION; LICHENIFORMIS; PGA
AB Poly(gamma-glutamic acid) (gamma-PGA) is a promising biomaterial with a wide range of unique applications. To extensively screen gamma-PGA-producing bacteria with high yield and different molecular weight, we developed an integrated high-throughput strategy. Firstly, gamma-PGA-producing bacteria were selected in a primary screen plate containing a basic dye (neutral red) based on the concentric zone formed through the electrostatic interaction between the dye and the secreted acidic polymer gamma-PGA. Then, the isolates were cultured in 50 ml tubes instead of 250 ml flasks. A good correlation of fermentation results in 50 ml tubes and 250 ml flasks was observed. Thirdly, the gamma-PGA yield and weight-average molecular weight (M (w)) were simultaneously determined by spectrophotomic assay (UV assay) and neutral red plate assay. The results showed that the diameter of the concentric zone varied among isolates and was negatively correlated with the weight-average molecular weight of gamma-PGA. The accuracy of the methods was comparable to that of high-performance liquid chromatography and gel permeation chromatography assay. Lastly, gamma-PGA obtained from the target isolates was rapidly identified using thin layer chromatography assay. With this strategy, 13 bacteria with high yield and various molecular weights of gamma-PGA from 500 obvious single colonies on the primary screen plate were obtained.
C1 [Zeng, Wei; He, Yangyang; Wang, Dayun; Liang, Zhiqun] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China.
   [Zeng, Wei; Lin, Yuanshan; Qi, Zongxian; He, Yangyang; Wang, Dayun; Chen, Guiguang; Liang, Zhiqun] Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Guangxi, Peoples R China.
RP Liang, ZQ (reprint author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, 100 Daxue Rd, Nanning 530004, Guangxi, Peoples R China.
EM zqliang@gxu.edu.cn
FU National Natural Science Foundation of China [21062001]
FX This work was financially supported by the National Natural Science
   Foundation of China (21062001).
CR Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Bhattacharyya D, 1998, J MEMBRANE SCI, V141, P121, DOI 10.1016/S0376-7388(97)00301-3
   BIRRER GA, 1994, INT J BIOL MACROMOL, V16, P265, DOI 10.1016/0141-8130(94)90032-9
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   Buchs J, 2001, BIOCHEM ENG J, V7, P91, DOI 10.1016/S1369-703X(00)00106-6
   Cao MF, 2011, BIORESOURCE TECHNOL, V102, P4251, DOI 10.1016/j.biortech.2010.12.065
   Chen GG, 2011, WORLD J MICROB BIOT, V27, P1519, DOI 10.1007/s11274-010-0595-0
   CHENG C, 1989, AGR BIOL CHEM TOKYO, V53, P2369, DOI 10.1080/00021369.1989.10869686
   CHOI HJ, 1995, RADIAT PHYS CHEM, V46, P175, DOI 10.1016/0969-806X(95)00009-M
   Gao H, 2010, APPL MICROBIOL BIOT, V85, P1219, DOI 10.1007/s00253-009-2345-5
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   Hames BD, 2000, INSTANT NOTE BIOCH, P23
   Ito Y, 1996, BIOSCI BIOTECH BIOCH, V60, P1239, DOI 10.1271/bbb.60.1239
   IVANOVICS G., 1937, Zeitschrift fur Immunitatsforschung, V90, P5
   Ivanovics G., 1937, Z IMMUNITATSFORSCH, V90, P304
   Jung DY, 2005, BIOTECHNOL BIOPROC E, V10, P289, DOI 10.1007/BF02931844
   Kambourova M, 2001, APPL ENVIRON MICROB, V67, P1004, DOI 10.1128/AEM.67.2.1004-1007.2001
   Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   Li C, 1998, CANCER RES, V58, P2404
   Li S, 2011, J IND MICROBIOL BIOT, V38, P557, DOI 10.1007/s10295-010-0803-9
   Mitsuiki M, 1998, J AGR FOOD CHEM, V46, P891, DOI 10.1021/jf970797m
   Murao S, 1969, KOBUNSHI, V16, P1204
   Nishikawa M, 2002, APPL ENVIRON MICROB, V68, P3575, DOI 10.1128/AEM.68.7.3575-3581.2002
   Richard A, 2006, BIOCHEM ENG J, V30, P303, DOI 10.1016/j.bej.2006.05.014
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Shi F, 2006, APPL BIOCHEM BIOTECH, V133, P271, DOI 10.1385/ABAB:133:3:271
   Shih IL, 2002, ENZYME MICROB TECH, V31, P213, DOI 10.1016/S0141-0229(02)00103-5
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Soliman NA, 2005, APPL MICROBIOL BIOT, V69, P259, DOI 10.1007/s00253-005-1982-6
   Wang JF, 2008, WORLD J MICROB BIOT, V24, P1885, DOI 10.1007/s11274-008-9686-6
   Wei XT, 2010, APPL BIOCHEM BIOTECH, V160, P1332, DOI 10.1007/s12010-009-8681-1
   Xu H, 2005, PROCESS BIOCHEM, V40, P519, DOI 10.1016/j.procbio.2003.09.025
   Yahata K., 1992, POLYM PREPR-JAPAN, V41, P1077
   Yamaguchi F, 1996, BIOSCI BIOTECH BIOCH, V60, P255, DOI 10.1271/bbb.60.255
   Yao J, 2009, J MOL CATAL B-ENZYM, V56, P158, DOI 10.1016/j.molcatb.2007.12.027
   YOKOI H, 1995, J FERMENT BIOENG, V79, P378, DOI 10.1016/0922-338X(95)94000-H
   Zeng W, 2012, INT J BIOL MACROMOL, V51, P83, DOI 10.1016/j.ijbiomac.2012.04.005
   Zhang HL, 2012, BIORESOURCE TECHNOL, V116, P241, DOI 10.1016/j.biortech.2011.11.085
NR 40
TC 16
Z9 20
U1 2
U2 51
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2013
VL 97
IS 5
BP 2163
EP 2172
DI 10.1007/s00253-013-4717-0
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 088LS
UT WOS:000314836600032
PM 23361839
DA 2018-10-20
ER

PT J
AU Maslekar, S
   Smith, K
   Harji, D
   Griffiths, B
   Sagar, PM
AF Maslekar, S.
   Smith, K.
   Harji, D.
   Griffiths, B.
   Sagar, P. M.
TI Injectable Collagen for the Treatment of Fecal Incontinence: Long-term
   Results
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Meeting of the American-Society-of-Colon-and-Rectal-Surgeons (ASCRS)
CY JUN 02-06, 2012
CL San Antonio, TX
SP Amer Soc Colon & Rectal Surg (ASCRS)
DE Injectable bulking agents; Intra-anal collagen; Fecal incontinence;
   Internal anal sphincter; Collagen
ID SILICONE BIOMATERIAL; INJECTION; IMPLANTS; MANAGEMENT
AB BACKGROUND: Fecal incontinence is a distressing condition that is difficult to treat. Injection of bulking agents has been used to treat passive fecal incontinence. However, no long-term results are available.
   OBJECTIVE: The aim of this study was to assess the long-term clinical effectiveness of intra-anal injection of collagen for passive fecal incontinence.
   DESIGN: This research is a retrospective cohort study from a prospectively collected database
   SETTING: This investigation took place in a high-volume tertiary colorectal department.
   PATIENTS: All patients who underwent intra-anal injection of collagen for passive fecal incontinence with internal sphincter dysfunction between January 2006 and December 2009 were included in the study. Data including demographic details, preoperative anorectal physiology, and outcome measures were collected prospectively and maintained in a database
   MAIN OUTCOME MEASURES: The primary outcomes measured were the Cleveland Clinic Florida incontinence score and the responses to a subjective patient satisfaction questionnaire before the procedure and at subsequent follow-up visits. Data were analyzed by using SPSS v19.0.
   RESULTS: One hundred patients (70 female; mean age, 61 years (range, 36-82)) were followed up for a minimum duration of 36 months. Fifty-six patients (56%) had an improvement in fecal incontinence score from a mean of 14 (range, 9-18) to a mean of 8 (range, 5-14). A total of 68% reported subjective improvement in symptoms. Thirty-eight patients (38%) required a repeat injection of collagen, and a further 15 patients required a third injection. The median interval between the first and final injection was 12 months (range, 4-16 months). Age was the only independent predictor of successful outcome (p = 0.032). There was no morbidity.
   LIMITATIONS: This study was limited by its nonrandomized retrospective design.
   CONCLUSIONS: Injection of collagen into the internal anal sphincter is simple, safe, and effective in patients with passive fecal incontinence, although repeat injections are necessary in approximately half of the patients.
C1 [Maslekar, S.; Smith, K.; Harji, D.; Griffiths, B.; Sagar, P. M.] St James Univ Hosp, John Goligher Colorectal Unit, Leeds LS9 7TF, W Yorkshire, England.
RP Sagar, PM (reprint author), St James Univ Hosp, John Goligher Colorectal Unit, Leeds LS9 7TF, W Yorkshire, England.
EM peter-sagar@aol.com
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   FeltBersma RJF, 1996, DIS COLON RECTUM, V39, P878, DOI 10.1007/BF02053986
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   SHAFIK A, 1993, INT SURG, V78, P159
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
NR 19
TC 17
Z9 18
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAR
PY 2013
VL 56
IS 3
BP 354
EP 359
DI 10.1097/DCR.0b013e3182805276
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 088YP
UT WOS:000314874100018
PM 23392151
DA 2018-10-20
ER

PT J
AU Evans, SF
   Parent, JB
   Lasko, CE
   Zhen, XW
   Knothe, UR
   Lemaire, T
   Tate, MLK
AF Evans, Sarah F.
   Parent, Jonathan B.
   Lasko, Colin E.
   Zhen, Xiaowen
   Knothe, Ulf R.
   Lemaire, Thibault
   Tate, Melissa L. Knothe
TI Periosteum, bone's "smart" bounding membrane, exhibits
   direction-dependent permeability
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE PERIOSTEUM; PERMEABILITY; FLUID TRANSPORT; ANISOTROPY; PRE-STRESS;
   BARRIER MEMBRANE; SMART MATERIAL
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; STREAMING POTENTIALS;
   BARRIER FUNCTION; TIGHT JUNCTIONS; CORTICAL BONE; COMPRESSION; TISSUE;
   CELLS; FLUID
AB The periosteum serves as bone's bounding membrane, exhibits hallmarks of semipermeable epithelial barrier membranes, and contains mechanically sensitive progenitor cells capable of generating bone. The current paucity of data regarding the periosteum's permeability and bidirectional transport properties provided the impetus for the current study. In ovine femur and tibia samples, the periosteum's hydraulic permeability coefficient, k, was calculated using Darcy's Law and a custom-designed permeability tester to apply controlled, volumetric flow of phosphate-buffered saline through periosteum samples. Based on these data, ovine periosteum demonstrates mechanically responsive and directionally dependent (anisotropic) permeability properties. At baseline flow rates comparable to interstitial fluid flow (0.5 mu L/s), permeability is low and does not exhibit anisotropy. In contrast, at high flow rates comparable to those prevailing during traumatic injury, femoral periosteum exhibits an order of magnitude higher permeability compared to baseline flow rates. In addition, at high flow rates permeability exhibits significant directional dependence, with permeability higher in the bone to muscle direction than vice versa. Furthermore, compared to periosteum in which the intrinsic tension (pre-stress) is maintained, free relaxation of the tibial periosteum after resection significantly increases its permeability in both flow directions. Hence, the structure and mechanical stress state of periosteum influences its role as bone's bounding membrane. During periods of homeostasis, periosteum may serve as a barrier membrane on the outer surface of bone, allowing for equal albeit low quiescent molecular communication between tissue compartments including bone and muscle. In contrast, increases in pressure and baseline flow rates within the periosteum resulting from injury, trauma, and/or disease may result in a significant increase in periosteum permeability and consequently in increased molecular communication between tissue compartments. Elucidation of the periosteum's permeability properties is key to understanding periosteal mechanobiology in bone health and healing, as well as to elucidate periosteum structure and function as a smart biomaterial that allows bidirectional and mechanically responsive fluid transport. (c) 2013 American Society for Bone and Mineral Research.
C1 [Evans, Sarah F.; Parent, Jonathan B.; Lasko, Colin E.; Zhen, Xiaowen; Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Knothe, Ulf R.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
   [Lemaire, Thibault] Univ Paris Est Creteil, Lab Modelisat & Simulat Multi Echelle, Paris, France.
   [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA.
RP Tate, MLK (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 512A Wickenden Bldg,2071 Martin Luther King Jr Dr, Cleveland, OH 44106 USA.
EM knothetate@case.edu
RI Knothe, Ulf/N-6545-2014; Knothe Tate, Melissa L./O-2086-2015
OI Knothe, Ulf/0000-0002-1406-6014; Knothe Tate, Melissa
   L./0000-0002-3552-2525
FU AO Research Fund [F-07-99k]; National Science Foundation [EEC-0552804];
   Alexander von Humboldt Foundation; NSF [CMMI-0826435]; AO Foundation
   [F-07-99k]; NSF REU
FX These studies were supported in part by the AO Research Fund (F-07-99k),
   the National Science Foundation (EEC-0552804, REU Program) and the
   Alexander von Humboldt Foundation. We thank the staff of the Case
   Western Reserve Animal Research Center for their assistance in sample
   collection.; MLKT has a patent pending for flow directing materials and
   systems [Knothe Tate ML, Anderson EJ (2009) Flow Directing Materials and
   Systems. U.S. Patent and Trademark Office Appl. No. US 2009/0053109] as
   well as a patent pending for the biologics-enhanced mechanoactive
   reconstruction sheet technology designed to act as a periosteum
   substitute [Knothe Tate ML, Knothe U (2010) Multilayer Surgical
   Membrane, PCT WO 2011/109817 A2]. Further, she has a patent issued in
   the arena of composition and method to induce bone healing and repair
   [Knothe Tate ML, Knothe UR (February 1, 2011) Composition and method for
   inducing bone growth and healing. U.S. Patent No.: US 7,879,107 B2.].
   SFE was supported by a NSF International Participation grant
   (CMMI-0826435) as well as funding received through the AO Foundation
   (F-07-99K). MLKT was supported in part through the Alexander von
   Humboldt Foundation's Fellowship for Senior Researchers. XZ was
   supported through a NSF REU fellowship.
CR Allen MR, 2005, BONE, V36, P311, DOI 10.1016/j.bone.2004.10.013
   Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014
   Amsdorf E.J., 2009, TISSUE ENG PART A, V15, P2637
   Anderson EJ, 2008, MICROFLUID NANOFLUID, V4, P193, DOI 10.1007/s10404-007-0156-5
   Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126
   Babb A L, 1973, Proc Eur Dial Transplant Assoc, V10, P247
   Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004
   Beno T, 2006, J BIOMECH, V39, P2378, DOI 10.1016/j.biomech.2005.08.005
   Brookes M, 1998, BLOOD SUPPLY BONE SC
   Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486
   Center for Functional Anatomy and Evolution Johns Hopkins University School of Medicine, 1997, MOMENTMACRO
   Chang H, 2012, STEM CELL TRANSL MED, V1, P480, DOI 10.5966/sctm.2011-0056
   Christensen D. A., 2009, SYNTHESIS LECT BIOME, V4, P17, DOI DOI 10.2200/S00182ED1V01Y200903BME028
   de Mara CS, 2011, CLINICS, V66, P487, DOI 10.1590/S1807-59322011000300022
   Ensminger M. E., 1986, SHEEP GOAT SCI
   ERIKSSON C, 1974, ANN NY ACAD SCI, V238, P321, DOI 10.1111/j.1749-6632.1974.tb26801.x
   Evans SF, 2013, BIOMATERIALS, V34, P1878, DOI 10.1016/j.biomaterials.2012.09.024
   Evans SF, 2013, TISSUE EN B IN PRESS
   Federico S, 2008, BIOMECH MODEL MECHAN, V7, P367, DOI 10.1007/s10237-007-0091-0
   Foolen J, 2008, J ORTHOP RES, V26, P1263, DOI 10.1002/jor.20586
   Foolen J, 2009, J BIOMECH, V42, P152, DOI 10.1016/j.jbiomech.2008.10.019
   Gailani G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3200908
   Gardinier JD, 2010, BONE, V46, P1075, DOI 10.1016/j.bone.2010.01.371
   GROSS D, 1982, J BIOMECH, V15, P277, DOI 10.1016/0021-9290(82)90174-9
   Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X
   Kameo Y, 2010, J MECH BEHAV BIOMED, V3, P240, DOI 10.1016/j.jmbbm.2009.10.005
   Knothe UR, 2010, J BIOMECH, V43, P2728, DOI 10.1016/j.jbiomech.2010.06.026
   LAI WM, 1981, J BIOMECH ENG-T ASME, V103, P61, DOI 10.1115/1.3138261
   LAI WM, 1980, BIORHEOLOGY, V17, P111
   LANYON LE, 1981, J BONE JOINT SURG AM, V63, P989, DOI 10.2106/00004623-198163060-00017
   Lemaire T, 2012, BIOMECH MODEL MECHAN, V11, P933, DOI 10.1007/s10237-011-0363-6
   Lemonnier S, 2013, T ORS, V38, P770
   LI G, 1987, MICROVASC RES, V34, P302, DOI 10.1016/0026-2862(87)90063-X
   McBride SH, 2011, J BIOMECH, V44, P1954, DOI 10.1016/j.jbiomech.2011.04.036
   McBride SH, 2011, ANN BIOMED ENG, V39, P1570, DOI 10.1007/s10439-010-0242-9
   McCarthy KM, 1996, J CELL SCI, V109, P2287
   Mercurio AD, 2012, J ORTHOP RES, V30, P561, DOI 10.1002/jor.21537
   Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010
   Moore S.R., 2013, T ORS, V38, P0733
   Oklahoma State University, 1997, BREEDS LIV SHEEP DOR
   Phelps JE, 2000, AM J PHYSIOL-HEART C, V278, pH469
   Pollack SR, 1984, FERROELECTRICS, V60, P297, DOI 10.1080/00150198408017530
   Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-92900(03)00127-1
   Queensland Schools Animal Ethics Committee, SPEC SPEC INFORMATIO
   REICHERT ILH, 1995, J BONE JOINT SURG BR, V77B, P490
   Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000155377.95940.81
   Romero-Suarez S, 2011, 2011 ANN M AM SOC BO
   Tami AE, 2003, BIORHEOLOGY, V40, P577
   Tate MLK, 2012, TECHNOL HEALTH CARE, V20, P363, DOI 10.3233/THC-2012-0686
   Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512
   Tate MLK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028702
   Tate MLK, 2011, J MECH BEHAV BIOMED, V4, P829, DOI 10.1016/j.jmbbm.2011.03.009
   Tate MLK, 2010, J ORTHOP RES, V28, P1657, DOI 10.1002/jor.21190
   Tate MLK, 2009, BIOMATERIALS, V30, P133, DOI 10.1016/j.biomaterials.2008.09.028
   Tate MLK, 2011, SMART STRUCT SYST, V7, P223, DOI 10.12989/sss.2011.7.3.223
   Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4
   Tsui YK, 2009, J MATER SCI-MATER M, V20, P1729, DOI 10.1007/s10856-009-3722-4
   Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007
   Weiss JA, 2006, J BIOMECH, V39, P276, DOI 10.1016/j.jbiomech.2004.11.016
   Wen DM, 2010, ANN BIOMED ENG, V38, P558, DOI 10.1007/s10439-009-9858-z
   Wilson W, 2005, MED ENG PHYS, V27, P810, DOI 10.1016/j.medengphy.2005.03.004
   Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004
NR 62
TC 29
Z9 30
U1 2
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD MAR
PY 2013
VL 28
IS 3
BP 608
EP 617
DI 10.1002/jbmr.1777
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 092FZ
UT WOS:000315106300020
PM 23018813
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, N
   Jin, Y
   Xue, LZ
   Li, PY
   Yan, DY
   Zhu, XY
AF Li, Nan
   Jin, Yue
   Xue, Li-zhe
   Li, Pei-yong
   Yan, De-yue
   Zhu, Xin-yuan
TI Re-188-labeled hyperbranched polysulfonamine as a robust tool for
   targeted cancer diagnosis and radioimmunotherapy
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Hyperbranched polymer; Nuclear imaging; Active targeting; Single photon
   emission computed tomography (SPECT)
ID GROWTH-FACTOR RECEPTOR; EXON 4-DELETION VARIANT; DRUG-DELIVERY;
   SDS-PAGE; BIOLOGICAL EVALUATION; MONOCLONAL-ANTIBODY; GOLD NANORODS;
   POLYMERS; THERAPY; PHARMACOKINETICS
AB Hyperbranched polysulfonamine (HPSA) is a promising biomaterial due to its highly branched spherical architecture and efficient intracellular translocation. To realize the functionalization of HPSA, both N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) for tethering the human-mouse chimeric monoclonal antibody CH12 and N-hydroxy succinimidyl S-acetylmercaptoacetyltriglycinate (NHS-MAG(3)) for labeling Re-188 were sequentially grafted onto the primary amine terminals of HPSA via covalent linkages, attaining the SPDP-HPSA-MAG(3) intermediate. In order to reserve the structural integrity of CH12, the fragment crystallizable (Fc) region was also processed by oxidation of oligosaccharide moieties with sodium periodate and then reacted with N-(kappa-maleimidoundecanoic acid) hydrazide (KMUH). After chelating Re-188 with MAG(3) group, the SPDP was reduced to PDP and connected onto the maleinimide group at the Fc region. As a result, both the epidermal growth factor receptor vIII (EGFRvIII) targeted monoclonal antibody CH12 and the radionuclide Re-188 were conjugated to the HPSA-based vehicles, forming the Re-188-labeled and CH12-tethered HPSA (CH12-HPSA-Re-188). The molecular weight and in vitro stability of CH12-HPSA-Re-188 were evaluated by gel electrophoresis and paper chromatography. On one hand, the CH12-HPSA-Re-188 could specifically bind to the EGFRvIII-positive human hepatocarcinoma cells in vitro. On the other hand, it could also target at the tumor tissue of nude mice in vivo. Hence, the CH12-HPSA-Re-188 could effectively target at the human hepatocarcinoma and facilitate the tumor detection and targeted radioimmunotherapy.
C1 [Li, Nan; Xue, Li-zhe; Li, Pei-yong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nucl Med, Shanghai 200025, Peoples R China.
   [Jin, Yue; Yan, De-yue; Zhu, Xin-yuan] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
RP Li, PY (reprint author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nucl Med, Shanghai 200025, Peoples R China.
EM peiyli@vip.sina.com; xyzhu@sjtu.edu.cn
FU National Natural Science Foundation of China [20974062, 30700175];
   National Basic Research Program [2009CB930400, 2012CB821500]; China
   National Funds for Distinguished Young Scientists [21025417]
FX The work was financially supported by the National Natural Science
   Foundation of China (Nos. 20974062, 30700175), National Basic Research
   Program (Nos. 2009CB930400, 2012CB821500), and China National Funds for
   Distinguished Young Scientists (No. 21025417).
CR Boschi A, 2003, BIOCONJUGATE CHEM, V14, P1279, DOI 10.1021/bc034124n
   Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Cha MY, 2012, J MED CHEM, V55, P2846, DOI 10.1021/jm201758g
   Chen L., 2006, ANGEW CHEM, V118, P93
   Chen SY, 2009, CHEM J CHINESE U, V30, P825
   Chen SY, 2011, MACROMOL BIOSCI, V11, P828, DOI 10.1002/mabi.201000473
   Chen Y, 2011, BIOCONJUGATE CHEM, V22, P1162, DOI 10.1021/bc200010w
   Dadachova E, 1997, NUCL MED BIOL, V24, P605, DOI 10.1016/S0969-8051(97)00079-6
   Das S, 2010, J PROTEOME RES, V9, P6696, DOI 10.1021/pr100843x
   Delcea M, 2011, ADV DRUG DELIVER REV, V63, P730, DOI 10.1016/j.addr.2011.03.010
   Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f
   Guin S., 2009, MOL PHARM, V7, P386
   Hamoudeh M, 2008, ADV DRUG DELIVER REV, V60, P1329, DOI 10.1016/j.addr.2008.04.013
   Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a
   Huang XH, 2007, NANO LETT, V7, P1591, DOI 10.1021/nl070472c
   Hussain AF, 2011, BIOCONJUGATE CHEM, V22, P2487, DOI 10.1021/bc200304k
   Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005
   Iznaga-Escobar N, 2001, APPL RADIAT ISOTOPES, V54, P399, DOI 10.1016/S0969-8043(00)00277-3
   Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004
   Jiang H, 2011, J BIOL CHEM, V286, P5913, DOI 10.1074/jbc.M110.192252
   Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s
   Kim JH, 2007, PROG POLYM SCI, V32, P1031, DOI 10.1016/j.progpolymsci.2007.05.016
   Lee J, 2010, BIOCONJUGATE CHEM, V21, P940, DOI 10.1021/bc9004975
   Leschied JR, 2012, CLIN NUCL MED, V37, P382, DOI 10.1097/RLU.0b013e318239249f
   Liu JY, 2011, ANGEW CHEM INT EDIT, V50, P9162, DOI 10.1002/anie.201102280
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010
   Meier RJ, 2008, ANAL CHEM, V80, P6274, DOI 10.1021/ac800581v
   Noh T, 2008, J POLYM SCI POL CHEM, V46, P7321, DOI 10.1002/pola.23036
   Ongarora BG, 2012, J MED CHEM, V55, P3725, DOI 10.1021/jm201544y
   Quiles S, 2009, J MED CHEM, V53, P586, DOI 10.1021/jm900899
   Sano D, 2012, ACS NANO, V6, P2497, DOI 10.1021/nn204885f
   Schottelius M, 2002, BIOCONJUGATE CHEM, V13, P1021, DOI 10.1021/bc0200069
   Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180
   Schweitzer D, 2002, INORG CHEM, V41, P3128, DOI 10.1021/ic0109187
   Sharpe MA, 2012, ACS NANO, V6, P3114, DOI 10.1021/nn2048679
   Shi JB, 2008, PROG CHEM, V20, P558
   Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009
   Szabo Z, 2011, SEMIN NUCL MED, V41, P20, DOI 10.1053/j.semnuclmed.2010.09.003
   Wangler C, 2008, BIOCONJUGATE CHEM, V19, P813, DOI 10.1021/bc700308q
   Walther M, 2007, BIOCONJUGATE CHEM, V18, P216, DOI 10.1021/bc0601222
   Wang H, 2012, FASEB J, V26, P73, DOI 10.1096/fj.11-191064
   Wang H, 2011, NEOPLASIA, V13, P461, DOI 10.1593/neo.101744
   Yan DY, 2000, MACROMOLECULES, V33, P7693, DOI 10.1021/ma000438j
   Yu J, 2010, J AM CHEM SOC, V132, P1929, DOI 10.1021/ja908139y
   Zhang Y, 2012, MOL PHARMACEUT, V9, P645, DOI 10.1021/mp200592m
   Zhou YF, 2010, ADV MATER, V22, P4567, DOI 10.1002/adma.201000369
   Zilberstein G, 2007, ANAL CHEM, V79, P8624, DOI 10.1021/ac701598y
NR 49
TC 10
Z9 10
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD MAR
PY 2013
VL 31
IS 3
BP 530
EP 540
DI 10.1007/s10118-013-1242-7
PG 11
WC Polymer Science
SC Polymer Science
GA 086TY
UT WOS:000314711400018
DA 2018-10-20
ER

PT J
AU Kido, HW
   Oliveira, P
   Parizotto, NA
   Crovace, MC
   Zanotto, ED
   Peitl, O
   Fernandes, KPS
   Mesquita-Ferrari, RA
   Ribeiro, DA
   Renno, ACM
AF Kido, Hueliton W.
   Oliveira, Poliani
   Parizotto, Nivaldo A.
   Crovace, Murilo C.
   Zanotto, Edgar D.
   Peitl-Filho, Oscar
   Fernandes, Kristianne P. S.
   Mesquita-Ferrari, Raquel A.
   Ribeiro, Daniel A.
   Renno, Ana Claudia M.
TI Histopathological, cytotoxicity and genotoxicity evaluation of
   Biosilicate (R) glass-ceramic scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; tissue response; bioactive material; scaffold;
   biomaterial
ID IN-VITRO; BONE REGENERATION; BIOCOMPATIBILITY; GROWTH; ASSAY;
   PROLIFERATION; BIOMATERIAL; CELLS
AB This study evaluated the biocompatibility of Biosilicate (R) scaffolds by means of histopathological, cytotoxicity, and genotoxicity analysis. The histopathologic analysis of the biomaterial was performed using 65 male rats, distributed into the groups: control and Biosilicate (R), evaluated at 7, 15, 30, 45, and 60 days after implantation. The cytotoxicity analysis was performed by the methyl thiazolyl tetrazolium (MTT) assay, with various concentrations of extracts from the biomaterial in culture of osteoblasts and fibroblasts after 24, 72, and 120 h. The genotoxicity analysis (comet assay) was performed in osteoblasts and fibroblasts after contact with the biomaterial during 24, 72, and 96 h. In the histopathology analysis, we observed a foreign body reaction, characterized by the presence of granulation tissue after 7 days of implantation of the biomaterial, and fibrosis connective tissue and multinucleated giant cells for longer periods. In the cytotoxicity analysis, extracts from the biomaterial did not inhibit the proliferation of osteoblasts and fibroblasts, and relatively low concentrations (12.5% and 25%) stimulated the proliferation of both cell types after 72 and 120 h. The analysis of genotoxicity showed that Biosilicate (R) did not induce DNA damage in both lineages tested in all periods. The results showed that the Biosilicate (R) scaffolds present in vivo and in vitro biocompatibility. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 667673, 2013.
C1 [Kido, Hueliton W.; Oliveira, Poliani; Parizotto, Nivaldo A.] Fed Univ Sao Carlos UFSCar, Postgrad Program Biotechnol, Dept Physiotherapy, Sao Carlos, SP, Brazil.
   [Crovace, Murilo C.; Zanotto, Edgar D.; Peitl-Filho, Oscar] Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab LaMaV, Dept Mat Engn, Sao Carlos, SP, Brazil.
   [Fernandes, Kristianne P. S.; Mesquita-Ferrari, Raquel A.] Nove de Julho Univ UNINOVE, Dept Rehabil Sci & Biophoton Appl Hlth Sci, Sao Paulo, Brazil.
   [Ribeiro, Daniel A.; Renno, Ana Claudia M.] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
RP Renno, ACM (reprint author), Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
EM a.renno@unifesp.br
RI Ferrari, Raquel/I-4419-2016; Kido, Hueliton/O-9970-2015; Zanotto,
   Edgar/A-7992-2011; Parizotto, Nivaldo/D-5347-2014; Renno, Ana
   Claudia/C-1266-2015; CerTEV, CeRTEV/J-6817-2015; Crovace,
   Murilo/B-9124-2013
OI Kido, Hueliton/0000-0001-8554-432X; Zanotto, Edgar/0000-0003-4931-4505;
   Parizotto, Nivaldo/0000-0003-1774-9053; 
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Claes L, 2007, PROG BIOPHYS MOL BIO, V93, P384, DOI 10.1016/j.pbiomolbio.2006.07.021
   Crovace MC, 2009, THESIS FEDERAL U SAO
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Ferraz MP, 2000, BIOMATERIALS, V21, P813, DOI 10.1016/S0142-9612(99)00249-5
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hadjiargyrou M., 1998, CLIN ORTHOP S, V355, P216
   Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Liu W, 2011, J STAT COMPUT SIM, V81, P1483, DOI 10.1080/00949655.2010.492473
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Misra SK, 2010, BIOMATERIALS, V31, P2806, DOI 10.1016/j.biomaterials.2009.12.045
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Noushad M, 2009, TOXICOL IN VITRO, V23, P1145, DOI 10.1016/j.tiv.2009.05.025
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Ribeiro Daniel Araki, 2005, Braz. oral res., V19, P183, DOI 10.1590/S1806-83242005000300005
   Serrano MC, 2008, TISSUE ENG PT A, V14, P617, DOI 10.1089/tea.2007.0205
   Siqueira RL, 2011, QUIM NOVA, VXY, P1
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Vogel M, 2004, J BIOMED MATER RES A, V70A, P370, DOI 10.1002/jbm.a.30048
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   ZANOTTO ED, 2004, Patent No. 2004074199
   Zimmermann G, 2007, INJURY, V38, pS33, DOI 10.1016/S0020-1383(07)80007-6
NR 31
TC 10
Z9 10
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2013
VL 101
IS 3
BP 667
EP 673
DI 10.1002/jbm.a.34360
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 078PU
UT WOS:000314112500007
PM 22941855
DA 2018-10-20
ER

PT J
AU Hall, B
   Jones, L
   Forrest, JA
AF Hall, B.
   Jones, L.
   Forrest, J. A.
TI Measuring the kinetics and activity of adsorbed proteins: In vitro
   lysozyme deposited onto hydrogel contact lenses over short time periods
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; contact lens; protein activity on biomaterials;
   protein surface activity; lysozyme kinetics
ID EGG-WHITE LYSOZYME; GIANT PAPILLARY CONJUNCTIVITIS; QUARTZ-CRYSTAL
   MICROBALANCE; SILICONE-HYDROGEL; GROUP-II; SECONDARY STRUCTURE;
   BIOLOGICAL-ACTIVITY; LIPID DEPOSITION; ADSORPTION; SURFACE
AB A new process has been developed to determine the biological activity of an intact layer of lysozyme deposited onto a biomaterial surface. This process is applied to a number of common hydrogel contact lenses. The activity of the surface-adsorbed protein is measured using a standard micrococcal activity assay, with extra steps to distinguish between protein on the surface and protein in solution. This is in contrast to protein extraction work in which the activity of all adsorbed protein is measured. For ionic materials, which are known to deposit large amounts of protein, particularly positively charged proteins such as lysozyme, there is evidence for loosely bound protein re-entering the solution, thus making it impossible to truly separate out the surface-adsorbed protein. This optimized process provides the first quantification of the biological activity of an intact layer of surface-adsorbed protein at a hydrogel interface. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 755764, 2013.
C1 [Hall, B.; Jones, L.; Forrest, J. A.] Univ Waterloo, Sch Optometry, Ctr Contact Lens Res, Waterloo, ON N2L 3G1, Canada.
   [Jones, L.; Forrest, J. A.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.
   [Jones, L.; Forrest, J. A.] Univ Waterloo, Guelph Waterloo Phys Inst, Waterloo, ON N2L 3G1, Canada.
RP Forrest, JA (reprint author), Univ Waterloo, Sch Optometry, Ctr Contact Lens Res, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM jforrest@uwaterloo.ca
OI Jones, Lyndon/0000-0002-7409-7349
FU Natural Sciences and Engineering Research Council (NSERC) of Canada;
   OGSST
FX Contract grant sponsor: Natural Sciences and Engineering Research
   Council (NSERC) of Canada; The authors thank Doerte Luensmann for
   critical reading of the manuscript. B.H. acknowledges the support of
   OGSST through a graduate scholarship.
CR ALLANSMITH MR, 1977, AM J OPHTHALMOL, V83, P697, DOI 10.1016/0002-9394(77)90137-4
   Bontempo Andrew R., 2001, CLAO Journal, V27, P75
   Brecher AS, 1999, FUNDAM CLIN PHARM, V13, P107, DOI 10.1111/j.1472-8206.1999.tb00328.x
   Bruinsma GM, 2002, INVEST OPHTH VIS SCI, V43, P3646
   Cheng L, 2004, CURR EYE RES, V28, P93, DOI 10.1076/ceyr.28.2.93.26231
   Chhabra S, 2007, INT J PHARM, V342, P72, DOI 10.1016/j.ijpharm.2007.04.034
   Dai Y, 1997, J BIOL CHEM, V272, P27572, DOI 10.1074/jbc.272.44.27572
   Dumbleton Kathy, 2002, Cont Lens Anterior Eye, V25, P137, DOI 10.1016/S1367-0484(02)00009-7
   Elhers WH, 2008, CURR OPIN ALLERGY CL, V8, P445, DOI 10.1097/ACI.0b013e32830e6af0
   Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023
   Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8
   FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119
   Garrett Q, 1999, INVEST OPHTH VIS SCI, V40, P897
   Glasier MA, 2008, CURR EYE RES, V33, P1, DOI 10.1080/02713680701830278
   Gonzalez-Meijome JM, 2009, J BIOMED MATER RES B, V88B, P75, DOI 10.1002/jbm.b.31153
   Gonzalez-Meijome JM, 2006, J BIOMED MATER RES B, V76B, P412, DOI 10.1002/jbm.b.30387
   Guryca Vilem, 2007, Cont Lens Anterior Eye, V30, P215, DOI 10.1016/j.clae.2007.02.010
   Hart D E, 1989, J Am Optom Assoc, V60, P195
   Hart DE, 1999, OPTOMETRY VISION SCI, V76, P616, DOI 10.1097/00006324-199909000-00016
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Heaton RJ, 1995, BIOCHEM SOC T, V23, pS502, DOI 10.1042/bst023502s
   Ichijima Hideji, 2000, CLAO Journal, V26, P18
   IHLENFELD JV, 1979, J BIOMED MATER RES, V13, P577, DOI 10.1002/jbm.820130405
   Imoto T, 1972, ENZYME
   ITO Y, 1990, J BIOCHEM-TOKYO, V107, P236, DOI 10.1093/oxfordjournals.jbchem.a123032
   Ito Y, 1999, EUR J BIOCHEM, V259, P456, DOI 10.1046/j.1432-1327.1999.00064.x
   Janatova J, 2000, ASAIO J, V46, pS53, DOI 10.1097/00002480-200011000-00038
   JONES B, 1990, CLAO Journal, V16, P43
   Jones L, 1996, OPTOMETRY VISION SCI, V73, P16, DOI 10.1097/00006324-199601000-00003
   Jones L, 2000, OPTOMETRY VISION SCI, V77, P503, DOI 10.1097/00006324-200010000-00004
   Karlsson LM, 2003, J COLLOID INTERF SCI, V266, P40, DOI 10.1016/S0021-9797(03)00595-2
   Keith EO, 2001, BIOTECHNOL APPL BIOC, V34, P5, DOI 10.1042/BA20010012
   Keuren JFW, 2002, THROMB HAEMOSTASIS, V87, P742
   Laurents DV, 1997, BIOCHEMISTRY-US, V36, P1496, DOI 10.1021/bi962198z
   LIN S T, 1991, CLAO Journal, V17, P44
   LINDBLAD B, 1987, J BIOMED MATER RES, V21, P99, DOI 10.1002/jbm.820210113
   Lorentz H, 2007, OPTOMETRY VISION SCI, V84, P946, DOI 10.1097/OPX.0b013e318157a6c1
   Luensmann D, 2010, MOL VIS, V16, P79
   Luensmann D, 2009, CURR EYE RES, V34, P683, DOI 10.1080/02713680903015900
   Maldonado-Codina C, 2007, J BIOMED MATER RES A, V83A, P496, DOI 10.1002/jbm.a.31260
   Meadows David L., 1994, CLAO Journal, V20, P237
   MORRISSEY BW, 1976, T AM SOC ART INT ORG, V22, P278
   MORSKY P, 1983, ANAL BIOCHEM, V128, P77, DOI 10.1016/0003-2697(83)90347-0
   MYERS RI, 1991, OPTOMETRY VISION SCI, V68, P776, DOI 10.1097/00006324-199110000-00003
   Nichols JJ, 2011, CONTACT LENS SPECTRU, V26, P24
   Puleo DA, 2009, INVESTIGATING PROTEI, P19
   Refojo MF, 1977, CONTACT LENS J, V3, P23
   Roux P, 1997, J BIOL CHEM, V272, P24843, DOI 10.1074/jbc.272.40.24843
   SACK RA, 1987, INVEST OPHTH VIS SCI, V28, P842
   Sasahara K, 2000, BIOCHEMISTRY-US, V39, P6475, DOI 10.1021/bi992560k
   Senchyna M, 2004, CURR EYE RES, V28, P25, DOI 10.1076/ceyr.28.1.25.23496
   SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0
   Spaeth K, 1997, J COLLOID INTERF SCI, V196, P128, DOI 10.1006/jcis.1997.5200
   SPRING TF, 1973, MED J AUSTRALIA, V1, P449
   Subbaraman Lakshman N, 2007, Eye Contact Lens, V33, P169, DOI 10.1097/01.icl.0000248155.23800.20
   Subbaraman LN, 2006, CURR EYE RES, V31, P787, DOI 10.1080/02713680600888799
   Subbaraman LN, 2010, J BIOMAT SCI-POLYM E, V21, P343, DOI 10.1163/156856209X415873
   Suwala Maciej, 2007, Eye Contact Lens, V33, P138, DOI 10.1097/01.icl.0000244155.87409.f6
   Teichroeb JH, 2008, J COLLOID INTERF SCI, V325, P157, DOI 10.1016/j.jcis.2008.05.052
   Teichroeb JH, 2008, OPTOMETRY VISION SCI, V85, P1151, DOI 10.1097/OPX.0b013e31818e8ad6
   VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024
   VANTRAPPEN G, 1976, AM J DIG DIS, V21, P547, DOI 10.1007/BF01464761
   Welle A, 2004, J BIOMAT SCI-POLYM E, V15, P357, DOI 10.1163/156856204322977238
   Wu Y, 2007, J FOOD SCI, V72, pM369, DOI 10.1111/j.1750-3841.2007.00529.x
   Zhang F, 2006, INVEST OPHTH VIS SCI, V47, P2405
   Zhang Shangtong, 2005, Cont Lens Anterior Eye, V28, P113, DOI 10.1016/j.clae.2005.06.003
NR 66
TC 13
Z9 13
U1 0
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2013
VL 101
IS 3
BP 755
EP 764
DI 10.1002/jbm.a.34357
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 078PU
UT WOS:000314112500017
PM 22961890
DA 2018-10-20
ER

PT J
AU Nectow, AR
   Gil, ES
   Kaplan, DL
   Kilmer, ME
AF Nectow, Alexander R.
   Gil, Eun Seok
   Kaplan, David L.
   Kilmer, Misha E.
TI A statistical algorithm for assessing cellular alignment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cellular alignment; P19 cells; algorithm; silk
ID PERIPHERAL-NERVE REGENERATION; EMBRYONAL CARCINOMA-CELLS; NEURITE
   OUTGROWTH; DIFFERENTIATION; STRATEGIES; SCAFFOLDS; GUIDANCE; NEURONS;
   GROWTH
AB Current statistical techniques for analyzing cellular alignment data in the fields of biomaterials and tissue engineering are limited because of heuristic and less quantitative approaches. For example, generally a cutoff degree limit (commonly 20 degrees) is arbitrarily defined within which cells are considered aligned. The effectiveness of a patterned biomaterial in guiding the alignment of cells, such as neurons, is often critical to predict relationships between the biomaterial design and biological outcomes, both in vitro and in vivo. This becomes particularly important in the case of peripheral neurons, which require precise axon guidance to obtain successful regenerative outcomes. To address this issue, we have developed a protocol for processing cellular alignment data sets, which implicitly determines an angle of alignment. This was accomplished as follows: cells aligning with an underlying, anisotropic scaffold display uniformly distributed angles up to a cutoff point determined by how effective the biomaterial is in aligning cells. Therefore, this fact was then used to determine where an alignment angle data set diverges from a uniform distribution. This was accomplished by measuring the spacing between the collected, increasingly ordered angles and analyzing their underlying distributions using a normalized cumulative periodogram criterion. The proposed protocol offers a novel way to implicitly define cellular alignment, with respect to various anisotropic biomaterials. This method may also offer an alternative to assess cellular alignment, which could offer improved predictive measures related to biological outcomes. Furthermore, the approach described can be used for a broad range of cell types grown on 2D surfaces, but would not be applicable to 3D scaffold systems in the present format. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 884-891, 2013.
C1 [Nectow, Alexander R.; Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kilmer, Misha E.] Tufts Univ, Dept Math, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
FU Tissue Engineering Resource Center (TERC) through the NIH [P41EB002520];
   National Institute of Biomedical Imaging and Bioengineering; Armed
   Forces Institute of Regenerative Medicine (AFIRM)
FX Contract grant sponsor: Tissue Engineering Resource Center (TERC)
   through the NIH; contract grant number: P41EB002520; Contract grant
   sponsors: National Institute of Biomedical Imaging and Bioengineering,
   Armed Forces Institute of Regenerative Medicine (AFIRM)
CR Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bray MAP, 2010, BIOMATERIALS, V31, P5143, DOI 10.1016/j.biomaterials.2010.03.028
   Cecchini M, 2007, NANOTECHNOLOGY, V18, P1
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Haines C, 2010, J NEUROSCI METH, V187, P52, DOI 10.1016/j.jneumeth.2009.12.010
   Hansen PC, 2006, BIT, V46, P41, DOI 10.1007/s10543-006-0042-7
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271
   JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   MCBURNEY MW, 1988, J NEUROSCI, V8, P1063
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   Sun MZ, 2010, J MATER SCI-MATER M, V21, P2765, DOI 10.1007/s10856-010-4120-7
   Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r
   Xu F, 2011, TISSUE ENG PART C-ME, V17, P641, DOI 10.1089/ten.tec.2011.0038
NR 27
TC 2
Z9 2
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2013
VL 101
IS 3
BP 884
EP 891
DI 10.1002/jbm.a.34385
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 078PU
UT WOS:000314112500029
PM 23008168
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Simson, J
   Crist, J
   Strehin, I
   Lu, QZ
   Elisseeff, JH
AF Simson, Jacob
   Crist, Joshua
   Strehin, Iossif
   Lu, Qiaozhi
   Elisseeff, Jennifer H.
TI An orthopedic tissue adhesive for targeted delivery of intraoperative
   biologics
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE intraoperative biologics; tissue adhesive; PRP; bone marrow;
   osteogenesis
ID PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; CHONDROITIN-SULFATE;
   GROWTH-FACTOR; IN-VITRO; SUSTAINED-RELEASE; COLLAGEN SCAFFOLD; MENISCAL
   CELLS; BONE-FORMATION; REPAIR
AB Tissue adhesives can bind together damaged tissues and serve as tools to deliver and localize therapeutics to facilitate regeneration. One emerging therapeutic trend in orthopedics is the use of intraoperative biologics (IOB), such as bone marrow (BM) and platelet-rich plasma (PRP), to stimulate healing. Here, we introduce the application of the biomaterial chondroitin sulfate succinimidyl succinate (CS-NHS) to deliver IOB in a hydrogel adhesive. We demonstrate the biomaterial's ability to bind various tissue types and its cellular biocompatibility with encapsulated human mesenchymal stem cells (hMSCs). Further, we examine in detail the CS-NHS adhesive combined with BM aspirate for use in bone applications. hMSCs were encapsulated in CS-BM and cultured for 5 weeks in osteogenic medium. Quantitative RT-PCR demonstrated osteogenesis via upregulation of the osteogenic transcription factor Runx2 and bone markers alkaline phosphatase and osteocalcin. Significant deposition of calcium and osteocalcin was detected using biochemical, histological, and immunohistochemical techniques. Shear testing demonstrated that the CS-BM adhesive exhibited an adhesive strength approximately an order of magnitude stronger than fibrin glue and approaching that of a cyanoacrylate adhesive. These results indicate that CS-NHS is a promising delivery tool for IOB in orthopedic applications requiring a strong, degradable, and biocompatible adhesive that supports bone growth. (C) 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 392400, 2013
C1 [Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
   Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
FU Department of Defense [W81X WH-l1-2-0022]
FX Grant sponsor: Department of Defense; Grant number: W81X WH-l1-2-0022.
CR Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546
   Bhargava MM, 1999, AM J SPORT MED, V27, P636, DOI 10.1177/03635465990270051601
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   CHOW TW, 1983, THROMB RES, V29, P243, DOI 10.1016/0049-3848(83)90146-9
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Creaney L, 2011, BRIT J SPORT MED, V45, P966, DOI 10.1136/bjsm.2010.082503
   de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Everts Peter A M, 2006, J Extra Corpor Technol, V38, P174
   Fischer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017581
   Fortier LA, 2010, J BONE JOINT SURG AM, V92A, P1927, DOI 10.2106/JBJS.I.01284
   Gobbi GK, 2011, CARTILAGE, V2, P14
   Han B, 2009, J BONE JOINT SURG AM, V91A, P1459, DOI 10.2106/JBJS.H.00246
   Harrison S, 2011, AM J SPORT MED, V39, P729, DOI 10.1177/0363546511401576
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Lee H, 2008, TISSUE ENG PART A, V14, P1
   Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078
   Lin Sylvia S, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P4358
   LINDE A, 1983, J BIOL CHEM, V258, P1698
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850
   MOSS M, 1965, ORAL SURG ORAL MED O, V20, P795, DOI 10.1016/0030-4220(65)90143-X
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Nagata Maria J H, 2010, Eur J Dent, V4, P395
   Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579
   NEVO Z, 1972, P NATL ACAD SCI USA, V69, P2069, DOI 10.1073/pnas.69.8.2069
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sanchez M, 2007, AM J SPORT MED, V35, P245, DOI 10.1177/0363546506294078
   Sarkar MR, 2006, BIOMATERIALS, V27, P1817, DOI 10.1016/j.biomaterials.2005.10.039
   Sim R., 1993, Singapore Medical Journal, V34, P412
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Strehin I, 2009, J CATARACT REFR SURG, V35, P567, DOI 10.1016/j.jcrs.2008.11.035
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   You TM, 2007, INT J ORAL MAX IMPL, V22, P417
   Zhao GQ, 2009, BIOMATERIALS, V30, P3241, DOI 10.1016/j.biomaterials.2009.02.027
NR 50
TC 15
Z9 15
U1 0
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2013
VL 31
IS 3
BP 392
EP 400
DI 10.1002/jor.22247
PG 9
WC Orthopedics
SC Orthopedics
GA 076TJ
UT WOS:000313980600008
PM 23097279
OA Bronze
DA 2018-10-20
ER

PT J
AU Shmueli, RB
   Bhise, NS
   Green, JJ
AF Shmueli, Ron B.
   Bhise, Nupura S.
   Green, Jordan J.
TI Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle
   Tracking Analysis and High-throughput Flow Cytometry
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biomedical Engineering; Issue 73; Bioengineering; Tissue Engineering;
   Cellular Biology; Medicine; Genetics; Biocompatible Materials;
   Biopolymers; Drug Delivery Systems; Nanotechnology; bioengineering
   (general); Therapeutics; Nanoparticle; poly(beta-amino ester);
   high-throughput; transfection; nanoparticle tracking analysis;
   biomaterial; gene delivery; flow cytometry
AB Non-viral gene delivery using polymeric nanoparticles has emerged as an attractive approach for gene therapy to treat genetic diseases(1) and as a technology for regenerative medicine(2). Unlike viruses, which have significant safety issues, polymeric nanoparticles can be designed to be non-toxic, non-immunogenic, non-mutagenic, easier to synthesize, chemically versatile, capable of carrying larger nucleic acid cargo and biodegradable and/or environmentally responsive. Cationic polymers self-assemble with negatively charged DNA via electrostatic interaction to form complexes on the order of 100 nm that are commonly termed polymeric nanoparticles. Examples of biomaterials used to form nanoscale polycationic gene delivery nanoparticles include polylysine, polyphosphoesters, poly(amidoamines)s and polyethylenimine (PEI), which is a non-degradable off-the-shelf cationic polymer commonly used for nucleic acid delivery(1,3). Poly(beta-amino ester) s (PBAEs) are a newer class of cationic polymers(4) that are hydrolytically degradable(5,6) and have been shown to be effective at gene delivery to hard-to-transfect cell types such as human retinal endothelial cells (HRECs) (7), mouse mammary epithelial cells(8), human brain cancer cells(9) and macrovascular (human umbilical vein, HUVECs) endothelial cells(10).
   A new protocol to characterize polymeric nanoparticles utilizing nanoparticle tracking analysis (NTA) is described. In this approach, both the particle size distribution and the distribution of the number of plasmids per particle are obtained(11). In addition, a high-throughput 96-well plate transfection assay for rapid screening of the transfection efficacy of polymeric nanoparticles is presented. In this protocol, poly(beta-amino ester) s (PBAEs) are used as model polymers and human retinal endothelial cells (HRECs) are used as model human cells. This protocol can be easily adapted to evaluate any polymeric nanoparticle and any cell type of interest in a multi-well plate format.
C1 [Shmueli, Ron B.; Bhise, Nupura S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Biomed Engn Dept, Baltimore, MD 21218 USA.
   [Shmueli, Ron B.; Bhise, Nupura S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD 21218 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Biomed Engn Dept, Baltimore, MD 21218 USA.
EM green@jhu.edu
RI Bhise, Nupura/P-1718-2014
FU TEDCO MSCRF [2009-MSCRFE-0098-00]; NIH [R21CA152473]
FX The authors thank the TEDCO MSCRF (2009-MSCRFE-0098-00) and NIH
   R21CA152473 for support.
CR Bhise NS, 2012, SMALL, V8, P367, DOI 10.1002/smll.201101718
   Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Collins L, 2004, BBA-GEN SUBJECTS, V1672, P12, DOI 10.1016/j.bbagen.2004.02.004
   Green JJ, 2006, BIOCONJUGATE CHEM, V17, P1162, DOI 10.1021/bc0600968
   Green JJ, 2012, ANN BIOMED ENG, V40, P1408, DOI 10.1007/s10439-012-0550-3
   Ho YP, 2006, J CONTROL RELEASE, V116, P83, DOI 10.1016/j.jconrel.2006.09.005
   Kreiss P, 1999, NUCLEIC ACIDS RES, V27, P3792, DOI 10.1093/nar/27.19.3792
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Pitard B, 1997, P NATL ACAD SCI USA, V94, P14412, DOI 10.1073/pnas.94.26.14412
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Sheyn D, 2010, ADV DRUG DELIVER REV, V62, P683, DOI 10.1016/j.addr.2010.01.002
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
NR 17
TC 0
Z9 0
U1 1
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAR
PY 2013
IS 73
AR UNSP e50176
DI 10.3791/50176
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QW
UT WOS:000209226900025
PM 23486314
OA Green Published
DA 2018-10-20
ER

PT J
AU Abdul-Kader, AM
   Turos, A
AF Abdul-Kader, A. M.
   Turos, A.
TI High-energy He ion bombardment-induced modifications of surface
   properties of UHMWPE
SO SURFACE INNOVATIONS
LA English
DT Article
DE biomaterial; polymers; morphology; surface roughness; ion implantation;
   structural properties
AB Ultra high-molecular-weight polyethylene (UHMWPE) is the material of choice for the load-bearing surfaces of total joint implants. This is primarily due to its good wear resistance. However, failure is often observed as a result of the UHMWPE brittleness. In order to improve its mechanical properties, UHMWPE was bombarded with 4-MeV He ions to fl uence ranging from 10(12) to 5 x 10(14) ions/cm(2). Changes of surface layer composition produced by ion bombardment of UHMWPE samples were studied. Polymer radiolysis due to the ion bombardment leading to hydrogen release was studied by means of nuclear reaction analysis using the H-1(N-15, alpha gamma)C-12 reaction. Hydrogen release increasing with the ion fl uence was observed and correlated to the ion linear energy transfer. Moreover, important oxidation of bombarded samples was also noticed. These effects resulted in important modifi cations of the surface properties of bombarded material such as increase of hardness and improved wettability.
C1 [Abdul-Kader, A. M.] Umm Al Qura Univ, Univ Coll, Dept Phys, Phys, Alqunfoza, Saudi Arabia.
   [Abdul-Kader, A. M.] Helwan Univ, Dept Phys, Phys, Cairo, Egypt.
   [Turos, A.] Inst Elect Mat Technol, Phys, Warsaw, Poland.
   [Turos, A.] Natl Ctr Nucl Res, Phys, Otwock, Poland.
RP Abdul-Kader, AM (reprint author), Umm Al Qura Univ, Univ Coll, Dept Phys, Phys, Alqunfoza, Saudi Arabia.
EM atawab2001@yahoo.com
CR Abdul-Kader AM, 2010, PHILOS MAG, V90, P2543, DOI 10.1080/14786431003630728
   Abdul-Kader AM, 2009, APPL SURF SCI, V255, P5016, DOI 10.1016/j.apsusc.2008.12.057
   Abdul-Kader A. M., 2009, APPL SURF SCI, V255, P7790
   Abdul-Kader AM, 2005, NUCL INSTRUM METH B, V240, P152, DOI 10.1016/j.nimb.2005.06.106
   Abdul-Kader AM, 2005, VACUUM, V78, P281, DOI 10.1016/j.vacuum.2005.01.039
   ADEL ME, 1989, J APPL PHYS, V66, P3248, DOI 10.1063/1.344116
   Costa L, 1997, POLYM DEGRAD STABIL, V55, P329, DOI 10.1016/S0141-3910(96)00170-X
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   Costic RS, 2003, J ORTHOPAED RES, V21, P379, DOI 10.1016/S0736-0266(02)00197-3
   Decker EL, 1999, COLLOID SURFACE A, V156, P177, DOI 10.1016/S0927-7757(99)00069-2
   Donald L. W., 1998, ELECT OPTICAL POLYM
   Kumar V, 2012, NUCL INSTRUM METH B, V287, P4, DOI 10.1016/j.nimb.2012.06.010
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Lee E. H., 1996, POLYIMIDES FUNDAMENT
   Mallegol J, 2001, NUCL INSTRUM METH B, V185, P283, DOI 10.1016/S0168-583X(01)00944-2
   MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Radwan RM, 2008, NUCL INSTRUM METH B, V266, P3588, DOI 10.1016/j.nimb.2008.06.011
   RANDALL JN, 1983, APPL PHYS LETT, V42, P457, DOI 10.1063/1.93969
   Rockova-Hlavackova K, 2004, NUCL INSTRUM METH B, V225, P275, DOI 10.1016/j.nimb.2004.05.004
   Singh NL, 2007, MAT SCI ENG B-SOLID, V137, P85, DOI 10.1016/j.mseb.2006.10.013
   Turos A, 2006, NUCL INSTRUM METH B, V249, P660, DOI 10.1016/j.nimb.2006.03.075
   Turos A., 2009, VACUUM, V83, P554
   Valenza A, 2004, POLYMER, V45, P1707, DOI 10.1016/j.polymer.2003.12.056
   Virk HS, 1998, J PHYS D APPL PHYS, V31, P3139, DOI 10.1088/0022-3727/31/21/020
   Walker SR, 1998, NUCL INSTRUM METH B, V136, P707, DOI 10.1016/S0168-583X(97)00886-0
   Wang YQ, 2000, NUCL INSTRUM METH B, V161, P1027, DOI 10.1016/S0168-583X(99)00989-1
   Wielunski LS, 1997, NUCL INSTRUM METH B, V127, P698, DOI 10.1016/S0168-583X(96)01160-3
   WROBEL AM, 1978, POLYMER, V19, P908, DOI 10.1016/0032-3861(78)90197-0
   Ziegler J. F., 1985, STOPPING RANGES IONS, VI
NR 30
TC 0
Z9 0
U1 0
U2 4
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2013
VL 1
IS 1
BP 60
EP 66
DI 10.1680/si.12.00002
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA V41LB
UT WOS:000209546600008
DA 2018-10-20
ER

PT J
AU Tan, HC
   Poh, CK
   Cai, YL
   Soe, MT
   Wang, WS
AF Tan, Hark Chuan
   Poh, Chye Khoon
   Cai, Yanli
   Soe, Min Thun
   Wang, Wilson
TI Covalently grafted BMP-7 peptide to reduce macrophage/monocyte activity:
   An in vitro study on cobalt chromium alloy
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE implant; inflammation; bioengineering; surface modification; covalent
   binding; bone morphogenic protein
ID BONE MORPHOGENETIC PROTEIN-7; TOTAL HIP-REPLACEMENT; ORTHOPEDIC
   IMPLANTS; SURFACE-CHEMISTRY; METAL SENSITIVITY; GENE-EXPRESSION;
   INFLAMMATION; BIOMATERIALS; CELLS; CYTOKINE
AB Cobalt chromium (CoCr) alloy is widely used in orthopedic implants but its functional longevity is susceptible to inflammation related complications. Reduction of the development of chronic inflammation on the biomaterial surface would enhance direct bone-implant bonding and improve implant survival and long-term results. The BMP-7 peptide was derived from the knuckle epitope of bone morphogenic protein-7 (BMP-7) and was conjugated via a cysteine amino acid at the N-terminus. Mouse RAW 264.7 monocytes/macrophages were seeded on the CoCr substrates and inflammation was induced via lipopolysaccharide (LPS) challenge. The effects of BMP-7 peptide on inflammation were evaluated by measuring the expression of inflammatory markers like toll-like receptor-4 (TLR-4), tumor necrosis factor- (TNF-), and monocyte chemotactic protein-1 (MCP-1). ELISA and qPCR assays were used to study the inflammatory signals. BMP-7 signaling pathway activation was shown by the presence of phosphorylation of Smad1/5/8. Utilizing the reactivity of polydopamine films to immobilize BMP-7 peptide onto metal substrates may provide a promising approach for applications in situations where reduction of inflammation around implants would be beneficial in improving surgical outcome, bone healing, and implant integration. Biotechnol. Bioeng. 2013; 110: 969979. (c) 2012 Wiley Periodicals, Inc.
C1 [Tan, Hark Chuan; Poh, Chye Khoon; Cai, Yanli; Soe, Min Thun; Wang, Wilson] Natl Univ Singapore Hosp, Orthopaed Diagnost Ctr, Singapore 119074, Singapore.
RP Wang, WS (reprint author), Natl Univ Singapore Hosp, Orthopaed Diagnost Ctr, Level 3,5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
EM doswangw@nus.edu.sg
FU National Medical Research Council
FX Contract grant sponsor: National Medical Research Council
CR Aldridge C, 2008, J SURG RES, V149, P296, DOI 10.1016/j.jss.2007.12.758
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Balasundaram G, 2008, J BIOMED MATER RES A, V84A, P447, DOI 10.1002/jbm.a.31388
   Bobacz K, 2007, ARTHRITIS RHEUM, V56, P1880, DOI 10.1002/art.22637
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Chatzinikolaidou M, 2010, ACTA BIOMATER, V6, P4405, DOI 10.1016/j.actbio.2010.06.009
   Chen YP, 2009, J BIOMED MATER RES A, V91A, P296, DOI 10.1002/jbm.a.32246
   Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107
   Decking R, 2003, J BIOMED MATER RES B, V64B, P99, DOI 10.1002/jbm.b.10555
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Frigerio E, 2011, CONTACT DERMATITIS, V64, P273, DOI 10.1111/j.1600-0536.2011.01886.x
   Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hong S, 2011, NANOMEDICINE-UK, V6, P793, DOI [10.2217/nnm.11.76, 10.2217/NNM.11.76]
   Hunt JA, 2005, BIOMATERIALS, V26, P5890, DOI 10.1016/j.biomaterials.2005.03.004
   Jakobsen SS, 2007, EUR CELLS MATER, V14, P45, DOI 10.22203/eCM.v014a05
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kang CH, 2012, J MED FOOD, V15, P44, DOI 10.1089/jmf.2010.1540
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001
   Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557
   Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704
   Mercado AE, 2009, J CONTROL RELEASE, V140, P148, DOI 10.1016/j.jconrel.2009.08.009
   Messer RLW, 2007, J BIOMED MATER RES B, V83B, P58, DOI 10.1002/jbm.b.30766
   Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043
   Oyegunwa AO, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-59
   Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034
   Poh CK, 2011, J ORTHOP RES, V29, P1424, DOI 10.1002/jor.21409
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Ren WP, 2008, J BIOMED MATER RES A, V85A, P1043, DOI 10.1002/jbm.a.31665
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5
   Suska F, 2005, BIOMATERIALS, V26, P5942, DOI 10.1016/j.biomaterials.2005.03.017
   Takahashi T, 2011, CELL TISSUE RES, V344, P321, DOI 10.1007/s00441-011-1154-1
   Thomas P, 2009, ALLERGY, V64, P1157, DOI 10.1111/j.1398-9995.2009.01966.x
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001
   Westermark A, 2011, INT J ORAL MAX SURG, V40, P18, DOI 10.1016/j.ijom.2010.09.009
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
   Zwartele RE, 2012, ARCH ORTHOP TRAUM SU, V132, P535, DOI 10.1007/s00402-011-1432-0
NR 49
TC 5
Z9 5
U1 0
U2 41
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR
PY 2013
VL 110
IS 3
BP 969
EP 979
DI 10.1002/bit.24756
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 074IP
UT WOS:000313806400030
PM 23055400
DA 2018-10-20
ER

PT J
AU Medina-Torres, L
   Garcia-Cruz, EE
   Calderas, F
   Laredo, RFG
   Sanchez-Olivares, G
   Gallegos-Infante, JA
   Rocha-Guzman, NE
   Rodriguez-Ramirez, J
AF Medina-Torres, L.
   Garcia-Cruz, E. E.
   Calderas, F.
   Gonzalez Laredo, R. F.
   Sanchez-Olivares, G.
   Gallegos-Infante, J. A.
   Rocha-Guzman, N. E.
   Rodriguez-Ramirez, J.
TI Microencapsulation by spray drying of gallic acid with nopal mucilage
   (Opuntia ficus indica)
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Nopal mucilage; Rheological behavior; Bioactive compounds; Gallic acid;
   Spray drying
ID ANTIOXIDANT PROPERTIES; ENCAPSULATION; PIGMENTS; CHITOSAN; EXTRACT;
   POWDER; FOOD; WINE; L.
AB The spray-drying process has been previously used to encapsulate food ingredients such as antioxidants. Thus the objective of this work was to produce microcapsules of gallic acid, a phenolic compound that acts as antioxidant, by spray drying with an aqueous extract of nopal mucilage (Ofi), which acted as an encapsulating agent. The theological response and the particle size distribution of the final solutions containing gallic acid at concentrations of 6 g/100 mL were characterized along with the control sample, no gallic acid added, to elucidate the degree of encapsulation. The drying parameters to prepare the microcapsules with extract of nopal mucilage were: inlet air temperature (130 and 170 degrees C) and speed atomization (14,000 and 20,000 rpm). The rehydrated biopolymer showed a non-Newtonian pseudo-plastic behavior. The Cross Model was used to model the rheological data. Values for "m" varied between 0.55 and 0.85, and for "time characteristic, lambda", the range was between 0.0071 and 0.021 s. The mechanical spectra showed that the sample with gallic acid was stable long term (>2 days) and presented a bimodal particle size distribution. This study demonstrated the effectiveness of nopal mucilage when utilized as wall biomaterial in microencapsulation of gallic acid by the spray-drying process. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Medina-Torres, L.; Calderas, F.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Ingn Quim, Mexico City 04510, DF, Mexico.
   [Garcia-Cruz, E. E.; Rodriguez-Ramirez, J.] CIIDIR IPN Oaxaca, Inst Politecn Nacl, Xoxocotlan 71230, Oaxaca, Mexico.
   [Gonzalez Laredo, R. F.; Gallegos-Infante, J. A.; Rocha-Guzman, N. E.] Inst Tecnol Durango, Dept Ing Quim & Bioquim, Durango 34080, Dgo, Mexico.
   [Sanchez-Olivares, G.] CIATEC, AC Omega 201, Leon 37545, Gto, Mexico.
RP Medina-Torres, L (reprint author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Ingn Quim, Mexico City 04510, DF, Mexico.
EM luismt@unam.mx
RI Calderas, Fausto/A-4930-2013; Calderas, Fausto/C-5842-2015
OI Calderas, Fausto/0000-0002-3652-4223; Calderas,
   Fausto/0000-0002-3652-4223; Medina-Torres, Luis/0000-0002-9963-821X;
   Gonzalez-Laredo, Ruben Francisco/0000-0001-6329-1413; Sanchez-Olivares,
   Guadalupe/0000-0003-0633-8398; Rocha Guzman, Nuria
   Elizabeth/0000-0002-5715-8939; Rodriguez-Ramirez,
   Juan/0000-0002-0866-9230
CR Abu-Jdayil B, 2004, INT J FOOD PROP, V7, P483, DOI [10.1081/JFP-200032940, 10.1081/JFP-120040203]
   Ahmed M, 2010, LWT-FOOD SCI TECHNOL, V43, P1307, DOI 10.1016/j.lwt.2010.05.014
   Barnes H.A., 2000, HDB ELEMENTARY RHEOL
   Borgogna M, 2010, FOOD CHEM, V122, P416, DOI 10.1016/j.foodchem.2009.07.043
   Cai YZ, 2000, J FOOD SCI, V65, P1248, DOI 10.1111/j.1365-2621.2000.tb10273.x
   Campos JBG, 2009, J POLYM SCI B, V47, P2259
   Cardenas A., 1997, J PROFESSIONAL ASS C, V2, P152
   Chegini G. R., 2007, World Journal of Agricultural Sciences, V3, P230
   Chiou D, 2007, J FOOD ENG, V82, P84, DOI 10.1016/j.jfoodeng.2007.01.021
   Cho YS, 2011, CARBOHYD POLYM, V83, P1617, DOI 10.1016/j.carbpol.2010.10.019
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   Del-Valle V, 2005, FOOD CHEM, V91, P751, DOI 10.1016/j.foochem.2004.07.002
   Diaz F., 2006, ELECT J ENV AGR FOOD
   Ersus S, 2007, J FOOD ENG, V80, P805, DOI 10.1016/j.jfoodeng.2006.07.009
   Fang ZX, 2010, TRENDS FOOD SCI TECH, V21, P510, DOI 10.1016/j.tifs.2010.08.003
   Ferk F, 2011, MUTAT RES-FUND MOL M, V715, P61, DOI 10.1016/j.mrfmmm.2011.07.010
   Georgetti SR, 2008, LWT-FOOD SCI TECHNOL, V41, P1521, DOI 10.1016/j.lwt.2007.09.001
   Gharsallaoui A, 2007, FOOD RES INT, V40, P1107, DOI 10.1016/j.foodres.2007.07.004
   Gunasekaran S, 2000, TRENDS FOOD SCI TECH, V11, P115, DOI 10.1016/S0924-2244(00)00058-3
   Hassan BH, 1998, J FOOD ENG, V35, P459, DOI 10.1016/S0260-8774(98)00044-2
   Hill A., 2006, AM LAB NEWS
   Kha TC, 2010, J FOOD ENG, V98, P385, DOI 10.1016/j.jfoodeng.2010.01.016
   Kirkwood DH, 2008, MATER LETT, V62, P3981, DOI 10.1016/j.matlet.2008.05.059
   Koocheki A, 2009, J FOOD ENG, V91, P490, DOI 10.1016/j.jfoodeng.2008.09.028
   Kosaraju SL, 2008, NUTR DIET, V65, pS48, DOI 10.1111/j.1747-0080.2008.00261.x
   Kosaraju SL, 2006, CARBOHYD POLYM, V64, P163, DOI 10.1016/j.carbpol.2005.11.027
   Leon Martinez F. M., 2011, CARBOHYD POLYM, V84, P439
   Liu ZQ, 2004, J FOOD ENG, V65, P391, DOI 10.1016/j.jfoodeng.2004.01.038
   Loksuwan J, 2007, FOOD HYDROCOLLOID, V21, P928, DOI 10.1016/j.foodhyd.2006.10.011
   Martinez F.M.L, 2010, CARBOHYD POLYM, V81, P864
   MCGARVIE D, 1981, CARBOHYD RES, V88, P305, DOI 10.1016/S0008-6215(00)85543-3
   Medina Torres L, 2009, COLLOID SURF A, V352, P38
   Medina Torres L., 2000, FOOD HYDROCOLLOIDS, V14, P417
   Medina Torres L, 2006, CARBOHYD POLYM, V63, P299
   Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4
   Negi AS, 2005, BIOORG MED CHEM LETT, V15, P1243, DOI 10.1016/j.bmcl.2004.11.079
   OROZCO AC, 2007, 6 C IB ING AL GUAN M, P277
   Pasanphan W, 2008, CARBOHYD POLYM, V72, P169, DOI 10.1016/j.carbpol.2007.08.002
   Saenz C, 2004, J ARID ENVIRON, V57, P275, DOI 10.1016/S0140-1963(03)00106-X
   Saenz C, 2009, FOOD CHEM, V114, P616, DOI 10.1016/j.foodchem.2008.09.095
   Saez V, 2003, REV IBEROAMERICANA P, V4, P111
   Seid M.J., 2008, FOOD RES INT, V41, P172
   Sengul M, 2005, FOOD CONTROL, V16, P73, DOI 10.1016/j.foodcont.2003.11.010
   Servais C, 2002, J FOOD ENG, V51, P201, DOI 10.1016/S0260-8774(01)00056-5
   STLEGER AS, 1979, LANCET, V1, P1017
   Takkouche B, 2002, AM J EPIDEMIOL, V155, P853, DOI 10.1093/aje/155.9.853
   Walton DE, 1999, CHEM ENG RES DES, V77, P21, DOI 10.1205/026387699525846
   Wang Y, 2009, EUR FOOD RES TECHNOL, V229, P391, DOI 10.1007/s00217-009-1064-6
   Xu CL, 2009, CARBOHYD POLYM, V75, P498, DOI 10.1016/j.carbpol.2008.08.016
   Zakarian A.J., 1982, IND ENG CHEM PROC DD, V21, P107
   Zbicinski I, 2002, CHEM ENG J, V86, P207, DOI 10.1016/S1385-8947(01)00291-1
   Zhang LF, 2007, J SCI FOOD AGR, V87, P2192, DOI 10.1002/jsfa.2899
NR 52
TC 37
Z9 38
U1 2
U2 116
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0023-6438
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PD MAR
PY 2013
VL 50
IS 2
BP 642
EP 650
DI 10.1016/j.lwt.2012.07.038
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 038SE
UT WOS:000311193600039
DA 2018-10-20
ER

PT J
AU Zuo, PP
   Feng, HF
   Xu, ZZ
   Zhang, LF
   Zhang, YL
   Xia, W
   Zhang, WQ
AF Zuo, Ping-Ping
   Feng, Hua-Feng
   Xu, Zhi-Zhen
   Zhang, Ling-Fan
   Zhang, Yu-Long
   Xia, Wei
   Zhang, Wen-Qing
TI Fabrication of biocompatible and mechanically reinforced graphene
   oxide-chitosan nanocomposite films
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Graphene oxide; Chitosan; Chemical modification; Biocompatibility;
   Biofilms
ID EXFOLIATED GRAPHITE OXIDE; CHEMICAL-REDUCTION; CARBON NANOTUBES;
   NANOSHEETS; CHITIN; NANOPLATELETS; CYTOTOXICITY; COMPOSITES; STRENGTH;
   DELIVERY
AB Background: Graphene oxide (GO) can be dispersed through functionalization, or chemically converted to make different graphene-based nanocomposites with excellent mechanical and thermal properties. Chitosan, a partially deacetylated derivative of chitin, is extensively used for food packaging, biosensors, water treatment, and drug delivery. GO can be evenly dispersed in chitosan matrix through the formation of amide linkages between them, which is different from previous reports focusing on preparing GO/chitosan nanocomposites through physical mixing.
   Results: In this study, free-standing graphene oxide-chitosan (GO-chitosan) nanocomposite films have been prepared. The GO-chitosan films are biologically compatible and mechanically reinforced. Through the formation of amide linkages between GO's carboxylic acid groups and chitosan's amine groups, GO could be evenly dispersed within the chitosan matrix. We also characterized the GO-chitosan composite films using element analysis, Fourier transform infrared spectroscopy, X-ray photo electron spectroscopy, differential scanning calorimetry, and thermo gravimetric analysis. Compared to pristine chitosan film, the tensile strength of GO-chitosan film is improved by 2.5 folds and Young's modulus increases by nearly 4.6 folds. The glass transition temperature of GO-chitosan composite film shifts from 118 degrees C to 158 degrees C compared to the pristine chitosan, indicating its enhanced thermal stability. GO-chitosan composite film was also evaluated for its biocompatibility with C3H10T1/2 cells by in vitro fluorescent staining. The graphene oxide-reinforced chitosan composite films could have applications in functional biomaterials.
   Conclusion: The present study describes a useful and simple method to chemically attach biocompatible chitosan onto graphene oxide. We envision that the GO-chitosan film will open avenues for next-generation graphene applications in the realm of functional biomaterial.
C1 [Zuo, Ping-Ping; Feng, Hua-Feng; Xu, Zhi-Zhen; Zhang, Ling-Fan; Zhang, Yu-Long; Xia, Wei; Zhang, Wen-Qing] E China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China.
RP Xia, W (reprint author), E China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai Key Lab Funct Mat Chem, 130 Meilong Rd, Shanghai 200237, Peoples R China.
EM xiawei1999@ecust.edu.cn; zhwqing@ecust.edu.cn
FU National Key Technologies R&D Program of China [2010BAK67B15]
FX This work was supported by National Key Technologies R&D Program of
   China (Grant 2010BAK67B15).
CR Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802
   Compton OC, 2010, ADV MATER, V22, P892, DOI 10.1002/adma.200902069
   Datta P, 2012, CARBOHYD POLYM, V87, P1354, DOI 10.1016/j.carbpol.2011.09.023
   Eda G, 2009, NANO LETT, V9, P814, DOI 10.1021/nl8035367
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Han DL, 2011, CARBOHYD POLYM, V83, P653, DOI 10.1016/j.carbpol.2010.08.038
   Hu FX, 2012, ANAL CHIM ACTA, V724, P40, DOI 10.1016/j.aca.2012.02.037
   Hu XG, 2012, CARBON, V50, P2772, DOI 10.1016/j.carbon.2012.02.038
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lim HN, 2012, J NON-CRYST SOLIDS, V358, P525, DOI 10.1016/j.jnoncrysol.2011.11.007
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Meng SY, 2011, J BONE MINER METAB, V29, P535, DOI 10.1007/s00774-010-0257-1
   Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201
   Pan YZ, 2011, CARBOHYD POLYM, V83, P1908, DOI 10.1016/j.carbpol.2010.10.054
   Ramanathan T, 2008, NAT NANOTECHNOL, V3, P327, DOI 10.1038/nnano.2008.96
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shen JF, 2011, J COLLOID INTERF SCI, V356, P543, DOI 10.1016/j.jcis.2011.01.052
   Shen JF, 2009, SMALL, V5, P82, DOI 10.1002/smll.200800988
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Vadukumpully S, 2011, CARBON, V49, P198, DOI 10.1016/j.carbon.2010.09.004
   Yang K., 2012, SMALL, DOI 10.1002/smll.201201417
   Yang XM, 2010, ACS APPL MATER INTER, V2, P1707, DOI 10.1021/am100222m
   Yang YF, 2009, LANGMUIR, V25, P11808, DOI 10.1021/la901441p
   Zhao X, 2010, MACROMOLECULES, V43, P2357, DOI 10.1021/ma902862u
   Zhou XS, 2010, CHEM COMMUN, V46, P3663, DOI 10.1039/c0cc00049c
NR 40
TC 67
Z9 68
U1 4
U2 211
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD FEB 25
PY 2013
VL 7
AR 39
DI 10.1186/1752-153X-7-39
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 127UY
UT WOS:000317725500001
PM 23442350
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Meade, KA
   White, KJ
   Pickford, CE
   Holley, RJ
   Marson, A
   Tillotson, D
   van Kuppevelt, TH
   Whittle, JD
   Day, AJ
   Merry, CLR
AF Meade, Kate A.
   White, Kathryn J.
   Pickford, Claire E.
   Holley, Rebecca J.
   Marson, Andrew
   Tillotson, Donna
   van Kuppevelt, Toin H.
   Whittle, Jason D.
   Day, Anthony J.
   Merry, Catherine L. R.
TI Immobilization of Heparan Sulfate on Electrospun Meshes to Support
   Embryonic Stem Cell Culture and Differentiation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EXTRACELLULAR-MATRIX; PROTEIN INTERACTIONS; BINDING SURFACES;
   SELF-RENEWAL; BONE-MARROW; IN-VIVO; SCAFFOLDS; SPECIFICATION;
   HYALURONAN; ANTIBODIES
AB As our understanding of what guides the behavior of multi- and pluripotent stem cells deepens, so too does our ability to utilize certain cues to manipulate their behavior and maximize their therapeutic potential. Engineered, biologically functionalized materials have the capacity to influence stem cell behavior through a powerful combination of biological, mechanical, and topographical cues. Here, we present the development of a novel electrospun scaffold, functionalized with glycosaminoglycans (GAGs) ionically immobilized onto the fiber surface. Bound GAGs retained the ability to interact with GAG-binding molecules and, crucially, presented GAG sulfation motifs fundamental to mediating stem cell behavior. Bound GAG proved to be biologically active, rescuing the neural differentiation capacity of heparan sulfate-deficient mouse embryonic stem cells and functioning in concert with FGF4 to facilitate the formation of extensive neural processes across the scaffold surface. The combination of GAGs with electrospun scaffolds creates a biomaterial with potent applicability for the propagation and effective differentiation of pluripotent stem cells.
C1 [Meade, Kate A.; White, Kathryn J.; Pickford, Claire E.; Marson, Andrew; Tillotson, Donna; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Stem Cell Glycobiol Grp, Manchester M1 7HS, Lancs, England.
   [White, Kathryn J.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Holley, Rebecca J.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England.
   [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands.
   [Whittle, Jason D.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia.
RP Day, AJ (reprint author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM Anthony.day@manchester.ac.uk; catherine.merry@manchester.ac.uk
RI Pickford, Claire/C-9815-2013; Whittle, Jason/E-5842-2011; Kuppevelt,
   A.H.M.S.M./L-4463-2015; Day, Anthony/O-1658-2015
OI Whittle, Jason/0000-0002-8250-1639; Day, Anthony/0000-0002-1415-3134;
   merry, catherine/0000-0002-3490-2809
FU Engineering and Physical Sciences Research Council; Medical Research
   Council; The Human Frontier Science Program; Engineering and Physical
   Sciences Research Council [EP/H046070/1]; Medical Research Council
   [G0701165]
FX This work was supported by the Engineering and Physical Sciences
   Research Council (to K. M., A. J. D., A. M., and C. L. R. M.), the
   Medical Research Council (to C. L. R. M.), and The Human Frontier
   Science Program (to R. J. H., C. P., and C. L. R. M.).
CR Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Bateman KL, 2000, ADV EXP MED BIOL, V480, P65
   Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002
   Beamson G., 1992, HIGH RESOLUTION XPS
   Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200
   Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442
   Helledie T, 2012, STEM CELLS DEV, V21, P1897, DOI 10.1089/scd.2011.0367
   Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474
   Holley RJ, 2011, J BIOL CHEM, V286, P6241, DOI 10.1074/jbc.M110.178483
   Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062
   Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI [10.1089/ten.tea.2009.0414, 10.1089/ten.TEA.2009.0414]
   Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848
   Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200
   Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055
   Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132
   Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200
   Nur-E-Kamal A, 2008, MOL CELL BIOCHEM, V309, P157, DOI 10.1007/s11010-007-9654-8
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   Park K, 2009, MACROMOL BIOSCI, V9, P221, DOI 10.1002/mabi.200800187
   Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7
   Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Robinson DE, 2012, BIOMATERIALS, V33, P1007, DOI 10.1016/j.biomaterials.2011.10.042
   Shard AG, 2004, J PHYS CHEM B, V108, P12472, DOI 10.1021/jp048250f
   Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383
   Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X
   Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405
   Spadaccio C, 2010, REGEN MED, V5, P645, DOI 10.2217/RME.10.25
   Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200
   van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960
   Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z
   Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744
   Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
NR 50
TC 25
Z9 26
U1 0
U2 43
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 22
PY 2013
VL 288
IS 8
BP 5530
EP 5538
DI 10.1074/jbc.M112.423012
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 095NY
UT WOS:000315342500027
PM 23235146
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Seif-Naraghi, SB
   Singelyn, JM
   Salvatore, MA
   Osborn, KG
   Wang, JJ
   Sampat, U
   Kwan, OL
   Strachan, GM
   Wong, J
   Schup-Magoffin, PJ
   Braden, RL
   Bartels, K
   DeQuach, JA
   Preul, M
   Kinsey, AM
   DeMaria, AN
   Dib, N
   Christman, KL
AF Seif-Naraghi, Sonya B.
   Singelyn, Jennifer M.
   Salvatore, Michael A.
   Osborn, Kent G.
   Wang, Jean J.
   Sampat, Unatti
   Kwan, Oi Ling
   Strachan, G. Monet
   Wong, Jonathan
   Schup-Magoffin, Pamela J.
   Braden, Rebecca L.
   Bartels, Kendra
   DeQuach, Jessica A.
   Preul, Mark
   Kinsey, Adam M.
   DeMaria, Anthony N.
   Dib, Nabil
   Christman, Karen L.
TI Safety and Efficacy of an Injectable Extracellular Matrix Hydrogel for
   Treating Myocardial Infarction
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; ISCHEMIC-HEART-DISEASE; CELL THERAPY;
   INJECTION; INTRACORONARY; EXPANSION; SWINE; MODEL; BIOMATERIALS;
   SURVIVAL
AB New therapies are needed to prevent heart failure after myocardial infarction (MI). As experimental treatment strategies for MI approach translation, safety and efficacy must be established in relevant animal models that mimic the clinical situation. We have developed an injectable hydrogel derived from porcine myocardial extracellular matrix as a scaffold for cardiac repair after MI. We establish the safety and efficacy of this injectable biomaterial in large-and small-animal studies that simulate the clinical setting. Infarcted pigs were treated with percutaneous transendocardial injections of the myocardial matrix hydrogel 2 weeks after MI and evaluated after 3 months. Echocardiography indicated improvement in cardiac function, ventricular volumes, and global wall motion scores. Furthermore, a significantly larger zone of cardiac muscle was found at the endocardium in matrix-injected pigs compared to controls. In rats, we establish the safety of this biomaterial and explore the host response via direct injection into the left ventricular lumen and in an inflammation study, both of which support the biocompatibility of this material. Hemocompatibility studies with human blood indicate that exposure to the material at relevant concentrations does not affect clotting times or platelet activation. This work therefore provides a strong platform to move forward in clinical studies with this cardiac-specific biomaterial that can be delivered by catheter.
C1 [Seif-Naraghi, Sonya B.; Singelyn, Jennifer M.; Osborn, Kent G.; Wang, Jean J.; Sampat, Unatti; Kwan, Oi Ling; Strachan, G. Monet; Schup-Magoffin, Pamela J.; Braden, Rebecca L.; Bartels, Kendra; DeMaria, Anthony N.; Dib, Nabil; Christman, Karen L.] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Salvatore, Michael A.; DeQuach, Jessica A.; Kinsey, Adam M.] Ventrix Inc, San Diego, CA 92109 USA.
   [Wong, Jonathan] Biol Delivery Syst, Irwindale, CA 91706 USA.
   [Preul, Mark] Barrow Neurol Inst, Phoenix, AZ 85013 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, La Jolla, CA 92093 USA.
EM christman@eng.ucsd.edu
FU Wallace H. Coulter Foundation; NSF [101442]; NIH [1R43HL108459-01A1,
   1R01HL113468-01A1]
FX This work was supported by the Wallace H. Coulter Foundation (Miami,
   FL), the NSF (101442), and the NIH (1R43HL108459-01A1 and
   1R01HL113468-01A1). S.B.S.-N. held a graduate research fellowship from
   the NSF.
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004565
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V53, P256, DOI 10.1016/j.vascn.2005.10.005
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64
   Hamamoto H, 2009, ANN THORAC SURG, V87, P794, DOI 10.1016/j.athoracsur.2008.11.057
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Johnson T.D., 2012, EXPERT OPIN DRUG DEL, V10, P59
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   Laham RJ, 2000, J AM COLL CARDIOL, V36, P2132, DOI 10.1016/S0735-1097(00)00988-8
   Laham RJ, 1999, DRUG METAB DISPOS, V27, P821
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Szummer KE, 2005, EUR HEART J, V26, P2114, DOI 10.1093/eurheartj/ehi352
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Velazquez EJ, 2003, EUR J HEART FAIL, V5, P537, DOI 10.1016/S1388-9842(03)00112-0
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
NR 37
TC 119
Z9 126
U1 4
U2 67
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD FEB 20
PY 2013
VL 5
IS 173
AR 173ra25
DI 10.1126/scitranslmed.3005503
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 094KQ
UT WOS:000315262000004
PM 23427245
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Raveendran, S
   Dhandayuthapani, B
   Nagaoka, Y
   Yoshida, Y
   Maekawa, T
   Kumar, DS
AF Raveendran, Sreejith
   Dhandayuthapani, Brahatheeswaran
   Nagaoka, Yutaka
   Yoshida, Yasuhiko
   Maekawa, Toru
   Kumar, D. Sakthi
TI Biocompatible nanofibers based on extremophilic bacterial
   polysaccharide, Mauran from Halomonas maura
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Mauran; Nanofiber; Extremophiles; Polysaccharides; Scaffolds; Tissue
   engineering; Bacterial polysaccharides
ID DRUG-DELIVERY; BIOLOGICAL-ACTIVITIES; EXOPOLYSACCHARIDES; NANOPARTICLES;
   MEMBRANES; BLEND; ACID
AB Extremophilic bacterial polysaccharide based biocompatible nanofibers were produced for the first time via electrospinning technique. Mauran (MR), an extremophilic sulfated exopolysaccharide was extracted from moderately halophilic bacterium, Halomonas maura and characterized for the application of nanofiber synthesis. Thin-uniform MR nanofibers were produced using homogenous solutions of poly (vinyl alcohol) (PVA) blended with different concentrations of MR. Characterization of complex MR/PVA nanofibers were performed using scanning electron microscope and analyzed for the cytotoxicity using mouse fibroblast cells as well as mesenchymal stem cells. An average of 120 nm sized nanofibers were produced and tested for an enhanced cell growth under in vitro conditions in comparison with control. MR and MR/PVA nanofibers were found to be an excellent biomaterial for the migration, proliferation and differentiation of mammalian cells, which was confirmed by cell adhesion studies and confocal microcopy. Interestingly, biological and physicochemical properties of MR hasten the application of MR based nanofibers for various biomedical applications like tissue engineering and drug delivery. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Raveendran, Sreejith; Dhandayuthapani, Brahatheeswaran; Nagaoka, Yutaka; Yoshida, Yasuhiko; Maekawa, Toru; Kumar, D. Sakthi] Toyo Univ, Bionano Elect Res Ctr, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama 3508585, Japan.
RP Kumar, DS (reprint author), Toyo Univ, Bionano Elect Res Ctr, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama 3508585, Japan.
EM sakthi@toyo.jp
OI Kumar, Sakthi/0000-0003-4624-7327; Raveendran,
   Sreejith/0000-0001-7499-304X
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan; programme of the Strategic Research Foundation at private
   universities [S1101017]
FX Sreejith Raveendran and Brahatheeswaran Dhandayuthapani would like to
   acknowledge their sincere gratitude to the Ministry of Education,
   Culture, Sports, Science and Technology (MEXT), Japan for the financial
   support under the Monbukagakusho fellowship during the research. Also,
   part of this study has been supported by a grant for the programme of
   the Strategic Research Foundation at private universities S1101017,
   organized by the MEXT, Japan since April 2012.
CR Arias S, 2003, EXTREMOPHILES, V7, P319, DOI 10.1007/s00792-003-0325-8
   Berry SM, 2011, BIOMATERIALS, V32, P1872, DOI 10.1016/j.biomaterials.2010.11.023
   Costa LS, 2010, BIOMED PHARMACOTHER, V64, P21, DOI 10.1016/j.biopha.2009.03.005
   Dev A, 2010, CARBOHYD POLYM, V80, P833, DOI 10.1016/j.carbpol.2009.12.040
   Dhandayuthapani B., 2011, INT J POLYM SCI
   Dhandayuthapani B., 2012, INT J BIOMATERIALS
   Dhandayuthapani B, 2011, MATER RES-IBERO-AM J, V14, P317, DOI 10.1590/S1516-14392011005000064
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Gibson H. S., 2002, J ADV MAT, V34, P44
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Gomez-Ordonez E, 2011, FOOD HYDROCOLLOID, V25, P1514, DOI 10.1016/j.foodhyd.2011.02.009
   HOSOYA M, 1991, ANTIMICROB AGENTS CH, V35, P2515, DOI 10.1128/AAC.35.12.2515
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Llamas I, 2006, ANTON LEEUW INT J G, V89, P395, DOI 10.1007/s10482-005-9043-9
   Mestechicina N. M., 2010, APPL BIOCHEM MICROB, V46, P291
   Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2
   Nichols CM, 2005, MICROB ECOL, V49, P578, DOI 10.1007/s00248-004-0093-8
   Nie XH, 2006, INT J BIOL MACROMOL, V39, P228, DOI 10.1016/j.ijbiomac.2006.03.030
   Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174
   O'Donnell Christopher D, 2008, Virol Sin, V23, P383, DOI 10.1007/s12250-008-2992-1
   Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779
   Raveendran S., 2011, CARBOHYDRATE POLYM
   Razzak MT, 1999, RADIAT PHYS CHEM, V55, P153, DOI 10.1016/S0969-806X(98)00320-X
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Toskas G, 2011, CARBOHYD POLYM, V84, P1093, DOI 10.1016/j.carbpol.2010.12.075
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
NR 31
TC 14
Z9 14
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2013
VL 92
IS 2
BP 1225
EP 1233
DI 10.1016/j.carbpol.2012.10.033
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 099JI
UT WOS:000315616900036
PM 23399150
DA 2018-10-20
ER

PT J
AU Du, XZ
   Yang, LX
   Ye, X
   Li, B
AF Du, Xuezhu
   Yang, Lingxiao
   Ye, Xiao
   Li, Bin
TI Antibacterial activity of konjac glucomannan/chitosan blend films and
   their irradiation-modified counterparts
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Konjac glucomannan; Chitosan; Blend films; Gamma irradiation;
   Antibacterial effects; Biomaterial
ID CONDENSED STATE STRUCTURE; CHITOSAN; MEMBRANE
AB Antibacterial activity of glucomannan/chitosan (KGM/CHI) blend films and their irradiation-modified counterparts were tested. The KGM/CHI blend films after irradiation showed good antibacterial effects against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Antibacterial activity of the blend films increased with the increase of the content of chitosan. After different dose irradiation, there was no obvious change in the antibacterial effects against St. aureus of the blend films, but the antibacterial effects against E. coli and P. aeruginosa increased significantly. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Du, Xuezhu] Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China.
   [Yang, Lingxiao; Ye, Xiao; Li, Bin] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Peoples R China.
   [Li, Bin] Huazhong Agr Univ, Key Lab Environm Correlat Dietol, Minist Educ, Wuhan 430070, Peoples R China.
RP Li, B (reprint author), Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Peoples R China.
EM libinfood@mail.hzau.edu.cn
FU Research Fund for the Doctoral Program of Higher Education of China
   [20100146110006]
FX This work was financially supported by Research Fund for the Doctoral
   Program of Higher Education of China (20100146110006).
CR ALLAN CR, 1979, EXP MYCOL, V3, P285, DOI 10.1016/S0147-5975(79)80054-7
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Jiang T., 2002, CHITOSAN
   Kume T., 1982, 2ND P INT C CHIT CHI, P66
   Li B, 2004, J APPL POLYM SCI, V93, P2775, DOI 10.1002/app.20769
   Li B, 2011, CARBOHYD POLYM, V83, P44, DOI 10.1016/j.carbpol.2010.07.017
   Matsuhashi S, 1997, J SCI FOOD AGR, V73, P237, DOI 10.1002/(SICI)1097-0010(199702)73:2<237::AID-JSFA711>3.0.CO;2-4
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Spasova M, 2004, E-POLYMERS
   Tham LX, 2001, RADIAT PHYS CHEM, V61, P171
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Zhao L, 2003, CARBOHYD POLYM, V53, P439, DOI 10.1016/S0144-8617(03)00103-6
NR 17
TC 9
Z9 11
U1 5
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2013
VL 92
IS 2
BP 1302
EP 1307
DI 10.1016/j.carbpol.2012.10.006
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 099JI
UT WOS:000315616900044
PM 23399158
DA 2018-10-20
ER

PT J
AU Pei, Y
   Yang, J
   Liu, P
   Xu, M
   Zhang, XZ
   Zhang, LN
AF Pei, Ying
   Yang, Juan
   Liu, Pan
   Xu, Min
   Zhang, Xianzheng
   Zhang, Lina
TI Fabrication, properties and bioapplications of cellulose/collagen
   hydrolysate composite films
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Cellulose; Collagen hydrolysate; Composite film; Non-covalent bond;
   Biocompatibility
ID BIODEGRADABLE PACKING MATERIALS; SODIUM CARBOXYMETHYL CELLULOSE;
   NAOH/UREA AQUEOUS-SOLUTIONS; MECHANICAL-PROPERTIES; BACTERIAL CELLULOSE;
   SOLID-STATE; THERMOPLASTIC BLENDS; COLLAGEN HYDROLYSATE;
   CONTROLLED-RELEASE; PROTEIN FILMS
AB In this work, a series of cellulose/collagen hydrolysate (RC/CH) films were prepared in NaOH/urea aqueous solution via a simple, low-cost and green pathway. To overcome the disadvantages (brittleness, poor water resistance) of CH as biomaterials, CH was combined with regenerated cellulose (RC) film to construct RC/CH composite materials, leading to vast improvement of the water resistance of CH. Crosslinking with genipin further improved the mechanical properties of the RC/CH films in the wet state. Their structure and properties were characterized by elemental analysis, Fourier transform infra-red (FT-IR) spectra, ultraviolet-visible (UV-vis), scanning electron microscopy (SEM), amino acid analysis, tensile testing, cell adhesion and toxicity tests. The mechanical properties and water resistance of the crosslinked RC/CH films were significantly improved, which made collagen hydrolysate as biomaterial could be used at wet state. Moreover, the RC/CH films exhibited good biocompatibility by proliferation of COS7 cells on the surface, supporting cell adhesion and growth. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Pei, Ying; Yang, Juan; Liu, Pan; Zhang, Xianzheng; Zhang, Lina] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
   [Xu, Min] E China Normal Univ, Dept Phys, Shanghai 20041, Peoples R China.
RP Zhang, LN (reprint author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
EM lnzhang@public.wh.hb.cn
FU National Basic Research Program of China (973 Program) [2010CB732203];
   National Natural Science Foundation of China [20874079]
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2010CB732203), and the National Natural Science Foundation
   of China (20874079).
CR Alexy P, 2003, POLYM TEST, V22, P811, DOI 10.1016/S0142-9418(03)00015-1
   Alexy P, 2003, POLYM TEST, V22, P801, DOI 10.1016/S0142-9418(03)00016-3
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Cai J, 2005, MACROMOL BIOSCI, V5, P539, DOI 10.1002/mabi.200400222
   Cai J, 2007, ADV MATER, V19, P821, DOI 10.1002/adma.200601521
   Cai J, 2006, J POLYM SCI POL PHYS, V44, P3093, DOI 10.1002/polb.20938
   Cai Z., 2010, J NANOTECHNOLOGY ENG, V1
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chang CY, 2010, CARBOHYD POLYM, V82, P122, DOI 10.1016/j.carbpol.2010.04.033
   Chang CY, 2009, POLYMER, V50, P5467, DOI 10.1016/j.polymer.2009.06.001
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Deng JZ, 2011, ACTA BIOMATER, V7, P2200, DOI 10.1016/j.actbio.2011.02.003
   Dong ZF, 2006, J MEMBRANE SCI, V280, P37, DOI 10.1016/j.memsci.2006.01.002
   Fengel D, 1989, WOOD CHEM ULTRASTRUC, P66
   Ferreira CO, 2009, FOOD RES INT, V42, P807, DOI 10.1016/j.foodres.2009.03.005
   Gavillon R, 2008, BIOMACROMOLECULES, V9, P269, DOI 10.1021/bm700972k
   He M, 2012, CARBOHYD POLYM, V87, P2512, DOI 10.1016/j.carbpol.2011.11.029
   Huang FW, 2010, ACTA BIOMATER, V6, P4285, DOI 10.1016/j.actbio.2010.06.016
   Huster D, 2002, POPTRONICS, V3, P48
   ISOGAI A, 1989, MACROMOLECULES, V22, P3168, DOI 10.1021/ma00197a045
   Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P324, DOI 10.1111/j.1067-1927.2005.130316.x
   Kim DY, 2002, CELLULOSE, V9, P361, DOI 10.1023/A:1021140726936
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   KONDO T, 1994, MACROMOLECULES, V27, P210, DOI 10.1021/ma00079a031
   Langmaier F, 2008, J THERM ANAL CALORIM, V93, P547, DOI 10.1007/s10973-007-8293-3
   Langmaier F., 2001, International Journal of Cosmetic Science, V23, P193, DOI 10.1046/j.0412-5463.2001.00081.x
   Langmaier F, 2002, Int J Cosmet Sci, V24, P273, DOI 10.1046/j.1467-2494.2002.00151.x
   Langmaler F, 2008, WASTE MANAGE, V28, P549, DOI 10.1016/j.wasman.2007.02.003
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2004, CARBOHYD POLYM, V56, P251, DOI 10.1016/j.carbpol.2003.04.001
   Lee SW, 2003, ANAL CHIM ACTA, V480, P267, DOI 10.1016/S0003-2670(03)00023-0
   Liang SM, 2007, MACROMOL CHEM PHYSIC, V208, P594, DOI 10.1002/macp.200600579
   Lii CY, 2002, CARBOHYD POLYM, V50, P19, DOI 10.1016/S0144-8617(01)00372-1
   Lin SB, 2009, FOOD HYDROCOLLOID, V23, P2195, DOI 10.1016/j.foodhyd.2009.05.011
   Liu SL, 2009, MACROMOL BIOSCI, V9, P29, DOI 10.1002/mabi.200800096
   Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556
   Luo XG, 2010, J CHROMATOGR A, V1217, P5922, DOI 10.1016/j.chroma.2010.07.026
   Mascal M., 2008, ANGEW CHEM, V120, P8042, DOI DOI 10.1002/ANGE.200801594
   Morimura S, 2002, PROCESS BIOCHEM, V37, P1403, DOI 10.1016/S0032-9592(02)00024-9
   Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Olivas GI, 2008, LWT-FOOD SCI TECHNOL, V41, P359, DOI 10.1016/j.lwt.2007.02.015
   Pei Y, 2011, ACTA POLYM SIN, P1098, DOI 10.3724/SP.J.1105.2011.11143
   Rathna GVN, 1996, J MACROMOL SCI PURE, VA33, P1199, DOI 10.1080/10601329608010914
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Read SM, 2002, SCIENCE, V295, P59, DOI 10.1126/science.1068155
   Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   SAITO H, 1992, J BIOCHEM-TOKYO, V111, P376, DOI 10.1093/oxfordjournals.jbchem.a123765
   Sun YX, 2008, J BIOMED MATER RES A, V84A, P1102, DOI 10.1002/jbm.a.31520
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   Wiegand C, 2006, CELLULOSE, V13, P689, DOI 10.1007/s10570-006-9073-0
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang G, 2001, J APPL POLYM SCI, V81, P3260, DOI 10.1002/app.1781
   Yang QL, 2009, MACROMOL BIOSCI, V9, P849, DOI 10.1002/mabi.200900008
   Zeng X, 2009, PHARM RES-DORDR, V26, P1931, DOI 10.1007/s11095-009-9920-4
NR 61
TC 25
Z9 30
U1 2
U2 148
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2013
VL 92
IS 2
BP 1752
EP 1760
DI 10.1016/j.carbpol.2012.11.029
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 099JI
UT WOS:000315616900102
PM 23399216
DA 2018-10-20
ER

PT J
AU Li, ZZ
   Cho, S
   Kwon, IC
   Janat-Amsbury, MM
   Huh, KM
AF Li, Zhengzheng
   Cho, Sungpil
   Kwon, Ick Chan
   Janat-Amsbury, Margit M.
   Huh, Kang Moo
TI Preparation and characterization of glycol chitin as a new thermogelling
   polymer for biomedical applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Glycol chitosan; Glycol chitin; N-acetylation; Sol-gel transition;
   Thermogelling system
ID DRUG-DELIVERY SYSTEMS; WATER-SOLUBLE CHITIN; IN-SITU; THERMOSENSITIVE
   HYDROGEL; CHITOSAN; DOXORUBICIN; GEL; RELEASE; NANOPARTICLES;
   DEGRADATION
AB In this study, a new thermo-sensitive polymer, glycol chitin, was synthesized by controlled N-acetylation of glycol chitosan and evaluated as a thermogelling system. The physico-chemical properties of glycol chitins with different degrees of acetylation (DA) were investigated in terms of degradation, cytotoxicity, rheological properties, and in vitro and in vivo gel formation. Aqueous solutions of glycol chitins were flowable freely at room temperature but quickly became a durable gel at body temperature. Thermoreversible sol gel transition properties were observed with fast gelation kinetics. Glycol chitins with higher DA showed faster degradation in the presence of lysozyme. They exhibited no significant biological toxicity against human cell lines. An anti-cancer drug, doxorubicin, could be incorporated into the hydrogel by a simple mixing process and released in a sustained pattern over 13 days. Our findings suggest that glycol chitins could be useful as a new thermogelling biomaterial for drug delivery and injectable tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Li, Zhengzheng; Huh, Kang Moo] Chungnam Natl Univ, Dept Polymer Sci & Engn, Taejon 305764, South Korea.
   [Cho, Sungpil; Janat-Amsbury, Margit M.] Univ Utah, Div Gynecol Oncol, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA.
   [Kwon, Ick Chan] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea.
RP Janat-Amsbury, MM (reprint author), Univ Utah, Div Gynecol Oncol, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA.
EM margit.janat-amsbury@hsc.utah.edu; khuh@cnu.ac.kr
FU Winova Co., Ltd., Republic of Korea; University of Utah
FX This study was partly supported by Winova Co., Ltd., Republic of Korea
   and also partly supported by the University of Utah Faculty and Creative
   Grant [MM.JA].
CR Al-Abd AM, 2010, J CONTROL RELEASE, V142, P101, DOI 10.1016/j.jconrel.2009.10.003
   BALLY MB, 1990, CANCER CHEMOTH PHARM, V27, P13, DOI 10.1007/BF00689270
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   De Groot CJ, 2002, INT J CANCER, V98, P134, DOI 10.1002/ijc.10167
   DEVERDIERE AC, 1994, CANCER CHEMOTH PHARM, V33, P504
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JEONG B, 2001, CHEM COMMUN, V16, P1516
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Knight DK, 2007, J BIOMED MATER RES A, V83A, P787, DOI 10.1002/jbm.a.31430
   Knight DK, 2006, ACS SYM SER, V934, P227
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee J, 2006, POLYMER, V47, P3760, DOI 10.1016/j.polymer.2006.03.109
   Lee SY, 2007, J CONTROL RELEASE, V119, P313, DOI 10.1016/j.jconrel.2007.03.007
   Lee Y, 2010, SOFT MATTER, V6, P977, DOI 10.1039/b919944f
   Missirlis D, 2006, SOFT MATTER, V2, P1067, DOI 10.1039/b607437e
   Muzzarelli RAA, 2007, CARBOHYD POLYM, V70, P274, DOI 10.1016/j.carbpol.2007.04.008
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Omelyanenko V, 1998, J CONTROL RELEASE, V53, P25, DOI 10.1016/S0168-3659(97)00235-6
   Potta T, 2010, BIOMATERIALS, V31, P8107, DOI 10.1016/j.biomaterials.2010.07.029
   RAHMAN A, 1986, BRIT J CANCER, V54, P401, DOI 10.1038/bjc.1986.190
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Sonia TA, 2011, ADV POLYM SCI, V243, P23, DOI 10.1007/12_2011_117
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Tang YF, 2007, CARBOHYD POLYM, V67, P491, DOI 10.1016/j.carbpol.2006.06.015
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Wang J, 2008, RES CHEM INTERMEDIAT, V34, P169, DOI 10.1163/156856708783623483
   Xu Y, 2005, POLYMER, V46, P7410, DOI 10.1016/j.polymer.2005.05.128
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 40
TC 29
Z9 29
U1 1
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2013
VL 92
IS 2
BP 2267
EP 2275
DI 10.1016/j.carbpol.2012.11.068
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 099JI
UT WOS:000315616900173
PM 23399287
DA 2018-10-20
ER

PT J
AU Zhang, ML
   Ruan, CS
   Dou, SH
   Tu, XD
   Ma, YF
   Wang, YL
AF Zhang, Maolan
   Ruan, Changshun
   Dou, Shuhua
   Tu, Xudong
   Ma, Yufei
   Wang, Yuanliang
TI A novel functional biomaterial: Synthesis, characterization and in-vitro
   antibacterial activity
SO MATERIALS LETTERS
LA English
DT Article
DE Antibacterial biomaterial; Ethylenediaminetetraacetic dianhydride;
   1,4-Diaminobutane; Anhydrous piperazine
ID POLYMERS; NANOPARTICLES; INFECTION; ADHESION; DESIGN; FIBERS
AB A novel antibacterial biomaterial (PEB) was prepared with ethylenediaminetetraacetic dianhydride (EDTAD), 1,4-diaminobutane (BOA) and anhydrous piperazine (PP) by a condensation polymerization reaction under simple and mild condition. The obtained material's chemical structure was characterized by Fourier transform infrared spectrometry (FTIR) and H-1 nuclear magnetic resonance (H-1 NMR). Moreover, the antibacterial properties of this material were tested with Staphylococcus aureus by the disc diffusion method and the results revealed that it had an excellent antibacterial activity for S. aureus. Specially, the antibacterial properties of PEB depended on its composition; the greater the content of BOA, the stronger the antibacterial ability. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Zhang, Maolan; Tu, Xudong; Ma, Yufei; Wang, Yuanliang] Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Minist Educ,Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
   [Ruan, Changshun; Dou, Shuhua] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518055, Peoples R China.
RP Wang, YL (reprint author), Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Minist Educ,Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
EM wyl@cqu.edu.cn
FU National Science and Technology Support Program of China
   [2012BAI17B03-4]; National Natural Science Foundation of China
   [11032012, 31200723]; Development of Strategic Emerging Industries of
   Shenzhen Basic Research Project [JCYJ20120617122433296]
FX This study was supported by the National Science and Technology Support
   Program of China (No.2012BAI17B03-4), the National Natural Science
   Foundation of China (Grant nos. 11032012 and 31200723) and the
   Development of Strategic Emerging Industries of Shenzhen Basic Research
   Project (JCYJ20120617122433296).
CR Abid CKVZ, 2010, J APPL POLYM SCI, V116, P1640, DOI 10.1002/app.31510
   Anwar H, 1990, ANTIMICROB AGENTS CH, V71, P101
   Chen CY, 2008, MATER LETT, V62, P3607, DOI 10.1016/j.matlet.2008.04.008
   Chen L, 2008, POLYMER, V49, P1266, DOI 10.1016/j.polymer.2008.01.003
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dong HC, 2011, BIOMACROMOLECULES, V12, P1305, DOI 10.1021/bm200031v
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Lin L, 2011, MATER LETT, V65, P1375, DOI 10.1016/j.matlet.2011.02.006
   Luo YF, 2011, EUR POLYM J, V47, P40, DOI 10.1016/j.eurpolymj.2010.11.001
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ruan CS, 2012, POLYM INT, V61, P524, DOI 10.1002/pi.3197
   Zarchi MAK, 2012, POLYM DEGRAD STABIL, V97, P392, DOI 10.1016/j.polymdegradstab.2011.12.002
NR 13
TC 2
Z9 2
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2013
VL 93
BP 282
EP 284
DI 10.1016/j.matlet.2012.11.103
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 099GA
UT WOS:000315608300077
DA 2018-10-20
ER

PT J
AU Yagati, AK
   Lee, T
   Min, J
   Choi, JW
AF Yagati, Ajay Kumar
   Lee, Taek
   Min, Junhong
   Choi, Jeong-Woo
TI A robust nanoscale biomemory device composed of recombinant azurin on
   hexagonally packed Au-nano array
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Proceedings Paper
CT 22nd Anniversary World Congress on Biosensors / Summer School on Printed
   Biosensors and Electronics
CY MAY 15-18, 2012
CL Cancun, MEXICO
SP Elsevier, Linkoping Univ, Erkon
DE Recombinant azurin; Cyclic voltammetry; Electrochemical scanning
   tunneling microscopy; Nanosphere; Nanoscale biomemory; Nanobiochip
ID SCANNING TUNNELING MICROSCOPE; NANOSPHERE LITHOGRAPHY; GOLD;
   NANOPARTICLES; FERREDOXIN; VARIANTS; STORAGE; SURFACE
AB We developed a nanoscale memory device consisting of signal-responsive biomaterial, which is capable of switching physical properties (such as electrical/electrochemical, optical, and magnetic) upon application of appropriate electrical signals to perform memory switching. Here, we propose a highly robust surface-confined switch composed of an electroactive cysteine-modified azurin immobilized on an Au hexagonal pattern formed on indium tin oxide (ITO) substrates that can be controlled electrochemically and reversibly converted between its redox states. The memory effect is based on conductance switching, which leads to the occurrence of bistable states and behaves as an extremely robust redox switch in which an electrochemical input is transduced into optical and magnetic outputs under ambient conditions. The fact that this molecular surface switch, operating at very low voltages, can be patterned and addressed locally, and also has good stability and excellent reversibility, makes it a promising platform for nonvolatile memory devices. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Lee, Taek; Choi, Jeong-Woo] Sogang Univ, Dept Chem & Biomol Engn, Seoul 121742, South Korea.
   [Yagati, Ajay Kumar; Choi, Jeong-Woo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 121742, South Korea.
   [Min, Junhong] Chung Ang Univ, Sch Integrat Engn, Seoul 156756, South Korea.
RP Choi, JW (reprint author), Sogang Univ, Dept Chem & Biomol Engn, 35 Baekbeom Ro Sinsu Dong, Seoul 121742, South Korea.
EM jwchoi@sogang.ac.kr
RI Yagati, Ajay Kumar/C-4959-2012
OI Yagati, Ajay Kumar/0000-0003-1177-5816; Min, Junhong/0000-0001-9410-8204
CR Behringer RE, 1996, APPL PHYS LETT, V68, P1034, DOI 10.1063/1.116239
   Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n
   Choi JW, 2009, BIOCHIP J, V3, P157
   EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0
   GROENEVELD CM, 1985, EUR J BIOCHEM, V153, P559, DOI 10.1111/j.1432-1033.1985.tb09337.x
   HAN J, 1993, J AM CHEM SOC, V115, P4256, DOI 10.1021/ja00063a048
   Hao E, 2004, NANO LETT, V4, P327, DOI 10.1021/nl0351542
   Jung M, 2004, ELECTROCHIM ACTA, V50, P857, DOI 10.1016/j.electacta.2004.02.057
   Lee T, 2011, BIOMATERIALS, V32, P3815, DOI 10.1016/j.biomaterials.2011.01.072
   Lee T, 2010, ADV MATER, V22, P510, DOI 10.1002/adma.200902288
   Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648
   Liz-Marzan LM, 2004, MATER TODAY, V7, P26, DOI 10.1016/S1369-7021(04)00080-X
   Pham LQ, 2011, RADIAT PHYS CHEM, V80, P638, DOI 10.1016/j.radphyschem.2011.01.004
   Rinaldi R, 2002, ADV MATER, V14, P1453, DOI 10.1002/1521-4095(20021016)14:20<1453::AID-ADMA1453>3.0.CO;2-C
   RODER H, 1993, NATURE, V366, P141, DOI 10.1038/366141a0
   Sau TK, 2010, ADV MATER, V22, P1805, DOI 10.1002/adma.200902557
   SOLOMON EI, 1980, J AM CHEM SOC, V102, P168, DOI 10.1021/ja00521a029
   STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319
   Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55
   Vaseashta A, 2005, SCI TECHNOL ADV MAT, V6, P312, DOI 10.1016/j.stam.2005.02.018
   Waser R, 2004, NAT MATER, V3, P81, DOI 10.1038/nmat1067
   Whitney AV, 2004, NANO LETT, V4, P1507, DOI 10.1021/nl049345w
   Williams JA, 2007, LANGMUIR, V23, P3103, DOI 10.1021/la061472f
   Winzer M, 1996, APPL PHYS A-MATER, V63, P617
   Yagati AK, 2010, J NANOSCI NANOTECHNO, V10, P3220, DOI 10.1166/jnn.2010.2229
   Yagati AK, 2009, ELECTROCHEM COMMUN, V11, P854, DOI 10.1016/j.elecom.2009.02.014
   Yagati AK, 2009, BIOSENS BIOELECTRON, V24, P1503, DOI 10.1016/j.bios.2008.07.080
   Zuppella P, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115303
NR 28
TC 18
Z9 18
U1 0
U2 37
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD FEB 15
PY 2013
VL 40
IS 1
SI SI
BP 283
EP 290
DI 10.1016/j.bios.2012.07.055
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 061CX
UT WOS:000312825800045
PM 22884649
DA 2018-10-20
ER

PT J
AU Mochales, C
   Frank, S
   Zehbe, R
   Traykova, T
   Fleckenstein, C
   Maerten, A
   Fleck, C
   Mueller, WD
AF Mochales, Carolina
   Frank, Stefan
   Zehbe, Rolf
   Traykova, Tania
   Fleckenstein, Christine
   Maerten, Anke
   Fleck, Claudia
   Mueller, Wolf-Dieter
TI Tetragonal and Cubic Zirconia Multi layered Ceramic Constructs Created
   by EPD
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MECHANICAL-PROPERTIES; COMPOSITE ELECTROLYTES; DEPOSITION; COATINGS;
   PHASE; BIOMATERIAL; SYSTEM; CELLS
AB The interest in electrophoretic deposition (EPD) for nanomaterials and ceramics production has widely increased due to the versatility of this technique to effectively combine different materials in unique shapes and structures. We successfully established an EPD layering process with submicrometer sized powders of Y-TZP with different mol percentages of yttrium oxide (3 and 8%) and produced multilayers of alternating tetragonal and cubic phases with a clearly defined interface. The rationale behind the design of these multilayer constructs was to optimize the properties of the final ceramic by combining the high mechanical toughness of the tetragonal phase of zirconia together with the high ionic conductivity of its cubic phase. In this work, a preliminary study of the mechanical properties of these constructs proved the good mechanical integrity of the multilayered constructs obtained as well as crack deflection in the interface between tetragonal and cubic zirconia layers.
C1 [Mochales, Carolina; Frank, Stefan; Fleckenstein, Christine; Mueller, Wolf-Dieter] Charite, Sch Dent, D-14197 Berlin, Germany.
   [Zehbe, Rolf; Traykova, Tania; Maerten, Anke; Fleck, Claudia] Berlin Inst Technol, D-10623 Berlin, Germany.
RP Mochales, C (reprint author), Charite, Sch Dent, D-14197 Berlin, Germany.
EM carolina.mochales-palau@charite.de
RI Maerten, Anke/A-8704-2012
OI Zehbe, Rolf/0000-0002-0169-9058
FU DFG (Deutsche Forschungsgemeinschaft) [SPP1420]
FX The authors thank the "Zentraleinrichtung Elektronenmikroskopie" (ZELMI)
   for EDX and SEM analysis, as well as Dr. Uwe Kuhlmann (Technische
   Universitat Berlin, Department of Chemistry, Max-Volmer-Laboratory) for
   supplying the Raman spectra. We gratefully acknowledge the financial
   support of the DFG (Deutsche Forschungsgemeinschaft) for our project
   within SPP1420 (http:
   //spp1420.mpikg.mpg.de/projects/hierarchy-of-microstructural-features-as
   -the-origin-of-fracture-resistance-in-dentine-and-ceramic-composites).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Bocanegra-Bernal MH, 2002, J MATER SCI, V37, P4947, DOI 10.1023/A:1021099308957
   Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3
   Chen LB, 2006, SURF REV LETT, V13, P535, DOI 10.1142/S0218625X06008670
   Chen Y, 2012, J POWER SOURCES, V213, P93, DOI 10.1016/j.jpowsour.2012.03.109
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Corni I, 2008, J EUR CERAM SOC, V28, P1353, DOI 10.1016/j.jeurceramsoc.2007.12.011
   DROUIN D, 2002, MONTE CARLO SIMULATI
   Ferrari B, 2010, J EUR CERAM SOC, V30, P1069, DOI 10.1016/j.jeurceramsoc.2009.08.022
   Ghatee M, 2010, INT J HYDROGEN ENERG, V35, P9427, DOI 10.1016/j.ijhydene.2010.02.120
   Ghatee M, 2009, SOLID STATE IONICS, V180, P57, DOI 10.1016/j.ssi.2008.10.006
   Goswami B, 2004, HIGH TEMP MAT PR-ISR, V23, P73
   Graeve O.A., 2008, CERAMIC GLASS MAT ST, P169
   Green D. J., 1989, TRANSFORMATION TOUGH
   Keyvani A, 2012, J ALLOY COMPD, V541, P488, DOI 10.1016/j.jallcom.2012.06.062
   LANGE FF, 1982, J MATER SCI, V17, P235, DOI 10.1007/BF00809058
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Moritz K, 2010, J EUR CERAM SOC, V30, P1203, DOI 10.1016/j.jeurceramsoc.2009.05.034
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Roos E, 2012, CERAM INT, V38, P3317, DOI 10.1016/j.ceramint.2011.12.041
   SARKAR P, 1993, CERAM ENG SCI P, V14, P707
   SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853
   Shao ZP, 2012, PROG MATER SCI, V57, P804, DOI 10.1016/j.pmatsci.2011.08.002
   Suciu C, 2012, CERAM INT, V38, P357, DOI 10.1016/j.ceramint.2011.07.014
   Tiwari SK, 2012, CORROS SCI, V63, P334, DOI 10.1016/j.corsci.2012.06.026
   Zehbe R, 2010, ACTA BIOMATER, V6, P2097, DOI 10.1016/j.actbio.2009.11.020
NR 28
TC 4
Z9 4
U1 1
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD FEB 14
PY 2013
VL 117
IS 6
BP 1694
EP 1701
DI 10.1021/jp3064432
PG 8
WC Chemistry, Physical
SC Chemistry
GA 093HF
UT WOS:000315181600026
PM 23130870
DA 2018-10-20
ER

PT J
AU Zhong, J
   Ma, MJ
   Zhou, J
   Wei, DX
   Yan, ZG
   He, DN
AF Zhong, Jian
   Ma, Mengjia
   Zhou, Juan
   Wei, Daixu
   Yan, Zhigiang
   He, Dannong
TI Tip-Induced Micropatterning of Silk Fibroin Protein Using In Situ
   Solution Atomic Force Microscopy
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE contact mode; in situ solution atomic force microscopy; silk fibroin;
   sol-gel transition; tapping mode; tip-induced micropatterning
ID DIP-PEN NANOLITHOGRAPHY; SELF-ASSEMBLED MONOLAYERS; SCANNING PROBE
   LITHOGRAPHY; TAPPING MODE; SURFACE; NANOSTRUCTURES; FABRICATION;
   NANOPARTICLES; BIOMOLECULES; BIOMATERIAL
AB Silk fibroin (SF) is a promising candidate for a variety of application in the fields of tissue engineering, drug delivery, and biomedical optics. Recent research has already begun to explore the construction of nano- and micropatterned SF films under ambient environment. The structure and biocompatibility of SF are dependent on SF state (solution or solid) and the method of drying the SF solution to prepare various biomaterials such as films, sponges, and fibers. Therefore, it is important to explore the construction of SF nano- and micropatterns under aqueous solution. This paper reports a novel application of atomic force microscopy (AFM) under liquid for direct deposition of the relatively hydrophobic protein SF onto hydrophilic mica. We demonstrate that the AFM tip, in either the contact or the tapping mode, can fabricate SF micropatterns on mica with controlled surface topography. We show that the deposition process requires a mechanical force-induced SF sol-gel transition followed by a transfer to the mica surface at the tip-surface contact, and the efficiency of this process depends on not only AFM operation mode but also the SF bulk concentration, the SF amount on mica, and the AFM tip spring constant.
C1 [Zhong, Jian; Zhou, Juan; Wei, Daixu; Yan, Zhigiang; He, Dannong] Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
   [Ma, Mengjia; He, Dannong] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Shanghai 200240, Peoples R China.
RP Zhong, J (reprint author), Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
EM jianzhongpku@hotmail.com
RI Yan, Zhiqiang/O-5832-2017; Yan, Zhiqiang/P-9909-2017; Zhong,
   Jian/B-3743-2015
OI Yan, Zhiqiang/0000-0002-3176-5757; Zhong, Jian/0000-0002-2475-3221; He,
   Dannong/0000-0003-4921-1063
FU National Natural Science Foundation of China [51203024]; National High
   Technology Research and Development Program of China (863 Program)
   [2012AA030309]; Shanghai Pujiang Talent Program [12PJ1430300]; Special
   Fund for Talents in Minhang District of Shanghai; Shanghai Municipal
   Science and Technology Commission [11ZR1425200]
FX This research has been supported by research grants from the National
   Natural Science Foundation of China (51203024), the National High
   Technology Research and Development Program of China (863 Program
   2012AA030309), Shanghai Pujiang Talent Program (12PJ1430300), the
   Special Fund for Talents in Minhang District of Shanghai (2012), and the
   Shanghai Municipal Science and Technology Commission (11ZR1425200). We
   thank Prof. Zhifeng Shao (Shanghai Jiao Tong University) for his helpful
   discussions and English editing. We also thank the Instrumental Analysis
   Center of Shanghai Jiao Tong University for the use of Jasco J-815
   spectrometer.
CR Agarwal G, 2003, J AM CHEM SOC, V125, P580, DOI 10.1021/ja020471g
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Cheung CL, 2003, J AM CHEM SOC, V125, P6848, DOI 10.1021/ja034479h
   Cho Y, 2004, J PHYS CHEM B, V108, P15223, DOI 10.1021/jp048359n
   Czajkowsky DM, 2012, ACS NANO, V6, P190, DOI 10.1021/nn203356p
   Demers LM, 2002, SCIENCE, V296, P1836, DOI 10.1126/science.1071480
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Glezos N, 2002, BIOSENS BIOELECTRON, V17, P279, DOI 10.1016/S0956-5663(01)00295-0
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Harnett CK, 2001, LANGMUIR, V17, P178, DOI 10.1021/la0009543
   Holland C, 2012, SOFT MATTER, V8, P2590, DOI 10.1039/c2sm06886a
   Inoue S, 2003, NANO LETT, V3, P1329, DOI 10.1021/nl0340327
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Jiang HZ, 2005, LANGMUIR, V21, P5242, DOI 10.1021/la0501785
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Ke L, 2012, ACS APPL MATER INTER, V4, P1247, DOI 10.1021/am201391f
   Kim M, 2011, ADV MATER, V23, P5684, DOI 10.1002/adma.201103316
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kramer S, 2003, CHEM REV, V103, P4367, DOI 10.1021/cr020704m
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Lenhert S, 2010, SCANNING, V32, P15, DOI 10.1002/sca.20166
   Li HW, 2003, LANGMUIR, V19, P1963, DOI 10.1021/la0269098
   Liang J, 2007, LANGMUIR, V23, P6142, DOI 10.1021/la063385t
   Liu GY, 2000, ACCOUNTS CHEM RES, V33, P457, DOI 10.1021/ar980081s
   Liu XG, 2002, ADV MATER, V14, P231, DOI 10.1002/1521-4095(20020205)14:3<231::AID-ADMA231>3.0.CO;2-R
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Martinez-Otero A, 2011, CHEM COMMUN, V47, P6864, DOI 10.1039/c0cc03838e
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mirkin CA, 2007, ACS NANO, V1, P79, DOI 10.1021/nn700228m
   Nam J.M., 2004, ANGEW CHEM, V116, P1266
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Noy A, 2002, NANO LETT, V2, P109, DOI 10.1021/nl010081c
   Onses MS, 2011, ACS NANO, V5, P7899, DOI 10.1021/nn2021277
   Pernites RB, 2011, ACS APPL MATER INTER, V3, P817, DOI 10.1021/am101168g
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332
   Rozhok S, 2005, SMALL, V1, P445, DOI 10.1002/smll.200400072
   Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   Shi SL, 2011, ACS APPL MATER INTER, V3, P4174, DOI 10.1021/am2010338
   Sistiabudi R, 2007, J PHYS CHEM C, V111, P11676, DOI 10.1021/jp072757j
   Smith JC, 2003, NANO LETT, V3, P883, DOI 10.1021/nl025956h
   Soh HT, 2001, SCANNING PROBE LITHO
   Truskett VN, 2006, TRENDS BIOTECHNOL, V24, P312, DOI 10.1016/j.tibtech.2006.05.005
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang WCM, 2008, ACS NANO, V2, P2135, DOI 10.1021/nn8005416
   Wang XH, 2010, ACS APPL MATER INTER, V2, P2904, DOI 10.1021/am1005964
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wong LS, 2012, NANOSCALE, V4, P659, DOI 10.1039/c1nr11443c
   Wu CC, 2011, SMALL, V7, P989, DOI 10.1002/smll.201001749
   Wu CC, 2010, ACS NANO, V4, P1083, DOI 10.1021/nn901270c
   Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   Yan YD, 2010, SMALL, V6, P724, DOI 10.1002/smll.200901947
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang FC, 2010, ACS NANO, V4, P5791, DOI 10.1021/nn101541m
   Zhang Y, 2002, NANO LETT, V2, P1389, DOI 10.1021/nl0202298
   Zhang Y, 2011, MICROSC RES TECHNIQ, V74, P614, DOI 10.1002/jemt.20925
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zheng JW, 2000, LANGMUIR, V16, P9673, DOI 10.1021/la000705e
   Zheng ZK, 2010, J PHYS CHEM C, V114, P19220, DOI 10.1021/jp106296x
   Zhong J, 2011, INTEGR BIOL-UK, V3, P632, DOI 10.1039/c0ib00157k
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou J, 2009, INT J BIOL MACROMOL, V45, P504, DOI 10.1016/j.ijbiomac.2009.09.006
   Zhou XZ, 2011, SMALL, V7, P2273, DOI 10.1002/smll.201002381
   Zhou XZ, 2011, CHEM SOC REV, V40, P5221, DOI 10.1039/c1cs15045f
   Zhou XC, 2011, NANOSCALE, V3, P4929, DOI 10.1039/c1nr11238d
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 74
TC 25
Z9 25
U1 2
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 13
PY 2013
VL 5
IS 3
BP 737
EP 746
DI 10.1021/am302271g
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 091WE
UT WOS:000315079700037
PM 23276203
DA 2018-10-20
ER

PT J
AU Pripotnev, S
   Walker, K
   Coyle, M
   Filardo, F
   Dargaville, B
   Rasoul, F
   Tsai, E
AF Pripotnev, Stahs
   Walker, Krystal
   Coyle, Matt
   Filardo, Fiona
   Dargaville, Bronwin
   Rasoul, Firas
   Tsai, Eve
TI The Effects of UV Sterilization of a Poly(Caprolactone-Urethane)
   Biomaterial on Rodent Brain and Spinal Cord Neural Progenitor Cell
   Biocompatibility
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY MAR 16-23, 2013
CL San Diego, CA
SP Amer Acad Neurol
C1 [Pripotnev, Stahs] Schulich Sch Med & Dent, Nepean, ON, Canada.
   [Walker, Krystal; Tsai, Eve] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
   [Coyle, Matt] Univ Ottawa, Ottawa, ON, Canada.
   [Filardo, Fiona; Dargaville, Bronwin; Rasoul, Firas] Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
   [Dargaville, Bronwin; Rasoul, Firas] Ctr Adv Imaging, Brisbane, Qld, Australia.
RI Tsai, Eve/D-7007-2014
OI Tsai, Eve/0000-0002-8152-349X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 12
PY 2013
VL 80
SU S
MA P03262
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA AB8VR
UT WOS:000332068602230
DA 2018-10-20
ER

PT J
AU Ward, A
   Quinn, KP
   Bellas, E
   Georgakoudi, I
   Kaplan, DL
AF Ward, Andrew
   Quinn, Kyle P.
   Bellas, Evangelia
   Georgakoudi, Irene
   Kaplan, David L.
TI Noninvasive Metabolic Imaging of Engineered 3D Human Adipose Tissue in a
   Perfusion Bioreactor
SO PLOS ONE
LA English
DT Article
ID SILK FIBROIN; IN-VITRO; BLADDER AUGMENTATION; STEM-CELLS; BIOMATERIAL;
   MODEL; VIVO
AB The efficacy and economy of most in vitro human models used in research is limited by the lack of a physiologically-relevant three-dimensional perfused environment and the inability to noninvasively quantify the structural and biochemical characteristics of the tissue. The goal of this project was to develop a perfusion bioreactor system compatible with two-photon imaging to noninvasively assess tissue engineered human adipose tissue structure and function in vitro. Three-dimensional (3D) vascularized human adipose tissues were engineered in vitro, before being introduced to a perfusion environment and tracked over time by automated quantification of endogenous markers of metabolism using two-photon excited fluorescence (TPEF). Depth-resolved image stacks were analyzed for redox ratio metabolic profiling and compared to prior analyses performed on 3D engineered adipose tissue in static culture. Traditional assessments with H&E staining were used to qualitatively measure extracellular matrix generation and cell density with respect to location within the tissue. The distribution of cells within the tissue and average cellular redox ratios were different between static and perfusion cultures, while the trends of decreased redox ratio and increased cellular proliferation with time in both static and perfusion cultures were similar. These results establish a basis for noninvasive optical tracking of tissue structure and function in vitro, which can be applied to future studies to assess tissue development or drug toxicity screening and disease progression.
C1 [Ward, Andrew; Quinn, Kyle P.; Bellas, Evangelia; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
OI Quinn, Kyle/0000-0002-6876-3608
FU National Institutes of Health (NIH) [P41 EB002520-05]; National
   Institute of Biomedical Imaging and Bioengineering/NIH [R01EB007542];
   National Institute of Arthritis and Musculoskeletal and Skin
   Diseases/NIH [F32AR061933]; Armed Forces Institute of Regenerative
   Medicine
FX All funding for this project was from the National Institutes of Health
   (NIH) (grant P41 EB002520-05 (Tissue Engineering Resource Center),
   R01EB007542 from National Institute of Biomedical Imaging and
   Bioengineering/NIH and F32AR061933 from National Institute of Arthritis
   and Musculoskeletal and Skin Diseases/NIH). The authors also thank Armed
   Forces Institute of Regenerative Medicine for support. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169
   Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]
   Fournier RL, 1999, BASIC TRANSPORT PHEN
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Georgakoudi I, 2012, ANN REV BIOMED ENG
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024
   Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352
   Job Charles K, 2003, Indian J Pathol Microbiol, V46, P541
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470
   Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Provenzano PP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940365
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Ren JG, 2010, PLOS ONE, V5
   Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019
   Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Soini E, 2000, BIOCHEM SOC T, V28, P70, DOI 10.1042/bst0280070
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 26
TC 18
Z9 18
U1 1
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2013
VL 8
IS 2
AR e55696
DI 10.1371/journal.pone.0055696
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 092WJ
UT WOS:000315153400144
PM 23405199
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Singh, A
   Zhan, JA
   Ye, ZY
   Elisseeff, JH
AF Singh, Anirudha
   Zhan, Jianan
   Ye, Zhaoyang
   Elisseeff, Jennifer H.
TI Modular Multifunctional Poly(ethylene glycol) Hydrogels for Stem Cell
   Differentiation
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE functional biomaterials; poly(ethylene glycol); -cyclodextrin; tissue
   engineering; hydrogels
ID HYDROLYZABLE POLYROTAXANE; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY;
   ADHESION; BIOMATERIALS; SCAFFOLDS; BINDING; CYCLODEXTRINS;
   OPPORTUNITIES; REGENERATION
AB Synthetic polymers are employed to create highly defined microenvironments with controlled biochemical and biophysical properties for cell culture and tissue engineering. Chemical modification is required to input biological or chemical ligands, which often changes the fundamental structural properties of the material. Here, a simple modular biomaterial design strategy is reported that employs functional cyclodextrin nanobeads threaded onto poly(ethylene glycol) (PEG) polymer necklaces to form multifunctional hydrogels. Nanobeads with desired chemical or biological functionalities can be simply threaded onto the PEG chains to form hydrogels, creating an accessible platform for users. The design and synthesis of these multifunctional hydrogels are described, structure-property relationships are elucidated, and applications ranging from stem cell culture and differentiation to tissue engineering are demonstrated.
C1 [Singh, Anirudha; Zhan, Jianan; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21231 USA.
   [Singh, Anirudha; Zhan, Jianan; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Ye, Zhaoyang] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China.
RP Singh, A (reprint author), Johns Hopkins Univ, Wilmer Eye Inst, 400 N Broadway,Robert H & Clarice Smith Bldg, Baltimore, MD 21231 USA.
EM jhe@jhu.edu
RI Zhan, Jianan/B-6448-2018
FU Maryland Stem Cell Research Foundation; National Science Foundation
   [CMMI 0948053]; Jules Stein Chair; National Institutes of Health [NIDCR
   R01DE016887]
FX The authors gratefully acknowledge the Maryland Stem Cell Research
   Foundation for a Postdoctoral research fellowship (A. S.), National
   Science Foundation (CMMI 0948053), the Jules Stein Chair and National
   Institutes of Health (NIDCR R01DE016887) for financial support. They
   also thank Dr. Qiongyu Guo and Prof. Denise Montell of Johns Hopkins
   University for their valuable suggestions and comments of this
   manuscript.
CR ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Cairo CW, 2002, J AM CHEM SOC, V124, P1615, DOI 10.1021/ja016727k
   Ceccato M, 1997, LANGMUIR, V13, P2436, DOI 10.1021/la9609231
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Fujimoto M, 2005, J BIOMAT SCI-POLYM E, V16, P1611, DOI 10.1163/156856205774576664
   Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   Hein CD, 2010, MACROMOL BIOSCI, V10, P1544, DOI 10.1002/mabi.201000205
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang NS, 2011, CELL TISSUE RES, V344, P499, DOI 10.1007/s00441-011-1153-2
   Hyun H, 2011, MACROMOL BIOSCI, V11, P765, DOI 10.1002/mabi.201000507
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Khan AR, 1998, CHEM REV, V98, P1977, DOI 10.1021/cr970012b
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kopecek J, 2009, J POLYM SCI POL CHEM, V47, P5929, DOI 10.1002/pola.23607
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570
   Li JJ, 2011, ADV BIOCHEM ENG BIOT, V125, P207, DOI 10.1007/10_2010_91
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Loethen S, 2007, POLYM REV, V47, P383, DOI 10.1080/15583720701455145
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nelson A, 2004, J AM CHEM SOC, V126, P11914, DOI 10.1021/ja0491073
   Tran NQ, 2011, MACROMOL RES, V19, P300, DOI 10.1007/s13233-011-0309-y
   Onagi H, 2003, CHEM-EUR J, V9, P5978, DOI 10.1002/chem.200305280
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Tachaboonyakiat W, 2004, J BIOMAT SCI-POLYM E, V15, P1389, DOI 10.1163/1568562042368086
   van de Manakker F, 2009, BIOMACROMOLECULES, V10, P3157, DOI 10.1021/bm901065f
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Watanabe J, 2002, BIOMATERIALS, V23, P4041, DOI 10.1016/S0142-9612(02)00122-9
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001
   Yui N, 2006, CHEM-EUR J, V12, P6730, DOI 10.1002/chem.200600370
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 50
TC 26
Z9 26
U1 2
U2 95
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD FEB 5
PY 2013
VL 23
IS 5
BP 575
EP 582
DI 10.1002/adfm.201201902
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 083MO
UT WOS:000314468600006
DA 2018-10-20
ER

PT J
AU Wach, RA
   Adamus, A
   Olejnik, AK
   Dzierzawska, J
   Rosiak, JM
AF Wach, Radoslaw A.
   Adamus, Agnieszka
   Olejnik, Alicja K.
   Dzierzawska, Joanna
   Rosiak, Janusz M.
TI Nerve guidance channels based on PLLA-PTMC biomaterial
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; electron beam irradiation; nerve regeneration;
   poly(L-lactic acid); poly(trimethylene carbonate)
ID RADIATION CROSS-LINKING; TRIMETHYLENE CARBONATE; L-LACTIDE;
   POLY(TRIMETHYLENE CARBONATE); 1,3-TRIMETHYLENE CARBONATE;
   EPSILON-CAPROLACTONE; AQUEOUS-SOLUTIONS; REGENERATION; COPOLYMERS;
   CONDUITS
AB Biodegradable polymers of poly(lactic acid) (PLLA) and synthesized in-house poly(trimethylene carbonate) (PTMC) with admixture of water-soluble methyl cellulose (MC) were used for development of nerve guidance tubes for peripheral nervous system regeneration after injury. Fabrication method involved phase separation of viscous dixane solution of polymers mixture seat on a rod in a proper nonsolvent, which resulted in tubular structure of large porosity. Influence of electron beam sterilization on molecular weight, thermal properties of the polymers, and mechanical performance of the tubes was evaluated. Admixture of hydrophilic MC to synthetic polymers resulted in modification of mechanical properties of the channels. Extraction of MC showed potential of the tubes for releasing water-soluble bioactive molecules, such as for instance growth factors. Basic in vitro MTT and LDH assays showed no cytotoxic effect of manufactured tubes, therefore, animal experimentations may be considered. (c) 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013
C1 [Wach, Radoslaw A.; Adamus, Agnieszka; Olejnik, Alicja K.; Dzierzawska, Joanna; Rosiak, Janusz M.] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, PL-90924 Lodz, Poland.
RP Wach, RA (reprint author), Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, Wroblewskiego 15, PL-90924 Lodz, Poland.
EM wach@mitr.p.lodz.pl
FU European Commission ['NerveRegeneration' MIGR-CT-2007-206269]; Ministry
   of Science and Higher Education, Poland: SPB [843/7 PR UE/2008/7]
FX This work has been financed by the European Commission project
   'NerveRegeneration' MIGR-CT-2007-206269 within 7FP and by the Ministry
   of Science and Higher Education, Poland: SPB grant 843/7 PR UE/2008/7.
CR Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   [Anonymous], 1999, POLYM DATA HDB, P627
   Belkas JS, 2004, OPER TECH ORTHOP, V14, P190
   Booth A. F., 1999, STERILIZATION MED DE, P71
   Chiang HY, 2005, J NEUROPATH EXP NEUR, V64, P576, DOI 10.1097/01.jnen.0000171654.24836.bd
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dickson G.R., 2011, J POLYM DEGRAD STAB, V96, P76
   DUDA A, 1994, MACROMOL RAPID COMM, V15, P559, DOI 10.1002/marc.1994.030150617
   Evans GRD, 2000, J BIOMAT SCI-POLYM E, V11, P869, DOI 10.1163/156856200744066
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hashimoto T, 2005, J MATER SCI-MATER M, V16, P503, DOI 10.1007/s10856-005-0524-1
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jozwiakowska J, 2011, POLYM DEGRAD STABIL, V96, P1430, DOI 10.1016/j.polymdegradstab.2011.05.010
   Kowalska-Ludwicka K, ARCH MED SC IN PRESS
   Loo SCJ, 2004, POLYM DEGRAD STABIL, V83, P259, DOI 10.1016/S0141-3910(03)00271-4
   Luis AL, 2007, BIO-MED MATER ENG, V17, P39
   Middleton J.C., 1998, J MED PLAST BIOMATER, V5, P30
   Nair S.L., 2007, PROG POLYM SCI, V32, P762
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   Penkert G., 2004, PERIPHERAL NERVE LES, P23
   Pierucci A, 2008, TISSUE ENG PT A, V14, P595, DOI 10.1089/tea.2007.0271
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031
   Ruckenstein E, 1998, J APPL POLYM SCI, V69, P1429, DOI 10.1002/(SICI)1097-4628(19980815)69:7<1429::AID-APP18>3.0.CO;2-O
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Song Y, 2010, ACTA BIOMATER, V6, P1269, DOI 10.1016/j.actbio.2009.10.002
   Sowik P., 2008, THESIS TU LODZ LODZ
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Wach R. A., 2002, THESIS GUNMA U JAPAN
   Wach RA, 2003, RADIAT PHYS CHEM, V68, P771, DOI 10.1016/S0969-806X(03)00403-1
   Wach RA, 2003, NUCL INSTRUM METH B, V211, P533, DOI 10.1016/S0168-583X(03)01513-1
   Wach RA, 2002, MACROMOL MATER ENG, V287, P285, DOI 10.1002/1439-2054(20020401)287:4<285::AID-MAME285>3.0.CO;2-3
   WANG H, 2003, OPERATIVE TECHNIQUES, V9, P59
   Weir NA, 2004, P I MECH ENG H, V218, P307, DOI 10.1243/0954411041932782
   WILLIAMS LR, 1987, NEUROCHEM RES, V12, P851, DOI 10.1007/BF00966306
   YOSHIOKA S, 1995, RADIAT PHYS CHEM, V46, P281, DOI 10.1016/0969-806X(95)00025-S
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
   Zhang Z., 2006, J CONTROL RELEASE, V116, P28
   Zhou Z, 2008, J APPL POLYM SCI, V107, P3267, DOI 10.1002/app.27323
NR 47
TC 7
Z9 8
U1 3
U2 62
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 5
PY 2013
VL 127
IS 3
BP 2259
EP 2268
DI 10.1002/app.37932
PG 10
WC Polymer Science
SC Polymer Science
GA 030XJ
UT WOS:000310603100101
DA 2018-10-20
ER

PT J
AU Cheng, NC
   Estes, BT
   Young, TH
   Guilak, F
AF Cheng, Nai-Chen
   Estes, Bradley T.
   Young, Tai-Horng
   Guilak, Farshid
TI Genipin-Crosslinked Cartilage-Derived Matrix as a Scaffold for Human
   Adipose-Derived Stem Cell Chondrogenesis
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BIOLOGICAL TISSUE FIXATION; COLLAGEN-GAG SCAFFOLDS; IN-VITRO;
   EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES;
   LINKING REAGENT; BONE-MARROW; ENGINEERED CARTILAGE; HYALURONIC-ACID
AB Autologous cell-based tissue engineering using three-dimensional scaffolds holds much promise for the repair of cartilage defects. Previously, we reported on the development of a porous scaffold derived solely from native articular cartilage, which can induce human adipose-derived stem cells (ASCs) to differentiate into a chondrogenic phenotype without exogenous growth factors. However, this ASC-seeded cartilage-derived matrix (CDM) contracts over time in culture, which may limit certain clinical applications. The present study aimed to investigate the ability of chemical crosslinking using a natural biologic crosslinker, genipin, to prevent scaffold contraction while preserving the chondrogenic potential of CDM. CDM scaffolds were crosslinked in various genipin concentrations, seeded with ASCs, and then cultured for 4 weeks to evaluate the influence of chemical crosslinking on scaffold contraction and ASC chondrogenesis. At the highest crosslinking degree of 89%, most cells failed to attach to the scaffolds and resulted in poor formation of a new extracellular matrix. Scaffolds with a low crosslinking density of 4% experienced cell-mediated contraction similar to our original report on noncrosslinked CDM. Using a 0.05% genipin solution, a crosslinking degree of 50% was achieved, and the ASC-seeded constructs exhibited no significant contraction during the culture period. Moreover, expression of cartilage-specific genes, synthesis, and accumulation of cartilage-related macromolecules and the development of mechanical properties were comparable to the original CDM. These findings support the potential use of a moderately (i.e., approximately one-half of the available lysine or hydroxylysine residues being crosslinked) crosslinked CDM as a contraction-free biomaterial for cartilage tissue engineering.
C1 [Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, Durham, NC 27710 USA.
   [Cheng, Nai-Chen; Estes, Bradley T.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   [Cheng, Nai-Chen; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan.
   [Cheng, Nai-Chen; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Cheng, Nai-Chen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Cheng, Naichen/H-7596-2013
OI Cheng, Naichen/0000-0003-4071-5628; Guilak, Farshid/0000-0001-7380-0330
FU National Institutes of Health [AG15768, AR50245, AR48182, AR48852,
   AR057600]; National Taiwan University Hospital [NTUH. 100-1690,
   101-1962]
FX We would like to thank Dr. Melissa McHale for critical comments on the
   manuscript. This work was supported in part by the National Institutes
   of Health grants AG15768, AR50245, AR48182, AR48852, and AR057600, and
   grants from the National Taiwan University Hospital (NTUH. 100-1690 and
   101-1962).
CR Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   BAUMGAERTNER MR, 1990, CLIN ORTHOP RELAT R, P197
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CauichRodriguez JV, 1996, BIOMATERIALS, V17, P2259, DOI 10.1016/0142-9612(96)00058-0
   Chang Y, 2005, J BIOTECHNOL, V120, P207, DOI 10.1016/j.jbiotec.2005.06.029
   Chang Y, 2004, TISSUE ENG, V10, P881, DOI 10.1089/1076327041348509
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Cheng NC, 2011, REGEN MED, V6, P81, DOI [10.2217/rme.10.87, 10.2217/RME.10.87]
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Diekman BO, 2010, J BIOMED MATER RES A, V93A, P994, DOI 10.1002/jbm.a.32589
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Guilak F, 2004, BASIC ORTHOPAEDIC BI, P259
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Jeong CG, 2011, ACTA BIOMATER, V7, P505, DOI 10.1016/j.actbio.2010.08.027
   Johnson LL, 2001, CLIN ORTHOP RELAT R, pS306
   Kim HA, 2001, J RHEUMATOL, V28, P2038
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Lima EG, 2009, J BIOMED MATER RES A, V91A, P692, DOI 10.1002/jbm.a.32305
   Little D, 2010, TISSUE ENG PT A, V16, P2307, DOI 10.1089/ten.tea.2009.0720
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853
   Mobasheri A, 2009, HISTOL HISTOPATHOL, V24, P347, DOI 10.14670/HH-24.347
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106
   Stryer L., 1988, BIOCHEMISTRY-US
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   Thirion S, 2004, METH MOLEC MED, V100, P1
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wei YY, 2008, J ORTHOP RES, V26, P27, DOI 10.1002/jor.20468
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
NR 63
TC 46
Z9 48
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2013
VL 19
IS 3-4
BP 484
EP 496
DI 10.1089/ten.tea.2012.0384
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 069GQ
UT WOS:000313423700017
PM 23088537
OA Green Published
DA 2018-10-20
ER

PT J
AU Remy, M
   Bareille, R
   Rerat, V
   Bourget, C
   Marchand-Brynaert, J
   Bordenave, L
AF Remy, Murielle
   Bareille, Reine
   Rerat, Vincent
   Bourget, Chantal
   Marchand-Brynaert, Jacqueline
   Bordenave, Laurence
TI Polyethylene terephthalate membrane grafted with peptidomimetics:
   endothelial cell compatibility and retention under shear stress
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyethylene terephthalate; surface grafting; biomimetic material;
   endothelial cell; vascular graft; mechanical test
ID NF-KAPPA-B; VASCULAR ENDOTHELIUM; RGD PEPTIDOMIMETICS; GENE-EXPRESSION;
   GRGDS PEPTIDE; IN-VITRO; ADHESION; SURFACE; BIOMATERIALS; ACTIVATION
AB The present work aimed to treat a polyethylene terephthalate (PET) surface to make the biomaterial more attractive' in terms of attachment and shear stress response to endothelial cells with a view to possible applications in vascular grafting. A surface wet-chemistry protocol was applied to graft track-etched PET membranes with RGD peptidomimetics based on the tyrosine template and active at the nano-level vs. isolated human (v3) receptor, which was monitored by X-ray photoelectron spectroscopy, contact angle measurement and atomic force microscopy for characterization. A primary culture of human saphenous vein endothelial cells was used before and after sterilization of the membranes (heat treatment or -ray irradiation) to test the benefit of grafting. The optimal surface concentrations of grafted molecules were around 50pmol/cm(2). Compared to GRGDS, the peptidomimetics promoted cell attachment with similar or slightly better performances. Endothelialized grafted supports were further exposed to 2h of shear stress mimicking arterial conditions. Cells were lost on non-grafted PET whereas cells on grafted polymers sterilized by -ray irradiation withstood forces with no significant difference in focal contacts. At the mRNA level, cells on functionalized PET were able to respond to shear stress with NFkB upregulation. Thus, grafting of peptidomimetics as ligands of the (v3) integrin could be a relevant strategy to improve the adhesion of human endothelial cells and to obtain an efficient endothelialized PET for the surgery of small-diameter vascular prostheses.
C1 [Rerat, Vincent; Marchand-Brynaert, Jacqueline] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium.
   [Remy, Murielle; Bareille, Reine; Bourget, Chantal; Bordenave, Laurence] Univ Bordeaux, U1026, F-33000 Bordeaux, France.
   [Remy, Murielle; Bareille, Reine; Bourget, Chantal; Bordenave, Laurence] INSERM, U1026, F-33000 Bordeaux, France.
   [Bordenave, Laurence] CHU Bordeaux, INSERM, CIC IT Biomat, F-33000 Bordeaux, France.
RP Remy, M (reprint author), Univ Bordeaux, U1026, F-33000 Bordeaux, France.
EM murielle.remy@u-bordeaux2.fr
FU Walloon Government (Belgium) through the BIOWIN program TARGETUM; Fonds
   pour la Recherche Scientifique (F.R.S.-FNRS, Belgium); Fonds pour la
   Recherche dans l'Industrie et l'Agriculture (F.R.I.A.-FNRS, Belgium);
   Universite Catholique de Louvain (UCL, Louvain-la-Neuve, Belgium)
FX This work was supported by the Walloon Government (Belgium) through the
   BIOWIN program TARGETUM, the Fonds pour la Recherche Scientifique
   (F.R.S.-FNRS, Belgium), the Fonds pour la Recherche dans l'Industrie et
   l'Agriculture (F.R.I.A.-FNRS, Belgium), and the Universite Catholique de
   Louvain (UCL, Louvain-la-Neuve, Belgium). V. R. is an F. R. I. A. fellow
   and J.M.-B. is a senior research associate of F. R. S. FNRS. Sabrina
   Devouge is acknowledged for technical assistance. Prof. B. Nysten (UCL)
   is acknowledged for the AFM analyses. Patrick Guitton is thanked for
   graphic assistance.
CR Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Berard X, 2009, ACTA BIOMATER, V5, P1147, DOI 10.1016/j.actbio.2008.10.002
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Biltresse S, 2005, BIOMATERIALS, V26, P4576, DOI 10.1016/j.biomaterials.2004.11.042
   Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440-5.3-337
   Buchalla R, 2006, RADIAT PHYS CHEM, V75, P129, DOI 10.1016/j.radphyschem.2005.05.012
   Cacciari B, 2005, CURR MED CHEM, V12, P51, DOI 10.2174/0929867053363522
   Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Daculsi R, 2008, J BIOMECH, V41, P2781, DOI 10.1016/j.jbiomech.2008.06.003
   Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Du Y, 2008, BIOMATERIALS, V29, P290, DOI 10.1016/j.biomaterials.2007.09.016
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fernandez P, 2006, TISSUE ENG, V12, P1, DOI 10.1089/ten.2006.12.1
   Fievez V, 2009, EUR J PHARM BIOPHARM, V73, P16, DOI 10.1016/j.ejpb.2009.04.009
   Francois S, 2009, ACTA BIOMATER, V5, P2418, DOI 10.1016/j.actbio.2009.03.013
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jeon DH, 2004, RADIAT PHYS CHEM, V71, P1059, DOI 10.1016/j.radphyschem.2003.10.009
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Lee MH, 2007, J BIOMED MATER RES A, V81A, P150, DOI 10.1002/jbm.a.31065
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   Mavromatis K, 2000, ARTERIOSCLER THROMB, V20, P1889
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Miller, 2000, DRUG DISCOV TODAY, V5, P397
   NAIR PD, 1984, BIOMATERIALS, V5, P305, DOI 10.1016/0142-9612(84)90079-6
   Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399
   Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com
   Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009
   Pourcelle V, 2007, BIOMACROMOLECULES, V8, P3977, DOI 10.1021/bm700841y
   Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001
   Rerat V, 2010, BIOORG MED CHEM LETT, V20, P1861, DOI 10.1016/j.bmcl.2010.01.150
   Rerat V, 2010, J POLYM SCI POL CHEM, V48, P195, DOI 10.1002/pola.23778
   Rerat V, 2009, J MED CHEM, V52, P7029, DOI 10.1021/jm901133z
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Scott EA, 2010, ACTA BIOMATER, V6, P29, DOI 10.1016/j.actbio.2009.07.009
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Thebaud NB, 2010, J TISSUE ENG REGEN M, V4, P473, DOI 10.1002/term.261
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 53
TC 8
Z9 8
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD FEB 1
PY 2013
VL 24
IS 3
BP 269
EP 286
DI 10.1080/09205063.2012.690275
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 104RE
UT WOS:000316011600003
PM 23565647
DA 2018-10-20
ER

PT J
AU Krishnamoorthy, G
   Sehgal, PK
   Mandal, AB
   Sadulla, S
AF Krishnamoorthy, Ganesan
   Sehgal, Praveen Kumar
   Mandal, Asit Baran
   Sadulla, Sayeed
TI Novel collagen scaffolds prepared by using unnatural D-amino acids
   assisted EDC/NHS crosslinking
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; collagen matrix; D-amino acids; biodegradation;
   biocompatible
ID FOREIGN-BODY REACTION; CELL-ADHESION; BIOMATERIALS; DESIGN; PEPTIDE;
   TISSUE; MICROBIOLOGY; NUTRITION; CHEMISTRY; HYDROGEL
AB This work discusses the preparation and characterization of novel collagen scaffolds by using unnatural D-amino acids (Coll-D-AAs)-assisted 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)/N-hydroxyl succinimide(NHS)-initiated crosslinking. The mechanical strength, hydrothermal and structural stability, resistance to biodegradation and the biocompatibility of Coll-D-AAs matrices were investigated. The results from Thermo mechanical analysis, Differential scanning calorimetric analysis and Thermo gravimetric analysis of the Coll-D-AAs matrices indicate a significant increase in the tensile strength (TS, 180 +/- 3), % elongation (% E, 80 +/- 9), elastic modulus (E, 170 +/- 4) denaturation temperature (T-d, 108 +/- 4) and a significant decrease in decomposition rate (T-g, 64 +/- 6). Scanning electron microscopic and Atomic force microscopic analyses revealed a well-ordered with properly oriented and well-aligned structure of the Coll-D-AAs matrices. FT-IR results suggest that the incorporation of D-AAs favours the molecular stability of collagen matrix. The D-AAs stabilizing the collagen matrices against degradation by collagenase would have been brought about by protecting the active sites in collagen. The Coll-D-AAs matrices have good biocompatibility when compared with native collagen matrix. Molecular docking studies also indicate better understanding of bonding pattern of collagen with D-AAs. These Coll-D-AAs matrices have been produced in high mechanical strength, thermally and biologically stable, and highly biocompatible forms that can be further manipulated into the functional matrix suitable in designing scaffolds for tissue engineering and regenerative medical applications.
C1 [Krishnamoorthy, Ganesan; Sehgal, Praveen Kumar; Mandal, Asit Baran; Sadulla, Sayeed] CSIR, Cent Leather Res Inst, Biomat Dev Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Mandal, AB (reprint author), CSIR, Cent Leather Res Inst, Biomat Dev Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM abmandal@hotmail.com
RI Mandal, Asit Baran/B-9977-2009
FU Council of Scientific & Industrial Research (CSIR), New Delhi,
   Government of India
FX The first author acknowledges the Council of Scientific & Industrial
   Research (CSIR), New Delhi, Government of India, for his CSIR-SRF
   fellowship.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1985, ANN NY ACAD SCI, V446, P67, DOI 10.1111/j.1749-6632.1985.tb18391.x
   ANDERSON JM, 1974, J BIOMED MATER RES, V8, P197, DOI 10.1002/jbm.820080320
   Annavarapu S, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-61
   [Anonymous], 2005, MED CHEM REV ONLINE, V2, P303
   Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Connor RE, 2007, POLYM REV, V47, P9, DOI 10.1080/15583720601109552
   DICKINSON HR, 1981, J BIOMED MATER RES, V15, P577, DOI 10.1002/jbm.820150412
   Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054
   Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u
   Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555
   Haack T, 1997, LETT PEPT SCI, V4, P377, DOI 10.1023/A:1008825727500
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Horng JC, 2007, PROTEIN SCI, V16, P208, DOI 10.1110/ps.062560107
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Katti KS, 2010, PHILOS T R SOC A, V368, P1963, DOI 10.1098/rsta.2010.0008
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krishnamoorthy G, 2008, J APPL POLYM SCI, V108, P199, DOI 10.1002/app.27430
   Krishnamoorthy G, 2012, J HAZARD MATER, V215, P173, DOI 10.1016/j.jhazmat.2012.02.046
   Latacz Gniewomir, 2006, Acta Pol Pharm, V63, P430
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liang GL, 2009, LANGMUIR, V25, P8419, DOI 10.1021/la804271d
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245
   Oh JE, 1999, BIOORGAN MED CHEM, V7, P2985, DOI 10.1016/S0968-0896(99)00247-3
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   Sehgal PK, 2001, Indian Patent. DEL, Patent No. [201, 2001201]
   Shah NK, 1999, BIOPOLYMERS, V49, P297
   Stachel I, 2010, BIOMACROMOLECULES, V11, P698, DOI 10.1021/bm901284x
   Tanaka H, 2008, CHEM-ASIAN J, V3, P2033, DOI 10.1002/asia.200800250
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tsai SP, 2007, J APPL POLYM SCI, V105, P1774, DOI 10.1002/app.26157
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yamauchi K, 2004, BIOMATERIALS, V25, P5481, DOI 10.1016/j.biomaterials.2003.12.057
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang LH, 2005, J BIOMED MATER RES A, V73A, P468, DOI 10.1002/jbm.a.30363
NR 43
TC 8
Z9 8
U1 3
U2 77
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD FEB 1
PY 2013
VL 24
IS 3
BP 344
EP 364
DI 10.1080/09205063.2012.690280
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 104RE
UT WOS:000316011600008
PM 23565652
DA 2018-10-20
ER

PT J
AU Karakas, A
   Yoruc, ABH
   Gokce, H
   Karabulut, A
   Erdogan, DC
AF Karakas, A.
   Yoruc, A. B. Hazar
   Gokce, H.
   Karabulut, A.
   Erdogan, D. Ceylan
TI Effect of Different Phosphorus Precursors on Biomimetic Hydroxyapatite
   Powder Properties
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 2nd International Congress on Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 26-29, 2012
CL Antalya, TURKEY
SP Gebze Inst Technol, Izmir Katip Celebi Univ, Istanbul Kultur Univ, Doga Nanobiotech Inc, Terra Lab, Inc, LOT Oriel Grp Europe, Redoks Inc, Edinburgh Instruments, Anamed & Analitik Grp, NanoMagnet Instruments Ltd, Maney Publishing
AB Hydroxyapatite is the main component of natural hard tissues, such as teeth and bone. It has been studied extensively as a candidate biomaterial for its use in prosthetic applications. Hydroxyapatite was formulated as Ca-10(PO4)(6)(OH)(2) and it has a high stability under physiological conditions. Also hydroxyapatite can be synthesized using different calcium and phosphorus precursors. In this study, biomimetic hydroxyapatite powder has been synthesized simulating physiological conditions. Synthetic body fluids which have the same composition as human blood plasma instead of pure water were used as precipitation media to obtain biological conditions. Recent research involved the effect of different Ca-precursors however aim of this study is to determine the effect of phosphorus resources. In this study, the synthesis of hydroxyapatite powder is carried out by using biomimetic method in synthetic body fluids. Calcium acetate [Ca(CH3COO)(2), CA] and diammonium hydrogen phosphate [(NH4)(2)HPO4, DAHP], ammonium dihydrogen phosphate [NH4H2PO4, ADHP], dipotassium hydrogen phosphate [K2HPO4, DPHP] and orthophosphoric acid [H3PO4, OPA] were used as Ca- and P-precursors. Chemical structures of synthesized powders have been examined by Fourier transform infrared and X-ray diffraction. Results showed that synthesized powders have a pure hydroxyapatite structure. However, ADHP precursors have an unfavorable effect on sintered hydroxyapatite powders. Using ADHP phase transition was caused in pure hydroxyapatite structure and apatite and whitlockite were observed as secondary phases. Their particle size, surface area determination and morphological structures have been characterized by Zeta-Sizer, biomimetic hydroxyapatite the Brunauer-Emmett-Teller analysis and scanning electron microscopy images, respectively. As a result different starting materials have affected the structure, particle size and morphological properties of biomimetic hydroxyapatite. DOI: 10.12693/APhysPolA.123.418
C1 [Karakas, A.; Yoruc, A. B. Hazar; Karabulut, A.; Erdogan, D. Ceylan] Yildiz Tekn Univ, Sci & Technol Applicat & Res Ctr, TR-34349 Istanbul, Turkey.
   [Gokce, H.] Istanbul Tech Univ, TR-34469 Istanbul, Turkey.
RP Karakas, A (reprint author), Yildiz Tekn Univ, Sci & Technol Applicat & Res Ctr, TR-34349 Istanbul, Turkey.
RI Karabulut, Aydin/B-2887-2016
OI Karabulut, Aydin/0000-0002-8712-2435
CR Garcia C, 2012, INORG CHEM COMMUN, V20, P90, DOI 10.1016/j.inoche.2012.02.024
   Goubin M., 2009, CRYSTAL GROWTH DESIG, V9, P2991
   Karakas A, 2012, ACTA PHYS POL A, V121, P236, DOI 10.12693/APhysPolA.121.236
   Ohtsuki C, 2007, J EUR CERAM SOC, V27, P1527, DOI 10.1016/j.jeurceramsoc.2006.04.018
   Roll S.J., THESIS NATL I TECH R
   Saber-Samandari S, 2009, ACTA BIOMATER, V5, P2206, DOI 10.1016/j.actbio.2009.02.009
   Smith C. D., 2002, AIP C P, V620, P651
   Tas A.C., 1997, Turkish Patent Institute, Patent No. [99/0037, 990037]
   Tas AC, 2000, BIOMATERIALS, V21, P1429
NR 9
TC 1
Z9 1
U1 0
U2 13
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD FEB
PY 2013
VL 123
IS 2
BP 418
EP 420
DI 10.12693/APhysPolA.123.418
PG 3
WC Physics, Multidisciplinary
SC Physics
GA 125LP
UT WOS:000317541600088
OA Bronze
DA 2018-10-20
ER

PT J
AU Golus, J
   Stankevic, M
   Sawicki, R
   Los, R
   Malm, A
   Ginalska, G
AF Golus, Joanna
   Stankevic, Magdalena
   Sawicki, Rafal
   Los, Renate
   Malm, Anna
   Ginalska, Grazyna
TI Quantitative analysis of biofilm formed on vascular prostheses by
   Staphylococcus epidermidis with different ica and aap genetic status
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Staphylococcus epidermidis; Biofilm; Implant infections; Vascular
   prostheses; Biomaterial surface modification
ID DEVICE-RELATED INFECTION; BACTERIAL-INFECTIONS; IN-VITRO; MECHANISMS;
   MANAGEMENT; SURFACES; BIOMATERIALS; PATHOGENESIS; PROTEIN; AUREUS
AB Objectives: This study aims to examine biofilm formed on vascular prostheses by Staphylococcus epidermidis with different ica and aap genetic status, and to evaluate the effect of antibiotic-modified prostheses on bacterial colonization.
   Methods: Biofilm formation was determined using fluorescence microscopy imaging. Quantitative analysis was conducted using the biofilm coverage ratio (BCR) calculations.
   Results: Our investigations prove that the BCR method with fluorescent dye enabled an accurate assessment of biofilm coverage and comparison of the obtained results. The ica(+)aap(+) strains formed a biofilm on all of the examined vascular prostheses. Uni-Graft (R) modified with covalently immobilized amikacin was effective in preventing bacterial adherence.
   Conclusions: Molecular biology techniques combined with phenotype studies give a broad insight into biofilm formation mechanisms. On the other hand, fluorescence microscopy imaging along with BCR calculations are reliable and simple tools to quantitatively estimate biofilm formation, as well as the effectiveness of antimicrobial prosthesis modification.
C1 [Golus, Joanna; Stankevic, Magdalena; Sawicki, Rafal; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, PL-20093 Lublin, Poland.
   [Los, Renate; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, PL-20093 Lublin, Poland.
RP Golus, J (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1 St, PL-20093 Lublin, Poland.
EM joanna.golus@umlub.pl
OI Ginalska, Grazyna/0000-0002-9961-4226
FU Medical University in Lublin, Poland [DS 2]; Operational Program
   Development of Eastern Poland, Priority Axis I, Modern Economy,
   Operations 1.3. Innovations Promotion [POPW.01.03.00-06-010/09-00]
FX This work was supported by a DS 2 grant (Medical University in Lublin,
   Poland). The paper was developed using the equipment purchased as part
   of agreement No. POPW.01.03.00-06-010/09-00 Operational Program
   Development of Eastern Poland 2007-2013, Priority Axis I, Modern
   Economy, Operations 1.3. Innovations Promotion.
CR Adachi K, 2007, J ORTHOP SCI, V12, P178, DOI 10.1007/s00776-006-1102-1
   Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x
   Arciola CR, 2006, J BIOMED MATER RES A, V76A, P425, DOI 10.1002/jbm.a.30552
   Bordi C, 2011, ANN INTENSIVE CARE, V1, P1, DOI DOI 10.1186/2110-5820-1-19
   Cafiso V, 2004, CLIN MICROBIOL INFEC, V10, P1081, DOI 10.1111/j.1469-0691.2004.01024.x
   Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   de Araujo GL, 2006, J ANTIMICROB CHEMOTH, V57, P855, DOI 10.1093/jac/dkl071
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Ginalska G, 2003, International classification: GO1N33/00, Patent No. [PL20030358934 20030228, 20030358934]
   Ginalska G, 2009, Polish Patent, Patent No. [PL201383, 201383]
   Hamilton MA, 2002, J AOAC INT, V85, P479
   Jain A, 2009, J MICROBIOL METH, V76, P88, DOI 10.1016/j.mimet.2008.09.017
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Lehnhardt FJ, 2002, EUR J VASC ENDOVASC, V23, P127, DOI 10.1053/ejvs.2001.1571
   Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x
   Los R, 2010, FEMS MICROBIOL LETT, V310, P97, DOI 10.1111/j.1574-6968.2010.02050.x
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Osinska-Jaroszuk M, 2009, EUR J VASC ENDOVASC, V38, P697, DOI 10.1016/j.ejvs.2009.09.003
   Petrelli D, 2006, EUR J CLIN MICROBIOL, V25, P773, DOI 10.1007/s10096-006-0226-8
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Stevens NT, 2008, CLIN MICROBIOL INFEC, V14, P719, DOI 10.1111/j.1469-0691.2008.02012.x
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 34
TC 2
Z9 4
U1 2
U2 18
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2013
VL 36
IS 2
BP 105
EP 112
DI 10.5301/ijao.5000157
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 127PC
UT WOS:000317709900004
PM 23280080
DA 2018-10-20
ER

PT J
AU Aperador, W
   Caicedo, JC
   Vera, R
AF Aperador, W.
   Caicedo, J. C.
   Vera, R.
TI Assessment of the Corrosion Resistance of Fermanal Steel Coated With
   TiC(N)/TiNb(CN) Heterostructures for Use As a Biomaterial
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomaterials; Fermanal; TiCN/TiNbCN; Hanks solution
ID 316LVM STAINLESS-STEEL; AL-C ALLOYS; METALLIC BIOMATERIALS; SURFACE;
   COATINGS; ENHANCEMENT; TI-6AL-4V; IMPEDANCE; IMPLANTS; TICN
AB This study aims to assess corrosion resistance on multilayer coatings of [TiCN/TiNbCN]n in a physiological medium with 1, 50 and 150 bilayer periods deposited on silicon (100) and Fermanal steel (FeMnAl) substrates using R. F. reactive magnetron sputtering with a radio frequency source (13.56 MHz) and two TiC and Nb targets. The multilayers were characterized using X-ray diffraction (XRD) and scanning electron microscopy (SEM). The electrochemical behavior simulated by the corporal environment was assessed using electrochemical impedance spectroscopy and Hanks solution as the electrolyte. The morphology of the attack mechanism on the coated and uncoated steel samples was characterized using SEM. The corrosion products were assessed using XRD. A notable increase was observed in corrosion resistance with the deposits of multilayer coatings on the FeMnAl alloy substrates, suggesting the spatial period effect (Lambda) in the decreased degradation seen on the coatings. This result corroborates the benefits of varying the bilayer period.
C1 [Aperador, W.] Univ Mil Nueva Granada, Dept Engn, Bogota 6343200, Colombia.
   [Caicedo, J. C.] Univ Valle, Tribol Grp Polymers Powder & Solid Residue Transf, Cali, Colombia.
   [Vera, R.] Pontificia Univ Catolica Valparaiso, Inst Chem, Corros Lab, Valparaiso, Chile.
RP Aperador, W (reprint author), Univ Mil Nueva Granada, Dept Engn, Carrera 11 101-80, Bogota 6343200, Colombia.
EM g.ing.materiales@gmail.com
FU El patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia,
   la Tecnologia y la Innovacion Serveis Cientifico-Francisco Jose de
   Caldas [275-2011]; Universidad Militar Nueva Granada
FX This research was supported by "El patrimonio Autonomo Fondo Nacional de
   Financiamiento para la Ciencia, la Tecnologia y la Innovacion Serveis
   Cientifico-Francisco Jose de Caldas" under contract RC-No. 275-2011, and
   Universidad Militar Nueva Granada. The authors also wish to acknowledge
   the technical support of the Universitat de Barcelona.
CR Alcazar G.A. Perez, 2004, COLOMB CIENC, V28, P265
   Aperador Willian, 2012, Rev. LatinAm. Metal. Mater., V32, P236
   BIALON J, 1983, MATER SCI ENG, V59, P217, DOI 10.1016/0025-5416(83)90169-6
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Bou-Saleh Z, 2007, THIN SOLID FILMS, V515, P4727, DOI 10.1016/j.tsf.2006.11.054
   Caicedo JC, 2010, APPL SURF SCI, V256, P2876, DOI 10.1016/j.apsusc.2009.11.042
   COOK SD, 1987, BIOMATERIALS, V8, P177, DOI 10.1016/0142-9612(87)90060-3
   Cordoba JM, 2007, J MATER CHEM, V17, P650, DOI 10.1039/b613566h
   Diomidis N, 2012, ACTA BIOMATER, V8, P852, DOI 10.1016/j.actbio.2011.09.034
   Farnoush H, 2012, CERAM INT, V38, P4885, DOI 10.1016/j.ceramint.2012.02.079
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Kannan MB, 2008, CORROS SCI, V50, P2879, DOI 10.1016/j.corsci.2008.07.024
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Levi G, 1998, MATER LETT, V35, P344, DOI 10.1016/S0167-577X(97)00276-0
   Lins VFC, 2005, APPL SURF SCI, V250, P124, DOI 10.1016/j.apsusc.2004.12.040
   Mohsen Q, 2012, INT J ELECTROCHEM SC, V7, P4510
   Moon B.H., 2011, APPL SURF SCI, V258, P2088
   Moreno H, 2010, APPL SURF SCI, V257, P1098, DOI 10.1016/j.apsusc.2010.08.024
   Petrovic Z, 2012, INT J ELECTROCHEM SC, V7, P9232
   Polo JL, 2002, J ELECTROANAL CHEM, V537, P183, DOI 10.1016/S0022-0728(02)01224-X
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Samuel S, 2008, MAT SCI ENG C-BIO S, V28, P414, DOI 10.1016/j.msec.2007.04.029
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Subramanian B, 2011, SURF COAT TECH, V205, P5014, DOI 10.1016/j.surfcoat.2011.05.004
   Tapash R., 2011, PROGR MAT SCI, V56, P1137
   TJONG SC, 1990, MATER CHARACT, V24, P275, DOI 10.1016/1044-5803(90)90055-O
   Wang CJ, 2002, MATER CHEM PHYS, V76, P151, DOI 10.1016/S0254-0584(01)00515-6
   Zhang YS, 2002, MAT SCI ENG A-STRUCT, V334, P19, DOI 10.1016/S0921-5093(01)01781-6
NR 29
TC 4
Z9 4
U1 0
U2 23
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2013
VL 8
IS 2
BP 2778
EP 2790
PG 13
WC Electrochemistry
SC Electrochemistry
GA 112BE
UT WOS:000316565800104
DA 2018-10-20
ER

PT J
AU Islam, KN
   Bin Abu Bakar, MZ
   Ali, ME
   Bin Hussein, MZ
   Noordin, MM
   Loqman, MY
   Miah, G
   Wahid, H
   Hashim, U
AF Islam, Kh. Nurul
   Bin Abu Bakar, Md Zuki
   Ali, Md. Eaqub
   Bin Hussein, Mohd Zobir
   Noordin, Mustapha M.
   Loqman, M. Y.
   Miah, Gous
   Wahid, Hanif
   Hashim, Uda
TI A novel method for the synthesis of calcium carbonate (aragonite)
   nanoparticles from cockle shells
SO POWDER TECHNOLOGY
LA English
DT Article
DE Cockle shells; Aragonite nanoparticles; Biomaterials; Biomineralization
   catalyst
ID SELF-DISPERSING PROPERTIES; CONTROLLABLE SYNTHESIS; POLYMORPHS; FILMS
AB We report a simple, novel and low-cost method for the synthesis of aragonite nanoparticles from cockle shells. Aragonite is one of the least abundant biogenic polymorphs of calcium carbonate and is widely used as a biomaterial for the repair of fractured bone, development of advanced drug delivery systems, and tissue scaffolds. The method involves a simple mechanical grinding of the micron-sized cockle shell powders in the presence of a non-toxic and non-hazardous biomineralization catalyst, dodecyl dimethyl betaine (BS-12). The method produces rod-shaped aragonite particles with a diameter of 20 +/- 5 nm with good reproducibility and without any additional impurities. This was confirmed by a combined analysis of variable pressure scanning electron microscopy (VPSEM), transmission electron microscopy (TEM), Fourier transmission infrared spectroscopy (FTIR), thermogravimetric analyzer (TGA), X-ray diffraction spectroscopy (XRD) and energy dispersive X-ray analyser (EDX). The method should find potential applications in industry for the large scale synthesis of aragonite nanoparticles from a low cost but abundant natural resource such as cockle shells. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Islam, Kh. Nurul; Bin Abu Bakar, Md Zuki] Univ Putra Malaysia, Lab Anat & Histol, Dept Vet Preclin Sci, Fac Vet Med, Serdang 43400, Darul Ehsan, Malaysia.
   [Bin Abu Bakar, Md Zuki] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Darul Ehsan, Malaysia.
   [Ali, Md. Eaqub] Univ Malaya, Nanotechnol & Catalysis Res Ctr, Kuala Lumpur 50603, Malaysia.
   [Bin Hussein, Mohd Zobir; Wahid, Hanif] Univ Putra Malaysia, Lab Nanomat, Dept Chem, Fac Sci, Serdang 43400, Darul Ehsan, Malaysia.
   [Noordin, Mustapha M.] Univ Putra Malaysia, Pathol Lab, Dept Vet Pathol & Microbiol, Fac Vet Med, Serdang 43400, Darul Ehsan, Malaysia.
   [Loqman, M. Y.] Univ Putra Malaysia, Dept Clin Vet Studies, Fac Vet Med, Serdang 43400, Darul Ehsan, Malaysia.
   [Miah, Gous] Univ Putra Malaysia, Lab Food Crops, Inst Trop Agr, Serdang 43400, Darul Ehsan, Malaysia.
   [Hashim, Uda] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar 01000, Perlis, Malaysia.
RP Bin Abu Bakar, MZ (reprint author), Univ Putra Malaysia, Lab Anat & Histol, Dept Vet Preclin Sci, Fac Vet Med, Serdang 43400, Darul Ehsan, Malaysia.
EM knislam@yahoo.com; zuki@vet.upm.edu.my; eaqubali@gmail.com;
   mzobir@science.upm.edu.my; noordin@vet.upm.edu.my;
   loqman@vet.upm.edu.my; g_miah@yahoo.co.uk; hanifwahid82@gmail.com;
   uda@unimap.edu.my
RI Ali, M. E./E-1948-2012
OI Ali, M. E./0000-0002-7384-3936; hashim, uda/0000-0001-5118-6069;
   HUSSEIN, MOHD ZOBIR/0000-0002-0741-261X; Miah, Gous/0000-0003-3980-7891;
   Wahid, Mohd Haniff/0000-0002-2721-8697; Scopus,
   UniMAP/0000-0003-1327-8215; Mohamed Mustapha,
   Noordin/0000-0001-9288-797X
FU Fundamental Research Grand Scheme of Malaysia (FRGS)
FX The authors gratefully acknowledge the financial support from the
   Fundamental Research Grand Scheme of Malaysia (FRGS).
CR Ali ME, 2011, J NANOMATER, DOI 10.1155/2011/781098
   Bala H, 2005, COLLOID SURFACE A, V252, P129, DOI 10.1016/j.colsurfa.2004.10.064
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Chen J, 2009, POWDER TECHNOL, V189, P64, DOI 10.1016/j.powtec.2008.06.004
   Choi CS, 2000, BIOMATERIALS, V21, P213, DOI 10.1016/S0142-9612(99)00120-9
   Guo F, 2007, MATER LETT, V61, P4937, DOI 10.1016/j.matlet.2007.03.075
   Islam KN, 2011, POWDER TECHNOL, V213, P188, DOI 10.1016/j.powtec.2011.07.031
   KAWAGUCHI H, 1992, COLLOID POLYM SCI, V270, P1176, DOI 10.1007/BF01095057
   Lakshminarayanan R, 2003, CRYST GROWTH DES, V3, P953, DOI 10.1021/cg034022j
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Wada N, 2004, J COLLOID INTERF SCI, V279, P167, DOI 10.1016/j.jcis.2004.06.060
   Wang CY, 2007, COLLOID SURFACE A, V297, P179, DOI 10.1016/j.colsurfa.2006.10.045
   Wang CY, 2006, POWDER TECHNOL, V163, P134, DOI 10.1016/j.powtec.2005.12.019
   Xu ZP, 2006, CHEM ENG SCI, V61, P1027, DOI 10.1016/j.ces.2005.06.019
NR 14
TC 27
Z9 28
U1 0
U2 62
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0032-5910
J9 POWDER TECHNOL
JI Powder Technol.
PD FEB
PY 2013
VL 235
BP 70
EP 75
DI 10.1016/j.powtec.2012.09.041
PG 6
WC Engineering, Chemical
SC Engineering
GA 105BA
UT WOS:000316039400008
DA 2018-10-20
ER

PT J
AU Yi, JS
   Lee, HJ
   Lee, HJ
   Lee, IW
   Yang, JH
AF Yi, Jin-Seok
   Lee, Hyung-Jin
   Lee, Hong-Jae
   Lee, Il-Woo
   Yang, Ji-Ho
TI Rat Peripheral Nerve Regeneration Using Nerve Guidance Channel by
   Porcine Small Intestinal Submucosa
SO JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
LA English
DT Article
DE Small intestinal submucosa; Sciatic nerve; Peripheral nerve
   regeneration; Myelination
ID ACHILLES-TENDON REPAIR; POLYGLYCOLIC ACID; VASCULAR GRAFTS; CONDUIT;
   TUBE; COLLAGEN; PERFORMANCE; GUIDE
AB Objective : In order to develop a novel nerve guidance channel using porcine small intestinal submucosa (SIS) for nerve regeneration, we investigated the possibility of SIS, a tissue consisting of acellular collagen material without cellular immunogenicity, and containing many kinds of growth factors, as a natural material with a new bioactive functionality.
   Methods : Left sciatic nerves were cut 5 mm in length, in 14 Sprague-Dawley rats. Grafts between the cut nerve ends were performed with a silicone tube (Silicon group, n=7) and rolled porcine SIS (SIS group, n=7). All rats underwent a motor function test and an electromyography (EMG) study on 4 and 10 weeks after grafting. After last EMG studies, the grafts, including proximal and distal nerve segments, were retrieved for histological analysis.
   Results : Foot ulcers, due to hypesthesia, were fewer in SIS group than in Silicon group. The run time tests for motor function study were 2.67 seconds in Silicon group and 5.92 seconds in SIS group. Rats in SIS group showed a better EMG response for distal motor latency and amplitude than in Silicon group. Histologically, all grafts contained some axons and myelination. However, the number of axons and the degree of myelination were significantly higher in SIS group than Silicon group.
   Conclusion : These, results show that the porcine SIS was an excellent option as a natural biomaterial for peripheral nerve regeneration since this material contains many kinds of nerve growth factors. Furthermore, it could be used as a biocompatible barrier covering neural tissue.
C1 [Yi, Jin-Seok; Lee, Hyung-Jin; Lee, Hong-Jae; Lee, Il-Woo; Yang, Ji-Ho] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, Taejon 301723, South Korea.
RP Yang, JH (reprint author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, 64 Daeheung Ro, Taejon 301723, South Korea.
EM yangjiho1963@gmail.com
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   DANIELSEN N, 1995, BRAIN RES, V681, P105, DOI 10.1016/0006-8993(95)00300-F
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   Favaro G, 1990, ASAIO Trans, V36, pM291
   Geoffrion R, 2011, FEMALE PELVIC MED RE, V17, P174, DOI 10.1097/SPV.0b013e31821e5dcf
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1
   Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7
   KIYOTANI T, 1995, ASAIO J, V41, pM657, DOI 10.1097/00002480-199507000-00092
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Liu ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020520
   Lundborg G, 1996, SCAND J PLAST RECONS, V30, P105, DOI 10.3109/02844319609056391
   Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G
   Owen K, 2012, EUR J VASC ENDOVASC, V43, P573, DOI 10.1016/j.ejvs.2012.01.027
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Tu DD, 2012, J VIS EXP IN PRESS
   Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang XB, 2012, EUR J RADIOL, V81, pE281, DOI 10.1016/j.ejrad.2011.06.011
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zhao Q, 1997, BRAIN RES, V769, P125, DOI 10.1016/S0006-8993(97)00620-3
NR 30
TC 7
Z9 8
U1 0
U2 8
PU KOREAN NEUROSURGICAL SOC
PI SEOUL
PA #402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130,
   SOUTH KOREA
SN 2005-3711
J9 J KOREAN NEUROSURG S
JI J. Korean. Neurosurg. Soc.
PD FEB
PY 2013
VL 53
IS 2
BP 65
EP 71
DI 10.3340/jkns.2013.53.2.65
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 112GU
UT WOS:000316581500001
PM 23560168
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Sun, C
   Miao, JJ
   Yan, J
   Yang, K
   Mao, C
   Ju, J
   Shen, J
AF Sun, Chong
   Miao, Jingjing
   Yan, Jie
   Yang, Kai
   Mao, Chun
   Ju, Jing
   Shen, Jian
TI Applications of antibiofouling PEG-coating in electrochemical biosensors
   for determination of glucose in whole blood
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Whole blood; Antibiofouling; Carboxymethyl-PEG-carboxymethyl; Biosensor
ID IN-VITRO; ANTIFOULING COATINGS; PROTEIN ADSORPTION; PLATELET-ADHESION;
   OXIDASE; COAGULATION; SURFACES; HEMOCOMPATIBILITY; POLYURETHANES;
   COMPATIBILITY
AB Polyethyleneglycol-modified surfaces have become popular for anti-biofouling applications. In this paper, a novel glucose biosensor was fabricated by immobilizing glucose oxidase (GOx) onto the carboxymethyl-PEG-carboxymethyl (CM-PEG-CM) biomaterial film on the surface of glassy carbon electrode (GCE). The biosensor was applied in whole blood directly, which was based on the low values of polymer-water interfacial energy, resistance to protein adsorption and cell adhesion. The entrapped GOx could preserve its bioactivity and exhibited an excellent electrochemical behavior with a formal potential of -290 mV in phosphate buffer solution (PBS) (pH=7.4). Response studies to glucose were carried out using differential pulsed voltammetry (DPV). The results indicated that the modified electrode can be used to determine glucose without interference from L-ascorbic acid (AA) and uric acid (UA) with the low detection limit of 1.24 x 10(-5) M. The data obtained from the biosensor showed good agreement with those from a biochemical analyzer in hospital. The GOx biosensor modified with CM-PEG-CM will have essential meaning and practical application in future that attributed to the effect of anti-biofouling and good performance. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Sun, Chong; Miao, Jingjing; Yan, Jie; Yang, Kai; Mao, Chun; Ju, Jing; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
   [Sun, Chong] Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.
   [Shen, Jian] Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China.
RP Mao, C (reprint author), Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
EM maochun127@yahoo.cn; shenjian@nju.edu.cn
FU NSFC [21144002]; NSFJS [BK2011781]; RFDP [20113207120005]; Major Program
   for the Natural Science Fundamental Research of the Higher Education
   Institutions of Jiangsu Province [12KJA150006]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions; Base of
   production, education & research of prospective joint research project
   of Jiangsu Province [BY2011109]
FX The work is supported by NSFC (21144002), NSFJS (BK2011781), RFDP
   (20113207120005), Major Program for the Natural Science Fundamental
   Research of the Higher Education Institutions of Jiangsu Province
   (12KJA150006), the Priority Academic Program Development of Jiangsu
   Higher Education Institutions, and Base of production, education &
   research of prospective joint research project of Jiangsu Province
   (BY2011109).
CR Alibeik S, 2007, J BIOMAT SCI-POLYM E, V18, P1195, DOI 10.1163/156856207781554055
   Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Bradley AJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P185, DOI 10.1006/abbi.1998.0798
   Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129
   CHAN AYW, 1989, CLIN CHEM, V35, P315
   Chen KJ, 2012, BIOSENS BIOELECTRON, V33, P75, DOI 10.1016/j.bios.2011.12.020
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Ferrero F, 2012, J NANOSCI NANOTECHNO, V12, P4803, DOI 10.1166/jnn.2012.4902
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRANT S, 1988, POLYM COMMUN, V29, P342
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   JENKINS CSP, 1971, BLOOD-J HEMATOL, V37, P395
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kainthan RK, 2006, BIOMATERIALS, V27, P5377, DOI 10.1016/j.biomaterials.2006.06.021
   Lin BC, 2010, CHEM MATER, V22, P6718, DOI 10.1021/cm102957g
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   MASSINI P, 1974, HAEMOSTASIS, V3, P8
   Molina P, 1997, TETRAHEDRON, V53, P3281, DOI 10.1016/S0040-4020(97)00038-0
   Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Qiu LH, 2011, CHEM COMMUN, V47, P2934, DOI 10.1039/c0cc04865h
   Rahman MM, 2010, SENSORS-BASEL, V10, P4855, DOI 10.3390/s100504855
   Sacks DB, 2002, CLIN CHEM, V48, P436
   Senel M, 2012, CURR APPL PHYS, V12, P1118, DOI 10.1016/j.cap.2012.02.004
   Skrabalak SE, 2007, ADV MATER, V19, P3177, DOI 10.1002/adma.200701972
   Tang H, 2004, ANAL BIOCHEM, V331, P89, DOI 10.1016/j.ab.2004.05.005
   Torchilin VP, 2007, AAPS J, V9, P128
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#
   Wang LS, 2012, BIOSENS BIOELECTRON, V38, P421, DOI 10.1016/j.bios.2012.05.025
   Wang YP, 2012, CHEM COMMUN, V48, P738, DOI 10.1039/c1cc15429j
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wu LX, 2010, ACS APPL MATER INTER, V2, P2781, DOI 10.1021/am1004249
   Wu XM, 2008, ELECTROCHIM ACTA, V54, P738, DOI 10.1016/j.electacta.2008.06.071
   Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001
   Yoo EH, 2010, SENSORS-BASEL, V10, P4558, DOI 10.3390/s100504558
   Zhao J, 2011, CHEM COMMUN, V47, P11516, DOI 10.1039/c1cc15069c
   Zoldak G, 2004, J BIOL CHEM, V279, P47601, DOI 10.1074/jbc.M406883200
NR 43
TC 17
Z9 17
U1 4
U2 77
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 1
PY 2013
VL 89
BP 549
EP 554
DI 10.1016/j.electacta.2012.11.005
PG 6
WC Electrochemistry
SC Electrochemistry
GA 098OI
UT WOS:000315558200071
DA 2018-10-20
ER

PT J
AU Trzebicka, B
   Robak, B
   Trzcinska, R
   Szweda, D
   Suder, P
   Silberring, J
   Dworak, A
AF Trzebicka, Barbara
   Robak, Barbara
   Trzcinska, Roza
   Szweda, Dawid
   Suder, Piotr
   Silberring, Jerzy
   Dworak, Andrzej
TI Thermosensitive PNIPAM-peptide conjugate - Synthesis and aggregation
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE PNIPAM-peptide conjugate; Thermosensitivity; Aggregation; Mesoglobules;
   Nanomaterials
ID TRANSFER RADICAL POLYMERIZATION; POLY-N-ISOPROPYLACRYLAMIDE; SOLID-PHASE
   SYNTHESIS; BLOCK-COPOLYMERS; OLIGOPEPTIDE; MESOGLOBULES; TEMPERATURE;
   INITIATORS; SEPARATION; NANOTUBES
AB This paper describes the synthesis of enzymatically cleavable hybrid biomaterial - poly(N-isopropylacrylamide)-pentapeptide conjugate through atom transfer radical polymerization of N-isopropylacrylamide from a resin-loaded peptide macroinitiator. A pentapeptide labeled with a dansyl group (Gly-Arg-Lys-Phe-Gly-dansyl) was synthesized using solid-phase peptide synthesis (SPPS) with the use of Fmoc protected amino acids. An ATRP peptide-based macroinitiator was obtained by the coupling of 2-bromopropionic acid to the N-terminus of peptide molecule. The ATRP of NIPAM was performed in heterogenic conditions using macroinitiator anchored on polystyrene resin. The well-defined PNIPAM-Gly-Arg-Lys-Phe-Gly-dansyl conjugate with an average molar mass of 30,400 g/mol and molar mass dispersity of 1.14 was obtained. The PNIPAM-Gly-Arg-Lys-Phe-Gly-dansyl conjugate underwent a phase transition upon heating in aqueous solution, with the formation of spherical nanoparticles (mesoglobules) with peptide forming the particles' corona. Tryptic hydrolysis of mesoglobules formed by bioconjugate showed that the presence of Lys or Arg residues in the structure of the conjugate provided a simple route to cleavage peptide fragments from mesoglobules. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Trzebicka, Barbara; Robak, Barbara; Trzcinska, Roza; Szweda, Dawid; Silberring, Jerzy; Dworak, Andrzej] Polish Acad Sci, Ctr Polymer & Carbon Mat, PL-41819 Zabrze, Poland.
   [Suder, Piotr; Silberring, Jerzy] AGH Univ Sci & Technol, PL-30059 Krakow, Poland.
RP Dworak, A (reprint author), Polish Acad Sci, Ctr Polymer & Carbon Mat, M Curie Sklodowskiej 34, PL-41819 Zabrze, Poland.
EM adworak@cmpw-pan.edu.pl
RI Dworak, Andrzej/D-1460-2017
FU Ministry of Science and Higher Education [NN 209 144136]; European
   Social Fund within the RFSD 2 project
FX The authors acknowledge the Ministry of Science and Higher Education
   Grants NN 209 144136 for financial support. B. Robak, R. Trzcinska and
   D. Szweda gratefully acknowledge the European Social Fund within the
   RFSD 2 project for financial support.
CR Ayres L, 2005, J POLYM SCI POL CHEM, V43, P6355, DOI 10.1002/pola.21107
   Ayres N, 2002, MACROMOLECULES, V35, P3849, DOI 10.1021/ma0116001
   Becker ML, 2005, BIOMACROMOLECULES, V6, P220, DOI 10.1021/bm049551y
   Borner HG, 2009, PROG POLYM SCI, V34, P811, DOI 10.1016/j.progpolymsci.2009.05.001
   Bulmus V, 2001, J CONTROL RELEASE, V76, P265, DOI 10.1016/S0168-3659(01)00433-3
   Burchard W, 1999, ADV POLYM SCI, V143, P113
   Chan W. C., 2000, FMOC SOLID PHASE PEP
   Couet J, 2006, MACROMOLECULES, V39, P7258, DOI 10.1021/ma061200j
   Couet J, 2005, ANGEW CHEM INT EDIT, V44, P3297, DOI 10.1002/anie.200462993
   Dawson KA, 1997, PHYSICA A, V244, P68, DOI 10.1016/S0378-4371(97)00299-9
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gorelov AV, 1997, PHYSICA A, V240, P443, DOI 10.1016/S0378-4371(97)00192-1
   Han SY, 2004, TETRAHEDRON, V60, P2447, DOI 10.1016/j.tet.2004.01.020
   Hentschel J, 2007, MACROMOLECULES, V40, P9224, DOI 10.1021/ma071810z
   Huang CJ, 2008, MACROMOLECULES, V41, P7041, DOI 10.1021/ma801221m
   KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6
   Klok HA, 2009, MACROMOLECULES, V42, P7990, DOI 10.1021/ma901561t
   Limer A, 2006, MACROMOLECULES, V39, P1353, DOI 10.1021/ma051443w
   Lutz JF, 2008, PROG POLYM SCI, V33, P1, DOI 10.1016/j.progpolymsci.2007.07.005
   Masci G, 2004, MACROMOL RAPID COMM, V25, P559, DOI 10.1002/marc.200300140
   Mei Y, 2004, J AM CHEM SOC, V126, P3472, DOI 10.1021/ja039583d
   Millard P.E., 2008, POLYM PREPR AM CHEM, V49, P121
   Moller M, 2011, ORG BIOMOL CHEM, V9, P2403, DOI 10.1039/c0ob01047b
   Molawi K, 2007, CHEM COMMUN, P5173, DOI 10.1039/b713083j
   Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200
   Paira TK, 2010, MACROMOLECULES, V43, P4050, DOI 10.1021/ma1001904
   Rettig H, 2004, MACROMOL RAPID COMM, V25, P1251, DOI 10.1002/marc.200400140
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Stoica F, 2008, CHEM COMMUN, P4433, DOI 10.1039/b806782a
   Subiros-Funosas R, 2009, CHEM-EUR J, V15, P9394, DOI 10.1002/chem.200900614
   ten Cate MGJ, 2005, MACROMOLECULES, V38, P10643, DOI 10.1021/ma0519415
   Trzcinska R, 2012, J POLYM SCI POL CHEM, V50, P3104, DOI 10.1002/pola.26097
   Van Hest JCM, 2007, POLYM REV, V47, P63, DOI 10.1080/15583720601109578
   Weda P, 2008, POLYMER, V49, P1467, DOI 10.1016/j.polymer.2008.01.059
   Ye JD, 2009, J PHYS CHEM B, V113, P676, DOI 10.1021/jp808905s
NR 35
TC 13
Z9 14
U1 2
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD FEB
PY 2013
VL 49
IS 2
BP 499
EP 509
DI 10.1016/j.eurpolymj.2012.11.005
PG 11
WC Polymer Science
SC Polymer Science
GA 101FF
UT WOS:000315759900023
DA 2018-10-20
ER

PT J
AU McIntosh, KR
   Frazier, T
   Rowan, BG
   Gimble, JM
AF McIntosh, Kevin R.
   Frazier, Trivia
   Rowan, Brian G.
   Gimble, Jeffrey M.
TI Evolution and future prospects of adipose-derived immunomodulatory cell
   therapeutics
SO EXPERT REVIEW OF CLINICAL IMMUNOLOGY
LA English
DT Review
DE adipose-derived stem or stromal cell; allogeneic use; anti-inflammatory;
   autologous use; bone marrow-derived stem or stromal cell; clinical
   applications; immunosuppression; mixed lymphocyte reaction; stromal
   vascular fraction
ID MESENCHYMAL-STEM-CELLS; HUMAN BONE-MARROW; COMPLEX PERIANAL FISTULA;
   THERAPY POSITION STATEMENT; UMBILICAL-CORD BLOOD; VERSUS-HOST-DISEASE;
   STROMAL CELLS; IN-VITRO; INSULIN-RESISTANCE; PROGENITOR CELLS
AB Over the past two decades, tissue engineering and regenerative medicine have evolved from what many considered a theoretical science to what is now a clinical reality. Tissue engineering combines biomaterial scaffolds, growth factors and stem or progenitor cells to repair damaged tissues. Adipose tissue, an abundant and easily accessed tissue, is a potential source of stromal/stem cells for regenerative therapeutic applications. Like bone marrow-derived mesenchymal stem cells, adipose-derived stromal/stem cells display both immunomodulatory and immunosuppressive properties. The adipose cells exert these actions, in part, through their secretion of paracrine growth factors. This review highlights recent developments in the isolation, characterization and preclinical application of adipose-derived cells and the challenges facing their translation into clinical practice.
C1 [McIntosh, Kevin R.] Synapt Res, Baltimore, MD USA.
   [Frazier, Trivia; Rowan, Brian G.] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA.
   [Gimble, Jeffrey M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA USA.
RP Gimble, JM (reprint author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA USA.
EM gimblejm@pbrc.edu
CR Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0
   Afizah H, 2007, TISSUE ENG, V13, P659, DOI 10.1089/ten.2006.0118
   Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186
   Altman AM, 2008, AESTHET PLAST SURG, V32, P56, DOI 10.1007/s00266-007-9008-7
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503
   Bochev I, 2008, CELL BIOL INT, V32, P384, DOI 10.1016/j.cellbi.2007.12.007
   Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34
   Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cavallo C, 2011, J CELL BIOCHEM, V112, P1418, DOI 10.1002/jcb.23058
   Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189
   Choi EW, 2011, J GENE MED, V13, P3, DOI 10.1002/jgm.1531
   Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194
   Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x
   Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5
   Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Crop MJ, 2010, CLIN EXP IMMUNOL, V162, P474, DOI 10.1111/j.1365-2249.2010.04256.x
   Crop MJ, 2010, STEM CELLS DEV, V19, P1843, DOI 10.1089/scd.2009.0368
   Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Danisovic L, 2009, GEN PHYSIOL BIOPHYS, V28, P56, DOI 10.4149/gpb_2009_01_56
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]
   Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Frisbie DD, 2009, J ORTHOP RES, V27, P1675, DOI 10.1002/jor.20933
   Gal P, 2007, ACTA VET BRNO, V76, P265, DOI 10.2754/avb200776020265
   Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-0052-6
   Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3
   Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI [10.1517/14712590802321613, 10.1517/14712598.8.9.1417 ]
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Garcia-Olmo D, 2009, INT J COLORECTAL DIS, V24, P27, DOI 10.1007/s00384-008-0559-0
   Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041
   Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881
   Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923
   Hegyi B, 2012, BIOCHEM BIOPH RES CO, V419, P215, DOI 10.1016/j.bbrc.2012.01.150
   Hicok KC, 2011, METHODS MOL BIOL, V702, P87, DOI 10.1007/978-1-61737-960-4_8
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Huang JI, 2005, J ORTHOP RES, V23, P1383, DOI 10.1016/j.orthres.2005.03.018
   Hui JHP, 2005, TISSUE ENG, V11, P904, DOI 10.1089/ten.2005.11.904
   Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005
   Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010
   Jurgens WJ, 2011, J ORTHOP RES, V29, P853, DOI 10.1002/jor.21314
   Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001
   Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kim M, 2011, DERMATOL SURG, V37, P750, DOI 10.1111/j.1524-4725.2011.01765.x
   Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100
   Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7
   Koenen TB, 2011, ENDOCRINOLOGY, V152, P3769, DOI 10.1210/en.2010-1480
   Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793
   Kronsteiner B, 2011, STEM CELLS DEV, V20, P2115, DOI 10.1089/scd.2011.0031
   Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7
   Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x
   Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029
   Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636
   Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.09.1042
   Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   OWEN M, 1988, J CELL SCI, P63
   OWEN M, 1988, CIBA F SYMP, V136, P42
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   PIETRANGELI CE, 1988, EUR J IMMUNOL, V18, P863, DOI 10.1002/eji.1830180606
   Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3
   Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005
   Pond CM, 2002, CYTOKINE, V17, P131, DOI 10.1006/cyto.2001.0999
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356
   Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29
   Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036
   Rubin JP, 2012, PLAST RECONSTR SURG, V129, P1029, DOI 10.1097/PRS.0b013e31824a2a8e
   Schaffler A, 2006, ENDOCR REV, V27, P449, DOI 10.1210/er.2005-0022
   Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012
   Sterodimas A, 2011, AESTHET SURG J, V31, P682, DOI 10.1177/1090820X11415976
   Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003
   Sundin M, 2007, HAEMATOL-HEMATOL J, V92, P1208, DOI 10.3324/haematol.11446
   Taxonera C, 2009, WORLD J GASTROENTERO, V15, P4263, DOI 10.3748/wjg.15.4263
   Technau A, 2011, CYTOTHERAPY, V13, P310, DOI 10.3109/14653249.2010.504769
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Wan CD, 2008, HEPATOB PANCREAT DIS, V7, P29
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   WEISS L, 1984, AM J ANAT, V170, P447, DOI 10.1002/aja.1001700317
   Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387
   WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228
   Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008
   Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021
   Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
   Yoshimura K, 2010, BREAST J, V16, P169, DOI 10.1111/j.1524-4741.2009.00873.x
   Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528
   Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
   Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 130
TC 17
Z9 19
U1 1
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1744-666X
EI 1744-8409
J9 EXPERT REV CLIN IMMU
JI Expert Rev. Clin. Immunol.
PD FEB
PY 2013
VL 9
IS 2
BP 175
EP 184
DI 10.1586/ECI.12.96
PG 10
WC Immunology
SC Immunology
GA 098UP
UT WOS:000315574900019
PM 23390948
DA 2018-10-20
ER

PT J
AU Yan, SQ
   Li, MZ
   Zhang, Q
   Wang, JN
AF Yan, Shuqin
   Li, Mingzhong
   Zhang, Qiang
   Wang, Jiannan
TI Blend films based on silk fibroin/hyaluronic acid
SO FIBERS AND POLYMERS
LA English
DT Article
DE Silk fibroin; Blend films; Crosslinking; Structure; Biocompatibility
ID HYALURONIC-ACID; PHYSICAL-PROPERTIES; IN-VITRO; BOMBYX-MORI; FIBROIN;
   CHITOSAN; GELATIN; MATRIX; CONFORMATION; BIOMATERIAL
AB Protein and polysaccharide was the most important extracellular matrix in dermal tissue. In this study, Silk fibroin (SF) / hyaluronic acid (HA) blend films mimicking the dermal tissue components were prepared and investigated. The results indicated that HA and SF has a good miscibility, HA interfered with SF to form crystal structure. By using EDC as cross-linker, effective cross-linking function on SF and HA macromolecules was reacted, the water solubility of the blend films decreased obviously after being cross-linked by EDC. The existence of EDC could promote SF to form Silk I structure. L929 cells were seeded on these blend films and showed normal attachment morphology. Cell-matrix interactions established by newly formed extracellular matrix were observed after 5 days in culture. The MTT assay showed that cell proliferation on the SF/HA blend films were enhanced significantly compared with that on the SF and HA films. These new 2D SF/HA blend films provided a favorable microenvironment for the proliferation of L929 cells and hold a potential for dermal tissue regeneration.
C1 [Yan, Shuqin; Zhang, Qiang] Wuhan Text Univ, Coll Text Sci & Engn, Wuhan 430073, Peoples R China.
   [Li, Mingzhong; Zhang, Qiang; Wang, Jiannan] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215123, Peoples R China.
RP Yan, SQ (reprint author), Wuhan Text Univ, Coll Text Sci & Engn, Wuhan 430073, Peoples R China.
EM ysq_zq@163.com
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Bodo M., 1993, INT J DEV BIOL, V37, P34
   Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   GILLI R, 1994, CARBOHYD RES, V263, P315, DOI 10.1016/0008-6215(94)00147-2
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Greco RM, 1998, J CELL PHYSIOL, V177, P465, DOI 10.1002/(SICI)1097-4652(199812)177:3<465::AID-JCP9>3.0.CO;2-5
   Hokputsa S, 2003, CARBOHYD POLYM, V52, P111, DOI 10.1016/S0144-8617(02)00298-9
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kazuaki K., 2003, J CHROMATOGR B, V797, P347
   Kolodziejska I, 2007, FOOD CHEM, V103, P295, DOI 10.1016/j.foodchem.2006.07.049
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Lee KH, 2005, FIBER POLYM, V6, P181, DOI 10.1007/BF02875641
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu YC, 1996, J APPL POLYM SCI, V61, P641, DOI 10.1002/(SICI)1097-4628(19960725)61:4<641::AID-APP7>3.0.CO;2-L
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Malay O, 2008, J THERM ANAL CALORIM, V94, P749, DOI 10.1007/s10973-008-9368-5
   Malay O, 2007, INT J BIOL MACROMOL, V40, P387, DOI 10.1016/j.ijbiomac.2006.09.017
   Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   RAPPORT MM, 1951, NATURE, V168, P996, DOI 10.1038/168996b0
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Shepard S, 1996, ANN PLAS SURG, V36, P65, DOI 10.1097/00000637-199601000-00013
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yan S. Q., 2010, JFBI, V3, P2
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
NR 39
TC 3
Z9 3
U1 7
U2 54
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD FEB
PY 2013
VL 14
IS 2
BP 188
EP 194
DI 10.1007/s12221-013-0188-2
PG 7
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 098UV
UT WOS:000315575500003
DA 2018-10-20
ER

PT J
AU Pinheiro, ALB
   Santos, NRS
   Oliveira, PC
   Aciole, GTS
   Ramos, TA
   Gonzalez, TA
   da Silva, LN
   Barbosa, AFS
   Silveira, L
AF Pinheiro, Antonio L. B.
   Silva Santos, Nicole Ribeiro
   Oliveira, Priscila Chagas
   Santos Aciole, Gilberth Tadeu
   Ramos, Thais Andrade
   Gonzalez, Tayna Assuncao
   da Silva, Lais Nogueira
   Santos Barbosa, Artur Felipe
   Silveira Junior, Landulfo
TI The efficacy of the use of IR laser phototherapy associated to biphasic
   ceramic graft and guided bone regeneration on surgical fractures treated
   with miniplates: a Raman spectral study on rabbits
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterials; Bone repair; Internal rigid fixation; Phototherapy
ID MORPHOGENETIC PROTEINS; RODENT MODEL; IN-VIVO; MANDIBULAR FRACTURES;
   DENTAL IMPLANTS; BOVINE BONE; SPECTROSCOPY; LIGHT; PHOTOBIOMODULATION;
   THERAPY
AB The aim of the present study was to assess, by Raman spectroscopy, the repair of surgical fractures fixed with internal rigid fixation (IRF) treated or not with IR laser (lambda 780 nm, 50 mW, 4 x 4 J/cm(2) = 16 J/cm(2), I center dot = 0.5 cm(2), CW) associated or not to the use of hydroxyapatite and guided bone regeneration (GBR). Surgical tibial fractures were created under general anesthesia on 15 rabbits that were divided into five groups, maintained on individual cages, at day/night cycle, fed with solid laboratory pelted diet and had water ad libitum. The fractures in groups II, III, IV and V were fixed with miniplates. Animals in groups III and V were grafted with hydroxyapatite and GBR technique used. Animals in groups IV and V were irradiated at every other day during 2 weeks (4 x 4 J/cm(2), 16 J/cm(2) = 112 J/cm(2)). Observation time was that of 30 days. After animal death, specimens were taken and kept in liquid nitrogen and used for Raman spectroscopy. Raman spectroscopy showed significant differences between groups (p < 0.001). Basal readings showed mean value of 1,234 +/- 220.1. Group internal rigid fixation + biomaterial + laser showed higher readings (3,521 +/- 2,670) and group internal rigid fixation + biomaterial the lowest (212.2 +/- 119.8). In conclusion, the results of the present investigation are important clinically as spectral analysis of bone component evidenced increased levels of CHA on fractured sites by using the association of laser light to a ceramic graft.
C1 [Pinheiro, Antonio L. B.; Silva Santos, Nicole Ribeiro; Oliveira, Priscila Chagas; Santos Aciole, Gilberth Tadeu; Ramos, Thais Andrade; Gonzalez, Tayna Assuncao; da Silva, Lais Nogueira; Santos Barbosa, Artur Felipe] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.; Silveira Junior, Landulfo] Univ Camilo Castelo Branco, BR-12245230 Sao Paulo, Brazil.
   [Pinheiro, Antonio L. B.] Inst Nacl Ciencia & Tecnol Opt & Foton, BR-13560970 Sao Paulo, Brazil.
   [Silveira Junior, Landulfo] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose dos Campos, BR-12247004 Sao Paulo, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br; ribeironicole@hotmail.com; pchagas2005@yahoo.com.br;
   gilberthaciole@hotmail.com; thais_andraderamos@hotmail.com;
   tayna_gonzalez@yahoo.com.br; lay_lica@hotmail.com;
   arturfelipes@gmail.com; land-jr@uol.com.br
RI Barbosa, Artur/G-3839-2012; Silveira, Landulfo/I-2474-2012; Pinheiro,
   Antonio Luiz/A-1962-2008
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321
CR Alpha C, 2006, J ORAL MAXIL SURG, V64, P659, DOI 10.1016/j.joms.2005.12.013
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho F.B., 2011, P SOC PHOTO-OPT INS, V7887
   Chritah A, 2005, J ORAL MAXIL SURG, V63, P1737, DOI 10.1016/j.joms.2005.08.022
   Erdogan O, 2006, J ORAL MAXIL SURG, V64, P180, DOI 10.1016/j.joms.2005.10.027
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Le Guehennec L, 2007, EUR CELLS MATER, V8, P1
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Nogueira G. V., 2005, J BIOMED OPT, V10
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Penel G, 2005, BONE, V36, P893, DOI 10.1016/j.bone.2005.02.012
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Silva Junior N, 2002, J CLIN LASER MED SUR, V20, P83
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
NR 26
TC 19
Z9 21
U1 0
U2 8
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
J9 LASER MED SCI
JI Lasers Med. Sci.
PD FEB
PY 2013
VL 28
IS 2
BP 513
EP 518
DI 10.1007/s10103-012-1096-1
PG 6
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 098WI
UT WOS:000315579400022
PM 22526972
DA 2018-10-20
ER

PT J
AU Liu, T
   Lai, DZ
   Feng, XX
   Zhu, HL
   Chen, JY
AF Liu, Tao
   Lai, Dongzhi
   Feng, Xinxing
   Zhu, Hailin
   Chen, Jianyong
TI Synthesis and characterization of a novel mesoporous bioactive
   glass/hydroxyapatite nanocomposite
SO MATERIALS LETTERS
LA English
DT Article
DE Mesoporous bioactive glasses; Hydroxyapatite; Nanoparticles;
   Nanocomposites; Biomaterials
ID CARBON SPHERES; DRUG-DELIVERY; HYDROXYAPATITE; GLASSES; NANOPARTICLES;
   PHOSPHATE; SYSTEM
AB A novel mesoporous bioactive glass/hydroxyapatite (MBG-HA) nanocomposite was fabricated via hydrothermal synthesis under glucose-assisted conditions using P123 as a mesoporous template. Glucose was used to create hydrophilic carbon spheres, which enriched calcium ions to form HA nanoparticles around the surface. The texture properties of the MBG-HA nanocomposite were determined through a series of characterization techniques. Compared with MBG, HA nanoparticles were distributed around the mesostructure of the MBG-HA matrix. In vitro bioactive assays showed a faster apatite-like phase formation on the surface of the MBG-HA nanocomposite than that on the surface of the MBG. The novel nanocomposite with enhanced biocompatibility can potentially be used as a biomaterial for bone tissue engineering. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.
C1 [Liu, Tao; Lai, Dongzhi; Zhu, Hailin; Chen, Jianyong] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Zhejiang, Peoples R China.
   [Feng, Xinxing] PLA, Gen Logist Dept, Quartermaster Res Inst, Beijing 100082, Peoples R China.
RP Chen, JY (reprint author), Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Zhejiang, Peoples R China.
EM jychen58@yahoo.cn
FU National Natural Science Foundation of China [50973096, 50903073,
   31070867]
FX The research was supported by the National Natural Science Foundation of
   China (Grant nos. 50973096, 50903073 and 31070867).
CR Borowka A, 2011, MATER LETT, V65, P175, DOI 10.1016/j.matlet.2010.09.023
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Cicuendez M, 2012, CHEM MATER, V24, P1100, DOI 10.1021/cm203416x
   Gerhardt LC, 2010, MATERIALS, V3, P3687
   Horcajada P, 2004, SOLID STATE SCI, V6, P1295, DOI 10.1016/j.solidstatesciences.2004.07.026
   Ito H, 2008, CRYST GROWTH DES, V8, P1055, DOI 10.1021/cg070443f
   Jagadeesan D, 2008, J PHYS CHEM C, V112, P7379, DOI 10.1021/jp800850m
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Sun XM, 2004, ANGEW CHEM INT EDIT, V43, P597, DOI 10.1002/anie.200352386
   Wang X, 2006, ADV MATER, V18, P2031, DOI 10.1002/adma.200600033
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yun HS, 2007, MATER LETT, V61, P4569, DOI 10.1016/j.matlet.2007.02.075
NR 15
TC 11
Z9 11
U1 3
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 1
PY 2013
VL 92
BP 444
EP 447
DI 10.1016/j.matlet.2012.10.084
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 104YU
UT WOS:000316033500121
DA 2018-10-20
ER

PT J
AU Taylor, MJ
   Sahota, TS
AF Taylor, M. J.
   Sahota, T. S.
TI CLOSED-LOOP INSULIN DELIVERY IN DIABETIC PIGS USING A SMART BIOMATERIAL
   DEVICE
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Meeting Abstract
C1 [Taylor, M. J.; Sahota, T. S.] De Montfort Univ, Sch Pharm, Leicester, Leics, England.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB
PY 2013
VL 15
SU 1
BP A24
EP A24
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 097IM
UT WOS:000315467200067
DA 2018-10-20
ER

PT J
AU Park, KM
   Park, SM
   Yang, SR
   Hong, SH
   Woo, HM
AF Park, Kyung-Mee
   Park, Sung-Min
   Yang, Se-Ran
   Hong, Seok-Ho
   Woo, Heung-Myong
TI Preparation of immunogen-reduced and biocompatible extracellular
   matrices from porcine liver
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Biomaterial; Biomatrix; Extracellular matrices (ECM); Porcine; Liver;
   Immunogen
ID SMALL-INTESTINAL SUBMUCOSA; SODIUM LAURYL SULFATE; ENDOGENOUS
   RETROVIRUS; HEART-VALVES; DONOR DNA; IN-VIVO; TRANSPLANTATION; SCAFFOLD;
   MODEL; DEGRADATION
AB Decellularized biologic matrices are plausible biomedical materials for the bioengineering in liver transplantation. However, one of the concerns for safe medical application is the lack of objective assessment of the immunogen within the materials and the in vivo immune responses to the matrices. The purpose of this study was the production of immunogen-reduced and biocompatible matrices from porcine liver. In the present study, 0.1% SDS solution was effective for removing DNA fragments and sequences encoding possible immunogenic and viral antigens within the matrices. The PCR analysis showed that galactose-alpha-1,3 galactose beta-1,4-N-acetylglucosamine (1,3 gal), swine leukocyte antigen (SLA), and porcine endogenous retrovirus (PERV) were completely removed in the matrices. Collagen and glycosaminoglycans (GAGs) were preserved over 63%-71%, respectively, compared to those of native liver. The implanted decellularized tissues showed minimal host responses and naturally degraded within 10 weeks. In this study, we produced immunogen-reduced and biocompatible extracellular matrices from porcine liver. Although future investigations would be required to determine the mechanism of the host reaction, this study could provide useful information of porcine liver-derived biologic matrices for liver researches. (C) 2012, The Society for Biotechnology, Japan. All rights reserved.
C1 [Park, Kyung-Mee; Woo, Heung-Myong] Kangwon Natl Univ, Stem Cell Inst KNU, Sch Vet Med, Chunchon 200701, Gangwon, South Korea.
   [Park, Sung-Min; Yang, Se-Ran; Hong, Seok-Ho] Kangwon Natl Univ, Stem Cell Inst KNU, Sch Med, Chunchon 200701, Gangwon, South Korea.
   [Woo, Heung-Myong] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA.
RP Woo, HM (reprint author), Kangwon Natl Univ, Stem Cell Inst KNU, Sch Vet Med, Chunchon 200701, Gangwon, South Korea.
EM vethouse2000@gmail.com; heart@kangwon.ac.kr; seran.yang@gmail.com;
   seokhohong1972@gmail.com; woohm@kangwon.ac.kr
FU Next-Generation BioGreen 21 program, Rural Development Administration,
   Republic of Korea [PJ008030, PJ008032]
FX This work was supported by a grant from the Next-Generation BioGreen 21
   program (nos. PJ008030 and PJ008032), Rural Development Administration,
   Republic of Korea.
CR Akiyoshi DE, 1998, J VIROL, V72, P4503
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145
   Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033
   BRAVERY CA, 1995, TRANSPLANTATION, V60, P1024, DOI 10.1097/00007890-199511150-00025
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cyganek-Niemiec A, 2012, INT J ARTIF ORGANS, V35, P25, DOI 10.5301/ijao.5000071
   De Kock J, 2011, ARCH TOXICOL, V85, P607, DOI 10.1007/s00204-011-0706-1
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   FAUCHER JA, 1978, J SOC COSMET CHEM, V29, P323
   Wollmann LCFD, 2011, REV BRAS CIR CARDIOV, V26, P490, DOI 10.5935/1678-9741.20110029
   Fukumitsu K, 2011, TRANSPL P, V43, P2137, DOI 10.1016/j.transproceed.2011.05.014
   Gentile P., SURG INNOV
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Hausen B, 1999, J HEART LUNG TRANSPL, V18, P714, DOI 10.1016/S1053-2498(99)00032-7
   Higashiyama SJ, 2003, J BIOSCI BIOENG, V96, P83, DOI 10.1016/S1389-1723(03)90102-2
   Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009
   Kallenbach K, 2004, BIOMATERIALS, V25, P3613, DOI 10.1016/j.biomaterials.2003.10.040
   Katsuda T, 2010, J BIOCHEM, V148, P281, DOI 10.1093/jb/mvq063
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   KNOOP C, 1994, TRANSPLANTATION, V58, P1335
   LAUTENSCHLAGER I, 1988, TRANSPLANTATION, V46, P41, DOI 10.1097/00007890-198807000-00006
   Leyh RG, 2003, J THORAC CARDIOV SUR, V126, P1000, DOI 10.1016/S0022-5223(03)00353-2
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   LODEN M, 1990, J SOC COSMET CHEM, V41, P227
   Logan JS, 2000, CURR OPIN IMMUNOL, V12, P563, DOI 10.1016/S0952-7915(00)00139-4
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   Moore PN, 2003, J COSMET SCI, V54, P29
   Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI 10.1089/ten.TEA.2009.0602
   Ning LJ, 2012, J BIOMED MATER RES A, V100A, P1448, DOI 10.1002/jbm.a.34083
   Olszewski WL, 2005, TRANSPLANT INT, V18, P412, DOI 10.1111/j.1432-2277.2004.00050.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Park KM, 2012, TRANSPL P, V44, P1146, DOI 10.1016/j.transproceed.2012.03.043
   Park KM, 2012, TRANSPL P, V44, P1151, DOI 10.1016/j.transproceed.2012.03.017
   Popp SK, 2007, IMMUNOL CELL BIOL, V85, P238, DOI 10.1038/sj.icb.7100028
   Prabha S, 2008, INDIAN J MED MICROBI, V26, P228, DOI 10.4103/0255-0857.42032
   Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   RHEIN LD, 1990, DERMATOLOGICA, V180, P18, DOI 10.1159/000247979
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Rutkowska J, 2007, ANN TRANSPL, V12, P12
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Soto-Gutierrez A, 2011, MOL PATHOL LIB, V5, P17, DOI 10.1007/978-1-4419-7107-4_3
   Spriewald BM, 1998, TRANSPLANTATION, V66, P77, DOI 10.1097/00007890-199807150-00012
   Takahashi S, 2009, J BIOSCI BIOENG, V108, P544, DOI 10.1016/j.jbiosc.2009.06.013
   Takeda M, 2005, J BIOSCI BIOENG, V100, P77, DOI 10.1263/jbb.100.77
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Tudorache I, 2007, J HEART VALVE DIS, V16, P567
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   VILAPLANA J, 1992, CONTACT DERMATITIS, V26, P289, DOI 10.1111/j.1600-0536.1992.tb00120.x
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   WILHELM KP, 1993, J INVEST DERMATOL, V101, P310, DOI 10.1111/1523-1747.ep12365467
   WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041
   YAMADA K, 1995, J IMMUNOL, V155, P5249
NR 65
TC 15
Z9 15
U1 0
U2 26
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD FEB
PY 2013
VL 115
IS 2
BP 207
EP 215
DI 10.1016/j.jbiosc.2012.08.023
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 100LQ
UT WOS:000315703100017
PM 23068617
DA 2018-10-20
ER

PT J
AU Yu, L
   Sheng, WJ
   Yang, DC
   Ding, JD
AF Yu, Lin
   Sheng, Wenjia
   Yang, Dicheng
   Ding, Jiandong
TI Design of molecular parameters to achieve block copolymers with a powder
   form at dry state and a temperature-induced sol-gel transition in water
   without unexpected gelling prior to heating
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE hydrogel; sol-gel transition; powder form; sol stability; block
   copolymer
ID STRUCTURE-PROPERTY RELATIONSHIPS; RING-OPENING POLYMERIZATION; REVERSE
   THERMAL GELATION; TRIBLOCK COPOLYMERS; AQUEOUS-SOLUTIONS;
   EPSILON-CAPROLACTONE; THERMOREVERSIBLE GELATION; HYDROLYTIC DEGRADATION;
   POLY(ETHYLENE GLYCOL); MULTIBLOCK COPOLYMER
AB Thermogelling block copolymers composed of polyester and polyether are faced with a dilemma of achieving powder form in order to easily handle the samples in the bulk state and avoid unexpected ahead-of-time gelling of the corresponding polymer aqueous solution below the thermogelling temperature due to the spontaneous crystallization of some polymer segments in water. In order to resolve this dilemma, we synthesized amphiphilic poly(E >-caprolactone-co-glycolide)-poly(ethylene glycol)-poly(E >-caprolactone-co-glycolide) (PCGA-PEG-PCGA) triblock copolymers with a series of ratios regarding caprolactone (CL) and glycolide (GA). The different polymer morphologies from powder to sticky paste were obatined by altering the ratios to adjust the ability of crytallization for the PCGA blocks. All of the copolymers reported in this paper were able to dissolve in water, and their aqueous solutions underwent a sol-gel transition upon heating. The polymer with an appropriate CL/GA ratio not only exhibited the powder form in the bulk state, but also achieved the sol stability in water. The triblock copolymers formed micelles in water and the micellar aggregation occurred with increasing temperature, resulting in physical gelation upon the percolation of micelles. The injectability and gellability of the copolymer-water systems were confirmed both in vitro and in vivo. Consequently, this study provides a promising injectable biomaterial, and also affords a new successful case of the molecular design of functional polymers, based upon common monomers.
C1 [Yu, Lin; Sheng, Wenjia; Yang, Dicheng; Ding, Jiandong] Fudan Univ, Dept Macromol Sci, Adv Mat Lab, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Yu, Lin; Ding, Jiandong] Fudan Univ, Key Lab Smart Drug Delivery PLA, Shanghai 200433, Peoples R China.
   [Yu, Lin; Ding, Jiandong] Fudan Univ, Minist Educ, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, Adv Mat Lab, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU Chinese Ministry of Science and Technology [2009CB930000, 2011CB606203];
   NSF of China [50903021, 21034002, 91127028]; Specialized Research Fund
   for the Doctoral Program of Higher Education of China [20090071120014]
FX The group was supported by Chinese Ministry of Science and Technology
   (973 Programs No. 2009CB930000 and No. 2011CB606203), NSF of China
   (Grants No. 50903021, No. 21034002, and No. 91127028), and the
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China (No. 20090071120014).
CR Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Censi R, 2010, J CONTROL RELEASE, V148, pE28, DOI 10.1016/j.jconrel.2010.07.039
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Huynh CT, 2011, MACROMOLECULES, V44, P6629, DOI 10.1021/ma201261m
   Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j
   Dobrzynski P, 2005, BIOMACROMOLECULES, V6, P483, DOI 10.1021/bm0494592
   Huynh DP, 2010, MACROMOL RES, V18, P192, DOI 10.1007/s13233-009-0182-0
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang ZQ, 2008, MACROMOL RAPID COMM, V29, P1264, DOI 10.1002/marc.200800186
   Jiang ZQ, 2007, J POLYM SCI POL CHEM, V45, P4091, DOI 10.1002/pola.22222
   Jin R, 2011, J CONTROL RELEASE, V152, P186, DOI 10.1016/j.jconrel.2011.01.031
   Jo S, 2006, MACROMOL BIOSCI, V6, P923, DOI 10.1002/mabi.200600127
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Jun I, 2011, MACROMOL RES, V19, P911, DOI 10.1007/s13233-011-0909-6
   Kang YM, 2011, BIOMATERIALS, V32, P4556, DOI 10.1016/j.biomaterials.2011.03.007
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kim JI, 2011, SOFT MATTER, V7, P8650, DOI 10.1039/c1sm05977g
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee H, 2012, MACROMOL RES, V20, P106, DOI 10.1007/s13233-012-0074-6
   Li SM, 2005, BIOMACROMOLECULES, V6, P489, DOI 10.1021/bm049458+
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Nagahama K, 2008, J POLYM SCI POL CHEM, V46, P6317, DOI 10.1002/pola.22943
   Nagahama K, 2009, POLYMER, V50, P3547, DOI 10.1016/j.polymer.2009.05.045
   Tran NQ, 2011, MACROMOL RES, V19, P300, DOI 10.1007/s13233-011-0309-y
   Ni PY, 2012, J BIOMED MATER RES A, V100A, P171, DOI 10.1002/jbm.a.33262
   Pack JW, 2002, J POLYM SCI POL CHEM, V40, P544, DOI 10.1002/pola.10123
   Park MR, 2010, POLYM DEGRAD STABIL, V95, P935, DOI 10.1016/j.polymdegradstab.2010.03.024
   Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Park SH, 2011, SOFT MATTER, V7, P6515, DOI 10.1039/c1sm05505d
   Potta T, 2010, BIOMACROMOLECULES, V11, P1741, DOI 10.1021/bm100197y
   Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x
   Tian D, 1997, MACROMOLECULES, V30, P1947, DOI 10.1021/ma961614k
   Wang WW, 2012, SOFT MATTER, V8, P1575, DOI 10.1039/c1sm06693e
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2012, MACROMOL RES, V20, P234, DOI 10.1007/s13233-012-0049-7
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2010, COLLOID POLYM SCI, V288, P1151, DOI 10.1007/s00396-010-2246-2
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yu YX, 2011, J BIOMED MATER RES A, V99A, P316, DOI 10.1002/jbm.a.33199
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
NR 52
TC 13
Z9 13
U1 5
U2 82
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD FEB
PY 2013
VL 21
IS 2
BP 207
EP 215
DI 10.1007/s13233-013-1021-x
PG 9
WC Polymer Science
SC Polymer Science
GA 097BT
UT WOS:000315449700014
DA 2018-10-20
ER

PT J
AU Brown, BN
   Badylak, SF
AF Brown, Bryan N.
   Badylak, Stephen F.
TI Expanded applications, shifting paradigms and an improved understanding
   of host-biomaterial interactions
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterials; Biocompatibility; Foreign body reaction; Host response;
   Macrophage
ID SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX SCAFFOLDS; MACROPHAGE
   ACTIVATION; SURFACE-TOPOGRAPHY; STEM-CELLS; IN-VITRO; PROINFLAMMATORY
   CYTOKINES; MUSCULAR-DYSTROPHY; CELLULAR-RESPONSES; BIOLOGIC SCAFFOLDS
AB The conventional approach to biomaterial design and development typically focuses upon the mechanical and material properties with long-term objectives that include an inert host immune response and long-lasting mechanical and structural support. The emergence of and interest in tissue engineering and regenerative medicine have driven the development of novel cell-friendly biomaterials, materials with tailored degradation rates, materials with highly specific architectures and surfaces, and vehicles for delivery of bioactive molecules, among numerous other advancements. Each of these biomaterial developments supports specific strategies for tissue repair and reconstruction. These advancements in biomaterial form and function, combined with new knowledge of innate and acquired immune system biology, provide an impetus for re-examination of host-biomaterial interactions, including host-biomaterial interface events, spatial and temporal patterns of in vivo biomaterial remodeling, and related downstream functional outcomes. An examination of such issues is provided herein with a particular focus on macrophage polarization and its implications in tissue engineering and regenerative medicine. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Suite 300,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR Adamson R, 2009, J Wound Care, V18, P349
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Black AF, 1998, FASEB J, V12, P1331
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chang S, 2003, J VASC SURG, V37, P1082, DOI 10.1067/mva.2003.160
   Charriere GM, 2006, EXP CELL RES, V312, P3205, DOI 10.1016/j.yexcr.2006.06.034
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Freytes DO, 2012, CELLS TISSUES ORGANS, V195, P171, DOI 10.1159/000331392
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   HENSON PM, 1980, AM J PATHOL, V101, P494
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Khandwekar A, 2012, J BIOMED MATER RES A, V100A, P2211, DOI 10.1002/jbm.a.34146
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009
   Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545
   Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Remlinger NT, 2010, BIOMATERIALS, V31, P3520, DOI 10.1016/j.biomaterials.2010.01.067
   Robbins SL, 2010, ROBBINS COTRAN PATHO
   Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/RES.00001776670.72216.9b
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010
   Seta N, 2010, EXP HEMATOL, V38, P557, DOI 10.1016/j.exphem.2010.03.015
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 1986, P CONS C EUR SOC BIO
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100
NR 96
TC 88
Z9 89
U1 5
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 4948
EP 4955
DI 10.1016/j.actbio.2012.10.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800001
PM 23099303
DA 2018-10-20
ER

PT J
AU Velard, F
   Braux, J
   Amedee, J
   Laquerriere, P
AF Velard, Frederic
   Braux, Julien
   Amedee, Joelle
   Laquerriere, Patrice
TI Inflammatory cell response to calcium phosphate biomaterial particles:
   An overview
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Calcium phosphate; Biocompatibility; Inflammation; Functionalization
ID MONOCYTES IN-VITRO; NF-KAPPA-B; INHIBITS OSTEOCLAST FORMATION;
   INTERFERON-GAMMA PRODUCTION; COLONY-STIMULATING FACTOR; FEMORAL-NECK
   FRACTURES; TOTAL HIP-ARTHROPLASTY; OSTEOBLAST-LIKE CELLS;
   NECROSIS-FACTOR-ALPHA; HYDROXYAPATITE PARTICLES
AB Bone is a metabolically active and highly organized tissue consisting of a mineral phase of hydroxyapatite (HA) and amorphous calcium phosphate (CaP) crystals deposited in an organic matrix. One objective of bone tissue engineering is to mimic the chemical and structural properties of this complex tissue. CaP ceramics, such as sintered HA and beta-tricalcium phosphate, are widely used as bone substitutes or prosthesis coatings because of their osteoconductive properties. These ceramic interactions with tissues induce a cell response that can be different according to the composition of the material. In this review, we discuss inflammatory cell responses to CaP materials to provide a comprehensive overview of mechanisms governing the integration or loosening of implants, which remains a major concern in tissue engineering. A focus on the effects of the functionalization of CaP biomaterials highlights potential ways to increase tissue integration and limit rejection processes. (C) 2012 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Velard, Frederic; Braux, Julien] Univ Reims, UFR Odontol, CHU Reims, SFR CAP Sante FED 4231,EA Biomat & Inflammat Site, F-51095 Reims, France.
   [Amedee, Joelle] Univ Bordeaux, INSERM U1026, F-33076 Bordeaux, France.
   [Laquerriere, Patrice] Inst Pluridisciplinaire Hubert Curien, CNRS UMR 7178, F-67037 Strasbourg, France.
   [Laquerriere, Patrice] Univ Strasbourg, F-67037 Strasbourg, France.
RP Laquerriere, P (reprint author), Inst Pluridisciplinaire Hubert Curien, CNRS UMR 7178, 23 Rue Loess, F-67037 Strasbourg, France.
EM patrice.laquerriere@iphc.cnrs.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013; Laquerriere, Patrice/P-1025-2016
OI Laquerriere, Patrice/0000-0001-7637-9094; VELARD,
   Frederic/0000-0002-4826-2160
CR Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595
   Albee FH, 1920, ANN SURG, V71, P32
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023
   Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005
   Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Benhayoune H, 2000, BIOMATERIALS, V21, P235, DOI 10.1016/S0142-9612(99)00138-6
   Blake T, 1998, J TOXICOL ENV HEAL A, V54, P243
   Bloebaum RD, 1997, CLIN ORTHOP RELAT R, P109
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2006, J BIOMED MATER RES A, V78A, P709, DOI 10.1002/jbm.a.30726
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Buache E, 2012, ACTA BIOMATER, V8, P3113, DOI 10.1016/j.actbio.2012.04.045
   Burt HM, 1997, DIGEST DIS SCI, V42, P1283, DOI 10.1023/A:1018870511257
   CAMBRAY GJ, 1981, RHEUMATOL INT, V1, P11, DOI 10.1007/BF00541217
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353
   Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612
   Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196
   Cheung HS, 1997, OSTEOARTHR CARTILAGE, V5, P145, DOI 10.1016/S1063-4584(97)80009-X
   Connell P, 1997, J AM COLL NUTR, V16, P411, DOI 10.1080/07315724.1997.10718706
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Davis Gerald S., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P53
   Day RM, 2005, J BIOMED MATER RES A, V73A, P73, DOI 10.1002/jbm.a.30262
   DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215
   DEGROOT K, 1993, CERAM INT, V19, P363, DOI 10.1016/0272-8842(93)90050-2
   Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761
   Ea HK, 2005, ARTHRITIS RES THER, V7, pR915, DOI 10.1186/ar1763
   EVANS EJ, 1991, BIOMATERIALS, V12, P574, DOI 10.1016/0142-9612(91)90054-E
   Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862
   Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Fukuchi N, 1995, BIO-MED MATER ENG, V5, P219
   Gauthier O, 1999, BONE, V25, p71S, DOI 10.1016/S8756-3282(99)00137-4
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Grandjean-Laquerriere A, 2005, BIOMATERIALS, V26, P2361, DOI 10.1016/j.biomaterials.2004.07.036
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Grassi F, 2003, HISTOCHEM CELL BIOL, V120, P391, DOI 10.1007/s00418-003-0587-3
   Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501
   Haase H, 2007, BIOMETALS, V20, P579, DOI 10.1007/s10534-006-9029-8
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6
   Hanifi A, 2010, J MATER SCI-MATER M, V21, P2601, DOI 10.1007/s10856-010-4123-4
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   Hie M, 2011, EUR J PHARMACOL, V668, P140, DOI 10.1016/j.ejphar.2011.07.003
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333
   Horwood NJ, 2001, J IMMUNOL, V166, P4915, DOI 10.4049/jimmunol.166.8.4915
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Jallot E, 1999, EUR PHYS J-APPL PHYS, V6, P205, DOI 10.1051/epjap:1999172
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAWAGUCHI H, 1992, J PERIODONTAL RES, V27, P48, DOI 10.1111/j.1600-0765.1992.tb02085.x
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338
   Laggner H, 2006, FREE RADICAL BIO MED, V40, P436, DOI 10.1016/j.freeradbiomed.2005.08.030
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   Laquerriere P, 2001, J BIOMED MATER RES, V58, P238, DOI 10.1002/1097-4636(2001)58:3<238::AID-JBM1012>3.3.CO;2-9
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laquerriere P, 2004, COLLOID SURFACE B, V33, P39, DOI 10.1016/j.colsurfb.2003.08.012
   Laquerriere P, 2003, COLLOID SURFACE B, V30, P207, DOI 10.1016/S0927-7765(03)00083-3
   Le Nihouannen D, 2008, BIOMATERIALS, V29, P3253, DOI 10.1016/j.biomaterials.2008.03.035
   Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15
   Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0
   Liao S, 2006, J BIOMED MATER RES A, V76A, P820, DOI 10.1002/jbm.a.30582
   Lisignoli G, 1999, J RHEUMATOL, V26, P791
   Macaulay W, 2006, J AM ACAD ORTHOP SUR, V14, P287, DOI 10.5435/00124635-200605000-00004
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Marriott I, 2002, J INTERF CYTOK RES, V22, P1049, DOI 10.1089/107999002760624288
   Marshall JD, 1999, CLIN IMMUNOL, V90, P15, DOI 10.1006/clim.1998.4633
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   Miyamoto RG, 2008, J AM ACAD ORTHOP SUR, V16, P596, DOI 10.5435/00124635-200810000-00005
   Mormann M, 2008, MOL IMMUNOL, V45, P3330, DOI 10.1016/j.molimm.2008.04.022
   Morita S, 1998, BIOMATERIALS, V19, P1601, DOI 10.1016/S0142-9612(97)00120-8
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Motskin M, 2011, BIOMATERIALS, V32, P9470, DOI 10.1016/j.biomaterials.2011.08.060
   MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554
   Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   NAGASE M, 1993, FEBS LETT, V325, P247, DOI 10.1016/0014-5793(93)81082-B
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5
   OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0
   Oonishi H, 2008, CLIN ORTHOP RELAT R, V466, P373, DOI 10.1007/s11999-007-0057-7
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Penolazzi L, 2008, CELL BIOL INT, V32, P320, DOI 10.1016/j.cellbi.2007.08.030
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809
   PRYSTOWSKY JB, 1995, DIGEST DIS SCI, V40, P412, DOI 10.1007/BF02065430
   Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256
   Puren AJ, 1998, J INFECT DIS, V178, P1830, DOI 10.1086/314481
   Raaymakers Ernst L F B, 2006, Acta Chir Orthop Traumatol Cech, V73, P45
   Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666
   Romer P, 2012, ANN ANAT, V194, P208, DOI 10.1016/j.aanat.2011.09.008
   ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, pS94, DOI 10.1007/BF01673412
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S
   Shetty AA, 2005, J BONE JOINT SURG BR, V87B, P1050, DOI 10.1302/0301-620X.87B8.16011
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   Spyrou P, 2002, CLIN ORAL IMPLAN RES, V13, P623, DOI 10.1034/j.1600-0501.2002.130608.x
   Stuyt RJL, 2003, IMMUNOLOGY, V110, P329, DOI 10.1046/j.1365-2567.2003.01747.x
   Sun J, 2009, IEEE T NANOBIOSCI, V8, P78, DOI 10.1109/TNB.2009.2016465
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Sun JS, 1999, J BIOMED MATER RES, V45, P311
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065
   Trindade MCD, 2001, BIOMATERIALS, V22, P2067, DOI 10.1016/S0142-9612(00)00376-8
   Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005
   VAES G, 1988, CLIN ORTHOP RELAT R, V231, P239
   Velard F, 2010, BIOMATERIALS, V31, P2001, DOI 10.1016/j.biomaterials.2009.11.066
   Velard F, 2009, ACTA BIOMATER, V5, P1708, DOI 10.1016/j.actbio.2009.01.008
   Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022
   von Bulow V, 2007, J IMMUNOL, V179, P4180, DOI 10.4049/jimmunol.179.6.4180
   Voor MJ, 2004, J BIOMED MATER RES B, V71B, P398, DOI 10.1002/jbm.b.30109
   Wagner JG, 2000, PHARMACOL REV, V52, P349
   Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843
   Wellinghausen N, 1998, J LEUKOCYTE BIOL, V64, P571
   Yamada N, 2002, BONE, V30, P901, DOI 10.1016/S8756-3282(02)00722-6
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
   Zoli A, 1998, CLIN RHEUMATOL, V17, P378, DOI 10.1007/BF01450895
NR 140
TC 55
Z9 55
U1 0
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 4956
EP 4963
DI 10.1016/j.actbio.2012.09.035
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800002
PM 23036944
DA 2018-10-20
ER

PT J
AU Rasekh, M
   Ahmad, Z
   Frangos, CC
   Bozec, L
   Edirisinghe, M
   Day, RM
AF Rasekh, Manoochehr
   Ahmad, Zeeshan
   Frangos, Constantinos C.
   Bozec, Laurent
   Edirisinghe, Mohan
   Day, Richard M.
TI Spatial and temporal evaluation of cell attachment to printed
   polycaprolactone microfibres
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Direct writing; Printing; Electrohydrodynamic; Topography; Time-lapse
   microscopy
ID IN-VITRO BIOCOMPATIBILITY; SURFACE-TOPOGRAPHY; DEPOSITION; ROUGHNESS;
   DISCHARGE; FILMS; FIBROBLASTS; OSTEOBLASTS; SCAFFOLDS; TITANIUM
AB Surface topography plays a crucial role in influencing cellular responses and has therefore been utilized in the development of numerous implantable devices. Whilst numerous studies have either investigated cell attachment or migration post-attachment, few have looked at the early-stages of this process temporally. The aim of this study was to evaluate the use of time-lapse microscopy to study the behaviour of fibroblasts cultured with polycaprolactone microfibres and to assess spatially and temporally the cell-structure interaction over a 24 h period. Ordered polymeric structures were printed (predetermined) onto glass substrates using an electrohydrodynamic direct write process to produce fine (3-5 mu m wide) structures. Fibroblast attachment and migration were characterized as a function of distance perpendicular from structures (similar to 17.3, 34.6 and 51.9 mu m). The use of time-lapse microscopy revealed a gradual decrease in cell attachment as the distance from the microfibres was increased. The technique also revealed that some cells were attaching and detaching from the microflbre multiple times. Our findings demonstrate that time-lapse microscopy is a useful technique for evaluating early-stage cell-biomaterial interaction that is capable of recording important events that might otherwise be overlooked. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rasekh, Manoochehr; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Ahmad, Zeeshan] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Frangos, Constantinos C.; Day, Richard M.] UCL, Div Med, Appl Biomed Engn Grp, London WC1E 6JJ, England.
   [Bozec, Laurent] UCL, Eastman Dent Inst, London WC1X 8LD, England.
RP Day, RM (reprint author), UCL, Div Med, Appl Biomed Engn Grp, Rockefeller Bldg,21 Univ St, London WC1E 6JJ, England.
EM r.m.day@ucl.ac.uk
RI Frangos, Constantinos/B-8861-2009
OI Frangos, Constantinos/0000-0002-7677-7989; Ahmad,
   Zeeshan/0000-0001-8863-6211
FU Department of Health's NIHR as a Comprehensive Biomedical Research
   Centre
FX The authors are grateful for the technical support of Nicola Mordan, UCL
   Eastman Dental Institute (UCL) and the Archaeology Department at
   University College London for use of their SEM and microscopy equipment.
   The authors also wish to thank Daniel Gilmartin, UCL Research Department
   of Cell and Developmental Biology for assistance with the time-lapse
   microscopy. Part of this work was undertaken at UCL/UCLH, which receives
   funding from the Department of Health's NIHR as a Comprehensive
   Biomedical Research Centre.
CR Ahmad Z, 2008, J R SOC INTERFACE, V5, P1255, DOI 10.1098/rsif.2008.0247
   Ahmad Z, 2008, J MATER SCI-MATER M, V19, P3093, DOI 10.1007/s10856-008-3436-z
   Ahmad Z, 2010, MACROMOL MATER ENG, V295, P315, DOI 10.1002/mame.200900396
   Ahn SH, 2011, BIOMACROMOLECULES, V12, P4256, DOI 10.1021/bm201126j
   Alberts B, 2002, MOL BIOL CELL
   Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Bax DV, 2011, BIOMATERIALS, V32, P6710, DOI 10.1016/j.biomaterials.2011.05.060
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Borra JP, 2004, J AEROSOL SCI, V35, P1313, DOI 10.1016/j.jaerosci.2004.05.011
   Borra JP, 1999, J AEROSOL SCI, V30, P913, DOI 10.1016/S0021-8502(98)00779-4
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   D'Sa RA, 2010, ACTA BIOMATER, V6, P2609, DOI 10.1016/j.actbio.2010.01.015
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Hamilton DW, 2006, TISSUE ENG, V12, P189, DOI 10.1089/ten.2006.12.189
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Paine MD, 2007, J AEROSOL SCI, V38, P315, DOI 10.1016/j.jaerosci.2006.12.004
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   Rasekh M, 2011, ADV ENG MATER, V13, pB296, DOI 10.1002/adem.201080126
   Schwarz MLR, 2009, J BIOMED MATER RES A, V89A, P667, DOI 10.1002/jbm.a.32000
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Thian ES, 2008, BIOMATERIALS, V29, P1833, DOI 10.1016/j.biomaterials.2008.01.007
   Vaquette C, 2006, BIO-MED MATER ENG, V16, pS131
   Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531
   Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994
   Wang XF, 2008, BIOMATERIALS, V29, P2049, DOI 10.1016/j.biomaterials.2007.12.047
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
NR 33
TC 9
Z9 9
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 5052
EP 5062
DI 10.1016/j.actbio.2012.09.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800012
PM 23036949
DA 2018-10-20
ER

PT J
AU Ciofani, G
   Genchi, GG
   Liakos, I
   Athanassiou, A
   Mattoli, V
   Bandiera, A
AF Ciofani, Gianni
   Genchi, Giada G.
   Liakos, Ioannis
   Athanassiou, Athanassia
   Mattoli, Virgilio
   Bandiera, Antonella
TI Human recombinant elastin-like protein coatings for muscle cell
   proliferation and differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Human elastin-like polypeptides (HELPs); Recombinant proteins; Protein
   coatings; H9c2; Myoblast proliferation and differentiation
ID SELF-ASSEMBLED MONOLAYERS; IN-VITRO; EXPRESSION; ADHESION; POLYPEPTIDES;
   BEHAVIOR; TROPOELASTIN; TRANSITION; PREDICTION; PHENOTYPE
AB Recombinant proteins represent a new and promising class of polymeric materials in the field of biomaterials research. An important model for biomaterial design is elastin, the protein accounting for the elasticity of several tissues. Human elastin-like polypeptides (HELPs) have been developed as recombinant versions of elastin with the purpose of enhancing some peculiar characteristics of the native protein, like self-assembling. In this paper, we report on a comparative study of rat myoblasts response to coatings based on two different HELP macromolecules, with respect to control cultures on bare cell culture polystyrene and on a standard collagen coating. Cell behavior was analyzed in terms of adhesion, proliferation and differentiation. The collected data strongly suggest the use of HELPs as excellent biomaterials for tissue engineering and regenerative medicine applications. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ciofani, Gianni; Genchi, Giada G.; Mattoli, Virgilio] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, I-56025 Pisa, Italy.
   [Genchi, Giada G.] Scuola Super Sant Anna, BioRobot Inst, I-56025 Pisa, Italy.
   [Liakos, Ioannis; Athanassiou, Athanassia] Ist Italiano Tecnol, Ctr Biomol Nanotechnol, I-73010 Lecce, Italy.
   [Bandiera, Antonella] Univ Trieste, Dept DSV, I-34127 Trieste, Italy.
RP Ciofani, G (reprint author), Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM gianni.ciofani@iit.it
RI Mattoli, Virgilio/A-6744-2017; ATHANASSIOU, ATHANASSIA/B-4197-2018;
   Liakos, Ioannis/C-5847-2014; Ciofani, Gianni/D-3761-2009
OI Mattoli, Virgilio/0000-0002-4715-8353; ATHANASSIOU,
   ATHANASSIA/0000-0002-6533-3231; Liakos, Ioannis/0000-0001-6403-1058;
   Ciofani, Gianni/0000-0003-1192-3647; Genchi, Giada
   Graziana/0000-0002-2154-7991
CR Adamson AW, 1990, PHYS CHEM SURFACES
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Bandiera A, 2005, BIOTECHNOL APPL BIOC, V42, P247, DOI 10.1042/BA20050114
   Bandiera A, 2011, ENZYME MICROB TECH, V49, P347, DOI 10.1016/j.enzmictec.2011.06.012
   Bandiera A, 2010, BIOMACROMOLECULES, V11, P3256, DOI 10.1021/bm100644m
   Bandiera A, 2010, PREP BIOCHEM BIOTECH, V40, P198, DOI 10.1080/10826068.2010.488541
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   BOONEN KJM, 2009, AM J PHYSIOL-CELL PH, V296, P1338
   Bozzini S, 2011, J MATER SCI-MATER M, V22, P2641, DOI 10.1007/s10856-011-4451-z
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022
   Jeon WB, 2011, J BIOMED MATER RES A, V97A, P152, DOI 10.1002/jbm.a.33041
   KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   McArthur SL, 2006, SURF INTERFACE ANAL, V38, P1380, DOI 10.1002/sia.2498
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Minato A, 2012, BIOMATERIALS, V33, P515, DOI 10.1016/j.biomaterials.2011.09.070
   Nakaoka R, 2010, J BIOMED MATER RES A, V94A, P524, DOI 10.1002/jbm.a.32714
   Peterson WJ, 2002, CELL PROLIFERAT, V35, P9, DOI 10.1046/j.1365-2184.2002.00219.x
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Srivastava GK, 2011, J BIOMED MATER RES A, V97A, P243, DOI 10.1002/jbm.a.33050
   Stern MM, 2009, BIOMATERIALS, V30, P239
   Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018
   URRY DW, 1974, BIOCHIM BIOPHYS ACTA, V371, P597, DOI 10.1016/0005-2795(74)90057-9
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vanea E, 2011, APPL SURF SCI, V257, P2346, DOI 10.1016/j.apsusc.2010.09.101
   Vissing K, 2005, J APPL PHYSIOL, V99, P164, DOI 10.1152/japplphysiol.01172.2004
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu WM, 1998, DEVELOPMENT, V125, P327
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
NR 47
TC 14
Z9 14
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 5111
EP 5121
DI 10.1016/j.actbio.2012.10.016
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800018
PM 23085563
DA 2018-10-20
ER

PT J
AU Chung, EJ
   Jakus, AE
   Shah, RN
AF Chung, Eun Ji
   Jakus, Adam E.
   Shah, Ramille N.
TI In situ forming collagen-hyaluronic acid membrane structures: Mechanism
   of self-assembly and applications in regenerative medicine
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Self-assembly; Membrane; Collagen; Cell encapsulation; Bioplotting
ID BIOMEDICAL APPLICATIONS; CROSS-LINKING; GROWTH-FACTOR; DELIVERY;
   SCAFFOLD; BIOCOMPATIBILITY; HYDROXYAPATITE; MICROSPHERES; BIOMATERIAL;
   TENDONS
AB Bioactive, in situ forming materials have the potential to complement minimally invasive surgical procedures and enhance tissue healing. For such biomaterials to be adopted in the clinic, they must be cost-effective, easily handled by the surgeon and have a history of biocompatibility. To this end, we report a novel and facile self-assembling strategy to create membranes and encapsulating structures using collagen and hyaluronic acid (HA). Unlike membranes built by layer-by-layer deposition of oppositely charged biomolecules, the collagen-HA membranes described here form a diffusion barrier upon electrostatic interaction of the oppositely charged biomolecules, which is further driven by osmotic pressure imbalances. The resulting membranes have a nanofibrous architecture, a thicknesses of 130 mu m and a tensile modulus (0.59 +/- 0.06 MPa) that can increase 7-fold using carbodiimide chemistry (4.42 +/- 1.46 MPa). Collagen-HA membranes support mesenchymal stem cell proliferation and have a slow and steady protein release profile (7% at day 28), offering opportunities for targeted tissue regeneration. We demonstrate the capacity to encapsulate cells by injecting HA into the collagen solution, and enhance allograft and implant biocompatibility through a coating technique. This study describes a novel mechanism of collagen-HA membrane formation and provides the groundwork to apply these membranes in a variety of tissue engineering applications. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chung, Eun Ji; Jakus, Adam E.; Shah, Ramille N.] Northwestern Univ, Inst BioNantechnol Med, Chicago, IL 60611 USA.
   [Jakus, Adam E.; Shah, Ramille N.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Shah, Ramille N.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.
RP Shah, RN (reprint author), Northwestern Univ, Inst BioNantechnol Med, Chicago, IL 60611 USA.
EM ramille-shah@northwestern.edu
RI Shah, Ramille/E-3737-2010
FU IBNAM-Baxter Early Career Award; NSF-NSEC; NSF-MRSEC; Keck Foundation;
   State of Illinois; Northwestern University
FX The authors acknowledge the financial support from the-IBNAM-Baxter
   Early Career Award granted to E.J.C., which supported this research. The
   authors also acknowledge Mark Seniw, Dr. Karpagavalli Ramji and Adam
   Weingarten, for assistance in producing illustrations, synthesizing
   hydroxyapatite and measuring osmolarity, respectively. Experiments made
   use of the following facilities at Northwestern University: Electron
   Probe Instrumentation Center (EPIC) of the NUANCE Center, the Biological
   Imaging Facility (BIF) and the Institute for BioNanotechnology in
   Medicine (IBNAM). The NUANCE Center is supported by the NSF-NSEC,
   NSF-MRSEC, Keck Foundation, the State of Illinois and Northwestern
   University.
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Berenson MC, 1996, J ORTHOP RES, V14, P518, DOI 10.1002/jor.1100140404
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k
   Ceccarelli F, 2007, CLIN ORTHOP RELAT R, P188, DOI 10.1097/BLO.0b013e3180396f07
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Fawzi-Grancher S, 2009, J MATER SCI-MATER M, V20, P1709, DOI 10.1007/s10856-009-3726-0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Joester D, 2003, ANGEW CHEM INT EDIT, V42, P1486, DOI 10.1002/anie.200250284
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kuo JW, 2006, PRACTICAL ASPECTS HY
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li JX, 2006, MACROMOL RAPID COMM, V27, P114, DOI 10.1002/marc.200500726
   LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003
   Lowack K, 1998, MACROMOLECULES, V31, P823, DOI 10.1021/ma9614454
   Luong ND, 2008, MAT SCI ENG C-BIO S, V28, P1242, DOI 10.1016/j.msec.2007.11.005
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Maleki A, 2008, MACROMOL SYMP, V274, P131, DOI 10.1002/masy.200851418
   MARCUS R, 1987, ANNU REV MED, V38, P129, DOI 10.1146/annurev.med.38.1.129
   Miller BS, 2005, SPORTS MED ARTHROSC, V13, P3, DOI 10.1097/01.jsa.0000151936.57097.d9
   MINAMI A, 1982, HAND, V14, P111, DOI 10.1016/S0072-968X(82)80001-6
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nishiyama N, 2003, J DENT RES, V82, P257, DOI 10.1177/154405910308200403
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Rehakova M, 1996, J BIOMED MATER RES, V30, P369, DOI 10.1002/(SICI)1097-4636(199603)30:3<369::AID-JBM11>3.0.CO;2-F
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024
   Suuronen EJ, 2006, CIRCULATION, V114, pI138
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
NR 43
TC 14
Z9 16
U1 3
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 5153
EP 5161
DI 10.1016/j.actbio.2012.09.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800022
PM 23022546
DA 2018-10-20
ER

PT J
AU Yazici, H
   Fong, H
   Wilson, B
   Oren, EE
   Amos, FA
   Zhang, H
   Evans, JS
   Snead, ML
   Sarikaya, M
   Tamerler, C
AF Yazici, H.
   Fong, H.
   Wilson, B.
   Oren, E. E.
   Amos, F. A.
   Zhang, H.
   Evans, J. S.
   Snead, M. L.
   Sarikaya, M.
   Tamerler, C.
TI Biological response on a titanium implant-grade surface functionalized
   with modular peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Implants; Titanium binding peptide; Molecular recognition; Biomaterial
   interface; Bioenabled surface modification
ID QUARTZ-CRYSTAL MICROBALANCE; PLASMON RESONANCE SPECTROSCOPY;
   PROTEIN-PROTEIN INTERACTIONS; OSTEOBLAST-LIKE CELLS; SPRAYED BIOCERAMIC
   COATINGS; SELF-ASSEMBLED MONOLAYERS; BINDING PEPTIDES; MOLECULAR
   BIOMIMETICS; IN-VITRO; REPEATING POLYPEPTIDES
AB Titanium (Ti) and its alloys are among the most successful implantable materials for dental and orthopedic applications. The combination of excellent mechanical and corrosion resistance properties makes them highly desirable as endosseous implants that can withstand a demanding biomechanical environment. Yet, the success of the implant depends on its osteointegration, which is modulated by the biological reactions occurring at the interface of the implant. A recent development for improving biological responses on the Ti-implant surface has been the realization that bifunctional peptides can impart material binding specificity not only because of their molecular recognition of the inorganic material surface, but also through their self-assembly and ease of biological conjugation properties. To assess peptide-based functionalization on bioactivity, the present authors generated a set of peptides for implant-grade Ti, using cell surface display methods. Out of 60 unique peptides selected by this method, two of the strongest titanium binding peptides, TiBP1 and TiBP2, were further characterized for molecular structure and adsorption properties. These two peptides demonstrated unique, but similar molecular conformations different from that of a weak binder peptide, TiBP60. Adsorption measurements on a Ti surface revealed that their disassociation constants were 15-fold less than TiBP60. Their flexible and modular use in biological surface functionalization were demonstrated by conjugating them with an integrin recognizing peptide motif, RGDS. The functionalization of the Ti surface by the selected peptides significantly enhanced the bioactivity of osteoblast and fibroblast cells on implant-grade materials. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yazici, H.; Fong, H.; Wilson, B.; Oren, E. E.; Sarikaya, M.; Tamerler, C.] Univ Washington, Dept Mat Sci & Engn, Genetically Engn Mat Sci & Engn Ctr, Seattle, WA 98195 USA.
   [Yazici, H.; Tamerler, C.] Istanbul Tech Univ, Mol Biol & Genet Dept, TR-80626 Istanbul, Turkey.
   [Amos, F. A.; Evans, J. S.] NYU, Chem Phys Lab, New York, NY 10010 USA.
   [Amos, F. A.; Evans, J. S.] NYU, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.
   [Zhang, H.] Univ Washington, Sch Dent, Dept Restorat Dent, Seattle, WA 98195 USA.
   [Snead, M. L.] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.
RP Tamerler, C (reprint author), Univ Washington, Dept Mat Sci & Engn, Genetically Engn Mat Sci & Engn Ctr, Seattle, WA 98195 USA.
EM candan@u.washington.edu
RI Oren, Ersin Emre/B-5672-2011; Yazici, Hilal/F-6870-2013
OI Oren, Ersin Emre/0000-0001-5902-083X; Tamerler,
   Candan/0000-0001-7055-1156; Tamerler, Candan/0000-0002-1960-2218
FU NIH [1R21AR062249-01]; NSF-MRSEC Program through the University of
   Washington GEMSEC [DMR 0520567]; NSF-BioMaterial Program; NSF-IRES;
   TUBITAK/NSF [TBAG 107T250]; Institute of Science and Technology via
   Graduate Thesis Supporting Fund at Istanbul Technical University
   [34009]; National Institute for Dental & Craniofacial Research [DE
   130045]
FX This research is supported by NIH 1R21AR062249-01, NSF-MRSEC Program
   through the University of Washington GEMSEC DMR 0520567, NSF-BioMaterial
   Program, NSF-IRES and TUBITAK/NSF joint project (TBAG 107T250), and
   Institute of Science and Technology via Graduate Thesis Supporting Fund
   at Istanbul Technical University (Project Number 34009), National
   Institute for Dental & Craniofacial Research Grant # DE 130045 (MLS).
   Portions of this work (CD) represent contribution number 68 from the
   Laboratory of Chemical Physics, New York University.
CR Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P
   Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P421, DOI 10.1002/jbm.a.10080
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P431, DOI 10.1002/jbm.a.10084
   Bigi A, 2008, BIOMATERIALS, V29, P1730, DOI 10.1016/j.biomaterials.2007.12.011
   BOYER R, 1994, MAT PROPERTIES HDB T
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   Chang CK, 2001, J BIOMED MATER RES, V56, P17, DOI 10.1002/1097-4636(200107)56:1<17::AID-JBM1063>3.0.CO;2-T
   Chen HB, 2008, LANGMUIR, V24, P6852, DOI 10.1021/la800314p
   Chen HB, 2006, ANAL CHEM, V78, P4872, DOI 10.1021/ac0603025
   Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Delak K, 2008, CRYST GROWTH DES, V8, P4481, DOI 10.1021/cg8004294
   Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a
   Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e
   Evans JS, 2008, MRS BULL, V33, P514, DOI 10.1557/mrs2008.103
   Fang Y, 2008, J MATER CHEM, V18, P3871, DOI 10.1039/b806797j
   Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 2009, J R SOC INTERFACE, V6, pS361, DOI 10.1098/rsif.2008.0427.focus
   Heimann RB, 1998, J BIOMED MATER RES, V43, P441, DOI 10.1002/(SICI)1097-4636(199824)43:4<441::AID-JBM12>3.3.CO;2-N
   Hnilova M, 2008, LANGMUIR, V24, P12440, DOI 10.1021/la801468c
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Kriplani U, 2005, CURR OPIN BIOTECH, V16, P470, DOI 10.1016/j.copbio.2005.07.001
   Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060
   Kurzweg H, 1998, BIOMATERIALS, V19, P1507, DOI 10.1016/S0142-9612(98)00067-2
   Limson J, 2004, S AFR J SCI, V100, P678
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Martin HJ, 2007, LANGMUIR, V23, P6645, DOI 10.1021/la063284v
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074
   Ogawa T, 2008, J DENT RES, V87, P751, DOI 10.1177/154405910808700809
   Oren EE, 2005, NANO LETT, V5, P415, DOI 10.1021/nl048425x
   Pesquero NC, 2010, BIOSENS BIOELECTRON, V26, P36, DOI 10.1016/j.bios.2010.04.047
   Pfeiffer I, 2004, J AM CHEM SOC, V126, P10224, DOI 10.1021/ja048514b
   Rakngarm A, 2009, J MECH BEHAV BIOMED, V2, P444, DOI 10.1016/j.jmbbm.2008.11.001
   Rautray TR, 2010, J BIOMED MATER RES B, V93B, P581, DOI 10.1002/jbm.b.31596
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Shiba K, 2010, CURR OPIN BIOTECH, V21, P412, DOI 10.1016/j.copbio.2010.07.008
   Su XD, 2005, BIOSENS BIOELECTRON, V21, P719, DOI 10.1016/j.bios.2005.01.006
   Su XD, 2004, SENSOR ACTUAT B-CHEM, V100, P309, DOI 10.1016/j.snb.2004.01.020
   Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Tamerler C, 2010, BIOPOLYMERS, V94, P78, DOI 10.1002/bip.21368
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vreuls C, 2010, J INORG BIOCHEM, V104, P1013, DOI 10.1016/j.jinorgbio.2010.05.008
   Weiger MC, 2010, BIOMATERIALS, V31, P2955, DOI 10.1016/j.biomaterials.2010.01.012
   Wustman BA, 2002, BIOPOLYMERS, V65, P362, DOI 10.1002/bip.10274
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu GZ, 1999, BIOPOLYMERS, V49, P303
NR 72
TC 47
Z9 48
U1 3
U2 168
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2013
VL 9
IS 2
BP 5341
EP 5352
DI 10.1016/j.actbio.2012.11.004
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 093DB
UT WOS:000315170800043
PM 23159566
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, MC
   Zhao, GH
   Tang, YT
   Shi, HJ
   Yang, NJ
AF Liu, Meichuan
   Zhao, Guohua
   Tang, Yiting
   Shi, Huijie
   Yang, Nianjun
TI Direct Electrochemistry of Hemoglobin on Vertically Aligned Carbon
   Hybrid TiO2 Nanotubes and Its Highly Sensitive Biosensor Performance
SO CHINESE JOURNAL OF CHEMISTRY
LA English
DT Article
DE carbon hybrid TiO2 nanotubes; direct electron transfer; electrochemical
   biosensors; hemoglobin
ID TEMPERATURE IONIC LIQUIDS; HORSERADISH-PEROXIDASE; ENZYMATIC-ACTIVITY;
   COMPOSITE FILM; ARRAYS; ELECTRODE; GRAPHENE; TITANIUM; ELECTROCATALYSIS;
   ANODIZATION
AB The present work is focused on developing a novel biomaterial platform to achieve enhanced direct electron transfer (DET) of hemoprotein and higher biosensor performance on vertically aligned carbon hybrid TiO2 nanotubes (C-TiO2 NTs). Using a simple surfactant-assisted method, controllable hybridization of TiO2 NTs with conductive amorphous carbon species is realized. The obtained C-TiO2 NTs is ingeniously chosen to serve as an ideal "vessel" for protein immobilization and biosensor applications. Results show that the appropriate hybridization of C into TiO2 NTs leads to a much better conductivity of TiO2 NTs without destroying their preponderant tubular structures or damaging their excellent biocompatibility and hydrophilicity. When used in loading proteins, the C-TiO2 NTs can be used as a super vessel for rapid and substantive immobilization of hemoglobin (Hb), with a large surface electroactive Hb coverage () of 3.3x109 mol center dot cm2. Enhanced DET of Hb is commendably observed on the constructed Hb/C-TiO2 NTs biosensor with a couple of well-defined redox peaks in a fast electron transfer process. The biosensor further exhibits fast response, high sensitivity and stability for the amperometric biosensing of H2O2 with the detection limit as low as 3.1x108 mol/L.
C1 [Liu, Meichuan; Zhao, Guohua; Tang, Yiting; Shi, Huijie] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.
   [Liu, Meichuan; Zhao, Guohua] Tongji Univ, Key Lab Yangtze River Water Environm, Minist Educ, Shanghai 200092, Peoples R China.
   [Yang, Nianjun] Fraunhofer Inst Appl Solid State Phys, D-79108 Freiburg, Germany.
RP Zhao, GH (reprint author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.
EM g.zhao@tongji.edu.cn
OI Yang, Nianjun/0000-0002-5558-2314
FU National Natural Science Foundation of China (NSFC) [21277099,
   21107081]; NSFC Research Fund for International Young Scientists
   [21150110336]; Fundamental Research Funds for the Central Universities
FX This work is supported by the National Natural Science Foundation of
   China (NSFC, Nos. 21277099, 21107081), NSFC Research Fund for
   International Young Scientists (No. 21150110336) and the Fundamental
   Research Funds for the Central Universities.
CR Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Chen L, 2012, ACTA CHIM SINICA, V70, P15, DOI 10.6023/A1105275
   Cui RJ, 2011, CHINESE J CHEM, V29, P2481, DOI 10.1002/cjoc.201180420
   Dai ZH, 2004, BIOSENS BIOELECTRON, V19, P861, DOI 10.1016/j.bios.2003.08.024
   Feigel IM, 2011, J MATER CHEM, V21, P8940, DOI 10.1039/c1jm10521c
   Ho JAA, 2009, ANAL CHEM, V81, P1340, DOI 10.1021/ac801832h
   Jia NQ, 2008, ELECTROCHEM COMMUN, V10, P774, DOI 10.1016/j.elecom.2008.01.044
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   Kuila T, 2011, BIOSENS BIOELECTRON, V26, P4637, DOI 10.1016/j.bios.2011.05.039
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Liu MC, 2012, INT J ENVIRON AN CH, V92, P534, DOI 10.1080/03067310903582325
   Liu MC, 2010, ENVIRON SCI TECHNOL, V44, P4241, DOI 10.1021/es1003507
   Liu MC, 2009, ELECTROCHEM COMMUN, V11, P1397, DOI 10.1016/j.elecom.2009.05.015
   Liu SQ, 2005, LANGMUIR, V21, P8409, DOI 10.1021/la050875x
   Ma L, 2012, ACTA CHIM SINICA, V70, P567, DOI 10.6023/A1108312
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Pumera M, 2010, TRAC-TREND ANAL CHEM, V29, P954, DOI 10.1016/j.trac.2010.05.011
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Sheng C, 2012, CHINESE J CHEM, V30, P1565, DOI 10.1002/cjoc.201200113
   Wang J, 2006, BIOSENS BIOELECTRON, V21, P1887, DOI 10.1016/j.bios.2005.10.027
   Wang SF, 2005, LANGMUIR, V21, P9260, DOI 10.1021/la050947k
   Wu FH, 2008, BIOSENS BIOELECTRON, V24, P198, DOI 10.1016/j.bios.2008.03.031
   Xiao P, 2007, ELECTROCHEM COMMUN, V9, P2441, DOI 10.1016/j.elecom.2007.07.020
   Xie YB, 2007, BIOSENS BIOELECTRON, V22, P2812, DOI 10.1016/j.bios.2006.11.016
   Yang HP, 2011, ACTA CHIM SINICA, V69, P536
   Yeom SH, 2011, FRONT BIOSCI-LANDMRK, V16, P997, DOI 10.2741/3731
   Yin HS, 2011, BIOSENS BIOELECTRON, V30, P112, DOI 10.1016/j.bios.2011.08.039
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   Zhang Y, 2011, CHINESE J CHEM, V29, P685, DOI 10.1002/cjoc.201190141
   Zhao GH, 2008, J PHYS CHEM C, V112, P14786, DOI 10.1021/jp712054c
NR 32
TC 8
Z9 8
U1 0
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1001-604X
J9 CHINESE J CHEM
JI Chin. J. Chem.
PD FEB
PY 2013
VL 31
IS 2
BP 215
EP 220
DI 10.1002/cjoc.201200883
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 092JT
UT WOS:000315117500009
DA 2018-10-20
ER

PT J
AU Pivonka, P
   Buenzli, PR
   Scheiner, S
   Hellmich, C
   Dunstan, CR
AF Pivonka, Peter
   Buenzli, Pascal R.
   Scheiner, Stefan
   Hellmich, Christian
   Dunstan, Colin R.
TI The influence of bone surface availability in bone remodelling-A
   mathematical model including coupled geometrical and biomechanical
   regulations of bone cells
SO ENGINEERING STRUCTURES
LA English
DT Article
DE Mechanical feedback; Geometrical feedback; Specific surface; Bone
   remodelling; Bone stiffness; Osteoporosis
ID SKELETAL STRUCTURAL ADAPTATIONS; MECHANICAL USAGE SATMU; REDEFINING
   WOLFF LAW; CORTICAL BONE; PARATHYROID-HORMONE; ELASTIC PROPERTIES;
   ANISOTROPIC ELASTICITY; ANABOLIC RESPONSE; LINING CELLS; POROSITY
AB Bone is a biomaterial undergoing continuous renewal. The renewal process is known as bone remodelling and is operated by bone-resorbing cells (osteoclasts) and bone-forming cells (osteoblasts). An important function of bone remodelling is the repair of microcracks accumulating in the bone matrix due to mechanical loading. Cell-cell communication between cells of the osteoclastic lineage and cells of the osteoblastic lineage is thought to couple resorption and formation so as to preserve bone integrity and achieve homeostatic bone renewal. Both biochemical and biomechanical regulatory mechanisms have been identified in this coupling. Many bone pathologies are associated with an alteration of bone cell interactions and a consequent disruption of bone homeostasis. In osteoporosis, for example, this disruption leads to long-term bone loss and increased fragility, and can ultimately result in fractures.
   Here we focus on an additional and poorly understood potential regulatory mechanism of bone cells, that involves the morphology of the microstructure of bone. Bone cells can only remove and replace bone at a bone surface. However, the microscopic availability of bone surface depends in turn on the ever-changing bone microstructure. The importance of this geometrical dependence is unknown and difficult to quantify experimentally. Therefore, we develop a sophisticated mathematical model of bone cell interactions that takes into account biochemical, biomechanical and geometrical regulations. We then investigate numerically the influence of bone surface availability in bone remodelling within a representative bone tissue sample. Biochemical regulations included in the model involve signalling molecules of the receptor-activator nuclear factor kappa B pathway (RANK-RANKL-OPG), macrophage colony-stimulating factor (MCSF), transforming growth factor beta(TGF beta), and parathyroid hormone (PTH). For the biomechanical regulation of bone cells, a multiscale homogenisation scheme is used to determine the microscopic strains generated at the level of the extravascular matrix hosting the osteocytes by macroscopic loading. The interdependence between the bone cells' activity, which modifies the bone microstructure, and changes in the microscopic bone surface availability, which in turn influences bone cell development and activity, is implemented using a remarkable experimental relationship between bone specific surface and bone porosity. Our model suggests that geometrical regulation of the activation of new remodelling events could have a significant effect on bone porosity and bone stiffness in osteoporosis. On the other hand, geometrical regulation of late stages of osteoblast and osteoclast differentiation seems less significant. We conclude that the development of osteoporosis is probably accelerated by this geometrical regulation in cortical bone, but probably slowed down in trabecular bone. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Pivonka, Peter; Buenzli, Pascal R.; Scheiner, Stefan] Univ Western Australia, Engn Computat Biol Grp, Perth, WA 6009, Australia.
   [Scheiner, Stefan; Hellmich, Christian] Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Dunstan, Colin R.] Univ Sydney, Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
RP Pivonka, P (reprint author), Univ Western Australia, Engn Computat Biol Grp, Perth, WA 6009, Australia.
EM peter.pivonka@uwa.edu.au; pascal.buenzli@uwa.edu.au;
   stefan.scheiner@tuwien.ac.at; christian.hellmich@tuwien.ac.at;
   c.dunstan@usyd.edu.au
RI Dunstan, Colin/G-6214-2013
OI Dunstan, Colin/0000-0001-7586-4071; Pivonka, Peter/0000-0001-9183-530X;
   Buenzli, Pascal/0000-0003-3962-5393; Scheiner,
   Stefan/0000-0003-1078-7807
FU Australian Research Council (ARC) [DP-0988427]; European Research
   Council (ERC) [FP7-257023]
FX Financial support by the Australian Research Council (ARC), in the
   framework of the project Multiscale modelling of transport through
   deformable porous materials (Project No. DP-0988427) and by the European
   Research Council (ERC) in the framework of the project Multiscale
   poro-micromechanics of bone materials, with links to biology and
   medicine (Project No. FP7-257023) are gratefully acknowledged.
CR ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224
   Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009
   Buenzli PR, 2012, J THEOR BIOL, V307, P42, DOI 10.1016/j.jtbi.2012.04.019
   Burger EH, 2003, J BIOMECH, V36, P1453, DOI 10.1016/S0021-9290(03)00126-X
   Burr DB, 2001, J BONE MINER RES, V16, P157, DOI 10.1359/jbmr.2001.16.1.157
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760
   Cooper DML, 2007, BONE, V40, P957, DOI 10.1016/j.bone.2006.11.011
   DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632
   DULLIEN FAL, 1992, POROUS MEDIA FLUID T
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3
   FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402
   FROST HM, 1990, ANAT RECORD, V226, P414, DOI 10.1002/ar.1092260403
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   Grimal Q, 2011, BIOMECH MODEL MECHAN, V10, P925, DOI 10.1007/s10237-010-0284-9
   Hazelwood SJ, 2001, J BIOMECH, V34, P299, DOI 10.1016/S0021-9290(00)00221-9
   Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI 10.1007/s10439-007-9393-8
   Hellmich C, 2004, BIOMECH MODEL MECHAN, V2, P219, DOI 10.1007/S10237-004-0040-0
   KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   LAWS N, 1977, J ELASTICITY, V7, P91, DOI 10.1007/BF00041133
   Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x
   Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023
   Ma YF, 1999, J BONE MINER RES, V14, P439, DOI 10.1359/jbmr.1999.14.3.439
   Malandrino A, 2012, MATER LETT, V78, P154, DOI 10.1016/j.matlet.2012.03.052
   Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133
   MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6
   MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179
   Martin RB, 1998, SKELETAL TISSUE MECH
   Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243
   Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   MOSEKILDE L, 1990, BONE MINER, V10, P13, DOI 10.1016/0169-6009(90)90046-I
   Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020
   PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303
   PARFITT AM, 1983, BONE HISTOMORPHOMETR, P143
   Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025
   Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021
   RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F
   Robling AG, 1999, CELLS TISSUES ORGANS, V164, P192, DOI 10.1159/000016659
   Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2
   Ruimerman R., 2005, THESIS EINDHOVEN U T
   Scheiner S, 2012, P CD ROM 11 BIENN C, P1
   Scheiner S, 2012, P 9 IASTED INT C BIO, P657
   Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8
   Smit TH, 2000, J BONE MINER RES, V15, P301, DOI 10.1359/jbmr.2000.15.2.301
   Stevenson JC, 2007, ATLAS OSTEOPOROSIS
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Thomas CDL, 2006, J ANAT, V209, P219, DOI 10.1111/j.1469-7580.2006.00589.x
   Thomas CDL, 2005, J ANAT, V206, P115, DOI 10.1111/j.1469-7580.2005.00384.x
   TURNER CH, 1990, J BIOMECH, V23, P549, DOI 10.1016/0021-9290(90)90048-8
   Turner RT, 2006, J APPL PHYSIOL, V101, P881, DOI 10.1152/japplphysiol.01622.2005
   van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009
   Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027494
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
NR 59
TC 17
Z9 19
U1 3
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-0296
J9 ENG STRUCT
JI Eng. Struct.
PD FEB
PY 2013
VL 47
SI SI
BP 134
EP 147
DI 10.1016/j.engstruct.2012.09.006
PG 14
WC Engineering, Civil
SC Engineering
GA 090XT
UT WOS:000315014000013
DA 2018-10-20
ER

PT J
AU Matsiko, A
   Levingstone, TJ
   O'Brien, FJ
AF Matsiko, Amos
   Levingstone, Tanya J.
   O'Brien, Fergal J.
TI Advanced Strategies for Articular Cartilage Defect Repair
SO MATERIALS
LA English
DT Review
DE articular cartilage; biomaterials; chondrogenesis; scaffolds; tissue
   engineering
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   GROWTH-FACTOR-I; INFRAPATELLAR FAT PAD; COLLAGEN-GLYCOSAMINOGLYCAN
   SCAFFOLDS; BONE-MARROW; ADIPOSE-TISSUE; CHONDROGENIC DIFFERENTIATION;
   PORE-SIZE; CHONDRAL DEFECTS
AB Articular cartilage is a unique tissue owing to its ability to withstand repetitive compressive stress throughout an individual's lifetime. However, its major limitation is the inability to heal even the most minor injuries. There still remains an inherent lack of strategies that stimulate hyaline-like articular cartilage growth with appropriate functional properties. Recent scientific advances in tissue engineering have made significant steps towards development of constructs for articular cartilage repair. In particular, research has shown the potential of biomaterial physico-chemical properties significantly influencing the proliferation, differentiation and matrix deposition by progenitor cells. Accordingly, this highlights the potential of using such properties to direct the lineage towards which such cells follow. Moreover, the use of soluble growth factors to enhance the bioactivity and regenerative capacity of biomaterials has recently been adopted by researchers in the field of tissue engineering. In addition, gene therapy is a growing area that has found noteworthy use in tissue engineering partly due to the potential to overcome some drawbacks associated with current growth factor delivery systems. In this context, such advanced strategies in biomaterial science, cell-based and growth factor-based therapies that have been employed in the restoration and repair of damaged articular cartilage will be the focus of this review article.
C1 [Matsiko, Amos; Levingstone, Tanya J.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dublin 2, Ireland.
   [Matsiko, Amos; Levingstone, Tanya J.; O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, 123 St Stephens Green, Dublin 2, Ireland.
EM amosmatsiko@rcsi.ie; tanyalevingstone@rcsi.ie; fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Levingstone,
   Tanya/0000-0002-9751-2314; Matsiko, Amos/0000-0003-4740-5489
FU Health Research Board of Ireland; European Research Council
FX We acknowledge Elaine Quinlan for providing SEM images. We also
   acknowledge financial support from the Health Research Board of Ireland
   and the European Research Council.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Adam C, 1998, CLIN BIOMECH, V13, P1, DOI 10.1016/S0268-0033(97)85881-0
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Alhag M, 2011, ORAL MAXILLOFAC SURG, V15, P31, DOI 10.1007/s10006-010-0241-x
   Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   ATKINS EDT, 1972, NATURE-NEW BIOL, V235, P253
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bekkers JEJ, 2012, CARTILAGE, V3, p43S, DOI 10.1177/1947603511416973
   Bentley G, 2012, J BONE JOINT SURG BR, V94B, P504, DOI 10.1302/0301-620X.94B4.27495
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007
   Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Brandl A, 2010, J ORTHOP RES, V28, P354, DOI 10.1002/jor.21007
   Briggs TWR, 2003, J BONE JOINT SURG BR, V85B, P1077, DOI 10.1302/0301-620X.85B7.13672
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckley CT, 2012, J MECH BEHAV BIOMED, V11, P102, DOI 10.1016/j.jmbbm.2011.09.004
   Buckley CT, 2010, J BIOMECH, V43, P920, DOI 10.1016/j.jbiomech.2009.11.005
   BUCKWALTER JA, 1997, OPERATIVE TECHNIQUES, V7, P263
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cascio BM, 2008, OPER TECHN SPORT MED, V16, P221, DOI 10.1053/j.otsm.2009.01.001
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Cole BJ, 2009, J BONE JOINT SURG AM, V91A, P1778
   Coutts RD, 2001, CLIN ORTHOP RELAT R, pS271, DOI 10.1097/00003086-200110001-00025
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   Detterline AJ, 2005, ORTHOP NURS, V24, P361
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Dickhut A, 2010, TISSUE ENG PT A, V16, P453, DOI [10.1089/ten.tea.2009.0168, 10.1089/ten.TEA.2009.0168]
   Diekman BO, 2010, J BIOMED MATER RES A, V93A, P994, DOI 10.1002/jbm.a.32589
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587
   Driesang IMK, 2000, J ORTHOPAED RES, V18, P909, DOI 10.1002/jor.1100180609
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380
   Fan JB, 2009, TISSUE ENG PART B-RE, V15, P75, DOI 10.1089/ten.teb.2008.0586
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Filardo G., 2012, AM J SPORTS MED, V41, P95
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   Fischman J., 1999, TIME MAGAZINE
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P667, DOI 10.1016/j.joca.2007.09.013
   Fritz J. R., 2009, CURR RHEUMATOL REV, V5, P8
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Getgood A, 2009, TRAUMA, V23, P189
   GHADIALLY JA, 1977, VIRCHOWS ARCH B, V25, P125
   Gigante A, 2012, ARTHROSC TEC, V1, pE175, DOI 10.1016/j.eats.2012.07.001
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Goldstein SA, 2000, CLIN ORTHOP RELAT R, pS113
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020
   Havlas V, 2011, ACTA CHIR ORTHOP TR, V78, P138
   Huang FS, 2004, AM J SPORT MED, V32, P1842, DOI 10.1177/0363546504264895
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   JITSUIKI J, 1994, ARTHROSCOPY, V10, P659, DOI 10.1016/S0749-8063(05)80065-9
   JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khan W., 2008, ARTHRITIS RES THER, V10, P1
   Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211
   Kieswetter K, 1997, ENDOCRINE, V6, P257, DOI 10.1007/BF02820501
   Kim HJ, 2010, J BIOMED MATER RES A, V92A, P659, DOI 10.1002/jbm.a.32414
   Kim YJ, 2008, BIOCHEM BIOPH RES CO, V373, P104, DOI 10.1016/j.bbrc.2008.05.183
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kovach IS, 1996, BIOPHYS CHEM, V59, P61, DOI 10.1016/0301-4622(95)00115-8
   Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117
   Louie LK, 1997, TISSUE ENG, V3, P187, DOI 10.1089/ten.1997.3.187
   Lyons Frank, 2008, Technol Health Care, V16, P305
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MASON JM, 2000, CLIN ORTHOP S, V379, pS171
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   MINAS T, 1998, CURR OPIN ORTHOP, V9, P46
   Mithoefer K, 2009, AM J SPORT MED, V37, p167S, DOI 10.1177/0363546509351650
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Niemeyer P, 2008, AM J SPORT MED, V36, P2091, DOI 10.1177/0363546508322131
   Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oh SH, 2010, BIOMACROMOLECULES, V11, P1948, DOI 10.1021/bm100199m
   Owens BD, 2002, ARTHROSCOPY, V18, P151, DOI 10.1053/jars.2002.29906
   Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plewes LW, 1940, BRIT J SURG, V27, P682, DOI 10.1002/bjs.18002710807
   Rawe J., 2000, TIME MAGAZINE
   Reich CM, 2012, VET RES COMMUN, V36, P139, DOI 10.1007/s11259-012-9523-0
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Robertson WB, 2007, KNEE, V14, P117, DOI 10.1016/j.knee.2006.11.009
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Schagemann JC, 2010, BIOMATERIALS, V31, P2798, DOI 10.1016/j.biomaterials.2009.12.037
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Sgaglione Nicholas A, 2004, J Knee Surg, V17, P235
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546
   Soltz MA, 2000, ANN BIOMED ENG, V28, P150, DOI 10.1114/1.239
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Steinwachs MR, 2008, INJURY, V39, pS26, DOI 10.1016/j.injury.2008.01.042
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x
   Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103
   Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.tea.2010.0517, 10.1089/ten.TEA.2010.0517]
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Zaslav K, 2009, AM J SPORT MED, V37, P42, DOI 10.1177/0363546508322897
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 171
TC 35
Z9 37
U1 1
U2 80
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2013
VL 6
IS 2
BP 637
EP 668
DI 10.3390/ma6020637
PG 32
WC Materials Science, Multidisciplinary
SC Materials Science
GA 096IY
UT WOS:000315398600018
PM 28809332
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Romana, L
   Thomas, P
   Bilas, P
   Mansot, JL
   Merrifiels, M
   Bercion, Y
   Aranda, DA
AF Romana, L.
   Thomas, P.
   Bilas, P.
   Mansot, J. L.
   Merrifiels, M.
   Bercion, Y.
   Aldana Aranda, D.
TI Use of nanoindentation technique for a better understanding of the
   fracture toughness of Strombus gigas conch shell
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE Nanomechanical properties; Structure; Fracture; Conch shell; Strombus
   gigas
ID MECHANICAL-PROPERTIES; MOLLUSK SHELLS; NACRE; INDENTATION; DEFORMATION;
   COMPOSITES; NANOSCALE; DESIGN; ORIGIN
AB In this work the nanochemical properties of the composite organomineral biomaterial constituting Strombus gigas conch shell are studied by means of dynamic mechanical analyses associated to nanoidentation technique. The measurements are performed on shell samples presenting different surface orientations relative to the growth axis of the conch shell. The influence of the organic component of the biomaterial on its nanomechanical properties is also investigated by studying fresh and dried S. gigas conch shells. Monocrystalline aragonite is used as a reference.
   For the understanding of nanochemical,behaviour, special attention is paid to the pop in events observed on the load/displacement curves which results from nanofractures' initiation and propagation occuring during the load process. In order to better understand the mechanical properties systematic 'studies of the structure and morphology are performed using scanning electron microscopy, atomic force microscopy and X-ray diffractometry.
   The hardness and Young's modulus values measured on bio aragonite samples are close to those of the aragonite mineral standard. This surprising result shows that, H and E values are not related to the bio composition and lamellar structure of the bio aragonite. However, it was found that the organic layer and the micro architecture strongly influence the nanofracture initiation and propagation processes in the samples. Statistic study of the pop-in events can help to predict the macroscopic mechanical behaviour of the material. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Romana, L.; Thomas, P.; Bilas, P.; Mansot, J. L.; Merrifiels, M.] Univ Antilles Guyane, GTSI, Campus Fouillole, F-97159 Pointe a Pitre, Guadeloupe, Guadeloupe.
   [Mansot, J. L.; Bercion, Y.] Ctr Commun Caracterisat Mat, F-97159 Pointe a Pitre, Guadeloupe, Guadeloupe.
   [Aldana Aranda, D.] CINVESTAV IPN Unidad Merida, Lab Biol & Acuacultura Moluscos, Cordemex 97310, Mexico.
RP Romana, L (reprint author), Univ Antilles Guyane, GTSI, Campus Fouillole, F-97159 Pointe a Pitre, Guadeloupe, Guadeloupe.
EM laurence.romana@univ-ag.fr
OI Thomas, Philippe/0000-0001-9085-6758; Bercion, Yves/0000-0003-1735-4983;
   Bilas, Philippe/0000-0003-0211-1348; ROMANA,
   Laurence/0000-0003-2436-1989
CR Ballarini R, 2005, INT J FRACTURE, V135, P187, DOI 10.1007/s10704-005-3949-0
   Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239
   Bignardi C, 2010, J NANOSCI NANOTECHNO, V10, P6453, DOI 10.1166/jnn.2010.2626
   Bruet BJF, 2005, J MATER RES, V20, P2400, DOI 10.1557/JMR.2005.0273
   Espinosa HD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1172
   Fleischli DF, 2008, ACTA BIOMATER, V4, P1964
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Hay J, 2010, EXP TECHNIQUES, V34, P86, DOI 10.1111/j.1747-1567.2010.00618.x
   Hou DF, 2004, BIOMATERIALS, V25, P751, DOI 10.1016/S0142-9612(03)00555-6
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kamat S, 2000, NATURE, V405, P1036
   Kamat S, 2004, ACTA MATER, V52, P2395, DOI 10.1016/j.actamat.2004.01.030
   Kearney C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255505
   KuhnSpearing LT, 1996, J MATER SCI, V31, P6583, DOI 10.1007/BF00356266
   Li XD, 2004, NANOTECHNOLOGY, V15, P211, DOI 10.1088/0957-4484/15/1/038
   Li XD, 2006, NANO LETT, V6, P2301, DOI 10.1021/nl061775u
   Liang Y, 2008, MAT SCI ENG A-STRUCT, V483-84, P309, DOI 10.1016/j.msea.2006.09.156
   Lin AYM, 2006, MAT SCI ENG C-BIO S, V26, P1380, DOI 10.1016/j.msec.2005.08.016
   Menig R, 2001, MAT SCI ENG A-STRUCT, V297, P203, DOI 10.1016/S0921-5093(00)01228-4
   Meyers MA, 2006, JOM-US, V58, P35, DOI 10.1007/s11837-006-0138-1
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295
   Scurr DJ, 2006, J MATER RES, V21, P3099, DOI 10.1557/JMR.2006.0382
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Su XW, 2004, CHEM MATER, V16, P581, DOI 10.1021/cm0305731
NR 26
TC 10
Z9 10
U1 2
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
EI 1873-4189
J9 MATER CHARACT
JI Mater. Charact.
PD FEB
PY 2013
VL 76
BP 55
EP 68
DI 10.1016/j.matchar.2012.11.010
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 095WR
UT WOS:000315366200008
DA 2018-10-20
ER

PT J
AU Raj, KR
   Kardam, A
   Arora, JK
   Srivastava, S
   Srivastava, MM
AF Raj, Kumar Rohit
   Kardam, Abhishek
   Arora, Jyoti Kumar
   Srivastava, Shalini
   Srivastava, M. M.
TI Prediction of the As(III) and As(V) Abatement Capacity of Zea mays Cob
   Powder: ANN Modelling
SO NATIONAL ACADEMY SCIENCE LETTERS-INDIA
LA English
DT Article
DE Arsenic decontamination; Biosorption; Zea mays cob powder; Optimization;
   ANN modeling
ID NEURAL-NETWORK ANN; SURFACE METHODOLOGY RSM; ARSENIC REMOVAL;
   DRINKING-WATER; OPTIMIZATION; BIOMASS; PLANT; IONS
AB Arsenic contamination of ground water is unfolding as one of the worst natural geo environmental disaster to date. Due to increasing environmental awareness and legal constraints imposed on discharge of effluents, the need for cost effective alternative technologies is essential for removal of arsenic from water bodies. Zea mays cob powder (ZMCP) is an excellent biomaterial as it is largely available as a waste and having high sorption capacity, hence, used for the present study. Optimization of the process variables (biomaterial dosage, contact time, arsenic concentration, volume and pH) for the decontamination of As(III) and As(V) using artificial neural network modeling were studied. Back-Propagation and Levenberg-Marquardt techniques are used to train various neural network architectures and the accuracy of the obtained models have been examined by using testing data set. The minimum mean square error in the group of five variables was determined for training and cross validation are 1.48275E-05 and 0.000140872 respectively. The performance of the network for predicting the sorption efficiency of biosorbent is found to be very impressive.
C1 [Raj, Kumar Rohit; Kardam, Abhishek; Srivastava, Shalini; Srivastava, M. M.] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
   [Arora, Jyoti Kumar] Dayalbagh Educ Inst, Tech Coll, Dept Math, Agra 282110, Uttar Pradesh, India.
RP Srivastava, MM (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM dei.smohanm@gmail.com
FU UGC
FX The authors gratefully acknowledge Prof. V. G. Das, Director and Prof.
   L. D. Khemani, Head, Department of Chemistry, Dayalbagh Educational
   Institute, Dayalbagh, Agra. Author also gratefully acknowledges UGC for
   providing financial assistance.
CR Alvarado S, 2008, BIORESOURCE TECHNOL, V99, P8436, DOI 10.1016/j.biortech.2008.02.051
   Amuda OS, 2006, J HAZARD MATER, V129, P69, DOI 10.1016/j.jhazmat.2005.07.078
   Anirudhan TS, 2007, CHEMOSPHERE, V66, P60, DOI 10.1016/j.chemosphere.2006.05.031
   Bose U., 2011, International Journal of Chemical Technology, V3, P14
   Desai KM, 2008, BIOCHEM ENG J, V41, P266, DOI 10.1016/j.bej.2008.05.009
   Duarte Antonio ALS, 2009, SUSTAINABILITY, V1, P1288
   Egila J. N., 2011, International Journal of Physical Sciences, V6, P2152
   Hossain SM, 2006, CHEM BIOCHEM ENG Q, V20, P209
   Igwe JC, 2005, AFR J BIOTECHNOL, V4, P1113
   Kardam A., 2011, IJMTT, V2, P23
   Karim M, 2000, WATER RES, V34, P304, DOI 10.1016/S0043-1354(99)00128-1
   Kumari P, 2005, J IND MICROBIOL BIOT, V32, P521, DOI 10.1007/s10295-005-0042-7
   Lamm SH, 2004, J OCCUP ENVIRON MED, V46, P298, DOI 10.1097/01.jom.0000116801.67556.8f
   Malik AH, 2009, J HAZARD MATER, V168, P1, DOI 10.1016/j.jhazmat.2009.02.031
   Norgaard M., 2000, NEURAL NETWORKS MODE
   Oboh OI, 2008, AFR J BIOTECHNOL, V7, P4508
   Park YS, 2004, SCI TOTAL ENVIRON, V327, P105, DOI 10.1016/j.scitotenv.2004.01.014
   Pokhrel D, 2008, BIORESOURCE TECHNOL, V99, P2067, DOI 10.1016/j.biortech.2007.04.023
   Prakash A, 2011, ENVIRON MODEL ASSESS, V16, P503, DOI 10.1007/s10666-011-9270-6
   Rafeaah W., 2009, WORLD APPL SCI J, V5, P84
   Raj KR, 2012, CHEMISTRY OF PHYTOPOTENTIALS: HEALTH, ENERGY AND ENVIRONMENTAL PERSPECTIVES, P243, DOI 10.1007/978-3-642-23394-4_51
   Raj Kumar Rohit, 2010, Journal of Water Resource and Protection, V2, P331, DOI 10.4236/jwarp.2010.24038
   Raj KR, 2010, J RADIOANAL NUCL CH, V283, P797, DOI 10.1007/s10967-009-0415-x
   Ranjan D, 2009, IND ENG CHEM RES, V48, P10180, DOI 10.1021/ie9008771
   Saha D, 2010, HEAT MASS TRANSFER, V46, P431, DOI 10.1007/s00231-010-0584-8
   Saha W, 2007, MATER DESIGN, V28, P1747
   Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539
   Yoshida T, 2004, TOXICOL APPL PHARM, V198, P243, DOI 10.1016/j.taap.2003.10.002
   Youssefi S, 2009, DRY TECHNOL, V27, P910, DOI 10.1080/07373930902988247
NR 29
TC 1
Z9 1
U1 0
U2 12
PU NATL ACAD SCIENCES INDIA
PI ALLAHABAD
PA 5 LAJPATRAI RD, ALLAHABAD 211002, INDIA
SN 0250-541X
J9 NATL ACAD SCI LETT
JI Natl. Acad. Sci. Lett.-India
PD FEB
PY 2013
VL 36
IS 1
BP 41
EP 47
DI 10.1007/s40009-012-0101-3
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 095KV
UT WOS:000315334200006
DA 2018-10-20
ER

PT J
AU Sterodimas, A
   de Faria, J
AF Sterodimas, Aris
   de Faria, Jose
TI Human Auricular Tissue Engineering in an Immunocompetent Animal Model
SO AESTHETIC SURGERY JOURNAL
LA English
DT Article
DE auricular tissue engineering; human ear; stem cells; anotia;
   biomolecules; biomaterial
ID MESENCHYMAL STEM-CELLS; DIFFERENT CHONDROCYTES; HUMAN EAR; CARTILAGE;
   RECONSTRUCTION; GROWTH; DIFFERENTIATION; SHAPE
AB Background: Tissue engineering has the potential to provide ear-shaped cartilaginous constructs in the near future. Previous attempts to engineer human ear-shaped constructs mimicked human shape and characteristics but were done in immunocompromised animal models.
   Objectives: The authors design and evaluate a novel, 3-dimensional (3D) cell-copolymer construct resembling a human ear that was subsequently implanted in an immunocompetent rabbit model.
   Materials: Mesenchymal progenitor cells that were obtained from perichondrium and chondrium of a rabbit auricular cartilaginous site were expanded in vitro to chondrocytes and seeded onto biodegradable alginate and silk polymer ear-shaped scaffolds. After implantation in the back of 6 immunocompetent rabbits for 8 weeks, cell/scaffold constructs were harvested and analyzed in terms of size, shape, and histology.
   Results: Data from this study suggest that auricular mesenchymal progenitor cells derived from rabbit perichondrium and chondrium are suitable for development of tissue-engineered human ear models with retention over time of 3D construct architecture. Gross morphology revealed that the silk alginate scaffold diminished slightly the size dimensions but maintained shape and flexibility. Histological analysis showed formation of cartilage tissue along with type II collagen and proteoglycan extracellular matrix components of the silk alginate construct.
   Conclusions: This study demonstrates for the first time that it is possible to engineer an ear cartilage construct that resembles the human ear not only in shape but also in size and flexibility in a real test model. This study also confirms that the association of silk, alginate, and perichondrium and chondrium mesenchymal cells is a reliable method to produce an engineered auricular cartilage construct. Further long-term research needs to be done to confirm these observations.
C1 [Sterodimas, Aris; de Faria, Jose] Pontif Catholic Univ Rio de Janeiro, Dept Plast Surg, Ivo Pitanguy Inst, Rio De Janeiro, Brazil.
   [Sterodimas, Aris; de Faria, Jose] Carlos Chagas Postgrad Med Inst, Rio De Janeiro, Brazil.
RP Sterodimas, A (reprint author), 4224 Av Epitacio Pessoa, BR-22280020 Rio De Janeiro, Brazil.
EM aris@sterodimas.com
CR Baptista LS, 2008, KEY ENG MATER, V396-398, P437
   Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.TEB.2011.0326, 10.1089/ten.teb.2011.0326]
   Cao Y, 1997, PLAST RECONSTR SURG, V100, P303
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   Ebisawa K, 2004, TISSUE ENG, V10, P921, DOI 10.1089/1076327041348437
   Feucht A, 2011, HNO, V59, P239, DOI 10.1007/s00106-011-2270-7
   Hadlock T A, 1998, Facial Plast Surg, V14, P197, DOI 10.1055/s-2008-1064345
   Hellingman CA, 2011, CELL TRANSPLANT, V20, P925, DOI 10.3727/096368910X539119
   Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691
   Jang HG, 2011, ANAT REC, V294, P559, DOI 10.1002/ar.21343
   Kita M, 2006, AM J RHINOL, V20, P489, DOI 10.2500/ajr.2006.20.2927
   Kobayashi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026393
   Koch R James, 2002, Facial Plast Surg, V18, P59, DOI 10.1055/s-2002-19828
   Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Renner Gregory, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P277, DOI 10.1097/01.moo.0000133069.44030.86
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Sterodimas A., 2011, ADIPOSE DERIVED STEM, P165
   Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046
   Sterodimas A, 2009, ANN PLAS SURG, V62, P97, DOI 10.1097/SAP.0b013e3181788ec9
   Tam MDBS, 2010, ANAT SCI EDUC, V3, P261, DOI 10.1002/ase.175
   Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D
   Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627
NR 28
TC 10
Z9 11
U1 0
U2 19
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1090-820X
J9 AESTHET SURG J
JI Aesthet. Surg. J.
PD FEB
PY 2013
VL 33
IS 2
BP 283
EP 289
DI 10.1177/1090820X12472902
PG 7
WC Surgery
SC Surgery
GA 088SB
UT WOS:000314856300014
PM 23335644
OA Bronze
DA 2018-10-20
ER

PT J
AU Saha, N
   Monge, C
   Dulong, V
   Picart, C
   Glinel, K
AF Saha, Naresh
   Monge, Claire
   Dulong, Virginie
   Picart, Catherine
   Glinel, Karine
TI Influence of Polyelectrolyte Film Stiffness on Bacterial Growth
SO BIOMACROMOLECULES
LA English
DT Article
ID CELL-ADHESION; MULTILAYER FILMS; BIOMATERIAL SURFACES; BIOFILM
   FORMATION; CROSS-LINKING; INFECTIONS; SUBSTRATE; MODULUS; DEPOSITION;
   CHEMISTRY
AB Photo-cross-linkable polyelectrolyte films, whose nanomechanical properties can be varied under UV light illumination, were prepared from poly(L-lysine) (PLL) and a hyaluronan derivative modified with photoreactive vinylbenzyl groups (HAVB). The adhesion and the growth of two model bacteria, namely Escherichia coli and Lactococcus lactis, were studied on non-cross-linked and cross-linked films to investigate how the film stiffness influences the bacterial behavior. While the Gram positive L. lactis was shown to grow slowly on both films, independently of their rigidity, the Gram negative E. coli exhibited a more rapid growth on non-cross-linked softer films compared to the stiffer ones. Experiments performed on photopatterned films showing both soft and stiff regions, confirmed a faster development of E. coli colonies on softer regions. Interestingly, this behavior is opposite to the one reported before for mammalian cells. Therefore, the photo-crosslinked (PLL/HAVB) films are interesting coatings for tissue engineering since they promote the growth of mammalian cells while limiting the bacterial colonization.
C1 [Saha, Naresh; Glinel, Karine] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, Bio & Soft Matter Div, B-1348 Louvain, Belgium.
   [Saha, Naresh; Monge, Claire; Picart, Catherine] Grenoble Inst Technol, CNRS, UMR 5628, LMGP, F-38016 Grenoble, France.
   [Dulong, Virginie] Univ Rouen, CNRS, UMR 6270, Lab Polymeres, F-76821 Mont St Aignan, France.
RP Glinel, K (reprint author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci, Bio & Soft Matter Div, Croix Sud 1, B-1348 Louvain, Belgium.
EM karine.glinel@uclouvain.be
RI Monge, Claire/E-2933-2012
OI PICART, Catherine/0000-0002-4854-6366; PICART,
   Catherine/0000-0003-0130-1000
FU ERASMUS MUNDUS Programme of the European Union and within the frame of
   the French-Belgium Tournesol Programme [26595ZJ]; European Research
   Council for financial support (ERC Starting Grant) [GA 259370]
FX We thank Prof. A. M. Jonas (UCL) for the image analysis routine program,
   S. Derclaye and Dr. C. Marie (UCL) for their technical assistance with
   the bacterial assays, Prof. B. Nysten for technical assistance with AFM,
   Prof. P. Soumillon, Prof. J.-F. Collet, and Prof. P. Hols (UCL) for
   kindly providing the bacterial strains, and Prof. Y. Dufrene (UCL) for
   helpful discussions. Dr. T. Boudou is thanked for his assistance with
   AFM measurements. KG. benefits from a "M.I.S - Mandat ULYSSE" from the
   Belgium F.R.S. FNRS. This research is performed within the frame of the
   International Doctoral School in Functional Materials funded by the
   ERASMUS MUNDUS Programme of the European Union and within the frame of
   the French-Belgium Tournesol Programme (Project 26595ZJ). C.P. wishes to
   thank the European Research Council for financial support (ERC Starting
   Grant GA 259370).
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Bakker DP, 2003, COLLOID SURFACE B, V32, P179, DOI 10.1016/S0927-7765(03)00159-0
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Costerton B, 2004, BIOMATERIALS SCI INT, P345
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Deghorain M, 2010, J BIOL CHEM, V285, P24003, DOI 10.1074/jbc.M110.143636
   Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Kohnen W, 2003, BIOMATERIALS, V24, P4865, DOI 10.1016/S0142-9612(03)00379-X
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557
   Livermore D, 2004, NAT REV MICROBIOL, V2, P73, DOI 10.1038/nrmicro798
   Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9
   Monge C., 2013, ADV FUNCT M IN PRESS
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Reshes G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046001
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro.1322
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Vazquez CP, 2009, LANGMUIR, V25, P3556, DOI 10.1021/la803577t
NR 51
TC 24
Z9 25
U1 5
U2 96
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2013
VL 14
IS 2
BP 520
EP 528
DI 10.1021/bm301774a
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 089KD
UT WOS:000314908500027
PM 23289403
OA Green Accepted
DA 2018-10-20
ER

PT J
AU de Guzman, RC
   Saul, JM
   Ellenburg, MD
   Merrill, MR
   Coan, HB
   Smith, TL
   Van Dyke, ME
AF de Guzman, Roche C.
   Saul, Justin M.
   Ellenburg, Mary D.
   Merrill, Michelle R.
   Coan, Heather B.
   Smith, Thomas L.
   Van Dyke, Mark E.
TI Bone regeneration with BMP-2 delivered from keratose scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Keratin; Keratose biomaterial; BMP-2 delivery; Critical-size defect;
   Bone regeneration; Tissue engineering
ID MORPHOGENETIC PROTEIN-2; TIBIAL FRACTURES; INTERBODY FUSION; COLLAGEN
   SPONGES; ADVERSE EVENTS; DEFECTS; RECONSTRUCTION; BIOMATERIALS;
   MANAGEMENT; KERATINS
AB Infuse (R) is used clinically to promote bone repair. Its efficacy is dependent on a crosslinked collagen carrier/scaffold system that has come under scrutiny due to an inability to control BMP-2 release, which may result in unwanted outcomes such as heterotopic ossification. In this study, keratose biomaterial was evaluated as a new carrier/scaffold. Keratose was mixed with BMP-2, fabricated into a scaffold, and implanted into a critical-size rat femoral defect. This construct showed bridging as early as 4 weeks and induced trabecular morphology characteristic of a remodeling hard fracture callus at 16 weeks. Compared to the normal cortical bone, the regenerated tissue had greater volume and mineral content but less density and ultimate shear stress values. Moreover, mu-CT, biomechanics, FTIR-ATR spectroscopy, and polarized light microscopy data showed regeneration using keratose was similar to an Infuse control. However, unlike Infuse's collagen carrier system, in vitro analysis showed that BMP-2 release correlated with keratose scaffold degradation. Surprisingly, treatment with keratose only led to deposition of more bone outgrowth than the untreated negative control at the 8-week time point. The application of keratose also demonstrated a notable reduction of adipose tissues within the gap. While not able to induce osteogenesis on its own, keratose may be the first biomaterial capable of suppressing adipose tissue formation, thereby indirectly enhancing bone regeneration. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [de Guzman, Roche C.; Smith, Thomas L.; Van Dyke, Mark E.] Wake Forest Univ Hlth Sci, Dept Orthopaed Surg, Winston Salem, NC 27157 USA.
   [Saul, Justin M.] Miami Univ, Dept Chem & Paper Engn, Oxford, OH 45056 USA.
   [Ellenburg, Mary D.; Merrill, Michelle R.; Coan, Heather B.] Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 23061 USA.
EM mvandyk5@vt.edu
RI de Guzman, Roche/K-8832-2015; Saul, Justin/I-1765-2016
OI de Guzman, Roche/0000-0001-6051-4765; 
FU KeraNetics LLC; US Army; KeraNetics, LLC
FX Dr. Van Dyke holds stock and is an officer of KeraNetics LLC, who
   provided partial funding for this research. Wake Forest University
   Health Sciences has a potential financial interest in KeraNetics through
   licensing agreements.; The authors would like to thank the following for
   their invaluable assistance: Luke Burnett and Richard St. Clair
   (scientific discussions), Maria Bahawdory, Jillian Richter, Bailey
   Fearing, and Lauren Pace (keratin preparation), Robert Guldberg Lab and
   Dennis Brown at Georgia Tech (fabrication of internal fixator plates),
   Erin Mitchell and ARP staff (animal care), Mandy Lockard (X-ray
   fluoroscopy), Debra Fuller, Sandra Kaminsky, and Josh Tan (mu-CT scans),
   Peter Mente at North Carolina State (torsional testing), and Cathy
   Mathis and Bridgette Jones (histology). This work was supported by the
   US Army and KeraNetics, LLC.
CR ALEXANDER P, 1950, BIOCHEM J, V46, P27, DOI 10.1042/bj0460027
   ALEXANDER P, 1950, NATURE, V166, P396, DOI 10.1038/166396a0
   Balseiro S, 2010, SPINE J, V10, pe6, DOI DOI 10.1016/J.SPINEE.2010.04.013
   Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446
   Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8
   Carreon LY, 2008, SPINE, V33, P391, DOI 10.1097/BRS.0b013e3181642a49
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   FERRETTI JL, 1995, BONE, V16, P119, DOI 10.1016/8756-3282(95)80021-H
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Figueiredo MM, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P315
   Fuchs B, 2008, EJSO-EUR J SURG ONC, V34, P1271, DOI 10.1016/j.ejso.2007.11.010
   Gazi E, 2007, ANAL BIOANAL CHEM, V387, P1621, DOI 10.1007/s00216-006-1093-y
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Ghodadra N, 2008, BIOL-TARGETS THER, V2, P345
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Guo J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008050.pub2
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596
   Keating JF, 2005, J BONE JOINT SURG BR, V87B, P142, DOI 10.1302/0301-620X.87B2.15874
   Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004
   Kwong FNK, 2008, J AM ACAD ORTHOP SUR, V16, P619, DOI 10.5435/00124635-200811000-00001
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   MANN FA, 1989, SEMIN VET MED SURG, V4, P312
   McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b
   McKee Michael D, 2006, J Am Acad Orthop Surg, V14, pS163
   Miller-Chou BA, 2003, PROG POLYM SCI, V28, P1223, DOI 10.1016/S0079-6700(03)00045-5
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schwartz ND, 2006, J ORTHOPAEDICS, V3, pe2
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078
   Suntornsaratoon P, 2010, J PHYSIOL SCI, V60, P1, DOI 10.1007/s12576-009-0059-1
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024
   Ulstrup AK, 2008, ACTA ORTHOP BELG, V74, P291
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Woo EJ, 2012, J ORAL MAXIL SURG, V70, P765, DOI 10.1016/j.joms.2011.09.008
NR 43
TC 62
Z9 63
U1 3
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2013
VL 34
IS 6
BP 1644
EP 1656
DI 10.1016/j.biomaterials.2012.11.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 090TH
UT WOS:000315002400002
PM 23211447
DA 2018-10-20
ER

PT J
AU Glover, DJ
   Giger, L
   Kim, JR
   Clark, DS
AF Glover, Dominic J.
   Giger, Lars
   Kim, Jihyun R.
   Clark, Douglas S.
TI Engineering protein filaments with enhanced thermostability for
   nanomaterials
SO BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Biomaterial; Coiled-coil; Nanowire; Prefoldin; Thermostable
ID HELICAL COILED-COILS; LEUCINE-ZIPPER; PEPTIDE; STABILITY; NANOWIRES;
   BIOMINERALIZATION; NANOPARTICLES; BIOCATALYSIS; SPECIFICITY; JANNASCHII
AB Self-assembling protein templates have enormous potential as biomaterials for the fabrication of multifunctional nanostructures that require precise positioning of individual molecules in regular patterns over large surface areas. Furthermore, the development of protein templates that are stable under extreme conditions of heat or chemical denaturants will expand processing conditions and end-use applications for biomaterials that require exceptional stability and robustness. In the present work, we characterized the high thermal stability of a filamentous protein template, the gamma-prefoldin (gamma PFD) from the hyperthermophile Methanocaldococcus jannaschii, and subsequently used rational design to further enhance the filament's thermal stability for application as a biotemplate in the creation of platinum nanowires. The gamma PFD assembles into long fibers with lengths that exceed 2 mu m, which when heated to various temperatures and examined by transmission electron microscopy, revealed a T-m of 93 degrees C for the quaternary filament structure. Subsequently, we increased the hydrophobicity of the alpha-helices of the gamma PFD's coiled-coil, which appeared to strengthen the filamentous structure, leading to filaments of greater length at elevated temperatures. These enhanced filaments functioned as templates for the synthesis of platinum nanowires at unprecedented temperatures, and may create new opportunities for other applications of nanoscale biotemplates that require exceptional thermal stability.
C1 [Glover, Dominic J.; Giger, Lars; Kim, Jihyun R.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.
RP Clark, DS (reprint author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.
EM clark@berkeley.edu
FU Air Force Office of Scientific Research [FA9550-10-1-0214]; Swiss
   National Science Foundation (SNSF)
FX This research was supported by the Air Force Office of Scientific
   Research (FA9550-10-1-0214). Lars Giger was funded by the Swiss National
   Science Foundation (SNSF).
CR Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352
   Boonyaratanakornkit BB, 2005, ENVIRON MICROBIOL, V7, P789, DOI 10.1111/j.1462-2920.2005.00751.x
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200
   Dujardin E, 2003, NANO LETT, V3, P413, DOI 10.1021/nl034004o
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011
   GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015
   Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s
   Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421
   Guo Y, 2000, BIOPHYS CHEM, V85, P179, DOI 10.1016/S0301-4622(00)00119-8
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200
   Littlechild JA, 2011, BIOCHEM SOC T, V39, P155, DOI 10.1042/BST0390155
   Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Mason JM, 2009, BIOCHEMISTRY-US, V48, P10380, DOI 10.1021/bi901401e
   Matousek WM, 2007, J MOL BIOL, V374, P206, DOI 10.1016/j.jmb.2007.09.007
   McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797
   McMillan RA, 2002, NAT MATER, V1, P247, DOI 10.1038/nmat775
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   POTEKHIN SA, 1994, PROTEIN ENG, V7, P1097, DOI 10.1093/protein/7.9.1097
   Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544
   Slocik JM, 2008, SMALL, V4, P548, DOI 10.1002/smll.200700920
   Slocik JM, 2009, SMALL, V5, P2038, DOI 10.1002/smll.200900499
   Subburaman K, 2006, P NATL ACAD SCI USA, V103, P14672, DOI 10.1073/pnas.0602952103
   Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588
   Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x
   Whitehead TA, 2008, SMALL, V4, P956, DOI 10.1002/smll.200700848
   Whitehead TA, 2007, PROTEIN SCI, V16, P626, DOI 10.1110/ps.062599907
   Whitehead TA, 2009, BIOPOLYMERS, V91, P496, DOI 10.1002/bip.21157
   Xie JP, 2007, J PHYS CHEM C, V111, P10226, DOI 10.1021/jp0719715
   Yu YH, 1996, BIOPHYS CHEM, V59, P299, DOI 10.1016/0301-4622(95)00131-X
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250
   Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171
NR 37
TC 8
Z9 8
U1 3
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1860-6768
J9 BIOTECHNOL J
JI Biotechnol. J.
PD FEB
PY 2013
VL 8
IS 2
SI SI
BP 228
EP 236
DI 10.1002/biot.201200009
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 086AR
UT WOS:000314655900009
PM 22965482
DA 2018-10-20
ER

PT J
AU Monaco, C
   Tucci, A
   Esposito, L
   Scotti, R
AF Monaco, Carlo
   Tucci, Antonella
   Esposito, Leonardo
   Scotti, Roberto
TI Microstructural changes produced by abrading Y-TZP in presintered and
   sintered conditions
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Zirconia; CAD CAM; Abrading; Tetragonal; Y-TZP
ID INDENTATION TOUGHNESS EQUATIONS; FRACTURE-TOUGHNESS; FLEXURAL STRENGTH;
   ZIRCONIA; SURFACE; BIOMATERIAL; CERAMICS; EROSION
AB Objective: To evaluate the effect of abrading before and after sintering using alumina-based abrasives on the surface of yttria-tetragonal zirconia polycrystals. Particular attention was paid to the amount of surface stress-assisted phase transformation (tetragonal -> monocliwmonoclinic)andthepresenceofmicrocracks.
   Methods: Pre-sintered zirconia ceramic specimens (ZirCAD; Ivoclar Vivadent) were first surface-ground flat with #600-800-1000-grit SiC paper. They were then surface-treated with different grain size abrasives before and after the sintering step. Samples that underwent no surface treatment were used as controls. For each condition, eight specimens were prepared. The physical/mechanical characteristics of zirconia material were determined by measuring density, porosity, grain size, hardness, and fracture toughness. The effects of surface treatments were assessed by surface roughness measurements, quantitative X-ray diffraction analysis, and scanning electron microscopy.
   Results: With increased dimensions of the abrasive particles, the abraded surfaces of zirconia specimens exhibited a widespread system of microcracks and an increased monoclinic zirconia quantity. These structural changes likely affect the aging of the material during its clinical service. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Monaco, Carlo; Tucci, Antonella; Esposito, Leonardo; Scotti, Roberto] Univ Bologna, Dept Oral Sci, Div Prosthodont & Maxillofacial Rehabil, I-40125 Bologna, Italy.
RP Monaco, C (reprint author), Univ Bologna, Dept Oral Sci, Div Prosthodont & Maxillofacial Rehabil, Via S Vitale 59, I-40125 Bologna, Italy.
EM carlo.monaco2@unibo.it
CR Abou Tara M, 2011, J DENT, V39, P208, DOI 10.1016/j.jdent.2010.12.005
   Aboushelib MN, 2007, J PROSTHET DENT, V97, P379
   [Anonymous], 1993, 6232 EN
   [Anonymous], 1993, 6234 EN
   Blatz MB, 2004, J PROSTHET DENT, V91, P356, DOI 10.1016/j.prosdent.2004.02.001
   Blatz MB, 2002, QUINTESSENCE INT, V33, P415
   Bonfante EA, 2010, J DENT, V38, P707, DOI 10.1016/j.jdent.2010.04.001
   Bonfante EA, 2010, J DENT, V38, P318, DOI 10.1016/j.jdent.2009.12.004
   Chang JH, 2009, J EUROPEAN CERAMIC S, V29, P2665
   de Arellano-Lopez AR, 2004, J EUR CERAM SOC, V24, P861, DOI 10.1016/S0955-22219(03)00321-2
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Garvie RC, 1984, J AM CERAM SOC, V67, P119
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2004, DENT MATER, V20, P449, DOI 10.1016/j.dental.2003.05.002
   Harder S, 2010, J DENT, V38, P875, DOI 10.1016/j.jdent.2010.07.012
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159
   Kondoh J, 2004, J ALLOY COMPD, V375, P270, DOI 10.1016/j.jallcom.2003.11.129
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   PONTON CB, 1989, MATER SCI TECH SER, V5, P865, DOI 10.1179/mst.1989.5.9.865
   PONTON CB, 1989, MATER SCI TECH SER, V5, P961, DOI 10.1179/mst.1989.5.10.961
   Raigrodski AJ, 2004, J PROSTHET DENT, V92, P557, DOI 10.1016/j.prosdent.2004.09.015
   Rateick RG, 2006, WEAR, V261, P773, DOI 10.1016/j.wear.2006.01.012
   Stevenson B, 2010, J DENT, V38, P361, DOI 10.1016/j.jdent.2010.01.009
   SWAIN MV, 1985, J AM CERAM SOC, V68, pC97
   Vagopoulou T., 2009, EUR J ESTHET DENT, V4, P2
   VIRKAR AV, 1986, J AM CERAM SOC, V69, pC224
NR 29
TC 32
Z9 33
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
J9 J DENT
JI J. Dent.
PD FEB
PY 2013
VL 41
IS 2
BP 121
EP 126
DI 10.1016/j.jdent.2012.06.009
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 088ZE
UT WOS:000314876000004
PM 22796498
DA 2018-10-20
ER

PT J
AU Ignjatovic, N
   Ajdukovic, Z
   Savic, V
   Najman, S
   Mihailovic, D
   Vasiljevic, P
   Stojanovic, Z
   Uskokovic, V
   Uskokovic, D
AF Ignjatovic, Nenad
   Ajdukovic, Zorica
   Savic, Vojin
   Najman, Stevo
   Mihailovic, Dragan
   Vasiljevic, Perica
   Stojanovic, Zoran
   Uskokovic, Vuk
   Uskokovic, Dragan
TI Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of
   mandibular osteoporotic bones
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE; TIGHT JUNCTION; IN-VITRO; RECONSTRUCTION;
   REPLACEMENT; MANDIBLES; CHLORIDE; DELIVERY; CELLS; ACTIN
AB Indications exist that paramagnetic calcium phosphates may be able to promote regeneration of bone faster than their regular, diamagnetic counterparts. In this study, analyzed was the influence of paramagnetic cobalt-substituted hydroxyapatite nanoparticles on osteoporotic alveolar bone regeneration in rats. Simultaneously, biocompatibility of the material was tested in vitro, on osteoblastic MC3T3-E1 and epithelial Caco-2 cells in culture. The material was shown to be biocompatible and nontoxic when added to epithelial monolayers in vitro, while it caused a substantial decrease in the cell viability as well as deformation of the cytoskeleton and cell morphology when incubated with the osteoblastic cells. In the course of 6 months after the implantation of the material containing different amounts of cobalt, ranging from 5 to 12 wt%, in the osteoporotic alveolar bone of the lower jaw, the following parameters were investigated: histopathological parameters, alkaline phosphatase and alveolar bone density. The best result in terms of osteoporotic bone tissue regeneration was observed for hydroxyapatite nanoparticles with the largest content of cobalt ions. The histological analysis showed a high level of reparatory ability of the nanoparticulate material implanted in the bone defect, paralleled by a corresponding increase in the alveolar bone density. The combined effect of growth factors from autologous plasma admixed to cobalt-substituted hydroxyapatite was furthermore shown to have a crucial effect on the augmented osteoporotic bone regeneration upon the implantation of the biomaterial investigated in this study.
C1 [Ignjatovic, Nenad; Stojanovic, Zoran; Uskokovic, Dragan] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   [Ajdukovic, Zorica] Univ Nis, Fac Med, Dept Prosthodont, Clin Stomatol, Nish, Serbia.
   [Savic, Vojin; Najman, Stevo] Univ Nis, Fac Med, Inst Biomed Res, Nish, Serbia.
   [Mihailovic, Dragan] Univ Nis, Fac Med, Inst Pathol, Nish, Serbia.
   [Vasiljevic, Perica] Univ Nis, Fac Sci, Dept Biol & Ecol, Nish, Serbia.
   [Uskokovic, Vuk] Univ Calif San Francisco, Therapeut Micro & Nanotechnol Lab, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.
RP Uskokovic, V (reprint author), Univ Calif San Francisco, Therapeut Micro & Nanotechnol Lab, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.
EM vuk21@yahoo.com
RI Stojanovic, Zoran/A-7417-2011; Uskokovic, Dragan/B-4129-2008;
   Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Uskokovic, Vuk/0000-0003-3256-1606;
   Vasiljevic, Perica/0000-0003-0006-7187; Najman,
   Stevo/0000-0002-2411-9802; Stojanovic, Zoran S./0000-0002-5989-0031
FU Ministry of Education and Science of the Republic of Serbia [III45004];
   NIH/NIDCR [K99-DE021416]
FX The research presented in this paper was supported by the Ministry of
   Education and Science of the Republic of Serbia under the Project No.
   III45004 and by the NIH/NIDCR grant K99-DE021416. Confocal microscopy
   data for this study were acquired at the Nikon Imaging Center at
   University of California, San Francisco. FE-SEM images were obtained by
   courtesy of Dr. Sreco Skapin from Jozef Stefan Institute. Authors would
   also like to thank MSc. Ljilijana Veselinovic for XRD measurements.
CR ABDELFATTAH WI, 1994, BIOMATERIALS, V15, P609, DOI 10.1016/0142-9612(94)90211-9
   Ajdukovic Z, 2005, J BIOMATER APPL, V20, P179, DOI 10.1177/0885328205050519
   Ajdukovic Z, 2007, J BIOMATER APPL, V21, P317, DOI 10.1177/0885328207073760
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Britti D, 2005, JAVMA-J AM VET MED A, V226, P951, DOI 10.2460/javma.2005.226.951
   de Lima IR, 2011, J BIOMED MATER RES A, V98A, P351, DOI 10.1002/jbm.a.33126
   El Ouassouli A, 1999, J CHIM PHYS PCB, V96, P1212, DOI 10.1051/jcp:1999208
   Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745
   Gill HS, 2012, TRENDS MOL MED, V18, P145, DOI 10.1016/j.molmed.2011.12.002
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Gurbay A, 2012, BIOL TRACE ELEM RES, V148, P110, DOI 10.1007/s12011-012-9331-y
   Hallab NJ, 2012, EUR SPINE J
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Homolka P, 2002, RADIOLOGY, V224, P247, DOI 10.1148/radiol.2241010948
   Horev-Azaria L, 2011, TOXICOL SCI, V122, P489, DOI 10.1093/toxsci/kfr124
   Ignjatovic N, 2008, ADV APPL CERAM, V107, P142, DOI 10.1179/174367608X263421
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic NL, 2010, J BIOMED MATER RES B, V94B, P108, DOI 10.1002/jbm.b.31630
   Ito A, 2006, CANCER IMMUNOL IMMUN, V55, P320, DOI 10.1007/s00262-005-0049-y
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lantin AC, 2011, TOXICOL LETT, V201, P42, DOI 10.1016/j.toxlet.2010.12.003
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Li Y, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012024
   Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080
   Macleod Iain, 2008, Dent Update, V35, P590
   Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008
   Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c
   Meunier PJ, 2005, OSTEOPOROSIS INT, V16, P1203, DOI 10.1007/s00198-004-1828-6
   Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305
   Patel B, 2012, MAT SCI ENG C-MATER, V32, P1222, DOI 10.1016/j.msec.2012.03.012
   Pelclova D, 2012, CLIN TOXICOL, V50, P262, DOI 10.3109/15563650.2012.670244
   Pollahne W, 1996, MED BILD, V3, P37
   Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071
   Ratner D. B., 2004, BIOMATERIALS SCI INT, P23
   Seibel Markus J, 2006, Clin Biochem Rev, V27, P123
   Stojanovic Z, 2009, MATER MANUF PROCESS, V24, P1096, DOI 10.1080/10426910903032113
   Suomalainen A, 2009, DENTOMAXILLOFAC RAD, V38, P367, DOI 10.1259/dmfr/15779208
   Tami AE, 2009, BONE, V45, P1117, DOI 10.1016/j.bone.2009.07.090
   Uskokovic V, 2012, BIOMATERIALS, V33, P1663, DOI 10.1016/j.biomaterials.2011.11.010
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Veselinovic L, 2010, J APPL CRYSTALLOGR, V43, P320, DOI 10.1107/S0021889809051395
   Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179
   Yang SJ, 2004, J BIOCHEM MOL BIOL, V37, P480
   Zhang JM, 1998, J MATER SCI LETT, V17, P1077, DOI 10.1023/A:1006619729924
NR 46
TC 31
Z9 31
U1 0
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2013
VL 24
IS 2
BP 343
EP 354
DI 10.1007/s10856-012-4793-1
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 087PU
UT WOS:000314775100008
PM 23090835
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Thian, ES
   Konishi, T
   Kawanobe, Y
   Lim, PN
   Choong, C
   Ho, B
   Aizawa, M
AF Thian, E. S.
   Konishi, T.
   Kawanobe, Y.
   Lim, P. N.
   Choong, C.
   Ho, B.
   Aizawa, M.
TI Zinc-substituted hydroxyapatite: a biomaterial with enhanced bioactivity
   and antibacterial properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-FORMATION; STRUCTURAL-CHARACTERIZATION; ANTIMICROBIAL ACTIVITY;
   TRICALCIUM PHOSPHATE; CELL-ACTIVITY; COATINGS; HYDROXYLAPATITE;
   CERAMICS; GRANULES; BEHAVIOR
AB Hydroxyapatite (HA) is a synthetic biomaterial and has been found to promote new bone formation when implanted in a bone defect site. However, its use is often limited due to its slow osteointegration rate and low antibacterial activity, particularly where HA has to be used for long term biomedical applications. This work will describe the synthesis and detailed characterization of zinc-substituted HA (ZnHA) as an alternative biomaterial to HA. ZnHA containing 1.6 wt% Zn was synthesized via a co-precipitation reaction between calcium hydroxide, orthophosphoric acid and zinc nitrate hexahydrate. Single-phase ZnHA particles with a rod-like morphology measuring similar to 50 nm in length and similar to 15 nm in width, were obtained and characterized using transmission electron microscopy and X-ray diffraction. The substitution of Zn into HA resulted in a decrease in both the a- and c-axes of the unit cell parameters, thereby causing the HA crystal structure to alter. In vitro cell culture work showed that ZnHA possessed enhanced bioactivity since an increase in the growth of human adipose-derived mesenchymal stem cells along with the bone cell differentiation markers, were observed. In addition, antibacterial work demonstrated that ZnHA exhibited antimicrobial capability since there was a significant decrease in the number of viable Staphylococcus aureus bacteria after in contact with ZnHA.
C1 [Thian, E. S.; Lim, P. N.] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Thian, E. S.; Konishi, T.; Kawanobe, Y.; Aizawa, M.] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan.
   [Kawanobe, Y.; Aizawa, M.] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
   [Choong, C.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Ho, B.] Natl Univ Singapore, Dept Mircobiol, Singapore 119260, Singapore.
RP Thian, ES (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM mpetes@nus.edu.sg
RI Konishi, Toshiisa/A-9234-2015; Choong, Cleo/A-2240-2011
OI Thian, Eng San/0000-0001-6925-6811
FU Hitachi Scholarship Foundation (Japan) [HSF-R126]
FX This research was supported by Hitachi Scholarship Foundation (Japan)
   under Research Fellowship HSF-R126.
CR BIGI A, 1995, J INORG BIOCHEM, V58, P49, DOI 10.1016/0162-0134(94)00036-A
   Chen YK, 2010, SURF COAT TECH, V205, P1892, DOI 10.1016/j.surfcoat.2010.08.073
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Darouiche R. O., 2004, INFECT DIS CLIN PRAC, V12, P258
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   Du WL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085707
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Hayakawa S, 2007, J AM CERAM SOC, V90, P565, DOI 10.1111/j.1551-2916.2006.01396.x
   Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Li MO, 2008, J MATER SCI-MATER M, V19, P797, DOI 10.1007/s10856-007-3213-4
   Miyaji F, 2005, MATER RES BULL, V40, P209, DOI 10.1016/j.materresbull.2004.10.020
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Nan L, 2008, J MATER SCI-MATER M, V19, P3057, DOI 10.1007/s10856-008-3444-z
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Rossi L, 2001, J NUTR, V131, P1142
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Sogo Y, 2002, J BIOMED MATER RES, V62, P457, DOI 10.1002/jbm.10200
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Swetha M, 2012, J NANOSCI NANOTECHNO, V12, P167, DOI 10.1166/jnn.2012.5142
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Wang XP, 2010, ACTA BIOMATER, V6, P962, DOI 10.1016/j.actbio.2009.08.038
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Yamada Y, 2008, J BIOMED MATER RES A, V84A, P344, DOI 10.1002/jbm.a.31265
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAZDI M, 1991, CLIN ORTHOP RELAT R, P281
NR 36
TC 74
Z9 77
U1 1
U2 88
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2013
VL 24
IS 2
BP 437
EP 445
DI 10.1007/s10856-012-4817-x
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 087PU
UT WOS:000314775100015
PM 23160913
DA 2018-10-20
ER

PT J
AU Vishnoi, T
   Kumar, A
AF Vishnoi, Tanushree
   Kumar, Ashok
TI Conducting cryogel scaffold as a potential biomaterial for cell
   stimulation and proliferation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO CHARACTERIZATION;
   ELECTRICAL-STIMULATION; GELATIN CRYOGELS; CHITOSAN; POLYMER; FIELD;
   DISCOVERY
AB The aim of the study was to demonstrate the potential of the cryogelation technique for the synthesis of the conducting cryogel scaffolds which would encompass the advantages of the cryogel matrix, like the mechanical strength and interconnected porous network as well as the conductive properties of the incorporated conducting polymeric material, polypyrrole. The cryogels were synthesized using different combinations of oxidizing agents and surfactants like, sodium dodecyl sulfate (SDS)/ammonium persulfate (APS), SDS/iron chloride (FeCl3), cetyl trimethyl ammonium bromide (CTAB)/APS, and CTAB/FeCl3. The synthesized gels were characterized by scanning electron microscopic analysis for morphology, Fourier transform infrared spectroscopy for analyzing the presence of the polypyrrole (0.5-4 %) as nano-fillers in the gel. It was observed that the presence of these nano-fillers increased the swelling ratio by approximately 50 %. The synthesized conducting cryogels displayed high stress bearing capacity without being deformed as analysed by rheological measurements. The degradation studies showed 12-15 % degradation in 4 weeks time. In vitro studies with conducting and non-conducting cryogel scaffold were carried out to optimize the stimulation conditions for the two cell lines, neuro2a and cardiac muscle C2C12. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed approximately 25 and 15 % increase in the cell proliferation rate for neuro2a and C2C12 cell line, respectively. This was observed at a specific voltage of 100 mV and 2 V, for a specified duration of 2 h and 1 min, respectively for the conducting scaffold as compared to the control. This can play an important role in tissue engineering applications for cell lines where acquiring a high cell number and functionality is desired.
C1 [Vishnoi, Tanushree; Kumar, Ashok] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015
FU Department of Biotechnology (DBT), Ministry of Science and Technology,
   Govt. of India; Council of Scientific and Industrial Research (CSIR),
   India
FX This study was supported by the Department of Biotechnology (DBT),
   Ministry of Science and Technology, Govt. of India. Senior Research
   Fellowship to T. V. by Council of Scientific and Industrial Research
   (CSIR), India, is also duly acknowledged. Authors would also like to
   acknowledge Anton Parr Laboratory, Gurgaon, India for helping in the
   rheological characterization of matrices.
CR Amparat R, 2008, J MET MAT MINER, V18, P27
   Artin P, 2011, J ELECTROCHEM SOC, V158, P269
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117
   Chao PHG, 2007, CONNECT TISSUE RES, V48, P188, DOI 10.1080/03008200701424451
   Chew SY, 2007, J ELECTROCHEM SOC, V154, pA633, DOI 10.1149/1.2734778
   Chronakis IS, 2006, POLYMER, V47, P1597, DOI 10.1016/j.polymer.2006.01.032
   Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029
   GEDDES LA, 1971, IEEE SPECTRUM, V8, P38, DOI 10.1109/MSPEC.1971.5217888
   Gharavi N, 2010, International Journal of Nanomanufacturing, V5, P335
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Guimard NK, 2006, MRS P, P950
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kang HC, 2000, POLYMER, V41, P6931, DOI 10.1016/S0032-3861(00)00116-6
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kim IS, 2011, TISSUE ENG PT A, V17, P1327, DOI [10.1089/ten.TEA.2010.0519, 10.1089/ten.tea.2010.0519]
   Kumar A., 2008, EUR CELLS MATER, V16, P11
   Laleh GM, 2011, J TISSUE ENG REGEN M, V5, P17
   Lee YJ, 2010, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2010.5540237
   Levin M, 2009, SEMIN CELL DEV BIOL, V20, P543, DOI 10.1016/j.semcdb.2009.04.013
   Li L, 2004, J APPL POLYM SCI, V91, P303, DOI 10.1002/app.13257
   Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389
   McGuigan AP, 2007, J TISSUE ENG REGEN M, V1, P136, DOI 10.1002/term.14
   Nathalie K., 2007, PROG POLYM SCI, V32, P876
   Omastova M, 2003, SYNTHETIC MET, V138, P447, DOI 10.1016/S0379-6779(02)00498-8
   Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93
   PHILLIPS G, 1991, J APPL PHYS, V69, P899, DOI 10.1063/1.347331
   Pullar CE, 2010, BIOTECHNOL PROGR, V26, P664
   Rajeswari R, 2010, J R SOC INTERFACE, DOI [10.1098/rsif.2010.0120, DOI 10.1098/RSIF.2010.0120]
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Singh D, 2010, INT J BIOL SCI, V6, P371
   Srivastava A, 2010, J MATER SCI-MATER M, V21, P2937, DOI 10.1007/s10856-010-4124-3
   Sun LB, 2012, COLLOID SURFACE A, V397, P8, DOI 10.1016/j.colsurfa.2012.01.008
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Thongngam M, 2005, LANGMUIR, V21, P79, DOI 10.1021/la048711o
   Voo R, 2012, POLYM ADVAN TECHNOL, V23, P1620, DOI 10.1002/pat.3039
   Wan Y, 2005, J MEMBRANE SCI, V246, P193, DOI 10.1016/j.memsci.2004.07.032
   Wang K, 2012, CHITOSAN-BASED HYDROGELS: FUNCTIONS AND APPLICATIONS, P339
   Wei SY, 2011, J ELECTROCHEM SOC, V158, pK205, DOI 10.1149/2.048111jes
   Ying W, 2004, MACROMOL BIOSCI, V4, P882
   Ying W, 2005, J MATER SCI-MATER M, V16, P1017
   Zhang XT, 2006, J PHYS CHEM B, V110, P1158, DOI 10.1021/jp054335k
NR 44
TC 20
Z9 20
U1 6
U2 100
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2013
VL 24
IS 2
BP 447
EP 459
DI 10.1007/s10856-012-4795-z
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 087PU
UT WOS:000314775100016
PM 23124526
DA 2018-10-20
ER

PT J
AU Phull, MK
   Eydmann, T
   Roxburgh, J
   Sharpe, JR
   Lawrence-Watt, DJ
   Phillips, G
   Martin, Y
AF Phull, Manraj K.
   Eydmann, Trevor
   Roxburgh, Judy
   Sharpe, Justin R.
   Lawrence-Watt, Diana J.
   Phillips, Gary
   Martin, Yella
TI Novel macro-microporous gelatin scaffold fabricated by particulate
   leaching for soft tissue reconstruction with adipose-derived stem cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID STROMAL CELLS; IN-VITRO; BONE-MARROW; IMPLANTATION; DIFFERENTIATION;
   REGENERATION; ADIPOCYTES; SECRETION; EXPANSION; DEATH
AB The restoration of body contours as shaped by adipose tissue remains a clinical challenge specifically in patients who have experienced loss of contour due to trauma, surgical removal of tumours or congenital abnormalities. We have developed a novel macro-microporous biomaterial for use in soft tissue re-bulking and augmentation. Alginate beads provided the pore template for the construct. Incorporation, and subsequent dissolution, of the beads within a 7 % (w/v) gelatin matrix, produced a highly porous scaffold with an average pore size of 2.01 +/- A 0.08 mm. The ability of this scaffold to support the in vitro growth and differentiation of human adipose-derived stem cells (ADSCs) was then investigated. Histological analysis confirmed that the scaffold itself provided a suitable environment to support the growth of ADSCs on the scaffold walls. When delivered into the macropores in a fibrin hydrogel, ADSCs proliferated and filled the pores. In addition, ADSCs could readily be differentiated along the adipogenic lineage. These results therefore describe a novel scaffold that can support the proliferation and delivery of ADSCs. The scaffold is the first stage in developing a clinical alternative to current treatment methods for soft tissue reconstruction.
C1 [Phull, Manraj K.; Lawrence-Watt, Diana J.] Brighton Sussex Med Sch, Brighton, E Sussex, England.
   [Eydmann, Trevor; Roxburgh, Judy; Sharpe, Justin R.; Lawrence-Watt, Diana J.; Martin, Yella] Queen Victoria Hosp, Blond McIndoe Res Fdn, E Grinstead RH19 3DZ, W Sussex, England.
   [Phillips, Gary; Martin, Yella] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.
RP Martin, Y (reprint author), Queen Victoria Hosp, Blond McIndoe Res Fdn, Holtye Rd, E Grinstead RH19 3DZ, W Sussex, England.
EM yella.martin@blondmcindoe.com
OI Martin, Yella/0000-0003-2881-2441
CR Bronz G, 2011, ADIPOSE STEM CELLS R, P83
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Cherubino M, 2009, REGEN MED, V4, P109, DOI 10.2217/17460751.4.1.109
   Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]
   Currie LJ, 2003, BURNS, V29, P677, DOI 10.1016/S0305-4179(03)00155-4
   Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029
   Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19
   Frerich B, 2012, ARTIF ORGANS, V36, P227, DOI 10.1111/j.1525-1594.2011.01346.x
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Itoi Y, 2010, J PLAST RECONSTR AES, V63, P858, DOI 10.1016/j.bjps.2009.01.069
   Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI 10.1089/ten.TEB.2010.0559
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Pereira LH, 2011, ADIPOSE STEM CELLS R, P57
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rubin JP, 2007, PLAST RECONSTR SURG, V120, P414, DOI 10.1097/01.prs.0000267699.99369.a8
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Shanti RM, 2008, ANN PLAS SURG, V61, P566, DOI 10.1097/SAP.0b013e31816d9579
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b
   Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276
   Toledo LS, 2011, ADIPOSE STEM CELLS R, P45
   Verseijden F, 2010, CELL TRANSPLANT, V19, P1007, DOI 10.3727/09636890X492571
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Weiser B, 2009, CELLS TISSUES ORGANS, V189, P373, DOI 10.1159/000154270
   Yoshimura K, 2011, ADIPOSE STEM CELLS R, P67
   Zhou YL, 2011, TISSUE ENG PT A, V17, P2981, DOI 10.1089/ten.tea.2010.0707
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 33
TC 13
Z9 13
U1 0
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2013
VL 24
IS 2
BP 461
EP 467
DI 10.1007/s10856-012-4806-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 087PU
UT WOS:000314775100017
PM 23143193
DA 2018-10-20
ER

PT J
AU Claramunt, R
   Alvarez-Ayuso, L
   Garcia-Paez, JM
   Ros, A
   Casado, MC
AF Claramunt, Rafael
   Alvarez-Ayuso, Lourdes
   Maria Garcia-Paez, Jose
   Ros, Antonio
   Concepcion Casado, Maria
TI Changes in the Mechanical Properties of Chemically Treated Bovine
   Pericardium After a Short Uniaxial Cyclic Test
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Energy loss; Hysteresis; Tearing; Calf pericardium; Cardiac
   bioprostheses
ID HEART-VALVE BIOPROSTHESES; DETERIORATION; BIOMATERIALS; BEHAVIOR;
   FAILURE
AB The mechanical behavior of calf pericardium, a biomaterial utilized in the manufacture of cardiac bioprostheses, in response to a short tensile cyclic test has been evaluated. The trial involved 120 samples cut longitudinally or transversely, subjected to 10 cycles until a stress of between 1 and 3MPa was reached. Tests of hardness and tear propagation were performed, and the results were compared with a control series. The energy loss was also computed, and it was approximately 10-fold greater in the first cycle than the loss in the subsequent nine cycles. Despite this singularity, they correlated very precisely. The effect of the direction in which the tissue is cut on energy loss was not significant nor the difference between hardness prior to and after testing. The results of the tear propagation tests gave no statistical differences prior to and after testing. From the obtained results, it seems that the test carried out does not affect significantly the mechanical properties of calf pericardium.
C1 [Claramunt, Rafael; Maria Garcia-Paez, Jose; Ros, Antonio] UPM, ETSI Ind, Dept Struct Mech, Madrid 28006, Spain.
   [Alvarez-Ayuso, Lourdes] Hosp Univ Puerta de Hierro Majadahonda, Serv Expt Surg, Majadahonda, Spain.
   [Concepcion Casado, Maria] Univ Alcala De Henares, Dept Didact, Guadalajara, Spain.
RP Claramunt, R (reprint author), UPM, ETSI Ind, Lab Resistencia Mat, C Jose Gutierrez Abascal 2, Madrid 28006, Spain.
EM rclaramunt@etsii.upm.es
FU Fondo de Investigaciones Sanitarias [PI05/0048]; Ministerio de Ciencia e
   Innovacion, Spain [MAT2009-10258, AIB2010PT-00361]
FX This study was financed by grants no. PI05/0048 from the Fondo de
   Investigaciones Sanitarias, and MAT2009-10258 and AIB2010PT-00361 from
   the Ministerio de Ciencia e Innovacion, Spain. The authors wish to thank
   M. Messman for her translation of the text.
CR Barratt-Boyes BG, 1998, J THORAC CARDIOV SUR, V116, P1005, DOI 10.1016/S0022-5223(98)70053-4
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Claramunt R, 2011, J MECH BEHAV BIOMED, V4, P1929, DOI 10.1016/j.jmbbm.2011.06.009
   Paez JMG, 2007, J MATER SCI-MATER M, V18, P715, DOI 10.1007/s10856-006-0009-x
   Garcia Paez JM, 2010, ARTIF ORGANS, V34, P65
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Kent B, 1998, CARDIOVASC PATHOL, V7, P9
   Lau L, 2006, ANN THORAC SURG, V82, P2123, DOI 10.1016/j.athoracsur.2006.07.027
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 2002, J BIOMED MATER RES, V62, P73, DOI 10.1002/jbm.10266
   Rivero G, 2007, SENS LETT, V5, P263, DOI 10.1166/sl.2007.086
   Rojo FJ, 2010, J BIOMED MATER RES B, V95B, P414, DOI 10.1002/jbm.b.31732
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VESELY I, 1993, J THORAC CARDIOV SUR, V106, P288
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 20
TC 1
Z9 1
U1 2
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 2013
VL 37
IS 2
BP 183
EP 188
DI 10.1111/j.1525-1594.2012.01538.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 086AS
UT WOS:000314656000011
PM 23043423
DA 2018-10-20
ER

PT J
AU Golosova, OA
   Ivanov, MB
   Kolobov, YR
   Vershinina, TN
AF Golosova, O. A.
   Ivanov, M. B.
   Kolobov, Y. R.
   Vershinina, T. N.
TI Structure and properties of low modulus titanium alloy Ti-26Nb-7Mo-12Zr
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Titanium beta alloy; Elastic modulus; Wear test; Corrosion resistance;
   Biomaterials
ID CORROSION; BEHAVIOR
AB The calculation of the choice of a new low modulus titanium beta alloy was described. The investigations of the structure and properties (mechanical, tribological and corrosive) of low modulus titanium beta alloy Ti-26Nb-7Mo-12Zr after mechanical-thermal processing were carried out. An analysis of the results of experimental research showed that the formation of homogeneous fine grained structure by sheet rolling with subsequent annealing before quenching leads to decreased elastic modulus, increased plasticity and wear resistance. Therefore, new titanium beta alloy designed in the present study, Ti-26Nb-7Mo-12Zr, is expected to have good properties as biomaterial.
C1 [Golosova, O. A.; Ivanov, M. B.; Kolobov, Y. R.; Vershinina, T. N.] Belgorod Res Univ, Res Educ & Innovat Ctr Nanostruct Mat & Nanotechn, Belgorod, Russia.
RP Golosova, OA (reprint author), Belgorod Res Univ, Res Educ & Innovat Ctr Nanostruct Mat & Nanotechn, Belgorod, Russia.
EM golosova@bsu.edu.ru
RI Vershinina, Tatiana/D-1599-2013; Kolobov, Yuri/K-4116-2015
OI Vershinina, Tatiana/0000-0001-7140-7404; Kolobov,
   Yuri/0000-0002-1683-5614; Vershinina, Tatiana/0000-0002-7748-5443
FU Federal Target Program 'Scientific and scientific pedagogical cadres
   Innovative Russia'
FX The authors are grateful to Professor A. A. Zisman of CRISM 'Prometey'
   (St Petersburg, Russia) for the participation in the discussion of the
   choice of the alloying system of the new low modulus titanium beta
   alloy. The authors are also indebted to M. Y. Smolyakova for the help in
   carrying out corrosion and wear tests and for the participation in the
   discussion of the results. Funding support by Federal Target Program
   'Scientific and scientific pedagogical cadres Innovative Russia' for
   2009-2013 is gratefully acknowledged.
CR Breme J., 1999, TITANIUM 99 SCI TECH, P1187
   Chechulin B. B., 1977, TITANIUM ALLOYS ENG, P194
   Conzalez M., 2009, J MATER ENG PERFORM, V18, P490
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Golosova O A, 2011, Journal of Physics: Conference Series, V291, DOI 10.1088/1742-6596/291/1/012053
   Gunawarman B, 2005, MAT SCI ENG C-BIO S, V25, P304, DOI 10.1016/j.msec.2004.12.015
   Gyunter V. E., 1998, MED MAT SHAPE MEMORY, P5
   Hanawa T., 2011, P S STRUCT BIOM 21 C, P145
   I'in A. A., 2002, TECHNOL LIGHT ALLOYS, V3, P23
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kawashima A, 2003, MATER TRANS, V44, P1405, DOI 10.2320/matertrans.44.1405
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kollerov M. Y., 2001, RUSS METALL+, V2, P74
   Kolobov Yu.R., 2009, NANOTECHNOL RUSS, V4, P19, DOI DOI 10.1134/S1995078009110020
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Leyens C., 2003, TITANIUM TITANIUM AL
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MORINAGA M, 1992, TITANIUM 92 SCI TECH, P276
   Niinomi M., 1999, TITANIUM 99 SCI TECH, P1195
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Nitta K., 2011, P S STRUCT BIOM 21 C, P25
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Ryklina E. P., 2004, MET SCI HEAT TREAT, V46, P179
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Slater J. S., 1988, QUANTUM THEORY MOL S, V4
   Song Y., 1999, TITANIUM 99 SCI TECH, P1202
   [Вершинин Д.С. Vershinin D.S.], 2010, [Заводская лаборатория. Диагностика материалов, INORGANIC MATERIALS English translation of selected articles from Zavodskaya Laboratoriya. Diagnostika Materialov, Zavodskaya laboratoriya. Diagnostika materialov], V76, P45
   Wong J. Y., 2007, BUILD ENVIRON, P1
   Zhukova Y. S., 2010, RUSS METALL+, V6, P77
NR 29
TC 3
Z9 4
U1 1
U2 21
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD FEB
PY 2013
VL 29
IS 2
BP 204
EP 209
DI 10.1179/1743284712Y.0000000128
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 087NA
UT WOS:000314767200012
DA 2018-10-20
ER

PT J
AU Amna, T
   Hassan, MS
   Sheikh, FA
   Lee, HK
   Seo, KS
   Yoon, D
   Hwang, IH
AF Amna, Touseef
   Hassan, M. Shamshi
   Sheikh, Faheem A.
   Lee, Hak Kyo
   Seo, Kang-Seok
   Yoon, Duhak
   Hwang, I. H.
TI Zinc oxide-doped poly(urethane) spider web nanofibrous scaffold via
   one-step electrospinning: a novel matrix for tissue engineering
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Electrospinning; Composite nanofibers; NIH 3T3 fibroblasts;
   Cytotoxicity; Spider net
ID SEGMENTED POLYURETHANE; POLYMER NANOFIBERS; CARBON NANOTUBES;
   BIOCOMPATIBILITY; NANOWIRES; NANORODS; NANOWEBS
AB Zinc oxide (ZnO) nanostructures have been commonly studied for electronic purposes due to their unique piezoelectric and catalytic properties; however, recently, they have been also exploited for biomedical applications. The purpose of this study was to fabricate ZnO-doped poly(urethane) (PU) nanocomposite via one-step electrospinning technique. The utilized nanocomposite was prepared by using colloidal gel composed of ZnO and PU, and the obtained mats were vacuum dried at 60 A degrees C overnight. The physicochemical characterization of as-spun composite nanofibers was carried out by X-ray diffraction pattern, field emission scanning electron microscopy, energy-dispersive X-ray spectroscopy, electron probe microanalysis, and transmission electron microscopy, whereas the thermal behavior was analyzed by thermogravimetric analysis. The viability, attachment, and proliferation of NIH 3T3 mouse fibroblast cells on the ZnO/PU composite nanofibers were analyzed by in vitro cell compatibility test. The morphological features of the cells attached on nanofibers were examined by Bio-SEM. We conclude that the electrospun nanofibrous scaffolds with unique spider nets had good biocompatibility. Cytotoxicity experiments indicated that the mouse fibroblasts could attach to the nanocomposite after being cultured. Thus, the current work demonstrates that the as-synthesized ZnO/PU hybrid nanofibers represent a promising biomaterial to be exploited for various tissue engineering applications.
C1 [Amna, Touseef; Hwang, I. H.] Chonbuk Natl Univ, Dept Anim Sci, Jeonju 561756, South Korea.
   [Amna, Touseef; Hwang, I. H.] Chonbuk Natl Univ, Inst Rare Earth Biol Applicat, Jeonju 561756, South Korea.
   [Hassan, M. Shamshi] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Sheikh, Faheem A.] Univ Texas Pan Amer, Dept Chem, Edinburg, TX 78539 USA.
   [Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea.
   [Seo, Kang-Seok] Sunchon Natl Univ, Dept Anim Sci & Technol, Sunchon 540742, South Korea.
   [Yoon, Duhak] Kyungpook Natl Univ, Dept Anim Sci, Coll Ecol & Environm Sci, Sangju 742711, South Korea.
RP Amna, T (reprint author), Chonbuk Natl Univ, Dept Anim Sci, Jeonju 561756, South Korea.
EM touseefamna@gmail.com; inho.hwang@jbnu.ac.kr
RI Sheikh, Faheem/Q-9166-2018
OI Sheikh, Faheem/0000-0003-0942-4398
FU Rural Development Administration, Republic of Korea [PJ008191, PJ907055]
FX This work has been conducted and partly supported by a grant from
   Next-Generation BioGreen 21 Program (no. PJ008191) and a fund for FTA
   issues (no. PJ907055), Rural Development Administration, Republic of
   Korea.
CR Barakat NAM, 2009, POLYMER, V50, P4389, DOI 10.1016/j.polymer.2009.07.005
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Ding B, 2006, NANOTECHNOLOGY, V17, P3685, DOI 10.1088/0957-4484/17/15/011
   Ding B, 2010, MATER TODAY, V13, P16, DOI 10.1016/S1369-7021(10)70200-5
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Ge JJ, 2004, J AM CHEM SOC, V126, P15754, DOI 10.1021/ja048648p
   Hou HQ, 2004, ADV MATER, V16, P69, DOI 10.1002/adma.200306205
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Khlystalova TK, 1986, MECH COMPOS MATER, V21, P763, DOI DOI 10.1007/BF00605943
   Kidoaki S, 2006, J BIOMED MATER RES B, V76B, P219, DOI 10.1002/jbm.b.30336
   Kim YJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315202
   Kimmer D, 2009, J APPL POLYM SCI, V111, P2711, DOI 10.1002/app.29238
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Li XQ, 2009, COLLOID SURFACE B, V69, P221, DOI 10.1016/j.colsurfb.2008.11.031
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41
   Madhugiri S, 2003, J AM CHEM SOC, V125, P14531, DOI 10.1021/ja030326i
   Mao X, 2010, CARBOHYD POLYM, V80, P839, DOI 10.1016/j.carbpol.2009.12.041
   Pant HR, 2011, J HAZARD MATER, V185, P124, DOI 10.1016/j.jhazmat.2010.09.006
   Sheikh FA, 2011, APPL SURF SCI, V257, P3020, DOI 10.1016/j.apsusc.2010.10.110
   Wang ZL, 2008, SCI AM, V298, P82, DOI 10.1038/scientificamerican0108-82
   Yoon Y. I., 2009, CARBOHYD POLYM, V75, P246, DOI DOI 10.1016/J.CARBPOL.2008.07.015
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zhan SH, 2007, J COLLOID INTERF SCI, V308, P265, DOI 10.1016/j.jcis.2006.12.026
   Zhi J, 2006, SPECTROSC SPECT ANAL, V26, P624
NR 25
TC 20
Z9 21
U1 2
U2 107
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD FEB
PY 2013
VL 97
IS 4
BP 1725
EP 1734
DI 10.1007/s00253-012-4353-0
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 082QM
UT WOS:000314407300029
PM 22918299
DA 2018-10-20
ER

PT J
AU Guirado, JLC
   Fernandez, MPR
   Negri, B
   Ruiz, RAD
   de-Val, JEMS
   Gomez-Moreno, G
AF Calvo Guirado, Jose Luis
   Ramirez Fernandez, Maria Piedad
   Negri, Bruno
   Delgado Ruiz, Rafael Arcesio
   Mate Sanchez de-Val, Jose Eduardo
   Gomez-Moreno, Gerardo
TI Experimental Model of Bone Response to Collagenized Xenografts of
   Porcine Origin (OsteoBiol (R) mp3): A Radiological and Histomorphometric
   Study
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biomaterial; bone graft; collagenized porcine xenografts; hydroxyapatite
ID MAXILLARY SINUS AUGMENTATION; RECONSTITUTED COLLAGEN; IMPLANT PLACEMENT;
   AUTOGENOUS BONE; ALVEOLAR RIDGE; IN-VIVO; HYDROXYAPATITE; DEFECTS;
   BIOMATERIAL; GRAFTS
AB Background: Adequate alveolar ridges are fundamental to successful rehabilitation with implants. There are diverse techniques for reconstructing atrophied ridges, of which bone substitute grafts is one possibility. Purpose: The aim of this study was to carry out radiological and histomorphometric evaluations of bone response to collagenized porcine bone xenografts over a 4-month period following their insertion in rabbits' tibiae. Material and Methods: Twenty New Zealand rabbits were used. Twenty collagenized porcine bone xenografts (Osteobiol (R) mp3, Tecnoss Dental s.r.l., Torino, Italy), in granulated form of 600 to 1,000 mu m, were inserted in the proximal metaphyseal area of the animals' tibiae and 20 control areas were created. Following implantation, the animals were sacrificed in four groups of five, after 1, 2, 3, and 4 months, respectively. Radiological and histomorphometric studies were made. Results: After 4 months, radiological images revealed bone defects with a decrease in graft volume and the complete repair of the osseous defect. No healed or residual bone alterations attributable to the presence of the implants were observed. Histomorphometric analysis at 4 months found mean values for newly formed bone, residual graft material, and non-mineralized connective tissue of 25.4 +/- 1.8%, 36.37 +/- 3.0%, and 38.22 +/- 2.5%, respectively. There were no statistical differences in the length of cortical formation with collagenized porcine xenograft (98.9 +/- 1.1%) compared with the control samples (99.1 +/- 0.7%) at the end of the study period. Conclusions: The biomaterial used proved to be biocompatible, bioabsorbable, and osteoconductive and as such, a possible bone substitute that did not interfere with the bone's normal reparative processes.
C1 [Calvo Guirado, Jose Luis; Ramirez Fernandez, Maria Piedad; Negri, Bruno] Univ Murcia, Fac Med & Dent, Dept Implant Dent, Murcia 30007, Spain.
   [Delgado Ruiz, Rafael Arcesio; Mate Sanchez de-Val, Jose Eduardo] Univ Murcia, Fac Med & Dent, Dept Restorat Dent, Murcia 30007, Spain.
   [Gomez-Moreno, Gerardo] Univ Granada, Sch Dent, Dept Pharmacol Interact, Granada, Spain.
RP Guirado, JLC (reprint author), Univ Murcia, Fac Med & Dent, Hosp Morales Meseguer, 2 Planta Clin Odontol,Calle Marques de los Velez, Murcia 30007, Spain.
EM joseluis.calvo@um.es
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018; Gomez-Moreno,
   Gerardo/L-8123-2014
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; Gomez-Moreno,
   Gerardo/0000-0001-9094-4985; Delgado-Ruiz, Rafael/0000-0003-1721-0509;
   RAMIREZ FERNANDEZ, MARIA PIEDAD/0000-0003-1913-9902; calvo guirado, jose
   luis/0000-0002-4067-2253
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Borie DC, 1998, INFECT CONT HOSP EP, V19, P355
   Cancian DCJ, 2004, INT J ORAL MAX IMPL, V19, P73
   Cardaropoli D, 2008, INT J PERIODONT REST, V28, P469
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cutter CS, 2006, J LONG-TERM EFF MED, V16, P607
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   Ersanli S, 2004, J PERIODONTOL, V75, P750, DOI 10.1902/jop.2004.75.5.750
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Grimes JS, 2006, ORTHOPEDICS, V29, P145
   Hsu FY, 2005, J MATER SCI-MATER M, V16, P341, DOI 10.1007/s10856-005-0633-x
   Johansson LA, 2010, J ORAL MAXIL SURG, V68, P837, DOI 10.1016/j.joms.2009.07.093
   Kin SH, 2004, J BIOMED MATER RES B, V68, P69
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, P77
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
NR 27
TC 17
Z9 17
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD FEB
PY 2013
VL 15
IS 1
BP 143
EP 151
DI 10.1111/j.1708-8208.2011.00337.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 078PG
UT WOS:000314110900018
PM 21453393
DA 2018-10-20
ER

PT J
AU Bhushan, B
   Utter, J
AF Bhushan, Bharat
   Utter, Jason
TI Nanoscale adhesion, friction and wear of proteins on polystyrene
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polystyrene; Proteins; Adhesion; Friction; Wear
ID ATOMIC-FORCE MICROSCOPY; SILICON-BASED SURFACES; COLLAGEN; ADSORPTION;
   BIOMATERIALS; BIOMOLECULES; STREPTAVIDIN; FIBRONECTIN; BIOADHESION;
   DEVICES
AB Protein layers are routinely deployed on biomaterials and biological micro/nanoelectromechanical systems (bioMEMS/NEMS) as a functional layer allowing for specific molecular recognition, binding properties or to facilitate biocompatibility. In addition, uncoated biomaterial surfaces will have uncontrolled protein layers adsorbing to the surface within seconds of implantation, so a pre-defined protein layer will improve the host response. Implanted biomaterials also experience micromotion over time which may degrade any surface protein layers. Degradation of these protein layers may lead to system failure or an unwanted immune response. Therefore, it is important to characterize the interfacial properties of proteins on biomaterial surfaces. In this study, the nanoscale adhesion, friction and wear properties of proteins adsorbed to a spin coated polystyrene surface were measured using atomic force microscopy (AFM) in deionized (DI) water and phosphate buffered saline. Adhesion, friction and wear have been measured for bovine serum albumin (BSA), collagen, fibronectin and streptavidin (STA) in DI water and PBS as a function of protein concentration. These proteins were chosen due to their importance and widespread application in the biotechnology field. Adhesion and friction were also measured for BSA and STA at two different temperatures and different pH values to simulate a biological environment. Based on this study, adhesion, friction and wear mechanisms of the different proteins are discussed. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Bhushan, Bharat; Utter, Jason] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
RP Bhushan, B (reprint author), Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
EM Bhushan.2@osu.edu
RI Bhushan, Bharat/A-9684-2013
OI Bhushan, Bharat/0000-0001-7161-6601
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1992, PURE APPL CHEM, V64, P1777, DOI 10.1351/pac199264111777
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2006, ACTA BIOMATER, V2, P39, DOI 10.1016/j.actbio.2005.08.010
   Bhushan B, 2011, NANOTRIBOLOGY NANOME, VII
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Bhushan B, 2009, J R SOC INTERFACE, V6, P719, DOI 10.1098/rsif.2008.0398
   Black J, 1999, BIOL PERFORMANCE MAT
   Bridges A.W., 2008, THESIS GEORGIA I TEC
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Fan J, 2011, P I MECH ENG H, V225, P696, DOI 10.1177/0954411911401306
   Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   GREEN NM, 1990, METHOD ENZYMOL, V184, P51
   Hattori S, 1999, J BIOCHEM-TOKYO, V125, P676, DOI 10.1093/oxfordjournals.jbchem.a022336
   HIRAYAMA K, 1990, BIOCHEM BIOPH RES CO, V173, P639, DOI 10.1016/S0006-291X(05)80083-X
   Kosmulski M., 2001, CHEM PROPERTIES MAT
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Palacio MLB, 2012, PHILOS T R SOC A, V370, P2321, DOI 10.1098/rsta.2011.0483
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Park K., 1997, CONTROLLED DRUG DELI
   PETERS T, 1980, ALBUMIN OVERVIEW BIB
   PROCTOR RA, 1987, REV INFECT DIS, V9, pS317
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   RUAN JA, 1994, J TRIBOL-T ASME, V116, P378, DOI 10.1115/1.2927240
   Sagvolden G, 1998, LANGMUIR, V14, P5984, DOI 10.1021/la980271b
   Sastri V.R., 2010, MAT REQUIREMENTS PLA
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wise DL, 2000, BIOMATERIALS BIOENGI
   Xu SH, 2007, COLLOID POLYM SCI, V285, P899, DOI 10.1007/s.00396-006-1636-y
NR 40
TC 3
Z9 3
U1 0
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2013
VL 102
BP 484
EP 491
DI 10.1016/j.colsurfb.2012.09.002
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 067NI
UT WOS:000313301200070
PM 23085687
DA 2018-10-20
ER

PT J
AU Moroishi, H
   Yoshida, C
   Murakami, Y
AF Moroishi, Hitomi
   Yoshida, Chikara
   Murakami, Yoshihiko
TI A free-standing, sheet-shaped, "hydrophobic" biomaterial containing
   polymeric micelles formed from poly(ethylene glycol)-poly(lactic acid)
   block copolymer for possible incorporation/release of "hydrophilic"
   compounds
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polymeric micelle w/o emulsion; Sheet; Free-standing; Sustained release
ID TISSUE-ADHESIVE HYDROGEL; EMULSIFICATION TECHNIQUE; CONTROLLED-RELEASE;
   DRUG-DELIVERY; GROWTH-FACTOR; REGENERATION; NANOSHEETS; MEMBRANES;
   SURFACE; FILM
AB Sheet-shaped materials with a large contact area relative to the drug targeting site lead to advantages over conventional particle-shaped drug carriers and have several advantages for their biomedical applications. The present study proposes a methodology for preparing a novel sheet-shaped "hydrophobic" and biocompatible biomaterial in which polymeric micelles are uniformly dispersed for the incorporation of "hydrophilic" compounds into the sheet. The methoxy-terminated poly(ethylene glycol)-block-poly(lactic acid) block copolymer (CH3O-PEG-b-PLA) was successfully synthesized by means of the anionic ring-opening polymerization of both ethylene oxide and DL-lactide. CH3O-PEG-b-PLA was self-assembled and formed stable micelle-like w/o emulsion with a hydrophilic inner core in organic solvents. A sheet-shaped material containing a hydrophilic inner space for incorporating hydrophilic compounds was obtained by spin-coating both the micelle solution and a sheet-forming polymer. Fluorescent images of the sheet proved that polymeric micelles providing hydrophilic spaces were uniformly dispersed in the hydrophobic sheet. The facile technique presented in this paper can be a tool for fabricating sheet-shaped biomaterials that have a hydrophilic inner core and, consequently, that are suitable for the sustained release of hydrophilic compounds. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Moroishi, Hitomi; Yoshida, Chikara; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan.
RP Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan.
EM muray@cc.tuat.ac.jp
RI Murakami, Yoshihiko/C-9485-2013
FU Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (MEXT); Industrial Technology Research Grant Program
   from the New Energy and Industrial Technology Development Organization
   (NEDO) of Japan
FX This study was funded, in part, by Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (MEXT) and the Industrial Technology Research Grant Program
   from the New Energy and Industrial Technology Development Organization
   (NEDO) of Japan.
CR Balasubramanian V, 2010, EXPERT OPIN DRUG DEL, V7, P63, DOI 10.1517/17425240903394520
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Eck W, 2005, ADV MATER, V17, P2583, DOI 10.1002/adma.200500900
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017
   Liu R, 2005, J CONTROL RELEASE, V103, P31, DOI 10.1016/j.jconrel.2004.11.025
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330
   Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Murakami Y, 2009, J BIOMED MATER RES B, V91B, P102, DOI 10.1002/jbm.b.31378
   Okamura Y, 2008, COLLOID SURFACE A, V318, P184, DOI 10.1016/j.colsurfa.2007.12.049
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Qui Y., 2001, ADV DRUG DELIV REV, V53, P321
   Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Uchida Y, 2011, COLLOID SURFACE B, V84, P346, DOI 10.1016/j.colsurfb.2011.01.025
   Uchida Y, 2010, COLLOID SURFACE B, V79, P198, DOI 10.1016/j.colsurfb.2010.03.047
   Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Yang Y, 2008, EUR J PHARM BIOPHARM, V69, P106, DOI 10.1016/j.ejpb.2007.10.016
NR 26
TC 13
Z9 13
U1 3
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2013
VL 102
BP 597
EP 603
DI 10.1016/j.colsurfb.2012.08.050
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 067NI
UT WOS:000313301200085
PM 23107939
DA 2018-10-20
ER

PT J
AU Ha, YM
   Amna, T
   Kim, MH
   Kim, HC
   Hassan, MS
   Khil, MS
AF Ha, Yu-Mi
   Amna, Touseef
   Kim, Mi-Hee
   Kim, Hyun-Chel
   Hassan, M. Shamshi
   Khil, Myung-Seob
TI Novel silicificated PVAc/POSS composite nanofibrous mat via facile
   electrospinning technique: Potential scaffold for hard tissue
   engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE PVAc/POSS composite; Mineralization; Scaffolds; Myoblast cells;
   Electrospinning
ID POLY(VINYL ACETATE); IN-VIVO; BONE; HYDROXYAPATITE; EMBOLIZATION;
   REGENERATION; HYBRIDS; FIBERS; POSS
AB This study presents the fabrication of novel porous silicificated PVAc/POSS composite nanofibers by facile electrospinning technique and the interaction of synthesized mats with simulated body fluid (SBF). The physicochemical properties of the electrospun composites were determined by scanning electron microscopy, energy dispersive X-ray spectroscopy, transmission electron microscopy, electron probe micro-analysis, X-ray diffraction and thermogravimetry analysis. To examine the in vitro cytotoxicity, mouse myoblast C2C12 cells were treated with pristine and composite nanofibrous mats and the viability of cells was analyzed by cell counting kit-8 assay at regular time intervals. Our results indicated the enhanced nucleation and the formation of apatite-like structures at the surface of silicificated PVAc/POSS during the incubation of electrospun mats in SBF solution. Cytotoxicity experiments designated that the myoblasts could attach to the composite after being cultured. We observed in the present study that PVAc/POSS nanofibrous mat could support cell adhesion and guide the spreading behavior of myoblasts. We conclude that the new electrospun silicificated PVAc/POSS composite scaffold with unique porous morphology have excellent biocompatibility. Consequently, our investigation results showed that the as-spun porous PVAc/POSS composite nanofibrous scaffold could be a potential substrate for the proliferation and mineralization of osteoblasts, enhancing bone regeneration. The biocomposite mats represent a promising biomaterial to be exploited for various tissue engineering applications such as guided bone regeneration. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Ha, Yu-Mi; Kim, Mi-Hee; Hassan, M. Shamshi; Khil, Myung-Seob] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Amna, Touseef] Chonbuk Natl Univ, Inst Rare Earth Biol Applicat, Dept Anim Sci, Jeonju 561756, South Korea.
   [Kim, Hyun-Chel] Korean Inst Knit Ind, Iksan 570330, South Korea.
RP Hassan, MS (reprint author), Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
EM shamshi@jbnu.ac.kr; mskhil@jbnu.ac.kr
FU Industrial Strategic Technology Development Program [100037345];
   Ministry of Knowledge Economy (MKE, Korea)
FX This work was supported by the Industrial Strategic Technology
   Development Program, 100037345, funded by the Ministry of Knowledge
   Economy (MKE, Korea).
CR Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Cozza ES, 2010, MACROMOL MATER ENG, V295, P791, DOI 10.1002/mame.201000214
   Dalas E, 2003, J CRYST GROWTH, V255, P163, DOI 10.1016/S0022-0248(03)01209-0
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Goebel M.T., 1953, US patent, Patent No. 2629713
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hench L.L., 2008, KEY ENG MATER, V337, P151
   Hoshi T, 2007, POLYMER, V48, P1573, DOI 10.1016/j.polymer.2007.01.023
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim CK, 2007, MACROMOLECULES, V40, P4823, DOI 10.1021/ma070056e
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Ko GY, 2003, RADIOLOGY, V227, P407, DOI 10.1148/radiol.2272011702
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Liu YR, 2006, POLYM DEGRAD STABIL, V91, P2731, DOI 10.1016/j.polymdegradstab.2006.04.031
   MOLLY SS, 2010, MACROMOLECULES, V43, P581
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Park JY, 2008, J IND ENG CHEM, V14, P707, DOI 10.1016/j.jiec.2008.03.006
   Park KR, 2004, J APPL POLYM SCI, V91, P1612, DOI 10.1002/app.13299
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ramaseshan R, 2007, J APPL PHYS, V102, DOI 10.1063/1.2815499
   SADATO A, 1994, NEURORADIOLOGY, V36, P634, DOI 10.1007/BF00600429
   Tamaki R, 1998, APPL ORGANOMET CHEM, V12, P755, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<755::AID-AOC783>3.0.CO;2-A
   Toworfe G.K., 2006, BIOMATERIALS, V27, P63
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   WILSON J, 1993, INTRO BIOCERAMICS, V1, P63
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zhu PX, 2004, BIOMATERIALS, V25, P3915, DOI 10.1016/j.biomaterials.2003.10.022
NR 34
TC 19
Z9 19
U1 1
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2013
VL 102
BP 795
EP 802
DI 10.1016/j.colsurfb.2012.09.018
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 067NI
UT WOS:000313301200113
PM 23107958
DA 2018-10-20
ER

PT J
AU Chan, WH
   Houng, WL
   Lin, CAJ
   Lee, CH
   Li, PW
   Hsieh, JT
   Shen, JL
   Yeh, HI
   Chang, WH
AF Chan, Wen-Hsiung
   Houng, Wei-Li
   Lin, Cheng-An J.
   Lee, Chih-Hsien
   Li, Po-Wen
   Hsieh, Jyun-Tai
   Shen, Ji-Lin
   Yeh, Hung-I
   Chang, Walter H.
TI Impact of dihydrolipoic acid on mouse embryonic stem cells and related
   regulatory mechanisms
SO ENVIRONMENTAL TOXICOLOGY
LA English
DT Article
DE dihydrolipoic acid; apoptosis; oxidative stress; calcium; nitric oxide
ID ALPHA-LIPOIC ACID; NITRIC-OXIDE SYNTHASE; INDUCED OXIDATIVE STRESS;
   HUMAN MONONUCLEAR-CELLS; CARCINOMA A431 CELLS; DNA-DAMAGE; PHOTODYNAMIC
   THERAPY; CANCER-CELLS; NUCLEAR ACCUMULATION; THYMOCYTE APOPTOSIS
AB a-Lipoic acid (LA) is a thiol with antioxidant properties that protects against oxidative stress-induced apoptosis. LA is absorbed from the diet, taken up by cells and tissues, and subsequently reduced to dihydrolipoic acid (DHLA). Recently, DHLA has been used as the hydrophilic nanomaterial preparations, and therefore, determination of its bio-safety profile is essential. In this article, we show that DHLA (50100 mu M) induces apoptotic processes in mouse embryonic stem cells (ESC-B5), but exerts no injury effects at treatment dosages below 50 mu M. Higher concentrations of DHLA (50100 mu M) directly increased the reactive oxygen species (ROS) content in ESC-B5 cells, along with a significant increase in cytoplasmic free calcium and nitric oxide (NO) levels, loss of mitochondrial membrane potential (MMP), activation of caspases-9 and -3, and cell death. Pretreatment with NO scavengers suppressed the apoptotic biochemical changes induced by 100 mu M DHLA and promoted the gene expression levels of p53 and p21 involved in apoptotic signaling. Our results collectively indicate that DHLA at concentrations of 50100 mu M triggers apoptosis of ESC-B5 cells, which involves both ROS and NO. Importantly, at doses of less than 50 mu M (025 mu M), DHLA does not exert hazardous effects on ESC-B5 cell properties, including viability, development and differentiation. These results provide important information in terms of dosage safety and biocompatibility of DHLA to facilitate its further use as a precursor for biomaterial preparation. (C) 2011 Wiley Periodicals, Inc. Environ Toxicol, 28: 87-97, 2013.
C1 [Chan, Wen-Hsiung; Houng, Wei-Li] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli 32023, Taiwan.
   [Chan, Wen-Hsiung; Houng, Wei-Li] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli 32023, Taiwan.
   [Lin, Cheng-An J.; Lee, Chih-Hsien; Li, Po-Wen; Hsieh, Jyun-Tai; Chang, Walter H.] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli 32023, Taiwan.
   [Lin, Cheng-An J.; Lee, Chih-Hsien; Li, Po-Wen; Hsieh, Jyun-Tai; Chang, Walter H.] Chung Yuan Christian Univ, Ctr Nano Bioengn, Chungli 32023, Taiwan.
   [Shen, Ji-Lin] Chung Yuan Christian Univ, Dept Phys, Chungli 32023, Taiwan.
   [Yeh, Hung-I] Mackay Mem Hosp, Taipei, Taiwan.
RP Chang, WH (reprint author), Chung Yuan Christian Univ, Dept Biomed Engn, Chungli 32023, Taiwan.
EM whchang@cycu.edu.tw
FU National Science Council of Taiwan, R.O.C. [NSC 99-2120-M-038,
   98-2627-B-033-001, 98-2627-B-195-001]; Department of Health [DOH
   99-TD-N-111-001]; Specific Research Fields in Chung Yuan Christian
   University [CYCU-98-CR-BE]
FX Contract grant sponsor: National Science Council of Taiwan, R.O.C.;
   Contract grant numbers: NSC 99-2120-M-038, 98-2627-B-033-001,
   98-2627-B-195-001.; Contract grant sponsor: Department of Health.;
   Contract grant number: DOH 99-TD-N-111-001.; Contract grant sponsor:
   Specific Research Fields in Chung Yuan Christian University.; Contract
   grant number: CYCU-98-CR-BE.
CR Abdul HM, 2007, FREE RADICAL BIO MED, V42, P371, DOI 10.1016/j.freeradbiomed.2006.11.006
   Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2
   Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003
   Aoshima H, 1997, BBA-LIPID LIPID MET, V1345, P35, DOI 10.1016/S0005-2760(96)00159-2
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   Bilska A, 2005, PHARMACOL REP, V57, P570
   Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001
   BUSTAMANTE J, 1995, FREE RADICAL BIO MED, V19, P339, DOI 10.1016/0891-5849(95)00045-Y
   BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3
   Chan WH, 2008, IUBMB LIFE, V60, P171, DOI 10.1002/iub.30
   Chan WH, 2006, TOXICOL LETT, V167, P191, DOI 10.1016/j.toxlet.2006.09.007
   Chan WH, 2006, HUM REPROD, V21, P2985, DOI 10.1093/humrep/del255
   Chan WH, 2003, J CELL BIOCHEM, V90, P327, DOI 10.1002/jcb.10638
   Chan WH, 2006, TOXICOL LETT, V161, P1, DOI 10.1016/j.toxlet.2005.07.010
   Chan WH, 2005, J CELL BIOCHEM, V94, P1267, DOI 10.1002/jcb.20408
   Choi SY, 2009, ANN NY ACAD SCI, V1171, P149, DOI 10.1111/j.1749-6632.2009.04708.x
   Coleman MD, 2006, BASIC CLIN PHARMACOL, V99, P225, DOI 10.1111/j.1742-7843.2006.pto_499.x
   Dedkova EN, 2004, AM J PHYSIOL-CELL PH, V286, pC406, DOI 10.1152/ajpcell.00155.2003
   Dennis J, 2003, J NEUROSCI RES, V72, P76, DOI 10.1002/jnr.10539
   DEVASAGAYAM TPA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P409, DOI 10.1016/0167-4781(91)90133-7
   DEVASAGAYAM TPA, 1993, CHEM-BIOL INTERACT, V86, P79, DOI 10.1016/0009-2797(93)90113-D
   Ekmekcioglu S, 2005, CURR CANCER DRUG TAR, V5, P103, DOI 10.2174/1568009053202072
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005
   Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147
   Gomes ER, 2002, PHOTOCHEM PHOTOBIOL, V76, P423, DOI 10.1562/0031-8655(2002)076<0423:NOMTCD>2.0.CO;2
   HAENEN GRMM, 1991, BIOCHEM PHARMACOL, V42, P2244, DOI 10.1016/0006-2952(91)90363-A
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HARRISON EH, 1974, ARCH BIOCHEM BIOPHYS, V160, P514, DOI 10.1016/0003-9861(74)90428-7
   Hsieh MS, 2009, INT J MOL SCI, V10, P1445, DOI 10.3390/ijms10041445
   Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273
   Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408
   Inanami O, 1999, PHOTOCHEM PHOTOBIOL, V70, P650, DOI 10.1111/j.1751-1097.1999.tb08265.x
   KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9
   Li CQ, 2004, CANCER RES, V64, P3022, DOI 10.1158/0008-5472.CAN-03-1880
   Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021
   Lin CAJ, 2009, J MED BIOL ENG, V29, P276
   Lin CAJ, 2009, ACS NANO, V3, P395, DOI 10.1021/nn800632j
   Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211
   Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p
   Lovell Mark A, 2003, J Alzheimers Dis, V5, P229
   Lu ZB, 2006, FREE RADICAL BIO MED, V41, P1590, DOI 10.1016/j.freeradbiomed.2006.08.021
   Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208
   Moini H, 2002, TOXICOL APPL PHARM, V182, P84, DOI 10.1006/taap.2002.9437
   Morkunaite-Haimi S, 2003, BIOCHEM PHARMACOL, V65, P43, DOI 10.1016/S0006-2952(02)01450-8
   Moungjaroen J, 2006, J PHARMACOL EXP THER, V319, P1062, DOI 10.1124/jpet.106.110965
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099
   Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412
   Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9
   Perham RN, 2002, BIOCHEM SOC T, V30, P47, DOI 10.1042/bst0300047
   Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022
   Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200
   Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217
   Schweizer M, 1996, BIOCHEM PHARMACOL, V52, P1815, DOI 10.1016/S0006-2952(96)00459-5
   SCOTT BC, 1994, FREE RADICAL RES, V20, P119, DOI 10.3109/10715769409147509
   Selvakumar E, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-4
   SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565
   Simbula G, 2007, APOPTOSIS, V12, P113, DOI 10.1007/s10495-006-0487-9
   Singh LP, 2007, CELL BIOCHEM FUNCT, V25, P537, DOI 10.1027/cbf.1358
   SLATER AFG, 1995, BIOCHEM J, V306, P771, DOI 10.1042/bj3060771
   Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46
   STARY FE, 1975, J ORG CHEM, V40, P58, DOI 10.1021/jo00889a013
   STEVENS B, 1974, PHOTOCHEM PHOTOBIOL, V20, P515, DOI 10.1111/j.1751-1097.1974.tb06612.x
   SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221
   Wang YJ, 2008, FOOD CHEM TOXICOL, V46, P3739, DOI 10.1016/j.fct.2008.09.064
   Wenzel U, 2005, APOPTOSIS, V10, P359, DOI 10.1007/s10495-005-0810-x
   Wu HJ, 2007, TOXICOL IN VITRO, V21, P335, DOI 10.1016/j.tiv.2006.09.002
   Zheng YH, 2005, ONCOGENE, V24, P3339, DOI 10.1038/sj.onc.1208484
   Zhou H, 2005, TOXICOLOGY, V208, P223, DOI 10.1016/j.tox.2004.11.021
NR 71
TC 2
Z9 2
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-4081
EI 1522-7278
J9 ENVIRON TOXICOL
JI Environ. Toxicol.
PD FEB
PY 2013
VL 28
IS 2
BP 87
EP 97
DI 10.1002/tox.20700
PG 11
WC Environmental Sciences; Toxicology; Water Resources
SC Environmental Sciences & Ecology; Toxicology; Water Resources
GA 075GV
UT WOS:000313873500003
PM 21462292
DA 2018-10-20
ER

PT J
AU Huang, BD
   Zou, XN
   Li, HS
   Xue, QY
   Bunger, C
AF Huang, Baoding
   Zou, Xuenong
   Li, Haisheng
   Xue, Qingyun
   Bunger, Cody
TI Short-term alendronate treatment does not maintain a residual effect on
   spinal fusion with interbody devices and bone graft after treatment
   withdrawal: an experimental study on spinal fusion in pigs
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE Alendronate; Residual effect; Tantalum; Pig
ID POROUS TANTALUM; MODEL; FRACTURES; TITANIUM; INGROWTH; DENSITY; WOMEN
AB Whether alendronate treatment has a residual effect on bone ingrowth into porous biomaterial in humans or experimental animals after treatment withdrawal is still unknown. The purpose of this study was to investigate bone ingrowth into porous tantalum and carbon fiber interbody implants after discontinuing alendronate treatment in experimental spinal fusion in pigs.
   Twenty-four pigs were randomly divided into two groups of each 12 pigs. The pigs underwent anterior intervertebral lumbar arthrodeses at L2-3, L4-5 and L6-7. Each level was randomly allocated to one of the three implants: a porous tantalum ring with pedicle screw fixation, a porous tantalum ring or a carbon fiber cage with anterior staple fixation. The central hole of implants was packed with an autograft. Alendronate was given orally for the first 3 months to one of the two groups. The pigs were observed for 6 months postoperatively. Histology and micro-CT scans were done at the endpoint.
   The spinal fusion rates of each implant showed no differences between two treatment groups. Furthermore, no differences were found between two groups as for bone ingrowth into the central holes of implants and bone-implant interface in each implant, or as for the pores of tantalum implants. Trabecular bone microarchitecture in the central hole of the carbon fiber cage did not differ between two treatment groups.
   The application of ALN, with a dose equivalent to that given to humans during the first 3 months after surgery, does not maintain a residual effect on spinal fusion with porous tantalum ring and autograft after treatment withdrawal in a porcine ALIF model.
C1 [Huang, Baoding; Zou, Xuenong; Li, Haisheng; Xue, Qingyun; Bunger, Cody] Aarhus Univ Hosp, Orthopaed Res Lab, Spine Sect, Dept Orthopaed E, DK-8000 Aarhus C, Denmark.
   [Huang, Baoding; Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Orthopaed Res Inst, Guangzhou 510080, Guangdong, Peoples R China.
   [Huang, Baoding] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Orthopaed, Guangzhou 510655, Guangdong, Peoples R China.
RP Zou, XN (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Orthopaed Res Inst, Zhongshan 2nd Rd,58,Bldg 1, Guangzhou 510080, Guangdong, Peoples R China.
EM zxnong@hotmail.com
FU Danish Rheumatism Association; Institute of Experimental Clinical
   Research, University of Aarhus; Aarhus Spine Research Foundation in
   Denmark; Danish Council for Strategic Research project IMR:
   "Individualized musculoskeletal regeneration and reconstruction"
   [2101-07-0120]; 973 Program [2012CB619100]; NSFC [u0732001]; S&T project
   of Guangdong Province [2010B010800019]
FX The authors thank Anette Milton for technical assistance in histology,
   Bruce Robie, PhD, for excellent help in revising of the manuscript, and
   the Danish Institute of Agricultural Sciences, Research Center Foulum,
   for excellent cooperation. The Danish Rheumatism Association, the
   Institute of Experimental Clinical Research, University of Aarhus, and
   the Aarhus Spine Research Foundation in Denmark provided financial
   supports. This work was also supported by the Danish Council for
   Strategic Research project IMR: "Individualized musculoskeletal
   regeneration and reconstruction" (2101-07-0120), 973 Program (No.
   2012CB619100), the NSFC (No. u0732001), and the S&T project of Guangdong
   Province (2010B010800019). Hedrocel ALIF devices (Porous Tantalum
   Implants) was kindly supplied by Implex Corp., Allendale, NJ, USA, for
   the study. The experiments complied with the Danish Law on Animal
   Experiments and were approved by the Danish Ministry of Justice, J. No.
   1998-561-67.
CR Bagger YZ, 2003, BONE, V33, P301, DOI 10.1016/S8756-3282(03)00112-1
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bunger MH, 2006, EUR CELLS MATER, V12, P81
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Duarte PM, 2005, J PERIODONTOL, V76, P107, DOI 10.1902/jop.2005.76.1.107
   Huang RC, 2005, SPINE, V30, P2516, DOI 10.1097/01.brs.0000186470.28070.7b
   Lehman Ronald A Jr, 2004, Spine J, V4, P36, DOI 10.1016/S1529-9430(03)00427-3
   Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493
   LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201
   Lin J H, 1999, Int J Clin Pract Suppl, V101, P18
   Lund T, 1998, J BONE JOINT SURG BR, V80B, P351, DOI 10.1302/0301-620X.80B2.7693
   Nagahama K, 2011, J NEUROSURG-SPINE, V14, P500, DOI 10.3171/2010.11.SPINE10245
   Nakao S, 2011, SPINE, V36, P1446, DOI 10.1097/BRS.0b013e3181f49c47
   Nishitani K, 2009, AM J SPORTS MED S1, V37, P139
   Peter CP, 1996, J ORTHOP RES, V14, P74, DOI 10.1002/jor.1100140113
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Sama AA, 2004, CLIN ORTHOP RELAT R, P135, DOI 10.1097/01.blo.0000137825.50462.c5
   Schenk Robert K., 1993, P85
   Xue QY, 2010, INT ORTHOP, V34, P447, DOI 10.1007/s00264-009-0759-4
   Zou XN, 2003, ACTA ORTHOP SCAND, V74, P596, DOI 10.1080/00016470310018027
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 22
TC 1
Z9 1
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD FEB
PY 2013
VL 22
IS 2
BP 287
EP 295
DI 10.1007/s00586-012-2513-7
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 077XU
UT WOS:000314063500007
PM 23053753
OA Green Published
DA 2018-10-20
ER

PT J
AU Piccinini, M
   Rebaudi, A
   Sglavo, VM
   Bucciotti, F
   Pierfrancesco, R
AF Piccinini, Marzio
   Rebaudi, Alberto
   Sglavo, Vincenzo M.
   Bucciotti, Francesco
   Pierfrancesco, Robotti
TI A New HA/TTCP Material for Bone Augmentation: An In Vivo Histological
   Pilot Study in Primates Sinus Grafting
SO IMPLANT DENTISTRY
LA English
DT Article
DE bone regeneration; sinus graft; hydroxyapatite; synthetic bone grafts;
   tetracalcium phosphate
ID MAXILLARY SINUS; TRABECULAR BONE; TITANIUM IMPLANTS; DENTAL IMPLANTS;
   POROUS HYDROXYAPATITE; COMPUTED-TOMOGRAPHY; AUTOGENOUS BONE; PHOSPHATE;
   ARCHITECTURE; REGENERATION
AB Objective: Synthetic calcium phosphate bone substitutes are widely used in sinus graft procedures due to their osteoconductive and biocompatible properties. Hydroxyapatite (HA), beta-tricalcium phosphate (beta-TCP), and HA/beta-TCP composite are the most applied materials. The aim of this study was to propose a new mineralogical formulation, HA/tetra-calcium phosphate (TTCP), as biomaterial for bone regeneration in the maxillary sinus.
   Methods: Sinus grafts were performed by using granules of a HA/TTCP blend and a collagen membrane. Bone response at time points of 14 and 17 weeks was histologically evaluated.
   Results: After 14 weeks of healing, histomorphometric analysis showed the formation of new bone trabeculae among HA/TTCP granules. After 17 weeks, the bone trabeculae were thicker and HA/TTCP granules were still present. Histomorphometric analysis revealed a bone graft contact (BGC) of 64%.
   Conclusions: After 17 weeks from implantation, HA/TTCP synthetic bone graft performed very well as osteoconductive material: BGC was found very high, and bone volume and vital bone showed an ideal bone density for implant placement. HA/TTCP granules are accounted for to accelerate new bone formation and to reduce the time needed for the graft healing, thus achieving high quantity of the new bone formed. (Implant Dent 2013;22:83-90)
C1 [Piccinini, Marzio; Sglavo, Vincenzo M.] Univ Trento, Dept Mat Engn & Ind Technol, I-38123 Trento, Italy.
   [Rebaudi, Alberto] Univ Genoa, I-16126 Genoa, Italy.
   [Rebaudi, Alberto] Biomat Clin Res Assoc, Pescara, Italy.
   [Bucciotti, Francesco; Pierfrancesco, Robotti] Eurocoating SpA, Cire Pergine Valsugana, TN, Italy.
RP Piccinini, M (reprint author), Univ Trento, Dept Mat Engn & Ind Technol, Via Mesiano 77, I-38123 Trento, Italy.
EM marzio.piccinini@ing.unitn.it
OI sglavo, vincenzo m./0000-0001-9133-7204
FU Eurocoating Spa; Provincia Autonoma di Trento (Regional Public
   Authority)
FX This work is part of "CaP Project" cosponsored by Eurocoating Spa and
   Provincia Autonoma di Trento (Regional Public Authority).
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Berger G, 1997, MAT SCI LETT, V6, P7
   Blomqvist JE, 1997, J ORAL MAXIL SURG, V55, P804, DOI 10.1016/S0278-2391(97)90337-2
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Branemark PI, 1985, TISSUE INTEGRATED PR, P241
   Burguera EF, 2004, J BIOMED MATER RES A, V71A, P275, DOI 10.1002/jbm.a.30153
   de Vicente JC, 2010, CLIN ORAL IMPLAN RES, V21, P430, DOI 10.1111/j.1600-0501.2009.01877.x
   CAWOOD JI, 1994, INT J ORAL MAX SURG, V23, P219, DOI 10.1016/S0901-5027(05)80374-1
   Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.0.CO;2-8
   DALSTRA M, 1993, J BIOMECH, V26, P523, DOI 10.1016/0021-9290(93)90014-6
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Frost H M, 1983, Henry Ford Hosp Med J, V31, P3
   FROST HM, 1983, CLIN ORTHOP RELAT R, P286
   FROST HM, 1983, METAB BONE DIS RELAT, V4, P281, DOI 10.1016/S0221-8747(83)80001-0
   Garetto L P, 1995, Implant Dent, V4, P235, DOI 10.1097/00008505-199500440-00002
   Gbureck U, 2004, J DENT RES, V83, P425, DOI 10.1177/154405910408300514
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P401, DOI 10.1034/j.1600-0501.1997.080507.x
   JENSEN OT, 1990, J ORAL MAXIL SURG, V48, P771, DOI 10.1016/0278-2391(90)90103-9
   Jensen OT, 1998, INT J ORAL MAXILLOF, V13, P11
   KENT JN, 1989, J ORAL MAXIL SURG, V47, P238, DOI 10.1016/0278-2391(89)90225-5
   Kim H, 2005, J MATER SCI-MATER M, V16, P961, DOI 10.1007/s10856-005-4430-3
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   Lazzara R J, 1996, Curr Opin Periodontol, V3, P178
   Merten HA, 2000, OSTEOSYNTH INT S1, V8, P107
   Misch C E, 1987, Int J Oral Implantol, V4, P7
   MOSEKILDE L, 1990, BONE MINER, V10, P13, DOI 10.1016/0169-6009(90)90046-I
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Nevins ML, 2005, INT J PERIODONT REST, V25, P365
   ODGAARD A, 1990, J MICROSC-OXFORD, V159, P335, DOI 10.1111/j.1365-2818.1990.tb03038.x
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P487, DOI 10.1034/j.1600-0501.1997.080607.x
   Rebaudi A, 2004, INT J PERIODONT REST, V24, P317
   Rebaudi A, 2000, CLIN ORAL IMPLAN RES, V11, P396
   Rebaudi A, 2008, DOCTOR OS, V19, P479
   Recker RR, 1983, HISTOMORPHOMETRY TEC, P120
   Roberts W E, 1989, J Indiana Dent Assoc, V68, P19
   Roberts W E, 1992, Implant Dent, V1, P11, DOI 10.1097/00008505-199200110-00002
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Sennerby L, 2001, CLIN ORAL IMPLAN RES, V12, P91, DOI 10.1034/j.1600-0501.2001.012001091.x
   SZABO G, 1992, J LONG-TERM EFF MED, V2, P81
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Trisi P, 2006, INT J PERIODONT REST, V26, P113
   Trisi P, 2002, INT J PERIODONT REST, V22, P535
   Trisi P, 1998, INT J PERIODONT REST, V18, P151
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   Trisi P, 2002, INT J PERIODONT REST, V22, P31
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
NR 54
TC 10
Z9 10
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD FEB
PY 2013
VL 22
IS 1
BP 83
EP 90
DI 10.1097/ID.0b013e31827afc19
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 073FI
UT WOS:000313728500015
PM 23296033
DA 2018-10-20
ER

PT J
AU Sionkowska, A
   Planecka, A
AF Sionkowska, Alina
   Planecka, Anna
TI Preparation and characterization of silk fibroin/chitosan composite
   sponges for tissue engineering
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Silk fibroin; Chitosan; Scaffold; Biomaterial; Polymer blends
ID SCAFFOLDS; CHITOSAN; FIBROIN; BLENDS; BIOMATERIALS; PROTEIN; FILMS
AB In this study, three-dimensional silk fibroin/chitosan (SF/CTS) composite sponges were successfully prepared with an interconnected porous structure and proper mechanical properties. Silk fibroin and chitosan have the potential to mimic a natural extra-cellular matrix (ECM). For the sponge preparation, silk fibroin from the Bombyx mori silkworm and chitosan were used, in different proportions, as composites. Sponges were prepared by means of freezing and lyophylization of corresponding composite solutions. The properties of composite sponges, such as the microstructure as well as the chemical and physical properties were studied. In the present investigation, silk fibroin, chitosan and their mixtures were characterized by attenuated total reflection Fourier transform infra-red spectroscopy (ATR-FTIR), swelling properties, thermogravimetric analysis and scanning electron microscopy (SEM). The ATR-FTIR analysis indicated a shift of band corresponding to C=O, C-N, C-O-C. Moreover, NH groups of SF and C=O and NH2 groups of chitosan might have participated in a specific intermolecular interaction among themselves. Thermogravimetric results suggested a higher temperature of decomposition for SF/CTS sponges than sponges made of pure silk fibroin or chitosan. Scanning electron microscopy observations showed the sponges of SF/CTS with pore size from 20 to 150 gm, which is appropriate for cell growth. Biocompatibility of sponges was confirmed by in vitro test. SF/CTS sponges have sufficient mechanical integrity to resist handling during implantation and in vivo loading. Both the compressive modulus and compressive strength for the sponge decrease with the increase of silk fibroin content in the sponge. Sponges made of silk fibroin/chitosan mixtures can be interesting materials for tissue engineering as scaffold for temporary supporting the formation of new tissue and organs. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Sionkowska, Alina; Planecka, Anna] Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
RP Sionkowska, A (reprint author), Nicholas Copernicus Univ, Fac Chem, Gagarin 7, PL-87100 Torun, Poland.
EM as@chem.uni.torun.pl
RI Sionkowska, Alina/I-5599-2014
FU Nicolaus Copernicus University Rector; COST Action [TD0903 EC]
FX Financial support from the Grant of Nicolaus Copernicus University
   Rector and COST Action TD0903 EC is gratefully acknowledged. The authors
   thank Prof. Tomasz Drewa and his group (Anna Bajek and Aldona
   Rynkiewicz) for in vitro study of silk fibroin/chitosan sponges.
CR Ajisawa A, 1998, J SERIC SCI JPN, V67, P91
   Babu M., 2007, RJTA, V2, P21
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de Moraes MA, 2010, POLYMERS-BASEL, V2, P719, DOI 10.3390/polym2040719
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Han J, 2010, INT J BIOL MACROMOL, V46, P199, DOI 10.1016/j.ijbiomac.2009.11.004
   Kearns V, 2008, TOPICS TISSUE ENG, V4, P1
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Lewandowska K, 2005, EUR POLYM J, V41, P55, DOI 10.1016/j.eurpolymj.2004.08.016
   Lewandowska K, 2011, THERMOCHIM ACTA, V517, P90, DOI 10.1016/j.tca.2011.01.036
   Lewandowska K, 2009, THERMOCHIM ACTA, V493, P42, DOI 10.1016/j.tca.2009.04.003
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Miranda ES, 2011, TISSUE ENG PT A, V17, P2663, DOI 10.1089/ten.tea.2010.0635
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Muzzarelli R. A. A., 1997, CHITIN HDB, P109
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Niemczyk A., 2011, ENG BIOMATERIALS, V109-111, P74
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sarkar K, 2011, J APPL POLYM SCI, V121, P2239, DOI 10.1002/app.33832
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sionkowska A, 2003, EUR POLYM J, V39, P2135, DOI 10.1016/S0014-3057(03)00161-7
   Sionkowska A., 2005, CURRENT TOPICS POLYM
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Thein-Han WW, 2009, JOM-US, V61, P41, DOI 10.1007/s11837-009-0131-6
   Vachiraroj N, 2009, INT J BIOL MACROMOL, V45, P470, DOI 10.1016/j.ijbiomac.2009.07.010
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   Yang B, 2010, CARBOHYD POLYM, V80, P860, DOI 10.1016/j.carbpol.2009.12.044
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 38
TC 47
Z9 50
U1 3
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
J9 J MOL LIQ
JI J. Mol. Liq.
PD FEB
PY 2013
VL 178
BP 5
EP 14
DI 10.1016/j.molliq.2012.10.042
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 079SN
UT WOS:000314192600002
DA 2018-10-20
ER

PT J
AU Xu, KR
   Ouberai, MM
   Welland, ME
AF Xu, Kairuo
   Ouberai, Myriam M.
   Welland, Mark E.
TI A comprehensive study of lysozyme adsorption using dual polarization
   interferometry and quartz crystal microbalance with dissipation
SO BIOMATERIALS
LA English
DT Article
DE Protein adsorption; DPI; QCM-D; Percentage solvation; Viscoelastic
   property; Protein orientation
ID EGG-WHITE LYSOZYME; SCANNING FORCE MICROSCOPY; BOVINE SERUM-ALBUMIN;
   PROTEIN ADSORPTION; CONFORMATIONAL-CHANGES; ADSORBED PROTEINS;
   HYDROPHOBIC SURFACES; KINETICS; SILICA; RESOLUTION
AB Protein adsorption plays a crucial role in biomaterial surface science as it is directly linked to the biocompatibility of artificial biomaterial devices. Here, elucidation of protein adsorption mechanism is effected using dual polarization interferometry and a quartz crystal microbalance to characterize lysozyme layer properties on a silica surface at different coverage values. Lysozyme is observed to adsorb from sparse monolayer to multilayer coverage. At low coverage an irreversibly adsorbed layer is formed with slight deformation consistent with side-on orientation. At higher coverage values dynamic re-orientation effects are observed which lead to monolayer surface coverages of 2-3 ng/mm(2) corresponding to edge-on or/and end-on orientations. These monolayer thickness values ranged between 3 and 4.5 nm with a protein density value of 0.60 g/mL and with 50 wt% solvent mass. Further increase of coverage results formation of a multilayer structure. Using the hydration content and other physical layer properties a tentative model lysozyme adsorption is proposed. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Xu, Kairuo; Ouberai, Myriam M.; Welland, Mark E.] Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB3 0FF, England.
RP Welland, ME (reprint author), Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB3 0FF, England.
EM mew10@cam.ac.uk
FU BBSRC [BB/H003843/1]; Biotechnology and Biological Sciences Research
   Council [BB/H003843/1]
FX This research was supported by the BBSRC (No. BB/H003843/1). We would
   also like to thank Dr Marcus Swann for the helpful discussions.
CR Adamczyk Z, 2011, LANGMUIR, V27, P6868, DOI 10.1021/la200798d
   Aissaoui N, 2012, LANGMUIR, V28, P656, DOI 10.1021/la2036778
   Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Arkles B, 2009, SILANES AND OTHER COUPLING AGENTS, VOL 5, P51
   BALL A, 1995, LANGMUIR, V11, P3542, DOI 10.1021/la00009a042
   Bellion M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/40/404226
   Bingen P, 2008, ANAL CHEM, V80, P8880, DOI 10.1021/ac8011686
   BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0
   Bon C, 1999, ACTA CRYSTALLOGR D, V55, P978, DOI 10.1107/S0907444998018514
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Daly SM, 2005, LANGMUIR, V21, P1328, DOI 10.1021/la048316y
   Daly SM, 2003, LANGMUIR, V19, P3848, DOI 10.1021/la026690x
   Donose BC, 2006, J COLLOID INTERF SCI, V299, P233, DOI 10.1016/j.jcis.2006.01.044
   Etheve J, 2002, LANGMUIR, V18, P1777, DOI 10.1021/la011224d
   Ferreira GNM, 2009, TRENDS BIOTECHNOL, V27, P689, DOI 10.1016/j.tibtech.2009.09.003
   Freeman NJ, 2004, J PHYS-CONDENS MAT, V16, pS2493, DOI 10.1088/0953-8984/16/26/023
   Galus S, 2011, ZYWN-NAUK TECHNOL JA, V18, P66
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   Kao P, 2011, BIOMATERIALS, V32, P969, DOI 10.1016/j.biomaterials.2010.09.075
   Karim K, 2007, ANAL CHEM, V79, P3023, DOI 10.1021/ac051254b
   Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331
   Kittle JD, 2011, BIOMACROMOLECULES, V12, P2881, DOI 10.1021/bm200352q
   Kubiak-Ossowska K, 2010, LANGMUIR, V26, P15954, DOI 10.1021/la102960m
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Lu JR, 2004, LANGMUIR, V20, P1827, DOI 10.1021/la0360299
   Lundin M, 2010, COLLOID SURFACE B, V77, P1, DOI 10.1016/j.colsurfb.2009.12.019
   McArthur MA, 2010, COLLOID SURFACE B, V81, P58, DOI 10.1016/j.colsurfb.2010.06.024
   Moore JD, 2011, BIOSENS BIOELECTRON, V26, P2940, DOI 10.1016/j.bios.2010.11.043
   Patel AR, 2009, J PHARM SCI-US, V98, P3108, DOI 10.1002/jps.21610
   Paul S, 2008, J PHYS CHEM C, V112, P11822, DOI 10.1021/jp800975t
   Pellenc D, 2008, LANGMUIR, V24, P9648, DOI 10.1021/la801246k
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   Ricard-Blum S, 2006, ANAL BIOCHEM, V352, P252, DOI 10.1016/j.ab.2006.02.011
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Robeson JL, 1996, LANGMUIR, V12, P6104, DOI 10.1021/la960476p
   RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041
   Saraiva AM, 2010, LANGMUIR, V26, P12060, DOI 10.1021/la101203h
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   Teichroeb JH, 2008, J COLLOID INTERF SCI, V325, P157, DOI 10.1016/j.jcis.2008.05.052
   Thompsett AR, 2007, BBA-PROTEINS PROTEOM, V1774, P920, DOI 10.1016/j.bbapap.2007.05.007
   Vidal CV, 2010, COLLOID SURFACE B, V80, P1, DOI 10.1016/j.colsurfb.2010.05.005
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   WAHLGREN M, 1995, J COLLOID INTERF SCI, V175, P506, DOI 10.1006/jcis.1995.1482
   Wertz CF, 2002, LANGMUIR, V18, P1190, DOI 10.1021/la0108813
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zwang TJ, 2012, LANGMUIR, V28, P9616, DOI 10.1021/la301718m
NR 49
TC 31
Z9 33
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2013
VL 34
IS 5
BP 1461
EP 1470
DI 10.1016/j.biomaterials.2012.10.078
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076AR
UT WOS:000313929400002
PM 23195491
DA 2018-10-20
ER

PT J
AU Khan, IM
   Francis, L
   Theobald, PS
   Perni, S
   Young, RD
   Prokopovich, P
   Conlan, RS
   Archer, CW
AF Khan, Ilyas M.
   Francis, Lewis
   Theobald, Peter S.
   Perni, Stefano
   Young, Robert D.
   Prokopovich, Polina
   Conlan, R. Steven
   Archer, Charles W.
TI In vitro growth factor-induced bio engineering of mature articular
   cartilage
SO BIOMATERIALS
LA English
DT Article
DE Articular cartilage; Postnatal maturation; Biochemical; Repair
ID ATOMIC-FORCE MICROSCOPY; FULL-THICKNESS DEFECTS; COLLAGEN NETWORK;
   PROTEOGLYCAN METABOLISM; FUNCTIONAL ADAPTATION; SUB-POPULATIONS; IGF-I;
   REPAIR; TISSUE; CHONDROCYTES
AB Articular cartilage maturation is the postnatal development process that adapts joint surfaces to their site-specific biomechanical demands. Maturation involves gross morphological changes that occur through a process of synchronised growth and resorption of cartilage and generally ends at sexual maturity. The inability to induce maturation in biomaterial constructs designed for cartilage repair has been cited as a major cause for their failure in producing persistent cell-based repair of joint lesions. The combination of growth factors FGF2 and TGF beta 1 induces accelerated articular cartilage maturation in vitro such that many molecular and morphological characteristics of tissue maturation are observable. We hypothesised that experimental growth factor-induced maturation of immature cartilage would result in a biophysical and biochemical composition consistent with a mature phenotype. Using native immature and mature cartilage as reference, we observed that growth factor-treated immature cartilages displayed increased nano-compressive stiffness, decreased surface adhesion, decreased water content, increased collagen content and smoother surfaces, correlating with a convergence to the mature cartilage phenotype. Furthermore, increased gene expression of surface structural protein collagen type I in growth factor-treated explants compared to reference cartilages demonstrates that they are still in the dynamic phase of the postnatal developmental transition. These data provide a basis for understanding the regulation of postnatal maturation of articular cartilage and the application of growth factor-induced maturation in vitro and in vivo in order to repair and regenerate cartilage defects. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.
C1 [Khan, Ilyas M.; Archer, Charles W.] Cardiff Univ, Sch Biosci, Div Pathophysiol & Repair, Cardiff CF10 3AX, S Glam, Wales.
   [Khan, Ilyas M.; Francis, Lewis; Conlan, R. Steven] Swansea Univ, Ctr Nanohlth, Inst Life Sci, Coll Med, Swansea SA2 8PP, W Glam, Wales.
   [Theobald, Peter S.; Prokopovich, Polina] Cardiff Univ, Sch Engn, Inst Med Engn & Med Phys, The Parade CF24 3AA, Wales.
   [Perni, Stefano] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
   [Young, Robert D.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF24 4LU, S Glam, Wales.
   [Prokopovich, Polina] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales.
RP Khan, IM (reprint author), Swansea Univ, Ctr Nanohlth, Inst Life Sci, Coll Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM i.m.khan@swansea.ac.uk
RI Perni, Stefano/B-8158-2009
OI Perni, Stefano/0000-0002-3101-0098; Khan, Ilyas/0000-0002-3886-1987;
   Young, Robert D./0000-0002-1452-6682; Conlan,
   Robert/0000-0002-2562-3461; Prokopovich, Polina/0000-0002-5700-9570;
   Theobald, Peter/0000-0002-3227-7130
FU Arthritis Research UK [ARUK:18871, ARUK:18461]
FX IK and CWA gratefully acknowledge Arthritis Research UK for funding this
   study (ARUK:18871). PP would like to acknowledge Arthritis Research UK
   (ARUK:18461).
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Asanbaeva A, 2008, BIOMECH MODEL MECHAN, V7, P263, DOI 10.1007/s10237-007-0096-8
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Bland YS, 1996, ANAT EMBRYOL, V194, P607
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Brama PAJ, 2000, EQUINE VET J, V32, P217, DOI 10.2746/042516400776563626
   Brama PAJ, 2002, EQUINE VET J, V34, P265, DOI 10.2746/042516402776186146
   Brommer H, 2005, EQUINE VET J, V37, P148, DOI 10.2746/0425164054223769
   Bueckle H, 1973, SCI HARDNESS TESTING
   Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fortier LA, 2005, EQUINE VET J, V37, P37, DOI 10.2746/0425164054406838
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Guilak F, 2006, ANN NY ACAD SCI, V1068, P498, DOI 10.1196/annals.1346.011
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Heim LO, 2004, LANGMUIR, V20, P2760, DOI 10.1021/la036128m
   HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103
   Hughes L C, 2005, Eur Cell Mater, V9, P68
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2009, ADV MATER, V21, P3419, DOI 10.1002/adma.200801957
   Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Khan IM, 2011, ARTHRITIS RHEUM-US, V63, P3417, DOI 10.1002/art.30543
   Komistek RD, 2005, J BIOMECH, V38, P215, DOI 10.1016/j.jbiomech.2004.02.041
   LaPrade RF, 2008, AM J SPORT MED, V36, P360, DOI 10.1177/0363546507308359
   Little CB, 1997, OSTEOARTHR CARTILAGE, V5, P49, DOI 10.1016/S1063-4584(97)80031-3
   Luckham PF, 2004, ADV COLLOID INTERFAC, V111, P29, DOI 10.1016/j.cis.2004.07.008
   Moroco JR, 1997, CELL TISSUE RES, V289, P119, DOI 10.1007/s004410050857
   MOSHURCHAK EM, 1978, J ANAT, V126, P605
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4, DOI 10.2106/00004623-199801000-00003
   Nathan S, 2003, TISSUE ENG, V9, P733, DOI 10.1089/107632703768247412
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Neu CP, 2010, ARTHRITIS RHEUM-US, V62, P2680, DOI 10.1002/art.27577
   Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606
   Oda JY, 2007, BIOGERONTOLOGY, V8, P345, DOI 10.1007/s10522-006-9076-0
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Prokopovich P, 2010, LANGMUIR, V26, P17028, DOI 10.1021/la102208y
   Sah R. L., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P393
   SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020
   San Martin S, 2003, CELL MOL BIOL, V49, P673
   SEQUEIRA MM, 1995, AM J EPIDEMIOL, V142, P989, DOI 10.1093/oxfordjournals.aje.a117748
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/NNANO.2008.410, 10.1038/nnano.2008.410]
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5
   Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322
NR 56
TC 22
Z9 23
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2013
VL 34
IS 5
BP 1478
EP 1487
DI 10.1016/j.biomaterials.2012.09.076
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076AR
UT WOS:000313929400004
PM 23182922
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Unadkat, HV
   Groen, N
   Doorn, J
   Fischer, B
   Barradas, AMC
   Hulsman, M
   van de Peppel, J
   Moroni, L
   van Leeuwen, JP
   Reinders, MJT
   van Blitterswijk, CA
   de Boer, J
AF Unadkat, H. V.
   Groen, N.
   Doorn, J.
   Fischer, B.
   Barradas, A. M. C.
   Hulsman, M.
   van de Peppel, J.
   Moroni, L.
   van Leeuwen, J. P.
   Reinders, M. J. T.
   van Blitterswijk, C. A.
   de Boer, J.
TI High content imaging in the screening of biomaterial-induced MSC
   behavior
SO BIOMATERIALS
LA English
DT Article
DE Cell morphology; Gene expression; Mesenchymal stem cell; Molecular
   imaging; Polylactic acid; Surface roughness
ID EMBRYONIC STEM-CELLS; PROGENITOR CELLS; DIFFERENTIATION; LINEAGE;
   MICROARRAYS; EXPRESSION; INTERFACE; PHENOTYPE; GROWTH; FATE
AB Upon contact with a biomaterial, cells and surrounding tissues respond in a manner dictated by the physicochemical and mechanical properties of the material. Traditionally, cellular responses are monitored using invasive analytical methods that report the expression of genes or proteins. These analytical methods involve assessing commonly used markers for a predefined readout, masking the actual situation induced in the cells. Hence, a broader expression profile of the cellular response should be envisioned, which technically limits up scaling to higher throughput systems. However, it is increasingly recognized that morphometric readouts, obtained non-invasively, are related to gene expression patterns. Here, we introduced distinct surface roughness to three PLA surfaces, by exposure to oxygen plasma of different duration times. The response of mesenchymal stromal cells was compared to smooth untreated PLA surfaces without the addition of differentiation agents. Morphological and genome wide expression profiles revealed underlying cellular changes which was hidden for the commonly used gene markers for osteo-, chondro- and adipogenesis. Using 3 morphometric parameters, obtained by high content imaging, we were able to build a classifier and discriminate between oxygen plasma-induced modified sheets and non-modified PLA sheets where evaluating classical candidates missed this effect. This approach shows the feasibility to use noninvasive morphometric data in high-throughput systems to screen biomaterial surfaces indicating the underlying genetic biomaterial-induced changes. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Unadkat, H. V.; Groen, N.; Doorn, J.; Fischer, B.; Barradas, A. M. C.; Moroni, L.; van Blitterswijk, C. A.; de Boer, J.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Unadkat, H. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.
   [Hulsman, M.; Reinders, M. J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands.
   [van de Peppel, J.; van Leeuwen, J. P.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands.
RP de Boer, J (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM j.deboer@utwente.nl
RI Moroni, Lorenzo/D-2826-2014; Unadkat, Hemant/E-7827-2012
OI Moroni, Lorenzo/0000-0003-1298-6025; Unadkat,
   Hemant/0000-0002-6916-3874; van Blitterswijk,
   Clemens/0000-0003-2371-4615; Barradas, Ana/0000-0003-4221-8879; van
   Leeuwen, Johannes/0000-0002-2282-4006
FU Marie Curie Early Stage training program JOIN(ed)T; STW; TeRM; BMM
   program
FX The authors acknowledge the Marie Curie Early Stage training program
   JOIN(ed)T for funding of H.U., STW for funding JdB, TeRM for A.B. and
   J.D. and the BMM program for N.G. We wish to acknowledge Anne Carpenter
   and colleagues for their kind assistance with CellProfiler software, Dr.
   Auke Renard from Medisch Spectrum Twente for kindly providing us with
   bone marrow aspirates, Andre Uitterlinden for access to and assistance
   with Illumina microarray facility. We are also grateful to Vinod
   Subramaniam, Martin Bennink and Kim Sweers for assistance with atomic
   force microscopy and Dr. Rene Kalio from Folienwerk Wolfen GmbH (Wolfen,
   Germany) for kindly providing the materials.
CR Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Glowacki J, 1983, P SOC EXP BIOL MED, V172
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Logan DJ, 2010, J BIOMOL SCREEN, V15, P840, DOI 10.1177/1087057110370895
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mahmood TA, 2006, BIOMACROMOLECULES, V7, P3012, DOI 10.1021/bm060489+
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tare RS, 2009, BIOMATERIALS, V30, P1045, DOI 10.1016/j.biomaterials.2008.10.038
   Tourovskaia A, 2006, NAT PROTOC, V1, P1092, DOI 10.1038/nprot.2006.123
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 30
TC 8
Z9 8
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2013
VL 34
IS 5
BP 1498
EP 1505
DI 10.1016/j.biomaterials.2012.10.035
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076AR
UT WOS:000313929400006
PM 23182347
DA 2018-10-20
ER

PT J
AU Rim, NG
   Shin, CS
   Shin, H
AF Rim, Nae Gyune
   Shin, Choongsoo S.
   Shin, Heungsoo
TI Current approaches to electrospun nanofibers for tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ELECTRICALLY CONDUCTING POLYMER; SURFACE
   MODIFICATION; OSTEOGENIC DIFFERENTIATION; IN-VITRO;
   EXTRACELLULAR-MATRIX; BONE-FORMATION; DRUG-DELIVERY; BIOMEDICAL
   APPLICATIONS; ELECTROMAGNETIC-FIELDS
AB The ultimate goal of tissue engineering is to replace damaged tissues by applying engineering technology and the principles of life sciences. To successfully engineer a desirable tissue, three main elements of cells, scaffolds and growth factors need to be harmonized. Biomaterial-based scaffolds serve as a critical platform both to support cell adhesion and to deliver growth factors. Various methods of fabricating scaffolds have been investigated. One recently developed method that is growing in popularity is called electrospinning. Electrospinning is known for its capacity to make fibrous and porous structures that are similar to natural extracellular matrix (ECM). Other advantages to electrospinning include its ability to create relatively large surface to volume ratios, its ability to control fiber size from micro- to nano-scales and its versatility in material choice. Although early work with electrospun fibers has shown promise in the regeneration of certain types of tissues, further modification of their chemical, biological and mechanical properties would permit future advancements. In this paper, current approaches to the development of modular electrospun fibers as scaffolds for tissue engineering are discussed. Their chemical and physical characteristics can be tuned for the regeneration of specific target tissues by co-spinning of multiple materials and by post-modification of the surface of electrospun fibers. In addition, topology or structure can also be controlled to elicit specific responses from cells and tissues. The selection of proper polymers, suitable surface modification techniques and the control of the dimension and arrangement of the fibrous structure of electrospun fibers can offer versatility and tissue specificity, and therefore provide a blueprint for specific tissue engineering applications.
C1 [Rim, Nae Gyune; Shin, Heungsoo] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.
   [Shin, Choongsoo S.] Sogang Univ, Dept Mech Engn, Seoul 121742, South Korea.
   [Shin, Heungsoo] Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea.
   [Shin, Heungsoo] Hanyang Univ, Inst Aging Soc, Seoul 133791, South Korea.
RP Shin, CS (reprint author), Sogang Univ, Dept Mech Engn, 1 Shinsu Dong, Seoul 121742, South Korea.
EM cshin@sogang.ackr; hshin@hanyang.ac.kr
FU Hanyang University Institute of Aging Society [HY-2010-T]
FX This study was supported by a research grant from Hanyang University
   Institute of Aging Society in 2010 (HY-2010-T).
CR AARON RK, 1993, J CELL BIOCHEM, V52, P42, DOI 10.1002/jcb.240520107
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Gizdavic-Nikolaidis M, 2010, MACROMOL BIOSCI, V10, P1424, DOI 10.1002/mabi.201000237
   Goldman R, 1996, BIOELECTROMAGNETICS, V17, P450, DOI 10.1002/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2
   Guimaraes A, 2010, NANOMEDICINE-UK, V5, P539, DOI [10.2217/nnm.10.31, 10.2217/NNM.10.31]
   Guo Y, 2007, BIOMACROMOLECULES, V8, P3025, DOI 10.1021/bm070266z
   Hajiali H, 2011, INT J NANOMED, V6, P2133, DOI 10.2147/IJN.S24312
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Jeong SI, 2004, BIOMACROMOLECULES, V5, P1303, DOI 10.1021/bm049921i
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jha BS, 2011, J NANOMATER, DOI 10.1155/2011/348268
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Ji W, 2010, ACTA BIOMATER, V6, P4199, DOI 10.1016/j.actbio.2010.05.025
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Jun Z, 2005, E-POLYMERS, V2005, P038
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim MS, 2010, TISSUE ENG PT A, V16, P2999, DOI [10.1089/ten.tea.2009.0828, 10.1089/ten.TEA.2009.0828]
   Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kwon IK, 2001, J BIOMAT SCI-POLYM E, V12, P1147, DOI 10.1163/15685620152691904
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Lee JH, 2011, MACROMOL RES, V19, P172, DOI 10.1007/s13233-011-0206-4
   Li H, 2010, J BIOMAT SCI-POLYM E, V21, P803, DOI 10.1163/156856209X445302
   Li JX, 2006, BIOMACROMOLECULES, V7, P2243, DOI 10.1021/bm0603342
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li XQ, 2009, J APPL POLYM SCI, V111, P1564, DOI 10.1002/app.29056
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liao IC, 2009, J CONTROL RELEASE, V139, P48, DOI 10.1016/j.jconrel.2009.06.007
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lode A, 2008, J BIOMED MATER RES A, V86A, P749, DOI 10.1002/jbm.a.31581
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   McGonigle JS, 2008, J BIOMAT SCI-POLYM E, V19, P1021, DOI 10.1163/156856208784909381
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nho YC, 2004, RADIAT PHYS CHEM, V71, P239, DOI 10.1016/j.radphyschem.2004.03.046
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Ou JF, 2009, APPL SURF SCI, V256, P894, DOI 10.1016/j.apsusc.2009.08.081
   Pa JH, 2001, MACROMOL CHEM PHYS, V202, P985, DOI 10.1002/1521-3935(20010401)202:7<985::AID-MACP985>3.0.CO;2-2
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Park H, 2007, MACROMOL RES, V15, P238, DOI 10.1007/BF03218782
   Park JS, 2007, MACROMOL RES, V15, P424, DOI 10.1007/BF03218809
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   POLITIS MJ, 1989, NEUROSURGERY, V25, P71, DOI 10.1227/00006123-198907000-00012
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Shin YM, 2008, BIOMACROMOLECULES, V9, P1772, DOI 10.1021/bm701410g
   Shin YM, 2010, MACROMOL RES, V18, P472, DOI 10.1007/s13233-010-0507-z
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   SISKEN BF, 1993, J CELL BIOCHEM, V51, P404, DOI 10.1002/jcb.2400510404
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Wu BM, 1996, J CONTROL RELEASE, V40, P77, DOI 10.1016/0168-3659(95)00173-5
   Xi ZY, 2009, J MEMBRANE SCI, V327, P244, DOI 10.1016/j.memsci.2008.11.037
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Yoon H, 2011, J PHARM SCI-US, V100, P424, DOI 10.1002/jps.22310
   Zander NE, 2012, ACS APPL MATER INTER, V4, P2074, DOI 10.1021/am300045y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhang YZ, 2004, CHEM MATER, V16, P3406, DOI 10.1021/cm049580f
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
   Zong XH, 2002, ABSTR PAP AM CHEM S, V224, pU466
NR 115
TC 96
Z9 100
U1 2
U2 142
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2013
VL 8
IS 1
SI SI
AR 014102
DI 10.1088/1748-6041/8/1/014102
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 078QU
UT WOS:000314115100003
PM 23472258
DA 2018-10-20
ER

PT J
AU Xu, WJ
   Atala, A
   Yoo, JJ
   Lee, SJ
AF Xu, Weijie
   Atala, Anthony
   Yoo, James J.
   Lee, Sang Jin
TI Controllable dual protein delivery through electrospun fibrous scaffolds
   with different hydrophilicities
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; GROWTH-FACTOR DELIVERY; REGENERATIVE
   MEDICINE; VASCULAR GRAFT; NANOFIBERS; RELEASE; FIBERS; ANGIOGENESIS;
   SYSTEM
AB Tissue engineered scaffolds should actively participate not only in structural support but also in functional tissue regeneration. Thus, novel smart biomaterial scaffolds have been developed, which incorporate a variety of bioactive molecules to accelerate neo-tissue formation. The effective delivery of multiple bioactive molecules with distinct kinetics to target sites at an appropriate concentration and in a timely manner is desired to drive tissue development to completion. To achieve effective, controllable delivery of multiple factors, a dual protein delivery system has been developed by electrospinning poly(lactide-co-glycolide) (PLGA) with different hydrophilicities. Bovine serum albumin or myoglobin was incorporated into and released gradually from these electrospun fibrous PLGA scaffolds. All the scaffolds exhibited similar loading efficiencies of approximately 80% of the target proteins. The introduction of Pluronic F-127 (PF127) dramatically increased scaffold hydrophilicity, which affected the release kinetics of these proteins from the scaffolds. Furthermore, distinct protein release patterns were achieved when using dual protein-loaded scaffolds with different hydrophilicities when these scaffolds were fabricated by co-electrospinning. This system may be useful as a method for delivering multiple bioactive vehicles for tissue engineering applications.
C1 [Xu, Weijie; Atala, Anthony; Yoo, James J.; Lee, Sang Jin] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Xu, WJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM sjlee@wakehealth.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160; Lee, Sang Jin/0000-0002-3899-1909
FU Department of Energy [DE-FG02-09ER64711]; Telemedicine and Advanced
   Technology Research Center (TATRC) at the US Army Medical Research and
   Material Command (USAMRMC) [W81XWH-07-10718]
FX We would like to thank Dr Jennifer Olson for editorial assistance. This
   study was supported, in part, by the Department of Energy
   (DE-FG02-09ER64711) and the Telemedicine and Advanced Technology
   Research Center (TATRC) at the US Army Medical Research and Material
   Command (USAMRMC) through award W81XWH-07-10718.
CR Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Burger C, 2006, ANNU REV MATER RES, V36, P333, DOI 10.1146/annurev.matsci.36.011205.123537
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Cheng DX, 2009, TISSUE ENG PT A, V15, P1929, DOI 10.1089/ten.tea.2008.0470
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gupta RK, 1997, VACCINE, V15, P672, DOI 10.1016/S0264-410X(96)00233-2
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2009, J BIOMED MATER RES A, V90A, P205, DOI 10.1002/jbm.a.32081
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Lee SJ, 2012, HANDBOOK OF INTELLIGENT SCAFFOLDS FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P201
   Liao IC, 2009, J CONTROL RELEASE, V139, P48, DOI 10.1016/j.jconrel.2009.06.007
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Oh SH, 2012, J BIOMAT SCI-POLYM E, V23, P1673, DOI 10.1163/092050611X589518
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Su Y, 2009, COLLOID SURFACE B, V73, P376, DOI 10.1016/j.colsurfb.2009.06.009
   WALDMANN TA, 1977, ALBUMIN STRUCTURE FU, P255
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Xu XL, 2008, EUR J PHARM BIOPHARM, V70, P165, DOI 10.1016/j.ejpb.2008.03.010
NR 31
TC 18
Z9 18
U1 2
U2 69
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2013
VL 8
IS 1
SI SI
AR 014104
DI 10.1088/1748-6041/8/1/014104
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 078QU
UT WOS:000314115100005
PM 23353662
DA 2018-10-20
ER

PT J
AU Lombardi, AV
   Berend, KR
   Adams, JB
   Jefferson, RC
   Sneller, MA
AF Lombardi, Adolph V., Jr.
   Berend, Keith R.
   Adams, Joanne B.
   Jefferson, Ryan C.
   Sneller, Michael A.
TI Smoking May Be a Harbinger of Early Failure With Ultraporous Metal
   Acetabular Reconstruction
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID POROUS TANTALUM BIOMATERIAL; REVISION HIP-ARTHROPLASTY; HOST BONE
   CONTACT; TRABECULAR METAL; FOLLOW-UP; POSTOPERATIVE COMPLICATIONS;
   PELVIC DISCONTINUITY; RADIOLOGICAL EVALUATION; PERIOPERATIVE SMOKING;
   WOUND-INFECTION
AB Smoking is considered a risk factor for surgical complications in total hip arthroplasty (THA) and has been linked to a higher rate of aseptic loosening in uncemented acetabular components. Acetabular reconstruction with newer ultraporous metals in both complex primary and revision THA has increased survivorship but it is unclear whether smoking affects survival of these implants.
   We reviewed our early experience with THA using ultraporous acetabular components to assess the incidence and etiology of early failure and examine if any preoperative variables, including smoking, related to failure.
   We used ultraporous acetabular components in 498 patients (534 hips), beginning with one case each in 1999 and 2004, 17 in 2005, and the majority from 2006 through March 2010. There were 159 complex primary and 375 revision cases. Of these patients, 17% were smokers (averaging 35 pack-years), 31% previous smokers (averaging 29 pack-years), 41% nonsmokers, and 1% unknown. Failure modes possibly related to smoking were infection, aseptic loosening, or periacetabular fracture and unrelated were dislocation and implant breakage. Minimum followup was 1 month (average, 32 months; range, 1-78 months).
   There were 34 cup failures (6%): 17 infections, 14 aseptic loosening, and one each liner breakage, dislocation, and periacetabular fracture. The failure rate (uncontrolled for potentially confounding variables) was 10% in both current (9 of 89) and prior smokers (17 of 167) and 3% in nonsmokers 8 of 271).
   With ultraporous metal technology in complex primary and revision THA, smoking, both past and current, may be a risk factor for early failure.
   Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
C1 [Lombardi, Adolph V., Jr.; Berend, Keith R.; Adams, Joanne B.; Jefferson, Ryan C.; Sneller, Michael A.] Joint Implant Surg Inc, New Albany, OH USA.
   [Lombardi, Adolph V., Jr.; Berend, Keith R.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA.
   [Lombardi, Adolph V., Jr.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.
   [Lombardi, Adolph V., Jr.; Berend, Keith R.] Mt Carmel Hlth Syst, New Albany, OH USA.
RP Lombardi, AV (reprint author), Joint Implant Surg Inc, New Albany, OH USA.
EM lombardiav@joint-surgeons.com
FU Biomet; Stryker (Mahwah, NJ, USA); Piedmont Orthopaedic Society (Durham,
   NC, USA)
FX One of the authors (AVL) certifies that he has or may receive payments
   or benefits, in any one year, an amount in excess of USD 1,000,000, from
   Biomet, Inc (Warsaw, IN, USA) and Innomed, Inc (Savannah, GA, USA). One
   of the authors (KRB) certifies that he has or may receive payments or
   benefits, in any one year, an amount in excess of USD 1,000,000, from
   Biomet, Inc. The institution of the authors has received institutional
   research support from Biomet, Stryker (Mahwah, NJ, USA), and a grant
   from the Piedmont Orthopaedic Society (Durham, NC, USA).
CR AbdelSalam H, 2012, J ARTHROPLASTY, V27, P720, DOI 10.1016/j.arth.2011.09.027
   [Anonymous], BOD MEAS
   Argintar E, 2012, J AM ACAD ORTHOP SUR, V20, P359, DOI 10.5435/JAAOS-20-06-359
   Azodi OS, 2006, J BONE JOINT SURG BR, V88B, P1316, DOI 10.1302/0301-620X.88B10.17957
   Baad-Hansen T, 2011, ACTA ORTHOP, V82, P155, DOI 10.3109/17453674.2011.572251
   Alfaro JJB, 2010, HIP INT, V20, pS119, DOI 10.5301/HIP.2010.5297
   Blumenfeld TJ, 2012, CLIN ORTHOP RELAT R, V470, P435, DOI 10.1007/s11999-011-2075-8
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Chassanidis CG, 2012, J BONE JOINT SURG BR, V94B, P1427, DOI 10.1302/0301-620X.94B10.28405
   Davies JH, 2011, J ARTHROPLASTY, V26, P1245, DOI 10.1016/j.arth.2011.02.022
   Del Gaizo DJ, 2012, CLIN ORTHOP RELAT R, V470, P395, DOI 10.1007/s11999-011-2170-x
   Fernandez-Fairen M, 2010, J ARTHROPLASTY, V25, P865, DOI 10.1016/j.arth.2009.07.027
   Fini M, 2011, J BONE MINER METAB, V29, P633, DOI 10.1007/s00774-011-0309-1
   Flecher X, 2010, ORTHOP TRAUMATOL-SUR, V96, P235, DOI 10.1016/j.otsr.2009.11.014
   Flecher X, 2008, J ARTHROPLASTY, V23, P949, DOI 10.1016/j.arth.2007.08.019
   Gross AE, 2005, J ARTHROPLASTY, V20, P91, DOI 10.1016/j.arth.2005.03.020
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Hasart O, 2010, OPER ORTHOP TRAUMATO, V22, P268, DOI 10.1007/s00064-010-8026-9
   Hawn MT, 2011, ANN SURG, V254, P914, DOI 10.1097/SLA.0b013e31822d7f81
   Hoogendoorn JM, 2002, UNFALLCHIRURG, V105, P76, DOI 10.1007/s113-002-8170-8
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   Kim WY, 2008, HIP INT, V18, P17, DOI 10.5301/HIP.2008.285
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kosashvili Y, 2009, J BONE JOINT SURG BR, V91B, P870, DOI 10.1302/0301-620X.91B7.22181
   Kosashvili Y, 2010, CLIN ORTHOP RELAT R, V468, P466, DOI 10.1007/s11999-009-0935-2
   Kostakos AT, 2010, J ARTHROPLASTY, V25, P35, DOI 10.1016/j.arth.2008.09.027
   Kwiatkowski T C, 1996, Am J Orthop (Belle Mead NJ), V25, P590
   Kwong FNK, 2008, J AM ACAD ORTHOP SUR, V16, P619, DOI 10.5435/00124635-200811000-00001
   Lachiewicz PF, 2010, CLIN ORTHOP RELAT R, V468, P454, DOI 10.1007/s11999-009-0940-5
   Lakstein D, 2009, CLIN ORTHOP RELAT R, V467, P2318, DOI 10.1007/s11999-009-0772-3
   Lavernia CJ, 1999, CLIN ORTHOP RELAT R, P172
   Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d
   Lingaraj K, 2009, J BONE JOINT SURG BR, V91B, P1555, DOI 10.1302/0301-620X.91B12.22517
   Macheras GA, 2010, J BONE JOINT SURG BR, V92B, P624, DOI 10.1302/0301-620X.92B5.23256
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Malkani AL, 2009, J ARTHROPLASTY, V24, P1068, DOI 10.1016/j.arth.2008.07.008
   Markuszewski Jacek, 2011, Chir Narzadow Ruchu Ortop Pol, V76, P197
   Meldrum Russell D, 2005, Iowa Orthop J, V25, P17
   Moghaddam A, 2010, INJURY, V41, P1020, DOI 10.1016/j.injury.2010.03.014
   Moller AM, 2003, J BONE JOINT SURG BR, V85B, P178, DOI 10.1302/0301-620X.85B2.13717
   Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5
   Myles PS, 2002, ANESTHESIOLOGY, V97, P842, DOI 10.1097/00000542-200210000-00015
   Nakashima Y, 2012, MOD RHEUMATOL
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Paprosky W G, 1994, J Arthroplasty, V9, P33, DOI 10.1016/0883-5403(94)90135-X
   Paprosky WG, 2005, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.000194311.20901.f9
   Pierannunzii L, 2011, INT J IMMUNOPATH PH, V24, P133, DOI 10.1177/03946320110241S225
   Porter S E, 2001, J Am Acad Orthop Surg, V9, P9
   Ramappa M, 2009, HIP INT, V19, P239
   Rose PS, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000238854.16121.a3
   Siegmeth A, 2009, CLIN ORTHOP RELAT R, V467, P199, DOI 10.1007/s11999-008-0549-0
   SILVERSTEIN P, 1992, AM J MED, V93, pS22, DOI 10.1016/0002-9343(92)90623-J
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   Singh JA, 2011, ARTHRIT CARE RES, V63, P1365, DOI 10.1002/acr.20555
   Singh JA, 2011, J RHEUMATOL, V38, P1824, DOI 10.3899/jrheum.101221
   Skytta ET, 2011, J ARTHROPLASTY, V26, P342, DOI 10.1016/j.arth.2010.01.106
   Sloan A, 2010, SURG-J R COLL SURG E, V8, P111, DOI 10.1016/j.surge.2009.10.014
   Sorensen LT, 2012, ANN SURG, V255, P1069, DOI 10.1097/SLA.0b013e31824f632d
   Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5
   Sorensen LT, 2003, ANN SURG, V238, P1, DOI 10.1097/01.SLA.0000074980.39700.31
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   Sporer SM, 2006, J ARTHROPLASTY, V21, P87, DOI 10.1016/j.arth.2006.05.015
   Sternheim A, 2012, J BONE JOINT SURG BR, V94B, P158, DOI 10.1302/0301-620X.94B2.27871
   Thomsen T, 2009, BRIT J SURG, V96, P451, DOI 10.1002/bjs.6591
   Tonnesen H, 2009, BRIT J ANAESTH, V102, P297, DOI 10.1093/bja/aen401
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Van Kleunen JP, 2009, J ARTHROPLASTY, V24, P64, DOI 10.1016/j.arth.2009.02.001
   Weeden SH, 2006, J BONE JOINT SURG AM, V88A, P1266, DOI 10.2106/JBJS.E.00540
   Weeden SH, 2007, J ARTHROPLASTY, V22, P151, DOI 10.1016/j.arth.2007.04.024
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
NR 76
TC 9
Z9 10
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD FEB
PY 2013
VL 471
IS 2
BP 486
EP 497
DI 10.1007/s11999-012-2748-y
PG 12
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 074FO
UT WOS:000313798500022
PM 23292885
OA Green Published
DA 2018-10-20
ER

PT J
AU Amruthwar, SS
   Janorkar, AV
AF Amruthwar, Shruti S.
   Janorkar, Amol V.
TI In vitro evaluation of elastin-like polypeptide-collagen composite
   scaffold for bone tissue engineering
SO DENTAL MATERIALS
LA English
DT Article
DE Elastin-like polypeptide; Collagen; Composite; Osteoblast; Tissue
   engineering
ID DRUG-DELIVERY; HYDROGELS; CELLS; DIFFERENTIATION; DESIGN;
   HYDROXYAPATITE; REGENERATION; BIOMATERIAL; FABRICATION; CONSTRUCTS
AB Objectives. Collagen and elastin are two key structural proteins found in the extra-cellular matrices (ECMs) of most tissues, yet very little is known about the response of bone cells to elastin or its derivatives. Recently, we have designed and characterized a novel class of ECM-based composite scaffolds with collagen and a genetically engineered polymer, elastin-like polypeptide (ELP) and subsequently showed their superior mechanical properties and drug release characteristics compared to collagen scaffolds. The objective of this research was to evaluate osteoblast growth and expression on these composite scaffolds.
   Methods. A thorough biochemical and morphological characterization was performed on MC3T3-E1 pre-osteoblast cells cultured on collagen and ELP-collagen scaffolds. Cell viability was assessed using a live/dead assay. Total DNA content of all cells present on various surfaces was quantified. Pre-osteoblast differentiation was assessed by measuring the alkaline phosphatase and osteocalcin production. Mineral deposition by the cultured cells was visualized using the Von Kossa stain.
   Results. Our results showed that the ELP-collagen scaffolds were suitable substrates for cell culture that allowed MC3T3-E1 pre-osteoblast cell attachment, differentiation, and subsequent mineralization over a period of 3 weeks. The ELP-collagen scaffolds displayed equivalent biocompatibility and cell-interacting properties to those of the neat collagen scaffolds.
   Significance. The novel ELP-collagen composite material may have future implications as a scaffold material for bone tissue engineering applications, for example, the treatment of alveolar bone loss. (c) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Amruthwar, Shruti S.; Janorkar, Amol V.] Univ Mississippi, Med Ctr, Sch Dent, Dept Biomed Mat Sci, 2500 N State St, Jackson, MS 39216 USA.
RP Janorkar, AV (reprint author), Univ Mississippi, Med Ctr, Sch Dent, Dept Biomed Mat Sci, 2500 N State St, Jackson, MS 39216 USA.
EM ajanorkar@umc.edu
FU School of Dentistry
FX Based on a thesis submitted to the graduate faculty, University of
   Mississippi Medical Center, in partial fulfillment of the requirements
   for the M.S. degree. Financial support for this work by the School of
   Dentistry through the new faculty startup funding and the intramural
   research support program is gratefully acknowledged. Authors thank Dr.
   Aaron D. Puckett for his help in mechanical testing and Dr. Roger A.
   Johnson for his help in the planning of the cell culture experiments.
   This work made use of various instruments in the Department of
   Biomedical Materials Science User Facility.
CR Amruthwar SS, J BIOMEDICAL A UNPUB
   Angwarawong T, 2011, DENT MATER J, V30, P158, DOI 10.4012/dmj.2010-097
   Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Canciani E, 2010, DENT MATER, V26, pe66
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   CASSERBETTE M, 1990, CALCIFIED TISSUE INT, V46, P46, DOI 10.1007/BF02555824
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Degoricija L, 2008, BIOMACROMOLECULES, V9, P2863, DOI 10.1021/bm800658x
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023
   Gao CX, 2012, J BIOMED MATER RES A, V100A, P1324, DOI 10.1002/jbm.a.34072
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Kao Solon T, 2007, Oral Maxillofac Surg Clin North Am, V19, P513, DOI 10.1016/j.coms.2007.06.002
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lee Kang-Ho, 2010, J Periodontal Implant Sci, V40, P96, DOI 10.5051/jpis.2010.40.2.96
   Li Q, 2006, BIOMATERIALS, V27, P1027, DOI 10.1016/j.biomaterials.2005.07.019
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Rosa AL, 2008, EXPERT REV MED DEVIC, V5, P719, DOI 10.1586/17434440.5.6.719
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Streubel A, 2000, J CONTROL RELEASE, V69, P455, DOI 10.1016/S0168-3659(00)00334-5
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Weir MD, 2010, J BIOMED MATER RES A, V94A, P223, DOI 10.1002/jbm.a.32665
   Xu HHK, 2010, J DENT RES, V89, P1482, DOI 10.1177/0022034510384623
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zarate-Kalfopulos Baron, 2006, Cir Cir, V74, P217
NR 49
TC 31
Z9 31
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD FEB
PY 2013
VL 29
IS 2
BP 211
EP 220
DI 10.1016/j.dental.2012.10.003
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 073LV
UT WOS:000313745400012
PM 23127995
DA 2018-10-20
ER

PT J
AU Grech, L
   Mallia, B
   Camilleri, J
AF Grech, L.
   Mallia, B.
   Camilleri, J.
TI Investigation of the physical properties of tricalcium silicate
   cement-based root-end filling materials
SO DENTAL MATERIALS
LA English
DT Article
DE Bioaggregate; Biodentine; Dental materials; Micro-hardness; Root-end
   filling materials; Setting time; Tricalcium silicate cement; Washout
   resistance
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO BIOACTIVITY; SELF-SETTING
   PROPERTIES; WHITE PORTLAND-CEMENT; COMPOSITE BONE-CEMENT; SURFACE
   MICROHARDNESS; DENTAL BIOMATERIAL; PROROOT MTA; SERUM; TIME
AB Objective. Tricalcium silicate-based cements have been displayed as suitable root-end filling materials. The physical properties of prototype radiopacified tricalcium silicate cement, Bioaggregate and Biodentine were investigated. Intermediate restorative material was used as a control.
   Methods. The physical properties of a prototype zirconium oxide replaced tricalcium silicate cement and two proprietary cements composed of tricalcium silicate namely Bioaggregate and Biodentine were investigated. Intermediate restorative material (IRM) was used as a control. Radiopacity assessment was undertaken and expressed in thickness of aluminum. In addition the anti-washout resistance was investigated using a novel basket-drop method and the fluid uptake, sorption and solubility were investigated using a gravimetric method. The setting time was assessed using an indentation technique and compressive strength and micro-hardness of the test materials were investigated. All the testing was performed with the test materials immersed in Hank's balanced salt solution.
   Results. All the materials tested had a radiopacity value higher than 3 mm thickness of aluminum. IRM exhibited the highest radiopacity. Biodentine demonstrated a high washout, low fluid uptake and sorption values, low setting time and superior mechanical properties. The fluid uptake and setting time was the highest for Bioaggregate.
   Significance. The addition of admixtures to tricalcium silicate-based cements affects the physical properties of the materials. (c) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Grech, L.; Mallia, B.] Univ Malta, Fac Engn, Dept Met & Mat Engn, MSD-2090 Msida, Malta.
   [Camilleri, J.] Univ Malta, Fac Dent Surg, Dept Restorat Dent, MSD-2090 Msida, Malta.
RP Camilleri, J (reprint author), Univ Malta, Sch Med, Mater Dei Hosp, Fac Dent Surg,Dept Restorat Dent, MSD-2090 Msida, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365; Mallia,
   Bertram/0000-0002-4719-0855
FU Faculty of Dental Surgery; Research Grant Committee, University of Malta
FX The Faculty of Dental Surgery and the Research Grant Committee,
   University of Malta for funding; Mineral Research Processing, Septodont
   and Verio Dental Co. Ltd for the materials; Mr Nicholas Azzopardi of the
   Department of Civil and Structural Engineering, Faculty for the Built
   Environment and Mr. Luke Formosa of the Department of Metallurgy and
   Materials Engineering, Faculty of Engineering, University of Malta for
   their assistance.
CR Achternbosch M., 2003, HEAVY METALS CEMENT
   [Anonymous], 2010, BIOD SCI FIL ACT BIO
   Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012
   BioCeramix, 2011, BIOAGGR
   Bortoluzzi EA, 2009, J ENDODONT, V35, P550, DOI 10.1016/j.joen.2008.12.018
   Bramante CM, 2008, ORAL SURG ORAL MED O, V106, P909, DOI 10.1016/j.tripleo.2008.07.018
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2010, INT ENDOD J, V43, P231, DOI 10.1111/j.1365-2591.2009.01670.x
   Camilleri J, 2012, INT ENDOD J, V5, P737
   Chen CC, 2009, J ENDODONT
   Chong BS, 2003, INT ENDOD J, V36, P520, DOI 10.1046/j.1365-2591.2003.00682.x
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   De-Deus G, 2009, J ENDODONT, V35, P887, DOI 10.1016/j.joen.2009.03.003
   Duarte MAH, 2005, ORAL SURG ORAL MED O, V99, P648, DOI 10.1016/j.tripleo.2004.09.015
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Formosa LM, INT ENDODON IN PRESS
   Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133
   Huan ZG, 2008, J MATER SCI-MATER M, V19, P2913, DOI 10.1007/s10856-008-3423-4
   Huan ZG, 2007, J BIOMED MATER RES B, V82B, P352, DOI 10.1002/jbm.b.30740
   International Standards Organization, 2009, 4049 ISO
   International Standards Organization, 2007, 99171 ISO
   International Standards Organization, 2001, 6876 ISO
   Kang JS, 2012, SCANNING, V34, P207, DOI 10.1002/sca.20295
   Laurent P, 2008, DENT MATER, V24, P1486, DOI 10.1016/j.dental.2008.02.020
   Nekoofar MH, 2010, INT ENDOD J, V43, P849, DOI 10.1111/j.1365-2591.2010.01750.x
   Neville AM, 1995, PROPERTIES CONCRETE
   OWADALLY ID, 1994, INT ENDOD J, V27, P227, DOI 10.1111/j.1365-2591.1994.tb00260.x
   Paillere AM., 1995, 10 RIL
   Park JW, 2010, ORAL SURG ORAL MED O, V109, P155, DOI 10.1016/j.tripleo.2009.08.039
   Schembri M, 2010, J ENDODONT, V36, P1210, DOI 10.1016/j.joen.2010.02.011
   Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X
   Taddei P, 2009, J RAMAN SPECTROSC, V40, P1858, DOI 10.1002/jrs.2333
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   TORABINEJAD M, Patent No. 5769638
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Wang XP, 2007, J BIOMED MATER RES B, V81B, P410, DOI 10.1002/jbm.b.30678
   Wiltbank KB, 2007, J ENDODONT, V33, P1235, DOI 10.1016/j.joen.2007.06.016
   Zhao WY, 2008, J BIOMED MATER RES A, V85A, P336, DOI 10.1002/jbm.a.31523
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 40
TC 78
Z9 82
U1 5
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD FEB
PY 2013
VL 29
IS 2
BP E20
EP E28
DI 10.1016/j.dental.2012.11.007
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 073LV
UT WOS:000313745400003
PM 23199808
DA 2018-10-20
ER

PT J
AU Brown, EM
AF Brown, Eleanor M.
TI Development and utilization of a bovine type I collagen microfibril
   model
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Bovine type I collagen; Microfibril model; Crosslinks
ID CROSS-LINKING; MOLECULAR-DYNAMICS; TERMINAL TELOPEPTIDES; HELIX
   RECEPTOR; C-TELOPEPTIDE; FORCE-FIELD; STABILIZATION; STABILITY;
   HYDRATION; FIBRILS
AB The structure of fibrous collagen, a long triple helix that self-associates in a staggered array to form a matrix of fibrils, fibers and fiber bundles, makes it uniquely suitable as a scaffold for biomaterial engineering. A major challenge for this application is to stabilize collagen structure by means that are acceptable for the end use. The bovine type I collagen microfibril model, built by computer assisted modeling, comprised of five right-handed triple helices in a left-handed super coil containing gap and overlap regions as well as the nonhelical telopeptides is a tool for predicting or visualizing chemistry to stabilize the matrix, insert an active agent, or otherwise modify collagen. Published by Elsevier B.V.
C1 ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Brown, EM (reprint author), ARS, USDA, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM eleanor.brown@ars.usda.gov
CR Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Bronco S, 2006, J PHYS CHEM B, V110, P13227, DOI 10.1021/jp061776a
   Bronco S, 2004, J PHYS CHEM B, V108, P10101, DOI 10.1021/jp049172z
   Brown EM, 2008, J AM LEATHER CHEM AS, V103, P290
   Brown EM, 2011, J AM LEATHER CHEM AS, V106, P145
   Brown EM, 2009, J AM LEATHER CHEM AS, V104, P275
   Brown EM, 2004, J AM LEATHER CHEM AS, V99, P376
   BROWN EM, 1993, J AM LEATHER CHEM AS, V88, P2
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Bulo RE, 2007, MACROMOL BIOSCI, V7, P234, DOI 10.1002/mabi.200600208
   CHEN JM, 1991, J PROTEIN CHEM, V10, P535, DOI 10.1007/BF01025482
   CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804
   Covington AD, 2008, J SOC LEATH TECH CH, V92, P1
   Covington AD, 1997, CHEM SOC REV, V26, P111, DOI 10.1039/cs9972600111
   De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   Duarte AP, 2012, PROG POLYM SCI, V37, P1031, DOI 10.1016/j.progpolymsci.2011.12.003
   Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002
   Fietzek P P, 1976, Int Rev Connect Tissue Res, V7, P1
   Flory PJ, 1960, J AM CHEM SOC, V82, P4518, DOI 10.1021/ja01502a018
   George A, 1999, P INDIAN AS-CHEM SCI, V111, P121
   GOTSIS T, 1992, J SOC LEATH TECH CH, V76, P195
   Grove TZ, 2012, CURR OPIN STRUC BIOL, V22, P451, DOI 10.1016/j.sbi.2012.06.004
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Haslam E, 1997, J SOC LEATH TECH CH, V81, P45
   JONES EY, 1987, BIOPOLYMERS, V26, P463, DOI 10.1002/bip.360260403
   King G, 1996, PROTEIN ENG, V9, P43, DOI 10.1093/protein/9.1.43
   Kronick PL, 1998, J POLYM SCI POL PHYS, V36, P805, DOI 10.1002/(SICI)1099-0488(19980415)36:5<805::AID-POLB8>3.0.CO;2-J
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Madhan B, 2003, J AM LEATHER CHEM AS, V98, P263
   Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b
   Malone JP, 2004, PROTEINS, V54, P206, DOI 10.1002/prot.10526
   MECHANIC GL, 1987, BIOCHEMISTRY-US, V26, P3500, DOI 10.1021/bi00386a038
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Mogilner IG, 2002, J MOL GRAPH MODEL, V21, P209, DOI 10.1016/S1093-3263(02)00145-6
   Monti S, 2005, J PHYS CHEM B, V109, P11389, DOI 10.1021/jp0440941
   Okada H, 2008, BIOSCI BIOTECH BIOCH, V72, P1438, DOI 10.1271/bbb.70751
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   OTTER A, 1988, BIOCHEMISTRY-US, V27, P3560, DOI 10.1021/bi00410a006
   Qi PX, 2002, J AM LEATHER CHEM AS, V97, P235
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   RUIJGROK JM, 1994, J MATER SCI-MATER M, V5, P80, DOI 10.1007/BF00121695
   Scholnick F., 1992, J AM LEATHER CHEM AS, V92, P333
   Siggel L, 2006, J AM LEATHER CHEM AS, V101, P179
   Siggel L, 2007, J AM LEATHER CHEM AS, V102, P333
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0
   Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009
   Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200
   TAYLOR MM, 1992, J AM LEATHER CHEM AS, V87, P380
   Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   VEIS A, 1975, BIOPOLYMERS, V14, P895, DOI 10.1002/bip.1975.360140418
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
   Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42
NR 59
TC 6
Z9 6
U1 2
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2013
VL 53
BP 20
EP 25
DI 10.1016/j.ijbiomac.2012.10.029
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 073UE
UT WOS:000313767700003
PM 23131209
DA 2018-10-20
ER

PT J
AU Leung, LH
   Naguib, HE
AF Leung, Linus H.
   Naguib, Hani E.
TI Viscoelastic properties of poly(epsilon-caprolactone) - hydroxyapatite
   micro- and nano-composites
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE viscoelasticity; poly(e-caprolactone); hydroxyapatite; nano-composites;
   biomaterials
ID FIBER-REINFORCED POLY(EPSILON-CAPROLACTONE); DYNAMIC-MECHANICAL
   ANALYSIS; WET CORTICAL BONE; INTERFACIAL INTERACTION; BLENDS;
   POLYCAPROLACTONE; NANOCOMPOSITES; DEGRADATION; IRRADIATION; FABRICATION
AB Various composites have been proposed in the literature for the fabrication of bioscaffolds for bone tissue engineering. These materials include poly(epsilon-caprolactone) (PCL) with hydroxyapatite (HA). Since the biomaterial acts as the medium that transfers mechanical signals from the body to the cells, the fundamental properties of the biomaterials should be characterized. Furthermore, in order to control the processing of these materials into scaffolds, the characterization of the fundamental properties is also necessary. In this study, the physical, thermal, mechanical, and viscoelastic properties of the PCL-HA micro- and nano-composites were characterized. Although the addition of filler particles increased the compressive modulus by up to 450%, the thermal and viscoelastic properties were unaffected. Furthermore, although the presence of water plasticized the polymer, the viscoelastic behavior was only minimally affected. Testing the composites under various conditions showed that the addition of HA can strengthen PCL without changing its viscoelastic response. The results found in this study can be used to further understand and approximate the time-dependent behavior of scaffolds for bone tissue engineering. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Leung, Linus H.; Naguib, Hani E.] Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Naguib, Hani E.] Dept Mat Sci & Engn, Toronto, ON M5S 3G8, Canada.
   [Naguib, Hani E.] Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada.
RP Naguib, HE (reprint author), Inst Biomat & Biomed Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
EM naguib@mie.utoronoto.ca
FU Natural Sciences and Engineering Research Council (NSERC) of Canada;
   Canada Research Chairs Program; Canada Foundation of Innovation
FX The authors would like to acknowledge the financial support from the
   Natural Sciences and Engineering Research Council (NSERC) of Canada, the
   Canada Research Chairs Program, and the Canada Foundation of Innovation.
CR Ang KC, 2007, J BIOMED MATER RES A, V80A, P655, DOI 10.1002/jbm.a.30996
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Chen BQ, 2005, EUR POLYM J, V41, P453, DOI 10.1016/j.europolymj.2004.10.015
   Chen BQ, 2005, POLYM TEST, V24, P978, DOI 10.1016/j.polymertesting.2005.07.013
   Chen BQ, 2005, POLYM TEST, V24, P64, DOI 10.1016/j.polymertesting.2004.07.010
   Cherraf-Schweyer C., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P195, DOI 10.1080/10255840701284002
   Chun YS, 2000, POLYMER, V41, P8729, DOI 10.1016/S0032-3861(00)00263-9
   Di Maio E, 2004, POLYMER, V45, P8893, DOI 10.1016/j.polymer.2004.10.037
   Garner E, 2000, J BIOMECH ENG-T ASME, V122, P166, DOI 10.1115/1.429638
   HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C
   Han CY, 2007, POLYM INT, V56, P593, DOI 10.1002/pi.2156
   Hao J., 2002, J APPL POLYM SCI, V86, P676
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Koh YH, 2006, MATER LETT, V60, P1184, DOI 10.1016/j.matlet.2005.10.103
   Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722
   LAKES RS, 1979, J BIOMECH, V12, P657, DOI 10.1016/0021-9290(79)90016-2
   LAKES RS, 1979, J BIOMECH, V12, P679, DOI 10.1016/0021-9290(79)90017-4
   Leeke GA, 2006, J CHEM ENG DATA, V51, P1877, DOI 10.1021/je060230e
   Menard K. P., 2008, DYNAMIC MECH ANAL PR
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Perez CJ, 2008, MAT SCI ENG A-STRUCT, V480, P259, DOI 10.1016/j.msea.2007.07.031
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Reis R. L., 2002, DYNAMIC MECH ANAL PO, P139
   Vertuccio L, 2009, CARBOHYD POLYM, V75, P172, DOI 10.1016/j.carbpol.2008.07.020
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Yamashita J, 2002, J BIOMED MATER RES, V63, P31, DOI 10.1002/jbm.10086
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
   Yang AL, 2002, J APPL POLYM SCI, V84, P486, DOI 10.1002/app.10149
NR 29
TC 4
Z9 4
U1 0
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD FEB
PY 2013
VL 24
IS 2
BP 144
EP 150
DI 10.1002/pat.3061
PG 7
WC Polymer Science
SC Polymer Science
GA 077SV
UT WOS:000314049100002
DA 2018-10-20
ER

PT J
AU Salim, N
   Silikas, N
   Satterthwaite, JD
   Moore, C
   Ramage, G
   Rautemaa, R
AF Salim, N.
   Silikas, N.
   Satterthwaite, J. D.
   Moore, C.
   Ramage, G.
   Rautemaa, R.
TI Chlorhexidine-impregnated PEM/THFM polymer exhibits superior activity to
   fluconazole-impregnated polymer against Candida albicans biofilm
   formation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate; PEM/THFM;
   Antimicrobial; Candida biofilm; Biomaterial infection; Bone cement
ID IN-VITRO; SUSCEPTIBILITY; RELEASE; SYSTEM
AB Biofilm-associated infections represent a major challenge for biomaterials. Methods to alter the chemical characteristics of biomaterials offer an attractive solution for enhanced microbial control. The aim of this study was to investigate the efficacy of a poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate (PEM/THFM) acrylic model impregnated with fluconazole (FLU) or chlorhexidine (CHX) in preventing Candida biofilm formation in vitro. PEM/THFM disks impregnated with CHX (n = 50) or FLU (n = 50) and drug-free control disks (n = 50) were infected with Candida albicans ATCC 90028. Disks were incubated for 2, 7, 14, 21 or 28 days at 37 degrees C and the biofilm biomass and metabolic activity was quantified at each time point using crystal violet staining and XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] reduction assay. FLU disks exhibited poor overall biofilm inhibitory characteristics, with mean metabolic and biomass inhibition of 12.6% and 8.8%, respectively. Conversely, CHX disks were highly effective, significantly inhibiting biofilm development by 75% (P <= 0.001) and its metabolism by 84% (P <= 0.001) for all time points tested. The notable efficacy of CHX against C. albicans biofilms is a promising outcome to overcome the side effects and poor relative activity of conventional antifungal agents against Candida biofilms. These findings indicate that impregnation of PEM/THFM with antimicrobials has potential as a treatment modality for denture stomatitis. (C) 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
C1 [Salim, N.; Silikas, N.; Satterthwaite, J. D.] Univ Manchester, Sch Dent, Manchester M15 6FH, Lancs, England.
   [Salim, N.] Univ Jordan, Sch Dent, Amman, Jordan.
   [Moore, C.; Rautemaa, R.] Mycol Reference Ctr, Manchester M23 9LT, Lancs, England.
   [Ramage, G.] Univ Glasgow, Infect & Immun Res Grp, Glasgow Dent Sch, Sch Med,Coll Med Vet & Life Sci, Glasgow G2 3JZ, Lanark, Scotland.
   [Rautemaa, R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.
RP Rautemaa, R (reprint author), Wythenshawe Hosp, Educ & Res Ctr, 2nd Floor,Southmoor Rd, Manchester M23 9LT, Lancs, England.
EM riina.richardson@manchester.ac.uk
RI Silikas, Nick/B-2990-2009
OI Silikas, Nick/0000-0003-4576-4584; Richardson,
   Riina/0000-0002-1071-6040; Salim, Nesreen/0000-0002-5355-2269
CR Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Ellepola ANB, 2001, ORAL DIS, V7, P11, DOI 10.1034/j.1601-0825.2001.70103.x
   Frutos G, 2010, ACTA BIOMATER, V6, P804, DOI 10.1016/j.actbio.2009.08.028
   Lamfon H, 2004, J ANTIMICROB CHEMOTH, V53, P383, DOI 10.1093/jac/dkh071
   Meiller TF, 2001, ORAL SURG ORAL MED O, V91, P663, DOI 10.1067/moe.2001.113550
   Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0
   PATEL MP, 1994, J MATER SCI-MATER M, V5, P338, DOI 10.1007/BF00058958
   Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001
   Ramage G, 2011, ORAL SURG ORAL MED O, V111, P456, DOI 10.1016/j.tripleo.2010.10.043
   Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436
   Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606
   Redding S, 2009, ORAL SURG ORAL MED O, V107, P669, DOI 10.1016/j.tripleo.2009.01.021
   Salim N, 2012, J DENT, V40, P506, DOI 10.1016/j.jdent.2012.02.016
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
NR 15
TC 7
Z9 7
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD FEB
PY 2013
VL 41
IS 2
BP 193
EP 196
DI 10.1016/j.ijantimicag.2012.09.006
PG 4
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 072KK
UT WOS:000313669600017
PM 23127479
DA 2018-10-20
ER

PT J
AU Lippens, E
   De Smet, N
   Schauvliege, S
   Martens, A
   Gasthuys, F
   Schacht, E
   Cornelissen, R
AF Lippens, Evi
   De Smet, Nele
   Schauvliege, Stijn
   Martens, Ann
   Gasthuys, Frank
   Schacht, Etienne
   Cornelissen, Ria
TI Biocompatibility properties of surface-modified poly(dimethylsiloxane)
   for urinary applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Surface modification; plasma treatment; urinary bladder implant; salt
   deposition; AMPS; sulfobetaine
ID BIOMATERIAL ENCRUSTATION; POLYDIMETHYLSILOXANE; SULFOBETAINE; PLASMA;
   PRESSURE; POLYMERS; IMPROVE; TRACT; MODEL
AB An electronic sensor system for urinary bladder pressure monitoring requires an imbedding into a biocompatible, flexible, and liquid-impermeable material. Poly(dimethylsiloxane) (PDMS) was selected in the present set-up as packaging material because it fulfills the abovementioned requirements. However, the surface of PDMS is hydrophobic and causes undesired interactions with salts, proteins, and cells present in urine. To reduce possible interactions of urine salts in the urinary bladder, monomers, [2-(methacryloyloxy)ethyl]-dimethyl-3-sulfopropyl-ammonium hydroxide (sulfobetaine) and 2-acrylamido-2-methylpropyl sulfonic acid, were grafted onto the surface through oxygen plasma treatment. A reduction in salt deposition between the pure PDMS and the modified PDMS was observed both in vitro (artificial urine flow over the surface) and in vivo (implants into the urinary bladder of experimental pigs). Additionally, a 10-fold reduction in salt deposition was observed in vitro due to grafting of the monomers onto the surface. These modified PDMS materials proved also to be biocompatible in cell cultures, which was further confirmed by histological screening of the bladder tissue after implantation in an in vivo pig model.
C1 [Lippens, Evi; Cornelissen, Ria] Univ Ghent, Dept Basic Med Sci, B-9000 Ghent, Belgium.
   [De Smet, Nele; Schacht, Etienne] Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Schauvliege, Stijn; Martens, Ann; Gasthuys, Frank] Univ Ghent, Dept Surg & Anaesthesiol Domest Anim, Merelbeke, Belgium.
RP Cornelissen, R (reprint author), Univ Ghent, Dept Basic Med Sci, De Pintelaan 185,6B3, B-9000 Ghent, Belgium.
EM ria.cornelissen@UGent.be
RI Lippens, Evi/N-9850-2015
OI Lippens, Evi/0000-0001-9619-2438; Schauvliege, Stijn/0000-0002-7105-6517
FU IWT [SBO-BioFlex 04101]; Ghent University
FX This study was supported by IWT (SBO-BioFlex 04101). The authors thank
   Leen Pieters for her assistance with the histology of the tissue
   sections. The authors specially thank the staff at the Veterinary clinic
   at Ghent University for their effortless assistance during the in vivo
   implantation experiment. The authors thank Ghent University for the
   financial support and the use of the infrastructure.
CR Axisa F, 2009, IEEE ENG MED BIO, P4864, DOI 10.1109/IEMBS.2009.5332451
   Blau A, 2009, J BIOSCIENCES, V34, P59, DOI 10.1007/s12038-009-0009-3
   Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   Choong SKS, 1999, BJU INT, V83, P770
   Davison A. M., 2005, OXFORD TXB CLIN NEPH
   De Smet N, 2010, J BIOMATER SCI POLYM
   De Smet N, 2009, J BIOMAT SCI-POLYM E, V20, P2039, DOI 10.1163/156856208X397901
   Emmenegger CR, 2009, LANGMUIR, V25, P6328, DOI 10.1021/la900083s
   Jourand P, 2010, SENSOR ACTUAT A-PHYS, V162, P160, DOI 10.1016/j.sna.2010.01.035
   Khorasani MT, 2004, J BIOMAT SCI-POLYM E, V15, P59, DOI 10.1163/156856204322752237
   Parvin A, 2008, J APPL POLYM SCI, V107, P2343, DOI 10.1002/app.27281
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Tan SH, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3466882
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   Venkatesan N, 2011, UROL RES, V39, P29, DOI 10.1007/s00240-010-0280-7
   Venkatesan N, 2010, J ENDOUROL, V24, P191, DOI 10.1089/end.2009.0516
   Wipff PJ, 2009, BIOMATERIALS, V30, P1781, DOI 10.1016/j.biomaterials.2008.12.022
   Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475
NR 21
TC 3
Z9 3
U1 1
U2 49
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2013
VL 27
IS 6
BP 651
EP 660
DI 10.1177/0885328211422119
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 072HS
UT WOS:000313661500002
PM 22274880
DA 2018-10-20
ER

PT J
AU Lopez-Santos, C
   Fernandez-Gutierrez, M
   Yubero, F
   Vazquez-Lasa, B
   Cotrino, J
   Gonzalez-Elipe, A
   San Roman, J
AF Lopez-Santos, Carmen
   Fernandez-Gutierrez, Mar
   Yubero, Francisco
   Vazquez-Lasa, Blanca
   Cotrino, Jose
   Gonzalez-Elipe, Agustin
   San Roman, Julio
TI Effects of plasma surface treatments of diamond-like carbon and
   polymeric substrata on the cellular behavior of human fibroblasts
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Fibroblasts; plasma treatments; DLC; PET; LDPE; cellular behavior
ID RAPID COLORIMETRIC ASSAY; AMMONIA-PLASMA; BIOMEDICAL APPLICATIONS;
   NITROGEN PLASMAS; OXYGEN PLASMA; FILMS; ADHESION; WETTABILITY;
   FUNCTIONALIZATION; GROWTH
AB Surface properties play an important role in the functioning of a biomaterial in the biological environment. This work describes the influence of the changes that occurred on diamond-like carbon (DLC) and polymeric substrata by different nitrogen and ammonia plasmas treatments and its effects on the cell proliferation on these materials. All substrata were additionally subjected to the effect of neutral beams of nitrogen atoms and NH species for comparison purposes. Results about the proliferation, viability, and morphology of fibroblasts were correlated with surface chemical composition, surface tension, and topography. It was found that the presence of amine groups on the surface and the surface tension are beneficial factors for the cell growth. Surface roughness in DLC also plays a positive role in favoring cell adhesion and proliferation, but it can be detrimental for some of the treated polymers because of the accumulation of low molecular weight fragments formed as a result of the plasma treatments. Analysis of the overall results for each type of material allowed to define a unique parameter called 'factor of merit' accounting for the influence of the different surface characteristics on the cell deployment, which can be used to predict qualitatively the efficiency for cell growth.
C1 [Lopez-Santos, Carmen; Yubero, Francisco; Cotrino, Jose; Gonzalez-Elipe, Agustin] Univ Seville, CSIC, Inst Mat Sci Sevilla, Seville 41092, Spain.
   [Fernandez-Gutierrez, Mar; Vazquez-Lasa, Blanca; San Roman, Julio] CSIC, Inst Polymer Sci & Technol, Madrid 28006, Spain.
   [Fernandez-Gutierrez, Mar; Vazquez-Lasa, Blanca; San Roman, Julio] CIBER BBN, Zaragoza 50017, Spain.
   [Cotrino, Jose] Univ Seville, Fac Phys, Dept Theoret Phys Atom Mol & Nucl Phys, E-41012 Seville, Spain.
RP Vazquez-Lasa, B (reprint author), CSIC, Inst Polymer Sci & Technol, Juan de la Cierva 3, Madrid 28006, Spain.
EM bvazquez@ictp.csic.es
RI Lopez-Santos, Carmen/B-9711-2015; Fernandez-Gutierrez, Mar/D-3860-2014;
   Yubero, Francisco/E-7171-2015; Gonzalez-Elipe, Agustin R/C-7419-2015;
   Cotrino Bautista, Jose/G-5076-2015
OI Lopez-Santos, Carmen/0000-0001-8782-7331; Fernandez-Gutierrez,
   Mar/0000-0003-1739-1987; Yubero, Francisco/0000-0001-5107-9490;
   Gonzalez-Elipe, Agustin R/0000-0002-6417-1437; Cotrino Bautista,
   Jose/0000-0001-6538-2087; Vazquez, Blanca/0000-0001-5539-8026
FU Junta de Andalucia [P09-CTS- 5189]; Ministry of Science and Innovation
   [CONSOLIDER CSD2008-00023, MAT2010-21228, MAT2010-18155]
FX We thank the Junta de Andalucia (project P09-CTS- 5189) and the Ministry
   of Science and Innovation (projects CONSOLIDER CSD2008-00023,
   MAT2010-21228 and MAT2010-18155) for financial support. M.
   Fernandez-Gutierrrez also thanks the JAE-doc program of CSIC.
CR [Anonymous], 2009, ISO109935
   Barz J, 2006, PLASMA PROCESS POLYM, V3, P540, DOI 10.1002/ppap.200600028
   Beaulleu I, 2009, LANGMUIR, V25, P7169, DOI 10.1021/la9001972
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chu LQ, 2006, PLASMA PROCESS POLYM, V3, P498, DOI 10.1002/ppap.200600010
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Dumitrascu N, 2005, IEEE T PLASMA SCI, V33, P1710, DOI 10.1109/TPS.2005.856335
   Dumitrascu N, 2008, J BIOMED MATER RES B, V87B, P364, DOI 10.1002/jbm.b.31112
   Endrino JL, 2008, APPL SURF SCI, V254, P5323, DOI 10.1016/j.apsusc.2008.02.065
   Ghasemi M, 2007, LANGMUIR, V23, P11554, DOI 10.1021/la701126t
   Gomathi N, 2009, J ADHES SCI TECHNOL, V23, P1861, DOI 10.1163/016942409X12459095670593
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hauert R, 2003, DIAM RELAT MATER, V12, P171, DOI 10.1016/S0925-9635(03)00019-0
   JANCZUK B, 1992, J COLLOID INTERF SCI, V151, P333
   Keranov I, 2008, J APPL POLYM SCI, V110, P321, DOI 10.1002/app.28630
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim SH, 2007, J BIOMAT SCI-POLYM E, V18, P609, DOI 10.1163/156856207780852514
   Kotal V, 2007, PLASMA PROCESS POLYM, V4, P69, DOI 10.1002/ppap.200600069
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Legeay G, 1996, VIDE, V52, P225
   Lopez-Santos C, 2011, SURF COAT TECH, V205, P3356, DOI 10.1016/j.surfcoat.2010.11.038
   Lopez-Santos C, 2010, ACS APPL MATER INTER, V2, P980, DOI 10.1021/am100052w
   Lopez-Santos C, 2009, PLASMA PROCESS POLYM, V6, P555, DOI 10.1002/ppap.200900019
   Marciano FR, 2009, APPL SURF SCI, V255, P8377, DOI 10.1016/j.apsusc.2009.05.091
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MERCX FPM, 1994, POLYMER, V35, P2098, DOI 10.1016/0032-3861(94)90234-8
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Morent R, 2008, EUR PHYS J-APPL PHYS, V43, P289, DOI 10.1051/epjap:2008076
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Narushima K, 2008, JPN J APPL PHYS, V47, P3603, DOI 10.1143/JJAP.47.3603
   Oehr C, 1999, SURF COAT TECH, V116, P25, DOI 10.1016/S0257-8972(99)00201-7
   Ogino A, 2006, JPN J APPL PHYS 1, V45, P8494, DOI 10.1143/JJAP.45.8494
   Ozeki K, 2008, APPL SURF SCI, V254, P1614, DOI 10.1016/j.apsusc.2007.07.129
   Paynter RW, 1998, SURF INTERFACE ANAL, V26, P674, DOI 10.1002/(SICI)1096-9918(199808)26:9<674::AID-SIA414>3.0.CO;2-5
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Roy RK, 2007, DIAM RELAT MATER, V16, P1732, DOI 10.1016/j.diamond.2007.06.002
   Sabino MA, 2002, J MATER SCI, V37, P35, DOI 10.1023/A:1013129421038
   Sarra-Bournet C, 2006, J PHYS D APPL PHYS, V39, P3461, DOI 10.1088/0022-3727/39/16/S03
   Shirakura A, 2006, THIN SOLID FILMS, V494, P84, DOI 10.1016/j.tsf.2005.08.366
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Steffen HJ, 2000, SURF INTERFACE ANAL, V29, P386, DOI 10.1002/1096-9918(200006)29:6<386::AID-SIA882>3.0.CO;2-0
   Tajima S., 2006, APPL PHYS LETT, V89
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Uzumaki ET, 2006, THIN SOLID FILMS, V515, P293, DOI 10.1016/j.tsf.2005.12.081
   van Oss CJ, 1998, INTERFACIAL FORCES A
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P1444, DOI 10.1002/sia.2923
   Yang P, 2004, SURF COAT TECH, V186, P125, DOI 10.1016/j.surfcoat.2004.04.039
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   Yildirim ED, 2008, PLASMA PROCESS POLYM, V5, P58, DOI 10.1002/ppap.200700041
   Yokota T, 2007, SURF COAT TECH, V201, P8048, DOI 10.1016/j.surfcoat.2006.03.051
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
NR 58
TC 4
Z9 4
U1 0
U2 40
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2013
VL 27
IS 6
BP 669
EP 683
DI 10.1177/0885328211422832
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 072HS
UT WOS:000313661500004
PM 22090431
DA 2018-10-20
ER

PT J
AU Ramalingam, M
   Young, MF
   Thomas, V
   Sun, LM
   Chow, LC
   Tison, CK
   Chatterjee, K
   Miles, WC
   Simon, CG
AF Ramalingam, Murugan
   Young, Marian F.
   Thomas, Vinoy
   Sun, Limin
   Chow, Laurence C.
   Tison, Christopher K.
   Chatterjee, Kaushik
   Miles, William C.
   Simon, Carl G., Jr.
TI Nanofiber scaffold gradients for interfacial tissue engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Nanofibers; scaffolds; calcium phosphate; gradient; osteoblast
ID CELL-BIOMATERIAL INTERACTIONS; ELECTROSPUN POLYCAPROLACTONE; STEM-CELLS;
   BONE; PHOSPHATE; CALCIUM; PROLIFERATION; REGENERATION; 3D;
   DIFFERENTIATION
AB We have designed a 2-spinnerette device that can directly electrospin nanofiber scaffolds containing a gradient in composition that can be used to engineer interfacial tissues such as ligament and tendon. Two types of nanofibers are simultaneously electrospun in an overlapping pattern to create a nonwoven mat of nanofibers containing a composition gradient. The approach is an advance over previous methods due to its versatility - gradients can be formed from any materials that can be electrospun. A dye was used to characterize the 2-spinnerette approach and applicability to tissue engineering was demonstrated by fabricating nanofibers with gradients in amorphous calcium phosphate nanoparticles (nACP). Adhesion and proliferation of osteogenic cells (MC3T3-E1 murine pre-osteoblasts) on gradients was enhanced on the regions of the gradients that contained higher nACP content yielding a graded osteoblast response. Since increases in soluble calcium and phosphate ions stimulate osteoblast function, we measured their release and observed significant release from nanofibers containing nACP. The nanofiber-nACP gradients fabricated herein can be applied to generate tissues with osteoblast gradients such as ligaments or tendons. In conclusion, these results introduce a versatile approach for fabricating nanofiber gradients that can have application for engineering graded tissues.
C1 [Ramalingam, Murugan; Tison, Christopher K.; Chatterjee, Kaushik; Miles, William C.; Simon, Carl G., Jr.] NIST, Div Polymers, Gaithersburg, MD 20899 USA.
   [Ramalingam, Murugan; Young, Marian F.; Chatterjee, Kaushik] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.
   [Ramalingam, Murugan] Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res, F-67085 Strasbourg, France.
   [Thomas, Vinoy] NIST, Div Ceram, Gaithersburg, MD 20899 USA.
   [Thomas, Vinoy] Univ Alabama Birmingham, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
   [Sun, Limin; Chow, Laurence C.] NIST, Amer Dent Assoc, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
RP Simon, CG (reprint author), NIST, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
OI Chatterjee, Kaushik/0000-0002-7204-2926
FU National Academies/NRC NIBIB/NIH-NIST Post-doctoral Fellowship program
   (National Research Council, National Institute of Biomedical Imaging and
   Bioengineering, National Institutes of Health); NIST; NIH-NIDCR [R01
   DE16416]; Intramural Program of the NIH/NIDCR (National Institute of
   Dental and Craniofacial Research).; NIH/NIBIB [R21 EB006497- 01]
FX M.R., V.T., and K. C. acknowledge National Academies/NRC NIBIB/NIH-NIST
   Post-doctoral Fellowship program (National Research Council, National
   Institute of Biomedical Imaging and Bioengineering, National Institutes
   of Health). We thank G. Christopherson for help with figures. This work
   was supported by NIST, NIH/NIBIB R21 EB006497- 01, NIH-NIDCR R01
   DE16416, and the Intramural Program of the NIH/NIDCR (National Institute
   of Dental and Craniofacial Research). The 'standard deviation' (S. D.)
   is the same as the 'combined standard uncertainty of the mean' for the
   purposes of this work. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of NIH,
   ADA (American Dental Association), NIBIB, NIDCR, or NIST. This article,
   a contribution of NIST, is not subject to US copyright. Certain
   equipment and instruments or materials are identified in the paper to
   adequately specify the experimental details. Such identification does
   not imply recommendation by NIST nor does it imply the materials are
   necessarily the best available for the purpose.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chow LC, 2004, J RES NATL INST STAN, V109, P543, DOI 10.6028/jres.109.041
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Demirel M, 2011, INDIAN J ORTHOP, V45, P45, DOI 10.4103/0019-5413.73654
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Hammoudi TM, 2010, TISSUE ENG PART C-ME, V16, P1621, DOI [10.1089/ten.tec.2010.0146, 10.1089/ten.TEC.2010.0146]
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Kokkalis Zinon T, 2009, Tech Hand Up Extrem Surg, V13, P41, DOI 10.1097/BTH.0b013e31818be857
   Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Ovsianikov A, 2011, ACTA BIOMATER, V7, P967, DOI 10.1016/j.actbio.2010.10.023
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Simon CG, 2009, COMB CHEM HIGH T SCR, V12, P544, DOI 10.2174/138620709788681961
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Simon CG, 2004, J BIOMED MATER RES A, V68A, P628, DOI 10.1002/jbm.a.20008
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004
   Valmikinathan CM, 2009, COMB CHEM HIGH T SCR, V12, P656, DOI 10.2174/138620709788923683
   VOGEL GL, 1983, CARIES RES, V17, P23, DOI 10.1159/000260645
   Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang LS, 2000, ARTIF CELL BLOOD SUB, V28, P215, DOI 10.3109/10731190009119353
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
NR 48
TC 26
Z9 26
U1 2
U2 57
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2013
VL 27
IS 6
BP 695
EP 705
DI 10.1177/0885328211423783
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 072HS
UT WOS:000313661500006
PM 22286209
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ramezani-Dakhel, H
   Heshmati, V
AF Ramezani-Dakhel, H.
   Heshmati, V.
TI Clamshell powder as precursor of bionanofiller in polymeric matrixes
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Article
DE Clamshell; Bionanocomposite; Elastomer; Filler
ID RICE HUSK ASH; PINCTADA-MAXIMA; ORGANIC MATRIX; NACRE; RUBBER; NANOCLAY;
   BEHAVIOR; MOTHER; PEARL; NANOCOMPOSITE
AB In the current research, clamshell powder has been incorporated as biofiller in three elastomeric matrixes (i.e. natural rubber, styrene butadiene rubber and acrylonitrile butadiene rubber). Mechanical properties, curing behaviour and crosslink density of the compounds were evaluated. Through illustration of the shortcomings in the application of this biomaterial, our study sheds light on further applications of this biofiller in polymeric matrixes. Unexpected low specific surface area in consequence of the way of clamshell breakdown during grinding has been found to be the major reason for the observed mechanical properties. A qualitative model has been proposed to gain a better understanding of the clamshell breakdown. The model was confirmed using scanning electron microscope images and Brunauer-Emmett-Teller specific surface area test. The obtained results demonstrate the necessity of modification of the clamshell and doing more studies in this field.
C1 [Ramezani-Dakhel, H.; Heshmati, V.] Amirkabir Univ Technol, Dept Polymer Engn & Color Technol, Tehran, Iran.
RP Ramezani-Dakhel, H (reprint author), Amirkabir Univ Technol, Dept Polymer Engn & Color Technol, POB 15875-4413, Tehran, Iran.
EM hadi.ramezani@gmail.com
CR Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#
   Arayapranee W, 2008, J APPL POLYM SCI, V110, P1165, DOI 10.1002/app.28725
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007
   Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006
   Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239
   Brandrup J., 1999, POLYM HDB
   Bruet BJF, 2005, J MATER RES, V20, P2400, DOI 10.1557/JMR.2005.0273
   Dai JC, 1999, APPL CLAY SCI, V15, P51, DOI 10.1016/S0169-1317(99)00020-4
   Das A, 2008, EUR POLYM J, V44, P3456, DOI 10.1016/j.eurpolymj.2008.08.025
   Ishak ZAM, 1997, EUR POLYM J, V33, P73, DOI 10.1016/S0014-3057(96)00116-4
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Katti DR, 2004, REV ADV MATER SCI, V6, P162
   Katti KS, 2006, MAT SCI ENG C-BIO S, V26, P1317, DOI 10.1016/j.msec.2005.08.013
   Li TN, 2006, POLYM ENG SCI, V46, P1419, DOI 10.1002/pen.20629
   Lin W, 2008, MAT SCI ENG C-BIO S, V28, P1031, DOI 10.1016/j.msec.2007.04.030
   Mark J.E, 1998, POLYM DATA HDB
   Marzocca AJ, 2007, EUR POLYM J, V43, P2682, DOI 10.1016/j.eurpolymj.2007.02.034
   Mecdonald G. J. F., 1956, AM MINERAL, V41, P744
   Menig R, 2000, ACTA MATER, V48, P2383, DOI 10.1016/S1359-6454(99)00443-7
   Mohanty B, 2008, MECH RES COMMUN, V35, P17, DOI 10.1016/j.mechrescom.2007.09.006
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P113, DOI 10.1016/j.msec.2005.01.004
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   Ramezani-Dakhel H, 2010, J APPL POLYM SCI, V118, P969, DOI 10.1002/app.32458
   RAMEZANIDAKHEL H, 2008, E POLYM
   Shabani I, 2009, J APPL POLYM SCI, V111, P1670, DOI 10.1002/app.29159
   Solomon S. E., 1991, EGG EGGSHELL QUALITY
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Tan H, 2008, J APPL POLYM SCI, V109, P767, DOI 10.1002/app.28130
NR 30
TC 0
Z9 0
U1 0
U2 8
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PD FEB
PY 2013
VL 42
IS 1
BP 11
EP 18
DI 10.1179/1743289812Y.0000000005
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 073LA
UT WOS:000313743300002
DA 2018-10-20
ER

PT J
AU Chang, NJ
   Lin, CC
   Li, CF
   Su, K
   Yeh, ML
AF Chang, Nai-Jen
   Lin, Chih-Chan
   Li, Chien-Feng
   Su, Kai
   Yeh, Ming-Long
TI The Effect of Osteochondral Regeneration Using Polymer Constructs and
   Continuous Passive Motion Therapy in the Lower Weight-Bearing Zone of
   Femoral Trocheal Groove in Rabbits
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Cartilage; Biomaterial; Regenerative medicine; Physical therapy; Animal
   model
ID AUTOGENOUS PERIOSTEAL GRAFTS; FULL-THICKNESS DEFECTS;
   ARTICULAR-CARTILAGE; IN-VITRO; CLINICAL-APPLICATION; JOINT SURFACES;
   FOLLOW-UP; REPAIR; SCAFFOLD; NEOCHONDROGENESIS
AB Remedying patellofemoral osteochondral defects using clinical therapy remains challenging. Construct-based and cell-based regenerative medicine with in vitro physical stimuli has been progressively implemented. However, the effect of physical stimuli in situ in knee joints with degradable constructs is still not well-documented. Therefore, we studied whether it was practical to achieve articular cartilage repair using a poly(lactic-co-glycolic acid) (PLGA) construct in addition to early short-term continuous passive motion (CPM) for treatment of full-thickness osteochondral defects in the lower-weigh bearing (LWB) zone of the femoral trocheal groove. Twenty-six rabbits were randomly allocated into either intermittent active motion (IAM) or CPM treatment groups with or without PLGA constructs, termed PLGA construct-implanted (PCI) and empty defect knee models, respectively. Gross observation, histology, inflammatory cells, which were identified using H&E staining, total collagen and alignment, studied qualitatively using Masson's trichrome staining, glycosaminoglycan (GAG), identified using Alcian blue staining, and newly formed bone, observed using micro-CT, were evaluated at 4 and 12 weeks after surgery. Repair of osteochondral defects in the PCI-CPM group was more promising than all other groups. The better osteochondral defect repair in the PCI-CPM group corresponded to smooth cartilage surfaces, no inflammatory reaction, hyaline cartilaginous tissues composition, sound collagen alignment with positive collagen type II expression, higher GAG content, mature bone regeneration with osteocyte, clear tidemark formation, and better degradation of PLGA. In summary, the use of a simple PLGA construct coupled with passive motion promotes positive healing and may be a promising clinical intervention for osteochondral regeneration in LWB defects.
C1 [Chang, Nai-Jen; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
   [Lin, Chih-Chan] Chi Mei Med Ctr, Dept Med Res, Lab Anim Ctr, Tainan 701, Taiwan.
   [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Div Clin Pathol, Tainan 701, Taiwan.
   [Su, Kai] Nanyang Technol Univ, Div Bioengn & Biomed Engn, Singapore 637457, Singapore.
   [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
RP Yeh, ML (reprint author), Natl Cheng Kung Univ, Inst Biomed Engn, 1 Univ Rd, Tainan 701, Taiwan.
EM mlyeh@mail.ncku.edu.tw
FU National Science Council of Taiwan, R.O.C. [99-2627-B006-009-,
   99-2627-B006-018]
FX This work was supported by the National Science Council of Taiwan,
   R.O.C. (99-2627-B006-009- and 99-2627-B006-018).
CR Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x
   Becher C, 2008, ORTHOPADE, V37, P196, DOI 10.1007/s00132-008-1213-9
   Chang N. J., 2011, J BIOMAT SCI-POLYM E, DOI [10.1163/092050611X092611648, DOI 10.1163/092050611X092611648]
   Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Concaro S, 2009, ADV BIOCHEM ENG BIOT, V112, P125, DOI [10.1007/10_2008_10, 10.1007/978-3-540-69357-4_6]
   Du Plessis M, 2011, CLIN REHABIL, V25, P291, DOI 10.1177/0269215510380835
   Ferretti M, 2005, J ORTHOP RES, V23, P1165, DOI 10.1016/j.orthres.2005.01.025
   Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI 10.1089/ten.TEC.2008.0569
   Haasper C, 2008, INJURY, V39, pS66, DOI 10.1016/j.injury.2008.01.037
   Hinman RS, 2007, RHEUMATOLOGY, V46, P1057, DOI 10.1093/rheumatology/kem114
   Howard JS, 2010, CARTILAGE, V1, P276, DOI 10.1177/1947603510368055
   Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P792, DOI 10.1016/j.joca.2010.12.010
   Igarashi T, 2012, J BIOMED MATER RES A, V100A, P180, DOI 10.1002/jbm.a.33248
   Ikeda R, 2009, INT ORTHOP, V33, P821, DOI 10.1007/s00264-008-0532-0
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]
   KIM HKW, 1995, J RHEUMATOL, V22, P1714
   Kim TK, 2009, KNEE SURG SPORT TR A, V17, P1152, DOI 10.1007/s00167-009-0731-2
   Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Martin-Hernandez C, 2010, ARTHROSCOPY, V26, P76, DOI 10.1016/j.arthro.2009.07.005
   McWalter EJ, 2011, OSTEOARTHR CARTILAGE, V19, P801, DOI 10.1016/j.joca.2011.03.003
   O'Driscoll SW, 2000, J REHABIL RES DEV, V37, P179
   ODRISCOLL SW, 1986, CLIN ORTHOP RELAT R, P131
   ODRISCOLL SW, 1984, J BONE JOINT SURG AM, V66A, P1248, DOI 10.2106/00004623-198466080-00014
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Oshima Y, 2009, TISSUE ENG PART C-ME, V15, P595, DOI [10.1089/ten.tec.2008.0487, 10.1089/ten.TEC.2008.0487]
   Pascual-Garrido C, 2009, AM J SPORT MED, V37, p33S, DOI 10.1177/0363546509349605
   Riegger-Krugh CL, 2008, MED SCI SPORT EXER, V40, P206, DOI 10.1249/mss.0b013e31815cb228
   Rosen J., 2009, AM J SPORTS MED, V37, P720
   Rudert M, 2002, CELLS TISSUES ORGANS, V171, P229, DOI 10.1159/000063125
   SALTER RB, 1989, CLIN ORTHOP RELAT R, P12
   SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Sun SI, 2011, CHINESE MED J-PEKING, V124, P758, DOI 10.3760/cma.j.issn.0366-6999.2011.05.023
   Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2
   Swieszkowski W, 2007, BIOMOL ENG, V24, P489, DOI 10.1016/j.bioeng.2007.07.014
   Taskiran Emin, 2007, Acta Orthop Traumatol Turc, V41 Suppl 2, P70
   Tok F, 2011, RHEUMATOL INT, V31, P177, DOI 10.1007/s00296-009-1263-2
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Xie J, 2010, J BIOMED MATER RES B, V94B, P80, DOI 10.1002/jbm.b.31627
   Zhang Y., 2012, BIOMATERIALS, DOI [10.1016/j.biomaterials.2012.1001.1006, DOI 10.1016/J.BIOMATERIALS.2012.1001.1006]
NR 45
TC 5
Z9 5
U1 3
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2013
VL 41
IS 2
BP 385
EP 397
DI 10.1007/s10439-012-0656-7
PG 13
WC Engineering, Biomedical
SC Engineering
GA 069JR
UT WOS:000313432200015
PM 22987137
DA 2018-10-20
ER

PT J
AU Cassano, R
   Trombino, S
   Ferrarelli, T
   Nicoletta, FP
   Mauro, MV
   Giraldi, C
   Picci, N
AF Cassano, Roberta
   Trombino, Sonia
   Ferrarelli, Teresa
   Nicoletta, Fiore Pasquale
   Mauro, Maria Vittoria
   Giraldi, Cristina
   Picci, Nevio
TI Hemp fiber (Cannabis sativa L.) derivatives with antibacterial and
   chelating properties
SO CELLULOSE
LA English
DT Article
DE Hemp fibers; Functionalization; Biopolymer; Antibacterial; Chelation
ID CELLULOSE; MECHANISM; REMOVAL; CADMIUM; LIPASE
AB The aim of this study was to synthesize a new antibacterial and chelating biopolymer and to evaluate its germicidal activity and its ability in metal ions removal from aqueous solutions. The material was prepared via esterification of hemp with 2-benzyl-4-chlorophenol, a germicide agent, that was covalently coupled to cellulose backbone of hydrophilic fibers by a heterogeneous synthesis, to produce a functionalized biopolymer with a satisfactory degree of substitution. The obtained biopolymer was characterized by infrared spectroscopy and differential scanning calorimetry. Its antibacterial activity in inhibiting Staphylococcus aureus and Pseudomonas aeruginosa growth in Petri dishes, was evaluated. The results suggested that this biomaterial possesses an excellent in vitro antibacterial activity and so it can be efficiently employed in biomedical fields to ensure a protection against contaminations. On the other hand, the functionalized biopolymer interacts with metal ions thanks to its chelating functional groups. The absorption capacity for a selected metal ion such as Cd(II), was investigated in aqueous solution at pH 0.65, 4.1 and 7.0 by optical emission spectroscopy. This study showed that the new system is very effective in chelating cadmium ions showing the maximum efficiency at pH 4.1. This feature makes the synthesized biomaterial a potential candidate for metal ions removal.
   Hemp fiber (Cannabis sativa L.) derivatives with antibacterial and chelating properties. Roberta Cassano, Sonia Trombino, Teresa Ferrarelli, Fiore Pasquale Nicoletta, Maria Vittoria Mauro, Cristina Giraldi, Nevio Picci.
C1 [Cassano, Roberta; Trombino, Sonia; Ferrarelli, Teresa; Nicoletta, Fiore Pasquale; Picci, Nevio] Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
   [Mauro, Maria Vittoria; Giraldi, Cristina] Annunziata Hosp, Virol & Microbiol Serv, I-87100 Cosenza, Italy.
RP Trombino, S (reprint author), Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
EM sonia.trombino@unical.it
OI Picci, Nevio/0000-0003-1985-2724; Trombino, Sonia/0000-0001-9939-4457;
   Nicoletta, Fiore P./0000-0001-5961-1963
FU Academic Funds, MIUR (Programma di Ricerca di Rilevante Interesse
   Nazionale)
FX This work was financially supported by Academic Funds, MIUR (Programma
   di Ricerca di Rilevante Interesse Nazionale (2008).
CR APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279
   BESSMAN SP, 1957, ANN INTERN MED, V47, P1036, DOI 10.7326/0003-4819-47-5-1036
   Cassano R, 2007, J AGR FOOD CHEM, V55, P9489, DOI 10.1021/jf071711k
   Cassano R, 2010, BIOMACROMOLECULES, V11, P1716, DOI 10.1021/bm100404q
   Cassano R, 2009, CARBOHYD POLYM, V78, P639, DOI 10.1016/j.carbpol.2009.05.030
   Chidichimo G, 2006, Italian Patent, Patent No. [CZ2006A00006, 00006]
   Foglarova M, 2009, J APPL POLYM SCI, V112, P669, DOI 10.1002/app.29465
   Giorno L, 2007, J MEMBRANE SCI, V295, P95, DOI 10.1016/j.memsci.2007.02.041
   Giorno L, 2007, J CATAL, V247, P194, DOI 10.1016/j.jcat.2007.01.021
   ISOGAI A, 1984, J APPL POLYM SCI, V29, P3873, DOI 10.1002/app.1984.070291220
   Jansen JC, 2011, CELLULOSE, V18, P359, DOI 10.1007/s10570-011-9492-4
   JUDIS J, 1962, J PHARM SCI, V51, P261, DOI 10.1002/jps.2600510317
   Klarmann E, 1933, J AM CHEM SOC, V5, P4657
   Klemm D, 1998, COMPREHENSIVE CELLUL, VI, P236
   Klemm D, 1998, COMPREHENSIVE CELLUL, P374
   O'Connell DW, 2006, J APPL POLYM SCI, V99, P2888, DOI 10.1002/app.22568
   Pasquinelli F, 1981, DIAGNOSTICA E TECNIC, P222
   REYBROUCK G, 1985, PHARM WEEKBLAD, V7, P100, DOI 10.1007/BF01968710
   Salim R, 2008, J ENVIRON MANAGE, V87, P521, DOI 10.1016/j.jenvman.2007.01.028
   Shin EW, 2007, BIORESOURCE TECHNOL, V98, P588, DOI 10.1016/j.biortech.2006.02.024
   Trombino S., 2007, MACROMOL BIOSCI, V8, P85
   USP, 1995, OXIDIZED REGENERATED, P319
NR 22
TC 8
Z9 9
U1 0
U2 54
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD FEB
PY 2013
VL 20
IS 1
BP 547
EP 557
DI 10.1007/s10570-012-9804-3
PG 11
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 068KN
UT WOS:000313365700047
DA 2018-10-20
ER

PT J
AU Cho, SY
   Chae, SW
   Choi, KW
   Seok, HK
   Kim, YC
   Jung, JY
   Yang, SJ
   Kwon, GJ
   Kim, JT
   Assad, M
AF Cho, Sung Youn
   Chae, Soo-Won
   Choi, Kui Won
   Seok, Hyun Kwang
   Kim, Yu Chan
   Jung, Jae Young
   Yang, Seok Jo
   Kwon, Gyeong Je
   Kim, Jong Tack
   Assad, Michel
TI Biocompatibility and strength retention of biodegradable Mg-Ca-Zn alloy
   bone implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biodegradation; biodegradable metal; absorbable; bone screw; magnesium
ID IN-VIVO CORROSION; MAGNESIUM ALLOYS; MECHANICAL-PROPERTIES;
   INTERNAL-FIXATION; COMPOSITE RODS; RABBIT; POLYMERS; PART; BIOMATERIALS;
   SCREWS
AB The biocompatibility and strength retention of a Mg-Ca-Zn alloy were studied to evaluate its efficacy for osteosynthesis applications. Mg-Ca-Zn alloy and self-reinforced poly l-lactide (SR-PLLA) bone screws were implanted into New Zealand rabbits for radiography analysis, micro computed tomography analysis, histomorphometry, hematology, serum biochemistry, histopathology, and inductively coupled plasma mass spectrometry analysis. Bending and torsion tests were performed on intact specimens to find the initial mechanical strength of these Mg-Ca-Zn alloy bone screws. Strength retention of the Mg-Ca-Zn alloy implants were calculated from in vivo degradation rates and initial mechanical strength. Based on the animal study, Mg-Ca-Zn alloy bone screw showed absence of subcutaneous gas pockets, characteristic surface erosion properties, faster degradation rate than SR-PLLA bone screw, normal reference range of hematology and serum biochemistry, better histopathological response than SR-PLLA bone screw, and stable concentrations of each constituent element in soft tissues surrounding the implants. The initial strength and strength retention of Mg-Ca-Zn alloy were compared with those of various biomaterials. The initial strength of Mg-Ca-Zn alloy was higher than those of biostable and biodegradable polymers. The strength retention of Mg-Ca-Zn alloy bone screws was similar to those of biodegradable polymer. Therefore, this Mg-Ca-Zn alloy represents an excellent biodegradable biomaterial candidate for osteosynthesis applications. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Cho, Sung Youn; Chae, Soo-Won] Korea Univ, Dept Mech Engn, Seoul 136713, South Korea.
   [Seok, Hyun Kwang; Kim, Yu Chan] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Biomat, Seoul 136791, South Korea.
   [Jung, Jae Young] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul 136791, South Korea.
   [Yang, Seok Jo] Chungnam Natl Univ, Dept Mechatron Engn, Taejon 305764, South Korea.
   [Kwon, Gyeong Je; Kim, Jong Tack] U&I Corp, Div LDISQ & Biodegradable Met, Uijongbu 480050, South Korea.
   [Assad, Michel] AccelLAB Inc, Orthoped & Biomat Lab, Boisbriand, PQ, Canada.
RP Chae, SW (reprint author), Korea Univ, Dept Mech Engn, Seoul 136713, South Korea.
EM swchae@korea.ac.kr
RI Jung, Jae-Young/J-2677-2014
OI Jung, Jae-Young/0000-0002-6773-3730; Assad, Michel/0000-0001-8734-0267
FU Basic Science Research Program of Korea [2011-0001142]; Seoul R&BD
   program, Seoul Development Institute, Republic of Korea [SS100008];
   Korea Healthcare Technology R&D Project, Ministry of Health and Welfare,
   Republic of Korea [A101942]
FX Contract grant sponsor: Basic Science Research Program of Korea;
   contract grant number: 2011-0001142; Contract grant sponsor: Seoul R&BD
   program, Seoul Development Institute, Republic of Korea; contract grant
   number: SS100008; Contract grant sponsor: The Korea Healthcare
   Technology R&D Project, Ministry of Health and Welfare, Republic of
   Korea; contract grant number: A101942
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   [Anonymous], 2008, F54307E1 ASTM INT
   [Anonymous], 2008, F13808 ASTM INT
   [Anonymous], 2008, F13608E1 ASTM INT
   [Anonymous], 2008, F202608 ASTM INT
   Archetti I, 2008, 9 WORLD RABB C
   Assad M, 2003, J BIOMED MATER RES B, V64B, P121, DOI 10.1002/jbm.b.10531
   Assad M, 2010, PROTOCOL EVALUATION
   Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Brown H, 1926, J BIOL CHEM, V68, P729
   Buijs G, 2007, J ORAL MAXIL SURG, V65, P2142, DOI 10.1016/j.jams.2007.08.002
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   Cho SY, 2012, J BIOMED MATER RES B, V100B, P1535, DOI 10.1002/jbm.b.32722
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   FALANDYSZ J, 1994, SCI TOTAL ENVIRON, V141, P51, DOI 10.1016/0048-9697(94)90017-5
   Hermida M, 2006, MEAT SCI, V73, P635, DOI 10.1016/j.meatsci.2006.03.004
   International Organization for Standardization(ISO), 2007, 109936 ISO
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Lee JY, 2009, MET MATER INT, V15, P955, DOI 10.1007/s12540-009-0955-1
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lombardi-Boccia G, 2005, J FOOD COMPOS ANAL, V18, P39, DOI 10.1016/j.jfca.2003.10.007
   MAJOLA A, 1992, J MATER SCI-MATER M, V3, P43, DOI 10.1007/BF00702943
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   PIIPER J, 1962, J APPL PHYSIOL, V17, P268
   Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591
   Saikku-Backstrom A, 1999, J MATER SCI-MATER M, V10, P1, DOI 10.1023/A:1008828925090
   SHEELER P, 1964, COMP BIOCHEM PHYSIOL, V11, P139, DOI 10.1016/0010-406X(64)90101-X
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Suchenski M, 2010, ARTHROSCOPY, V26, P821, DOI 10.1016/j.arthro.2009.12.026
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   Witte F, 2008, ORTHOPADE, V37, P125, DOI 10.1007/s00132-008-1193-9
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
NR 48
TC 15
Z9 17
U1 2
U2 119
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2013
VL 101B
IS 2
BP 201
EP 212
DI 10.1002/jbm.b.32813
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068EP
UT WOS:000313348400001
PM 23115061
DA 2018-10-20
ER

PT J
AU Kuboyama, N
   Kiba, H
   Arai, K
   Uchida, R
   Tanimoto, Y
   Bhawal, UK
   Abiko, Y
   Miyamoto, S
   Knight, D
   Asakura, T
   Nishiyama, N
AF Kuboyama, Noboru
   Kiba, Hideo
   Arai, Kiyoshi
   Uchida, Ryoichiro
   Tanimoto, Yasuhiro
   Bhawal, Ujjal K.
   Abiko, Yoshimitsu
   Miyamoto, Sayaka
   Knight, David
   Asakura, Tetsuo
   Nishiyama, Norihiro
TI Silk fibroin-based scaffolds for bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE silk fibroin scaffold; surface morphology; scaffold; bone regeneration
ID OSTEOGENIC DIFFERENTIATION; IN-VITRO; CELLS; BIOMATERIAL; EXPRESSION
AB Porous scaffolds were prepared using regenerated Bombyx mori silk fibroin dissolved in water or hexafluoroisopropanol (HFIP). The effects of these two preparations on the formation and growth of new bone on implantation into the rabbit femoral epicondyle was examined. The aqueous-based fibroin (A-F) scaffold exhibited significantly greater osteoconductivity as judged by bone volume, bone mineral content, and bone mineral density at the implant site than the HFIP-based fibroin (HFIP-F) scaffold. Micro-CT analyses showed that the morphology of the newly formed bone differed significantly in the two types of silk fibroin scaffold. After 4 weeks of implantation, new trabecular bone was seen inside the pores of the A-F scaffold implant while the HFIP-F scaffold only contained necrotic cells. No trabecular bone was seen within the pores of the latter scaffolds, although the pores of these did contain giant cells and granulation tissue. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Kuboyama, Noboru] Nihon Univ, Dept Pharmacol, Sch Dent, Matsudo, Chiba 2718587, Japan.
   [Kiba, Hideo] Nihon Univ, Dept Oral Pathol, Sch Dent, Matsudo, Chiba 2718587, Japan.
   [Arai, Kiyoshi] Nihon Univ, Dept Pediat Dent, Sch Dent, Matsudo, Chiba 2718587, Japan.
   [Uchida, Ryoichiro; Tanimoto, Yasuhiro; Nishiyama, Norihiro] Nihon Univ, Dept Dent Biomat, Sch Dent, Matsudo, Chiba 2718587, Japan.
   [Bhawal, Ujjal K.; Abiko, Yoshimitsu] Nihon Univ, Dept Biochem & Mol Biol, Sch Dent, Matsudo, Chiba 2718587, Japan.
   [Miyamoto, Sayaka; Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
   [Knight, David] Oxford Biomat Ltd, Magdalen Ctr, Oxford OX4 4GX, England.
RP Nishiyama, N (reprint author), Nihon Univ, Dept Dent Biomat, Sch Dent, Matsudo, Chiba 2718587, Japan.
EM nishiyama.norihiro@nihon-u.ac.jp
RI Asakura, Tetsuo/B-9970-2013
FU Ministry of Education, Culture, Sports, Science and Technology
   [18105007, 23245045]; Ministry of Agriculture, Forestry and Fisheries of
   Japan (Agri-Health Translational Research Project)
FX Contract grant sponsor: Ministry of Education, Culture, Sports, Science
   and Technology; contract grant number: 18105007 and 23245045; Contract
   grant sponsor: the Ministry of Agriculture, Forestry and Fisheries of
   Japan (Agri-Health Translational Research Project)
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Hee CK, 2006, BIOMATERIALS, V27, P875, DOI 10.1016/j.biomaterials.2005.07.004
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shibli JA, 2007, J BIOMED MATER RES B, V80B, P377, DOI 10.1002/jbm.b.30608
   Stiehler ML, 2006, BIOMATERIALS, V27, P875
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 21
TC 21
Z9 23
U1 2
U2 60
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2013
VL 101B
IS 2
BP 295
EP 302
DI 10.1002/jbm.b.32839
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068EP
UT WOS:000313348400010
PM 23125151
DA 2018-10-20
ER

PT J
AU Noro, A
   Kaneko, M
   Murata, I
   Yoshinari, M
AF Noro, Akio
   Kaneko, Morio
   Murata, Isao
   Yoshinari, Masao
TI Influence of surface topography and surface physicochemistry on
   wettability of zirconia (tetragonal zirconia polycrystal)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zirconia; hydrophilicity; surface modification; oxygen plasma;
   ultraviolet light
ID LOW-TEMPERATURE DEGRADATION; TITANIUM IMPLANT SURFACES; OSTEOBLAST-LIKE
   CELLS; Y-TZP CERAMICS; ADHESION; STRENGTH; BIOMATERIAL; BONE;
   FUNCTIONALIZATION; HYDROPHILICITY
AB Surface modification technologies are available for tetragonal zirconia polycrystal (TZP) to enhance its bioactivity and osseointegration capability. The surface wettability of an implant material is one of the important factors in the process of osseointegration, possibly regulating protein adsorption, and subsequent cell behavior. The aim of this study was to clarify the effect of topographical or physicochemical modification of TZP ceramics on wettability to determine the potential of such treatment in application to implants. Several types of surface topography were produced by alumina blasting and acid etching with hydrofluoric acid; surface physicochemistry was modified with oxygen (O2) plasma, ultraviolet (UV) light, or hydrogen peroxide treatment. The obtained specimens were also subjected to storage under various conditions to evaluate their potential to maintain superhydrophilicity. The results showed that surface modification of surface topography or physicochemistry, especially of blast/acid etching as well as O2 plasma and UV treatment, greatly increased the surface wettability, resulting in superhydrophilicity. X-ray photoelectron spectroscopy revealed that a remarkable decrease in carbon content and the introduction of hydroxyl groups were responsible for the observed superhydrophilicity. Furthermore, superhydrophilicity was maintained, even after immersion in an aqueous solution, an important consideration in the clinical application of this technology. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Noro, Akio; Yoshinari, Masao] Tokyo Dent Coll, Div Oral Implants Res, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
   [Noro, Akio] Chiba Hosp, Div Gen Dent, Tokyo Dent Coll, Mihama Ku, Chiba 2618502, Japan.
   [Kaneko, Morio; Murata, Isao] Japan Inst Adv Dent, Minato Ku, Tokyo 1050014, Japan.
   Div Oral Implants Res, Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
RP Yoshinari, M (reprint author), Tokyo Dent Coll, Div Oral Implants Res, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
EM yosinari@tdc.ac.jp
FU Oral Health Science Center from Tokyo Dental College, a "High-Tech
   Research Center" Project for Private Universities: Matching Fund from
   MEXT (Ministry of Education, Culture, Sports, Science and Technology) of
   Japan [hrc7, hrc8]; Japan Society for the Promotion of Science
   [B:18390524, 18659581]
FX Contract grant sponsor: Oral Health Science Center Grant hrc7 and hrc8
   from Tokyo Dental College, a "High-Tech Research Center" Project for
   Private Universities: Matching Fund Subsidy from MEXT (Ministry of
   Education, Culture, Sports, Science and Technology) of Japan, 2006-2010
   and 2010-2012.; Contract grant sponsor: Japan Society for the Promotion
   of Science (Grant-in-Aid for Scientific Research); contract grant
   numbers: B:18390524 and 18659581
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   BOEHM HP, 1971, DISCUSS FARADAY SOC, P264
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Depprich R, 2008, HEAD FACE MED, V4, P1, DOI DOI 10.1186/1746-160X-4-1
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Drelich J, 2010, LANGMUIR, V26, P18621, DOI 10.1021/la1039893
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Feng XJ, 2006, ADV MATER, V18, P3063, DOI 10.1002/adma.200501961
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P281, DOI 10.1111/j.1600-0501.2011.02157.x
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kim WJ, 2009, LANGMUIR, V25, P11692, DOI 10.1021/la901615e
   Kirsten A, 2010, J BIOMED MATER RES B, V95B, P202, DOI 10.1002/jbm.b.31703
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x
   Kohal RJ, 2010, CLIN ORAL IMPLAN RES, V21, P1345, DOI 10.1111/j.1600-0501.2010.01954.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Liu Z, 2005, J PHYS CHEM B, V109, P1251, DOI 10.1021/jp046368q
   Park JH, 2011, ACTA BIOMATER
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Takeuchi M, 2005, J PHYS CHEM B, V109, P15422, DOI 10.1021/jp058075i
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang XC, 2006, ENVIRON SCI TECHNOL, V40, P2369, DOI 10.1021/es052000a
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wu JM, 2002, SCRIPTA MATER, V46, P101, DOI 10.1016/S1359-6462(01)01207-6
   Yoshinari M, 2002, MATER TRANS, V43, P2494, DOI 10.2320/matertrans.43.2494
   Yoshinari M, 2011, JPN DENT SCI REV, V47, P89, DOI 10.1016/j.jdsr.2011.03.001
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P166, DOI 10.1002/jbm.b.30083
   Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c
NR 50
TC 40
Z9 41
U1 1
U2 39
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2013
VL 101B
IS 2
BP 355
EP 363
DI 10.1002/jbm.b.32846
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068EP
UT WOS:000313348400017
PM 23165774
DA 2018-10-20
ER

PT J
AU McMahon, RE
   Wang, LN
   Skoracki, R
   Mathur, AB
AF McMahon, Rebecca E.
   Wang, Lina
   Skoracki, Roman
   Mathur, Anshu B.
TI Development of nanomaterials for bone repair and regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE bone; regenerative medicine; tissue engineering; nanomaterials;
   cell-material interactions
ID REFLECTION FLUORESCENCE MICROSCOPY; ELECTROSPUN COMPOSITE NANOFIBERS;
   ENHANCED OSTEOBLAST ADHESION; TISSUE ENGINEERING SCAFFOLDS; IN-VIVO
   BIOCOMPATIBILITY; NANO-FIBROUS SCAFFOLDS; NANOPHASE CERAMICS;
   CELL-ADHESION; NANOSTRUCTURED BIOMATERIALS; MECHANICAL-PROPERTIES
AB Bone is a nanocomposite composed of organic (mainly collagen) and inorganic (nanocrystalline hydroxyapatite) components, with a hierarchical structure ranging from nano- to macroscale. Its functions include providing mechanical support and transmitting physio-chemical and mechano-chemical cues. Clinical repair and reconstruction of bone defects has been conducted using autologous and allogeneic tissues and alloplastic materials, with functional limitations. The design and development of biomaterial scaffolds that will replace the form and function of native tissue while promoting regeneration without necrosis or scar formation is a challenging area of research. Nanomaterials and nanocomposites are promising platforms to recapitulate the organization of natural extracellular matrix for the fabrication of functional bone tissues because nanostructure provides a closer approximation to native bone architecture. Nanostructured scaffolds provide structural support for the cells and regulate cell proliferation, differentiation, and migration, which results in the formation of functional tissues. Unique properties of nanomaterials, such as increased wettability and surface area, lead to increased protein adsorption when compared with conventional biomaterials. Cellscaffold interactions at the cellmaterial nanointerface may be mediated by integrin-triggered signaling pathways that affect cell behavior. The materials selection and processing techniques can affect the chemical, physical, mechanical, and cellular recognition properties of biomaterials. In this article, we focused on reviewing current fabrication techniques for nanomaterials and nanocomposites, their cell interaction properties and their application in bone tissue engineering and regeneration. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [McMahon, Rebecca E.; Wang, Lina; Skoracki, Roman; Mathur, Anshu B.] Univ Texas MD Anderson Canc Ctr, Tissue Regenerat & Mol Cell Engn Lab, Dept Plast Surg, Houston, TX 77030 USA.
RP Mathur, AB (reprint author), Univ Texas MD Anderson Canc Ctr, Tissue Regenerat & Mol Cell Engn Lab, Dept Plast Surg, Houston, TX 77030 USA.
EM amathur@mdanderson.org
OI Mathur, Anshu/0000-0002-6689-5906
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   Arcangeli E, 2009, J APPL BIOMATER BIOM, V7, P52
   Arimura H, 2005, J BIOMAT SCI-POLYM E, V16, P1347, DOI 10.1163/156856205774472353
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Aryal S, 2006, SCRIPTA MATER, V54, P131, DOI 10.1016/j.scriptamat.2005.09.050
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bohner M, 2000, INJURY, V31, pS37
   Burmeister JS, 1998, BIOMATERIALS, V19, P307, DOI 10.1016/S0142-9612(97)00109-9
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Calandrelli L, 2010, J MATER SCI-MATER M, V21, P2923, DOI 10.1007/s10856-010-4156-8
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Cheng MH, 2005, TISSUE ENG, V11, P214, DOI 10.1089/ten.2005.11.214
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   Choi MG, 2005, P NATL ACAD SCI USA, V102, P4578, DOI 10.1073/pnas.0500693102
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Currey J.D., 2002, BONES STRUCTURE MECH
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Duan B, 2010, ACTA BIOMATER, V6, P4495, DOI 10.1016/j.actbio.2010.06.024
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fenniri H, 2001, J AM CHEM SOC, V123, P3854, DOI 10.1021/ja0058861
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gupta V, 2009, INT J NANOMED, V4, P115
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Ishihara A, 2012, EXPERT OPIN BIOL TH, V12, P411, DOI 10.1517/14712598.2012.661709
   James R, 2011, FRONT MATER SCI, V5, P342, DOI 10.1007/s11706-011-0151-3
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Khadka A, 2011, J CRANIOFAC SURG, V22, P1852, DOI 10.1097/SCS.0b013e31822e8274
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Laschke MW, 2006, J VASC RES, V43, P566
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lemperle G, 2004, PLAST RECONSTR SURG, V113, P1380, DOI 10.1097/01.PRS.0000112764.22839.7A
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Mathur AB, 2000, BIOPHYS J, V78, P1725, DOI 10.1016/S0006-3495(00)76724-5
   Matsuno T, 2008, DENT MATER J, V27, P827, DOI 10.4012/dmj.27.827
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Miller MJ, 2000, SEMIN SURG ONCOL, V19, P294
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Petrie TA, 2010, SCI TRANSL MED, V2
   Prabhakaran MP, 2011, J NANOSCI NANOTECHNO, V11, P3039, DOI 10.1166/jnn.2011.3753
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Qu D, 2011, J BIOMED MAT RES A
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rios CN, 2009, TISSUE ENG PT A, V15, P2717, DOI 10.1089/ten.TEA.2008.0360
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Scheller EL, 2012, J CRANIOFAC SURG, V23, P333, DOI 10.1097/SCS.0b013e318241dc11
   Schneider OD, 2009, ACTA BIOMATER, V5, P1775, DOI 10.1016/j.actbio.2008.11.030
   Schofer MD, 2011, J MATER SCI-MATER M, V22, P1753, DOI 10.1007/s10856-011-4341-4
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Song JH, 2007, J BIOMED MATER RES B, V83B, P248, DOI 10.1002/jbm.b.30790
   Thomas V, 2009, BIOTECHNOL BIOENG, V104, P1025, DOI 10.1002/bit.22467
   Toprak MS, 2007, ADV MATER, V19, P1362, DOI 10.1002/adma.200602114
   Van Tomme SR, 2008, BIOMACROMOLECULES, V9, P158, DOI 10.1021/bm700931q
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2009, J BIOMED MATER RES B, V91B, P545, DOI 10.1002/jbm.b.31428
   Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Zhang H, 2011, J BIOACT COMPAT POLY, V26, P16
   Zhang LJ, 2008, TISSUE ENG PT A, V14, P1353, DOI 10.1089/ten.tea.2006.0436
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
   Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005
NR 92
TC 77
Z9 80
U1 6
U2 351
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2013
VL 101B
IS 2
BP 387
EP 397
DI 10.1002/jbm.b.32823
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068EP
UT WOS:000313348400020
PM 23281143
DA 2018-10-20
ER

PT J
AU Zachman, AL
   Crowder, SW
   Ortiz, O
   Zienkiewicz, KJ
   Bronikowski, CM
   Yu, SS
   Giorgio, TD
   Guelcher, SA
   Kohn, J
   Sung, HJ
AF Zachman, Angela L.
   Crowder, Spencer W.
   Ortiz, Ophir
   Zienkiewicz, Katarzyna J.
   Bronikowski, Christine M.
   Yu, Shann S.
   Giorgio, Todd D.
   Guelcher, Scott A.
   Kohn, Joachim
   Sung, Hak-Joon
TI Pro-angiogenic and Anti-inflammatory Regulation by Functional Peptides
   Loaded in Polymeric Implants for Soft Tissue Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ACTIVATED HUMAN NEUTROPHILS; TETRAPEPTIDE ACSDKP; ENDOTHELIAL-CELLS;
   IN-VITRO; MACROPHAGE ACTIVATION; MYOCARDIAL-INFARCTION; AC-SDKP;
   INFLAMMATION; BIOMATERIALS; NEOVASCULARIZATION
AB Inflammation and angiogenesis are inevitable in vivo responses to biomaterial implants. Continuous progress has been made in biomaterial design to improve tissue interactions with an implant by either reducing inflammation or promoting angiogenesis. However, it has become increasingly clear that the physiological processes of inflammation and angiogenesis are interconnected through various molecular mechanisms. Hence, there is an unmet need for engineering functional tissues by simultaneous activation of pro-angiogenic and anti-inflammatory responses to biomaterial implants. In this work, the modulus and fibrinogen adsorption of porous scaffolds were tuned to meet the requirements (i.e., similar to 100 kPa and similar to 10 nm, respectively), for soft tissue regeneration by employing tyrosine-derived combinatorial polymers with polyethylene glycol crosslinkers. Two types of functional peptides (i.e., pro-angiogenic laminin-derived C16 and anti-inflammatory thymosin beta 4-derived Ac-SDKP) were loaded in porous scaffolds through collagen gel embedding so that peptides were released in a controlled fashion, mimicking degradation of the extracellular matrix. The results from (1) in vitro coculture of human umbilical vein endothelial cells and human blood-derived macrophages and (2) in vivo subcutaneous implantation revealed the directly proportional relationship between angiogenic activities (i.e., tubulogenesis and perfusion capacity) and inflammatory activities (i.e., phagocytosis and F4/80 expression) upon treatment with either type of peptide. Interestingly, cotreatment with both types of peptides upregulated the angiogenic responses, while downregulating the inflammatory responses. Also, anti-inflammatory Ac-SDKP peptides reduced production of pro-inflammatory cytokines (i.e., interleukin [IL]-1 beta, IL-/6, IL-8, and tumor necrosis factor alpha) even when treated in combination with pro-angiogenic C16 peptides. In addition to independent regulation of angiogenesis and inflammation, this study suggests a promising approach to improve soft tissue regeneration (e. g., blood vessel and heart muscle) when inflammatory diseases (e. g., ischemic tissue fibrosis and atherosclerosis) limit the regeneration process.
C1 [Zachman, Angela L.; Crowder, Spencer W.; Zienkiewicz, Katarzyna J.; Bronikowski, Christine M.; Yu, Shann S.; Giorgio, Todd D.; Guelcher, Scott A.; Sung, Hak-Joon] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
   [Zachman, Angela L.; Crowder, Spencer W.; Guelcher, Scott A.; Sung, Hak-Joon] Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37235 USA.
   [Ortiz, Ophir; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ USA.
   [Giorgio, Todd D.; Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.
RP Sung, HJ (reprint author), Vanderbilt Univ, Dept Biomed Engn, VU Stn,B 351631,2301 Vanderbilt Pl, Nashville, TN 37235 USA.
EM hak-joon.sung@vanderbilt.edu
RI Yu, Shann/D-2586-2011
OI Yu, Shann/0000-0002-4461-793X
FU NIH [HL091465]; NSF [1006558]; Department of Defense [W81XWH-10-1-0684]
FX The authors acknowledge Aidan R. W. Boone for his assistance in
   experimenting, the Vanderbilt Institute of Nanoscale Science and
   Engineering (VINSE) for SEM imaging, Jason Tucker-Swartz, Dr. Melissa
   Skala for OCT imaging, Dr. Hynda K. Kleinman (NIH) for her helpful
   discussions, the Vanderbilt University School of Medicine (VUMC) Cell
   Imaging Shared Resource for confocal imaging, and Will Stokes and Dr.
   Xintong Wang for HPLC measurement. This study was supported by NIH
   HL091465 and NSF 1006558. SSY and TDG acknowledge support from a grant
   from the Department of Defense Congressionally Directed Medical Research
   Programs #W81XWH-10-1-0684. VINSE is housed in facilities renovated
   under NSF ARI-R2 DMR-0963361.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Alexandru N, 2012, THROMB RES, V129, P116, DOI 10.1016/j.thromres.2011.09.026
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134
   Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7
   BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278
   Cavasin Maria A, 2006, Am J Cardiovasc Drugs, V6, P305, DOI 10.2165/00129784-200606050-00003
   Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453
   Choi APC, 2005, MED BIOL ENG COMPUT, V43, P258, DOI 10.1007/BF02345964
   Cingolani OH, 2004, HYPERTENSION, V43, P1067, DOI 10.1161/01.HYP.0000125013.22494.c5
   CLARK RAF, 1986, J CELL SCI, V82, P263
   Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0
   COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
   Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031
   Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Dziubla TD, 2004, J BIOMED MATER RES A, V68A, P603, DOI 10.1002/jbm.a.20023
   Fleiner M, 2004, CIRCULATION, V110, P2843, DOI 10.1161/01.CIR.0000146787.16297.E8
   Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813
   Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171
   Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62
   Kitamura N, 2000, CLIN EXP IMMUNOL, V120, P66, DOI 10.1046/j.1365-2249.2000.01162.x
   Kuratomi Y, 2002, BRIT J CANCER, V86, P1169, DOI 10.1038/sj/bjc/6600187
   Lee S, 2002, J CLIN INVEST, V110, P1105, DOI 10.1172/JCI200215755
   Liu JM, 2003, BLOOD, V101, P3014, DOI 10.1182/blood-2002-07-2315
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Magno MHR, 2010, J MATER CHEM, V20, P8885, DOI 10.1039/c0jm00868k
   Malinda KM, 1999, FASEB J, V13, P53
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799
   Ponce ML, 2003, CANCER RES, V63, P5060
   Ponce ML, 2001, FASEB J, V15, P1389, DOI 10.1096/fj.00-0736com
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09
   Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/01.hjh.0000098224.37783.55
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   Ring A, 2006, EUR J MED RES, V11, P471
   Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x
   Scapini P, 2002, J IMMUNOL, V168, P5798, DOI 10.4049/jimmunol.168.11.5798
   Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014
   Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307
   Sung HJ, 2008, EUR CELLS MATER, V15, P77, DOI 10.22203/eCM.v015a06
   Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006
   Sung HJ, 2010, SOFT MATTER, V6, P5196, DOI 10.1039/c0sm00172d
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Sung HJ, 2005, TISSUE ENG, V11, P267, DOI 10.1089/ten.2005.11.267
   Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Volkov L, 1996, CELL IMMUNOL, V168, P302, DOI 10.1006/cimm.1996.0080
   Waeckel L, 2006, ARTERIOSCL THROM VAS, V26, P773, DOI 10.1161/01.ATV.0000203510.96492.14
   WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2
   Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Xue Y, 2010, TOXICOL IN VITRO, V24, P404, DOI 10.1016/j.tiv.2009.10.018
   Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
NR 68
TC 14
Z9 14
U1 0
U2 41
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2013
VL 19
IS 3-4
BP 437
EP 447
DI 10.1089/ten.tea.2012.0158
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 069GQ
UT WOS:000313423700012
PM 22953721
OA Green Published
DA 2018-10-20
ER

PT J
AU Hussain, A
   Collins, G
   Yip, D
   Cho, CH
AF Hussain, Ali
   Collins, George
   Yip, Derek
   Cho, Cheul H.
TI Functional 3-D cardiac co-culture model using bioactive chitosan
   nanofiber scaffolds
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE electrospinning; chitosan nanofibers; fibronectin adsorption;
   cardiomyocytes; co-cultures
ID TISSUE ENGINEERING APPLICATIONS; GAP JUNCTION CHANNELS; LONG-TERM
   SURVIVAL; IN-VITRO; MYOCARDIAL-INFARCTION; NONPARENCHYMAL CELLS;
   EXTRACELLULAR-MATRIX; RAT HEPATOCYTES; HEART-FAILURE; FIBROBLASTS
AB The in vitro generation of a three-dimensional (3-D) myocardial tissue-like construct employing cells, biomaterials, and biomolecules is a promising strategy in cardiac tissue regeneration, drug testing, and tissue engineering applications. Despite significant progress in this field, current cardiac tissue models are not yet able to stably maintain functional characteristics of cardiomyocytes for long-term culture and therapeutic purposes. The objective of this study was to fabricate bioactive 3-D chitosan nanofiber scaffolds using an electrospinning technique and exploring its potential for long-term cardiac function in the 3-D co-culture model. Chitosan is a natural polysaccharide biomaterial that is biocompatible, biodegradable, non-toxic, and cost effective. Electrospun chitosan was utilized to provide structural scaffolding characterized by scale and architectural resemblance to the extracellular matrix (ECM) in vivo. The chitosan fibers were coated with fibronectin via adsorption in order to enhance cellular adhesion to the fibers and migration into the interfibrous milieu. Ventricular cardiomyocytes were harvested from neonatal rats and studied in various culture conditions (i.e., mono- and co-cultures) for their viability and function. Cellular morphology and functionality were examined using immunofluorescent staining for alpha-sarcomeric actin (SM-actin) and gap junction protein, Connexin-43 (Cx43). Scanning electron microscopy (SEM) and light microscopy were used to investigate cellular morphology, spatial organization, and contractions. Calcium indicator was used to monitor calcium ion flux of beating cardiomyocytes. The results demonstrate that the chitosan nanofibers retained their cylindrical morphology in long-term cell cultures and exhibited good cellular attachment and spreading in the presence of adhesion molecule, fibronectin. Cardiomyocyte mono-cultures resulted in loss of cardiomyocyte polarity and islands of non-coherent contractions. However, the cardiomyocyte-fibroblast co-cultures resulted in polarized cardiomyocyte morphology and retained their morphology and function for long-term culture. The Cx43 expression in the fibroblast co-culture was higher than the cardiomyocytes mono-culture and endothelial cells co-culture. In addition, fibroblast co-cultures demonstrated synchronized contractions involving large tissue-like cellular networks. To our knowledge, this is the first attempt to test chitosan nanofiber scaffolds as a 3-D cardiac co-culture model. Our results demonstrate that chitosan nanofibers can serve as a potential scaffold that can retain cardiac structure and function. These studies will provide useful information to develop a strategy that allows us to generate engineered 3-D cardiac tissue constructs using biocompatible and biodegradable chitosan nanofiber scaffolds for many tissue engineering applications. Biotechnol. Bioeng. 2013; 110: 637647. (c) 2012 Wiley Periodicals, Inc.
C1 [Hussain, Ali; Collins, George; Yip, Derek; Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Univ Hts Newark, NJ 07102 USA.
RP Cho, CH (reprint author), New Jersey Inst Technol, Dept Biomed Engn, Univ Hts Newark, NJ 07102 USA.
EM cho@njit.edu
FU Wallace H. Coulter Foundation; New Jersey Institute of Technology
FX We thank Dr. Junichi Sadoshima from University of Medicine and Dentistry
   of New Jersey (UMDNJ)-New Jersey Medical School for the technical
   support on isolating primary cardiomyocytes from neonatal rat heart. We
   thank Dr. Haesun Kim from Rutgers University for providing neonatal rat
   hearts. This study was partially supported by the Wallace H. Coulter
   Foundation and the startup funding from New Jersey Institute of
   Technology.
CR Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666
   Baig MK, 1998, AM HEART J, V135, pS216, DOI 10.1016/S0002-8703(98)70252-2
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Bhatia SN, 1999, FASEB J, V13, P1883
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Cho CH, 2008, BIOTECHNOL BIOENG, V101, P345, DOI 10.1002/bit.21911
   Cho CH, 2008, J BIOMED MATER RES A, V86A, P98, DOI 10.1002/jbm.a.31614
   CLEMENT B, 1984, HEPATOLOGY, V4, P373, DOI 10.1002/hep.1840040305
   Desai K, 2008, BIOMACROMOLECULES, V9, P1000, DOI 10.1021/bm701017z
   Doughty M, 1997, J AM COLL CARDIOL, V29, P1060
   Driesen RB, 2005, CARDIOVASC RES, V68, P37, DOI 10.1016/j.cardiores.2005.05.020
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C
   GOULET F, 1988, HEPATOLOGY, V8, P1010, DOI 10.1002/hep.1840080506
   GUILLOUZO A, 1984, BIOCHEM BIOPH RES CO, V120, P311, DOI 10.1016/0006-291X(84)91255-5
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kizana E, 2006, GENE THER, V13, P1611, DOI 10.1038/sj.gt.3302813
   KOH GY, 1993, AM J PHYSIOL, V264, pH1727
   KOH GY, 1993, J CLIN INVEST, V92, P1548, DOI 10.1172/JCI116734
   Kumar R.M.N.V., 2000, REACT FUNCT POLYM, V46, P1
   LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006
   LOREAL O, 1993, AM J PATHOL, V143, P538
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Martinez C, 2007, AM J GERIATR CARDIOL, V15, P82
   Matthew HW, 2003, BIODEGRADABLE POLY 2, V2, P35
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Packer M, 2002, J CARD FAIL, V8, P193, DOI 10.1054/jcaf.2002.128001
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   ROOK MB, 1992, AM J PHYSIOL, V263, pC959
   Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036
   Schussler Olivier, 2010, Asian Cardiovasc Thorac Ann, V18, P188, DOI 10.1177/0218492310361531
   SHARPE N, 1991, LANCET, V337, P872, DOI 10.1016/0140-6736(91)90202-Z
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003
   Stupack DG, 2005, CELL DEATH DIFFER, V12, P1021, DOI 10.1038/sj.cdd.4401658
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 53
TC 54
Z9 54
U1 5
U2 103
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD FEB
PY 2013
VL 110
IS 2
BP 637
EP 647
DI 10.1002/bit.24727
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 062TQ
UT WOS:000312945800029
PM 22991229
DA 2018-10-20
ER

PT J
AU Muth, J
   Poggie, M
   Kulesha, G
   Meneghini, RM
AF Muth, John
   Poggie, Matthew
   Kulesha, Gene
   Meneghini, R. Michael
TI Novel Highly Porous Metal Technology in Artificial Hip and Knee
   Replacement: Processing Methodologies and Clinical Applications
SO JOM
LA English
DT Article
ID TANTALUM BIOMATERIAL; BONE INGROWTH; COMPOSITES; IMPLANTS; FIXATION;
   SURFACE
AB Hip and knee replacement can dramatically improve a patient's quality of life through pain relief and restored function. Fixation of hip and knee replacement implants to bone is critical to the success of the procedure. A variety of roughened surfaces and three-dimensional porous surfaces have been used to enhance biological fixation on orthopedic implants. Recently, highly porous metals have emerged as versatile biomaterials that may enhance fixation to bone and are suitable to a number of applications in hip and knee replacement surgery. This article provides an overview of several processes used to create these implant surfaces.
C1 [Muth, John; Poggie, Matthew; Kulesha, Gene] Stryker Orthopaed, Mahwah, NJ 07430 USA.
   [Meneghini, R. Michael] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA.
RP Muth, J (reprint author), Stryker Orthopaed, Mahwah, NJ 07430 USA.
EM matt.poggie@stryker.com; rm_meneghini@yahoo.com
OI Meneghini, Robert/0000-0001-9602-3925
CR [Anonymous], 1994, GUID DOC TEST ORTH I
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Hofmann AA, 2001, CLIN ORTHOP RELAT R, P85
   HUNGERFORD DS, 1983, CLIN ORTHOP RELAT R, V176, P95
   LEMBERT E, 1972, CLIN ORTHOP RELAT R, P303
   Ngo C., ORS 2009 ANN M
   Pilliar R.M., 1980, ORTHOP REV, VIX, P85
   Ricci J.L., 1997, 23 ANN M SOC BIOM NE
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 14
TC 9
Z9 9
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD FEB
PY 2013
VL 65
IS 2
BP 318
EP 325
DI 10.1007/s11837-012-0528-5
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 064HM
UT WOS:000313064800024
OA Other Gold
DA 2018-10-20
ER

PT J
AU Osathanon, T
   Ritprajak, P
   Nowwarote, N
   Manokawinchoke, J
   Giachelli, C
   Pavasant, P
AF Osathanon, Thanaphum
   Ritprajak, Patcharee
   Nowwarote, Nunthawan
   Manokawinchoke, Jeeranan
   Giachelli, Cecilia
   Pavasant, Prasit
TI Surface-bound orientated Jagged-1 enhances osteogenic differentiation of
   human periodontal ligament-derived mesenchymal stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE notch signaling; Jagged-1; human periodontal ligament-derived
   mesenchymal stem cells; osteoblast differentiation; TWIST
ID HUMAN DENTAL-PULP; NOTCH SIGNALING PATHWAY; OSTEOBLASTIC
   DIFFERENTIATION; EXPRESSION; MINERALIZATION; INTERFACE
AB Notch signaling plays critical roles in various cell types by regulating cell fate determination and differentiation. Here, we investigated the ability to control differentiation of human periodontal ligament derived mesenchymal stem cells using modified surfaces containing the affinity immobilized Notch ligand, Jagged-1. After seeding human periodontal ligament derived mesenchymal stem cells (HPDLs) on Jagged-1 modified surfaces, expression of Notch signaling target genes, Hes-1 and Hey-1, was higher than those exposed to soluble Jagged-1 or control surfaces. Upregulation of Notch signaling target genes was attenuated after treatment with the ? secretase inhibitor. Upon seeding the cells on Jagged-1 immobilized surface and maintained in osteogenic medium, alkaline phosphatase enzymatic activity and mineralization as well as mRNA expression of alkaline phosphatase (ALP), collagen type I (COL I) and osteopontin (OPN) were significantly increased compared to those of controls. However, osteocalcin (OCN) mRNA expression level was decreased when cells were exposed to Jagged-1 modified surfaces. HPDLs on Jagged-1 modified surfaces expressed lower TWIST2 mRNA levels than the control, suggesting that the mechanism whereby Jagged-1 enhances osteogenic differentiation of HPDLs may occur through Notch signaling and TWIST regulation. In summary, an alteration of biomaterial interface using Notch ligands illustrates a promising system to control HPDLs differentiation toward osteogenic lineage. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Osathanon, Thanaphum; Ritprajak, Patcharee; Nowwarote, Nunthawan; Manokawinchoke, Jeeranan; Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Res Unit Mineralized Tissue, Bangkok, Thailand.
   [Osathanon, Thanaphum; Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok, Thailand.
   [Ritprajak, Patcharee] Chulalongkorn Univ, Fac Dent, Dept Microbiol, Bangkok, Thailand.
   [Giachelli, Cecilia] Univ Washington, Coll Engn, Dept Bioengn, Seattle, WA 98195 USA.
RP Pavasant, P (reprint author), Chulalongkorn Univ, Fac Dent, Res Unit Mineralized Tissue, Bangkok, Thailand.
EM prasit215@gmail.com
FU Thailand Research Fund [MRG5480112]; Chulalongkorn University Young
   Investigator Research Promotion Grant; Integrated Innovation Academic
   Center (IIAC) Chulalongkorn University Centenary Academic Development
   Project
FX Contract grant sponsors: Thailand Research Fund; contract grant number:
   MRG5480112, Chulalongkorn University Young Investigator Research
   Promotion Grant, and Integrated Innovation Academic Center (IIAC)
   Chulalongkorn University Centenary Academic Development Project
CR Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518
   Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Huang CYC, 2009, REGEN MED, V4, P809, DOI 10.2217/RME.09.55
   Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181
   Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526
   Komaki M, 2007, J CELL BIOCHEM, V100, P303, DOI 10.1002/jcb.21038
   Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287
   Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)91012-7, 10.1016/S0070-2153(10)92012-7]
   Lovschall H, 2005, EUR J ORAL SCI, V113, P312, DOI 10.1111/j.1600-0722.2005.00221.x
   Luckprom P, 2010, J PERIODONTAL RES, V45, P404, DOI 10.1111/j.1600-0765.2009.01256.x
   Mitsiadis T A, 2011, Adv Dent Res, V23, P275, DOI 10.1177/0022034511405386
   Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200
   Osathanon T, 2011, J CELL BIOCHEM, V112, P1807, DOI 10.1002/jcb.23097
   Sagi B, 2012, STEM CELLS DEV, V21, P814, DOI 10.1089/scd.2011.0551
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3
   Shimizu T, 2011, J BIOL CHEM, V286, P19138, DOI 10.1074/jbc.M110.175786
   Singhatanadgit W, 2009, TISSUE ENG PT A, V15, P2625, DOI [10.1089/ten.tea.2008.0442, 10.1089/ten.TEA.2008.0442]
   Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141
   Ugarte F, 2009, EXP HEMATOL, V37, P867, DOI 10.1016/j.exphem.2009.03.007
   Yousfi M, 2001, J CLIN INVEST, V107, P1153, DOI 10.1172/JCI11846
   Zhang C, 2008, J DENT RES, V87, P250, DOI 10.1177/154405910808700312
NR 27
TC 33
Z9 36
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 358
EP 367
DI 10.1002/jbm.a.34332
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000006
PM 22847978
DA 2018-10-20
ER

PT J
AU White, JC
   Stoppel, WL
   Roberts, SC
   Bhatia, SR
AF White, Joseph C.
   Stoppel, Whitney L.
   Roberts, Susan C.
   Bhatia, Surita R.
TI Addition of perfluorocarbons to alginate hydrogels significantly impacts
   molecular transport and fracture stress
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE perfluorocarbon; alginate; rheology; synthetic oxygen carrier; protein
   transport
ID OXYGEN CARRIERS; MATHEMATICAL-MODEL; NETWORK HYDROGELS; ISLET ISOLATION;
   CARDIAC TISSUE; IN-VITRO; DIFFUSION; DELIVERY; GELS; DIFFERENTIATION
AB Perfluorocarbons (PFCs) are used in biomaterial formulations to increase oxygen (O2) tension and create a homogeneous O2 environment in three-dimensional tissue constructs. It is unclear how PFCs affect mechanical and transport properties of the scaffold, which are critical for robustness, intracellular signaling, protein transport, and overall device efficacy. In this study, we investigate composite alginate hydrogels containing a perfluorooctyl bromide (PFOB) emulsion stabilized with Pluronic (R) F68 (F68). We demonstrate that PFC addition significantly affects biomaterial properties and performance. Solution and hydrogel mechanical properties and transport of representative hydrophilic (riboflavin), hydrophobic (methyl and ethyl paraben), and protein (bovine serum albumin, BSA) solutes were compared in alginate/F68 composite hydrogels with or without PFOB. Our results indicate that mechanical properties of the alginate/F68/PFOB hydrogels are not significantly affected under small strains, but a significant decrease fracture stress is observed. The effective diffusivity Deff of hydrophobic small molecules decreases with PFOB emulsion addition, yet the Deff of hydrophilic small molecules remained unaffected. For BSA, the Deff increased and the loading capacity decreased with PFOB emulsion addition. Thus, a trade-off between the desired increased O2 supply provided by PFCs and the mechanical weakening and change in transport of cellular signals must be carefully considered in the design of biomaterials containing PFCs. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [White, Joseph C.; Stoppel, Whitney L.; Roberts, Susan C.; Bhatia, Surita R.] Univ Massachusetts, Dept Chem Engn, Goessmann Lab 159, Amherst, MA 01003 USA.
RP Bhatia, SR (reprint author), Univ Massachusetts, Dept Chem Engn, Goessmann Lab 159, 686 N Pleasant St, Amherst, MA 01003 USA.
EM sbhatia@ecs.umass.edu
RI Bhatia, Surita/B-4536-2008; White, Joe/I-8148-2015
FU National Science Foundation (NSF) [CMMI-0531171]; Materials Research
   Science and Engineering Center (MRSEC) on Polymers [DMR-0213695];
   Institute for Cellular Engineering IGERT Program [DGE-0654128]; National
   Institutes of Health [T32 GM08515]
FX Contract grant sponsor: National Science Foundation (NSF); contract
   grant number: CMMI-0531171; Contract grant sponsor: Materials Research
   Science and Engineering Center (MRSEC) on Polymers; contract grant
   number: DMR-0213695; Contract grant sponsor: Institute for Cellular
   Engineering IGERT Program; contract grant number: DGE-0654128; Contract
   grant sponsor: National Institutes of Health; contract grant number: T32
   GM08515
CR Amsden B, 1999, BIOTECHNOL BIOENG, V65, P605, DOI 10.1002/(SICI)1097-0290(19991205)65:5<605::AID-BIT14>3.0.CO;2-C
   Calvino-Casilda V, 2008, J PHYS CHEM B, V112, P2809, DOI 10.1021/jp7106473
   Chin K, 2008, BIOTECHNOL PROGR, V24, P358, DOI 10.1021/bp070160f
   Crank J, 1975, MATH DIFFUSION, V8
   Deleris I, 2009, J FOOD ENG, V94, P205, DOI 10.1016/j.jfoodeng.2009.03.008
   DRAGET KI, 1990, CARBOHYD POLYM, V14, P159
   Fraker CA, 2007, STEM CELLS, V25, P3155, DOI 10.1634/stemcells.2007-0445
   FU JC, 1976, J BIOMED MATER RES, V10, P743, DOI 10.1002/jbm.820100507
   Fujita H, 2010, J BIOSCI BIOENG, V110, P359, DOI 10.1016/j.jbiosc.2010.02.012
   Gattas-Asfura KM, 2012, J BIOMED MATER RES A, V100A, P1963, DOI 10.1002/jbm.a.34052
   Goh F, 2010, J BIOTECHNOL, V150, P232, DOI 10.1016/j.jbiotec.2010.08.013
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Henry JA, 2007, J BIOMED MATER RES A, V82A, P669, DOI 10.1002/jbm.a.31094
   Hovgaard L, 1996, INT J PHARM, V132, P107, DOI 10.1016/0378-5173(95)04371-3
   Johnson AS, 2009, CHEM ENG SCI, V64, P4470, DOI 10.1016/j.ces.2009.06.028
   Johnson AT, 1999, BIOL PROCESS ENG ANA
   Khattak SF, 2007, BIOTECHNOL BIOENG, V96, P156, DOI 10.1002/bit.21151
   Kimelman-Bleich N, 2009, BIOMATERIALS, V30, P4639, DOI 10.1016/j.biomaterials.2009.05.027
   Kin T, 2006, TRANSPLANTATION, V82, P1286, DOI 10.1097/01.tp.0000244347.61060.af
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Luckham PF, 1999, J COLLOID INTERF SCI, V220, P347, DOI 10.1006/jcis.1999.6515
   Maillard E, 2008, TRANSPL P, V40, P372, DOI 10.1016/j.transproceed.2008.01.006
   Matsumoto S, 2000, TRANSPLANTATION, V69, pS213
   Pozrikidis C, 2003, MODELING SIMULATION, V10
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Ricordi C, 2003, TRANSPLANTATION, V75, P1524, DOI 10.1097/01.TP.0000058813.95063.7A
   Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c
   SHAO ZZ, 1993, PHARMACEUT RES, V10, P243, DOI 10.1023/A:1018990928259
   Sharma PK, 2008, COLLOID SURFACE B, V61, P53, DOI 10.1016/j.colsurfb.2007.07.002
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   Stoppel W.L., 2012, ENG BIOMATERIALS REG, P41
   Stoppel WL, 2011, ACTA BIOMATER, V7, P3988, DOI 10.1016/j.actbio.2011.07.009
   Tan Q, 2009, TISSUE ENG PT A, V15, P2471, DOI 10.1089/ten.tea.2008.0461
   Tanioka Y, 2004, AUGMENTATION TISSUE, P220
   YALKOWSKY SH, 1983, J PHARM SCI, V72, P866, DOI 10.1002/jps.2600720808
   Zhao Y, 2009, J COLLOID INTERF SCI, V332, P345, DOI 10.1016/j.jcis.2008.12.048
NR 40
TC 17
Z9 18
U1 5
U2 62
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 438
EP 446
DI 10.1002/jbm.a.34344
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000015
PM 22865503
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lv, W
   Luo, J
   Deng, Y
   Sun, YY
AF Lv, Wei
   Luo, Jie
   Deng, Ying
   Sun, Yuyu
TI Biomaterials immobilized with chitosan for rechargeable antimicrobial
   drug delivery
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; chitosan; antimicrobial; drug delivery; rechargeable
ID URINARY CATHETERS; BIOFILMS; INFECTIONS; RELEASE; AGENT; FILMS
AB Microbial contamination on medical device material surfaces causes serious problems including device-related infections. Here we report a new strategy to produce rechargeable antimicrobial biomaterial surfaces to address the issue. Methacrylic acid (MAA) was grafted onto the surfaces of polyurethane (PU), a widely used biomaterial with excellent biological and mechanical properties. Chitosan was covalently bonded onto the MAA-grafted surfaces. The new chitosan-containing PU strongly bound and then slowed release anionic antibiotics (e.g., rifampin) for weeks to months to kill microbes. The released drug could be recharged with the same or a different class of drugs to further extend antimicrobial duration. Also, the new surfaces demonstrated good biocompatibility against mammal cells, pointing to great potentials for a wide range of biomedical applications. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Lv, Wei; Luo, Jie; Deng, Ying; Sun, Yuyu] Univ S Dakota, Dept Biomed Engn, Sioux Falls, SD 57107 USA.
RP Sun, YY (reprint author), Univ S Dakota, Dept Biomed Engn, Sioux Falls, SD 57107 USA.
EM yuyu.sun@usd.edu
RI Carpenter, Dan/A-5404-2012
CR Aoki T, 2006, BIOSCI BIOTECH BIOCH, V70, P2349, DOI 10.1271/bbb.50398
   BANERJEE UC, 1992, BIOTECHNOL ADV, V10, P577, DOI 10.1016/0734-9750(92)91454-M
   Biering-Sorensen Fin, 2002, Curr Opin Urol, V12, P45, DOI 10.1097/00042307-200201000-00009
   Cao ZB, 2009, J BIOMED MATER RES A, V89A, P960, DOI 10.1002/jbm.a.32040
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   Chaiban G, 2005, J ANTIMICROB CHEMOTH, V55, P51, DOI 10.1093/jac/dkh499
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Dorr T, 2010, PLOS BIOL, V8, P1
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   FREW JE, 1983, ANAL CHIM ACTA, V155, P139, DOI 10.1016/S0003-2670(00)85587-7
   FUKUDA H, 1978, J BIOMED MATER RES, V12, P531, DOI 10.1002/jbm.820120408
   Gorman SP, 2001, BIOMATERIALS, V22, P2741, DOI 10.1016/S0142-9612(01)00017-5
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hu SG, 2004, CARBOHYD POLYM, V58, P173, DOI 10.1016/j.carbpol.2004.06.039
   Karlsson JO, 1996, POLYMER, V37, P4251, DOI 10.1016/0032-3861(96)00277-7
   KUNIN CM, 1987, J UROLOGY, V138, P899, DOI 10.1016/S0022-5347(17)43412-4
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Liao JD, 2005, BIOMACROMOLECULES, V6, P392, DOI 10.1021/bm0494951
   Liedl B, 2001, Curr Opin Urol, V11, P75, DOI 10.1097/00042307-200101000-00011
   Olayinka AA, 2009, BIOL RES, V42, P327, DOI [/S0716-97602009000300007, 10.4067/S0716-97602009000300007]
   Pai MP, 2001, ANN PHARMACOTHER, V35, P1255, DOI 10.1345/aph.10416
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X
   Rossi Giuliano, 2003, Recenti Progressi in Medicina, V94, P537
   Santander-Ortega MJ, 2010, J CONTROL RELEASE, V141, P85, DOI 10.1016/j.jconrel.2009.08.012
   Saxena S, 2010, CARBOHYD POLYM, V82, P1315, DOI 10.1016/j.carbpol.2010.07.014
   Shavi G, 2011, J MATER SCI-MATER M, V22, P865, DOI 10.1007/s10856-011-4274-y
   SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838
   Sutani K, 2002, RADIAT PHYS CHEM, V64, P331, DOI 10.1016/S0969-806X(01)00505-9
   Tenke P, 2004, INT J ANTIMICROB AG, V23, P67, DOI DOI 10.1016/J.IJANTIMICAG.2003.12.007
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Wagner KG, 2005, AASP J, V7, P668
   Williams KJ, 1998, J ANTIMICROB CHEMOTH, V42, P597, DOI 10.1093/jac/42.5.597
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
NR 38
TC 16
Z9 16
U1 2
U2 57
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 447
EP 455
DI 10.1002/jbm.a.34350
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000016
PM 22865542
DA 2018-10-20
ER

PT J
AU Misra, RDK
   Chaudhari, PM
AF Misra, R. D. K.
   Chaudhari, P. M.
TI Cellular interactions and stimulated biological functions mediated by
   nanostructured carbon for tissue reconstruction and tracheal tubes and
   sutures
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nylon; graphene oxide; osteoblasts; fibronectin; focal adhesion
   contacts; actin cytoskeleton
ID NEAR-INFRARED FLUORESCENCE; IN-VITRO; GENE-EXPRESSION; NANOTUBES;
   SURFACE; CELLS; OSTEOBLAST; ADHESION; DIFFERENTIATION; HYDROXYAPATITE
AB Nylon 6,6 is used for biological applications including gastrointestinal segments, tracheal tubes and sutures, vascular graft, and for hard tissue reconstruction. While it is a relatively inexpensive polymer, it is not widely acceptable as a preferred biomaterial because of bioactivity. To this end, we have discovered the exciting evidence that introduction of a novel nanostructured carbon, graphene, in the void space between the nylon chains and processing at elevated pressure favorably stimulates cellular functions and provides high degree of cytocompatibility. The cellsubstrate interactions on stand alone Nylon 6,6 and Nylon 6,6-graphene oxide hybrid system were investigated in terms of cell attachment, viability, proliferation, and assessment of proteins, actin, vinculin, and fibronectin. The enhanced biological functions in the nanostructured hybrid system are attributed to relatively superior hydrophilicity of the surface and to the presence of graphene. Furthermore, it is proposed that the negatively charged graphene interacts with the polar nature of cells and the culture medium, such that the interaction is promoted through polar forces. This is accomplished by investigating cell attachment, proliferation, and morphology, including cytomorphometry evaluation, and quantitative assessment of prominent proteins, actin, vinculin, and fibronectin that are sensitive to cellsubstrate interactions. Osteoblasts were studied to establish the practical viability of the hybrid nanostructured biomaterial. The study strengthens the foundation for utilizing nano- or quantum-size effects of nanostructured biomaterials. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Misra, R. D. K.; Chaudhari, P. M.] Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Biomat & Biomed Engn Res Lab, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Biomat & Biomed Engn Res Lab, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Bodhak S, 2010, ACTA BIOMATER, V6, P641, DOI 10.1016/j.actbio.2009.08.008
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Cheng K, 2005, BIOMATERIALS, V26, P6288, DOI 10.1016/j.biomaterials.2005.03.041
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   El-Warrak AO, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-7
   Feazell RP, 2007, J AM CHEM SOC, V129, P8438, DOI 10.1021/ja073231f
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   HUKKANEN M, 1998, CLIN ORTHOP RELAT R, V352, P53
   Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Karaca E, 2008, J BIOMED MATER RES B, V87B, P580, DOI 10.1002/jbm.b.31136
   Kilapadi KL, 2001, J BIOMED MATER RES, V57, P258
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170
   Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479
   Makropoulou M, 1995, LASER MED SCI, V10, P201, DOI 10.1007/BF02133332
   Makropoulou M, 1995, MAT SCI ENG R, V10, P201
   Mao C, 2005, CARBOHYD POLYM, V59, P19, DOI 10.1016/j.carbpol.2004.08.016
   Myllymaa K, 2010, THESIS U E FINLAND
   Rajesh JJ, 2002, J MATER SCI, V37, P2107
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   STEIN GS, 1990, FASEB J, V4, P3111
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Thian ES, 2010, ACTA BIOMATER, V6, P753
   Waugh DG, 2009, MAT SCI ENG C-MATER, V29, P2514, DOI 10.1016/j.msec.2009.07.020
   Welsher K, 2008, NANO LETT, V8, P586, DOI 10.1021/nl072949q
   Wilson NR, 2009, ACS NANO, V3, P2547, DOI 10.1021/nn900694t
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 39
TC 6
Z9 6
U1 4
U2 88
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 528
EP 536
DI 10.1002/jbm.a.34351
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000024
PM 22927360
DA 2018-10-20
ER

PT J
AU Choi, YJ
   Lee, JY
   Chung, CP
   Park, YJ
AF Choi, Yoon Jung
   Lee, Jue Yeon
   Chung, Chong-Pyoung
   Park, Yoon Jeong
TI Enhanced osteogenesis by collagen-binding peptide from bone sialoprotein
   in vitro and in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen-binding peptide; bone sialoprotein; osteoblastic
   differentiation; extracellular signal-regulated kinase; Protein kinase B
ID STEM-CELL DIFFERENTIATION; ACTIVATED PROTEIN-KINASE; MARROW STROMAL
   CELLS; OSTEOBLASTIC DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE;
   EXPRESSION; RUNX2; AKT; MINERALIZATION; PATHWAY
AB Bone sialoprotein (BSP) is a mineralized, tissue-specific, and noncollagenous protein. The binding of BSP to collagen is thought to be important for the initiation of bone mineralization and formation. In this study, we elucidated the osteogenic efficiency of the collagen-binding (CB) peptide derived from BSP in vitro and in vivo. The CB peptide increased osteoblastic differentiation marker gene and protein expression without affecting cell proliferation. The osteoblastic differentiation by the CB peptide is performed by the activation of extracellular signal-regulated kinase (ERK1/2) and protein kinase B (Akt). Notably, the activation of CB peptide-induced osteogenic differentiation was completely blocked to the basal level by the specific inhibitors for ERK1/2 (U0126) and Akt (LY294002). In vivo results further demonstrated that the CB peptide-coated hydroxyapatite scaffold was able to induce bone formation in the bone defect. Taken together, the CB peptide can be developed as an osteoblastic differentiation agent as well as a fusion biomaterial for bone regeneration therapy. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Lee, Jue Yeon; Chung, Chong-Pyoung; Park, Yoon Jeong] NIBEC, Res Inst, Seoul, South Korea.
   [Choi, Yoon Jung; Park, Yoon Jeong] Seoul Natl Univ, Sch Dent, Seoul 110749, South Korea.
   [Choi, Yoon Jung; Park, Yoon Jeong] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
RP Chung, CP (reprint author), NIBEC, Res Inst, Seoul, South Korea.
EM ccpperio@snu.ac.kr; parkyj@snu.ac.kr
FU Ministry of Health, Welfare and Family Affairs, Korea [A085056]
FX Contract grant sponsor: Ministry of Health, Welfare and Family Affairs,
   Korea; contract grant number: A085056
CR Alonso M, 2008, CYTOTHERAPY, V10, P597, DOI 10.1080/14653240802242084
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006
   Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621
   BRUDER SP, 1998, CLIN ORTHOP S, V355, pS247
   Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200
   CHEN JK, 1991, MATRIX, V11, P133, DOI 10.1016/S0934-8832(11)80217-9
   Choi YJ, 2012, BIOCHEM BIOPH RES CO, V419, P326, DOI 10.1016/j.bbrc.2012.02.022
   Choi YJ, 2010, BIOMATERIALS, V31, P7226, DOI 10.1016/j.biomaterials.2010.05.022
   Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200
   Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200
   Gordeladze JO, 2008, EXP CELL RES, V314, P1495, DOI 10.1016/j.yexcr.2007.12.023
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785
   Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362
   Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955
   Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Kotobuki N, 2008, CELL TISSUE RES, V332, P279, DOI 10.1007/s00441-008-0580-1
   Kozawa O, 2002, J CELL BIOCHEM, V84, P583, DOI 10.1002/jcb.10056
   Lee JY, 2008, J BIOMED MATER RES A, V87A, P688, DOI 10.1002/jbm.a.31721
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee JY, 2009, BIOTECHNOL APPL BIOC, V52, P69, DOI 10.1042/BA20070169
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104
   Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/em.2005-0303
   Park JB, 2007, J PERIODONTOL, V78, P157, DOI 10.1902/jop.2007.060200
   Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403
   Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Shin MK, 2008, CELL SIGNAL, V20, P613, DOI 10.1016/j.cellsig.2007.11.012
   Tye CE, 2005, J BIOL CHEM, V280, P13487, DOI 10.1074/jbc.M408923200
   Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030
   Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6
NR 37
TC 12
Z9 13
U1 0
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 547
EP 554
DI 10.1002/jbm.a.34356
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000026
PM 22926956
DA 2018-10-20
ER

PT J
AU Sokolov, A
   Hellerud, BC
   Tonnessen, TI
   Johannessen, EA
   Mollnes, TE
AF Sokolov, A.
   Hellerud, B. C.
   Tonnessen, T. I.
   Johannessen, E. A.
   Mollnes, T. E.
TI Activation of coagulation and platelets by candidate membranes of
   implantable devices in a whole blood model without soluble anticoagulant
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; complement; coagulation; implantable device; membrane
ID COMPLEMENT ACTIVATION; IN-VITRO; INFLAMMATORY RESPONSE; THROMBIN
   GENERATION; MICRODIALYSIS PROBE; CONTACT ACTIVATION; SURFACE;
   BIOMATERIALS; HEPARIN; BIOCOMPATIBILITY
AB Implantable devices are challenged with thrombus formation at their biomaterial interface. Thus the importance of identifying compatible biomaterials that will help to improve the performance of these devices are becoming increasingly paramount. The aim of this study was to evaluate the activation of coagulation and platelets by candidate membranes considered for use in implantable devices on the basis of an adapted whole blood model without soluble anticoagulants. Evaluated materials were incubated with whole blood without soluble anticoagulant in wells coated with heparin. Prothrombin fragment 1+2 (PTF 1+2), thrombin-antithrombin complex (TAT), and beta-thromboglobulin (BTG) were analyzed in plasma samples using enzyme immunoassays. The C5 inhibitor eculizumab was used to evaluate the role of complement. Incubation of two of the polyamide membranes PAR and PATF led to an increase in concentration of PTF 1+2 and TAT (p < 0.01 for PAR, ns for PATF). The BTG concentration was significantly increased for five materials [PAR, PATF, polycarbonate (PC), and two polyarylethersulphone membranes PAES-1 and PAES-2]. Complement inhibition had no effect on coagulation or platelet activation induced by PAR and PATF. In conclusion, PAR and PATF were not compatible with blood and should be avoided for use in implantable devices. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Sokolov, A.; Hellerud, B. C.; Mollnes, T. E.] Univ Oslo, Dept Immunol, N-0424 Oslo, Norway.
   [Tonnessen, T. I.] Natl Hosp Norway, Oslo Univ Hosp, Dept Emergencies & Crit Care Med, N-0424 Oslo, Norway.
   [Johannessen, E. A.] Vestfold Univ Coll, Dept Micro & Nanosyst Technol, N-3103 Tonsberg, Norway.
   [Mollnes, T. E.] Nordland Hosp, Somat Res Ctr, Res Lab, Bodo, Norway.
   [Mollnes, T. E.] Univ Tromso, N-9001 Tromso, Norway.
RP Sokolov, A (reprint author), Univ Oslo, Dept Immunol, PO 4950, N-0424 Oslo, Norway.
EM andrey.sokolov@medisin.uio.no
OI Johannessen, Erik/0000-0002-2222-8140
FU Lifecare AS, Bergen, Norway; Research Council of Norway [174392];
   Lifecare
FX Contract grant sponsor: Lifecare AS, Bergen, Norway; Contract grant
   sponsor: Research Council of Norway; contract grant number: 174392;
   Andrey Sokolov, role as PhD student at Institute of Immunology,
   University of Oslo and Oslo University Hospital Rikshospitalet, focusing
   on studies on implant materials. His project is currently funded by
   Lifecare. Erik Johannessen, role as former Project Manager employed by
   Lifecare (now appointed Associate Professor at Vestfold University
   College) and currently cosupervisor of PhD student Andrey Sokolov.
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034
   BOWRY SK, 1984, BIOMATERIALS, V5, P289, DOI 10.1016/0142-9612(84)90075-9
   Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   Clagett GP, 1994, HEMOSTASIS THROMBOSI, P1486
   DAVIES MI, 1995, DRUG METAB DISPOS, V23, P1072
   E. ISO, 2002, BIOL EV MED DEV 4, P10993
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028
   Ferraz N, 2008, J BIOMED MATER RES A, V87A, P575, DOI 10.1002/jbm.a.31818
   Ferraz N, 2010, MICROSC RES TECHNIQ, V73, P1101, DOI 10.1002/jemt.20854
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAKIM RM, 1984, KIDNEY INT, V26, P194, DOI 10.1038/ki.1984.155
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   HUMPEL C, 1994, EXP BRAIN RES, V98, P229
   Krieter DH, 2011, CONTRIB NEPHROL, V173, P130, DOI 10.1159/000329051
   Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Mollnes TE, 1999, THROMB HAEMOSTASIS, V82, P1132
   MOLLNES TE, 1993, CLIN EXP IMMUNOL, V91, P295
   Mollnes TE, 2002, BLOOD, V100, P1869
   Mollnes Tom Eirik, 2003, Methods Mol Biol, V225, P69
   Muthusubramaniam L, 2011, ANN BIOMED ENG, V39, P1296, DOI 10.1007/s10439-011-0256-y
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   OVRUM E, 1995, J THORAC CARDIOV SUR, V110, P1623, DOI 10.1016/S0022-5223(95)70023-4
   PAUL D, 1990, ARTIF ORGANS, V14, P122
   Rand MD, 1996, BLOOD, V88, P3432
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344
   SCHULTZE G, 1992, INT J ARTIF ORGANS, V15, P370
   Sokolov A, 2012, J BIOMED MATER RES A, V100A, P1142, DOI 10.1002/jbm.a.34054
   Sokolov Andrey, 2011, J Diabetes Sci Technol, V5, P1490
   Sokolov A, 2011, J BIOMED MATER RES B, V98B, P323, DOI 10.1002/jbm.b.31855
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Su BH, 2008, J MATER SCI-MATER M, V19, P745, DOI 10.1007/s10856-007-3006-9
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WOFFINDIN C, 1988, BIOMATERIALS, V9, P53, DOI 10.1016/0142-9612(88)90069-5
   Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014
NR 50
TC 7
Z9 7
U1 4
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 575
EP 581
DI 10.1002/jbm.a.34348
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000029
PM 22949225
DA 2018-10-20
ER

PT J
AU Oughlis, S
   Lessim, S
   Changotade, S
   Poirier, F
   Bollotte, F
   Peltzer, J
   Felgueiras, H
   Migonney, V
   Lataillade, JJ
   Lutomski, D
AF Oughlis, S.
   Lessim, S.
   Changotade, S.
   Poirier, F.
   Bollotte, F.
   Peltzer, J.
   Felgueiras, H.
   Migonney, V.
   Lataillade, J. J.
   Lutomski, D.
TI The osteogenic differentiation improvement of human mesenchymal stem
   cells on titanium grafted with polyNaSS bioactive polymer
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human mesenchymal stem cells; titanium biomaterial; cell
   differentiation; cell proliferation
ID IN-VITRO; DENTAL IMPLANTS; SURFACE; ADHESION; OSSEOINTEGRATION;
   SUBSTRATE; COLLAGEN; ACID; VIVO; BIOMATERIAL
AB Osseointegration of metallic implants used in orthopedic surgery requires that osteoprogenitor cells attach and adhere to the surface, then proliferate, differentiate into osteoblasts, and finally produce mineralized matrix. Because the ability of progenitor cells to attach to a scaffold surface during early stages is important in the development of new tissue structures, we developed in our laboratory, a strategy involving grafting of implants with a polymer of sodium styrene sulfonate (polyNaSS) used as a scaffold which enables human mesenchymal stem cells (hMSCs) interactions. In the present study, we investigated the cellular response of hMSCs to polyNaSS surfaces of titanium (Ti). In particular, cell proliferation, cell viability, cell differentiation, and cell spreading were evaluated. Results showed that cell proliferation and cell viability did not differ with any statistical significance between modified and unmodified Ti surfaces. Interestingly, culture of MSCs on polyNaSS surfaces resulted in a significant increase of cell spreading and cell differentiation compared with the other tested surfaces. These results suggest that titanium surface grafted with polyNaSS is a suitable scaffold for bone tissue engineering. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Oughlis, S.; Lessim, S.; Changotade, S.; Poirier, F.; Bollotte, F.; Peltzer, J.; Felgueiras, H.; Migonney, V.; Lutomski, D.] Univ Paris 13, CNRS, UMR 7244, CSPBAT LBPS,UFR SMBH, Bobigny, France.
   [Bollotte, F.; Peltzer, J.; Lataillade, J. J.] Ctr Transfus Sanguine Armees Jean Julliard, Unite Therapie Cellulaire, Clamart, France.
   [Bollotte, F.] EFS Nord France, Lille, France.
RP Lutomski, D (reprint author), Univ Paris 13, CNRS, UMR 7244, CSPBAT LBPS,UFR SMBH, Bobigny, France.
EM lutomski@smbh.univ-paris13.fr
RI Felgueiras, Helena/H-4323-2017
OI Felgueiras, Helena/0000-0002-4354-0256; MIGONNEY,
   VERONIQUE/0000-0002-1055-3720
FU Ministere de l'Education Nationale, de la Recherche et de la Technologie
   (MENRT); ANR Actisurf; CNRS
FX Contract grant sponsors: Ministere de l'Education Nationale, de la
   Recherche et de la Technologie (MENRT); ANR Actisurf; CNRS
CR Al-Hamdan K, 2011, CLIN ORAL IMPLAN RES, V22, P399, DOI 10.1111/j.1600-0501.2010.02106.x
   Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   Angwarawong T, 2011, DENT MATER J, V30, P158, DOI 10.4012/dmj.2010-097
   Bell BF, 2011, CLIN ORAL IMPLAN RES, V22, P865, DOI 10.1111/j.1600-0501.2010.02074.x
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Chen JS, 1998, J MATER SCI-MATER M, V9, P297, DOI 10.1023/A:1008825926440
   Curran JM, 2010, BIOMATERIALS, V31, DOI 10.1016/j.biomaterials.2009.11.090
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dimitrievska S, 2011, J BIOMED MATER RES A, V98A, P576, DOI 10.1002/jbm.a.32964
   El Khadali F, 2002, BIOMACROMOLECULES, V3, P51, DOI 10.1021/bm015563x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Jennissen HP, 1999, MATERIALWISS WERKST, V30, P838, DOI 10.1002/(SICI)1521-4052(199912)30:12<838::AID-MAWE838>3.0.CO;2-W
   Jinno T, 2004, J ARTHROPLASTY, V19, P102, DOI 10.1016/j.arth.2003.10.001
   Kushwaha M, 2012, DENT MATER, V28, P252, DOI 10.1016/j.dental.2011.10.010
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Marinucci L, 2010, ANN BIOMED ENG, V38, P640, DOI 10.1007/s10439-009-9898-4
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Miller CC, 2003, EXP DERMATOL, V12, P403, DOI 10.1034/j.1600-0625.2003.00023.x
   Morganstein DL, 2010, CELL RES, V20, P434, DOI 10.1038/cr.2010.11
   Morra M, 2011, J BIOMED MATER RES A, V96A, P449, DOI 10.1002/jbm.a.32948
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   Oughlis S, 2011, J CHROMATOGR B, V879, P3681, DOI 10.1016/j.jchromb.2011.10.006
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rapuano BE, 2011, COLLOID SURFACE B, V82, P95, DOI 10.1016/j.colsurfb.2010.08.023
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 40
TC 12
Z9 12
U1 2
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 582
EP 589
DI 10.1002/jbm.a.34336
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000030
PM 22961843
DA 2018-10-20
ER

PT J
AU Wu, ZK
   Li, N
   Wen, YH
AF Wu, Zhikai
   Li, Ning
   Wen, Yuhua
TI Effect of a small amount of Al2O3 addition on the hydrothermal
   degradation of 3Y-TZP
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MONOCLINIC PHASE-TRANSFORMATION; PARTIALLY-STABILIZED ZIRCONIA; Y-TZP;
   YTTRIA; CERAMICS; BIOMATERIAL; ALUMINA
AB The effects of 0-5 wt% Al2O3 addition on the aging sensibility and strength degradation of 3-mol-yttria-stabilized tetragonal zirconia polycrystal (3Y-TZP) were studied in this study. X-ray diffraction and field emission scanning electron microscopy were used to study the microstructures of aged specimens. The results showed that a small amount of Al2O3 addition could effectively improve the aging resistance of 3Y-TZP. The evolution of mechanical properties with aging time is different for 3Y-TZP with and without Al2O3 addition. Compared to the flexural strength, the fracture toughness and Vickers hardness of specimen are more susceptible to aging. The grain boundary segregated Al3+ plays a key role in retarding the tetragonal-to-monoclinic phase transformation of 3Y-TZP during aging.
C1 [Wu, Zhikai; Li, Ning; Wen, Yuhua] Sichuan Univ, Dept Mat Proc Engn, Coll Mfg Sci & Engn, Chengdu 610065, Peoples R China.
RP Wu, ZK (reprint author), Sichuan Univ, Dept Mat Proc Engn, Coll Mfg Sci & Engn, Chengdu 610065, Peoples R China.
EM wuzhikai@163.com
CR Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   KIHARA M, 1988, NIPPON SERAM KYO GAK, V96, P646
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Matsui K, 2003, J AM CERAM SOC, V86, P1401, DOI 10.1111/j.1151-2916.2003.tb03483.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   SATO T, 1985, J MATER SCI, V20, P3988, DOI 10.1007/BF00552389
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   TSUBAKINO H, 1991, J MATER SCI, V26, P5521, DOI 10.1007/BF00553654
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUKAMA K, 1985, J MATER SCI LETT, V4, P857, DOI 10.1007/BF00720523
NR 18
TC 3
Z9 3
U1 1
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD FEB
PY 2013
VL 48
IS 3
BP 1256
EP 1261
DI 10.1007/s10853-012-6867-3
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 062FO
UT WOS:000312904900033
DA 2018-10-20
ER

PT J
AU Shirakata, Y
   Yoshimoto, T
   Takeuchi, N
   Taniyama, K
   Noguchi, K
AF Shirakata, Y.
   Yoshimoto, T.
   Takeuchi, N.
   Taniyama, K.
   Noguchi, K.
TI Effects of EMD in combination with bone swaging and calcium phosphate
   bone cement on periodontal regeneration in one-wall intrabony defects in
   dogs
SO JOURNAL OF PERIODONTAL RESEARCH
LA English
DT Article
DE bone swaging; calcium phosphate; enamel matrix derivative; periodontal
   regeneration
ID ENAMEL MATRIX PROTEINS; CONTIGUOUS AUTOGENOUS TRANSPLANT; GROWTH-FACTOR;
   GRAFTS; REPAIR; AUGMENTATION; BIOMATERIAL; FIXATION; ADHESION
AB Background and Objective: Although the application of EMD is a widely accepted periodontal-regenerative therapy, its effects on noncontained intrabony defects are unpredictable because of the lack of a space-making property. The combined use of EMD and autogenous bone grafts reportedly stimulates significant periodontal regeneration in intrabony defects. The aim of the present study was to evaluate the effects of EMD in combination with bone swaging (BS) and injectable calcium phosphate bone cement (CPC), which was placed into the spaces between the grafted swaged bone and the proximal host bone, on periodontal healing in one-wall intrabony defects in dogs. Material and Methods: One-wall intrabony defects (3 mm wide and 5 mm deep) were surgically created on the mesial and distal sides of the bilateral mandibular premolars in four dogs. The 16 defects were assigned to one of the following treatments: EMD only, BS only, EMD with BS (EMD + BS), or EMD with BS and CPC (EMD + BS + CPC). The animals were killed 8 wk after surgery for histologic evaluation. Results: The height of newly formed bone was significantly greater in the EMD + BS + CPC group (3.73 +/- 0.30 mm) than in the BS-only (2.74 +/- 0.33 mm; p < 0.05) and EMD + BS (2.88 +/- 0.98 mm; p < 0.05) groups. The area of newly formed bone was significantly larger in the EMD + BS + CPC group (5.68 +/- 1.66 mm2) than in the EMD-only (3.68 +/- 0.33 mm2; p < 0.05), BS-only (3.48 +/- 1.26 mm2; p < 0.05) and EMD + BS (3.38 +/- 1.37 mm2; p < 0.05) groups. The EMD-only (4.63 +/- 0.42 mm), EMD + BS (4.67 +/- 0.30 mm) and EMD + BS + CPC (4.78 +/- 0.54 mm) groups showed significantly greater cementum formation than did the BS-only group (3.93 +/- 0.56 mm; p < 0.05). Conclusion: These results indicate that treatment with EMD + BS + CPC promotes favorable periodontal healing in one-wall intrabony defects in dogs.
C1 [Shirakata, Y.; Yoshimoto, T.; Takeuchi, N.; Taniyama, K.; Noguchi, K.] Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.
   [Shirakata, Y.] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.
RP Noguchi, K (reprint author), Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM kazuperi@dent.kagoshima-u.ac.jp
FU Ministry of Education, Science, Sports and Culture, Japan [22791931,
   21390525]
FX This study was supported by a Grant-in-Aid for Encouragement of Young
   Scientists B (No. 22791931 to Dr Y. Shirakata) and a Grant-in-Aid for
   Scientific Research B (No. 21390525 to Dr K. Noguchi) from the Ministry
   of Education, Science, Sports and Culture, Japan. Norian PDC was
   provided free of charge by Shofu Inc., Kyoto, Japan. The authors report
   no conflicts of interest related to this study.
CR Araujo MG, 1998, J CLIN PERIODONTOL, V25, P524, DOI 10.1111/j.1600-051X.1998.tb02482.x
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Baker DL, 2005, J CLIN PERIODONTOL, V32, P561, DOI 10.1111/j.1600-051X.2005.00714.x
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BURNETTE EW, 1967, J PERIODONTOL, V38, P148, DOI 10.1902/jop.1967.38.2.148
   Cochran DL, 2003, J PERIODONTOL, V74, P1043, DOI 10.1902/jop.2003.74.7.1043
   Cochran DL, 2003, J PERIODONTOL, V74, P1269, DOI 10.1902/jop.2003.74.9.1269
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Donos N, 2005, CLIN ORAL IMPLAN RES, V16, P133, DOI 10.1111/j.1600-0501.2004.01104.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P192, DOI 10.1034/j.1600-0501.2002.130210.x
   EWEN SJ, 1965, J PERIODONTOL, V36, P57, DOI 10.1902/jop.1965.36.1.57
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P669
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   Kim CS, 2005, J CLIN PERIODONTOL, V32, P583, DOI 10.1111/j.1600-051X.2005.00729.x
   Kwon HR, 2010, J CLIN PERIODONTOL, V37, P739, DOI 10.1111/j.1600-051X.2010.01576.x
   Lekovic V, 2000, J PERIODONTOL, V71, P1100
   LIN KY, 1990, PLAST RECONSTR SURG, V86, P449, DOI 10.1097/00006534-199009000-00010
   Mellonig J T, 1999, Int J Periodontics Restorative Dent, V19, P8
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   ROSS SE, 1966, PERIODONTICS, V4, P246
   Sakata J, 2006, INT J PERIODONT REST, V26, P161
   Schlueter SR, 2007, J PERIODONTOL, V78, P141, DOI 10.1902/jop.2007.060111
   Shirakata Y, 2007, J PERIODONTOL, V78, P889, DOI 10.1902/jop.2007.060353
   Shirakata Y, 2012, OR SURG OR MED OR PA, V114, P35, DOI 10.1016/j.tripleo.2011.05.028
   Shirakata Y, 2010, J CLIN PERIODONTOL, V37, P374, DOI 10.1111/j.1600-051X.2010.01539.x
   Sims TN, 1984, GLICKMANS CLIN PERIO, P819
   TONETTI MS, 1993, J PERIODONTOL, V64, P934, DOI 10.1902/jop.1993.64.10.934
   Tsitoura E, 2004, J CLIN PERIODONTOL, V31, P643, DOI 10.1111/j.1600-051X.2004.00555.x
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   WIKESJO UME, 1991, J PERIODONTOL, V62, P258, DOI 10.1902/jop.1991.62.4.258
   ZUBERY Y, 1993, J PERIODONTOL, V64, P66, DOI 10.1902/jop.1993.64.1.66
NR 34
TC 3
Z9 3
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3484
J9 J PERIODONTAL RES
JI J. Periodont. Res.
PD FEB
PY 2013
VL 48
IS 1
BP 37
EP 43
DI 10.1111/j.1600-0765.2012.01499.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 062TG
UT WOS:000312944800005
PM 22775137
DA 2018-10-20
ER

PT J
AU Saad, R
   Hawari, J
AF Saad, Rabih
   Hawari, Jalal
TI Grafting of lignin onto nanostructured silica SBA-15: preparation and
   characterization
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Lignin; Nanostructured silica SBA-15; Grafting; Characterization
ID ALKALI-SOLUBLE LIGNINS; MESOPOROUS SILICA; ADSORPTION; STABILITY;
   SORPTION; FIBERS; KRAFT; IONS
AB The slow decline in oil reserves with mounting oil prices is pushing industry to find more sustainable sources for industrial manufacturing. Lignin is the second most abundant natural renewable biopolymer that is underutilized and has many functional groups (-OH, phenolics) that make the biopolymer a convenient substrate for materials manufacturing by the industry. The present study thus describes grafting of lignin onto nanostructured silica SBA-15 (Santa Barbara amorphous 15) by first silylating lignin with triethoxychlorosilane followed by treatment of silylated lignin with SBA-15. The resulting nanocomposite denoted as LIG-SBA-15-G was then characterized by powder X-ray diffraction, infra-red (FTIR), P-31 nuclear magnetic resonance (P-31 NMR), N-2 adsorption (BET), scanning and transmission electron micrographs (SEM and TEM) and thermogravimetric analysis (TGA). X-ray data showed that LIG-SBA-15-G exhibited hexagonal structure closely similar to that observed for the SBA-15 host. FTIR of LIG-SBA-15-G showed characteristic absorption bands from lignin and attenuated Si-OH band due to its conversion to Si-O-Si ether bonds. Whereas, P-31 NMR revealed that the majority of hydroxyl groups in lignin were replaced by Si-O-LIG ether bonds in LIG-SBA-15-G. SEM images of LIG-SBA-15-G displayed little changes in the macroscopic structure as compared to SBA-15. TEM images showed some disordered area in LIG-SBA-15-G and the grafted lignin appeared as black film on the silica surface. Using BET analysis the surface area of LIG-SBA-15-G was found to be 560 m(2) g(-1). Finally, TGA showed that LIG-SBA-15-G was more thermally stable than lignin and contained 13 % w/w lignin. Understanding the physicochemical and structural properties of the resulting lignin-nanosilica hybrid material should help engineer a robust and sustainable biomaterial suitable for various application, e.g. removal of contaminants from contaminated water.
C1 [Saad, Rabih; Hawari, Jalal] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada.
RP Hawari, J (reprint author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.
EM jalal.hawari@cnrc-nrc.gc.ca
CR Akim LG, 2001, HOLZFORSCHUNG, V55, P386, DOI 10.1515/HF.2001.064
   Balakshin MY, 2003, J AGR FOOD CHEM, V51, P6116, DOI 10.1021/jf034372d
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bois L, 2003, COLLOID SURFACE A, V221, P221, DOI 10.1016/S0927-7757(03)00138-9
   Chytil S, 2008, MICROPOR MESOPOR MAT, V111, P134, DOI 10.1016/j.micromeso.2007.07.020
   Demirbas A, 2004, J HAZARD MATER, V109, P221, DOI 10.1016/j.jhazmat.2004.04.002
   GRANATA A, 1995, J AGR FOOD CHEM, V43, P1538, DOI 10.1021/jf00054a023
   Gupta R, 2010, BIORESOURCE TECHNOL, V101, P8185, DOI 10.1016/j.biortech.2010.05.039
   Harmita H, 2009, BIORESOURCE TECHNOL, V100, P6183, DOI 10.1016/j.biortech.2009.06.093
   Hasegawa I, 1998, J SOL-GEL SCI TECHN, V13, P485, DOI 10.1023/A:1008645900447
   Hayashi J, 1997, LANGMUIR, V13, P4185, DOI 10.1021/la970072c
   Kruk M, 2000, CHEM MATER, V12, P1961, DOI 10.1021/cm000164e
   Kumar MNS, 2009, J BIOBASED MATER BIO, V3, P1, DOI 10.1166/jbmb.2009.1001
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Qu YN, 2010, BIORESOURCE TECHNOL, V101, P8402, DOI 10.1016/j.biortech.2010.05.067
   Saad R, 2007, J COLLOID INTERF SCI, V311, P375, DOI 10.1016/j.jcis.2007.03.025
   Shah P, 2008, MICROPOR MESOPOR MAT, V114, P270, DOI 10.1016/j.micromeso.2008.01.013
   Shah P, 2008, MICROPOR MESOPOR MAT, V116, P157, DOI 10.1016/j.micromeso.2008.03.030
   Sun RC, 1999, J AGR FOOD CHEM, V47, P2930
   Suteu D, 2010, DESALINATION, V255, P84, DOI 10.1016/j.desal.2010.01.010
   Telysheva G, 2009, SCRIPTA MATER, V60, P687, DOI 10.1016/j.scriptamat.2008.12.051
   Wang JC, 2005, MICROPOR MESOPOR MAT, V83, P225, DOI 10.1016/j.micromeso.2005.04.012
   Wang XL, 2007, CHEMOSPHERE, V66, P1476, DOI 10.1016/j.chemosphere.2006.09.004
   Williams PT, 2006, BIOMASS BIOENERG, V30, P144, DOI 10.1016/j.biombioe.2005.11.006
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 26
TC 12
Z9 14
U1 6
U2 98
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
J9 J POROUS MAT
JI J. Porous Mat.
PD FEB
PY 2013
VL 20
IS 1
BP 227
EP 233
DI 10.1007/s10934-012-9592-z
PG 7
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 062QA
UT WOS:000312933400025
DA 2018-10-20
ER

PT J
AU de Luca, AC
   Stevens, JS
   Schroeder, SLM
   Guilbaud, JB
   Saiani, A
   Downes, S
   Terenghi, G
AF de Luca, A. C.
   Stevens, J. S.
   Schroeder, S. L. M.
   Guilbaud, J. -B.
   Saiani, A.
   Downes, S.
   Terenghi, G.
TI Immobilization of cell-binding peptides on poly-e-caprolactone film
   surface to biomimic the peripheral nervous system
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nerve regeneration; Schwann cell; surface modification; RGD peptide;
   polycaprolactone
ID STEM-CELLS; IN-VITRO; REGENERATION; BIOMATERIALS; ADHESION;
   FUNCTIONALIZATION; POLYMERIZATION; CONDUIT
AB Cell-material interactions are crucial for cell adhesion and proliferation on biomaterial surfaces. Immobilization of biomolecules leads to the formation of biomimetic substrates, improving cell response. We introduced RGD (Arg-Gly-Asp) sequences on poly-e-caprolactone (PCL) film surfaces using thiol chemistry to enhance Schwann cell (SC) response. XPS elemental analysis indicated an estimate of 23% peptide functionalization on the PCL surface, comparable with carbodiimide chemistry. Contact angle was not remarkably reduced; hence, cell response was only affected by chemical cues on the film surface. Adhesion and proliferation of Schwann cells were enhanced after PCL modification. Particularly, RGD immobilization increased cell attachment up to 40% after 6 h of culture. It was demonstrated that SC morphology changed from round to very elongated shape when surface modification was carried out, with an increase in the length of cellular processes up to 50% after 5 days of culture. Finally RGD immobilization triggered the formation of focal adhesion related to higher cell spreading. In summary, this study provides a method for immobilization of biomolecules on PCL films to be used in peripheral nerve repair, as demonstrated by the enhanced response of Schwann cells. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [de Luca, A. C.; Terenghi, G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Blond McIndoe Labs, Manchester M13 9PT, Lancs, England.
   [de Luca, A. C.; Guilbaud, J. -B.; Saiani, A.; Downes, S.] Univ Manchester, Sch Mat, Dept Engn & Phys Sci, Manchester M13 9PL, Lancs, England.
   [Stevens, J. S.; Schroeder, S. L. M.] Univ Manchester, Sch Chem Engn & Analyt Sci, Dept Chem Enginereering, Manchester M13 9PL, Lancs, England.
RP Terenghi, G (reprint author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Blond McIndoe Labs, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM giorgio.terenghi@manchester.ac.uk
RI Schroeder, Sven/A-5129-2010; Saiani, Alberto/D-9714-2011
OI Schroeder, Sven/0000-0002-4232-5378; Saiani,
   Alberto/0000-0002-5504-8306; Stevens, Joanna/0000-0002-1013-8447
FU Newby Trust Ltd.; EPSRC [EP/I013563/1]; Engineering and Physical
   Sciences Research Council [EP/I013563/1]
FX Contract grant sponsor: Newby Trust Ltd. for funding the project;
   Contract grant sponsor: EPSRC, Critical Mass Grant; contract grant
   number: EP/I013563/1
CR [Anonymous], 2000, XPS POL DAT
   Atala A, 2009, FDN REGENERATIVE MED
   Becer CR, 2009, MACROMOLECULES, V42, P2387, DOI 10.1021/ma9000176
   Bockelmann J, 2011, TISSUE ENG PT A, V17, P475, DOI [10.1089/ten.tea.2010.0369, 10.1089/ten.TEA.2010.0369]
   Boudreau J, 1999, BIOCHEM J, V339, P481
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   de Luca AC, 2014, J TISSUE ENG REGEN M, V8, P153, DOI 10.1002/term.1509
   Fairley N., 2005, CASA COOKBOOK RECI 1
   Faroni A, 2011, J NEUROSCI RES, V89, P1351, DOI 10.1002/jnr.22652
   Fox M., 2004, ORGANIC CHEM
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Haycock JW, 2011, TISSUE ENG PART B-RE, V44, P1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoyle CE, 2010, CHEM SOC REV, V39, P1355, DOI 10.1039/b901979k
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Koval IV, 2007, RUSS J ORG CHEM+, V43, P319, DOI 10.1134/S1070428007030013
   LASSNER F, 1995, MICROSURG, V16, P4, DOI 10.1002/micr.1920160104
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042
   Owen G Rh, 2005, Eur Cell Mater, V9, P85
   Perlin L, 2008, SOFT MATTER, V4, P2331, DOI 10.1039/b801646a
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Roth PJ, 2011, MACROMOL RAPID COMM, V32, P1123, DOI 10.1002/marc.201100127
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Stevens JS, 2011, ANGEW CHEM INT EDIT, V50, P9916, DOI 10.1002/anie.201103981
   Stevens JS, 2011, J PHARM SCI-US, V100, P942, DOI 10.1002/jps.22334
   Stevens JS, 2010, CRYST GROWTH DES, V10, P1435, DOI 10.1021/cg901481q
   Stevens JS, 2009, SURF INTERFACE ANAL, V41, P453, DOI 10.1002/sia.3047
   Sun H, 2006, POLYM INT, V55, P1336, DOI 10.1002/pi.2090
   Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681
   Sun M, 2007, P SOC PHOTO-OPT INS, V6423
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Tse KH, 2010, J BIOMED MATER RES A, V95A, P701, DOI 10.1002/jbm.a.32889
   Vladkova TG, 2010, INT J POLYM SCI, DOI 10.1155/2010/296094
   Vleggeert-Lankamp CLAM, 2007, J BIOMED MATER RES A, V80A, P965, DOI 10.1002/jbm.a.30941
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wei YJ, 2009, CELL TISSUE RES, V337, P361, DOI 10.1007/s00441-009-0836-4
   Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 48
TC 21
Z9 21
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2013
VL 101
IS 2
BP 491
EP 501
DI 10.1002/jbm.a.34345
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059TK
UT WOS:000312728000021
PM 22927333
DA 2018-10-20
ER

PT J
AU Hafezi, M
   Abbasi-shahni, M
   Zamanian, A
   Hesaraki, S
AF Hafezi, Masoud
   Abbasi-shahni, Marziyeh
   Zamanian, Ali
   Hesaraki, Saeed
TI Preparation and characterization of whitlockite-merwinite nanocomposite
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE Biomaterial; Bioceramic; Nanocomposite; Merwinite; Whitlockite
ID SIMULATED BODY-FLUID; BONE REPAIR; CERAMICS; GLASS; HYDROXYAPATITE;
   BIOACTIVITY; MAGNESIUM
AB The aim of this study is to investigate the properties of a novel nanocomposite made from whitlockite and nanostructured merwinite. In addition, the effect of merwinite on the apatite formation in this type of composite was evaluated. The nanostructured merwinite was successfully synthesized by the sol gel method. The synthesized merwinite was investigated by XRD and TEM. The nanocompositses were evaluated by SEM, FTIR before and after immersion in SBF. The apatite formation ability of the nanocomposites improved with an increase in the content of merwinite. Furthermore, SaSo-2 cells adhered and spread well on the nanocomposite. The results obtained in this experiment suggest that a whitlockite-merwinite nanocomposite could be a suitable choice for bone tissue engineering.
C1 [Hafezi, Masoud; Zamanian, Ali; Hesaraki, Saeed] Mat & Energy Res Ctr, Biomat Grp, Karaj, Iran.
   [Abbasi-shahni, Marziyeh] Yazd Sci & Technol Pk, BT Ctr, Pardis Pajoohesh Fanavaran Yazd, Yazd, Iran.
RP Hafezi, M (reprint author), Mat & Energy Res Ctr, Biomat Grp, Karaj, Iran.
EM mhafezi@merc.ac.ir
RI Hafezi Ardakani, Masoud/K-3589-2013
OI Hafezi Ardakani, Masoud/0000-0002-7199-3180; Hesaraki,
   Saeed/0000-0001-9147-5850
FU Iran National Science Foundation (INSF) [90007188]
FX The authors would like to acknowledge the Iran National Science
   Foundation (INSF) for the financial support of this work, through grant
   No. 90007188.
CR Abbasi-Shahni M., 2011, J KEY ENG MAT, V493-494, P582
   Abed E, 2007, CELL PROLIFERAT, V40, P849, DOI 10.1111/j.1365-2184.2007.00476.x
   Agathopoulosa S., 2006, J BIOMATERIALS, V27, P1832
   Bhatkar V., 2011, INT J ADV ENG SCI TE, V5, P184
   Dufrane D, 2003, J MATER SCI-MATER M, V14, P33, DOI 10.1023/A:1021545302732
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Grandi G, 2011, MATER RES-IBERO-AM J, V14, P11, DOI 10.1590/S1516-14392011005000020
   Hafezi-Ardakani M., 2010, J CERAM PROCESS RES, P11765
   Hafezi-Ardakani M, 2011, CERAM INT, V37, P175, DOI 10.1016/j.ceramint.2010.08.034
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kamitakahara M, 2006, J CERAM SOC JPN, V114, P82, DOI 10.2109/jcersj.114.82
   Karlsson KH, 2004, GLASS TECHNOL, V45, P157
   Klug H. P., 1962, XRAY DIFFRACTION PRO
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   MERROLLLI A, 2000, J MATER SCI-MATER M, V11, P219
   Meyer U., 2005, J EUR CELL MAT, V26, P39
   Ni SY, 2007, CERAM INT, V33, P83, DOI 10.1016/j.ceramint.2005.07.021
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   RADIN SR, 1994, J BIOMED MATER RES, V28, P1303, DOI 10.1002/jbm.820281108
   Sanosh KP, 2010, J ALLOY COMPD, V495, P113, DOI 10.1016/j.jallcom.2010.01.097
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Siriphannon P, 2000, J BIOMED MATER RES, V52, P30, DOI 10.1002/1097-4636(200010)52:1<30::AID-JBM5>3.0.CO;2-Z
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wu CS, 2007, SCI TECHNOL WELD JOI, V12, P1, DOI 10.1179/174329307X160548
NR 25
TC 2
Z9 2
U1 0
U2 2
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PD FEB
PY 2013
VL 14
IS 1
BP 96
EP 99
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA AC1BG
UT WOS:000332228600021
DA 2018-10-20
ER

PT J
AU Shopska, M
   Cherkezova-Zheleva, ZP
   Paneva, DG
   Iliev, M
   Kadinov, GB
   Mitov, IG
   Groudeva, VI
AF Shopska, Maya
   Cherkezova-Zheleva, Zara P.
   Paneva, Daniela G.
   Iliev, Mihail
   Kadinov, Georgi B.
   Mitov, Ivan G.
   Groudeva, Veneta I.
TI Biogenic iron compounds: XRD, Mossbauer and FTIR study
SO CENTRAL EUROPEAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Biogenic iron oxide materials; Sphaerotilus-Leptothrix group bacteria;
   Mossbauer spectroscopy; X-ray diffraction; IR spectroscopy
ID OXIDIZING BACTERIA; GOETHITE; SPECTROSCOPY; NANOPARTICLES;
   LEPIDOCROCITE; FERROOXIDANS; REMOVAL; OXIDES; ALPHA; GAMMA
AB Materials based on biogenic iron oxides, which are a product of the metabolic activities of the neutrophilic iron-oxidizing bacteria (NIOB) from Sphaerotilus-Leptothrix group, were investigated. Natural microbial probes were collected from freshwater flow from Vitosha Mountain (Bulgaria) and cultivated under laboratory conditions in respect to select suitable cultures and conditions (nutrition media) for biomaterial accumulation of biogenic oxides. Samples were studied by physicochemical methods: X-ray diffraction, Mossbauer spectroscopy and IR spectroscopy. Their phase composition and physicochemical properties were obtained. Presence of both amorphous and crystal phase (ultra- and highly dispersed particles) was proved. Iron-containing compound in the natural biomass consists of alpha-FeOOH. The cultivated materials have more complex composition with iron-containing ingredients as alpha-FeOOH, I"-FeOOH, I"-Fe2O3 and Fe3O4. The sample of natural biomass was tested in reaction of CO oxidation and it showed potential to be used as catalyst support.
C1 [Shopska, Maya; Cherkezova-Zheleva, Zara P.; Paneva, Daniela G.; Kadinov, Georgi B.; Mitov, Ivan G.] Bulgarian Acad Sci, Inst Catalysis, BU-1113 Sofia, Bulgaria.
   [Iliev, Mihail; Groudeva, Veneta I.] Univ Sofia, Fac Biol, Sofia 1164, Bulgaria.
RP Shopska, M (reprint author), Bulgarian Acad Sci, Inst Catalysis, BU-1113 Sofia, Bulgaria.
EM shopska@ic.bas.bg
RI Kadinov, Georgi/B-5257-2016; Paneva, Daniela/L-2594-2016;
   Cherkezova-Zheleva, Zara/L-3579-2016
OI Cherkezova-Zheleva, Zara/0000-0002-9287-3217; Shopska,
   Maya/0000-0002-9714-2464
FU Bulgarian National Science Fund at the Ministry of Education, Youth and
   Science [02/38/2009]
FX The authors are grateful for the financial support by the Bulgarian
   National Science Fund at the Ministry of Education, Youth and Science
   (Project 02/38/2009).
CR Ankrah DA, 2009, 13 INT WAT TECHN C I, P999
   Cherkezova-Zheleva Z., 2011, NANOSCIENCE NANOTECH, V11, P142
   Cornell RM, 2003, IRON OXIDES
   daCosta GM, 1995, CLAY CLAY MINER, V43, P656, DOI 10.1346/CCMN.1995.0430602
   Edwards KJ, 2003, APPL ENVIRON MICROB, V69, P2906, DOI 10.1128/AEM.69.5.2906-2913.2003
   Ellis D., 2003, MICROBIOLOGY IRON DE
   Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002
   Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667
   Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208
   Ferris FG, 2000, APPL GEOCHEM, V15, P1035, DOI 10.1016/S0883-2927(99)00093-1
   Fitzpatrick R.W., 1992, CATENA S, P263
   GADD GM, 1993, TRENDS BIOTECHNOL, V11, P353, DOI 10.1016/0167-7799(93)90158-6
   GEHRING AU, 1994, CLAY CLAY MINER, V42, P409, DOI 10.1346/CCMN.1994.0420405
   Groudeva V., BIOTECHNOL IN PRESS
   Hadrich A, 2001, VIB SPECTROSC, V26, P51, DOI 10.1016/S0924-2031(01)00100-X
   Hashimoto H, 2007, J MAGN MAGN MATER, V310, P2405, DOI 10.1016/j.jmmm.2006.10.793
   Jin S., 2010, J POWER SOURCES, V196, P3887
   Katsoyiannis I, 2002, CHEMOSPHERE, V47, P325, DOI 10.1016/S0045-6535(01)00306-X
   LAZAROFF N, 1982, APPL ENVIRON MICROB, V43, P924
   LEATHEN WW, 1956, J BACTERIOL, V72, P700
   Lee JY, 2001, CORROS SCI, V43, P803, DOI 10.1016/S0010-938X(00)00123-2
   Lieske R., 1919, PARASITENK INFEKTION, V49, P413
   Morup S, 1987, MOSSBAUER SPECTROSCO, V2
   MURAD E, 1982, AM MINERAL, V67, P1007
   Music S, 2000, CROAT CHEM ACTA, V73, P541
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Rentz JA, 2009, WATER RES, V43, P2029, DOI 10.1016/j.watres.2009.02.021
   Rubio C, 2006, J MICROBIOL METH, V64, P287, DOI 10.1016/j.mimet.2005.05.013
   Sakai T, 2010, ORG BIOMOL CHEM, V8, P336, DOI 10.1039/b919497e
   Schwertmann U., 1991, IRON OXIDES LAB
   Sobolev D, 2004, GEOMICROBIOL J, V21, P1, DOI 10.1080/01490450490253310
   Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1111/j.1574-6941.2001.tb00768.x
   Turunen S., 2009, PHYSL MAINTENANCE EN, V2, P166
   VANDENBERGHE RE, 1986, CLAY CLAY MINER, V34, P275, DOI 10.1346/CCMN.1986.0340307
   VANVEEN WL, 1973, A VAN LEEUW J MICROB, V39, P189, DOI 10.1007/BF02578852
   Veleva S., 2011, NANOSCIENCE NANOTECH, V12
   Weckler B, 1998, EUR J SOL STATE INOR, V35, P531, DOI 10.1016/S0992-4361(99)80017-4
   WINOGRADSKY S, 1891, ANN I PASTEUR, V5, P92
   Xin BP, 2009, BIORESOURCE TECHNOL, V100, P6163, DOI 10.1016/j.biortech.2009.06.086
NR 39
TC 12
Z9 12
U1 1
U2 82
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 1895-1066
J9 CENT EUR J CHEM
JI Cent. Eur. J. Chem
PD FEB
PY 2013
VL 11
IS 2
BP 215
EP 227
DI 10.2478/s11532-012-0148-5
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA 046QE
UT WOS:000311778700012
OA Other Gold
DA 2018-10-20
ER

PT J
AU Bahraminasab, M
   Sahari, BB
   Edwards, KL
   Farahmand, F
   Arumugam, M
AF Bahraminasab, Marjan
   Sahari, B. B.
   Edwards, K. L.
   Farahmand, Farzam
   Arumugam, Manohar
TI Aseptic loosening of femoral components - Materials engineering and
   design considerations
SO MATERIALS & DESIGN
LA English
DT Article
DE Knee prosthesis; Biomaterials; Functionally graded materials;
   Composites; Selection for material properties; Engineering design
ID TOTAL KNEE ARTHROPLASTY; FUNCTIONALLY GRADED MATERIALS; TOTAL JOINT
   REPLACEMENT; CROSS-LINKED UHMWPE; FOLLOW-UP; MOBILE-BEARING; HIP
   PROSTHESES; BIOMEDICAL APPLICATIONS; WEAR PERFORMANCE; IMPLANT FIXATION
AB Aseptic loosening is one of the main reasons for the revision of a total knee replacement (TKR). The design of the key component of a TKR, the femoral component, is particularly problematic because its failure can be the result of different causes. This makes the development of new biomaterials for use in the femoral component a challenging task. This paper focuses on the engineering design aspects in order to understand the limitations of current materials and design deficiencies. The paper describes the introduction of a new biomaterial for a femoral component and justifies the recommendation to use multi-functional materials as a possible solution to aseptic loosening. The potential advantages of applying functionally graded biomaterials (FGBMs) in prosthetic femur are explained by reducing the leading causes of failure including wear, micro-motion and stress-shielding effect. The ideas presented in this paper can be used as the basis for further research on the feasibility and advantages of applying FGBM in other superior implant designs. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Bahraminasab, Marjan; Sahari, B. B.] Univ Putra Malaysia, Dept Mech & Mfg Engn, Serdang, Malaysia.
   [Bahraminasab, Marjan] Islamic Azad Univ, Semnan Branch, Fac Engn, Semnan, Iran.
   [Sahari, B. B.] Univ Putra Malaysia, Inst Adv Technol, ITMA, Serdang, Malaysia.
   [Edwards, K. L.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.
   [Farahmand, Farzam] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.
   [Farahmand, Farzam] Univ Tehran Med Sci, RCSTIM, Tehran, Iran.
   [Arumugam, Manohar] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Orthoped Surg, Serdang, Malaysia.
RP Bahraminasab, M (reprint author), Univ Putra Malaysia, Dept Mech & Mfg Engn, Serdang, Malaysia.
EM m.bahraminasab@semnaniau.ac.ir
RI Baharaminasab, Marjan/F-3230-2011; Farahmand, Farzam/B-3921-2011
OI Baharaminasab, Marjan/0000-0003-3012-9799; Farahmand,
   Farzam/0000-0001-8900-7003; Sahari, Barkawi Bin/0000-0001-7138-6375;
   Edwards, Kevin/0000-0001-7619-9114
FU University Putra Malaysia
FX The first author would like to thank University Putra Malaysia for
   funding this work.
CR Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Axinte E, 2012, MATER DESIGN, V35, P518, DOI 10.1016/j.matdes.2011.09.028
   Badorf D, 1998, CERAMIC TORAL KNEE R
   Bahraminasab M, 2012, MATER DESIGN, V42, P459, DOI 10.1016/j.matdes.2012.05.046
   Bahraminasab M, 2011, MATER DESIGN, V32, P4471, DOI 10.1016/j.matdes.2011.03.046
   Baker PN, 2007, J BONE JOINT SURG BR, V89B, P1608, DOI 10.1302/0301-620X.89B12.19363
   Bal BS, 2005, CER ORTHO, P183, DOI 10.1007/3-7985-1540-9_28
   Bal SB, 2006, SEMIN ARTHROPLASTY, V17, P94
   Bellemans J, 2005, OXIDIZED ZIRCONIUM T, P370
   Bellemans J, 2005, TOTAL KNEE ARTHOPLAS
   Berger RA, 2001, CLIN ORTHOP RELAT R, P196
   Chang CW, 2011, J BONE JOINT SURG BR, V93B, P479, DOI 10.1302/0301-620X.93B4.25864
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chockalingam S, 2000, KNEE, V7, P233, DOI 10.1016/S0968-0160(00)00060-0
   Collier MB, 2005, J BONE JOINT SURG AM, V87A, P2702, DOI 10.2106/JBJS.E.00074
   Completo A, 2009, MATER DESIGN, V30, P1391, DOI 10.1016/j.matdes.2008.06.071
   Cristofolini L, 2009, KNEE, V16, P101, DOI 10.1016/j.knee.2008.08.006
   Davim JP, 2001, WEAR, V251, P1100, DOI 10.1016/S0043-1648(01)00741-4
   Davim JP, 2001, TRIBOL LETT, V11, P91, DOI 10.1023/A:1016607400392
   DesJardins JD, 2008, WEAR, V264, P245, DOI 10.1016/j.wear.2007.03.020
   DORLOT JM, 1989, J BIOMED MATER RES-A, V23, P299, DOI 10.1002/jbm.820231405
   DOWSON D, 1987, WEAR, V119, P277, DOI 10.1016/0043-1648(87)90036-6
   Edwards KL, 2008, MATER DESIGN, V29, P558, DOI 10.1016/j.matdes.2007.01.001
   Edwards KL, 2007, MATER DESIGN, V28, P1288, DOI 10.1016/j.matdes.2005.12.009
   Edwards KL, 2011, MATER DESIGN, V32, P1073, DOI 10.1016/j.matdes.2010.10.009
   Geetha M., 2008, PROG MATER SCI, V54, P397, DOI DOI 10.1016/1
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Goto K, 2005, BIOMATERIALS, V26, P6496, DOI 10.1016/j.biomaterials.2005.04.044
   Gupta SK, 2007, J ARTHROPLASTY, V22, P787, DOI 10.1016/j.arth.2007.05.041
   Hedia HS, 2005, J BIOMED MATER RES B, V75B, P74, DOI 10.1002/jbm.b.30275
   Heimke G, 2002, BIOMATERIALS, V23, P1539, DOI 10.1016/S0142-9612(01)00262-9
   Heiner AD, 2011, J ARTHROPLASTY, V27, P742
   Huang CH, 2002, J BONE JOINT SURG AM, V84A, P2224, DOI 10.2106/00004623-200212000-00015
   Ignatius A, 2005, BIOMATERIALS, V26, P2325, DOI 10.1016/j.biomaterials.2004.07.029
   Janssen D, 2006, P I MECH ENG H, V220, P533, DOI [10.1243/09544119JEIM61, 10.1243/09544119jeim61]
   Joshi N, 2008, J ARTHROPLASTY, V23, P1204, DOI 10.1016/j.arth.2007.10.016
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Khaw FM, 2002, J BONE JOINT SURG BR, V84B, P658, DOI 10.1302/0301-620X.84B5.12692
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lee MC, 2007, CER ORTHO, P123, DOI 10.1007/978-3-7985-1783-7_16
   Ljungberg LY, 2003, MATER DESIGN, V24, P519, DOI 10.1016/S0261-3069(03)00094-3
   Lombardi AV, 2007, J ARTHROPLASTY, V22, P25, DOI 10.1016/j.arth.2007.02.006
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mabry TM, 2007, J ARTHROPLASTY, V22, P100, DOI 10.1016/j.arth.2007.03.025
   Markel DC, 2003, SEMIN ARTHROPLASTY, V14, P222
   Marques N, 2002, KEY ENG MAT, V230-2, P487, DOI 10.4028/www.scientific.net/KEM.230-232.487
   Matweb, 2011, MAT PROP DAT
   Meijerink HJ, 2010, ACTA ORTHOP, V81, P337, DOI 10.3109/17453674.2010.483991
   Mittelmeier W, 2006, BIOCERAMICS AND ALTERNATIVE BEARINGS IN JOINT ARTHROPLASTY, P125, DOI 10.1007/978-3-7985-1635-9_20
   Mont Michael A, 2003, Instr Course Lect, V52, P397
   Narayan RJ, 2006, JOM-US, V58, P52, DOI 10.1007/s11837-006-0142-5
   Naudie DDR, 2007, J AM ACAD ORTHOP SUR, V15, P53, DOI 10.5435/00124635-200701000-00006
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nemat-Alla M, 2003, INT J SOLIDS STRUCT, V40, P7339, DOI 10.1016/j.ijsolstr.2003.08.017
   O'Rourke MR, 2002, J BONE JOINT SURG AM, V84A, P1362, DOI 10.2106/00004623-200208000-00012
   Oonishi H, 2006, BIOCERAMICS AND ALTERNATIVE BEARINGS IN JOINT ARTHROPLASTY, P101, DOI 10.1007/978-3-7985-1635-9_17
   Oonishi H, 2002, KEY ENG MAT, V218-2, P499, DOI 10.4028/www.scientific.net/KEM.218-220.499
   Oonishi H, 2002, KEY ENG MAT, V218-2, P479, DOI 10.4028/www.scientific.net/KEM.218-220.479
   Pandorf T, 2007, CER ORTHO, P137, DOI 10.1007/978-3-7985-1783-7_18
   Petrini L., 2011, J METALLURGY
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Pria P, 2006, BIOCERAMICS JOINT AR, P115
   Que L, 2000, J BIOMED MATER RES, V50, P322, DOI 10.1002/(SICI)1097-4636(20000605)50:3<322::AID-JBM5>3.0.CO;2-U
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   Renteria-Zamarron D, 2009, MATER DESIGN, V30, P3318, DOI 10.1016/j.matdes.2008.11.024
   Rodriguez JA, 2001, CLIN ORTHOP RELAT R, P10
   RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x
   Scholes SC, 2008, P I MECH ENG H, V222, P273, DOI 10.1243/09544119JEIM334
   Scholes SC, 2007, P I MECH ENG H, V221, P281, DOI 10.1243/09544119JEIM224
   Scholes SC, 2009, J MATER SCI-MATER M, V20, P163, DOI 10.1007/s10856-008-3558-3
   Seki T, 1999, J Orthop Sci, V4, P180, DOI 10.1007/s007760050091
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Skinner HB, 2006, SEMIN ARTHOPLASTY, V17, P196
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Soininvaara TA, 2004, KNEE, V11, P297, DOI 10.1016/j.knee.2003.09.006
   Spector B M, 2001, J Bone Joint Surg Am, V83-A Suppl 2 Pt 2, P80
   STONE MH, 1989, J BONE JOINT SURG BR, V71, P217
   Tsukamoto R, 2006, ACTA ORTHOP, V77, P505, DOI 10.1080/17453670610046479
   Utzschneider S, 2010, ACTA BIOMATER, V6, P4296, DOI 10.1016/j.actbio.2010.06.002
   Utzschneider S, 2009, CLIN BIOMECH, V24, P583, DOI 10.1016/j.clinbiomech.2009.04.007
   Van Jonbergen HPW, 2010, BMC MUSCULOSKEL DIS, P11
   van Lenthe GH, 2002, ACTA ORTHOP SCAND, V73, P630, DOI 10.3109/17453670209178027
   von Schewelov Thord, 2009, J Knee Surg, V22, P231
   Wang A, 1998, TRIBOL INT, V31, P661, DOI 10.1016/S0301-679X(98)00088-7
   Wang AG, 2008, J ARTHROPLASTY, V23, P559, DOI 10.1016/j.arth.2007.05.007
   Wang CJ, 2011, KEY ENG MATER, V450, P111, DOI 10.4028/www.scientific.net/KEM.450.111
   Wen HB, 1997, J MATER SCI-MATER M, V8, P765, DOI 10.1023/A:1018512612695
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Woolson ST, 2011, J ARTHROPLASTY, V26, P1219, DOI 10.1016/j.arth.2011.01.014
   Yang JH, 2011, J ARTHROPLASTY, V2, P1
NR 91
TC 28
Z9 28
U1 0
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD FEB
PY 2013
VL 44
BP 155
EP 163
DI 10.1016/j.matdes.2012.07.066
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 030LM
UT WOS:000310572200020
DA 2018-10-20
ER

PT J
AU Hung, BP
   Hutton, DL
   Grayson, WL
AF Hung, Ben P.
   Hutton, Daphne L.
   Grayson, Warren L.
TI Mechanical control of tissue-engineered bone
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
ID MINERALIZED MATRIX DEPOSITION; 3D PERFUSION CULTURE; FLUID-FLOW;
   IN-VITRO; STRAIN AMPLIFICATION; CELL; REGENERATION; SCAFFOLDS;
   MECHANOTRANSDUCTION; DIFFERENTIATION
AB Bone is a load-bearing tissue and physical forces play key roles in the development and maintenance of its structure. Mechanical cues can stimulate the expression of an osteogenic phenotype, enhance matrix and mineral deposition, and influence tissue organization to improve the functional outcome of engineered bone grafts. In recent years, a number of studies have investigated the effects of biophysical forces on the bone formation properties of osteoprogenitor cells. The application of physiologically relevant stimuli to tissue-engineered bone may be determined through observation and understanding of forces to which osteoblasts, osteoclasts, and osteocytes are exposed in native bone. Subsequently, these cues may be parameterized and their effects studied in well-defined in vitro systems. The osteo-inductive effects of three specific mechanical cues - shear stress, substrate rigidity, and nanotopography - on cells cultured in monolayer or in three-dimensional biomaterial scaffolds in vitro are reviewed. Additionally, we address the time-dependent effects of mechanical cues on vascular infiltration and de novo bone formation in acellular scaffolds implanted into load-bearing sites in vivo. Recent studies employing cutting-edge advances in biomaterial fabrication and bioreactor design have provided key insights into the role of mechanical cues on cellular fate and tissue properties of engineered bone grafts. By providing mechanistic understanding, future studies may go beyond empirical approaches to rational design of engineering systems to control tissue development.
C1 [Hung, Ben P.; Hutton, Daphne L.; Grayson, Warren L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Hung, Ben P.; Hutton, Daphne L.; Grayson, Warren L.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
RP Grayson, WL (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
EM wgrayson@jhmi.edu
FU Johns Hopkins University Biomedical Engineering Department; Maryland
   Stem Cell Research Fund; Department of Defense
FX This work was funded by Johns Hopkins University Biomedical Engineering
   Department and grants from the Maryland Stem Cell Research Fund and the
   Department of Defense.
CR Azami M, 2010, INT J ARTIF ORGANS, V33, P86
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   BASSEY EJ, 1994, OSTEOPOROSIS INT, V4, P72, DOI 10.1007/BF01623226
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Boerckel JD, 2012, J ORTHOP RES, V30, P1067, DOI 10.1002/jor.22042
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108
   Boerckel JD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148472
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62, DOI 10.1152/ajpendo.1999.276.1.E62
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Epari DR, 2006, BONE, V38, P864, DOI 10.1016/j.bone.2005.10.023
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824
   Grayson W.L., 2010, BIOTECHNOL BIOENG, V108, P1159
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101
   Hutmacher DW, 2012, CELL TISSUE RES, V347, P485, DOI 10.1007/s00441-012-1357-0
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Knight MM, 2002, BBA-GEN SUBJECTS, V1570, P1, DOI 10.1016/S0304-4165(02)00144-7
   Li J, 2012, J BIOMECH, V45, P247, DOI 10.1016/j.jbiomech.2011.10.037
   Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104
   McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248
   McNamara LE, 2011, J TISSUE ENG, V2010
   Nienhuijs MEL, 2010, J BIOMED MATER RES B, V92B, P517, DOI 10.1002/jbm.b.31546
   Nitzsche H, 2010, J BIOMED MATER RES A, V94A, P298, DOI 10.1002/jbm.a.32703
   Palomares KTS, 2009, J ORTHOP RES, V27, P1123, DOI 10.1002/jor.20863
   Porter BD, 2007, BIOMATERIALS, V28, P2525, DOI 10.1016/j.biomaterials.2007.01.013
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Rubin J, 1999, J ORTHOPAED RES, V17, P639, DOI 10.1002/jor.1100170504
   SHAW SR, 1988, AM J PHYSIOL, V254, pR78
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613
   Sundaramurthy S, 2006, J ORTHOP RES, V24, P229, DOI 10.1002/jor.20024
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.teb.2011.0440, 10.1089/ten.TEB.2011.0440]
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Umeda H, 2007, LARYNGOSCOPE, V117, P997, DOI 10.1097/MLG.0b013e3180471459
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   ZENG Y, 1994, ANN BIOMED ENG, V22, P280, DOI 10.1007/BF02368235
NR 48
TC 19
Z9 20
U1 1
U2 110
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JAN 31
PY 2013
VL 4
AR 10
DI 10.1186/scrt158
PG 7
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 086XR
UT WOS:000314723500002
PM 23369796
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bae, MS
   Kim, JE
   Lee, JB
   Heo, DN
   Yang, DH
   Kim, JH
   Kwon, KR
   Bang, JB
   Bae, H
   Kwon, IK
AF Bae, Min Soo
   Kim, Ji Eun
   Lee, Jung Bok
   Heo, Dong Nyoung
   Yang, Dae Hyeok
   Kim, Jin-Ho
   Kwon, Kung-Rock
   Bang, Jae Beum
   Bae, Hojae
   Kwon, Il Keun
TI ZrO2 surface chemically coated with hyaluronic acid hydrogel loading
   GDF-5 for osteogenesis in dentistry
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Zirconium dioxide; Photo-cured hyaluronic acid hydrogel; Growth and
   differentiation factor-5; Bone morphogenetic protein-2; Release
   kinetics; Bone formation
ID RECOMBINANT HUMAN GROWTH; NF-KAPPA-B; SKELETAL DEVELOPMENT; OSTEOBLAST
   FUNCTION; GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; BONE; TITANIUM;
   PHOTOPOLYMERIZATION
AB The objective of this study was to modify zirconium dioxide (ZrO2) with photo-cured hyaluronic acid hydrogel (pcHAgel), and to subsequently evaluate the bone regeneration potential of the modified ZrO2. In the present study. HA grafted onto a ZrO2 substrate was investigated for its biocompatibility and other properties. We describe the positive influences of ZrO2 surface-modified with pcHAgel (Zr-3) containing two different loads of growth and differentiation factor-5 (GDF-5) to aid new bone formation as compared to the same amount of BMP-2 (Zr-4-7). We characterized the Zr-3 for their surface morphology and chemical properties. Atomic force microscopy (AFM), scanning electron microscope (SEM), and Xray photoelectron spectroscopy (XPS) showed that the pcHAgel was successfully grafted onto the ZrO2 surface. The sustained release of GDF-5 and BMP-2 were observed to occur in the Zr-4-7. In vitro cell tests showed a higher level of MG63 cell proliferation and differentiation on Zr-4-7 than on Zr-3. The Zr-3 is a good biomaterial to deliver osteogenic differentiation factors such as BMP-2 and GDF-5, and GDF-5 can be useful as an effective alternative to aid new bone formation as compared to BMP-2. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Bae, Min Soo; Kim, Ji Eun; Lee, Jung Bok; Heo, Dong Nyoung; Yang, Dae Hyeok; Bae, Hojae; Kwon, Il Keun] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Sch Dent, Seoul 130701, South Korea.
   [Bae, Min Soo; Kim, Ji Eun; Lee, Jung Bok; Heo, Dong Nyoung; Yang, Dae Hyeok; Bae, Hojae; Kwon, Il Keun] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Kim, Jin-Ho; Kwon, Kung-Rock] Kyung Hee Univ, Sch Dent, Dept Prosthodont, Seoul 130701, South Korea.
   [Bang, Jae Beum] Kyung Hee Univ, Sch Dent, Dept Dent Educ, Seoul 130701, South Korea.
RP Kwon, IK (reprint author), Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Sch Dent, 1 Hoegi Dong, Seoul 130701, South Korea.
EM kwoni@khu.ac.kr
FU Basic Research Program of the Korea Science & Engineering Foundation
   [20110007746]; Pioneer Research Center Program [20110001689]; National
   Research Foundation of Korea [20110028336]; Ministry of Education
FX This work was supported by Grant No. 20110007746 from the Basic Research
   Program of the Korea Science & Engineering Foundation, Grant No.
   20110001689 from the Pioneer Research Center Program and Grant No.
   20110028336 from Happy Tech. Program through the National Research
   Foundation of Korea funded by the Ministry of Education.
CR Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455
   Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Choi JY, 2008, COLLOID SURFACE B, V67, P216, DOI 10.1016/j.colsurfb.2008.08.025
   Clapper JD, 2008, CHEM MATER, V20, P768, DOI 10.1021/cm702130r
   Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gruber RM, 2009, CLIN ORAL IMPLAN RES, V20, P175, DOI 10.1111/j.1600-0501.2008.01628.x
   He W, 2007, ADV MATER, V19, P3529, DOI 10.1002/adma.200700943
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567
   Huang HM, 2011, MED BIOL ENG COMPUT, V49, P701, DOI 10.1007/s11517-011-0742-2
   Hutchison JB, 2005, CHEM MATER, V17, P4789, DOI 10.1021/cm0504541
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jung U.W., 2010, J CLIN PERIODONTOL, V37, P271
   Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P1301, DOI 10.1111/j.1600-0501.2010.01949.x
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Morotome Y, 1998, BIOCHEM BIOPH RES CO, V244, P85, DOI 10.1006/bbrc.1998.8213
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Schwarz F, 2009, CLIN ORAL IMPLAN RES, V20, P1219, DOI 10.1111/j.1600-0501.2009.01796.x
   Sena K, 2003, J DENT RES, V82, P166, DOI 10.1177/154405910308200304
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200
   Tokarev I, 2010, ADV MATER, V22, P3446, DOI 10.1002/adma.201000165
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t
NR 36
TC 13
Z9 14
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2013
VL 92
IS 1
BP 167
EP 175
DI 10.1016/j.carbpol.2012.09.044
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 065KJ
UT WOS:000313146900022
PM 23218279
DA 2018-10-20
ER

PT J
AU Zhang, NZ
   Liu, HS
   Yu, L
   Liu, XX
   Zhang, L
   Chen, L
   Shanks, R
AF Zhang, Nuozi
   Liu, Hongsheng
   Yu, Long
   Liu, Xingxun
   Zhang, Liang
   Chen, Ling
   Shanks, Robert
TI Developing gelatin-starch blends for use as capsule materials
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; Pharmaceutical; Capsule; Gelatin; Starch; Blend
ID EDIBLE FILMS; BARRIER PROPERTIES; MECHANICAL-PROPERTIES; OXIDIZED
   STARCH; HARD CAPSULES; CORN STARCH; AMYLOSE; POLYOLS; WATER;
   MICROSTRUCTURE
AB Blends of gelatin with up to 50% hydroxypropylated high amylose (80%) corn starch were developed as capsule materials. Poly(ethylene glycol) (PEG) was used as both a plasticizer and a compatibilizer in the blends. In order to prepare hard capsules for pharmaceutical applications using the well-established method of dipping stainless steel mold pins into solution, solutions with higher solids concentrations (up to 30%) were developed. The solutions, films and capsules of the different gelatin-starch blends were characterized by viscosity, transparency, tensile testing, water contact angle and SEM. The linear microstructure of the high amylose starch, and the flexible and more hydrophilic hydroxylpropylene groups grafted onto the starch improved the compatibility between the gelatin and starch. SEM revealed a continuous phase of gelatin on the surface of films from all blends. The water contact angle of pure gelatin and the different blends were similar, indicating a continuous phase of gelatin. By optimizing temperature and incubation time to control viscosity, capsules of various blends were successfully developed. PEG increased the transparency and toughness of the various blends. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Zhang, Nuozi; Liu, Hongsheng; Yu, Long; Liu, Xingxun; Zhang, Liang; Chen, Ling] SCUT, CPFRR, ERCPSP, Sch Light Ind & Food Engn, Guangzhou 510640, Guangdong, Peoples R China.
   [Zhang, Nuozi; Yu, Long] Commonwealth Sci & Ind Res Org, Div Mat Sci & Engn, Clayton, Vic 3169, Australia.
   [Zhang, Nuozi; Shanks, Robert] RMIT Univ, Sch Appl Sci, Melbourne, Vic 3000, Australia.
RP Yu, L (reprint author), SCUT, CPFRR, ERCPSP, Sch Light Ind & Food Engn, Guangzhou 510640, Guangdong, Peoples R China.
EM long.yu@csiro.au
RI Liu, Xingxun/B-1780-2015
OI Liu, Xingxun/0000-0001-9101-3525; Shanks, Robert/0000-0003-3790-5148
FU NFSC [31130042, 21174043]; RFDPHE [20110172110027]; FRFCU [2012ZZ0085,
   2012ZB0006]
FX The authors from SCUT, China, would like to acknowledge the research
   funds NFSC (31130042, 21174043), RFDPHE (20110172110027) and FRFCU
   (2012ZZ0085, 2012ZB0006).
CR Abdulmola NA, 1996, CARBOHYD POLYM, V31, P53, DOI 10.1016/S0144-8617(96)00062-8
   Al-Hassan AA, 2012, FOOD HYDROCOLLOID, V26, P108, DOI 10.1016/j.foodhyd.2011.04.015
   Al-Tabakha MM, 2010, J PHARM PHARM SCI, V13, P428, DOI 10.18433/J3K881
   ARVANITOYANNIS I, 1994, CARBOHYD POLYM, V24, P1, DOI 10.1016/0144-8617(94)90111-2
   Arvanitoyannis I, 1996, CARBOHYD POLYM, V31, P179, DOI 10.1016/S0144-8617(96)00123-3
   Arvanitoyannis I, 1997, FOOD CHEM, V60, P593, DOI 10.1016/S0308-8146(97)00038-1
   Arvanitoyannis I, 1998, CARBOHYD POLYM, V36, P105, DOI 10.1016/S0144-8617(98)00017-4
   BALDWIN EA, 1995, CRIT REV FOOD SCI, V35, P509, DOI 10.1080/10408399509527713
   BILIADERIS CG, 1985, CARBOHYD POLYM, V5, P367, DOI 10.1016/0144-8617(85)90044-X
   Chiwele I, 2000, CHEM PHARM BULL, V48, P951
   Cole ET, 2008, ADV DRUG DELIVER REV, V60, P747, DOI 10.1016/j.addr.2007.09.009
   EITH L, 1987, MANUF CHEMIST, V58, P21
   Firoozmand H, 2009, FOOD HYDROCOLLOID, V23, P1081, DOI 10.1016/j.foodhyd.2008.07.013
   Gohil UC, 2004, INT J PHARM, V285, P51, DOI 10.1016/j.ijpharm.2004.07.008
   IDRISSI S, 1991, PHARM ACTA HELV, V66, P246
   Jagannath JH, 2003, J APPL POLYM SCI, V88, P64, DOI 10.1002/app.11602
   Jones B. E., 2004, PHARM CAPSULES, P23
   Jovanovich G, 1999, BIOPOLYMERS, V49, P81, DOI 10.1002/(SICI)1097-0282(199901)49:1<81::AID-BIP8>3.0.CO;2-D
   Ku MS, 2010, INT J PHARMACEUT, V386, P30, DOI 10.1016/j.ijpharm.2009.10.050
   Lan C, 2010, MACROMOL MATER ENG, V295, P1025, DOI 10.1002/mame.201000186
   Laohakunjit N, 2004, STARCH-STARKE, V56, P348, DOI 10.1002/star.200300249
   Li M, 2011, J FOOD ENG, V106, P95, DOI 10.1016/j.jfoodeng.2011.04.021
   Liu H. S., 2013, ACTA POLYM SIN, V<IT>1</IT>, P1
   Liu HS, 2007, CARBOHYD POLYM, V69, P756, DOI 10.1016/j.carbpol.2007.02.011
   Liu HS, 2009, CARBOHYD POLYM, V77, P662, DOI 10.1016/j.carbpol.2009.02.010
   Liu P, 2009, CARBOHYD POLYM, V77, P250, DOI 10.1016/j.carbpol.2008.12.027
   Mousia Z, 2001, BIOPOLYMERS, V62, P208, DOI 10.1002/bip.1015
   Mousia Z, 2000, POLYMER, V41, P1841, DOI 10.1016/S0032-3861(99)00335-3
   Ogura T., 1998, PHARM TECHNOL EUR, V10, P32
   Ong MH, 1998, FOOD HYDROCOLLOID, V12, P273, DOI 10.1016/S0268-005X(98)00015-0
   Psomiadou E, 1996, CARBOHYD POLYM, V31, P193, DOI 10.1016/S0144-8617(96)00077-X
   RAPHAELIDES S, 1988, CARBOHYD RES, V172, P65, DOI 10.1016/S0008-6215(00)90843-7
   Rindlav-Westling A, 1998, CARBOHYD POLYM, V36, P217, DOI 10.1016/S0144-8617(98)00025-3
   Stepto RFT, 1997, POLYM INT, V43, P155
   Tharanathan RN, 2005, CRIT REV FOOD SCI, V45, P371, DOI 10.1080/10408390590967702
   Vilivalam Vinod D., 2000, Pharmaceutical Science and Technology Today, V3, P64, DOI 10.1016/S1461-5347(99)00238-2
   Whistler R. L., 1984, STARCH CHEM TECHNOLO
   Wurzburg O. B., 1987, MODIFIED STARCHES PR
   Xie FW, 2009, J CEREAL SCI, V49, P371, DOI 10.1016/j.jcs.2009.01.002
   Yu L, 2005, J MATER SCI, V40, P111, DOI 10.1007/s10853-005-5694-1
NR 40
TC 37
Z9 39
U1 4
U2 117
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2013
VL 92
IS 1
BP 455
EP 461
DI 10.1016/j.carbpol.2012.09.048
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 065KJ
UT WOS:000313146900063
PM 23218320
DA 2018-10-20
ER

PT J
AU Chen, C
   Liu, MZ
   Gao, CM
   Lu, SY
   Chen, JC
   Yu, XY
   Ding, EY
   Yu, CM
   Guo, J
   Cui, GJ
AF Chen, Chen
   Liu, Mingzhu
   Gao, Chunmei
   Lu, Shaoyu
   Chen, Jiucun
   Yu, Xiyong
   Ding, Enyong
   Yu, Chuanming
   Guo, Jing
   Cui, Guijia
TI A convenient way to synthesize comb-shaped chitosan-graft-poly
   (N-isopropylacrylamide) copolymer
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; PNIPAAm; Comb-shape; pH/temperature multi-responsive; ATRP
ID TRANSFER RADICAL POLYMERIZATION; HYDROXYPROPYL CELLULOSE BACKBONES;
   SURFACE-INITIATED-ATRP; BIOMEDICAL APPLICATIONS; CHEMICAL-MODIFICATIONS;
   SIDE-CHAINS; TEMPERATURE; POLY(N-ISOPROPYLACRYLAMIDE); MACROMONOMERS;
   NANOPARTICLES
AB Comb-shaped copolymers comprised of hydrophobic and hydrophilic blocks are self-assembled in aqueous solution, which results that they are suitable for delivery of hydrophobic drug molecules. Chitosan (CS) is an important biomaterial used widely in medical applications. Herein, a comb-shaped cationic copolymer composed of long biocompatible CS main chains and short PNIPAAm side chains was prepared via atom transfer radical polymerization (ATRP) by attaching an ATRP initiating group to N-phthaloyl chitosan. By subsequent removal of the protective groups on N-phthaloyl chitosan-graft-poly(N-isopropylacrylamide) (PHCS-g-PNIPAAm) copolymer with N2H4 center dot H2O lead to the polymer pendant amino groups, this study attempted to synthesize a pH/temperature multi-responsive material. This chitosan-graft-poly(N-isopropylacrylamide) (CS-g-PNIPAAm) copolymer is self-assembled in aqueous solution into stimuli-responsive core-shell micelles with hydrodynamic diameters of about 170 nm. Structural organization and solution behavior were then investigated utilizing H-1 NMR spectroscopy, transmission electron microscopy (TEM) and dynamic light scattering (DLS). (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Chen, Chen; Liu, Mingzhu; Gao, Chunmei; Lu, Shaoyu; Chen, Jiucun; Yu, Chuanming; Guo, Jing; Cui, Guijia] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
   [Chen, Chen; Liu, Mingzhu; Gao, Chunmei; Lu, Shaoyu; Chen, Jiucun; Yu, Chuanming; Guo, Jing; Cui, Guijia] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
   [Yu, Xiyong] Guangdong Gen Hosp, Med Res Ctr, Guangzhou 510080, Guangdong, Peoples R China.
   [Ding, Enyong] S China Univ Technol, Coll Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Liu, MZ (reprint author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
EM mzliu@lzu.edu.cn
OI lu, shao yu/0000-0003-0171-6601
FU Ministry of Education of China [20090211110004]; Fund for Train Men for
   Profession of National Natural Science Foundation of China [J1103307]
FX We gratefully acknowledge the financial support of the Special Doctorial
   Program Fund of the Ministry of Education of China (Grant No.
   20090211110004) and the Fund for Train Men for Profession of National
   Natural Science Foundation of China (Grant No. J1103307).
CR Bao HQ, 2010, J PHYS CHEM B, V114, P10666, DOI 10.1021/jp105041z
   Chen C, 2013, CARBOHYD POLYM, V91, P269, DOI 10.1016/j.carbpol.2012.08.042
   Duan KR, 2010, COLLOID SURFACE B, V76, P475, DOI 10.1016/j.colsurfb.2009.12.007
   Estillore NC, 2010, MACROMOLECULES, V43, P6588, DOI 10.1021/ma100726z
   Fajardo AR, 2012, CHEM ENG J, V183, P253, DOI 10.1016/j.cej.2011.12.071
   Feng H, 2006, BIOMACROMOLECULES, V7, P3069, DOI 10.1021/bm060568l
   Gao HF, 2007, MACROMOLECULES, V40, P399, DOI 10.1021/ma062040d
   Gorrasi G, 2011, REACT FUNCT POLYM, V71, P23, DOI 10.1016/j.reactfunctpolym.2010.11.007
   Ho KM, 2010, COLLOID POLYM SCI, V288, P1503, DOI 10.1007/s00396-010-2276-9
   Ifuku S, 2008, BIOMACROMOLECULES, V9, P3308, DOI 10.1021/bm800911w
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kumar BAV, 2007, BIOMACROMOLECULES, V8, P566, DOI 10.1021/bm060753z
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Li P, 2008, IND ENG CHEM RES, V47, P7700, DOI 10.1021/ie800824q
   Lindqvist J, 2008, BIOMACROMOLECULES, V9, P2139, DOI 10.1021/bm800193n
   Liu L, 2010, REACT FUNCT POLYM, V70, P301, DOI 10.1016/j.reactfunctpolym.2010.02.003
   Liu QC, 2006, J POLYM SCI POL CHEM, V44, P6103, DOI 10.1002/pola.21699
   Ma L, 2010, LANGMUIR, V26, P8697, DOI 10.1021/la904431z
   Martins GV, 2011, LANGMUIR, V27, P8415, DOI 10.1021/la200832n
   Moustafine RI, 2008, EUR J PHARM BIOPHARM, V70, P215, DOI 10.1016/j.ejpb.2008.04.008
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   Ostmark E, 2007, BIOMACROMOLECULES, V8, P1138, DOI 10.1021/bm061043w
   Pillai C. K. S, 2006, CARBOHYD POLYM, V64, P254
   Qiao P, 2010, CHEM ENG J, V159, P257, DOI 10.1016/j.cej.2010.02.035
   Tang F, 2009, IND ENG CHEM RES, V48, P6216, DOI 10.1021/ie801935p
   Tapia C, 2004, EUR J PHARM BIOPHARM, V57, P65, DOI 10.1016/S0939-641(03)00153-X
   Thompson CJ, 2008, COLLOID POLYM SCI, V286, P1511, DOI 10.1007/s00396-008-1925-8
   Wan S, 2007, MACROMOLECULES, V40, P5552, DOI 10.1021/ma070147b
   WANG JS, 1995, MACROMOLECULES, V28, P7901, DOI 10.1021/ma00127a042
   Wang YP, 2009, REACT FUNCT POLYM, V69, P393, DOI 10.1016/j.reactfunctpolym.2009.03.005
   Wu T, 2008, CHEM MATER, V20, P101, DOI 10.1021/cm702073f
   Xu FJ, 2010, BIOCONJUGATE CHEM, V21, P456, DOI 10.1021/bc900337p
   Xu FJ, 2009, BIOCONJUGATE CHEM, V20, P1449, DOI 10.1021/bc900044h
   Yang LR, 2010, IND ENG CHEM RES, V49, P8518, DOI 10.1021/ie100587e
   Yang LQ, 2011, CHEM ENG J, V168, P115, DOI 10.1016/j.cej.2010.12.048
   Ye JD, 2009, J PHYS CHEM B, V113, P676, DOI 10.1021/jp808905s
   Ying GQ, 2011, CARBOHYD POLYM, V83, P1787, DOI 10.1016/j.carbpol.2010.10.037
   Zhao CW, 2011, COLLOID POLYM SCI, V289, P447, DOI 10.1007/s00396-010-2365-9
   Zheng JN, 2010, LANGMUIR, V26, P17156, DOI 10.1021/la1030203
NR 41
TC 24
Z9 24
U1 0
U2 152
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2013
VL 92
IS 1
BP 621
EP 628
DI 10.1016/j.carbpol.2012.09.014
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 065KJ
UT WOS:000313146900087
PM 23218344
DA 2018-10-20
ER

PT J
AU Bhang, SH
   Kwon, SH
   Lee, S
   Kim, GC
   Han, AM
   Kwon, YHK
   Kim, BS
AF Bhang, Suk Ho
   Kwon, Sun-Hyun
   Lee, Seahyoung
   Kim, Gui Chul
   Han, Ah Mi
   Kwon, Yun Hee Kim
   Kim, Byung-Soo
TI Enhanced neuronal differentiation of pheochromocytoma 12 cells on
   polydopamine-modified surface
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Cell adhesion; Neuronal differentiation; Pheochromocytoma 12 cell;
   Polydopamine
ID NERVE GROWTH-FACTOR; TO-SUBSTRATUM ADHESION; L-DOPA; PC12 CELLS;
   FUNCTIONAL-GROUPS; FACTOR SIGNALS; RHO GTPASES; TRKA; PROLIFERATION;
   MORPHOGENESIS
AB Since pheochromocytoma 12 (PC12) cells have the ability of neuronal differentiation upon nerve growth factor (NGF) treatment, they are a good model for studying the neuronal differentiation. Establishing a strong adhesion of PC12 cells to the culture substrate may increase neuronal differentiation, and the use of L-3,4-dihydroxypfienylalanine (L-DOPA), which is responsible for the adhesive property of mussel adhesive proteins (MAPs), is a feasible strategy for such strong adhesion. We hypothesized that a polydopamine-modified surface can promote PC12 cell adhesion and subsequent neuronal differentiation. We examined whether polydopamine-modified surface promotes PC12 cell adhesion, and further evaluated the neuronal differentiation of these cells. The polydopamine modification enhanced the cell adhesion and viability, and also promoted the neuronal differentiation of NGF-stimulated PC12 cells, as evidenced by the elongation of neurites and expression of neuronal differentiation markers, by increasing the activation of NGF/Trk-Rho GTPase signal pathway. Our findings will help develop an improved strategy for functionalizing biomaterial substrates for less-adhesive cells including neural cells. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Bhang, Suk Ho; Kwon, Sun-Hyun; Lee, Seahyoung; Kim, Byung-Soo] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
   [Kim, Gui Chul; Han, Ah Mi; Kwon, Yun Hee Kim] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea.
   [Han, Ah Mi; Kwon, Yun Hee Kim] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea.
   [Kim, Byung-Soo] Seoul Natl Univ, Engn Res Inst, Inst Chem Proc, BioMAX Inst, Seoul 151744, South Korea.
RP Kim, BS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
EM byungskim@snu.ac.kr
RI Kim, Byung-Soo/O-2352-2013
FU National Research Foundation of Korea [2010-0020352]
FX This work was supported by a Grant (2010-0020352) from the National
   Research Foundation of Korea.
CR Attiah DG, 2003, J MATER SCI-MATER M, V14, P1005, DOI 10.1023/A:1026363018805
   Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Bhang SH, 2009, BIOCHEM BIOPH RES CO, V382, P315, DOI 10.1016/j.bbrc.2009.03.016
   BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cellbio.4.1.43
   Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023
   Cheng NN, 1996, BRAIN RES, V743, P278, DOI 10.1016/S0006-8993(96)01056-6
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hong S, 2011, NANOMEDICINE-UK, V6, P793, DOI [10.2217/nnm.11.76, 10.2217/NNM.11.76]
   Janorkar AV, 2007, J BIOMED MATER RES B, V81B, P142, DOI 10.1002/jbm.b.30647
   Kim SH, 2012, J BIOMATER APPL, V27, P143, DOI 10.1177/0885328210397679
   Koshimura K, 2000, J NEUROSCI RES, V62, P112, DOI 10.1002/1097-4547(20001001)62:1<112::AID-JNR12>3.3.CO;2-Y
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lamour G, 2010, BIOMATERIALS, V31, P3762, DOI 10.1016/j.biomaterials.2010.01.099
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4
   Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547
   Mischel PS, 2002, BIOPHYS J, V83, P968, DOI 10.1016/S0006-3495(02)75222-3
   MONTINE TJ, 1995, NEURODEGENERATION, V4, P283, DOI 10.1016/1055-8330(95)90017-9
   Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200
   de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010
   SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P4055, DOI 10.1073/pnas.74.9.4055
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034
   Wojcik-Stanaszek L, 2011, ACTA NEUROBIOL EXP, V71, P103
   Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
NR 33
TC 9
Z9 9
U1 1
U2 37
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 25
PY 2013
VL 430
IS 4
BP 1294
EP 1300
DI 10.1016/j.bbrc.2012.11.123
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 091UL
UT WOS:000315075200019
PM 23261471
DA 2018-10-20
ER

PT J
AU Hines, DJ
   Kaplan, DL
AF Hines, Daniel J.
   Kaplan, David L.
TI Characterization of Small Molecule Controlled Release From Silk Films
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE controlled release; mathematical modeling; release mechanism; silk
   fibroin; small molecule; synthetic dye
ID CONTROLLED DRUG-DELIVERY; IN-VITRO; FIBROIN; BIOMATERIAL; SCAFFOLDS;
   POLYMER; MICROSPHERES; THEOPHYLLINE; SOLUBILITY; ADENOSINE
AB Release data for several dyes from untreated, water-annealed, and methanol-treated silk films are collected and modeled. Through modeling, Fickian diffusion is identified as the major release mechanism. Estimated diffusivities are compared with dye properties to characterize parameterproperty relationships. FTIRATR spectra of the silk films confirm an increase in the crystalline beta-sheet content within the silk films for methanol-treated and water-annealed films. An aqueous binding study is completed and shows weak binding of three dyes to the silk films. The Langmuir equation is fit to each of the binding curves and compared. The rate of diffusion from silk films is highly impacted by the molecular structure, water solubility, and molecular charge of the releasing solute and the matrix crystallinity.
C1 [Hines, Daniel J.; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Hines, Daniel J.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM daniel.hines@tufts.edu; david.kaplan@tufts.edu
FU National Institute of Health [P41EB002520, R01NS05780]
FX This work was funded by grants P41EB002520 and R01NS05780 from the
   National Institute of Health.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   BETTINI R, 1995, J CONTROL RELEASE, V37, P105, DOI 10.1016/0168-3659(95)00069-K
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kojic N, 2004, BIOMACROMOLECULES, V5, P1698, DOI 10.1021/bm034280x
   Kojic N, 2006, COMMUN NUMER METH EN, V22, P1003, DOI [10.1002/cnm.869, 10.1002/enm.869]
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   RAO KVR, 1990, J CONTROL RELEASE, V12, P133, DOI 10.1016/0168-3659(90)90089-C
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tang YQ, 2003, BIOMACROMOLECULES, V4, P1636, DOI 10.1021/bm030026t
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
NR 37
TC 5
Z9 5
U1 5
U2 64
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD JAN 25
PY 2013
VL 214
IS 2
SI SI
BP 280
EP 294
DI 10.1002/macp.201200407
PG 15
WC Polymer Science
SC Polymer Science
GA 073EO
UT WOS:000313726500016
DA 2018-10-20
ER

PT J
AU Macias, CE
   Bodugoz-Senturk, H
   Muratoglu, OK
AF Macias, Celia E.
   Bodugoz-Senturk, Hatice
   Muratoglu, Orhun K.
TI Quantification of PVA hydrogel dissolution in water and bovine serum
SO POLYMER
LA English
DT Article
DE Hydrogel; PVA; Cartilage
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; SEMICRYSTALLINE POLY(VINYL
   ALCOHOL); H ARTIFICIAL MENISCUS; POLY-VINYL ALCOHOL; POLYVINYL-ALCOHOL;
   CARTILAGE DEFECTS; RANDOMIZED-TRIAL; KNEE; MICROFRACTURE;
   TRANSPLANTATION
AB Poly(vinyl alcohol) (PVA) hydrogel is a candidate biomaterial for orthopaedic applications such as cartilage resurfacing due to its viscoelastic nature, high water content, and biocompatibility. PVA is not assumed to be biodegradable; however, depending on the level of physical and/or chemical crosslinking it may illicit dissolution either during storage in water or during in vivo use when articulating against cartilage. In addition, gravimetric quantification of wear during pre-clinical wear testing of a PVA-based implant is challenging due to unpredictable changes in water content. Our aim was to develop a method to detect dissolved PVA in water and bovine serum; bovine serum is the lubricant of choice for preclinical wear testing of orthopaedic implants. We used iodine complexation to determine PVA concentration in solution using UV-Vis spectrophotometry. We further refined this method to determine the effects of PVA molecular weight and the presence of poly(ethylene glycol) (PEG) that may be used in the fabrication of the gel. In addition, we developed a method for determining the amount of PVA dissolved in bovine serum to quantify the extent of PVA dissolution during pre-clinical wear studies. We were able to detect PVA in solution with concentrations as low as 10(-5) g/mL and created calibration curves for different solvents, i.e. water and bovine serum. Based on the calibrations, we quantified the dissolution behavior of PVA in water at 40 degrees C during a six month period and found that the dissolution from an untreated PVA hydrogel is 3 x 10(4) ppm, and could be lowered to 1 x 10(3) ppm by dehydration and/or annealing of the PVA hydrogel. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Muratoglu, Orhun K.] Massachusetts Gen Hosp, Harris Orthopaed Biomech & Biomat Lab, Dept Orthopaed Surg, Boston, MA 02114 USA.
   [Bodugoz-Senturk, Hatice; Muratoglu, Orhun K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
RP Muratoglu, OK (reprint author), Massachusetts Gen Hosp, Harris Orthopaed Biomech & Biomat Lab, Dept Orthopaed Surg, 55 Fruit St,GRJ 1206, Boston, MA 02114 USA.
EM omuratoglu@partners.org
FU Zimmer, Inc.
FX This study was funded by departmental research funds and by a sponsored
   research grant from Zimmer, Inc.
CR Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015
   Bodugoz-Senturk H, 2008, BIOMATERIALS, V29, P141, DOI 10.1016/j.biomaterials.2007.09.015
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Bugbee WD, 1999, CLIN SPORT MED, V18, P67, DOI 10.1016/S0278-5919(05)70130-7
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Cha WI, 1996, MACROMOL SYMP, V109, P115, DOI 10.1002/masy.19961090111
   Choi J, 2006, BIOMATERIALS, V28, P772
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   FINLEY JH, 1961, ANAL CHEM, V33, P1925, DOI 10.1021/ac50154a044
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Gu Z, 1999, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V16, P13
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Herrmann WO, 1927, BER DTSCH CHEM GES, V60, P1658, DOI 10.1002/cber.19270600733
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kobayashi M, 2004, J BIOMAT SCI-POLYM E, V15, P741, DOI 10.1163/156856204774196135
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Maher SA, 2007, J BIOMED MATER RES A, V83A, P145, DOI 10.1002/jbm.a.31255
   Mallapragada S. K., 1995, POLYM MAT SCI ENG P, V73, P22
   Mallapragada SK, 1997, J BIOMED MATER RES, V36, P125, DOI 10.1002/(SICI)1097-4636(199707)36:1<125::AID-JBM15>3.0.CO;2-H
   Mallapragada SK, 1997, AICHE J, V43, P870, DOI 10.1002/aic.690430403
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   MIYASAKA K, 1993, ADV POLYM SCI, V108, P91
   Miyazaki T, 2005, POLYMER, V46, P7436, DOI 10.1016/j.polymer.2005.05.129
   Noguchi H, 1997, J POLYM SCI POL PHYS, V35, P1701, DOI 10.1002/(SICI)1099-0488(199708)35:11<1701::AID-POLB4>3.3.CO;2-5
   Oka M, 2000, P I MECH ENG H, V214, pPart H
   Oka M, 1995, ARTIFICIAL INTERVERT
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Ruberti JW, 2004, SYSTEMS METHODS CONT
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   Wang BL, 2000, RADIAT PHYS CHEM, V59, P91, DOI 10.1016/S0969-806X(00)00188-2
   ZWICK MM, 1965, J APPL POLYM SCI, V9, P2393, DOI 10.1002/app.1965.070090706
NR 37
TC 11
Z9 11
U1 2
U2 66
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JAN 24
PY 2013
VL 54
IS 2
BP 724
EP 729
DI 10.1016/j.polymer.2012.11.068
PG 6
WC Polymer Science
SC Polymer Science
GA 078FV
UT WOS:000314085000031
DA 2018-10-20
ER

PT J
AU Shukla, S
   Bajpai, AK
AF Shukla, Seeta
   Bajpai, A. K.
TI Plaster of Paris-Reinforced Nanocomposites of Poly (2-hydroxyethyl
   Methacrylate-Co-acrylamide) as Alternative Orthopedic Material
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Biomaterial; Filler; Mechanical; Nanocomposites; Polymer
ID VITRO BLOOD COMPATIBILITY; WATER SORPTION PROPERTY; POLY(VINYL ALCOHOL);
   SPONGY CRYOGELS; NETWORKS IPNS; HYDROGELS; POLYMERIZATION; MICROSPHERES;
   COMPOSITES; BEHAVIOR
AB The present study is an attempt to develop a ceramic/polymer composite made by grafting 2-hydroxyethyl methacrylate (HEMA) and acrylamide (Am) onto polyvinyl alcohol (PVA) using free radical polymerization method and impregnating plaster of paris (PP) into the grafted polymer matrix. The prepared composites were characterized by Fourier transform spectroscopy, X-ray diffraction studies, Differential Scanning Calorimetry and Scanning Electron Microscopy. The composites also showed adequately good compressive strength and modulus. The water sorption behavior and porosity were found to be dependent on the chemical composition of the matrix. The in vitro blood compatibility of the nanocomposite was also determined.
C1 [Shukla, Seeta; Bajpai, A. K.] Govt Autonomous Sci Coll, Bose Mem Res Lab, Jabalpur 482001, MP, India.
RP Bajpai, AK (reprint author), Govt Autonomous Sci Coll, Bose Mem Res Lab, Jabalpur 482001, MP, India.
EM akbmrl@yahoo.co.in
CR AKIN H, 1995, J APPL POLYM SCI, V58, P95, DOI 10.1002/app.1995.070580110
   Aminabhavi TM, 2010, DES MONOMERS POLYM, V13, P497, DOI 10.1163/138577210X530558
   Bajpai A, 2005, POLYM INT, V54, P796, DOI 10.1002/pi.1773
   Bajpai AK, 2008, J MATER SCI-MATER M, V19, P1921, DOI 10.1007/s10856-007-3268-2
   Bajpai AK, 2007, J APPL POLYM SCI, V104, P1559, DOI 10.1002/app.25580
   Bajpai AK, 2007, POLYM INT, V56, P557, DOI 10.1002/pi.2171
   Bajpai AK, 2006, J MATER SCI-MATER M, V17, P49, DOI 10.1007/s10856-006-6329-z
   Bajpai AK, 2005, POLYM INT, V54, P1233, DOI 10.1002/pi.1813
   Bajpai AK, 2001, J APPL POLYM SCI, V81, P1238, DOI 10.1002/app.1546
   Bajpai AK, 2001, J MACROMOL SCI PURE, V38, P1123, DOI 10.1081/MA-100107133
   Bajpai AK, 2001, REACT FUNCT POLYM, V50, P9
   Buruiana EC, 2010, DES MONOMERS POLYM, V13, P167, DOI 10.1163/138577210X12634696333398
   Chandara C, 2009, WASTE MANAGE, V29, P1675, DOI 10.1016/j.wasman.2008.11.014
   FLORY PJ, 1953, PRINCIPLES POLYM CHE, P464
   Hussain R, 2000, TURK J CHEM, V24, P177
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Johnson J. E, 1959, J APPL POLYM SCI, V2, P205
   Khan F, 2012, DES MONOMERS POLYM, V15, P1, DOI 10.1163/156855511X606119
   Kusmanto F., 2007, CHEM ENG, V134, P6948
   Lindner T, 2009, J BONE JOINT SURG BR, V91B, P294, DOI 10.1302/0301-620X.91B3.21273
   Liu QH, 2012, POLYM-PLAST TECHNOL, V51, P251, DOI 10.1080/03602559.2011.625381
   Mabilleau G, 2008, J RAMAN SPECTROSC, V39, P767, DOI 10.1002/jrs.1960
   Magnussen RA, 2005, J ORTHOP RES, V23, P576, DOI 10.1016/j.orthres.2004.12.006
   Mallakpour S, 2012, DES MONOMERS POLYM, V15, P329, DOI 10.1163/156855511X615713
   Mishra S, 2006, POLYM-PLAST TECHNOL, V45, P1191, DOI 10.1080/03602550600887202
   Ning Y., 1989, CHIENES J POLYM SCI, V7, P315
   Pillai CKS, 2010, DES MONOMERS POLYM, V13, P87, DOI 10.1163/138577210X12634696333190
   Pourjavadi A, 2006, TURK J CHEM, V30, P595
   Prabakaran K., 2006, TRENDS BIOMATERIALS, V19, P84
   Rahaman M. N., 1995, CERAMIC PROCESSING S, P1
   Ramaraj B, 2008, POLYM-PLAST TECHNOL, V47, P733, DOI 10.1080/03602550802059170
   Serizawa T, 2002, MACROMOLECULES, V35, P10, DOI 10.1021/ma011362+
   Varaprasad K, 2010, INT J POLYM MATER, V59, P981, DOI 10.1080/00914037.2010.504147
   Wei P., 2011, INT J POLYM MATER, V60, P223
   Yeum JH, 2011, POLYM-PLAST TECHNOL, V50, P1149, DOI 10.1080/03602559.2011.566302
   Yu YQ, 2011, POLYM-PLAST TECHNOL, V50, P525, DOI 10.1080/03602559.2010.543735
   Zhang Y. Z., 2009, BIOMATER, V30, P2694
   Zikry AAF, 2008, INT J POLYM MATER, V57, P383, DOI 10.1080/00914030701729057
NR 38
TC 4
Z9 4
U1 2
U2 26
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD JAN 15
PY 2013
VL 52
IS 2
BP 133
EP 140
DI 10.1080/03602559.2012.727058
PG 8
WC Polymer Science
SC Polymer Science
GA 107HN
UT WOS:000316206500003
DA 2018-10-20
ER

PT J
AU Moayed, F
   Mashaghi, A
   Tans, SJ
AF Moayed, Fatemeh
   Mashaghi, Alireza
   Tans, Sander J.
TI A Polypeptide-DNA Hybrid with Selective Linking Capability Applied to
   Single Molecule Nano-Mechanical Measurements Using Optical Tweezers
SO PLOS ONE
LA English
DT Article
ID STREP-TAG; FORCE SPECTROSCOPY; AFFINITY PEPTIDE; PROTEIN; BIOTIN;
   STREPTAVIDIN; IMMOBILIZATION; TRANSLOCATION; PURIFICATION; DIGOXIGENIN
AB Many applications in biosensing, biomaterial engineering and single molecule biophysics require multiple non-covalent linkages between DNA, protein molecules, and surfaces that are specific yet strong. Here, we present a novel method to join proteins and dsDNA molecule at their ends, in an efficient, rapid and specific manner, based on the recently developed linkage between the protein StrepTactin (STN) and the peptide StrepTag II (ST). We introduce a two-step approach, in which we first construct a hybrid between DNA and a tandem of two STs peptides (tST). In a second step, this hybrid is linked to polystyrene bead surfaces and Maltose Binding Protein (MBP) using STN. Furthermore, we show the STN-tST linkage is more stable against forces applied by optical tweezers than the commonly used biotin-Streptavidin (STV) linkage. It can be used in conjunction with Neutravidin (NTV)-biotin linkages to form DNA tethers that can sustain applied forces above 65 pN for tens of minutes in a quarter of the cases. The method is general and can be applied to construct other surface-DNA and protein-DNA hybrids. The reversibility, high mechanical stability and specificity provided by this linking procedure make it highly suitable for single molecule mechanical studies, as well as biosensing and lab on chip applications.
C1 [Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] AMOLF Inst, Amsterdam, Netherlands.
   [Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.
RP Mashaghi, A (reprint author), AMOLF Inst, Amsterdam, Netherlands.
EM mashaghi@amolf.nl; tans@amolf.nl
RI Mashaghi, Alireza/Q-8218-2017
OI Mashaghi, Alireza/0000-0002-2157-1211
FU Foundation for Fundamental Research on Matter (FOM), part of the
   Netherlands Organisation for Scientific Research (NWO)
FX This work was supported by the research programme of the Foundation for
   Fundamental Research on Matter (FOM), which is part of the Netherlands
   Organisation for Scientific Research (NWO). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657
   Barhoumi A, 2009, CHEM PHYS LETT, V482, P171, DOI 10.1016/j.cplett.2009.09.076
   Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005
   Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y
   Cecconi C, 2011, METHODS MOL BIOL, V749, P255, DOI 10.1007/978-1-61779-142-0_18
   Chevalier J, 1997, J HISTOCHEM CYTOCHEM, V45, P481, DOI 10.1177/002215549704500401
   Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/NMETH.1450, 10.1038/nmeth.1450]
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Fuller DN, 2006, NUCLEIC ACIDS RES, V34, P1
   GRAY JI, 1978, J AM OIL CHEM SOC, V55, P539, DOI 10.1007/BF02668066
   Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298
   Gunnarsson A, 2009, NUCLEIC ACIDS RES, V37, P1
   Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070
   Hout M, 2008, NUCLEIC ACIDS RES, V36, P1
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kim M, 2012, ANGEW CHEM, V124, P1939
   Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1
   Langereis S, 2004, ORG BIOMOL CHEM, V2, P1271, DOI 10.1039/b402917h
   Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/NMAT2471, 10.1038/nmat2471]
   Lin CX, 2007, ANGEW CHEM INT EDIT, V46, P6089, DOI 10.1002/anie.200701767
   Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498
   Marie Aubin Tam E, 2011, CELL, V145, P257
   Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4
   Mashaghi A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3658825
   Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/nnano.2009.378, 10.1038/NNANO.2009.378]
   Medintz IL, 2006, CURR OPIN BIOTECH, V17, P17, DOI 10.1016/j.copbio.2006.01.002
   Neuert G, 2006, FEBS LETT, V580, P505, DOI 10.1016/j.febslet.2005.12.052
   Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205
   Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061
   SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109
   Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209
   Tang JL, 2008, NANO LETT, V8, P4312, DOI 10.1021/nl802092c
   Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102
   van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565
   van Mameren J, 2008, NUCLEIC ACIDS RES, V36, P4381, DOI 10.1093/nar/gkn412
   Waner MJ, 2004, BIOPHYS J, V87, P2701, DOI 10.1529/biophysj.104.047266
   WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.biochem.60.1.101
   Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668
NR 40
TC 6
Z9 6
U1 1
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2013
VL 8
IS 1
AR e54440
DI 10.1371/journal.pone.0054440
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 086SQ
UT WOS:000314707700059
PM 23336001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hsiang, CY
   Hseu, YC
   Chang, YC
   Kumar, KJS
   Ho, TY
   Yang, HL
AF Hsiang, Chien-Yun
   Hseu, You-Cheng
   Chang, Yi-Chih
   Kumar, K. J. Senthil
   Ho, Tin-Yun
   Yang, Hsin-Ling
TI Toona sinensis and its major bioactive compound gallic acid inhibit
   LPS-induced inflammation in nuclear factor-kappa B transgenic mice as
   evaluated by in vivo bioluminescence imaging
SO FOOD CHEMISTRY
LA English
DT Article
DE Toona sinensis; Gallic acid; Nuclear factor-kappa B; Interleukin-1 beta;
   Tumour necrosis factor-alpha; Thioredoxin-like 4B
ID HOST-BIOMATERIAL INTERACTION; ANTIOXIDANT ACTIVITIES; MICROARRAY
   ANALYSIS; OXIDATIVE STRESS; GENE-EXPRESSION; LEAF EXTRACT; CELLS;
   APOPTOSIS; MODELS; DAMAGE
AB In the present study, we investigated the anti-inflammatory effects of a nutritious vegetable Toona sinensis (leaf extracts, TS) and its major bioactive compound gallic acid (GA) by analysing LPS-induced NF-kappa B activation in transgenic mice, using bioluminescence imaging. Mice were challenged intraperitoneally with LPS (1 mg/kg) and treated orally with TS or GA (100 or 5 mg/kg, respectively). In vivo and ex vivo imaging showed that LPS increased NF-kappa B luminescence in the abdominal region, which was significantly inhibited by TS or GA. Immunohistochemical and ELISA analyses confirmed that TS and GA inhibited LPS-induced NF-kappa B, interleukin-1 beta, and tumour necrosis factor-alpha expression. Microarray analysis revealed that biological pathways associated with metabolism and the immune responses were affected by TS or GA. Particularly, LPS-induced thioredoxin-like 4B (TXNL4B) 2 expression in the small intestine, and TXNL4B, iNOS, and COX-2 expression in RAW 264.7 cells were significantly inhibited by TS or GA. Thus, the anti-inflammatory potential of TS was mediated by the downregulation of NF-kappa B pathway. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan.
   [Hseu, You-Cheng; Kumar, K. J. Senthil] China Med Univ, Dept Cosmeceut, Taichung 40402, Taiwan.
   [Chang, Yi-Chih] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 40402, Taiwan.
   [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung 40402, Taiwan.
   [Yang, Hsin-Ling] China Med Univ, Inst Nutr, Taichung 40402, Taiwan.
RP Ho, TY (reprint author), China Med Univ, Grad Inst Chinese Med, Taichung 40402, Taiwan.
EM tyh@mail.cmu.edu.tw; hlyang@mail.cmu.edu.tw
RI Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015
FU National Research Program for Genomic Medicine, National Science Council
   [NSC 95-2320-B-039-024-MY2, NSC 97-2320-B-039-042, NSC
   100-2324-B-039-001, NSC100-2320-B-039-020]; Committee on Chinese
   Medicine and Pharmacy at the Department of Health [CCMP100-RD-048,
   CCMP101-RD-103]; China Medical University [CMU98-S-23, CMU-C-02,
   CMU100-S-16, CMU100-S-34, CMU100-TS-14]
FX This work was supported by the National Research Program for Genomic
   Medicine, National Science Council (NSC 95-2320-B-039-024-MY2, NSC
   97-2320-B-039-042, NSC 100-2324-B-039-001 and NSC100-2320-B-039-020),
   the Committee on Chinese Medicine and Pharmacy at the Department of
   Health (CCMP100-RD-048 and CCMP101-RD-103), and the China Medical
   University (CMU98-S-23, CMU-C-02, CMU100-S-16, CMU100-S-34, and
   CMU100-TS-14).
CR Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Chang HL, 2006, GYNECOL ONCOL, V102, P309, DOI 10.1016/j.ygyno.2005.12.023
   Chen HM, 2009, CANCER LETT, V286, P161, DOI 10.1016/j.canlet.2009.05.040
   Chen YY, 2010, ACTA PHARMACOL SIN, V31, P227, DOI 10.1038/aps.2009.197
   Cheng HM, 2010, J ETHNOPHARMACOL, V132, P429, DOI 10.1016/j.jep.2010.08.022
   Cheng WY, 2007, PHARMACOL RES, V56, P474, DOI 10.1016/j.phrs.2007.09.009
   Chia YC, 2010, MOLECULES, V15, P8377, DOI 10.3390/molecules15118377
   Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239
   Edmonds Jennifer M., 1998, Curtis's Botanical Magazine, V15, P186, DOI 10.1111/1467-8748.00169
   Hidalgo M, 2012, GENES NUTR, V7, P295, DOI 10.1007/s12263-011-0263-5
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003
   Hseu YC, 2011, J ETHNOPHARMACOL, V134, P111, DOI 10.1016/j.jep.2010.11.058
   Hseu YC, 2010, FOOD CHEM TOXICOL, V48, P2319, DOI 10.1016/j.fct.2010.05.066
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Hsieh TJ, 2004, FOOD CHEM TOXICOL, V42, P843, DOI 10.1016/j.fct.2004.01.008
   Hsu Hseng-Kuang, 2003, Kaohsiung Journal of Medical Sciences, V19, P385
   Huang HL, 2012, J AGR FOOD CHEM, V60, P2328, DOI 10.1021/jf203709q
   Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4
   Kim MJ, 2011, MOL NUTR FOOD RES, V55, P1798, DOI 10.1002/mnfr.201100262
   Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063
   KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535
   Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291
   Liao JW, 2006, BRIT J NUTR, V96, P400, DOI 10.1079/BJN20061823
   Okamoto T, 2000, PROG INFLAM RES, P119
   Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144
   Quideau S, 2001, ANGEW CHEM, V50, P586
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   Song LP, 2005, LIFE SCI, V76, P1473, DOI 10.1016/j.lfs.2004.08.026
   Yang HL, 2006, FOOD CHEM TOXICOL, V44, P1978, DOI 10.1016/j.fct.2006.06.027
   Yang HL, 2012, J AGR FOOD CHEM, V60, P522, DOI 10.1021/jf2040675
   Yang HL, 2011, J ETHNOPHARMACOL, V137, P669, DOI 10.1016/j.jep.2011.06.017
   Yang Yu-Chiao, 2003, Kaohsiung Journal of Medical Sciences, V19, P327
NR 33
TC 55
Z9 57
U1 3
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JAN 15
PY 2013
VL 136
IS 2
BP 426
EP 434
DI 10.1016/j.foodchem.2012.08.009
PG 9
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 079SW
UT WOS:000314193500021
PM 23122080
DA 2018-10-20
ER

PT J
AU Khandelwal, H
   Singh, G
   Agrawal, K
   Prakash, S
   Agarwal, RD
AF Khandelwal, Himanshu
   Singh, Gurbhinder
   Agrawal, Khelendra
   Prakash, Satya
   Agarwal, R. D.
TI Characterization of hydroxyapatite coating by pulse laser deposition
   technique on stainless steel 316 L by varying laser energy
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Pulse laser deposition; Hydroxyapatite; Coatings; Thin films; Laser
   energy; Stainless steel
ID THIN-FILMS; HYDROXYLAPATITE FILMS; ABLATION; TI-6AL-4V; ALLOY
AB Hydroxyapatite is an attractive biomaterial mainly used in bone and tooth implants because it closely resembles human tooth and bone mineral and has proven to be biologically compatible with these tissues. In spite of this advantage of hydroxyapatite it has also certain limitation like inferior mechanical properties which do not make it suitable for long term load bearing applications; hence a lot of research is going on in the development of hydroxyapatite coating over various metallic implants. These metallic implants have good biocompatibility and mechanical properties. The aim of the present work is to deposit hydroxyapatite coating over stainless steel grade 316 L by pulse laser deposition technique by varying laser energy. To know the effect of this variation, the coatings were than characterized in detail by X-ray diffraction, finite emission-scanning electron microscope, atomic force microscope and energy dispersive X-ray spectroscopy. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Khandelwal, Himanshu] Indian Inst Technol, Bombay, Maharashtra, India.
   [Singh, Gurbhinder] Bhai Maha Singh Coll Engn, Muktsar, Panjab, India.
   [Agrawal, Khelendra] Apex Inst Engn, Jaipur, Rajasthan, India.
   [Prakash, Satya; Agarwal, R. D.] IIT Roorkee, Roorkee, Uttar Pradesh, India.
RP Khandelwal, H (reprint author), Indian Inst Technol, Bombay, Maharashtra, India.
EM khandelwal_iit@yahoo.com; gurbinder@yahoo.com
OI singh, gurbhinder/0000-0003-3099-9882
CR [Anonymous], 2001, EUROPEAN WHITE BOOK
   Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   BAERI P, 1992, APPL SURF SCI, V54, P210, DOI 10.1016/0169-4332(92)90046-Z
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Bao QH, 2005, APPL SURF SCI, V252, P1538, DOI 10.1016/j.apsusc.2005.02.127
   Brunette D. M., 2001, TITANIUM MED
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   Dinda GP, 2009, ACTA BIOMATER, V5, P1821, DOI 10.1016/j.actbio.2009.01.027
   Dostalova T, 2001, J BIOMED OPT, V6, P239, DOI 10.1117/1.1357191
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   JELINEK M, 1995, THIN SOLID FILMS, V257, P125, DOI 10.1016/0040-6090(94)06340-0
   Jelinek M, 2002, MOL CRYST LIQ CRYST, V374, P599
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   Mroz W., 2006, NATO SCI SERIES 2, V223
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Tri LQ, 2009, APPL SURF SCI, V256, P76, DOI 10.1016/j.apsusc.2009.07.062
   Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994
NR 18
TC 23
Z9 23
U1 0
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 15
PY 2013
VL 265
BP 30
EP 35
DI 10.1016/j.apsusc.2012.10.072
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 062XT
UT WOS:000312958500005
DA 2018-10-20
ER

PT J
AU Naghavi, N
   de Mel, A
   Alavijeh, OS
   Cousins, BG
   Seifalian, AM
AF Naghavi, Noora
   de Mel, Achala
   Alavijeh, Omid Sadeghi
   Cousins, Brian G.
   Seifalian, Alexander M.
TI Nitric Oxide Donors for Cardiovascular Implant Applications
SO SMALL
LA English
DT Review
DE nitric oxide; biomaterials; nanomaterials; microparticles;
   cardiovascular devices
ID IN-SITU ENDOTHELIALIZATION; DRUG-DELIVERY SYSTEMS; GOLD NANOPARTICLES;
   S-NITROSOTHIOLS; BIOMEDICAL APPLICATIONS; INTIMAL HYPERPLASIA;
   NANOCOMPOSITE BIOMATERIAL; THERAPEUTIC APPLICATIONS; CATALYTIC
   GENERATION; INTRAVASCULAR STENTS
AB In an era of increased cardiovascular disease burden in the ageing population, there is great demand for devices that come in to contact with the blood such as heart valves, stents, and bypass grafts that offer life saving treatments. Nitric oxide (NO) elution from healthy endothelial tissue that lines the vessels maintains haemostasis throughout the vasculature. Surgical devices that release NO are desirable treatment options and N-diazeniumdiolates and S-nitrosothiols are recognized as preferred donor molecules. There is a keen interest to investigate newer methods by which NO donors can be retained within biomaterials so that their release and kinetic profiles can be optimized. A range of polymeric scaffolds incorporating microparticles and nanomaterials are presenting solutions to current challenges, and have been investigated in a range of clinical applications. This review outlines the application of NO donors for cardiovascular therapy using biomaterials that release NO locally to prevent thrombosis and intimal hyperplasia (IH) and enhance endothelialization in the fabrication of next generation cardiovascular device technology.
C1 [Naghavi, Noora; de Mel, Achala; Alavijeh, Omid Sadeghi; Cousins, Brian G.; Seifalian, Alexander M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
   [de Mel, Achala] UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
   [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, London, England.
   [Seifalian, Alexander M.] UCL, LCN, London WC1E 6BT, England.
RP Seifalian, AM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
EM a.seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Abizaid A, 2010, CIRC-CARDIOVASC INTE, V3, P384, DOI 10.1161/CIRCINTERVENTIONS.109.891192
   Ahanchi SS, 2007, J VASC SURG, V45, p64A, DOI 10.1016/j.jvs.2007.02.027
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267
   Al-Sa'doni HH, 2004, CURR MED CHEM, V11, P2679
   Bakhshi R, 2011, COLLOID SURFACE B, V86, P93, DOI 10.1016/j.colsurfb.2011.03.024
   Balbatun A, 2003, ACTA BIOCHIM POL, V50, P61
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Caruso EB, 2007, J AM CHEM SOC, V129, P480, DOI 10.1021/ja067568d
   Centola M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014102
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Cohen BE, 2010, NATURE, V467, P407, DOI 10.1038/467407a
   Coneski PN, 2012, CHEM SOC REV, V41, P3753, DOI 10.1039/c2cs15271a
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093
   Damodaran VB, 2012, J MATER CHEM, V22, P5990, DOI 10.1039/c2jm16554f
   de M. A., 2008, EXPERT REV CARDIOVAS, V6, P1259
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Mel A, 2012, J BIOMED MATER RES A, V100A, P2348, DOI 10.1002/jbm.a.34177
   de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Dinh B, 2005, NITRIC OXIDE-BIOL CH, V13, P204, DOI 10.1016/j.niox.2005.07.003
   Dinh BT, 2008, NITRIC OXIDE-BIOL CH, V18, P113, DOI 10.1016/j.niox.2007.11.001
   Do YS, 2004, RADIOLOGY, V230, P377, DOI 10.1148/radiol.2302020417
   Fitzgerald KT, 2011, SMALL, V7, P705, DOI 10.1002/smll.201001347
   Fleser PS, 2004, J VASC SURG, V40, P803, DOI 10.1016/j.jvs.2004.07.007
   Friedman A, 2009, EXPERT OPIN DRUG DEL, V6, P1113, DOI 10.1517/17425240903196743
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082
   Gao Y, 2011, SMALL, V7, P2133, DOI 10.1002/smll.201100474
   Gappa-Fahlenkamp H, 2005, BIOMATERIALS, V26, P3479, DOI 10.1016/j.biomaterials.2004.09.028
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Ghanbari H, 2010, ACTA BIOMATER, V6, P4249, DOI 10.1016/j.actbio.2010.06.015
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Giustarini D, 2003, CLIN CHIM ACTA, V330, P85, DOI 10.1016/S0009-8981(03)00046-9
   Gomes AJ, 2008, J INORG BIOCHEM, V102, P757, DOI 10.1016/j.jinorgbio.2007.11.012
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Halpenny GM, 2010, ACS MED CHEM LETT, V1, P180, DOI 10.1021/ml1000646
   Hamid Huda, 2007, Mcgill J Med, V10, P105
   Hrabie JA, 2002, CHEM REV, V102, P1135, DOI 10.1021/cr000028t
   Huang SL, 2009, J AM COLL CARDIOL, V54, P652, DOI 10.1016/j.jacc.2009.04.039
   Hwang S, 2006, ANGEW CHEM INT EDIT, V45, P2745, DOI 10.1002/anie.200503588
   Hwang S, 2008, BIOMATERIALS, V29, P2443, DOI 10.1016/j.biomaterials.2008.02.004
   Jain S, 2012, BRIT J RADIOL, V85, P101, DOI 10.1259/bjr/59448833
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Jiang L, 2011, SMALL, V7, P1309, DOI 10.1002/smll.201002356
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kabir AMN, 2011, FUTUR CARDIOL, V7, P251, DOI [10.2217/fca.11.1, 10.2217/FCA.11.1]
   Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406
   Kannan RY, 2007, PLAST RECONSTR SURG, V119, P1653, DOI 10.1097/01.prs.0000246404.53831.4c
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Karnabatidis D, 2009, J ENDOVASC THER, V16, P153, DOI 10.1583/08-2593.1
   Kim BYS, 2010, NEW ENGL J MED, V363, P2434, DOI 10.1056/NEJMra0912273
   Kim J, 2011, BIOCONJUGATE CHEM, V22, P1031, DOI 10.1021/bc100405c
   Kim KS, 2011, CURR PHARM DESIGN, V17, P1825
   Knoll W, 2011, SMALL, V7, P1384, DOI 10.1002/smll.201100026
   Koehler JJ, 2008, J PHYS CHEM B, V112, P15086, DOI 10.1021/jp803276u
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Li ZQ, 2011, EXPERT OPIN DRUG DEL, V8, P991, DOI 10.1517/17425247.2011.581656
   Lin CE, 2005, EXPERT OPIN THER PAT, V15, P483, DOI 10.1517/13543776.15.5.483
   Lin CE, 2004, J MED CHEM, V47, P2276, DOI 10.1021/jm0304111
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Maurer N, 2001, EXPERT OPIN BIOL TH, V1, P923, DOI 10.1517/14712598.1.6.923
   Medina C, 2007, BRIT J PHARMACOL, V150, P552, DOI 10.1038/sj.bjp.0707130
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Mody VV, 2010, J PHARM BIOALLIED SC, V2, P282, DOI 10.4103/0975-7406.72127
   Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10
   Nichols SP, 2012, ADV DRUG DELIVER REV, V64, P1177, DOI 10.1016/j.addr.2012.03.002
   Orive G, 2004, TRENDS PHARMACOL SCI, V25, P382, DOI 10.1016/j.tips.2004.05.006
   Patel S D, 2010, Ther Adv Cardiovasc Dis, V4, P129, DOI 10.1177/1753944710362903
   Polizzi MA, 2007, LANGMUIR, V23, P4938, DOI 10.1021/la0633841
   Prabhakaran P., 2011, BIOMED MATER, V6
   Puiu SC, 2009, J BIOMED MATER RES B, V91B, P203, DOI 10.1002/jbm.b.31391
   Puskas JE, 2009, WIRES NANOMED NANOBI, V1, P451, DOI 10.1002/wnan.038
   Reynolds MM, 2010, J MATER CHEM, V20, P3107, DOI 10.1039/c000152j
   Reynolds MM, 2006, BIOMACROMOLECULES, V7, P987, DOI 10.1021/bm060028o
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Riccio DA, 2011, CHEM MATER, V23, P1727, DOI 10.1021/cm102510q
   Rothrock AR, 2005, J AM CHEM SOC, V127, P9362, DOI 10.1021/ja052027u
   Saraiva J, 2011, J DRUG DELIV, DOI 10.1155/2011/936438
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Scharn DM, 2012, EUR J VASC ENDOVASC, V43, P66, DOI 10.1016/j.ejvs.2011.09.009
   Seabra AB, 2008, ARTIF ORGANS, V32, P262, DOI 10.1111/j.1525-1594.2008.00540.x
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   Service RF, 2010, SCIENCE, V330, P314, DOI 10.1126/science.330.6002.314
   Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x
   Shin JH, 2008, CHEM MATER, V20, P239, DOI 10.1021/cm702526q
   Shin JH, 2007, J AM CHEM SOC, V129, P4612, DOI 10.1021/ja0674338
   Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234
   Siepmann J, 2006, PROG COLL POL SCI S, V133, P15, DOI 10.1007/2882_053
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Sorragi CD, 2011, CELL BIOCHEM FUNCT, V29, P207, DOI 10.1002/cbf.1738
   Steffel J, 2008, ANN MED, V40, P242, DOI 10.1080/07853890801964948
   Tai LA, 2010, NITRIC OXIDE-BIOL CH, V23, P60, DOI 10.1016/j.niox.2010.04.003
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Taite LJ, 2011, CARDIOVASC ENG TECHN, V2, P113, DOI DOI 10.1007/S13239-011-0040-Z
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Teirstein PS, 2010, CIRCULATION, V122, P5, DOI 10.1161/CIRCULATIONAHA.110.962423
   Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Verma S, 2005, NEW ENGL J MED, V353, P730, DOI 10.1056/NEJMcibr052030
   Vittorino E, 2012, J COLLOID INTERF SCI, V368, P191, DOI 10.1016/j.jcis.2011.09.084
   Waltham M, 2004, ANZ J SURG, V74, P719, DOI 10.1111/j.1445-1433.2004.03174.x
   Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020
   Weng YJ, 2011, BIOMATERIALS, V32, P1253, DOI 10.1016/j.biomaterials.2010.10.039
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Yan BP, 2011, CIRC J, V75, P756, DOI 10.1253/circj.CJ-11-0103
   Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhang Y, 2011, SMALL, V7, P3261, DOI 10.1002/smll.201100597
NR 121
TC 55
Z9 56
U1 5
U2 127
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD JAN 14
PY 2013
VL 9
IS 1
BP 22
EP 35
DI 10.1002/smll.201200458
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 063IE
UT WOS:000312988900002
PM 23136136
DA 2018-10-20
ER

PT J
AU Sharma, B
   Fermanian, S
   Gibson, M
   Unterman, S
   Herzka, DA
   Cascio, B
   Coburn, J
   Hui, AY
   Marcus, N
   Gold, GE
   Elisseeff, JH
AF Sharma, Blanka
   Fermanian, Sara
   Gibson, Matthew
   Unterman, Shimon
   Herzka, Daniel A.
   Cascio, Brett
   Coburn, Jeannine
   Hui, Alexander Y.
   Marcus, Norman
   Gold, Garry E.
   Elisseeff, Jennifer H.
TI Human Cartilage Repair with a Photoreactive Adhesive-Hydrogel Composite
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   MICROFRACTURE TECHNIQUE; CHONDROITIN SULFATE; RANDOMIZED-TRIAL;
   FOLLOW-UP; KNEE; DEFECTS; DIFFERENTIATION; BONE
AB Surgical options for cartilage resurfacing may be significantly improved by advances and application of biomaterials that direct tissue repair. A poly(ethylene glycol) diacrylate (PEGDA) hydrogel was designed to support cartilage matrix production, with easy surgical application. A model in vitro system demonstrated deposition of cartilage-specific extracellular matrix in the hydrogel biomaterial and stimulation of adjacent cartilage tissue development by mesenchymal stem cells. For translation to the joint environment, a chondroitin sulfate adhesive was applied to covalently bond and adhere the hydrogel to cartilage and bone tissue in articular defects. After preclinical testing in a caprine model, a pilot clinical study was initiated where the biomaterials system was combined with standard microfracture surgery in 15 patients with focal cartilage defects on the medial femoral condyle. Control patients were treated with microfracture alone. Magnetic resonance imaging showed that treated patients achieved significantly higher levels of tissue fill compared to controls. Magnetic resonance spin-spin relaxation times (T-2) showed decreasing water content and increased tissue organization over time. Treated patients had less pain compared with controls, whereas knee function [International Knee Documentation Committee (IKDC)] scores increased to similar levels between the groups over the 6 months evaluated. No major adverse events were observed over the study period. With further clinical testing, this practical biomaterials strategy has the potential to improve the treatment of articular cartilage defects.
C1 [Sharma, Blanka; Gibson, Matthew; Unterman, Shimon; Herzka, Daniel A.; Coburn, Jeannine; Hui, Alexander Y.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.
   [Sharma, Blanka; Gibson, Matthew; Unterman, Shimon; Herzka, Daniel A.; Coburn, Jeannine; Hui, Alexander Y.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Cascio, Brett] Lake Charles Mem Hosp, Dept Orthoped, Lake Charles, LA 70601 USA.
   [Coburn, Jeannine; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
   [Gold, Garry E.] Stanford Univ, Dept Radiol Bioengn & Orthopaed Surg, Stanford, CA 94305 USA.
RP Gold, GE (reprint author), Stanford Univ, Dept Radiol Bioengn & Orthopaed Surg, Stanford, CA 94305 USA.
EM gold@stanford.edu; jhe@jhu.edu
OI Coburn, Jeannine M./0000-0001-6354-5436; Herzka,
   Daniel/0000-0002-9400-7814
FU Arthritis Foundation; NIH [R01AR054005, 5R01EB005517, 2R01EB002524-08,
   1K24AR062068-01, 1P01159992-01]; State of Maryland Technology
   Development Corporation; Cartilix Inc.; Biomet
FX Funding for the biomaterials work was provided to J.H.E. by the
   Arthritis Foundation and the NIH (grants R01AR054005 and 5R01EB005517),
   and to G.E.G. by the NIH (grants 2R01EB002524-08, 1K24AR062068-01, and
   1P01159992-01) and the Arthritis Foundation. Large-animal studies were
   supported by the State of Maryland Technology Development Corporation
   and Cartilix Inc. Clinical studies were supported by Cartilix Inc. and
   Biomet.
CR Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P1316, DOI 10.1007/s00167-010-1356-1
   Brown WE, 2004, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000129162.36302.4f
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Custers RJH, 2009, J BONE JOINT SURG AM, V91A, P900, DOI 10.2106/JBJS.H.00668
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Fortier LA, 2012, J KNEE SURG, V25, P3, DOI 10.1055/s-0032-1310389
   Gersh KC, 2009, THROMB HAEMOSTASIS, V102, P1169, DOI 10.1160/TH09-03-0199
   Hambly K, 2008, AM J SPORT MED, V36, P1695, DOI 10.1177/0363546508317718
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kang SW, 2008, BIOTECHNOL LETT, V30, P435, DOI 10.1007/s10529-007-9576-2
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Lam WA, 2011, NAT MATER, V10, P61, DOI [10.1038/nmat2903, 10.1038/NMAT2903]
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Martin I, 2012, TISSUE ENG PT A, V18, P2268, DOI [10.1089/ten.TEA.2012.0169, 10.1089/ten.tea.2012.0169]
   McCarty WJ, 2011, J ORTHOP RES, V29, P240, DOI 10.1002/jor.21209
   Methot S., 2010, INT CART REP SOC BAR
   Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mosher TJ, 2010, OSTEOARTHR CARTILAGE, V18, P358, DOI 10.1016/j.joca.2009.11.011
   Mosher TJ, 2005, RADIOLOGY, V234, P245, DOI 10.1148/radiol.2341040041
   Mosher TJ, 2001, AM J ROENTGENOL, V177, P665, DOI 10.2214/ajr.177.3.1770665
   Musumeci G, 2011, HISTOL HISTOPATHOL, V26, P1265, DOI 10.14670/HH-26.1265
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Rothenberg AR, 2011, STEM CELLS DEV, V20, P405, DOI 10.1089/scd.2010.0097
   Schmidt O, 2006, BIOTECHNOL BIOENG, V95, P1061, DOI 10.1002/bit.21072
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Van Assche D, 2010, KNEE SURG SPORT TR A, V18, P486, DOI 10.1007/s00167-009-0955-1
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 37
TC 86
Z9 89
U1 19
U2 159
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 9
PY 2013
VL 5
IS 167
AR 167ra6
DI 10.1126/scitranslmed.3004838
PG 9
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 071ED
UT WOS:000313568200004
PM 23303605
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schultz, KM
   Campo-Deano, L
   Baldwin, AD
   Kiick, KL
   Clasen, C
   Furst, EM
AF Schultz, Kelly M.
   Campo-Deano, Laura
   Baldwin, Aaron D.
   Kiick, Kristi L.
   Clasen, Christian
   Furst, Eric M.
TI Electrospinning covalently cross-linking biocompatible hydrogelators
SO POLYMER
LA English
DT Article
DE Microrheology; Electrospinning; Hydrogels
ID BREAKUP EXTENSIONAL RHEOMETRY; MESENCHYMAL STEM-CELLS; NANOFIBROUS
   SCAFFOLDS; BIOMATERIAL HYDROGELATORS; AQUEOUS-SOLUTIONS;
   POLYMER-SOLUTIONS; SMALL-DIAMETER; GEL POINT; FIBERS; MICRORHEOLOGY
AB Many hydrogel materials of interest are homogeneous on the micrometer scale. Electrospinning, the formation of sub-micrometer to micrometer diameter fibers by a jet of fluid formed under an electric field, is one process being explored to create rich microstructures. However, electrospinning a hydrogel system as it reacts requires an understanding of the gelation kinetics and corresponding rheology near the liquid-solid transition. In this study, we correlate the structure of electrospun fibers of a covalently cross-linked hydrogelator with the corresponding gelation transition and kinetics. Polyethylene oxide (PEO) is used as a carrier polymer in a chemically cross-linking poly(ethylene glycol)-high molecular weight heparin (PEG-HMWH) hydrogel. Using measurements of gelation kinetics from multiple particle tracking microrheology (MPT), we correlate the material rheology with the formation of stable fibers. An equilibrated, cross-linked hydrogel is also spun and the PEO is dissolved. In both cases, microstructural features of the electrospun fibers are retained, confirming the covalent nature of the network. The ability to spin fibers of a cross-linking hydrogel system ultimately enables the engineering of materials and microstructural length scales suitable for biological applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Schultz, Kelly M.; Furst, Eric M.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA.
   [Schultz, Kelly M.; Furst, Eric M.] Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
   [Campo-Deano, Laura; Clasen, Christian] Univ Louvain, Dept Chem Engn, B-3001 Louvain, Belgium.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem & Biomol Engn, 150 Acad St, Newark, DE 19716 USA.
EM furst@udel.edu
RI Campo-Deano, Laura/D-1343-2011; Clasen, Christian/B-7770-2013
OI Clasen, Christian/0000-0002-9253-9008; Campo Deano,
   Laura/0000-0003-2493-3238
FU National Science Foundation [CBET-0730292, DGE-0221651]; European
   research council [203043]; National Institutes of Health
   [5-P20-RR016472-10]; NSF;  [P20-RR017716]
FX Funding for this work was provided by the National Science Foundation
   (grant nos. CBET-0730292 for microrheology and DGE-0221651 for
   synthesis), the European research council (ERC-2007-StG starting grant
   203043 NANOFIB for the electrospinning) and the National Institutes of
   Health (5-P20-RR016472-10). E.M.F. acknowledges financial support for
   biomaterial microrheology under P20-RR017716. The contents of the
   manuscript are the sole responsibility of the authors and do not
   necessarily reflect the official views of the National Institutes of
   Health nor of the National Center for Research Resources. K.M.S.
   acknowledges financial support by the NSF Graduate Research Fellowship
   Program.
CR ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Breedveld V, 2003, J MATER SCI, V38, P4461, DOI 10.1023/A:1027321232318
   Campo-Deano L, 2010, J NON-NEWTON FLUID, V165, P1688, DOI 10.1016/j.jnnfm.2010.09.007
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Clasen C, 2006, J FLUID MECH, V556, P283, DOI 10.1017/S0022112006009633
   Clasen C, 2012, AICHE J, V58, P3242, DOI 10.1002/aic.13704
   Clasen C, 2010, KOREA-AUST RHEOL J, V22, P331
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Dong Y, 2008, TISSUE ENG PART A, V16, P283
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Gentilini C, 2012, ADV HEALTHCARE MAT
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Ji Y, 2006, MACROMOL BIOSCI, V6, P811, DOI 10.1002/mabi.200600132
   Jin Y, 2008, J APPL POLYM SCI, V109, P3337, DOI 10.1002/app.28371
   Kim SH, 2005, MACROMOLECULES, V38, P3719, DOI 10.1021/ma050308g
   Larsen T, 2008, KOREA-AUST RHEOL J, V20, P165
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lee JY, 2010, J BIOMED MATER RES A, V92A, P1398, DOI 10.1002/jbm.a.32471
   Lee KH, 2003, POLYMER, V44, P4029, DOI 10.1016/S0032-3861(03)00345-8
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu S, 2009, MACROMOLECULES, V42, P3, DOI 10.1021/ma801782q
   Liu Y, 2007, REACT FUNCT POLYM, V67, P461, DOI 10.1016/j.reactfunctpolym.2007.02.008
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Oliveira MSN, 2006, J NON-NEWTON FLUID, V137, P137, DOI 10.1016/j.jnnfm.2006.01.014
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Regev O, 2010, POLYMER, V51, P2611, DOI 10.1016/j.polymer.2010.03.061
   Reneker DH, 2009, MRS P
   Rutledge GC, 2007, ADV DRUG DELIVER REV, V59, P1384, DOI 10.1016/j.addr.2007.04.020
   Schultz KM, 2012, ACS MACRO LETT, V1, P706, DOI 10.1021/mz300106y
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schultz KM, 2011, BIOMACROMOLECULES, V12, P4178, DOI 10.1021/bm201214r
   Schultz KM, 2011, LAB CHIP, V11, P3802, DOI 10.1039/c1lc20376b
   Schultz KM, 2009, MACROMOLECULES, V42, P5310, DOI 10.1021/ma900766u
   Schultz KM, 2009, SOFT MATTER, V5, P740, DOI 10.1039/b818178k
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tsai WW, 2010, J PHYS CHEM B, V114, P14778, DOI 10.1021/jp105227p
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Yu JH, 2006, POLYMER, V47, P4789, DOI 10.1016/j.polymer.2006.04.050
   Zawko SA, 2011, J BIOMED MATER RES A, V98A, P287, DOI 10.1002/jbm.a.33114
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
NR 59
TC 9
Z9 9
U1 5
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN 8
PY 2013
VL 54
IS 1
BP 363
EP 371
DI 10.1016/j.polymer.2012.09.060
PG 9
WC Polymer Science
SC Polymer Science
GA 190QT
UT WOS:000322356000042
PM 23459473
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Unadkat, HV
   Rewagad, RR
   Hulsman, M
   Hulshof, GFB
   Truckenmuller, RK
   Stamatialis, DF
   Reinders, MJT
   Eijkel, JCT
   van den Berg, A
   van Blitterswijk, CA
   de Boer, J
AF Unadkat, H. V.
   Rewagad, R. R.
   Hulsman, M.
   Hulshof, G. F. B.
   Truckenmuller, R. K.
   Stamatialis, D. F.
   Reinders, M. J. T.
   Eijkel, J. C. T.
   van den Berg, A.
   van Blitterswijk, C. A.
   de Boer, J.
TI A modular versatile chip carrier for high-throughput screening of
   cell-biomaterial interactions
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE high throughput; computational fluid dynamics modelling;
   cell-biomaterial interactions
ID MESENCHYMAL STEM-CELLS; COMBINATORIAL; MICROENVIRONMENTS; POLYMERS;
   GROWTH; FATE
AB The field of biomaterials research is witnessing a steady rise in high-throughput screening approaches, comprising arrays of materials of different physico-chemical composition in a chip format. Even though the cell arrays provide many benefits in terms of throughput, they also bring new challenges. One of them is the establishment of robust homogeneous cell seeding techniques and strong control over cell culture, especially for long time periods. To meet these demands, seeding cells with low variation per tester area is required, in addition to robust cell culture parameters. In this study, we describe the development of a modular chip carrier which represents an important step in standardizing cell seeding and cell culture conditions in array formats. Our carrier allows flexible and controlled cell seeding and subsequent cell culture using dynamic perfusion. To demonstrate the application of our device, we successfully cultured and evaluated C2C12 premyoblast cell viability under dynamic conditions for a period of 5 days using an automated pipeline for image acquisition and analysis. In addition, using computational fluid dynamics, lactate and BMP-2 as model molecules, we estimated that there is good exchange of nutrients and metabolites with the flowing medium, whereas no cross-talk between adjacent TestUnits should be expected. Moreover, the shear stresses to the cells can be tailored uniformly over the entire chip area. Based on these findings, we believe our chip carrier may be a versatile tool for high-throughput cell experiments in biomaterials sciences.
C1 [Unadkat, H. V.; Rewagad, R. R.; Hulshof, G. F. B.; Truckenmuller, R. K.; van Blitterswijk, C. A.; de Boer, J.] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 Enschede, Netherlands.
   [Hulshof, G. F. B.; Stamatialis, D. F.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 Enschede, Netherlands.
   [Eijkel, J. C. T.; van den Berg, A.] Univ Twente, MESA Res Inst, BIOS Lab On A Chip Grp, NL-7500 Enschede, Netherlands.
   [Hulsman, M.; Reinders, M. J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands.
RP de Boer, J (reprint author), Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 Enschede, Netherlands.
EM j.deboer@utwente.nl
RI Unadkat, Hemant/E-7827-2012; van den Berg, Albert/B-4648-2013; Eijkel,
   Jan/E-4397-2011
OI Unadkat, Hemant/0000-0002-6916-3874; van den Berg,
   Albert/0000-0001-9019-933X; Eijkel, Jan/0000-0003-3325-419X; van
   Blitterswijk, Clemens/0000-0003-2371-4615
FU Marie Curie JOIN(ed)T early stage research fellowship
FX We thank Dr Gustavo Higuera Sierra for helpful discussion, Mr Bjorn
   Harink for assistance with figures, Mr Sip Jan Boorsma and Mr Dominic
   Post for technical help with the fabrication. H.V.U. received financial
   support from Marie Curie JOIN(ed)T early stage research fellowship.
CR Amis EJ, 2004, NAT MATER, V3, P83, DOI 10.1038/nmat1064
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   BOX GEP, 1978, STAT EXPT INTRO DESI
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Glossop JR, 2009, GENE EXPR PATTERNS, V9, P381, DOI 10.1016/j.gep.2009.01.001
   Higuera G, 2009, TISSUE ENG PT A, V15, P2653, DOI 10.1089/ten.TEA.2008.0328
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2
   Schop D, 2009, TISSUE ENG PT A, V15, P1877, DOI 10.1089/ten.tea.2008.0345
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41
NR 16
TC 4
Z9 5
U1 0
U2 41
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JAN 6
PY 2013
VL 10
IS 78
AR 20120753
DI 10.1098/rsif.2012.0753
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048UT
UT WOS:000311939400031
PM 23152103
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Trouillas, M
   Prat, M
   Doucet, C
   Ernou, I
   Laplace-Builhe, C
   Saint Blancard, P
   Holy, X
   Lataillade, JJ
AF Trouillas, Marina
   Prat, Marie
   Doucet, Christelle
   Ernou, Isabelle
   Laplace-Builhe, Corinne
   Saint Blancard, Patrick
   Holy, Xavier
   Lataillade, Jean-Jacques
TI A new platelet cryoprecipitate glue promoting bone formation after
   ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude
   mice
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; CRITICAL-SIZE DEFECTS; STEM-CELLS; RICH
   PLASMA; IN-VIVO; PROGENITOR CELLS; GROWTH-FACTOR; OSTEOGENIC
   DIFFERENTIATION; LONG BONES; MARROW
AB Introduction: This study investigated the promising effect of a new Platelet Glue obtained from Cryoprecipitation of Apheresis Platelet products (PGCAP) used in combination with Mesenchymal Stromal Cells (MSC) loaded on ceramic biomaterials to provide novel strategies enhancing bone repair.
   Methods: PGCAP growth factor content was analyzed by ELISA and compared to other platelet and plasma-derived products. MSC loaded on biomaterials (65% hydroxyapatite/35% beta-TCP or 100% beta-TCP) were embedded in PGCAP and grown in presence or not of osteogenic induction medium for 21 days. Biomaterials were then implanted subcutaneously in immunodeficient mice for 28 days. Effect of PGCAP on MSC was evaluated in vitro by proliferation and osteoblastic gene expression analysis and in vivo by histology and immunohistochemistry.
   Results: We showed that PGCAP, compared to other platelet-derived products, allowed concentrating large amount of growth factors and cytokines which promoted MSC and osteoprogenitor proliferation. Next, we found that PGCAP improves the proliferation of MSC and osteogenic-induced MSC. Furthermore, we demonstrated that PGCAP up-regulates the mRNA expression of osteogenic markers (Collagen type I, Osteonectin, Osteopontin and Runx2). In vivo, type I collagen expressed in ectopic bone-like tissue was highly enhanced in biomaterials embedded in PGCAP in the absence of osteogenic pre-induction. Better results were obtained with 65% hydroxyapatite/35% beta-TCP biomaterials as compared to 100% beta-TCP.
   Conclusions: We have demonstrated that PGCAP is able to enhance in vitro MSC proliferation, osteoblastic differentiation and in vivo bone formation in the absence of osteogenic pre-induction. This clinically adaptable platelet glue could be of interest for improving bone repair.
C1 [Trouillas, Marina; Prat, Marie; Ernou, Isabelle; Lataillade, Jean-Jacques] Ctr Transfus Sanguine Armees Jean Julliard, Dept Res, F-92141 Clamart, France.
   [Doucet, Christelle] Celogos, F-75003 Paris, France.
   [Laplace-Builhe, Corinne] Inst Gustave Roussy, IRCIV, UMR8081, F-94805 Villejuif, France.
   [Saint Blancard, Patrick] Hop Percy, Serv Anat Pathol, F-92141 Clamart, France.
   [Holy, Xavier] Inst Rech Biomed Armees, Dept Physiol Aerosp, F-91223 Bretigny Sur Orge, France.
   [Lataillade, Jean-Jacques] Ecole Val de Grace, Paris, France.
RP Trouillas, M (reprint author), Ctr Transfus Sanguine Armees Jean Julliard, Dept Res, 1 Rue Lieutenant Raoul Batany, F-92141 Clamart, France.
EM trouillasmarina@gmail.com
OI LAPLACE-BUILHE, Corinne/0000-0003-2885-6073
FU Delegation Generale pour l'Armement (Paris, France)
FX We thank Arnaud Destainville and Ceraver for the great support in
   supplying biomaterials. Grants were obtained from Delegation Generale
   pour l'Armement (Paris, France).
CR Anitua E, 2001, Pract Proced Aesthet Dent, V13, P487
   Anitua E, 2009, CELL PROLIFERAT, V42, P162, DOI 10.1111/j.1365-2184.2009.00583.x
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139
   Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007
   Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665
   Callum JL, 2009, TRANSFUS MED REV, V23, P177, DOI 10.1016/j.tmrv.2009.03.001
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Giovanini AF, 2010, BONE, V46, P1597, DOI 10.1016/j.bone.2010.02.026
   Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hakimi M, 2010, INJURY, V41, P717, DOI 10.1016/j.injury.2009.12.005
   HEIPLE KG, 1987, ORTHOP CLIN N AM, V18, P179
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93
   Levi B, 2011, STEM CELLS DEV, V20, P243, DOI 10.1089/scd.2010.0250
   Li HW, 2007, BIOCHEM BIOPH RES CO, V356, P836, DOI 10.1016/j.bbrc.2007.02.165
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Luong-Van E, 2007, J MOL HISTOL, V38, P459, DOI 10.1007/s10735-007-9129-y
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772
   Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515
   Pieri F, 2008, J CLIN PERIODONTOL, V35, P539, DOI 10.1111/j.1600-051X.2008.01220.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Ranly DM, 2007, J BONE JOINT SURG AM, V89A, P139, DOI 10.2106/JBJS.F.00388
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Song IH, 2009, J ORTHOP RES, V27, P916, DOI 10.1002/jor.20838
   Tasso R, 2012, BIOMATERIALS, V33, P2086, DOI 10.1016/j.biomaterials.2011.11.043
   Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064
   Thorn JJ, 2004, INT J ORAL MAX SURG, V33, P95, DOI 10.1054/ijom.2003.0461
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   Visser LC, 2010, TISSUE ENG PT A, V16, P1021, DOI [10.1089/ten.tea.2009.0254, 10.1089/ten.TEA.2009.0254]
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 68
TC 6
Z9 6
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JAN 4
PY 2013
VL 4
AR 1
DI 10.1186/scrt149
PG 18
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 086XD
UT WOS:000314721800001
PM 23290259
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Casteleijn, MG
   Urtti, A
   Sarkhel, S
AF Casteleijn, Marco G.
   Urtti, Arto
   Sarkhel, Sanjay
TI Expression without boundaries: Cell-free protein synthesis in
   pharmaceutical research
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Protein engineering; Cell free expression; Protein expression; High
   throughput; Protein development
ID COLONY-STIMULATING FACTOR; INTEGRAL MEMBRANE-PROTEINS; HIGH-THROUGHPUT
   PROTEOMICS; FREE TRANSLATION SYSTEM; IN-VITRO SYNTHESIS;
   ESCHERICHIA-COLI; WHEAT-GERM; DIRECTED EVOLUTION; RECOMBINANT PROTEINS;
   SOLUBLE EXPRESSION
AB Proteins are an increasingly important class of new drugs. Pharmaceutical proteins are usually expressed in cell based systems in the development phase and in production, and although cell free methods have recently emerged they have not been used widely for therapeutic protein development or production. Cell free expression methodology is well suited for pharmaceutical protein expression and engineering and will probably become more commonly used in the future. Cell free expression allows protein engineering in high throughput format, flexible strategies for glycosylation and chemical conjugation, and allows easy use of unnatural amino acids as building blocks of proteins. Thus, cell free expression can be used to modify protein solubility, stability, and pharmacokinetics of therapeutic proteins. Likewise, it is potentially useful in protein development for biomaterial matrices, nanoparticles, and vaccines. This review illustrates the potential of cell free expression in pharmaceutical protein research and development while highlighting both advantages and limitations of the method. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Casteleijn, Marco G.; Urtti, Arto; Sarkhel, Sanjay] Univ Helsinki, Ctr Drug Res, FIN-00014 Helsinki, Finland.
RP Urtti, A (reprint author), Univ Helsinki, Ctr Drug Res, Viikinkaari 5 E, FIN-00014 Helsinki, Finland.
EM arto.urtti@helsinki.fi
RI Sarkhel, Sanjay/C-9571-2014
OI Sarkhel, Sanjay/0000-0003-2369-6605; Casteleijn,
   Marco/0000-0001-6617-1513
CR Aguiar JC, 2004, GENOME RES, V14, P2076, DOI 10.1101/gr.2416604
   Ahn JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026875
   Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002
   Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747
   Betton JM, 2003, CURR PROTEIN PEPT SC, V4, P73, DOI 10.2174/1389203033380359
   Brideau-Andersen AD, 2007, P NATL ACAD SCI USA, V104, P8269, DOI 10.1073/pnas.0609001104
   Calhoun KA, 2005, BIOTECHNOL PROGR, V21, P1146, DOI 10.1021/bp050052y
   Canalle LA, 2010, CHEM SOC REV, V39, P329, DOI 10.1039/b807871h
   Carlson E.D., 2011, BIOTECHNOL ADV
   Chandra H, 2010, PROTEOMICS, V10, P717, DOI 10.1002/pmic.200900462
   CHIOU CJ, 1990, FEBS LETT, V259, P249, DOI 10.1016/0014-5793(90)80020-J
   Cho H, 2011, P NATL ACAD SCI USA, V108, P9060, DOI 10.1073/pnas.1100387108
   Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0
   Chuang VTG, 2002, PHARMACEUT RES, V19, P569
   COLLINS J, 1979, GENE, V6, P29, DOI 10.1016/0378-1119(79)90083-0
   Das KMP, 2011, INT J MOL SCI, V12, P2064, DOI 10.3390/ijms12032064
   Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008
   Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026
   Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101
   Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069
   Endo Y, 2003, BIOTECHNOL ADV, V21, P695, DOI 10.1016/S0734-9750(03)00105-8
   Enfors S.-O., 2000, BIOPROCESS TECHNOLOG
   Georgiou G, 2005, CURR OPIN BIOTECH, V16, P538, DOI 10.1016/j.copbio.2005.07.008
   Goerke AR, 2008, BIOTECHNOL BIOENG, V99, P351, DOI 10.1002/bit.21567
   Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002
   Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273
   Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202
   GREVE JM, 1982, CELL, V31, P749, DOI 10.1016/0092-8674(82)90329-4
   Guarino C., 2011, GLYCOBIOLOGY
   Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008
   Hamamatsu N, 2006, PROTEIN ENG DES SEL, V19, P483, DOI 10.1093/protein/gzl034
   He M, 2007, BIOCHEM SOC T, V35, P962, DOI 10.1042/BST0350962
   He MY, 2005, EXPERT REV PROTEOMIC, V2, P421, DOI 10.1586/14789450.2.3.421
   Henderson GE, 2011, BIOCONJUGATE CHEM, V22, P903, DOI 10.1021/bc100510g
   Hirao I, 2002, NAT BIOTECHNOL, V20, P177, DOI 10.1038/nbt0202-177
   Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013
   Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1069/j.pep.2004.10.018
   Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013
   Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2
   Jestin JL, 2004, J BIOTECHNOL, V113, P85, DOI 10.1016/j.jbiotec.2004.03.032
   Kim DM, 2000, BIOTECHNOL PROGR, V16, P385, DOI 10.1021/bp000031y
   Kim DM, 2004, BIOTECHNOL BIOENG, V85, P122, DOI 10.1002/bit.10865
   Kim SW, 2007, PROTEIN EXPRES PURIF, V55, P159, DOI 10.1016/j.pep.2007.04.003
   Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x
   Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x
   Koga Y, 2003, J MOL BIOL, V331, P585, DOI 10.1016/S0022-2836(03)00782-4
   Kraft M, 2007, APPL MICROBIOL BIOT, V76, P1413, DOI 10.1007/s00253-007-1121-7
   Kumar G, 2009, BIOTECHNIQUES, V47, P637, DOI 10.2144/000113171
   Lesley SA, 2001, PROTEIN EXPRES PURIF, V22, P159, DOI 10.1006/prep.2001.1465
   LIBBY RT, 1987, DNA-J MOLEC CELL BIO, V6, P221, DOI 10.1089/dna.1987.6.221
   Lutz S., 2008, PROTEIN ENG HDB
   Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559
   Matsumoto K, 2008, J BIOTECHNOL, V133, P453, DOI 10.1016/j.jbiotec.2007.11.009
   MORIHARA K, 1979, NATURE, V280, P412, DOI 10.1038/280412a0
   Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a
   Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024
   Neubauer A, 2007, J BIOTECHNOL, V128, P308, DOI 10.1016/j.jbiotec.2006.10.017
   NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588
   Noble SL, 1998, AM FAM PHYSICIAN, V57, P279
   OZES ON, 1992, J INTERFERON RES, V12, P55, DOI 10.1089/jir.1992.12.55
   Pan CQ, 1998, J BIOL CHEM, V273, P11701, DOI 10.1074/jbc.273.19.11701
   Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024
   Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054
   POPOLO L, 1986, J BIOL CHEM, V261, P3479
   PRICE V, 1987, GENE, V55, P287, DOI 10.1016/0378-1119(87)90288-5
   Reetz MT, 2009, MOL BIOSYST, V5, P115, DOI 10.1039/b814862g
   Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746
   ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330
   Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141
   Sainathan SK, 2005, PROTEIN EXPRES PURIF, V44, P94, DOI 10.1016/j.pep.2005.08.014
   Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399
   Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3
   Schliebs W, 1997, BIOCHEMISTRY-US, V36, P9655, DOI 10.1021/bi963086a
   Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802
   Siurkus J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-35
   SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301
   Swartz JR, 2012, AICHE J, V58, P5, DOI 10.1002/aic.13701
   Swartz JR, 2009, NAT BIOTECHNOL, V27, P731, DOI 10.1038/nbt0809-731
   Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07
   Tsuboi T, 2010, ACTA TROP, V114, P171, DOI 10.1016/j.actatropica.2009.10.024
   Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011
   Vermasvuori R, 2009, BIOTECHNOL PROGR, V25, P95, DOI [10.1021/bp.69, 10.1002/btpr.69]
   Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917
   Watanabe M, 2010, METHODS MOL BIOL, V607, P149, DOI 10.1007/978-1-60327-331-2_13
   Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002
   Yin G, 2004, BIOTECHNOL BIOENG, V86, P188, DOI 10.1002/bit.10827
   Zawada JF, 2011, BIOTECHNOL BIOENG, V108, P1570, DOI 10.1002/bit.23103
   ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411
   ZUPPINGER K, 1987, DIABETOLOGIA, V30, P912, DOI 10.1007/BF00295873
NR 89
TC 26
Z9 26
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JAN 2
PY 2013
VL 440
IS 1
BP 39
EP 47
DI 10.1016/j.ijpharm.2012.04.005
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 072FS
UT WOS:000313655300006
PM 22521712
DA 2018-10-20
ER

PT J
AU Raveendran, S
   Poulose, AC
   Yoshida, Y
   Maekawa, T
   Kumar, DS
AF Raveendran, Sreejith
   Poulose, Aby C.
   Yoshida, Yasuhiko
   Maekawa, Toru
   Kumar, D. Sakthi
TI Bacterial exopolysaccharide based nanoparticles for sustained drug
   delivery, cancer chemotherapy and bioimaging
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Mauran; Sustained release; Bacterial polysaccharides; Extremophiles;
   Chitosan; Cancer therapy and bioimaging; Halomonas
ID HALOMONAS-MAURA; SULFATED POLYSACCHARIDES; PARTICLES; CARRIERS; SYSTEMS;
   ACID; HIV; PH
AB introduction of a novel biocompatible, stable, biomaterial for drug delivery application remains always challenging. In the present study, we report the synthesis of an extremophilic bacterial sulfated polysaccharide based nanoparticle as a stable biocompatible material for drug delivery, evaluation of anticancer efficacy and bioimaging. Mauran (MR), the sulfated exopolysaccharide extracted from a moderately halophilic bacterium, Halomonas maura was used for the synthesis of nanoparticles along with chitosan (CH). MR/CH nanoparticles were synthesized by simple polyelectrolyte complexation of anionic MR and cationic CH. The MR/CH hybrid nanoparticles formed were ranging between 30 and 200 nm in diameter with an overall positive zeta potential of 27.5 +/- 5 mV and was found to be stable under storage in solution for at least 8 weeks. In vitro drug release studies showed a sustained and prolonged delivery of 5-fluorouracil (5FU) for 10-12 days from MR/CH nanoparticles under three different pHs of 4.5, 6.9 and 7.4 respectively. Cytotoxicity assay revealed that MR/CH nanoparticles were non-cytotoxic towards normal cells and toxic to cancer cells. Also, 5FU loaded MR/CH nanoparticles were found more effective than free 5FU in its sustained and controlled manner of killing breast adenocarcinoma cells. Fluorescein isothiocyanate (FITC) labeled MR/CH nanoparticles were used for cell binding and uptake studies; thereby demonstrating the application of dye tagged MR/CH nanoparticles for safe and nontoxic mode of live cellular imaging. We report the introduction of an extremophilic bacterial polysaccharide, MR, for the first time as a novel biocompatible and stable biomaterial to the world of nanotechnology, pharmaceutics and biomedical technology. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Raveendran, Sreejith; Poulose, Aby C.; Yoshida, Yasuhiko; Maekawa, Toru; Kumar, D. Sakthi] Toyo Univ, Grad Sch Interdisciplinary New Sci, Bionano Elect Res Ctr, Kawagoe, Saitama 3508585, Japan.
RP Kumar, DS (reprint author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Bionano Elect Res Ctr, Kawagoe, Saitama 3508585, Japan.
EM sakthi@toyo.jp
OI Kumar, Sakthi/0000-0003-4624-7327; Raveendran,
   Sreejith/0000-0001-7499-304X
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan; programme of the strategic research foundation at private
   universities [S1101017]
FX Sreejith Raveendran and Aby C. Poulose would like to acknowledge their
   sincere gratitude to the Ministry of Education, Culture, Sports, Science
   and Technology (MEXT), Japan for the financial support under the
   Monbukagakusho fellowship during the research. Also, part of this study
   has been supported by a grant for the programme of the strategic
   research foundation at private universities S1101017, organized by the
   MEXT, Japan since April 2012.
CR Arad S, 2010, CURR OPIN BIOTECH, V21, P358, DOI 10.1016/j.copbio.2010.02.008
   Argandona M, 2005, FEMS MICROBIOL LETT, V244, P69, DOI 10.1016/j.femsle.2005.01.019
   Arias S, 2003, EXTREMOPHILES, V7, P319, DOI 10.1007/s00792-003-0325-8
   Bakkialakshmi S., 2011, J PHARM SCI RES, V3, P1326
   Bhumkar R. D., 2006, AAPS PHARMSCITECH, V7
   Bouchotroch S, 2001, INT J SYST EVOL MICR, V51, P1625, DOI 10.1099/00207713-51-5-1625
   Calvo C, 1998, J IND MICROBIOL BIOT, V20, P205, DOI 10.1038/sj.jim.2900513
   Cheng JJ, 2009, PROCESS BIOCHEM, V44, P453, DOI 10.1016/j.procbio.2008.12.012
   Dev A, 2010, CARBOHYD POLYM, V80, P833, DOI 10.1016/j.carbpol.2009.12.040
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Ge Y., 2006, NANOSCALE RES LETT, V4, P287
   Gomez-Ordonez E, 2011, FOOD HYDROCOLLOID, V25, P1514, DOI 10.1016/j.foodhyd.2011.02.009
   Grenha A, 2010, J BIOMED MATER RES A, V92A, P1265, DOI 10.1002/jbm.a.32466
   HOSOYA M, 1991, ANTIMICROB AGENTS CH, V35, P2515, DOI 10.1128/AAC.35.12.2515
   Huang LL, 2010, CARBOHYD POLYM, V80, P168, DOI 10.1016/j.carbpol.2009.11.007
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Lin YH, 2009, BIOMATERIALS, V30, P3332, DOI 10.1016/j.biomaterials.2009.02.036
   Liu ZG, 2007, J BIOMED MATER RES A, V83A, P806, DOI 10.1002/jbm.a.31407
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Llamas I, 2006, ANTON LEEUW INT J G, V89, P395, DOI 10.1007/s10482-005-9043-9
   Luscher-Mattli M, 2000, ANTIVIR CHEM CHEMOTH, V11, P249
   McCarron PA, 2000, J PHARM PHARMACOL, V52, P1451, DOI 10.1211/0022357001777658
   Nair K Lekha, 2011, Int J Nanomedicine, V6, P1685, DOI 10.2147/IJN.S20165
   Nichols CM, 2005, MICROB ECOL, V49, P578, DOI 10.1007/s00248-004-0093-8
   QUESADA E, 1990, INT J SYST BACTERIOL, V40, P261, DOI 10.1099/00207713-40-3-261
   Rougeaux H, 1996, CARBOHYD POLYM, V31, P237, DOI 10.1016/S0144-8617(96)00079-3
   Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021
   Sivabalan M., 2011, PHARM GLOBALE IJCP, V2, P1
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Toida T, 2003, TRENDS GLYCOSCI GLYC, V15, P29, DOI 10.4052/tigg.15.29
   Xu T, 2007, MAT SCI ENG C-BIO S, V27, P579, DOI 10.1016/j.msec.2006.05.029
NR 32
TC 27
Z9 30
U1 1
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2013
VL 91
IS 1
BP 22
EP 32
DI 10.1016/j.carbpol.2012.07.079
PG 11
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 026DH
UT WOS:000310253800004
PM 23044101
DA 2018-10-20
ER

PT J
AU Upadhyaya, L
   Singh, J
   Agarwal, V
   Tewari, RP
AF Upadhyaya, Laxmi
   Singh, Jay
   Agarwal, Vishnu
   Tewari, Ravi Prakash
TI Biomedical applications of carboxymethyl chitosans
SO CARBOHYDRATE POLYMERS
LA English
DT Review
DE Carboxymethyl chitosan; Tissue engineering; Drug delivery; Gene therapy;
   Bioimaging
ID TARGETED DRUG-DELIVERY; N,O-CARBOXYMETHYL CHITOSAN;
   O-CARBOXYMETHYLCHITOSAN; IN-VITRO; N-CARBOXYMETHYLCHITOSAN;
   ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS-SOLUTION; ORAL
   DELIVERY; N,N-DICARBOXYMETHYL CHITOSAN
AB This review outlines the recent developments on carboxymethyl chitosan-based bio-medical applications. Carboxymethyl chitosan, a water soluble derivative of chitosan, with enhanced biological and physicochemical properties compared to chitosan, has emerged as a promising candidate for different biomedical applications. Introducing small chemical groups like carboxymethyl to the chitosan structure can drastically increase the solubility of chitosan at neutral and alkaline pH values without affecting their characteristic properties. Due to improved biocompatibility, high moisture retention ability more viscosity and enhanced antimicrobial property of carboxymethyl chitosan than chitosan makes it promising candidate for hydrogels and wound healing applications. The biodegradability and biocompatibility of carboxymethyl chitosan has significant interest with application as biomaterial for tissue engineering. Apart from this, the easy of carboxymethyl chitosan can be easily processed into nanoparticles so it has shown promise for drug delivery, bioimaging, biosensors and gene therapy applications. The contribution of carboxymethyl chitosan to green chemistry in the recent years has also been given in detail. This review will focus on preparative methods and physicochemical and biological properties of carboxymethyl chitosan with particular emphasis on biomedical and pharmaceutical applications of this derivative of chitosan. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Singh, Jay] Natl Phys Lab, CSIR, Mat Phys & Engn Div,Dept Sci & Technol, Ctr Biomol Elect,Biomed Instrumentat Sect, New Delhi 110012, India.
   [Upadhyaya, Laxmi; Tewari, Ravi Prakash] MotiLal Nehru Natl Inst Technol, Dept Appl Mech, Allahabad 211004, Uttar Pradesh, India.
   [Agarwal, Vishnu] MotiLal Nehru Natl Inst Technol, Dept Appl Mech Biotechnol, Allahabad 211004, Uttar Pradesh, India.
RP Singh, J (reprint author), Natl Phys Lab, CSIR, Mat Phys & Engn Div,Dept Sci & Technol, Ctr Biomol Elect,Biomed Instrumentat Sect, Dr KS Krishnan Marg, New Delhi 110012, India.
EM laxmi4.phd@gmail.com; jay_singh143@yahoo.co.in
RI Singh, Jay/N-8856-2013
OI Singh, Jay/0000-0002-3793-0450
FU Ministry of Human Resource Development, Govt. of India
FX The authors would like to thank Ministry of Human Resource Development,
   Govt. of India for providing fellowship for research. The authors also
   want to acknowledge the Director, Motilal Nehru National Institute of
   Technology, Allahabad, India for providing other necessary facilities
   for research work. Authors have kindly acknowledged to Dr. M.
   Srivastava, Assistant Professor, Department of Physics, DIT Institute of
   Technology Noida, India, who has checked the English language.
CR Abreu FOMS, 2009, POLYM INT, V58, P1267, DOI 10.1002/pi.2657
   Anitha A, 2011, CARBOHYD POLYM, V83, P452, DOI 10.1016/j.carbpol.2010.08.008
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Beppu M. M., 2007, SCIENCE, V30, P126
   Bhattacharya D, 2011, NANOSCALE, V3, P1653, DOI 10.1039/c0nr00821d
   Binghui Wang, 2010, Engineering, V2, P387, DOI 10.4236/eng.2010.25050
   Budiraharjo R, 2012, J COLLOID INTERF SCI, V366, P224, DOI 10.1016/j.jcis.2011.09.072
   Cai KY, 2001, J BIOMAT SCI-POLYM E, V12, P1303, DOI 10.1163/156856202753419240
   Chan V, 2001, LANGMUIR, V17, P3749, DOI 10.1021/la001754u
   Chatterjee S, 2010, BIORESOURCE TECHNOL, V101, P1800, DOI 10.1016/j.biortech.2009.10.051
   Chen J, 2007, RADIAT PHYS CHEM, V76, P1425, DOI 10.1016/j.radphyschem.2007.02.045
   Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100
   Chen LY, 2003, CARBOHYD RES, V338, P333, DOI 10.1016/S0008-6215(02)00462-7
   Chen Q, 2006, EUR J PHARMACOL, V541, P1, DOI 10.1016/j.ejphar.2006.03.044
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Chen SB, 2010, CARBOHYD POLYM, V82, P747, DOI 10.1016/j.carbpol.2010.05.046
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Chen Y, 2009, CARBOHYD POLYM, V75, P287, DOI 10.1016/j.carbpol.2008.07.022
   Chenguang Liu, 2007, Current Applied Physics, V7, pe125, DOI 10.1016/j.cap.2006.11.031
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   D'Agostini O, 2011, MAT SCI ENG C-MATER, V31, P677, DOI 10.1016/j.msec.2010.12.015
   Dalia L. H., 2011, J RADIOANAL NUCL CH, V290, P557
   de Britto D, 2011, POLYM INT, V60, P910, DOI 10.1002/pi.3038
   Debrassi A, 2011, ACTA BIOMATER, V7, P3078, DOI 10.1016/j.actbio.2011.05.001
   DELBEN F, 1989, CARBOHYD POLYM, V11, P221, DOI 10.1016/0144-8617(89)90052-0
   Di Colo G, 2004, INT J PHARM, V273, P37, DOI 10.1016/j.ijpharm.2003.12.018
   Duarte ARC, 2010, J SUPERCRIT FLUID, V54, P282, DOI 10.1016/j.supflu.2010.05.017
   El Shafei A, 2011, CARBOHYD POLYM, V83, P920, DOI 10.1016/j.carbpol.2010.08.083
   El-Sharif AA, 2011, CURR MICROBIOL, V62, P739, DOI 10.1007/s00284-010-9777-0
   El-Sherbiny IM, 2010, CARBOHYD POLYM, V80, P1125, DOI 10.1016/j.carbpol.2010.01.034
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Feng T, 2008, CARBOHYD POLYM, V73, P126, DOI 10.1016/j.carbpol.2007.11.003
   Fu DW, 2011, BIOCHEM BIOPH RES CO, V408, P110, DOI 10.1016/j.bbrc.2011.03.130
   Fu XF, 2007, CARBOHYD POLYM, V68, P511, DOI 10.1016/j.carbpol.2006.11.001
   Gandhi MR, 2011, CARBOHYD POLYM, V83, P1082, DOI 10.1016/j.carbpol.2010.08.079
   Ge HC, 2005, CARBOHYD RES, V340, P1351, DOI 10.1016/j.carres.2005.02.025
   Gibbs G, 2003, J APPL POLYM SCI, V90, P1073, DOI 10.1002/app.12761
   Guo BL, 2007, CARBOHYD RES, V342, P2416, DOI 10.1016/j.carres.2007.07.007
   Guo ZY, 2008, CARBOHYD POLYM, V73, P173, DOI 10.1016/j.carbpol.2007.10.021
   Guo ZY, 2006, CARBOHYD RES, V341, P351, DOI 10.1016/j.carres.2005.11.002
   Guo ZY, 2005, BIOORG MED CHEM LETT, V15, P4600, DOI 10.1016/j.bmcl.2005.06.095
   Hasegawa M, 2001, JPN J CANCER RES, V92, P459, DOI 10.1111/j.1349-7006.2001.tb01116.x
   Hiroki A, 2009, RADIAT PHYS CHEM, V78, P1076, DOI 10.1016/j.radphyschem.2009.05.003
   Hjerde RJN, 1997, CARBOHYD POLYM, V34, P131, DOI 10.1016/S0144-8617(97)00113-6
   Homayoni H, 2009, CARBOHYD POLYM, V77, P656, DOI 10.1016/j.carbpol.2009.02.008
   Huang L, 2008, CARBOHYD POLYM, V71, P690, DOI 10.1016/j.carbpol.2007.06.020
   Huang L, 2007, J COLLOID INTERF SCI, V316, P398, DOI 10.1016/j.jcis.2007.07.039
   Jayakumar R, 2009, INT J BIOL MACROMOL, V45, P135, DOI 10.1016/j.ijbiomac.2009.04.016
   Jeong YI, 2010, COLLOID SURFACE B, V79, P149, DOI 10.1016/j.colsurfb.2010.03.037
   Ji JO, 2011, POLYM BULL, V67, P1201, DOI 10.1007/s00289-011-0449-4
   Jiao YP, 2009, CHINESE SCI BULL, V54, P3167, DOI 10.1007/s11434-009-0266-4
   Joshi JA, 2006, POLYMER, V47, P2198, DOI 10.1016/j.polymer.2005.11.050
   Joshi JM, 2007, CARBOHYD POLYM, V67, P427, DOI 10.1016/j.carbpol.2006.06.021
   Khan M. S., 2012, INT J BIOL PHARM RES, V3, P113
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Kogan G, 2004, TOXICOL APPL PHARM, V201, P303, DOI 10.1016/j.taap.2004.05.009
   Kokubo T, 2004, BIOMATERIALS, V25, P4485, DOI 10.1016/j.biomaterials.2003.11.007
   Kong XP, 2012, CARBOHYD POLYM, V88, P336, DOI 10.1016/j.carbpol.2011.12.019
   Lameiro MH, 2006, INT J PHARMACEUT, V312, P119, DOI 10.1016/j.ijpharm.2006.01.006
   Laudenslager MJ, 2008, BIOMACROMOLECULES, V9, P2682, DOI 10.1021/bm800835e
   Li P, 2012, INT J NANOMED, V7, P925, DOI 10.2147/IJN.S26955
   Li XY, 2012, INT J BIOL MACROMOL, V50, P1299, DOI 10.1016/j.ijbiomac.2012.03.008
   Liang XF, 2008, LANGMUIR, V24, P7147, DOI 10.1021/la703775a
   Liang XF, 2008, ACTA PHYS-CHIM SIN, V24, P223, DOI 10.1016/S1872-1508(08)60011-X
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Liu SQ, 2005, RHEUMATOL INT, V26, P52, DOI 10.1007/s00296-004-0569-3
   Liu TY, 2006, LANGMUIR, V22, P9740, DOI 10.1021/la061471n
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Liu XF, 2012, CARBOHYD POLYM, V89, P104, DOI 10.1016/j.carbpol.2012.02.057
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   Lu GY, 2009, J BIOMATER APPL, V23, P435, DOI 10.1177/0885328208091661
   Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z
   Mai T T T, 2012, ADV NATURAL SCI NANO, V3
   Mathew ME, 2010, CARBOHYD POLYM, V80, P442, DOI 10.1016/j.carbpol.2009.11.047
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   Mishra D, 2011, MAT SCI ENG C-MATER, V31, P1295, DOI 10.1016/j.msec.2011.04.007
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI R, 1992, CARBOHYD POLYM, V19, P29, DOI 10.1016/0144-8617(92)90051-Q
   MUZZARELLI R, 1989, CARBOHYD POLYM, V11, P307, DOI 10.1016/0144-8617(89)90005-2
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P99, DOI 10.1016/0144-8617(93)90084-H
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   Muzzarelli RAA, 2001, BIOMACROMOLECULES, V2, P165, DOI 10.1021/bm000091s
   MUZZARELLI RAA, 1989, CARBOHYD POLYM, V11, P293, DOI 10.1016/0144-8617(89)90004-0
   MUZZARELLI RAA, 1994, INT J BIOL MACROMOL, V16, P177, DOI 10.1016/0141-8130(94)90048-5
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063
   NIETO JM, 1992, CARBOHYD POLYM, V18, P221, DOI 10.1016/0144-8617(92)90067-Z
   Pang HT, 2007, CARBOHYD POLYM, V69, P419, DOI 10.1016/j.carbpol.2006.12.026
   Patale RL, 2011, CARBOHYD POLYM, V85, P105, DOI 10.1016/j.carbpol.2011.02.001
   Pestov AV, 2007, RUSS J APPL CHEM+, V80, P1154, DOI 10.1134/S1070427207070282
   Prabaharan M, 2007, REACT FUNCT POLYM, V67, P43, DOI 10.1016/j.reactfunctpolym.2006.09.001
   Rinaudo M, 2001, CARBOHYD POLYM, V46, P339, DOI 10.1016/S0144-8617(00)00333-7
   RINAUDO M, 1992, INT J BIOL MACROMOL, V14, P122, DOI 10.1016/S0141-8130(05)80001-7
   Sabaa MW, 2010, CARBOHYD POLYM, V79, P998, DOI 10.1016/j.carbpol.2009.10.024
   Miranda MES, 2006, POLYM INT, V55, P961, DOI 10.1002/pi.2060
   Sashiwa H, 2003, BIOMACROMOLECULES, V4, P1250, DOI 10.1021/bm030022o
   Sayin B, 2008, INT J PHARMACEUT, V363, P139, DOI 10.1016/j.ijpharm.2008.06.029
   Sayin B, 2009, EUR J PHARM SCI, V38, P362, DOI 10.1016/j.ejps.2009.08.010
   Seyfarth F, 2008, INT J PHARM, V353, P139, DOI 10.1016/j.ijpharm.2007.11.029
   Shang XX, 2012, ADV MATER RES-SWITZ, V490-495, P3782, DOI 10.4028/www.scientific.net/AMR.490-495.3782
   Shen JM, 2012, CARBOHYD POLYM, V88, P239, DOI 10.1016/j.carbpol.2011.11.087
   Shi ZL, 2009, ACS APPL MATER INTER, V1, P328, DOI 10.1021/am8000538
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   SHIGEMASA Y, 1995, CHEM LETT, P623, DOI 10.1246/cl.1995.623
   Shoukry AA, 2012, CENT EUR J CHEM, V10, P59, DOI 10.2478/s11532-011-0116-5
   Sini TK, 2005, POLYMER, V46, P3128, DOI 10.1016/j.polymer.2005.02.035
   Skorik YA, 2003, CARBOHYD RES, V338, P271, DOI 10.1016/S0008-6215(02)00432-9
   Sun LP, 2006, POLYMER, V47, P1796, DOI 10.1016/j.polymer.2006.01.073
   Sun S, 2006, REACT FUNCT POLYM, V66, P819, DOI 10.1016/j.reactfunctpolym.2005.11.008
   Sun SL, 2006, SEP PURIF TECHNOL, V49, P197, DOI 10.1016/j.seppur.2005.09.013
   Sun SL, 2006, J HAZARD MATER, V131, P103, DOI 10.1016/j.jhazmat.2005.09.012
   Sun T, 2003, EUR POLYM J, V39, P189, DOI 10.1016/S0014-3057(02)00174-X
   Sun T, 2007, EUR FOOD RES TECHNOL, V225, P451, DOI 10.1007/s00217-006-0439-1
   Tan YL, 2011, J MATER SCI-MATER M, V22, P1213, DOI 10.1007/s10856-011-4302-y
   Tan YL, 2009, COLLOID SURFACE B, V69, P178, DOI 10.1016/j.colsurfb.2008.11.026
   Tang YJ, 2012, CARBOHYD POLYM, V88, P46, DOI 10.1016/j.carbpol.2011.11.058
   Tavakol M, 2009, CARBOHYD POLYM, V77, P326, DOI 10.1016/j.carbpol.2009.01.005
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Tokura S, 1996, MACROMOL SYMP, V101, P389, DOI 10.1002/masy.19961010144
   Vaghani SS, 2012, CARBOHYD RES, V347, P76, DOI 10.1016/j.carres.2011.04.048
   Vu D. A., 2010, J BIOTERROR BIODEF, V1, P102
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wang G, 2010, BIOTECHNOL LETT, V32, P59, DOI 10.1007/s10529-009-0123-1
   Wang HD, 2010, DIAM RELAT MATER, V19, P441, DOI 10.1016/j.diamond.2010.01.032
   Wang J, 2010, J PHYS CHEM C, V114, P18940, DOI 10.1021/jp105906p
   Wang L, 2008, CHEM ENG J, V143, P43, DOI 10.1016/j.cej.2007.12.007
   Wang M, 2008, CARBOHYD POLYM, V74, P498, DOI 10.1016/j.carbpol.2008.04.008
   Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007
   Wang YS, 2007, CARBOHYD POLYM, V69, P597, DOI 10.1016/j.carbpol.2007.01.016
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Wongpanit P, 2005, MACROMOL BIOSCI, V5, P1001, DOI 10.1002/mabi.200500081
   Wu HB, 2004, ANN RHEUM DIS, V63, P369, DOI 10.1136/ard.2002.001461
   Xie M, 2005, CHEM COMMUN, P5518, DOI 10.1039/b509781a
   Xu Q, 2006, BIOSENS BIOELECTRON, V22, P768, DOI 10.1016/j.bios.2006.02.010
   Xu Q, 2006, REACT FUNCT POLYM, V66, P863, DOI 10.1016/j.reactfunctpolym.2005.11.015
   Yang C, 2010, CARBOHYD POLYM, V82, P1297, DOI 10.1016/j.carbpol.2010.07.013
   Yin LC, 2007, BIOMATERIALS, V28, P1258, DOI 10.1016/j.biomaterials.2006.11.008
   Yoshii F, 2003, NUCL INSTRUM METH B, V208, P320, DOI 10.1016/S0168-583X(03)00624-4
   Yu SH, 2012, CARBOHYD POLYM, V87, P531, DOI 10.1016/j.carbpol.2011.08.015
   Zhang LX, 2010, ELECTROCHEM COMMUN, V12, P1249, DOI 10.1016/j.elecom.2010.06.031
   Zhang W, 2008, SCRIPTA MATER, V59, P211, DOI 10.1016/j.scriptamat.2008.03.006
   Zhang YF, 2009, MAT SCI ENG C-MATER, V29, P2045, DOI 10.1016/j.msec.2009.04.003
   Zhao DK, 2011, CARBOHYD POLYM, V85, P832, DOI 10.1016/j.carbpol.2011.04.007
   Zhao L, 2006, CARBOHYD POLYM, V64, P473, DOI 10.1016/j.carbpol.2005.12.014
   Zhao L, 2003, CARBOHYD POLYM, V53, P439, DOI 10.1016/S0144-8617(03)00103-6
   Zhao L, 2008, BIORESOURCE TECHNOL, V99, P1911, DOI 10.1016/j.biortech.2007.03.030
   Zheng H, 2011, CARBOHYD POLYM, V84, P1048, DOI 10.1016/j.carbpol.2010.12.067
   Zheng ML, 2011, CARBOHYD POLYM, V86, P231, DOI 10.1016/j.carbpol.2011.04.038
   Zhong ZM, 2009, INT J BIOL MACROMOL, V45, P163, DOI 10.1016/j.ijbiomac.2009.04.020
   Zhou J, 2004, SURGERY, V135, P307, DOI 10.1016/j.surg.2003.07.005
   Zhou J, 2008, J THORAC CARDIOV SUR, V135, P777, DOI 10.1016/j.jtcvs.2007.09.033
   Zhou Y, 2012, MAT SCI ENG C-MATER, V32, P994, DOI 10.1016/j.msec.2012.02.029
   Zhou Y, 2012, RADIAT PHYS CHEM, V81, P553, DOI 10.1016/j.radphyschem.2012.01.014
   Zhou YS, 2009, CARBOHYD POLYM, V75, P293, DOI 10.1016/j.carbpol.2008.07.024
   Zhu A., 2009, BIOMATERIALS, V26, P6873
   Zhu AP, 2008, INT J PHARM, V350, P361, DOI 10.1016/j.ijpharm.2007.09.004
   Zhu AP, 2007, COLLOID POLYM SCI, V285, P1535, DOI 10.1007/s00396-007-1716-7
   Zhu AP, 2007, CARBOHYD POLYM, V68, P693, DOI 10.1016/j.carbpol.2006.08.007
   Zhu AP, 2006, CARBOHYD POLYM, V63, P89, DOI 10.1016/j.carbpol.2005.08.006
   Zhu AP, 2005, COLLOID SURFACE B, V43, P143, DOI 10.1016/j.colsurfb.2005.04.009
   Zou AF, 2012, J PHARM SCI-US, V101, P627, DOI 10.1002/jps.22798
NR 165
TC 111
Z9 118
U1 6
U2 260
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2013
VL 91
IS 1
BP 452
EP 466
DI 10.1016/j.carbpol.2012.07.076
PG 15
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 026DH
UT WOS:000310253800059
PM 23044156
DA 2018-10-20
ER

PT B
AU Jarvis, D
   Edwards, A
   Bhattarai, N
AF Jarvis, David
   Edwards, Angela
   Bhattarai, Narayan
GP ASME
TI EXTRACTION AND PRODUCTION OF KERATIN-BASED NANOFIBERS FOR BIOMEDICAL
   APPLICATIONS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION, 2013, VOL 2B
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE2013)
CY NOV 15-21, 2013
CL San Diego, CA
SP ASME
ID HAIR; REGENERATION
AB Keratin, a natural biomaterial found within the hair, nails, and epidermis of humans, has shown promise of being a useful material for tissue engineering scaffolds and drug delivery systems, due in part to its favorable biological qualities. The scaffolds generated by electrospinning are useful in proliferating cells, and can even biodegrade over time, reducing the impact on the body and not invoking any adverse tissue response. This research details the extraction process of keratin from human hair, and using electrospinning to weave the keratin into nanofibrous polymers. Using a synthetic polymer solution, for example, polycaprolactone (PCL) in trifluoroethanol (TFE), keratin was easily mixed and successfully electrospun into nanofibers. The fiber formation characteristics and nanofiber morphology was studied under a scanning electron microscope (SEM).
C1 [Jarvis, David] N Carolina Agr & Tech State Univ, Dept Chem Biol & Bioengn, Greensboro, NC 27411 USA.
   N Carolina Agr & Tech State Univ, NSF ERC Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
RP Jarvis, D (reprint author), N Carolina Agr & Tech State Univ, Dept Chem Biol & Bioengn, Greensboro, NC 27411 USA.
CR Alibardi L, 2009, J ANAT, V214, P560, DOI 10.1111/j.1469-7580.2009.01045.x
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   Dittmer T., 2011, GENOME BIOL, V12
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Huttner KM, 2012, J INVEST DERMATOL, V132, pS65
   JARRETT A, 1958, BRIT J DERMATOL, V70, P271, DOI 10.1111/j.1365-2133.1958.tb13339.x
   Kharin A., 2009, J BIOMEDICAL OPTICS, V14
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Newth R, 1985, NATURE, V314, P32
   Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381
   Rogers MA, 2004, DIFFERENTIATION, V72, P527, DOI 10.1111/j.1432-0436.2004.07209006.x
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sow WT, 2013, NANOMEDICINE-UK, V8, P531, DOI [10.2217/NNM.13.38, 10.2217/nnm.13.38]
   Taylor MA, 2013, ARCH NAT HIST, V40, P178, DOI 10.3366/anh.2013.0153
NR 17
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5619-2
PY 2013
AR V02BT02A004
PG 5
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BD3HD
UT WOS:000359682300004
DA 2018-10-20
ER

PT S
AU Madsen, JB
   Pakkanen, KI
   Lee, S
AF Madsen, Jan Busk
   Pakkanen, Kirsi I.
   Lee, Seunghwan
BE Dan, Y
TI Investigation of the Thermostability of Bovine Submaxillary Mucin (BSM)
   and Its Impact on Lubrication
SO 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND TECHNOLOGY -
   ICBET 2013
SE APCBEE Procedia
LA English
DT Proceedings Paper
CT 3rd International Conference on Biomedical Engineering and Technology
   (ICBET)
CY MAY 19-20, 2013
CL Copenhagen, DENMARK
DE Bovine Submaxillary Mucin; Biolubrication; Surface Coating; Biotribology
ID BACTERIAL ADHESION; SURFACES; CONFORMATION; BIOMATERIAL; ADSORPTION
AB Bovine Submaxillary Mucin (BSM) generates thin film layers via spontaneous adsorption onto hydrophobic surfaces such as Poly(dimethylsiloxane) (PDMS) and High Density Polyethylene (HDPE). A characteristic feature of mucin is its tribological- or lubricating properties. Circular dichroismspectroscopyrevealed that BSM is thermally stable over a wide range of temperatures (5-85 degrees C) in its conformation, and Pin-on-Disk tribometry at low speeds showed negligible influence on lubricating properties. Employing the Mini Traction Machine, BSM was found to retain comparable lubricating properties after heating to 80 degrees C and subsequent cooling. Random coiled secondary- and lack of tertiary structure in BSM is believed to contribute to the heat tolerance observed with regards to its conformational and lubrication properties. (C) 2013 The Authors. Published by Elsevier B.V.
C1 [Madsen, Jan Busk; Pakkanen, Kirsi I.; Lee, Seunghwan] Tech Univ Denmark, Dept Mech Engn, DK-2800 Lyngby, Denmark.
RP Lee, S (reprint author), Tech Univ Denmark, Dept Mech Engn, DK-2800 Lyngby, Denmark.
EM seele@mek.dtu.dk
RI Lee, Seunghwan/K-8382-2014
OI Lee, Seunghwan/0000-0002-0797-1446
CR BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Bushnak IA, 2010, BIOFOULING, V26, P387, DOI 10.1080/08927011003646809
   Lee S, 2005, LANGMUIR, V21, P8344, DOI 10.1021/la050779w
   LINDERBERG J, 1970, J AM CHEM SOC, V92, P2619, DOI 10.1021/ja00712a005
   Sandberg T, 2007, MICROSC RES TECHNIQ, V70, P864, DOI 10.1002/jemt.20489
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P773, DOI 10.1002/jbm.a.32315
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266
   Sandberg T, 2009, J MATER SCI-MATER M, V20, P621, DOI 10.1007/s10856-008-3595-y
   Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Shi L, 2001, BIOTECHNOL LETT, V23, P437, DOI 10.1023/A:1010370205120
   STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559
NR 12
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-6708
J9 APCBEE PROC
PY 2013
VL 7
BP 21
EP 26
DI 10.1016/j.apcbee.2013.08.006
PG 6
WC Engineering, Biomedical
SC Engineering
GA BB7FM
UT WOS:000345452500004
OA Other Gold, Green Published
DA 2018-10-20
ER

PT S
AU Suzuki, O
   Anada, T
AF Suzuki, Osamu
   Anada, Takahisa
GP IEEE
TI Synthetic octacalcium phosphate: a possible carrier for mesenchymal stem
   cells in bone regeneration
SO 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 35th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY JUL 03-07, 2013
CL Osaka, JAPAN
SP IEEE Engn Med Biol Soc, Japanese Soc Med & Biol Engn
ID COLLAGEN SCAFFOLD; CRYSTAL-CHEMISTRY; HYDROXYAPATITE; COMPOSITE
AB The present paper reviews biomaterial studies of synthetic octacalcium phosphate (OCP) as a scaffold of osteoblastic cells. OCP crystals have been suggested to be one of precursor phases in hydroxyapatite (HA) crystal formation in bone and tooth. The recent intensive biomaterials and tissue engineering studies using synthetic OCP disclosed the potential function of OCP as a bioactive material as well as synthetic HA materials due to its highly osteoconductive and biodegradable properties. In vitro studies showed that OCP crystals exhibit a positive effect on osteoblastic cell differentiation. In vivo studies confirmed that the materials of OCP in a granule forms and OCP-based composite materials with natural polymers, such as gelatin and collagen, enhance bone regeneration if implanted in various model bone defects with critical-sized diameters, defined as a defect which does not heal spontaneously throughout the lifetime of the animals. One of particular characteristics of OCP, found as a mechanism to enhance bone regeneration in vivo, is a process of progressive conversion from OCP to HA at physiological conditions. The OCP-HA conversion is accompanied by progressive physicochemical changes of the material properties, which affects the tissue reaction around the crystals where osteoblastic cells are encountered. Mesenchymal stem cells (MSCs) seeded in an OCP-based material enhanced bone regeneration in the rat critical-sized calvaria defect more than that by the material alone. The overall results reveal that OCP crystals have an effect on osteoblastic cell differentiation including the differentiation of MSCs in vivo. The evidence collected experimentally in the laboratory was presented.
C1 [Suzuki, Osamu; Anada, Takahisa] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 9808575, Japan.
RP Suzuki, O (reprint author), Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 9808575, Japan.
EM suzuki-o@m.tohoku.ac.jp; anada@m.tohoku.ac.jp
CR Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]
   AOKI H, 1991, SCI MED APPL HYDROXY
   Barrias CC, 2005, J BIOMED MATER RES A, V74A, P545, DOI 10.1002/jbm.a.30348
   BROWN WALTER E., 1966, CLIN ORTHO RELAT RES, V44, P205
   BROWN WE, 1981, PROG CRYST GROWTH CH, V4, P59, DOI 10.1016/0146-3535(81)90048-4
   Fuji T, 2009, TISSUE ENG PT A, V15, P3525, DOI [10.1089/ten.tea.2009.0048, 10.1089/ten.TEA.2009.0048]
   Handa T, 2012, ACTA BIOMATER, V8, P1190, DOI 10.1016/j.actbio.2011.12.002
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Honda Y, 2009, TISSUE ENG PT A, V15, P1965, DOI 10.1089/ten.tea.2008.0300
   JARCHO M, 1977, J BIOENG, V1, P79
   Kamakura S, 2006, J BIOMED MATER RES B, V79B, P210, DOI 10.1002/jbm.b.30531
   Kawai T, 2011, EUR CELLS MATER, V22, P124, DOI 10.22203/eCM.v022a10
   Kawai T, 2011, CLIN IMPLANT DENT R, V13, P112, DOI 10.1111/j.1708-8208.2009.00192.x
   Kawai T, 2009, TISSUE ENG PT A, V15, P23, DOI 10.1089/ten.tea.2008.0141
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Miyatake N, 2009, BIOMATERIALS, V30, P1005, DOI 10.1016/j.biomaterials.2008.10.058
   Oyane A, 2012, ACTA BIOMATER, V8, P2034, DOI 10.1016/j.actbio.2012.02.003
   Shibuya I, 2013, CELL TISSUE RES, V352, P401, DOI 10.1007/s00441-012-1548-8
   Shiwaku Y, 2012, ACTA BIOMATER, V8, P4417, DOI 10.1016/j.actbio.2012.07.041
   Suzuki Kentaro, 2012, Phosphorus Research Bulletin, V26, P53
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   SUZUKI O, 1995, CELL MATER, V5, P45
   Suzuki O., 2013, JPN DENT SC IN PRESS
   Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065
   Wang XG, 2015, J TISSUE ENG REGEN M, V9, P1310, DOI 10.1002/term.1669
NR 30
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-0216-7
J9 IEEE ENG MED BIO
PY 2013
BP 397
EP 400
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB2DX
UT WOS:000341702100096
PM 24109707
DA 2018-10-20
ER

PT S
AU Jeong, J
   Shin, S
   Lee, GJ
   Gwon, TM
   Park, JH
   Kim, SJ
AF Jeong, Joonsoo
   Shin, Soowon
   Lee, Geun Jae
   Gwon, Tae Mok
   Park, Jeong Hoan
   Kim, Sung June
GP IEEE
TI Advancements in Fabrication Process of Microelectrode Array for a
   Retinal Prosthesis using Liquid Crystal Polymer (LCP)
SO 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 35th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY JUL 03-07, 2013
CL Osaka, JAPAN
SP IEEE Engn Med Biol Soc, Japanese Soc Med & Biol Engn
ID VISION
AB Liquid Crystal Polymer (LCP) has been considered as an alternative biomaterial for implantable biomedical devices primarily for its low moisture absorption rate compared with conventional polymers such as polyimide, parylene and silicone elastomers. A novel retinal prosthetic device based on monolithic encapsulation of LCP is being developed in which entire neural stimulation circuitries are integrated into a thin and eye-conformable structure. Micromachining techniques for fabrication of a LCP retinal electrode array have been previously reported. In this research, however, for being used as a part of the LCP-based retinal implant, we developed advanced fabrication process of LCP retinal electrode through new approaches such as electroplating and laser-machining in order to achieve higher mechanical robustness, long-term reliability and flexibility. Thickened metal tracks could contribute to higher mechanical strength as well as higher long-term reliability when combined with laser-ablation process by allowing high-pressure lamination. Laser-thinning technique could improve the flexibility of LCP electrode.
C1 [Jeong, Joonsoo; Shin, Soowon; Lee, Geun Jae; Gwon, Tae Mok; Park, Jeong Hoan; Kim, Sung June] Seoul Natl Univ, Dept Elect Engn & Comp Sci, Seoul 151744, South Korea.
RP Kim, SJ (reprint author), Seoul Natl Univ, Dept Elect Engn & Comp Sci, Seoul 151744, South Korea.
EM joonsso.jeong@gmail.com; swshin88@gmail.com; biruhan27@gmail.com;
   eatbambam@gmail.com; tteem0920@gmail.com; kimsj@snu.ac.kr
CR Chow EY, 2010, IEEE T BIOMED CIRC S, V4, P340, DOI 10.1109/TBCAS.2010.2081364
   Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836
   Guenther T, 2012, EXPERT REV MED DEVIC, V9, P33, DOI 10.1586/ERD.11.58
   Jeong J, 2012, SENSOR MATER, V24, P189
   Kelly SK, 2011, IEEE T BIO-MED ENG, V58, P3197, DOI 10.1109/TBME.2011.2165713
   Lee SW, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2136341
   Lee SW, 2009, INVEST OPHTH VIS SCI, V50, P5859, DOI 10.1167/iovs.09-3743
   Lee SE, 2012, IEEE T BIO-MED ENG, V59, P2085, DOI 10.1109/TBME.2012.2196274
   Rodger DC, 2006, SENSOR ACTUAT B-CHEM, V117, P107, DOI 10.1016/j.snb.2005.11.010
   Schuettler M, 2005, J NEURAL ENG, V2, pS121, DOI 10.1088/1741-2560/2/1/013
   Shire DB, 2009, IEEE T BIO-MED ENG, V56, P2502, DOI 10.1109/TBME.2009.2021401
   Wang XF, 2003, J MICROMECH MICROENG, V13, P628, DOI 10.1088/0960-1317/13/5/314
   Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042
   Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996
NR 14
TC 6
Z9 6
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-0216-7
J9 IEEE ENG MED BIO
PY 2013
BP 5295
EP 5298
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB2DX
UT WOS:000341702105176
PM 24110931
DA 2018-10-20
ER

PT S
AU Omes, C
   Fassina, L
   Van Vlierberghe, S
   Magenes, G
   Dubruel, P
   Vaghi, P
   Reguzzoni, M
   Riva, F
AF Omes, Claudia
   Fassina, Lorenzo
   Van Vlierberghe, Sandra
   Magenes, Giovanni
   Dubruel, Peter
   Vaghi, Patrizia
   Reguzzoni, Marcella
   Riva, Federica
GP IEEE
TI A case of successful interaction between cells derived from human
   ovarian follicular liquid and gelatin cryogel for biotech and medical
   applications
SO 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 35th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY JUL 03-07, 2013
CL Osaka, JAPAN
SP IEEE Engn Med Biol Soc, Japanese Soc Med & Biol Engn
ID MESENCHYMAL STEM-CELLS; HUMAN SAOS-2 OSTEOBLASTS; HUMAN ADIPOSE-TISSUE;
   IN-VITRO; DIFFERENTIATION; PERSPECTIVES; FABRICATION; HYDROGELS;
   CULTURE; SURFACE
AB Significant research efforts have been undertaken in the last decade to develop specific cell-based therapies and, in particular, adult multipotent mesenchymal stem cells (MSCs) hold great promise toward such regenerative strategies. Biomaterials have been widely used in reconstructive bone surgery to heal critical-size bone defects due to trauma, tumor resection, and tissue degeneration. In particular, gelatin cryogel scaffolds are promising new biomaterials owing to their biocompatibility. There is an increasing demand for MSC-based regenerative approaches in the musculoskeletal system. Combining stem cells with biomaterial scaffolds provides a promising strategy for tissue engineering. Our previous studies showed the possibility to obtain MSCs from the human ovarian follicular liquid (FL) that is usually wasted during in vitro fertilization (IVF). In this study, we tested the ability of these FL cells to grow on gelatin cryogel in comparison with MSCs derived from human bone marrow. Samples and controls were analyzed with confocal and scanning electron microscopes. Results demonstrated that FL cells could grow on the biomaterial not only on the top but also in the layers below till 60 m of deepness. Data suggested that the observed cells were mesenchymal since positive for vimentin and CD-44, typical MSC markers. Successful growth of putative MSCs derived from follicular liquid on 3D gelatin cryogel opens potential developments in biotech and medical applications.
C1 [Omes, Claudia] IRCCS Fdn Policlin San Matteo Pavia, Ctr Procreaz Medicalmente Assistita Ostetricia &, Pavia, Italy.
   [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, CIT, Dip Ingegneria Ind & Dell Informaz, Pavia, Italy.
   [Van Vlierberghe, Sandra; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Grp, Ghent, Belgium.
   [Vaghi, Patrizia] Univ Pavia, Cent Grandi Strumenti, Pavia, Italy.
   [Reguzzoni, Marcella] Univ Insubria, Dip Sci Chirurgiche & Morfologiche, Varese, Italy.
   [Riva, Federica] Univ Pavia, CIT, Med Sperimentale & Forense, Dip Sanita Pubblica Neurosci, I-27100 Pavia, Italy.
RP Omes, C (reprint author), IRCCS Fdn Policlin San Matteo Pavia, Ctr Procreaz Medicalmente Assistita Ostetricia &, Pavia, Italy.
EM claudia.omes@unipv.it; lorenzo.fassina@unipv.it;
   sandra.vanvlierberghe@ugent.be; giovanni.magenes@unipv.it;
   peter.dubruel@ugent.be; patrizia.vaghi@cgs.unipv.it;
   marcella.reguzzoni@uninsubria.it; federica.riva01@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632; Marcella, Reguzzoni/0000-0003-3738-6632
FU IRCCS Fondazione Policlinico San Matteo of Pavia, Ricerca Corrente
   [20070000260, 2007]; IRCCS Bioethics Committee [20080002153, 2008]
FX Research supported by IRCCS Fondazione Policlinico San Matteo of Pavia,
   Ricerca Corrente 2007 (Prot. # 20070000260, 2007) and approved by IRCCS
   Bioethics Committee (Prot. # 20080002153, 2008).
CR Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Fassina L, 2010, IEEE ENG MED BIO, P247, DOI 10.1109/IEMBS.2010.5627475
   Fassina L, 2010, J BIOMED MATER RES A, V93A, P1272, DOI 10.1002/jbm.a.32620
   Fassina L, 2008, IEEE ENG MED BIO, P3582, DOI 10.1109/IEMBS.2008.4649980
   Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Omes C, 2011, CYTOM PART A, V79A, P1033
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Riva F., HETEROGENEOUS UNPUB
   Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 19
TC 1
Z9 1
U1 1
U2 14
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-0216-7
J9 IEEE ENG MED BIO
PY 2013
BP 6240
EP 6243
DI 10.1109/EMBC.2013.6610979
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB2DX
UT WOS:000341702106158
PM 24111166
DA 2018-10-20
ER

PT S
AU Valles-Lluch, A
   Arnal-Pastor, M
   Martinez-Ramos, C
   Vilarino-Feltrer, G
   Vikingsson, L
   Pradas, MM
AF Valles-Lluch, A.
   Arnal-Pastor, M.
   Martinez-Ramos, C.
   Vilarino-Feltrer, G.
   Vikingsson, L.
   Monleon Pradas, M.
GP IEEE
TI Grid Polymeric Scaffolds with Polypeptide Gel Filling as Patches for
   Infarcted Tissue Regeneration
SO 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 35th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY JUL 03-07, 2013
CL Osaka, JAPAN
SP IEEE Engn Med Biol Soc, Japanese Soc Med & Biol Engn
ID ASSEMBLING PEPTIDE SCAFFOLDS; ENDOTHELIAL-CELLS; HYALURONIC-ACID; PORES;
   BIOMATERIAL; SURFACES
AB Scaffolds of poly(ethyl acrylate) (PEA) with interconnected cylindrical orthogonal pores filled with a selfassembling peptide (SAP) gel are here proposed as patches for infarcted tissue regeneration. These combined systems aim to support cell therapy and meet further requirements posed by the application: the three-dimensional architecture of the elastomeric scaffold is expected to lodge the cells of interest in the damaged zone avoiding their death or migration, and at the same time conduct cell behavior and give mechanical support if necessary; the ECM-like polypeptide gel provides a cell-friendly aqueous microenvironment, facilitates diffusion of nutrients and cell wastes and is expected to improve the distribution and viability of the seeded cells within the pores and stimulate angiogenesis.
C1 [Valles-Lluch, A.; Arnal-Pastor, M.; Martinez-Ramos, C.; Vilarino-Feltrer, G.; Vikingsson, L.; Monleon Pradas, M.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
RP Valles-Lluch, A (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Cno Vera S-N, Valencia 46022, Spain.
EM avalles@ter.upv.es
RI Valles-Lluch, Ana/D-1891-2010; MartiAnez-Ramos, Cristina/G-1591-2015;
   Martinez-Ramos, Cristina/B-8917-2015
OI Valles-Lluch, Ana/0000-0002-7896-8666; MartiAnez-Ramos,
   Cristina/0000-0002-6540-4714; Martinez-Ramos,
   Cristina/0000-0001-7981-2324; Vilarino Feltrer,
   Guillermo/0000-0002-3063-3808; MONLEON PRADAS,
   MANUEL/0000-0001-6457-0414
CR Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Arnal-Pastor M, 2011, J COLLOID INTERF SCI, V361, P361, DOI 10.1016/j.jcis.2011.05.013
   Blan NR, 2008, J BIOMED MATER RES A, V86A, P195, DOI 10.1002/jbm.a.31642
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   Diego RB, 2005, J MATER SCI-MATER M, V16, P693, DOI 10.1007/s10856-005-2604-7
   Estelles JM, 2007, J MATER SCI, V42, P8629, DOI 10.1007/s10853-007-1727-2
   Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gibson L.J., 1997, CELLULAR SOLIDS STRU, P186
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c
   Riedel T, 2009, J BIOMED MATER RES A, V88A, P437, DOI 10.1002/jbm.a.31755
   Hernandez JCR, 2008, J BIOMED MATER RES B, V84B, P541, DOI 10.1002/jbm.b.30902
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Zhao XJ, 2006, ADV POLYM SCI, P145, DOI 10.1007/12_088
NR 18
TC 4
Z9 4
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-0216-7
J9 IEEE ENG MED BIO
PY 2013
BP 6961
EP 6964
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB2DX
UT WOS:000341702107086
PM 24111346
DA 2018-10-20
ER

PT S
AU Moghanaki, SK
   Khoshandam, B
   Mirhaj, MH
AF Moghanaki, S. Khani
   Khoshandam, B.
   Mirhaj, M. H.
BE Zheng, L
   Skuroda, S
   Liu, H
   Du, B
   Wei, J
   Zhao, Y
TI Calculation of Moisture Content and Drying Rate during Microwave Drying
SO APPLIED MATERIALS AND TECHNOLOGIES FOR MODERN MANUFACTURING, PTS 1-4
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 3rd International Conference on Applied Mechanics, Materials and
   Manufacturing (ICAMMM 2013)
CY AUG 24-25, 2013
CL Dalian, PEOPLES R CHINA
SP Dalian Polytechn Univ, Liaoning Key Lab Clean Text, Liaoning Engn Technol Res Ctr Clean Text
DE microwave; drying; fruit; moisture content; drying rate
AB Convectional dryers work at high temperature and usually lead to loss of quality for sensitive biomaterial products (especially in nutrition). In this way the researchers found the microwave power more effective and suitable for drying processes. Some of microwave drying advantages include the following: short drying time, high quality of product, low operating temperature, flexibility in producing wide range of products and easier process controlling. The article calculated the moisture content and drying rate during drying process. Microwave power, holder tray speed, dimension of samples, irradiation time were considered; under these conditions experiments were done and the results show that microwave method has more advantages as comparing with convectional methods.
C1 [Moghanaki, S. Khani; Khoshandam, B.; Mirhaj, M. H.] Univ Semnan, Fac Chem Engn, Semnan, Iran.
RP Moghanaki, SK (reprint author), Univ Semnan, Fac Chem Engn, Semnan, Iran.
EM samad.khani1986@gmail.com; bkhoshandam@gmail.com; m.h.mirhaj@gmail.com
CR Buffler C. R., 1993, MICROWAVE COOKING PR
   Decareau R.V., 1985, MICROWAVE COOKING PR
   Drying MM, 2001, J FOOD ENG, V48, P177
   Dutta B, 2012, DRY TECHNOL, V30, P891, DOI 10.1080/07373937.2012.678957
   Mana L.V., 2012, J FOOD PROCESSING TE, V3, P186
   Mishra S., 2006, ASABE SEC M
   Orikasa T., 2008, Nippon Shokuhin Kagaku Kogaku Kaishi = Journal of the Japanese Society for Food Science and Technology, V55, P350, DOI 10.3136/nskkk.55.350
   Sacilik K, 2006, J FOOD ENG, V73, P281, DOI 10.1016/j.jfoodeng.2005.03.024
   SJOHOLM I, 1995, J FOOD ENG, V25, P123, DOI 10.1016/0260-8774(94)00001-P
NR 9
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-888-2
J9 APPL MECH MATER
PY 2013
VL 423-426
BP 746
EP 749
DI 10.4028/www.scientific.net/AMM.423-426.746
PG 4
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BA9GU
UT WOS:000339363800150
DA 2018-10-20
ER

PT S
AU Zhan, KH
   Xie, L
   Wang, XH
   Zuo, BQ
   Bai, L
AF Zhan, Kuihua
   Xie, Liang
   Wang, Xinhong
   Zuo, Baoqi
   Bai, Lun
BE Bai, L
   Chen, GQ
TI Observations of Skin Tissue Regenerations in Biomaterial Scaffolds with
   Different Biodegradability
SO SILK, PROTECTIVE CLOTHING AND ECO-TEXTILES
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 8th China International Silk Conference (ISC 2013) / 4th Asian
   Protective Clothing Conference (APCC 2013) / Eco-Friendly Textile Dyeing
   and Finishing Conference
CY SEP 08-10, 2013
CL Suzhou, PEOPLES R CHINA
DE Silk fibroin; Polyvinyl alcohol; Neovascularization;
   Immunohistochemistry; Tissue regeneration
ID ANGIOGENESIS
AB Objective: To explore the effects of the biodegradability of biomaterial scaffolds on skin tissue regeneration and its neovascularization by the animal experiments. Methods: A piece of porous silk fibroin film (SF) of easy biodegradation and a piece of porous polyvinyl alcohol film (PVA) of hard biodegradation were implanted into a same skin wound of adult rat, and the differences in the regenerative blood vessel and tissue at 5, 10, 16, 41 days after surgery were observed by histological methods. Results: (1) at 10 days after surgery, the SF started to degrade, the closed areas without cell infiltration were opened up and the entire material was filled with the regenerative tissue, and there were still the closed areas in the PVA, (2) the new vascular network remodeling in the SF and PVA appeared at 10 days and 41 days after surgery, respectively, and (3) at 16 days after surgery, most of the SF material had degraded and substantially been replaced with the regenerative tissue, and the visible degradation of the PVA appeared at 41 days after surgery. Conclusion: The good biodegradability of the SF was helpful both to all vascularization of the material and to the regenerative blood vessels remodeling, and the regenerative tissue was closer to the normal dermal tissue than in the PVA.
C1 [Zhan, Kuihua; Zuo, Baoqi; Bai, Lun] Soochow Univ, Coll Text & Clothing Engn, 178 Ganjiang East Rd, Suzhou 215006, Peoples R China.
   [Zhan, Kuihua] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215006, Peoples R China.
   [Xie, Liang; Wang, Xinhong] Second Affiliated Hosp Soochow Univ, Dept Orthopaed, Suzhou 215004, Peoples R China.
RP Bai, L (reprint author), Soochow Univ, Coll Text & Clothing Engn, 178 Ganjiang East Rd, Suzhou 215006, Peoples R China.
EM zhankuihua@suda.edu.cn; xieliang840815@163.com; xinhonghot@126.com;
   bqzuo@suda.edu.cn; bailun@suda.edu.cn
OI Zhan, Kuihua/0000-0003-3638-9743
FU national key basic research and developing project of China
   [2005CB623906]
FX We thank Mingzhong Li for assisting with the material preparation; Yuhai
   Chai and Yongzhen Chen for assisting with the histology experiments.
   This work was partially supported by the national key basic research and
   developing project of China: Basic Research of the Tissue Inducing
   Biomaterial Used in Medicine (Project no. 2005CB623906).
CR Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Guan GP, 2009, MATER SCI FORUM, V610-613, P1113, DOI 10.4028/www.scientific.net/MSF.610-613.1113
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Takasu A, 2002, POLYMER, V43, P227, DOI 10.1016/S0032-3861(01)00583-3
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
NR 7
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-838-7
J9 ADV MATER RES-SWITZ
PY 2013
VL 796
BP 79
EP +
DI 10.4028/www.scientific.net/AMR.796.79
PG 2
WC Materials Science, Textiles
SC Materials Science
GA BA8UB
UT WOS:000338688900014
DA 2018-10-20
ER

PT B
AU Sivarasu, S
   James, SP
   Mathew, TL
AF Sivarasu, Sudesh
   James, Sam Prasanna
   Mathew, T. Lazar
GP ASME
TI FINITE ELEMENT METHOD ORIENTED FAILURE ANALYSIS OF MEDICAL IMPLANTS -
   ARTIFICAL KNEE
SO ASME 2013 CONFERENCE ON FRONTIERS IN MEDICAL DEVICES: APPLICATIONS OF
   COMPUTER MODELING AND SIMULATION
LA English
DT Proceedings Paper
CT ASME Conference on Frontiers in Medical Devices - Applications of
   Computer Modeling and Simulation (FMD)
CY SEP 11-13, 2013
CL Washington, DC
SP ASME, Bioengineering Div
AB The application of Finite Element Modelling in Medical Applications has been evolving as the field of high importance especially in the development of medical devices. The Total Knee Arthroplasty [TKA] has been in existence for over 6 decades till now. The generic artificial knee implants used in the TKA have the restriction in its range of motion with around 90 degrees. A new design allowing flexion extension range of over 120 degrees was designed with a view to facilitate partial squatting and the same is used for the analysis purpose. The new design of the artificial knee has a flexion extension range of 130 degrees. The higher flexion of the knee is obtained by use of the rotating platform knee design principle and also by adopting a multi-radii approach for the femoral component design.
   The loading conditions of 10 times the body weight are considered for structural analyses of the novel knee. A maximum load of 700Kg were subjected on the knee implants. The finite element analyses of the designs were carried out based on standard biomaterial used in orthopedic implants. In this paper we have discussed the results of analyses of an artificial knee with Ti alloy. The results of the analyses were used in identifying areas of extreme stresses within the design and the spot prone for higher deformation. Based on these results slight modification on the designs was carried out. The results are also verified whether the body is within the linear deformation levels. As the results obtained were very satisfactory the models have been recommended for prototyping.
C1 [Sivarasu, Sudesh] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, MRC MIRU Biomed Engn Div, ZA-7700 Rondebosch, South Africa.
RP Sivarasu, S (reprint author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, MRC MIRU Biomed Engn Div, ZA-7700 Rondebosch, South Africa.
OI Sivarasu, Sudesh/0000-0002-0812-568X
CR Sivarasu Sudesh, 2009, Applied Bionics and Biomechanics, V5, P77, DOI 10.1080/11762320802564200
   Sivarasu S, 2007, J LONG-TERM EFF MED, V17, P313
   Sivarasu S, 2008, J LONG-TERM EFF MED, V18, P259
   Sivarasu S, 2008, IFBME SERIES, V23, P1497
   Sivarasu S, 2009, BIOMED ENG-APP BAS C, V21, P279, DOI 10.4015/S1016237209001337
   Sivarasu Sudesh, 2008, INCOB 08 VITU IND FE
   Sivarasu Sudesh, 2009, INTERNET J BIOENGINE, V4, DOI [10.5580/2778, DOI 10.5580/2778]
   Sudesh S, 2007, LIFE SCI SYSTEMS APP, P112
NR 8
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5600-0
PY 2013
AR UNSP V001T10A038
DI 10.1115/FMD2013-16145
PG 2
WC Engineering, Biomedical; Engineering, Mechanical
SC Engineering
GA BA6CX
UT WOS:000337098700070
DA 2018-10-20
ER

PT B
AU Dissanayake, DMSC
   Ismail, FM
AF Dissanayake, D. M. S. C.
   Ismail, F. M.
BE Rekdalsbakken, W
   Bye, RT
   Zhang, H
TI MATHEMATICAL MODELING OF BACTERIAL CELLULOSE PRODUCTION BY ACETOBACTER
   XYLINUM USING ROTATING BIOLOGICAL FERMENTOR
SO PROCEEDINGS 27TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS
   2013
LA English
DT Proceedings Paper
CT 27th European Conference on Modelling and Simulation, ECMS 2013
CY MAY 27-30, 2013
CL Aalesung Univ Coll, Alesund, NORWAY
SP European Council Modell & Simulat, Aalesund Univ Coll, Res Council Norway, More & Romsdal Cty Municipal, Rolls Royce Marine, Offshore Simulator Ctr AS, Farstad Shipp, Sparebanken More, Tekna, Norwegian Maritime Competence Ctr
HO Aalesung Univ Coll
DE Mathematical model; Rotating Biological Fermentor; Bacterial Cellulose
ID GROWTH; CULTURE
AB Bacterial cellulose (BC) has a basic cellulose structure that gives high purity, high crystalline ability, high mechanical strength, and high water holding capacity. During the last few decades, BC has gained as an important biomaterial because of these unique physical and chemical characteristics. BC is synthesized by Acetobacter xylinum extracellularly in a suitable substrate media. Researchers have produced BC using a synthetic media or using coconut water and inoculating with Acetobacter xylinum in a static fermentation system. In order to eliminate shortcomings in static fermentation and to achieve increased cellulose production, agitated and aerated fermentation systems were experimented. Rotating Biological Fermentor (RBF) is an is aerated and agitated system, which gives continuous oxygen flux to the fermentation medium thereby increasing the yield of biomass and cellulose synthesized.
   In this study, a mathematical model for the synthesis of BC in a RBF system was developed. The growth of cellulose is considered as a biofilm from a mono culture. Glucose depletion, cellulose production and microbial growth in the fermentation medium were explained using the developed models. It was shown that the simulated and experimental results were in close agreement. In addition, the model was successful in predicting yield of cellulose at different rotational speeds of the RBF unit.
C1 [Dissanayake, D. M. S. C.; Ismail, F. M.] Univ Moratuwa, Dept Chem & Proc Engn, Katubedda, Moratuwa, Sri Lanka.
RP Dissanayake, DMSC (reprint author), Univ Moratuwa, Dept Chem & Proc Engn, Katubedda, Moratuwa, Sri Lanka.
EM susanthadmscd@gmail.com; marliya_i@uom.lk
CR Alpkvist E, 2006, BIOTECHNOL BIOENG, V94, P961, DOI 10.1002/bit.20917
   Bungay H. R., 1999, U.S. Patent, Patent No. [5,955,326, 5955326]
   Cheng C. K., 2009, J BIOL ENG, p3 
   Dissanayake D.M.S.C, 2013, P 2 SRI LANK ROUND T
   Erkmen O, 2002, J FOOD ENG, V52, P161, DOI 10.1016/S0260-8774(01)00099-1
   Gamage N.S., 2012, THESIS U MORATUWA SR
   GRADY CPL, 1972, BIOTECHNOL BIOENG, V14, P391, DOI 10.1002/bit.260140310
   Hammes F., 2007, MODELING PILNKTONIC, V6
   Hornung M, 2009, ENG LIFE SCI, V9, P342, DOI 10.1002/elsc.200900038
   Jayakody J.R.U.C., 2011, ANN T IESL, P406
   Kenneth T., 2008, ONLINE TXB BACTERIOL, V3
   Kouda T, 2000, US Patent, Patent No. [6,013,490, 6013490]
   Lee W.M., 2007, WATER RES, V41, P4317
   Lina F., 2005, BIOMEDICAL ENG FRONT, P249
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   NOVICK A, 1955, ANNU REV MICROBIOL, V9, P97, DOI 10.1146/annurev.mi.09.100155.000525
   Patel UD, 2008, J COLLOID INTERF SCI, V319, P462, DOI 10.1016/j.jcis.2007.12.019
   Reichert P., 1998, AQUASIM 2 O USER MAN
   Tantratian S., 2005, J SCI CHULANKONG U, V30, P179
   Verschuren PG, 2000, J BIOSCI BIOENG, V89, P414, DOI 10.1016/S1389-1723(00)89089-1
   Wanner O., 2004, WATER SCI TECHNOL, V49, P11
   WILDERER PA, 1989, LIFE SCI R, V46, P5
   Yang YK, 1998, J FERMENT BIOENG, V85, P312, DOI 10.1016/S0922-338X(97)85681-4
   Yoshinaga F, 1997, BIOSCI BIOTECH BIOCH, V61, P219, DOI 10.1271/bbb.61.219
NR 24
TC 0
Z9 0
U1 1
U2 6
PU EUROPEAN COUNCIL MODELLING & SIMULATION
PI NOTTINGHAM
PA SCHOOL COMPUTING & MATHEMATICS, NOTTINGHAM TRENT UNIV, BURTON STREET,
   NOTTINGHAM, NG1 4BU, ENGLAND
BN 978-0-9564944-6-7
PY 2013
BP 459
EP 465
PG 7
WC Computer Science, Interdisciplinary Applications; Mathematics, Applied
SC Computer Science; Mathematics
GA BA6ER
UT WOS:000337114500070
DA 2018-10-20
ER

PT S
AU Fan, H
   Feng, CH
   Lin, Y
AF Fan, Hao
   Feng, Cuihan
   Lin, Yan
BE Bu, J
   Kim, YH
TI A new host-guest biomaterial apply for DNA sequence electrochemical
   detection
SO ADVANCED ENGINEERING MATERIALS III, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Engineering Materials and
   Technology (AEMT 2013)
CY MAY 11-12, 2013
CL Zhangjiajie, PEOPLES R CHINA
SP Hebei Prov Key Lab Inorgan Nonmetall Mat, Korea Maritime Univ
DE DNA; electrochemical; homogeneous; Cyclodextrins; double-labeled probe
ID HYBRIDIZATION
AB In this paper, a novel dually-labeled DNA probe (DLP) in a stem-loop structure was designed to be labeled at one end with dabcyl, working as a guest molecule, and at its another end with CdS nanoparticle, working as an electrochemical tag to indicate the electrochemical signal of hybridization occurrence. One alpha-cyclodextrin/multi-walled carbon nanotube modified glassy carbon electrode (alpha-CD/MCNTs/GCE) was fabricated for the hybridizer capture. The DLP could recognize target DNA through hybridization event between complementary bases in the loop of probe DNA and target DNA. Without binding with target DNA, the DLP kept its stem-loop structure which held dabcyl molecule shielded by the loop of probe DNA and CdS nanoparticle. This structure blocked dabcyl from entering the cavity of alpha-CD on the electrode. Once hybridization happened, the stem-loop structure of hairpin DNA opened and then dabcyl molecule could be easily captured by alpha-CD on the electrode. Thus, the electrochemical response of the CdS nanoparticle label at the other end of the hybridizer was proportional with the concentration of target DNA.
C1 [Fan, Hao; Feng, Cuihan; Lin, Yan] JiangXi Univ Tradit Chinese Med, Dept Pharm, Nanchang 330004, Jiangxi, Peoples R China.
RP Fan, H (reprint author), JiangXi Univ Tradit Chinese Med, Dept Pharm, Nanchang 330004, Jiangxi, Peoples R China.
EM fanhao11@yahoo.com.cn; 46405695@qq.com; 54428116@qq.com
CR Fan H., 2008, ELECTROANAL, V19, P2113
   Hansen JA, 2006, J AM CHEM SOC, V128, P3860, DOI 10.1021/ja0574116
   Jiang L, 2001, CHEM J CHINESE U, V22, P1397
   Napier ME, 1997, BIOCONJUGATE CHEM, V8, P906, DOI 10.1021/bc9701149
   Wang J, 1999, CHEM-EUR J, V5, P1681, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1681::AID-CHEM1681>3.0.CO;2-U
   Wang ZH, 2003, ELECTROANAL, V15, P1129, DOI 10.1002/elan.200390137
   Youssouti H.K., 1997, J AM CHEM SOC, V119, P7388
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-763-2
J9 ADV MATER RES-SWITZ
PY 2013
VL 750-752
BP 1495
EP 1498
DI 10.4028/www.scientific.net/AMR.750-752.1495
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Materials Science
GA BA5GQ
UT WOS:000336636100318
DA 2018-10-20
ER

PT S
AU Ratanasongtham, P
   Watanesk, R
   Watanesk, S
AF Ratanasongtham, Pacharawan
   Watanesk, Ruangsri
   Watanesk, Surasak
BE Bu, J
   Kim, YH
TI Comparison of Porosity Improvement of Silk Fibroin Membrane Using
   Polyethylene Glycol and Glutaraldehyde for Increasing Oxygen
   Permeability
SO ADVANCED ENGINEERING MATERIALS III, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Engineering Materials and
   Technology (AEMT 2013)
CY MAY 11-12, 2013
CL Zhangjiajie, PEOPLES R CHINA
SP Hebei Prov Key Lab Inorgan Nonmetall Mat, Korea Maritime Univ
DE silk fibroin; polyethylene glycol; glutaraldehyde; porous membrane
ID GLUCOSE BIOSENSOR; BLEND MEMBRANE; FILMS; GELATIN; OXIDASE
AB Biomaterial is one of the good candidates for porous membrane preparation according to its environmental friendliness. In this work, the porous membranes of silk fibroin (SF) were prepared by solution casting with the addition of polyethylene glycol (PEG) and glutaraldehyde (GTA) aiming to improve the porosity and oxygen permeability of SF membrane. The conformation of SF was changed from random coil to beta sheet form after treatment with MeOH. The interaction existing between SF chains and both PEG and GTA were characterized using Fourier Transform Infrared spectroscopy (FT-TR). The addition of PEG could produce more porosity in the membrane than GTA confirmed by their morphology observed from scanning electron microscopy (SEM). Moreover, the swelling behavior of the SF-PEG and SF-GTA membranes depended on the porous structure of the membrane which directly correlated to their oxygen permeability. The porosity of the SF membranes increased with the increase of PEG and GTA contents up to 40% and 3%w/w, respectively. After that, their porosity decreased as seen through the SEM and water swelling results. In addition, the SF-PEG membrane turned out to have higher degrees of both porosity and oxygen permeability than the SF-GTA membrane which related to its water swelling behavior.
C1 [Ratanasongtham, Pacharawan; Watanesk, Ruangsri; Watanesk, Surasak] Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50200, Thailand.
RP Ratanasongtham, P (reprint author), Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50200, Thailand.
EM fah_ut@hotmail.com; ruangsri@gmail.com; swatanes@gmail.conn
CR Akyilmaz E, 1999, TALANTA, V50, P87, DOI 10.1016/S0039-9140(99)00107-1
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Kuchaiyaphum P, 2013, J APPL POLYM SCI, V129, P2614, DOI 10.1002/app.38977
   Liu YC, 1996, J BIOTECHNOL, V46, P131, DOI 10.1016/0168-1656(95)00182-4
   Mao Y, 2006, J MEMBRANE SCI, V279, P246, DOI 10.1016/j.memsci.2005.07.048
   Mingzhong L., 2003, INT J BIOL MACROMOL, V32, P159
   Moonsri P, 2008, J APPL POLYM SCI, V108, P1402, DOI 10.1002/app.27528
   Oyrton Monteiro Jr A.C., 1999, INT J BIOL MACROMOL, V26, P119
   Ray M., 2010, DES MONOMERS POLYM, V13, P93
   Rohindra D. R., 2004, S PACIFIC J NATURAL, V22, P32, DOI DOI 10.1071/SP04005
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Shan D, 2006, ANAL BIOCHEM, V356, P215, DOI 10.1016/j.ab.2006.05.005
   Srisuwan Y., 2012, Natural Science, V4, P454
   Yang WS, 2005, TOP CATAL, V35, P155, DOI 10.1007/s11244-005-3820-6
   Yin HS, 2010, ANAL CHIM ACTA, V659, P144, DOI 10.1016/j.aca.2009.11.051
   Zeng MF, 2004, J MEMBRANE SCI, V245, P95, DOI 10.1016/j.memsci.2004.08.004
   Zeng MF, 2004, J APPL POLYM SCI, V91, P2840, DOI 10.1002/app.13469
   Zhang P, 2010, J MEMBRANE SCI, V362, P113, DOI 10.1016/j.memsci.2010.06.024
NR 20
TC 1
Z9 1
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-763-2
J9 ADV MATER RES-SWITZ
PY 2013
VL 750-752
BP 1601
EP 1608
DI 10.4028/www.scientific.net/AMR.750-752.1601
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Materials Science
GA BA5GQ
UT WOS:000336636101008
DA 2018-10-20
ER

PT S
AU Leong, CH
   Lim, KF
   Muchtar, A
   Yahaya, N
AF Leong, C. H.
   Lim, K. F.
   Muchtar, Andanastuti
   Yahaya, Norziha
BE Bu, J
   Kim, YH
TI Decomposition of hydroxyapatite in hydroxyapatite/zirconia composites
   for dental applications
SO ADVANCED ENGINEERING MATERIALS III, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Engineering Materials and
   Technology (AEMT 2013)
CY MAY 11-12, 2013
CL Zhangjiajie, PEOPLES R CHINA
SP Hebei Prov Key Lab Inorgan Nonmetall Mat, Korea Maritime Univ
DE Hydroxyapatite; Zirconia; dental applications; biomaterials; sintering;
   HA/ZrO2 composites; decomposition of hydroxppatite
ID HUMAN TOOTH ENAMEL; MECHANICAL-PROPERTIES; MICROTRIBOLOGICAL BEHAVIOR;
   THERMAL-DECOMPOSITION; ZIRCONIA COMPOSITES; MICROSTRUCTURE; BIOCERAMICS;
   COATINGS; PHASE
AB Hydroxyapatite (HA) has been widely used as a biomaterial because HA has excellent biocompatibility, but the mechanical properties of HA are not sufficiently strong for dental applications. To enhance these mechanical properties, zirconia (ZrO2) has been introduced as a second phase material. However, doping of ZrO2 favors HA decomposition at low temperatures. In this paper, the effect of adding ZrO2 on HA decomposition is discussed. Experimental results in previous studies are compared with theoretical results of chemical equations. The ideal percentage of doped ZrO2 should be <10 wt.% to prevent HA decomposition unless a special sintering method is applied.
C1 [Leong, C. H.; Lim, K. F.; Muchtar, Andanastuti] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
   [Yahaya, Norziha] Univ Kebangsaan Malaysia, Fac Dent, Dept Prosthodont, Kuala Lumpur 50300, Malaysia.
RP Leong, CH (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
EM cheehuan@hotmail.my; kokfong@me.com; muchtar@eng.ukm.my;
   norziha73@hotmail.com
RI Muchtar, Andanastuti/E-3806-2017
OI Muchtar, Andanastuti/0000-0002-1599-8964
FU Universiti Kebangsaan Malaysia (UKM) under Arus Perdana
   [UKM-AP-NBT-14-2010, GUP-2012-060]
FX The authors acknowledge the sponsorship granted by the Universiti
   Kebangsaan Malaysia (UKM) under the Arus Perdana Grant
   UKM-AP-NBT-14-2010 and GUP-2012-060.
CR Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Chiu CY, 2007, CERAM INT, V33, P715, DOI 10.1016/j.ceramint.2005.12.008
   Cihlar J, 1999, J MATER SCI, V34, P6121, DOI 10.1023/A:1004769820545
   Curran DJ, 2010, J MATER SCI-MATER M, V21, P1109, DOI 10.1007/s10856-009-3974-z
   Ergun C, 2011, CERAM INT, V37, P935, DOI 10.1016/j.ceramint.2010.11.001
   Evis Z., CERAMICS INT, V33
   Evis Z, 2009, J EUR CERAM SOC, V29, P621, DOI 10.1016/j.jeurceramsoc.2008.07.020
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Khalil KA, 2007, MAT SCI ENG A-STRUCT, V456, P368, DOI 10.1016/j.msea.2006.12.005
   Kim HW, 2002, BIOMATERIALS, V23, P4113, DOI 10.1016/S0142-9612(02)00150-3
   Kim SW, 2013, COMPOS PART B-ENG, V45, P1689, DOI 10.1016/j.compositesb.2012.09.077
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Miao XG, 2004, CERAM INT, V30, P1793, DOI 10.1016/j.ceramint.2003.12.117
   Nath S, 2008, SCRIPTA MATER, V58, P1054, DOI 10.1016/j.scriptamat.2008.01.045
   OBrien W J, 2009, DENT MAT THEIR SELEC
   Silva NRFA, 2010, MATERIALS, V3, P863, DOI 10.3390/ma3020863
   Towler MR, 2001, J MATER SCI LETT, V20, P1719, DOI 10.1023/A:1012435124012
   Zheng J, 2013, TRIBOL INT, V63, P177, DOI 10.1016/j.triboint.2012.04.019
   Zheng SY, 2011, WEAR, V271, P2290, DOI 10.1016/j.wear.2010.11.020
NR 19
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-763-2
J9 ADV MATER RES-SWITZ
PY 2013
VL 750-752
BP 1664
EP +
DI 10.4028/www.scientific.net/AMR.750-752.1664
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Materials Science
GA BA5GQ
UT WOS:000336636101021
DA 2018-10-20
ER

PT S
AU Chen, HY
   Shan, YK
   Qin, YY
   Zhou, GX
   Yuan, ML
AF Chen, Hai-Yun
   Shan, Yu-Kai
   Qin, Yu-Yue
   Zhou, Guo-Xian
   Yuan, Ming-Long
BE Bu, J
   Kim, YH
TI Synthesis of poly(ethylene glycol) derivatives
SO ADVANCED ENGINEERING MATERIALS III, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Engineering Materials and
   Technology (AEMT 2013)
CY MAY 11-12, 2013
CL Zhangjiajie, PEOPLES R CHINA
SP Hebei Prov Key Lab Inorgan Nonmetall Mat, Korea Maritime Univ
DE poly (ethylene glycol); derivatives; synthesis
AB To expand the extent of conjugation with biologically active molecules (biopolymers, peptides, drugs, etc.) and biomaterial substrates, we synthesized a serial of poly (ethylene glycol) (PEG) derivatives (PEG-2000-NH2, MPEG-1200-NH2, and APEG-1200-NH2) in three efficient steps. The end groups were characterized by H-1 NMR spectroscopy.
C1 [Chen, Hai-Yun; Shan, Yu-Kai; Zhou, Guo-Xian; Yuan, Ming-Long] Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming 650500, Yunnan, Peoples R China.
   [Qin, Yu-Yue] Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Yunnan, Peoples R China.
RP Chen, HY (reprint author), Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming 650500, Yunnan, Peoples R China.
EM chenhy1960@163.com; 471175768@qq.com; rabbqy@163.com;
   zhouguoxianhq@163.com; yml@vip.163.com
FU National Natural Science Foundation of China [31160198]; Applied Basic
   Research Project of Yunnan [2011FB084]; High-End Technology
   Professionals Introduction Plan in Yunnan province [2010CI119]; Natural
   Science Foundation of Yunnan [2010FXW004]
FX This work was financially supported by the National Natural Science
   Foundation of China (31160198), the Applied Basic Research Project of
   Yunnan (2011FB084), High-End Technology Professionals Introduction Plan
   in Yunnan province (2010CI119), the Natural Science Foundation of Yunnan
   (2010FXW004).
CR Du J, 2007, CELLULOSE, V14, P543, DOI 10.1007/s10570-007-9122-3
   Gourrierec L. L., 2008, TETRAHEDRON, V64, P2233
   Li J, 2003, BIOMACROMOLECULES, V4, P1055, DOI 10.1021/bm034069l
   Won CY, 2004, POLYM BULL, V52, P109, DOI 10.1007/s00289-004-0264-2
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
   Zalipsky S., 1990, J BIOACT COMPAT POLY, V5, P227
   Zhao Y, 2011, MOL BIOL REP, V38, P2455, DOI 10.1007/s11033-010-0381-y
NR 7
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-763-2
J9 ADV MATER RES-SWITZ
PY 2013
VL 750-752
BP 1674
EP +
DI 10.4028/www.scientific.net/AMR.750-752.1674
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Materials Science
GA BA5GQ
UT WOS:000336636101023
DA 2018-10-20
ER

PT S
AU Dang, X
   Li, XJ
AF Dang, Xue
   Li, Xiao Jing
BE Xu, B
   Li, HY
TI The application of functional collagen biomaterials and tissue
   engineering in tissue repair for exercise-induced injury
SO ADVANCED MATERIALS RESEARCHES AND APPLICATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Materials and its Application
   (AMA 2013)
CY JUN 22-24, 2013
CL Wuhan, PEOPLES R CHINA
SP Wuhan Inst Technol, Beijing Mat Res Ctr, Int Mat Res Soc
DE functional collagen biomaterials; tissue engineering; tissue repair
AB Function of biological material refers to the activity of biological materials affect biochemical or physiological process, which composed by the materials and the active components is carried by the materials. Collagen material is widely used as a biomaterial, and growth factor could promote cell proliferation, migration and differentiation, so often used activation collagen material. By means of gene engineering technology in growth factor on the collagen binding domain (CBD), growth factor binds to collagen materials prepare the specific growth factor, directional anchored to the formation of collagen biomaterials collagen materials.
C1 [Dang, Xue] Shandong Univ, Sch Phys Educ, Jinan, Peoples R China.
   [Li, Xiao Jing] ShanXi Normal Univ, Inst Phys Educ, Shanghai, Peoples R China.
RP Dang, X (reprint author), Shandong Univ, Sch Phys Educ, Jinan, Peoples R China.
EM sddxdangxue@163.com; hjxyhpf@163.com
CR Cao JN, 2013, BIOMATERIALS, V34, P1302, DOI 10.1016/j.biomaterials.2012.10.031
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   Skopinska-Wisniewska J., 2009, APPL SURF SCI, V255
   Zeugolis D.I., 2011, COMPREHENSIVE BIOMAT, V2, P261
NR 5
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-787-8
J9 ADV MATER RES-SWITZ
PY 2013
VL 763
BP 143
EP +
DI 10.4028/www.scientific.net/AMR.763.143
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BA5FZ
UT WOS:000336633700032
DA 2018-10-20
ER

PT S
AU Phoudee, W
   Wattanakaroon, W
AF Phoudee, Wimol
   Wattanakaroon, Wanida
BE Sombatsompop, N
   Bhattacharyya, D
   Cheung, KHY
TI Activity of Ciprofloxacin and Tobramycin-loaded Natural Peptide Dressing
   on Biofilms and Planktonic Cells
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES IV
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 4th International Conference on Multi-Functional Materials and
   Structures (MFMS 2013)
CY JUL 14-17, 2013
CL King Mongkut's Univ Technol Thonburi, Bangkok, THAILAND
SP King Mongkut's Univ Technol Thonburi, King Mongkut's Technol Thonburi, Sch Energy Environm & Mat, King Mongkut's Univ Technol Thonburi, Polym Process & Flow Res Grp, Thai Journal Citat Index Ctr, Siam Cement Publ Co, Global Connect Publ Co Ltd, V P Wood Co Ltd
HO King Mongkut's Univ Technol Thonburi
DE Peptide; Biomaterials; Wound dressing; Biofilm; Antimicrobial activity
AB Application of dressing material is generally aimed to maintain a moist environment at the wound interface, allow gaseous exchange, prevent the wound directly contact to microorganisms and remove excess exudates. The wound dressing synthesized from biocompatible materials are of interest due to the desired properties such as non-toxic, non-allergenic, non-adherent, and easily removed without trauma. The objective of this research is to synthesize a multifunctional peptide dressing which could provide an antimicrobial activity against Pseudomonas aeruginosa planktonic bacteria and biofilms and help tissue regeneration. Sample suspensions of the 6% (w/v) BSA and 8% (w/v) peptide extract heated for 30 minutes were used for hydrogel dressing preparation. For gel pad casting, 8% (w/v) BSA also heated to 100 degrees C for 20 minutes followed by rapid cooling in cold water. To crosslink their structure, 0.25% (w/v) NaCl solution was added. The suspensions were later cooled down at 4 degrees C for 2 hours. Both hydrogel dressings contained either 10 mu g/ml of ciprofloxacin or 10 mu g/ml of tobramycin and 10 mu M of astaxanthin. The antimicrobial test indicated that the BSA hydrogel had the activity against planktonic cells with the log reduction value of 6.19 +/- 0.12 for ciprofloxacin and 6.50 +/- 0.51 for tobramycin. The peptide hydrogel containing ciprofloxacin and tobramycin resulted in 7.68 +/- 0.33 and 6.13 +/- 0.40 log reduction, respectively. Both antibiotic drugs exhibited lower effect on the viability of P. aeruginosa in colony biofilms. The qualitative results observed with the wound pads also revealed higher viability of established biofilms, suggesting the antibiotic tolerance of these biofilms. This finding aids in the development of novel biomaterial wound dressing.
C1 [Phoudee, Wimol; Wattanakaroon, Wanida] Silpakorn Univ, Fac Engn & Ind Technol, Dept Biotechnol, Nakhon Pathom 73000, Thailand.
RP Wattanakaroon, W (reprint author), Silpakorn Univ, Fac Engn & Ind Technol, Dept Biotechnol, Nakhon Pathom 73000, Thailand.
EM wanida@su.ac.th
CR Akintayo ET, 1999, FOOD CHEM, V66, P51, DOI 10.1016/S0308-8146(98)00155-1
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003
NR 3
TC 0
Z9 0
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-771-7
J9 ADV MATER RES-SWITZ
PY 2013
VL 747
BP 107
EP 110
DI 10.4028/www.scientific.net/AMR.747.107
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Composites
SC Materials Science
GA BA4RT
UT WOS:000336185200025
DA 2018-10-20
ER

PT J
AU Zorn, K
   Mitro, D
   Vorndran, E
   Gbureck, U
   Muller, FA
AF Zorn, Katharina
   Mitro, Daniel
   Vorndran, Elke
   Gbureck, Uwe
   Mueller, Frank A.
TI Hydrothermal synthesis of calcium-deficient hydroxyapatite whiskers and
   their thermal transformation to polycrystalline beta-tricalcium
   phosphate short fibers
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE apatite; biomaterial; material chemistry; material structure; synthesis
ID BIOCOMPATIBLE WHISKERS; HIGH-TEMPERATURE; MORPHOLOGY; STOICHIOMETRY;
   PRECIPITATION; REPLACEMENT; CERAMICS
AB Resorbable calcium phosphate fibers are of particular interest to reinforce biodegradable bone substitutes for load-bearing applications. The aim of the present study was to prepare calcium-deficient hydroxyapatite (dHAp) whiskers with a molar Ca/P ratio of 1.5 by a hydrothermal synthesis and to transform them to beta-tricalcium phosphate (beta-TCP) by a subsequent thermal treatment. For the hydrothermal synthesis, calcium tripolyphosphate was used and different amounts of 2-propanol were added to adjust the pH. Average whisker lengths of 160 mu m were obtained at a 2-propanol content of 27 volume-percent. However, 33% dicalcium phosphate anhydrate (DCPA) were present as a secondary phase. The amount of DCPA could be reduced by increasing the amount of 2-propanol. Whisker samples consisting of 88% dHAp and 12% DCPA were selected to investigate microstructural changes and phase transformations during thermal treatment. Polycrystalline single phase beta-TCP short fibers were obtained after a thermal treatment at 1125 degrees C.
C1 [Zorn, Katharina; Mitro, Daniel; Mueller, Frank A.] Univ Jena, Inst Mat Sci & Technol IMT, Jena, Germany.
   [Vorndran, Elke; Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
RP Muller, FA (reprint author), Univ Jena, Inst Mat Sci & Technol IMT, Jena, Germany.
EM frank.mueller@uni-jena.de
RI Vorndran, Elke/G-6226-2012; Gbureck, Uwe/G-1430-2012
FU Deutsche Forschungsgemeinschaft [DFG Gb1/11-2, DFG Mu1803/7-2]
FX The authors would like to acknowledge financial support from the
   Deutsche Forschungsgemeinschaft (grant nos. DFG Gb1/11-2 and DFG
   Mu1803/7-2). The authors would also like to express their thanks to Dr.
   P. Scholz (Technical Chemistry and Environmental Chemistry,
   Friedrich-Schiller-University of Jena) for the valuable discussion
   concerning the nitrate reduction mechanism.
CR DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Descamps M, 2007, J EUR CERAM SOC, V27, P2401, DOI 10.1016/j.jeurceramsoc.2006.09.005
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   FRANCIS MD, 1971, CALC TISS RES, V6, P335
   Ioku K., 1998, REV HIGH PRESSURE SC, V7, P1398
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   Lak A, 2008, J AM CERAM SOC, V91, P3292, DOI 10.1111/j.1551-2916.2008.02600.x
   Lin FH, 1998, BIOMATERIALS, V19, P1101, DOI 10.1016/S0142-9612(98)00040-4
   Marchi J, 2007, MATER RES BULL, V42, P1040, DOI 10.1016/j.materresbull.2006.09.015
   Mizutani Y, 2005, J EUR CERAM SOC, V25, P3181, DOI 10.1016/j.jeurceramsoc.2004.07.028
   Mizutani Y, 1998, BRIT CERAM T, V97, P105
   Muller FA, 2007, J AM CERAM SOC, V90, P3694, DOI [10.1111/j.1551-2916.2007.01967.x, 10.1111/J.1551-2916.2007.01967.x]
   Neira IS, 2008, J MATER SCI, V43, P2171, DOI 10.1007/s10853-007-2032-9
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Roeder RK, 2006, J AM CERAM SOC, V89, P2096, DOI 10.1111/j.1551-2916.2006.01067.x
   Shen WH, 2011, J CATAL, V280, P161, DOI 10.1016/j.jcat.2011.03.014
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   SUCHANEK W, 1995, J MATER RES, V10, P521, DOI 10.1557/JMR.1995.0521
   Tas AC, 2001, J AM CERAM SOC, V84, P295
   Valdes JJP, 1997, J MATER SCI-MATER M, V8, P297
   Walsh W. R., 1994, BIOMATERIALS, V15, P15137
   Watanabe T, 2009, J CERAM SOC JPN, V117, P759, DOI 10.2109/jcersj2.117.759
   WELCH JH, 1961, J CHEM SOC, P4442, DOI 10.1039/jr9610004442
   YASUKAWA A, 1994, POLYHEDRON, V13, P3071, DOI 10.1016/S0277-5387(00)83673-6
   Yasukawa A, 1999, MATER RES BULL, V34, P589, DOI 10.1016/S0025-5408(99)00044-6
   Yoon SY, 2005, MATER CHEM PHYS, V91, P48, DOI 10.1016/j.matchemphys.2004.10.049
   Yoshimura M, 2008, J MATER SCI, V43, P2085, DOI 10.1007/s10853-007-1853-x
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   Zhang HQ, 2010, ACTA BIOMATER, V6, P3216, DOI 10.1016/j.actbio.2010.02.011
   Zhang HQ, 2003, CERAM INT, V29, P413, DOI 10.1016/S0272-8842(02)00153-0
NR 34
TC 1
Z9 1
U1 1
U2 17
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2013
VL 2
IS 1
BP 11
EP 19
DI 10.1680/bbn.12.00019
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH8ZJ
UT WOS:000336427100003
DA 2018-10-20
ER

PT S
AU Suciu, O
   Ioanovici, T
   Bereteu, L
AF Suciu, Oana
   Ioanovici, Teodora
   Bereteu, Liviu
BE Herisanu, N
   Marinca, V
TI Mechanical Properties of Hydroxyapatite Doped with Magnesium, Used in
   Bone Implants
SO ACOUSTICS & VIBRATION OF MECHANICAL STRUCTURES
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 12th International Symposium Acoustics and Vibration of Mechanical
   Structures (AVMS 2013)
CY MAY 23-24, 2013
CL Timisoara, ROMANIA
SP Politehn Univ Timisoara, Acoust & Vibrat Lab, Univ Nis, Noise & Vibrat Lab, Fac Occupat Safety, Romanian Acad, Ctr Fundamental & Adv Techn Res Timisoara Branch, Romanian Acoust Soc
DE hydroxyapatite; magnesium doping; wet precipitation; mechanical
   properties; bone implants
AB Hydroxyapatite is a biomaterial, more exactly a bioceramic, from a category of materials frequently used in bone implants. In order to improve mechanical properties, hydroxyapatite is doped with different chemical substitutes, among which the most used are: Mg-2*, Zn-2*, La-3*, Y-3*, In Bi-3* CO32-, Si and Mn. In the paper are presented the modality of obtaining hydroxyapatite doped with magnesium through wet precipitation method and also the determination of its main mechanical characteristics. There is also an analysis on the effects of magnesium on the following mechanical properties: density, hardness, longitudinal modulus of elasticity, conductibility and thermal stability.
C1 [Suciu, Oana] Univ Med & Pharm, Rehabil Dept, Timisoara, Romania.
   [Ioanovici, Teodora; Bereteu, Liviu] Politech Univ Timisoara, Dept Mech & Mat Strength, Timisoara 300222, Romania.
RP Suciu, O (reprint author), Univ Med & Pharm, Rehabil Dept, Timisoara, Romania.
EM oanabereteu78@yahoo.com; teodora_joanovici@yahoo.com;
   liviu.bereteu@mec.upt.ro
CR Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Demirkol Nermin, 2012, Key Engineering Materials, V493-494, P588, DOI 10.4028/www.scientific.net/KEM.493-494.588
   Fadeev IV, 2003, INORG MATER+, V39, P947, DOI 10.1023/A:1025509305805
   Fidancevska E., 2002, Science of Sintering, V34, P241, DOI 10.2298/SOS0203241F
   Ioanovici T., 2011, 3 INT C E HLTH BIOEN, V1, P1
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Nather A., 2005, BONE GRAFTS BONE SUB, P450
   Olson Harry F., 1955, ELEMENTS ACOUSTICAL
   Pramanik S., 2005, TRENDS BIOMATER ARTI, V19, P46
   Suciu O., 2013, ISCS UNPUB, V13
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Yeo W. H., 2008, ICCBT, V182 F-16, P181
NR 13
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-877-6
J9 APPL MECH MATER
PY 2013
VL 430
BP 222
EP +
DI 10.4028/www.scientific.net/AMM.430.222
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BA4KA
UT WOS:000335880800036
DA 2018-10-20
ER

PT S
AU Shen, ZJ
   Zhao, Q
   Zhang, Y
AF Shen, Zhi Juan
   Zhao, Qiao
   Zhang, Yong
BE Zhang, H
   Jin, D
   Zhao, XJ
TI The research about biological materials and exercise-induced articular
   cartilage injury\
SO ADVANCED RESEARCH ON MATERIAL ENGINEERING, CHEMISTRY AND ENVIRONMENT
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Material Engineering, Chemistry and
   Environment (MECE 2013)
CY AUG 24-25, 2013
CL Wuhan, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE biological materials; articular cartilage injury; tissue repair
AB The composite scaffold has well biocompatibility and biodegradability, and it is assembled by a certain fraction ratio and mode, which is a biodegradable stent and gains many applications at present time in cartilage tissue engineering. The composite scaffold has good biocompatibility, toughness, porosity and mechanical strength. The preparation of composite scaffold is not only about the composite of biological materials with the same kind, but also about the different materials. Due to the composite scaffold, the biological materials have the complementarity, and meet the needs of ideal biomaterial scaffolds to some extent, which has positive implications on the repair of articular cartilage in exercise training.
C1 [Shen, Zhi Juan] Xing Tai Med Coll, Xingtai, Peoples R China.
   Sports Inst Hebei Normal Univ, Hebei, Peoples R China.
   [Zhang, Yong] Hebei Phy Educ Inst, Hebei, Peoples R China.
RP Shen, ZJ (reprint author), Xing Tai Med Coll, Xingtai, Peoples R China.
EM xtyzzsj@163.com; zhaoqiaotyx@163.com; zytyxy129@163.com
CR Butz KD, 2011, J BIOMECH, V44, P2667, DOI 10.1016/j.jbiomech.2011.08.005
   Chan SMT, 2011, J BIOMECH, V44, P2015, DOI 10.1016/j.jbiomech.2011.04.015
   Franke O, 2011, MAT SCI ENG C-MATER, V31, P789, DOI 10.1016/j.msec.2010.12.005
   Garcia JJ, 2007, J BIOMECH, V40, P1737, DOI 10.1016/j.jbiomech.2006.08.001
   Turunen SM, 2013, OSTEOARTHR CARTILAGE, V21, P505, DOI 10.1016/j.joca.2012.12.001
NR 5
TC 0
Z9 0
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-822-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 788
BP 52
EP +
DI 10.4028/www.scientific.net/AMR.788.52
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BA4RW
UT WOS:000336185800013
DA 2018-10-20
ER

PT S
AU Reyes, L
   Cavazos, JL
   Garza, T
   Gomez, I
AF Reyes, L.
   Cavazos, J. L.
   Garza, T.
   Gomez, I.
BA Korsunsky, AM
BF Korsunsky, AM
BE Ao, SI
   Gelman, L
   Hukins, DWL
   Hunter, A
TI Biological Synthesis of TiNi-TiO2 Nanocomposite and Their
   Characterization
SO WORLD CONGRESS ON ENGINEERING - WCE 2013, VOL III
SE Lecture Notes in Engineering and Computer Science
LA English
DT Proceedings Paper
CT World Congress on Engineering (WCE 2013)
CY JUL 03-05, 2013
CL Imperial Coll London, London, ENGLAND
SP IAENG, Soc Artificial Intelligence, IAENG, Soc Bioinformat, IAENG, Soc Comp Sci, IAENG, Soc Data Mining, IAENG, Soc Elect Engn, IAENG, Soc Imaging Engn, IAENG, Soc Ind Engn, IAENG, Soc Informat Syst Engn, IAENG, Soc Internet Comp & Web Serv, IAENG, Soc Mech Engn, IAENG, Soc Operat Res, IAENG, Soc Sci Comp, IAENG, Soc Software Engn, IAENG, Soc Software Engn, IAENG, Soc Wireless Networks
HO Imperial Coll London
DE TiNi; TiO2; nanocomposite; biosynthesis
ID GOLD NANOPARTICLES; BIOSYNTHESIS; FUNGUS
AB The results of the extracellular synthesis of TiNi-TiO2 nanocomposite by a native strain of fungus resistant to heavy metals at room temperature are presented. The nanocomposite were characterized by X-Ray Diffraction, Differential Scanning Calorimetric (DSC), FE-SEM and AFM. X-Ray diffraction analysis shows that phases obtained were TiNi in martensite (M) and austenite (A) polymorphs. The phases for TiO2 in two polymorphs were found: Anatase and Rutile. Differential Scanning Calorimetric analysis revealed a value of the transformation hysteresis Af-Ms equal to 12 degrees C. FE-SEM showed that particles obtained have size already of 15-200 nm. AFM analysis show nanoparticles with spherical morphology formed at the edge of hyphae. The nanocomposite was sintered at 500 degrees C. After, it was characterized as biomaterial under physiological serum and presents the formation of hydroxyapatite.
C1 [Reyes, L.; Gomez, I.] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, San Nicolas De Los Garza 66450, NL, Mexico.
   [Cavazos, J. L.; Gomez, I.] Univ Autonoma Nuevo Leon, Fac Ingn Mecan Elet, San Nicolas de los Garza 66450, Mexico.
RP Reyes, L (reprint author), Univ Autonoma Nuevo Leon, Fac Ciencias Quim, San Nicolas De Los Garza 66450, NL, Mexico.
EM luisrech@hotmail.com; jlcavazos@mail.uanl.mx; mteresaggzz@yahoo.com;
   idaliagomezmx@yahoo.com.mx
FU CONACYT [CB-2010/157745]
FX Manuscript received March 23, 2013; revised April 9, 2013. This work was
   supported in part by the CONACYT under Grant CB-2010/157745.
CR Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323
   Ahmad A, 2005, J BIOMED NANOTECHNOL, V1, P47, DOI 10.1166/jbn.2005.012
   Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k
   Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m
   Beveridge T.J., 2000, BIOMINERALIZATION BI, P7
   Bfilainsa KC, 2006, COLLOID SURFACE B, V47, P160, DOI 10.1016/j.colsurfb.2005.11.026
   Khodorenko V.N., 2001, TECH PHYS LETT, V27, P80
   Kumar SA, 2007, J BIOMED NANOTECHNOL, V3, P190, DOI 10.1166/jbn.2007.027
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lutjering Gerd, 2003, TITANIUM, P340
   Moreno B., 2009, B SOC CERAM 5, P321
   Mukherjee P, 2001, ANGEW CHEM INT EDIT, V40, P3585, DOI 10.1002/1521-3773(20011001)40:19<3585::AID-ANIE3585>3.0.CO;2-K
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Resnina N, 2009, J ALLOY COMPD, V486, P304, DOI 10.1016/j.jallcom.2009.06.132
   Ryhanen J., 1999, THESIS
   Sastry M, 2003, CURRENT SCI, P85
   Schabes-Retchkiman PS, 2006, OPT MATER, V29, P95, DOI 10.1016/j.optmat.2006.03.014
   Senapati S, 2004, INDIAN J PHYS PT-A, V78A, P101
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Zheng YJ, 2009, MATER LETT, V63, P949, DOI 10.1016/j.matlet.2009.01.069
NR 20
TC 0
Z9 0
U1 0
U2 0
PU INT ASSOC ENGINEERS-IAENG
PI HONG KONG
PA UNIT 1, 1-F, 37-39 HUNG TO ROAD, KWUN TONG, HONG KONG, 00000, PEOPLES R
   CHINA
SN 2078-0958
BN 978-988-19252-9-9
J9 LECT NOTES ENG COMP
PY 2013
BP 2043
EP +
PG 3
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Computer Science; Engineering
GA BA4JS
UT WOS:000335870100106
DA 2018-10-20
ER

PT S
AU Wu, XP
   Zhu, WB
   Wang, DC
   Chen, QH
AF Wu, Xiaopei
   Zhu, Weibo
   Wang, Duancheng
   Chen, Qinghua
BE Jiang, YT
   He, F
TI A Modification of Spherical Particles Calcium Sulfate for Alveolar Bone
   Defect
SO ADVANCES ON MATERIALS ENGINEERING
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Materials Engineering (ICMEN 2013)
CY MAY 17-19, 2013
CL Nanjing, PEOPLES R CHINA
DE calcium sulfate; spherical particles; alveolar bone; sodium silicate
ID GRAFT SUBSTITUTE; APATITE
AB Calcium sulfate hemihydrate has been used for many years as a biomaterial. However, too fast a degradation rate and lack of bioactivity have limited its application in orthopaedic field. Herein, alpha-Calcium sulfate hemihydrate is used as the raw material to prepare spherical particles calcium sulfate with stir method. Microstructures, degradation, and bioactivity of the materials were characterized by XRD, FT-IR and SEM. The effects of solutions of sodium silicate (Na2SiO3) on the structure and properties of the materials were analyzed. The results indicate that both the interface structure and the surface crystal binding state of the spherical particles calcium sulfate are changed by the solutions. The bioactivity was significantly improved by the solutions of Na2SiO3. With increasing the concentration of solutions in the materials, the degradation rate of the materials is decreased. Si-O network membrane which contains a large amount of Si-OH was formed on the surface of calcium sulfate. Therefore, the degradation rate was decreased and the bioactivity was significantly improved.
C1 [Wu, Xiaopei; Zhu, Weibo; Wang, Duancheng; Chen, Qinghua] Kunming Univ Sci & Technol, Sch Mat Sci & Engn, Kunming 650093, Peoples R China.
RP Wu, XP (reprint author), Kunming Univ Sci & Technol, Sch Mat Sci & Engn, Kunming 650093, Peoples R China.
EM wxp06134@sina.com; 625296056@qq.com; 410235244@qq.com;
   chenqinghua_ynl@163.com
CR Bell G., 1989, ADV CEM RES, V2, P61
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Bose B, 2003, NEUROSURG QUART, V13, P251, DOI 10.1097/00013414-200312000-00003
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Chen X. F., 2003, ACTA MAT RES, V17, P266
   Dong L. M., 2004, FUNCTIONAL MAT, V35, P2397
   Farmer V. C., 1982, INFRARED SPECTROSCOP
   Gu BX, 2001, J NUCL MATER, V297, P345, DOI 10.1016/S0022-3115(01)00631-6
   Guo YP, 2009, RARE METAL MAT ENG, V38, P834
   Hiromu F., 1980, WASEDA DAIGAKU RIKO, V89, P88
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   POVARENNYKH AS, 1978, MINERAL, V63, P956
   Rubia F. S. L., 2003, J NONCRYSTALLINE SOL, V330, P216
   Wan T., 2007, FUNCTIONAL MAT, V5, P846
   [魏均强 Wei Junqiang], 2010, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V27, P1589
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   Xie J.X., 1987, APPL INFRARED SPECTR
NR 18
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-801-1
J9 APPL MECH MATER
PY 2013
VL 377
BP 199
EP 203
DI 10.4028/www.scientific.net/AMM.377.199
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BA4KZ
UT WOS:000335932900036
DA 2018-10-20
ER

PT S
AU Montree, A
   Teanchai, K
   Siriprom, W
AF Montree, A.
   Teanchai, K.
   Siriprom, W.
BE Kaewkhao, J
   Limsuwan, P
   Kim, HJ
   Djamal, M
TI Preparation and Characterization the Cheap Mineral (Calcium Compound):
   The Preliminary Survey in the Natural Material
SO APPLIED PHYSICS AND MATERIAL APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Applied Physics and Material Applications
   (ICAPMA 2013)
CY FEB 20-22, 2013
CL Petchaburi, THAILAND
SP Ctr Excellence Glass Technol & Mat Sci, Nakhon Pathom Rajabhat Univ, Burapha Univ, Rajamangala Univ Technol
DE X-Ray Diffraction (XRD); Fourier Transform Infrared Spectroscopy
   (FT-IR); Calcium compound
ID BONES
AB The present work reports the production of biomaterial, while the potential in bio mineralization were studied with three conventional analysis techniques, X-Ray Diffraction (XRD) were confirm the crystal structure, Energy Dispersive X-Ray Fluorescence (EDXRF) and Fourier Transform Infrared Spectroscopy (FT-IR) study trace element and molecular composition, respectively. The results of XRD reveal that, the egg shells have a crystalline of calcium carbonate in phase calcite and fishbone have a crystalline of calcium phosphate in phase hydroxyapatite, respectively. The composition of both mineral and the level of metals element were investigated by EDXRF. The major composition was identified as Calcium (Ca) and other element are Potassium (K), Phosphorus(P) Sulfur (Al), Zinc (Zn), Ferrum (Fe), Copper(Cu) and Strontium (Sr). In addition, the deeply investigate molecular composition both mineral used using FT-IR spectroscopic analysis.
C1 [Montree, A.; Siriprom, W.] Kasetsart Univ, Fac Sci Si Racha, Si Racha Campus, Chon Buri 20230, Thailand.
   [Teanchai, K.; Siriprom, W.] Kasetsart Univ, Fac Sci Si Racha, Mat Sci & Appl Phys Res Unit, Chon Buri 20230, Thailand.
   [Siriprom, W.] Commiss Higher Educ, THEP Ctr, Thailand Ctr Excellence Phys, Bangkok 10400, Thailand.
RP Montree, A (reprint author), Kasetsart Univ, Fac Sci Si Racha, Si Racha Campus, Chon Buri 20230, Thailand.
EM W.siriprom@hotmail.com
FU Kasetsart University
FX This work was financial support provided from Faculty of Science at Si
   Racha, Kasetsart University, Si Racha campus, the authors gratefully
   acknowledged
CR Lunge S, 2012, J HAZARD MATER, V237, P161, DOI 10.1016/j.jhazmat.2012.08.023
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Toppe J, 2007, COMP BIOCHEM PHYS B, V146, P395, DOI 10.1016/j.cbpb.2006.11.020
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Zheng L, 2012, J CRYST GROWTH, V361, P217, DOI 10.1016/j.jcrysgro.2012.09.003
NR 5
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-778-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 770
BP 303
EP +
DI 10.4028/www.scientific.net/AMR.770.303
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BA4MH
UT WOS:000336002400074
DA 2018-10-20
ER

PT S
AU Kanthang, S
   Sompornpailin, K
AF Kanthang, Supha
   Sompornpailin, Kanokporn
BE Nukeaw, J
   Pecharapa, W
TI Increasing Plant Flavonoid Biomaterials in Response to UV-A Light
SO ADVANCES IN MATERIAL SCIENCE AND TECHNOLOGY
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Engineering, Applied Sciences, and
   Technology (ICEAST 2013)
CY AUG 21-24, 2013
CL Bangkok, THAILAND
DE flavonoids; light; MYB; UVA
ID ARABIDOPSIS-THALIANA; ANTHOCYANIN; RADIATION; ANTIOXIDANTS; SEEDLINGS;
   LEAVES
AB Flavonoid biomaterials have a protecting function from various stresses. We examined the flavonoid biosynthesis in plant treated under visible light (VL) and additional UV-A light. The transgenic tobacco containing PRODUCTION OF ANTHOCYANIN PIGMENT 1 (PAP1) cDNA, involved in flavonoid biosynthesis from Arabidopsis thaliana, were used for studying the flavonoid biosynthesis under both light conditions comparing to non transgenic tobacco. The flavonoid biomaterials were extracted with acidic methanol and water solvent from treated plant leaves. The absorbance of each biomaterial in the extract was measured under specific wavelength using a spectrophotometer. Additional UV-A radiated to non transgenic and transgenic tobacco affect the increasing of p-coumaric acid, naringenin, apigenin and kaempherol biomaterials from themselves grown under VL (approximately 120-130%). However, PAP1 transgenic tobaccos under additional UV-A radiation enhance the accumulation of these biomaterials up to 160-180% higher than non transgenic tobaccos grown under VL condition. Moreover, PAP1 transgenic tobacco radiated with UVA light also significantly increased pelargonidin biomaterial. PAP1 transgenic tobaccos had a similar phenotype with non transgenic tobaccos but the color of fully expanding flower was more pink intensity than non transgenic.
C1 [Kanthang, Supha; Sompornpailin, Kanokporn] King Mongkuts Inst Technol Ladkrabang, Coll Nanotechnol, Bangkok 10520, Thailand.
RP Kanthang, S (reprint author), King Mongkuts Inst Technol Ladkrabang, Coll Nanotechnol, Bangkok 10520, Thailand.
EM jekapae@hotmail.com; kskanokp@kmitl.ac.th
CR Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014
   Barthelmebs L, 2000, APPL ENVIRON MICROB, V66, P3368, DOI 10.1128/AEM.66.8.3368-3375.2000
   Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383
   Close DC, 2003, BOT REV, V69, P149, DOI 10.1663/0006-8101(2003)069[0149:TEOFA]2.0.CO;2
   Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010
   Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x
   Harbome JB, 1998, PHYTOCHEMICAL METHOD
   Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572
   KOLESNIKOV PA, 1957, DOKL AKAD NAUK SSSR+, V112, P1079
   Kovacik J, 2011, J PHOTOCH PHOTOBIO B, V103, P243, DOI 10.1016/j.jphotobiol.2011.04.002
   Li X, 2010, J AGR FOOD CHEM, V58, P1639, DOI 10.1021/jf903527y
   Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018
   Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x
   Santos I, 2004, PLANT SCI, V167, P925, DOI 10.1016/j.plantsci.2004.05.035
   Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005
   Teixeira S, 2005, FREE RADICAL BIO MED, V39, P1099, DOI 10.1016/j.freeadbiomed.2005.05.028
   Winter TR, 2008, ENVIRON POLLUT, V155, P290, DOI 10.1016/j.envpol.2007.11.018
   Younis ME, 2010, PROTOPLASMA, V239, P39, DOI 10.1007/s00709-009-0080-5
   Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681
   Zuluaga DL, 2008, FUNCT PLANT BIOL, V35, P606, DOI 10.1071/FP08021
NR 20
TC 1
Z9 1
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-854-7
J9 ADV MATER RES-SWITZ
PY 2013
VL 802
BP 74
EP 78
DI 10.4028/www.scientific.net/AMR.802.74
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BA3XP
UT WOS:000335081600016
DA 2018-10-20
ER

PT S
AU Chen, AP
   Lou, CW
   Chuangl, YY
   Lin, MC
   Lin, JH
AF Chen, An-Pang
   Lou, Ching-Wen
   Chuang, Ya-Yuan
   Lin, Mei-Chen
   Lin, Jia-Horng
BE Kida, K
TI Manufacturing Technique and Antimicrobial Activity of Silver
   Nanoparticles
SO MACHINE DESIGN AND MANUFACTURING ENGINEERING II, PTS 1 AND 2
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 2nd International Conference on Machine Design and Manufacturing
   Engineering (ICMDME)
CY MAY 01-02, 2013
CL Jeju Island, SOUTH KOREA
DE Chitosan; nanoparticle; antimicrobial activity; Uv-visible spectrometer
ID CHITOSAN; FILMS
AB Recently, the biomaterial is in rapid development stage, which could be widely applying in medical application, due to its biodegradability, nontoxic and biocompatibility. Chitosan is naturally abundant polymers have the biodegradability, nontoxic and biocompatibility. In this research, the chitosan and silver nitrate were used to develop the antibacterial agent via nano technique. In the reaction system, the reaction time and stirring speed were discussed, which will affect the surface plasmon resonance. The particle sizes were measured using transmission electron microscopy (TEM) and UV visible spectrophotometry. The silver nanoparticles size was below 100 nm via TEM. In addition, the results of antimicrobial activity indicated that the antibacterial agent has well antimicrobial activity on staphylococcus aureus. Due to the silver nanoparticle provides relatively higher surface area to contact with bacteria affect DNA molecules by losing their replication abilities.
C1 [Chen, An-Pang; Chuang, Ya-Yuan; Lin, Mei-Chen; Lin, Jia-Horng] Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
   [Lou, Ching-Wen] Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat, Taichung 40601, Taiwan.
   [Lin, Jia-Horng] China Medi Univ, Sch Chinese Med, Taichung 40402, Taiwan.
   [Lin, Jia-Horng] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan.
RP Chen, AP (reprint author), Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
EM duncannano@gmail.com; cwlou@ctust.edu.tw; jhlin@fcu.edu.tw
FU National Science Council of the Taiwan [NSC-101-2622-E-035-008-CC2]
FX This work would especially like to thank National Science Council of the
   Taiwan, for financially supporting this research under Contract
   NSC-101-2622-E-035-008-CC2.
CR Chhatre A, 2012, COLLOID SURFACE A, V404, P83, DOI 10.1016/j.colsurfa.2012.04.016
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Hebeish A, 2011, CARBOHYD POLYM, V86, P1684, DOI 10.1016/j.carbpol.2011.06.086
   Hu JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/18/185710
   Kesting R.E., 1965, APPL POLYM, V9, P1873
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Murillo L.E., 2002, NANOTECH, V2
   Murphy RJ, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3425883
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sastry M, 1997, J PHYS CHEM B, V101, P4954, DOI 10.1021/jp964087f
   Yang TC, 2005, INT J FOOD MICROBIOL, V97, P237, DOI 10.1016/S0168-1605(03)00083-7
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
NR 13
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-781-6
J9 APPL MECH MATER
PY 2013
VL 365-366
BP 1169
EP +
DI 10.4028/www.scientific.net/AMM.365-366.1169
PG 2
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BA3EM
UT WOS:000334133200239
DA 2018-10-20
ER

PT S
AU Lemons, J
   Sarver, D
   Beck, P
   Petersen, D
   Eberhardt, A
AF Lemons, J.
   Sarver, D.
   Beck, P.
   Petersen, D.
   Eberhardt, A.
BE Kurtz, SM
   Greenwald, AS
   Mihalko, WM
   Lemons, JE
TI Approach, Rationale, and Examples of Metal-on-Metal Device Retrieval and
   Analysis for Evidence-Based Education
SO METAL-ON-METAL TOTAL HIP REPLACEMENT DEVICES
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT Symposium on Metal-on-Metal Total Hip Replacement Devices
CY MAY 08, 2011
CL Phoenix, AZ
SP ASTM, Comm F04
DE DRA; en bloc; explants; specimens
AB A program operated since 1970 is now transitioning to an evidenced-based education (EBE) format and is utilizing examples of medical device retrieval and analysis (DRA) to introduce basic and applied concepts on the compatibility and longevity of device and host interactions. This paper provides an approach to EBE utilizing principles from the physical and biological sciences, which could be useful to other programs. The requirements of DRA include compliance with all regulations for confidentiality and safety. Explanations of identifying, processing, analyzing, and reporting on revision explants and en bloc postmortem donor specimens have provided the details of how initial observations and hypotheses can lead to establishing mechanism-based cause effect relationships. Examples of surface interactions along total hip arthroplasty articulations and porous regions for biological fixation have been provided. DRA studies on human applications of surgical implant devices have provided quantitative data to accept hypotheses about reduced magnitudes of wear over time (0-20 yr) along metal on metal articulations of one device design and biomaterial. Also, the magnitude of ongrowth and ingrowth of bone into a specific rough/porous metallic surface (bone to implant contact) and the biomechanical properties of the bone within and away from the fixation have led to detailed discussions of osseous integration of joint prosthesis, and conditions of a stable fixation. Experience has shown the value of device retrieval and analysis study results as a component of evidence-based education within a sub-discipline area associated with medical treatments including surgical implant devices.
C1 [Lemons, J.; Beck, P.] Univ Alabama Birmingham, Sch Dent, Dept Clin & Community Sci, Birmingham, AL 35294 USA.
RP Lemons, J (reprint author), Univ Alabama Birmingham, Sch Dent, Dept Clin & Community Sci, Birmingham, AL 35294 USA.
EM jack.lemons@ortho.uab.edu
CR [Anonymous], 2011, WORKSH CHAR MET ON M
   [Anonymous], 2010, NIH TECHN ASS C IMPR
   Beck P., 2003, THESIS U ALABAMA BIR
   Gilmour CMP, 2008, J AM ACAD ORTHOP SUR, V16, pX, DOI 10.5435/00124635-200800001-00001
   Lemons J., 2011, ORTHOPAEDIC IMPLANTS
   Lemons J. E., 1996, SOC BIOM RETR C BUFF
   Lemons J. E., 1988, SOC BIOMATERIALS RET
   Lemons JE, 2010, ORAL MAXIL SURG CLIN, V22, P419, DOI 10.1016/j.coms.2010.06.002
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Roaf R., 1973, IMPLANTS SURG, P473
   Salvin R. E., 2001, ED RES, V31, P15
   Scott M., 1998, THESIS U ALABAMA BIR
   Scott ML, 1998, AM SOC TEST MATER, V1346, P159, DOI 10.1520/STP12837S
   Sivash K. M., 1967, ARTHROPLASTY HIP JOI
NR 14
TC 3
Z9 3
U1 0
U2 1
PU ASTM INTERNATIONAL
PI WEST CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, PO BOX C700, WEST CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 978-0-8031-7546-4
J9 AM SOC TEST MATER
PY 2013
VL 1560
BP 115
EP 129
DI 10.1520/STP156020120034
PG 15
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA3XJ
UT WOS:000335079200009
DA 2018-10-20
ER

PT B
AU Rosu, RA
   Popescu, M
   Serban, VA
   Perianu, IA
AF Rosu, Radu Alexandru
   Popescu, Mihaela
   Serban, Viorel-Aurel
   Perianu, Ion Aurel
GP TANGER Ltd
TI DEPOSITION OF ALUMINA CERAMIC BIOCOMPATIBLE LAYERS BY PLASMA SPRAYING
SO METAL 2013: 22ND INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 22nd International Conference on Metallurgy and Materials (METAL)
CY MAY 15-17, 2013
CL Brno, CZECH REPUBLIC
SP Tanger Ltd, Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Mat Informat Soc, Engn Acad Czech Republ, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Met & Mat, Italian Assoc Met, Austrian Soc Met & Mat, Portuguese Soc Mat
DE plasma spraying; biomaterial; microstructure
AB Medical implants used in medicine are made by different alloys such as stainless steels, cobalt and chromium alloys, titanium and its alloys. Among these alloys, titanium has the most interest because of its properties: high strength, low density, very good corrosion resistance. To increase the biocompatibility, titanium alloys are coated with ceramic layers by diverse methods. Alumina (Al2O3) is a biocompatible ceramic material that is commonly used in orthopedic to cover the metallic implants. In recent years it can be observed the growing interest in making alumina hip prostheses due to the lower operating life of polymer-metal joints often used. From all the thermal spraying methods, in the case of ceramics coating, plasma thermal spraying presents the best results because of the high temperatures developed by the plasma jet which are sufficient to melt the ceramic particles.
   The paper presents the experimental results on the deposition of alumina coatings on titanium alloy substrate by plasma thermal spraying method. X-ray diffraction performed on the powders used for coating and on the obtained layers shows that during the thermal spraying process the structure suffered minor changes. Scanning electron microscopy analysis shows that the deposited layers are dense, uniform and without cracks. The roughness of the deposited layers has values between 5.12 and 5.38 mu m which will ensure a good osseointegration of the implant in the human body.
C1 [Rosu, Radu Alexandru; Popescu, Mihaela; Serban, Viorel-Aurel; Perianu, Ion Aurel] Politehn Univ Timisoara, Timisoara, Romania.
RP Rosu, RA (reprint author), Politehn Univ Timisoara, Timisoara, Romania.
EM raduniz@gmail.com
RI Serban, Viorel - Aurel/G-4719-2016
CR DAVID F., 2008, BIOMATERIALS, V9, P1
   KAMACHI U. M, 2003, J INDIAN ACAD SC 3 4, V28, P601
   Levingstone TJ, 2008, THESIS DUBLIN CITY U
   Nasab M.B., 2010, TRENDS BIOMATER ARTI, V24, P69
   Pattyn C, 2008, ORTHOPEDICS, V31, P1078, DOI 10.3928/01477447-20081101-23
   Robert B. Heimann, 2002, CMU J, V1, P23
   Rodriguez B, 2004, APPL ENG MECH MED, P1
   Singh G., 2010, J MINER MAT CHARACT, V9, P1059
NR 8
TC 0
Z9 0
U1 0
U2 7
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-41-3
PY 2013
BP 977
EP 981
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BA1YL
UT WOS:000333163100160
DA 2018-10-20
ER

PT B
AU Novak, P
   Sita, L
   Knaislova, A
   Vojtech, D
AF Novak, Pavel
   Sita, Ladislav
   Knaislova, Anna
   Vojtech, Dalibor
GP TANGER Ltd
TI POWDER METALLURGY PREPARATION OF POROUS TITANIUM FOR MEDICAL IMPLANTS
SO METAL 2013: 22ND INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 22nd International Conference on Metallurgy and Materials (METAL)
CY MAY 15-17, 2013
CL Brno, CZECH REPUBLIC
SP Tanger Ltd, Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Mat Informat Soc, Engn Acad Czech Republ, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Met & Mat, Italian Assoc Met, Austrian Soc Met & Mat, Portuguese Soc Mat
DE porous; titanium; biomaterial; implant
AB Porous biomaterials are used for implants to improve the osteo-integration and to achieve the mechanical properties closer to the human bone. In this work, conditions of the powder metallurgy process were optimized to obtain porous biomaterial. The effects of titanium particle size, pressure used for powder pressing and sintering temperature on the porosity and mechanical properties were determined. The most significant effect on the porosity was found in the case of the size of titanium particles. The addition of the pore-forming agent was also successfully tested. As the pore former, the water-soluble salt (NaCl) was applied. A mixture of titanium and salt was prepared, compressed and leached in distilled water. After that, sintering was carried out under the optimized conditions.
C1 [Novak, Pavel; Sita, Ladislav; Knaislova, Anna; Vojtech, Dalibor] Inst Chem Technol, CR-16628 Prague, Czech Republic.
RP Novak, P (reprint author), Inst Chem Technol, CR-16628 Prague, Czech Republic.
EM panovak@vscht.cz
RI Novak, Pavel/F-1049-2017
OI Novak, Pavel/0000-0001-9947-2566
CR Barbas A, 2012, J MECH BEHAV BIOMED, V9, P34, DOI 10.1016/j.jmbbm.2012.01.008
   Braem A, 2012, MAT SCI ENG C-MATER, V32, P2292, DOI 10.1016/j.msec.2012.06.017
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Rubstein AP, 2012, DIAM RELAT MATER, V22, P128, DOI 10.1016/j.diamond.2011.12.030
   Sun JF, 2008, MATER LETT, V62, P3623, DOI 10.1016/j.matlet.2008.04.011
   Thomsen JS, 2002, BONE, V30, P502, DOI 10.1016/S8756-3282(01)00702-5
   Torres Y, 2012, J MATER PROCESS TECH, V212, P1061, DOI 10.1016/j.jmatprotec.2011.12.015
   Xiang CS, 2012, PROCEDIA ENGINEER, V27, P768, DOI 10.1016/j.proeng.2011.12.518
NR 10
TC 0
Z9 0
U1 0
U2 1
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-41-3
PY 2013
BP 1301
EP 1306
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BA1YL
UT WOS:000333163100213
DA 2018-10-20
ER

PT S
AU Davis, KA
   Henderson, JH
AF Davis, Kevin A.
   Henderson, James H.
GP IEEE
TI Dynamic Micropattern Geometry atop Shape Memory Polymers
SO 2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 39th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 05-07, 2013
CL Syracuse Univ, Syracuse, NY
SP Syracuse Univ, LC Smith Coll Engn & Comp Sci, Syracuse Biomaterials Inst, Hill Collaborat Environm Med Warrior Res, Syracuse Univ, Dept Biomed & Chem Engn, Syracuse Univ, CASE, IEEE, IEEE Comp Soc
HO Syracuse Univ
DE micropattern; biomaterial; stem cells; mechanobiology
AB Substrates micropatterned with cell adhesion proteins have been used to investigate how protein density and geometry affect cell behaviors such as cell migration, growth, and differentiation. Existing technologies are limited in that they typically feature protein micropatterns that are static and unable to change while cells are attached. Here we micropatterned shape memory polymer (SMP) substrates that were capable of transitioning from a stretched state to a contracted state to control the width of patterned lines presented to attached cells. We found that micropattern geometry changed as the SMP substrate transitioned to its unstretched shape. Cells attached to dynamic patterns balled up and contracted their nuclei. The results suggest that micropatterned SMP cell culture substrates can be used to study the temporal aspects of cell mechanobiology.
C1 [Davis, Kevin A.; Henderson, James H.] Syracuse Univ, Syracuse Biomat Inst, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
RP Davis, KA (reprint author), Syracuse Univ, Syracuse Biomat Inst, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
EM kadavi08@syr.edu
OI Henderson, James/0000-0003-3355-5953
CR Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Davis KA, 2011, JOVE-J VIS EXP, DOI 10.3791/2903
   Davis KA, 2011, BIOMATERIALS, V32, P2285, DOI 10.1016/j.biomaterials.2010.12.006
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
NR 4
TC 0
Z9 0
U1 0
U2 10
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-0-7695-4964-4
J9 NORTHEAST BIOENGIN C
PY 2013
BP 33
EP 34
DI 10.1109/NEBEC.2013.160
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BA1FW
UT WOS:000332455300017
DA 2018-10-20
ER

PT S
AU Chen, HC
   Yang, TH
   Thoreson, AR
   Zhao, CF
   Amadio, PC
   Su, FC
   Jia, WY
   Sun, YN
   An, KN
   Sun, MG
AF Chen, Hsin-Chen
   Yang, Tai-Hua
   Thoreson, Andrew R.
   Zhao, Chunfeng
   Amadio, Peter C.
   Su, Fong-Chin
   Jia, Wenyan
   Sun, Yung-Nien
   An, Kai-Nan
   Sun, Mingui
GP IEEE
TI Multiresolution Image Analysis for Automatic Quantification of Collagen
   Gel Contraction
SO 2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 39th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 05-07, 2013
CL Syracuse Univ, Syracuse, NY
SP Syracuse Univ, LC Smith Coll Engn & Comp Sci, Syracuse Biomaterials Inst, Hill Collaborat Environm Med Warrior Res, Syracuse Univ, Dept Biomed & Chem Engn, Syracuse Univ, CASE, IEEE, IEEE Comp Soc
HO Syracuse Univ
DE multiresolution; deformable model; gel contraction
AB Quantifying collagen gel contraction is important in tissue engineering and biological research because it provides spatial-temporal assessments of cell behaviors and tissue material properties. However, these assessments currently rely on manual processing, which is time-consuming and subjective to personal opinions. We present a multiresolution image analysis system for automatic quantification of gel contraction. This system includes a color conversion process to normalize and enhance the contrast between gel and background. Then, a deformable circular model is activated automatically to capture details of gel boundaries. These steps are coordinated by a multiresolution strategy. The target measurements are obtained after gel segmentation. Our experiments using 30 images demonstrated a high consistency between the proposed and manual segmentation methods. The system can process large-size images (4000x3000) at a rate of approximately one second per image. It thus serves as a useful tool for analyzing large biological and biomaterial imaging datasets efficiently and objectively.
C1 [Chen, Hsin-Chen; Jia, Wenyan; Sun, Mingui] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA.
RP Chen, HC (reprint author), Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA.
FU NIH/NIAMS [R01 AR49823]
FX This work was supported by a grant from NIH/NIAMS R01 AR49823.
CR Chen MY, 2008, J BIOMED MATER RES B, V84B, P218, DOI 10.1002/jbm.b.30863
   Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004
   Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629
   Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8
NR 4
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-0-7695-4964-4
J9 NORTHEAST BIOENGIN C
PY 2013
BP 64
EP +
DI 10.1109/NEBEC.2013.115
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BA1FW
UT WOS:000332455300033
DA 2018-10-20
ER

PT S
AU Ulsh, G
   Le, D
   McDermott, M
   Moy, J
   Collins, G
AF Ulsh, George
   Le, Dung
   McDermott, Maxwell
   Moy, Jennifer
   Collins, George
GP IEEE
TI ChitO(2)-Clot A Novel Hemostatic & Oxygen Releasing Biomaterial for
   Traumatic Injuries
SO 2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 39th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 05-07, 2013
CL Syracuse Univ, Syracuse, NY
SP Syracuse Univ, LC Smith Coll Engn & Comp Sci, Syracuse Biomaterials Inst, Hill Collaborat Environm Med Warrior Res, Syracuse Univ, Dept Biomed & Chem Engn, Syracuse Univ, CASE, IEEE, IEEE Comp Soc
HO Syracuse Univ
DE Traumatic Injury; Hemostatic; Wound Healing; Oxygen-Releasing; Naturally
   Derived; Re-absorbable; Biomaterials
ID CHITOSAN
AB ChitO(2)-Clot is a novel hemostatic wound dressing. ChitO(2)-Clot will help facilitate coagulation/clot formation as well as providing oxygen to the wound, all while being cost effective and competitive with current hemostatic dressings. The product is composed of a micro/nano sized fibrous mat made of chitosan that is doped with Perfluorocarbons (oxygen carrier). The user would pack a hemorrhaging wound with ChitO(2)-Clot in order to stop the bleeding. The chitosan in ChitO(2)-Clot rapidly absorbs the blood in the wound bed and forms a gelatinous clot that fills the empty void of the wound. The gelatinous clot filling this void in the tissue applies pressure to the damaged vasculature, which prevents further bleeding. Chitosan also activates the clot clotting cascade and causes the agglutination of red blood cells, accelerates coagulation in vivo by influencing the activation of platelets. The Perfluorocarbons (oxygen career) release oxygen into the wound bed to help facilitate the wound healing process. Over time, the chitosan in ChitO(2)-Clot will be reabsorbed by the body and converted into sugar, while the Perfluorocarbon (PFC) is expelled via gas exchange in the lungs.
C1 [Ulsh, George; Le, Dung; McDermott, Maxwell; Moy, Jennifer; Collins, George] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
RP Ulsh, G (reprint author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
EM gju2@njit.edu
CR Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Hussain A., 2012, BIOTECHNOLOGY BIOENG
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kang PL, 2011, CARBOHYD POLYM, V85, P565, DOI 10.1016/j.carbpol.2011.03.015
   Kavanagh, 2010, MRSA SURVEILLANCE CU, V3-1
   Kime P., 2012, ARMYTIMES GANNE 0628
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Robson M C, 2001, Curr Probl Surg, V38, P72, DOI 10.1067/msg.2001.111167
NR 8
TC 0
Z9 0
U1 0
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-0-7695-4964-4
J9 NORTHEAST BIOENGIN C
PY 2013
BP 100
EP 101
DI 10.1109/NEBEC.2013.67
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BA1FW
UT WOS:000332455300051
DA 2018-10-20
ER

PT S
AU Zhang, MH
   Khankhel, AH
   McHugh, KJ
   Saint-Geniez, M
AF Zhang, Michael H.
   Khankhel, Aimal H.
   McHugh, Kevin J.
   Saint-Geniez, Magali
GP IEEE
TI Pore-Cast Scaffold for Vascular Tissue Engineering
SO 2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 39th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 05-07, 2013
CL Syracuse Univ, Syracuse, NY
SP Syracuse Univ, LC Smith Coll Engn & Comp Sci, Syracuse Biomaterials Inst, Hill Collaborat Environm Med Warrior Res, Syracuse Univ, Dept Biomed & Chem Engn, Syracuse Univ, CASE, IEEE, IEEE Comp Soc
HO Syracuse Univ
DE biological scaffolds; biomaterial; blood vessel; endothelial cells;
   polymer scaffolds; tissue engineering; vascular graft
AB Transplantation of engineered vascular grafts has emerged as a potential therapeutic solution for cardiovascular disease treatment. Although engineered vascular grafts hold the potential to satisfy a large clinical need, thrombosis remains a major risk with the small-diameter grafts (<5 mm). Currently, electrospinning is considered the gold standard for scaffold construction. However, poorly controlled pore dimensions allow the migration of endothelial cells (EC) into the scaffold through large gaps, making it difficult to achieve a uniform monolayer. The aim of this study is to design and construct a thin, porous, non-thrombogenic film as a scaffold for vascular grafts. Pore dimensions will be controlled by using a casting technique, thereby reducing the problem of cell migration into the scaffold. A confluent EC monolayer can then act as a barrier preventing blood-scaffold interaction, which will reduce the risk of thrombogenesis when implanted in vivo.
C1 [Zhang, Michael H.; Khankhel, Aimal H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [McHugh, Kevin J.; Saint-Geniez, Magali] Schepens Eye Res Inst, Boston, MA USA.
RP Zhang, MH (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM mhzhang@bu.edu; kaimal10@bu.edu; kevin.mchugh@schepens.harvard.edu;
   magali.saintgeniez@schepens.harvard.edu
OI McHugh, Kevin/0000-0001-6801-4431; SAINT-GENIEZ,
   MAGALI/0000-0001-9897-138X
CR Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
NR 3
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-0-7695-4964-4
J9 NORTHEAST BIOENGIN C
PY 2013
BP 297
EP +
DI 10.1109/NEBEC.2013.127
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BA1FW
UT WOS:000332455300150
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Kiyici, IA
   Gokce, H
   Agaogullari, D
   Kayali, ES
AF Oktar, F. N.
   Kiyici, I. A.
   Gokce, H.
   Agaogullari, D.
   Kayali, E. S.
BE Oral, AY
   Bahsi, ZB
   Sonmez, A
TI Tropical Sea Snail Shells: Possible Exotic Sources for Ceramic
   Biomaterial Synthesis
SO 3RD INTERNATIONAL ADVANCES IN APPLIED PHYSICS AND MATERIALS SCIENCE
   CONGRESS
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 3rd International Congress on Advances in Applied Physics and Materials
   Science
CY APR 24-28, 2013
CL Antalya, TURKEY
SP Doga Nanobiotech Inc, Mega Technol Serv Inc
DE Sea snail shells; mechano-chemical (ultrasonic) conversion;
   biomaterials; hydroxyapatite
ID POWDERS
AB In this study, chemical and structural properties of sea snail shell based bioceramic materials (i.e. hydroxyapatite, whitlockite and other phases) are produced by using mechano-chemical (ultrasonic) conversion method. For this purpose, differential thermal and gravimetric analysis (DTA/TG), X-ray diffraction, infra-red (IR) and scanning electron microscope (SEM) studies are performed.
C1 [Oktar, F. N.] Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Med Imaging Tech Dept, Istanbul, Turkey.
   [Oktar, F. N.] Marmara Univ, Nanotechnol & Biomat Res & Applicat Ctr, Istanbul, Turkey.
   [Kiyici, I. A.] Kocaeli Univ, Grad Sch Natural & Appl Sci Biomed Engn, Kocaeli, Turkey.
   [Gokce, H.; Kayali, E. S.] Istanbul Tech Univ, Met & Mat Engn Dept, Istanbul, Turkey.
   [Gokce, H.] Istanbul Tech Univ, Dr Adnan Tekin Mat Sci & Product Technol Appl Res, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
FU University of Technology Sydney<bold>, </bold>Australia
FX The authors are grateful to Prof. Dr. Besim Ben-Nissan from University
   of Technology Sydney<BOLD>, </BOLD>Sydney, Australia for very helpful
   discussions.
CR Agaogullari D, 2012, ACTA PHYS POL A, V121, P23
   Coelho TM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2369647
   Kel D., 2012, Key Engineering Materials, V493-494, P287, DOI 10.4028/www.scientific.net/KEM.493-494.287
   KEL D, 2011, INT J ARTIF ORGANS, V34, P700
   Oktar FN, 2010, INT J ARTIF ORGANS, V33, P467
   Oktar FN, 2006, KEY ENG MAT, V309-311, P27, DOI 10.4028/www.scientific.net/KEM.309-311.27
   Samur R, 2013, METALURGIJA, V52, P375
   Tamasan M, 2013, MAT SCI ENG C-MATER, V33, P2569, DOI 10.1016/j.msec.2013.02.019
   Tuyel A. U., 2007, J BIOTECHNOLOGY S, V131S, pS65
NR 9
TC 1
Z9 1
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1197-5
J9 AIP CONF PROC
PY 2013
VL 1569
BP 269
EP 274
DI 10.1063/1.4849274
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BA0KK
UT WOS:000331654900059
DA 2018-10-20
ER

PT J
AU Syarif, J
   Rohmannudin, TN
   Omar, MZ
   Sajuri, Z
   Harjanto, S
AF Syarif, J.
   Rohmannudin, T. N.
   Omar, M. Z.
   Sajuri, Z.
   Harjanto, S.
TI STABILITY OF THE BETA PHASE IN Ti-Mo-Cr ALLOY FABRICATED BY POWDER
   METALLURGY
SO JOURNAL OF MINING AND METALLURGY SECTION B-METALLURGY
LA English
DT Article
DE Alloying behavior; Oxygen; Critical cooling rate; Hardness; Corrosion
   resistance; Biomaterials
ID TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS;
   OXYGEN-CONTENT; NB-TA; MICROSTRUCTURE; ALPHA; TRANSFORMATION; BEHAVIOR;
   CARBON
AB A new beta Ti alloy was designed and fabricated by powder metallurgy process using pure metallic powders. The addition of Mo and Cr increased the stability of the beta phase. By contrast, O promoted alpha phase formation upon cooling. The addition of 18%Mo and 10%Cr stabilized the beta phase into ambient temperature. O increased the critical cooling rate of formation of alpha phase due to the prediction of the continuous cooling transformation diagram calculated by the Java-based Material Properties software. Sintering and solution treatment also enhanced the alloying behavior of pure powders to their designated chemical compositions. Hardness of the alloy decreased with increasing Mo and Cr content, which led to the decrease of alpha phase. The Ti-18% Mo-10% Cr alloy exhibited better corrosion resistance than a commercial Ti-6%Al-4%V alloy, which is used as current biomaterial.
C1 [Syarif, J.; Rohmannudin, T. N.; Omar, M. Z.; Sajuri, Z.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi 43600, Malaysia.
   [Harjanto, S.] Univ Indonesia, Fac Engn, Depok, Indonesia.
RP Syarif, J (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi 43600, Malaysia.
EM syarif@eng.ukm.my
FU UKM [UKM-AP-NBT-14-2010]; Malaysian MOHE [ERGS/1/2012/TK04/UKM/02/5]
FX Financial support from UKM (UKM-AP-NBT-14-2010) and from Malaysian MOHE
   (ERGS/1/2012/TK04/UKM/02/5) is greatly acknowledged.
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Akinlade DA, 2008, MAT SCI ENG A-STRUCT, V486, P626, DOI 10.1016/j.msea.2007.10.076
   [Anonymous], 1988, ANN BOOK ASTM STAND
   Arrazola PJ, 2009, J MATER PROCESS TECH, V209, P2223, DOI 10.1016/j.jmatprotec.2008.06.020
   BANIA PJ, 1990, BETA TITANIUM ALLOYS, P3
   Colling E. W., 1994, MAT PROPERTIES HDB T, P3
   Dobromyslov AV, 2001, SCRIPTA MATER, V44, P905, DOI 10.1016/S1359-6462(00)00694-1
   Donati MB, 2004, THROMBOSIS CANC, P47
   Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064
   Gomez M, 2009, ISIJ INT, V49, P302, DOI 10.2355/isijinternational.49.302
   Guo Z, 2005, MAT SCI ENG A-STRUCT, V392, P449, DOI 10.1016/j.msea.2004.09.020
   Guo Z, 2005, COMP MATER SCI, V32, P1, DOI 10.1016/j.commatsci.2004.05.004
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Li YG, 1999, ACTA MATER, V47, P2889, DOI 10.1016/S1359-6454(99)00173-1
   Lutjering G., 2007, TITANIUM, P30
   Martin J.A., 1997, SEGUIMIENTO MEDIANTE, P57
   McLean D., 1957, GRAIN BOUNDARIES MET
   Min XH, 2011, MAT SCI ENG A-STRUCT, V528, P4569, DOI 10.1016/j.msea.2011.02.071
   Morinaga M., 1993, P S TIT JUN 29 JUL 2, P217
   NAKAJIMA H, 1991, ISIJ INT, V31, P757, DOI 10.2355/isijinternational.31.757
   Neupane MP, 2009, INT J ELECTROCHEM SC, V4, P197
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Oh MS, 2004, METALL MATER TRANS A, V35A, P3071, DOI 10.1007/s11661-004-0052-5
   Pham MT, 1997, THIN SOLID FILMS, V310, P251, DOI 10.1016/S0040-6090(97)00330-1
   Pilliar RM, 2009, BIOMEDICAL MATERIALS, P41, DOI 10.1007/978-0-387-84872-3_2
   Qazi JI, 2004, JOM-US, V56, P49, DOI 10.1007/s11837-004-0253-9
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Saunders N, 2003, JOM-J MIN MET MAT S, V55, P60, DOI 10.1007/s11837-003-0013-2
   Saunders N, 2001, J PHASE EQUILIB, V22, P463, DOI 10.1361/105497101770333036
   SEAH MP, 1973, SCRIPTA METALL MATER, V7, P735, DOI 10.1016/0036-9748(73)90124-5
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Takaki S., 2000, MICROSTRUCTURE MAT, P100
   Takaki S, 2011, ADVANCED STEELS: THE RECENT SCENARIO IN STEEL SCIENCE AND TECHNOLOGY, P81, DOI 10.1007/978-3-642-17665-4_10
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Wain N, 2010, MAT SCI ENG A-STRUCT, V527, P7673, DOI 10.1016/j.msea.2010.08.032
   Wei QQ, 2011, MATER DESIGN, V32, P2934, DOI 10.1016/j.matdes.2010.11.049
   Wu XH, 2006, ACTA MATER, V54, P5433, DOI 10.1016/j.actamat.2006.07.002
NR 39
TC 8
Z9 8
U1 0
U2 11
PU TECHNICAL FACULTY, BOR-SERBIA
PI BOR
PA UNIV BELGRADE, VOJSKE JUGOSLAVIJE 12, BOR, 19210, SERBIA
SN 1450-5339
J9 J MIN METALL B
JI J. Min. Metall. Sect. B-Metall.
PY 2013
VL 49
IS 3
BP 285
EP 292
DI 10.2298/JMMB121024030S
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AB4VK
UT WOS:000331787800007
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Boboia, S
   Moldovan, M
   Ardelean, I
AF Boboia, S.
   Moldovan, M.
   Ardelean, I.
BE Lazar, MD
   Garabagiu, S
TI Determination of Residual Monomers Resulting From the Chemical
   Polymerization Process of Dental Materials
SO PROCESSES IN ISOTOPES AND MOLECULES (PIM 2013)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 9th International Conference on Processes in Isotopes and Molecules
   (PIM)
CY SEP 25-27, 2013
CL Cluj Napoca, ROMANIA
SP Natl Inst Res & Dev Isotop & Mol Technologies
DE Residual monomer; NMR; HPLC
ID COMPOSITES; RESINS; TIME; COMPONENTS; NMR
AB The residual monomer present in post-polymerized dental materials encourages premature degradation of the reconstructed tooth. That is why the residual monomer should be quantified in a simple, fast, accurate and reproducible manner. In our work we propose such an approach for accurate determination of the residual monomer in dental materials which is based on low-field nuclear magnetic resonance (NMR) relaxometry. The results of the NMR approach are compared with those of the high performance liquid chromatography (HPLC) technique. The samples under study contain the main monomers (2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane and triethylene glycol dimethacrylate) constituting the liquid phase of most dental materials and an initiator. Two samples were analyzed with different ratios of chemical initiation systems: N,N-dimethyl-p-toluide: benzoyl peroxide (1:2 and 0.7:1.2). The results obtained by both techniques highlight that by reducing the initiator the polymerization process slows down and the amount of residual monomer reduces. This prevents the premature degradation of the dental fillings and consequently the reduction of the biomaterial resistance.
C1 [Boboia, S.; Moldovan, M.] Univ Babes Bolyai, Raluca Ripan Chem Res Inst, Dept Polymer Composites, Cluj Napoca 400294, Romania.
   [Boboia, S.; Ardelean, I.] Tech Univ Cluj Napoca, Phys & Chem Dept, Cluj Napoca 400114, Romania.
RP Boboia, S (reprint author), Univ Babes Bolyai, Raluca Ripan Chem Res Inst, Dept Polymer Composites, Cluj Napoca 400294, Romania.
RI Moldovan, Marioara/N-6387-2017; Ardelean, Ioan/B-7363-2011
OI Ardelean, Ioan/0000-0001-8082-6600
FU Romanian Ministry of Education and Research [165/2012]
FX This work was funded by: the Romanian Ministry of Education and
   Research, National project PNII no: 165/2012.
CR Atai M, 2006, DENT MATER, V22, P785, DOI 10.1016/j.dental.2006.02.009
   Cadenaro M, 2008, DENT MATER, V24, P681, DOI 10.1016/j.dental.2007.06.031
   CAUGHMAN WF, 1991, BIOMATERIALS, V12, P737, DOI 10.1016/0142-9612(91)90022-3
   Douglas W.H., 1973, J MATER SCI, V13, P2600
   FERRACANE JL, 1984, J DENT RES, V63, P1093, DOI 10.1177/00220345840630081901
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   Ionas M., 2010, AMT, VII, P120
   Kimmich R., 1997, NMR TOMOGRAPHY DIFFU
   Kwon TY, 2012, J INVESTIG CLIN DENT, V3, P3, DOI 10.1111/j.2041-1626.2012.00114.x
   Litvinov VM, 2005, MACROMOL SYMP, V230, P20, DOI 10.1002/masy.200551137
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Moharamzadeh K, 2007, J MATER SCI-MATER M, V18, P133, DOI 10.1007/s10856-006-0671-z
   Netto AM, 2013, APPL MAGN RESON, V44, P1027, DOI 10.1007/s00723-013-0458-6
   RUYTER IE, 1981, ACTA ODONTOL SCAND, V39, P27, DOI 10.3109/00016358109162255
   Samanidou V, 2012, J LIQ CHROMATOGR R T, V35, P511, DOI 10.1080/10826076.2011.601501
   Sideridou I, 2004, BIOMATERIALS, V25, P367, DOI 10.1016/S0142-9612(03)00529-5
   Watts DC, 2005, DENT MATER, V21, P27, DOI 10.1016/j.dental.2004.10.003
   Wendl B, 2004, EUR J ORTHODONT, V26, P545, DOI 10.1093/ejo/26.5.545
NR 18
TC 0
Z9 0
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1193-7
J9 AIP CONF PROC
PY 2013
VL 1565
BP 90
EP 93
DI 10.1063/1.4833703
PG 4
WC Physics, Applied
SC Physics
GA BA0KM
UT WOS:000331659100019
DA 2018-10-20
ER

PT J
AU Hiebl, B
   Hopperdietzel, C
   Hunigen, H
   Jung, F
   Scharnagl, N
AF Hiebl, B.
   Hopperdietzel, C.
   Huenigen, H.
   Jung, F.
   Scharnagl, N.
TI Influence of a silicon (Si-14)-based coating substrate for biomaterials
   on fibroblast growth and human C5a
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterial; silicon; coating; cardiovascular; tissue engineering
ID VASCULAR GRAFTS; PROLIFERATION; SURFACE; CELLS; BIOCOMPATIBILITY;
   DIFFERENTIATION; DISSOLUTION; MECHANISMS; PRODUCTS; IMPLANTS
AB Despite considerable efforts in biomaterial development there is still a lack on substrates for cardiovascular tissue engineering approaches which allow the establishment of a tight a functional endothelial layer on their surface to provide hemocompatibility. The study aimed to test the biocompatibility of a silicon (Si-14)-based coating substrate (Supershine Medicare, Permanon) which was designed to resist temperatures from -40 degrees C up to 300 degrees C and which allows the use of established heat-inducing sterilization techniques respectively. By X-ray photoelectron spectroscopy it could be validated that this substrate is able to establish a 40-50 nm thick layer of silica, oxygen and carbon without including any further elements from the substrate on an exemplary selection of materials (silicone, soda-lime-silica glass, stainless steel). Analysis of the LDH-release, the cell activity/proliferation (MTS assay) and the cell phenotype after growing 3T3 cells with extracts of the coated materials did not indicate any signs of cytotoxicity. Additionally by measuring the C5a release after exposure of the coated materials with human serum it could be demonstrated, that the coating had no impact on the activation of the complement system. These results generally suggest the tested substrate as a promising candidate for the coating of materials which are aimed to be used in cardiovascular tissue engineering approaches.
C1 [Hiebl, B.] Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Germany.
   [Hopperdietzel, C.; Huenigen, H.] Free Univ Berlin, Fac Vet Med, Inst Vet Anat, Berlin, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Scharnagl, N.] Helmholtz Zentrum Geesthacht, Zentrum Mat & Kustenforsch GmbH, Magnesium Innovat Ctr, Inst Mat Res, Geesthacht, Germany.
RP Hiebl, B (reprint author), Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Germany.
EM bernhard.hiebl@medizin.uni-halle.de
RI Jung, Friedrich/L-1301-2013
OI Jung, Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Baroni T, 2001, J INVEST MED, V49, P146, DOI 10.2310/6650.2001.34041
   Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404
   Fischer AB, 1998, TOXICOL LETT, V96-7, P97
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kang JL, 2000, J TOXICOL ENV HEAL A, V60, P27, DOI 10.1080/009841000156574
   Kim K.A., 2002, ANN OCCUP HYG, V46, P18
   KLEINSOYER C, 1989, BIOMATERIALS, V10, P85, DOI 10.1016/0142-9612(89)90036-7
   Lim B, 2008, J CARDIOVASC ELECTR, V19, P843, DOI 10.1111/j.1540-8167.2008.01117.x
   Mayer A, 2009, TOXICOLOGY, V258, P139, DOI 10.1016/j.tox.2009.01.015
   MIYAMOTO M, 1990, BIOMATERIALS, V11, P385, DOI 10.1016/0142-9612(90)90091-4
   Muthusubramaniam L, 2011, ANN BIOMED ENG, V39, P1296, DOI 10.1007/s10439-011-0256-y
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Trescher K, 2012, CLIN HEMORHEOL MICRO, V52, P391, DOI 10.3233/CH-2012-1613
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu C., 2012, J BIOMATER APPL
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu Q, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485703
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
NR 28
TC 2
Z9 2
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2013
VL 55
IS 4
BP 491
EP 499
DI 10.3233/CH-131785
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AA4JG
UT WOS:000331061300011
PM 24113502
DA 2018-10-20
ER

PT J
AU Konig, J
   Kohl, B
   Kratz, K
   Jung, F
   Lendlein, A
   Ertel, W
   Schulze-Tanzil, G
AF Koenig, Josephine
   Kohl, Benjamin
   Kratz, Karl
   Jung, Friedrich
   Lendlein, Andreas
   Ertel, Wolfgang
   Schulze-Tanzil, Gundula
TI Effect of polystyrene and polyether imide cell culture inserts with
   different roughness on chondrocyte metabolic activity and gene
   expression profiles of aggrecan and collagen
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Chondrocytes; polymeric cell culture inserts; surface roughness
ID SURFACE-ROUGHNESS; MATURATION; POLYMER; STATE
AB In vitro cultured autologous chondrocytes can be used for implantation to support cartilage repair. For this purpose, a very small number of autologous cells harvested from a biopsy have to be expanded in monolayer culture. Commercially available polymer surfaces lead to chondrocyte dedifferentiation. Hence, the demanding need for optimized polymers and surface topologies supporting chondrocytes' differentiated phenotypes in vitro arises.
   In this study we explored the effect of tailored cell culture plate inserts prepared from polystyrene (PS) and polyether imide (PEI) exhibiting three different roughness levels (R0, RI, RII) on chondrocyte morphology, metabolism and gene expression profile. As a control, commercially available tissue culture plastic (TCP) dishes were included.
   Primary porcine articular chondrocytes were seeded on tailored PS and PEI inserts with three different roughness levels. The metabolic activity of the chondrocytes was determined after 24 hours using alamar blue assay. Chondrocyte gene expression profiles (aggrecan, type I and type II collagen) were monitored after 48 hours using Real Time Detection (RTD)-PCR. Chondrocytes cultured on PS and PEI surfaces formed cell clusters after 24 and 48 hours, which was not observed on TCP. The metabolic activity of chondrocytes cultured on PS was lower than of chondrocytes cultured on PEI, but also lower than on TCP.
   Gene expression analyses revealed an elevated expression of cartilage-specific aggrecan and an impaired expression of both collagen types by chondrocytes on PS and PEI compared with TCP. In summary, PEI is a biocompatible biomaterial suitable for chondrocyte culturing, which can be further chemically functionalized for generating specific surface interactions or covalent binding of biomolecules.
C1 [Koenig, Josephine; Kohl, Benjamin; Ertel, Wolfgang; Schulze-Tanzil, Gundula] Charite, Dept Orthopaed Trauma & Reconstruct Surg, D-14195 Berlin, Germany.
   [Kratz, Karl; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Kratz, Karl; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin BCRT, Teltow, Germany.
RP Schulze-Tanzil, G (reprint author), Charite, Dept Orthopaed Trauma & Reconstruct Surg, Campus Benjamin Franklin,FEM,Garystr 5, D-14195 Berlin, Germany.
EM gundula.schulze-tanzil@charite.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013; Jung,
   Friedrich/L-1301-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670;
   Jung, Friedrich/0000-0001-8098-7180; Kohl, Benjamin/0000-0002-2298-6830
FU Sonnenfeld foundation
FX The present study was conducted with equipment funded by the Sonnenfeld
   foundation. The authors would like to thank Mr. Robert Jeziorski and
   Mrs. Manuela Keller for their technical assistance regarding the
   processing and characterization of the polymer inserts.
CR Boyan BD, 1999, J ORTHOP RES, V17, P446, DOI 10.1002/jor.1100170322
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Haudenschild Dominik R., 2009, Molecular & Cellular Biomechanics, V6, P135
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Kim SB, 2013, J BIOMED MATER RES A, V101, P1708, DOI 10.1002/jbm.a.34474
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Neffe A. T., 2007, MED DEVICE TECHNOL, V18, P18
   Neffe Axel T, 2007, Med Device Technol, V18, P14
   Park EH, 2008, CELL BIOL INT, V32, P1272, DOI 10.1016/j.cellbi.2008.07.013
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Schneider T, 2012, CLIN HEMORHEOL MICRO, V52, P325, DOI 10.3233/CH-2012-1608
   Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Seifert B, 2002, ARTIF ORGANS, V26, P189, DOI 10.1046/j.1525-1594.2002.06876.x
   Wagner E, 2004, PHARM RES, V21, P8, DOI 10.1023/B:PHAM.0000012146.04068.56
   Xu X., 2013, CLIN HEMORHEOLOGY MI
NR 18
TC 3
Z9 3
U1 1
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2013
VL 55
IS 4
BP 523
EP 533
DI 10.3233/CH-131788
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AA4JG
UT WOS:000331061300014
PM 24099988
DA 2018-10-20
ER

PT B
AU Araya, S
   Zolotovsky, E
   Gidekel, M
AF Araya, Sergio
   Zolotovsky, Ekaterina
   Gidekel, Manuel
BE Achten, H
   Pavlicek, J
   Hulin, J
   Matejovska, D
TI Living Architecture Micro performances of bio fabrication
SO ECAADE 2012, VOL 2: PHYSICAL DIGITALITY
LA English
DT Proceedings Paper
CT 30th International Conference on Education and Research in Computer
   Aided Architectural Design in Europe (eCAADe)
CY SEP 12-14, 2012
CL Czech Tech Univ, Fac Architecture, Prague, CZECH REPUBLIC
SP Autodesk GmbH, Bentley Syst, Czech Tech Univ, Rectors Off
HO Czech Tech Univ, Fac Architecture
DE Synthetic Biology; Architecture; Design; Biofabrication; Biomaterial
ID ACETOBACTER-XYLINUM
AB This ongoing research study explores novel modes of design and fabrication by combining digital tools and technologies with living biological systems within controlled environments in order to induce specific biological functions and material production processes. The main objective is to design and implement a biological fabrication technique, using bacteria, to produce physical components for architecture and product design.
C1 [Araya, Sergio] Univ Adolfo Ibanez, Design Lab, Santiago, Chile.
   [Zolotovsky, Ekaterina] MIT, Sch Architecture & Planning, Computat Grp, Cambridge, MA 02139 USA.
   [Gidekel, Manuel] Univ Adolfo Ibanez, Venture Lab, Ibanez, Chile.
RP Araya, S (reprint author), Univ Adolfo Ibanez, Design Lab, Santiago, Chile.
EM sergio.araya@uai.cl; zolka@mit.edu; manuel.gidekel@uai.cl
CR Araya S, 2011, THESIS
   Beguin P, 1994, FEMS MICROBIOLOGY RE, DOI 10.1111/j.1574-6976.1994.tb00033.x/pdf
   Brown Jr RM, 1985, BIOEXPO85, P325
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Hwang JW, 1999, J BIOSCI BIOENG, V88, P183, DOI 10.1016/S1389-1723(99)80199-6
   Kalinowska H, 1996, BIOPOLYMERS
   Kaplan DL, 2004, BIOMATERIALS, P419
   SAXENA IM, 1990, PLANT MOL BIOL, V15, P673, DOI 10.1007/BF00016118
   THOMAS K. L., 2007, MAT MATTERS ARCHITEC
   U. S. Army's Natick, 1974, CHEM ENG NEWS, V52, DOI [10.1021/cen-v052n021.p020, DOI 10.1021/CEN-V052N021.P020]
   Zolotovsky E, 2012, THESIS
NR 11
TC 0
Z9 0
U1 1
U2 1
PU ECAADE-EDUCATION & RESEARCH COMPUTER AIDED ARCHITECTURAL DESIGN EUROPE
PI BRUSSELS
PA DEPT ARCHITECTURE SINT-LUCAS BRUSSELS-GHENT, HOGESCHOOL VOOR WETENSCHAP
   & KUNST, PALEIZENSTRAAT 65, BRUSSELS, 1030, BELGIUM
BN 978-9-4912070-3-7
PY 2013
BP 447
EP 457
PG 11
WC Architecture; Education & Educational Research
SC Architecture; Education & Educational Research
GA BJT77
UT WOS:000330320600047
DA 2018-10-20
ER

PT S
AU Yan, TT
   Wu, XP
   Leng, CY
   Chen, QH
AF Yan, Tingting
   Wu, Xiaopei
   Leng, Chongyan
   Chen, Qinghua
BE Zhang, H
   Jin, D
   Zhao, XJ
TI Preparation and characterization of calcium sulfate spherical particles
   for dentistry
SO ADVANCED RESEARCH ON AUTOMATION, COMMUNICATION, ARCHITECTONICS AND
   MATERIALS, III
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Automation, Communication,
   Architectonics and Materials (ACAM 2013)
CY MAY 25-26, 2013
CL Beijing, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE calcium sulfate; spherical particles; alveolar bone; biomaterial
AB In this article, calcium sulfate spherical particles were prepared to be used in alveolar bone defect repairing. We used alpha-calcium sulfate hemihydrate powder to prepare spherical particles of calcium sulfate with stir pelletizing method. The effect of powder addition, pelletizing time and concentration of water-glass on properties of the spherical particles were studied. It was indicated that with increasing of the powder addition, the particle size of the spherical particles was decreased. Prolonging the pelletizing time can improve the compression strength in certain conditions. With increasing of the concentration of water-glass used in preparation process, the shape of the spherical particles becomes non-circular, the granulous stem yield was decreased and the compression strength of the spherical particles was improved.
C1 [Yan, Tingting; Wu, Xiaopei; Leng, Chongyan; Chen, Qinghua] Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
RP Chen, QH (reprint author), Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
EM yantting@gmail.com; chenqinghua_yn1@163.com
CR Bell G., 1989, ADV CEM RES, V2, P61
   Capes C E, 1992, GRANULATION TECHNOLO
   Gu BX, 2001, J NUCL MATER, V297, P345, DOI 10.1016/S0022-3115(01)00631-6
   [胡继林 Hu Jilin], 2011, [硅酸盐通报, Bulletin of the Chinese Ceramic Society], V30, P288
   Owusa Yaw. A, 1982, ADV COLLOID INTERFAC, P57
   PETTIER LF, 1978, J BONE JOINT SURG, V60, P820
   Tuominen T, 2005, INT ORTHOP, V25, P5
   Zhang J., 1987, INTRO FERROUS METALL, P51
NR 8
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-749-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 738
BP 13
EP 17
DI 10.4028/www.scientific.net/AMR.738.13
PG 5
WC Automation & Control Systems; Computer Science, Information Systems;
   Materials Science, Multidisciplinary
SC Automation & Control Systems; Computer Science; Materials Science
GA BJT49
UT WOS:000330197600003
DA 2018-10-20
ER

PT S
AU Yan, TT
   Cui, YS
   Chen, QH
AF Yan, Tingting
   Cui, Yongshun
   Chen, Qinghua
BE Zhang, H
   Jin, D
   Zhao, XJ
TI Study on the preparation of strontium-doped hydroxyapatite whisker
SO ADVANCED RESEARCH ON AUTOMATION, COMMUNICATION, ARCHITECTONICS AND
   MATERIALS, III
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Automation, Communication,
   Architectonics and Materials (ACAM 2013)
CY MAY 25-26, 2013
CL Beijing, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE hydroxyapatite; whisker; strontium; biomaterial
ID SINTERING ADDITIVES; CERAMICS
AB Hydroxyapatite is well used as bone repair materials, due to its properties that can be combined with strontium to improve mechanical property and degradation property. In this article, hydroxyapatite whiskers with different amount of doped strontium were prepared with diammonium phosphate, calcium nitrate and strontium nitrate at 94 degrees C. Fourier transform infrared spectroscopy (FTIR) was used to identify the functional groups. X-ray diffraction (XRD) analysis was carried out to study the phase composition and crystallinity of the whisker. The morphology of the whiskers was characterized by scanning electron microscope (SEM). It was indicated that strontium can be doped in hydroxyapatite with proper process and then the strontium-doped hydroxyapatite whiskers were produced successfully.
C1 [Yan, Tingting; Cui, Yongshun; Chen, Qinghua] Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
RP Chen, QH (reprint author), Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
EM yantting@gmail.com; chenqinghua_yn1@163.com
CR Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Kandori K, 1997, J AM CERAM SOC, V80, P1157
   Knepper M, 1998, J MATER SCI-MATER M, V9, P589, DOI 10.1023/A:1008965626695
   Liao R, 2000, SHANGHAI J STOMATOLO, V9, P73
   ROY DM, 1974, MATER RES BULL, V9, P35, DOI 10.1016/0025-5408(74)90005-1
   Shi S, 2006, INTRO BIOMATERIALS, P18
   Suchanek W, 1997, BIOMATERIALS, V18, P923, DOI 10.1016/S0142-9612(97)00019-7
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   YASUKAWA A, 1994, POLYHEDRON, V13, P3071, DOI 10.1016/S0277-5387(00)83673-6
NR 10
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-749-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 738
BP 26
EP 29
DI 10.4028/www.scientific.net/AMR.738.26
PG 4
WC Automation & Control Systems; Computer Science, Information Systems;
   Materials Science, Multidisciplinary
SC Automation & Control Systems; Computer Science; Materials Science
GA BJT49
UT WOS:000330197600006
DA 2018-10-20
ER

PT S
AU Yan, TT
   Wu, XP
   Cui, YS
   Chen, QH
   Yang, ZD
AF Yan, Tingting
   Wu, Xiaopei
   Cui, Yongshun
   Chen, Qinghua
   Yang, Zhongda
BE Zhang, H
   Jin, D
   Zhao, XJ
TI Porous calcium sulfate/hydroxyapatite whiskers scaffold for bone tissue
   engineering
SO ADVANCED RESEARCH ON AUTOMATION, COMMUNICATION, ARCHITECTONICS AND
   MATERIALS, III
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Automation, Communication,
   Architectonics and Materials (ACAM 2013)
CY MAY 25-26, 2013
CL Beijing, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE calcium sulfate; hydroxyapatite whisker; porous scaffold; biomaterial
ID BIODEGRADABLE SCAFFOLDS; HYDROXYAPATITE
AB Porous calcium sulfate/hydroxyapatite whiskers composites scaffold is possible to be used in bone tissue engineering, for its biocompatibility, controllable degradation, and good mechanical properties. In this study, porous calcium sulfate/hydroxyapatite whisker composite scaffolds were fabricated by adding pore-forming agent and were characterized. The characteristics of the porous scaffolds were assessed by means of scanning electron microscopy (SEM), X-ray diffraction (XRD) and immersing testing techniques. It is shown that the scaffolds prepared in this article have the porous structure with the content of CaSO4 and HA. The scaffolds prepared in this article have been confirmed to be ideally used as biodegradable implants.
C1 [Yan, Tingting; Wu, Xiaopei; Cui, Yongshun; Chen, Qinghua; Yang, Zhongda] Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
RP Chen, QH (reprint author), Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming 650093, Peoples R China.
EM yantting@gmail.com; chenqinghua_yn1@163.com
CR Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Hu HT, 2012, MICROELECTRON ENG, V98, P566, DOI 10.1016/j.mee.2012.07.001
   Hui JHP, 2012, ORTHOP CLIN N AM, V43, P255, DOI 10.1016/j.ocl.2012.01.002
   PETTIER LF, 1978, J BONE JOINT SURG, V60, P820
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Uchida T, 2008, J BIOTECHNOL, V133, P213, DOI 10.1016/j.jbiotec.2007.08.017
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
NR 10
TC 2
Z9 2
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-749-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 738
BP 38
EP 41
DI 10.4028/www.scientific.net/AMR.738.38
PG 4
WC Automation & Control Systems; Computer Science, Information Systems;
   Materials Science, Multidisciplinary
SC Automation & Control Systems; Computer Science; Materials Science
GA BJT49
UT WOS:000330197600009
DA 2018-10-20
ER

PT J
AU Klymov, A
   Prodanov, L
   Lamers, E
   Jansen, JA
   Walboomers, XF
AF Klymov, Alexey
   Prodanov, Ljupcho
   Lamers, Edwin
   Jansen, John A.
   Walboomers, X. Frank
TI Understanding the role of nano-topography on the surface of a
   bone-implant
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; MESENCHYMAL STEM-CELLS; POLYMER-DEMIXED
   NANOTOPOGRAPHY; ENHANCED OSTEOBLAST ADHESION; ELECTRON-BEAM LITHOGRAPHY;
   SERUM-ALBUMIN ADSORPTION; IN-VITRO; COLLOIDAL LITHOGRAPHY; PROTEIN
   ADSORPTION; CONTACT GUIDANCE
AB Bone-implant material development is proceeding at a high pace, and has shifted from straightforward biomaterial testing to more advanced cell-targeted approaches for surface modification and design. It has been long known that cells can recognize and respond to topographical features by changing their morphology and behavior. The progress in surface analytical devices, as well as in techniques for production of topographical features on the nanometer scale allow for the characterization of natural tissues and the reproduction of biomimetic nanofeatures in material surfaces. In this review some of the most common surface-characterization and surface-manufacturing techniques will be addressed and results from in vitro and in vivo studies will be presented. Knowledge on biomaterial nanotopography can be exploited for active stimulation and control of cellular behavior like attachment, migration, spreading, gene expression, proliferation, differentiation and secretion of matrix components.
C1 [Klymov, Alexey; Prodanov, Ljupcho; Lamers, Edwin; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Klymov, A (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM f.walboomers@dent.umcn.nl
RI Walboomers, X.Frank/B-3692-2013; Jansen, John/H-8055-2014
CR ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bae IH, 2010, J BIOMED MATER RES B, V93B, P484, DOI 10.1002/jbm.b.31606
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598
   Berry CC, 2007, IEEE T NANOBIOSCI, V6, P201, DOI 10.1109/TNB.2007.903457
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Born M., 1999, PRINCIPLES OPTICS EL, pxxxiii
   Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Burns K, 2009, J BIOMED MATER RES A, V88A, P561, DOI 10.1002/jbm.a.31899
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chakraborty Abhijit, 2011, Indian J Dent Res, V22, P277, DOI 10.4103/0970-9290.84304
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   D'Anto V, 2012, ANGLE ORTHOD, V82, P922, DOI 10.2319/100211-620.1
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2007, INT J NANOMED, V2, P373
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   de Boor J, 2009, OPT LETT, V34, P1783, DOI 10.1364/OL.34.001783
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dugal A, 2010, J MAXILLOFAC ORAL SU, V9, P403, DOI 10.1007/s12663-010-0094-8
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ercan B, 2010, BIOMATERIALS, V31, P3684, DOI 10.1016/j.biomaterials.2010.01.078
   Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fusi M, 2009, APPL SURF SCI, V255, P5334, DOI 10.1016/j.apsusc.2008.06.206
   Garcia AB, 1997, J COLLOID INTERF SCI, V192, P363, DOI 10.1006/jcis.1997.5007
   Geblinger D, 2012, J R SOC INTERFACE, V9, P1599, DOI 10.1098/rsif.2011.0659
   Giavaresi G, 2006, J BIOMAT SCI-POLYM E, V17, P1405, DOI 10.1163/156856206778937226
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI [10.1146/annurev.cellbio.042308.113318, 10.1146/annurev.cellbio.012308.113318]
   Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129
   Hanarp P, 2003, COLLOID SURFACE A, V214, P23, DOI 10.1016/S0927-7757(02)00367-9
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Harrysson OLA, 2004, CLIN ORTHOP RELAT R, P162, DOI 10.1097/01.blo.0000127115.05754.ce
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729
   Hulleberg G, 2008, ACTA ORTHOP, V79, P609, DOI 10.1080/17453670810016614
   Hwang Debby, 2006, Implant Dent, V15, P353, DOI 10.1097/01.id.0000247855.75691.03
   Hwang D, 2007, IMPLANT DENT, V16, P13, DOI 10.1097/ID.0b013e31803276c8
   JAN KM, 1973, J GEN PHYSIOL, V61, P638, DOI 10.1085/jgp.61.5.638
   Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911
   Johnsen SP, 2006, J BONE JOINT SURG BR, V88B, P1303, DOI 10.1302/0301-620X.88B10.17399
   Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954
   Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279
   Kress S, 2012, ADV BIOCHEM ENG BIOT, V126, P263, DOI 10.1007/10_2011_108
   Kubo K, 2008, J BIOMED MATER RES A, V87A, P380, DOI 10.1002/jbm.a.31791
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E., 2012, EUR CELLS MATER, V23, P193
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lauritsen JV, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/26/263001
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lenhert S, 2007, LANGMUIR, V23, P10216, DOI 10.1021/la701043f
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Liu HN, 2010, J BIOMED MATER RES A, V93A, P1180, DOI 10.1002/jbm.a.32614
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Makela KT, 2008, J BONE JOINT SURG AM, V90A, P2160, DOI 10.2106/JBJS.G.00870
   Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meirelles L, 2008, CLIN IMPLANT DENT R, V10, P245, DOI 10.1111/j.1708-8208.2008.00089.x
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Mendes VC, 2009, J BIOMED MATER RES A, V90A, P577, DOI 10.1002/jbm.a.32126
   Michler GH, 2008, SPRINGER LAB MAN POL, P1
   Moore GE, 1998, P IEEE, V86, P82, DOI 10.1109/JPROC.1998.658762
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Nicolau DV, 2010, BIOSENS BIOELECTRON, V26, P1337, DOI 10.1016/j.bios.2010.07.044
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Ogawa T, 2008, J DENT RES, V87, P751, DOI 10.1177/154405910808700809
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Palmquist A, 2013, CLIN IMPLANT DENT R, V15, P96, DOI 10.1111/j.1708-8208.2011.00361.x
   Palmquist A, 2012, J R SOC INTERFACE, V9, P396, DOI 10.1098/rsif.2011.0420
   Palmquist A, 2011, J BIOMED MATER RES B, V97B, P289, DOI 10.1002/jbm.b.31814
   Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Salvi JD, 2010, J BIOMECH, V43, P3058, DOI 10.1016/j.jbiomech.2010.07.015
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Shang SH, 2010, EUR CELLS MATER, V19, P180, DOI 10.22203/eCM.v019a18
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Smith GC, 2011, ACTA BIOMATER, V7, P3209, DOI 10.1016/j.actbio.2011.05.003
   Sreekanth KV, 2010, APPL OPTICS, V49, P6710, DOI 10.1364/AO.49.006710
   Stamm M., 2008, POLYM SURFACES INTER
   Strietzel FP, 2007, J CLIN PERIODONTOL, V34, P523, DOI 10.1111/j.1600-051X.2007.01083.x
   Svanborg LM, 2010, J BIOMED MATER RES B, V92B, P462, DOI 10.1002/jbm.b.31538
   Szaflarski JP, 2008, MED SCI MONITOR, V14, pCR243
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tan C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/12/125303
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thoreson EJ, 2006, J COLLOID INTERF SCI, V298, P94, DOI 10.1016/j.jcis.2005.11.054
   Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409
   Toth M, 2007, NANO LETT, V7, P525, DOI 10.1021/nl062848c
   Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3
   Ungersbock A., 1994, Bio-Medical Materials and Engineering, V4, P317
   van Putten EG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.193905
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764
   Webb HK, 2012, SCANNING, V34, P257, DOI 10.1002/sca.21002
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Williams D. F., 1999, WILLIAMS DICT BIOMAT, Vxvii
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Wood MA, 2007, J R SOC INTERFACE, V4, P1, DOI 10.1098/rsif.2006.0149
   Wood MA, 2002, NANOTECHNOLOGY, V13, P605, DOI 10.1088/0957-4484/13/5/312
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 167
TC 28
Z9 28
U1 4
U2 56
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 2
BP 135
EP 151
DI 10.1039/c2bm00032f
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA 295RL
UT WOS:000330133100002
DA 2018-10-20
ER

PT J
AU Smith, BS
   Capellato, P
   Kelley, S
   Gonzalez-Juarrero, M
   Popat, KC
AF Smith, Barbara S.
   Capellato, Patricia
   Kelley, Sean
   Gonzalez-Juarrero, Mercedes
   Popat, Ketul C.
TI Reduced in vitro immune response on titania nanotube arrays compared to
   titanium surface
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID FOREIGN-BODY REACTION; NANOPOROUS ALUMINA MEMBRANES; TIO2 NANOTUBES;
   CELL FATE; ORTHOPEDIC IMPLANTS; OSTEOBLAST RESPONSE; NITRIC-OXIDE;
   GROWTH; BIOCOMPATIBILITY; DIFFERENTIATION
AB Material surfaces that provide biomimetic cues, such as nanoscale architectures, have been shown to alter cell/biomaterial interactions. Recent studies have identified titania nanotube arrays as strong candidates for use in interfaces on implantable devices due to their ability to elicit improved cellular functionality. However, limited information exists regarding the immune response of nanotube arrays. Thus, in this study, we have investigated the short- and long-term immune cell reaction of titania nanotube arrays. Whole blood lysate (containing leukocytes, thrombocytes and trace amounts of erythrocytes), isolated from human blood, were cultured on titania nanotube arrays and biomedical grade titanium (as a control) for 2 hours and 2 and 7 days. In order to determine the in vitro immune response on titania nanotube arrays, immune cell functionality was evaluated by cellular viability, adhesion, proliferation, morphology, cytokine/chemokine expression, with and without lipopolysaccharide (LPS), and nitric oxide release. The results presented in this study indicate a decrease in short-and long-term monocyte, macrophage and neutrophil functionality on titania nanotube arrays as compared to the control substrate. This work shows a reduced stimulation of the immune response on titania nanotube arrays, identifying this specific nanoarchitecture as a potentially optimal interface for implantable biomedical devices.
C1 [Smith, Barbara S.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.
   [Capellato, Patricia] Sao Paulo State Univ, UNESP, Fac Engn Guaratingueta, Dept Mat, BR-12516410 Guaratingueta, SP, Brazil.
   [Capellato, Patricia; Kelley, Sean; Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
RP Smith, BS (reprint author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.
EM ketul.popat@colostate.edu
OI Capellato, Patricia/0000-0002-6397-5820; Popat, Ketul
   C./0000-0002-2417-7789
FU National Science Foundation [CBET - 0827827]; Colorado Office of
   Economic Development and International Trade
FX Financial support for this work was provided by the National Science
   Foundation (CBET - 0827827) and the Colorado Office of Economic
   Development and International Trade. The authors would like to thank D.
   Bolchen and the staff at Garth Englund Blood Center for their
   professional assistance with the blood collection.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bhargava D, 2010, ACTA NEUROCHIR, V152, P173, DOI 10.1007/s00701-009-0394-2
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Brodie C, 1998, J NEUROIMMUNOL, V81, P20, DOI 10.1016/S0165-5728(97)00154-9
   COHEN J, 1959, J BONE JOINT SURG AM, V41, P152, DOI 10.2106/00004623-195941010-00018
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   DICARLO E F, 1992, Clinical Materials, V9, P235, DOI 10.1016/0267-6605(92)90104-2
   Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
   Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021
   JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   John D., 2007, BIOMATERIALS, V28, P5058
   Khang D, 2006, INT J NANOMED, V1, P65, DOI 10.2147/nano.2006.1.1.65
   Kodama A, 2009, ACTA BIOMATER, V5, P2322, DOI 10.1016/j.actbio.2009.02.032
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   La Flamme KE, 2007, BIOMATERIALS, V28, P2638, DOI 10.1016/j.biomaterials.2007.02.010
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI 10.2217/NNM.10.54
   Lin Y, 2011, J DENT RES, V90, P251, DOI 10.1177/0022034510384872
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Messinger SD, 2009, DISABIL REHABIL, V31, P2130, DOI 10.3109/09638280902943223
   Mooney V, 1971, J BIOMED MATER RES, V5, P143
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166
   Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103
   Nammas W, 2011, INT J CARDIOL, V146, P456, DOI 10.1016/j.ijcard.2010.10.119
   NATHAN C, 1992, FASEB J, V6, P3051
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Park GE, 2005, J BIOMED NANOTECHNOL, V1, P18, DOI 10.1166/jbn.2005.003
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Paulose M, 2006, J PHYS CHEM B, V110, P16179, DOI 10.1021/jp064020k
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rhee H. J., 1979, CELL TISSUE RES, V197, P355
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Ruan CM, 2005, J PHYS CHEM B, V109, P15754, DOI 10.1021/jp052736u
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Shokrollahi P, 2010, J BIOMED MATER RES A, V95A, P209, DOI 10.1002/jbm.a.32828
   Smith BS, 2011, ACTA BIOMATER, V7, P2686, DOI 10.1016/j.actbio.2011.03.014
   Smith BS, 2010, J BIOMED MATER RES A, V95A, P350, DOI 10.1002/jbm.a.32853
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Speroni B. F., 2011, MINERVA STOMATOL, V60, P123
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002
   von der Mark K, 2009, P NATL ACAD SCI USA, V106, pE60, DOI 10.1073/pnas.0903663106
   von Wilmowsky C, 2012, CLIN ORAL IMPLAN RES, V23, P359, DOI 10.1111/j.1600-0501.2010.02139.x
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Yang DJ, 2008, MATER LETT, V62, P775, DOI 10.1016/j.matlet.2007.06.058
   Young-Taeg S., 2003, BIOMATERIALS, V24, P3893
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 73
TC 26
Z9 26
U1 0
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 3
BP 322
EP 332
DI 10.1039/c2bm00079b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 295RQ
UT WOS:000330133600010
DA 2018-10-20
ER

PT J
AU Coelho, NM
   Salmeron-Sanchez, M
   Altankov, G
AF Miranda Coelho, Nuno
   Salmeron-Sanchez, Manuel
   Altankov, George
TI Fibroblasts remodeling of type IV collagen at a biomaterials interface
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SUBSTRATUM-BOUND FIBRONECTIN; CELL-MATRIX ADHESIONS;
   EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; IN-VITRO; ENDOTHELIAL-CELLS;
   INTEGRINS; BINDING; FIBRILLOGENESIS; POLYMERIZATION
AB This paper describes the fate of adsorbed type IV collagen (Col IV) in contact with fibroblasts on model biomaterial surfaces, varying in wettability, chemistry and charge. We found that fibroblasts not only interact but also tend to remodel differently adsorbed Col IV employing two distinct mechanisms: mechanical reorganization and proteolytic degradation. Apart from the trend of adsorption -NH2 > CH3 > COOH > OH- the cells interact better with NH2 and OH surfaces -i.e. independently of the amount of adsorbed Col IV - evident from the quantitative measurements of cell adhesion and spreading and the improved recruitment of alpha 1 and alpha 2 integrins as well as p-FAK in focal adhesions. The linearly arranged Col IV co-localize with FN fibrils formed from either secreted, or exogenously added protein, which confirms their interdependence during a reorganization process. We further found that this reorganization is better pronounced on hydrophilic OH and positively charged NH2 surfaces correlating with the improved cellular interaction. Conversely, the fibroblasts tend to round on COOH and CH3 surfaces in compliance with the altered integrin signaling and also the increased pericellular proteolysis activity quantified by the increased de-quenching of adsorbed FITC-Col IV and zymography. Taken together, these results show that remodeling of Col IV at a cell-biomaterial interface depends strongly on the surface properties of a material and affects significantly its biological performance.
C1 [Miranda Coelho, Nuno; Altankov, George] Inst Bioengn Catalunya, Barcelona, Spain.
   [Miranda Coelho, Nuno] Univ Politecn Cataluna, Barcelona, Spain.
   [Salmeron-Sanchez, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.
   [Salmeron-Sanchez, Manuel; Altankov, George] CIBER Bioingn Biomat & Nanomed, Madrid, Spain.
   [Altankov, George] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain.
RP Coelho, NM (reprint author), Inst Bioengn Catalunya, Barcelona, Spain.
EM george.altankov@icrea.cat
RI Salmeron-Sanchez, Manuel/E-4680-2010
OI Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Coelho,
   Nuno/0000-0001-7128-1362
FU Spanish Ministry of Science and Innovation [MAT2012-38359-C03-03];
   CIBER-BBN [S-2011-2012]; ICREA
FX The current work was supported by the Spanish Ministry of Science and
   Innovation, through projects MAT2012-38359-C03-03 to GA and a
   collaborative intramural project S-2011-2012 with CIBER-BBN.
CR Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Altankov G, 2010, NATO SCI PEACE SEC A, P19, DOI 10.1007/978-90-481-8790-4_2
   Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Charonis A, 2005, CURR MED CHEM, V12, P1495, DOI 10.2174/0929867054039071
   Chernousov MA, 1998, J CELL SCI, V111, P2763
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165
   Fleischmajer R, 1998, ANN NY ACAD SCI, V857, P212, DOI 10.1111/j.1749-6632.1998.tb10118.x
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Goody MF, 2010, MOL REPROD DEV, V77, P475, DOI 10.1002/mrd.21157
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gustavsson J, 2008, J MATER SCI-MATER M, V19, P1839, DOI 10.1007/s10856-008-3384-7
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   INGHAM KC, 1988, J BIOL CHEM, V263, P4624
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   Maneva-Radicheva L, 2008, HISTOL HISTOPATHOL, V23, P833, DOI 10.14670/HH-23.833
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Coelho NM, 2011, BIOTECHNOL BIOENG, V108, P3009, DOI 10.1002/bit.23265
   Coelho NM, 2011, TISSUE ENG PT A, V17, P2245, DOI [10.1089/ten.tea.2010.0713, 10.1089/ten.TEA.2010.0713]
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009
   Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   WOODLEY DT, 1988, J INVEST DERMATOL, V90, P679, DOI 10.1111/1523-1747.ep12560880
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911
   Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308
   Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200
NR 56
TC 10
Z9 10
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 5
BP 494
EP 502
DI 10.1039/c3bm00163f
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 295RX
UT WOS:000330134300006
DA 2018-10-20
ER

PT J
AU Newland, B
   Dowd, E
   Pandit, A
AF Newland, Ben
   Dowd, Eilis
   Pandit, Abhay
TI Biomaterial approaches to gene therapies for neurodegenerative disorders
   of the CNS
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; MESENCHYMAL STEM-CELLS;
   IMMOBILIZED CONCENTRATION GRADIENTS; LACTOFERRIN-MODIFIED NANOPARTICLES;
   STRIATAL TYROSINE-HYDROXYLASE; MODIFIED SILICA NANOPARTICLES; AMINO-ACID
   DECARBOXYLASE; SINGLE CYCLIZED MOLECULE; COLLAGEN HOLLOW SPHERES
AB Neurodegeneration gives rise to a wide range of disorders which represent a growing health burden to both western societies and developing countries. Whilst for many disorders such as Alzheimer's and Parkinson's disease the cause is unknown, gene therapy is becoming the forefront of novel potential therapies described in the literature and has entered clinical trials. Furthermore, although in somewhat an earlier stage, biomaterials offer means of enhancing gene therapy strategies either through new delivery methods or provision of support for genetically manipulated cells. This review outlines recent uses of biomaterials in the CNS and captures recent advances in non-viral gene delivery to the brain. Three dimensional scaffolding systems for ex vivo gene delivery to the brain are also discussed highlighting the progress of hydrogel mediated cell delivery. This review also addresses the difficulties and safety considerations of these approaches; illustrating the ability of biomaterial strategies to significantly improve outcomes of gene therapies for neurodegenerative disorders.
C1 [Newland, Ben; Pandit, Abhay] Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Dowd, Eilis] Natl Univ Ireland Univ Coll Galway, Galway, Ireland.
RP Newland, B (reprint author), Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
OI Newland, Ben/0000-0002-5214-2604; Dowd, Eilis/0000-0002-2668-539X
FU Science Foundation of Ireland, Strategic Research Cluster (SRC)
   [07/SRC/B1163]
FX The authors wish to thank Science Foundation of Ireland, Strategic
   Research Cluster (SRC) (grant no. 07/SRC/B1163) for financial support.
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y
   Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952
   Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3
   Barati S, 2006, EXP NEUROL, V202, P179, DOI 10.1016/j.expneurol.2006.05.027
   BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8
   Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bensadoun JC, 2003, J CONTROL RELEASE, V87, P107, DOI 10.1016/S0168-3659(02)00353-X
   BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
   Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   Boado RJ, 2011, J DRUG DELIV, V2011, DOI DOI 10.1155/2011/296151
   BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076
   Bonoiu AC, 2011, NANOMEDICINE-UK, V6, P617, DOI [10.2217/NNM.11.20, 10.2217/nnm.11.20]
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104
   Browne S, 2012, MOL PHARMACEUT, V9, P3099, DOI 10.1021/mp300231d
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   Cardoso ALC, 2010, J CONTROL RELEASE, V142, P392, DOI 10.1016/j.jconrel.2009.11.004
   Cardoso ALC, 2008, J CONTROL RELEASE, V132, P113, DOI 10.1016/j.jconrel.2008.08.014
   Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a
   Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0
   Chu C, 2006, PHARM RES, V23, P1586, DOI 10.1007/s11095-006-0274-x
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Corso T. D., 2005, FOLIA MORPHOL, V64, P1130
   Corso TD, 2005, MOL BRAIN RES, V139, P361, DOI 10.1016/j.molbrainres.2005.05.032
   COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703
   Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d
   Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   da Cruz MTG, 2005, GENE THER, V12, P1242, DOI 10.1038/sj.gt.3302516
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Deyner R., 2012, PARKINSONS DIS, V2012, P1
   Doleski S, 2010, J BIOMED MATER RES A, V94A, P457, DOI 10.1002/jbm.a.32642
   Dong YX, 2010, POLYM CHEM-UK, V1, P827, DOI 10.1039/c0py00101e
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dunnett SB, 2011, CURR OPIN ORGAN TRAN, V16, P632, DOI 10.1097/MOT.0b013e32834c2356
   Emmett CJ, 1996, EXP NEUROL, V140, P151, DOI 10.1006/exnr.1996.0125
   Eriksdotter-Jonhagen M, 2012, DEMENT GERIATR COGN, V33, P18, DOI 10.1159/000336051
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761
   Fisher Lisa J., 1994, Current Opinion in Neurobiology, V4, P735, DOI 10.1016/0959-4388(94)90017-5
   Fjord-Larsen L, 2010, MOL THER, V18, P2164, DOI 10.1038/mt.2010.154
   Fletcher AM, 2011, NEUROSCIENCE, V194, P220, DOI 10.1016/j.neuroscience.2011.07.072
   Flintoft L, 2011, NAT REV GENET, V12, P296, DOI 10.1038/nrg2990
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Gash DM, 2005, ANN NEUROL, V58, P224, DOI 10.1002/ana.20549
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001
   Goula D, 1998, GENE THER, V5, P712, DOI 10.1038/sj.gt.3300635
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659
   Hecker JG, 2001, MOL THER, V3, P375, DOI 10.1006/mthe.2001.0272
   HEFTI F, 1986, J NEUROSCI, V6, P2155
   HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302
   Helary C, 2012, ACTA BIOMATER, V8, P4208, DOI 10.1016/j.actbio.2012.06.017
   Hoban DB, 2013, BRAIN BEHAV IMMUN, V27, P91, DOI 10.1016/j.bbi.2012.10.001
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOKFELT T, 1973, BRAIN RES, V53, P175, DOI 10.1016/0006-8993(73)90776-2
   Holladay C, 2010, NANOSCALE, V2, P2718, DOI 10.1039/c0nr00456a
   Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
   Huang RQ, 2008, BIOMATERIALS, V29, P238, DOI 10.1016/j.biomaterials.2007.09.024
   Huang RQ, 2010, J NEUROL SCI, V290, P123, DOI 10.1016/j.jns.2009.09.032
   Huang RQ, 2009, J GENE MED, V11, P754, DOI 10.1002/jgm.1361
   Humphries C, 2012, NATURE, V484, pS10, DOI 10.1038/nature11108
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Imaoka T, 1998, HUM GENE THER, V9, P1093, DOI 10.1089/hum.1998.9.7-1093
   Imaoka T, 1998, BRAIN RES, V780, P119, DOI 10.1016/S0006-8993(97)01142-6
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0
   Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246
   Kang CE, 2013, CELLS TISSUES ORGANS, V197, P55, DOI 10.1159/000339589
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Ke WL, 2009, BIOMATERIALS, V30, P6976, DOI 10.1016/j.biomaterials.2009.08.049
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Kim ID, 2010, J CONTROL RELEASE, V142, P422, DOI 10.1016/j.jconrel.2009.11.011
   Kim I, 2012, SPACE, P20
   Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.053683100
   Klejbor I, 2007, J NEUROSCI METH, V165, P230, DOI 10.1016/j.jneumeth.2007.06.011
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Ko YT, 2009, J CONTROL RELEASE, V133, P230, DOI 10.1016/j.jconrel.2008.10.013
   Kofler P, 1998, CELL TRANSPLANT, V7, P175, DOI 10.1016/S0963-6897(97)00162-0
   Kolli S, 2013, BIOCONJUGATE CHEM, V24, P314, DOI 10.1021/bc3004099
   Kotchey GP, 2012, ACCOUNTS CHEM RES, V45, P1770, DOI 10.1021/ar300106h
   KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108
   Kulkarni M. M., 2010, MOL PHARM, V8, P439
   Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086
   Lacerda L, 2008, ADV MATER, V20, P225, DOI 10.1002/adma.200702334
   Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005
   Lanfer B, 2010, TISSUE ENG PT A, V16, P1103, DOI [10.1089/ten.tea.2009.0282, 10.1089/ten.TEA.2009.0282]
   Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Lee M, 2005, PHARM RES, V22, P1, DOI 10.1007/s11095-004-9003-5
   LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0
   Lemkine GF, 1999, J DRUG TARGET, V7, P305, DOI 10.3109/10611869909085513
   Lemkine GF, 2002, MOL CELL NEUROSCI, V19, P165, DOI 10.1006/mcne.2001.1084
   LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534
   Levine RM, 2013, SOFT MATTER, V9, P985, DOI 10.1039/c2sm26633d
   Lewitus DY, 2011, BIOMATERIALS, V32, P5543, DOI 10.1016/j.biomaterials.2011.04.052
   Li Y, 2004, GENE THER, V11, P109, DOI 10.1038/sj.gt.3302135
   Li-Xin Z., 1992, NEUROREPORT, V3, P700
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557
   Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200
   Liu Y, 2009, BIOMATERIALS, V30, P4195, DOI 10.1016/j.biomaterials.2009.02.051
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   LOVENBERG W, 1962, J BIOL CHEM, V237, P89
   Lu KW, 2002, J NEUROTRAUM, V19, P1081, DOI 10.1089/089771502760341983
   Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Mahor S, 2011, CURR DRUG DELIV, V8, P354, DOI 10.2174/156720111795768031
   Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6
   Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009
   Martinez-Ramos C, 2012, J BIOMED MATER RES A, V100A, P3276, DOI 10.1002/jbm.a.34273
   Martres MP, 1998, EUR J NEUROSCI, V10, P3607, DOI 10.1046/j.1460-9568.1998.00366.x
   Mathupala SP, 2009, EXPERT OPIN THER PAT, V19, P137, DOI 10.1517/13543770802680195
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909
   Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040
   Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Mulcahy P, 2012, NEUROSCIENCE, V203, P170, DOI 10.1016/j.neuroscience.2011.12.011
   NAGATSU T, 1964, J BIOL CHEM, V239, P2910
   Nakaji-Hirabayashi T, 2009, BIOMATERIALS, V30, P4581, DOI 10.1016/j.biomaterials.2009.05.009
   Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y
   Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0
   Neu M, 2007, J CONTROL RELEASE, V124, P69, DOI 10.1016/j.jconrel.2007.08.009
   Newland B, 2013, ACS CHEM NEUROSCI, V4, P540, DOI 10.1021/cn4000023
   Newland B, 2013, BIOMATERIALS, V34, P2130, DOI 10.1016/j.biomaterials.2012.11.049
   Newland B, 2012, J AM CHEM SOC, V134, P4782, DOI 10.1021/ja2105575
   Newland B, 2010, CHEM COMMUN, V46, P4698, DOI 10.1039/c0cc00439a
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Nouri A, 2012, J MATER SCI-MATER M, V23, P2967, DOI 10.1007/s10856-012-4753-9
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Nunes A, 2012, J CONTROL RELEASE, V161, P290, DOI 10.1016/j.jconrel.2012.03.026
   Nunes A, 2012, NANOMEDICINE-UK, V7, P1485, DOI [10.2217/NNM.12.33, 10.2217/nnm.12.33]
   O'Mahony AM, 2012, ACS CHEM NEUROSCI, V3, P744, DOI 10.1021/cn3000372
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oh S, 2007, J NEUROSURG, V107, P136, DOI 10.3171/JNS-07/07/0136
   ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Ozbas-Turan S, 2003, J PHARM PHARM SCI, V6, P27
   Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Palmgren B, 2012, EXP NEUROL, V235, P599, DOI 10.1016/j.expneurol.2012.03.014
   Pandita D, 2011, BIOMACROMOLECULES, V12, P472, DOI 10.1021/bm1012647
   Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913
   Perez AP, 2012, INT J NANOMED, V7, P1373, DOI 10.2147/IJN.S28261
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920
   Qian Y, 2013, BIOMATERIALS, V34, P2117, DOI 10.1016/j.biomaterials.2012.11.050
   Raemdonck K, 2009, SOFT MATTER, V5, P707, DOI 10.1039/b811923f
   Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2
   Reis AV, 2006, POLYMER, V47, P2023, DOI 10.1016/j.polymer.2006.01.058
   Rethore G, 2009, TISSUE ENG PART C-ME, V15, P605, DOI [10.1089/ten.tec.2008.0581, 10.1089/ten.TEC.2008.0581]
   Roam JL, 2010, BIOMATERIALS, V31, P8642, DOI 10.1016/j.biomaterials.2010.07.085
   Roberts MJ, 2012, ADV DRUG DELIVER REV, V64, P116, DOI 10.1016/j.addr.2012.09.025
   ROESSLER BJ, 1994, NEUROSCI LETT, V167, P5, DOI 10.1016/0304-3940(94)91015-4
   Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066
   Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101
   SABATE O, 1995, NAT GENET, V9, P256, DOI 10.1038/ng0395-256
   Saeed AO, 2012, CHEM COMMUN, V48, P585, DOI 10.1039/c1cc16538k
   Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006
   Saltzman WM, 1999, PHARMACEUT RES, V16, P232, DOI 10.1023/A:1018824324275
   Santos JL, 2010, J CONTROL RELEASE, V144, P55, DOI 10.1016/j.jconrel.2010.01.034
   Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877
   Schallon A, 2010, REACT FUNCT POLYM, V70, P1, DOI 10.1016/j.reactfunctpolym.2009.09.006
   Schellinger JG, 2013, BIOMATERIALS, V34, P2318, DOI 10.1016/j.biomaterials.2012.09.072
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Schwartz B, 1995, HUM GENE THER, V6, P1515, DOI 10.1089/hum.1995.6.12-1515
   Segovia J, 1998, GENE THER, V5, P1650, DOI 10.1038/sj.gt.3300776
   Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861
   Shi NY, 2001, PHARMACEUT RES, V18, P1091, DOI 10.1023/A:1010910523202
   Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497
   Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098
   Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x
   Sinha S, 2000, ANN NY ACAD SCI, V920, P206
   Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216
   SLEVIN JT, 2006, NEUROSURG FOCUS, V20, P1
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638
   Stachowiak EK, 2009, INTEGR BIOL, V1, P394, DOI 10.1039/b902617g
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Synatschke CV, 2011, BIOMACROMOLECULES, V12, P4247, DOI 10.1021/bm201111d
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tan JJ, 2011, POLYM CHEM-UK, V2, P672, DOI 10.1039/c0py00348d
   Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874
   Tang GP, 2003, BIOMATERIALS, V24, P2351, DOI 10.1016/S0142-9612(03)00029-2
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Tornqvist N, 2000, EXP NEUROL, V164, P130, DOI 10.1006/exnr.2000.7411
   de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019
   Tu CL, 2013, POLYM CHEM-UK, V4, P393, DOI 10.1039/c2py20523h
   Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Voges Jurgen, 2002, J Exp Ther Oncol, V2, P70, DOI 10.1046/j.1359-4117.2002.01012.x
   Wang S, 2001, MOL THER, V3, P658, DOI 10.1006/mthe.2001.0324
   Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629
   Wei H, 2012, J AM CHEM SOC, V134, P16554, DOI 10.1021/ja3085803
   WILLIAMS LR, 1991, EXP NEUROL, V113, P31, DOI 10.1016/0014-4886(91)90143-Z
   WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231
   Winkler J, 1997, ANN NEUROL, V41, P82, DOI 10.1002/ana.410410114
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Writer MJ, 2012, J CONTROL RELEASE, V162, P340, DOI 10.1016/j.jconrel.2012.07.002
   Wu DQ, 2008, BIOMACROMOLECULES, V9, P1155, DOI 10.1021/bm7010328
   Xia CF, 2008, J GENE MED, V10, P306, DOI 10.1002/jgm.1152
   Xia CF, 2007, J GENE MED, V9, P605, DOI 10.1002/jgm.1046
   Xu CY, 2007, POLYM BULL, V58, P53, DOI 10.1007/s00289-006-0597-0
   Yamasaki Yasundo, 1996, Keio Journal of Medicine, V45, P225
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yao L, 2012, DRUG DISCOV TODAY, V17, P998, DOI 10.1016/j.drudis.2012.05.009
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yurek DM, 2011, MOL IMAGING, V10, P327, DOI 10.2310/7290.2010.00053
   Yurek DM, 2009, CELL TRANSPLANT, V18, P1183, DOI 10.3727/096368909X12483162196881
   Yurek DM, 2009, MOL THER, V17, P641, DOI 10.1038/mt.2009.2
   Zeng JM, 2007, BIOMATERIALS, V28, P1443, DOI 10.1016/j.biomaterials.2006.11.015
   Zhang JJ, 2011, ADV MATER, V23, P5098, DOI 10.1002/adma.201103349
   Zhang J, 2009, POLYMER, V50, P2516, DOI 10.1016/j.polymer.2009.03.044
   Zhang LX, 1997, NEUROSCIENCE, V77, P15, DOI 10.1016/S0306-4522(96)00420-4
   ZHANG LX, 1993, NEUROPEPTIDES, V25, P73, DOI 10.1016/0143-4179(93)90072-I
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
   Zhang Y, 2003, MOL VIS, V9, P465
   Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740
   Zhang Y, 2004, HUM GENE THER, V15, P339, DOI 10.1089/104303404322959498
   Zhang Y, 2003, MOL THER, V7, P11, DOI 10.1016/S1525-0016(02)00018-7
   Zhang Y, 2003, HUM GENE THER, V14, P1, DOI 10.1089/10430340360464660
   Zhang Y, 2008, PHARM RES-DORD, V25, P400, DOI 10.1007/s11095-007-9357-6
   Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111
   Zheng Y, 2012, CHEM COMMUN, V48, P3085, DOI 10.1039/c2cc17780c
   Zheng Y, 2011, J AM CHEM SOC, V133, P13130, DOI 10.1021/ja2039425
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
   Zhu CN, 2004, J GENE MED, V6, P906, DOI 10.1002/jgm.579
   Zietlow R, 2005, J ANAT, V207, P227, DOI 10.1111/j.1469-7580.2005.00449.x
   Zietlow R, 2012, EXP NEUROL, V235, P563, DOI 10.1016/j.expneurol.2012.03.010
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 267
TC 14
Z9 14
U1 1
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 6
BP 556
EP 576
DI 10.1039/c3bm60030k
PG 21
WC Materials Science, Biomaterials
SC Materials Science
GA 295SD
UT WOS:000330134900001
DA 2018-10-20
ER

PT J
AU Bye, FJ
   Bissoli, J
   Black, L
   Bullock, AJ
   Puwanun, S
   Moharamzadeh, K
   Reilly, GC
   Ryan, AJ
   MacNeil, S
AF Bye, Frazer J.
   Bissoli, Julio
   Black, Leanne
   Bullock, Anthony J.
   Puwanun, Sasima
   Moharamzadeh, Keyvan
   Reilly, Gwendolen C.
   Ryan, Anthony J.
   MacNeil, Sheila
TI Development of bilayer and trilayer nanofibrous/microfibrous scaffolds
   for regenerative medicine
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS;
   TISSUE ENGINEERING SCAFFOLDS; XENOBIOTIC-FREE CULTURE; POLYCAPROLACTONE
   SCAFFOLDS; HYDROLYTIC DEGRADATION; HUMAN KERATINOCYTES; BUCCAL MUCOSA;
   POLYMERS; DEVICES
AB Many biomaterial scaffolds have been developed for use in tissue engineering usually for populating with a single cell-type. In this study we demonstrate the production of bilayer and trilayer nanofibrous/microfibrous biodegradable scaffolds suitable for the support, proliferation and yet segregation of different tissues - here used to separate soft tissue from bone forming tissue and keratinocytes from fibroblasts. Essentially we describe a nanofibre barrier membrane which is permeable to nutrients coupled with attached microfibers (either on one side or both sides) to support the proliferation of different cell types either side but prevents migration of cells across the barrier. Such membranes would be suitable for guided tissue regeneration in areas where one wishes to support both soft and hard tissues but keep them separated. We describe a sterile bilayer membrane electrospun from polyhydroxybutyrate-co-hydroxyvalerate (PHBV) (nanofibres) and polylactic acid (PLA) or poly e-caprolactone (PCL) (microfibres) and a trilayer membrane electrospun in layers of PLA, PHBV, then PLA. These membranes are biocompatible, biodegradable and capable of supporting two different cell populations.
C1 [Bye, Frazer J.; Bissoli, Julio; Black, Leanne; Bullock, Anthony J.; Puwanun, Sasima; Reilly, Gwendolen C.; MacNeil, Sheila] Univ Sheffield, Kroto Res Inst, Sheffield S7 1LN, S Yorkshire, England.
   [Moharamzadeh, Keyvan] Univ Sheffield, Sch Clin Dent, Acad Unit Restorat Dent, Sheffield S10 2TA, S Yorkshire, England.
   [Ryan, Anthony J.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
RP Bye, FJ (reprint author), Univ Sheffield, Kroto Res Inst, Broad Lane, Sheffield S7 1LN, S Yorkshire, England.
EM k.moharamzadeh@sheffield.ac.uk; a.ryan@sheffield.ac.uk;
   s.macneil@sheffield.ac.uk
RI Ryan, Anthony/D-9294-2016
OI Ryan, Anthony/0000-0001-7737-0526; Moharamzadeh,
   Keyvan/0000-0002-8842-4638; Bullock, Anthony/0000-0003-0579-3997
FU BBSRC; Narusuan University
FX We thank the BBSRC for funding a PhD for Frazer Bye and the Narusuan
   University for funding a PhD for Sasima Puwanun.
CR Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2004.04723.x
   Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Bornstein M., 1994, 20 YEARS GUIDED BONE, P86
   Bullock AJ, 2006, TISSUE ENG, V12, P245, DOI 10.1089/ten.2006.12.245
   Bye FJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4172
   Canton I, 2010, BIOTECHNOL BIOENG, V105, P396, DOI 10.1002/bit.22530
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   D'Agnostino, 2009, US Pat., Patent No. 20090112259
   de Peppo GM, 2010, TISSUE ENG PT A, V16, P3413, DOI [10.1089/ten.tea.2010.0052, 10.1089/ten.TEA.2010.0052]
   Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12
   DULLIEN FAL, 1979, POROUS MEDIA FLUID T
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Griffith LG, 2001, JAMA-J AM MED ASSOC, V285, P556, DOI 10.1001/jama.285.5.556
   Guarino V, 2008, BIOMATERIALS, V29, P3662, DOI 10.1016/j.biomaterials.2008.05.024
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hu JA, 2010, TISSUE ENG PT A, V16, P3507, DOI [10.1089/ten.tea.2010.0097, 10.1089/ten.TEA.2010.0097]
   Ikada Y., 2006, INTERFACE, V3, P589, DOI DOI 10.1098/RSIF.2006.0124
   Ivanovski S, 2009, AUST DENT J, V54, pS118, DOI 10.1111/j.1834-7819.2009.01150.x
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Karlsson C., 2009, STEM CELL RES, P39
   Langford RJ, 2003, PLAST RECONSTR SURG, V111, P1591, DOI 10.1097/01.PRS.0000057971.87632.37
   Larrick JW, 2010, REJUV RES, V13, P265, DOI 10.1089/rej.2009.0969
   Li HY, 2008, J MATER SCI-MATER M, V19, P67, DOI 10.1007/s10856-007-3170-y
   Lilja J, 2003, Scand J Surg, V92, P269
   Lundgren D, 1999, J CLIN PERIODONTOL, V26, P56, DOI 10.1034/j.1600-051X.1999.260110.x
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moreau JL, 2007, J ORAL MAXIL SURG, V65, P2503, DOI 10.1016/j.joms.2007.06.648
   Mossey P., 2004, WHO M INT COLL RES C
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   NELLHAUS G, 1968, PEDIATRICS, V41, P106
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rowinski W, 2007, ANN TRANSPL, V12, P5
   Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Schantz JT, 2003, TISSUE ENG, V9, pS113, DOI 10.1089/10763270360697021
   SCHANTZ JT, 2006, NEUROSURGERY, V58
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Shishatskaya E., 2001, DOKL AKAD NAUK, V383, P109
   SOMMERLAD BC, 1989, J ROY SOC MED, V82, P677
   Suggs L.J., 2007, PHYS PROPERTIES POLY, P939
   Sun T, 2004, WOUND REPAIR REGEN, V12, P626, DOI 10.1111/j.1067-1927.2004.12609.x
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Terada S, 2000, YONSEI MED J, V41, P685, DOI 10.3349/ymj.2000.41.6.685
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Warnke PH, 2006, LANCET, V368, P181, DOI 10.1016/S0140-6736(06)68937-X
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   Yen A., 2010, GERONTOLOGY, V57, P85
NR 60
TC 26
Z9 26
U1 1
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 9
BP 942
EP 951
DI 10.1039/c3bm60074b
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 295SY
UT WOS:000330137000006
DA 2018-10-20
ER

PT J
AU Zhou, CC
   Hong, YL
   Zhang, XD
AF Zhou, Changchun
   Hong, Youliang
   Zhang, Xingdong
TI Applications of nanostructured calcium phosphate in tissue engineering
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; POLY(VINYL ALCOHOL) HYDROGEL;
   ARTICULAR-CARTILAGE REPAIR; NITRIC-OXIDE SYNTHASE; OSTEOBLAST-LIKE
   CELLS; MONOCYTES IN-VITRO; HYDROXYAPATITE NANOPARTICLES; NANOCRYSTALLINE
   HYDROXYAPATITE; NANO-HYDROXYAPATITE; POROUS HYDROXYAPATITE
AB Nanostructured calcium phosphate (CaP) is an important biomaterial for hard tissue repair with potential applications in some soft tissues as reported by recent studies. Herein, we shed light on recent research progress with respect to the biological effects of nanostructured CaP in some specific biological systems, including bone, cartilage, blood vessels, and nerve repair or regeneration. Specific cellular and molecular biological effects of nanostructured CaP and nanostructured CaP-based composites on numerous types of cells are summarized. Finally, the cytotoxicity and inflammatory response of nanostructured CaP are discussed.
C1 [Zhou, Changchun; Hong, Youliang; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Hong, YL (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM hyl@scu.edu.cn
FU National High-tech RD Program [2011AA030105]; National Natural Science
   Foundation of China [31170928]; Youth Scholar Fund [20090181120078]
FX The authors wish to express their appreciation to Professor Wei Li and
   Mr. Russell Borduin from the University of Texas at Austin for their
   helpful suggestions and criticism. This work was supported by The
   National High-tech R&D Program (2011AA030105), The National Natural
   Science Foundation of China (Grant 31170928) and The Youth Scholar Fund
   (20090181120078).
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Adele B., 2003, OSTEOPOROS INT S5, V14, pS
   Albrecht C, 2009, TOXICOL IN VITRO, V23, P520, DOI 10.1016/j.tiv.2009.01.005
   Alghamdi HS, 2013, CLIN ORAL IMPLAN RES, V24, P475, DOI 10.1111/j.1600-0501.2011.02409.x
   Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Barralet JE, 2004, J MATER SCI-MATER M, V15, P407, DOI 10.1023/B:JMSM.0000021111.48592.ab
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   BARRON KD, 1975, J NEUROPATH EXP NEUR, V34, P222, DOI 10.1097/00005072-197505000-00002
   Blake T, 1998, J TOXICOL ENV HEAL A, V54, P243
   Bongio M, 2011, Eur Cell Mater, V22, P359
   Bose S, 2010, ACTA BIOMATER, V6, P3782, DOI 10.1016/j.actbio.2010.03.016
   Boskey A, 2003, OSTEOPOROSIS INT, V14, pS16, DOI 10.1007/s00198-003-1468-2
   Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Cantara S, 2004, FASEB J, V18, P1943, DOI 10.1096/fj.04-2114fje
   Catledge SA, 2002, J NANOSCI NANOTECHNO, V2, P293, DOI 10.1166/jnn.2002.116
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chan CK, 2006, NANOMEDICINE-UK, V1, P177, DOI 10.2217/17435889.1.2.177
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   CHEN F, 2012, NANO BIOMED ENG, V4, P41, DOI DOI 10.5101/NBE.V4I1.P41-49
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Cheng L, 2006, KEY ENG MAT, V309-311, P943, DOI 10.4028/www.scientific.net/KEM.309-311.943
   Choi SW, 2010, LANGMUIR, V26, P12126, DOI 10.1021/la101519b
   Chu SH, 2012, INT J NANOMED, V7, P3659, DOI 10.2147/IJN.S33584
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   Costa DO, 2012, ACS APPL MATER INTER, V4, P1490, DOI 10.1021/am201735k
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Donnini S, 2002, ANTIOXID REDOX SIGN, V4, P817, DOI 10.1089/152308602760598972
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   E. Commission, 2007, SCI COMM EM NEWL ID
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Epple M, 2010, J MATER CHEM, V20, P18, DOI 10.1039/b910885h
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Fu Q, 2005, J BIOMED MATER RES A, V74A, P156, DOI 10.1002/jbm.a.30322
   Fu Q, 2008, J BIOMATER APPL, V23, P37, DOI 10.1177/0885328207081350
   Fu QN, 2004, J MATER SCI-MATER M, V15, P1333, DOI 10.1007/s10856-004-5742-4
   Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528
   Gaiser BK, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S2
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Grandjean-Laquerriere A, 2005, BIOMATERIALS, V26, P2361, DOI 10.1016/j.biomaterials.2004.07.036
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011
   GUENTHER HL, 1986, ENDOCRINOLOGY, V119, P193, DOI 10.1210/endo-119-1-193
   Guha AK, 2009, COLLOID SURFACE B, V73, P146, DOI 10.1016/j.colsurfb.2009.05.009
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501
   Han YJ, 2007, BIOFACTORS, V30, P205, DOI 10.1002/biof.5520300402
   Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041
   Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   Hayakawa S, 2009, ACTA BIOMATER, V5, P2152, DOI 10.1016/j.actbio.2009.02.018
   Heijnen HFG, 2004, J HISTOCHEM CYTOCHEM, V52, P1277, DOI 10.1369/jhc4A6307.2004
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Huang Y, 2012, NANOSCALE, V4, P2484, DOI 10.1039/c2nr12072k
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Jin XB, 2008, J BIOMED MATER RES A, V86A, P1077, DOI 10.1002/jbm.a.31656
   Kamitakahara M, 2012, COLLOID SURFACE B, V97, P236, DOI 10.1016/j.colsurfb.2012.03.033
   Kandori K, 2011, J PHYS CHEM B, V115, P653, DOI 10.1021/jp110441e
   Kasaj A, 2012, CLIN ORAL INVEST, V16, P745, DOI 10.1007/s00784-011-0570-7
   Kasaj Adrian, 2008, J Oral Sci, V50, P279, DOI 10.2334/josnusd.50.279
   Kateb B, 2011, NEUROIMAGE, V54, pS106, DOI 10.1016/j.neuroimage.2010.01.105
   Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0
   Kilian O, 2005, GROWTH FACTORS, V23, P125, DOI 10.1080/08977190500126306
   Kim DW, 2010, LANGMUIR, V26, P384, DOI 10.1021/la902157z
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Leeuwenburgh SCG, 2007, J BIOMAT SCI-POLYM E, V18, P1547
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Li B, 2008, APPL SURF SCI, V255, P357, DOI 10.1016/j.apsusc.2008.06.114
   Li S., 1996, BIOCERAMICS, V9, P225
   Lin KL, 2007, CERAM INT, V33, P979, DOI 10.1016/j.ceramint.2006.02.011
   Liu ML, 2012, NANOSCALE, V4, P3201, DOI 10.1039/c2nr30072a
   Liu Xiao xuan, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P185
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Liu ZS, 2003, WORLD J GASTROENTERO, V9, P1968, DOI 10.3748/wjg.v9.i9.1968
   Loo SCJ, 2010, CURR PHARM BIOTECHNO, V11, P333, DOI 10.2174/138920110791233343
   Lu YP, 2008, ACTA BIOMATER, V4, P1865, DOI 10.1016/j.actbio.2008.05.016
   Merz DC, 2001, GENETICS, V158, P1071
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Morbidelli L, 2003, CURR PHARM DESIGN, V9, P521, DOI 10.2174/1381612033391405
   Moriarty P, 2001, REP PROG PHYS, V64, P297, DOI 10.1088/0034-4885/64/3/201
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Nan AJ, 2008, NANO LETT, V8, P2150, DOI 10.1021/nl0802741
   Nelson M, 2006, INT J NANOMED, V1, P339
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2010, J MATER SCI, V45, P5495, DOI 10.1007/s10853-010-4607-0
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Perez RA, 2013, J TISSUE ENG REGEN M, V7, P353, DOI 10.1002/term.530
   Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191
   Pezzatini S, 2006, J BIOMED MATER RES A, V76A, P656, DOI 10.1002/jbm.a.30524
   Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016
   Phillips MJ, 2003, J MATER SCI-MATER M, V14, P875, DOI 10.1023/A:1025682626383
   Qing FZ, 2012, J MATER SCI-MATER M, V23, P2245, DOI 10.1007/s10856-012-4703-6
   RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Richardson PG, 2012, LEUKEMIA, V26, P595, DOI 10.1038/leu.2011.346
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rogel MR, 2008, J MATER CHEM, V18, P4233, DOI 10.1039/b804692a
   Roohani-Esfahani SI, 2011, ACTA BIOMATER, V7, P1307, DOI 10.1016/j.actbio.2010.10.015
   Samee M, 2008, J PHARMACOL SCI, V108, P18, DOI 10.1254/jphs.08036FP
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Schouten C, 2010, ACTA BIOMATER, V6, P2227, DOI 10.1016/j.actbio.2009.11.030
   Sethuraman S, 2007, J BIOMED MATER RES A, V82A, P884, DOI 10.1002/jbm.a.31277
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Shibli SMA, 2009, J MATER SCI-MATER M, V20, P711, DOI 10.1007/s10856-008-3629-5
   Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Streicher RM, 2007, NANOMEDICINE-UK, V2, P861, DOI 10.2217/17435889.2.6.861
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suh WH, 2009, PROG NEUROBIOL, V87, P133, DOI 10.1016/j.pneurobio.2008.09.009
   Syed S, 2013, CURR ALLERGY ASTHM R, V13, P50, DOI 10.1007/s11882-012-0302-3
   Sylvie J, 2010, J BIOMED NANOTECHNOL, V6, P158, DOI 10.1166/jbn.2010.1109
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Tan K, 2007, GENE THER, V14, P828, DOI 10.1038/sj.gt.3302937
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   Tang XD, 2010, INT J CANCER, V126, P90, DOI 10.1002/ijc.24710
   Tudorachi N, 2011, J POLYM ENVIRON, V19, P546, DOI 10.1007/s10924-011-0282-8
   Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440
   Wang LJ, 2006, BIOINTERPHASES, V1, P106, DOI 10.1116/1.2354575
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Xia XR, 2010, NAT NANOTECHNOL, V5, P671, DOI [10.1038/NNANO.2010.164, 10.1038/nnano.2010.164]
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Xu JL, 2009, BIOMATERIALS, V30, P5385, DOI 10.1016/j.biomaterials.2009.07.002
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Yudoh K, 2007, ARTHRITIS RHEUM, V56, P3307, DOI 10.1002/art.22917
   Zeng S, 2011, J BIOMED NANOTECHNOL, V7, P549, DOI 10.1166/jbn.2011.1316
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhao XX, 2013, ARCH TOXICOL, V87, P1037, DOI 10.1007/s00204-012-0827-1
   Zhao X, 2013, SMALL, V9, P1734, DOI 10.1002/smll.201200639
   Zhao XX, 2011, NANOTOXICOLOGY, V5, P182, DOI 10.3109/17435390.2010.503943
   Zhao YT, 2011, J NANOSCI NANOTECHNO, V11, P11069, DOI 10.1166/jnn.2011.3946
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu XD, 2012, J BIOMED MATER RES B, V100B, P516, DOI 10.1002/jbm.b.31978
   Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
   Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606
NR 172
TC 22
Z9 23
U1 8
U2 67
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 10
BP 1012
EP 1028
DI 10.1039/c3bm60058k
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA 295TF
UT WOS:000330137700001
DA 2018-10-20
ER

PT J
AU Chung, C
   Pruitt, BL
   Heilshorn, SC
AF Chung, Cindy
   Pruitt, Beth L.
   Heilshorn, Sarah C.
TI Spontaneous cardiomyocyte differentiation of mouse embryoid bodies
   regulated by hydrogel crosslink density
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SUBSTRATE STIFFNESS AFFECTS; STEM-CELL DIFFERENTIATION; MATRIX
   METALLOPROTEINASES; CARDIAC MYOCYTES; BODY FORMATION; IN-VITRO; 3D;
   HEART; BIOMATERIAL; PHENOTYPE
AB Cellular therapies have great potential to provide alternative treatment options for those suffering from heart disease. In order to optimize cell delivery for therapeutic efficacy, a greater understanding of parameters that impact stem cell differentiation, survival, growth, and development are needed. In this study, we examine the role of hydrogel crosslink density on spontaneous cardiomyocyte (CM) differentiation of murine embryoid bodies (EBs). CM differentiation was accelerated in hydrogels of low crosslink density, where 100% of the hydrogels were positive for CM differentiation compared to only 53% in the high crosslink density group after 8 days of culture. DNA microarray data suggests that enhanced CM differentiation in the low crosslink density hydrogels was not tissue specific but rather a result of favoured EB development and cell proliferation. Additionally, enhanced EB growth and differentiation in low crosslink density hydrogels was independent of RGD ligand density and not a consequence of enhanced diffusion. We also demonstrate that matrix metalloproteinase activity is required for spontaneous CM differentiation in 3D hydrogels. Low hydrogel crosslink density regulates spontaneous EB differentiation by promoting EB growth and development. Elucidating the effects of microenvironmental cues on cell differentiation can aid in the optimization of stem cell-based therapies for tissue regeneration.
RP Chung, C (reprint author), McCullough Bldg,476 Lomita Mall, Stanford, CA USA.
EM heilshorn@stanford.edu
OI Pruitt, Beth L./0000-0002-4861-2124
FU NIH [1DP2OD006477, 1R01 DK0085720, 1R21AR06235901]; NSF [DMR-0846363,
   EFRI-CBE 0735551]; AHA [10POST4190103]
FX The authors thank R. T. Lee and R. D. Kamm for the generous gift of
   mouse ESCs that express EGFP under transcriptional control of a
   cardiac-specific promoter (alpha-myosin heavy chain), Karen Dubbin for
   help with FRAP experiments, and Rebecca Taylor for helpful discussions.
   Additionally, the authors thank the Stanford Functional Genomics
   Facility and Vida Shokoohi for help in generating DNA microarray data.
   The authors acknowledge funding support from NIH 1DP2OD006477 (SCH), NIH
   1R01 DK0085720 (SCH), NIH 1R21AR06235901 (SCH), NSF DMR-0846363 (SCH),
   NSF EFRI-CBE 0735551 (BLP) and AHA 10POST4190103 (CC).
CR Augustin S, 2009, ANTICANCER RES, V29, P1335
   Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951
   Bax NAM, 2012, J MOL CELL CARDIOL, V53, P497, DOI 10.1016/j.yjmcc.2012.07.003
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419
   Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655
   Chung C, 2012, BIOMACROMOLECULES, V13, P3912, DOI 10.1021/bm3015279
   Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Giobbe GG, 2012, BIOTECHNOL BIOENG, V109, P3119, DOI 10.1002/bit.24571
   He WJ, 2012, BIOL PHARM BULL, V35, P308, DOI 10.1248/bpb.35.308
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lloyd-Jones D, 2009, CIRCULATION, V121, pe46
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Sargent CY, 2010, BIOTECHNOL BIOENG, V105, P611, DOI 10.1002/bit.22578
   Schukur L, 2013, ADV HEALTHC MATER, V2, P195, DOI 10.1002/adhm.201200194
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
NR 45
TC 12
Z9 12
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2013
VL 1
IS 10
BP 1082
EP 1090
DI 10.1039/c3bm60139k
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 295TF
UT WOS:000330137700009
PM 24748962
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kulkova, J
   Abdulmajeed, AA
   Kononen, E
   Narhi, TO
AF Kulkova, Julia
   Abdulmajeed, Aous A.
   Kononen, Eija
   Narhi, Timo O.
TI Biofilm medium leads to apatite formation on bioactive surfaces
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Bioactive glass; Bioactive implants surfaces; Bacterial-biofilm growing
   medium; Simulated body fluid; Apatite formation
ID GLASS MICROSPHERES; BONE-FORMATION; GENE-TRANSFER; ENHANCEMENT; 45S5
AB Purpose: When investigating apatite formation on biomaterial surfaces, simulated body fluid (SBF) is used as an in vitro solution, however, it does not provide an appropriate environment for the growth of bacterial biofilm. The aim of the present study was to compare the bioactivity in terms of apatite formation on two bioactive glass (BAG) composite surfaces using both SBF and bacterial-biofilm growing medium (BM).
   Methods: Polymer composite substrates with different percentages of BAG-particles (50% and 75% by weight) were prepared. Plain resin substrates were used as a negative control. The substrates were immersed in SBF and BM for 3 days. The surface and, subsequently, the cross-sections of the substrates were examined with scanning electron microscopy (SEM) and x-ray energy dispersive spectroscopy (EDS).
   Results: All the investigated BAG-composite surfaces showed apatite formation after immersion in SBF and BM liquid media.
   Conclusions: The use of BM is a promising method for studies involving simultaneous biofilm growth and apatite formation on bioactive surfaces.
C1 [Kulkova, Julia; Kononen, Eija] Univ Turku, Inst Dent, Dept Periodontol, FI-20520 Turku, Finland.
   [Abdulmajeed, Aous A.; Narhi, Timo O.] Univ Turku, Inst Dent, Dept Prosthet Dent, FI-20520 Turku, Finland.
   [Abdulmajeed, Aous A.] Univ Turku, Inst Dent, Finnish Doctoral Program Oral Sci FINDOS, FI-20520 Turku, Finland.
   [Kulkova, Julia; Abdulmajeed, Aous A.; Narhi, Timo O.] Univ Turku, Turku Clin Biomat Ctr TCBC, FI-20520 Turku, Finland.
   [Narhi, Timo O.] Univ Turku, Cent Hosp, Clin Oral Dis, FI-20520 Turku, Finland.
RP Kulkova, J (reprint author), Univ Turku, Turku Clin Biomat Ctr TCBC, Itainen Pitkakatu 4B, FI-20520 Turku, Finland.
EM julia.kulkova@utu.fi
FU Centre for International Mobility, Helsinki; CIMO Fellowship/ws14
   [TM-11-7802]
FX Centre for International Mobility, P.O.Box 343, Hakanlemenranta 6,
   FI-00531, Helsinki. TM-11-7802 CIMO Fellowship/ws14.
CR Allan I, 2002, CLIN ORAL IMPLAN RES, V13, P53, DOI 10.1034/j.1600-0501.2002.130106.x
   Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Prabhakar A R, 2010, Indian J Dent Res, V21, P30, DOI 10.4103/0970-9290.62807
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Stoor P, 1996, MICROB ECOL HEALTH D, V9, P109, DOI 10.1002/(SICI)1234-987X(199605)9:3<109::AID-MEH417>3.3.CO;2-M
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
NR 13
TC 3
Z9 3
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2013
VL 11
IS 2
BP 95
EP 98
DI 10.5301/JABFM.5000154
PG 4
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 290XQ
UT WOS:000329792300004
PM 23728537
DA 2018-10-20
ER

PT S
AU Cornock, R
   Beirne, S
   Wallace, GG
AF Cornock, Rhys
   Beirne, Stephen
   Wallace, Gordon G.
GP IEEE
TI Development of a Coaxial Melt Extrusion Printing Process for Specialised
   Composite Bioscaffold Fabrication
SO 2013 IEEE/ASME INTERNATIONAL CONFERENCE ON ADVANCED INTELLIGENT
   MECHATRONICS (AIM): MECHATRONICS FOR HUMAN WELLBEING
SE IEEE ASME International Conference on Advanced Intelligent Mechatronics
LA English
DT Proceedings Paper
CT IEEE/ASME International Conference on Advanced Intelligent Mechatronics
   (AIM) - Mechatronics for Human Wellbeing
CY JUL 09-12, 2013
CL Wollongong, AUSTRALIA
SP IEEE, ASME, RA, IES, DSC, Univ Wollongong, Engn Mfg, Def Mat Technol Ctr, ARC Ctr Excellence Electromaterials Sci, Engineers Australia, Robot Soc Japan, Univ Wollongong, Smart Infrastructure Facil, BesTech Sensors & Instrumentat, Universal Tech Training Serv, Tech & Sci Equipment
ID SCAFFOLDS; DESIGN
AB The increased popularity of Additive Fabrication (AF) processing techniques in recent years has catalysed its application in a wide range of research disciplines. The use of Solid Freeform Fabrication (SFF) as a technique for the synthesis of functional biomaterial scaffolds for tissue engineering implants epitomises the level of specialisation, as well as the diversity in application, that is possible through the utilisation of an additive approach. While these scaffolds can provide ideal cellular interfaces and be impregnated with growth factors and electrically conducting nanomaterials, the processing itself provides only minimal flexibility with respect to the number of composite materials which can be implemented to reach these targets of function. In this work, a method for the Coaxial Melt Extrusion Printing (CMEP) of multifunctional, conductive and biocompatible co-fibres is presented. This allows for the coupling of two materials into an encapsulated core and shell configuration, and their subsequent extrusion into complex scaffold and path-oriented architectures. Selective Laser Melting was implemented to produce a high resolution stainless steel 316L coaxial extrusion nozzle, exhibiting diameters of 300 mu m/900 mu m for the inner and outer nozzles respectively. Following post processing, this component was employed as the cornerstone technology for the development of a computer numerically controlled coaxial extrusion printing system.
C1 [Cornock, Rhys; Beirne, Stephen; Wallace, Gordon G.] Univ Wollongong, IPRI, AIIM, Wollongong, NSW 2500, Australia.
RP Cornock, R (reprint author), Univ Wollongong, IPRI, AIIM, Wollongong, NSW 2500, Australia.
EM gwallace@uow.edu.au
RI Beirne, Stephen/I-6775-2013; Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]
   Foroughi J, 2011, J MATER CHEM, V21, P6421, DOI 10.1039/c0jm04406g
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631
   Park SH, 2012, J MATER SCI-MATER M, V23, P2671, DOI 10.1007/s10856-012-4738-8
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Rao RV, 2007, J MATER PROCESS TECH, V194, P81, DOI 10.1016/j.jmatprotec.2007.04.003
   Realizer, SLM 50 DESKT MACH
   Sayyar S., 2012, 15 INT C ADV MAT PRO
   Sayyar S, 2013, CARBON, V52, P296, DOI 10.1016/j.carbon.2012.09.031
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Wallace G. G., 2012, ORGANIC BIONICS
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Wehmoller M, 2005, INT CONGR SER, V1281, P690, DOI 10.1016/j.ics.2005.03.155
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
NR 23
TC 4
Z9 4
U1 2
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2159-6255
BN 978-1-4673-5320-5
J9 IEEE ASME INT C ADV
PY 2013
BP 973
EP 978
PG 6
WC Engineering, Electrical & Electronic; Robotics
SC Engineering; Robotics
GA BJK74
UT WOS:000328705300162
DA 2018-10-20
ER

PT J
AU Tymczyna, L
   Chmielowiec-Korzeniowska, A
   Paluszak, Z
   Dobrowolska, M
   Banach, M
   Pulit, J
AF Tymczyna, Leszek
   Chmielowiec-Korzeniowska, Anna
   Paluszak, Zbigniew
   Dobrowolska, Magadalena
   Banach, Marcin
   Pulit, Jolanta
TI The use of oak chips and coconut fiber as biofilter media to remove vocs
   in rendering process
SO ACTA BIOCHIMICA POLONICA
LA English
DT Article; Proceedings Paper
CT 5th Central European Congress of Life Sciences (EUROBIOTECH)
CY 2013
CL Krakow, POLAND
DE rendering plants; biofiltration; oak bark; coconut fiber
ID BIOFILTRATION; EMISSIONS; INDUSTRY
AB The study evaluated the effectiveness of air biofiltration in rendering plants. The biofilter material comprised compost soil (40%) and peat (40%) mixed up with coconut fiber (medium A) and oak bark (medium B). During biofiltration average VOCs reduction reached 88.4% for medium A and 89.7% for medium B. A positive relationship of aldehyde reduction from material humidity (r = 0.502; alpha<0.05) was also noted. Other biomaterial parameters did not affect the treatment efficiency.
C1 [Tymczyna, Leszek; Chmielowiec-Korzeniowska, Anna; Dobrowolska, Magadalena] Univ Life Sci, Lublin, Poland.
   [Paluszak, Zbigniew] Univ Technol & Life Sci, Bydgoszcz, Poland.
   [Banach, Marcin; Pulit, Jolanta] Cracow Univ Technol, Krakow, Poland.
RP Chmielowiec-Korzeniowska, A (reprint author), Univ Life Sci, Lublin, Poland.
EM anna.korzeniowska@up.lublin.pl
OI Chmielowiec-Korzeniowska, Anna/0000-0002-3869-9596
CR Anet B, 2013, J ENVIRON MANAGE, V128, P981, DOI 10.1016/j.jenvman.2013.06.028
   Anet B, 2012, CHEM ENGINEER TRANS, V30, P61, DOI 10.3303/CET1230011
   Chmielowiec-Korzeniowska A, 2012, PRZEM CHEM, V91, P706
   Deshusses MA, 1997, CURR OPIN BIOTECH, V8, P335, DOI 10.1016/S0958-1669(97)80013-4
   Kastner JR, 2003, J AIR WASTE MANAGE, V53, P1218, DOI 10.1080/10473289.2003.10466282
   Kastner JR, 2002, J AIR WASTE MANAGE, V52, P459, DOI 10.1080/10473289.2002.10470800
   KOSMIDER J, 2002, ODORE, P242
   Luo J, 2006, BIORESOURCE TECHNOL, V97, P1461, DOI 10.1016/j.biortech.2005.07.011
   Morgan-Sagastume JM, 2006, BIORESOURCE TECHNOL, V97, P1546, DOI 10.1016/j.biortech.2005.06.003
   Ramirez-Lopez E, 2003, BIORESOURCE TECHNOL, V88, P259, DOI 10.1016/S0960-8524(02)00315-2
   Sercu B, 2005, J AIR WASTE MANAGE, V55, P1217, DOI 10.1080/10473289.2005.10464715
   Sironi S, 2007, CHEM ENG J, V131, P225, DOI 10.1016/j.cej.2006.11.015
NR 12
TC 1
Z9 1
U1 0
U2 5
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
EI 1734-154X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PY 2013
VL 60
IS 4
BP 747
EP 751
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 287QN
UT WOS:000329557400041
PM 24432326
DA 2018-10-20
ER

PT J
AU Yu, XH
   Wei, M
AF Yu, Xiaohua
   Wei, Mei
TI Cellular Performance Comparison of Biomimetic Calcium Phosphate Coating
   and Alkaline-Treated Titanium Surface
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; CELLS IN-VITRO; OCTACALCIUM PHOSPHATE; OSTEOBLAST
   ADHESION; PROTEIN ADSORPTION; BONE; HYDROXYAPATITE; IMPLANTS; BEHAVIOR;
   DIFFERENTIATION
AB The influence of biomimetic calcium phosphate coating on osteoblasts behavior in vitro is not well established yet. In this study, we investigated the behavior of osteoblastic rat osteosarcoma 17/2.8 cells (ROS17/2.8) on two groups of biomaterial surfaces: alkaline-treated titanium surface (ATT) and biomimetic calcium phosphate coated ATT (CaP). The cell attachment, proliferation, differentiation, and morphology on these surfaces were extensively evaluated to reveal the impact of substrate surface on osteoblastic cell responses. It was found that the ROS17/2.8 cells cultured on the ATT surface had higher attachment and proliferation rates compared to those on the CaP surface. Our results also showed that the calcium phosphate coatings generated in this work have an inhibiting effect on osteoblast adhesion and further influenced the proliferation and differentiation of osteoblast compared to the ATT surface in vitro. Cells on the ATT surface also exhibited a higher alkaline phosphatase activity than on the CaP surface after two weeks of culture. Immunofluorescence staining and scanning electron microscopy results showed that the cells adhered and spread faster on the ATT surface than on the CaP surface. These results collectively suggested that substrate surface properties directly influence cell adhesion on different biomaterials, which would result in further influence on the cell proliferation and differentiation.
C1 [Yu, Xiaohua; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, 97 North Eagleville Rd,Unit 3136, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
RI Yu, Xiaohua/J-9903-2014
FU National Science Foundation [BES 0503315, CBET-1133883]; NIH
   [R21AR059962]
FX The authors would like to thank the National Science Foundation (BES
   0503315 and CBET-1133883) and the NIH (R21AR059962) for their support of
   the research. The authors would like to thank Dr. Carol Norris of the
   Department of Molecular and Cell Biology, University of Connecticut for
   her help with fluorescence microscopy and Dr. Jim Romanow of the
   Department of Physiology and Neurobiology, University of Connecticut for
   his help with SEM sample preparation.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Choi SY, 2012, J MATER CHEM, V22, P25288, DOI 10.1039/c2jm33354f
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   GOODMAN SB, 1993, BIOMATERIALS, V14, P723, DOI 10.1016/0142-9612(93)90035-Z
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Jordan DR, 2002, CAN J OPHTHALMOL, V37, P7, DOI 10.1016/S0008-4182(02)80092-8
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luo C, 2012, J MATER CHEM, V22, P15654, DOI 10.1039/c2jm32007j
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Nagano M, 1996, J BIOMED MATER RES, V31, P487, DOI 10.1002/(SICI)1097-4636(199608)31:4<487::AID-JBM8>3.3.CO;2-M
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Nebe JB, 2008, ACTA BIOMATER, V4, P1985, DOI 10.1016/j.actbio.2008.05.028
   Okada S, 2010, ACTA BIOMATER, V6, P591, DOI 10.1016/j.actbio.2009.07.037
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Oreffo ROC, 1998, TISSUE ENG, V4, P293, DOI 10.1089/ten.1998.4.293
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Qu HB, 2008, J BIOMED MATER RES B, V84B, P436, DOI 10.1002/jbm.b.30889
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Wang JW, 2009, J BIOMED MATER RES A, V90A, P664, DOI 10.1002/jbm.a.32128
   Wen HB, 1999, J BIOMED MATER RES, V46, P245, DOI 10.1002/(SICI)1097-4636(199908)46:2<245::AID-JBM14>3.0.CO;2-A
   Weng J, 2002, BIOMATERIALS, V23, P2623, DOI 10.1016/S0142-9612(01)00393-3
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Xia ZM, 2012, J BIOMED MATER RES B, V100B, P871, DOI 10.1002/jbm.b.31970
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yu X, 2014, BIOMATERIALS SCI
   Yu X, 2012, J TISSUE ENG REGENER
   Yu XH, 2012, J MATER SCI-MATER M, V23, P2177, DOI 10.1007/s10856-012-4682-7
   Yu XH, 2012, J MATER CHEM, V22, P9721, DOI 10.1039/c2jm30332a
   Yu XH, 2011, J BIOMED MATER RES B, V97B, P345, DOI 10.1002/jbm.b.31820
   Yu XH, 2009, J MATER SCI-MATER M, V20, P287, DOI 10.1007/s10856-008-3571-6
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
NR 54
TC 4
Z9 4
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 832790
DI 10.1155/2013/832790
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 289IO
UT WOS:000329675500001
PM 24455730
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dwivedi, P
   Narvi, SS
   Tewari, RP
AF Dwivedi, Poushpi
   Narvi, Shahid S.
   Tewari, Ravi P.
TI Application of polymer nanocomposites in the nanomedicine landscape:
   envisaging strategies to combat implant associated infections
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Review
DE Biomaterial; Biopolymer; Nanocomposite; Nanomedicine; Nanotechnology
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIBACTERIAL SILVER COATINGS; IN-VIVO
   EVALUATION; EXTERNAL FIXATION; ORTHOPEDIC IMPLANTS; METAL NANOPARTICLES;
   BACTERIAL ADHESION; CONTROLLED-RELEASE; URINARY CATHETERS; GENERATED
   SILVER
AB This review article presents an overview of the potential biomedical application of polymer nanocomposites arising from different chemistries, compositions, and constructions. The interaction between the chosen matrix and the filler is of critical importance. The existing polymer used in the biomedical arena includes aliphatic polyesters such as polylactide (PLA), poly(epsilon-caprolactone) (PCL), poly(p-dioxanone) (PPDO), poly(butylenes succinate) (PBS), poly(hydroxyalkanoate)s, and natural biopolymers such as starch, cellulose, chitin, chitosan, lignin, and proteins. The nanosized fillers utilized to fabricate the nanocomposites are inorganic, organic, and metal particles such as clays, magnetites, hydroxyapatite, nanotubes chitin whiskers, lignin, cellulose, Au, Ag, Cu, etc. These nanomaterials are taking root in a variety of diverse healthcare applications in the sector of nanomedicine including the domain of medical implants and devices. Despite sterilization and aseptic procedures the use of these biomedical devices and prosthesis to improve the patient's 'quality of life' is facing a major impediment because of bacterial colonization causing nosocomial infection, together with the multi-drug-resistant 'super-bugs' posing a serious threat to its utility. This paper discusses the current efforts and key research challenges in the development of self-sterilizing nanocomposite biomaterials for potential application in this area.
C1 [Dwivedi, Poushpi; Narvi, Shahid S.] Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad, Uttar Pradesh, India.
   [Tewari, Ravi P.] Motilal Nehru Natl Inst Technol, Dept Appl Mech, Allahabad, Uttar Pradesh, India.
RP Dwivedi, P (reprint author), Care of Dwivedi M, 125 Garivan Tolla, Allahabad 211003, Uttar Pradesh, India.
EM poushpibhu@yahoo.com
CR Actis Dato A, 1992, MINERVA CARDIOANGIOL, V40, P225
   Albert DE, 1998, MED DEVICE DIAGNOSTI, V20, P96
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   [Anonymous], 1994, 109931 ISO
   [Anonymous], 10993 ISO
   Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009
   Arunkumar L, 2005, RESONANCE, V10, P6
   Baquero F, 1997, J ANTIMICROB CHEMOTH, V39, P1, DOI 10.1093/jac/39.suppl_1.1
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Burgos-Asperilla L, 2007, J MATER CHEM, V17, P4233, DOI 10.1039/b706011d
   BUTLER WT, 1995, INT J DEV BIOL, V39, P169
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Choy J. H., 2000, ANGEW CHEM INT EDIT, V22, P4041
   COLLINGE CA, 1994, ORTHOPEDICS, V17, P445
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Compton J, 2006, POLYMER, V47, P5303, DOI 10.1016/j.polymer.2006.05.048
   Cordero J, 1996, J ORTHOPAED RES, V14, P663, DOI 10.1002/jor.1100140423
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   CREDE CSF, 1881, ARCH GYNAKOL, V17, P50, DOI DOI 10.1007/BF01977793
   Darder M, 2003, CHEM MATER, V15, P3774, DOI 10.1021/cm0343047
   De Paulis AN, 2003, J CLIN MICROBIOL, V41, P1219, DOI 10.1128/JCM.41.3.1219-1224.2003
   dos Santos DS, 2004, LANGMUIR, V20, P10273, DOI 10.1021/la048328j
   Dowling DP, 2003, SURF COAT TECH, V163, P637, DOI 10.1016/S0257-8972(02)00689-8
   Dowling DP, 2001, THIN SOLID FILMS, V398, P602, DOI 10.1016/S0040-6090(01)01326-8
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   ELEK SD, 1956, ANN NY ACAD SCI, V65, P85, DOI 10.1111/j.1749-6632.1956.tb36626.x
   Elliott JC, 1994, STRUCTURE CHEM APATI
   European Science Foundation. Nanomedicine, 2005, ESF EUR MED RES COUN
   Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473
   Fratzl P., 2002, FIBRE DIFFR REV, V210, P32
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091
   Ghose S, 2008, COMPOS SCI TECHNOL, V68, P1843, DOI 10.1016/j.compscitech.2008.01.016
   Gibson R.F., 1994, PRINCIPLES COMPOSITE
   Gomez-Aviles A, 2007, ANGEW CHEM INT EDIT, V46, P923, DOI 10.1002/anie.200603802
   Grainger DW, 2004, EXPERT OPIN BIOL TH, V4, P1029, DOI 10.1517/14712598.4.7.1029
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Gu LR, 2005, CHEM COMMUN, P874, DOI 10.1039/b415015e
   Guo ZH, 2008, COMPOS SCI TECHNOL, V68, P2551, DOI 10.1016/j.compscitech.2008.05.017
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang XY, 2008, COMPOS SCI TECHNOL, V68, P2134, DOI 10.1016/j.compscitech.2008.03.009
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   KOCIALKOWSKI A, 1990, INJURY, V21, P142, DOI 10.1016/0020-1383(90)90082-6
   Krishnamoorti R, ACS S SERIES, V804
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Lai KK, 2002, AM J INFECT CONTROL, V30, P221, DOI 10.1067/mic.2002.12018
   Langsrud S, 2003, INT BIODETER BIODEGR, V51, P283, DOI 10.1016/S0964-8305(03)00039-8
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lee JY, 2006, POLYMER, V47, P7970, DOI 10.1016/j.polymer.2006.09.034
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Lowe AM, 1998, MOL MICROBIOL, V27, P967, DOI 10.1046/j.1365-2958.1998.00741.x
   Mallick K, 2006, EUR POLYM J, V42, P670, DOI 10.1016/j.eurpolymj.2005.09.020
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Matthews F.L., 1994, COMPOSITE MAT ENG SC
   Mazumder S.K., 2002, COMPOSITES MANUFACTU
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   Nair LS, 2008, J BONE JOINT SURG AM, V90A, P128, DOI 10.2106/JBJS.G.01520
   Nicolais LF, 2003, METAL POLYM NANOCOMP
   Nyczyk A, 2009, SYNTHETIC MET, V159, P561, DOI 10.1016/j.synthmet.2008.11.019
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   Oriakhi C, 1998, CHEM BRIT, V34, P59
   Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.012.009
   Park JB, 1992, BIOMATERIALS, V194
   Parvizi J, 2007, EXPERT REV MED DEVIC, V4, P55, DOI 10.1586/17434440.4.1.55
   Patwardhan SV, 2003, CHEM COMMUN, P1122, DOI 10.1039/b302056h
   Paul MA, 2005, MACROMOL CHEM PHYSIC, V206, P484, DOI 10.1002/macp.200400324
   Poelstra KA, 2000, J BIOMED MATER RES, V51, P224, DOI 10.1002/(SICI)1097-4636(200008)51:2<224::AID-JBM11>3.0.CO;2-G
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   RUBBO H, 1994, J BIOL CHEM, V269, P26066
   Ruiz AI, 2006, J NANOSCI NANOTECHNO, V6, P1602, DOI 10.1166/jnn.2006.216
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   Schierholz JM, 2001, J CHEMOTHERAPY, V13, P239, DOI 10.1179/joc.2001.13.Supplement-2.239
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Sharma S. C., 2000, COMPOSITE MAT
   Sheldon R. P., 1982, COMPOSITE POLYM MAT
   Siemann U, 2005, PROG COLL POL SCI S, V130, P1
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   Steckelberg James M., 1994, P259
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Sugawara A, 2000, CHEM COMMUN, P487, DOI 10.1039/a909566g
   Szobota J. S., 1988, GUIDE MAT CHARACTERI, P13
   The Royal Society and the Royal Academy of Engineering, 2004, NAN NAN
   Toxicology subgroup Tripartite Subcommittee on Medical Devices, 1987, TRIP SUBC MED DEV TR
   Tsuang YH, 2008, ARTIF ORGANS, V32, P167, DOI 10.1111/j.1525-1594.2007.00530.x
   Urban JA, 2003, CURR TREAT OPTIONS I, V5
   Varahramyan K, 2009, NANOTECHNOLOGY SCI M
   Walder B, 2002, INFECT CONT HOSP EP, V23, P748, DOI 10.1086/502005
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   WEINER S, 1992, FASEB J, V6, P879
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   WOHRMANN RM, 1998, INFECTION, V26, P49
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zotti G, 2008, CHEM MATER, V20, P6509, DOI 10.1021/cm801836j
NR 109
TC 10
Z9 10
U1 11
U2 105
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2013
VL 11
IS 3
BP 129
EP 142
DI 10.5301/JABFM.2013.11544
PG 14
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 290YD
UT WOS:000329793600001
PM 24127037
DA 2018-10-20
ER

PT J
AU Martin-Lopez, E
   Nieto-Diaz, M
   Nieto-Sampedro, M
AF Martin-Lopez, Eduardo
   Nieto-Diaz, Manuel
   Nieto-Sampedro, Manuel
TI Influence of chitosan concentration on cell viability and proliferation
   in vitro by changing film topography
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Chitosan; Cell proliferation; Chitosan tubes; Film topography;
   Nano-roughness; Polymer concentration
ID HUMAN-ENDOTHELIAL-CELLS; PROTEIN ADSORPTION; COMPOSITE FILMS;
   NANOMETER-SCALE; TISSUE; SURFACE; GROWTH; SCAFFOLDS; GELATIN; VIVO
AB Purpose: Chitosan is a natural polysaccharide which can form gels and scaffolds that support its use as a biomaterial in various tissue engineering applications. A useful feature of chitosan polymer is that you can manipulate its properties easily. Thus, in this work we studied the effect of varying chitosan concentration in the topography and the biological properties of the chitosan films, as well as the effects in the structure of 3D gels in order to be used as nerve bridges.
   Methods: Analysis of film topographies were addressed by swelling test and atomic force microscopy (AFM). In vitro biological properties were assessed through MTT viability assays on cultures of blood-brain barrier forming endothelial (bEnd5), glioma (C6) and postmitotic neuron (NGF-differentiated PC12) cell lines. The structure of tridimensional gels was studied by environmental scanning electron microscopy.
   Results: Topography of 1% chitosan films showed a AFM profile with higher nano-roughness profile than that observed in 2% films, which was smoother. Moreover, swelling rate was not affected. Topography changes affected cell viability as shown by the MTT assays. Our results showed that 2% chitosan films promoted higher proliferation and viability of C6 and PC12 respectively than 1% films. Conversely, neither 1% nor 2% films promoted viability of bEnd5 cells. In order to establish the feasibility of both type of chitosan solutions as nerve bridges, we constructed 3D gels by alkaline precipitation. Resulting gels showed that only 2% gels were rigid enough to be effectively used as nerve bridges.
   Conclusions: These results establish that changes in chitosan concentration affects the polymer surface topography, which has a direct effect in the growing cell behavior. Additionally, higher concentration of chitosan gels are required to be used in neural tissue engineering.
C1 [Martin-Lopez, Eduardo; Nieto-Sampedro, Manuel] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, E-28002 Madrid, Spain.
   [Nieto-Diaz, Manuel; Nieto-Sampedro, Manuel] SESCAM, Hosp Nacl Paraplej, Expt Neurol Unit, Toledo, Spain.
RP Martin-Lopez, E (reprint author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.
EM elopez@cns.bcm.edu
RI Nieto-Diaz, Manuel/R-5163-2017
FU Spanish Ministry of Education and Science [SAF 2006-11224]; Community of
   Madrid; Hospital Nacional de Paraplejicos Foundation for Integration and
   Research (FUHNPAIIN)
FX This research was funded by the Spanish Ministry of Education and
   Science (grant SAF 2006-11224). Eduardo Martin-Lopez was supported by
   fellowships from the Community of Madrid and the Hospital Nacional de
   Paraplejicos Foundation for Integration and Research (FUHNPAIIN).
CR Aggarwal D, 2009, ACTA BIOMATER, V5, P1575, DOI 10.1016/j.actbio.2009.01.003
   ANTHONSEN MW, 1993, CARBOHYD POLYM, V22, P193, DOI 10.1016/0144-8617(93)90140-Y
   BEREZOVSKAYA OL, 1995, J NEUROSCI RES, V42, P192, DOI 10.1002/jnr.490420206
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Cho MH, 2008, TISSUE ENG PT A, V14, P1099, DOI [10.1089/ten.tea.2007.0305, 10.1089/tea.2007.0305]
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Denuziere A., 2000, Annales Pharmaceutiques Francaises, V58, P47
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Ghosh A, 2010, INT J BIOL MACROMOL, V46, P179, DOI 10.1016/j.ijbiomac.2009.11.006
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hamano T, 1998, J BIOMAT SCI-POLYM E, V9, P985, DOI 10.1163/156856298X00299
   Hernandez R, 2009, J COLLOID INTERF SCI, V339, P53, DOI 10.1016/j.jcis.2009.07.066
   Knupfer H, 2001, ANTICANCER RES, V21, P2797
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Lee EJ, 2010, J MATER SCI-MATER M, V21, P207, DOI 10.1007/s10856-009-3835-9
   Lee K, 2006, TISSUE ENG
   Lv PP, 2011, BIOMACROMOLECULES, V12, P4230, DOI 10.1021/bm2010774
   Martin-Lopez E, 2010, J BIOMATER IN PRESS
   Martin-Lopez E, 2012, J BIOMAT SCI-POLYM E, V23, P207, DOI 10.1163/092050610X546426
   Mingyu Cheng, 2004, J Biomater Appl, V19, P59, DOI 10.1177/0885328204043450
   Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033
   Patel M, 2006, TISSUE ENG, V12, P3189, DOI 10.1089/ten.2006.12.3189
   Pulieri E, 2008, J BIOMED MATER RES A, V86A, P311, DOI 10.1002/jbm.a.31492
   RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Sun XJ, 2011, TISSUE ENG PT A, V17, P2369, DOI [10.1089/ten.tea.2011.0027, 10.1089/ten.TEA.2011.0027]
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Tillman J, 2006, BIOMATERIALS, V27, P5618, DOI 10.1016/j.biomaterials.2006.07.006
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   YANAGISAWA I, 1989, Journal of Oral Implantology, V15, P168
   Yang T, 2007, J PHARM SCI-US, V96, P3196, DOI 10.1002/jps.21002
   Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979
NR 44
TC 2
Z9 2
U1 0
U2 14
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2013
VL 11
IS 3
BP 151
EP 158
DI 10.5301/JABFM.2012.10449
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 290YD
UT WOS:000329793600003
PM 23413128
DA 2018-10-20
ER

PT B
AU Pfeiffer, H
   Heer, P
   Sekler, H
   Winkelmans, M
   Wevers, M
AF Pfeiffer, H.
   Heer, P.
   Sekler, H.
   Winkelmans, M.
   Wevers, M.
BE Chang, FK
TI Structural Health Monitoring Using Percolation Sensors-New User Cases
   from Operational Airliners and Chemical Plants
SO STRUCTURAL HEALTH MONITORING 2013, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 9th International Workshop on Structural Health Monitoring (IWSHM)
CY SEP 10-12, 2013
CL Stanford Univ, Stanford, CA
SP AF Off Sci Res, Army Res Lab, Off Naval Res, Boeing, Airbus, Embraer
HO Stanford Univ
ID WATER
AB Materials that are prone to corrosion are normally protected from a wet environment, and this can be achieved by isolations, such as casings, coatings or seals. However, as a result of the intensive use of engineering structures, those isolations can be damaged and aqueous liquids arising from spillage, condensation or rain can enter those confined spaces. An interesting tool to detect the underlying structural damage of sealings would be offered by the detection of hidden harmful liquids by appropriate sensor networks.
   Percolation sensors for detecting harmful liquids can be considered as bioinspired sensors. Their specific performance is in analogy to the swelling of organic materials after the uptake of water. It is well-known that all living organisms require aqueous liquids for enabling all sorts of biological functions, and the regulation of the respective water content is therefore essential. In analogy with the interaction of water with biomaterial, the swelling of organic compounds can be used to develop a group of sensors that are proven to be useful in various SHM applications.
   For this purpose, different percolation sensors were developed, and since two years, three operational airliners from Lufthansa were equipped with percolation sensor networks (Boeing 737-500, 2 x Boeing 747-400) protecting the floor structure below the galley, the lavatory and the service doors areas. Moreover, a couple of percolation sensors were installed in the isolations of outdoor pipelines in chemical installations of BASF Antwerp. The results obtained are very promising in all cases, and they show that the presence of corrosive liquids is indicated in a very reliable way proving the presence of structural damage of casings, coatings and seals.
C1 [Pfeiffer, H.; Wevers, M.] Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44,Bus 2450, B-3001 Louvain, Belgium.
   [Heer, P.; Sekler, H.] Lufthansa Tech AG, Frankfurt, Germany.
   [Winkelmans, M.; Wevers, M.] BASF Antwerp, B-2040 Antwerp, Belgium.
RP Pfeiffer, H (reprint author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44,Bus 2450, B-3001 Louvain, Belgium.
EM helge.pfeiffer@mtm.kuleuven.be
RI Wevers, Martine/S-4700-2016
OI Wevers, Martine/0000-0002-8797-5454; Pfeiffer, Helge/0000-0002-2918-2990
FU European Community's Seventh Framework Programme [212912]; Industrial
   Research Fund of KU Leuven [IOFM/11/012]
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Programme [FP7/2007-2013] under
   grant agreement n degrees 212912 and from the Industrial Research Fund
   of KU Leuven [IOFM/11/012].
CR Adam J., 1995, PHYS CHEM BIOPHYS
   Aksan A., 2009, J BIOMECH ENG T ASME, V131
   [Anonymous], 2012, LHT CONNECTION LUFTH
   Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021
   EISENBLATTER S, 1994, CHEM PHYS LETT, V228, P89, DOI 10.1016/0009-2614(94)00901-5
   ESSAM JW, 1980, REP PROG PHYS, V43, P833, DOI 10.1088/0034-4885/43/7/001
   HOPPE W, 1982, BIOPHYSIK
   LENEVEU DM, 1976, NATURE, V259, P601, DOI 10.1038/259601a0
   Marsh D, 2011, BIOPHYS J, V101, P2704, DOI 10.1016/j.bpj.2011.10.031
   Pfeiffer H., 2011, INT WORKSH STRUCT HL, P1572
   Pfeiffer H., 2010, CORROSION PREVENTION
   Pfeiffer H., 2012, 6 EUR WORKSH STRUCT
   Pfeiffer H, 2012, SENSOR ACTUAT B-CHEM, V161, P791, DOI 10.1016/j.snb.2011.11.034
   Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195
NR 14
TC 0
Z9 0
U1 0
U2 0
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-115-7
PY 2013
BP 2130
EP +
PG 2
WC Engineering, Civil; Engineering, Mechanical
SC Engineering
GA BJN59
UT WOS:000329292700260
DA 2018-10-20
ER

PT S
AU Santos, FA
   Fernandes, MHFV
   Davim, E
   Pinatti, DG
   Lazar, DRR
   Santos, C
AF Santos, F. A.
   Fernandes, M. H. F. V.
   Davim, E.
   Pinatti, D. G.
   Lazar, D. R. R.
   Santos, C.
GP IOP
TI Crystallization process of a biomaterial, the lithium disilicate,
   obtained from rice husk silica
SO 2ND INTERNATIONAL CONFERENCE ON COMPETITIVE MATERIALS AND TECHNOLOGICAL
   PROCESSES (IC-CMTP2)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 2nd International Conference on Competitive Materials and Technological
   Processes (IC-CMTP)
CY OCT 08-12, 2012
CL Miskolc, HUNGARY
SP Int Sci Advisory Board, Int Org Board
ID GLASS-CERAMICS; NONISOTHERMAL CRYSTALLIZATION; KINETICS; P2O5;
   MICROSTRUCTURE; NUCLEATION
AB In this work, the crystallization process of lithium disilicate glass-ceramic was investigated with SiO2 from rice husk silica replacing the high-purity SiO2 starting powder form commercial source. Glasses were developed at the stoichiometric composition of 66%.molSiO(2):33%.molLiO(2) using commercial SiO2 and the one obtained by thermochemical treatment of rice husk. To compare the SiO2 sources, the influence of the one from rice husk on crystallization process was measured using different granulometry, analyzing microstructure and the kinetic behavior. Investigations were carried out by means of differential thermal analysis (DTA), X-ray diffractometry (XRD) and scanning electron microscopy (SEM). Amorphous glasses were obtained after melting at 1550 degrees C. The position of lithium disilicate glass-ceramic crystallization peaks (Tp) are between 550 to 660 degrees C to different granulometry (<63mm, 63mm < x < 250mm and 1mm < x < 2mm) and DTA heat rates (5; 10; 15; and 20 degrees C/min) in both glasses, and the relevant formed crystalline phase after DTA analysis (verified for XRD) was Li2Si2O5. SEM images showed the increase of glass substitution for crystalline phase to both glass-ceramics from different silica sources.
C1 [Santos, F. A.; Pinatti, D. G.; Santos, C.] Univ Sao Paulo, Escola Engn Lorena, Dept Engn Mat, BR-12600000 Lorena, SP, Brazil.
   [Santos, F. A.; Lazar, D. R. R.] IPEN, BR-05508000 Sao Paulo, SP, Brazil.
   [Fernandes, M. H. F. V.; Davim, E.] Univ Aveiro, P-3810489 Aveiro, Portugal.
   [Santos, C.] UriFOA Ctr Univ Volta Redonda, BR-27240560 Volta Redonda, Brazil.
RP Santos, FA (reprint author), Univ Sao Paulo, Escola Engn Lorena, Dept Engn Mat, BR-12600000 Lorena, SP, Brazil.
EM felipeantunes@usp.br
RI Lazar, Dolores/F-2904-2012
OI Lazar, Dolores/0000-0001-7384-304X; Davim, Erika/0000-0002-7763-7005; V
   Fernandes, Maria Helena/0000-0002-1240-2512
FU FAPESP; CNPq; CAPES
FX The authors acknowledge the FAPESP, CNPq and CAPES, for financial
   support.
CR Arora A, 2008, PHYSICA B, V403, P1738, DOI 10.1016/j.physb.2007.10.001
   Arvind A, 2008, J PHYS CHEM SOLIDS, V69, P2622, DOI 10.1016/j.jpcs.2008.06.003
   Barrett JM, 1980, Glass compsn. for forming glass-ceramic-casting and heat treating glass-ceramic for dental restorations, Patent No. [US4189325-A, 4189325]
   Goharian P, 2010, J NON-CRYST SOLIDS, V356, P208, DOI 10.1016/j.jnoncrysol.2009.11.015
   Holand W, 2002, GLASS CERAMIC TECHNO
   Holand W, 2007, J EUR CERAM SOC, V27, P1521, DOI 10.1016/j.jeurceramsoc.2006.04.101
   JAMES PF, 1985, J NON-CRYST SOLIDS, V73, P517, DOI 10.1016/0022-3093(85)90372-2
   Kim SJ, 2004, SOLID STATE COMMUN, V131, P129, DOI 10.1016/j.ssc.2004.04.033
   Kniess C. T., 2000, QUIM NOVA, V25, P926
   McMillan PW, 1979, GLASS CERAMICS
   Ota R, 1997, J NON-CRYST SOLIDS, V219, P70, DOI 10.1016/S0022-3093(97)00253-6
   Schmidt A, 1997, PHYS CHEM GLASSES, V38, P161
   Siqueira E. J., 2007, CERAM INT, V35, P213
   STOOKEY SD, 1959, IND ENG CHEM, V51, P805, DOI 10.1021/ie50595a022
   STOOKEY SD, 1953, IND ENG CHEM, V45, P115, DOI 10.1021/ie50517a039
   STRNAD Z, 1986, GLASS CERAMIC MAT GL, V8
   Wen G, 2007, ACTA MATER, V55, P3583, DOI 10.1016/j.actamat.2007.02.009
   Wu J., 1985, U. S. Patent, Patent No. [4,515,634, 4515634]
   Yuan ZZ, 2006, J ALLOY COMPD, V407, P163, DOI 10.1016/j.jallcom.2005.06.022
   Zanotto ED, 1997, J NON-CRYST SOLIDS, V219, P42, DOI 10.1016/S0022-3093(97)00249-4
   Zheng X, 2008, ACTA MATER, V56, P549, DOI 10.1016/j.actamat.2007.10.024
NR 21
TC 2
Z9 2
U1 0
U2 5
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2013
VL 47
AR UNSP 012003
DI 10.1088/1757-899X/47/1/012003
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJM79
UT WOS:000329184000003
OA Other Gold
DA 2018-10-20
ER

PT S
AU Pavon, J
   El-Atwani, O
   Walker, E
   Arias, SL
   Allain, JP
AF Pavon, J.
   El-Atwani, Osman
   Walker, E.
   Arias, S. L.
   Allain, J. P.
GP IEEE
TI Titanium Surface Modification by Directed Irradiation Synthesis (DIS):
   Nanostructuring for Regenerative Medicine
SO 2013 PAN AMERICAN HEALTH CARE EXCHANGES (PAHCE)
SE Pan American Health Care Exchanges
LA English
DT Proceedings Paper
CT 8th Pan American Health Care Exchanges Conference (PAHCE)
CY APR 29-MAY 04, 2013
CL Medellin, COLOMBIA
SP IEEE Morelos Mexico EMB Chapter, IEEE Colombia Sect, IEEE LA EMB Chapter, Univ Antioquia, Univ Pontificia Bolivariana, Escuela Ingn Antioquia, USM Materialise, EMCO, GBarco, Medinistros, AMAREY, Smart Management Choice, Colcafe, Revista Semana, Medellin Convent Bur
DE Biomaterials; Regenerative Medicine; Surface Modification; Surface
   Irradiation; Nano-structuring
AB Bone tissue damages and even some spinal cord pathologies can be treated by using titanium implants. Despite the fact that its use proved to be highly effective, it also has some limitations, mainly due to titanium being currently assumed to be a first generation biomaterial [1]. Tissue growth and regeneration on Ti implants can be only achieved by modifying them to a third generation biomaterial, allowing surrounded tissue to be influenced at molecular level [2].
C1 [Pavon, J.; El-Atwani, Osman; Arias, S. L.; Allain, J. P.] Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA.
   [Pavon, J.; El-Atwani, Osman; Arias, S. L.; Allain, J. P.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   [Pavon, J.] Univ Antioquia, Bioengn Program, Biomat & Biomech Grp, Medellin, Colombia.
   [Walker, E.; Allain, J. P.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
RP Pavon, J (reprint author), Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA.
EM jpavonpa@purdue.edu
CR Allain Jean Paul, 2013, NANONEUROSURGERY
   Aparicio C., 2005, THESIS U POLITECNICA, P55
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2327-8161
BN 978-1-4673-6257-3; 978-1-4673-6254-2
J9 PANAM HEALT CARE
PY 2013
PG 1
WC Medical Informatics
SC Medical Informatics
GA BJK67
UT WOS:000328694600118
DA 2018-10-20
ER

PT S
AU Pavon, J
   El-Atwani, O
   Arias, SL
   Gordon, E
   Allain, JP
   Tigno, T
   Armonda, R
AF Pavon, Juan
   El-Atwani, Osman
   Arias, Sandra L.
   Gordon, Emily
   Allain, Jean Paul
   Tigno, Teodoro
   Armonda, Rocco
GP IEEE
TI New Biomaterial for Treatment of Penetrating Brain Injury (PBI)
   Aneurysms: Nanostructured NiTi by Directed Irradiation Synthesis (DIS)
SO 2013 PAN AMERICAN HEALTH CARE EXCHANGES (PAHCE)
SE Pan American Health Care Exchanges
LA English
DT Proceedings Paper
CT 8th Pan American Health Care Exchanges Conference (PAHCE)
CY APR 29-MAY 04, 2013
CL Medellin, COLOMBIA
SP IEEE Morelos Mexico EMB Chapter, IEEE Colombia Sect, IEEE LA EMB Chapter, Univ Antioquia, Univ Pontificia Bolivariana, Escuela Ingn Antioquia, USM Materialise, EMCO, GBarco, Medinistros, AMAREY, Smart Management Choice, Colcafe, Revista Semana, Medellin Convent Bur
DE Nano-biomaterials; Surface Modification; Biomaterials Irradiation;
   Surface Nano-structuring; Regenerative Medicine
AB Clinical approaches for aneurysms treatments, surgical clipping or endovascular coiling, have showed limited success due to parent artery thrombosis, coil migration and the surgical risks inherent in an open craniotomy procedure. In that sense, there is an increasing interest in neurosurgery to develop new alternatives for treatment of this kind of disease.
C1 [Pavon, Juan; El-Atwani, Osman; Arias, Sandra L.; Allain, Jean Paul] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
RP Pavon, J (reprint author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
EM jpavonpa@purdue.edu
CR Allain Jean Paul, 2013, NANONEUROSURGERY
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2327-8161
BN 978-1-4673-6257-3; 978-1-4673-6254-2
J9 PANAM HEALT CARE
PY 2013
PG 1
WC Medical Informatics
SC Medical Informatics
GA BJK67
UT WOS:000328694600130
DA 2018-10-20
ER

PT J
AU Sigg, SJ
   Schuster, TB
   Meier, WP
AF Sigg, Severin J.
   Schuster, Thomas B.
   Meier, Wolfgang P.
TI Self-assembled Structures from Amphiphilic Peptides
SO CHIMIA
LA English
DT Article
DE Amphiphilic peptides; Biomaterial; Bionanotechnology; Gene delivery;
   Self-assembly
ID SURFACTANT-LIKE PEPTIDES; MULTICOMPARTMENT MICELLES; GENE-DELIVERY; FORM
   NANOTUBES; OLIGOPEPTIDES; NANOVESICLES; PROPENSITY; COPOLYMERS;
   MEMBRANE; PROTEINS
AB Nanotechnology and its applications are strongly influenced by structures self-assembled from a variety of different materials. This review covers nanostructures, including micelles, rod-like micelles, fibers and peptide beads, self-assembled from de novo designed amphiphilic peptides. The latter are promising candidates for the development of nanoscale carrier systems because they are completely composed of amino acids. In addition to designing primary sequences, secondary structure and external parameters are also discussed with respect to their impact on self-assembly. Moreover, the assembly process itself is examined. Potential applications range from gene and drug delivery devices to diagnostics, thereby highlighting the versatility of the system.
C1 [Sigg, Severin J.; Schuster, Thomas B.; Meier, Wolfgang P.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Meier, WP (reprint author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM wolfgang.meier@unibas.ch
FU Gerbert Ruf Stiftung 'Peptide Targeted Transport System' [GRS - 048/11];
   SNSF; NCCR Nanosciences
FX Financial support by Gerbert Ruf Stiftung 'Peptide Targeted Transport
   System' (GRS - 048/11), the SNSF, and the NCCR Nanosciences is
   gratefully acknowledged. The authors thank Dr. Dirk de Bruyn Ouboter,
   Prof. Cornelia Palivan and RM Subasic for discussion and reading the
   manuscript. We also thank Ruth Pfalzberger for her help with the
   preparation of the graphics.
CR Adams DJ, 2007, LANGMUIR, V23, P12729, DOI 10.1021/la7011183
   Baumann MK, 2008, LANGMUIR, V24, P7645, DOI 10.1021/la801605b
   Belegrinou S, 2010, SOFT MATTER, V6, P179, DOI 10.1039/b917318h
   Braun J, 2011, MACROMOL CHEM PHYS, V212, P1245, DOI 10.1002/macp.201100012
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Bucak S, 2009, LANGMUIR, V25, P4262, DOI 10.1021/la804175h
   Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a
   Chen CX, 2010, BIOMACROMOLECULES, V11, P402, DOI 10.1021/bm901130u
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   de Raad M, 2012, J CONTROL RELEASE, V158, P433, DOI 10.1016/j.jconrel.2011.09.078
   Dittrich C, 2010, MACROMOL BIOSCI, V10, P1406, DOI 10.1002/mabi.201000221
   Egli S, 2011, POLYMERS-BASEL, V3, P252, DOI 10.3390/polym3010252
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Huang ZP, 2013, J MATER CHEM B, V1, P2297, DOI 10.1039/c3tb20156b
   Jahnke E, 2006, ANGEW CHEM INT EDIT, V45, P5383, DOI 10.1002/anie.200600610
   Khoe U, 2009, LANGMUIR, V25, P4111, DOI 10.1021/la8025232
   Kubowicz S, 2005, ANGEW CHEM INT EDIT, V44, P5262, DOI 10.1002/anie.200500584
   Langowska K, 2013, CHEM COMMUN, V49, P128, DOI 10.1039/c2cc36345c
   Lee OS, 2011, J AM CHEM SOC, V133, P3677, DOI 10.1021/ja110966y
   Lutz JF, 2005, MACROMOL CHEM PHYSIC, V206, P813, DOI 10.1002/macp.200500067
   Makovec T, 2000, BIOCHEM MOL BIOL EDU, V28, P244, DOI 10.1016/S0307-4412(00)00021-2
   Matter Y, 2011, MACROMOL CHEM PHYS, V212, P937, DOI 10.1002/macp.201000661
   Morris MC, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm053
   Najer A, 2013, NANOMEDICINE-UK, V8, P425, DOI [10.2217/NNM.13.11, 10.2217/nnm.13.11]
   Nakanishi Kazuhiro, 2008, Current Proteomics, V5, P161, DOI 10.2174/157016408785909622
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Ouboter DD, 2014, J BIOMED MATER RES A, V102, P1155, DOI 10.1002/jbm.a.34778
   Ouboter DDB, 2013, COLLOID SURFACE B, V112, P542, DOI 10.1016/j.colsurfb.2013.09.003
   Ouboter DD, 2011, J PHYS CHEM C, V115, P14583, DOI 10.1021/jp203048h
   Ponta A, 2010, PHARM RES-DORDR, V27, P2330, DOI 10.1007/s11095-010-0120-z
   Randal M, 1998, PROTEIN SCI, V7, P1057
   RINGSDORF H, 1975, J POLYM SCI POL SYM, P135
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   SARGES R, 1965, J AM CHEM SOC, V87, P2027, DOI 10.1021/ja01087a029
   Schuster TB, 2011, SMALL, V7, P2158, DOI 10.1002/smll.201100701
   Schuster TB, 2011, LANGMUIR, V27, P4578, DOI 10.1021/la200443p
   Schuster TB, 2010, SOFT MATTER, V6, P5596, DOI 10.1039/c0sm00442a
   Seow WY, 2009, ADV MATER, V21, P86, DOI 10.1002/adma.200800928
   Shu JY, 2013, ANNU REV PHYS CHEM, V64, P631, DOI 10.1146/annurev-physchem-040412-110108
   SPEK EJ, 1995, J AM CHEM SOC, V117, P10773, DOI 10.1021/ja00148a032
   Tang Q, 2012, LANGMUIR, V28, P16126, DOI 10.1021/la303299s
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   van Hell AJ, 2007, BIOMACROMOLECULES, V8, P2753, DOI 10.1021/bm0704267
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Von Berlepsch H, 2009, CHEM COMMUN, P2290, DOI 10.1039/b903658j
   Zhang XY, 2012, J POLYM SCI POL CHEM, V50, P2293, DOI 10.1002/pola.26000
NR 47
TC 5
Z9 5
U1 1
U2 20
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2013
VL 67
IS 12
BP 881
EP 884
DI 10.2533/chimia.2013.881
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 282DI
UT WOS:000329150100009
PM 24594331
DA 2018-10-20
ER

PT J
AU Drewnowska, O
   Turek, B
   Carstanjen, B
   Gajewski, Z
AF Drewnowska, O.
   Turek, B.
   Carstanjen, B.
   Gajewski, Z.
TI Chitosan - a promising biomaterial in veterinary medicine
SO POLISH JOURNAL OF VETERINARY SCIENCES
LA English
DT Review
DE chitosan; scaffolds; biomaterials; tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; FIBER-MESH
   SCAFFOLDS; GROWTH-FACTOR; IN-VITRO; CHITIN; HYALURONATE; FIBROBLASTS;
   HYDROGELS; DOGS
AB Biomaterials originate from natural substances and are widely used in medicine. Although they have to satisfy many conditions to be useful for treatment, more and more research is carried out with new types of biomaterials that can help replace various tissues such as tendons and bones. Chitosan is a very promising material, revealing unique features, which makes it useful for veterinary medicine - ntimicrobial activity, biocompatibility, biodegradability. It is also known as good scaffold material, especially when combined with other polymers. This article describes chitosan as a biomaterial and tissue engineering scaffold with possible applications in veterinary medicine.
C1 [Drewnowska, O.; Turek, B.; Carstanjen, B.; Gajewski, Z.] Warsaw Univ Life Sci, Fac Vet Med, Dept Large Anim Med Clin, PL-02797 Warsaw, Poland.
RP Drewnowska, O (reprint author), Warsaw Univ Life Sci, Fac Vet Med, Dept Large Anim Med Clin, Nowoursynowska 100, PL-02797 Warsaw, Poland.
EM vet.olgadrewnowska@gmail.com
OI Gajewski, Zdzislaw/0000-0001-8779-5050; Turek,
   Bernard/0000-0002-1065-5284; Drewnowska, Olga/0000-0002-8792-8674
CR Arca CH, 2008, J PHARM SCI, V33, P211
   Braconnot H., 1811, ANN CHIM PHYS, V79, P265
   Briggs T, 2009, J BIOMED MATER RES A, V91A, P975, DOI 10.1002/jbm.a.32310
   Chen JS, 2005, ARTIF ORGANS, V29, P104, DOI 10.1111/j.1525-1594.2005.29021.x
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Fedakar-Senyucel M, 2008, J PEDIATR SURG, V43, P290, DOI 10.1016/j.jpedsurg.2007.10.016
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   INUI H, 1995, BIOSCI BIOTECH BIOCH, V59, P2111, DOI 10.1271/bbb.59.2111
   Khanal DR, 2000, INDIAN VET J, V77, P1085
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Khor E., 2001, CHITIN FULFILLING BI
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   Kucharska M, 2010, PROG CHEM APPL CHITI, V15, P169
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Lin CH, 2008, TISSUE ENG PART C-ME, V14, P69, DOI 10.1089/tec.2007.0336
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Martins AM, 2008, TISSUE ENG PART A, V15, P1953
   Minami S, 1999, EXS, V87, P265
   Minami S, 1993, ADV CHITIN CHITOSAN, P61
   Morgan SM, 2009, BIOMATERIALS, V30, P1910, DOI 10.1016/j.biomaterials.2008.12.033
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   Muzzarelli RAA, 2007, CARBOHYD POLYM, V70, P274, DOI 10.1016/j.carbpol.2007.04.008
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Park H, 2009, MACROMOL BIOSCI, V9, P895, DOI 10.1002/mabi.200800376
   Penolazzi L, 2010, TISSUE ENG PART C-ME, V16, P141, DOI [10.1089/ten.tec.2008.0582, 10.1089/ten.TEC.2008.0582]
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Reed CR, 2009, ANN PLAS SURG, V62, P505, DOI 10.1097/SAP.0b013e31818e48bf
   Rouget C., 1859, CR HEBD ACAD SCI, V48, P792
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Shin JW, 2009, J BIOMAT SCI-POLYM E, V20, P757, DOI 10.1163/156856209X426808
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Zhao L, 2009, J MATER SCI-MATER M, V20, P949, DOI 10.1007/s10856-008-3645-5
NR 48
TC 2
Z9 2
U1 0
U2 22
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, UNIV WARMIA & MAZURY OLSZTYN
PI WARSZAWA
PA PL DEFILAD 1, WARSZAWA, 00-901, POLAND
SN 1505-1773
EI 2300-2557
J9 POL J VET SCI
JI Pol. J. Vet. Sci.
PY 2013
VL 16
IS 4
BP 843
EP 848
DI 10.2478/pjvs-2013-0119
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 276CE
UT WOS:000328724900031
PM 24597325
OA Other Gold
DA 2018-10-20
ER

PT S
AU Kasai, K
   Haruyama, Y
   Yamada, T
   Akiba, M
   Tominari, Y
   Kaji, T
   Terui, T
   Peper, F
   Tanaka, S
   Katagiri, Y
   Kikuchi, H
   Okada-Shudo, Y
   Otomo, A
AF Kasai, Katsuyuki
   Haruyama, Yoshihiro
   Yamada, Toshiki
   Akiba, Makoto
   Tominari, Yukihiro
   Kaji, Takahiro
   Terui, Toshifumi
   Peper, Ferdinand
   Tanaka, Shukichi
   Katagiri, Yoshitada
   Kikuchi, Hiroshi
   Okada-Shudo, Yoshiko
   Otomo, Akira
BE Kobayashi, N
   Ouchen, F
   Rau, I
TI Bacteriorhodopsin-based bipolar photosensor for biomimetic sensing
SO NANOBIOSYSTEMS: PROCESSING, CHARACTERIZATION, AND APPLICATIONS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanobiosystems - Processing, Characterization, and
   Applications VI
CY AUG 25-28, 2013
CL San Diego, CA
SP SPIE
DE Bacteriorhodopsin; Dip coating; Membrane protein; Photocurrent;
   Biomimetic sensing
ID PURPLE MEMBRANE; ARTIFICIAL PHOTORECEPTOR; HALOBACTERIUM-HALOBIUM;
   FILMS; MECHANISM
AB Bacteriorhodopsin (bR) is a promising biomaterial for several applications. Optical excitation of bR at an electrode-electrolyte interface generates differential photocurrents while an incident light is turned on and off. This unique functional response is similar to that seen in retinal neurons. The bR-based bipolar photosensor consists of the bR dip-coated thin films patterned on two ITO plates and the electrolyte solution. This bipolar photocell will function as a biomimetic photoreceptor cell. The bipolar structure, due to the photocurrent being generated in alignment with the cathodic direction, makes the excitatory and inhibitory regions possible. This scheme shows our bipolar cell can act as a basic unit of edge detection and forms the artificial visual receptive field.
C1 [Kasai, Katsuyuki; Haruyama, Yoshihiro; Yamada, Toshiki; Akiba, Makoto; Tominari, Yukihiro; Kaji, Takahiro; Terui, Toshifumi; Peper, Ferdinand; Tanaka, Shukichi; Katagiri, Yoshitada; Otomo, Akira] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Nishi Ku, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.
   [Katagiri, Yoshitada; Kikuchi, Hiroshi] Univ Electro Commun Technol, Kobe, Hyogo, Japan.
RP Kasai, K (reprint author), Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Nishi Ku, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.
EM kasai@nict.go.jp
CR He JA, 1998, J PHYS CHEM B, V102, P7067, DOI 10.1021/jp981612x
   He JA, 1999, ADV MATER, V11, P435, DOI 10.1002/(SICI)1521-4095(199904)11:6<435::AID-ADMA435>3.3.CO;2-L
   Jin YD, 2008, CHEM SOC REV, V37, P2422, DOI 10.1039/b806298f
   KANDORI H, 2011, MOL SCI, V5
   KASAI K, 2012, Patent No. 2012270679
   KATAGIRI Y, 2008, P SOC PHOTO-OPT INS, V7266, P1
   Koyama K, 1998, PHOTOCHEM PHOTOBIOL, V68, P400, DOI 10.1111/j.1751-1097.1998.tb09699.x
   Michels AF, 2004, APPL OPTICS, V43, P820, DOI 10.1364/AO.43.000820
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   MIYASAKA T, 1995, JPN J APPL PHYS 1, V34, P3920, DOI 10.1143/JJAP.34.3920
   MIYASAKA T, 1991, CHEM LETT, P1645, DOI 10.1246/cl.1991.1645
   MIYASAKA T, 1993, APPL OPTICS, V32, P6371, DOI 10.1364/AO.32.006371
   OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0
   OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853
   OKADA Y, 1993, JPN J APPL PHYS 1, V32, P3828, DOI 10.1143/JJAP.32.3828
   OKADASHUDO Y, 2012, SPIE NEWSROOM, P26, DOI DOI 10.1117/2.1201212.004599
   RACKER E, 1974, J BIOL CHEM, V249, P662
   Saga Y, 1999, J PHYS CHEM B, V103, P234, DOI 10.1021/jp982144u
   Saga Y, 1999, ANAL SCI, V15, P365, DOI 10.2116/analsci.15.365
   SAGA Y, 1997, SEISANKENKYU REPORT, V49, P154
   Sanio M, 1999, OPT LETT, V24, P379, DOI 10.1364/OL.24.000379
   Striven L., 1988, MATER RES SOC S P, V121, DOI [10.1557/PROC-121-717, DOI 10.1557/PR0C-121-717]
   TAKEI H, 1991, APPL OPTICS, V30, P500, DOI 10.1364/AO.30.000500
   THOMA R, 1991, OPT LETT, V16, P651, DOI 10.1364/OL.16.000651
   VARO G, 1983, BIOPHYS J, V43, P47, DOI 10.1016/S0006-3495(83)84322-7
   Wang JP, 1997, J PHYS CHEM B, V101, P3420, DOI 10.1021/jp962111j
   YAMADA T, 2013, JPN J APPL PHYS, V52
   Yamada T, 2012, CHEM PHYS LETT, V530, P113, DOI 10.1016/j.cplett.2012.01.063
   Yang JH, 1998, THIN SOLID FILMS, V324, P281, DOI 10.1016/S0040-6090(98)00367-8
NR 29
TC 4
Z9 4
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9667-6
J9 PROC SPIE
PY 2013
VL 8817
AR UNSP 88170N
DI 10.1117/12.2026517
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Characterization &
   Testing; Optics
SC Science & Technology - Other Topics; Materials Science; Optics
GA BJI62
UT WOS:000328343900015
DA 2018-10-20
ER

PT J
AU Turek, A
   Cwalina, B
   Kobielarz, M
AF Turek, Artur
   Cwalina, Beata
   Kobielarz, Magdalena
TI Radioisotopic investigation of crosslinking density in bovine
   pericardium used as a biomaterial
SO NUKLEONIKA
LA English
DT Article
DE bioprostheses; bovine pericardium (BP); crosslinking; methylene blue
   (MB); photooxidation; radioisotopic investigations
ID BIOPROSTHETIC HEART-VALVES; ATOMIC-FORCE MICROSCOPY;
   DIELECTRIC-SPECTROSCOPY; GLUTARALDEHYDE ACETALS; TANNIC-ACID; TISSUE;
   COLLAGEN; PROTEINS; CALCIFICATION; CROSSLINKING
AB Stabilized bovine pericardium (BP) belongs to tissues routinely applied in production of heart valves. Commercial products are manufactured from tissues crosslinked by glutaraldehyde (GA). Dye-mediated photooxidation was also proposed as an alternative method, which allows for the elimination of clinical failures of GA-treated tissues. The aim of the study was to investigate the density of BP stabilized by GA and the methylene blue-mediated photooxidation, as compared with a native tissue. Cross linking density was evaluated based on their ability to accumulate radioactive cobalt ions (Co-60(2+)) and the permeability to these ions. Radioactivity was examined using a gamma-spectrophotometer (Packard). The results showed the changes in the crosslinking density between the native tissues and photooxidized or GA-crosslinked tissues. Significant decreases in radioactivity were detected only in the thinnest tissues after photoxidation and in filtrates penetrating the same samples. Photooxidized pericardium of a larger thickness did not reveal any significant changes. Weight-dependence for the permeability was observed in the case of filtrates penetrating the GA-treated tissues. However, Co-60(2+)-accumulation in these samples remained at the same level. Photooxidation may lead to obtaining biomaterials with advantageous properties, i.e. a decreased calcium-binding capacity. Photooxidation efficiencies were dependent both on compactness and thickness of tissues and on process duration. It should be emphasized that the tissues' structure after photooxidation was characterized by lower density. This may point to the presence of crosslinks of a smaller compactness in comparison with GA treatment. It has been shown that the factor indeed influencing the result of crosslinking is tissue thickness.
C1 [Turek, Artur] Med Univ Silesia, Dept Biopharm, PL-41200 Sosnowiec, Poland.
   [Turek, Artur] Polish Acad Sci, Ctr Polymer & Carbon Mat, PL-41819 Zabrze, Poland.
   [Cwalina, Beata] Silesian Tech Univ, Dept Environm Biotechnol, PL-44100 Gliwice, Poland.
   [Kobielarz, Magdalena] Wroclaw Univ Technol, Div Biomed Engn & Expt Mech, PL-50371 Wroclaw, Poland.
RP Turek, A (reprint author), Med Univ Silesia, Dept Biopharm, 1 Narcyzow Str, PL-41200 Sosnowiec, Poland.
EM a.turek75@gmail.com
FU Medical University of Silesia [KNW-2-186/09]
FX This work was financially supported by the Medical University of Silesia
   (Grant no. KNW-2-186/09). The authors thank Dr A. Bogacz for his
   assistance during radioisotopic researches.
CR Au V, 2000, ARCH BIOCHEM BIOPHYS, V384, P133, DOI 10.1006/abbi.2000.2070
   Bianco RW, 1996, J HEART VALVE DIS, V5, P317
   Bodega F, 2000, J APPL PHYSIOL, V89, P2165
   Butterfield M, 2000, J HEART VALVE DIS, V9, P161
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Cwalina B, 2005, INT J ARTIF ORGANS, V28, P648
   Cwalina B, 2000, WAVE METHODS MECH BI, P115
   Cwalina B, 2002, ENG BIOMATERIALS, V23, P64
   DeLustro F, 2004, TISSUE ENG NOVEL DEL, P521
   Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119
   FUJIMORI E, 1965, BIOPOLYMERS, V3, P115, DOI 10.1002/bip.360030202
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Hetherington VJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-36
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jastrzebska M, 2006, J BIOMED MATER RES A, V78A, P148, DOI 10.1002/jbm.a.30717
   Jastrzebska M, 2005, EUR PHYS J E, V16, P381, DOI 10.1140/epje/i2004-10093-1
   Jastrzebska M, 2001, IEEE T DIELECT EL IN, V8, P527, DOI 10.1109/94.933378
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P417
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x
   Lee JM, 1996, J BIOMECH, V29, P829, DOI 10.1016/0021-9290(95)00121-2
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   MEADE KR, 1990, BIOMATERIALS, V11, P176, DOI 10.1016/0142-9612(90)90151-F
   MECHANIC GL, 1994, Patent No. 5332475
   Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01
   Moczar M, 1994, ASAIO J, V40, pM697, DOI 10.1097/00002480-199407000-00088
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Myers PO, 2010, J THORAC CARDIOV SUR, V140, P836, DOI 10.1016/j.jtcvs.2010.06.036
   NAIMARK WA, 1992, AM J PHYSIOL, V263, pH1095
   Remi E, 2011, BIOMATERIALS SCIENCE AND ENGINEERING, P437
   ROSENTHAL JT, 1983, ANN SURG, V198, P617, DOI 10.1097/00000658-198311000-00010
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Thoma R J, 1995, J Heart Valve Dis, V4, P214
   Turek A., 2009, ENG BIOMATERIALS, V89-91, P30
   Turek A, 2010, ENG BIOMATERIALS, V96, P99
   Turek A., 2010, NEW DEV BIOMEDICAL E, P543
   WEIL L, 1951, ARCH BIOCHEM BIOPHYS, V33, P90, DOI 10.1016/0003-9861(51)90084-7
   Westaby S, 1999, Semin Thorac Cardiovasc Surg, V11, P206
   Yoshioka SA, 2008, J MATER SCI-MATER M, V19, P1215, DOI 10.1007/s10856-007-0151-0
NR 44
TC 2
Z9 2
U1 1
U2 7
PU INST NUCLEAR CHEMISTRY TECHNOLOGY
PI WARSAW
PA DORODNA 16 STR, 03-195 WARSAW, POLAND
SN 0029-5922
J9 NUKLEONIKA
JI Nukleonika
PY 2013
VL 58
IS 4
BP 511
EP 517
PG 7
WC Chemistry, Inorganic & Nuclear; Physics, Nuclear
SC Chemistry; Physics
GA 275GK
UT WOS:000328664100009
DA 2018-10-20
ER

PT J
AU Pijocha, D
   Zima, A
   Paszkiewicz, Z
   Slosarczyk, A
AF Pijocha, Dawid
   Zima, Aneta
   Paszkiewicz, Zofia
   Slosarczyk, Anna
TI Physicochemical properties of the novel biphasic
   hydroxyapatite-magnesium phosphate biomaterial
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE composite; bone substitute; hydroxyapatite; magnesium phosphate cement
ID IN-VIVO EVALUATION; BONE CEMENTS; CALCIUM; CERAMICS; STRUVITE;
   BIOCOMPATIBILITY; PRECIPITATION; STRENGTH; IMPLANTS; BEHAVIOR
AB Besides high-temperature calcium phosphates (CaPs), low-temperature calcium phosphate bone cements (CPCs), due to excellent biological properties: bioactivity, biocompability and osteoconductivity, are successfully used as bone substitutes. However, some disadvantages, related mainly to their low resorption rate and poor mechanical properties result in limited range of applications of these implant materials to non-loaded places in the skeletal system. To overcome this problem, magnesium phosphate cements (MPCs) with high strength have been considered as biomaterials. The main disadvantage of MPCs is that the acid-base setting reaction is an exothermic process that must be strictly controlled to avoid tissue necrosis.
   In this work, a new composite bone substitute (Hydroxyapatite Magnesium Phosphate Material - HMPM) based on hydroxyapatite (HA) and magnesium phosphate cement (MPC) with sodium pyrophosphate applied as a retardant of setting reaction was obtained. Its setting time was adequate for clinical applications. Combining properties of HA and MPC has made it possible to obtain microporous (showing bimodal pore size distribution in the range of 0.005-1.700 micrometers) potential implant material showing good surgical handiness and sufficient mechanical strength. Effectiveness of sodium pyrophosphate as a retardant of exothermic setting reaction of the new cement formulation was confirmed. After setting and hardening, the material consisted of hydroxyapatite and struvite as crystalline phases. Unreacted magnesium oxide was not detected.
C1 [Pijocha, Dawid; Zima, Aneta; Paszkiewicz, Zofia; Slosarczyk, Anna] AGH Univ Sci & Technol, PL-30059 Krakow, Poland.
RP Pijocha, D (reprint author), AGH Univ Sci & Technol, Al Mickiewicza 30,B6,R 115, PL-30059 Krakow, Poland.
EM dav_p@o2.pl
RI Zima, Aneta/T-4607-2017
OI Zima, Aneta/0000-0002-1159-1331
FU European Union [UDA-POIG-01.03.01-00-005/09]
FX This work was supported by the European Union - project No.
   UDA-POIG-01.03.01-00-005/09.
CR Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Blitterswijk C.V., 2008, ACAD PRESS SERIES BI
   Bouropoulos NC, 2000, J CRYST GROWTH, V213, P381, DOI 10.1016/S0022-0248(00)00351-1
   BROWN WE, 1983, J DENT RES, V62, P672
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Doyle JD, 2002, WATER RES, V36, P3925, DOI 10.1016/S0043-1354(02)00126-4
   Doyle JD, 2000, PROCESS SAF ENVIRON, V78, P480, DOI 10.1205/095758200531023
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P223, DOI 10.1023/A:1008958112257
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   Gilham-Dayton P.A., 1963, BRIT CERAM T, V62, P895
   Ginebra MP, 2010, ADV DRUG DEL REV, V64, P1090
   Jacofsky DJ, 2012, J ARTHROPLASTY, V27, P305, DOI 10.1016/j.arth.2011.05.009
   Kim SY, 2012, J IND ENG CHEM, V18, P128, DOI 10.1016/j.jiec.2011.11.001
   Klammert U, 2011, ACTA BIOMATER, V7, P3469, DOI 10.1016/j.actbio.2011.05.022
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Li B, 2009, ACTA BIOMATER, V5, P134, DOI 10.1016/j.actbio.2008.07.035
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3500, DOI 10.1016/j.actbio.2012.05.033
   Mestres G, 2011, ACTA BIOMATER, V7, P1853, DOI 10.1016/j.actbio.2010.12.008
   Ooms EM, 2003, J BIOMED MATER RES B, V66B, P447, DOI 10.1002/jbm.b.10039
   Pijocha D, 2011, J ACHIEV MAT MANUF E, V49, P204
   Prosen E.M., 1941, US Patent, Patent No. 2209404
   Prosen E.M., 1939, Refractory Materials for Use in Making Dental Casting, Patent No. [US 2152152, 2152152]
   Scrimgeour SN, 2007, DENT MATER, V23, P934, DOI 10.1016/j.dental.2006.06.002
   SEEHRA SS, 1993, CEMENT CONCRETE RES, V23, P254, DOI 10.1016/0008-8846(93)90090-V
   Slosarczyk A, 1996, J AM CERAM SOC, V79, P2539
   Soudee E, 2002, CEMENT CONCRETE RES, V32, P153, DOI 10.1016/S0008-8846(01)00647-0
   Soudee E, 2000, CEMENT CONCRETE RES, V30, P315, DOI 10.1016/S0008-8846(99)00254-9
   Tamimi F, 2011, ACTA BIOMATER, V7, P2678, DOI 10.1016/j.actbio.2011.02.007
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Wolff KD, 2004, J CRANIO MAXILL SURG, V32, P71, DOI 10.1016/S1010-5182(03)00134-3
   Wu F, 2008, ACTA BIOMATER, V4, P1873, DOI 10.1016/j.actbio.2008.06.020
   Yu YL, 2010, COLLOID SURFACE B, V76, P496, DOI 10.1016/j.colsurfb.2009.12.010
   Zhu ZL, 2008, APPL SURF SCI, V255, P552, DOI 10.1016/j.apsusc.2008.06.055
   Zima A, 2012, CERAM INT, V38, P4935, DOI 10.1016/j.ceramint.2012.02.086
NR 37
TC 4
Z9 5
U1 0
U2 20
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2013
VL 15
IS 3
BP 53
EP 63
DI 10.5277/abb130307
PG 11
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 258UM
UT WOS:000327484200007
PM 24215450
DA 2018-10-20
ER

PT J
AU Shoaib, A
   Aslam, N
   Aslam, N
AF Shoaib, A.
   Aslam, N.
   Aslam, N.
TI TRICHODERMA HARZIANUM: ADSORPTION, DESORPTION, ISOTHERM AND FTIR STUDIES
SO JOURNAL OF ANIMAL AND PLANT SCIENCES
LA English
DT Article
DE Heavy metal; Cr (VI); waste water; adsorption; Fungus; Trichoderma
   harzianum
ID HEXAVALENT CHROMIUM REMOVAL; AQUEOUS-SOLUTIONS; BIOSORPTION; BIOMASS;
   REMEDIATION; EQUILIBRIUM; ADSORBENTS; KINETICS; IONS
AB Metal removal capability of indigenous soil fungus of Pakistan i.e. Trichoderma harzianum (Rifai) was determined through laboratory bioassays. Experiments were conducted in flasks by taking 0.1 g of powdered fungal biomass in 100 mL (25 mg/L) of metal solution kept at 150 rpm for 3 hours. Results showed that the biomass of T. harzianum exhibited significantly greater adsorption efficiency of 65% (capacity: 16.33 mg/g) for uptake of Cr(VI) ions from the aqueous solution. FTIR spectroscopy of the fungal biomass revealed the involvement of chitin and chitosan in metal adsorption process. Adsorption efficiency was significantly decreased (70-50%) and capacity increased (15-50 mg/g) with increase in Cr(VI) concentration from 20, 40.......100 mg/L. Batch data was well-defined by Langmuir and Freundlich isotherms. Solution pH evaluated in the range of 2, 4.....10 found to favor adsorption at pH 2 (efficiency: 70%, capacity 50 mg/g). Adsorption/ desorption trials using four acids indicted, maximum desorption of metal was occurred with HNO3 (q(des): 10 mg/g) followed by HCl (9 mg/g), CH3COOH (8 mg/g) and H2SO4 (7 mg/g). Adsorption based trials summarized that dried powdered biomass of T. harzianum is suitable and easily available indigenous biomaterial with viable application in the removal of Cr(VI) from the metal-bearing solution within the concentration of 20-100 mg/L.
C1 [Shoaib, A.; Aslam, N.] Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
   [Aslam, N.] Govt Coll Univ, Lahore, Pakistan.
RP Shoaib, A (reprint author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
EM aamnaa29@yahoo.com
CR Baral SS, 2006, BIOCHEM ENG J, V31, P216, DOI 10.1016/j.bej.2006.08.003
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   Deng L., 2006, MINER ENG, V22, P372
   Diniz V, 2006, SEP PURIF TECHNOL, V50, P71, DOI 10.1016/j.seppur.2005.11.010
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gochev VK, 2010, J SERB CHEM SOC, V75, P551, DOI 10.2998/JSC090331008G
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   HOLAN ZR, 1994, BIOTECHNOL BIOENG, V43, P1001, DOI 10.1002/bit.260431102
   Javaid A, 2010, PAK J BOT, V42, P2105
   Jeppu GP, 2012, J CONTAM HYDROL, V129, P46, DOI 10.1016/j.jconhyd.2011.12.001
   Kara A, 2012, WATER AIR SOIL POLL, V223, P2387, DOI 10.1007/s11270-011-1032-1
   Kehinde A.A., 2008, J APP SCI RES, V4, P1420
   Klimiuk E, 2002, POL J ENVIRON STUD, V11, P375
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Mulgund MG, 2011, INT J ENG SCI TECHNO, V3, P1642
   Nagh W.S., 2008, J ENVIRON SCI, V20, P1168
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Patty, 2001, J CHEM EDUC, V78, P351
   RAJENDER K, 2008, J CHEM ENG, V135, P202
   Shoaib A, 2012, INT J AGRIC BIOL, V14, P831
   Sivaprakash A, 2009, APPL ECOL ENV RES, V7, P45, DOI 10.15666/aeer/0701_045057
   Steel R. G. D., 1997, PRINCIPLES PROCEDURE
   Vankar PS, 2008, DESALINATION, V222, P255, DOI 10.1016/j.desal.2007.01.168
   Volesky B., 2005, BIOSORPTION APPL STR
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
NR 27
TC 2
Z9 2
U1 1
U2 5
PU PAKISTAN AGRICULTURAL SCIENTISTS FORUM
PI LAHORE
PA UNIV VETERINARY & ANIMAL SCIENCES, LAHORE, 00000, PAKISTAN
SN 1018-7081
J9 J ANIM PLANT SCI
JI J. Anim. Plant Sci.
PY 2013
VL 23
IS 5
BP 1460
EP 1465
PG 6
WC Agriculture, Multidisciplinary; Biology; Veterinary Sciences
SC Agriculture; Life Sciences & Biomedicine - Other Topics; Veterinary
   Sciences
GA 261WE
UT WOS:000327694500037
DA 2018-10-20
ER

PT J
AU Landy, BC
   VanGordon, SB
   McFetridge, PS
   Sikavitsas, VI
   Jarman-Smith, M
AF Landy, Bonnie C.
   VanGordon, Samuel B.
   McFetridge, Peter S.
   Sikavitsas, Vassilios I.
   Jarman-Smith, Marcus
TI Mechanical and in vitro investigation of a porous PEEK foam for medical
   device implants
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Biocompatibility; Bone; ESCA (electron spectroscopy for chemical
   analysis); Mechanical properties; Mesenchymal stem cell;
   Osteoconduction; Polyetheretherketone
ID BONE EXTRACELLULAR-MATRIX; POLYETHERETHERKETONE PEEK; STROMAL CELLS;
   OSTEOBLASTS; PLATES; BIOCOMPATIBILITY; DIFFERENTIATION; PROLIFERATION;
   BIOMATERIALS; FIBROBLASTS
AB Purpose: Implantable-grade polyetheretherketone (PEEK-OPTIMA (R)) is a high-performance thermoplastic that has been used in implant devices such as spinal-fusion cages since its introduction in 1999. Here, a new porous PEEK version was investigated.
   Methods: Porous PEEK was fabricated using industrial scale relevant methods of compounding with porogen filler, extrusion, and subsequent extraction with water at supercritical temperatures and pressures. Mechanical properties were assessed according to ISO standards. Marrow stromal cells were cultured on porous PEEK samples and in vitro cytocompatibility was assessed by total DNA, alkaline phosphatase activity, osteopontin, calcium, and cell morphology to indicate stages of proliferation, differentiation, and mineralization. Compressive strength was assessed statically on 21 day cell cultures and media-soaked samples and dynamically within a medical device application specific context for interbody fusion cages (ASTM F2077).
   Results: Manufacturing resulted in a biomaterial with similar to 50% porosity and a mean pore size of 100 microns. The porous PEEK was found to have: tensile strength (14.5MPa), strain at break (3.5%), impact strength (3.6 kJ/m(2)), flexural strength (21.6MPa), and flexural modulus (0.8GPa). Production of extracellular mineralized matrix occurred very early in the culture period, indicating a preferred surface for differentiation. SEM images revealed polygonal cell morphology supporting a differentiated osteoblastic-like phenotype. EDS analysis detected levels of carbon, phosphorus, and calcium coinciding with assay results for the proliferation and differentiation stages.
   Conclusion: Previous observations of cytocompatibility and calcification on the PEEK biomaterial could be carried through to this new porous form of the PEEK biomaterial. This helps porous PEEK to potentially offer more design options for implant devices requiring reduced modulus and/or increased tissue ingrowth aspects at the surface.
C1 [Landy, Bonnie C.; VanGordon, Samuel B.; Sikavitsas, Vassilios I.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Bioengn Ctr, Norman, OK 73019 USA.
   [McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA.
   [Jarman-Smith, Marcus] Invibio Ltd, IGTC, Hillhouse Int, Thornton Cleveleys, Lancs, England.
RP Sikavitsas, VI (reprint author), Univ Oklahoma, Sch Chem Biol & Mat Engn, Bioengn Ctr, Norman, OK 73019 USA.
EM vis@ou.edu
CR AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59
   Boinard E, 2000, POLYMER, V41, P1063, DOI 10.1016/S0032-3861(99)00259-1
   BRADLEY GW, 1979, J BONE JOINT SURG AM, V61, P866, DOI 10.2106/00004623-197961060-00010
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   Cook S D, 1995, J Oral Implantol, V21, P176
   Craig A, 1999, J BIOMED MATER RES, V47, P127
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kerr SH, 2009, World patent, Patent No. [WO 2009/099559, 2009099559]
   Kramschuster A, 2007, HIGHLY POROUS INJECT
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Macnair R., 1996, Cells and Materials, V6, P71
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Morrissette D, 2007, World patent, Patent No. [WO 2007/051307, 2007051307]
   Noiset O, 1999, J BIOMAT SCI-POLYM E, V10, P657, DOI 10.1163/156856299X00865
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pino M, 2008, ACTA BIOMATER, V4, P1827, DOI 10.1016/j.actbio.2008.05.004
   Poulsson AHC, 2009, EUR CELLS MATER, V18, P34
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   TERJESEN T, 1988, J ORTHOPAED RES, V6, P293, DOI 10.1002/jor.1100060218
   Trexel I, 2006, TREX MUCELL PROC
   von Wilmowsky C, 2008, J BIOMED MATER RES A, V87A, P896, DOI 10.1002/jbm.a.31822
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   WILLIAMS DF, 1987, J MATER SCI LETT, V6, P188, DOI 10.1007/BF01728981
   WOO SLY, 1976, J BONE JOINT SURG AM, V58, P190, DOI 10.2106/00004623-197658020-00005
NR 30
TC 11
Z9 11
U1 6
U2 61
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2013
VL 11
IS 1
BP 35
EP 44
DI 10.5301/JABFM.2012.9771
PG 10
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 262KV
UT WOS:000327734900005
PM 23413130
DA 2018-10-20
ER

PT J
AU Sutradhar, BC
   Hong, G
   Ge, ZG
   Kim, G
AF Sutradhar, Bibek Chandra
   Hong, Gyeongmi
   Ge, Zigang
   Kim, Gonhyung
TI Enhancement of Chondrogenesis via Co-culture of Bovine Chondrocytes with
   Demineralized Bone Matrix in Chitosan-alginate Beads
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Article
DE Co-culture; Chondrocytes; Chitosan; Alginate; Beads
ID MESENCHYMAL STEM-CELLS; IN-VITRO; ARTICULAR-CARTILAGE; STROMAL CELLS;
   TISSUE; SCAFFOLDS; HYDROGELS; HYDROXYAPATITE; BIOMATERIAL; DERIVATIVES
AB Cartilage injury leads to osteoarthritis and subsequent loss of mobility irreversibly if untreated. There is no widely established technology for the functional repair of large osteochondral defects, though some progress has been made in repairing/regenerating cartilage defects. In the present study, bovine chondrocytes were cultured in alginate or chitosan-alginate beads with and without co-culture of demineralized bone matrix (DBM) in vitro. After the four systems were maintained in vitro for four weeks, the cell morphology, proliferation, sulfated glycosaminoglycan (sGAG) synthesis, and gene expression were evaluated. The typical chondrocytic phenotype was maintained in all beads for the entire four weeks. The proliferation of chondrocytes in chitosan-alginate beads co-cultured with DBM was significantly (p < 0.05) higher than that in alginates. Histological analysis showed the typical round, plump morphology associated with an increased number of lacunae in chitosan-alginate beads. The production of sGAG also significantly (p < 0.05) increased in quality and quantity and type II collagen gene expression was maintained in the co-culture in chitosan-alginate beads. These results indicate that chondrocytes co-cultured with DBM in chitosan-alginate beads provide a preferred environment for high-density chondrogenesis with matrix synthesis, which may be considered as a sophisticated scaffold model for osteochondral tissue regeneration.
C1 [Sutradhar, Bibek Chandra; Hong, Gyeongmi; Kim, Gonhyung] Chungbuk Natl Univ, Coll Vet Med, Lab Vet Surg, Cheongju 361763, South Korea.
   [Ge, Zigang] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.
   [Ge, Zigang] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomat & Tissue Engn, Beijing 100871, Peoples R China.
RP Kim, G (reprint author), Chungbuk Natl Univ, Coll Vet Med, Lab Vet Surg, Cheongju 361763, South Korea.
EM ghkim@cbu.ac.kr
RI GE, Zigang/E-3576-2010
OI GE, Zigang/0000-0002-5202-0973; Kim, Gonhyung/0000-0002-9384-4741
FU National Research Foundation of Korea (NRF) [NRF-2010-E00009]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant (NRF-2010-E00009). The authors would like to thank Mr. Chao
   Li for constructive advice. Ms. Tanushree Thote for proofreading.
CR Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Andrade LR, 2011, CELL BIOL INT, V35, P293, DOI 10.1042/CBI20100273
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Dai YN, 2008, J BIOMED MATER RES B, V86B, P493, DOI 10.1002/jbm.b.31046
   Dodds RA, 2010, J BIOMATER APPL, V25, P195, DOI 10.1177/0885328209345552
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Gan L, 2007, TISSUE ENG, V13, P831, DOI 10.1089/ten.2006.0231
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gurevitch O, 2003, STEM CELLS, V21, P588, DOI 10.1634/stemcells.21-5-588
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970
   Li NY, 2009, J ORAL MAXIL SURG, V67, P1850, DOI 10.1016/j.joms.2009.04.029
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Lin P, 2009, NEUROENDOCRINOL LETT, V30, P204
   Liu GP, 2008, CALCIFIED TISSUE INT, V83, P176, DOI 10.1007/s00223-008-9159-9
   Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y
   LUYTEN FP, 1994, EXP CELL RES, V210, P224, DOI 10.1006/excr.1994.1033
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Nakamura S, 2006, J ORTHOP RES, V24, P733, DOI 10.1002/jor.20077
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ng SS, 2012, ACTA BIOMATER, V8, P244, DOI 10.1016/j.actbio.2011.08.018
   Ozdemir MT, 2011, INDIAN J ORTHOP, V45, P226, DOI 10.4103/0019-5413.80040
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Ragetly GR, 2010, J BIOMED MATER RES A, V93A, P46, DOI 10.1002/jbm.a.32514
   Salgado Antonio J, 2006, Curr Stem Cell Res Ther, V1, P345
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Takka S, 2010, AAPS PHARMSCITECH, V11, P460, DOI 10.1208/s12249-010-9406-z
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tsiridis E, 2009, EXPERT OPIN BIOL TH, V9, P9, DOI 10.1517/14712590802622473 
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211
   Zhang B, 2009, CHIN J TRAUMATOL, V12, P379, DOI 10.3760/cma.j.issn.1008-1275.2009.06.011
NR 49
TC 1
Z9 1
U1 0
U2 6
PU DEPT BIOMEDICAL ENGINEERING
PI TAINAN CITY
PA NAT CHENG KUNG UNIV, NO 1 UNIVERSITY RD, TAINAN CITY, TAIWAN 701,
   PEOPLES R CHINA
SN 1609-0985
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2013
VL 33
IS 5
BP 518
EP 525
DI 10.5405/jmbe.1137
PG 8
WC Engineering, Biomedical
SC Engineering
GA 258SB
UT WOS:000327477900013
DA 2018-10-20
ER

PT J
AU Firdous, S
   Waqas, W
   Idrees, M
   Nawaz, M
   Ikram, M
AF Firdous, S.
   Waqas, W.
   Idrees, M.
   Nawaz, M.
   Ikram, M.
TI Polarization Sensitive Optical Imaging of Biomaterials Using a Mueller
   Matrix Polarimetric Algorithm
SO LASERS IN ENGINEERING
LA English
DT Article
DE Optical imaging; biomaterial; ultra-high-molecular-weight polyethylene
   (UHMWPE); polarization; scattering; depolarization; Mueller matrix
ID MOLECULAR-WEIGHT POLYETHYLENE; PRODUCT DECOMPOSITIONS; POLAR
   DECOMPOSITION; UHMWPE; SYSTEMS; LASER
AB A complete and minimum set of necessary and sufficient conditions for a real 4 . 4 matrix to be a physical Mueller matrix with forward and reverse decomposition is obtained. The significant information or image contrast about the biomaterials can be obtained through polarization sensitive optical imaging technique. The Mueller matrices of the ultra-high molecular-weight-polyethylene (UHMWPE) from 400 to 800 nm wavelength of light were obtained experimentally and corresponding optical polarization measured parameters were simulated at different wavelengths for forward and reverse decomposition. Based on this decomposition. the diattenuation and the retardence of a Mueller Matrix can be defined and computed. The algorithm is useful for optical properties measurement and performing data reduction upon experimentally determined Mueller matrices. The UHMWPE is a unique polymer with outstanding physical and mechanical properties can be used as artificial bone substitute. By knowing the optical properties of UHMWPE through this imaging technique. the deficiencies can be removed in the material for replacement of joints. The developed model can also be applied to other biomaterials for their optical properties and data reduction.
C1 [Firdous, S.; Nawaz, M.] Natl Inst Lasers & Optron NILOP, Biophoton Lab, Photon Div, Islamabad, Pakistan.
   [Waqas, W.] Fed Urdu Univ Arts Sci &Technol, Dept Appl Phys, Islamabad, Pakistan.
   [Idrees, M.; Ikram, M.] PIEAS, Islamabad, Pakistan.
RP Firdous, S (reprint author), Natl Inst Lasers & Optron NILOP, Biophoton Lab, Photon Div, PO Nilore 45650, Islamabad, Pakistan.
EM shamaraz@gmail.com
RI Ikram, Masroor/G-9117-2011; Firdous, Shamaraz/I-8028-2015; Ikram,
   Masroor/G-3359-2015
CR Barron D, 2008, POLYMER, V49, P3111, DOI 10.1016/j.polymer.2008.05.004
   Brosseau C., 1998, FUNDAMENTALS POLARIZ
   Cameron BD, 1998, OPT LETT, V23, P485, DOI 10.1364/OL.23.000485
   CHIPMAN RA, 1989, OPT ENG, V28, P90, DOI 10.1117/12.7976914
   Collett E., 2003, POLARIZED LIGHT FIBR
   Crowley J, 2008, BIO-MED MATER ENG, V18, P149, DOI 10.3233/BME-2008-0518
   Estok DM, 2007, J ARTHROPLASTY, V22, P581, DOI 10.1016/j.arth.2006.07.009
   Firdous S, 2005, APPL OPTICS, V44, P1171, DOI 10.1364/AO.44.001171
   Firdous S, 2011, OPTIK, V122, P99, DOI 10.1016/j.ijleo.2009.10.008
   Firdous S., 2006, ANN BIOMEDICAL RES E, V5, P55
   Fuzail M., 2008, P 8 INT S ION RAD PO, P64
   Ghosh N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960934
   Gsell R.A., 1999, CHARACTERIZATION PRO
   Guyot S, 2003, OPTIK, V114, P289, DOI 10.1078/0030-4026-00264
   Ho SP, 2002, WEAR, V253, P1145, DOI 10.1016/S0043-1648(02)00220-X
   Jacques SL, 2000, LASER SURG MED, V26, P119, DOI 10.1002/(SICI)1096-9101(2000)26:2<119::AID-LSM3>3.3.CO;2-P
   Kucklick T., 2005, MED DEVICE R D HDB
   Kurtz S. M., 2004, UHMWPE HDB ULTRAHIGH
   Laude-Boulesteix B, 2004, APPL OPTICS, V43, P2824, DOI 10.1364/AO.43.002824
   Liu GL, 2002, P SOC PHOTO-OPT INS, V4617, P208, DOI 10.1117/12.472527
   Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106
   Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002
   Morio J, 2004, OPT LETT, V29, P2234, DOI 10.1364/OL.29.002234
   Ossikovski R, 2008, OPT COMMUN, V281, P2406, DOI 10.1016/j.optcom.2007.12.076
   Ossikovski R, 2007, OPT LETT, V32, P689, DOI 10.1364/OL.32.000689
   SHURCLIFF WA, 1962, POLARIZED LIGHT
   Tomasetti E, 1999, SURF INTERFACE ANAL, V27, P735, DOI 10.1002/(SICI)1096-9918(199908)27:8<735::AID-SIA567>3.3.CO;2-D
   Torrisi L, 2004, APPL SURF SCI, V227, P164, DOI 10.1016/j.apsusc.2003.11.078
   Twietmeyer KM, 2008, OPT EXPRESS, V16, P11589, DOI 10.1364/OE.16.011589
   Wolfe JE, 2006, APPL OPTICS, V45, P1688, DOI 10.1364/AO.45.001688
   Wood MFG, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065545
NR 31
TC 3
Z9 3
U1 0
U2 2
PU OLD CITY PUBLISHING INC
PI PHILADELPHIA
PA 628 NORTH 2ND ST, PHILADELPHIA, PA 19123 USA
SN 0898-1507
J9 LASER ENG
JI Laser Eng.
PY 2013
VL 26
IS 3-4
BP 157
EP 180
PG 24
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 261SI
UT WOS:000327684500004
DA 2018-10-20
ER

PT J
AU Ghaneian, MT
   Ehrampoush, MH
   Arany, AM
   Jamshidi, B
   Dehvari, M
AF Ghaneian, Mohammad Taghi
   Ehrampoush, Mohammad Hasan
   Arany, Asghar Mosleh
   Jamshidi, Behzad
   Dehvari, Mahboobeh
TI Equilibrium and kinetic studies of Cr (VI) removal from synthetic
   wastewater by Acroptilon repense flower powder
SO POLISH JOURNAL OF CHEMICAL TECHNOLOGY
LA English
DT Article
DE Acroptilon repens; Biosorbent; Hexavalent Chromium; Adsorption kinetic
   and isotherm
ID AQUEOUS-SOLUTIONS; ACTIVATED CARBON; CHROMIUM VI; ADSORPTION; CR(VI);
   BIOSORPTION; ADSORBENTS; CR(III); SAWDUST; BIOMASS
AB In this study the removal of Cr (VI) from synthetic wastewater was investigated using Acroptilon repens (Russian Knapweed) flower powder under various conditions (pH, contact time and initial concentration of Cr). The capacity of chromium adsorption at equilibrium conditions by this biosorbent was increased by adsorbate concentration. The results also showed that the removal efficiency of Cr (VI) was increased by increasing the contact time. By increasing the initial concentration of Cr (VI) solution, chromium removal was reduced. The suitability of adsorbents and their constants was tested or evaluated with the Langmuir, Freundlich and Temkin isotherms models. The results indicated that the Freundlich and Langmuir models (R-2 > 0.99) gave a better concordance to the adsorption data in comparison with the Temkin equation (R-2 = 0.97). The adsorption of Cr (VI) followed the pseudo-second-order kinetics (R-2 = 0.991). The study showed that Acroptilon repens flower powder can be used as an effective lignocellulosic biomaterial and biosorbent for the removal of Cr (VI) from wastewater.
C1 [Ghaneian, Mohammad Taghi; Ehrampoush, Mohammad Hasan; Jamshidi, Behzad; Dehvari, Mahboobeh] Shahid Sadoughi Univ Med Sci, Fac Publ Hlth, Dept Environm Hlth Engn, Yazd, Iran.
   [Arany, Asghar Mosleh] Yazd Univ, Dept Environm Engn, Yazd, Iran.
RP Jamshidi, B (reprint author), Shahid Sadoughi Univ Med Sci, Fac Publ Hlth, Dept Environm Hlth Engn, Yazd, Iran.
EM behzadjamshidi65@yahoo.com
RI Ehrampoush, mohammad hassan/Q-5028-2017
OI Ehrampoush, mohammad hassan/0000-0002-0388-3211; ehrampoush, Mohammad
   Hassan/0000-0001-7019-569X; Ghaneian, Mohammad Taghi/0000-0002-6665-2226
FU Shahid Sadoughi University of Medical Sciences. Yazd, Iran
FX Researchers would like to acknowledge and appreciate the financial
   support Shahid Sadoughi University of Medical Sciences. Yazd, Iran.
CR Ahmad R, 2005, WATER AIR SOIL POLL, V163, P169, DOI 10.1007/s11270-005-0217-x
   Albadarin AB, 2011, CHEM ENG J, V169, P20, DOI 10.1016/j.cej.2011.02.044
   Altun T, 2012, FOOD CHEM, V132, P693, DOI 10.1016/j.foodchem.2011.10.099
   Anandkumar J, 2011, J HAZARD MATER, V186, P1088, DOI 10.1016/j.jhazmat.2010.11.104
   ASTM, 2007, BOOK STAND, P396
   AWWA APHA, 2005, STANDARD METHODS EXA, P3
   CieslakGolonka M, 1996, POLYHEDRON, V15, P3667, DOI 10.1016/0277-5387(96)00141-6
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X
   Demirbas E, 2004, WATER SA, V30, P533
   Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Ghahremen A., 1995, FLORA IRAN, V3, P606
   Gupta VK, 2010, J COLLOID INTERF SCI, V342, P135, DOI 10.1016/j.jcis.2009.09.065
   Hafez AI, 2002, DESALINATION, V144, P237, DOI 10.1016/S0011-9164(02)00318-1
   Khan MA, 2011, J MED PLANTS RES, V5, P1471
   Lie Y., 2008, CHINESE SCI BULL, V53, P948
   Mahvi A. H., 2005, American Journal of Applied Sciences, V2, P372
   Melo JS, 2004, BIORESOURCE TECHNOL, V92, P151, DOI 10.1016/j.biortech.2003.08.015
   Miretzky P, 2010, J HAZARD MATER, V180, P1, DOI 10.1016/j.jhazmat.2010.04.060
   Mor S, 2007, BIORESOURCE TECHNOL, V98, P954, DOI 10.1016/j.biortech.2006.03.018
   Mozaffarian V.A., 1996, DICT IRANIAN PLANT N, P740
   Muthukumaran K, 2011, PROCEDIA ENVIRON SCI, V4, P266, DOI 10.1016/j.proenv.2011.03.032
   Neagu V, 2010, J HAZARD MATER, V183, P533, DOI 10.1016/j.jhazmat.2010.07.057
   Norouzi-Arasi H, 2006, FLAVOUR FRAG J, V21, P247, DOI 10.1002/ffj.1568
   Owlad M, 2010, BIORESOURCE TECHNOL, V101, P5098, DOI 10.1016/j.biortech.2010.01.135
   Rosales E, 2012, DESALINATION, V284, P150, DOI 10.1016/j.desal.2011.08.049
   Seyf-laye Alfa-Sika M, 2010, J SOIL SCI ENV MANAG, V1, P55
   Shamsa F, 2008, THAI J PHARM SCI, V32, p17 
   Tareen RB, 2010, PAK J BOT, V42, P1465
   Thamilarasu P, 2011, POL J CHEM TECHNOL, V13, P1, DOI 10.2478/v10026-011-0041-6
   Wahab MA, 2010, BIORESOURCE TECHNOL, V101, P5070, DOI 10.1016/j.biortech.2010.01.121
   Wu Y, 2008, BIORESOURCE TECHNOL, V99, P7709, DOI 10.1016/j.biortech.2008.01.069
   Yan GY, 2001, BIORESOURCE TECHNOL, V78, P243, DOI 10.1016/S0960-8524(01)00020-7
   Zhang H, 2010, J HAZARD MATER, V181, P801, DOI 10.1016/j.jhazmat.2010.05.084
   Zubair A, 2008, WATER AIR SOIL POLL, V191, P305, DOI 10.1007/s11270-008-9626-y
NR 37
TC 2
Z9 2
U1 2
U2 7
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 1509-8117
EI 1899-4741
J9 POL J CHEM TECHNOL
JI Pol. J. Chem. Technol.
PY 2013
VL 15
IS 2
BP 40
EP 47
DI 10.2478/pjct-2013-0022
PG 8
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 264NN
UT WOS:000327885000007
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Wu, JY
   Li, CW
   Tsai, CH
   Wang, GJ
AF Wu, Jau-Yi
   Li, Ching-Wen
   Tsai, Ching-Hsiu
   Wang, Gou-Jen
GP IEEE
TI Synthesis of Antibacterial TiO2/PLGA Composite Biofilms
SO 2013 8TH ANNUAL IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED
   AND MOLECULAR SYSTEMS (IEEE NEMS 2013)
LA English
DT Proceedings Paper
CT 8th Annual IEEE International Conference on Nano/Micro Engineered and
   Molecular Systems (NEMS)
CY APR 07-10, 2013
CL Suzhou, PEOPLES R CHINA
SP IEEE Elect & Elect Engineers, IEEE Nanotechnol Council, Sci & Technol Micro Nanofabricat Lab, Peking Univ, Soochow Univ, Sci & Technol Microsystem Lab, Chinese Acad Sci, Shanghai Inst Microsystem & Informat Technol, Chinese Acad Sci, Suzhou Inst Nano Tech & Nano Bion, Univ Calif, Los Angeles, Chinese Int NEMS Soc, Natl Nat Sci Fdn China, City Univ Hongkong, Nanopolis Suzhou, CHINANO, Suzhou Ind Park, MEMS Journal Inc
DE Titanium dioxide; TiO2/PLGA composite material; antibacterial material
ID HUMAN ENDOTHELIAL-CELLS; ULTRAFINE PARTICLES; STAPHYLOCOCCUS-AUREUS;
   NANOPARTICLE UPTAKE; IN-VITRO; TIO2; BACTERIA; INACTIVATION; SIZE;
   PROLIFERATION
AB The main purpose of this study was to develop a TiO2/PLGA composite biomaterial for artificial dressing applications. E. coli and S. aureus were used as biological indicators for the disinfection efficiency of the proposed TiO2/PLGA composite. Various concentration ratios of TiO2 verse PLGA were implemented to optimize the disinfection efficiency of the composite biomaterial. Cell seedings of BECs and L929s on the TiO2/PLGA composite biomaterial are further conducted to evaluate the feasibility of the TiO2/PLGA composite biomaterial on wound healing applications. Experimental results illustrated that TiO2/PLGA composite biofilms containing 10% of TiO2 nanoparticles revealed an effective antibacterial property but kept a comparatively low suppression on cell growth.
C1 [Wu, Jau-Yi; Wang, Gou-Jen] Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung 40227, Taiwan.
   [Li, Ching-Wen] Natl Chung Hsing Univ, Program Tissue Engn Regenerat Med, Taichung 40227, Taiwan.
   [Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Microbiol & Immunol, Taichung 40227, Taiwan.
RP Wang, GJ (reprint author), Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung 40227, Taiwan.
EM gjwang@dragon.nchu.edu.tw
OI Wang, Gou-Jen/0000-0002-2405-5474
FU national science council of Taiwan [NSC-100-2815-C-005-018-E]
FX The authors would like to offer their thanks to the national science
   council of Taiwan under grant number NSC-100-2815-C-005-018-E for their
   financial support of this research.
CR Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Allahverdiyev AM, 2011, FUTURE MICROBIOL, V6, P933, DOI [10.2217/FMB.11.78, 10.2217/fmb.11.78]
   Alpar B, 1999, Clin Oral Investig, V3, P41, DOI 10.1007/s007840050077
   Asahara T, 2009, JPN J INFECT DIS, V62, P378
   Bartczak D, 2011, SMALL, V7, P388, DOI 10.1002/smll.201001816
   Benabbou AK, 2007, APPL CATAL B-ENVIRON, V76, P257, DOI 10.1016/j.apcatb.2007.05.026
   Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Elder ACP, 2004, INHAL TOXICOL, V16, P461, DOI 10.1080/08958370490439669
   Heng MCY, 2011, INT J DERMATOL, V50, P1058, DOI 10.1111/j.1365-4632.2011.04940.x
   Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949
   Ibanez JA, 2003, J PHOTOCH PHOTOBIO A, V157, P81, DOI 10.1016/S1010-6030(03)00074-1
   Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649
   Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n
   Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4
   Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a
   Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5
   Nemmar A, 2002, AM J RESP CRIT CARE, V166, P998, DOI 10.1164/rccm.200110-026OC
   Nemmar A, 1999, TOXICOL APPL PHARM, V160, P250, DOI 10.1006/taap.1999.8762
   Paszek E, 2012, J BIOMED NANOTECHNOL, V8, P957, DOI 10.1166/jbn.2012.1463
   Peters K, 2004, J MATER SCI-MATER M, V15, P321, DOI 10.1023/B:JMSM.0000021095.36878.1b
   Punzoni S, 2011, FEBS J, V278, P400
   Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474
   Rincon AG, 2003, APPL CATAL B-ENVIRON, V44, P263, DOI 10.1016/S0926-3373(03)00076-6
   Samuel SP, 2012, INT J NANOMED, V7, P2943, DOI 10.2147/IJN.S30624
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Tamura K, 2004, KEY ENG MAT, V254-2, P919, DOI 10.4028/www.scientific.net/KEM.254-256.919
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Wang GJ, 2009, BIOMED MICRODEVICES, V11, P843, DOI 10.1007/s10544-009-9301-0
   Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014
   Yari A, 2012, J MATER SCI-MATER M, V23, P2187, DOI 10.1007/s10856-012-4683-6
   Yu BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/11/115603
   Zou SB, 2012, INT WOUND J
NR 33
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-6352-5; 978-1-4673-6351-8
PY 2013
BP 98
EP 103
PG 6
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BIA90
UT WOS:000327183000013
DA 2018-10-20
ER

PT J
AU Degeratu, CN
   Mabilleau, G
   Cincu, C
   Chappard, D
AF Degeratu, Cristinel N.
   Mabilleau, Guillaume
   Cincu, Corneliu
   Chappard, Daniel
TI Aluminum inhibits the growth of hydroxyapatite crystals developed on a
   biomimetic methacrylic polymer
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Aluminum; Mineralization; Hydroxyapatite; Biomimetic polymer;
   Calcification
ID SIMULATED BODY-FLUID; BONE-DISEASE; IN-VITRO; 2-HYDROXYETHYL
   METHACRYLATE; OSTEOMALACIA; BIOMATERIAL; DIALYSIS; MODEL;
   ENCEPHALOPATHY; MINERALIZATION
AB Project: Aluniinum (Al) is an increasing problem in biomedicine since it can interact with phosphates. Bone is one of the preferential target tissues of Al deposition: Al interacts with mineralization and/or bone cell activities. We searched the influence of Al deposition in hydroxyapatite developed on a biomimetic polymer (carboxymethylated poly(2-hydroxyethyl-methacrylate)) which mimics bone mineralization in the absence of cells.
   Procedures: Pellets of polymer were incubated for 5 days in a synthetic body fluid (SBF) to induce mineralization, then 21 days in SBF containing 20, 40 and 60 mu g/L Al3+. Other pellets were incubated in SBF containing commercial Al foil (33 mg/vial) either in 1,2 or 6 pieces. The mineral deposits were dissolved in HCl and Ca2+, PO43- and Al3+ content was measured. Hydroxyapatite was characterized by SEM and X energy-dispersive X-ray analysis (EDX).
   Results: The amount of Al3+ was dose-dependently increased in Ca/P deposits on the polymer pellets. At high concentration (or with the 6 Al foils) growth of hydroxyapatite calcospherite was inhibited; only calcified plates emerging from the polymer were observed. Pellets incubated with 1 and 2 Al foils exhibited a reduction in calcospherite diameter and an increase in the Al3+/Ca2+ ratio. EDX identified Al in the mineral deposits.
   Conclusions: In this acellular model, Al3+. altered the growth of calcospherites at low concentration and inhibited their development at high concentration. In SBF, a release of Al3+ from aluminum foils also inhibited mineralization. This study emphasizes the importance of Al in bone pathology and stresses the question of its release from biomaterials. (C) 2013 Elsevier GmbH. All rights reserved.
C1 [Degeratu, Cristinel N.; Cincu, Corneliu] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Bioresources & Polymer Sci, Bucharest 010072, Romania.
   [Degeratu, Cristinel N.; Mabilleau, Guillaume; Chappard, Daniel] LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA Grp Etud Remodelage Osseux & BioMat, F-49933 Angers, France.
   [Mabilleau, Guillaume; Chappard, Daniel] LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, SCIAM,Serv Commun Imageries & Anal Microscop, F-49933 Angers, France.
RP Chappard, D (reprint author), LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA Grp Etud Remodelage Osseux & BioMat, F-49933 Angers, France.
EM daniel.chappard@univ-angers.fr
RI Mabilleau, Guillaume/M-8261-2018
OI Mabilleau, Guillaume/0000-0003-1445-329X
FU Contrat de Plan Etat - Region "Pays de la Loire" Bioregos2; Sectoral
   Operational Program Human Resources Development of the Romanian Ministry
   of Labor, Family and Social Protection [POS-DRU/88/1.5/S/61178]
FX This work was made possible by grants from Contrat de Plan Etat - Region
   "Pays de la Loire" Bioregos2. M. Degeratu was funded by the Sectoral
   Operational Program Human Resources Development 2007-2013 of the
   Romanian Ministry of Labor, Family and Social Protection through the
   Financial Agreement POS-DRU/88/1.5/S/61178.
CR BANKS WA, 1989, NEUROSCI BIOBEHAV R, V13, P47, DOI 10.1016/S0149-7634(89)80051-X
   Beuvelot J, 2013, DIG J NANOMATER BIOS, V8, P207
   BLUMENTHAL NC, 1984, CALCIFIED TISSUE INT, V36, P439, DOI 10.1007/BF02405357
   Chappard D, 2005, BONE, V36, pS171
   Chappard D, 2004, CALCIFIED TISSUE INT, V74, P122, DOI 10.1007/s00223-003-0001-0
   Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6
   COURNOTWITMER G, 1981, KIDNEY INT, V20, P375, DOI 10.1038/ki.1981.149
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Echlin P, 1986, ADV SCANNING ELECT M
   Exley C, 2012, CURR INORG CHEM, V2, P3, DOI DOI 10.2174/1877944111202010003
   FAUGERE MC, 1986, J LAB CLIN MED, V107, P481
   Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023
   Filmon R., 2000, Morphologie, V84, P23
   Filmon R, 2002, J BONE MINER RES, V17, pS305
   Filmon R, 2002, BIOMATERIALS, V23, P3053, DOI 10.1016/S0142-9612(02)00069-8
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Gherardi R, 2011, BRAIN, V124, P1821
   GOODMAN WG, 1984, J CLIN INVEST, V73, P171, DOI 10.1172/JCI111188
   GOODMAN WG, 1985, AM J KIDNEY DIS, V6, P330, DOI 10.1016/S0272-6386(85)80089-5
   Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004
   Gutowska I, 2005, J BIOMED MATER RES A, V75A, P788, DOI 10.1002/jbm.a.30511
   HANAWA T, 1992, BIOMATERIALS, V13, P20, DOI 10.1016/0142-9612(92)90089-7
   HANTSON P, 1995, J TOXICOL-CLIN TOXIC, V33, P645, DOI 10.3109/15563659509010622
   Helmboldt O., 2000, ULLMANNS ENCY IND CH
   Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P276393, DOI 10.4061/2011/276393
   KING SW, 1981, CRC CR REV CL LAB SC, V14, P1, DOI 10.3109/10408368109105861
   Kiss T, 1996, COORDIN CHEM REV, V149, P329, DOI 10.1016/S0010-8545(96)90036-3
   Li X, 2011, BIOL TRACE ELEMENT R, V143
   Li XW, 2012, BIOL TRACE ELEM RES, V150, P502, DOI 10.1007/s12011-012-9523-5
   Mabilleau G, 2010, ACTA BIOMATER, V6, P1555, DOI 10.1016/j.actbio.2009.10.035
   MALLUCHE HH, 1988, BLOOD PURIFICAT, V6, P1, DOI 10.1159/000169479
   Nayak P, 2002, ENVIRON RES, V89, P101, DOI 10.1006/enrs.2002.4352
   PARISIEN M, 1988, J BONE MINER RES, V3, P259
   PARKINSON IS, 1981, J CLIN PATHOL, V34, P1285, DOI 10.1136/jcp.34.11.1285
   PENNINGTON JAT, 1995, FOOD ADDIT CONTAM, V12, P119, DOI 10.1080/02652039509374286
   PIERIDES AM, 1978, INT J ARTIF ORGANS, V1, P206
   Quarles DL, 1985, J CLIN INVEST, V75, P1441
   Russe P., 2011, Morphologie, V95, P51, DOI 10.1016/j.morpho.2011.02.003
   SAVARINO L, 1993, BIOMATERIALS, V14, P900, DOI 10.1016/0142-9612(93)90131-K
   SEDMAN AB, 1987, J CLIN INVEST, V79, P86, DOI 10.1172/JCI112813
   Sutter B, 2002, SOIL SCI SOC AM J, V66, P455, DOI 10.2136/sssaj2002.4550
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   VALKOVIC V, 1980, ORIGINS LIFE EVOL B, V10, P301, DOI 10.1007/BF00928408
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
   Yokel RA, 2008, FOOD CHEM TOXICOL, V46, P2261, DOI 10.1016/j.fct.2008.03.004
NR 47
TC 4
Z9 5
U1 1
U2 22
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2013
VL 27
IS 4
BP 346
EP 351
DI 10.1016/j.jtemb.2013.05.004
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 252IR
UT WOS:000326998900014
PM 23867705
DA 2018-10-20
ER

PT J
AU Hilmi, AM
   Halim, AS
   Jaafar, H
   Asiah, A
   Hassan, A
AF Hilmi, Abu Bakar Mohd
   Halim, Ahmad Sukari
   Jaafar, Hasnan
   Asiah, Abu Bakar
   Hassan, Asma
TI Chitosan Dermal Substitute and Chitosan Skin Substitute Contribute to
   Accelerated Full-Thickness Wound Healing in Irradiated Rats
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; RADIATION-THERAPY; HAIR FOLLICLE; STROMAL CELLS;
   FIBROBLASTS; REPAIR; PROLIFERATION; TRANSPLANTATION; BIOMATERIALS;
   REGENERATION
AB Wounds with full-thickness skin loss are commonly managed by skin grafting. In the absence of a graft, reepithelialization is imperfect and leads to increased scar formation. Biomaterials can alter wound healing so that it produces more regenerative tissue and fewer scars. This current study use the new chitosan based biomaterial in full-thickness wound with impaired healing on rat model. Wounds were evaluated after being treated with a chitosan dermal substitute, a chitosan skin substitute, or duoderm CGF. Wounds treated with the chitosan skin substitute showed the most re-epithelialization (33.2 +/- 2.8%), longest epithelial tongue (1.62 +/- 0.13 mm), and shortest migratory tongue distance (7.11 +/- 0.25 mm). The scar size of wounds treated with the chitosan dermal substitute (0.13 +/- 0.02 cm) and chitosan skin substitute (0.16 +/- 0.05 cm) were significantly decreased (P < 0.05) compared with duoderm (0.45 +/- 0.11 cm). Human leukocyte antigen (HLA) expression on days 7, 14, and 21 revealed the presence of human hair follicle stem cells and fibroblasts that were incorporated into and surviving in the irradiated wound. We have proven that a chitosan dermal substitute and chitosan skin substitute are suitable for wound healing in full-thickness wounds that are impaired due to radiation.
C1 [Hilmi, Abu Bakar Mohd; Halim, Ahmad Sukari; Jaafar, Hasnan; Hassan, Asma] Univ Sains Malaysia, Sch Med Sci, Reconstruct Sci Unit, Kelantan 16150, Malaysia.
   [Asiah, Abu Bakar] Univ Sains Malaysia, Sch Dent Sci, Craniofacial Lab, Kelantan 16150, Malaysia.
RP Hilmi, AM (reprint author), Univ Sains Malaysia, Sch Med Sci, Reconstruct Sci Unit, Kelantan 16150, Malaysia.
EM hilmiab@yahoo.com; ashalim@kb.usm.my
OI Halim, Ahmad Sukari/0000-0001-8999-6403
FU Universiti Sains Malaysia [1001/PPSP/8144012]; IAEA
FX The authors appreciated the assistance of Rageshwari Ramupillai from
   Carl Zeiss (M), who standardized the quality of the fluorescent
   analysis, the Animal Research and Service Centre staff, and the
   Craniofacial and Pathology laboratory staff for their technical
   assistance and advice. The authors thank the Universiti Sains Malaysia
   for awarding them the PRGS Grant 1001/PPSP/8144012 as well as the IAEA
   for Grant support.
CR Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   BIEL MA, 1993, LASER SURG MED, V13, P672, DOI 10.1002/lsm.1900130612
   Bryant R. A., 2007, ACUTE CHRONIC WOUNDS
   Burns JL, 2003, CLIN PLAST SURG, V30, P47, DOI 10.1016/S0094-1298(02)00074-3
   CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7
   Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54
   CROFT CB, 1970, J ANAT, V106, P63
   Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x
   Flach CR, 2010, BIOL MED PHYS BIOMED, P365, DOI 10.1007/978-3-642-02649-2_15
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Haubner F, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-162
   Hilmi AM, 2013, CENT EUR J BIOL, V8, P432, DOI 10.2478/s11535-013-0149-6
   Hilmi M., 2013, SPRINGERPLUS, V2, P79
   Holloway S, 2012, WOUND CARE ESSENTIAL, P83
   Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328
   Kaspler P, 2009, RADIAT RES, V172, P106, DOI 10.1667/RR1649.1
   Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023
   Liang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029999
   Mansilla E, 2005, TRANSPL P, V37, P292, DOI 10.1016/j.transproceed.2005.01.070
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nicola M. D., 2002, BLOOD, V99, P3838
   Nishiyama T, 2011, PLOS ONE, V6
   NPUAP, 2007, SUPP SURF STAND IN T
   Ohyama H, 2002, CYTOKINE, V17, P175, DOI 10.1006/cyto.2001.0976
   Periyasamy R., 2013, INT J BASIC APPL MED, V3, P267
   ROCKWELL WB, 1989, PLAST RECONSTR SURG, V84, P827, DOI 10.1097/00006534-198911000-00021
   Sandulache VC, 2003, ARCH OTOLARYNGOL, V129, P345, DOI 10.1001/archotol.129.3.345
   Schwenter F, 2004, HUM GENE THER, V15, P669, DOI 10.1089/1043034041361172
   Stoff A, 2009, EXP DERMATOL, V18, P362, DOI 10.1111/j.1600-0625.2008.00792.x
   Sussman C., 2007, WOUND CARE COLLABORA, P21
   Sussman C., 2007, WOUND CARE COLLABORA, P85
   Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9
   Yi T, 2012, ARCH PHARM RES, V35, P213, DOI 10.1007/s12272-012-0202-z
   Yussof S. J. M., 2011, ISRN MAT SCI, V2011
   Ziv-Polat O, 2010, BIOMATERIALS, V31, P741, DOI 10.1016/j.biomaterials.2009.09.093
NR 37
TC 4
Z9 4
U1 0
U2 10
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 795458
DI 10.1155/2013/795458
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 257AG
UT WOS:000327354700001
PM 24324974
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Barbaglio, A
   Tricarico, S
   Di Benedetto, C
   Fassini, D
   Lima, AP
   Ribeiro, AR
   Ribeiro, CC
   Sugni, M
   Bonasoro, F
   Wilkie, I
   Barbosa, M
   Candia Carnevali, MD
AF Barbaglio, Alice
   Tricarico, Serena
   Di Benedetto, Cristiano
   Fassini, Dario
   Lima, Ana Paula
   Ribeiro, Ana R.
   Ribeiro, Cristina C.
   Sugni, Michela
   Bonasoro, Francesco
   Wilkie, Iain
   Barbosa, Mario
   Candia Carnevali, M. Daniela
TI The smart connective tissue of echinoderms: a materializing promise for
   biotech applications
SO CAHIERS DE BIOLOGIE MARINE
LA English
DT Article; Proceedings Paper
CT 14th International Echinoderm Conference (IEC)
CY AUG 20-24, 2012
CL Royal Acad Sci Belgium, Brussels, BELGIUM
SP Natl Fund Sci Res, Univ Libre Bruxelles, Univ Mons, Univ Catholique Louvain, Belgian Sci Policy Off, FEI, Jeol, Titertek Berthold
HO Royal Acad Sci Belgium
DE Mutable collagenous tissue; Echinoderm; Biomaterials; Collagen; Sea
   urchin
ID SEA-CUCUMBER DERMIS; MUTABLE MECHANICAL-PROPERTIES;
   PARACENTROTUS-LIVIDUS; COLLAGEN FIBRILS; FUNCTIONAL-MORPHOLOGY;
   PERISTOMIAL MEMBRANE; STICHOPUS-JAPONICUS; HOLOTHURIAN DERMIS;
   STIFFENING FACTOR; CATCH APPARATUS
AB Echinoderm Mutable Collagenous Tissues (MCTs) undergo nervously mediated, drastic and reversible changes in their passive mechanical properties. MCT mutability is involved in autotomy, posture maintenance and motility, and, as a consequence, it influences all aspects of echinoderm biology (nutrition, reproduction, habitat selection, self-defense and predatory behavior) representing a key-factor for the ecological success of the phylum. Besides this, MCT performance represents a topic of remarkable interest for many different applied fields. A biomimetic research route looks at MCTs as a source of inspiration for the development of smart and innovative biomaterials with great potential for in vitro and in vivo applications when controlled and reversible plasticization and/or stiffening of the extracellular matrix is required. The MIMESIS (Marine Invertebrate Models & Engineered Substrates for Innovative bio-Scaffolds) project has been developed within this scientific context. The selected echinoderm model is the common sea urchin Paracentrotus lividus. This project is based on a multidisciplinary approach combining functional biology with biomaterial engineering. A brief review of recent morphological, biomolecular, biomechanical and biochemical results on P lividus MCTs are here presented in a biotechnological perspective, taking into account also a promising application regarding the use of MCT-derived substrata for cell culture studies.
C1 [Barbaglio, Alice; Tricarico, Serena; Di Benedetto, Cristiano; Fassini, Dario; Sugni, Michela; Bonasoro, Francesco; Candia Carnevali, M. Daniela] Univ Milan, Biosci Dept, I-20133 Milan, Italy.
   [Lima, Ana Paula; Ribeiro, Ana R.; Ribeiro, Cristina C.; Barbosa, Mario] Univ Porto, Biomat Div, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Ribeiro, Cristina C.] ISEP Inst Super Engn Porto, Phys Dep, P-4200072 Oporto, Portugal.
   [Wilkie, Iain] Glasgow Caledonian Univ, Biol & Biomed Sci Dept, Glasgow G4 0BA, Lanark, Scotland.
RP Barbaglio, A (reprint author), Univ Milan, Biosci Dept, Via Celoria 26, I-20133 Milan, Italy.
EM alice.barbaglio@unimi.it
RI Ribeiro, Cristina/O-1842-2017
OI Ribeiro, Cristina/0000-0002-7802-7364; fassini,
   dario/0000-0001-6608-5121; Lima, Ana Paula/0000-0001-5070-1540;
   BONASORO, FRANCESCO/0000-0002-1559-0707; Candia Carnevali,
   M.Daniela/0000-0002-0215-8843; Barbosa, Mario/0000-0003-3568-7482;
   Barbaglio, Alice/0000-0003-0122-0331
CR ANDRIETTI F, 1990, J ZOOL, V220, P345, DOI 10.1111/j.1469-7998.1990.tb04312.x
   Barbaglio A., 2011, MAR ENVIRON RES, V76, P108
   Birenheide R, 1996, BIOL BULL, V191, P1, DOI 10.2307/1543055
   BONASORO F, 1995, B ZOOL, V62, P121, DOI 10.1080/11250009509356060
   CARNEVALI MDC, 1993, ZOOMORPHOLOGY, V113, P173
   Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403
   Cluzel C, 2000, MATRIX BIOL, V19, P545, DOI 10.1016/S0945-053X(00)00109-8
   Cluzel C, 2001, J BIOL CHEM, V276, P18108, DOI 10.1074/jbc.M009597200
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   DALESSIO M, 1990, J BIOL CHEM, V265, P7050
   DIBENEDETTO C, 2011, PROGENITOR CELLS REG
   Hayashi, 1986, J EXP BIOL, V125, P71
   Hennebert E, 2010, J EXP BIOL, V213, P1162, DOI 10.1242/jeb.037903
   HIDAKA M, 1983, J EXP BIOL, V103, P1
   Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3
   Koob TJ, 1999, J EXP BIOL, V202, P2291
   MATSUMURA T, 1974, CONNECT TISSUE RES, V2, P117, DOI 10.3109/03008207409152097
   MOTOKAWA T, 1981, COMP BIOCHEM PHYS C, V70, P41, DOI 10.1016/0306-4492(81)90076-9
   PUCCIMINAFRA I, 1978, J SUBMICR CYTOL PATH, V10, P53
   Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778
   Ribeiro AR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0038-6
   Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016
   Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822
   Santos R, 2005, J EXP BIOL, V208, P2277, DOI 10.1242/jeb.01641
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   SZULGIT GK, 1994, ECHINODERMS THROUGH TIME, P887
   Szulgit GK, 2000, J EXP BIOL, V203, P1539
   Takahashi K., 1967, Journal of the Faculty of Science Tokyo University Zoology, V11, P109
   Takemae N, 2005, BIOL BULL-US, V208, P29, DOI 10.2307/3593098
   Takemae N, 2009, BIOL BULL-US, V216, P45
   Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178
   Tamori M, 2010, J EXP BIOL, V213, P1960, DOI 10.1242/jeb.038505
   Thurmond FA, 1996, J EXP BIOL, V199, P1817
   Tipper J., 2003, MATRIX BIOL, V21, P625
   Tricarico S., 2012, ECHINODERMS 2010, P106
   TROTTER JA, 1995, J EXP BIOL, V198, P1951
   TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814
   Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1
   TROTTER JA, 1989, CELL TISSUE RES, V258, P527
   Trotter JA, 2000, BIOCHEM SOC T, V28, P357, DOI 10.1042/0300-5127:0280357
   Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5
   Trotter JA, 1995, COMP BIOCHEM PHYS A, V112, P463, DOI 10.1016/0300-9629(95)02015-2
   Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61
   Wilkie IC, 2010, J EXP BIOL, V213, P2104, DOI 10.1242/jeb.039578
   WILKIE IC, 1994, B ZOOL, V61, P39, DOI 10.1080/11250009409355857
   WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105
   WILKIE IC, 1979, CELL TISSUE RES, V197, P515
   Wilkie IC, 2005, PROG MOLEC, V39, P221
   Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185
   WILKIE IC, 1983, MAR BEHAV PHYSIOL, V9, P229, DOI 10.1080/10236248309378595
   Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149
NR 51
TC 2
Z9 2
U1 2
U2 24
PU CAHIERS DE BIOLOGIE MARINE
PI ROSCOFF
PA STATION BIOLOGIQUE PLACE GEORGES TEISSIER, 29680 ROSCOFF, FRANCE
SN 0007-9723
EI 2262-3094
J9 CAH BIOL MAR
JI Cah. Biol. Mar.
PY 2013
VL 54
IS 4
SI SI
BP 713
EP 720
PG 8
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA 251TS
UT WOS:000326954200032
DA 2018-10-20
ER

PT J
AU Marques, DR
   dos Santos, LA
   Schopf, LF
   de Fraga, JCS
AF Marques, Douglas Ramos
   dos Santos, Luis Alberto
   Schopf, Luciano Ferraz
   Soares de Fraga, Jose Carlos
TI Analysis of Poly(Lactic-co-Glycolic Acid)/Poly(Isoprene) Polymeric Blend
   for Application as Biomaterial
SO POLIMEROS-CIENCIA E TECNOLOGIA
LA English
DT Article
DE PLGA; latex; FTIR; DSC; tensile; hardness; implantability; cell
   viability
ID STENT; CYTOTOXICITY; RADIATION; INTERFACE; STENOSIS; LATEX
AB The application of renewable raw materials encourages research in the biopolymers area. The Poly(Lactic-co-Glycolic Acid)/Poly(Isoprene) (PLGA/IR) blend combines biocompatibility for application in the health field with excellent mechanical properties. The blend was obtained by solubilization of polymers in organic solvents. To investigate the polymer thermochemical properties, FTIR and DSC were applied. To investigate the composition's influence over polymer mechanical properties, tensile and hardness test were applied. To analyze the blends response in the cell environment, a stent was produced by injection molding process, and Cell Viability Test and Previous Implantability were used. The Infrared spectra show that chemical composition is related only with polymers proportion in the blend. The calorimetry shows a partial miscibility in the blend. The tensile test shows that adding Poly(Isoprene) to Poly(Lactic-co-Glycolic Acid) induced a relevant reduction in the Young modulus, tensile stress and tenacity of the material, which was altered from the fragile raw PLGA to a ductile material. The composition did not affect the blend hardness. The cell viability test shows that the blend has potential application as biomaterial, while the first results of implantability indicate that the polymeric stent kept its original position and caused low fibrosis.
C1 [Marques, Douglas Ramos; dos Santos, Luis Alberto] Univ Fed Rio Grande do Sul, BR-91501970 Porto Alegre, RS, Brazil.
   [Schopf, Luciano Ferraz; Soares de Fraga, Jose Carlos] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, BR-91501970 Porto Alegre, RS, Brazil.
RP Marques, DR (reprint author), Univ Fed Rio Grande do Sul, Av Bento Goncalves,9500,Setor 4,Predio 74,Sala 12, BR-91501970 Porto Alegre, RS, Brazil.
EM douglas.marques@ufrgs.br
FU Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX The authors would like to thank the Coordenadoria de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) and the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial
   support of this study.
CR American Society for Testing and Materials-ASTM, 2000, D2240 STAND TEST MET
   Antoniou E, 2010, EUR POLYM J, V46, P324, DOI 10.1016/j.eurpolymj.2009.10.005
   Associacao Brasileira de Normas Tecnicas - ABNT, 2003, 1099301 NBR ISO ABNT
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Brouwer AM, 2008, ANN NY ACAD SCI, V1130, P157, DOI 10.1196/annals.1430.014
   Callister W.D., 1997, MAT SCI ENG INTRO
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Cibulkova Z, 2006, J THERM ANAL CALORIM, V84, P709, DOI 10.1007/s10973-005-7547-1
   Ciesielski A., 1999, INTRO RUBBER TECHNOL
   dos Santos RL, 2010, ORTHOD CRANIOFAC RES, V13, P28, DOI 10.1111/j.1601-6343.2009.01469.x
   DUMON JF, 1990, CHEST, V97, P328, DOI 10.1378/chest.97.2.328
   Franz A, 2007, DENT MATER, V23, P1438, DOI 10.1016/j.dental.2007.05.014
   Hanson S., 1996, BIOMATERIALS SCI, DOI DOI 10.1016/B978-0-08-050014-0.50010-9
   Hsu CL, 2011, FOOD CHEM, V127, P127, DOI 10.1016/j.foodchem.2010.12.100
   Isotalo TM, 2006, BJU INT, V97, P856, DOI 10.1111/j.1464-410X.2006.06000.x
   Jahno V. D, 2005, THESIS U FEDERAL RIO
   Jin HJ, 2000, EUR POLYM J, V36, P165, DOI 10.1016/S0014-3057(99)00041-5
   Kadla J, 2003, COMPOS, V35, P395
   Klopffer W., 1984, INTRO POLYM SPECTROS, DOI DOI 10.1007/978-3-642-69373-1
   Koschutnig K, 2009, TOXICOL IN VITRO, V23, P755, DOI 10.1016/j.tiv.2009.03.007
   Lipatov YS, 2002, PROG POLYM SCI, V27, P1721, DOI 10.1016/S0079-6700(02)00021-7
   Mano E. B., 2004, POLIMEROS COMO MAT E
   Mano E. B., 2004, QUIMICA EXPT POLIMER
   Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09
   Motta A. C., 2006, REV MAT, V11, P340
   Motta Adriana C., 2006, Polímeros, V16, P26, DOI 10.1590/S0104-14282006000100008
   Pandey A, 2008, J MECH BEHAV BIOMED, V1, P227, DOI 10.1016/j.jmbbm.2007.12.001
   Queiroz D. P., 2000, THESIS U ESTADUAL CA
   REZENDE CA, 2003, POLIMEROS, V13, P36, DOI DOI 10.1590/S0104-14282003000100009
   Siddaramaiah M. N., 2010, J APP POL SCI, V121, P3070, DOI DOI 10.1002/APP.33957
   Silverstein R. M., 2005, IDENTIFICACAO ESPECT
   Stevens M. P., 1999, POLYM CHEM INTRO
   TALJA M, 1995, J UROLOGY, V154, P2089, DOI 10.1016/S0022-5347(01)66702-8
   Thistlethwaite PA, 2008, J THORAC CARDIOV SUR, V136, P1569, DOI 10.1016/j.jtcvs.2008.08.021
   Tsuneizumi Y, 2010, POLYM DEGRAD STABIL, V95, P1387, DOI 10.1016/j.polymdegradstab.2010.01.019
   Tsutsui H, 2008, RESPIROLOGY, V13, P632, DOI 10.1111/j.1440-1843.2008.01309.x
   Upadhyay D, 2011, J APPL POLYM SCI, V120, P932, DOI 10.1002/app.33106
   Wood DE, 2003, ANN THORAC SURG, V76, P167, DOI 10.1016/S0003-4975(03)00033-X
   Xavier Rogério Gastal, 2008, J. bras. pneumol., V34, P21, DOI 10.1590/S1806-37132008000100005
NR 39
TC 7
Z9 7
U1 0
U2 10
PU ASSOC BRASIL POLIMEROS
PI SAO CARLOS
PA RUA GEMINIANO COSTA NO 355, CP 490 13560-970, SAO CARLOS, SP 00000,
   BRAZIL
SN 0104-1428
J9 POLIMEROS
JI Polimeros
PY 2013
VL 23
IS 5
BP 579
EP 584
DI 10.4322/polimeros.2013.099
PG 6
WC Polymer Science
SC Polymer Science
GA 256KS
UT WOS:000327309700001
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Gnavi, S
   Barwig, C
   Freier, T
   Haastert-Talini, K
   Grothe, C
   Geuna, S
AF Gnavi, Sara
   Barwig, Christina
   Freier, Thomas
   Haastert-Talini, Kirsten
   Grothe, Claudia
   Geuna, Stefano
BE Geuna, S
   Perroteau, I
   Tos, P
   Battiston, B
TI The Use of Chitosan-Based Scaffolds to Enhance Regeneration in the
   Nervous System
SO TISSUE ENGINEERING OF THE PERIPHERAL NERVE: BIOMATERIALS AND PHYSICAL
   THERAPY
SE International Review of Neurobiology
LA English
DT Review; Book Chapter
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; DOG SCIATIC-NERVE; LONGITUDINALLY
   ORIENTED MICROCHANNELS; TISSUE ENGINEERING APPLICATIONS; ENSHEATHING
   GLIA TRANSPLANTS; LAMININ-CONTAINING GEL; IN-VIVO EVALUATION;
   SCHWANN-CELLS; MECHANICAL-PROPERTIES
AB Various biomaterials have been proposed to build up scaffolds for promoting neural repair. Among them, chitosan, a derivative of chitin, has been raising more and more interest among basic and clinical scientists. A number of studies with neuronal and glial cell cultures have shown that this biomaterial has biomimetic properties, which make it a good candidate for developing innovative devices for neural repair. Yet, in vivo experimental studies have shown that chitosan can be successfully used to create scaffolds that promote regeneration both in the central and in the peripheral nervous system. In this review, the relevant literature on the use of chitosan in the nervous tissue, either alone or in combination with other components, is overviewed. Altogether, the promising in vitro and in vivo experimental results make it possible to foresee that time for clinical trials with chitosan-based nerve regeneration-promoting devices is approaching quickly.
C1 [Gnavi, Sara; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Inst Neurosci, Cavalieri Ottolenghi Fdn NICO,Osped San Luigi, Orbassano, TO, Italy.
   [Barwig, Christina; Freier, Thomas] Medovent GmbH, Mainz, Germany.
   [Haastert-Talini, Kirsten; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, Hannover, Germany.
   [Haastert-Talini, Kirsten; Grothe, Claudia] Hannover Med Sch, Ctr Syst Neurosci ZSN, Hannover, Germany.
RP Geuna, S (reprint author), Univ Turin, Dept Clin & Biol Sci, Inst Neurosci, Cavalieri Ottolenghi Fdn NICO,Osped San Luigi, Reg Gonzole 10, Orbassano, TO, Italy.
EM stefano.geuna@unito.it
RI Haastert-Talini, Kirsten/D-2348-2010
OI Haastert-Talini, Kirsten/0000-0003-2502-8969; Gnavi,
   Sara/0000-0002-3230-7424
CR Acosta N, 2003, MACROMOL BIOSCI, V3, P546, DOI 10.1002/mabi.200300009
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2002, EUROPEAN PHARMACOPEI, P1774
   Ao Q, 2006, J BIOMED MATER RES A, V77A, P11, DOI 10.1002/jbm.a.30593
   Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   ASTM, 2001, F210301 ASTM
   Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   BRAY GM, 1987, J EXP BIOL, V132, P5
   Bunge MB, 2002, PROG BRAIN RES, V137, P275
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P791, DOI 10.1163/1568562053992496
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Chavez-Delgado ME, 2005, J BIOMED MATER RES B, V74B, P589, DOI 10.1002/jbm.b.30243
   Chavez-Delgado ME, 2003, J BIOMED MATER RES B, V67B, P702, DOI 10.1002/jbm.b.10059
   Chen X, 2011, J MATER SCI-MATER M, V22, P2347, DOI 10.1007/s10856-011-4401-9
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Cheng MY, 2004, J BIOMATER APPL, V19, P59, DOI 10.1177/0885328204043450
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Desarnaud F, 1998, J NEUROCHEM, V71, P1765
   Dhiman HK, 2004, BIOMATERIALS, V25, P5147, DOI 10.1016/j.biomaterials.2003.12.025
   Di Vita G, 2008, INT J IMMUNOPATH PH, V21, P207, DOI 10.1177/039463200802100123
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Domard A., 2002, POLYM BIOMATERIALS, V9, P187
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eroglu H, 2010, CHEM PHARM BULL, V58, P1161, DOI 10.1248/cpb.58.1161
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488
   Fang P, 2010, CHINESE J PHYSIOL, V53, P208, DOI 10.4077/CJP.2010.AMK047
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009
   Gazzeri R, 2009, ACTA NEUROCHIR, V151, P537, DOI 10.1007/s00701-009-0290-9
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Gong YP, 2009, MICROSURG, V29, P650, DOI 10.1002/micr.20686
   Goraltchouk A, 2006, J CONTROL RELEASE, V110, P400, DOI 10.1016/j.jconrel.2005.10.019
   GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0
   Gravvanis AI, 2004, MICROSURG, V24, P408, DOI 10.1002/micr.20055
   Grothe C, 2006, BRAIN RES REV, V51, P293, DOI 10.1016/j.brainresrev.2005.12.001
   Gu JH, 2012, J TISSUE ENG REGEN M, V6, P163, DOI 10.1002/term.407
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Guennoun R, 2001, MOL BRAIN RES, V90, P75, DOI 10.1016/S0169-328X(01)00094-8
   Guo XD, 2012, CELL TRANSPLANT, V21, P1177, DOI 10.3727/096368911X612503
   Gustafson SB, 2007, PREHOSP EMERG CARE, V11, P172, DOI 10.1080/10903120701205893
   Han HY, 2010, BIOTECHNOL LETT, V32, P585, DOI 10.1007/s10529-009-0186-z
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Hsu SH, 2007, BIOMED MICRODEVICES, V9, P665, DOI 10.1007/s10544-007-9068-0
   Hsu SH, 2013, ACTA BIOMATER, V9, P6606, DOI 10.1016/j.actbio.2013.01.025
   Hsueh YY, 2012, CELLS TISSUES ORGANS, V196, P117, DOI 10.1159/000332045
   Hu N, 2013, BIOMATERIALS, V34, P100, DOI 10.1016/j.biomaterials.2012.09.020
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Huang YC, 2005, J BIOMED MATER RES B, V74B, P659, DOI 10.1002/jbm.b.30267
   Huang YC, 2007, J BIOMED MATER RES A, V82A, P842, DOI 10.1002/jbm.a.31036
   Huang YC, 2011, J BIOMED MATER RES A, V99A, P86, DOI 10.1002/jbm.a.33164
   Ide C, 1996, NEUROSCI RES, V25, P101
   Ishikawa N, 2007, J BIOMED MATER RES A, V83A, P33, DOI 10.1002/jbm.a.31126
   Itoh S, 2005, J BIOMED MATER RES B, V73B, P375, DOI 10.1002/jbm.b.30224
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Jia ZC, 2010, BIOTECHNOL LETT, V32, P1325, DOI 10.1007/s10529-010-0287-8
   Jiang MR, 2009, NEUROSCI LETT, V454, P239, DOI 10.1016/j.neulet.2009.03.042
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   JungTestas I, 1996, J STEROID BIOCHEM, V58, P77, DOI 10.1016/0960-0760(96)00009-X
   Kam HM, 1999, J BIOMED MATER RES, V48, P881, DOI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Karsten E., 2012, JOVE-J VIS EXP, V68, P1
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744
   KLEINMAN HK, 1988, P NATL ACAD SCI USA, V85, P1282, DOI 10.1073/pnas.85.4.1282
   Koenig HL, 2000, REV REPROD, V5, P189
   Kofuji K, 2001, BIOL PHARM BULL, V24, P205, DOI 10.1248/bpb.24.205
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuo YC, 2013, COLLOID SURFACE B, V103, P595, DOI 10.1016/j.colsurfb.2012.11.001
   Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057
   Liu Yong, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P1235
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   Marcol W, 2011, MICROSURG, V31, P642, DOI 10.1002/micr.20945
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Matsumoto I, 2010, INTERACT CARDIOV TH, V10, P498, DOI 10.1510/icvts.2009.227744
   Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909
   Mumper R.J., 1995, P INT S CONTR REL BI, V22, P178
   MUZZARELLI RAA, 1977, CHITIN
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2010, NEUROREPORT, V21, P871, DOI 10.1097/WNR.0b013e32833d9695
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Patel M, 2008, J BIOMATER APPL, V23, P101, DOI 10.1177/0885328207084521
   Patel M, 2007, J TISSUE ENG REGEN M, V1, P360, DOI 10.1002/term.44
   Patel M, 2006, TISSUE ENG, V12, P3189, DOI 10.1089/ten.2006.12.3189
   Patel M, 2009, J BIOMED MATER RES A, V90A, P154, DOI 10.1002/jbm.a.32072
   Patel M, 2008, TISSUE ENG PART C-ME, V14, P365, DOI 10.1089/ten.tec.2008.0166
   Pavinatto FJ, 2007, BIOMACROMOLECULES, V8, P1633, DOI 10.1021/bm0701550
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Pfister LA, 2008, EUR J PHARM BIOPHARM, V69, P563, DOI 10.1016/j.ejpb.2008.01.014
   Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Rickett TA, 2011, BIOMACROMOLECULES, V12, P57, DOI 10.1021/bm101004r
   Rosales-Cortes M, 2003, REV NEUROLOGIA, V36, P1137
   Rosales-Cortes M, 2003, J BIOMATER APPL, V18, P15, DOI 10.1177/088532803033204
   Roy K, 1999, NAT MED, V5, P387
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   SASHIWA H, 1991, CARBOHYD POLYM, V16, P291, DOI 10.1016/0144-8617(91)90114-R
   SEPHEL GC, 1989, DEV NEUROSCI-BASEL, V11, P313, DOI 10.1159/000111909
   Shen H, 2010, J BIOMED MATER RES B, V95B, P161, DOI 10.1002/jbm.b.31696
   Simoes MJ, 2011, ACTA MEDICA PORT, V24, P43
   Simoes Maria J., 2010, Italian Journal of Anatomy and Embryology, V115, P190
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Soria JM, 2006, J BIOMED MATER RES A, V79A, P495, DOI 10.1002/jbm.a.30803
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vachoud L, 2001, BIOMACROMOLECULES, V2, P1294, DOI 10.1021/bm0155874
   Vasconcelos BCE, 2000, J ORAL MAXIL SURG, V58, P1257, DOI 10.1053/joms.2000.16626
   Wang AJ, 2007, BIOTECHNOL LETT, V29, P1697, DOI 10.1007/s10529-007-9460-0
   Wang AJ, 2006, J BIOMED MATER RES A, V79A, P36, DOI 10.1002/jbm.a.30683
   Wang Dabin, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P190
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wang W, 2010, ACTA BIOMATER, V6, P4027, DOI 10.1016/j.actbio.2010.04.027
   Wang W, 2009, J BIOMED MATER RES A, V91A, P994, DOI 10.1002/jbm.a.32329
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wei Xin, 2003, Chin J Traumatol, V6, P131
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xie F, 2008, MICROSURG, V28, P471, DOI 10.1002/micr.20514
   Xie Feng, 2005, Zhonghua Zheng Xing Wai Ke Za Zhi, V21, P295
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Xu HX, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045006
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xue CB, 2012, NEUROREHAB NEURAL RE, V26, P96, DOI 10.1177/1545968311420444
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Yang F, 2002, J BIOMATER APPL, V16, P215, DOI 10.1106/088532802021176
   Yang YM, 2004, BIOTECHNOL LETT, V26, P1793, DOI 10.1007/s10529-004-4611-z
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOSHII S, 1987, EXP NEUROL, V96, P469, DOI 10.1016/0014-4886(87)90064-1
   Yoshii S, 2009, TISSUE ENG REGEN MED, V3, P19, DOI DOI 10.1002/TERM.130
   Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang Pei-xun, 2005, Zhonghua Wai Ke Za Zhi, V43, P1344
   Zheng L, 2012, J MATER SCI-MATER M, V23, P2291, DOI 10.1007/s10856-012-4694-3
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
   Zuo YY, 2006, PEDIATR RES, V60, P125, DOI 10.1203/01.pdr.0000227558.14024.57
NR 202
TC 29
Z9 29
U1 3
U2 69
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0074-7742
BN 978-0-12-420045-6
J9 INT REV NEUROBIOL
JI Int. Rev. Neurobiol.
PY 2013
VL 109
BP 1
EP 62
DI 10.1016/B978-0-12-420045-6.00001-8
PG 62
WC Cell & Tissue Engineering; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA BIC21
UT WOS:000327358600002
PM 24093605
DA 2018-10-20
ER

PT J
AU Barba, M
   Cicione, C
   Bernardini, C
   Michetti, F
   Lattanzi, W
AF Barba, Marta
   Cicione, Claudia
   Bernardini, Camilla
   Michetti, Fabrizio
   Lattanzi, Wanda
TI Adipose-Derived Mesenchymal Cells for Bone Regereneration: State of the
   Art
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID LIM MINERALIZATION PROTEIN-3; CALVARIAL DEFECT MODEL; MARROW STROMAL
   CELLS; IN-VIVO OSTEOGENESIS; STEM-CELLS; STEM/PROGENITOR CELLS;
   GENE-THERAPY; MORPHOGENETIC PROTEIN-2; INTERNATIONAL-SOCIETY;
   REGENERATIVE MEDICINE
AB Adipose tissue represents a hot topic in regenerative medicine because of the tissue source abundance, the relatively easy retrieval, and the inherent biological properties of mesenchymal stem cells residing in its stroma. Adipose-derived mesenchymal stem cells (ASCs) are indeed multipotent somatic stem cells exhibiting growth kinetics and plasticity, proved to induce efficient tissue ASCregeneration in several biomedical applications. A defined consensus for their isolation, classification, and characterization has been very recently achieved. In particular, bone tissue reconstruction and regeneration based on ASCs has emerged as a promising approach to restore structure and function of bone compromised by injury or disease. ASCs have been used in combination with osteoinductive biomaterial and/or osteogenic molecules, in either static or dynamic culture systems, to improve bone regeneration in several animal models. To date, few clinical trials on ASC-based bone reconstruction have been concluded and proved effective. The aim of this review is to dissect the state of the art on ASC use in bone regenerative applications in the attempt to provide a comprehensive coverage of the topics, from the basic laboratory to recent clinical applications.
C1 [Barba, Marta; Cicione, Claudia; Bernardini, Camilla; Michetti, Fabrizio; Lattanzi, Wanda] Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, I-00168 Rome, Italy.
   [Michetti, Fabrizio; Lattanzi, Wanda] Latium Musculoskeletal Tissue Bank, I-00168 Rome, Italy.
RP Lattanzi, W (reprint author), Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Largo F Vito 1, I-00168 Rome, Italy.
EM wanda.lattanzi@rm.unicatt.it
OI Barba, Marta/0000-0001-6084-7666; cicione, claudia/0000-0003-1351-3641
CR Abbott A, 2013, NATURE, V495, P418, DOI 10.1038/495418a
   ALBERTSON KS, 1991, CLIN ORTHOP RELAT R, P113
   Arrigoni E, 2013, J ORTHOP SCI, V18, P331, DOI 10.1007/s00776-012-0349-y
   Bai WF, 2013, CYTOTHERAPY, V15, P961, DOI 10.1016/j.jcyt.2013.03.001
   Bailey AM, 2010, CURR STEM CELL RES T, V5, P95
   Barba M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/813894
   Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581
   Bellotti C, 2013, INT J IMMUNOPATH PH, V26, P3, DOI 10.1177/03946320130260S102
   Bernardini C, 2010, GENE EXPRESSION, V15, P27, DOI 10.3727/105221610X12819686555097
   Bianchi F, 2013, CELL TRANSPLANT, V22, P2063, DOI 10.3727/096368912X657855
   Boden SD, 1998, SPINE, V23, P2486, DOI 10.1097/00007632-199812010-00003
   Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006
   Bussolati B, 2008, AM J NEPHROL, V28, P813, DOI 10.1159/000137681
   Cai S, 2011, CNS NEUROL DISORD-DR, V10, P500, DOI 10.2174/187152711795563930
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cao Z, 2012, BIOTECHNOL LETT, V34, P1151, DOI 10.1007/s10529-012-0884-9
   Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25
   Chao YH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759503
   Choi J.W., 2012, ANN PLASTIC SURG
   Chou YF, 2011, CONNECT TISSUE RES, V52, P109, DOI 10.3109/03008207.2010.484514
   Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200
   Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537
   Declercq HA, 2013, BIOMATERIALS, V34, P1004, DOI 10.1016/j.biomaterials.2012.10.051
   Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3
   Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z
   Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   Fernandez FB, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035005
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   FRIEDENSTEIN A, 1961, ACTA ANAT, V45, P31
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19
   Gomez-Ambrosi J, 2008, OBES SURG, V18, P1134, DOI 10.1007/s11695-008-9548-1
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Guercio A, 2013, CELL BIOL INT, V37, P789, DOI 10.1002/cbin.10090
   Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064
   Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3
   He J, 2013, MOL MED REP, V7, P1111, DOI 10.3892/mmr.2013.1307
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Hong J. M., 2012, ACTA BIOMATERIALIA
   Hu FH, 2013, CELL REPROGRAM, V15, P224, DOI 10.1089/cell.2012.0077
   James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461
   Janssen FW, 2006, J BIOMED MATER RES A, V79A, P338, DOI 10.1002/jbm.a.30794
   Jo CH, 2013, CELL TISSUE RES, V353, P41, DOI 10.1007/s00441-013-1619-5
   Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299
   Kapur SK, 2013, BIOCHIMIE
   Keibl C, 2011, INJURY, V42, P814, DOI 10.1016/j.injury.2011.03.007
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kim HP, 2012, CURR STEM CELL RES T, V7, P165
   Kim JY, 2010, TISSUE ENG PT A, V16, P2229, DOI [10.1089/ten.tea.2009.0644, 10.1089/ten.TEA.2009.0644]
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Kruyt MC, 2006, BIOMATERIALS, V27, P5099, DOI 10.1016/j.biomaterials.2006.05.048
   Lattanzi W, 2008, GENE THER, V15, P1330, DOI 10.1038/gt.2008.116
   Lattanzi W, 2005, Eur Rev Med Pharmacol Sci, V9, P167
   Lattanzi W., 2011, OSTEOGENESIS
   Lattanzi W, 2013, BONE, V52, P474, DOI 10.1016/j.bone.2012.09.004
   Lattanzi W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/468705
   Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736
   Lee SJ, 2010, BIOMATERIALS, V31, P5652, DOI 10.1016/j.biomaterials.2010.03.019
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Levi B, 2011, STEM CELLS, V29, P2018, DOI 10.1002/stem.757
   Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670
   Levi B, 2011, PLAST RECONSTR SURG, V127, P1118, DOI 10.1097/PRS.0b013e318205f274
   Levi B, 2011, PLAST RECONSTR SURG, V127, P1130, DOI 10.1097/PRS.0b013e3182043712
   Levi B, 2011, STEM CELLS DEV, V20, P243, DOI 10.1089/scd.2010.0250
   Li JJ, 2012, J SURG RES, V176, pE13, DOI 10.1016/j.jss.2011.12.011
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liao H. T., 2013, J TISSUE ENG REGENER
   Lin CY, 2013, BIOMATERIALS, V34, P9401, DOI 10.1016/j.biomaterials.2013.08.051
   Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979
   Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282
   Liu GP, 2013, BIOMATERIALS, V34, P2655, DOI 10.1016/j.biomaterials.2013.01.004
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Lo D. D., 2012, J VISUALIZED EXPT, V68
   Longo UG, 2012, CURR STEM CELL RES T, V7, P272
   Lopez MJ, 2013, VET SURG, V42, P1, DOI 10.1111/j.1532-950X.2012.01077.x
   Man Y, 2012, BIOMATERIALS, V33, P8802, DOI 10.1016/j.biomaterials.2012.08.054
   Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z
   Martinetti R, 2004, KEY ENG MAT, V254-2, P1095, DOI 10.4028/www.scientific.net/KEM.254-256.1095
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Miyazaki M, 2008, SPINE, V33, P863, DOI 10.1097/BRS.0b013e31816b45c3
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Moroni L, 2013, J CELL PHYSIOL, V228, P680, DOI 10.1002/jcp.24223
   Neirinckx V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064723
   Pan Y, 2012, MOL CELL BIOCHEM, V368, P127, DOI 10.1007/s11010-012-1351-6
   Papadimitropoulos A, 2011, EUR CELLS MATER, V21, P445, DOI 10.22203/eCM.v021a33
   Parrilla C, 2011, ARCH OTOLARYNGOL, V137, P463, DOI 10.1001/archoto.2011.61
   Parrilla C, 2010, HEAD NECK-J SCI SPEC, V32, P310, DOI 10.1002/hed.21185
   Peng CA, 1996, ANN BIOMED ENG, V24, P373, DOI 10.1007/BF02660886
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pola E, 2004, GENE THER, V11, P683, DOI 10.1038/sj.gt.3302207
   Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021
   Puglisi MA, 2011, EUR REV MED PHARMACO, V15, P355
   Puglisi MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860578
   Qing W, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/410879
   Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z
   Requicha JF, 2012, STEM CELL REV REP, V8, P1211, DOI 10.1007/s12015-012-9397-0
   Rhee SC, 2011, STEM CELLS DEV, V20, P233, DOI 10.1089/scd.2009.0525
   Sandor GK, 2013, J ORAL MAXIL SURG, V71, P938, DOI 10.1016/j.joms.2012.11.014
   Saulnier N, 2009, EUR REV MED PHARMACO, V13, P71
   Saulnier N, 2011, CYTOTHERAPY, V13, P329, DOI 10.3109/14653249.2010.515576
   Saulnier N, 2010, DIGEST LIVER DIS, V42, P895, DOI 10.1016/j.dld.2010.04.013
   Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Schubert T, 2013, BIOMATERIALS, V34, P3279, DOI 10.1016/j.biomaterials.2013.01.057
   Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Shen FH, 2013, SPINE J, V13, P32, DOI 10.1016/j.spinee.2013.01.002
   Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858
   Sheyn D, 2011, MOL PHARMACEUT, V8, P1592, DOI 10.1021/mp200226c
   Shoji T, 2010, LAB INVEST, V90, P637, DOI 10.1038/labinvest.2010.39
   Silva A. R., 2013, J BIOMEDICAL MAT R A
   Smith DM, 2011, PLAST RECONSTR SURG, V128, P1053, DOI 10.1097/PRS.0b013e31822b65e4
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Stockmann P, 2012, J CRANIO MAXILL SURG, V40, P310, DOI 10.1016/j.jcms.2011.05.004
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   Valcz G, 2011, PATHOL ONCOL RES, V17, P11, DOI 10.1007/s12253-010-9262-x
   Von Eyben FE, 2004, ANN NY ACAD SCI, V1030, P508, DOI 10.1196/annals.1329.063
   Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wilson SM, 2012, J ORAL MAXIL SURG, V70, pE193, DOI 10.1016/j.joms.2011.10.029
   Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535
   Yang Siming, 2012, Front Med, V6, P41, DOI 10.1007/s11684-012-0175-9
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265
   Zanetti A. S, 2012, J TISSUE ENG REGENER
   Zanetti A. S., 2013, J BIOMATERIALS APPL
   Zhang Y, 2012, GROWTH FACTORS, V30, P333, DOI 10.3109/08977194.2012.720574
   Zimmerlin L, 2013, CYTOM PART A, V83A, P134, DOI 10.1002/cyto.a.22227
   Zimmerlin L, 2012, CYTOM PART A, V81A, P12, DOI 10.1002/cyto.a.21168
   Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813
NR 156
TC 41
Z9 43
U1 1
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 416391
DI 10.1155/2013/416391
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 253GT
UT WOS:000327072900001
PM 24307997
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Roch, T
   Kratz, K
   Ma, N
   Jung, F
   Lendlein, A
AF Roch, Toralf
   Kratz, Karl
   Ma, Nan
   Jung, Friedrich
   Lendlein, Andreas
TI The influence of polystyrene and poly(ether imide) inserts with
   different roughness, on the activation of dendritic cells
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 6th Joint Meeting of the International-Society-of-Biorheology and the
   International-Society-of-Clinical-Hemorheology / 14th International
   Congress of Biorheology / 7th International Conference of Clinical
   Hemorheology
CY JUL 04-07, 2012
CL Koc Univ, Istanbul, TURKEY
SP Int Soc Biorheol, Int Soc Clin Hemorheol
HO Koc Univ
DE Biomaterials; roughness; dendritic cells; cell culture devices
ID CARDIOVASCULAR IMPLANTS; IMMUNE CELLS; RESPONSES; SURFACES;
   BIOMATERIALS; POLARIZATION; CHEMOKINES; POLYMERS; MEDICINE; T(H)2
AB Dendritic cells (DC) have a pivotal role during inflammation. DC efficiently present antigens to T cells and shape the subsequent immune response by the secretion of pro-or anti-inflammatory cytokines and by the expression of co-stimulatory molecules. They respond to "danger signals" such as microbial products or fragments from necrotic cells or tissues, but were also described to be reactive towards biomaterials. However, how mechanical and physical properties of the subjacent substrate influences the DC activation is currently poorly understood. In this study micro patterned inserts prepared from polystyrene (PS) as well as from poly (ether imide) (PEI) with three different roughness levels of i) Rq = 0.29 mu m (PS) and 0.23 mu m (PEI); ii) Rq = 3.47 mu m (PS) and 3.92 mu m (PEI); and iii) Rq = 22.16 mu m (PS) and 22.65 mu m (PEI) were analyzed for their capacity to influence the activation of human monocytes derived DC. Since the DC were directly cultured in the inserts, the effects of the testing material alone could be investigated and influences from additional culture dish material could be excluded.
   The viability, the expression of the DC activation markers, and their cytokine/chemokine secretion were determined after the incubation with the different inserts in vitro.
   Both the PS and the PEI inserts did not influence the survival of the DC and their expression of co-stimulatory molecules. The expression of inflammatory cytokines was not altered by the PEI and PS inserts. However, the secretion of chemokines such as CCL2, CCL3, and CCL4 was influenced by the different roughness levels, indicating that material roughness has the capacity to modulate the DC phenotype.
   The data presented here will help to understand the interaction of DC with structured polymer surfaces. Biomaterial-induced immuno-modulatory effects mediated by DC may promote tissue regeneration or could potentially reduce inflammation caused by the implant material.
C1 [Roch, Toralf; Kratz, Karl; Ma, Nan; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Jung, Friedrich; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Mat Med, Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Jung, Friedrich; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Mat Med, Berlin, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Kratz, Karl/K-7115-2013; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013; Ma, Nan/L-1282-2013
OI Kratz, Karl/0000-0002-9229-4266; Jung, Friedrich/0000-0001-8098-7180;
   Lendlein, Andreas/0000-0003-4126-4670; Ma, Nan/0000-0003-4006-1003;
   Roch, Toralf/0000-0003-2948-8700
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1, DOI 10.3233/CH-2010-1256A
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Boese G, 2007, TISSUE ENG, V13, P2995, DOI 10.1089/ten.2006.0442
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838
   Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097
   Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kress S, 2012, ADV BIOCHEM ENG BIOT, V126, P263, DOI 10.1007/10_2011_108
   Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x
   Manthey HD, 2011, THROMB HAEMOSTASIS, V106, P772, DOI 10.1160/TH11-05-0296
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   Rickert D, 2006, EUR ARCH OTO-RHINO-L, V263, P215, DOI 10.1007/s00405-005-0950-1
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Shastri VP, 2010, MRS BULL, V35, P571, DOI 10.1557/mrs2010.524
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217
   von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003
   Wang XW, 2010, CLIN HEMORHEOL MICRO, V46, P265, DOI 10.3233/CH-2010-1334
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
   Wischke C, 2011, CLIN HEMORHEOL MICRO, V49, P347, DOI 10.3233/CH-2011-1485
   Wood J.C., 2001, CLOSE ENCOUNTERS SCU, V1
   Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227
   Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118
NR 43
TC 6
Z9 6
U1 1
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2013
VL 55
IS 1
BP 157
EP 168
DI 10.3233/CH-131699
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 247WI
UT WOS:000326653200017
PM 23455842
DA 2018-10-20
ER

PT J
AU Santhiya, D
   Alajangi, HK
   Anjum, F
   Murugavel, S
   Ganguli, M
AF Santhiya, Deenan
   Alajangi, Hema Kumari
   Anjum, Fara
   Murugavel, Sevi
   Ganguli, Munia
TI Bio-inspired synthesis of microporous bioactive glass-ceramic using
   CT-DNA as a template
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VITRO BIOACTIVITY; COMPOSITE SCAFFOLDS; SODIUM-SILICATE; BONE; 45S5;
   BIOMATERIALS; DISSOLUTION; CARTILAGE; DELIVERY; GELATIN
AB We report, for the first time, bio-inspired synthesis of a bioactive glass-ceramic with superior textural properties in atmospheric conditions using CT-DNA as template. The phase composition, structure, morphology, and textural properties of the bioactive glass sample were evaluated with various analytical techniques before and after in vitro tests. The BET surface area analysis of the obtained glass-ceramic sample reveals that it possesses a high surface area with a range of (micro-to meso-) pore sizes. The TEM analysis of the glass-ceramic phase indicates that the amorphous phase consists of spherical particles, whereas the crystalline phase is found to have needle-like shape. In the glass-ceramic, we find a new type of crystalline phase (Na0.11Ca0.89)(P0.11Si0.89)O-3, which is different from the earlier observation on 45S5 (R) glass-ceramic sample. The accelerated in vitro bioactivity of the glass-ceramic is evidenced based on the hydroxyl carbonate apatite (HCA) layer formation on the glass-ceramic surface after immersing the bioglass sample in simulated body fluid (SBF), by FTIR, SEM and EDX analysis. Additionally, the ion release kinetics of the bioglass sample in SBF is followed by ICP-AES with simultaneous pH measurements. The in vitro cytotoxicity experiments on the glass-ceramic sample using osteosarcoma cells by following the MTT assay method indicate that the sample has good biocompatibility and may serve as an effective biomaterial for bone tissue engineering.
C1 [Santhiya, Deenan; Alajangi, Hema Kumari; Anjum, Fara] Delhi Technol Univ, Dept Appl Chem & Polymer Technol, Delhi 110042, India.
   [Murugavel, Sevi] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India.
   [Ganguli, Munia] Inst Genom & Integrat Biol CSIR, Delhi 110025, India.
RP Santhiya, D (reprint author), Delhi Technol Univ, Dept Appl Chem & Polymer Technol, Bawana Rd, Delhi 110042, India.
EM deenan.santhiya@dce.ac.in
CR Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Atanasova P., 2009, NANOTECHNOLOGY, V20
   Bauermann LP, 2006, CHEM MATER, V18, P2016, DOI 10.1021/cm052317+
   Chen QZ, 2007, ACTA BIOMATER, V3, P551, DOI 10.1016/j.actbio.2007.01.008
   Chen QZ, 2011, ACTA BIOMATER, V7, P3616, DOI 10.1016/j.actbio.2011.06.005
   Chen QZ, 2010, ACTA BIOMATER, V6, P4143, DOI 10.1016/j.actbio.2010.04.022
   Chen QZ, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-2
   Chen QZ, 2006, ADV ENG MATER, V8, P285, DOI 10.1002/adem.200500259
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   De Aza PN, 2007, BOL SOC ESP CERAM V, V46, P45, DOI 10.3989/cyv.2007.v46.i2.249
   Dillow A. K., 2002, BIOMIMETICS MAT DESI
   Ding SJ, 2011, J MATER CHEM, V21, P12793, DOI 10.1039/c1jm11171j
   Falini G, 2000, INT J INORG MATER, V2, P455, DOI 10.1016/S1466-6049(00)00040-4
   Gentleman E, 2006, J MATER SCI-MATER M, V17, P1029, DOI 10.1007/s10856-006-0440-z
   Gerstel P, 2006, CHEM MATER, V18, P179, DOI 10.1021/cm051542o
   Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HERMAN A.S., 1963, INFRARED HDB
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu J, 2007, MICROPOR MESOPOR MAT, V106, P62, DOI 10.1016/j.micromeso.2007.02.045
   Liu XY, 2003, J AM CHEM SOC, V125, P888, DOI 10.1021/ja020355d
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   Mozafari M, 2010, ADV COMPOS LETT, V19, P91
   Nychka JA, 2009, JOM-US, V61, P45, DOI 10.1007/s11837-009-0132-5
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Salgado J., 2004, MACROMOL BIOSCI, V4, P743
   Santhiya D, 2010, LANGMUIR, V26, P6494, DOI 10.1021/la9039557
   Scott TG, 2013, J NANOSCI NANOTECHNO, V13, P1, DOI 10.1166/jnn.2013.6733
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Shalak R., 1988, TISSUE ENG, P26
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   Vaid C, 2013, MAT SCI ENG C-MATER, V33, P959, DOI 10.1016/j.msec.2012.11.028
   Vaid C, 2012, MICROPOR MESOPOR MAT, V159, P17, DOI 10.1016/j.micromeso.2012.04.010
   Volkmer D, 2005, MAT SCI ENG C-BIO S, V25, P161, DOI 10.1016/j.msec.2005.01.006
   Will J, 2012, ADV BIOCHEM ENG BIOT, V126, P195, DOI 10.1007/10_2011_106
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Yu HD, 2010, CHEM COMMUN, V46, P6578, DOI 10.1039/c0cc01348j
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
   Zhu Y., 2009, MICROPOR MESOPOR MAT, V118, P182
NR 53
TC 9
Z9 9
U1 2
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 45
BP 6329
EP 6338
DI 10.1039/c3tb21212b
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 247UV
UT WOS:000326648800016
DA 2018-10-20
ER

PT J
AU Lee, HS
   Tomczyk, N
   Kandel, J
   Composto, RJ
   Eckmann, DM
AF Lee, Hyun-Su
   Tomczyk, Nancy
   Kandel, Judith
   Composto, Russell J.
   Eckmann, David M.
TI Hemocompatibility of chitosan/poly(acrylic acid) grafted polyurethane
   tubing
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PLASMA GLOW-DISCHARGE; SURFACE CHARACTERIZATION; PROTEIN ADSORPTION;
   FILM THICKNESS; IMMOBILIZATION; ACTIVATION; HEPARIN; CHITOSAN; CONTACT;
   COAGULATION
AB The activation and adhesion of platelets or whole blood exposed to chitosan (CH) grafted surfaces is used to evaluate the hemocompatibility of biomaterials. The biomaterial surfaces are polyurethane (PU) tubes grafted with an inner poly(acrylic acid) (PAA) and an outer CH or quaternary ammonium modified CH (CH-Q) brush. The CH, CH-Q and PAA grafted layers were characterized by ellipsometry and fluorescence microscopy. Material wear tests demonstrate that CH (CH-Q) is stably grafted onto PU tubes upon exposure to saline solution for 7 days. Using quartz-crystal microbalances with dissipation (QCM-D), in situ adsorption of blood plasma proteins on CH and CH-Q compared to a silicon oxide control was measured. The QCM-D results showed that the physically adsorbed plasma protein layer on CH-Q and CH surfaces is softer and more viscous than the protein layer on the SiO2 surface. The CH-Q layer thus has the weakest interaction with plasma proteins. Whole blood and platelet adhesion was reduced by similar to 92% on CH-Q, which showed the weakest interaction with plasma protein but more viscous adsorbed plasma protein layer, compared to SiO2. Last, to examine the biologic response of platelets and neutrophils to biomaterial surfaces, CH (CH-Q)/PAA, PAA and PU tubes were tested using a Chandler Loop apparatus as an ex vivo model and flow cytometry. The blood adhesion and biologic response results showed that CH and CH-Q reduced adhesion and activation of platelets and neutrophils and improved hemocompatibility relative to other surfaces (PU and PAA). Our studies demonstrated that the properties of physically adsorbed plasma protein layer on biomaterial surfaces correlates with blood coagulation on biomaterial surfaces.
C1 [Lee, Hyun-Su; Tomczyk, Nancy; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Composto, Russell J.; Eckmann, David M.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.
   [Kandel, Judith; Composto, Russell J.; Eckmann, David M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), Univ Penn, Dept Anesthesiol & Crit Care, 331 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.
EM David.Eckmann@uphs.upenn.edu
OI Lee, Hyun-Su/0000-0002-5245-8430
FU National Institutes of Health [NIH R01 HL60230]; Pennsylvania
   Nanomaterials Commercialization Center [NANO-2013-0065]; Benjamin
   Franklin Technology Partners of Southeastern PA [NTI 1011-05-10]; NSF
   [CEMRI/DMR11-20901]
FX This work was supported by the National Institutes of Health (NIH R01
   HL60230). We (RJC, DME, HSL) also acknowledge funding from the
   Pennsylvania Nanomaterials Commercialization Center (NANO-2013-0065) and
   Benjamin Franklin Technology Partners of Southeastern PA (NTI
   1011-05-10). We thank Stephen R. Thom and Tatyana Milovanova for their
   assistance with the flow cytometry measurements. We also thank Jamie
   Ford for his assistance with electron microscopy, housed in the Penn
   Regional Nanotechnology Center and supported in part by NSF,
   CEMRI/DMR11-20901.
CR Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   BRAUDE AI, 1973, J INFECT DIS, V128, pS157, DOI 10.1093/infdis/128.Supplement_1.S157
   Choi HS, 2004, SURF COAT TECH, V182, P55, DOI 10.1016/S0257-8972(02)00880-6
   COLMAN RW, 1987, ANN NY ACAD SCI, V516, P253, DOI 10.1111/j.1749-6632.1987.tb33046.x
   De H., 2012, Method for the detection and/or quantification of the interaction of platelets with interaction partners, Patent No. [WO2012038370A1, 2012038370]
   Eckmann DM, 2013, COLLOID SURFACE B, V108, P44, DOI 10.1016/j.colsurfb.2013.02.013
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Frederick S., 2007, WILEY ENCY CHEM BIOL
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Lee H. S., 2012, PMSE PREPR, V107, P183
   Lee H. S., 2012, PMSE PREPR, V107, P183
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Liu X, 2012, ACS APPL MATER INTER, V4, P5169, DOI 10.1021/am301104c
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Monchaux E, 2008, J BIOMED MATER RES A, V85A, P1052, DOI 10.1002/jbm.a.31580
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sinn S, 2011, J MATER SCI-MATER M, V22, P1521, DOI 10.1007/s10856-011-4335-2
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   Tsai IY, 2011, SOFT MATTER, V7, P3599, DOI 10.1039/c0sm01353f
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Vogt BD, 2004, J PHYS CHEM B, V108, P12685, DOI 10.1021/jp0481005
   VROMAN L, 1974, SCIENCE, V184, P585, DOI 10.1126/science.184.4136.585
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
NR 33
TC 8
Z9 8
U1 4
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 46
BP 6382
EP 6391
DI 10.1039/c3tb21218a
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 249PA
UT WOS:000326787900005
PM 24349719
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Huang, Y
   Liu, DB
   Xia, M
   Anguilano, L
AF Huang, Y.
   Liu, D-B.
   Xia, M.
   Anguilano, L.
BE Stone, I
   McKay, B
   Fan, ZY
TI Characterization of an Mg-2Zn-1Ca 1 beta-TCP Composite Fabricated by
   High Shear Solidification and ECAE
SO LIGHT METALS TECHNOLOGY 2013
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Light Metals Technology Conference (LMT 2013)
CY JUL 24-26, 2013
CL Brunel Univ, BCAST, Old Windsor, ENGLAND
HO Brunel Univ, BCAST
DE Mg matrix composite; High shear solidification; ECAE; Grain refinement;
   Corrosion resistance; Biomaterial
ID ALLOY
AB A biodegradable Mg matrix and nano beta-tricalcium phosphate (beta-TCP) particles reinforced composite Mg-2Zn-1Ca-1 beta-TCP was fabricated for biomedical applications by high shear solidification combined with equal channel angular extrusion (ECAE). Optical and electron microscopy, EBSD analysis and mechanical and electrochemical testing were carried out to characterize the microstructure, texture and mechanical and corrosion resistance of the material. The high shear solidification resulted in a fine and uniform grain structure with beta-TCP particles evenly distributed in the matrix in clusters of 5-20 mu m in size. The as-cast microstructure was replaced by a refined deformation microstructure after ECAE processing at 300 degrees C, during which the beta-TCP particle clusters were largely dispersed, giving rise to the formation of a uniform dispersion of individual beta-TCP particles in the matrix. The deformation processing by ECAE increased both the hardness and the corrosion resistance of the material. The dispersed individual nano beta-TCP particles were considered to be an important factor responsible for the improved corrosion resistance after ECAE. Texture development during ECAE and its effect on the corrosion resistance was examined.
C1 [Huang, Y.; Xia, M.] Brunel Univ, BCAST, Kingston Lane, Uxbridge UB8 3PH, Middx, England.
RP Huang, Y (reprint author), Brunel Univ, BCAST, Kingston Lane, Uxbridge UB8 3PH, Middx, England.
EM yan.huang@brunel.ac.uk; debaoliu@126.com; Mingxu.xia@brunel.ac.uk;
   lorna.anguilano@brunel.ac.uk
RI Fan, Zhongyun/A-3576-2012; xia, mingxu/C-4070-2011; Huang,
   Yan/A-8044-2010
OI Huang, Yan/0000-0002-6315-5224; xia, mingxu/0000-0002-3113-4795
CR Brar HS, 2011, JOM-US, V63, P100, DOI 10.1007/s11837-011-0048-8
   Fan Z, 2009, ACTA MATER, V57, P4891, DOI 10.1016/j.actamat.2009.06.052
   Figueiredo RB, 2010, MAT SCI ENG A-STRUCT, V527, P1709, DOI 10.1016/j.msea.2009.10.061
   He S, 2011, T NONFERR METAL SOC, V11, P814
   Huang Y, 2008, ACTA MATER, V56, P1619, DOI 10.1016/j.actamat.2007.12.017
   Liu DB, 2012, MATER LETT, V82, P7, DOI 10.1016/j.matlet.2012.05.035
   Polmear I.J., 1999, MAGNESIUM MAGNESIUM, P14
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
NR 9
TC 2
Z9 2
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 765
BP 813
EP +
DI 10.4028/www.scientific.net/MSF.765.813
PG 2
WC Engineering, Mechanical; Metallurgy & Metallurgical Engineering
SC Engineering; Metallurgy & Metallurgical Engineering
GA BHQ88
UT WOS:000326408600158
DA 2018-10-20
ER

PT J
AU Neumann, A
   Christel, A
   Kasper, C
   Behrens, P
AF Neumann, Anne
   Christel, Anne
   Kasper, Cornelia
   Behrens, Peter
TI BMP2-loaded nanoporous silica nanoparticles promote osteogenic
   differentiation of human mesenchymal stem cells
SO RSC ADVANCES
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; LOCAL-DRUG DELIVERY;
   MESOPOROUS SILICA; OSTEOBLAST DIFFERENTIATION; TITANIUM SURFACES;
   GROWTH-FACTOR; BMP-2; REGENERATION; EXPRESSION
AB Nanoporous (or mesoporous) silica materials have been extensively investigated as a novel biomaterial in the last few years, especially with regard to bone tissue engineering. Due to their high specific surface areas, capability for chemical modification, and their large pore volumes, nanoporous silica nanoparticles (NPSNPs) are of tremendous interest as drug delivery systems. In this study, we describe the immobilization of the bone growth factor BMP2 on NPSNPs in biologically relevant amounts, using coupling via an aminosilane linker. The amount of BMP2 loaded onto NPSNPs was determined using two different methods. The biocompatibility of NPSNPs was tested with different cell lines upon exposure to different particle concentrations. Whereas standard cell types (HepG2, NIH3T3) are relatively insensitive against NPSNPs, adMSC cells (adipose-derived human mesenchymal stem cells) show a somewhat reduced viability. adMSC cells were also used to test for the osteoinductive effect of the BMP2-carrying NPSNPs. Histological staining reveals the osteogenic differentiation of the human mesenchymal stem cells. Even BMP-free amino-modified NPSNPs show a certain osteoinductive effect, which is however significantly stronger with immobilized BMP2 and can furthermore be enhanced by supplemental dexamethasone. We therefore suggest that NPSNPs carrying BMP2 are suitable for application in bone tissue engineering, e.g. in the construction of scaffolds.
C1 [Neumann, Anne; Kasper, Cornelia] Univ Nat Resources & Life Sci, Dept Biotechnol, A-1190 Vienna, Austria.
   [Christel, Anne; Behrens, Peter] Leibniz Univ Hannover, Cluster Excellence Hearing4all, Inst Anorgan Chem, D-30167 Hannover, Germany.
RP Kasper, C (reprint author), Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.
EM Cornelia.Kasper@boku.ac.at; Peter.Behrens@acb.uni-hannover.de
FU Cluster of Excellence Rebirth within the PhD program Regenerative
   Sciences; Cluster of Excellence Hearing4all; DFG [SFB599]; Research Unit
   [548]
FX A.N. and A.C. contributed equally to this work. A.C. was in part
   supported by the Cluster of Excellence Rebirth within the PhD program
   Regenerative Sciences. Furthermore, this work was in part supported by
   the Cluster of Excellence Hearing4all and by the DFG within the
   Collaborative Research Area SFB599 and the Research Unit 548. We thank
   Alexandra Satalov for help with the experiments. The BMP2 used in this
   study was kindly provided by Prof. Walter Sebald.
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871
   Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580
   Cai Q, 2001, CHEM MATER, V13, P258, DOI 10.1021/cm990661z
   Cauvel A, 1997, LANGMUIR, V13, P2773, DOI 10.1021/la962059i
   Chatzinikolaidou M, 2002, MATERIALWISS WERKST, V33, P720, DOI 10.1002/mawe.200290002
   Chen AM, 2009, SMALL, V5, P2673, DOI 10.1002/smll.200900621
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen S, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/065003
   Chen S, 2011, J MATER CHEM, V21, P4332, DOI 10.1039/c0jm03823g
   Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006
   Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001
   Ehlert N, 2013, CHEM SOC REV, V42, P3847, DOI 10.1039/c3cs35359a
   Ehlert N, 2011, ACTA BIOMATER, V7, P1772, DOI 10.1016/j.actbio.2010.12.028
   Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g
   Fowler CE, 2001, ADV MATER, V13, P649, DOI 10.1002/1521-4095(200105)13:9<649::AID-ADMA649>3.0.CO;2-G
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Grassel Susanne, 2012, Methods Mol Biol, V879, P203, DOI 10.1007/978-1-61779-815-3_14
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Hesse Daniela, 2013, Otol Neurotol, V34, P1138, DOI 10.1097/MAO.0b013e3182839671
   Hildebrandt C, 2009, ANN ANAT, V191, P23, DOI 10.1016/j.aanat.2008.09.009
   Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955
   Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje
   Huang DM, 2008, TOXICOL APPL PHARM, V231, P208, DOI 10.1016/j.taap.2008.04.009
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kobler J, 2008, ACS NANO, V2, P791, DOI 10.1021/nn700008s
   Lavrentieva A, 2013, ADV BIOCHEM ENG BIOT, V129, P73, DOI 10.1007/10_2012_133
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9
   Luca L, 2010, INT J PHARMACEUT, V391, P48, DOI 10.1016/j.ijpharm.2010.02.015
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   MUNDY GR, 1995, BONE, V17, pS71, DOI 10.1016/8756-3282(95)00182-D
   Noel D, 2003, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74
   Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Qiao ZA, 2009, CHEM MATER, V21, P3823, DOI 10.1021/cm901335k
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Radu DR, 2004, J AM CHEM SOC, V126, P13216, DOI 10.1021/ja046275m
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797
   Turck C, 2007, ACTA OTO-LARYNGOL, V127, P801, DOI 10.1080/00016480601053032
   Vallet-Regi M, 2012, PHILOS T R SOC A, V370, P1400, DOI 10.1098/rsta.2011.0258
   Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789
   Wagner S., 2012, THESIS LEIBNIZ U HAN
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Yamada H, 2012, CHEM MATER, V24, P1462, DOI 10.1021/cm3001688
   Yoon ST, 2002, CLIN ORTHOP RELAT R, P33
NR 64
TC 27
Z9 27
U1 1
U2 64
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 46
BP 24222
EP 24230
DI 10.1039/c3ra44734k
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 248ZI
UT WOS:000326745100051
DA 2018-10-20
ER

PT J
AU dos Santos, R
   Rocha, A
   Matias, A
   Duarte, C
   Sa-Nogueira, I
   Lourenco, N
   Borges, JP
   Vidinha, P
AF dos Santos, Renato
   Rocha, Angelo
   Matias, Ana
   Duarte, Catarina
   Sa-Nogueira, Isabel
   Lourenco, Nuno
   Borges, Joao Paulo
   Vidinha, Pedro
TI Development of antimicrobial Ion Jelly fibers
SO RSC ADVANCES
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; GELATIN SOLUTION; CROSS-LINKING; NANOFIBERS;
   CHITOSAN; POLYMERS; LIQUIDS; BIOMATERIAL; TOXICITY; MEDICINE
AB We report a method to obtain electrospun fibers based on ionic liquids and gelatin, exhibiting antimicrobial properties.
C1 [dos Santos, Renato; Vidinha, Pedro] Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal.
   [Rocha, Angelo; Lourenco, Nuno] Inst Super Tecn, IBB, Ctr Biol & Chem Engn, P-1049001 Lisbon, Portugal.
   [Matias, Ana; Duarte, Catarina] IBET ITQB UNL Inst Biol Expt & Tecnol, P-2780 Oeiras, Portugal.
   [Matias, Ana; Duarte, Catarina] Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal.
   [Sa-Nogueira, Isabel] Univ Nova Lisboa, CREM Ctr Recursos Microbiol, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal.
   [Borges, Joao Paulo] Univ Nova Lisboa, CENIMAT I3N, Dept Ciencia Mat, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal.
RP dos Santos, R (reprint author), Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal.
EM pm.gomes@fct.unl.pt; jpb@fct.unl.pt
RI Duarte, Catarina/E-8404-2016; Institute of Chemistry - USP, Dept. of
   Chemistry/B-8988-2012; de Sa-Nogueira, Isabel/B-9139-2011; Borges,
   Joao/C-9078-2009; vidinha, Pedro/H-3426-2013
OI Duarte, Catarina/0000-0002-4633-5979; de Sa-Nogueira,
   Isabel/0000-0001-6665-7994; Borges, Joao/0000-0002-3996-6545; vidinha,
   Pedro/0000-0002-3907-4969; Matias, Ana/0000-0002-4888-9414; Lourenco,
   Nuno/0000-0001-9329-2724
FU Fundacao para a Ciencia e a Tecnologia (FCT/MEC)
   [PEst-C/EQB/LA0006/2011]; FCT-MEC through Strategic [PEst-C/CTM/LA0025,
   PEst-OE/EQB/LA0023, PEst-OE/BIA/UI0457, PEst-OE/EQB/LA0004,
   PTDC/EQU-EQU/104552, PTDC/EBB-EBI/099237, PTDC/CTM/100244,
   SFRH/BPD/41546, SFRH/BPD/41175]
FX This work has been supported by Fundacao para a Ciencia e a Tecnologia
   (FCT/MEC) through projects/grants PEst-C/EQB/LA0006/2011, FCT-MEC
   through Strategic PEst-C/CTM/LA0025/2013-2014, PEst-OE/EQB/LA0023/2011
   PEst-OE/BIA/UI0457/2011, PEst-OE/EQB/LA0004/2011
   PTDC/EQU-EQU/104552/2008, PTDC/EBB-EBI/099237/2008,
   PTDC/CTM/100244/2008, SFRH/BPD/41546/2007 (P. Vidinha),
   SFRH/BPD/41175/2007 (N. Lourenco), and by FEDER. The NMR spectrometers
   are part of the National NMR Network (RNRMN) and are funded by Fundacao
   para a Ciencia e a Tecnologia.
CR Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bshena O, 2011, FUTURE MED CHEM, V3, P1821, DOI [10.4155/fmc.11.131, 10.4155/FMC.11.131]
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Dias AMA, 2012, ACTA BIOMATER, V8, P1366, DOI 10.1016/j.actbio.2011.10.034
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   He JH, 2007, CHAOS SOLITON FRACT, V33, P26, DOI 10.1016/j.chaos.2006.09.023
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Konsoula R, 2005, TOXICOL IN VITRO, V19, P675, DOI 10.1016/j.tiv.2005.03.006
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   de Carvalho RNL, 2013, J POLYM SCI POL PHYS, V51, P817, DOI 10.1002/polb.23252
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lourenco NMT, 2011, REACT FUNCT POLYM, V71, P489, DOI 10.1016/j.reactfunctpolym.2011.01.006
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Pernak J, 2007, CHEM-EUR J, V13, P6817, DOI 10.1002/chem.200700285
   Pimenta AFR, 2012, MATER LETT, V83, P161, DOI 10.1016/j.matlet.2012.04.146
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   Putten P.L.V., 1979, ANTON LEEUW INT J G, V45, P622, DOI DOI 10.1007/BF00403669
   Reneker DH, 2007, ADV APPL MECH, V41, P43, DOI 10.1016/S0065-2156(07)41002-X
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rose P.I., 1987, ENCY POLYM SCI ENG, P488
   Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6
   Saw MM, 2012, ANAESTH INTENS CARE, V40, P17
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Vidinha P, 2008, CHEM COMMUN, P5842, DOI 10.1039/b811647d
   Vijayaraghavan R, 2010, CHEM COMMUN, V46, P294, DOI 10.1039/b910601d
   Zhang S, 2009, STRUCT BOND, V131, P143, DOI 10.1007/430_2008_5
   Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136
   Zhao DB, 2007, CLEAN-SOIL AIR WATER, V35, P42, DOI 10.1002/clen.200600015
NR 37
TC 6
Z9 6
U1 1
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 46
BP 24400
EP 24405
DI 10.1039/c3ra44258f
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 248ZI
UT WOS:000326745100071
DA 2018-10-20
ER

PT J
AU Zhan, K
   Bai, L
   Xie, L
   Wang, X
   Zuo, B
AF Zhan, K.
   Bai, L.
   Xie, L.
   Wang, X.
   Zuo, B.
TI ANGIOGENESIS IN BIOMATERIAL SCAFFOLDS WITH DIFFERENT BIODEGRADABILITY
SO CARDIOLOGY
LA English
DT Meeting Abstract
C1 [Zhan, K.] Soochow Univ, Sch Mech & Elect Engn, Suzhou, Peoples R China.
   [Bai, L.; Zuo, B.] Soochow Univ, Sch Text & Clothing Engn, Suzhou, Peoples R China.
   [Xie, L.; Wang, X.] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0008-6312
EI 1421-9751
J9 CARDIOLOGY
JI Cardiology
PY 2013
VL 126
SU 2
BP 367
EP 367
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 245CR
UT WOS:000326437200363
DA 2018-10-20
ER

PT J
AU Gouveia, RM
   Castelletto, V
   Alcock, SG
   Hamley, IW
   Connon, CJ
AF Gouveia, Ricardo M.
   Castelletto, Valeria
   Alcock, Simon G.
   Hamley, Ian W.
   Connon, Che J.
TI Bioactive films produced from self-assembling peptide amphiphiles as
   versatile substrates for tuning cell adhesion and tissue architecture in
   serum-free conditions
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID EXTRACELLULAR-MATRIX; CORNEAL STROMA; IN-VITRO; BIOMATERIALS;
   ORGANIZATION; INTEGRINS; PROTEOGLYCAN; KERATOCYTES;
   POLY(TETRAFLUOROETHYLENE); TRANSPARENCY
AB The development of versatile bioactive surfaces able to emulate in vivo conditions is of enormous importance to the future of cell and tissue therapy. Tuning cell behaviour on two-dimensional surfaces so that the cells perform as if they were in a natural three-dimensional tissue represents a significant challenge, but one that must be met if the early promise of cell and tissue therapy is to be fully realised. Due to the inherent complexities involved in the manufacture of biomimetic three-dimensional substrates, the scaling up of engineered tissue-based therapies may be simpler if based upon proven two-dimensional culture systems. In this work, we developed new coating materials composed of the self-assembling peptide amphiphiles (PAs) C(16)G(3)RGD (RGD) and C(16)G(3)RGDS (RGDS) shown to control cell adhesion and tissue architecture while avoiding the use of serum. When mixed with the C16ETTES diluent PA at 13 : 87 (mol mol(-1)) ratio at 1.25 x 10(-3) M, the bioactive PAs were shown to support optimal adhesion, maximal proliferation, and prolonged viability of human corneal stromal fibroblasts (hCSFs), while improving the cell phenotype. These PAs also provided stable adhesive coatings on highly-hydrophobic surfaces composed of striated polytetrafluoroethylene (PTFE), significantly enhancing proliferation of aligned cells and increasing the complexity of the produced tissue. The thickness and structure of this highly-organised tissue were similar to those observed in vivo, comprising aligned newly-deposited extracellular matrix. As such, the developed coatings can constitute a versatile biomaterial for applications in cell biology, tissue engineering, and regenerative medicine requiring serum-free conditions.
C1 [Gouveia, Ricardo M.; Castelletto, Valeria; Hamley, Ian W.; Connon, Che J.] Univ Reading, Sch Chem Food & Pharm, Reading RG6 6UB, Berks, England.
   [Alcock, Simon G.] Diamond Light Source Ltd, Opt & Metrol Grp, Didcot OX11 0DE, Oxon, England.
RP Connon, CJ (reprint author), Univ Reading, Sch Chem Food & Pharm, Reading RG6 6UB, Berks, England.
EM c.j.connon@reading.ac.uk
RI Connon, Che/B-3128-2012; Hamley, Ian/D-1643-2009
OI Connon, Che/0000-0001-8264-6531; Hamley, Ian/0000-0002-4549-0926;
   Gouveia, Ricardo/0000-0002-2968-1298
FU BBSRC [BB/I008187/1, BB/J019836/1]; Biotechnology and Biological
   Sciences Research Council [BB/J019836/1, BB/I008187/1]
FX We are grateful to the BBSRC (grants numbers BB/I008187/1 and
   BB/J019836/1) for. nancial support. We kindly acknowledge M. Leyland,
   Royal Berkshire Hospital for supplying the post- mortem corneal rings.
   We thank K. Feldman, Department of Materials, ETH Zurich for providing
   the PTFE-coated slides, and P. Harris and M. Spink, Centre for Advanced
   Microscopy of the University of Reading for technical assistance with
   SEM. We are grateful to S. Furzeland and D. Atkins, Unilever, Colworth,
   UK, for technical assistance with cryo-TEM.
CR Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409
   Bueno EM, 2009, TISSUE ENG PT A, V15, P3559, DOI [10.1089/ten.tea.2008.0404, 10.1089/ten.TEA.2008.0404]
   Castelletto V, 2013, FARADAY DISCUSS, V166, P381, DOI 10.1039/c3fd00064h
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Connon CJ, 2003, OPHTHALMIC RES, V35, P177, DOI 10.1159/000071168
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   DIETZ P, 1993, J MATER SCI, V28, P1372, DOI 10.1007/BF01191980
   Gasiorowski JZ, 2011, BIOMACROMOLECULES, V12, P3549, DOI 10.1021/bm200763y
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gribova V, 2011, J MATER CHEM, V21, P14354, DOI 10.1039/c1jm11372k
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730
   Kao WWY, 2003, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   MASUR SK, 1993, INVEST OPHTH VIS SCI, V34, P2690
   MEEK KM, 1993, BIOPHYS J, V64, P273, DOI 10.1016/S0006-3495(93)81364-X
   Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574
   Orwin EJ, 2003, J BIOMECH ENG-T ASME, V125, P439, DOI 10.1115/1.1589773
   Palladino P, 2012, LANGMUIR, V28, P12209, DOI 10.1021/la302123h
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074
   Quantock AJ, 2008, DEV DYNAM, V237, P2607, DOI 10.1002/dvdy.21579
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001
   Sadatmousavi P, 2011, CURR PHARM BIOTECHNO, V12, P1089, DOI 10.2174/138920111796117409
   Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200
   Song WL, 2013, SOFT MATTER, V9, P2985, DOI 10.1039/c3sm27739a
   Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   WITTMANN JC, 1991, NATURE, V352, P414, DOI 10.1038/352414a0
   Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 54
TC 27
Z9 27
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 44
BP 6157
EP 6169
DI 10.1039/c3tb21031f
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA 242MA
UT WOS:000326244900017
OA Bronze
DA 2018-10-20
ER

PT J
AU Tanalp, J
   Karapinar-Kazandag, M
   Dolekoglu, S
   Kayahan, MB
AF Tanalp, Jale
   Karapinar-Kazandag, Meric
   Dolekoglu, Semanur
   Kayahan, Mehmet Baybora
TI Comparison of the Radiopacities of Different Root-End Filling and Repair
   Materials
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID MINERAL TRIOXIDE AGGREGATE; TRICALCIUM SILICATE CEMENT; RESTORATIVE
   MATERIAL; PHYSICAL-PROPERTIES; DENTAL BIOMATERIAL; PORTLAND-CEMENT; PULP
   CELLS; BIODENTINE; INDUCTION; MTA
AB This study evaluated the radiopacity of 3 repair materials, Biodentine, MM-MTA, and MTA Angelus. Standardized cylindrical rings were prepared. Samples of Biodentine MM-MTA and MTA Angelus were prepared (n = 10 in each group), filled into the rings, and preserved at 37 degrees C until setting. A 1 mm thick dentin slice was used as control. All set specimens were removed and radiographed along with the dentine slice and a graduated aluminium step wedge. Digital images were transferred to the computer using a software. The radiographic densities of the specimens were determined, and the values were converted into millimetres of aluminium (mm Al). One-way ANOVA was used for intergroup comparison, whereas Tukey HSD test was used for detecting the group with the difference. The mean radiopacities of Biodentine, MTA Angelus, and MM-MTA were 2.8 +/- 0.48, 4.72 +/- 0.45, and 5.18 +/- 0.51 mm Al, respectively. The radiopacity of Biodentine was significantly lower compared to other materials (P = 0.001), whereas no significant difference was noted between MTA Angelus and MM-MTA (P = 0.109). All materials had significantly higher radiopacities compared to dentine. The relatively lower radiopacity of Biodentine can be improved to achieve more reliable results in procedures such as retrograde fillings.
C1 [Tanalp, Jale; Karapinar-Kazandag, Meric; Kayahan, Mehmet Baybora] Yeditepe Univ, Dept Endodont, Fac Dent, TR-34728 Istanbul, Turkey.
   [Dolekoglu, Semanur] Yeditepe Univ, Dept Oral Radiol, Fac Dent, TR-34728 Istanbul, Turkey.
RP Tanalp, J (reprint author), Yeditepe Univ, Dept Endodont, Fac Dent, Bagdat Caddesi 238, TR-34728 Istanbul, Turkey.
EM jtanalp@yahoo.com
CR American Dental Association, 1984, J AM DENT ASSOC, V108, P108
   [Anonymous], 2001, 6876 ISO
   Bortoluzzi EA, 2009, ORAL SURG ORAL MED O, V108, P628, DOI 10.1016/j.tripleo.2009.04.044
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2012, INT ENDOD J, V45, P737, DOI 10.1111/j.1365-2591.2012.02027.x
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Cavenago B. C., 2013, INT ENDODONTIC J
   Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018
   Cutajar A, 2011, DENT MATER, V27, P879, DOI 10.1016/j.dental.2011.04.012
   Dammaschke T., 2012, SEPTODONT CASE STUDI
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Grech L, 2013, INT ENDOD J, V46, P632, DOI 10.1111/iej.12039
   Islam I, 2006, J ENDODONT, V32, P193, DOI 10.1016/j.joen.2005.10.043
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Koubi G, 2013, CLIN ORAL INVEST, V17, P243, DOI 10.1007/s00784-012-0701-9
   Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x
   Laurent P, 2008, DENT MATER, V24, P1486, DOI 10.1016/j.dental.2008.02.020
   Min KS, 2007, J ENDODONT, V33, P1342, DOI 10.1016/j.joen.2007.07.012
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X
   Tagger M, 2004, INT ENDOD J, V37, P260, DOI 10.1111/j.0143-2885.2004.00787.x
   Tagger M, 2003, J ENDODONT, V29, P751, DOI 10.1097/00004770-200311000-00016
   Tanomaru M, 2008, J APPL ORAL SCI, V16, P376, DOI 10.1590/S1678-77572008000600004
   Torabinejad M, 1996, ENDOD DENT TRAUMATOL, V12, P161
   Vivan RR, 2009, ORAL SURG ORAL MED O, V108, pE35, DOI 10.1016/j.tripleo.2009.07.037
   Yilmaz HG, 2010, J ENDODONT, V36, P160, DOI 10.1016/j.joen.2009.07.002
NR 26
TC 6
Z9 6
U1 1
U2 8
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2013
AR 594950
DI 10.1155/2013/594950
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 246CL
UT WOS:000326514400001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Uliniuc, A
   Hamaide, T
   Popa, M
   Bacaita, S
AF Uliniuc, A.
   Hamaide, T.
   Popa, M.
   Bacaita, S.
TI Modified Starch-Based Hydrogels Cross-Linked with Citric Acid and their
   use as Drug Delivery Systems for Levofloxacin
SO SOFT MATERIALS
LA English
DT Article
DE Biomaterial; Citric acid; Hydrogel; Starch
ID LINKING; RELEASE; MODELS; FILMS
AB New amphiphilic starch-polyester graft copolymer and chemically modified starch with fatty acid chains were synthesized and then cross-linked with a nontoxic agent, citric acid, in order to obtain hydrogels with a controlled hydrophilicity. They present well-defined pores, a controlled water retention degree and different time ranges for releasing the drug, depending on the synthesis parameters. The new hydrogels may be used in the biomaterials field as matrices for delivering biologically active agents, for coating a surface or a synthetic implant.
C1 [Uliniuc, A.; Popa, M.; Bacaita, S.] Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Iasi 700050, Romania.
   [Uliniuc, A.; Hamaide, T.] Univ Lyon 1, UMR Villeurbanne, F-69622 Villeurbanne, France.
RP Popa, M (reprint author), Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, 73 Prof Dr Docent Dimitrie Mangeron St, Iasi 700050, Romania.
EM marpopa@tuiasi.ro
RI Bacaita, Elena Simona/K-5583-2014
OI Bacaita, Elena Simona/0000-0001-8063-596X
FU BRAIN "Doctoral scholarships as an investment in intelligence" project;
   project PERFORM-ERA "Postdoctoral Performance for Integration in the
   European Research Area" [ID-57649]; European Social Found; Romanian
   Government
FX This paper was realized with the support of BRAIN "Doctoral scholarships
   as an investment in intelligence" project and by the project PERFORM-ERA
   "Postdoctoral Performance for Integration in the European Research Area"
   (ID-57649), financed by the European Social Found and Romanian
   Government.
CR Bengtsson M, 2003, CARBOHYD POLYM, V54, P1, DOI 10.1016/S0144-8617(03)00121-8
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Coma V, 2003, CARBOHYD POLYM, V51, P265, DOI 10.1016/S0144-8617(02)00191-1
   Dash S, 2010, ACTA POL PHARM, V67, P217
   Demitri C, 2008, J APPL POLYM SCI, V110, P2453, DOI 10.1002/app.28660
   Despot R, 2008, DRVNA IND, V59, P55
   Dubois P, 1999, POLYMER, V40, P3091, DOI 10.1016/S0032-3861(98)00110-4
   Gawish SM, 2009, POLYM-PLAST TECHNOL, V48, P701, DOI 10.1080/03602550902824572
   Guimaraes LF, 2010, ORAL SURG ORAL MED O, V110, P665, DOI 10.1016/j.tripleo.2010.07.003
   Gyawali D, 2010, BIOMATERIALS, V31, P9092, DOI 10.1016/j.biomaterials.2010.08.022
   Ho, 2006, J HAZARDOUS MAT, V136, P681
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215
   Lu D. R., 2009, EXPRESS POLYM LETT, V3, P66
   McDonald PF, 2010, J MATER SCI, V45, P1284, DOI 10.1007/s10853-009-4080-9
   Meseguer-Duenas JM, 2011, J MATER SCI-MATER M, V22, P11, DOI 10.1007/s10856-010-4182-6
   Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082
   Oral E, 2007, NUCL INSTRUM METH B, V265, P18, DOI 10.1016/j.nimb.2007.08.022
   Reddy N, 2010, FOOD CHEM, V118, P702, DOI 10.1016/j.foodchem.2009.05.050
   Saito Y, 2005, TOXICOLOGY, V210, P235, DOI 10.1016/j.tox.2005.02.006
   Sebti I, 2003, J AGR FOOD CHEM, V51, P6468, DOI 10.1021/jf0302613
   Xie XJ, 2004, STARCH-STARKE, V56, P364, DOI 10.1002/star.200300261
   ZHOU YJ, 1995, J APPL POLYM SCI, V58, P1523, DOI 10.1002/app.1995.070580915
NR 23
TC 12
Z9 12
U1 2
U2 29
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1539-445X
EI 1539-4468
J9 SOFT MATER
JI Soft Mater.
PD JAN 1
PY 2013
VL 11
IS 4
BP 483
EP 493
DI 10.1080/1539445X.2012.710698
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 248PJ
UT WOS:000326713300013
DA 2018-10-20
ER

PT B
AU Bonabi, A
   Aydogan, DB
   Hyttinen, J
AF Bonabi, Ashkan
   Aydogan, Dogu Baran
   Hyttinen, Jari
BE AlDabass, D
   Orsoni, A
   Yunus, J
   Cant, R
   Ibrahim, Z
TI Simulation of Microporous Architecture's Effects on Fluid Flow
   Characteristics in Cell Seeding
SO UKSIM-AMSS 15TH INTERNATIONAL CONFERENCE ON COMPUTER MODELLING AND
   SIMULATION (UKSIM 2013)
LA English
DT Proceedings Paper
CT UKSim-AMSS 15th International Conference on Computer Modelling and
   Simulation (UKSim)
CY APR 10-12, 2013
CL Emmanuel Coll, Cambridge, ENGLAND
SP UK Simulat Soc, Asia Modelling & Simulat Soc, IEEE Comp Soc (UK & RI), IEEE Reg 8, IEEE, European Federat Simulat Soc, European Council Modelling & Simulat, Kingston Univ, Imperial Coll, Machine Intelligence Res Labs, Norwegian Univ Sci & Technol, Nottingham Trent Univ, Univ Technol Malaysia, Univ Sci Malaysia, Univ Malaysia Sabah, Univ Technol Mara, Univ Malaysia Perlis, Univ Malaysia Pahang, IEEE Reg 10, Kasetsart Univ, Inst Teknologi Bandung, IEEE UK & RI
HO Emmanuel Coll
DE components; Tissue Engineering; Finite Volume Method; Computational
   Fluid Dynamic; Modeling
AB Microscaffolds play a crucial role in cell culturing. They can be designed and produced in different ways depending on the applications and materials used. The cell medium (fluid) transports the cells into the microscaffold and is an effective factor for cell growth and stimulation. The architecture of microscaffolds influences fluid flow characteristics such as velocity and shear stress during cell seeding. Shear stress is known to stimulate the cells in scaffolds. Therefore, it is interesting for biomaterial researchers and scaffold designers, to understand how the shape and porosity of the microscaffold influences the dynamics of fluid flows. In this work, we modeled the flow in three-dimensional rectangular, cylindrical, and spherical micropore networks with various porosities. The velocity distribution and mean wall shear stress are computed and compared for a single-phase flow. It is noted that grid independency is achieved when any further increase in the number of cells did not adversely affect the simulation results. Results show that spherical micropores with porosity higher than 80% are suitable for those types of cells that must be stimulated with low shear stress. In contrast, rectangular and cylindrical micropore networks can be used for cells that should be stimulated with high shear stress.
C1 [Bonabi, Ashkan] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.
   BioMediTech, Tampere, Finland.
RP Bonabi, A (reprint author), Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.
EM ashkan.bonabi@tut.fi; baran.aydogan@tut.fi; jari.hyttinen@tut.fi
RI Hyttinen, Jari/G-4280-2014
OI Hyttinen, Jari/0000-0003-1850-3055
FU Characterization and modeling of 3D-microstructures (MIKAMA); Finnish
   Funding Agency for Technology and Innovation (TEKES)
FX This work was supported through the in Characterization and modeling of
   3D-microstructures (MIKAMA) project, which is funded by the Finnish
   Funding Agency for Technology and Innovation (TEKES).
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   [Anonymous], 1981, LOW REYNOLDS NUMBER
   Batchelor GK, 2000, INTRO FLUID MECH
   Czernuszka, 2007, CHEM ENG RES DESIGN, V85
   Hollister SJ, 2002, BIOMATERIALS, V23
   Kapyla Elli, 2012, J MICROMECHANICS MIC, V22
   Kirby B.J., 2010, MICRO NANOSCALE FLUI
   Kushaari K., INT C COMP MOD SIM U
   Leal L.G., 2007, ADV TRANSPORT PHENOM, P3
   Lina Cheng Yu, 2004, J BIOMECHANICS, V37
   Melchels FPW, 2011, BIOMATERIALS, V32, P2878, DOI 10.1016/j.biomaterials.2011.01.023
   Melchels Ferry P.W., 2010, ACTA BIOMATERIALIA, V6
   Narayana Tejaswini, 2010, SIMULATION CELL SEED
   Olivares Andy L., 2009, BIOMATERIAL, V30
   Park Joong Yull, 2010, BIORHEOLOGY, V47, P165
   Sadir Sahba, 2011, MODELING BIOSCAFFOLD
   Sandino C., 2008, J BIOMECHANICS, V41
   Schaffer S, 2011, U CALSCAFFOLD MAT HE
   Voronov Roman, 2010, J BIOMECHANICS, V43
NR 19
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-0-7695-4994-1; 978-1-4673-6421-8
PY 2013
BP 84
EP 89
DI 10.1109/UKSim.2013.116
PG 6
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BHD63
UT WOS:000325091800015
DA 2018-10-20
ER

PT S
AU Baheti, V
   Padil, VVT
   Militky, J
   Cernik, M
AF Baheti, Vijay
   Padil, Vinod Vellora Thekkae
   Militky, Jiri
   Cernik, Miroslav
BE Li, Y
   Yao, M
   Gao, Y
   Li, JS
TI Study of Jute Nanofiber as a Natural Biosorbent for Efficient
   Remediation of Hg2+ Ion from Aqueous Environment
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT 6th Textile Bioengineering and Informatics Symposium (TBIS 2013)
CY SEP 26-28, 2013
CL Xian Polytechn Univ, Xian, PEOPLES R CHINA
SP SDL Atlas Ltd, Shenzhen Huijie Grp Co Ltd, Natl Bridge Ind SZ Co Ltd, Hong Kong Res Inst Text & Apparel, Text Biofunct Mat Ind Technol Innovat Union, Hong Kong Polytechn Univ, Xian Polytecn Univ, Academician Res Base New Text Mat, Guangdong Hong Kong Int Text Bioengineer Joint Res Ctr, Key Lab Funct Text Mat & Prod, Key Lab Shaanxi Prov Funct Fabr, Shaanxi Res Ctr Garment Engn Technol, Shaanxi Res Ctr Automat Text Print & Dye, Shaanxi Res Ctr Ind Engn Technol, Sci & Technol Innovat Project 13115, Shaanxi Res Ctr Text Measurement & Control Engn Technol, Sci & Technol Innovat Project 13115, Shaanxi Univ Res Ctr Philosophy & Social Sci, Key Res Base Text Econ Management, Shaanxi Res Ctr Smart Grid Power Transformer, Online Monitor & Fault Diag Technol
HO Xian Polytechn Univ
DE Jute Nanofibers; Hg Biosorption; Adsorption Kinetics
AB The biosorption characteristics of mercury ions from aqueous solution using jute nanofibers, cellulose-based natural fibers, were explored as a function of pH, nanofiber concentration, contact time and temperature. Jute nanofibers were assessed by various spectroscopy and microscopy techniques. The maximum biosorption capacity of the fiber calculated by the Langmuir model was found to be 85.5 mg g(-1). The adsorption experiments revealed that ion-exchange and complexation play a principal role in the biosorption process. The present experimental evidence implies that jute nanofibers could be a potential natural biomaterial for the removal of environmental contaminations from textile and chemical industries.
C1 [Baheti, Vijay; Militky, Jiri] Tech Univ Liberec, Liberec 46117, Czech Republic.
RP Baheti, V (reprint author), Tech Univ Liberec, Studentska 1402-2, Liberec 46117, Czech Republic.
EM vijaykumar.baheti@gmail.com
RI Militky, Jiri/N-2135-2015; Cernik, Miroslav/B-4390-2013; Baheti,
   Vijay/N-2953-2015
OI Cernik, Miroslav/0000-0002-7554-020X; Baheti, Vijay/0000-0003-2284-0900
CR Basu G, 2009, IND CROP PROD, V29, P281, DOI 10.1016/j.indcrop.2008.05.008
   Ray D, 2002, J APPL POLYM SCI, V85, P2594, DOI 10.1002/app.10934
   Shukla S, 2005, J CHEM TECHNOL BIOT, V80, P176, DOI 10.1002/jctb.1176
   Statistics FAO, 2005, JUT KEN SIS AB COIR, P20
NR 4
TC 0
Z9 0
U1 0
U2 4
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2013
BP 161
EP 165
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Textiles
SC Materials Science
GA BHM36
UT WOS:000325906000025
DA 2018-10-20
ER

PT S
AU Zhang, ZQ
   Zhang, C
   Lei, H
   Zhao, LL
   Yang, RH
   Shuai, C
   Chen, JC
   Qu, P
AF Zhang, Zhongqing
   Zhang, Chi
   Lei, Hong
   Zhao, Lingling
   Yang, Ruihuan
   Shuai, Chuang
   Chen, Jichao
   Qu, Peng
BE Zeng, JM
   Zhu, HX
   Kong, JY
TI A Novel Biomaterial from Acrylamide Graft on NaOH-Urea Modified Rice
   Husk
SO ADVANCES IN CHEMICAL, MATERIAL AND METALLURGICAL ENGINEERING, PTS 1-5
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Chemical, Material and Metallurgical
   Engineering (ICCMME 2012)
CY DEC 15-16, 2012
CL Kunming, PEOPLES R CHINA
SP Wuhan Univ Sci & Technol, Auckland Univ Technol, Guangxi Univ
DE Rice husk; NaOH/Urea; Graft; Acrylamide
ID AQUEOUS-SOLUTIONS; CELLULOSE; ACID; DISSOLUTION; ADSORPTION; REMOVAL
AB Rice husk is a plentiful agricultural byproduct. In this paper, rice husk (RH) surface was first treated by NaOH/urea into a modified-rice husk(MRH), then the MRH was used as a new template for polymerization of acrylamide(AM) on MRH, as a result, the product named as MRH-g-AM, was formed by the free-radical initiation in aqueous solution using ammonium persulfate as an initiator. The polymer grafted on the MRH was considered as a novel copolymer which was thereafter analyzed by FTIR and SEM. The product was washed thoroughly with distilled water to remove all unreactive chemicals. The results showed that MRH was successfully reacted with AM. The SEM images indicated that MRH-g-AM appeared distinct cracks and formed a loosen structure in comparison with RH, indicating the facilitation of heavy metal ion adsorption in the future wastewater treatment.
C1 [Zhang, Zhongqing; Zhang, Chi; Lei, Hong; Zhao, Lingling; Yang, Ruihuan; Shuai, Chuang; Chen, Jichao; Qu, Peng] Minist Educ, Engn Res Ctr Biomass Mat, Beijing, Peoples R China.
RP Zhang, ZQ (reprint author), Minist Educ, Engn Res Ctr Biomass Mat, Beijing, Peoples R China.
EM zzqswust@163.com; zcbomac@gmail.com; leihong@swust.eud.cn;
   zhaolingling01@126.com; 15138714467@163.com; gameboy1226@126.com;
   18084880682@189.cn; qupeng20062008@sina.com
OI Lei, Hong/0000-0001-5640-2111
CR Adam F, 2012, CATAL TODAY, V190, P2, DOI 10.1016/j.cattod.2012.04.056
   Cai J, 2005, MACROMOL BIOSCI, V5, P539, DOI 10.1002/mabi.200400222
   Chakraborty S, 2011, CARBOHYD POLYM, V86, P1533, DOI 10.1016/j.carbpol.2011.06.058
   Daifullah AAM, 2004, CHEM ENG PROCESS, V43, P193, DOI 10.1016/S0255-2701(03)00014-X
   Hsu ST, 2007, BIORESOURCE TECHNOL, V98, P3617, DOI 10.1016/j.biortech.2006.11.060
   Morsi SM, 2011, J COLLOID INTERF SCI, V360, P377, DOI 10.1016/j.jcis.2011.04.065
   [邵强 SHAO Qiang], 2007, [化工进展, Chemical Industry and Engineering Progress], V26, P1201
   Wong KK, 2003, CHEMOSPHERE, V50, P23, DOI 10.1016/S0045-6535(02)00598-2
   Yang F, 2009, CARBOHYD POLYM, V78, P95, DOI 10.1016/j.carbpol.2009.04.004
   Ye HP, 2010, BIORESOURCE TECHNOL, V101, P5175, DOI 10.1016/j.biortech.2010.02.027
   Zhang SA, 2010, CARBOHYD POLYM, V81, P668, DOI 10.1016/j.carbpol.2010.03.029
NR 11
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-589-8
J9 ADV MATER RES-SWITZ
PY 2013
VL 634-638
BP 879
EP 882
DI 10.4028/www.scientific.net/AMR.634-638.879
PG 4
WC Engineering, Chemical; Materials Science, Multidisciplinary; Metallurgy
   & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA BGD41
UT WOS:000322420400172
DA 2018-10-20
ER

PT J
AU Hyland, LL
   Taraban, MB
   Yu, YB
AF Hyland, Laura L.
   Taraban, Marc B.
   Yu, Y. Bruce
TI Using small-angle scattering techniques to understand mechanical
   properties of biopolymer-based biomaterials
SO SOFT MATTER
LA English
DT Review
ID X-RAY-SCATTERING; ASSEMBLING PEPTIDE SCAFFOLDS;
   FIBROBLAST-GROWTH-FACTOR; CROSS-LINKED GEL; NEUTRON-SCATTERING;
   CHONDROITIN SULFATE; CONTROLLED-RELEASE; CELLULOSE BIOSYNTHESIS;
   OLIGOPEPTIDE HYDROGELS; NANOSCALE STRUCTURES
AB The design and engineering of innovative biopolymer-based biomaterials for a variety of biomedical applications should be based on the understanding of the relationship between their nanoscale structure and mechanical properties. Down the road, such understanding could be fundamental to tune the properties of engineered tissues, extracellular matrices for cell delivery and proliferation/differentiation, etc. In this tutorial review, we attempt to show in what way biomaterial structural data can aid in the understanding of bulk material properties. We begin with some background on common types of biopolymers used in biomaterials research, discuss some typical mechanical testing techniques and then review how others in the field of biomaterials have utilized small-angle scattering for material characterization. Detailed examples are then used to show the full range of possible characterization techniques available for biopolymer-based biomaterials. Future developments in the area of material characterization by small-angle scattering will undoubtedly facilitate the use of structural data to control the kinetics of assembly and final properties of prospective biomaterials.
C1 [Hyland, Laura L.; Taraban, Marc B.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Taraban, Marc B.; Yu, Y. Bruce] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD USA.
RP Yu, YB (reprint author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD USA.
EM byu@rx.umaryland.edu
FU NIH [EB004416]; U.S. DOE [DE-AC02-06CH11357]; program of General User
   Proposals [GUP-24524]; National Science Foundation [DMR-0944772]
FX Our work on biomaterials has been supported by the NIH under grant
   EB004416. Use of the Advanced Photon Source, an Office of Science User
   Facility operated for the U.S. Department of Energy (DOE) Office of
   Science by Argonne National Laboratory, was supported by the U.S. DOE
   under Contract no. DE-AC02-06CH11357. Beamtime was awarded through the
   program of General User Proposals to GUP-24524. SANS experiments at NIST
   NCNR were based upon activities supported in part by the National
   Science Foundation under Agreement no. DMR-0944772. The writing of this
   manuscript was supported in part by EB012003.
CR Barron LD, 2008, SPACE SCI REV, V135, P187, DOI 10.1007/s11214-007-9254-7
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berg J. M., 2012, BIOCHEMISTRY-US, P338
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877
   Brown RM, 1996, TRENDS PLANT SCI, V1, P149
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Caputo FE, 2001, MACROMOLECULES, V34, P6684, DOI 10.1021/ma0107556
   Chinen N, 2003, J BIOMED MATER RES A, V67A, P61, DOI 10.1002/jbm.a.10061
   Choudhary S, 2012, CARBOHYD POLYM, V87, P524, DOI 10.1016/j.carbpol.2011.08.025
   Clasen C, 2001, PROG POLYM SCI, V26, P1839, DOI 10.1016/S0079-6700(01)00024-7
   deGennes PG, 1979, SCALING CONCEPTS POL
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Dykes LMC, 2010, POLYMER, V51, P4916, DOI 10.1016/j.polymer.2010.08.013
   Egelhaaf SU, 1999, PHYS REV LETT, V82, P2804, DOI 10.1103/PhysRevLett.82.2804
   Feigin L. A., 1987, STRUCTURE ANAL SMALL
   Feng Y, 2011, CHEM COMMUN, V47, P10455, DOI 10.1039/c1cc13943f
   Feuz L, 2007, EUR PHYS J E, V23, P237, DOI 10.1140/epje/i2007-10180-9
   Fratzl P, 2003, J APPL CRYSTALLOGR, V36, P397, DOI 10.1107/S0021889803000335
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gamini A, 2002, BIOMATERIALS, V23, P1161, DOI 10.1016/S0142-9612(01)00231-9
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Glatter O., 1982, SMALL ANGLE SCATTERI
   Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623
   Guerra Giulio D., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/303708
   Guilbaud JB, 2011, CHEM SOC REV, V40, P1200, DOI 10.1039/c0cs00105h
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hule RA, 2009, MACROMOLECULES, V42, P7137, DOI 10.1021/ma9003242
   Hyland LL, 2013, BIOMACROMOLECULES, V14, P406, DOI 10.1021/bm301598g
   Hyland LL, 2012, BIOPOLYMERS, V97, P177, DOI 10.1002/bip.21722
   Hyland LL, 2011, BIOPOLYMERS, V95, P840, DOI 10.1002/bip.21687
   Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222
   Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351
   Kadajji VG, 2011, POLYMERS-BASEL, V3, P1972, DOI 10.3390/polym3041972
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   Lapasin R., 1995, RHEOLOGY IND POLYSAC
   Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liao SW, 2009, J AM CHEM SOC, V131, P17638, DOI 10.1021/ja907097t
   Lippiello L, 2003, OSTEOARTHR CARTILAGE, V11, P335, DOI 10.1016/S1063-4584(03)00026-8
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Luk A, 2012, ACTA BIOMATER, V8, P1459, DOI 10.1016/j.actbio.2011.12.026
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Markarian MZ, 2012, MACROMOLECULES, V45, P1016, DOI 10.1021/ma2022666
   Mezger T. G, 2006, RHEOLOGY HDB USERS R
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nakamura S, 2006, J BIOMED MATER RES A, V78A, P364, DOI 10.1002/jbm.a.30688
   Newbloom GM, 2012, SOFT MATTER, V8, P8854, DOI 10.1039/c2sm26114f
   Nishinari K, 2003, CURR OPIN COLLOID IN, V8, P396, DOI 10.1016/S1359-0294(03)00099-2
   Nishinari K., 2005, J BIOL MACROMOL, V5, P47
   Pedersen JS, 1996, MACROMOLECULES, V29, P7602, DOI 10.1021/ma9607630
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pujari S, 2011, RHEOL ACTA, V50, P3, DOI 10.1007/s00397-010-0492-3
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ramachandran S, 2006, CHEM MATER, V18, P6157, DOI [10.1021/cm061071l, 10.1021/cm0610711]
   Rendon S, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3108531
   ROSSMURPHY SB, 1993, BIORHEOLOGY, V30, P217
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shinohara Y, 2006, MACROMOLECULES, V39, P7386, DOI 10.1021/ma061037s
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simis KS, 2006, BIOMATERIALS, V27, P1688, DOI 10.1016/j.biomaterials.2005.09.033
   Spinozzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049644
   Spinozzi F, 2012, BIOPHYS J, V103, P511, DOI 10.1016/j.bpj.2012.06.037
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05
   Tada T, 1999, CARBOHYD POLYM, V39, P53, DOI 10.1016/S0144-8617(98)00157-X
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.3.CO;2-E
   Taraban MB, 2012, CHEM MATER, V24, P2299, DOI 10.1021/cm300422q
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vacanti JP, 1999, LANCET, V354, pSI32
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang JY, 2002, P NATL ACAD SCI USA, V99, P14362, DOI 10.1073/pnas.222536599
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Weigandt KM, 2011, SOFT MATTER, V7, P9992, DOI 10.1039/c1sm06176c
   Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105
   Wilson KS, 2007, J BIOMED MATER RES A, V81A, P113, DOI 10.1002/jbm.a.30975
   Yamada Y, 2012, BIOMATERIALS, V33, P4118, DOI 10.1016/j.biomaterials.2012.02.044
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu B.Y, 2005, CHEM MATER, V17, P6583
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
NR 107
TC 4
Z9 4
U1 2
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 43
BP 10218
EP 10228
DI 10.1039/c3sm51209f
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 238ZD
UT WOS:000325990000001
PM 24273590
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Yamada, N
   Wada, M
   Kabir, MH
   Gong, J
   Furukawa, H
AF Yamada, Naoya
   Wada, Masato
   Kabir, M. Hasnat
   Gong, Jin
   Furukawa, Hidemitsu
BE Goulbourne, NC
   Naguib, HE
TI Observation instrument of dynamic friction interface of gel engineering
   materials with polarized optical microscopic
SO BEHAVIOR AND MECHANICS OF MULTIFUNCTIONAL MATERIALS AND COMPOSITES 2013
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Behavior and Mechanics of Multifunctional Materials and
   Composites
CY MAR 10-14, 2013
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers
DE Gel; friction coefficient; interface of friction; direct observation
ID HYDROGELS
AB Gels are soft and wet materials that differ from hard and dry materials like metals, plastics and ceramics. They have some unique characteristic such as low frictional properties, high water content and materials permeability. A decade earlier, DN gels having a mechanical strength of 30MPa of the maximum breaking stress in compression was developed and it is a prospective material as the biomaterial of the human body. Indeed it frictional coefficient and mechanical strength are comparable to our cartilages. In this study, we focus on the dynamic frictional interface of hydrogels and aim to develop a new apparatus with a polarization microscope for observation. The dynamical interface is observed by the friction of gel and glass with hudroxypropylcellulose (HPC) polymer solution sandwiching. At the beginning, we rubbed hydrogel and glass with HPC solution sandwiching on stage of polarization microscope. Second step, we designed a new system which combined microscope with friction measuring machine. The comparison between direct observation with this instrument and measurement of friction coefficient will become a foothold to elucidate distinctive frictional phenomena that can be seen in soft and wet materials.
C1 [Yamada, Naoya; Wada, Masato; Kabir, M. Hasnat; Gong, Jin; Furukawa, Hidemitsu] Yamagata Univ, Grad Sch Sci & Engn, Dept Mech Syst Engn, Soft & Wet Matter Engn Lab SWEL, Yonezawa, Yamagata 9998510, Japan.
RP Yamada, N (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Mech Syst Engn, Soft & Wet Matter Engn Lab SWEL, 4-3-16 Jonan, Yonezawa, Yamagata 9998510, Japan.
EM furukawa@yz.yamagata-u.ac.jp
CR Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hidema Ruri, 2011, Journal of Solid Mechanics and Materials Engineering, V5, P838, DOI 10.1299/jmmp.5.838
   Kamada K, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/28/284107
   Wada M., 2013, J SOLID MECH MAT ENG, V7
NR 5
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9472-6
J9 PROC SPIE
PY 2013
VL 8689
AR 86890I
DI 10.1117/12.2009204
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Composites;
   Optics
SC Materials Science; Optics
GA BGK42
UT WOS:000323320000014
DA 2018-10-20
ER

PT J
AU Shida, T
   Koseki, H
   Yoda, I
   Horiuchi, H
   Sakoda, H
   Osaki, M
AF Shida, Takayuki
   Koseki, Hironobu
   Yoda, Itaru
   Horiuchi, Hidehiko
   Sakoda, Hideyuki
   Osaki, Makoto
TI A dherence ability of Staphylococcus epidermidis on prosthetic
   biomaterials: an in vitro study
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE bacterial adhesion; implant; infection; surface character
ID OF-THE-LITERATURE; BACTERIAL ADHESION; SURFACE-ROUGHNESS; BIOFILM
   FORMATION; SUBGINGIVAL PLAQUE; INFECTION; IMPLANTS; VIVO; SUPRAGINGIVAL;
   ARTHROPLASTY
AB Bacterial adhesion to the surface of biomaterials is an essential step in the -pathogenesis of implant-related infections. In this in vitro research, we evaluated the ability of -Staphylococcus epidermidis to adhere to the surface of solid biomaterials, including oxidized zirconium-niobium alloy (Oxinium), cobalt-chromium-molybdenum alloy, titanium alloy, commercially pure titanium, and stainless steel, and performed a biomaterial-to-biomaterial comparison. The test specimens were physically analyzed to quantitatively determine the viable adherent density of the S. epidermidis strain RP62A (American Type Culture Collection [ ATCC] 35984). Field emission scanning electron microscope and laser microscope examination revealed a featureless, smooth surface in all specimens (average roughness,10 nm). The amounts of S. epidermidis that adhered to the biomaterial were significantly lower for Oxinium and the cobaltchromium- molybdenum alloy than for commercially pure titanium. These results suggest that Oxinium and cobalt-chromium-molybdenum alloy are less susceptible to bacterial adherence and are less inclined to infection than other materials of a similar degree of smoothness.
C1 [Shida, Takayuki; Koseki, Hironobu; Yoda, Itaru; Horiuchi, Hidehiko; Osaki, Makoto] Nagasaki Univ, Grad Sch Med, Dept Orthoped Surg, Nagasaki 8528501, Japan.
   [Sakoda, Hideyuki] Natl Inst Hlth Sci, Div Med Devices, Tokyo, Japan.
RP Koseki, H (reprint author), Nagasaki Univ, Grad Sch Med, Dept Orthoped Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM koseki@nagasaki-u.ac.jp
FU Japan Society for the Promotion of Science (JSPS); KAKENHI [24592236]
FX The authors gratefully acknowledge Smith and Nephew Richards Ltd
   (Cirencester, UK) for kindly contributing the test components. This work
   was partially supported by the Japan Society for the Promotion of
   Science (JSPS) KAKENHI, grant number 24592236.
CR Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Busscher H J, 1997, Adv Dent Res, V11, P24
   Chu Vivian H, 2005, Am J Med, V118, P1416
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Henriques M, 2004, COLLOID SURFACE B, V33, P235, DOI 10.1016/j.colsurfb.2003.10.012
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   HUNTER G, 2005, J ASTM INT, V2
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004
   Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Steinberg D, 1998, CLIN ORAL IMPLAN RES, V9, P67, DOI 10.1034/j.1600-0501.1998.090201.x
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 38
TC 25
Z9 26
U1 0
U2 13
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 3955
EP 3961
DI 10.2147/IJN.S51994
PG 7
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 232VX
UT WOS:000325523600001
PM 24143100
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wu, L
   Zhu, FF
   Tao, GS
AF Wu, Li
   Zhu, Fufan
   Tao, Guangshi
TI In-Vitro Biocompatibility Evaluation of Collagen-Hyaluronic
   Acid/Bioactive Glass Nanocomposite Scaffold
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE collagen; hyaluronic acid; nano-bioactive glass; composite scaffold;
   biocompatibility
ID EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLDS; CROSS-LINKING; ACID;
   MINERALIZATION; HYDROXYAPATITE; BIOMATERIAL; HYDROGELS; CULTURE; CELLS
AB A nano-structured scaffold was designed for bone repair using collagen, hyaluronic acid (HYA) and nano-bioactive glass (NBaG) as its main components. The collagen-HYA/NBaG scaffold was prepared by using a freeze-drying technique and characterized by scanning electron microscopy (SEM). Osteoblastls were seeded on these scaffolds and their proliferation rate, alkaline phosphatase (ALP) activity and ability to form mineralized bone nodules were compared with those osteoblasts grown on cell culture plastic surfaces. The cross-section morphology shows that the collagen-HYA/NBaG scaffold possessed a three-dimensional (3D) interconnected homogenous porous structure. The results obtained from biological assessment show that this scaffold did not negatively affect osteoblasts proliferation rate and improves osteoblasts function as shown by increasing the ALP activity and calcium deposition and formation of mineralized bone nodules. Therefore, the composite scaffolds could provide a favorable environment for initial cell adhesion, maintained cell viability and cell proliferation, and had good in-vitro biocompatibility.
C1 [Wu, Li; Zhu, Fufan; Tao, Guangshi] Cent S Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Changsha 410011, Hunan, Peoples R China.
   [Wu, Li] Cent S Univ, Affiliated Tumor Hosp, Hunan Prov Tumor Hosp, Dept Gynecol Neoplasm, Changsha 410011, Hunan, Peoples R China.
RP Wu, L (reprint author), Cent S Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Changsha 410011, Hunan, Peoples R China.
EM csuwuli@163.com
CR Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Foppiano S, 2007, ACTA BIOMATER, V3, P765, DOI 10.1016/j.actbio.2007.02.011
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   He ZQ, 2009, POLYM-PLAST TECHNOL, V48, P1020, DOI 10.1080/03602550903092534
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Mozafari M, 2010, APPL SURF SCI, V257, P1740, DOI 10.1016/j.apsusc.2010.09.008
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zhou ZH, 2013, POLYM-PLAST TECHNOL, V52, P45, DOI 10.1080/03602559.2012.718400
   Zhou ZH, 2012, POLYM POLYM COMPOS, V20, P791, DOI 10.1177/096739111202000904
NR 20
TC 5
Z9 5
U1 1
U2 9
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1060-1325
EI 1520-5738
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PD JAN 1
PY 2013
VL 50
IS 11
BP 1121
EP 1125
DI 10.1080/10601325.2013.829360
PG 5
WC Polymer Science
SC Polymer Science
GA 220TY
UT WOS:000324611000004
DA 2018-10-20
ER

PT J
AU Kostina, NY
   Sharifi, S
   Pereira, AD
   Michalek, J
   Grijpma, DW
   Rodriguez-Emmenegger, C
AF Kostina, Nina Yu.
   Sharifi, Shahriar
   Pereira, Andres de los Santos
   Michalek, Jiri
   Grijpma, Dirk W.
   Rodriguez-Emmenegger, Cesar
TI Novel antifouling self-healing poly(carboxybetaine
   methacrylamide-co-HEMA) nanocomposite hydrogels with superior mechanical
   properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ZWITTERIONIC HYDROGELS; BIOMATERIAL SURFACES; BLOOD-PLASMA; ADSORPTION;
   CARBOXYBETAINE; SULFOBETAINE; NETWORK; PROTEIN; ADHESIONS; SCAFFOLDS
AB Novel antifouling highly wettable hydrogels with superior mechanical and self-healing properties are presented. Hydrogels were prepared by UV-initiated copolymerisation of non-fouling zwitterionic carboxybetaine methacrylamide (CBMAA-3) and 2-hydroxyethyl methacrylate (HEMA) in the presence of uniformly dispersed clay nanoparticles (Laponite XLG) in water. The nanoparticles acted as physical cross-linkers resulting in excellent mechanical resistance. The effects of composition such as the amount of nanoclay and the HEMA/CBMAA-3 molar ratio on the physical properties of the nanocomposite hydrogels were investigated. These gels showed outstanding composition- dependent mechanical properties, exhibiting remarkably large elongations at break (>= 1800%) and high strengths and moduli even at higher molar contents of CBMAA-3 and higher degrees of swelling (DS). Furthermore, these hydrogels were able to repair mechanical damage without the use of any healing agent by spontaneous reconstruction of cross-links across a damaged interface.
C1 [Kostina, Nina Yu.; Pereira, Andres de los Santos; Michalek, Jiri; Rodriguez-Emmenegger, Cesar] Acad Sci Czech Republic, Inst Macromol Chem, Vvi, CR-16206 Prague, Czech Republic.
   [Sharifi, Shahriar; Grijpma, Dirk W.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Biomat Sci & Technol, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands.
   [Rodriguez-Emmenegger, Cesar] Univ Republica, Coll Engn, Montevideo 11300, Uruguay.
RP Rodriguez-Emmenegger, C (reprint author), Acad Sci Czech Republic, Inst Macromol Chem, Vvi, Heyrovsky Sq 2, CR-16206 Prague, Czech Republic.
EM rodriguez@imc.cas.cz
RI de los Santos Pereira, Andres/G-5141-2014; Rodriguez-Emmenegger,
   Cesar/A-6387-2016; Michalek, Jiri/D-7251-2013; Rodriguez-Emmenegger,
   Cesar/G-3604-2014
OI de los Santos Pereira, Andres/0000-0002-0138-1357; Rodriguez-Emmenegger,
   Cesar/0000-0003-0745-0840; Rodriguez-Emmenegger,
   Cesar/0000-0003-0745-0840; Sharifi, shahriar/0000-0002-3853-5428
FU KAN [200520804]; Grant Agency of the Czech Republic [13-00939S]; Czech
   Science Foundation (GACR) [P205/12/1702, P106/12/1451, P205-12-1702,
   P205-12-G118, P106-12-451]
FX This work was supported by KAN 200520804, Grant Agency of the Czech
   Republic 13-00939S and by Czech Science Foundation (GACR) under
   Contracts no. P205/12/1702, P106/12/1451, P205-12-1702, P205-12-G118,
   and P106-12-451.
CR Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   BRYNDA E, 1984, J BIOMED MATER RES, V18, P685, DOI 10.1002/jbm.820180609
   Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   Carr LR, 2011, BIOMATERIALS, V32, P961, DOI 10.1016/j.biomaterials.2010.09.067
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Edlund U, 2012, POLYM CHEM-UK, V3, P2920, DOI 10.1039/c2py20421e
   Emmenegger CR, 2009, LANGMUIR, V25, P6328, DOI 10.1021/la900083s
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Haraguchi K, 2006, BIOMACROMOLECULES, V7, P3267, DOI 10.1021/bm060549b
   Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248
   Haraguchi K, 2011, POLYM J, V43, P223, DOI 10.1038/pj.2010.141
   Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hower JC, 2008, J PHYS CHEM B, V113, P197
   HUGLIN MB, 1991, POLYMER, V32, P3354, DOI 10.1016/0032-3861(91)90538-T
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Kostina NY, 2012, BIOMACROMOLECULES, V13, P4164, DOI 10.1021/bm301441x
   Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040
   Kudaibergenov S., 2006, SUPRAMOLECULAR POLYM, P157
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Rodriguez-Emmenegger C., 2011, BIOSENS BIOELECTRON, V26, P4545
   Rodriguez-Emmenegger C., 2011, MACROMOL RAPID COMMU, V32, P958
   Rodriguez-Emmenegger C., 2012, MACROMOL BIOSCI, V12, P1413
   Rodriguez-Emmenegger C., 2009, LANGMUIR, V25, P6328
   Rodriguez-Emmenegger C., 2011, MACROMOL RAPID COMMU, V32, P952
   Rodriguez-Emmenegger C., 2012, MACROMOL BIOSCI, V12, P525
   Rodriguez-Emmenegger C., 2011, BIOMACROMOLECULES, V12, P1058
   Rolando B., 2009, HYDROGELS BIOL PROPE
   Shao Q, 2010, J PHYS CHEM B, V114, P16625, DOI 10.1021/jp107272n
   Studenovska H., 2007, J MATER SCI-MATER M, V19, P615
   Tanaka Y, 2005, PROG POLYM SCI, V30, P1, DOI 10.1016/j.progpolymsci.2004.11.003
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010
   Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zhang Z, 2008, J PHYS CHEM B, V112, P5327, DOI 10.1021/jp710683w
   Zhang Z, 2009, J BIOMAT SCI-POLYM E, V20, P1845, DOI 10.1163/156856208X386444
NR 46
TC 29
Z9 29
U1 3
U2 105
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 41
BP 5644
EP 5650
DI 10.1039/c3tb20704h
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 235ZO
UT WOS:000325762800014
DA 2018-10-20
ER

PT J
AU Zhang, YF
   Wei, LF
   Chang, J
   Miron, RJ
   Shi, B
   Yi, SQ
   Wu, CT
AF Zhang, Yufeng
   Wei, Lingfei
   Chang, Jiang
   Miron, Richard J.
   Shi, Bin
   Yi, Siqi
   Wu, Chengtie
TI Strontium-incorporated mesoporous bioactive glass scaffolds stimulating
   in vitro proliferation and differentiation of bone marrow stromal cells
   and in vivo regeneration of osteoporotic bone defects
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SUBSTITUTED HYDROXYAPATITES; RANELATE TREATMENT;
   GENE-EXPRESSION; DRUG-DELIVERY; RISK; RATS; SR; OSTEOSTIMULATION;
   MINERALIZATION
AB Osteoporosis is one of the most widely occurring bone disorders characterized by low bone mineral density and poor bone strength. Strontium ranelate, as a treatment option, has received significant attention in recent years due to its ability to halt the progress of osteoporosis by simultaneously improving bone formation and reducing bone resorption. Although much emphasis has been given to the treatment of osteoporosis and fracture prevention using pharmacological agents, much less attention has been placed on the repair of critical-sized bone fractures caused by osteoporosis. The aim of the present study was to prepare strontium-incorporated mesoporous bioactive glass (Sr-MBG) scaffolds in order to combine the therapeutic effects of Sr2+ ions on osteoporosis with the bioactivity of MBG to regenerate osteoporotic-related fractures. Prior to animal implantation, the effects of Sr-containing ionic products from Sr-MBG scaffolds on the proliferation and differentiation of bone marrow stromal cells (BMSCs) from osteoporotic bone were investigated in an in vitro culture system. The results showed that Sr-MBG scaffolds significantly increased the proliferation of BMSCs in a concentration dependent manner and were able to stimulate the expression of osteoblast differentiation markers including Alpl, Col1a1, Runx2 and Bglap as assessed by real-time PCR. Critical sized femur defects in ovariectomised rats were created to simulate an osteoporotic phenotype. At time points 2, 4 and 8 weeks post-implantation, the in vivo osteogenetic efficiency was systematically evaluated by mu CT analysis, hematoxylin and eosin staining, and immunohistochemistry (type I collagen). The results showed that the incorporation of Sr into MBG scaffolds significantly stimulated new bone formation in osteoporotic bone defects when compared to MBG scaffolds alone. Furthermore, it was generally found that Sr release in blood was maintained at a very low level and the Sr, Si, Ca and P excretion by urine operated in an a similar manner to blank control animals. Our results suggested that Sr-MBG scaffolds could be a promising biomaterial for regenerating osteoporosis-related fractures by the release of Sr-containing ionic products.
C1 [Zhang, Yufeng; Wei, Lingfei; Miron, Richard J.; Shi, Bin; Yi, Siqi] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China.
   [Zhang, Yufeng; Wei, Lingfei; Miron, Richard J.; Shi, Bin; Yi, Siqi] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Peoples R China.
   [Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhang, YF (reprint author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Peoples R China.
EM zyf@whu.edu.cn; chengtiewu@mail.sic.ac.cn
OI Wei, Lingfei/0000-0001-5035-4817
FU Program for New Century Excellent Talents in University [NCET-11-0414];
   Excellent Youth Foundation of Hubei; Recruitment Program of Global Young
   Talent, China; Shanghai Pujiang Talent Program [12PJ1409500]; Natural
   Science Foundation of China [81271108, 81201202, 31370963, 51061160499]
FX The authors report no conflict of interest for this study. This project
   was supported by Program for New Century Excellent Talents in University
   (NCET-11-0414), Excellent Youth Foundation of Hubei, the Recruitment
   Program of Global Young Talent, China (Dr Wu), Shanghai Pujiang Talent
   Program (12PJ1409500) and Natural Science Foundation of China (Grant
   81271108, 81201202, 31370963, and 51061160499).
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   Blake GM, 2009, J BONE MINER RES, V24, P1354, DOI [10.1359/jbmr.090601, 10.1359/JBMR.090601]
   Boonen S, 2012, J BONE MINER RES, V27, P963, DOI 10.1002/jbmr.1570
   Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020
   Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   da Silva JM, 2011, ORAL SURG ORAL MED O, V111, P260, DOI 10.1016/j.tripleo.2010.08.016
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424
   Gorustovich AA, 2010, J BIOMED MATER RES A, V92A, P232, DOI 10.1002/jbm.a.32355
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/JBMR.080205, 10.1359/jbmr.080205]
   Hulsart-Billstrom G, 2013, J BIOMED MATER RES A, V101, P2322, DOI 10.1002/jbm.a.34526
   Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012
   Jebahi S, 2012, J APPL BIOMED, V10, P195, DOI 10.2478/v10136-012-0009-8
   Jeon O, 2008, TISSUE ENG PT A, V14, P1285, DOI 10.1089/ten.tea.2007.0253
   King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x
   Landi E, 2008, ACTA BIOMATER, V4, P656, DOI 10.1016/j.actbio.2007.10.010
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Mendonca G, 2009, INT J ORAL MAX IMPL, V24, P205
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Moazzaz P, 2005, SPINE, V30, P1706, DOI 10.1097/01.brs.0000172230.01655.55
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   Nardone V, 2012, INT J BIOMATER, V2012
   Ni GX, 2006, BIOMATERIALS, V27, P4348, DOI 10.1016/j.biomaterials.2006.03.048
   Oste L, 2005, KIDNEY INT, V67, P920, DOI 10.1111/j.1523-1755.2005.00156.x
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311
   Peng SL, 2011, J BONE MINER RES, V26, P1272, DOI 10.1002/jbmr.325
   Pouria A, 2012, BIOINORG CHEM APPL, DOI 10.1155/2012/976495
   Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   RODAN GA, 1995, ANN NY ACAD SCI, V760, P1, DOI 10.1111/j.1749-6632.1995.tb44614.x
   Roschger P, 2010, J BONE MINER RES, V25, P891, DOI 10.1359/jbmr.091028
   Roy M, 2012, J BIOMED MATER RES A, V100A, P2450, DOI 10.1002/jbm.a.34181
   Seeman E, 2008, J BONE MINER RES, V23, P433, DOI 10.1359/JBMR.071105
   Teitelbaum SL, 2010, CELL STEM CELL, V7, P553, DOI 10.1016/j.stem.2010.10.004
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2013, J MATER CHEM B, V1, P2710, DOI 10.1039/c3tb20275e
   Wu CT, 2013, J MATER CHEM B, V1, P876, DOI 10.1039/c2tb00391k
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, ACTA BIOMATER, V8, P3805, DOI 10.1016/j.actbio.2012.06.023
   Wu CT, 2012, J MATER CHEM, V22, P16801, DOI 10.1039/c2jm33387b
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhang YF, 2012, BONE, V51, P704, DOI 10.1016/j.bone.2012.06.029
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhao WY, 2007, J MATER SCI-MATER M, V18, P917, DOI 10.1007/s10856-006-0069-y
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 66
TC 38
Z9 39
U1 8
U2 100
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 41
BP 5711
EP 5722
DI 10.1039/c3tb21047b
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA 235ZO
UT WOS:000325762800021
DA 2018-10-20
ER

PT J
AU Pan, W
   Todai, M
   Nakano, T
AF Pan, Wang
   Todai, Mitsuharu
   Nakano, Takayoshi
TI beta-Phase Instability in Binary Ti-xNb Biomaterial Single Crystals
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterials; electrical resistivity; omega-phase; Debye temperature;
   lattice modulation
ID LOW YOUNGS MODULUS; OMEGA-PHASE; TITANIUM-ALLOYS; TINBSN ALLOYS; SN
   CONTENT; NB; ZR; SUPERELASTICITY; MICROSTRUCTURE; TRANSFORMATION
AB The omega-phase transformation and beta-phase stability in Ti-xNb (28 <= x <= 40 at%) single crystals were investigated using electrical resistivity measurements, transmission electron microscopy (TEM) observations, and specific heat measurements. The crystal for x = 28 exhibits distinct anomalous negative temperature dependence of the resistivity coefficient and thermal hysteresis accompanied by the presence of the athermal omega-phase and beta-phase lattice modulation. Although the crystal for x = 30 appears in the beta-phase lattice modulation, it does not exhibit a clear negative temperature dependence of the resistivity coefficient or the athermal omega-phase. The crystal of x = 30 also shows a relatively high absolute value of resistivity at 15 K among the crystals for 28 <= x <= 40 and a low Debye temperature in a normal conductive state. The crystal for x = 30 that shows the lattice modulation, high resistivity, and low beta-phase Debye temperature correspond to the low stability of the beta-phase. Moreover, the stability strongly depends on the Nb content of the binary Ti-Nb crystal.
C1 [Pan, Wang; Todai, Mitsuharu; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
RP Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
EM nakano@mat.eng.osaka-u.ac.jp
OI Wang, Pan/0000-0002-2079-9580
FU "Funding Program for Next Generation World-Leading Researchers" from the
   Ministry of Education, Culture, Sports, Science and Technology, Japan;
   Ministry of Education, Culture, Sports, Science and Technology, Japan
FX This work was supported by the "Funding Program for Next Generation
   World-Leading Researchers" and by a grant-in-aid for scientific research
   and development from the Ministry of Education, Culture, Sports, Science
   and Technology, Japan.
CR Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   AMES SL, 1954, ACTA METALL MATER, V2, P831, DOI 10.1016/0001-6160(54)90036-X
   BISHOFF J, 1982, CRYOGENICS, V22, P131, DOI 10.1016/0011-2275(82)90109-6
   Choi MS, 2005, SCRIPTA MATER, V53, P869, DOI 10.1016/j.scriptamat.2005.05.040
   DEFONTAINE D, 1971, ACTA METALL MATER, V19, P1153, DOI 10.1016/0001-6160(71)90047-2
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hermann R, 2012, SCRIPTA MATER, V66, P198, DOI 10.1016/j.scriptamat.2011.10.039
   HO JC, 1972, PHYS REV B, V6, P3727, DOI 10.1103/PhysRevB.6.3727
   IKEDA M, 1988, J JPN I MET, V52, P1206, DOI 10.2320/jinstmet1952.52.12_1206
   Inamura T, 2005, MATER TRANS, V46, P1597, DOI 10.2320/matertrans.46.1597
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee SH, 2012, J MECH BEHAV BIOMED, V14, P48, DOI 10.1016/j.jmbbm.2012.05.005
   Lee SH, 2012, METALL MATER TRANS A, V43A, P1588, DOI 10.1007/s11661-011-0986-3
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Nakano T, 2012, BONE, V51, P741, DOI 10.1016/j.bone.2012.07.003
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Noyama Y, 2012, MATER TRANS, V53, P565, DOI 10.2320/matertrans.M2011358
   Tahara M, 2011, ACTA MATER, V59, P6208, DOI 10.1016/j.actamat.2011.06.015
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Tane M, 2010, ACTA MATER, V58, P6790, DOI 10.1016/j.actamat.2010.09.007
   Todai M., J ALLOY COM IN PRESS, DOI [org/10.1016/j.jallcom.2012.02.026, DOI 10.1016/J.JALLC0M.2012.02.026]
   Todai M, 2011, SCRIPTA MATER, V64, P541, DOI 10.1016/j.scriptamat.2010.11.039
   Wang BL, 2008, MAT SCI ENG A-STRUCT, V486, P146, DOI 10.1016/j.msea.2007.08.073
   WILLIAMS JC, 1973, METALL TRANS, V4, P2701, DOI 10.1007/BF02644570
   Yamamoto T, 2008, MAT SCI ENG A-STRUCT, V481, P239, DOI 10.1016/j.msea.2006.12.190
   You L, 2012, SCRIPTA MATER, V67, P57, DOI 10.1016/j.scriptamat.2012.03.020
   ZENER C, 1947, PHYS REV, V71, P846, DOI 10.1103/PhysRev.71.846
   Zhang YW, 2011, ACTA MATER, V59, P3081, DOI 10.1016/j.actamat.2011.01.048
NR 33
TC 9
Z9 9
U1 1
U2 14
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2013
VL 54
IS 2
BP 156
EP 160
DI 10.2320/matertrans.MC201202
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 235EZ
UT WOS:000325700600006
OA Bronze
DA 2018-10-20
ER

PT J
AU Yuan, Y
   Zhou, SG
   Yang, GQ
   Yu, Z
AF Yuan, Yong
   Zhou, Shungui
   Yang, Guiqin
   Yu, Zhen
TI Electrochemical biomemory devices based on self-assembled
   graphene-Shewanella oneidensis composite biofilms
SO RSC ADVANCES
LA English
DT Article
ID EXTRACELLULAR ELECTRON-TRANSFER; MICROBIAL FUEL-CELLS;
   GEOBACTER-SULFURREDUCENS; RECOMBINANT AZURIN; STORAGE; BACTERIA; CHARGE;
   OXIDE
AB Interest in biomaterial-combined memory devices is on the rise due to their redox properties and electron transport capacities in nature. However, many attempts have been made to develop the protein-based memory devices. Here, we developed a novel biomemory device that was comprised of living Shewanella oneidensis MR-1 cells and microbially reduced graphene. Charge storage and release properties of the composite biofilm were investigated with electrochemical methods. The results showed the redox behavior of in vivo c-type cytochromes with electrochemically controllable electric states regarded as "write" and "erase" processes. Furthermore, the graphene modified biofilm had significantly improved charge storage and release properties due to the synergetic effects between graphene and the electrochemically active biofilm. The current signal of the biomemory device was two orders higher than those of protein-based biomemory systems. The findings provide a new opportunity for memory design since the composite biofilm can be inexpensively produced and is self-repairable and replicable, which is advantageous to abiological and protein-based biomemory devices.
C1 [Yuan, Yong; Zhou, Shungui; Yang, Guiqin; Yu, Zhen] Guangdong Inst Ecoenvironm & Soil Sci, Guangzhou 510650, Guangdong, Peoples R China.
RP Zhou, SG (reprint author), Guangdong Inst Ecoenvironm & Soil Sci, 808 Tianyuan Rd, Guangzhou 510650, Guangdong, Peoples R China.
EM sgzhou@soil.gd.cn
RI yuan, yong/B-1042-2010
FU National Natural Science Foundation of China [41101211, 21277035,
   21177030]
FX This study was supported jointly by the National Natural Science
   Foundation of China (Nos. 41101211, 21277035 and 21177030)
CR Arugula MA, 2012, CHEM COMMUN, V48, P10174, DOI 10.1039/c2cc35595g
   Biswas S, 2010, CHEM MATER, V22, P5667, DOI 10.1021/cm101132g
   Busalmen JP, 2008, ANGEW CHEM INT EDIT, V47, P4874, DOI 10.1002/anie.200801310
   Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x
   Huang YX, 2011, CHEM COMMUN, V47, P5795, DOI 10.1039/c1cc10159e
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jain A, 2011, ELECTROCHIM ACTA, V56, P10776, DOI 10.1016/j.electacta.2011.02.073
   Katuri KP, 2010, CHEM COMMUN, V46, P4758, DOI 10.1039/c003342a
   Kim SU, 2010, BIOMATERIALS, V31, P1293, DOI 10.1016/j.biomaterials.2009.10.032
   Kim SU, 2009, CURR APPL PHYS, V9, pE71, DOI 10.1016/j.cap.2008.12.033
   Lee B. T., 2010, ADV MATER, V22, P510
   Lee T, 2011, ELECTROANAL, V23, P2023, DOI 10.1002/elan.201100182
   Lee T, 2011, BIOMATERIALS, V32, P3815, DOI 10.1016/j.biomaterials.2011.01.072
   Lee T, 2011, BIOSENS BIOELECTRON, V26, P2304, DOI 10.1016/j.bios.2010.09.057
   Li QL, 2004, APPL PHYS LETT, V85, P1829, DOI 10.1063/1.1782254
   Li ZJ, 2011, CHEM COMMUN, V47, P3060, DOI 10.1039/c0cc05037g
   Malvankar NS, 2012, CHEMPHYSCHEM, V13, P463, DOI 10.1002/cphc.201100865
   Michaela T. A., 2011, ENERG ENVIRON SCI, V4, P4907
   Min J, 2010, BIOTECHNOL BIOPROC E, V15, P30, DOI [10.1007/s12257-009-3074-4, 10.1007/S12257-009-3074-4]
   Schrott GD, 2011, ELECTROCHIM ACTA, V56, P10791, DOI 10.1016/j.electacta.2011.07.001
   Tang LH, 2009, ADV FUNCT MATER, V19, P2782, DOI 10.1002/adfm.200900377
   Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55
   Uria N, 2011, ENVIRON SCI TECHNOL, V45, P10250, DOI 10.1021/es2025214
   Wu WG, 2011, ELECTROCHEM COMMUN, V13, P872, DOI 10.1016/j.elecom.2011.05.025
   Xiao L, 2012, J POWER SOURCES, V208, P187, DOI 10.1016/j.jpowsour.2012.02.036
   Xu GR, 2007, B KOR CHEM SOC, V28, P889
   Yu GH, 2011, NANO LETT, V11, P2905, DOI 10.1021/nl2013828
   Yuan Y, 2012, ELECTROCHEM COMMUN, V18, P62, DOI 10.1016/j.elecom.2012.02.004
   Yuan Y, 2012, BIORESOURCE TECHNOL, V116, P453, DOI 10.1016/j.biortech.2012.03.118
   Zhuang L, 2012, ELECTROCHEM COMMUN, V21, P69, DOI 10.1016/j.elecom.2012.05.010
NR 30
TC 3
Z9 3
U1 2
U2 56
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 41
BP 18844
EP 18848
DI 10.1039/c3ra42850h
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 231HX
UT WOS:000325408300020
DA 2018-10-20
ER

PT J
AU Gardner, AB
   Lee, SKC
   Woods, EC
   Acharya, AP
AF Gardner, Austin B.
   Lee, Simon K. C.
   Woods, Elliot C.
   Acharya, Abhinav P.
TI Biomaterials-Based Modulation of the Immune System
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID DENDRITIC CELLS; DRUG-DELIVERY; SURFACE-TOPOGRAPHY; CYTOSOLIC DELIVERY;
   IN-VIVO; BIOCOMPATIBILITY; VACCINES; MICROPARTICLES; PARTICLES;
   NANOPARTICLES
AB The immune system is traditionally considered from the perspective of defending against bacterial or viral infections. However, foreign materials like implants can also illicit immune responses. These immune responses are mediated by a large number of molecular signals, including cytokines, antibodies and reactive radical species, and cell types, including macrophages, neutrophils, natural killer cells, T-cells, B-cells, and dendritic cells. Most often, these molecular signals lead to the generation of fibrous encapsulation of the biomaterials, thereby shielding the body from these biomaterials. In this review we will focus on two different types of biomaterials: those that actively modulate the immune response, as seen in antigen delivery vehicles for vaccines, and those that illicit relatively small immune response, which are important for implantable materials. The first serves to actively influence the immune response by co-opting certain immune pathways, while the second tries to mimic the properties of the host in an attempt to remain undetected by the immune system. As these are two very different end points, each type of biomaterial has been studied and developed separately and in recent years, many advances have been made in each respective area, which will be highlighted in this review.
C1 [Gardner, Austin B.; Lee, Simon K. C.; Woods, Elliot C.; Acharya, Abhinav P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Acharya, AP (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM acharyaabhinavp@gmail.com
RI Acharya, Abhinav/J-8384-2013
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2013, BIOMATERIALS, V34, P3422, DOI 10.1016/j.biomaterials.2013.01.032
   Acharya AP, 2011, ACTA BIOMATER, V7, P180, DOI 10.1016/j.actbio.2010.08.026
   Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x
   Choe SW, 2010, ACTA BIOMATER, V6, P3491, DOI 10.1016/j.actbio.2010.03.006
   Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128
   Cohen JL, 2008, BIOCONJUGATE CHEM, V19, P876, DOI 10.1021/bc700414j
   Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008
   Cruz LJ, 2011, BIOMATERIALS, V32, P6791, DOI 10.1016/j.biomaterials.2011.04.082
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   Flanary S, 2009, BIOCONJUGATE CHEM, V20, P241, DOI 10.1021/bc800317a
   Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i
   Hu YH, 2009, BIOMACROMOLECULES, V10, P756, DOI 10.1021/bm801199z
   Huang YB, 2000, J CONTROL RELEASE, V65, P63, DOI 10.1016/S0168-3659(99)00233-3
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Paramonov SE, 2008, BIOCONJUGATE CHEM, V19, P911, DOI 10.1021/bc7004472
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Sano A, 1998, ADV DRUG DELIV REV, V31, P247
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Weintraub W. S., 2007, AM J CARDIOL, V100, pS3, DOI DOI 10.1016/J.AMJCARD.2007.06.002
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Yaseen M, 2010, BIOMATERIALS, V31, P3781, DOI 10.1016/j.biomaterials.2010.01.107
NR 41
TC 21
Z9 21
U1 2
U2 33
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 732182
DI 10.1155/2013/732182
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 230SQ
UT WOS:000325363500001
PM 24171170
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Renno, ACM
   Bossini, PS
   Crovace, MC
   Rodrigues, ACM
   Zanotto, ED
   Parizotto, NA
AF Renno, Ana Claudia M.
   Bossini, Paulo Sergio
   Crovace, Murilo C.
   Rodrigues, Ana Candida M.
   Zanotto, Edgar Dutra
   Parizotto, Nivaldo Antonio
TI Characterization and In Vivo Biological Performance of Biosilicate
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID P2O5-NA2O-CAO-SIO2 GLASS-CERAMICS; BIOACTIVE GLASS; BONE REGENERATION;
   VITRO; SUBSTITUTES; SCAFFOLDS; 45S5
AB After an introduction showing the growing interest in glasses and glass-ceramics as biomaterials used for bone healing, we describe a new biomaterial named Biosilicate. Biosilicate is the designation of a group of fully crystallized glass-ceramics of the Na2O-CaO-SiO2-P2O5 system. Several in vitro tests have shown that Biosilicate is a very active biomaterial and that the HCA layer is formed in less than 24 hours of exposure to "simulated body fluid" (SBF) solution. Also, in vitro studies with osteoblastic cells have shown that Biosilicate disks supported significantly larger areas of calcified matrix compared to 45S5 Bioglass, indicating that this bioactive glass-ceramic may promote enhancement of in vitro bone-like tissue formation in osteogenic cell cultures. Finally, due to its special characteristics, Biosilicate has also been successfully tested in several in vivo studies. These studies revealed that the material is biocompatible, presents excellent bioactive properties, and is effective to stimulate the deposition of newly formed bone in animal models. All these data highlight the huge potential of Biosilicate to be used in bone regeneration applications.
C1 [Renno, Ana Claudia M.; Bossini, Paulo Sergio] Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, SP, Brazil.
   [Crovace, Murilo C.; Rodrigues, Ana Candida M.; Zanotto, Edgar Dutra] Univ Fed Sao Carlos, Dept Mat Engn, Vitreous Mat Lab, BR-13565905 Sao Carlos, SP, Brazil.
   [Parizotto, Nivaldo Antonio] Univ Fed Sao Carlos, Dept Physiotherapy, BR-13565905 Sao Carlos, SP, Brazil.
RP Renno, ACM (reprint author), Univ Fed Sao Paulo, Dept Biosci, Ave Ana Costa 95, BR-11060001 Santos, SP, Brazil.
EM acmr_ft@yahoo.com.br
RI CerTEV, CeRTEV/J-6817-2015; Renno, Ana Claudia/C-1266-2015; Zanotto,
   Edgar/A-7992-2011; Parizotto, Nivaldo/D-5347-2014; Bossini,
   Paulo/G-2333-2014
OI Zanotto, Edgar/0000-0003-4931-4505; Parizotto,
   Nivaldo/0000-0003-1774-9053; Crovace, Murilo/0000-0002-6993-6363
CR Azenha Marcelo Rodrigues, 2010, Braz. Dent. J., V21, P383, DOI 10.1590/S0103-64402010000500001
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Martins CHG, 2011, J MATER SCI-MATER M, V22, P1439, DOI 10.1007/s10856-011-4330-7
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2007, ELEMENTS, V3, P393, DOI 10.2113/GSELEMENTS.3.6.393
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Renno ACM, 2010, PHOTOMED LASER SURG, V28, P131, DOI 10.1089/pho.2009.2487
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Peitl O, 2012, ACTA BIOMATER, V8, P321, DOI 10.1016/j.actbio.2011.10.014
   Ravagnani C., 2004, C03C1000 U FED SAO C
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Souza M. T., 2011, THESIS FEDERAL U SAO
   Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zimmermann G, 2007, INJURY, V38, pS33, DOI 10.1016/S0020-1383(07)80007-6
NR 28
TC 16
Z9 16
U1 0
U2 10
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 141427
DI 10.1155/2013/141427
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 230XQ
UT WOS:000325377100001
PM 24205501
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Okabe, T
   Okajima, J
   Komiya, A
   Luo, Y
   Takahashi, I
   Maruyama, S
AF Okabe, Takahiro
   Okajima, Junnosuke
   Komiya, Atsuki
   Luo, Yun
   Takahashi, Ichiro
   Maruyama, Shigenao
TI Inverse Method for Estimating Local Thermal Diffusivity of Biomaterials
SO JOURNAL OF THERMAL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Flow Dynamics
CY SEP 19-21, 2012
CL Sendai, JAPAN
DE Point-Contact Method; Measurement Method; Biomaterial; Real Coded
   Genetic Algorithm; Inverse Problem; Thermophysical Property
ID PERFUSION; TISSUES
AB This paper describes an inverse method for estimating the local thermal diffusivity of biomaterials such as meats and vegetables using a thermophysical handy tester. A thermophysical handy tester is a fast, non-invasive, in-situ, local device for measuring the thermophysical properties of a material. However, it cannot be applied to soft or liquid materials precisely. In this study, an inverse analysis of this device was conducted to make it applicable to the measurement of the thermophysical properties of these materials. In the proposed inverse analysis, a real coded genetic algorithm (GA) was used to minimize the objective function. First, a calibration experiment of the device was conducted by using water to determine the apparatus constant. Then, this inverse method was validated by measuring the thermal diffusivity of some materials such as agar-gelled water, silicone oil, and glycerol. It was found that, the estimated thermal diffusivity shows good agreement with the reference value. Moreover, the thermal diffusivity of various biomaterials such as vegetables and meats was estimated, and reasonable values could be obtained by a proposed method.
C1 [Okabe, Takahiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 980, Japan.
   [Okajima, Junnosuke; Komiya, Atsuki; Maruyama, Shigenao] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 980, Japan.
   [Luo, Yun] Shanghai Jiao Tong Univ, Inst Biomed Mfg & Life Qual Engn, Sch Mech Engn, Shanghai 200240, Peoples R China.
   [Takahashi, Ichiro] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan.
RP Okabe, T (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6 Aoba, Sendai, Miyagi 980, Japan.
EM okabe@pixy.ifs.tohoku.ac.jp
RI Okajima, Junnosuke/G-5959-2015
OI Okajima, Junnosuke/0000-0003-3857-474X
CR Bhattacharya A, 2003, PHYSIOL MEAS, V24, P769, DOI 10.1088/0967-3334/24/3/312
   Gene R., 1936, ANN REPORT DIRECTOR, V5, P211
   Incropera F. P, 2002, FUNDAMENTALS HEAT MA
   Japan Society of Thermophysical Properties, 2008, JAP SOC THERM PROP T, p[314, 519, 585]
   Kato K, 2010, J THERM SCI TECH-JPN, V5, P87, DOI 10.1299/jtst.5.87
   Koshikawa Y, 2006, HEAT TRANSF-ASIAN RE, V35, P421, DOI 10.1002/htj.20124
   Maruyama S., 2011, P 8 INT C FLOW DYN, P534
   Maruyama S, 2011, HEAT TRANSF-ASIAN RE, V40, P114, DOI 10.1002/htj.20334
   Matthews F. V., 1968, T ASAE, V11, P558
   Okabe T., 2012, NETSU BUSSEI, V26, P136
   Okajima J., 2008, P 29 JAP S THERM PRO, P278
   Okajima J, 2010, INT J HEAT FLUID FL, V31, P1012, DOI 10.1016/j.ijheatfluidflow.2010.08.008
   Okajima J, 2009, J THERM BIOL, V34, P377, DOI 10.1016/j.jtherbio.2009.08.001
   Ono I, 2000, COMPUT METHOD APPL M, V186, P483, DOI 10.1016/S0045-7825(99)00398-9
   Ono I., 1999, J JAPANESE SOC ARTIF, V14, P1146
   Patankar S V, 1980, NUMERICAL HEAT TRANS
   Rahman S., 1995, FOOD PROPERTIES HDB
   Sato H., 1997, Journal of Japanese Society for Artificial Intelligence, V12, P734
   Shitzer A., 1985, HEAT TRANSFER MED BI, V2, P414
   Takahashi I., 2003, Heat Transfer-Asian Research, V32, P191, DOI 10.1002/htj.10084
   Takahashi I., 2003, Heat Transfer-Asian Research, V32, P202, DOI 10.1002/htj.10085
   VALVANO JW, 1984, J BIOMECH ENG-T ASME, V106, P187, DOI 10.1115/1.3138481
   Wan KT, 2003, THIN SOLID FILMS, V425, P150, DOI 10.1016/S0040-6090(02)01103-3
   Yue K, 2008, CELL BIOCHEM BIOPHYS, V50, P41, DOI 10.1007/s12013-007-0038-1
NR 24
TC 1
Z9 1
U1 0
U2 17
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG., SHINANOMACHI 35, SHINJUKU-KU, TOKYO,
   160-0016, JAPAN
SN 1880-5566
J9 J THERM SCI TECH-JPN
JI J Therm. Sci. Technol.
PY 2013
VL 8
IS 2
SI SI
BP 395
EP 406
DI 10.1299/jtst.8.395
PG 12
WC Thermodynamics
SC Thermodynamics
GA 225RO
UT WOS:000324980200007
OA Bronze
DA 2018-10-20
ER

PT J
AU Gerullis, H
   Georgas, E
   Eimer, C
   Arndt, C
   Barski, D
   Lammers, B
   Klosterhalfen, B
   Boros, M
   Otto, T
AF Gerullis, Holger
   Georgas, Evangelos
   Eimer, Christoph
   Arndt, Christian
   Barski, Dimitri
   Lammers, Bernhard
   Klosterhalfen, Bernd
   Boros, Mihaly
   Otto, Thomas
TI Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts
   In Vitro: Development Stage of a Surgical Innovation
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID FOREIGN-BODY RESPONSE; POLYPROPYLENE MESH; MECHANICAL-PROPERTIES; HERNIA
   MESHES; REPAIR; MODEL; BIOMATERIAL; ADHESIONS
AB Purpose. To investigate mesh coating modalities with autologous blood components in a recently developed in vitro test system for biocompatibility assessment of alloplastic materials. Materials and Methods. Seven different mesh types, currently used in various indications, were randomly investigated. Meshes were coated prior to cultivation with autologous peripheral blood mononuclear cells (PBMCs), platelets, and blood plasma. Pretreatedmeshes were incubated over 6 weeks in a minced tissue assay, representative for fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. Adherence of those tissues on the meshes was microscopically investigated and semiquantitatively assessed using a previously described scoring system. Results. Coating with peripheral blood mononuclear cells did not affect the adherence score, whereas coating with platelets and blood plasma increased the score suggesting improved biocompatibility in vitro. The previous ranking of native meshes remained consistent after coating. Conclusion. Plasma coating of meshes improves their biocompatibility score in a novel in vitro test system.
C1 [Gerullis, Holger; Georgas, Evangelos; Eimer, Christoph; Arndt, Christian; Barski, Dimitri; Otto, Thomas] Lukas Hosp, Dept Urol, D-41464 Neuss, Germany.
   [Gerullis, Holger; Otto, Thomas] Univ Essen Gesamthsch, West German Canc Ctr WTZ, Essen, Germany.
   [Lammers, Bernhard] Lukas Hosp, Dept Surg, D-41464 Neuss, Germany.
   [Klosterhalfen, Bernd] German Ctr Implant Pathol, Duren, Germany.
   [Boros, Mihaly] Univ Szeged, Dept Expt Surg, Szeged, Hungary.
RP Gerullis, H (reprint author), Lukas Hosp, Dept Urol, Preussenstr 84, D-41464 Neuss, Germany.
EM holger.gerullis@gmx.net
OI Barski, Dimitri/0000-0001-8611-8250
FU DAAD/DFG (German Research Foundation) [ID50753662]
FX This work was supported by the DAAD/DFG (German Research Foundation)
   ID50753662.
CR Afonso JS, 2008, INT UROGYNECOL J, V19, P375, DOI 10.1007/s00192-007-0446-1
   Binnebosel M, 2010, LANGENBECK ARCH SURG, V395, P413, DOI 10.1007/s00423-010-0601-x
   Brandt CJ, 2011, J BIOMED MATER RES A, V99A, P335, DOI 10.1002/jbm.a.33136
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150
   Champault G, 2007, Hernia, V11, P125, DOI 10.1007/s10029-006-0179-y
   Clave A, 2010, INT UROGYNECOL J, V21, P261, DOI 10.1007/s00192-009-1021-8
   Crowley RT, 1941, ANN SURG, V113, P1088, DOI 10.1097/00000658-194106000-00041
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   Emans P, 2009, ANN BIOMED ENG, V37, P410, DOI 10.1007/s10439-008-9608-7
   Fotino M, 1971, Ann Clin Lab Sci, V1, P131
   Gerullis, SURG INNOVA IN PRESS
   Gerullis H., SURG TECHNO IN PRESS
   Junge K, 2005, Hernia, V9, P115, DOI 10.1007/s10029-004-0292-8
   Klinge U, 1999, EUR J SURG, V165, P665
   Klinge U, 2012, HERNIA, V16, P251, DOI 10.1007/s10029-012-0913-6
   Langer C, 2005, CHIRURG, V76, P876, DOI 10.1007/s00104-005-1036-8
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8
   Melman L, 2011, HERNIA, V15, P423, DOI 10.1007/s10029-011-0787-z
   Menchen LC, 2012, CURR UROL REP, V13, P231, DOI 10.1007/s11934-012-0244-2
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
   Schonleben F, 2006, INT J COLORECTAL DIS, V21, P840, DOI 10.1007/s00384-006-0091-z
   Shah Bhavin C, 2009, Am J Surg, V198, P759, DOI 10.1016/j.amjsurg.2009.04.025
   Shin D, 2005, ANN SURG, V241, P553, DOI 10.1097/01.sla.0000157318.13975.2a
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
NR 28
TC 11
Z9 12
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 536814
DI 10.1155/2013/536814
PG 6
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 226FK
UT WOS:000325019800001
PM 24151608
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhao, XY
   Zhu, YJ
   Chen, F
   Lu, BQ
   Qi, C
   Zhao, J
   Wu, J
AF Zhao, Xin-Yu
   Zhu, Ying-Jie
   Chen, Feng
   Lu, Bing-Qiang
   Qi, Chao
   Zhao, Jing
   Wu, Jin
TI Hydrothermal synthesis of hydroxyapatite nanorods and nanowires using
   riboflavin-5 '-phosphate monosodium salt as a new phosphorus source and
   their application in protein adsorption
SO CRYSTENGCOMM
LA English
DT Article
ID DRUG-DELIVERY; CALCIUM ORTHOPHOSPHATES; DOPED HYDROXYAPATITE; HOLLOW
   MICROSPHERES; RAPID SYNTHESIS; PHOSPHATE; PHOTOLUMINESCENCE;
   NANOSTRUCTURES; LUMINESCENT; NANOFIBERS
AB Hydroxyapatite (HA), as the main inorganic constituent in vertebrate hard tissues, is an important biomaterial for the application in drug delivery and protein adsorption. Herein, we report a simple and green hydrothermal synthesis of HA nanorods and nanowires by using the biocompatible biomolecule riboflavin-5'-phosphate monosodium salt (RP) as a new phosphorus source. In this method, the RP molecules hydrolyze to form inorganic phosphate ions under hydrothermal conditions, and these phosphate ions react with calcium ions to form HA nanorods or nanowires after nucleation and crystal growth. The effects of experimental conditions including hydrothermal temperature, heating time and pH value of the initial solution on the hydrolysis process of RP molecules are investigated. A possible formation mechanism of HA nanorods and nanowires is proposed. The as-prepared HA nanorods and nanowires are explored for the potential application in protein adsorption. The hemoglobin (Hb) loading capacities of HA nanowires and HA nanorods increase with increasing initial Hb concentration. The Hb loading capacities of HA nanowires and HA nanorods are determined to be as high as 289 mg g(-1) and 298 mg g(-1), respectively, at an initial Hb concentration of 2000 mg mL(-1). The pH-dependent Hb release property of Hb-loaded HA nanowires and HA nanorods has been found. The experimental results indicate that the products are promising for applications in protein adsorption.
C1 [Zhao, Xin-Yu; Zhu, Ying-Jie; Chen, Feng; Lu, Bing-Qiang; Qi, Chao; Zhao, Jing; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhao, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI CHEN, Feng/E-4310-2016; Qi, Chao/N-5957-2015; Chen, Feng/D-6406-2012
OI CHEN, Feng/0000-0002-1162-1684; Chen, Feng/0000-0002-1162-1684
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51172260, 51121064,
   51102258]; Science and Technology Commission of Shanghai [11nm0506600,
   12ZR1452100]; Fund for Youth Scholar of State Key Laboratory of High
   Performance Ceramics and Superfine Microstructure
FX Financial support from the National Basic Research Program of China (973
   Program, No. 2012CB933600), the National Natural Science Foundation of
   China (51172260, 51121064, 51102258), the Science and Technology
   Commission of Shanghai (11nm0506600, 12ZR1452100), and the Fund for
   Youth Scholar of State Key Laboratory of High Performance Ceramics and
   Superfine Microstructure is gratefully acknowledged.
CR Andre RS, 2012, J ALLOY COMPD, V531, P50, DOI 10.1016/j.jallcom.2012.02.053
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Chen F, 2010, ACTA BIOMATER, V6, P3013, DOI 10.1016/j.actbio.2010.02.015
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   Ghomi H, 2011, J SOL-GEL SCI TECHN, V58, P642, DOI 10.1007/s10971-011-2439-2
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Kandori K, 2011, J PHYS CHEM B, V115, P653, DOI 10.1021/jp110441e
   Lee HJ, 2010, CHEM COMMUN, V46, P377, DOI 10.1039/b913732g
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2013, CHEM-EUR J, V19, P981, DOI 10.1002/chem.201202829
   Qi C, 2013, CHEM-ASIAN J, V8, P88, DOI 10.1002/asia.201200901
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   Qi C, 2012, MATER LETT, V85, P71, DOI 10.1016/j.matlet.2012.06.106
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Wang JW, 2011, J APPL POLYM SCI, V121, P3531, DOI 10.1002/app.34140
   Wang KW, 2011, MATER LETT, V65, P2361, DOI 10.1016/j.matlet.2011.04.104
   Wang KW, 2010, CHEM-ASIAN J, V5, P2477, DOI 10.1002/asia.201000463
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yang Q, 2005, CHEM MATER, V17, P5999, DOI 10.1021/cm051198v
   Ye F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245605
   Zhang CM, 2010, BIOMATERIALS, V31, P3374, DOI 10.1016/j.biomaterials.2010.01.044
   Zhao XY, 2013, CRYSTENGCOMM, V15, P206, DOI 10.1039/c2ce26315g
   Zhao XY, 2012, CHEM-ASIAN J, V7, P1610, DOI 10.1002/asia.201100954
NR 29
TC 34
Z9 36
U1 1
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1466-8033
J9 CRYSTENGCOMM
JI Crystengcomm
PY 2013
VL 15
IS 39
BP 7926
EP 7935
DI 10.1039/c3ce41255e
PG 10
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA 219YF
UT WOS:000324546900011
DA 2018-10-20
ER

PT J
AU Puvaneswary, S
   Raghavendran, HRB
   Ibrahim, NS
   Murali, MR
   Merican, AM
   Kamarul, T
AF Puvaneswary, Subramaniam
   Raghavendran, Hanumantha Rao Balaji
   Ibrahim, Nurul Syuhada
   Murali, Malliga Raman
   Merican, Azhar Mahmood
   Kamarul, T.
TI A Comparative Study on Morphochemical Properties and Osteogenic Cell
   Differentiation within Bone Graft and Coral Graft Culture Systems
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Osteogenic; Porous materials; Tissue engineering; Biomaterial; Coral
   graft; Microstructure
ID SURFACE-ROUGHNESS; GENE-EXPRESSION; MATRIX; SCAFFOLD
AB The objective of this study was to compare the morphological and chemical composition of bone graft (BG) and coral graft (CG) as well as their osteogenic differentiation potential using rabbit mesenchymal stem cells (rMSCs) in vitro. SEM analysis of BG and CG revealed that the pores in these grafts were interconnected, and their micro-CT confirmed pore sizes in the range of 107-315 mu m and 103-514 mu m with a total porosity of 92% and 94%, respectively. EDS analysis indicated that the level of calcium in CG was relatively higher than that in BG. FTIR of BG and CG confirmed the presence of functional groups corresponding to carbonyl, aromatic, alkyl, and alkane groups. XRD results revealed that the phase content of the inorganic layer comprised highly crystalline form of calcium carbonate and carbon. Atomic force microscopy analysis showed CG had better surface roughness compared to BG. In addition, significantly higher levels of osteogenic differentiation markers, namely, alkaline phosphatase (ALP), Osteocalcin (OC) levels, and Osteonectin and Runx2, Integrin gene expression were detected in the CG cultures, when compared with those in the BG cultures. In conclusion, our results demonstrate that the osteogenic differentiation of rMSCs is relatively superior in coral graft than in bone graft culture system.
C1 [Puvaneswary, Subramaniam; Raghavendran, Hanumantha Rao Balaji; Ibrahim, Nurul Syuhada; Murali, Malliga Raman; Merican, Azhar Mahmood; Kamarul, T.] Univ Malaya, Fac Med, Dept Orthopaed Surg, Tissue Engn Grp,NOCERAL, Kuala Lumpur 50603, Malaysia.
EM tkzrea@um.edu.my
RI balaji raghavendran, hanumantha rao/B-8507-2012; Malliga Raman,
   Murali/A-6987-2012; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Malliga Raman, Murali/0000-0002-5696-4541; Tunku Zainol Abidin, Tunku
   Kamarul Zaman/0000-0002-6028-1313
FU Fundamental Research Grant Scheme FRGS [FP016]; HIRG-MOHE, University
   Malaya
FX The authors are grateful to the Fundamental Research Grant Scheme FRGS
   (FP016) and HIRG-MOHE, University Malaya for supporting this study.
CR AL-Salihi KA, 2009, BRAZ J ORAL SCI, V8, P210
   Blackwood KA, 2012, INT J POLYM SCI, V2012, P1
   Combes C, 2006, J BIOMED MATER RES A, V79A, P318, DOI 10.1002/jbm.a.30795
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Foo LH, 2008, J BIOMED MATER RES A, V87A, P215, DOI 10.1002/jbm.a.31765
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6
   KELM RJ, 1994, J BIOL CHEM, V269, P30147
   Krishna murithy G, 2013, CERAMIC INT IN PRESS
   Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
NR 15
TC 8
Z9 8
U1 2
U2 14
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
J9 INT J MED SCI
JI Int. J. Med. Sci.
PY 2013
VL 10
IS 11
BP 1608
EP 1614
DI 10.7150/ijms.6496
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 218DX
UT WOS:000324414100027
PM 24151432
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rajangam, T
   An, SSA
AF Rajangam, Thanavel
   An, Seong Soo A.
TI Fibrinogen and fibrin based micro and nano scaffolds incorporated with
   drugs, proteins, cells and genes for therapeutic biomedical applications
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE biomaterial; polymer composite; cross-linking; growth factor; drug
   delivery; controlled release; tissue regeneration
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING
   APPLICATIONS; SPINAL-CORD-INJURY; BONE MORPHOGENETIC PROTEINS; COATED
   COLLAGEN PATCH; ANGIOGENESIS IN-VIVO; OF-THE-ART; V BETA 3;
   CONTROLLED-RELEASE
AB Over the past two decades, many types of natural and synthetic polymer-based micro- and nanocarriers, with exciting properties and applications, have been developed for application in various types of tissue regeneration, including bone, cartilage, nerve, blood vessels, and skin. The development of suitable polymers scaffold designs to aid the repair of specific cell types have created diverse and important potentials in tissue restoration. Fibrinogen (Fbg)- and fibrin (Fbn)-based micro- and nanostructures can provide suitable natural matrix environments. Since these primary materials are abundantly available in blood as the main coagulation proteins, they can easily interact with damaged tissues and cells through native biochemical interactions. Fbg- and Fbn-based micro and nanostructures can also be consecutively furnished/or encapsulated and specifically delivered, with multiple growth factors, proteins, and stem cells, in structures designed to aid in specific phases of the tissue regeneration process. The present review has been carried out to demonstrate the progress made with micro and nanoscaffold applications and features a number of applications of Fbg- and Fbn-based carriers in the field of biomaterials, including the delivery of drugs, active biomolecules, cells, and genes, that have been effectively used in tissue engineering and regenerative medicine.
C1 [Rajangam, Thanavel; An, Seong Soo A.] Gachon Univ, Dept Bionanotechnol, Songnam 461701, Gyeonggi Do, South Korea.
RP An, SSA (reprint author), Gachon Univ, Dept Bionanotechnol, San 65, Songnam 461701, Gyeonggi Do, South Korea.
EM seongaan@gachon.ac.kr
FU National Research Foundation of Korea (NRF); Korean government (MEST)
   [2012R1A2A2A03046819]; GRRC program of Gyeonggi province [GRRCKyungwon
   2013-A01]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korean government (MEST) (2012R1A2A2A03046819:
   Development of biodegradable and biocompatible nano-patterned
   microfibers and microtubes for skin and vascular tissue engineering) and
   the GRRC program of Gyeonggi province [GRRCKyungwon 2013-A01,
   Development of Microfluidic Chip for diagnosis of disease].
CR AARONSON SA, 1991, ANN NY ACAD SCI, V638, P62, DOI 10.1111/j.1749-6632.1991.tb49018.x
   Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   ALBREKTSSON T, 1982, ACTA ORTHOP SCAND, V53, P757, DOI 10.3109/17453678208992288
   ALI IU, 1978, CELL, V14, P439, DOI 10.1016/0092-8674(78)90129-0
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Arkudas A, 2007, MOL MED, V13, P480, DOI 10.2119/2007-00057.Arkudas
   ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   Asahara T, 1996, CIRCULATION, V94, P3291, DOI 10.1161/01.CIR.94.12.3291
   Bennet D, 2011, J MATER SCI, V46, P4723, DOI 10.1007/s10853-011-5510-z
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bhang SH, 2007, J BIOMED MATER RES A, V80A, P998, DOI 10.1002/jbm.a.31050
   BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   BOWERSOX JC, 1982, CANCER RES, V42, P2547
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Brown KJ, 1996, LAB INVEST, V75, P539
   BUCALA R, 1994, MOL MED, V1, P71
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   CENTRELLA M, 1986, ENDOCRINOLOGY, V119, P2306, DOI 10.1210/endo-119-5-2306
   Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005
   CHEN WYJ, 1992, J INVEST DERMATOL, V99, P559, DOI 10.1111/1523-1747.ep12667378
   Chen ZW, 2011, J MICROENCAPSUL, V28, P344, DOI 10.3109/02652048.2011.569764
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Chung YI, 2010, J CONTROL RELEASE, V143, P282, DOI 10.1016/j.jconrel.2010.01.010
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   COSTANTINI V, 1992, CANCER METAST REV, V11, P283, DOI 10.1007/BF01307183
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230
   DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   DEBLOIS C, 1994, BIOMATERIALS, V15, P665, DOI 10.1016/0142-9612(94)90164-3
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Einhaus CM, 2004, CLIN CANCER RES, V10, P7001, DOI 10.1158/1078-0432.CCR-04-0118
   Erdogan D, 2008, J BIOMED MATER RES B, V85B, P272, DOI 10.1002/jbm.b.30916
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   FASOL R, 1994, J THORAC CARDIOV SUR, V107, P1432
   Filova E, 2008, J BIOMED MATER RES B, V87B, P415, DOI 10.1002/jbm.b.31119
   Frisman I, 2010, ACTA BIOMATER, V6, P2518, DOI 10.1016/j.actbio.2009.07.015
   Fu X.B., 2005, INT J COSMETIC SCI, V27, P40
   FURLAN M, 1975, THROMB RES, V7, P827, DOI 10.1016/0049-3848(75)90086-9
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036
   Gorodetsky R, 1999, J INVEST DERMATOL, V112, P866, DOI 10.1046/j.1523-1747.1999.00600.x
   GREISLER HP, 1992, SURGERY, V112, P244
   Grill R, 1997, J NEUROSCI, V17, P5560
   Gurevich O, 2002, TISSUE ENG, V8, P661, DOI 10.1089/107632702760240571
   Gwak SJ, 2005, CELL TRANSPLANT, V14, P809, DOI 10.3727/000000005783982521
   Han CM, 2010, J ZHEJIANG UNIV-SC B, V11, P524, DOI 10.1631/jzus.B0900400
   Han DQ, 2008, MED HYPOTHESES, V71, P374, DOI 10.1016/j.mehy.2008.01.035
   Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com
   Hartmann A, 2008, DERMATOL SURG, V34, P922, DOI 10.1111/j.1524-4725.2008.34178.x
   Hasegawa T, 1999, ANGIOLOGY, V50, P487, DOI 10.1177/000331979905000607
   HASHIMOTO J, 1992, AM J SPORT MED, V20, P537, DOI 10.1177/036354659202000509
   Haugh MG, 2012, J MECH BEHAV BIOMED, V16, P66, DOI 10.1016/j.jmbbm.2012.10.009
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   HO HO, 1994, DRUG DEV IND PHARM, V20, P535, DOI 10.3109/03639049409038316
   HO HO, 1995, J CONTROL RELEASE, V34, P65, DOI 10.1016/0168-3659(94)00126-F
   Horch RE, 2001, TRANSPLANT P, V33, P642, DOI 10.1016/S0041-1345(00)02181-3
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Ikari Y, 2000, J BIOL CHEM, V275, P12799, DOI 10.1074/jbc.275.17.12799
   Ishimura M, 1997, ARTHROSCOPY, V13, P551, DOI 10.1016/S0749-8063(97)90179-1
   Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019
   Iwaya K, 1999, NEUROSURGERY, V44, P589, DOI 10.1097/00006123-199903000-00085
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kim SJ, 2010, POLYMER, V51, P1320, DOI 10.1016/j.polymer.2010.01.025
   Kitajima T, 2009, ACTA BIOMATER, V5, P2623, DOI 10.1016/j.actbio.2009.03.022
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Kubota K, 2004, COLLOID SURFACE B, V38, P103, DOI 10.1016/j.colsurfb.2004.02.017
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Kundu B, 1999, PEPTIDES, V20, P523, DOI 10.1016/S0196-9781(99)00034-0
   Le Nihouannen D, 2007, J MATER SCI-MATER M, V18, P225, DOI 10.1007/s10856-006-0684-7
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Lee TC, 2006, NEUROSURGERY, V58, P373, DOI 10.1227/01.NEU.0000199725.03186.F6
   Lei YG, 2011, J CONTROL RELEASE, V153, P255, DOI 10.1016/j.jconrel.2011.01.028
   Lei YG, 2010, BIOMATERIALS, V31, P9106, DOI 10.1016/j.biomaterials.2010.08.016
   Levi M, 1999, NAT MED, V5, P107, DOI 10.1038/4795
   Liu Y, 2007, CELL BIOL INT, V31, P985, DOI 10.1016/j.cellbi.2007.03.009
   Lorusso R, 2011, ANN THORAC SURG, V91, P917, DOI 10.1016/j.athoracsur.2010.08.015
   Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P283, DOI 10.1016/S1359-0286(02)00075-X
   MARDER VJ, 1971, SCAND J HAEMATOL, P21
   Marimuthu M, 2009, CURR NANOSCI, V5, P189, DOI 10.2174/157341309788185389
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   McManus MC, 2008, J ENG FIBER FABR, V3
   Meinhart J, 1999, ANN PLAS SURG, V42, P673, DOI 10.1097/00000637-199906000-00016
   MIHALYI E, 1963, ACTA CHEM SCAND, V17, P277, DOI 10.3891/acta.chem.scand.17s-0277
   Mimura T, 2008, OSTEOARTHR CARTILAGE, V16, P1083, DOI 10.1016/j.joca.2008.02.003
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1370
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P3384
   Mogford JE, 2009, WOUND REPAIR REGEN, V17, P405, DOI 10.1111/j.1524-475X.2009.00481.x
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Natarajan N, 2005, J MACROMOL SCI PURE, VA42, P945, DOI 10.1081/MA-200063188
   Ng R, 2012, RSC ADV, V2, P10110, DOI 10.1039/c2ra21085a
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Okumura M, 1996, BIOL PHARM BULL, V19, P530
   Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Oss-Ronen L, 2011, ACTA BIOMATER, V7, P163, DOI 10.1016/j.actbio.2010.07.017
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Patel S, 2010, J BONE JOINT SURG BR, V92B, P1325, DOI 10.1302/0301-620X.92B10.24828
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Petratos PB, 2002, WOUND REPAIR REGEN, V10, P252, DOI 10.1046/j.1524-475X.2002.10409.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   POSTLETHWAITE AE, 1981, J EXP MED, V153, P494, DOI 10.1084/jem.153.2.494
   Rajangam T, 2013, INT J NANOMED, V8, P1037, DOI 10.2147/IJN.S37784
   Rajangam T, 2012, B KOREAN CHEM SOC, V33, P2075, DOI 10.5012/bkcs.2012.33.6.2075
   Rajangam T, 2011, BIOCHIP J, V5, P175, DOI 10.1007/s13206-011-5211-3
   Rejinold NS, 2011, J BIOMED NANOTECHNOL, V7, P521, DOI 10.1166/jbn.2011.1320
   Rejinold NS, 2011, INT J BIOL MACROMOL, V48, P98, DOI 10.1016/j.ijbiomac.2010.10.003
   Rejinold NS, 2010, INT J BIOL MACROMOL, V47, P37, DOI 10.1016/j.ijbiomac.2010.03.023
   REMOLD HG, 1981, CELL IMMUNOL, V58, P175, DOI 10.1016/0008-8749(81)90159-3
   ROBSON MC, 1992, ANN SURG, V216, P401, DOI 10.1097/00000658-199210000-00002
   Roeddecker K, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P28, DOI 10.1007/BF01552155
   Romero MI, 2001, J NEUROSCI, V21, P8408
   ROUSOU J, 1989, J THORAC CARDIOV SUR, V97, P194
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Saraf A, 2006, ADV DRUG DELIVER REV, V58, P592, DOI 10.1016/j.addr.2006.03.005
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Scotti C, 2009, KNEE SURG SPORT TR A, V17, P645, DOI 10.1007/s00167-009-0745-9
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Shireman PK, 2000, J VASC SURG, V31, P936, DOI 10.1067/mva.2000.106420
   Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8
   Smoljanovic T, 2007, COLLEGIUM ANTROPOL, V31, P923
   STANDKER L, 1995, BIOCHEM BIOPH RES CO, V215, P896, DOI 10.1006/bbrc.1995.2548
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   VanBelle E, 1997, CIRCULATION, V95, P438
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0
   Wilcke I, 2007, LANGENBECK ARCH SURG, V392, P305, DOI 10.1007/s00423-007-0194-1
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WITTKAMPF ARM, 1989, J CRANIO MAXILL SURG, V17, P179, DOI 10.1016/S1010-5182(89)80019-8
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wu XP, 2006, MICROVASC RES, V71, P12, DOI 10.1016/j.mvr.2005.11.004
   Xu W, 2007, J BIOACT COMPAT POL, V22, P363, DOI 10.1177/0883911507079451
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yamamoto M, 2005, TOHOKU J EXP MED, V207, P33, DOI 10.1620/tjem.207.33
   Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067
   Yang HS, 2010, TISSUE ENG PT A, V16, P2113, DOI [10.1089/ten.tea.2009.0673, 10.1089/ten.TEA.2009.0673]
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
   Zhao HG, 2009, J MATER SCI-MATER M, V20, P135, DOI 10.1007/s10856-008-3543-x
   Zhong Y, 2007, J CONTROL RELEASE, V122, P331, DOI 10.1016/j.jconrel.2007.05.016
   Zhou WJ, 2011, J MATER SCI-MATER M, V22, P1221, DOI 10.1007/s10856-011-4304-9
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 202
TC 44
Z9 47
U1 1
U2 64
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 3641
EP 3662
DI 10.2147/IJN.S43945
PG 22
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 223GU
UT WOS:000324793500001
PM 24106425
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lamberti, F
   Giulitti, S
   Giomo, M
   Elvassore, N
AF Lamberti, Francesco
   Giulitti, Stefano
   Giomo, Monica
   Elvassore, Nicola
TI Biosensing with electroconductive biomimetic soft materials
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; CARBON-NANOTUBES; ELECTRICAL-CONDUCTIVITY;
   GLUCOSE-OXIDASE; MECHANICAL-PROPERTIES; MULTIELECTRODE ARRAY; SCAFFOLD
   DESIGN; CELL-CULTURE; IN-VITRO; HYDROGELS
AB The development of smart biomaterials able to quantitatively analyse the dynamics of biological systems with high temporal resolution in biomimetic environments is of paramount importance in biophysics, biology and medicine. In this context, we develop a biosensing water-based soft biomaterial with tunable mechanical properties through the generation of an electroconductive nano-element network. As a proof of concept, in order to detect glucose concentration, we fabricate an electroconductive polyacrylamide glucose oxidase (GOx) loaded hydrogel (HY) modified with a small amount of single-walled carbon nanotubes (SWNTs) (up to 0.85 wt%). MicroRaman maps and optical analysis show the nanotube distribution in the samples at different mass fractions. Electrochemical impedance spectra and their fitting with equivalent circuit models reveal electron conduction in the charged hydrogels in addition to ionic conductivity. The effective resulting resistance of the nanostructured network is comparable to that of a gold electrode. These findings were also confirmed by cyclic voltammetry. Interestingly, heterogeneous clustering of SWNTs shows double electric mechanisms and efficiencies. GOx-SWNT doped hydrogels show a linear glucose concentration response in the range between 0.1 mM and 1.6 mM; taken together these results show high detection limits for glucose (down to 15 mu M) and a sensitivity of 0.63 mu A mM(-1). In the perspective of monitoring cell dynamics, hydrogel functionalization allows cell adhesion and long-term cell culture, and atomic force microscopy is used for mapping the doped hydrogel stiffness. Myoblasts, cells sensitive to mechanical substrate properties, show proper differentiation of phenotype in the SWNT-HYs with nominal physiological stiffness.
C1 [Lamberti, Francesco; Giulitti, Stefano; Giomo, Monica; Elvassore, Nicola] Univ Padua, Dept Ind Engn, Padua, Italy.
   [Lamberti, Francesco; Giulitti, Stefano; Elvassore, Nicola] Venetian Inst Mol Med, I-35100 Padua, Italy.
RP Elvassore, N (reprint author), Univ Padua, Dept Ind Engn, Via Marzolo 9, Padua, Italy.
EM nicola.elvassore@unipd.it
FU University of Padova; Ministry of University
FX We thank the University of Padova and Ministry of University for
   financial support and Brian Choi (Park Systems Corp., Suwon, Korea) for
   valuable help with the AFM distance curve measurements and analysis.
CR Aizawa Y, 2012, PROG POLYM SCI, V37, P645, DOI 10.1016/j.progpolymsci.2011.11.004
   Bajpai AK, 2008, EXPRESS POLYM LETT, V2, P26, DOI 10.3144/expresspolymlett.2008.5
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h
   Cimetta E, 2009, BIOMED MICRODEVICES, V11, P389, DOI 10.1007/s10544-008-9245-9
   COLEMAN JN, 1998, PHYS REV B, P7492, DOI DOI 10.1103/PHYSREVB.58.R7492
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Dai TY, 2010, COMPOS SCI TECHNOL, V70, P498, DOI 10.1016/j.compscitech.2009.11.027
   Delvaux M, 2003, BIOSENS BIOELECTRON, V18, P943, DOI 10.1016/S0956-5663(02)00209-9
   Dispenza C, 2007, RADIAT PHYS CHEM, V76, P1371, DOI 10.1016/j.radphyschem.2007.02.036
   Dispenza C, 2006, POLYMER, V47, P961, DOI 10.1016/j.polymer.2005.12.071
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Fu YC, 2011, ANAL CHEM, V83, P6511, DOI 10.1021/ac200471v
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1
   Grover CN, 2012, ACTA BIOMATER, V8, P3080, DOI 10.1016/j.actbio.2012.05.006
   Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jandt KD, 2001, SURF SCI, V491, P303, DOI 10.1016/S0039-6028(01)01296-1
   Janovak L, 2010, APPL SURF SCI, V256, P2809, DOI 10.1016/j.apsusc.2009.11.032
   Kim HD, 2012, INTEGR BIOL-UK, V4, P37, DOI 10.1039/c1ib00069a
   Kim J, 2010, NAT MATER, V9, P159, DOI [10.1038/NMAT2606, 10.1038/nmat2606]
   Lamberti F, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4705368
   Leroux Y, 2007, ELECTROCHEM COMMUN, V9, P1258, DOI 10.1016/j.elecom.2007.01.015
   Liang B, 2013, BIOSENS BIOELECTRON, V43, P131, DOI 10.1016/j.bios.2012.11.040
   Loveday D, 2004, JCT COATINGSTECH, V1, P46
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Meincke O, 2004, POLYMER, V45, P739, DOI 10.1016/j.polymer.2003.12.013
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moulton SE, 2004, CURR APPL PHYS, V4, P402, DOI 10.1016/j.cap.2003.11.059
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5
   Pringle JM, 2008, ADV FUNCT MATER, V18, P2031, DOI 10.1002/adfm.200701147
   Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187
   Roa JJ, 2011, RECENT PAT NANOTECH, V5, P27, DOI 10.2174/187221011794474985
   Serena E, 2010, INTEGR BIOL-UK, V2, P193, DOI 10.1039/b921401a
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Silva LMC, 2011, ENVIRON TECHNOL, V32, P493, DOI 10.1080/09593330.2010.504234
   Suzuki I, 2005, LAB CHIP, V5, P241, DOI 10.1039/b406885h
   Tang QW, 2008, J APPL POLYM SCI, V108, P1490, DOI 10.1002/app.27716
   Thompson M, 2005, ACCREDIT QUAL ASSUR, V10, P82, DOI 10.1007/s00769-004-0871-5
   Wallace GG, 2002, J NANOSCI NANOTECHNO, V2, P441, DOI 10.1166/jnn.2002.142
   Wang J, 2005, ANAL CHIM ACTA, V539, P209, DOI 10.1016/j.aca.2005.02.059
   Wang YL, 2011, BIOSENS BIOELECTRON, V30, P107, DOI 10.1016/j.bios.2011.08.038
   Wen ZH, 2009, J PHYS CHEM C, V113, P13482, DOI 10.1021/jp902830z
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Yang MH, 2006, BIOMATERIALS, V27, P5944, DOI 10.1016/j.biomaterials.2006.08.014
   Yao YL, 2007, ANAL BIOANAL CHEM, V387, P303, DOI 10.1007/s00216-006-0924-1
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Zatti S, 2012, LANGMUIR, V28, P2718, DOI 10.1021/la204776e
NR 57
TC 8
Z9 8
U1 2
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 38
BP 5083
EP 5091
DI 10.1039/c3tb20666a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 218II
UT WOS:000324425600022
DA 2018-10-20
ER

PT S
AU Soares, LGP
   Aciole, JMS
   Aciole, GTS
   Barbosa, AFS
   Silveira, L
   Pinheiro, ALB
AF Soares, Luiz G. P.
   Aciole, Jouber M. S.
   Aciole, Gilberth T. S.
   Barbosa, Artur F. S.
   Silveira-Junior, Landulfo
   Pinheiro, Antonio L. B.
BE Hamblin, MR
   Arany, PR
   Carroll, JD
TI Raman Study of the Effect of LED Light on Grafted Bone Defects
SO MECHANISMS FOR LOW-LIGHT THERAPY VIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy VIII
CY FEB 02, 2013
CL San Francisco, CA
SP SPIE
DE Biomaterial; Bone; Phototherapy; Raman Spectroscopy
ID INFRARED-LASER PHOTOBIOMODULATION; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; SPECTROSCOPY; THERAPY; ASSOCIATION; NM
AB Benefits of the isolated or combined use light and biomaterials on bone healing have been suggested. Our group has used several models to assess the effects of laser on bone. A Raman spectral analysis on surgical bone defects grafted or not with Hydroxyapatite (HA), treated or not with LED was carried out. 40 rats were divided into 4 groups. On Group I the defect was filled with the clot. On Group II, the defect was filled with the HA. On groups III the defect was filled with Clot and further irradiated with LED and on group IV the defects was filled with the HA and further irradiated with LED. LED (lambda 850 +/- 10nm, 150mW, A = 0.5cm(2), 68s, 20 J/cm(2) per session, 140 J/cm(2) per treatment) was applied at 48 h intervals during 15 days. Specimens were taken after 15 and 30 days after surgery and kept on liquid nitrogen, and underwent Raman analysis. For this, the peak of hydroxyapatite (similar to 960 cm(-1)) was used as marker of bone mineralization. Significant difference was observed at both times (p<0.05). When the biomaterial was used higher peaks were observed. Association with LED further improved the intensity. Conclusion: It is concluded that LED light improved the effect of the HA.
C1 [Soares, Luiz G. P.; Aciole, Jouber M. S.; Aciole, Gilberth T. S.; Barbosa, Artur F. S.; Pinheiro, Antonio L. B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
RP Soares, LGP (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Barbosa, Artur/G-3839-2012; Silveira, Landulfo/I-2474-2012; Pinheiro,
   Antonio Luiz/A-1962-2008
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321
CR Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho F. B., 2011, P SOC PHOTO-OPT INS, V7887, P1
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Kavukcuoglu NB, 2009, J MECH BEHAV BIOMED, V2, P254
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Penel G, 2005, BONE, V36, P893, DOI 10.1016/j.bone.2005.02.012
   Pinheiro A. L. B., 2011, LASER MED SCI, V27, P1013
   Pinheiro A. L. B., 2012, LASER MED SCI, DOI [10.1007/s10103-012-1096-1, DOI 10.1007/S10103-012-1096-1(2012)]
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   PINHEIRO ALB, 2001, LASER THER, V13, P73
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
NR 26
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9338-5
J9 PROC SPIE
PY 2013
VL 8569
AR UNSP 85690L
DI 10.1117/12.2002584
PG 8
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BHA24
UT WOS:000324803700012
DA 2018-10-20
ER

PT J
AU Baillif, S
   Baziard-Mouysset, G
   Roques, C
   Baziard, Y
   Kodjikian, L
AF Baillif, Stephanie
   Baziard-Mouysset, Genevieve
   Roques, Christine
   Baziard, Yves
   Kodjikian, Laurent
TI Calculation of Intraocular Lens Surface Free Energy and its Components
   from Contact Angle Measurements
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Contact angle; Biomaterial; Hydrophobicity; lntraocular lens; Surface
   free energy
ID BACTERIAL ADHESION; BIOFILM FORMATION; TENSION; GONIOMETRY; ADHERENCE
AB One of the most important biomaterial characteristics involved in bacterial adhesion on intraocular lenses (IOLs) is hydrophobicity. We calculated the hydrophobicity parameters of IOLs made of 6 different materials (polymethylmethacrylate, PMMA, heparin surface-modified PMMA, HSM-PMMA, silicone, hydrophilic and hydrophobic acrylics and collamer). Values of IOL surface free energy components were determined from contact angle measurements, using the Fowkes, Owens-Wendt and Good-van Oss calculations. Contact angles were higher for silicone and hydrophobic acrylic materials and lower for collamer and hydrophilic acrylic materials. The values of IOL surface free energy components obtained with the 3 different calculations were homogenous. According to the Owens-Wendt calculation, the IOLs could be separated into dispersive implants (hydrophobic acrylic, silicone and PMMA) and polar implants (collamer, hydrophilic acrylic and HSM-PMMA). Copyright (C) 2013 S. Karger AG, Basel
C1 [Baillif, Stephanie] Univ Nice St Roch, Ctr Hosp, Serv Ophtalmol, Nice, France.
   [Baillif, Stephanie; Kodjikian, Laurent] Univ Lyon 1, Lab Reparat Tissulaire Interact Biol & Biomat, Lyon, France.
   [Kodjikian, Laurent] Univ Lyon Croix Rousse, Ctr Hosp, Serv Ophtalmol, Lyon, France.
   [Baziard-Mouysset, Genevieve] Univ Toulouse 3, Fac Pharm, Lab Genie Chim, F-31062 Toulouse, France.
   [Roques, Christine] Univ Toulouse 3, Fac Pharm, Lab Bacteriol Virol & Microbiol Ind, F-31062 Toulouse, France.
   [Baziard, Yves] Ecole Natl Engn, Lab Genie Prod, Tarbes, France.
RP Kodjikian, L (reprint author), Croix Rousse Univ Hosp, Dept Ophthalmol, 103 Grande Rue Croix Rousse, FR-69004 Lyon, France.
EM kodjikian.laurent@wanadoo.fr
RI roques, christine/D-9889-2014
OI baillif, stephanie/0000-0003-1700-8570
CR Alava J, 2005, J MATER SCI-MATER M, V16, P313, DOI 10.1007/s10856-005-0629-6
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Baillif S, 2008, J CATARACT REFR SURG, V34, P153, DOI 10.1016/j.jcrs.2007.07.058
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   CUSUMANO A, 1991, OPHTHALMOLOGY, V98, P1703
   Dick HB, 2001, OPHTHALMIC RES, V33, P303, DOI 10.1159/000055685
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Fowkes F.M., 1987, J ADHES SCI TECHNOL, V1, P7, DOI DOI 10.1163/156856187X00049
   Gallardo-Moreno AM, 2011, COLLOID SURFACE B, V88, P373, DOI 10.1016/j.colsurfb.2011.07.016
   Good RJ, 1960, J PHYS CHEM-US, V64, P1960
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HOLLANDER A, 1995, J COLLOID INTERF SCI, V169, P493, DOI 10.1006/jcis.1995.1060
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4382, DOI 10.1167/iovs-03-0185
   Kwok DY, 1999, COLLOID SURFACE A, V156, P191, DOI 10.1016/S0927-7757(99)00070-9
   Legeais JM, 2002, TXB OPHTHALMOLOGY, P1880
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Rutter P. R., 1980, MICROBIAL ADHESION S, P79
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Shimizu K, 2006, CURR EYE RES, V31, P989, DOI 10.1080/02713680601038816
   Sousa C., 2009, INT J BIOMATER, V2009
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Tehrani M, 2004, OPHTHALMOLOGICA, V218, P57, DOI 10.1159/000074568
   van Oss CJ, 1996, INTERFACIAL FORCES A, P402
   Wiencek KM, 1997, BIOFOULING, V11, P293, DOI 10.1080/08927019709378338
   WU S, 1979, J COLLOID INTERF SCI, V71, P605, DOI 10.1016/0021-9797(79)90332-1
   Wu WJ, 1999, ADV COLLOID INTERFAC, V79, P229, DOI 10.1016/S0001-8686(98)00072-4
   Zisman WA, 1963, IND ENG CHEM, V55, P18, DOI DOI 10.1021/JE50646A003
   Zisman WA, 1972, J PAINT TECH, V44, P42
NR 30
TC 3
Z9 3
U1 1
U2 15
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2013
VL 50
IS 3
BP 165
EP 173
DI 10.1159/000348738
PG 9
WC Ophthalmology
SC Ophthalmology
GA 223DH
UT WOS:000324783800005
PM 24008974
DA 2018-10-20
ER

PT J
AU Walke, W
   Przondziono, J
AF Walke, W.
   Przondziono, J.
TI PHYSICOCHEMICAL AND ELECTROCHEMICAL PROPERTIES OF AISI 316L STAINLESS
   STEEL USED FOR IMPLANTS IN HUMAN URINARY SYSTEM
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE AISI 316L stainless steel; electrochemical impedance spectroscopy (EIS);
   X-ray Photoelectron Spectroscopy (XPS); Scanning Electron Microscopy
   (SEM)
ID BEHAVIOR
AB The main purpose of this study was to evaluate physicochemical and electrochemical properties of AISI 316L stainless steel with modified surface, used for implants in human urinary system. In order to simulate conditions, which occur in the tissue environment of the urinary system, the test pieces were exposed in a urinary solution at temperature of T=37 +/- 1 degrees C, for a period of 30 days. Evaluation of physicochemical properties of biomaterial was made on the basis of surface chemical analysis (XPS). To evaluate the effects which occur on the surface of the examined steel, Electrochemical Impedance Spectroscopy (EIS) method was also employed. Analysis of test results shows favourable influence of the suggested surface treatment of AISI 316L stainless steel. Samples having electrolytically polished and chemically passivated surface featured the best physicochemical and electrochemical characteristics.
C1 [Walke, W.] Silesian Tech Univ, Inst Engn Mat & Biomat, PL-44100 Gliwice, Poland.
   [Przondziono, J.] Silesian Tech Univ, Dept Mat Technol, PL-40019 Katowice, Poland.
RP Walke, W (reprint author), Silesian Tech Univ, Inst Engn Mat & Biomat, Konarskiego 18A, PL-44100 Gliwice, Poland.
CR [Anonymous], 1099315 PNEN ISO
   Baron A., 2007, J ACHIEV MAT MANUF E, V21, P23
   Bozzini B, 2008, J MATER SCI-MATER M, V19, P3443, DOI 10.1007/s10856-008-3487-1
   JEROMIN LM, 2001, DOCTORS GUIDE, V10, P83
   Kajzer W., 2007, International Journal of Microstructure and Materials Properties, V2, P188, DOI 10.1504/IJMMP.2007.014285
   Kajzer W, 2007, J ACHIEVEMENTS MAT M, V20, P123
   Kajzer W, 2006, J ACHIEV MAT MANUF E, V18, P115
   Losiewicz B., 2003, OCHRONA PRZED KOROZJ, P49
   Madlani G.H., 1995, UROLOGY, V5, P846
   Mogoda AS, 2004, J APPL ELECTROCHEM, V34, P873, DOI 10.1023/B:JACH.0000040447.26482.bd
   SKRODZKA M, 2007, UROLOGICAL REV, V4, P53
   Steinemann S. G., 1980, ADV BIOMATER, V1, P1
NR 12
TC 1
Z9 1
U1 1
U2 8
PU POLISH ACAD SCIENCES COMMITTEE METALLURGY
PI KRAKOW
PA AL MICKIEWICZA 30, AGH, PAW., A-4,III P., POK 312B, 30-059 KRAKOW,
   POLAND
SN 1733-3490
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2013
VL 58
IS 2
BP 625
EP 630
DI 10.2478/amm-2013-0048
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 212ZC
UT WOS:000324021100060
OA Bronze
DA 2018-10-20
ER

PT S
AU Djeridi, R
   Ould Ouali, M
AF Djeridi, Rachid
   Ould Ouali, Mohand
BE DeSousa, RA
   Valente, R
TI Numerical implementation and finite element analysis of anisotropic
   hyperelastic biomaterials - Influence of fibers orientation
SO CURRENT STATE-OF-THE-ART ON MATERIAL FORMING: NUMERICAL AND EXPERIMENTAL
   APPROACHES AT DIFFERENT LENGTH-SCALES, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 16th ESAFORM Conference on Material Forming (ESAFORM 2013)
CY APR 22-24, 2013
CL Univ Aveiro, Aveiro, PORTUGAL
SP European Sci Assoc Mat Form
HO Univ Aveiro
DE Numerical implementation; jacobian matrix; biomaterials; anisotropic
   hyperelasticity; fiber reinforced material
ID CONSTITUTIVE MODELS; ENERGY FUNCTION; ELASTICITY; BEHAVIOR; RUBBER;
   FORMULATION; MECHANICS; STRAINS
AB Modeling anisotropic behavior of fiber reinforced rubberlike materials is actually of a great interest in many industrials sectors. Indeed, accurately description of the mechanical response and damage of such materials allows the increase of the lifecycle of these materials which generally evolve under several environment conditions. In this paper theoretical study and finite element analysis of anisotropic biomaterials is presented. The mechanical model adopted to achieve this study has been implemented into the finite element code Abaqus using an implicit scheme. This constitutive law has been utilized to perform some numerical simulations. The material parameters of the model have been determined by numerical calibration. One fiber family is considered in this work. Effects of the fiber orientation on the mechanical response and stiffness change of biomaterial is studied. Both the compressible and incompressible states have been taken into account. The results show firstly the capability of the model to reproduce the known results and that optimal fiber orientation can be found.
C1 [Djeridi, Rachid; Ould Ouali, Mohand] Univ Tizi Ouzou, LEC2M, Tizi Ouzou, Algeria.
RP Djeridi, R (reprint author), Univ Tizi Ouzou, LEC2M, Tizi Ouzou, Algeria.
EM djeridi_rachid@yahoo.fr; m_ouldouali@mail.ummto.dz
OI OULD OUALI, Mohand/0000-0001-7958-4974
CR Boyce MC, 2000, RUBBER CHEM TECHNOL, V73, P504, DOI 10.5254/1.3547602
   Christensen R. M., 1979, MECH COMPOSITE MAT
   Diani J, 2006, INT J SOLIDS STRUCT, V43, P3044, DOI 10.1016/j.ijsolstr.2005.06.045
   Dorfmann A, 2004, INT J SOLIDS STRUCT, V41, P1855, DOI 10.1016/j.ijsolstr.2003.11.014
   Doyle T.C., 1956, ADV APPL MECH
   FUNG YC, 1979, AM J PHYSIOL, V237, pH620
   Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073
   Gibson R.F., 1994, PRINCIPLES COMPOSITE
   Green A., 1970, LARGE ELASTIC DEFORM
   Hart-Smith L., 1966, J APPL MATH PHYS, V17, P608
   HAYES WC, 1971, J APPL PHYSIOL, V31, P562
   Holzapfel GA, 2002, EUR J MECH A-SOLID, V21, P441, DOI 10.1016/S0997-7538(01)01206-2
   Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333
   Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1
   HUMPHREY JD, 1987, J BIOMECH ENG-T ASME, V109, P298, DOI 10.1115/1.3138684
   Itskov M, 2004, INT J SOLIDS STRUCT, V41, P3833, DOI 10.1016/j.ijsolstr.2004.02.027
   Johnson AF, 1996, COMPUTER AIDED DESIGN IN COMPOSITE MATERIAL TECHNOLOGY V, P233
   Johnson GA, 1996, J BIOMECH ENG-T ASME, V118, P221, DOI 10.1115/1.2795963
   Jones RM., 1975, MECH COMPOSITE MAT
   Kaliske M, 2000, COMPUT METHOD APPL M, V185, P225, DOI 10.1016/S0045-7825(99)00261-3
   Klee K.-D., 1982, P PRESS VESS PIP C O
   Kyriacou SK, 1996, COMPUT MECH, V18, P269
   Lambert-Diani J, 1999, EUR J MECH A-SOLID, V18, P1027, DOI 10.1016/S0997-7538(99)00147-3
   Lurie A.I., 1990, N HOLLAND SERIES APP
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   PINSKY PM, 1991, J BIOMECH, V24, P907, DOI 10.1016/0021-9290(91)90169-N
   PUSO MA, 1998, ASME, V120, P162
   RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004
   Schroder J, 2005, INT J SOLIDS STRUCT, V42, P4352, DOI 10.1016/j.ijsolstr.2004.11.021
   Schroder J., 1996, THESIS U HANNOVER
   Simo J., 1998, INTERDISCIPLINARY AP, V7
   Spencer A., 1984, CONTINUUM THEORY MEC
   Spencer A.J.M., 1984, CISM COURSES LECT, V282
   Suhubi E.S., CONTINUUM PHYS
   Timmel M., 2007, P 6 LS DYNA FOR FRAN, P1
   Truesdell C., 1965, HDB PHYS, VIII
   Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3
NR 39
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 554-557
BP 2414
EP 2423
DI 10.4028/www.scientific.net/KEM.554-557.2414
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGA76
UT WOS:000322092101074
DA 2018-10-20
ER

PT S
AU Hamaguchi, K
   Tsuchiyama, T
   Matsushita, J
AF Hamaguchi, Kazuya
   Tsuchiyama, Tomoyuki
   Matsushita, Jun-ichi
BE Kai, T
   Mizuta, K
   Nakazato, T
   Matsunaga, N
   Hirata, Y
   Sameshima, S
   Tsutsui, T
   Yoshida, M
   Kim, H
   Yang, JF
   Sekino, T
TI Oxidation of Tantalum Nitride
SO ECO-MATERIALS PROCESSING AND DESIGN XIV
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 14th International Symposium on Eco-Materials Processing & Design
   (ISEPD)
CY JAN 15-18, 2013
CL Kagoshima, JAPAN
SP Kagoshima Univ, Dept Chem Engn, JSPS, KOSEF & NSCF, China Japan Korea A3 Foresight Program, Kagoshima Univ, Fac Engn, Ceram Soc Japan, Basic Sci Div
DE TaN; Ta2O5; oxidation; biomaterial
ID ALLOY
AB Tantalum (Ta) can be use a suture for operation and implant material in order not to react with body fluid and stimulate a human body [1,2]. In this study, the stable oxide of a tantalum, tantalum oxide layer produced by oxidation of the tantalum nitride, TaN powders by high temperature oxidation were investigated in order to determine the possibility of its a distributed aid for biomaterial composite such as an artificial root etc. The sample, TaN powder oxidized at high temperature exhibited a steady mass gain with increasing oxidation temperature. Based on the results of the XRD, tantalum oxide, Ta2O5 was detected on the samples. It is considered, the TaN showed a good oxidation film produced by high temperature oxidation.
C1 [Hamaguchi, Kazuya; Tsuchiyama, Tomoyuki; Matsushita, Jun-ichi] Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan.
RP Hamaguchi, K (reprint author), Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan.
EM jmatsu@keyaki.cc.u-tokai.ac.jp
FU Nagaoka University of Technology from the China-Japan-Korea (CJK) A3
   Foresight Program by JSPS; KOSEF; NSCF
FX This work was supported in part by Nagaoka University of Technology from
   the China-Japan-Korea (CJK) A3 Foresight Program by JSPS, KOSEF and
   NSCF.
CR Akahori T, 2008, MATER TRANS, V49, P365, DOI 10.2320/matertrans.MRA2007207
   Akahori T, 2007, MATER TRANS, V48, P293, DOI 10.2320/matertrans.48.293
   Fujii Tomoyuki, 2010, Journal of Solid Mechanics and Materials Engineering, V4, P1699, DOI 10.1299/jmmp.4.1699
   Matsuno T, 1998, J MATER SCI LETT, V17, P1349, DOI 10.1023/A:1026487222287
   Spanos N, 2006, J MATER SCI, V41, P1805, DOI 10.1007/s10853-006-2953-9
NR 5
TC 2
Z9 2
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 761
BP 125
EP +
DI 10.4028/www.scientific.net/MSF.761.125
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BGU11
UT WOS:000324148300026
DA 2018-10-20
ER

PT S
AU Ishiwata, K
   Tawara, K
   Matsushita, J
AF Ishiwata, Kazuki
   Tawara, Kazumasa
   Matsushita, Jun-ichi
BE Kai, T
   Mizuta, K
   Nakazato, T
   Matsunaga, N
   Hirata, Y
   Sameshima, S
   Tsutsui, T
   Yoshida, M
   Kim, H
   Yang, JF
   Sekino, T
TI Characterization of Hydroxyapatite containing of Titanium Hydride
   Sintered Body by Nano Size Powder
SO ECO-MATERIALS PROCESSING AND DESIGN XIV
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 14th International Symposium on Eco-Materials Processing & Design
   (ISEPD)
CY JAN 15-18, 2013
CL Kagoshima, JAPAN
SP Kagoshima Univ, Dept Chem Engn, JSPS, KOSEF & NSCF, China Japan Korea A3 Foresight Program, Kagoshima Univ, Fac Engn, Ceram Soc Japan, Basic Sci Div
DE hydroxyapatite; sintered body; bioceramic
AB The material study on bioactivitying artificial bone is lacking results for improve the quality of life (QOL) for individuals to fulfill their happy life in the society, which requires artificial bone to be replaced with neonatal bone by absorbing, regenerating the bone, which is not possible. Hydroxyapatite Caio(PO4)(6)(OH)(2), (HAp) has excellent biomaterial for biomedical and dental applications because of its superior properties. However, HAp had poor mechanical properties such as low hardness and fracture toughness. In this study, HAp containing titanium and titanium hydride (TiH2) sintered bodies were studied in order to investigate the possibility of its advanced biomaterials application. The nano particle size starting powders were milled by using mortar and muddler equipment. The sintered bodies were prepared by pressureless sintering at argon-hydrogen gas atmosphere. The samples were evaluated for bioactive performance by using simulated body fluid (SBF) solution for. The HAp-Ti, the HAp-TiH2 composite material is attractive as a bioceramics compared with HAp ceramics.
C1 [Ishiwata, Kazuki; Tawara, Kazumasa; Matsushita, Jun-ichi] Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan.
RP Ishiwata, K (reprint author), Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan.
EM jmatsu@keyaki.cc.u-tokai.ac.jp
FU Nagaoka University of Technology from the China-Japan-Korea (CJK) A3
   Foresight Program by JSPS; KOSEF; NSCF
FX This work was supported in part by Nagaoka University of Technology from
   the China-Japan-Korea (CJK) A3 Foresight Program by JSPS, KOSEF and
   NSCF.
CR Hayakawa T, 2008, J CERAM SOC JPN, V116, P68, DOI 10.2109/jcersj2.116.68
   Kumar RR, 2002, MATER LETT, V55, P133, DOI 10.1016/S0167-577X(01)00635-8
   Son J.S., 2011, JAPAN, V31, P113
   Yang J.H., 2010, JAPAN, V29, P480
NR 4
TC 0
Z9 1
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 761
BP 135
EP +
DI 10.4028/www.scientific.net/MSF.761.135
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BGU11
UT WOS:000324148300028
DA 2018-10-20
ER

PT S
AU Wu, TH
   Chen, KS
   Shen, LH
AF Wu, Te-Hsing
   Chen, Ko-Shao
   Shen, Lie-Hang
BE Liu, XH
   Zhang, KF
   Li, MZ
TI The Surface Modification and Characteristics of Useful Expanded PTFE
   Composites by Photo-radiation Methods
SO MATERIAL DESIGN, PROCESSING AND APPLICATIONS, PARTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 4th International Conference on Manufacturing Science and Engineering
   (ICMSE 2013)
CY MAR 30-31, 2013
CL Dalian, PEOPLES R CHINA
SP NE Univ, Harbin Inst Technol, Jilin Univ
DE Expanded polytetrafluoroethylene gamma-ray technology; plasma deposition
ID HYDROGELS
AB In this study, We immobilized hydrogel material onto expanded polytetrafluoroethylene (ePTFE) film and used as an functional biomaterial. The material is a film containing titanium oxide onto polymer sheet. The hydrogel film is hydrophilic, bacterial inactivated and bio-compatible. In order to improve the ePTFE film biocompatibility, the cold plasma or gamma-ray technology was used with acetic acid as monomer to deposit onto ePTFE film and then (N-isopropylacrylamide) was grafted onto the surface by radiation photo-grafting. The characteristics of the material surface were evaluated with X-ray photoelectron spectroscopy (XPS), FTIR and water contact angle. It was found that the contact angle of water on the untreated ePTFE significantly decrease from125 degrees to 72 degrees after ePTFE film being treated with acetic acid plasma deposition procedure. Due to the hydrophilicity of poly (N-isopropylacrylamide), so the contact angle of water on the ePTFE-g-NIPAAm almost approached to 0 degrees. This thermal-sensitive ePTFE hydrogels can be applied to artificial guiding tube and wound dressing material.
C1 [Wu, Te-Hsing; Chen, Ko-Shao; Shen, Lie-Hang] Inst Nucl Energy Res Rocaec, Tao Yuan, Taiwan.
RP Wu, TH (reprint author), Inst Nucl Energy Res Rocaec, Tao Yuan, Taiwan.
EM thwu@iner.gov.tw
CR Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ozturk V, 2002, POLYMER, V43, P5017, DOI 10.1016/S0032-3861(02)00357-9
   Rodriguez E, 2003, MACROMOL MATER ENG, V288, P607, DOI 10.1002/mame.200350006
NR 4
TC 0
Z9 0
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-692-5
J9 ADV MATER RES-SWITZ
PY 2013
VL 690-693
BP 1636
EP +
DI 10.4028/www.scientific.net/AMR.690-693.1636
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BGD89
UT WOS:000322498600336
DA 2018-10-20
ER

PT J
AU Uklejewski, R
   Winiecki, M
   Rogala, P
AF Uklejewski, Ryszard
   Winiecki, Mariusz
   Rogala, Piotr
TI Computer Aided Stereometric Evaluation of Porostructuralosteoconductive
   Properties of Intra-Osseous Implant Porous Coatings
SO METROLOGY AND MEASUREMENT SYSTEMS
LA English
DT Article
DE surface topography; porous coating characterization; poroaccessibility;
   3D measurement
ID ORTHOPEDIC IMPLANTS; BONE; FIXATION; PROSTHESIS; INGROWTH; SURFACE;
   TISSUE
AB The proper interaction of bone tissue the natural porous biomaterial - with a porous coated intra-osseous implant is conditioned, among others, by the implant porous coating poroaccessibility for bone tissue adaptive ingrowth. The poroaccessibility is the ability of implant porous coating outer layer to accommodate the ingrowing bone tissue filling in its pore space and effective new formed bone mineralizing in the pores to form a biomechanically functional bone-implant fixation. The functional features of the microtopography of intra-osseous implant porous surfaces together with the porosity of pore space of the outer layer of the porous coating are called by bioengineers the porostructural-osteoconductive properties of the porous coated implant. The properties are crucial for successful adaptive bone tissue ingrowth and further long-term (secondary) biomechanical stability of the bone-implant interface. The poroaccessibility of intra-osseous implants porous coating outer layers is characterized by the introduced in our previous papers - set of stereometric parameters of poroaccessibility: the effective volumetric porosity phi(Vef), the index of the porous coating space capacity V-PM, the representative surface porosity phi(Srep), the representative pore size P-Srep the representative angle of the poroaccessibility Omega(rep) and the bone-implant interface adhesive sin face enlargement index psi, Presented in this paper, an original method of evaluation of the porostructural-osteoconductive properties of ultra osseous implant porous coatings outer layer by means of the parameters of poroaccessibility was preliminary verified during experimental tests performed on the representative examples of porous coated femoral stems and acetabular cups of various hip endoprostheses. The computer aided stereometric evaluation of the microstructure of implant porous coatings outer layer can be now realized by the authoring application software PoroAccess_1.0 elaborated in our research team in Java programming language.
C1 [Uklejewski, Ryszard; Winiecki, Mariusz] Casimir Great Univ, Inst Technol, Dept Med Bioengn Fundamentals, PL-85064 Bydgoszcz, Poland.
   [Uklejewski, Ryszard; Winiecki, Mariusz] Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, Lab Biomat & Bioproc Engn, PL-60965 Poznan, Poland.
   [Rogala, Piotr] Poznan Univ Med Sci, Dept Spine Surg Oncol Orthopaed & Traumatol, PL-61545 Poznan, Poland.
RP Uklejewski, R (reprint author), Casimir Great Univ, Inst Technol, Dept Med Bioengn Fundamentals, Chodkiewicza 30, PL-85064 Bydgoszcz, Poland.
EM uklejew@ukw.edu.pl; winiecki@ukw.edu.pl; progala@orsk.ump.edu.pl
RI Winiecki, Mariusz/J-4565-2013
OI Winiecki, Mariusz/0000-0002-3568-2473
FU Polish Ministry of Science [4T07C05629, NN518412638]
FX This research was supported by the Polish Ministry of Science by
   research project no 4T07C05629 (2005-2008): "Experimental investigation
   and design of the constructional properties of hone porous implants
   fixations" and the research project no NN518412638 (2010-2014): The
   optimization of the manufacturing directives and the termochemical
   surface modification of prototypes of the minimally invasive RIIA
   endoprostheses and porous hone implants" (Head of the projects: R.
   Uklejewski),
CR Abott E. J., 1933, MECH ENG, V55, P569
   Bragdon CR, 2004, J BONE JOINT SURG AM, V86A, P105, DOI 10.2106/00004623-200412002-00015
   BROOKER AF, 1984, J BONE JOINT SURG AM, V66A, P619, DOI 10.2106/00004623-198466040-00021
   COOK SD, 1985, CLIN ORTHOP RELAT R, P271
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   GALANTE J, 1973, J BIOMED MATER RES, V7, P43, DOI 10.1002/jbm.820070305
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Landor I, 2007, ARCH ORTHOP TRAUM SU, V127, P81, DOI 10.1007/s00402-006-0235-1
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Rogala P., 2007, P 11 INT C METR PROP, P241
   Rogala P., 2007, P 6 SEM SURF STER ME, P61
   Rogala P., 2006, ENG BIOMAT, V54-55, P1
   Rogala P., 2006, J BIOMECH S1, V39, pS14
   Rogala Piotr, 2002, Chir Narzadow Ruchu Ortop Pol, V67, P309
   Rogala Piotr, 2002, Chir Narzadow Ruchu Ortop Pol, V67, P395
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Stout K. J, 2000, DEV METHODS CHARACTE
   Stryla W, 2004, INT J REHABIL RES, V27, P175
   Stryla W., 2007, ENG BIOMAT, V69-72, P93
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Svehla M, 2002, J ARTHROPLASTY, V17, P304, DOI 10.1054/arth.2002.30410
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Uklejewski R, 2008, METROL MEAS SYST, V15, P215
   Uklejewski R., 2011, P 13 INT C METR PROP, P103
   Winiecki M., 2006, THESIS POZNAN U TECH
   Yang YZ, 2000, J BIOMED MATER RES, V52, P333, DOI 10.1002/1097-4636(200011)52:2<333::AID-JBM12>3.3.CO;2-K
NR 28
TC 0
Z9 0
U1 0
U2 8
PU POLISH ACAD SCIENCES COMMITTEE METROLOGY & RES EQUIPMENT
PI WARSAW
PA UL MIODOWA 10, WARSAW, 00251, POLAND
SN 0860-8229
J9 METROL MEAS SYST
JI Metrol. Meas. Syst.
PY 2013
VL 20
IS 3
BP 431
EP 442
DI 10.2478/mms-2013-0037
PG 12
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA 213AW
UT WOS:000324026300010
OA Bronze
DA 2018-10-20
ER

PT J
AU Shoaib, A
   Aslam, N
   Athar, MM
   Akhtar, S
   Nafisa
   Khurshid, S
AF Shoaib, Amna
   Aslam, Nida
   Athar, M. Makshoof
   Akhtar, Sundus
   Nafisa
   Khurshid, Saba
TI Removal of Cr(III) through Bread Mold Fungus
SO POLISH JOURNAL OF ENVIRONMENTAL STUDIES
LA English
DT Article
DE adsorption; bread mold fungus; metal; Cr(III); desorption
ID AQUEOUS-SOLUTION; SACCHAROMYCES-CEREVISIAE; HEXAVALENT CHROMIUM;
   ASPERGILLUS-NIGER; HEAVY-METALS; BIOSORPTION; WATER; BIOMASS; CR;
   ADSORPTION
AB Cr(III) removal ability of indigenous soil fungus of Pakistan (i.e. Rhizopus arrhizus Fisher) was checked through batch trails. Experiments were performed by taking 0.1 g of powdered fungal biomass in 100 mL of metal solution kept at 150 rpm for 3 hours. Results of FTIR spectroscopy revealed that amine (-NH2) and hydroxyl (-OH) groups participated in Cr(III) binding with the fungal biomass. There was an inversely proportional relationship between adsorption efficiency and capacity on increasing initial metal concentration in the range of 20-100 mg/L. The adsorption capacity of fungal biomass was 43.47 mg/g as determined by Langmuir isotherm. High correlation coefficient (R-2: 0.99) acquired through Langumir and Frendulich models adequately described the adsorption mechanism on fungal biomass. pH optimization trials in the range of 2-10 exhibited significantly greater adsorption efficiency of 75% at pH 4, while metal removal rate declined with increasing pH. Adsorption/adsorption trials with four acids indicted that maximum desorption of Cr(III) was found with HCl, followed by HNO3, CH3COOH, and H2SO4. Adsorption-based trials summarized that R. arrhizus is a potential and inexpensive biomaterial with viable application in the removal of Cr(III) from the aqueous solution.
C1 [Shoaib, Amna; Aslam, Nida; Akhtar, Sundus; Nafisa; Khurshid, Saba] Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
   [Athar, M. Makshoof] Univ Punjab, Ist Chem, Lahore, Pakistan.
RP Shoaib, A (reprint author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
EM aamnaa29@yahoomail.com
CR Ahmad Iqbal, 2006, Indian J Exp Biol, V44, P73
   [Anonymous], 2001, NATL ENV QUALITY STA
   Babel S, 2007, INT J ENVIRON SCI TE, V4, P99, DOI 10.1007/BF03325967
   Barros J., 2003, BRAZ J CHEM ENG, V20, P229
   Cavaco SA, 2007, J HAZARD MATER, V144, P634, DOI 10.1016/j.jhazmat.2007.01.087
   Costa M, 2003, TOXICOL APPL PHARM, V188, P1, DOI 10.1016/S0041-008X(03)00011-5
   Diniz V, 2006, SEP PURIF TECHNOL, V50, P71, DOI 10.1016/j.seppur.2005.11.010
   Dubey SP, 2007, J HAZARD MATER, V145, P465, DOI 10.1016/j.jhazmat.2006.11.041
   Ebner C., 2002, EUR J MINER PROCESS, V2, P168
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0
   Iqbal Ahmad, 2005, Journal of Applied Sciences and Environmental Management, V9, P123
   Javaid A., 2008, MYCOPATH, V6, P1
   Kadirvelu K, 2000, ENVIRON TECHNOL, V21, P1091, DOI 10.1080/09593330.2000.9618995
   Khambhaty Y, 2009, WORLD J MICROB BIOT, V25, P1413, DOI 10.1007/s11274-009-0028-0
   Kumar J. I. N., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P317
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Lokeshwari N., 2009, GLOBAL J ENV RES, V3, P29
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Masood Alam, 2009, Rasayan Journal of Chemistry, V2, P791
   Mitic-Stojanovic DL, 2011, WATER SA, V37, P303
   Mohan D, 2005, IND ENG CHEM RES, V44, P1027, DOI 10.1021/ie0400898
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   PATTY FEIST L, 2001, J CHEM EDUC, V78, P351
   Prigione V, 2009, BIORESOURCE TECHNOL, V100, P2770, DOI 10.1016/j.biortech.2009.01.002
   Rafique U, 2010, J CHEM SOC PAKISTAN, V32, P644
   RAJENDER K, 2008, J CHEM ENG, V135, P202
   Sag Y, 2001, SEPAR PURIF METHOD, V30, P1, DOI 10.1081/SPM-100102984
   Sari A, 2007, J HAZARD MATER, V144, P41, DOI 10.1016/j.jhazmat.2006.09.080
   Sepehr M. N., 2005, Iranian Journal of Environmental Health Science & Engineering, V2, P273
   Shrestha R, 2007, INT J ENVIRON SCI TE, V4, P413, DOI 10.1007/BF03325975
   Steel R.G.D., 1980, PRINCIPLES PROCEDURE
   Subbaiah MV, 2008, E-J CHEM, V5, P499
   Vinodhini V., 2009, American-Eurasian Journal of Scientific Research, V4, P324
   Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001
   Wang JL, 2002, PROCESS BIOCHEM, V37, P847, DOI 10.1016/S0032-9592(01)00284-9
   Wankasi D, 2005, AFR J BIOTECHNOL, V4, P923
   Yousefi N., 2011, SACHA J ENV STUD, V1, P81
NR 38
TC 5
Z9 6
U1 0
U2 1
PU HARD
PI OLSZTYN 5
PA POST-OFFICE BOX, 10-718 OLSZTYN 5, POLAND
SN 1230-1485
EI 2083-5906
J9 POL J ENVIRON STUD
JI Pol. J. Environ. Stud.
PY 2013
VL 22
IS 4
BP 1171
EP 1176
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 204WT
UT WOS:000323402700022
DA 2018-10-20
ER

PT B
AU Tran, PL
   Gamboa, JR
   McCracken, KE
   Yoon, JY
   Slepian, MJ
AF Tran, Phat L.
   Gamboa, Jessica R.
   McCracken, Katherine E.
   Yoon, Jeong-Yeol
   Slepian, Marvin J.
GP ASME
TI INTERACTION WITH NANOSCALE TOPOGRAPHY: THE USE OF NANOWELL-TRAPPED
   CHARGED LIGAND-BEARING NANOPARTICLE SURFACES TO MODULATE PHYSIOLOGICAL
   FOCAL ADHESIONS IN ENDOTHELIAL CELLS
SO PROCEEDINGS OF THE ASME 2ND GLOBAL CONGRESS ON NANOENGINEERING FOR
   MEDICINE AND BIOLOGY, NEMB 2013
LA English
DT Proceedings Paper
CT 2nd ASME Global Congress on NanoEngineering for Medicine and Biology
CY FEB 04-06, 2013
CL Boston, MA
SP ASME
ID IN-VITRO; MIGRATION; PECAM-1; BIOLOGY; PLATELET; MOLECULE; BEHAVIOR
AB Achieving cell adhesion, growth and homeostasis on an underlying biomaterial surface may be a desirable feature in implant device design and tissue engineering. Insight has been gained from numerous cell patterning strategies where spatial cues and physical constraints have been shown to regulate the structure and function of cells. Despite significant advances in modifying substrates for cellular attachment, migration - and proliferation, the achievement of confluent and aligned growth of functional endothelial cells on cardiovascular blood-contacting implants under physiologically significant wall shear stress has proven difficult. Recently we have reported on a method that enhances cellular adhesion under flow conditions on synthetic polymer surfaces, without reliance on pro-adhesive protein biomaterials, which are often thrombogenic. In this method we utilize electron beam lithography and size-dependent self-assembly to fabricate line arrays of nanowells allowing entrapment and retention of charged nanoparticles, covalently conjugated with a RGD adhesive ligand, GRGDSPK. This approach is an additive strategy of combining substrata topographic alteration, electrostatic charge and biochemical ligands, all uniquely incorporated as an ensemble of charged, ligand-bearing nanoparticles entrapped in arrays of nanowells. However, the modulation of endothelial cell physiologic mechanisms as a result of ensemble surface exposure remains to be characterized.
   In this report, we extend our studies and probe cell physiologic mechanisms altered as a result of nanofeatured surface exposure. We first examined the functional intactness or normalcy of endothelial cells adherent to the nanofeatured ensemble surface utilizing standard immunostaining and flow cytometry methods. We found beta 1-integrin expression dominated quiescent adherent endothelial cells while alpha V beta 3-integrins expression was more common in migratory cells. Endothelial cells were noted to express high levels of PECAM-1 over time when exposed to nanofeatured surface and RGD peptides. For understanding the contribution of the nanofeatured surface (entrapped RGD conjugated nanoparticles) to cell adhesion, cytochalasin B was used to alter cell spreading. Confocal microscopy illustrated the uptake of nanoparticles in endothelial cells on composite surfaces, as well as the inhibition of this endocytosis by cytochalasin B. After prohibiting the cells from engulfing nanoparticles, we found an 80% reduction in cell adhesion; suggesting that an endocytic mechanism might play a role in maintaining cell adhesion. Nanofeatured ensemble surfaces appear to be good substrates for achieving a high level of EC adhesion, with maintained growth and stability.
C1 [Tran, Phat L.; Gamboa, Jessica R.; McCracken, Katherine E.; Yoon, Jeong-Yeol; Slepian, Marvin J.] Univ Arizona, Tucson, AZ 85721 USA.
RP Tran, PL (reprint author), Univ Arizona, Tucson, AZ 85721 USA.
CR Albelda S, 1990, J FEDERATION AM SOC, V4, P2868
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   BEAUVAIS A, 1995, J CELL BIOL, V128, P699, DOI 10.1083/jcb.128.4.699
   Blattler T, 2006, J NANOSCI NANOTECHNO, V6, P2237, DOI 10.1166/jnn.2006.501
   Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765
   Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002
   Hoffman AS, 2004, BIOMATERIALS SCI INT
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   KIRCHBERG K, 1995, EXP CELL RES, V220, P29, DOI 10.1006/excr.1995.1288
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   Lin A, 2010, J BIOMED MATER RES A, V93A, P833, DOI 10.1002/jbm.a.32592
   Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r
   Mwenifumbo S, 2008, BIOMEDICAL NANOSTRUCTURES, P225
   Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129
   Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9
   Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   SIMIONESCU M, 1986, ANNU REV PHYSIOL, V48, P279
   Slepian MJ, 1998, CIRCULATION, V97, P1818, DOI 10.1161/01.CIR.97.18.1818
   TANAKA Y, 1992, J EXP MED, V176, P245, DOI 10.1084/jem.176.1.245
   Tran P.L, 2011, ADV HE IN PRESS 1005
   Tran PL, 2010, ANAL BIOANAL CHEM, V398, P759, DOI 10.1007/s00216-010-3990-3
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   Yoo JW, 2010, MACROMOL RAPID COMM, V31, P142, DOI 10.1002/marc.200900592
NR 29
TC 0
Z9 0
U1 0
U2 6
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4533-2
PY 2013
BP 117
EP 124
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGR82
UT WOS:000323918200041
DA 2018-10-20
ER

PT J
AU Oe, K
   Jingushi, S
   Iida, H
   Tomita, N
AF Oe, Kenichi
   Jingushi, Seiya
   Iida, Hirokazu
   Tomita, Naohide
TI Evaluation of the clinical performance of ultrahigh molecular weight
   polyethylene fiber cable using a dog osteosynthesis model
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Ultrahigh molecular weight polyethylene fiber cable; biomaterials;
   osteosynthesis; greater trochanter osteotomy
ID TROCHANTERIC OSTEOTOMY; HIP-REPLACEMENT; GREATER TROCHANTER; GRIP
   SYSTEM; WIRE; COMPLICATIONS; REATTACHMENT; FIXATION
AB The purpose of this study was to assess the removability and biological reactivity of an ultrahigh molecular weight polyethylene (UHMWPE) fiber cable as a new biomaterial for osteosynthesis. We used a pull-out test and an implantation test to analyze the performance of the UHMWPE fiber cable using a dog model, and compared its characteristics with those of a wire cable and a soft wire. In the pull-out test, the UHMWPE fiber cable was as easy to remove as the soft wire, and both the UHMWPE fiber cable and the soft wire were significantly easier to remove than the wire cable. The fixation capability and the biological reactivity of the UHMWPE fiber cable were examined in an osteosynthesis model of the dog greater trochanter, and were compared with those of the soft wire. The bone union rate, assessed radiographically, was very similar when using the UHMWPE fiber cable and the soft wire. However, in the soft wire group, both the surface of the greater trochanter under the fixation material and the penetration area around the fixation material showed an increased tendency toward a biological reaction, including inflammation and granulation tissue formation, as compared to the UHMWPE fiber cable group. The UHMWPE fiber cable was as easily removed from the bone tissue as the soft wire, and was easier to remove than the wire cable. Additionally, the UHMWPE fiber cable caused reduced biological reactivity with the surrounding tissue, as compared with the soft wire. In conclusion, the UHMWPE fiber cable appeared to be a suitable fixation material for osteosynthesis.
C1 [Oe, Kenichi; Iida, Hirokazu] Kansai Med Univ, Dept Orthopaed Surg, Osaka, Japan.
   [Jingushi, Seiya] Kyushu Rosai Hosp, Dept Orthopaed Surg, Kitakyushu, Fukuoka 8000296, Japan.
   [Tomita, Naohide] Kyoto Univ, Grad Sch Engn, Bioengn Lab, Kyoto, Japan.
RP Jingushi, S (reprint author), Kyushu Rosai Hosp, Dept Orthopaed Surg, Kokura Minami Ku, 1-1 Sone Kita Machi, Kitakyushu, Fukuoka 8000296, Japan.
EM jingushi.orth@kyushuh.rofuku.go.jp
FU Alfresa Pharma Co.
FX This study was supported by a grant from Alfresa Pharma Co. The funds
   were used to pay for all aspects of the study, including the animals,
   chemicals and supplies. We would like to thank Yasumi Ishida, Tsutomu
   Morihara and Yasuo Sasai. We are also obliged to Dai Watanabe, Yoshikazu
   Nagashima, Makoto Ishigami, Kayoko Kudo and Koichi Suwa for their
   excellent technical assistance with this project.
CR AMSTUTZ HC, 1978, J BONE JOINT SURG AM, V60, P214, DOI 10.2106/00004623-197860020-00013
   DALL DM, 1983, J BONE JOINT SURG BR, V65, P55
   Dickman CA, 1997, SPINE, V22, P596, DOI 10.1097/00007632-199703150-00004
   Eftekhar N.S., 1993, TOTAL HIP ARTHROPLAS, P16
   JENSEN NF, 1986, CLIN ORTHOP RELAT R, P174
   KELLEY SS, 1992, CLIN ORTHOP RELAT R, P140
   Murakami H, 2006, J SPINAL DISORD TECH, V19, P442, DOI 10.1097/00024720-200608000-00012
   Naughton CK, 2004, J ANDROL, V25, P545
   NUTTON RW, 1984, J BONE JOINT SURG BR, V66, P180
   OH I, 1985, CLIN ORTHOP RELAT R, P228
   RITTER MA, 1991, J BONE JOINT SURG BR, V73, P580
   Silverton CD, 1996, J ARTHROPLASTY, V11, P400, DOI 10.1016/S0883-5403(96)80029-5
   WROBLEWSKI BM, 1985, J BONE JOINT SURG BR, V67, P736
NR 13
TC 0
Z9 1
U1 1
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2013
VL 23
IS 5
BP 329
EP 338
DI 10.3233/BME-130757
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 210PD
UT WOS:000323845500002
PM 23988705
DA 2018-10-20
ER

PT J
AU Martin-Lopez, E
   Darder, M
   Ruiz-Hitzky, E
   Sampedro, MN
AF Martin-Lopez, Eduardo
   Darder, Margarita
   Ruiz-Hitzky, Eduardo
   Nieto Sampedro, Manuel
TI Agar-based bridges as biocompatible candidates to provide guide cues in
   spinal cord injury repair
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Agar; kappa-carrageenan; gelatin; xanthan gum; polysulfone; axonal
   regeneration; spinal cord bridges
ID PERIPHERAL-NERVE REGENERATION; ADULT-RAT; AXONAL REGENERATION; PROTEIN
   ADSORPTION; NEURITE OUTGROWTH; SCHWANN-CELLS; FIBRIN GELS; SCAFFOLDS;
   MATRIX; CHANNELS
AB BACKGROUND: Spinal bridge implants are strategic to provide growth surfaces for axonal regeneration after spinal cord injuries. The design of an appropriate substrate, one that is suitable for implantation, must involve careful testing of the biomaterial properties both in vitro and in vivo.
   OBJECTIVE: The goal of this work was to test the structure, stability and biological response after spinal bridges implantation of several biopolymers, composed of mixtures of agar (AG), as structural matrix scaffold, with kappa-carrageenan (Kc), gelatin (G), xanthan gum (Xn) and polysulfone (PS).
   METHODS: Biopolymer structures were studied by environmental scanning electron microscopy, whereas the stability of gels was analyzed by in vitro degradation and swelling tests. The biocompatibility of these materials and their ability to promote cell growth and axonal regeneration were studied by implantation of spinal bridges containing empty linear channels in an acute rat spinal cord transection model at thoracic level (T8).
   RESULTS AND CONCLUSIONS: All gel mixtures gave rise to porous structures and they were stables to degradation, excepting the AG+G mixture. Spinal bridges constructed from all mixtures were implanted during a month in adult rats. After this time a low host reaction occurred to all bridge materials as well as neurite and cell ingrowths through the empty channels. Neurites within the bridges were mostly peripheral sensory fibers such as those positive for CGRP, whereas there was a lack of regeneration of central axons crossing from the spinal tissue to bridges. Many of these neurites established closed contacts with non-myelin Schwann cells. The histological analysis revealed a high accumulation of collagen fibers within the channels. Unexpected was the apparent loss of channels linearity which affected the growth of neurites and cells, indicating the need for additional regeneration strategies and vertebrae bridge fixing.
C1 [Martin-Lopez, Eduardo; Nieto Sampedro, Manuel] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, E-28002 Madrid, Spain.
   [Darder, Margarita; Ruiz-Hitzky, Eduardo] Madrid Inst Mat Sci, Dept New Architectures Mat Chem, Madrid, Spain.
   [Nieto Sampedro, Manuel] Natl Hosp Parapleg, Expt Neurol Unit, Toledo, Spain.
RP Martin-Lopez, E (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.
EM elopez@cns.bcm.edu
RI Darder, Margarita/H-9214-2015; Ruiz-Hitzky, Eduardo/G-2727-2010
OI Darder, Margarita/0000-0002-7032-0419; Ruiz-Hitzky,
   Eduardo/0000-0003-4383-7698
CR Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Belyantseva IA, 1999, EUR J NEUROSCI, V11, P457, DOI 10.1046/j.1460-9568.1999.00458.x
   Bertram U, 2006, EUR J PHARM SCI, V27, P62, DOI 10.1016/j.ejps.2005.08.005
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558
   Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622
   He QR, 2009, J MATER SCI-MATER M, V20, P1457, DOI 10.1007/s10856-009-3702-8
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   LABRADOR RO, 1995, NEUROREPORT, V6, P2022, DOI 10.1097/00001756-199510010-00017
   Mihai G, 2008, J NEUROTRAUM, V25, P1, DOI 10.1089/neu.2007.0338
   MILLARUELO AI, 1988, BRAIN RES, V466, P219
   Mingyu Cheng, 2004, J Biomater Appl, V19, P59, DOI 10.1177/0885328204043450
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Neafsey E. J., 1996, BRAIN RES, V396, P77
   Ng CEL, 2002, J NEUROSCI RES, V67, P559, DOI 10.1002/jnr.10134
   Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015
   Salgado-Ceballos H, 1998, BRAIN RES, V782, P126
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   TRAUB RJ, 1989, J COMP NEUROL, V287, P225, DOI 10.1002/cne.902870206
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zinck NDT, 2007, EXP NEUROL, V204, P777, DOI 10.1016/j.expneurol.2007.01.011
NR 47
TC 1
Z9 2
U1 2
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2013
VL 23
IS 5
BP 405
EP 421
DI 10.3233/BME-130763
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 210PD
UT WOS:000323845500008
PM 23988711
DA 2018-10-20
ER

PT J
AU Prodanov, L
   van Loon, JJWA
   te Riet, J
   Jansen, JA
   Walboomers, XF
AF Prodanov, Ljupcho
   van Loon, Jack J. W. A.
   te Riet, Joost
   Jansen, John A.
   Walboomers, X. Frank
TI Substrate Nanotexture and Hypergravity Through Centrifugation Enhance
   Initial Osteoblastogenesis
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID INCREASED BAX/BCL-2 RATIO; MATRIX DEPOSITION; CELLS; BONE; BEHAVIOR;
   PROLIFERATION; MICROGRAVITY; INCREASES; APOPTOSIS; RELEASE
AB Mimicking the structural nanomolecular extracellular matrix with synthetically designed nanosized materials is a relatively new approach, which can be applied in the field of bone tissue engineering. Likewise, bone tissue-engineered constructs can be aided in their development by the use of several types of mechanical stimuli. In this study, we wanted to combine nanotextured biomaterials and centrifugation in one multifactorial system. Mesenchymal stem cells were isolated from rat bone marrow, and cultured on a nanogrooved polystyrene substrate (200-nm-wide pitch with a depth of 50 nm). Constant centrifugation of 10 g was applied to cells up to 7 days. Results showed that on a nanogrooved substrate osteoblast-like cells align parallel to the groove direction. Centrifugation of 10 g also affected cell morphology on a smooth surface. Moreover, cell alignment was significantly reduced for cells grown on nanogrooved substrates, which were subsequently subjected to centrifugation. Independently, both stimuli increased the number of cells after 7 days of culture. However, when both stimuli were combined, an additive effect on cell number was observed, followed by an enhanced effect on osteocalcin mRNA expression and matrix mineralization. In conclusion, biomaterial surface modification as well as centrifugation are effective means to enhance bone cell behavior, moreover, readily available to many tissue engineers.
C1 [Prodanov, Ljupcho; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6525 EX Nijmegen, Netherlands.
   [van Loon, Jack J. W. A.] Univ Amsterdam, DESC ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.
   [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands.
   [van Loon, Jack J. W. A.] ESA, TEC MMG, Estec, Noordwijk, Netherlands.
   [te Riet, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 EX Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI te Riet, Joost/L-1584-2015; van Loon, Jack/A-4250-2013; Jansen,
   John/H-8055-2014; Walboomers, X.Frank/B-3692-2013
OI te Riet, Joost/0000-0002-9093-010X; 
FU Microgravity Research Program of NWO-Netherlands Space Office (NSO)
   [ALW-GO-MG 07-01, MG-057]; Dutch Technology Foundation STW, applied
   science division of NWO; Netherlands Organization for Scientific
   Research (NWO) [680-47-421]
FX This study was supported by the Microgravity Research Program of
   NWO-Netherlands Space Office (NSO, Grant ALW-GO-MG 07-01, and MG-057),
   the Dutch Technology Foundation STW, applied science division of NWO.
   Joost te Riet is supported by personal VENI grant (680-47-421) of The
   Netherlands Organization for Scientific Research (NWO). We would like to
   acknowledge the support of Mr. Alan Dowson from ESA-ESTEC-TEC-MMG.
CR ALBRECHTBUEHLER G, 1977, J CELL BIOL, V72, P595, DOI 10.1083/jcb.72.3.595
   Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034
   Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4
   BRUNS RR, 1976, J CELL BIOL, V68, P521, DOI 10.1083/jcb.68.3.521
   Burton R R, 1994, J Gravit Physiol, V1, pP15
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hess R., 2011, J BIOMECH ENG, V132
   Hughes L C, 2005, Eur Cell Mater, V9, P68
   HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116
   Kacena MA, 2004, MICROGRAVITY SCI TEC, V15, P28, DOI 10.1007/BF02870949
   Kato Y, 2003, ZOOL SCI, V20, P1373, DOI 10.2108/zsj.20.1373
   Lamers E., 2011, EUROPEAN CELLS MAT, V20, P329
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702
   Loboa E.G., 2012, TISSUE ENG PART B-RE, V16, P435
   Loesberg WA, 2006, CELL MOTIL CYTOSKEL, V63, P384, DOI 10.1002/cm.20132
   Lumachi F, 2009, ANN NY ACAD SCI, V1173, pE60, DOI 10.1111/j.1749-6632.2009.04953.x
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]
   MIWA M, 1991, BONE MINER, V14, P15, DOI 10.1016/0169-6009(91)90099-L
   Morita S, 2004, ANN NY ACAD SCI, V1030, P158, DOI 10.1196/annals.1329.020
   Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1
   Pestov I D, 1997, J Gravit Physiol, V4, pP93
   Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050
   Puetzer JL, 2012, TISSUE ENG PT A, V18, P1365, DOI [10.1089/ten.tea.2011.0589, 10.1089/ten.TEA.2011.0589]
   Salakou S, 2007, IN VIVO, V21, P123
   Searby ND, 2005, AM J PHYSIOL-CELL PH, V289, pC148, DOI 10.1152/ajpcell.00524.2003
   Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901
   van Delft FCMJ, 2008, MICROELECTRON ENG, V85, P1362, DOI 10.1016/j.mee.2008.01.028
   Van Loon JJWA, 2009, J MICROSC-OXFORD, V233, P234, DOI 10.1111/j.1365-2818.2009.03113.x
   van Loon J. J. W. A., 2008, ESA
   van Loon Jack J W A, 2004, J Gravit Physiol, V11, P29
   VANLOON JJWA, 1995, J BONE MINER RES, V10, P550
   Walboomers XF, 2006, J BIOMED MATER RES A, V76A, P16, DOI 10.1002/jbm.a.30304
   Wiren KM, 2006, BONE, V38, P637, DOI 10.1016/j.bone.2005.10.029
   Zhang F, 2011, TISSUE ENG PART B-RE, V17, P115, DOI [10.1089/ten.teb.2010.0549, 10.1089/ten.TEB.2010.0549]
NR 38
TC 7
Z9 9
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2013
VL 19
IS 1-2
BP 114
EP 124
DI 10.1089/ten.tea.2012.0267
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 057XS
UT WOS:000312598400012
PM 22871341
OA Green Published
DA 2018-10-20
ER

PT J
AU Orth, P
   Cucchiarini, M
   Kohn, D
   Madry, H
AF Orth, Patrick
   Cucchiarini, Magali
   Kohn, Dieter
   Madry, Henning
TI ALTERATIONS OF THE SUBCHONDRAL BONE IN OSTEOCHONDRAL REPAIR -
   TRANSLATIONAL DATA AND CLINICAL EVIDENCE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Subchondral bone; microarchitecture; marrow stimulation; microfracture;
   subchondral drilling; abrasion arthroplasty
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE REPAIR; 3RD
   CARPAL BONE; SHEEP TEMPOROMANDIBULAR-JOINT; MARROW-STIMULATION
   TECHNIQUES; LEUKEMIA INHIBITORY FACTOR; FULL-THICKNESS CARTILAGE;
   DEFECTS IN-VIVO; KAPPA-B LIGAND; CHONDRAL DEFECTS
AB Alterations of the subchondral bone are pathological features associated with spontaneous osteochondral repair and with articular cartilage repair procedures. The aim of this review is to discuss their incidence, extent and relevance, focusing on recent knowledge gained from both translational models and clinical studies of articular cartilage repair. Efforts to unravel the complexity of subchondral bone alterations have identified (1) the upward migration of the subchondral bone plate, (2) the formation of intralesional osteophytes, (3) the appearance of subchondral bone cysts, and (4) the impairment of the osseous microarchitecture as potential problems. Their incidence and extent varies among the different small and large animal models of cartilage repair, operative principles, and over time. When placed in the context of recent clinical investigations, these deteriorations of the subchondral bone likely are an additional, previously underestimated factor that influences the long-term outcome of cartilage repair strategies. Understanding the role of the subchondral bone in both experimental and clinical articular cartilage repair thus holds great promise of being translated into further improved cell-or biomaterial-based techniques to preserve and restore the entire osteochondral unit.
C1 [Orth, Patrick; Cucchiarini, Magali; Madry, Henning] Univ Saarland, Ctr Expt Orthopaed, D-66421 Homburg, Germany.
   [Orth, Patrick; Kohn, Dieter; Madry, Henning] Univ Saarland, Med Ctr, Dept Orthopaed Surg, D-66421 Homburg, Germany.
RP Madry, H (reprint author), Univ Saarland, Ctr Expt Orthopaed, Kirrberger Str,Bldg 37, D-66421 Homburg, Germany.
EM henning.madry@uks.eu
FU Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin (GOTS);
   Alwin Jager Stiftung (AJS); Deutsche Arthrose-Hilfe e.V.; Gesellschaft
   fur Arthroskopie und Gelenkchirurgie (AGA)
FX Supported in part by the Gesellschaft fur Orthopadisch-Traumatologische
   Sportmedizin (GOTS), the Alwin Jager Stiftung (AJS), the Deutsche
   Arthrose-Hilfe e.V., and the Gesellschaft fur Arthroskopie und
   Gelenkchirurgie (AGA). We wish to confirm that there are no known
   conflicts of interest associated with this publication and there has
   been no significant financial support for this work that could have
   influenced its outcome.
CR Anderson AF, 2009, AM J SPORT MED, V37, p7S, DOI 10.1177/0363546509354205
   Aroen A, 2006, J ORTHOP RES, V24, P1069, DOI 10.1002/jor.20104
   Bachmann G, 2004, RADIOLOGE, V44, P773, DOI 10.1007/s00117-004-1084-y
   Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   Batty L, 2011, ANZ J SURG, V81, P18, DOI 10.1111/j.1445-2197.2010.05495.x
   Benazzo F, 2008, J ORTHOP RES, V26, P631, DOI 10.1002/jor.20530
   Blom AB, 2010, CURR DRUG TARGETS, V11, P620
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BROOM ND, 1982, J ANAT, V135, P65
   Brown WE, 2004, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000129162.36302.4f
   BULLOUGH PG, 1983, J BONE JOINT SURG BR, V65, P72
   Burr DB, 2004, J RHEUMATOL, V31, P77
   Chen HM, 2011, J ORTHOP RES, V29, P1178, DOI 10.1002/jor.21386
   Chen HM, 2011, AM J SPORT MED, V39, P1731, DOI 10.1177/0363546511403282
   Chen HM, 2009, J ORTHOP RES, V27, P1432, DOI 10.1002/jor.20905
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   Cole BJ, 2009, J BONE JOINT SURG AM, V91A, P1778
   Cox LGE, 2011, BONE, V49, P762, DOI 10.1016/j.bone.2011.06.028
   Cucchiarini M, 2013, J MOL MED, V91, P625, DOI 10.1007/s00109-012-0978-9
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001
   Drobnic M, 2010, J BONE JOINT SURG BR, V92B, P602, DOI 10.1302/0301-620X.92B3.22558
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Fortier LA, 2012, J KNEE SURG, V25, P3, DOI 10.1055/s-0032-1310389
   Frisbie DD, 2006, AM J SPORT MED, V34, P1824, DOI 10.1177/0363546506289882
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Funck-Brentano T, 2011, CYTOKINE GROWTH F R, V22, P91, DOI 10.1016/j.cytogfr.2011.04.003
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Gerber HP, 1999, NAT MED, V5, P623
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gill T J, 2000, Am J Knee Surg, V13, P33
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Goebel L, 2012, OSTEOARTHR CARTILAGE, V20, P1046, DOI 10.1016/j.joca.2012.05.010
   Gomoll AH, 2010, J BONE JOINT SURG AM, V92A, P2470
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Grana W A, 2000, Am J Knee Surg, V13, P29
   GREEN WT, 1970, ARCH PATHOL, V90, P151
   Greenfield EM, 1996, J BIOL CHEM, V271, P10984, DOI 10.1074/jbc.271.18.10984
   Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018
   Guettler JH, 2004, AM J SPORT MED, V32, P1451, DOI 10.1177/0363546504263234
   HANIE EA, 1992, EQUINE VET J, V24, P382, DOI 10.1111/j.2042-3306.1992.tb02860.x
   Hayter Catherine, 2011, J Knee Surg, V24, P225
   Heir S, 2012, KNEE SURG SPORT TR A, V20, P197, DOI 10.1007/s00167-011-1596-8
   Henderson IJP, 2005, KNEE, V12, P435, DOI 10.1016/j.knee.2005.04.003
   Henrotin Y, 2009, BIO-MED MATER ENG, V19, P311, DOI 10.3233/BME-2009-0596
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   HOWARD RD, 1994, AM J VET RES, V55, P1158
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hunziker EB, 2003, OSTEOARTHR CARTILAGE, V11, P320, DOI 10.1016/S1063-4584(03)00031-1
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182
   Hurtig M, 2001, VET SURG, V30, P228, DOI 10.1053/jvet.2001.23348
   IGONO MO, 1983, VET RES COMMUN, V6, P223, DOI 10.1007/BF02214916
   ISHIMARU JI, 1992, INT J ORAL MAX SURG, V21, P239, DOI 10.1016/S0901-5027(05)80228-0
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Jeffery A K, 1973, J Bone Joint Surg Br, V55, P262
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Johnson LL, 2001, CLIN ORTHOP RELAT R, pS306
   JOYCE ME, 1991, PROG CLIN BIOL RES, V365, P391
   Kaul G, 2012, KNEE SURG SPORT TR A, V20, P2315, DOI 10.1007/s00167-011-1853-x
   Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013
   Kiss A, 2014, J TISSUE ENG REGEN M, V8, P41, DOI 10.1002/term.1495
   Klinger P, 2011, ARTHRITIS RHEUM-US, V63, P2721, DOI 10.1002/art.30335
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Lajeunesse D, 1999, OSTEOARTHR CARTILAGE, V7, P321, DOI 10.1053/joca.1998.0180
   Lane JG, 2004, AM J SPORT MED, V32, P1440, DOI 10.1177/0363546504263945
   Li B, 2013, J BIOMED MATER RES A, V101, P3097, DOI 10.1002/jbm.a.34618
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P417, DOI 10.1007/s00167-010-1071-y
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Marchand C, 2011, TISSUE ENG PART C-ME, V17, P475, DOI [10.1089/ten.tec.2010.0417, 10.1089/ten.TEC.2010.0417]
   Marchand C, 2012, TISSUE ENG PT A, V18, P508, DOI [10.1089/ten.tea.2011.0178, 10.1089/ten.TEA.2011.0178]
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Mastbergen SC, 2008, OSTEOARTHR CARTILAGE, V16, P919, DOI 10.1016/j.joca.2007.11.010
   Menetrey J, 2010, KNEE SURG SPORT TR A, V18, P463, DOI 10.1007/s00167-010-1053-0
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Miyamoto K, 2002, J ORAL MAXIL SURG, V60, P66, DOI 10.1053/joms.2002.29077
   Moran CJ, 2012, AM J SPORT MED, V40, P934, DOI 10.1177/0363546511426677
   Nam EK, 2004, AM J SPORT MED, V32, P308, DOI 10.1177/0363546503259616
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Orth P, 2013, OSTEOARTHR CARTILAGE, V21, P614, DOI 10.1016/j.joca.2013.01.008
   Orth P, 2012, OSTEOARTHR CARTILAGE, V20, P1161, DOI 10.1016/j.joca.2012.06.008
   Orth P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-5
   Orth P, 2012, AM J SPORT MED, V40, P828, DOI 10.1177/0363546511430376
   Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353
   Pape D, 2013, KNEE SURG SPORT TR A, V21, P228, DOI 10.1007/s00167-012-2135-y
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Pearce SG, 2001, ARTHROSCOPY, V17, P50, DOI 10.1053/jars.2001.19966
   Potter HG, 2009, J BONE JOINT SURG AM, V91A, P126, DOI 10.2106/JBJS.H.01386
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014
   Qiu YS, 2003, OSTEOARTHR CARTILAGE, V11, P810, DOI 10.1016/S1063-4584(03)00164-X
   RADIN EL, 1991, SEMIN ARTHRITIS RHEU, V21, P12, DOI 10.1016/0049-0172(91)90036-Y
   Ramappa Arun J, 2007, J Knee Surg, V20, P228
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   RECABARREN SE, 1987, J DEV PHYSIOL, V9, P399
   Riyami Masoud, 2009, J Orthop Surg Res, V4, P13, DOI 10.1186/1749-799X-4-13
   Rockel JS, 2011, J ORTHOP RES, V29, P810, DOI 10.1002/jor.21372
   Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005
   Ruschke K, 2012, CELL TISSUE RES, V347, P521, DOI 10.1007/s00441-011-1283-6
   Safran MR, 2010, J AM ACAD ORTHOP SUR, V18, P259, DOI 10.5435/00124635-201005000-00002
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054
   Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541
   SHAHGALDI BF, 1991, J BONE JOINT SURG BR, V73, P57
   SHAMIS LD, 1989, AM J VET RES, V50, P290
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Sniekers YH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-20
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09
   Tat SK, 2008, CLIN EXP RHEUMATOL, V26, P295
   Tetteh ES, 2012, J ORTHOP SPORT PHYS, V42, P243, DOI 10.2519/jospt.2012.3673
   VACHON A, 1986, AM J VET RES, V47, P2637
   van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   Vasiliadis HS, 2010, AM J SPORT MED, V38, P943, DOI 10.1177/0363546509358266
   Visna P, 2004, ACTA CHIR BELG, V104, P709, DOI 10.1080/00015458.2004.11679648
   Von Keudella A, 2012, EUR J RADIOL, V81, P1618, DOI 10.1016/j.ejrad.2011.04.071
   von Rechenberg B, 2003, OSTEOARTHR CARTILAGE, V11, P265, DOI 10.1016/S1063-4584(03)00006-2
   Wei N, 2003, J APPL RES, V3
   Wei N, 2003, CURR OSTEOPOROS REP, V9, P237
   Williams Iii Riley J, 2008, Instr Course Lect, V57, P553
   Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946
NR 135
TC 44
Z9 46
U1 2
U2 19
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 299
EP 316
DI 10.22203/eCM.v025a21
PG 18
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 206ZS
UT WOS:000323566400002
PM 23813020
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Basu, A
   Mishra, B
   Leong, SSJ
AF Basu, Anindya
   Mishra, Biswajit
   Leong, Susanna Su Jan
TI Immobilization of polybia-MPI by allyl glycidyl ether based brush
   chemistry to generate a novel antimicrobial surface
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MULTIPOINT COVALENT ATTACHMENT; LIVING GRAFT-POLYMERIZATION;
   SITE-DIRECTED MUTAGENESIS; ANTIBACTERIAL SURFACES; PEPTIDE DATABASE;
   DESIGN; INFECTION; PROTEINS; TOOL; STABILIZATION
AB Significant efforts towards the covalent immobilization of antimicrobial peptides (AMPs) on biomaterial surfaces are under way to render implantable biodevices with antimicrobial functionalities. Towards this aim, we studied the potential and effectiveness of a novel AMP candidate, polybia-MPI (Pmpi), for immobilization on a silicon substrate using allyl glycidyl ether (AGE) based polymerization chemistry. A statistical Design of Experiment (DoE) platform was developed to quantitatively understand the effects of different immobilization parameters on the final tethered peptide surface concentration. Our platform demonstrates efficient tethering of Pmpi up to similar to 10 mu g cm(-2) on silicon wafers. Concentration dependent antimicrobial activities of the 'AGE-Pmpi'-tethered surfaces were observed, where a 70% reduction in bacterial colonies was achieved at a Pmpi surface concentration of 4.47 mu g cm(-2). The 'AGE-Pmpi'-tethered surfaces retained their antibacterial property after 3 days of incubation in artificial urine, and a 4-fold reduction in biofilm formation was also evident, as determined by ellipsometry. FESEM and ATP leakage assay showed that the immobilized Pmpi compromised bacterial membrane integrity but showed negligible cytotoxicity against human red blood cells.
C1 [Basu, Anindya; Mishra, Biswajit] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Leong, Susanna Su Jan] Singapore Inst Technol, Singapore, Singapore.
RP Leong, SSJ (reprint author), Singapore Inst Technol, 10 Dover Dr, Singapore, Singapore.
EM Leong@SingaporeTech.edu.sg
RI Basu, Anindya/N-5561-2017
OI Basu, Anindya/0000-0001-7196-4614
FU BEP A*STAR [1490001]
FX This work is supported by funding from BEP A*STAR (grant no. 1490001).
CR Abian O, 2004, APPL ENVIRON MICROB, V70, P1249, DOI 10.1128/AEM.70.2.1249-1251.2004
   ASPNES DE, 1979, PHYS REV B, V20, P3292, DOI 10.1103/PhysRevB.20.3292
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Basu A, 2012, J CHROMATOGR A, V1223, P64, DOI 10.1016/j.chroma.2011.12.037
   Basu A, 2011, APPL MICROBIOL BIOT, V90, P181, DOI 10.1007/s00253-010-3058-5
   Bernik DL, 2007, RECENT PAT NANOTECH, V1, P186, DOI 10.2174/187221007782360402
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200
   Chung CJ, 2008, J BIOMED MATER RES B, V85B, P220, DOI 10.1002/jbm.b.30939
   de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49
   Dean S. N., 2011, BMC MICROBIOL, P114
   Deng JP, 2009, PROG POLYM SCI, V34, P156, DOI 10.1016/j.progpolymsci.2008.06.002
   Cabrera MPD, 2008, EUR BIOPHYS J BIOPHY, V37, P879, DOI 10.1007/s00249-008-0299-7
   Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Otero-Gonzalez AJ, 2010, FASEB J, V24, P1320, DOI 10.1096/fj.09-143388
   Kowalczuk D, 2010, INT J PHARMACEUT, V402, P175, DOI 10.1016/j.ijpharm.2010.10.014
   LEGRANGE JD, 1993, LANGMUIR, V9, P1749, DOI 10.1021/la00031a023
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Mahanta N, 2012, RSC ADV, V2, P11389, DOI 10.1039/c2ra20637d
   Mateo C, 2003, BIOMACROMOLECULES, V4, P772, DOI 10.1021/bm0257661
   Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n
   Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q
   Mishra B, 2013, RSC ADV, V3, P9534, DOI 10.1039/c3ra40887f
   Mishra B, 2013, BBA-BIOMEMBRANES, V1828, P677, DOI 10.1016/j.bbamem.2012.09.021
   Mishra B, 2010, AMINO ACIDS, V39, P1493, DOI 10.1007/s00726-010-0618-z
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Park KH, 2008, J PEPT SCI, V14, P876, DOI 10.1002/psc.1019
   Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26
   Souza BM, 2005, PEPTIDES, V26, P2157, DOI 10.1016/j.peptides.2005.04.026
   Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-38
   Thierry B, 2008, LANGMUIR, V24, P10187, DOI 10.1021/la801140u
   Turkova J, 1999, J CHROMATOGR B, V722, P11, DOI 10.1016/S0378-4347(98)00434-4
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   VOGEL AI, 1954, J PHYS CHEM-US, V58, P174, DOI 10.1021/j150512a015
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11
   Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823
   Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025
   Wheatley JB, 1999, J CHROMATOGR A, V849, P1, DOI 10.1016/S0021-9673(99)00484-7
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
   Yang WT, 1996, MACROMOLECULES, V29, P3308, DOI 10.1021/ma9515543
NR 51
TC 18
Z9 18
U1 2
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 37
BP 4746
EP 4755
DI 10.1039/c3tb20805b
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 209MP
UT WOS:000323762000006
DA 2018-10-20
ER

PT J
AU Versace, DL
   Ramier, J
   Babinot, J
   Lemechko, P
   Soppera, O
   Lalevee, J
   Albanese, P
   Renard, E
   Langlois, V
AF Versace, Davy-Louis
   Ramier, Julien
   Babinot, Julien
   Lemechko, Pierre
   Soppera, Olivier
   Lalevee, Jacques
   Albanese, Patricia
   Renard, Estelle
   Langlois, Valerie
TI Photoinduced modification of the natural biopolymer
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microfibrous surface with
   anthraquinone-derived dextran for biological applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TISSUE-ENGINEERING APPLICATIONS; IN-VITRO BIOCOMPATIBILITY;
   MECHANICAL-PROPERTIES; RADICAL POLYMERIZATION; BONE REGENERATION; HUMAN
   FIBROBLASTS; HYALURONIC-ACID; FIBER MATS; SCAFFOLDS; NANOFIBERS
AB A straightforward and versatile method for immobilizing polysaccharides on the surface of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) electrospun fibers is developed with the objective of designing a new functional biomaterial having a significant effect on cell proliferation. The approach relies on a one-step procedure: UV grafting of a photosensitive dextran (AQ-Dext) on the surface of PHBHV fibers according to a "grafting onto" method, with the use of an anthraquinone derivative. The photografting is conducted through a photoinduced free radical process employing an anthraquinone-based photosensitizer in aqueous medium. Under appropriate conditions, AQ-Dext reacts with C-H sigma-bonds of the polymer substrate (PHBHV) to produce a semianthraquinone radical according to an H-abstraction reaction. This radical recombines together with the alkylradical (R-center dot) formed at the surface of PHBHV fibers via the oxygen atom of the anthraquinone photolinker. The photochemical mechanism of the AQ-Dext photolysis is entirely described for the first time by an electron spin resonance technique and laser flash photolysis. The modified PHBHV microfibrous scaffolds are extensively characterized by water contact angle measurements, XPS analysis and atomic force microscopy, confirming the covalent grafting of dextran on PHBHV fibers. Finally, a primary investigation demonstrates that dextran modified PHBHV fibers are permissive for optimized cell colonization and proliferation. The cell morphologies are described by SEM micrographs, revealing a significant affinity and favorable interactions for adherence of human mesenchymal stem cells (hMSCs) on scaffolds provided by dextran chemical structure. Moreover, the proliferation rate of hMSCs increases on this new functionalized biomaterial associated with a higher extra-cellular matrix production after 5 days of culture in comparison with native PHBHV fibers.
C1 [Versace, Davy-Louis; Ramier, Julien; Babinot, Julien; Lemechko, Pierre; Renard, Estelle; Langlois, Valerie] Univ Paris Est Creteil Val de Marne, Inst Chim & Mat Paris Est, Equipe Syst Polymeres Complexes, UMR 7182,CNRS, F-94320 Thiais, France.
   [Soppera, Olivier; Lalevee, Jacques] Inst Sci Mat Mulhouse, LRC 7228, F-68057 Mulhouse, France.
   [Albanese, Patricia] Univ Paris Est Creteil Val de Marne, CNRS, EAC 7149, Lab Croissance Cellulaire Reparat & Regenerat Tis, F-94010 Creteil, France.
RP Versace, DL (reprint author), Univ Paris Est Creteil Val de Marne, Inst Chim & Mat Paris Est, Equipe Syst Polymeres Complexes, UMR 7182,CNRS, 2-8 Rue Henri Dunant, F-94320 Thiais, France.
EM versace@icmpe.cnrs.fr
RI LANGLOIS, Valerie/C-2584-2016; Versace, Davy-Louis/D-8124-2016
CR Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392
   ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   Asran AS, 2010, BIOMACROMOLECULES, V11, P3413, DOI 10.1021/bm100912v
   Babinot J, 2013, MACROMOL RAPID COMM, V34, P362, DOI 10.1002/marc.201200692
   Babinot J, 2012, CHEM COMMUN, V48, P5364, DOI 10.1039/c2cc30482a
   Babinot J, 2012, J COLLOID INTERF SCI, V375, P88, DOI 10.1016/j.jcis.2012.02.042
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Bhat VT, 2008, POLYM INT, V57, P124, DOI 10.1002/pi.2332
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Catalina F, 2001, POLYMER, V42, P1825, DOI 10.1016/S0032-3861(00)00409-2
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   Coelho JFJ, 2010, J APPL POLYM SCI, V116, P718, DOI 10.1002/app.31465
   De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Edahiro J, 2006, LANGMUIR, V22, P5224, DOI 10.1021/1a060318q
   Fionov AV, 2009, RUSS CHEM B+, V58, P538, DOI 10.1007/s11172-009-0053-z
   Fouassier J.-P., 1993, RAD CURING POLYM SCI
   Garrido L, 2011, J APPL POLYM SCI, V119, P3286, DOI 10.1002/app.32920
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Habnouni S. E., 2011, ADV FUNCT MATER, V21, P3321
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hazer B, 2010, INT J POLYM SCI, DOI 10.1155/2010/423460
   Heinze T, 2006, ADV POLYM SCI, V205, P199, DOI 10.1007/12_100
   Hocking P., 1994, CHEM TECHNOLOGY BIOD
   Hornig S, 2007, CARBOHYD POLYM, V68, P280, DOI 10.1016/j.carbpol.2006.12.007
   Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8
   Hu SG, 2003, J APPL POLYM SCI, V88, P2797, DOI 10.1002/app.12055
   Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Innocentini-Mei LH, 2003, MACROMOL SYMP, V197, P77, DOI 10.1002/masy.200350708
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Kang IK, 2001, INT J BIOL MACROMOL, V28, P205, DOI 10.1016/S0141-8130(00)00165-3
   Ke Y, 2007, J APPL POLYM SCI, V104, P4088, DOI 10.1002/app.25678
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kontturi E. J., 2005, SURFACE CHEM CELLULO
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lao HK, 2007, BIOMACROMOLECULES, V8, P416, DOI 10.1021/bm0609700
   Lao HK, 2011, J APPL POLYM SCI, V120, P184, DOI 10.1002/app.32967
   Lao HK, 2010, J APPL POLYM SCI, V116, P288, DOI 10.1002/app.31507
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lemechko P, 2013, REACT FUNCT POLYM, V73, P237, DOI 10.1016/j.reactfunctpolym.2012.10.012
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li X, 2009, ACTA BIOMATER, V5, P2002, DOI 10.1016/j.actbio.2009.01.035
   Li YJ, 2012, CARBOHYD POLYM, V90, P1445, DOI 10.1016/j.carbpol.2012.07.013
   Liebert T, 2011, BIOMACROMOLECULES, V12, P3107, DOI 10.1021/bm200841b
   Linhart W, 2006, J MATER SCI, V41, P4806, DOI 10.1007/s10853-006-0023-x
   Liu KL, 2010, J PHYS CHEM B, V114, P7489, DOI 10.1021/jp1018247
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Nguyen TH, 2010, J MATER SCI-MATER M, V21, P1969, DOI 10.1007/s10856-010-4048-y
   Nowakowska M, 2004, BIOMACROMOLECULES, V5, P1009, DOI 10.1021/bm034506w
   Padon KS, 2001, J POLYM SCI POL CHEM, V39, P715, DOI 10.1002/1099-0518(20010301)39:5<715::AID-POLA1043>3.0.CO;2-O
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Patnaik S, 2007, INT J PHARM, V342, P184, DOI 10.1016/j.ijpharm.2007.04.038
   Peschel G, 2008, J BIOMED MATER RES A, V85A, P1072, DOI 10.1002/jbm.a.31666
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Polzonetti G, 1998, CHEM PHYS LETT, V292, P515, DOI 10.1016/S0009-2614(98)00695-2
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Renard E, 2010, J APPL POLYM SCI, V117, P1888, DOI 10.1002/app.32041
   Rocco MLM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2966356
   Rupp B, 2010, GREEN CHEM, V12, P1796, DOI 10.1039/c0gc00066c
   Sasmazel HT, 2011, INT J BIOL MACROMOL, V49, P838, DOI 10.1016/j.ijbiomac.2011.07.022
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   Scholl A, 2004, J CHEM PHYS, V121, P10260, DOI 10.1063/1.1807812
   Sheng ZY, 2004, J PHOTOCH PHOTOBIO A, V161, P99, DOI 10.1016/S1010-6030(03)00279-X
   Sombatmankhong K, 2006, J POLYM SCI POL PHYS, V44, P2923, DOI 10.1002/polb.20915
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Veleirinho B, 2011, MATER LETT, V65, P2216, DOI 10.1016/j.matlet.2011.04.058
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Versace DL, 2013, ADV HEALTHC MATER, V2, P1008, DOI 10.1002/adhm.201200269
   Versace DL, 2012, GREEN CHEM, V14, P788, DOI 10.1039/c2gc16399c
   Wang YY, 2011, BIOMACROMOLECULES, V12, P551, DOI 10.1021/bm100886w
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wondraczek H, 2008, MACROMOL BIOSCI, V8, P606, DOI 10.1002/mabi.200800056
   Wondraczek H, 2011, CARBOHYD POLYM, V83, P1048, DOI 10.1016/j.carbpol.2010.10.014
   Wondraczek H, 2010, EUR POLYM J, V46, P1688, DOI 10.1016/j.eurpolymj.2010.06.005
   WONG SK, 1972, CAN J CHEMISTRY, V50, P3052, DOI 10.1139/v72-484
   Wulkersdorfer B, 2010, INT J POLYM SCI, DOI 10.1155/2010/436178
   Xu SL, 2006, J APPL POLYM SCI, V102, P3782, DOI 10.1002/app.24742
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
NR 100
TC 4
Z9 4
U1 4
U2 55
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 37
BP 4834
EP 4844
DI 10.1039/c3tb20869a
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 209MP
UT WOS:000323762000016
DA 2018-10-20
ER

PT J
AU Baillif, S
   LeDuff, F
   Hartmann, DJ
   Kodjikian, L
AF Baillif, Stephanie
   LeDuff, Frank
   Hartmann, Daniel J.
   Kodjikian, Laurent
TI Staphylococcus epidermidis Biofilm Formation and Structural Organization
   on Different Types of Intraocular Lenses under in vitro Flow Conditions
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Bacterial adhesion; Biofilm; Bioreactor; Electron microscopy;
   Intraocular lens
ID SCANNING-ELECTRON-MICROSCOPY; BACTERIAL ADHESION; ICA LOCUS; ADHERENCE;
   MECHANISMS; INFECTION
AB Aim: To compare the adherence and structural organization of Staphylococcus epidermidis biofilm on intraocular lenses (IOLs).Methods:IOLs made of 3 different biomateria Is [polymethyl methacrylate (PMMA), hydrophilic acrylic or hydrophobic acrylic] were incubated into an S. epidermidis bacterial solution. Scanning electron microscopy was used to count the bound bacteria and to analyze the structural biofilm architecture. Results: After 4-6 h of incubation, adherence was statistically weakest on the hydrophilic acrylic polymer. On the hydrophobic acrylic material, the bacterial cells tended to cover the substratum in a horizontal spread in a continuous monolayer. On the hydrophilic acrylic material or on the PMMA material bacterial cells tended to form only few, small scattered cell clusters. Conclusions: The data suggest that the pattern of S. epidermidis adhesion varies with the IOL biomaterial. Hydrophobic IOLs seem to be more permissive to S. epidermidis adhesion. Copyright (C) 2013 S. Karger AG, Basel
C1 [Baillif, Stephanie] St Roch Univ Hosp, Dept Ophthalmol, Nice, France.
   [LeDuff, Frank] Cimiez Univ Hosp, Dept Biostat, Nice, France.
   [Baillif, Stephanie; Hartmann, Daniel J.; Kodjikian, Laurent] Univ Lyon 1, CNBS MATEIS UMR 5510, Lyon, France.
   [Kodjikian, Laurent] Univ Lyon, Croix Rousse Hosp, Dept Ophthalmol, Lyon, France.
RP Kodjikian, L (reprint author), Croix Rousse Univ Hosp, Dept Ophthalmol, 103 Grande Rue Croix Rousse, FR-69004 Lyon, France.
EM kodjikian.laurent@wanadoo.ft
OI baillif, stephanie/0000-0003-1700-8570
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Baillif S, 2008, J CATARACT REFR SURG, V34, P153, DOI 10.1016/j.jcrs.2007.07.058
   Baillif S, 2006, INVEST OPHTH VIS SCI, V47, P3410, DOI 10.1167/iovs.05-1070
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217
   CUSUMANO A, 1991, OPHTHALMOLOGY, V98, P1703
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Ecoffet M, 1985, ENCY MED CHIRURG
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   GRIFFITHS PG, 1989, BRIT J OPHTHALMOL, V73, P402, DOI 10.1136/bjo.73.6.402
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x
   Han DP, 1996, AM J OPHTHALMOL, V122, P1
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4382, DOI 10.1167/iovs-03-0185
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   Purevdorj-Gage LB, 2004, MICROBIAL BIOFILMS, P160
   Shimizu K, 2006, CURR EYE RES, V31, P989, DOI 10.1080/02713680601038816
   Sousa C., 2009, INT J BIOMATER, V2009
   Srinivasan R, 2002, J CATARACT REFR SURG, V28, P2173, DOI 10.1016/S0886-3350(02)01493-1
   Stoodley P, 1999, BIOFOULING, V14, P75, DOI 10.1080/08927019909378398
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
NR 28
TC 4
Z9 4
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2013
VL 50
IS 2
BP 83
EP 90
DI 10.1159/000350550
PG 8
WC Ophthalmology
SC Ophthalmology
GA 207IU
UT WOS:000323592900001
PM 23797392
DA 2018-10-20
ER

PT S
AU Globus, T
   Moyer, A
   Gelmont, B
   Khromova, T
   Sizov, I
   Ferrance, J
AF Globus, Tatiana
   Moyer, Aaron
   Gelmont, Boris
   Khromova, Tatyana
   Sizov, Igor
   Ferrance, Jerome
BE Anwar, MF
   Crowe, TW
   Manzur, T
TI Sub-Terahertz Resonance Spectroscopy of Biological Macromolecules and
   Cells
SO TERAHERTZ PHYSICS, DEVICES, AND SYSTEMS VII: ADVANCED APPLICATIONS IN
   INDUSTRY AND DEFENSE
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Terahertz Physics, Devices, and Systems VII - Advanced
   Applications in Industry and Defense
CY APR 29-30, 2013
CL Baltimore, MD
SP SPIE
DE vibrational resonance spectroscopy; sub-terahertz spectrometer; diverse
   relaxation dynamics; intense and narrow specific resonances; absorption
   fingerprints; discrimination capability; bacterial cells and molecular
   components
ID PERIODIC SUBWAVELENGTH STRUCTURES; ABSORPTION
AB Recently we introduced a Sub-THz spectroscopic system for characterizing vibrational resonance features from biological materials. This new, continuous-wave, frequency-domain spectroscopic sensor operates at room temperature between 315 and 480 GHz with spectral resolution of at least 1 GHz and utilizes the source and detector components from Virginia Diode, Inc. In this work we present experimental results and interpretation of spectroscopic signatures from bacterial cells and their biological macromolecule structural components. Transmission and absorption spectra of the bacterial protein thioredoxin, DNA and lyophilized cells of Escherichia coli (E. coli), as well as spores of Bacillus subtillis and B. atrophaeus have been characterized. Experimental results for biomolecules are compared with absorption spectra calculated using molecular dynamics simulation, and confirm the underlying physics for resonance spectroscopy based on interactions between THz radiation and vibrational modes or groups of modes of atomic motions. Such interactions result in multiple intense and narrow specific resonances in transmission/absorption spectra from nano-gram samples with spectral line widths as small as 3 GHz. The results of this study indicate diverse relaxation dynamic mechanisms relevant to sub-THz vibrational spectroscopy, including long-lasting processes. We demonstrate that high sensitivity in resolved specific absorption fingerprints provides conditions for reliable detection, identification and discrimination capability, to the level of strains of the same bacteria, and for monitoring interactions between biomaterials and reagents in near real-time. Additionally, it creates the basis for the development of new types of advanced biological sensors through integrating the developed system with a microfluidic platform for biomaterial samples.
C1 [Globus, Tatiana; Moyer, Aaron; Gelmont, Boris; Khromova, Tatyana; Sizov, Igor; Ferrance, Jerome] Vibratess LLC, Charlottesville, VA 22903 USA.
RP Globus, T (reprint author), Vibratess LLC, Charlottesville, VA 22903 USA.
EM tg9a@virginia.edu
RI Sizov, Igor/A-1814-2014
OI Sizov, Igor/0000-0003-0726-2006; Ferrance, Jerome/0000-0003-1020-8289
CR Alijabbari N, 2012, J MOL MODEL, V18, P2209, DOI 10.1007/s00894-011-1238-6
   Bass R. B., 2004, 15 INT S SPAC THZ TE, P392
   Burke SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004
   Bykhovski A., 2007, INT J HIGH SPEED ELE, V17, P225
   Bykhovski A., 2005, SPIE P, V5995, P1
   BYKHOVSKI A, 2008, INT J HI SPE ELE SYS, V18, P109
   Gelmont B, 2008, IEEE SENS J, V8, P791, DOI 10.1109/JSEN.2008.923222
   Gelmont B, 2011, IEEE T NANOTECHNOL, V10, P83, DOI 10.1109/TNANO.2010.2064785
   Globus T, 2003, J PHYS D APPL PHYS, V36, P1314, DOI 10.1088/0022-3727/36/11/312
   Globus T., 2003, International Journal of High Speed Electronics and Systems, V13, P903, DOI 10.1142/S0129156403002083
   Globus T, 2004, P SOC PHOTO-OPT INS, V5268, P10, DOI 10.1117/12.519172
   Globus T., 2012, IEEE SENS J, V13, P72
   Globus T, 2012, AM J BIOMED ENG, V2, P143, DOI [10.5923/j.ajbe.20120204.01, DOI 10.5923/J.AJBE.20120204.01]
   Globus T., 2011, CHEM BIOL SCI TECHN
   Globus T., 2013, ADV BIOSCI BIOTECHNO, V4, P493, DOI DOI 10.4236/ABB.2013.43A065
   Globus T., 2010, DTRA 2010 CBD S T C
   Globus T, 2006, J PHYS D APPL PHYS, V39, P3405, DOI 10.1088/0022-3727/39/15/028
   Heilweil E. J., 2008, TERAHERTZ SPECTROSCO, P269
   Johnson TJ, 2005, CHEM PHYS LETT, V403, P152, DOI 10.1016/j.cplett.2004.12.095
   Li XW, 2008, J PHYS CHEM A, V112, P12090, DOI 10.1021/jp806630w
   Parthasarathy R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153906
   Qiu WH, 2007, P NATL ACAD SCI USA, V104, P5366, DOI 10.1073/pnas.0608498104
   Woolard DL, 2005, P IEEE, V93, P1722, DOI 10.1109/JPROC.2005.853539
NR 23
TC 0
Z9 0
U1 2
U2 21
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9507-5
J9 PROC SPIE
PY 2013
VL 8716
AR UNSP 87160N
DI 10.1117/12.2016108
PG 7
WC Optics; Physics, Applied
SC Optics; Physics
GA BGO35
UT WOS:000323621000013
DA 2018-10-20
ER

PT J
AU Chaudhari, A
   Vanmellaert, L
   Bauwens, M
   Vermaelen, P
   Deroose, CM
   Naert, I
   Cardoso, MV
   Martens, JA
   Duyck, J
AF Chaudhari, Amol
   Vanmellaert, Lieve
   Bauwens, Matthias
   Vermaelen, Peter
   Deroose, Christophe M.
   Naert, Ignace
   Cardoso, Marcio Vivan
   Martens, Johan A.
   Duyck, Joke
TI In Vitro and In Vivo Investigation of the Potential of Amorphous
   Microporous Silica as a Protein Delivery Vehicle
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; POSITRON-EMISSION-TOMOGRAPHY; BOVINE
   SERUM-ALBUMIN; CONTROLLED-RELEASE; GROWTH-FACTORS; PERIODONTAL
   REGENERATION; ADSORPTION; SURFACES; SYSTEMS; CARRIER
AB Delivering growth factors (GFs) at bone/implant interface needs to be optimized to achieve faster osseointegration. Amorphous microporous silica (AMS) has a potential to be used as a carrier and delivery platform for GFs. In this work, adsorption (loading) and release (delivery) mechanism of a model protein, bovine serum albumin (BSA), from AMS was investigated in vitro as well as in vivo. In general, strong BSA adsorption to AMS was observed. The interaction was stronger at lower pH owing to favorable electrostatic interaction. In vitro evaluation of BSA release revealed a peculiar release profile, involving a burst release followed by a 6 h period without appreciable BSA release and a further slower release later. Experimental data supporting this observation are discussed. Apart from understanding protein/biomaterial (BSA/AMS) interaction, determination of in vivo protein release is an essential aspect of the evaluation of a protein delivery system. In this regard micropositron emission tomography (mu-PET) was used in an exploratory experiment to determine in vivo BSA release profile from AMS. Results suggest stronger in vivo retention of BSA when adsorbed on AMS. This study highlights the possible use of AMS as a controlled protein delivery platform which may facilitate osseointegration.
C1 [Chaudhari, Amol; Naert, Ignace; Cardoso, Marcio Vivan; Duyck, Joke] Katholieke Univ Leuven, BIOMAT Res Grp, Dept Prosthet Dent, B-3000 Louvain, Belgium.
   [Vanmellaert, Lieve] Katholieke Univ Leuven, Rega Inst, Bacteriol Lab, B-3000 Louvain, Belgium.
   [Bauwens, Matthias] Katholieke Univ Leuven, Lab Radiopharm, B-3000 Louvain, Belgium.
   [Vermaelen, Peter; Deroose, Christophe M.] Katholieke Univ Leuven, B-3000 Louvain, Belgium.
   [Martens, Johan A.] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium.
RP Duyck, J (reprint author), Katholieke Univ Leuven, BIOMAT Res Grp, Dept Prosthet Dent, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM joke.duyck@uz.kuleuven.be
OI Martens, Johan/0000-0002-9292-2357; Naert, Ignace/0000-0001-7007-1443
FU Katholieke Universiteit Leuven [IDO 06/013]; Flemish government
FX The work was part of an interdisciplinary research project (IDO 06/013)
   funded by Katholieke Universiteit Leuven. Johan A. Martens acknowledges
   the Flemish government for long-term structural funding (Methusalem).
CR AERTS C, 2010, ASTRON ASTROPHYS LIB, P1
   Aerts CA, 2007, J PHYS CHEM C, V111, P13404, DOI 10.1021/jp0735076
   Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318
   Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   CLAESSON PM, 1995, ADV COLLOID INTERFAC, V57, P161, DOI 10.1016/0001-8686(95)00241-H
   Cullinane DM, 2002, J ORTHOPAED RES, V20, P1240, DOI 10.1016/S0736-0266(02)00056-6
   Dereka XE, 2006, GROWTH FACTORS, V24, P260, DOI 10.1080/08977190601060990
   Fukuzaki S, 1996, J FERMENT BIOENG, V81, P163, DOI 10.1016/0922-338X(96)87596-9
   Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882
   Giacomelli CE, 2001, J COLLOID INTERF SCI, V233, P234, DOI 10.1006/jcis.2000.7219
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665
   Herschman HR, 2003, CURR OPIN IMMUNOL, V15, P378, DOI 10.1016/S0952-7915(03)00066-9
   Hinderliter A, 2006, J PHYS-CONDENS MAT, V18, pS1257, DOI 10.1088/0953-8984/18/28/S09
   Ho J, 2008, J CHEM TECHNOL BIOT, V83, P351, DOI 10.1002/jctb.1818
   Isobe M, 1999, J BIOMED MATER RES, V45, P36, DOI 10.1002/(SICI)1097-4636(199904)45:1<36::AID-JBM5>3.0.CO;2-I
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   King GN, 2002, J PERIODONTOL, V73, P925, DOI 10.1902/jop.2002.73.8.925
   King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   KONDO A, 1992, J COLLOID INTERF SCI, V150, P344, DOI 10.1016/0021-9797(92)90204-Y
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6
   Liu Y, 2006, PHILOS T ROY SOC A, V364, P233, DOI 10.1098/rsta.2005.1685
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MAIER WF, 1993, ADV MATER, V5, P726, DOI 10.1002/adma.19930051008
   Malmsten M, 1997, J COLLOID INTERF SCI, V193, P88, DOI 10.1006/jcis.1997.5039
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   PeulaGarcia JM, 1997, COLLOID POLYM SCI, V275, P198, DOI 10.1007/s003960050072
   Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226
   Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001
   ROUQUEROL J, 1994, STUD SURF SCI CATAL, V87, P1
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Shcharbin D, 2009, J CONTROL RELEASE, V135, P186, DOI 10.1016/j.jconrel.2009.01.015
   Stutz H, 2009, ELECTROPHORESIS, V30, P2032, DOI 10.1002/elps.200900015
   Tang QL, 2006, J CONTROL RELEASE, V114, P41, DOI 10.1016/j.jconrel.2006.05.006
   Verraedt E, 2010, J CONTROL RELEASE, V142, P47, DOI 10.1016/j.jconrel.2009.09.022
   Verraedt E, 2011, INT J PHARMACEUT, V419, P28, DOI 10.1016/j.ijpharm.2011.06.053
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   WRIGHT AK, 1975, BIOPHYS J, V15, P137, DOI 10.1016/S0006-3495(75)85797-3
NR 52
TC 2
Z9 2
U1 0
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 306418
DI 10.1155/2013/306418
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 203EO
UT WOS:000323273900001
PM 23991413
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chavda, H
   Modhia, I
   Mehta, A
   Patel, R
   Patel, C
AF Chavda, Hitesh
   Modhia, Ishan
   Mehta, Anant
   Patel, Rupal
   Patel, Chhagan
TI Development of Bioadhesive Chitosan Superporous Hydrogel Composite
   Particles Based Intestinal Drug Delivery System
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID RELEASE; POLYMERS; BIOCOMPATIBILITY; MECHANISM; MATRICES; WATER
AB Bioadhesive superporous hydrogel composite (SPHC) particles were developed for an intestinal delivery of metoprolol succinate and characterized for density, porosity, swelling, morphology, and bioadhesion studies. Chitosan and HPMC were used as bioadhesive and release retardant polymers, respectively. A 3(2) full factorial design was applied to optimize the concentration of chitosan and HPMC. The drug loaded bioadhesive SPHC particles were filled in capsule, and the capsule was coated with cellulose acetate phthalate and evaluated for drug content, in vitro drug release, and stability studies. To ascertain the drug release kinetics, the drug release profiles were fitted for mathematical models. The prepared system remains bioadhesive up to eight hours in intestine and showed Hixson-Crowell release with anomalous nonfickian type of drug transport. The application of SPHC polymer particles as a biomaterial carrier opens a new insight into bioadhesive drug delivery system and could be a future platform for other molecules for intestinal delivery.
C1 [Chavda, Hitesh; Modhia, Ishan; Mehta, Anant; Patel, Rupal] Gujarat Technol Univ, Shri Sarvajanik Pharm Coll, Dept Pharmaceut & Pharmaceut Technol, Mehsana 384001, Gujarat, India.
   [Patel, Chhagan] Gujarat Technol Univ, Shri Sarvajanik Pharm Coll, Dept Pharmaceut Chem, Mehsana 384001, Gujarat, India.
RP Chavda, H (reprint author), Gujarat Technol Univ, Shri Sarvajanik Pharm Coll, Dept Pharmaceut & Pharmaceut Technol, Mehsana 384001, Gujarat, India.
EM hitcvd@yahoo.com
CR [Anonymous], 2012, MET
   BADIGER MV, 1993, BIOMATERIALS, V14, P1059, DOI 10.1016/0142-9612(93)90206-H
   Chavda H.V., 2010, TRENDS BIOMATER ARTI, V24, P83
   Chen J, 2000, J CONTROL RELEASE, V65, P73, DOI 10.1016/S0168-3659(99)00238-2
   Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W
   Chowdary K.P.R., 2003, AAS PHARM SCI TECH, V4, P87, DOI DOI 10.1208/PT040339
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Davis SS, 2006, VACCINE, V24, pS7, DOI 10.1016/j.vaccines.2005.01.102
   Dorkoosh FA, 2002, INT J PHARM, V241, P35, DOI 10.1016/S0378-5173(02)00115-1
   Dorkoosh FA, 2002, PHARMACEUT RES, V19, P1532, DOI 10.1023/A:1020416918624
   Dorkoosh FA, 2001, J CONTROL RELEASE, V71, P307, DOI 10.1016/S0168-3659(01)00232-2
   Gafourian T, 2007, J PHARM SCI-US, V96, P3334, DOI 10.1002/jps.20990
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hixson AW, 1931, IND ENG CHEM, V23, P923, DOI 10.1021/ie50260a018
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Kumar M. N, 2010, INT J PHARM PHARM SC, V2, P53
   Lee YM, 1997, POLYMER, V38, P2415, DOI 10.1016/S0032-3861(96)00789-6
   Omidian H, 2007, J PHARM PHARMACOL, V59, P317, DOI 10.1211/jpp.59.3.0001
   Patel J. K., 2006, PHARM REV, V4
   Peniche C, 1997, POLYMER, V38, P5977, DOI 10.1016/S0032-3861(96)01058-0
   Risbud MV, 2000, DRUG DELIV, V7, P69
   Sadeghi AMM, 2009, J CONTROL RELEASE, V134, P11, DOI 10.1016/j.jconrel.2008.10.012
   Satish C. S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P133
   Tang C, 2007, J APPL POLYM SCI, V104, P2785, DOI 10.1002/app.25930
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Yin LC, 2009, FOOD CHEM TOXICOL, V47, P1139, DOI 10.1016/j.fct.2009.01.043
NR 28
TC 3
Z9 3
U1 0
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 563651
DI 10.1155/2013/563651
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 203IE
UT WOS:000323284600001
PM 23984380
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Xu, WF
   Liu, F
   Li, K
   Xiong, FH
   Huang, QH
   Liao, XL
AF Xu, Wen-feng
   Liu, Fei
   Li, Kui
   Xiong, Fu-hang
   Huang, Qiu-hong
   Liao, Xiao-ling
BE Zhao, G
   Lu, L
   Long, B
   Nie, Z
TI Surface Modification and Coating of the Carbon/Carbon Composite in the
   Medical Fields
SO CHINA FUNCTIONAL MATERIALS TECHNOLOGY AND INDUSTRY FORUM
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT China Functional Materials Technology and Industry Forum (CFMTIF 2012)
CY NOV 09-12, 2012
CL Kunming, PEOPLES R CHINA
SP Chinese Functional Mat Soc, Natl Instrument Functional Mat Engn Technol Res Ctr, Chongqing Mat Res Inst, Chongqing Functional Mat Period Press, Yunnan Univ
DE Carbon/Carbon composite; Surface modification; Coating; Osteoinductivity
ID ELECTROCHEMICAL DEPOSITION; HYDROXYAPATITE; BIOMATERIAL; CARBON
AB Carbon/Carbon composite is considered to be one of the best biomaterials substitute to human hard tissues due to its excellent biocompatibility and the much closed elastic modulus to human skeleton. It has been widely used and studied to the fields of artificial bones materials, but the osteoinductivity need to be improved. In recent years, the commonly used surface modification to improve their bone induction, such as hydroxyapatite, chitosan and so on, which prompted the adsorption of osseous protein, adhesion and growth of cells. It is believed the surface modification and coating of the carbon/carbon composite should promote its application in artificial bones. This article reviews the modified coat of medical carbon / carbon composites in recent years, and proposed some recommendations for the development of medical carbon / carbon composite in the future.
C1 [Xu, Wen-feng; Liu, Fei; Li, Kui; Xiong, Fu-hang; Huang, Qiu-hong; Liao, Xiao-ling] ChongQing Univ Sci & Technol, Inst Biomat & Living Cell Imaging Tech, Sch Met & Mat Engn, Chongqing 401331, Peoples R China.
RP Xu, WF (reprint author), ChongQing Univ Sci & Technol, Inst Biomat & Living Cell Imaging Tech, Sch Met & Mat Engn, Chongqing 401331, Peoples R China.
EM xwf_228@163.com
CR Ali F., 2004, BIOMATERIALS, V25, P2075
   Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   Hou X.H., 2001, SEVERAL ISSUES CARBO
   Huang ZH, 2009, ACTA POLYM SIN, P273
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ishihara S, 2010, ACTA BIOMATER, V6, P830, DOI 10.1016/j.actbio.2009.10.019
   Li Muqin, 2003, CHINA SURFACE ENG, V16, P31
   Li SH, 1998, J BIOMED MATER RES, V40, P520
   Li SP, 2000, INTRO BIOMEDICAL MAT
   Liao XL, 2011, CELL MOL BIOENG, V4, P579, DOI 10.1007/s12195-011-0204-9
   Lucie B., 2001, J BIOMED MATER RES, V54, P567
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Ni XY, 2012, J INORG MATER, V27, P545, DOI 10.3724/SP.J.1077.2012.00545
   Ning C. Y., 2007, CHINESE MAT SCI TECH, V4, P61
   Pan J., 2011, MAT REV, V6, P51
   Quist AP, 2005, ANAL BIOANAL CHEM, V381, P591, DOI 10.1007/s00216-004-2847-z
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sui J. L., 2011, MAT MECH ENG, V35, P19
   Taton TA, 2001, NATURE, V412, P491, DOI 10.1038/35087687
   Wang YB, 2011, ACTA POLYM SIN, P1244, DOI 10.3724/SP.J.1105.2011.10309
   Xing X. B., 2004, RARE METAL MAT ENG, V33, P313
   Xiong XB, 2005, RARE METAL MAT ENG, V34, P515
   [熊信柏 XIONG Xin-bo], 2009, [机械工程材料, Materials for Mechanical Engineering], V33, P1
   Xiong XB, 2009, ACTA BIOMATER, V5, P1785, DOI 10.1016/j.actbio.2008.12.007
   [熊信柏 Xiong Xinbo], 2003, [西北工业大学学报, Journal of Northwestern Polytechnical University], V21, P356
   [杨玉卫 YANG Yuwei], 2008, [硅酸盐通报, Bulletin of the Chinese Ceramic Society], V27, P119
   Zhai Y.Q., 2006, MATER ENG, P60
   Zhang G. H., 1990, CHINESE J BIOMEDICAL, V9, P92
   [张国光 ZHANG Guoguang], 2008, [表面技术, Surface Technology], V37, P61
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
   Zhao M.Y., 2011, CHINESE J MAT RES, V21, P243
   Zhao XN, 2012, SURF INTERFACE ANAL, V44, P21, DOI 10.1002/sia.3764
   Zheng Y. H., 1996, J S CHINA U TECHNOLO, V24, P34
NR 35
TC 0
Z9 0
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-685-7
J9 APPL MECH MATER
PY 2013
VL 320
BP 435
EP 440
DI 10.4028/www.scientific.net/AMM.320.435
PG 6
WC Engineering, Mechanical; Nanoscience & Nanotechnology; Materials
   Science, Coatings & Films
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BGK29
UT WOS:000323293000078
DA 2018-10-20
ER

PT S
AU Li, N
   Wu, ZK
   Jian, C
   Zhao, WQ
   Yan, JZ
AF Li, Ning
   Wu, Zhi-kai
   Jian, Chao
   Zhao, Wan-qian
   Yan, Jia-Zhen
BE Zhao, G
   Lu, L
   Long, B
   Nie, Z
TI CAD/CAM Zirconia for Dental Application
SO CHINA FUNCTIONAL MATERIALS TECHNOLOGY AND INDUSTRY FORUM
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT China Functional Materials Technology and Industry Forum (CFMTIF 2012)
CY NOV 09-12, 2012
CL Kunming, PEOPLES R CHINA
SP Chinese Functional Mat Soc, Natl Instrument Functional Mat Engn Technol Res Ctr, Chongqing Mat Res Inst, Chongqing Functional Mat Period Press, Yunnan Univ
DE Dental Zirconia; CAD/CAM Technique; Mechanical Properties;
   Transformation Toughing; Low Temperature Aging
ID STABILIZED ZIRCONIA; FRACTURE-TOUGHNESS; CERAMICS; STRENGTH;
   BIOMATERIAL; DEGRADATION; FUTURE
AB During the 20th century, both dental materials and dental technologies for the fabrication of dental prosthesis progressed remarkably. Owing to the increased demand of safety and aesthetics, 3 mol% yttria stabilized tetragonal zirconia polycrystalline has been recently introduced in prosthetic dentistry for the fabrication of crowns and fixed partial dentures, in combination with CAD/CAM technique. This greatly changed the conventional dental laboratory work which is labor-intensive and experience-dependent. This review mainly introduced the state of dental zirconia and the application of CAD/CAM technology in dentistry.
C1 [Li, Ning; Wu, Zhi-kai; Jian, Chao; Zhao, Wan-qian; Yan, Jia-Zhen] Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610064, Peoples R China.
RP Li, N (reprint author), Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610064, Peoples R China.
EM lining@scu.edu.cn; wuzhikai@163.com
CR Ajmal K., 2009, U.S. Patent, Patent No. [7,497,983 B2, 7497983]
   Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Cattani-Lorente M., 2011, ACTA BIOMATER, V7, P858
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Christian R., 2007, U.S. Patent, Patent No. [0292597A1, 0292597]
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Duret F., 1975, P INT C COMPUT, V1, P500
   Fujisald H., 2009, E.P. Patent, Patent No. 0729325
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Goldstein A, 1999, J EUR CERAM SOC, V19, P2067, DOI 10.1016/S0955-2219(99)00020-5
   Guazzato M, 2004, DENT MATER, V20, P449, DOI 10.1016/j.dental.2003.05.002
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   Helmer J. D., 1969, RES BIOC S CLEMS U S
   HEUER AH, 1987, J AM CERAM SOC, V70, P689, DOI 10.1111/j.1151-2916.1987.tb04865.x
   HEUER AH, 1982, J AM CERAM SOC, V65, P642, DOI 10.1111/j.1151-2916.1982.tb09946.x
   Hiroyuki F., 2011, U.S. Patent, Patent No. 0027742
   Jon B., 2008, J EUR CERAM SOC, V28, P973
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Larsson C, 2006, SWED DENT J, V30, P45
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Liu Perng-Ru, 2005, Compend Contin Educ Dent, V26, P507
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Miyazaki T, 2009, DENT MATER J, V28, P44, DOI 10.4012/dmj.28.44
   Nakasuga M., 2011, U.S. Patent, Patent No. 7871950
   Nightingale SA, 1996, J MATER SCI, V31, P5039, DOI 10.1007/BF00355903
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rekow ED, 2006, J AM DENT ASSOC, V137, P5
   Steyern P, 2005, J ORAL REHABIL, V32, P180
   Sundh A, 2006, DENT MATER, V22, P778, DOI 10.1016/j.dental.2005.11.006
   Suttor D, 2004, US Patent, Patent No. [6709694, 6,709,694]
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   Takashi M., 2009, DENT MATER J, V28, P44
   Yilmaz H, 2007, J PROSTHET DENT, V98, P120, DOI 10.1016/S0022-3913(07)60045-6
   Yuanfu Y., 2008, W CHINA J STOMATOLOG, V26, P556
NR 40
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-685-7
J9 APPL MECH MATER
PY 2013
VL 320
BP 505
EP 511
DI 10.4028/www.scientific.net/AMM.320.505
PG 7
WC Engineering, Mechanical; Nanoscience & Nanotechnology; Materials
   Science, Coatings & Films
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BGK29
UT WOS:000323293000090
DA 2018-10-20
ER

PT J
AU Takemoto, S
   Hattori, M
   Yoshinari, M
   Kawada, E
   Oda, Y
AF Takemoto, Shinji
   Hattori, Masayuki
   Yoshinari, Masao
   Kawada, Eiji
   Oda, Yutaka
TI Discoloration of titanium alloy in acidic saline solutions with peroxide
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Discoloration; Dissolution; Peroxide; Titanium alloy; Surface oxide film
ID HYDROGEN-PEROXIDE; CORROSION-RESISTANCE; METALLIC TITANIUM;
   OXIDE-GROWTH; FLUORIDE; BIOMATERIAL; IMPLANTS; BEHAVIOR; RELEASE; GELS
AB The objective of this study was to compare corrosion behavior in several titanium alloys with immersion in acidulated saline solutions containing hydrogen peroxide. Seven types of titanium alloy were immersed in saline solutions with varying levels of pH and hydrogen peroxide content, and resulting differences in color and release of metallic-elements determined in each alloy. Some alloys were characterized using Auger electron spectroscopy. Ti-55Ni alloy showed a high level of dissolution and difference in color. With immersion in solution containing hydrogen peroxide at pH 4, the other alloys showed a marked difference in color but a low level of dissolution. The formation of a thick oxide film was observed in commercially pure titanium showing discoloration. The results suggest that discoloration in titanium alloys immersed in hydrogen peroxide-containing acidulated solutions is caused by an increase in the thickness of this oxide film, whereas discoloration of Ti-55Ni is caused by corrosion.
C1 [Takemoto, Shinji; Hattori, Masayuki; Yoshinari, Masao; Kawada, Eiji; Oda, Yutaka] Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, Chiba 2618502, Japan.
RP Takemoto, S (reprint author), Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.
EM takemoto@tdc.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [19390500, 20791478, 24792154]
FX This study was supported in part by a Grant-in Aid for Scientific
   Research (No. 19390500, No. 20791478, No. 24792154) from the Ministry of
   Education, Culture, Sports, Science and Technology, Japan. The AES
   measurements were performed under an inter-university cooperative
   research program run by the Advanced Research Center of Metallic
   Glasses, Institute for Materials Research, Tohoku University. The
   authors thank Ms. Akiko Katsuta and Ms. Mikiko Sato of the Department of
   Dental Materials Science of Tokyo Dental College for preparation of
   specimens, and Mr. Yoshihiro Murakami of the Institute for Materials
   Research of Tohoku University for the AES measurements. Finally, we
   would like to thank Associate Prof. Jeremy Williams, Tokyo Dental
   College, for assistance with the English of this manuscript.
CR [Anonymous], 2006, 226742006 ISO
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Hattori M, 2001, Dent Mater J, V20, P16
   JOHNSTON WM, 1989, J DENT RES, V68, P819, DOI 10.1177/00220345890680051301
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Mohsen CA, 2010, J PROSTHODONT, V19, P33, DOI 10.1111/j.1532-849X.2009.00519.x
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Mu Y, 2002, J MATER SCI-MATER M, V13, P583, DOI 10.1023/A:1015130911394
   Noguchi T, 2008, DENT MATER J, V27, P117, DOI 10.4012/dmj.27.117
   Ohkubo C, 2008, J ORAL REHABIL, V35, P706, DOI 10.1111/j.1365-2842.2007.01821.x
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Soma H, 2001, QUINTESSENCE DENT TE, V26, P462
   Sutton A J, 2001, J Prosthodont, V10, P102, DOI 10.1053/jpro.2001.26149
   Takayama Y, 2009, J PROSTHODONT RES, V53, P53, DOI 10.1016/j.jpor.2008.08.011
   Takemoto S, 2004, DENT MATER J, V23, P379, DOI 10.4012/dmj.23.379
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   TENGVALL P, 1990, J COLLOID INTERF SCI, V139, P575, DOI 10.1016/0021-9797(90)90131-7
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
NR 24
TC 4
Z9 4
U1 0
U2 15
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD JAN
PY 2013
VL 32
IS 1
BP 19
EP 24
DI 10.4012/dmj.2012-194
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 205TH
UT WOS:000323467200003
PM 23370866
OA Bronze
DA 2018-10-20
ER

PT J
AU Rieger, KA
   Birch, NP
   Schiffman, JD
AF Rieger, Katrina A.
   Birch, Nathan P.
   Schiffman, Jessica D.
TI Designing electrospun nanofiber mats to promote wound healing - a review
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID DRUG-DELIVERY SYSTEMS; UNIAXIALLY ALIGNED ARRAYS; BOMBYX-MORI SILK;
   SILVER NANOPARTICLES; CELLULOSE-ACETATE; RELEASE PROFILES; FIBER MATS;
   POLY(ETHYLENE OXIDE); CHITOSAN NANOFIBERS; BIOLOGIC DRESSINGS
AB Current strategies to treat chronic wounds offer limited relief to the 7.75 million patients who suffer from burns or chronic skin ulcers. Thus, as long as chronic wounds remain a global healthcare problem, the development of alternate treatments remain desperately needed. This review explores the recent strategies employed to tailor electrospun nanofiber mats towards accelerating the wound healing process. Porous nanofiber mats readily produced by the electrospinning process offer a promising solution to the management of wounds. The matrix chemistry, surface functionality, and mat degradation rate all can be fine-tuned to govern the interactions that occur at the materials-biology interface. In this review, first we briefly discuss the wound healing process and then highlight recent advances in drug release, biologics encapsulation, and antibacterial activity that have been demonstrated via electrospinning. While this versatile biomaterial has shown much progress, commercializing nanofiber mats that fully address the needs of an individual patient remains an ambitious challenge.
C1 [Rieger, Katrina A.; Birch, Nathan P.; Schiffman, Jessica D.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Schiffman, JD (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
EM schiffman@ecs.umass.edu
OI Schiffman, Jessica/0000-0002-1265-5392
FU NSF [DGE-0654128]; NSF Center for Hierarchical Manufacturing at the
   University of Massachusetts (NSEC) [CMMI-1025020]
FX KAR would like to thank the NSF-sponsored Institute for Cellular
   Engineering IGERT program (DGE-0654128). This work was supported by the
   NSF Center for Hierarchical Manufacturing at the University of
   Massachusetts (NSEC, CMMI-1025020).
CR Amna T, 2012, APPL MICROBIOL BIOT, V93, P743, DOI 10.1007/s00253-011-3459-0
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Azad AM, 2010, J MATER RES, V25, P1761, DOI 10.1557/JMR.2010.0237
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Brenner EK, 2012, CARBOHYD POLYM, V87, P926, DOI 10.1016/j.carbpol.2011.07.033
   Canton I, 2010, BIOTECHNOL BIOENG, V105, P396, DOI 10.1002/bit.22530
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Charernsriwilaiwat N, 2012, INT J PHARMACEUT, V427, P379, DOI 10.1016/j.ijpharm.2012.02.010
   Chen L, 2008, POLYMER, V49, P1266, DOI 10.1016/j.polymer.2008.01.003
   Chen L, 2010, CHEM MATER, V22, P1429, DOI 10.1021/cm902834a
   Chern PL, 2009, DERMATOL SURG, V35, P891, DOI 10.1111/j.1524-4725.2009.01153.x
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choi JS, 2011, J MATER CHEM, V21, P5258, DOI 10.1039/c0jm03706k
   Cooley J. F., 1902, U.S. Patent, Patent No. [692631, 692,631]
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Doshi J., 2012, J ELECTROSTAT, V35, P1
   Engel Y, 2012, MATER TODAY, V15, P478, DOI 10.1016/S1369-7021(12)70217-1
   Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x
   Flanagan M., 2005, WOUNDS INT, P74
   Formhals A, 1938, U. S. Patent, Patent No. [2,123,992, 2123992]
   Formhals A, 1939, U. S. Patent, Patent No. [2,158,416, 2158416]
   Formhals A, 1939, U. S. Patent, Patent No. [US 2160962, 2160962, 2,160,962]
   Frey MW, 2008, POLYM REV, V48, P378, DOI 10.1080/15583720802022281
   Game FL, 2012, DIABETES-METAB RES, V28, P119, DOI 10.1002/dmrr.2246
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Gilbert W., 1628, MAGNET MAGNETIC BODI
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Gumusderelioglu M, 2011, J BIOMED MATER RES A, V98A, P461, DOI 10.1002/jbm.a.33143
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Han J, 2009, INT J PHARMACEUT, V382, P215, DOI 10.1016/j.ijpharm.2009.07.027
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Jannesari Marziyeh, 2011, Int J Nanomedicine, V6, P993, DOI 10.2147/IJN.S17595
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jones V, 2006, BRIT MED J, V332, P777, DOI 10.1136/bmj.332.7544.777
   Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Kang S, 2009, ENVIRON SCI TECHNOL, V43, P2648, DOI 10.1021/es8031506
   Kang YO, 2010, J BIOMED MATER RES B, V92B, P568, DOI 10.1002/jbm.b.31554
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Kim HS, 2010, J CONTROL RELEASE, V145, P264, DOI 10.1016/j.jconrel.2010.03.006
   Klossner R. R., 2008, SOLUTIONS, P2947
   Kontogiannopoulos KN, 2011, INT J PHARMACEUT, V409, P216, DOI 10.1016/j.ijpharm.2011.02.004
   Lakshman LR, 2010, J MACROMOL SCI A, V47, P1012, DOI 10.1080/10601325.2010.508001
   Larmor J., 1898, Proceedings of the Royal Society of London, V63, P365, DOI 10.1098/rspl.1898.0043
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226
   Liao YL, 2008, POLYMER, V49, P5294, DOI 10.1016/j.polymer.2008.09.045
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Liu HQ, 2002, J POLYM SCI POL PHYS, V40, P2119, DOI 10.1002/polb.10261
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Liu SB, 2009, ACS NANO, V3, P3891, DOI 10.1021/nn901252r
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Lui W., 2013, ACS MACRO LETT, V2, P466
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Lyon DY, 2008, ENVIRON SCI TECHNOL, V42, P8127, DOI 10.1021/es801869m
   Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McKee MG, 2006, MACROMOLECULES, V39, P575, DOI 10.1021/ma051786u
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Miao JJ, 2011, BIOMATERIALS, V32, P9557, DOI 10.1016/j.biomaterials.2011.08.080
   Mit-uppatham C, 2004, MACROMOL CHEM PHYSIC, V205, P2327, DOI 10.1002/macp.200400225
   MORTON WJ, 1902, Patent No. 705691
   Murphy P. S., 2012, PLAST SURG INT, P1
   Nguyen T. T. T., 2011, CARBOHYD POLYM, V86, P1799, DOI DOI 10.1016/J.CARBP0L.2011.07.014
   Nguyen TH, 2011, J BIOMED MATER RES B, V96B, P225, DOI 10.1002/jbm.b.31756
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Ojha SS, 2008, BIOMACROMOLECULES, V9, P2523, DOI 10.1021/bm800551q
   Pakravan M, 2012, BIOMACROMOLECULES, V13, P412, DOI 10.1021/bm201444v
   Penchev H, 2009, MACROMOL BIOSCI, V9, P884, DOI 10.1002/mabi.200900003
   PRUITT BA, 1984, ARCH SURG-CHICAGO, V119, P312
   Qi HX, 2006, BIOMACROMOLECULES, V7, P2327, DOI 10.1021/bm060264z
   Reznik SN, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2206747
   Rieger K. A., 2013, ANTIBACTERI IN PRESS
   Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021
   Said SS, 2012, EUR J PHARM BIOPHARM, V80, P85, DOI 10.1016/j.ejpb.2011.08.007
   Schiffman JD, 2013, J MATER SCI, V48, P7856, DOI 10.1007/s10853-013-7426-2
   Schiffman JD, 2011, LANGMUIR, V27, P13159, DOI 10.1021/la202605z
   Schiffman JD, 2011, ACS APPL MATER INTER, V3, P462, DOI 10.1021/am101043y
   Schiffman JD, 2011, CARBOHYD POLYM, V84, P1252, DOI 10.1016/j.carbpol.2011.01.013
   Schiffman JD, 2009, POLYM ENG SCI, V49, P1918, DOI 10.1002/pen.21434
   Shai A., 2005, WOUND HEALING ULCERS
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037
   Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020
   Spasova M, 2008, MACROMOL BIOSCI, V8, P153, DOI 10.1002/mabi.200700129
   Su Y., 2010, J BIOMAT SCI-POLYM E, P165
   Su Y. E., 2012, J BIOMAT SCI-POLYM E, V19, P1022, DOI [10.1177/1087054712461177, DOI 10.1177/1087054712461177]
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   TAYLOR G, 1966, PROC R SOC LON SER-A, V291, P145, DOI 10.1098/rspa.1966.0085
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Uppal R, 2011, J BIOMED MATER RES B, V97B, P20, DOI 10.1002/jbm.b.31776
   Wang LG, 2012, RSC ADV, V2, P2433, DOI 10.1039/c2ra00484d
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109
   Xu JQ, 2011, MATER LETT, V65, P2800, DOI 10.1016/j.matlet.2011.06.018
   Xu X., 2010, J APPL POLYM SCI, P588
   Xu XL, 2006, MACROMOL RAPID COMM, V27, P1637, DOI 10.1002/marc.200600384
   Xu XL, 2005, J CONTROL RELEASE, V108, P33, DOI 10.1016/j.jconrel.2005.07.021
   Yan LD, 2011, FIBER POLYM, V12, P207, DOI 10.1007/s12221-011-0207-0
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang Y, 2008, J BIOMED MATER RES A, V86A, P374, DOI 10.1002/jbm.a.31595
   Yarin AL, 2011, POLYM ADVAN TECHNOL, V22, P310, DOI 10.1002/pat.1781
   Zahedi P., 2009, POLYM ADVAN TECHNOL, V21, P77, DOI DOI 10.1002/PAT.1625
   Zhang Q, 2007, MATER LETT, V61, P4027, DOI 10.1016/j.matlet.2007.01.011
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zodrow K. R., 2012, LANGMUIR, V39, P13993
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 124
TC 143
Z9 149
U1 23
U2 354
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 36
BP 4531
EP 4541
DI 10.1039/c3tb20795a
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 205ZL
UT WOS:000323484100001
DA 2018-10-20
ER

PT J
AU Oh, S
   Na, IY
   Choi, KH
AF Oh, Seunghan
   Na, In-Young
   Choi, Kyoung-Hee
TI The Effect of Curcumin Against in vitro Adhesion of Implant
   Device-associated Bacteria on Nanosized Titanium Dioxide
SO JOURNAL OF NANO RESEARCH
LA English
DT Article
DE nanotubes; titanium dioxide; Streptococcus mutans; bacterial adhesion;
   curcumin
ID ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS; HELICOBACTER-PYLORI; WATER
   DISINFECTION; BIOFILM FORMATION; PHOTOCATALYST; ADSORPTION; PROTEINS;
   FILMS
AB Although titanium dioxide (TiO2) is an implantable biomaterial with its antibacterial activity, infection on TiO2 surfaces remains a problem for medical settings. According to our previous studies, curcumin, the main component of turmeric (Curcuma longa), partially hindered the attachment of Streptococcus mutans to human tooth surfaces. Therefore, it was examined whether several implant device-associated bacteria were able to adhere to nanosized TiO2 surfaces. In addition, the effect of curcumin on the bacterial adhesion was investigated. Bacterial strains were cultured on pure Ti and TiO2 surfaces with various nanotube sizes in the absence or presence of curcumin and observed by scanning electron microscopy. Consequently, most bacteria adhered to Ti and TiO2 surfaces. However, curcumin increased the adhesion of bacteria including S. mutans. The results suggest that bacterial adhesion to implant titanium surfaces can be augmented via curcumin ingestion.
C1 [Oh, Seunghan] Wonkwang Univ, Dept Dent Biomat, Coll Dent, Iksan 570749, Chonbuk, South Korea.
   [Na, In-Young] Wonkwang Univ, Dept Life Sci, Iksan 570749, Chonbuk, South Korea.
   [Choi, Kyoung-Hee] Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan 570749, Chonbuk, South Korea.
   [Oh, Seunghan; Choi, Kyoung-Hee] Wonkwang Univ, Inst Biomat Implant, Iksan 570749, Chonbuk, South Korea.
RP Choi, KH (reprint author), Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan 570749, Chonbuk, South Korea.
EM shoh@wku.ac.kr; track109@naver.com; kheechoi@wku.ac.kr
FU Wonkwang University
FX This paper was supported by Wonkwang University in 2012.
CR Barao VA, 2011, J DENT RES, V90, P613, DOI 10.1177/0022034510396880
   BERNARD BK, 1990, J TOXICOL ENV HEALTH, V29, P417, DOI 10.1080/15287399009531402
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7
   Choi H, 2006, APPL CATAL B-ENVIRON, V63, P60, DOI 10.1016/j.apcatb.2005.09.012
   Deng DM, 2009, J ENDODONT, V35, P1249, DOI 10.1016/j.joen.2009.05.038
   FELMINGHAM D, 1992, CLIN INFECT DIS, V15, P295, DOI 10.1093/clinids/15.2.295
   Halpin RM, 2008, EUR FOOD RES TECHNOL, V227, P1499, DOI 10.1007/s00217-008-0872-4
   Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x
   Joyanes P, 2000, EUR J CLIN MICROBIOL, V19, P124, DOI 10.1007/s100960050443
   Joyanes P, 1999, CLIN MICROBIOL INFEC, V5, P382
   Kaida Takahiro, 2004, J Cosmet Sci, V55, P219
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015
   Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Pattiyathanee P, 2009, AFR J BIOTECHNOL, V8, P5106
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004
   Rogers SS, 2008, LANGMUIR, V24, P13549, DOI 10.1021/la802442d
   RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Song J, 2012, EUR J CLIN MICROBIOL, V31, P1347, DOI 10.1007/s10096-011-1448-y
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   WEI C, 1994, ENVIRON SCI TECHNOL, V28, P934, DOI 10.1021/es00054a027
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Zile MA, 2011, J BIOMED MATER RES A, V97A, P59, DOI 10.1002/jbm.a.33028
NR 32
TC 0
Z9 0
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZUERICH
PA LAUBISRUTISTR 24, STAFA-ZUERICH, CH-8712, SWITZERLAND
SN 1662-5250
J9 J NANO RES-SW
JI J. Nano Res.
PY 2013
VL 23
BP 83
EP 90
DI 10.4028/www.scientific.net/JNanoR.23.83
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 205TY
UT WOS:000323468900011
DA 2018-10-20
ER

PT J
AU Chen, Y
   Yan, YT
   Li, XM
   Li, H
   Yuan, Y
   Gao, XY
   Wu, XX
   Zhong, JS
   Lin, BM
   Fan, YB
   Yu, B
AF Chen, Yan
   Yan, Yuting
   Li, Xiaoming
   Li, He
   Yuan, Yue
   Gao, Xiaoying
   Wu, Xixi
   Zhong, Jisheng
   Lin, Bomiao
   Fan, Yubo
   Yu, Bo
TI Osteogenesis Capability and Degradation Property Evaluation of
   Injectable Biomaterials: Comparison of Computed Tomography and
   Ultrasound
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID ECTOPIC BONE-FORMATION; IN-VIVO; QUANTITATIVE ULTRASOUND; STEM-CELLS;
   SCAFFOLDS; DELIVERY; VITRO; DIFFERENTIATION; REGENERATION; HYDROGEL
AB Injectable biomaterials, which can be physically inserted into a target site without the use of surgery, have received increasing attention in tissue engineering during the last decade. There is also a growing need for quantitative evaluation of the injectable biomaterial directly and noninvasively. The objectives of this study are to originate a quantitative noninvasive technique for evaluation of in situ forming bone biomaterials and to validate the feasibility of diagnostic ultrasound images analysis technique. The potential of ultrasound for quantitative evaluation of tissue development was compared with computed tomography (CT) in vivo. A strong correlation was witnessed between ultrasound gray-scale values (GV) and volumetric mean of CT value (HUm) (r = 0.95). Meanwhile, the volume of the material area could be estimated by ultrasound maximum cross-section pixel, which demonstrates a certain consistency with CT mask volume in 3D reconstruction images (r = 0.87). In conclusion, ultrasound imaging, which is corresponding with the traditional CT, can be used to evaluate osteogenesis capability and degradation property of injectable biomaterials. It may be a noninvasive, nonradioactive, and effective aid to monitor ossification and reconstruction of biomaterials at the implant region for bone defect repair.
C1 [Chen, Yan] Southern Med Univ, Zhujiang Hosp, Dept Ultrason Diag, Guangzhou 510282, Guangdong, Peoples R China.
   [Yan, Yuting; Li, He; Yuan, Yue; Gao, Xiaoying; Wu, Xixi; Zhong, Jisheng] Southern Med Univ, Clin Med Coll 2, Guangzhou 510282, Guangdong, Peoples R China.
   [Li, Xiaoming; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China.
   [Lin, Bomiao] Southern Med Univ, Zhujiang Hosp, Dept Radiol, Guangzhou 510282, Guangdong, Peoples R China.
   [Yu, Bo] Southern Med Univ, Zhujiang Hosp, Dept Orthoped, Guangzhou 510282, Guangdong, Peoples R China.
RP Li, XM (reprint author), Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China.
EM x.m.li@hotmail.com; gzyubo@gmail.com
FU National Basic Research Program of China (Program 973) [2011CB710901];
   National Natural Science Foundation of China [81101348, 31000431];
   Natural Science Foundation of Guangdong Province, China
   [10451051501004727, 10151051501000107]; Guangdong Medical Scientific
   Research Project [A2013385]; Doctoral Fund of Ministry of Education,
   China [20114433120004]; Beijing Nova Program [2010B011]; Program for New
   Century Excellent Talents (NCET) in University from Ministry of
   Education of China; National Undergraduate Training Programs for
   Innovation and Entrepreneurship, China [201212121020]; outstanding
   person fund of Zhujiang Hospital
FX The authors are grateful for the financial support from the National
   Basic Research Program of China (Program 973, no. 2011CB710901),
   National Natural Science Foundation of China (nos. 81101348 and
   31000431), Natural Science Foundation of Guangdong Province, China (nos.
   10451051501004727 and 10151051501000107), Guangdong Medical Scientific
   Research Project (A2013385), Doctoral Fund of Ministry of Education,
   China (20114433120004), the Beijing Nova Program (no. 2010B011), Program
   for New Century Excellent Talents (NCET) in University from Ministry of
   Education of China, National Undergraduate Training Programs for
   Innovation and Entrepreneurship, China (no. 201212121020), and
   outstanding person fund of Zhujiang Hospital.
CR Amini AA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024105
   Bacchetta J., 2013, PEDIAT RHEUMATOLOGY, V11
   Binulal N. S., 2012, BIOMEDICAL MAT, V7
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/939821
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/401084
   Hulsart-Billstrom G., 2012, J TISSUE ENG REGENER
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Langton C M, 1984, Eng Med, V13, P89
   Li X., 2013, J BIOMEDICAL MAT R A
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Lu M. H., 2012, COMP MATH MATH PHYS, V2012, DOI DOI 10.1155/2012/979847
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Mueske N. M., 2013, J CLIN DENSITOM, pS1094
   Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009
   Olszynski W. P., 2013, J BONE MINERAL RES
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Taylor WR, 2002, J BIOMECH, V35, P767, DOI 10.1016/S0021-9290(02)00022-2
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Whitmarsh T, 2012, BONE, V51, P896, DOI 10.1016/j.bone.2012.08.114
   Zhang YF, 2011, TISSUE ENG PART C-ME, V17, P789, DOI 10.1089/ten.tec.2010.0453
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 29
TC 2
Z9 2
U1 2
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2013
AR 763937
DI 10.1155/2013/763937
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 204CO
UT WOS:000323342800001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Barua, S
   Das, G
   Aidew, L
   Buragohain, AK
   Karak, N
AF Barua, Shaswat
   Das, Gautam
   Aidew, Lipika
   Buragohain, Alak K.
   Karak, Niranjan
TI Copper-copper oxide coated nanofibrillar cellulose: a promising
   biomaterial
SO RSC ADVANCES
LA English
DT Article
ID PERIPHERAL-BLOOD FIBROCYTES; BOVINE SERUM-ALBUMIN; GREEN SYNTHESIS;
   ANTIBACTERIAL PROPERTIES; SILVER NANOPARTICLES; NANOCELLULOSE;
   NANOCOMPOSITES; CELLS; ACID
AB Nanocellulose is gaining impetus as a hierarchical material in many advanced applications. The isolation of nanocellulose from easily available bio-resources is an area to be delved into thoroughly. This article highlights the isolation of nanofibrillar cellulose from an abundant natural source, Colocasia esculenta, by a chemical method. The nanofibrils were coated with copper-copper oxide nanoparticles through a 'green' reductive technique using the alcoholic extract of Terminalia chebula fruit. The prepared fibrils and the nanohybrid were characterized by Fourier transformed infrared spectroscopy, X-ray diffraction and transmission electron microscopic studies. The coated nanofibrils showed promising antimicrobial activity against Staphyllococcus aureus, Escherichia coli and Candida albicans. The nanohybrid was quite compatible with peripheral blood mononuclear cells (PBMC) as well as mammalian red blood cells (RBCs). The structural integrity of bovine serum albumin (BSA) was unaltered upon interaction with the nanohybrid. The biocompatible and antimicrobial nanohybrid presented here possesses high potential to be used as a biomaterial in a suitable niche of modern biomedical fields.
C1 [Barua, Shaswat; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Napaam 784028, Assam, India.
   [Das, Gautam] Gachon Univ, Dept Environm & Energy Engn, Songnam 461701, Gyeonggi, South Korea.
   [Aidew, Lipika; Buragohain, Alak K.] Tezpur Univ, Dept Mol Biol & Biotechnol, Napaam 784028, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Napaam 784028, Assam, India.
EM karakniranjan@yahoo.com
RI Karak, Niranjan/A-1030-2014; Barua, Shaswat/A-5032-2013
OI Karak, Niranjan/0000-0002-3402-9536; Barua, Shaswat/0000-0003-0050-3698;
   Das, Gautam/0000-0003-2817-2720
FU NRB [DNRD/05/4003/NRB/251]; SAP (UGC), India [F.3-30/2009(SAP-II)];
   FIST, India [SR/FST/CSI-203/209/1]
FX The authors express their gratitude to NRB for financial assistance
   through the grant no. DNRD/05/4003/NRB/251 dated 29.02.12, SAP (UGC),
   India through the grant no. F.3-30/2009(SAP-II) and FIST program-2009
   (DST), India through the grant no. SR/FST/CSI-203/209/1 dated
   06.05.2010. RSIC, NEHU, Shillong is acknowledged for the TEM imaging.
   The authors are thankful to Mr. Dipankar Kalita, Food Engineering
   technology, Tezpur University for technical support.
CR Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556
   Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Anyaogu KC, 2008, LANGMUIR, V24, P4340, DOI 10.1021/la800102f
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Barua S, 2013, ADV SCI ENG MED, V5, P201
   Barua S, 2013, COLLOID SURFACE B, V105, P37, DOI 10.1016/j.colsurfb.2012.12.015
   Cao XB, 2003, J CRYST GROWTH, V254, P164, DOI 10.1016/S0022-0248(03)01115-1
   Chen SG, 2012, J MATER CHEM, V22, P9092, DOI 10.1039/c2jm00063f
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dan ZG, 2005, THIN SOLID FILMS, V492, P93, DOI 10.1016/j.tsf.2005.06
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Dongping S, 2007, J WUHAN UNIV TECHNOL, V22, P677
   Dutta S, 2009, BIORESOURCE TECHNOL, V100, P6391, DOI 10.1016/j.biortech.2009.06.029
   Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8
   Gulcin I, 2010, ARAB J CHEM, V3, P43, DOI 10.1016/j.arabjc.2009.12.008
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hamed O. A., 2012, BIORESOURCES, V7, P1490
   Honary S, 2012, DIG J NANOMATER BIOS, V7, P999
   HUSSAIN M, 1984, J SCI FOOD AGR, V35, P1112, DOI 10.1002/jsfa.2740351010
   Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b
   Jankovic IA, 2010, NANOSCALE RES LETT, V5, P81, DOI 10.1007/s11671-009-9447-y
   Jia BQ, 2012, ACS APPL MATER INTER, V4, P2897, DOI 10.1021/am3007609
   Kathiravan A, 2009, POLYHEDRON, V28, P157, DOI 10.1016/j.poly.2008.09.023
   KLEIN J, 1986, J COLLOID INTERF SCI, V111, P305, DOI 10.1016/0021-9797(86)90037-8
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Kramer F, 2006, MACROMOL SYMP, V244, P136, DOI 10.1002/masy.200651213
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   Mandal A, 2011, CARBOHYD POLYM, V86, P1291, DOI 10.1016/j.carbpol.2011.06.030
   Manohar V. R., 2012, DRUG INVENTION TODAY, V4, P491
   Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9
   Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a
   Ouyang Y, 2013, COLLOID SURFACE B, V107, P107, DOI 10.1016/j.colsurfb.2013.01.073
   Pramanik A, 2012, COLLOID SURFACE B, V96, P50, DOI 10.1016/j.colsurfb.2012.03.021
   Rahman A, 2009, INDONES J CHEM, V9, P355
   Rastogi L, 2013, COLLOID SURFACE B, V108, P134, DOI 10.1016/j.colsurfb.2013.02.031
   Rathinamoorthy R., 2012, J PHARM SCI NANOTECH, V4, P1549
   Ravindran A, 2010, COLLOID SURFACE B, V76, P32, DOI 10.1016/j.colsurfb.2009.10.005
   Rodriguez J, 2006, BBA-GEN SUBJECTS, V1760, P1333, DOI 10.1016/j.bbagen.2006.04.005
   Wang H, 2002, J CRYST GROWTH, V244, P88, DOI 10.1016/S0022-0248(02)01571-3
   Weir E, 2008, ANALYST, V133, P835, DOI 10.1039/b715532h
   Xu ZX, 2012, RSC ADV, V2, P11404, DOI 10.1039/c2ra21745g
   Yang JG, 2006, CHEM LETT, V35, P1190, DOI 10.1246/cl.2006.1190
   Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61
NR 43
TC 24
Z9 24
U1 2
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 35
BP 14997
EP 15004
DI 10.1039/c3ra42209g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 201HU
UT WOS:000323132100019
DA 2018-10-20
ER

PT S
AU Terasaki, D
   Sobel, M
   Irvin, C
   Wijelath, E
   Ratner, BD
AF Terasaki, Dale
   Sobel, Michael
   Irvin, Colleen
   Wijelath, Errol
   Ratner, Buddy D.
BE Scholz, C
   Kressler, J
TI Biomaterial-Induced Angiogenesis To Address Peripheral Vascular Disease:
   The Application of Sphere Templated Hydrogels
SO TAILORED POLYMER ARCHITECTURES FOR PHARMACEUTICAL AND BIOMEDICAL
   APPLICATIONS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT 11th International Biorelated Polymer Symposium / 243rd
   American-Chemical-Society National Meeting
CY MAR 25-29, 2012
CL San Diego, CA
SP Amer Chem Soc, Div Polymer Chem Inc
ID ISCHEMIC SKELETAL-MUSCLE; FIBROBLAST-GROWTH-FACTOR; BLOOD-VESSEL GROWTH;
   ARTERIAL-DISEASE; LIMB ISCHEMIA; RABBIT MODEL; THERAPY; ARTERIOGENESIS;
   GRAFTS; OLDER
AB Peripheral arterial disease (PAD) is the atherosclerotic arterial occlusive disease of the legs that leads to muscle ischemia, disability, and limb loss. Therapeutic approaches that can restore circulation to ischemic limbs are needed. Here we explore the potential of a sphere-templated hydrogel scaffold with 30 micron diameter interconnected pores to induce an angiogenic response. A variant of this scaffold with 60 micron diameter parallel channels in addition to the 30 micron spherical pores was studied to determine if larger vessels might form in the larger channels. As a control, expanded polytetrafluoroethylene (PTFE) was studied. The three types of porous materials were implanted in mouse muscle for two weeks. The scaffold with 30 micron spherical pores showed the highest level of angiogenesis. However, only capillary-dimension blood vessels were seen in all materials.
C1 [Terasaki, Dale; Irvin, Colleen; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Terasaki, D (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
CR BAFFOUR R, 1992, J VASC SURG, V16, P181, DOI 10.1016/0741-5214(92)90106-I
   Blum A, 2012, ATHEROSCLEROSIS, V223, P269, DOI 10.1016/j.atherosclerosis.2012.03.017
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bush RL, 1998, J VASC SURG, V28, P919, DOI 10.1016/S0741-5214(98)70070-9
   CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605
   Germani A, 2009, CARDIOVASC THER, V27, P289, DOI 10.1111/j.1755-5922.2009.00105.x
   Grundmann S, 2006, J VASC SURG, V43, P1263, DOI 10.1016/j.jvs.2006.02.049
   Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173
   Hoefer IE, 2001, CARDIOVASC RES, V49, P609, DOI 10.1016/S0008-6363(00)00243-1
   Hopkins SP, 1998, J VASC SURG, V27, P886, DOI 10.1016/S0741-5214(98)70269-1
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Lawall H, 2011, J VASC SURG, V53, P445, DOI 10.1016/j.jvs.2010.08.060
   Lee SL, 2001, J VASC SURG, V34, P1096, DOI 10.1067/mva.2001.117889
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Marshall A. J., 2004, T 7 WORLD BIOM C SYD, P710
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Maseri A., 1993, COLLATERAL CIRCULATI, P381
   Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x
   Purcell PJ, 2000, MON LABOR REV, V123, P19
   Sussman E., 2011, THESIS U WASHINGTON
   UNGER EF, 1994, AM J PHYSIOL, V266, pH1588
   Yamada N, 2006, J VASC SURG, V44, P1322, DOI 10.1016/j.jvs.2006.07.051
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 24
TC 0
Z9 0
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2798-9
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2013
VL 1135
BP 245
EP 257
PG 13
WC Chemistry, Applied; Polymer Science
SC Chemistry; Polymer Science
GA BGK25
UT WOS:000323292000015
DA 2018-10-20
ER

PT S
AU Fang, YS
   Ming, QZ
   Yuan, HJ
AF Fang, Yan Shi
   Ming, Qin Zhi
   Yuan, Hou Jiang
BE Zhang, H
   Jin, D
   Zhao, XJ
TI The Application of Biomaterials and Tissue Engineering on Wrist Ligament
   Injury
SO ADVANCED RESEARCH ON INFORMATION SCIENCE, AUTOMATION AND MATERIAL
   SYSTEMS III
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Information Science, Automation and
   Material System (ISAM 2013)
CY APR 13-14, 2013
CL Guangzhou, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE Biomaterials; Tissue engineering; Wrist ligament injury
AB This paper summarized the application of main artificial biomaterials and tissue engineering on repair of exercise-induced wrist ligament injury, on the basis of analysis about artificial biomaterial intervention of wrist ligament injury. At present, the anatomical, histological and biomechanical properties of wrist ligament has been studied in the domestic and foreign research; however, the studies about the application of artificial biomaterials and tissue engineering technology in the repair or reconstruction of exercise-induced Wrist ligament injury were very rare. With the development and progress of cell biology and molecular biology methods and technology, the research of ligament injury repair has entered a new stage, the new development of artificial biomaterials and tissue engineering provide a new direction for the Treatment and rehabilitation of exercise-induced wrist ligament injury.
EM cuihc1981@163.com; qinqinfz@163.com; bdxyhjy@163.com
CR Chung E, 2009, J SURG EDUC, V66, P208, DOI 10.1016/j.jsurg.2009.06.007
   Milgram S, 2007, NUCL INSTRUM METH B, V260, P254, DOI 10.1016/j.nimb.2007.02.030
   Smallman R.E., 1999, MODERN PHYS METALLUR, P406
   Tatiana M, 2007, OPTICAL FIBER TECHNO, V13, P27
   Tidswell HK, 2008, BONE, V43, P724, DOI 10.1016/j.bone.2008.06.003
NR 5
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-706-9
J9 ADV MATER RES-SWITZ
PY 2013
VL 703
BP 75
EP 78
DI 10.4028/www.scientific.net/AMR.703.75
PG 4
WC Automation & Control Systems; Materials Science, Multidisciplinary
SC Automation & Control Systems; Materials Science
GA BGF57
UT WOS:000322747300018
DA 2018-10-20
ER

PT J
AU Wei, GJ
   Yao, M
   Wang, YS
   Zhou, CW
   Wan, DY
   Lei, PZ
   Wen, J
   Lei, HW
   Dong, DM
AF Wei, Guo-Jun
   Yao, Meng
   Wang, Yan-Song
   Zhou, Chang-Wei
   Wan, De-Yu
   Lei, Peng-Zhen
   Wen, Jian
   Lei, Hong-Wei
   Dong, Da-Ming
TI Promotion of peripheral nerve regeneration of a peptide compound
   hydrogel scaffold
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE peripheral nerve injury; silk fibroin; peptide; hydrogel; scaffold
ID SILK FIBROIN; CELLS; NANOTECHNOLOGY; BIOMATERIALS; REPAIR;
   RECONSTRUCTION; GUIDES; PC12
AB Background: Peripheral nerve injury is a common trauma, but presents a significant challenge to the clinic. Silk-based materials have recently become an important biomaterial for tissue engineering applications due to silk's biocompatibility and impressive mechanical and degradative properties. In the present study, a silk fibroin peptide (SF16) was designed and used as a component of the hydrogel scaffold for the repair of peripheral nerve injury.
   Methods: The SF16 peptide's structure was characterized using spectrophotometry and atomic force microscopy, and the SF16 hydrogel was analyzed using scanning electron microscopy. The effects of the SF16 hydrogel on the viability and growth of live cells was first assessed in vitro, on PC12 cells. The in vivo test model involved the repair of a nerve gap with tubular nerve guides, through which it was possible to identify if the SF16 hydrogel would have the potential to enhance nerve regeneration. In this model physiological saline was set as the negative control, and collagen as the positive control. Walking track analysis and electrophysiological methods were used to evaluate the functional recovery of the nerve at 4 and 8 weeks after surgery.
   Results: Analysis of the SF16 peptide's characteristics indicated that it consisted of a well-defined secondary structure and exhibited self-assembly. Results of scanning electron microscopy showed that the peptide based hydrogel may represent a porous scaffold that is viable for repair of peripheral nerve injury. Analysis of cell culture also supported that the hydrogel was an effective matrix to maintain the viability, morphology and proliferation of PC12 cells. Electrophysiology demonstrated that the use of the hydrogel scaffold (SF16 or collagen) resulted in a significant improvement in amplitude recovery in the in vivo model compared to physiological saline. Moreover, nerve cells in the SF16 hydrogel group displayed greater axon density, larger average axon diameter and thicker myelin compared to those of the group that received physiological saline.
   Conclusion: The SF16 hydrogel scaffold may promote excellent axonal regeneration and functional recovery after peripheral nerve injury, and the SF16 peptide may be a candidate for nerve tissue engineering applications.
C1 [Wei, Guo-Jun; Yao, Meng; Wang, Yan-Song; Zhou, Chang-Wei; Wan, De-Yu; Lei, Peng-Zhen; Wen, Jian; Dong, Da-Ming] Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed, Harbin 150001, Peoples R China.
   [Lei, Hong-Wei] Harbin Med Univ, Affiliated Hosp 2, Dept Rheumatol, Harbin 150001, Peoples R China.
RP Dong, DM (reprint author), Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed, Harbin 150001, Peoples R China.
EM damingdong2009@yahoo.com
FU Youth Foundation of the 2nd Affiliated Hospital of Harbin Medical
   University [QN2010-16]
FX This work was supported by grants from Youth Foundation of the 2nd
   Affiliated Hospital of Harbin Medical University (No QN2010-16).
CR Bender MD, 2004, BIOMATERIALS, V25, P1269, DOI 10.1016/j.biomaterials.2003.08.046
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Preda Rucsanda C, 2013, Methods Mol Biol, V996, P19, DOI 10.1007/978-1-62703-354-1_2
   Raimondo S, 2011, ANN ANAT, V193, P334, DOI 10.1016/j.aanat.2011.03.001
   Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x
   Rickett TA, 2011, BIOMACROMOLECULES, V12, P57, DOI 10.1021/bm101004r
   Rymer SJ, 2011, THER DELIV, V2, P1043, DOI 10.4155/TDE.11.74
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Waddell RL, 2003, BIOTECHNOL PROGR, V19, P1767, DOI 10.1021/bp034086m
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 24
TC 13
Z9 13
U1 1
U2 52
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 3217
EP 3225
DI 10.2147/IJN.S43681
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 204GJ
UT WOS:000323352900001
PM 24009419
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mangano, C
   Perrotti, V
   Shibli, JA
   Mangano, F
   Ricci, L
   Piattelli, A
   Iezzi, G
AF Mangano, Carlo
   Perrotti, Vittoria
   Shibli, Jamil A.
   Mangano, Francesco
   Ricci, Laura
   Piattelli, Adriano
   Iezzi, Giovanna
TI Maxillary Sinus Grafting with Biphasic Calcium Phosphate Ceramics:
   Clinical and Histologic Evaluation in Man
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone regeneration; biphasic calcium phosphate; human histology; sinus
   augmentation
ID ANORGANIC BOVINE BONE; FLOOR AUGMENTATION; TRICALCIUM PHOSPHATE; IMPLANT
   SURVIVAL; DENTAL IMPLANTS; FOLLOW-UP; HYDROXYAPATITE; ELEVATION;
   BIOMATERIALS; SUBSTITUTES
AB Purpose: To evaluate the clinical and histologic aspects of bone formation in maxillary sinus augmentation using macroporous biphasic calcium phosphate (MBCP) comprising hydroxyapatite/tricalcium phosphate (HA/TCP) 60/40 as bone-grafting material. Materials and Methods: A total of 10 patients and 12 sinuses grafted with MBCP in two-stage sinus augmentation were included in the present study. After a healing period of 6 months, bone core biopsies were harvested during implant insertion and evaluated under light microscopy. Results: The histologic examination showed that the MBCP particles were in close contact with new bone in all biopsies. Histomorphometric evaluation demonstrated that newly formed bone constituted 28.3% +/- 2.7%, residual grafted material 27.3% +/- 1.2%, and marrow spaces 45.9% +/- 1.9%. Conclusions: Histologic investigation showed that the MBCP grafted particles were embedded and integrated in the newly formed bone; this bone was in close and tight contact with the biomaterial particles. Data from the preliminary results demonstrated that MBCP is a biocompatible and osteoconductive material that can be successfully used as a grafting material for sinus floor augmentation.
C1 [Mangano, Carlo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
   [Perrotti, Vittoria; Ricci, Laura; Piattelli, Adriano; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Shibli, Jamil A.] Univ Guarulhos, Dept Periodontol, Dent Res Div, Sao Paulo, Brazil.
   [Shibli, Jamil A.] Univ Guarulhos, Oral Implantol Clin, Sao Paulo, Brazil.
RP Piattelli, A (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Shibli, Jamil/A-1361-2014
OI Shibli, Jamil/0000-0003-1971-0195; Mangano,
   Francesco/0000-0001-5488-4268
FU Ministry of Education, University and Research (M.I.U.R.), Rome, Italy
FX This work was partially supported by the Ministry of Education,
   University and Research (M.I.U.R.), Rome, Italy. The authors reported no
   conflicts of interest related to this study.
CR Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Barone A, 2006, INT J ORAL MAX IMPL, V21, P81
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2008, CLIN ORAL IMPLAN RES, V19, P511, DOI 10.1111/j.1600-0501.2007.01498.x
   Barone A, 2011, J PERIODONTOL, V82, P219, DOI 10.1902/jop.2010.100177
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Bernstein Simon, 2006, Implant Dent, V15, P219, DOI 10.1097/01.id.0000226824.39526.71
   Blomqvist JE, 1998, ORAL SURG ORAL MED O, V86, P268, DOI 10.1016/S1079-2104(98)90170-6
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Campion CR, 2011, J BIOMED MATER RES B, V97B, P245, DOI 10.1002/jbm.b.31807
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P481, DOI 10.1111/j.1600-0501.2010.02042.x
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Daculsi G, 1989, BIOCERAMICS, V2, P3
   Engelke W, 2003, INT J ORAL MAX IMPL, V18, P135
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P396, DOI 10.1034/j.1600-0501.2002.130408.x
   HOLLINGER JO, 1996, CLIN ORTHOP RELAT R, V324, P55
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Lee JH, 2008, CLIN ORAL IMPLAN RES, V19, P767, DOI 10.1111/j.1600-0501.2008.01520.x
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Maiorana C, 2005, INT J ORAL MAX IMPL, V20, P261
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli A, 1993, Bull Group Int Rech Sci Stomatol Odontol, V36, P115
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Springer IN, 2006, TISSUE ENG, V12, P2649, DOI 10.1089/ten.2006.12.2649
   Tan YF, 2007, J BIOMED MATER RES A, V82A, P152, DOI 10.1002/jbm.a.31125
   Tiwana Paul S, 2006, Dent Clin North Am, V50, P409, DOI 10.1016/j.cden.2006.03.004
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   Ueda M, 2001, ARTIF ORGANS, V25, P164, DOI 10.1046/j.1525-1594.2001.025003164.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Yamamichi N, 2008, INT J PERIODONT REST, V28, P163
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 51
TC 26
Z9 27
U1 1
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2013
VL 28
IS 1
BP 51
EP 56
DI 10.11607/jomi.2667
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 186RT
UT WOS:000322062600011
PM 23377047
OA Bronze
DA 2018-10-20
ER

PT J
AU Subramanian, A
   Krishnan, UM
   Sethuraman, S
AF Subramanian, Anuradha
   Krishnan, Uma Maheswari
   Sethuraman, Swaminathan
TI In Vivo Biocompatibility of PLGA-Polyhexylthiophene Nanofiber Scaffolds
   in a Rat Model
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID POLY 3-HEXYLTHIOPHENE-2,5-DIYL; ELECTROACTIVE POLYMERS; NEURITE
   OUTGROWTH; NEURAL INTERFACES; TISSUE-RESPONSE; POLYPYRROLE;
   POLY(ANHYDRIDE-CO-IMIDES); REGENERATION; COMPOSITE; VITRO
AB Electroactive polymers have applications in tissue engineering as a physical template for cell adhesion and carry electrical signals to improve tissue regeneration. Present study demonstrated the biocompatibility and biodegradability of poly(lactide-co-glycolide)poly(3-hexylthiophene) (PLGA-PHT) blend electrospun scaffolds in a subcutaneous rat model. The biocompatibility of PLGA-undoped PHT, PLGA-doped PHT, and aligned PLGA-doped PHT nanofibers was evaluated and compared with random PLGA fibers. The animals were sacrificed at 2, 4, and 8 weeks; the surrounding tissue along with the implant was removed to evaluate biocompatibility and biodegradability by histologic analysis and GPC, respectively. Histology results demonstrated that all scaffolds except PLGA-undoped PHT showed decrease in inflammation over time. It was observed that the aligned PLGA-doped PHT fibers elicited moderate response at 2 weeks, which further reduced to a mild response over time with well-organized tissue structure and collagen deposition. The degradation of aligned nanofibers was found to be very slow when compared to random fibers. Further, there was no reduction in the molecular weight of undoped form of PHT throughout the study. These experiments revealed the biocompatibility and biodegradability of PLGA-PHT nanofibers that potentiate it to be used as a biomaterial for various applications.
C1 [Subramanian, Anuradha; Krishnan, Uma Maheswari; Sethuraman, Swaminathan] SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur 613401, Tamil Nadu, India.
RP Sethuraman, S (reprint author), SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur 613401, Tamil Nadu, India.
EM swami@sastra.edu
FU Nano Mission Council; Department of Science & Technology, Government of
   India [SR/S%/NM-07/2006, SR/NM/PG-16/2007]; Indian Council for Medical
   Research [35/12/2009-BMS]
FX The authors wish to acknowledge the financial assistance granted by the
   Nano Mission Council, Department of Science & Technology, Government of
   India (SR/S%/NM-07/2006 and SR/NM/PG-16/2007) and the Indian Council for
   Medical Research (35/12/2009-BMS).
CR Asplund M, 2010, POLYM CHEM-UK, V1, P1374, DOI 10.1039/c0py00077a
   Bianco A, 2007, SYNTHETIC MET, V157, P276, DOI 10.1016/j.synthmet.2007.03.006
   Bidez P. R., 2006, J BIOMATERIALS SCI, V17, P199
   Chronakis IS, 2006, POLYMER, V47, P1597, DOI 10.1016/j.polymer.2006.01.032
   CLEARY PT, 1992, J ENDODONT, V18, P63, DOI 10.1016/S0099-2399(06)81372-5
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Gonzalez R, 2005, SYNTHETIC MET, V151, P275, DOI 10.1016/j.synthmet.2005.05.007
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Groenendaal BL, 2000, ADV MATER, V12, P481, DOI 10.1002/(SICI)1521-4095(200004)12:7<481::AID-ADMA481>3.0.CO;2-C
   Guterman E., 2003, POLYM PREPR, V43, P766
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Hazen H. R., 1983, THESIS INDIAN U SCH
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ibim SM, 1998, BIOMATERIALS, V19, P941, DOI 10.1016/S0142-9612(98)00019-2
   Kamalesh S, 2000, J BIOMED MATER RES, V52, P467, DOI 10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.3.CO;2-Y
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P209, DOI 10.1016/0142-9612(93)90025-W
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   MITCHELL D. F., 1959, JOUR AMER DENTAL ASSOC, V59, P954
   Newton C W, 1980, J Endod, V6, P509, DOI 10.1016/S0099-2399(80)80197-X
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Otero TF, 2003, ADV MATER, V15, P279, DOI 10.1002/adma.200390066
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Sethuraman S, 2006, J BIOMED MATER RES A, V77A, P679, DOI 10.1002/jbm.a.30620
   Subramanian A, 2012, J MATER SCI-MATER M, V23, P1797, DOI 10.1007/s10856-012-4654-y
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   Wei Y, 2004, CONT TOPICS ADV POLY, P430
   Widge AS, 2007, BIOSENS BIOELECTRON, V22, P1723, DOI 10.1016/j.bios.2006.08.011
   Yamamoto T, 2003, REACT FUNCT POLYM, V55, P231, DOI 10.1016/S1381-5148(02)00220-1
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Zhang QS, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035008
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
NR 36
TC 7
Z9 7
U1 0
U2 17
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 390518
DI 10.1155/2013/390518
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 194TK
UT WOS:000322655400001
PM 23971031
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shi, ZT
   Chen, JJ
AF Shi, Zhentian
   Chen, Jiajun
TI The influence of defoamer on removal of PAHs in soil washing
SO JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION
LA English
DT Article
ID HYDROPHOBIC PARTICLES; FOAM; OIL; ANTIFOAMS; STABILITY
AB The use of surfactants during soil washing process can create massive foam, which has a negative impact on the effective use of equipment. A series of tests was conducted to evaluate the defoaming performance of three defoamers and to investigate the influence on removal of polycyclic aromatic hydrocarbons (PAHs) during enhanced soil washing by the addition of the defoamer. Results showed that polydimethylsiloxane oil, which is the most common biomaterial used in commercial antifoaming and defoaming agents, has the best defoaming performance. With the addition of 0.1% polydimethylsiloxane oil, the removal ratios of total 16 PAHs (sigma PAHs) increased up to 53.48% and 75.92% when washing time was 5 min and 30 min, respectively, compared with the removal ratios of 44.12% and 67.28% with Triton X-100 solution only. This indicated that the proper selection of defoamer not only solves massive foaming problem but also brings out a positive influence on PAH removal during the soil washing process.
   Implications: Three kinds of defoamers (kieselguhr, dodecanol, and polydimethylsiloxane oil) were collected to destroy the foam produced by Triton X-100. Among those defoamers, the polydimethylsiloxane (PDMS) oil has the best defoaming performances. The surface tension of the Triton X-100 solution with the addition of PDMS was lower. The addition of PDMS could improve the removal ratio of sigma PAHs during soil washing. That may be attributed to the addition of the nonionic surfactant Tergitol NP-10 as the emulsifier in the defoamer. After all, the results do not provide any indication of the influence on the solubilization micelles. It is thus questionable whether other components of PDMS oil could improve the PAH solubilization.
C1 [Chen, Jiajun] Beijing Normal Univ, Minist Educ, Key Lab Water & Sediment Sci, Sch Environm, Beijing 100875, Peoples R China.
   [Shi, Zhentian] Beijing Normal Univ, Minist Educ, Key Lab Water & Sediment Sci, Exsitu Soil Remediat Technol Grp,Sch Environm, Beijing 100875, Peoples R China.
RP Chen, JJ (reprint author), Beijing Normal Univ, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China.
EM jeffchen@bnu.edu.cn
FU Beijing Municipal Science and Technology Commission for the Beijing Key
   Science and Technology Project [SF2008-02]; Research Fund for the
   Doctoral Program of Higher Education [20120003110033]
FX This study is funded by Beijing Municipal Science and Technology
   Commission for the Beijing Key Science and Technology Project
   "Development of Integrated Ex-situ Soil Remediation Technology"
   (SF2008-02), and supported by the Research Fund for the Doctoral Program
   of Higher Education (number 20120003110033).
CR ABRIOLA LM, 1993, ENVIRON SCI TECHNOL, V27, P2341, DOI 10.1021/es00048a006
   AVEYARD R, 1994, ADV COLLOID INTERFAC, V48, P93, DOI 10.1016/0001-8686(94)80005-7
   AVEYARD R, 1993, LANGMUIR, V9, P604, DOI 10.1021/la00026a041
   AVEYARD R, 1993, J CHEM SOC FARADAY T, V89, P4313, DOI 10.1039/ft9938904313
   Bergeron V, 1997, COLLOID SURFACE A, V122, P103, DOI 10.1016/S0927-7757(96)03774-0
   Denkov ND, 2002, LANGMUIR, V18, P5810, DOI 10.1021/la020073r
   GARRETT PR, 1994, COLLOID SURFACE A, V85, P159, DOI 10.1016/0927-7757(93)02678-8
   GARRETT PR, 1993, J COLLOID INTERF SCI, V159, P214, DOI 10.1006/jcis.1993.1315
   Harkmgs WD, 1959, PHYS METHODS ORGAN 1, V1
   Joshi KS, 2009, J COLLOID INTERF SCI, V339, P446, DOI 10.1016/j.jcis.2009.07.072
   KOCZO K, 1994, J COLLOID INTERF SCI, V166, P225, DOI 10.1006/jcis.1994.1288
   Laha S, 2009, J ENVIRON MANAGE, V90, P95, DOI 10.1016/j.jenvman.2008.08.006
   Peng S, 2011, CHEMOSPHERE, V82, P1173, DOI 10.1016/j.chemosphere.2010.11.076
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Pugh RJ, 1996, ADV COLLOID INTERFAC, V64, P67, DOI 10.1016/0001-8686(95)00280-4
   ROBINSON JV, 1948, J SOC CHEM IND-L, V67, P361, DOI 10.1002/jctb.5000670908
   ROSS S, 1950, J PHYS COLLOID CHEM, V54, P429, DOI 10.1021/j150477a018
NR 17
TC 1
Z9 1
U1 1
U2 26
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1096-2247
J9 J AIR WASTE MANAGE
JI J. Air Waste Manage. Assoc.
PD JAN 1
PY 2013
VL 63
IS 1
BP 80
EP 86
DI 10.1080/10962247.2012.735627
PG 7
WC Engineering, Environmental; Environmental Sciences; Meteorology &
   Atmospheric Sciences
SC Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric
   Sciences
GA 194LZ
UT WOS:000322636100009
PM 23447866
OA Bronze
DA 2018-10-20
ER

PT S
AU Stylianou, A
   Yova, D
   Alexandratou, E
   Petri, A
AF Stylianou, A.
   Yova, D.
   Alexandratou, E.
   Petri, A.
BE Cartwright, AN
   Nicolau, DV
TI Atomic Force Imaging Microscopy Investigation of the Interaction of
   Ultraviolet Radiation with Collagen Thin Films
SO NANOSCALE IMAGING, SENSING, AND ACTUATION FOR BIOMEDICAL APPLICATIONS X
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanoscale Imaging, Sensing, and Actuation for Biomedical
   Applications X
CY FEB 06-07, 2013
CL San Francisco, CA
SP SPIE
DE Atomic Force Microscopy; Collagen Thin Films; UV; Nanocharacterization;
   Biomaterials
ID UV-IRRADIATION; I FIBRILS; CELLS; AFM; SCAFFOLDS; BIOMATERIAL;
   MORPHOLOGY; CULTURE; FIBERS
AB Collagen is the major fibrous protein in the extracellular matrix and consists a significant component of skin, bone, cartilage and tendon. Due to its unique properties, it has been widely used as scaffold or culture substrate for tissue regeneration or/and cell-substrate interaction studies. The ultraviolet light-collagen interaction investigations are crucial for the improvement of many applications such as that of the UV irradiation in the field of biomaterials, as sterilizing and photo-cross-linking method. The aim of this paper was to investigate the mechanisms of UV-collagen interactions by developing a collagen-based, well characterized, surface with controlled topography of collagen thin films in the nanoscale range. The methodology was to quantify the collagen surface modification induced on ultraviolet radiation and correlate it with changes induced in cells. Surface nanoscale characterization was performed by Atomic Force Microscopy (AFM) which is a powerful tool and offers quantitative and qualitative information with a non-destructive manner. In order to investigate cells behavior, the irradiated films were used for in vitro cultivation of human skin fibroblasts and the cells morphology, migration and alignment were assessed with fluorescence microscopy imaging and image processing methods. The clarification of the effects of UV light on collagen thin films and the way of cells behavior to the different modifications that UV induced to the collagen-based surfaces will contribute to the better understanding of cell-matrix interactions in the nanoscale and will assist the appropriate use of UV light for developing biomaterials.
C1 [Stylianou, A.; Yova, D.; Alexandratou, E.; Petri, A.] Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Iroon Polytechniou 9, Athens 15780, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Iroon Polytechniou 9, Athens 15780, Greece.
OI Stylianou, Andreas/0000-0002-1641-1854
FU European Union (European Social Fund ESF); Greek national; National
   Strategic Reference Framework (NSRF)
FX This research has been co-financed by the European Union (European
   Social Fund ESF) and Greek national funds through the Operational
   Program "Education and Lifelong Learning" of the National Strategic
   Reference Framework (NSRF) - Research Funding Program: Heracleitus II.
   Investing in knowledge society through the European Social Fund.
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Achilli M, 2010, MACROMOL BIOSCI, V10, P307, DOI 10.1002/mabi.200900248
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081
   Fathima NN, 2008, COLLOID SURFACE B, V62, P11, DOI 10.1016/j.colsurfb.2007.09.006
   Fathima NN, 2007, J APPL POLYM SCI, V104, P3642, DOI 10.1002/app.26129
   Fessel G, 2012, J ORTHOP RES, V30, P973, DOI 10.1002/jor.22014
   Francis LW, 2010, J MICROSC-OXFORD, V240, P111, DOI 10.1111/j.1365-2818.2010.03392.x
   Francis LW, 2010, BIOL CELL, V102, P133, DOI 10.1042/BC20090127
   Fratzl P., 2008, COLLAGEN STRUCTURE M, P506
   Gaspar A, 2011, J Med Life, V4, P172
   Hecht E, 2011, ANAL BIOANAL CHEM, V399, P2369, DOI 10.1007/s00216-010-4407-z
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Ionita I, 2010, ROM REP PHYS, V62, P634
   Jariashvili K, 2012, BIOPOLYMERS, V97, P189, DOI 10.1002/bip.21725
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Metreveli NO, 2010, ECOTOX ENVIRON SAFE, V73, P448, DOI 10.1016/j.ecoenv.2009.12.005
   Morris V. J., 2008, ATOMIC FORCE MICROSC, P332
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Rajan N, 2008, BIOTECHNOL PROGR, V24, P884, DOI 10.1002/btpr.3
   Reungpatthanaphong P, 2003, J BIOCHEM BIOPH METH, V57, P1, DOI 10.1016/S0165-022X(03)00032-0
   Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069
   Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730
   Silver FH, 2009, J ENG FIBER FABR, V4, P9
   Sionkowska A, 2008, APPL SURF SCI, V255, P2030, DOI 10.1016/j.apsusc.2008.06.200
   Sionkowska A, 2009, APPL SURF SCI, V255, P4135, DOI 10.1016/j.apsusc.2008.10.108
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2009, 9 INT C INF TECHN AP, DOI [10.1109/itab.2009.5394311, DOI 10.1109/ITAB.2009.5394311]
   STYLIANOU A, 2012, 5 INT C EM TECHN NON, P415
   Stylianou A., 2010, 12 MED C MED BIOL EN, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A., 2011, IFMBE P, V37, P1058
   Torikai A, 1999, J APPL POLYM SCI, V73, P1259, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1259::AID-APP20>3.0.CO;2-#
   Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
NR 43
TC 3
Z9 3
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9363-7
J9 PROC SPIE
PY 2013
VL 8594
AR 85940E
DI 10.1117/12.2002460
PG 15
WC Engineering, Biomedical; Optics; Imaging Science & Photographic
   Technology
SC Engineering; Optics; Imaging Science & Photographic Technology
GA BFX96
UT WOS:000321844500012
DA 2018-10-20
ER

PT J
AU Kiyan, Y
   Kurselis, K
   Kiyan, R
   Haller, H
   Chichkov, BN
   Dumler, I
AF Kiyan, Yulia
   Kurselis, Kestutis
   Kiyan, Roman
   Haller, Hermann
   Chichkov, Boris N.
   Dumler, Inna
TI Urokinase Receptor Counteracts Vascular Smooth Muscle Cell Functional
   Changes Induced by Surface Topography
SO THERANOSTICS
LA English
DT Article
DE urokinase receptor; focal adhesion; vascular smooth muscle cell;
   vascular injury; microstructured biomaterial
ID MULTIPLE GROOVED SUBSTRATA; MESENCHYMAL STEM-CELLS; 2-PHOTON
   POLYMERIZATION; PLASMINOGEN-ACTIVATOR; BEHAVIOR; DIFFERENTIATION;
   ADHESION; DISEASE; ATHEROSCLEROSIS; DEVICES
AB Current treatments for human coronary artery disease necessitate the development of the next generations of vascular bioimplants. Recent reports provide evidence that controlling cell orientation and morphology through topographical patterning might be beneficial for bioimplants and tissue engineering scaffolds. However, a concise understanding of cellular events underlying cell-biomaterial interaction remains missing. In this study, applying methods of laser material processing, we aimed to obtain useful markers to guide in the choice of better vascular biomaterials. Our data show that topographically treated human primary vascular smooth muscle cells (VSMC) have a distinct differentiation profile. In particular, cultivation of VSMC on the microgrooved biocompatible polymer E-shell induces VSMC modulation from synthetic to contractile phenotype and directs formation and maintaining of cell-cell communication and adhesion structures. We show that the urokinase receptor (uPAR) interferes with VSMC behavior on microstructured surfaces and serves as a critical regulator of VSMC functional fate. Our findings suggest that microtopography of the E-shell polymer could be important in determining VSMC phenotype and cytoskeleton organization. They further suggest uPAR as a useful target in the development of predictive models for clinical VSMC phenotyping on functional advanced biomaterials.
C1 [Kiyan, Yulia; Haller, Hermann; Dumler, Inna] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany.
   [Kurselis, Kestutis; Kiyan, Roman; Chichkov, Boris N.] Laser Zentrum Hannover eV, Nanotechnol Dept, D-30419 Hannover, Germany.
RP Dumler, I (reprint author), Hannover Med Sch, Dept Nephrol, Vasc Biol Res Lab, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM dumler.inna@mh-hannover.de
RI Chichkov, Boris/M-4112-2015
OI Chichkov, Boris/0000-0002-8129-7373; Kiyan, Yulia/0000-0002-2063-6327
FU Else Kroener-Fresenius-Stiftung [P59/10//A101/10]; Deutsche
   Forschungsgemeinschaft [DU 344/7-1, KI 1376/2-1]
FX We thank Petra Wuebbolt-Lehmann and Birgit Habermeier for excellent
   technical assistance. This study was funded by the Grant P59/10//A101/10
   from Else Kroener-Fresenius-Stiftung; Grants from the Deutsche
   Forschungsgemeinschaft [DU 344/7-1 and KI 1376/2-1]; Grant "Development
   and fabrication of functional micromechanical and
   MicroOptoElectro-Mechanical Systems (MOEMS) by ultra-high resolution 3D
   multi-photo material processing of new polymer materials" from the
   Deutsche Forschungsgemeinschaft.
CR Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Dangers M, 2010, J VASC RES, V47, P432, DOI 10.1159/000281583
   Doraiswamy A, 2006, ACTA BIOMATER, V2, P267, DOI 10.1016/j.actbio.2006.01.004
   DUNN GA, 1986, J CELL SCI, V83, P313
   Fuhrman B, 2012, ATHEROSCLEROSIS, V32, P449
   Garas SM, 2001, PHARMACOL THERAPEUT, V92, P165, DOI 10.1016/S0163-7258(01)00168-1
   Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262
   Guduru D, 2011, INT J ARTIF ORGANS, V34, P963, DOI [10.5301/ijao.5000012, 10.5301/IJAO.5000012]
   Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030
   Kiyan J, 2009, BIOCHEM J, V423, P343, DOI 10.1042/BJ20090447
   Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Li LJ, 2007, MATER TODAY, V10, P30, DOI 10.1016/S1369-7021(07)70130-X
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Mai JY, 2007, BIOMED MICRODEVICES, V9, P523, DOI 10.1007/s10544-007-9060-8
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6603, DOI 10.1016/j.apsusc.2007.01.062
   Ovsianikov A, 2007, INT J APPL CERAM TEC, V4, P22, DOI 10.1111/j.1744-7402.2007.02115.x
   Ovsianikov A, 2007, SPRINGER SER OPT SCI, V129, P121
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pareta RA, 2009, BIOTECHNOL BIOENG, V103, P459, DOI 10.1002/bit.22276
   Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001
   Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9
   Schlie S, 2007, J BIOMATER APPL, V22, P275, DOI 10.1177/0885328207077590
   Shushakova N, 2005, J IMMUNOL, V175, P4060, DOI 10.4049/jimmunol.175.6.4060
   Song MB, 2009, EXP BIOL MED, V234, P1192, DOI 10.3181/0902-RM-80
   Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56
   Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
NR 42
TC 4
Z9 4
U1 2
U2 9
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2013
VL 3
IS 7
BP 516
EP 526
DI 10.7150/thno.4119
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 196RB
UT WOS:000322792100007
PM 23843899
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Daskalova, A
   Selimis, A
   Manousaki, A
   Gray, D
   Ranella, A
   Fotakis, C
AF Daskalova, A.
   Selimis, A.
   Manousaki, A.
   Gray, D.
   Ranella, A.
   Fotakis, C.
BE Dreischuh, T
   Daskalova, A
TI Surface modification of collagen-based biomaterial induced by pulse
   width variable femtosecond laser pulses
SO 17TH INTERNATIONAL SCHOOL ON QUANTUM ELECTRONICS: LASER PHYSICS AND
   APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 17th International School on Quantum Electronics - Laser Physics and
   Applications (ISQE)
CY SEP 24-28, 2012
CL Nessebar, BULGARIA
SP Bulgarian Acad Sci, Inst Elect, SPIE, Opt Soc Amer, European Off Aerosp Res & Dev, AF Off Sci Res, US AF Res Lab, Bulgarian Sci Fund, Bulgarian Acad Sci, European Phys Soc, Natl Tech Univ Athens, Sch Appl Math & Phys Sci, IEEE Bulgaria Sect, Vivacom Fund, Siemens
DE Collagen; biomaterials; extracellular matrix; nanofoam; ultra-short
   laser processing; tissue engineering; surface modification; fs ablation
ID ABLATION; TISSUE; SKIN
AB The ability to produce idealized cellular constructs is essential for understanding and controlling intercellular processes and ultimately for producing engineered tissue replacements. Preliminary results have been obtained on collagen modification by irradiation with single and multiple pulses of femtosecond laser with variable pulse duration. Irradiation of collagen thin film by single pulses of femtosecond duration results in creation of foam layer with micrometer thickness. The structure and thickness of the layer strongly depends on the number of the applied laser pulses. The surface properties of collagen thin films before and after Ti-sapphire irradiation with 800 nm were investigated by means of the technique Field Emission Scanning Electron Microscope (FESEM). Based on the FESEM results, it was possible to identify an energy density range as the ablation threshold for collagen thin films. The laser-induced foam formation was characterized over the intensity range 3 - 4.2x10(11) W/cm(2). The results of the field emission scanning electron microscopy, showed that by tailoring the laser pulse duration, improved the uniformity of the pore network. Examination of the interaction of ultra-short laser pulses with collagen films is useful for controlling the chemical and microstructural modification of the created foam layer.
C1 [Daskalova, A.] Bulgarian Acad Sci, Inst Elect, 72 Tzarigradsko Chaussee Blvd, BU-1784 Sofia, Bulgaria.
   [Selimis, A.; Manousaki, A.; Gray, D.; Ranella, A.; Fotakis, C.] IESL, FORTH, Iraklion 71110, Greece.
   [Manousaki, A.; Fotakis, C.] Univ Crete, Dept Phys, Iraklion 71110, Greece.
RP Daskalova, A (reprint author), Bulgarian Acad Sci, Inst Elect, 72 Tzarigradsko Chaussee Blvd, BU-1784 Sofia, Bulgaria.
EM a_daskalova@code.bg
FU Bulgarian Science Fund [DMU03/15]; FP7 Marie Curie Transfer of Knowledge
   Program of the European community [MTKD-CT-2005-029194]
FX This work is supported by the Bulgarian Science Fund (project No:
   DMU03/15) and by FP7 Marie Curie Transfer of Knowledge Program of the
   European community (project No: MTKD-CT-2005-029194).
CR Chung SH, 2009, APPL PHYS A-MATER, V96, P335, DOI 10.1007/s00339-009-5201-7
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jaksch H., 1996, MAT WORLD
   Khang G., 2007, MANUAL BIOMATERIALS, V4
   Kinikoglu B, 2011, J MATER SCI-MATER M, V22, P1541, DOI 10.1007/s10856-011-4315-6
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Lazare S, 2005, APPL PHYS A-MATER, V81, P465, DOI 10.1007/s00339-005-3260-y
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   Loesel FH, 1998, APPL PHYS B-LASERS O, V66, P121, DOI 10.1007/s003400050365
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sionkowska A, 2008, MOL CRYST LIQ CRYST, V486, P1292, DOI 10.1080/15421400801921710
   Tsai P., 2009, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2009.02.003, DOI 10.1016/J.C0PBI0.2009.02.003]
   Vogel A., 2007, P 3 INT NAN S HAND O, P249
   Vogel A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038102
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
NR 16
TC 0
Z9 0
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9568-6
J9 PROC SPIE
PY 2013
VL 8770
AR 877016
DI 10.1117/12.2012699
PG 7
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BES40
UT WOS:000317935300042
DA 2018-10-20
ER

PT S
AU Cattalini, JP
   Garcia, J
   Boccaccini, AR
   Lucangioli, S
   Mourino, V
AF Cattalini, J. P.
   Garcia, J.
   Boccaccini, A. R.
   Lucangioli, S.
   Mourino, V
BE Bartolo, P
   Fernandes, P
TI A new calcium releasing nano-composite biomaterial for bone tissue
   engineering scaffolds
SO 3RD INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING (ICTE2013)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd ECCOMAS Thematic Conference on Tissue Engineering (ICTE)
CY JUN 06-08, 2013
CL Leiria, PORTUGAL
SP European Community Assoc Computat Methods Appl Sci (ECCOMAS), Libbey, Mais Centro, Quadro Referencia Estrategico Nacl (QREN), Uniao Europeia, Fundo Europeu Desenvolvimento Reg, Ministerio Ciencia, Tecnologia & Ensino Super, Fundacao Ciencia & Tecnologia (FCT)
DE Composites; Biomaterials; Scaffolds; Films; Calcium
AB A biomaterial with bioactive glass nanoparticles (nBG) and Ca2+ incorporated into alginate matrix was developed. Films characterization was carried out by SEM, IR, tensile strength measurements, bioactivity assay, degradation and swelling studies. Ca2+ release from films was analyzed. Freeze-dried-scaffolds were also fabricated. Films showed the development of a homogeneous matrix and the mechanical properties were improved when nBG were incorporated. The bioactive nature of nBG containing films was confirmed by studies in simulated body fluid. Degradation was negligible and a good swelling capacity was observed. Moreover Ca2+ was released in a controlled manner. In scaffolds fabricated by freeze-drying, pores were seen to be uniform and well distributed. According to the characterization results, these composite biomaterials are attractive candidates for the fabrication of bone tissue engineering scaffolds. (C) 2013 The Authors. Published by Elsevier Ltd.
C1 [Cattalini, J. P.; Garcia, J.; Lucangioli, S.; Mourino, V] Univ Buenos Aires, Fac Pharm & Biochem, 956 Junin 6th Floor, RA-1113 Buenos Aires, DF, Argentina.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany.
RP Mourino, V (reprint author), Univ Buenos Aires, Fac Pharm & Biochem, 956 Junin 6th Floor, RA-1113 Buenos Aires, DF, Argentina.
EM vmourino@ffyb.uba.ar
CR Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   CATTALINI JP, 2013, CURR ANAL CHEM
   Chiara G, 2012, INT J MOL SCI, V13, P737, DOI 10.3390/ijms13010737
   Dorozhkin SV, 2010, J FUNCT BIOMATER, V1, P22, DOI 10.3390/jfb1010022
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Mourino V, 2011, SOFT MATTER, V7, P6705, DOI 10.1039/c1sm05331k
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
NR 10
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2013
VL 59
BP 78
EP 84
DI 10.1016/j.proeng.2013.05.096
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BGB00
UT WOS:000322118400011
OA Green Published, Other Gold
DA 2018-10-20
ER

PT S
AU Musson, DS
   McIntosh, J
   Callon, KE
   Chhana, A
   Dunbar, PR
   Naot, D
   Cornish, J
AF Musson, David S.
   McIntosh, Julie
   Callon, Karen E.
   Chhana, Ashika
   Dunbar, P. Rod
   Naot, Dorit
   Cornish, Jillian
BE Bartolo, P
   Fernandes, P
TI The need for thorough in vitro testing of biomaterial scaffolds: two
   case studies
SO 3RD INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING (ICTE2013)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd ECCOMAS Thematic Conference on Tissue Engineering (ICTE)
CY JUN 06-08, 2013
CL Leiria, PORTUGAL
SP European Community Assoc Computat Methods Appl Sci (ECCOMAS), Libbey, Mais Centro, Quadro Referencia Estrategico Nacl (QREN), Uniao Europeia, Fundo Europeu Desenvolvimento Reg, Ministerio Ciencia, Tecnologia & Ensino Super, Fundacao Ciencia & Tecnologia (FCT)
DE Biomaterial implants; musculoskeletal disorders; tissue engineering;
   tendon; evaluation
ID ROTATOR CUFF REPAIR; TENDON; TEARS
AB Tissue engineered scaffolds are an integral part of future regenerative efforts, whether as carriers for stem cells and growth factors, or as acellular supports on their own. These scaffolds will be inserted at the site of injury, aim to provide temporary mechanical support and promote appropriate cell attachment and growth. Millions of dollars are spent on the development of biomaterial scaffolds, with many put into animal studies and clinical use without proper evaluation, often leading to unfavourable outcomes and associated patient morbidity.
   We exposed two novel scaffolds designed for use in tendon regeneration to a series of in vitro tests, the first a decellularised extracellular matrix (ECM), the second a silk-like material. SEM images were taken to evaluate scaffold nanostructure. Primary human dendritic cells were exposed to scaffolds, with FACS analysis of cell-surface activation markers determining scaffold immunogenicity. Growth of primary tenocytes was analysed using live-dead staining and alamarBlue (R) fluorescence, for cytocompatability. While, phenotypic retention was assessed through real-time PCR analysis of tenocytic genes.
   The decellularised ECM demonstrated low activation in the dendritic cell assay, suggesting low immunogenicity. The cytocompatability assays and real-time PCR analyses suggested that the material was indeed suitable for cell growth and differentiation. However, during the third biological repeat, no cells grew on the material, nor did they on the fourth and fifth repeat. In retrospect it appears that following the second repeat a new batch was tested, with very different properties to the first, which accounted for the reduced cytocompatability.
   The silk-like material produced some of the most repeatable and promising results with the cytocompatability and real-time PCR analyses, while the SEM demonstrated intertwined fibres suitable for cell alignment. However, the immunogenicity assay demonstrated that this material invoked high activation of the primary human dendritic cells, suggesting the material would be unsuitable for in vivo implantation.
   These studies have highlighted that without stringent testing in vitro, great time and expense would have been spent taking these materials forward for animal studies and potentially clinical studies, when clearly they are not suitable for these in their current incarnation. (C) 2013 The Authors. Published by Elsevier Ltd.
C1 [Musson, David S.; Callon, Karen E.; Chhana, Ashika; Naot, Dorit; Cornish, Jillian] Univ Auckland, Dept Med, Auckland 1042, New Zealand.
   [McIntosh, Julie; Dunbar, P. Rod] Univ Auckland, Sch Biol Sci, Auckland 1042, New Zealand.
RP Musson, DS (reprint author), Univ Auckland, Dept Med, Auckland 1042, New Zealand.
EM d.musson@auckland.ac.nz
RI Dunbar, Rod/C-2570-2012
OI Dunbar, Rod/0000-0001-9626-2600; Musson, David/0000-0003-2109-8791;
   Naot, Dorit/0000-0001-9498-2639
FU Auckland Medical Research Foundation Fellowship and the Maurice Wilkins
   Centre, NZ
FX This study was funded by an Auckland Medical Research Foundation
   Fellowship and the Maurice Wilkins Centre, NZ. These funding sources had
   no involvement in the study design; in the collection, analysis and
   interpretation data; in the writing of the report; nor in the decision
   to submit the paper for publication.
CR [Anonymous], 2009, 1099312009 ISO
   Barber FA, 2012, ARTHROSCOPY, V28, P8, DOI 10.1016/j.arthro.2011.06.038
   Bjornsson HC, 2011, ACTA ORTHOP, V82, P187, DOI 10.3109/17453674.2011.566144
   Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   De Deyne PG, 2007, J SHOULDER ELB SURG, V16, p164S, DOI 10.1016/j.jse.2007.02.111
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Scheideler L., 2013, ACTA BIOMATER
   Stoll C, 2010, J ORTHOP RES, V28, P1170, DOI 10.1002/jor.21109
   Vitale MA, 2007, J SHOULDER ELB SURG, V16, P181, DOI 10.1016/j.jse.2006.06.013
   Wong Ivan, 2010, J Shoulder Elbow Surg, V19, P104, DOI 10.1016/j.jse.2009.12.017
NR 16
TC 3
Z9 3
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2013
VL 59
BP 138
EP 143
DI 10.1016/j.proeng.2013.05.103
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BGB00
UT WOS:000322118400018
OA Other Gold
DA 2018-10-20
ER

PT S
AU Kucukgul, C
   Ozler, B
   Karakas, HE
   Gozuacik, D
   Koc, B
AF Kucukgul, Can
   Ozler, Burce
   Karakas, H. Ezgi
   Gozuacik, Devrim
   Koc, Bahattin
BE Bartolo, P
   Fernandes, P
TI 3D hybrid bioprinting of macrovascular structures
SO 3RD INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING (ICTE2013)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd ECCOMAS Thematic Conference on Tissue Engineering (ICTE)
CY JUN 06-08, 2013
CL Leiria, PORTUGAL
SP European Community Assoc Computat Methods Appl Sci (ECCOMAS), Libbey, Mais Centro, Quadro Referencia Estrategico Nacl (QREN), Uniao Europeia, Fundo Europeu Desenvolvimento Reg, Ministerio Ciencia, Tecnologia & Ensino Super, Fundacao Ciencia & Tecnologia (FCT)
DE scaffold free vascular tissue engineering; computer aided biomodeling;
   3D bioprinting; hybrid cell-biomaterial printing
AB Thousands of people die each year due the cardiovascular health problems. The most common treatments for cardiovascular health diseases are autografts and blood vessel transplantations which has limitations due to lack of donors and the patient's conditions. Although there are several scaffold based studies about vascular tissue engineering, scaffold-based vascular grafts have some side effects including chronic inflammation, thrombosis and rejection after in-vivo implantation. Additionally, there are some problems with cell to cell interaction, the assembly and alignment of ECM components and the host response to scaffolds. Therefore, vascular tissue engineering studies tend towards scaffold-free techniques. In this paper, novel computer aided algorithms and methods are developed for 3D printing of scaffold-free macrovascular structures. An example aorta model is generated using imaging and segmentation software. The developed algorithms are implemented using Rhinoscript. In order to support printed cell aggregates, support structures with 'Cake' and 'Zigzag' patterns are developed and 3D printed. (C) 2013 The Authors. Published by Elsevier Ltd.
C1 [Kucukgul, Can; Ozler, Burce; Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
   [Karakas, H. Ezgi; Gozuacik, Devrim] Sabanci Univ Bioengn, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
RP Koc, B (reprint author), Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
EM bahattiinkoc@sabanciuniv.edu
RI Devrim, Gozuacik/C-3330-2008; Koc, Bahattin/D-7277-2012
OI Devrim, Gozuacik/0000-0001-7739-2346; Koc, Bahattin/0000-0001-9073-8516;
   Karakas, Hacer Ezgi/0000-0001-5368-5064
FU Scientific and Technological Research Council of Turkey (TUBITAK)
   [112M094]; Sabanci University
FX This research is supported by The Scientific and Technological Research
   Council of Turkey (TUBITAK) grant number 112M094 and the Sabanci
   University.
CR Domingos M, 2011, VIRTUAL PHYS PROTOTY, V6, P157, DOI 10.1080/17452759.2011.605839
   Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Khoda A. B., 2013, J COMPUTER IN PRESS
   Khoda AKM, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034106
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001
   Melchels FPW, 2010, ACTA BIOMATER, V6, P4208, DOI 10.1016/j.actbio.2010.06.012
   Nemeno-Guanzon J., 2012, J BIOMEDICINE BIOTEC
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
NR 12
TC 16
Z9 16
U1 2
U2 74
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2013
VL 59
BP 183
EP 192
DI 10.1016/j.proeng.2013.05.109
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BGB00
UT WOS:000322118400024
OA Other Gold
DA 2018-10-20
ER

PT S
AU Zerva, I
   Simitzi, C
   Ranella, A
   Stratakis, E
   Fotakis, C
   Athanassakis, I
AF Zerva, I.
   Simitzi, C.
   Ranella, A.
   Stratakis, E.
   Fotakis, C.
   Athanassakis, I.
BE Bartolo, P
   Fernandes, P
TI 3-dimensional laser structured scaffolds improve macrophage adherence
   and antigen-specific response
SO 3RD INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING (ICTE2013)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd ECCOMAS Thematic Conference on Tissue Engineering (ICTE)
CY JUN 06-08, 2013
CL Leiria, PORTUGAL
SP European Community Assoc Computat Methods Appl Sci (ECCOMAS), Libbey, Mais Centro, Quadro Referencia Estrategico Nacl (QREN), Uniao Europeia, Fundo Europeu Desenvolvimento Reg, Ministerio Ciencia, Tecnologia & Ensino Super, Fundacao Ciencia & Tecnologia (FCT)
DE scaffold; macrophages; antigen presentation; adherence; antibody
   production
ID WATER REPELLENCY; WETTABILITY; VACCINES; SURFACES
AB Biomaterial surface properties are determined by the synergistic effect of the morphology and chemistry. Specific combinations of chemical and topographical cues, similar to those experienced by cells during in vivo development, have been shown to control cellular adhesion, migration and function. The aim of the study was to investigate whether 3D micro and submicron laser textured transplantable Si scaffolds with tunable morphology and chemistry could support macrophage adherence, antigen presentation and specific antibody production. The 3D scaffolds could provide useful materials for in vitro and in vivo applications. (C) 2013 The Authors. Published by Elsevier Ltd.
C1 [Zerva, I.; Simitzi, C.; Athanassakis, I.] Dept Biol, Iraklion 71409, Crete, Greece.
   [Ranella, A.; Stratakis, E.; Fotakis, C.; Athanassakis, I.] IESL, Iraklion 71409, Crete, Greece.
RP Athanassakis, I (reprint author), Dept Biol, Iraklion 71409, Crete, Greece.
EM ioann_zer@hotmail.com
RI Stratakis, Emmanuel/B-5365-2011
OI Stratakis, Emmanuel/0000-0002-1908-8618
CR ALVING CR, 1993, ANN NY ACAD SCI, V690, P265
   Barberoglou M, 2009, APPL SURF SCI, V255, P5425, DOI 10.1016/j.apsusc.2008.07.130
   Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Chen XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012185
   Fotakis C, 2007, J PHYS CONF SER, V59, P266, DOI 10.1088/1742-6596/59/1/056
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   GUPTA RK, 1995, VACCINE, V13, P1623, DOI 10.1016/0264-410X(95)00112-E
   Janeway Jr AC, 2001, IMMUNOBIOLOGY
   Klas SD, 2008, VACCINE, V26, P5494, DOI 10.1016/j.vaccine.2008.07.062
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.1440-1711.2004.01286.x
   Papadopoulou E., 2010, TISSUE ENG C, P498
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Stratakis E, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3553235
   Stratakis E., 2009, LASER STRUCTURING WA
   Stratakis E, 2010, CHEM COMMUN, V46, P4136, DOI 10.1039/c003294h
   Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223
   Vevis K, 2012, IMMUNOBIOLOGY, V217, P100, DOI 10.1016/j.imbio.2011.07.029
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zorba V, 2006, NANOTECHNOLOGY, V17, P3234, DOI 10.1088/0957-4484/17/13/026
   Zorba V, 2008, ADV MATER, V20, P4049, DOI 10.1002/adma.200800651
NR 22
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2013
VL 59
BP 211
EP 218
DI 10.1016/j.proeng.2013.05.113
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BGB00
UT WOS:000322118400028
OA Other Gold
DA 2018-10-20
ER

PT S
AU Sousa, I
   Mendes, A
   Bartolo, PJ
AF Sousa, Ines
   Mendes, Ausenda
   Bartolo, Paulo J.
BE Bartolo, P
   Fernandes, P
TI PCL scaffolds with collagen bioactivator for applications in Tissue
   Engineering
SO 3RD INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING (ICTE2013)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd ECCOMAS Thematic Conference on Tissue Engineering (ICTE)
CY JUN 06-08, 2013
CL Leiria, PORTUGAL
SP European Community Assoc Computat Methods Appl Sci (ECCOMAS), Libbey, Mais Centro, Quadro Referencia Estrategico Nacl (QREN), Uniao Europeia, Fundo Europeu Desenvolvimento Reg, Ministerio Ciencia, Tecnologia & Ensino Super, Fundacao Ciencia & Tecnologia (FCT)
DE Biocompatibility; Collagen; Poly(epsilon-caprolactona); Scaffolds;
   Tissue Engineering
ID SURFACE MODIFICATION; ACID
AB The need for human tissues is fundament in certain genetic diseases or accidents of everyday life, they are a primary source for public health. In recent years, to alleviate these effects there was an improvement in the development of tissue engineering, scaffolds or matrices, to support an adequate mechanical and biological environment necessary for the regeneration of damaged tissues. These scaffolds are structures allowing adhesion, differentiation, cell proliferation and the supply of nutrients for growing cells.
   This paper aims to obtain PCL scaffolds bioactivators, to use as support matrices for the development of human tissues, as PCL is a biomaterial widely used in the biomedical field, due to its biocompatibility, mechanical strength and biodegradability. However, this biomaterial is hydrophobic, which means that there are difficulties in cell adhesion. To solve this problem, a coating of PCL scaffolds with collagen was used, since collagen is a hydrophilic protein existing in the formation of various tissues, so improves cell adhesion. (C) 2013 The Authors. Published by Elsevier Ltd.
C1 [Sousa, Ines; Mendes, Ausenda; Bartolo, Paulo J.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
RP Bartolo, PJ (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
EM ines.sousa@ipleiria.pt
RI Bartolo, Paulo/F-2421-2013
OI Bartolo, Paulo/0000-0003-3683-726X; Mendes, Ausenda/0000-0003-3004-8972
CR Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   Bartolo PJ, 2008, VIRTUAL PROTOTYPING & BIO MANUFACTURING IN MEDICAL APPLICATIONS, P149, DOI 10.1007/978-0-387-68831-2_8
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Dinucci D., 2009, INT J BIOMATERIALS
   Hoque ME, 2008, TISSUE ENG PT A, V14, P907
   Wu W, 2007, BRIT J ORAL MAX SURG, V45, P272, DOI 10.1016/j.bjoms.2006.09.004
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 8
TC 13
Z9 13
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2013
VL 59
BP 279
EP 284
DI 10.1016/j.proeng.2013.05.122
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BGB00
UT WOS:000322118400037
OA Other Gold
DA 2018-10-20
ER

PT S
AU Shu, JY
   Panganiban, B
   Xu, T
AF Shu, Jessica Y.
   Panganiban, Brian
   Xu, Ting
BE Johnson, MA
   Martinez, TJ
TI Peptide-Polymer Conjugates: From Fundamental Science to Application
SO ANNUAL REVIEW OF PHYSICAL CHEMISTRY, VOL 64
SE Annual Review of Physical Chemistry
LA English
DT Review; Book Chapter
DE hybrid biomaterial; self-assembly; polymer conformation; protein-polymer
   interaction
ID HYBRID BLOCK-COPOLYMERS; SOLID-STATE STRUCTURE; DIBLOCK COPOLYMERS;
   GIANT AMPHIPHILES; DRUG-DELIVERY; GENE DELIVERY; POLY(ETHYLENE GLYCOL);
   COFACTOR RECONSTITUTION; RADICAL POLYMERIZATION; SYNTHETIC STRATEGIES
AB Peptide/protein-polymer conjugates make up a new class of soft matter comprising natural and synthetic building blocks. They have the potential to combine the advantages of proteins and synthetic polymers (i.e., the precise chemical structure and diverse functionalities of biomolecules and the stability and processability of synthetic polymers) to generate hybrid materials with properties yet to be realized with either component alone. Here we briefly discuss recent developments in the design, fundamental understanding, and self-assembly of various peptide-polymer conjugates, as well as emerging biological and nonbiological applications that range from nanomedicine, to separation, and beyond.
C1 [Shu, Jessica Y.; Panganiban, Brian; Xu, Ting] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   [Xu, Ting] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   [Xu, Ting] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Shu, JY (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
EM tingxu@berkeley.edu
CR Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Apostolovic B, 2010, BIOMACROMOLECULES, V11, P1187, DOI 10.1021/bm901313c
   Babin J, 2005, FARADAY DISCUSS, V128, P179, DOI 10.1039/b403203a
   Bae Y, 2009, ADV DRUG DELIVER REV, V61, P768, DOI 10.1016/j.addr.2009.04.016
   BILLOT JP, 1976, MAKROMOL CHEM, V177, P1889
   Boerakker MJ, 2006, CHEM-EUR J, V12, P6071, DOI 10.1002/chem.200600089
   Boerakker MJ, 2002, ANGEW CHEM INT EDIT, V41, P4239, DOI 10.1002/1521-3773(20021115)41:22<4239::AID-ANIE4239>3.0.CO;2-E
   Borner HG, 2007, SOFT MATTER, V3, P394, DOI 10.1039/b615985k
   Borner HG, 2007, MACROMOL CHEM PHYSIC, V208, P124, DOI 10.1002/macp.200600559
   Boerner HG, 2009, PROG POLYM SCI, V34, P811
   Braunecker WA, 2007, PROG POLYM SCI, V32, P93, DOI 10.1016/j.progpolymsci.2006.11.002
   Cabral H, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014109
   Castelletto V, 2010, LANGMUIR, V26, P11624, DOI 10.1021/la101806z
   Castelletto V, 2010, POLYM CHEM-UK, V1, P453, DOI 10.1039/b9py00349e
   Checot F, 2002, ANGEW CHEM INT EDIT, V41, P1339, DOI 10.1002/1521-3773(20020415)41:8<1339::AID-ANIE1339>3.0.CO;2-N
   CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013
   CHYTRY V, 1978, MAKROMOL CHEM, V179, P329
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427
   Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923
   De P, 2008, J AM CHEM SOC, V130, P11288, DOI 10.1021/ja804495v
   Deacon SPE, 2011, BIOMACROMOLECULES, V12, P19, DOI 10.1021/bm100843e
   Dehn S, 2011, POLYM REV, V51, P214, DOI 10.1080/15583724.2011.566404
   Delaittre G, 2009, CHEM-EUR J, V15, P12600, DOI 10.1002/chem.200902063
   Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008
   Deming TJ, 1997, ADV MATER, V9, P299, DOI 10.1002/adma.19970090404
   Diegelmann SR, 2008, J AM CHEM SOC, V130, P13840, DOI 10.1021/ja805491d
   Diez I, 2010, SOFT MATTER, V6, P3160, DOI 10.1039/c0sm00153h
   Ding ZL, 1999, BIOCONJUGATE CHEM, V10, P395, DOI 10.1021/bc980108s
   Dirks AJ, 2009, SOFT MATTER, V5, P1692, DOI 10.1039/b816615c
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Doi T, 2000, SEN-I GAKKAISHI, V56, P221
   Dong H, 2012, ACS NANO, V6, P5320, DOI 10.1021/nn301142r
   DOUY A, 1982, POLYMER, V23, P1039, DOI 10.1016/0032-3861(82)90405-0
   Dube N, 2011, MACROMOL RAPID COMM, V32, P344, DOI 10.1002/marc.201000603
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Fee CJ, 2004, BIOCONJUGATE CHEM, V15, P1304, DOI 10.1021/bc049843w
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Gao GZ, 2007, MACROMOLECULES, V40, P2613, DOI 10.1021/ma062386p
   Garcia-Arellano H, 2002, BIOCONJUGATE CHEM, V13, P1336, DOI 10.1021/bc025561p
   Gauthier MA, 2008, CHEM COMMUN, P2591, DOI 10.1039/b719689j
   Geng Y, 2006, ANGEW CHEM INT EDIT, V45, P7578, DOI 10.1002/anie.200602739
   Hamley IW, 2008, ADV MATER, V20, P4394, DOI 10.1002/adma.200800266
   Hannink JM, 2001, ANGEW CHEM INT EDIT, V40, P4732, DOI 10.1002/1521-3773(20011217)40:24<4732::AID-ANIE4732>3.0.CO;2-P
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hawker CJ, 2005, MRS BULL, V30, P952, DOI 10.1557/mrs2005.249
   Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u
   Heredia KL, 2007, ORG BIOMOL CHEM, V5, P45, DOI 10.1039/b612355d
   Higuchi M, 2000, LANGMUIR, V16, P7061, DOI 10.1021/la000290x
   Hoffman AS, 1997, MACROMOL SYMP, V118, P553, DOI 10.1002/masy.19971180173
   Jain A, 2011, BIOMACROMOLECULES, V12, P2729, DOI 10.1021/bm2005017
   Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193
   Kagaya H, 2012, GENE THER, V19, P61, DOI 10.1038/gt.2011.74
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kessel S, 2008, MACROMOL RAPID COMM, V29, P316, DOI 10.1002/marc.200700742
   Klok HA, 2005, FARADAY DISCUSS, V128, P29, DOI 10.1039/b402273d
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Klok HA, 2006, ADV POLYM SCI, V202, P75, DOI 10.1007/12_083
   Kong XX, 2004, MACROMOLECULES, V37, P8180, DOI 10.1021/ma048888p
   Kopecek J, 2010, ADV DRUG DELIVER REV, V62, P122, DOI 10.1016/j.addr.2009.10.004
   Kopecek J, 2009, J POLYM SCI POL CHEM, V47, P5929, DOI 10.1002/pola.23607
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kuhnle H, 2009, ANGEW CHEM INT EDIT, V48, P6431, DOI 10.1002/anie.200805768
   Kuhnle RI, 2011, SOFT MATTER, V7, P9616, DOI 10.1039/c1sm05625e
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Kumar RJ, 2011, J AM CHEM SOC, V133, P8564, DOI 10.1021/ja110858k
   LAANE A, 1981, COLLECT CZECH CHEM C, V46, P1466, DOI 10.1135/cccc19811466
   Le Droumaguet B, 2008, ANGEW CHEM INT EDIT, V47, P6263, DOI 10.1002/anie.200801007
   Le Droumaguet B, 2007, J MATER CHEM, V17, P1916, DOI 10.1039/b618079e
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   Losik M, 2004, EUR PHYS J E, V15, P407, DOI 10.1140/epje/i2004-10057-5
   Lu YL, 2008, J PHARM SCI-US, V97, P2062, DOI 10.1002/jps.21170
   Lubbert A, 2005, LANGMUIR, V21, P6582, DOI 10.1021/la0502600
   Ludwigs S, 2005, MACROMOLECULES, V38, P7532, DOI 10.1021/ma0510690
   Lutz JF, 2008, PROG POLYM SCI, V33, P1, DOI 10.1016/j.progpolymsci.2007.07.005
   Marsden HR, 2008, J AM CHEM SOC, V130, P9386, DOI 10.1021/ja800254w
   Moller M, 2011, ORG BIOMOL CHEM, V9, P2403, DOI 10.1039/c0ob01047b
   Muenter AH, 2008, LANGMUIR, V24, P3306, DOI 10.1021/la701909m
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Osada K, 2006, ADV POLYM SCI, V202, P113, DOI 10.1007/12_084
   Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pai SS, 2011, BIOCONJUGATE CHEM, V22, P2317, DOI 10.1021/bc2003583
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866
   Presley AD, 2011, SOFT MATTER, V7, P172, DOI 10.1039/c0sm00817f
   Radu LC, 2009, MACROMOL BIOSCI, V9, P36, DOI 10.1002/mabi.200800193
   Rathore O, 2001, MACROMOLECULES, V34, P1477, DOI 10.1021/ma001553x
   Reynhout IC, 2007, J AM CHEM SOC, V129, P2327, DOI 10.1021/ja066790f
   Rodriguez-Hernandez J, 2005, J AM CHEM SOC, V127, P2026, DOI 10.1021/ja043920g
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Sahin E, 2009, BIOMACROMOLECULES, V10, P2740, DOI 10.1021/bm900474k
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Satchi R, 2001, BRIT J CANCER, V85, P1070, DOI 10.1054/bjoc.2001.2026
   Schillinger EK, 2009, ADV MATER, V21, P1562, DOI 10.1002/adma.200803110
   Schlaad H, 2004, MACROMOLECULES, V37, P2210, DOI 10.1021/ma035819m
   Schlaad H, 2002, POLYMER, V43, P5321, DOI 10.1016/S0032-3861(02)00360-9
   Schlaad H, 2006, ADV POLYM SCI, V202, P53, DOI 10.1007/12_082
   Shaytan AK, 2011, BEILSTEIN J NANOTECH, V2, P525, DOI 10.3762/bjnano.2.57
   Shaytan AK, 2011, ACS NANO, V5, P6894, DOI 10.1021/nn2011943
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Shu JY, 2008, BIOMACROMOLECULES, V9, P2111, DOI 10.1021/bm800113g
   Shu JY, 2012, BIOMACROMOLECULES, V13, P1945, DOI 10.1021/bm300561y
   Shu JY, 2010, BIOMACROMOLECULES, V11, P1443, DOI 10.1021/bm100009e
   Soo PL, 2004, J POLYM SCI POL PHYS, V42, P923, DOI 10.1002/polb.10739
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Svergun DI, 2008, BIOPHYS J, V94, P173, DOI 10.1529/biophysj.107.114314
   Thomas CS, 2011, ACS NANO, V5, P5697, DOI 10.1021/nn2013673
   Tian LF, 2012, CHEM SCI, V3, P1512, DOI 10.1039/c2sc00977c
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Vachutinsky Y, 2010, ISR J CHEM, V50, P175, DOI 10.1002/ijch.201000018
   Van Hest JCM, 2007, POLYM REV, V47, P63, DOI 10.1080/15583720601109578
   Vandermeulen GWM, 2005, MACROMOLECULES, V38, P761, DOI 10.1021/ma0485538
   Vandermeulen GWM, 2004, CHEMPHYSCHEM, V5, P488, DOI 10.1002/cphc.200301079
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Velonia K, 2002, J AM CHEM SOC, V124, P4224, DOI 10.1021/ja017809b
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Wall BD, 2011, ADV MATER, V23, P5009, DOI 10.1002/adma.201102963
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wigenius J, 2010, MACROMOL BIOSCI, V10, P836, DOI 10.1002/mabi.200900463
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014
   Xu T, 2011, ACS NANO, V5, P1376, DOI 10.1021/nn103083t
   Xu T, 2010, SOFT MATTER, V6, P212, DOI 10.1039/b914565f
   Yasayan G, 2011, POLYM CHEM-UK, V2, P1567, DOI 10.1039/c1py00128k
   Yu K, 1998, MACROMOLECULES, V31, P3509, DOI 10.1021/ma971419l
   Zanuy D, 2011, J PHYS CHEM B, V115, P8937, DOI 10.1021/jp2031187
   Zardeneta G, 1996, J ORAL MAXIL SURG, V54, P873, DOI 10.1016/S0278-2391(96)90540-6
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zoungrana T, 1997, COLLOID SURFACE B, V9, P157, DOI 10.1016/S0927-7765(97)00014-3
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 142
TC 98
Z9 99
U1 8
U2 185
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-426X
BN 978-0-8243-1064-6
J9 ANNU REV PHYS CHEM
JI Annu. Rev. Phys. Chem.
PY 2013
VL 64
BP 631
EP 657
DI 10.1146/annurev-physchem-040412-110108
PG 27
WC Chemistry, Physical
SC Chemistry
GA BFX47
UT WOS:000321771600028
PM 23331303
DA 2018-10-20
ER

PT S
AU Kim, JD
   Muhammad, W
   Lee, YG
AF Kim, Jung-Dae
   Muhammad, Waleed
   Lee, Yong-Gu
BE Parak, WJ
   Osinski, M
   Yamamoto, K
TI Stiffness Measurement of a biomaterial by Optical Manipulation of
   Microparticle
SO COLLOIDAL NANOCRYSTALS FOR BIOMEDICAL APPLICATIONS VIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Colloidal Nanocrystals for Biomedical Applications VIII
CY FEB 02-04, 2013
CL San Francisco, CA
SP SPIE
DE Optical tweezers; biomaterial; stiffness; force measurement
ID TRACEABLE FORCE METROLOGY; TWEEZERS; CALIBRATION; CANTILEVERS;
   MICROSCOPY; CELLS
AB Since the discovery of the trapping nature of laser beam, optical tweezers have been extensively employed to measure various parameters at micro/nano level. Optical tweezers show exceptional sensitivity to weak forces making it one of the most sensitive force measurement devices. In this work, we present a technique to measure the stiffness of a biomaterial at different points. For this purpose, a microparticle stuck at the bottom of the dish is illuminated by the trapping laser and respective QPD signal as a function of the distance between the focus of the laser and the center of the microparticle is monitored. After this, microparticle is trapped and manipulated towards the target biomaterial and when it touches the cell membrane, QPD signal shows variation. By comparing two different QPD signals and measuring the trap stiffness, a technique is described to measure the stiffness of the biomaterial at a particular point. We believe that this parameter can be used as a tool to identify and classify different biomaterials.
C1 [Kim, Jung-Dae; Muhammad, Waleed; Lee, Yong-Gu] Gwangju Inst Sci & Technol, Sch Mechatron, 3D Mfg Lab, Kwangju 500712, South Korea.
RP Lee, YG (reprint author), Gwangju Inst Sci & Technol, Sch Mechatron, 3D Mfg Lab, Kwangju 500712, South Korea.
EM lygu@gist.ac.kr
RI Parak, Wolfgang J./M-3998-2014
OI Parak, Wolfgang J./0000-0003-1672-6650
CR Bechhoefer J, 2002, AM J PHYS, V70, P393, DOI 10.1119/1.1445403
   Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003
   Fuhrmann A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015007
   Gates RS, 2006, MEAS SCI TECHNOL, V17, P2852, DOI 10.1088/0957-0233/17/10/041
   Ghislain L. P., 1995, US Patent, Patent No. 5445011
   Huisstede JHG, 2007, MICROSC RES TECHNIQ, V70, P26, DOI 10.1002/jemt.20382
   Kim MS, 2006, METROLOGIA, V43, P389, DOI 10.1088/0026-1394/43/5/008
   Leach R, 2006, MEAS SCI TECHNOL, V17, P467, DOI 10.1088/0957-0233/17/3/S02
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Pratt JR, 2005, MEAS SCI TECHNOL, V16, P2129, DOI 10.1088/0957-0233/16/11/002
   Pratt JR, 2004, J MATER RES, V19, P366, DOI 10.1557/jmr.2004.19.1.366
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247
   Tolic-Norrelykke IM, 2004, COMPUT PHYS COMMUN, V159, P225, DOI 10.1016/j.cpc.2004.02.012
   Villanueva G, 2006, MICROELECTRON ENG, V83, P1302, DOI 10.1016/j.mee.2006.01.223
NR 15
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9364-4
J9 PROC SPIE
PY 2013
VL 8595
AR 85951G
DI 10.1117/12.2005544
PG 8
WC Crystallography; Engineering, Biomedical; Optics
SC Crystallography; Engineering; Optics
GA BFY50
UT WOS:000321896700026
DA 2018-10-20
ER

PT J
AU Kim, W
AF Kim, Wookhyun
TI Recombinant protein polymers in biomaterials
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE Protein Polymer; Genetic Engineering; Biomaterial; Self-Assembly;
   Biomedical; Review
ID MUSSEL ADHESIVE PROTEIN; THERMALLY RESPONSIVE POLYPEPTIDE; HUMAN PROLYL
   4-HYDROXYLASE; SPIDER DRAGLINE SILK; ELASTIN-LIKE POLYMER;
   ESCHERICHIA-COLI; MYTILUS-EDULIS; DRUG-DELIVERY; MECHANICAL-PROPERTIES;
   TRIPLE HELICES
AB Naturally occurring protein-based materials have been found that function as critical components in biomechanical response, fibers and adhesives. A relatively small but growing number of recombinant protein-based materials that mimic the desired features of their natural sources, such as collagens, elastins and silks, are considered as an alternative to conventional synthetic polymers. Advances in genetic engineering have facilitated the synthesis of repetitive protein polymers with precise control of molecular weights which are designed by using synthetic genes encoding tandem repeats of oligopeptide originating from a modular domain of natural proteins. Many repeat sequences as protein polymer building blocks adopt a well-defined secondary structure and undergo self-assembly to result in physically cross-linked networks or with chemical cross-linking so that further form three-dimensional architectures similar to natural counterparts. In this review, recombinant protein polymers currently developed will be presented that have emerged as promising class of next generation biomaterials.
C1 [Kim, Wookhyun] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
   [Kim, Wookhyun] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Kim, W (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
EM wkim2@bidmc.harvard.edu
CR Adams SB, 2009, J BIOMED MATER RES B, V90B, P67, DOI 10.1002/jbm.b.31254
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   ANDERSON JP, 1994, BIOPOLYMERS, V34, P1049, DOI 10.1002/bip.360340808
   Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Chen THH, 2008, PHARM RES, V25, P683, DOI 10.1007/s11095-007-9382-5
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gim Y, 2008, BIOTECHNOL PROGR, V24, P1272, DOI [10.1002/btpr.65, 10.1021/bp.65]
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hart DS, 2007, J PHARM SCI-US, V96, P484, DOI 10.1002/jps.20755
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009
   Kaplan D. L., 1994, ACS S SER, V544
   Kersteen EA, 2004, PROTEIN EXPRES PURIF, V38, P279, DOI 10.1016/j.pep.2004.09.008
   Kim W, 2005, J AM CHEM SOC, V127, P18121, DOI 10.1021/ja054105j
   Kim W, 2007, POLYM REV, V47, P93, DOI 10.1080/15583720601109586
   Kim W, 2006, ANGEW CHEM INT EDIT, V45, P8141, DOI 10.1002/anie.200603227
   Kim W, 2010, ADV DRUG DELIVER REV, V62, P1468, DOI 10.1016/j.addr.2010.04.007
   Kim W, 2010, ANGEW CHEM INT EDIT, V49, P4257, DOI 10.1002/anie.201001356
   Kim WY, 2004, CHEMBIOCHEM, V5, P928, DOI 10.1002/cbic.200400052
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Kurihara H, 2005, BIOTECHNOL LETT, V27, P665, DOI 10.1007/s10529-005-4477-8
   LUAN CH, 1992, BIOPOLYMERS, V32, P1251, DOI 10.1002/bip.360320914
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050
   Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h
   Martin R, 2003, BIOPOLYMERS, V70, P435, DOI 10.1002/bip.10464
   Martinez-Osorio H, 2009, CURR EYE RES, V34, P48, DOI 10.1080/02713680802542053
   McGrath K. P., 1997, PROTEIN BASED MAT, P429
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Neubauer A, 2005, MATRIX BIOL, V24, P59, DOI 10.1016/j.matbio.2004.11.004
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Numata K, 2010, J CONTROL RELEASE, V146, P136, DOI 10.1016/j.jconrel.2010.05.006
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   Rabotyagova OS, 2011, BIOMACROMOLECULES, V12, P269, DOI 10.1021/bm100928x
   Raucher D, 2001, CANCER RES, V61, P7163
   Reguera J, 2003, MACROMOLECULES, V36, P8470, DOI 10.1021/ma034572q
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Shamji MF, 2008, SPINE, V33, P748, DOI 10.1097/BRS.0b013e3181695773
   STRAUSBERG RL, 1990, TRENDS BIOTECHNOL, V8, P53, DOI 10.1016/0167-7799(90)90134-J
   Tao AR, 2010, BIOMATERIALS, V31, P793, DOI 10.1016/j.biomaterials.2009.10.038
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   URRY DW, 1985, BIOCHEM BIOPH RES CO, V130, P50, DOI 10.1016/0006-291X(85)90380-8
   URRY DW, 1986, BIOPOLYMERS, V25, P1939, DOI 10.1002/bip.360251009
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1983, BIOL REV, V58, P209, DOI 10.1111/j.1469-185X.1983.tb00387.x
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wong HH, 1998, BIOTECHNOL BIOENG, V60, P271, DOI 10.1002/(SICI)1097-0290(19981105)60:3<271::AID-BIT1>3.0.CO;2-E
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Yin J, 2003, J BIOTECHNOL, V100, P181, DOI 10.1016/S0168-1656(02)00249-3
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
NR 103
TC 1
Z9 1
U1 3
U2 58
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2013
VL 18
BP 289
EP 304
DI 10.2741/4100
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 171UK
UT WOS:000320954800017
PM 23276922
DA 2018-10-20
ER

PT J
AU Yaneva, Z
   Georgieva, N
AF Yaneva, Zvezdelina
   Georgieva, Nedyalka
TI REMOVAL OF DIAZO DYE FROM THE AQUEOUS PHASE BY BIOSORPTION ONTO
   BALL-MILLED MAIZE COB (BMMC) BIOMASS OF Zea mays
SO MACEDONIAN JOURNAL OF CHEMISTRY AND CHEMICAL ENGINEERING
LA English
DT Article
DE Zea mays; Congo red; FTIR; biosorption; equilibrium; kinetics
ID CONGO RED-DYE; METHYLENE-BLUE; ADSORPTION PROPERTIES; EQUILIBRIUM
   ISOTHERM; KINETICS; SORPTION; CARBON; SHELL
AB The mechanism of Congo red (CR) biosorption by the agricultural waste material ball-milled maize cob (BMMC) biomass of Zea mays was studied by analyzing the effect of pH and biosorbent surface chemistry; the equilibrium and kinetic behavior of the sorbate/sorbent system were also investigated. Surface chemistry and morphology were characterized by potentiometric titration, pH of zero charge, FTIR analyses and digital microscopy (DM). The acidic and basic sites for the biomass were quantified as 3.68 and 5.25 mmol g(-1), respectively; therefore, the surface of the biomass was basic. The analysis of dye equilibrium isotherm data was done using the Langmuir, Freundlich and Redlich-Peterson models. CR biosorption on the agricultural waste biomaterial was mainly limited by chemisorption and/or intraparticle diffusion. The studies revealed that CR removal involved electrostatic interactions between negatively charged dye SO3- groups and positively charged adsorbent surfaces, H bonding between the oxygen- and nitrogen-containing functional groups of CR and the BM:MC surface and hydrophobic hydrophobic interactions between the dye and sorbent hydrophobic parts. The maximum biosorption capacity of Zea mays biomass (q 4.83 mg g(-1)) occurred at pH 7.
C1 [Yaneva, Zvezdelina; Georgieva, Nedyalka] Trakia Univ, Fac Vet Med, Dept Pharmacol Anim Physiol & Physiol Chem, Chem Unit, Stara Zagora 6000, Bulgaria.
RP Yaneva, Z (reprint author), Trakia Univ, Fac Vet Med, Dept Pharmacol Anim Physiol & Physiol Chem, Chem Unit, Students Campus, Stara Zagora 6000, Bulgaria.
EM z.yaneva@abv.bg
RI Georgieva, Nedyalka/E-6931-2012; Yaneva, Zvezdelina/P-3852-2014
OI Yaneva, Zvezdelina/0000-0001-8159-4530; Georgieva,
   Nedyalka/0000-0002-8959-3775
FU Faculty of Veterinary Medicine, Trakia University, Stara Zagora,
   Bulgaria [07/2011]
FX This study was supported financially by Project No. 07/2011, Faculty of
   Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria.
CR Ahmad R, 2010, APPL SURF SCI, V257, P1628, DOI 10.1016/j.apsusc.2010.08.111
   BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   CHIEN SH, 1980, SOIL SCI SOC AM J, V44, P265, DOI 10.2136/sssaj1980.03615995004400020013x
   Elahmadi MF, 2009, J HAZARD MATER, V168, P1163, DOI 10.1016/j.jhazmat.2009.02.139
   Elizalde-Gonzalez MP, 2008, BIORESOURCE TECHNOL, V99, P5134, DOI 10.1016/j.biortech.2007.09.023
   Farooq U, 2011, CHEM ENG J, V171, P400, DOI 10.1016/j.cej.2011.03.094
   Freundlich H. M. F., 1907, J PHYS CHEM-US, V57, P385, DOI DOI 10.1021/JE900585T
   Hameed B.H., 2010, J HAZARD MATER, V162, P939, DOI DOI 10.1016/J.JHAZMAT.2008.05.120
   Han RP, 2010, CARBOHYD POLYM, V79, P1140, DOI 10.1016/j.carbpol.2009.10.054
   Han XL, 2011, CHEM ENG J, V171, P1, DOI 10.1016/j.cej.2011.02.067
   Ho YS, 1998, ADSORPT SCI TECHNOL, V16, P243, DOI 10.1177/026361749801600401
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Issabayeva G, 2006, BIORESOURCE TECHNOL, V97, P2350, DOI 10.1016/j.biortech.2005.10.023
   Koumanova P, 2002, J HAZARD MATER, V90, P229
   Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Movahedi M, 2009, J IRAN CHEM SOC, V6, P570, DOI 10.1007/BF03246536
   Nadjia L., 2011, J CHEM ENG PROCESS T, V2, P1
   Pinheiro HM, 2004, DYES PIGMENTS, V61, P121, DOI 10.1016/j.dyepig.2003.10.009
   Rajamohan N., 2009, African Journal of Environmental Science and Technology, V3, P399
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Roginsky S. Z., 1934, ACTA PHYSICOCHIM URS, V1, P554
   Sabnis R., 2010, HDB BIOL DYES STRAIN, P106
   Sen TK, 2011, WATER AIR SOIL POLL, V218, P499, DOI 10.1007/s11270-010-0663-y
   Smaranda C, 2011, INT J ENVIRON RES, V5, P177
   Sponza DT, 2005, PROCESS BIOCHEM, V40, P2735, DOI 10.1016/j.procbio.2004.12.016
   Tor A, 2006, J HAZARD MATER, V138, P409, DOI 10.1016/j.jhazmat.2006.04.063
   Vieira SS, 2012, CHEM ENG J, V183, P152, DOI 10.1016/j.cej.2011.12.047
   Vimonses V, 2010, J HAZARD MATER, V177, P420, DOI 10.1016/j.jhazmat.2009.12.049
   Vimonses V, 2009, CHEM ENG J, V148, P354, DOI 10.1016/j.cej.2008.09.009
   Wang L, 2008, BIORESOURCE TECHNOL, V99, P1403, DOI 10.1016/j.biortech.2007.01.063
   Yaneva Z. L., 2012, INT REV CHEM ENG, V4, P127
   Yang YY, 2011, BIORESOURCE TECHNOL, V102, P828, DOI 10.1016/j.biortech.2010.08.125
   Zhang ZY, 2011, CHEM ENG J, V178, P122, DOI 10.1016/j.cej.2011.10.024
NR 35
TC 1
Z9 1
U1 1
U2 11
PU SOC CHEMISTS TECHNOLOGISTS MADECONIA
PI SKOPJE
PA STS CYRIL & METHODIUS UNIV, FAC TECHNOL  & METALLURGY, PO BOX 560, RUGER
   BOSKOVIC 16, SKOPJE, MK-1001, MACEDONIA
SN 1857-5552
J9 MACED J CHEM CHEM EN
JI Maced. J. Chem. Chem. Eng.
PY 2013
VL 32
IS 1
BP 133
EP 149
PG 17
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 187VJ
UT WOS:000322149300011
DA 2018-10-20
ER

PT J
AU Lin, IH
   Cheng, CC
   Huang, CW
   Liang, MC
   Chen, JK
   Ko, FH
   Chu, CW
   Huang, CF
   Chang, FC
AF Lin, I. -Hong
   Cheng, Chih-Chia
   Huang, Cheng-Wei
   Liang, Mei-Chih
   Chen, Jem-Kun
   Ko, Fu-Hsiang
   Chu, Chih-Wei
   Huang, Chih-Feng
   Chang, Feng-Chih
TI Nucleobase-grafted polycaprolactones as reversible networks in a novel
   biocompatible material
SO RSC ADVANCES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; SUPRAMOLECULAR POLYMERS; MOLECULAR
   RECOGNITION; CHEMICAL-MODIFICATION; HYDROGEN; COPOLYMERS; MONOMERS;
   SYSTEMS; POLY(EPSILON-CAPROLACTONE); CAPROLACTONE
AB A series of nucleobase-grafted polycaprolactones have been prepared which exhibits a high complementary ability in solution and solid states owing to the formation of uracil-adenine pairs by induced hierarchical self-assembly. In addition, they can self-organize into spherical structure and result in excellent biomaterial properties.
C1 [Chang, Feng-Chih] Natl Sun Yat Sen Univ, Dept Mat & Optoelect Sci, Kaohsiung 80424, Taiwan.
   [Lin, I. -Hong; Cheng, Chih-Chia; Huang, Cheng-Wei] Natl Chiao Tung Univ, Inst Appl Chem, Hsinchu 30050, Taiwan.
   [Liang, Mei-Chih] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
   [Chen, Jem-Kun] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.
   [Ko, Fu-Hsiang] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30050, Taiwan.
   [Chu, Chih-Wei] Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan.
   [Huang, Chih-Feng] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
RP Chang, FC (reprint author), Natl Sun Yat Sen Univ, Dept Mat & Optoelect Sci, Kaohsiung 80424, Taiwan.
EM chihchia.ac95g@nctu.edu.tw; changfc1973@gmail.com
RI Chang, Feng-Chih/G-5195-2010; Huang, Chih-Feng/C-2297-2012
OI Huang, Chih-Feng/0000-0002-8062-8708; Liang,
   Mei-Chih/0000-0002-7389-2455
FU National Science Council, Taiwan [NSC-101-2221-E-009-030-]
FX This study was support financially by the National Science Council,
   Taiwan (contract no. NSC-101-2221-E-009-030-). The authors wish to
   express their thanks to Dr Fu (Food Industry Research and Development
   Institute) for supplying the NCTC clone 929 and for their help during
   preliminary studies.
CR Archer EA, 2002, J AM CHEM SOC, V124, P5074, DOI 10.1021/ja012696h
   Binder WH, 2005, MACROMOLECULES, V38, P9405, DOI 10.1021/ma0518252
   Boal AK, 2000, NATURE, V404, P746
   Cheng CC, 2008, J POLYM SCI POL CHEM, V46, P6416, DOI 10.1002/pola.22949
   Das K, 2004, MACROMOLECULES, V37, P310, DOI 10.1021/ma0346355
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Feldman KE, 2009, MACROMOLECULES, V42, P9072, DOI 10.1021/ma901668w
   Fogleman EA, 2002, ANGEW CHEM INT EDIT, V41, P4026, DOI 10.1002/1521-3773(20021104)41:21<4026::AID-ANIE4026>3.0.CO;2-E
   Galow TH, 2000, J AM CHEM SOC, V122, P3595, DOI 10.1021/ja993735g
   Guan ZB, 2004, J AM CHEM SOC, V126, P2058, DOI 10.1021/ja039127p
   Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027
   Hirschberg JHKK, 1999, MACROMOLECULES, V32, P2696, DOI 10.1021/ma981950w
   HUISGEN R, 1989, PURE APPL CHEM, V61, P613, DOI 10.1351/pac198961040613
   Huisgen R, 1984, 1 3 DIPOLAR CYCLOADD, V1, P1
   Kataoka DE, 1999, NATURE, V402, P794, DOI 10.1038/45521
   Kato T, 2000, STRUCT BOND, V96, P95
   Khan A, 1999, MACROMOLECULES, V32, P6560, DOI 10.1021/ma990283j
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kolomiets E, 2006, MACROMOLECULES, V39, P1173, DOI 10.1021/ma0523522
   Krische MJ, 2000, STRUCT BOND, V96, P3
   Lenoir S, 2004, MACROMOLECULES, V37, P4055, DOI 10.1021/ma035003l
   Lin IH, 2010, MACROMOLECULES, V43, P1245, DOI 10.1021/ma9026614
   Lou XD, 2002, J POLYM SCI POL CHEM, V40, P2286, DOI 10.1002/pola.10318
   Lutz JF, 2005, MACROMOLECULES, V38, P8124, DOI 10.1021/ma051476b
   Mather BD, 2007, MACROMOLECULES, V40, P6834, DOI 10.1021/ma070865y
   Melendez RE, 2000, STRUCT BOND, V96, P31
   Nair KP, 2008, MACROMOLECULES, V41, P3429, DOI 10.1021/ma800279w
   Nojima S, 1997, POLYMER, V38, P2711, DOI 10.1016/S0032-3861(97)85605-4
   Park T, 2006, J AM CHEM SOC, V128, P11582, DOI 10.1021/ja0631854
   Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G
   Rieth S, 2007, SOFT MATTER, V3, P137, DOI 10.1039/b615009h
   Riva R, 2007, MACROMOLECULES, V40, P796, DOI 10.1021/ma0624090
   Roland JT, 2004, J AM CHEM SOC, V126, P14328, DOI 10.1021/ja0448871
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Sessler JL, 2005, CHEM COMMUN, P1939, DOI 10.1039/b418526a
   Shenhar R, 2005, J AM CHEM SOC, V127, P16318, DOI 10.1021/ja055490f
   Sherrington DC, 2001, CHEM SOC REV, V30, P83, DOI 10.1039/b008033k
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   Sijbesma RP, 2003, CHEM COMMUN, P5, DOI 10.1039/b205873c
   Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123
   Sivakova S, 2005, CHEM SOC REV, V34, P9, DOI 10.1039/b304608g
   Snip E, 2001, TETRAHEDRON LETT, V42, P2153, DOI 10.1016/S0040-4039(01)00095-8
   Tew GN, 1999, J AM CHEM SOC, V121, P9852, DOI 10.1021/ja991506o
   Thibault RJ, 2002, J AM CHEM SOC, V124, P15249, DOI 10.1021/ja026418+
   Tung PH, 2007, POLYMER, V48, P3192, DOI 10.1016/j.polymer.2007.03.071
   Uzun O, 2004, J AM CHEM SOC, V126, P14773, DOI 10.1021/ja047643p
   Vutukuri DR, 2004, J AM CHEM SOC, V126, P15636, DOI 10.1021/ja0449628
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Xu J, 2004, MACROMOLECULES, V37, P1863, DOI 10.1021/ma035546v
   Yamauchi K, 2004, MACROMOLECULES, V37, P3519, DOI 10.1021/ma049913u
   Yamauchi K, 2002, MACROMOLECULES, V35, P8745, DOI 10.1021/ma020961t
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
   Zimmerman SC, 2000, STRUCT BOND, V96, P63
   Zou S, 2005, ANGEW CHEM INT EDIT, V44, P956, DOI 10.1002/anie.200460963
NR 54
TC 12
Z9 12
U1 2
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 31
BP 12598
EP 12603
DI 10.1039/c3ra41412d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 183CM
UT WOS:000321791200013
DA 2018-10-20
ER

PT J
AU Deniz, F
AF Deniz, Fatih
TI Adsorption Properties of Low-Cost Biomaterial Derived from Prunus
   amygdalus L. for Dye Removal from Water
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID AQUEOUS-SOLUTIONS; MALACHITE GREEN; WASTES; ORANGE
AB The capability of Prunus amygdalus L. (almond) shell for dye removal from aqueous solutions was investigated and methyl orange was used as a model compound. The effects of operational parameters including pH, ionic strength, adsorbent concentration and mesh size, dye concentration, contact time, and temperature on the removal of dye were evaluated. The adsorption kinetics conformed to the pseudo-second-order kinetic model. The equilibrium data pointed out excellent fit to the Langmuir isotherm model with maximum monolayer adsorption capacity of 41.34 mg g(-1) at 293 K. Thermodynamic analysis proved a spontaneous, favorable, and exothermic process. It can be concluded that almond shell might be a potential low-cost adsorbent for methyl orange removal from aqueous media.
C1 Nigar Erturk Trade Vocat High Sch, TR-27590 Gaziantep, Turkey.
RP Deniz, F (reprint author), Nigar Erturk Trade Vocat High Sch, TR-27590 Gaziantep, Turkey.
EM f_deniz@windowslive.com
RI Deniz, Fatih/E-5471-2015
OI Deniz, Fatih/0000-0002-2771-2652
CR Allegre C, 2006, J MEMBRANE SCI, V269, P15, DOI 10.1016/j.memsci.2005.06.014
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Ansari R, 2011, CHEM PAP, V65, P1, DOI 10.2478/s11696-010-0083-x
   Ardejani FD, 2008, J HAZARD MATER, V151, P730, DOI 10.1016/j.jhazmat.2007.06.048
   Ayrilmis N, 2009, FOREST ECOL MANAG, V259, P65, DOI 10.1016/j.foreco.2009.09.043
   Bekci Z, 2009, J HAZARD MATER, V161, P1454, DOI 10.1016/j.jhazmat.2008.04.125
   Buvaneswari N, 2011, J HAZARD MATER, V189, P294, DOI 10.1016/j.jhazmat.2011.02.036
   Chowdhury S, 2010, CHEM ENG J, V164, P168, DOI 10.1016/j.cej.2010.08.050
   Das Saha P, 2012, COLLOID SURFACE B, V92, P262, DOI 10.1016/j.colsurfb.2011.11.057
   Esfahlan AJ, 2010, FOOD CHEM, V120, P349, DOI 10.1016/j.foodchem.2009.09.063
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Greluk M, 2011, CHEM ENG J, V170, P184, DOI 10.1016/j.cej.2011.03.052
   Han XL, 2011, CHEM ENG J, V171, P1, DOI 10.1016/j.cej.2011.02.067
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mittal A, 2007, J HAZARD MATER, V148, P229, DOI 10.1016/j.jhazmat.2007.02.028
   Ogugbue CJ, 2011, ECOL ENG, V37, P2056, DOI 10.1016/j.ecoleng.2011.09.003
   Rakhshaee R, 2011, CHINESE CHEM LETT, V22, P501, DOI 10.1016/j.cclet.2010.10.041
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Senturk HB, 2010, DESALINATION, V252, P81, DOI 10.1016/j.desal.2009.10.021
   Sharma P, 2011, ENVIRON MONIT ASSESS, V183, P151, DOI 10.1007/s10661-011-1914-0
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yu JX, 2011, ENG LIFE SCI, V11, P309, DOI 10.1002/elsc.201000158
NR 24
TC 13
Z9 14
U1 1
U2 13
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2013
AR 961671
DI 10.1155/2013/961671
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 189FL
UT WOS:000322252600001
PM 23935442
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pertici, V
   Amendola, J
   Laurin, J
   Gigmes, D
   Madaschi, L
   Carelli, S
   Marqueste, T
   Gorio, A
   Decherchi, P
AF Pertici, Vincent
   Amendola, Julien
   Laurin, Jerome
   Gigmes, Didier
   Madaschi, Laura
   Carelli, Stephana
   Marqueste, Tanguy
   Gorio, Alfredo
   Decherchi, Patrick
TI The use of poly(N-[2-hydroxypropyl]-methacrylamide) hydrogel to repair a
   T10 spinal cord hemisection in rat: a behavioural, electrophysiological
   and anatomical examination
SO ASN NEURO
LA English
DT Article
DE biomaterial; ED1; monosynaptic Ia afferent reflex; motoneuron
   recruitment; myelin; neurofilament; pHPMA; spasticity
ID EXERCISE PRESSOR REFLEX; CENTRAL-NERVOUS-SYSTEM; SOLEUS H-REFLEX; AXONAL
   REGENERATION; MONOSYNAPTIC REFLEX; GUIDANCE CHANNELS; ADULT RATS;
   STEM-CELLS; 2-HYDROXYETHYL METHACRYLATE; TRANSSYNAPTIC DEGENERATION
AB There have been considerable interests in attempting to reverse the deficit because of an SCI (spinal cord injury) by restoring neural pathways through the lesion and by rebuilding the tissue network. In order to provide an appropriate micro-environment for regrowing axotomized neurons and proliferating and migrating cells, we have implanted a small block of pHPMA [poly N-(2-hydroxypropyl)-methacrylamide] hydrogel into the hemisected T10 rat spinal cord. Locomotor activity was evaluated once a week during 14 weeks with the BBB rating scale in an open field. At the 14th week after SCI, the reflexivity of the sub-lesional region was measured. We also monitored the ventilatory frequency during an electrically induced muscle fatigue known to elicit the muscle metaboreflex and increase the respiratory rate. Spinal cords were then collected, fixed and stained with anti-ED-1 and anti-NF-H antibodies and FluoroMyelin. We show in this study that hydrogel-implanted animals exhibit: (i) an improved locomotor BBB score, (ii) an improved breathing adjustment to electrically evoked isometric contractions and (iii) an H-reflex recovery close to control animals. Qualitative histological results put in evidence higher accumulation of ED-1 positive cells (macrophages/monocytes) at the lesion border, a large number of NF-H positive axons penetrating the applied matrix, and myelin preservation both rostrally and caudally to the lesion. Our data confirm that pHPMA hydrogel is a potent biomaterial that can be used for improving neuromuscular adaptive mechanisms and H-reflex responses after SCI.
C1 [Pertici, Vincent; Amendola, Julien; Laurin, Jerome; Marqueste, Tanguy; Decherchi, Patrick] AMU, ISM Etienne Jules MAREY, Equipe Plasticit Syst Nerveux & Musculaire, UMR CNRS 7287, F-13288 Marseille 09, France.
   [Gigmes, Didier] AMU, ICR, Equipe Chim Radicalaire Organ & Polymeres Special, UMR CNRS 7273, F-13397 Marseille 20, France.
   [Madaschi, Laura; Carelli, Stephana; Gorio, Alfredo] Univ Milan, Osped San Paolo, Dipartimento Med Chirurg & Odontoiatria, Fac Med & Chirug, I-20142 Milan, Italy.
RP Decherchi, P (reprint author), AMU, ISM Etienne Jules MAREY, Equipe Plasticit Syst Nerveux & Musculaire, UMR CNRS 7287, Parc Sci & Technol Luminy,CC910-163 Ave Luminy, F-13288 Marseille 09, France.
EM patrick.decherchi@univ-amu.fr
OI DECHERCHI, Patrick/0000-0001-5639-852X
FU Aix-Marseille University (AMU); Centre National de la Recherche
   Scientifique (CNRS); NeuroGel en Marche; ALARME; Demain Debout
   Association; Combattre la Paralysie Association
FX This work was supported by the Aix-Marseille University (AMU), Centre
   National de la Recherche Scientifique (CNRS), NeuroGel en Marche,
   ALARME, Demain Debout and Combattre la Paralysie Associations.
CR Ahmed MR, 2004, BIOMATERIALS, V25, P2585, DOI 10.1016/j.biomaterials.2003.09.075
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   BAUER RM, 1989, AM J PHYSIOL, V257, pR1154
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   Bianco J, 2011, NEUROSCIENCE, V188, P182, DOI 10.1016/j.neuroscience.2011.04.066
   Bjugn R, 1997, EXP NEUROL, V148, P179, DOI 10.1006/exnr.1997.6610
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   Bottai D, 2010, EXP NEUROL, V223, P452, DOI 10.1016/j.expneurol.2010.01.010
   BURKE D, 1984, J NEUROPHYSIOL, V52, P435
   Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8
   Chang CW, 1998, AM J PHYS MED REHAB, V77, P118, DOI 10.1097/00002060-199803000-00006
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen XY, 2002, EXP BRAIN RES, V144, P88, DOI 10.1007/s00221-002-1026-8
   Chen XY, 2001, J NEUROTRAUM, V18, P313, DOI 10.1089/08977150151070973
   Cliffer KD, 1998, MUSCLE NERVE, V21, P1405, DOI 10.1002/(SICI)1097-4598(199811)21:11<1405::AID-MUS7>3.3.CO;2-D
   COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A
   Crisafulli A, 2009, EUR J APPL PHYSIOL, V106, P525, DOI 10.1007/s00421-009-1045-2
   Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036
   DANGELO CM, 1973, J NEUROSURG, V39, P209, DOI 10.3171/jns.1973.39.2.0209
   Darques JL, 1997, BRAIN RES, V750, P147, DOI 10.1016/S0006-8993(96)01341-8
   Decherchi P, 2007, EXP BRAIN RES, V183, P299, DOI 10.1007/s00221-007-1044-7
   DELWAIDE P J, 1973, Electromyography and Clinical Neurophysiology, V13, P515
   DIAMANTOPOULOS E, 1967, J NEUROL NEUROSUR PS, V30, P427, DOI 10.1136/jnnp.30.5.427
   ECCLES JC, 1951, J NEUROPHYSIOL, V14, P353
   EIDELBERG E, 1989, BRAIN RES BULL, V22, P39, DOI 10.1016/0361-9230(89)90125-1
   ELDRIDGE FL, 1985, RESP PHYSIOL, V59, P313, DOI 10.1016/0034-5687(85)90136-7
   ENGBERG I, 1968, J PHYSIOL-LONDON, V194, P201, DOI 10.1113/jphysiol.1968.sp008402
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   FRIEDMAN WA, 1981, J NEUROPHYSIOL, V46, P1349
   Frigon A, 2006, PROG BRAIN RES, V157, P231, DOI 10.1016/S0079-6123(06)57016-5
   GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979
   Gozariu M, 1998, BRAIN RES, V782, P343, DOI 10.1016/S0006-8993(97)01402-9
   Hasegawa Y, 1996, EUR J PHARMACOL, V295, P211, DOI 10.1016/0014-2999(95)00759-8
   Hasegawa Y, 1996, BRAIN RES, V738, P158, DOI 10.1016/0006-8993(96)00991-2
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574
   Holmes GM, 2005, EXP NEUROL, V193, P29, DOI 10.1016/j.expneurol.2005.01.002
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Hultborn H, 2003, J REHABIL MED, V35, P46, DOI 10.1080/16501960310010142
   HUNT CC, 1955, J GEN PHYSIOL, V38, P813, DOI 10.1085/jgp.38.6.813
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   IWAMOTO GA, 1985, J APPL PHYSIOL, V59, P459
   IWAMOTO GA, 1984, BRAIN RES, V292, P160, DOI 10.1016/0006-8993(84)90901-6
   Jimenez O, 2000, SPINAL CORD, V38, P532, DOI 10.1038/sj.sc.3101052
   KAELAN C, 1988, J NEUROL SCI, V86, P231, DOI 10.1016/0022-510X(88)90101-3
   Kaufman MP, 2002, CLIN AUTON RES, V12, P429, DOI 10.1007/s10286-002-0059-1
   KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1
   KOZELKA JW, 1985, J APPL PHYSIOL, V58, P1832
   Krogh A, 1913, J PHYSIOL-LONDON, V47, P112
   Lee HJ, 2009, EXP NEUROL, V216, P365, DOI 10.1016/j.expneurol.2008.12.009
   Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003
   Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003
   Little JW, 1999, ARCH PHYS MED REHAB, V80, P587, DOI 10.1016/S0003-9993(99)90204-6
   LLOYD DPC, 1957, J GEN PHYSIOL, V40, P409, DOI 10.1085/jgp.40.3.409
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   MAGLADERY JW, 1951, B JOHNS HOPKINS HOSP, V88, P520
   MAGLADERY JW, 1958, B JOHNS HOPKINS HOSP, V103, P236
   MAGLADERY JW, 1951, B JOHNS HOPKINS HOSP, V88, P499
   MALMSTEN J, 1983, ACTA PHYSIOL SCAND, V119, P435, DOI 10.1111/j.1748-1716.1983.tb07359.x
   Manjarrez E, 2000, J PHYSIOL-LONDON, V529, P445, DOI 10.1111/j.1469-7793.2000.00445.x
   MARCHAND R, 1990, NEUROSCIENCE, V36, P45, DOI 10.1016/0306-4522(90)90350-D
   Meek MF, 2001, BIOMATERIALS, V22, P1177, DOI 10.1016/S0142-9612(00)00340-9
   Metters A T, 1999, Biomed Sci Instrum, V35, P33
   Misiaszek JE, 2003, MUSCLE NERVE, V28, P144, DOI 10.1002/mus.10372
   MITCHELL JH, 1985, AM J CARDIOL, V55, pD34, DOI 10.1016/0002-9149(85)91053-7
   MITCHELL JH, 1977, AM J PHYSIOL, V233, pH374
   MITCHELL JH, 1983, ANNU REV PHYSIOL, V45, P229, DOI 10.1146/annurev.ph.45.030183.001305
   Montgomery CT, 1996, EXP NEUROL, V137, P277, DOI 10.1006/exnr.1996.0026
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Mori S, 1998, ANN NY ACAD SCI, V860, P94, DOI 10.1111/j.1749-6632.1998.tb09041.x
   OLSEN PZ, 1967, J NEUROL NEUROSUR PS, V30, P325, DOI 10.1136/jnnp.30.4.325
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   PEPPAS NA, 1985, J BIOMED MATER RES, V19, P397, DOI 10.1002/jbm.820190405
   Petersen N, 1998, J PHYSIOL-LONDON, V513, P599, DOI 10.1111/j.1469-7793.1998.599bb.x
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pierrot-Deseilligny E, 2000, NEUROPHYSIOL CLIN, V30, P67, DOI 10.1016/S0987-7053(00)00062-9
   Pradny M, 2005, J MATER SCI-MATER M, V16, P767, DOI 10.1007/s10856-005-2615-4
   Pradny M, 2002, J MATER SCI-MATER M, V13, P107, DOI 10.1023/A:1013659208319
   RATNER BD, 1973, J BIOMED MATER RES, V7, P353, DOI 10.1002/jbm.820070407
   Reese NB, 2006, SPINAL CORD, V44, P28, DOI 10.1038/sj.sc.3101810
   ROWELL LB, 1990, J APPL PHYSIOL, V69, P407
   Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933
   Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0
   Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727
   Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/0006-8993(96)00556-2
   SMITH JE, 1976, LIFE SCI, V19, P1525, DOI 10.1016/0024-3205(76)90097-7
   Stang F, 2005, BIO-MED MATER ENG, V15, P3
   Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1
   TABORIKOVA H, 1966, NATURE, V209, P206, DOI 10.1038/209206a0
   TAYLOR S, 1984, J NEUROL NEUROSUR PS, V47, P1102, DOI 10.1136/jnnp.47.10.1102
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473
   Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.3.CO;2-6
   Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002
   Valero-Cabre A, 2004, J NEUROPHYSIOL, V91, P2838, DOI 10.1152/jn.01177.2003
   Vitellaro-Zuccarello L, 2007, NEUROSCIENCE, V144, P865, DOI 10.1016/j.neuroscience.2006.10.023
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wilson LB, 1996, RESP PHYSIOL, V104, P137, DOI 10.1016/0034-5687(96)00032-1
   Woerly S, 1996, NEUROSCI LETT, V205, P197, DOI 10.1016/0304-3940(96)12349-1
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 2005, NEUROCHEM RES, V30, P721, DOI 10.1007/s11064-005-6866-8
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2001, INT J DEV NEUROSCI, V19, P63, DOI 10.1016/S0736-5748(00)00064-2
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Woerly S, 2000, NEUROSURG REV, V23, P59
   WOERLY S, 1993, BRAIN RES BULL, V30, P423, DOI 10.1016/0361-9230(93)90274-F
   Xia R, 2005, SPINAL CORD, V43, P14, DOI 10.1038/sj.sc.3101656
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yablon SA, 2004, AM J PHYS MED REHAB, V83, pS10, DOI 10.1097/01.PHM.0000141126.11008.7D
   ZENGEL JE, 1983, J NEUROPHYSIOL, V49, P922
NR 125
TC 11
Z9 11
U1 0
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1759-0914
J9 ASN NEURO
JI ASN Neuro
PY 2013
VL 5
IS 2
BP 149
EP 166
DI 10.1042/AN20120082
PG 18
WC Neurosciences
SC Neurosciences & Neurology
GA 181YT
UT WOS:000321707600006
PM 23614684
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU MacMillan, CP
   O'Donnell, PJ
   Smit, AM
   Evans, R
   Stachurski, ZH
   Torr, K
   West, M
   Baltunis, J
   Strabala, TJ
AF MacMillan, Colleen P.
   O'Donnell, Philip J.
   Smit, Anne-Marie
   Evans, Rob
   Stachurski, Zbigniew H.
   Torr, Kirk
   West, Mark
   Baltunis, Jacqueline
   Strabala, Timothy J.
TI A survey of the natural variation in biomechanical and cell wall
   properties in inflorescence stems reveals new insights into the utility
   of Arabidopsis as a wood model
SO FUNCTIONAL PLANT BIOLOGY
LA English
DT Article
DE microfibril angle; neutral carbohydrate content; SilviScan; stiffness;
   tensile strength
ID THALIANA BRASSICACEAE ECOTYPES; QUANTITATIVE TRAIT LOCI; DE-NOVO
   SYNTHESIS; GDP-L-FUCOSE; FLOWERING-TIME; CELLULOSE MICROFIBRILS; MUR1
   GENE; XYLOGLUCAN; ACCESSIONS; GENOME
AB The natural trait variation in Arabidopsis thaliana (L.) Heynh. accessions is an important resource for understanding many biological processes but it is underexploited for wood-related properties. Twelve A. thaliana accessions from diverse geographical locations were examined for variation in secondary growth, biomechanical properties, cell wall glycan content, cellulose microfibril angle (MFA) and flowering time. The effect of daylength was also examined. Secondary growth in rosette and inflorescence stems was observed in all accessions. Organised cellulose microfibrils in inflorescence stems were found in plants grown under long and short days. A substantial range of phenotypic variation was found in biochemical and wood-related biophysical characteristics, particularly for tensile strength, tensile stiffness, MFA and some cell wall components. The four monosaccharides galactose, arabinose, rhamnose and fucose strongly correlated with each other as well as with tensile strength and MFA, consistent with mutations in arabinogalactan protein and fucosyl-and xyloglucan galactosyl-transferase genes that result in decreases in strength. Conversely, these variables showed negative correlations with lignin content. Our data support the notion that large-scale natural variation studies of wood-related biomechanical and biochemical properties of inflorescence stems will be useful for the identification of novel genes important for wood formation and quality, and therefore biomaterial and renewable biofuel production.
C1 [MacMillan, Colleen P.; Baltunis, Jacqueline] CSIRO Plant Ind, Canberra, ACT 2601, Australia.
   [O'Donnell, Philip J.; Smit, Anne-Marie; Torr, Kirk; West, Mark; Strabala, Timothy J.] Scion, Rotorua 3046, New Zealand.
   [Evans, Rob] CSIRO Mat Sci & Engn, Melbourne, Vic 3168, Australia.
   [Stachurski, Zbigniew H.] Australian Natl Univ, Coll Engn, Canberra, ACT 0200, Australia.
RP Strabala, TJ (reprint author), Scion, Rotorua 3046, New Zealand.
EM tim.strabala@scionresearch.com
RI Strabala, Timothy/B-4472-2008; macmillan, colleen/D-1103-2010
OI Strabala, Timothy/0000-0002-0368-9400; macmillan,
   colleen/0000-0003-3594-5373; Stachurski, Zbigniew/0000-0002-1317-0178;
   Torr, Kirk/0000-0002-1989-8952
FU Foundation for Research, Science and Technology (NZ) [C04X0703]
FX This work was supported in part by Grant C04X0703 from the Foundation
   for Research, Science and Technology (NZ) to Scion. We thank Roger
   Newman, Stefan Hill and Lloyd Donaldson for many helpful discussions. We
   are also grateful to RogerNewman, Lloyd Donaldson, Filomena Pettolino,
   Jean Finnegan, Danny Llewellyn and Simon Southerton and the two
   anonymous reviewers for critically evaluating the manuscript.
CR Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x
   BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5
   Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x
   Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085
   Brennan M, 2012, CELLULOSE, V19, P1385, DOI 10.1007/s10570-012-9697-1
   CAVE ID, 1994, FOREST PROD J, V44, P43
   Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x
   Chang XF, 2008, J AGR FOOD CHEM, V56, P6825, DOI 10.1021/jf800775f
   Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941
   Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271
   Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414
   Girault R, 1997, INT J BIOL MACROMOL, V21, P179, DOI 10.1016/S0141-8130(97)00059-7
   Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244
   Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776
   Hepworth DG, 1998, ANN BOT-LONDON, V81, P761, DOI 10.1006/anbo.1998.0632
   Herakovich C. T., 1998, MECH FIBROUS COMPOSI
   Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042
   Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436
   Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344
   KARLSSON BH, 1993, AM J BOT, V80, P646, DOI 10.2307/2445435
   Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019
   KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x
   Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551
   Kutscha NP, 1972, SUITABILITY CERTAIN
   Lens F, 2012, NEW PHYTOL, V193, P12, DOI 10.1111/j.1469-8137.2011.03888.x
   LEVY S, 1991, PLANT J, V1, P195
   Lewandowska-Sabat AM, 2012, PLANT SCI, V185, P143, DOI 10.1016/j.plantsci.2011.10.009
   Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107
   MacKay JJ, 1997, P NATL ACAD SCI USA, V94, P8255, DOI 10.1073/pnas.94.15.8255
   MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x
   Mellerowicz EJ, 2012, J EXP BOT, V63, P551, DOI 10.1093/jxb/err339
   Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253
   Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02619
   Mouille G, 2006, PLANT PHYSIOL, V141, P1035, DOI 10.1104/pp.106.079384
   Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807
   Oda Y, 2012, CURR OPIN PLANT BIOL, V15, P38, DOI 10.1016/j.pbi.2011.10.005
   Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873
   Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515
   THEANDER O, 1991, ANIM FEED SCI TECH, V32, P35, DOI 10.1016/0377-8401(91)90007-F
   Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689
   UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6
   Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699
   Wagner A, 2007, P NATL ACAD SCI USA, V104, P11856, DOI 10.1073/pnas.0701428104
   Wyatt SE, 2010, RUSS J PLANT PHYSL+, V57, P363, DOI 10.1134/S1021443710030076
   Xu P, 2011, J MATER SCI, V46, P534, DOI 10.1007/s10853-010-5000-8
   Zhang J, 2011, CURR OPIN BIOTECH, V22, P293, DOI 10.1016/j.copbio.2010.11.008
   Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801
NR 47
TC 5
Z9 5
U1 2
U2 17
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 1445-4408
J9 FUNCT PLANT BIOL
JI Funct. Plant Biol.
PY 2013
VL 40
IS 7
BP 662
EP 676
DI 10.1071/FP12386
PG 15
WC Plant Sciences
SC Plant Sciences
GA 182SN
UT WOS:000321764500002
DA 2018-10-20
ER

PT J
AU Yin, HY
   Akasaki, T
   Sun, TL
   Nakajima, T
   Kurokawa, T
   Nonoyama, T
   Taira, T
   Saruwatari, Y
   Gong, JP
AF Yin, Haiyan
   Akasaki, Taigo
   Sun, Tao Lin
   Nakajima, Tasuku
   Kurokawa, Takayuki
   Nonoyama, Takayuki
   Taira, Toshio
   Saruwatari, Yoshiyuki
   Gong, Jian Ping
TI Double network hydrogels from polyzwitterions: high mechanical strength
   and excellent anti-biofouling properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PROTEIN ADSORPTION; PLATELET-ADHESION; PHOSPHOLIPID POLYMER;
   CARBOXYBETAINE POLYMERS; POLY(ETHYLENE GLYCOL); ZWITTERIONIC POLYMER;
   BLOOD-COMPATIBILITY; IN-VIVO; REDUCTION; SURFACE
AB Polyzwitterionic materials, which have both cationic and anionic groups in the polymeric repeat unit, show excellent anti-biofouling properties and are drawing more attention in the biomedical field. In this study, we have successfully synthesized novel single network hydrogels and double network (DN) hydrogels from the zwitterionic monomer, N-(carboxymethyl)-N,N-dimethyl-2-(methacryloyloxy) ethanaminium, inner salt (CDME). The polyCDME (PCDME) single network hydrogel behaves like a hydrophilic neutral hydrogel and its properties are not sensitive to temperature, pH, or ionic strength over a wide range. DN hydrogels using the poly(2-acrylamido-2-methylpropanesulfonic) (PAMPS) as the first network and PCDME as the second network, having a Young's modulus of 0.2-0.9 MPa, possess excellent mechanical strength (fracture stress: 1.2-1.4 MPa, fracture strain: 2.2-6.0 mm/mm) and toughness (work of extension at fracture: 0.9-2.4 MJ m(-3)) depending on the composition ratio of PCDME to PAMPS. The strength and toughness of the optimized PAMPS/PCDME DN is comparable to the normal PAMPS/PAAm DN hydrogels that use poly(acrylamide) (PAAm) as the second network. By macrophage adhesion test, both the PCDME hydrogels and the PAMPS/PCDME DN hydrogels have shown excellent anti-biofouling properties. These results demonstrate that the PCDME-based DN hydrogels have high potential as a novel soft and wet biomaterial.
C1 [Yin, Haiyan; Sun, Tao Lin] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan.
   [Akasaki, Taigo] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan.
   [Nakajima, Tasuku; Kurokawa, Takayuki; Nonoyama, Takayuki; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.
   [Taira, Toshio] Primary Cell Co Ltd, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   [Saruwatari, Yoshiyuki] Osaka Organ Chem Ind Ltd, Chuo Ku, Osaka 5410052, Japan.
RP Gong, JP (reprint author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.
EM gong@mail.sci.hokudai.ac.jp
RI Nakajima, Tasuku/E-5831-2017; Gong, Jian Ping/B-7019-2009; Kurokawa,
   Takayuki/B-7061-2009
OI Nakajima, Tasuku/0000-0002-2235-3478; Gong, Jian
   Ping/0000-0003-2228-2750; Kurokawa, Takayuki/0000-0001-6834-684X
FU Japan Society for the Promotion of Science (JSPS) [124225006]
FX This research was financially supported by a Grant-in-Aid for Scientific
   Research (S) (no. 124225006) from the Japan Society for the Promotion of
   Science (JSPS).
CR Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   Carr LR, 2011, BIOMATERIALS, V32, P6893, DOI 10.1016/j.biomaterials.2011.06.006
   Chen L, 2000, POLYMER, V41, P141, DOI 10.1016/S0032-3861(99)00161-5
   Chen YM, 2007, BIOMATERIALS, V28, P1752, DOI 10.1016/j.biomaterials.2006.12.005
   Cheng G, 2008, ANGEW CHEM INT EDIT, V47, P8831, DOI 10.1002/anie.200803570
   Cheo SHY, 2001, J MATER SCI-MATER M, V12, P377, DOI 10.1023/A:1011280416520
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Fujishita S, 2008, BIOL PHARM BULL, V31, P2309, DOI 10.1248/bpb.31.2309
   Goda T, 2009, J BIOMED MATER RES B, V89B, P184, DOI 10.1002/jbm.b.31204
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Haraguchi K, 2011, POLYM J, V43, P223, DOI 10.1038/pj.2010.141
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Huang M, 2007, MACROMOLECULES, V40, P6658, DOI 10.1021/ma062482q
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Ishiyama N, 2011, J BONE JOINT SURG AM, V93A, P142, DOI 10.2106/JBJS.I.01634
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3897, DOI 10.1016/S0142-9612(02)00135-7
   Kitano H, 2005, LANGMUIR, V21, P11932, DOI 10.1021/la0515571
   Kitano H, 2008, MACROMOL BIOSCI, V8, P77, DOI 10.1002/mabi.200700082
   Liang SM, 2009, CHEM COMMUN, P7518, DOI 10.1039/b916581a
   Liu WG, 2009, BIOMATERIALS, V30, P1551, DOI 10.1016/j.biomaterials.2008.11.022
   Marion K, 2006, J HOSP INFECT, V64, P136, DOI 10.1016/j.jhin.2006.06.011
   Matsuura K, 2007, MACROMOL CHEM PHYSIC, V208, P862, DOI 10.1002/macp.200600652
   Naficy S, 2011, AUST J CHEM, V64, P1007, DOI 10.1071/CH11156
   Nakajima T, 2012, ADV FUNCT MATER, V22, P4426, DOI 10.1002/adfm.201200809
   OBUKHOV SP, 1994, MACROMOLECULES, V27, P3191, DOI 10.1021/ma00090a012
   Ohsugi A, 2006, MACROMOL RAPID COMM, V27, P1242, DOI 10.1002/marc.200600234
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rubinstein M, 1996, MACROMOLECULES, V29, P398, DOI 10.1021/ma9511917
   Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x
   SCHULZ DN, 1986, POLYMER, V27, P1734, DOI 10.1016/0032-3861(86)90269-7
   Shi LY, 2012, MACROMOL BIOSCI, V12, P395, DOI 10.1002/mabi.201100336
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tada S, 2009, MACROMOL BIOSCI, V9, P63, DOI 10.1002/mabi.200800150
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tanabe Y, 2008, J MATER SCI-MATER M, V19, P1379, DOI 10.1007/s10856-007-3255-7
   Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790
   Willis SL, 2001, BIOMATERIALS, V22, P3261, DOI 10.1016/S0142-9612(01)00164-8
   Yang JJ, 2010, TISSUE ENG PT A, V16, P2529, DOI 10.1089/ten.TEA.2009.0647
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031
   Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223
   Zhang F, 2001, J BIOMED MATER RES, V56, P324, DOI 10.1002/1097-4636(20010905)56:3<324::AID-JBM1100>3.0.CO;2-P
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhang Z, 2009, J BIOMAT SCI-POLYM E, V20, P1845, DOI 10.1163/156856208X386444
NR 47
TC 51
Z9 51
U1 20
U2 168
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 30
BP 3685
EP 3693
DI 10.1039/c3tb20324g
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 180VF
UT WOS:000321626200008
DA 2018-10-20
ER

PT S
AU Yildirim, M
   Ferhanoglu, O
   Kobler, JB
   Zeitels, SM
   Ben-Yakar, A
AF Yildirim, Murat
   Ferhanoglu, Onur
   Kobler, James B.
   Zeitels, Steven M.
   Ben-Yakar, Adela
BE Periasamy, A
   Konig, K
   So, PTC
TI Maximum Imaging Depth Comparison in Porcine Vocal Folds Using 776-nm vs.
   1552-nm excitation wavelengths
SO MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES XIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Multiphoton Microscopy in the Biomedical Sciences XIII
CY FEB 03-05, 2013
CL San Francisco, CA
SP SPIE, Becker & Hickel GmbH, Boston Elect Corp, Coherent, Inc, Intelligent Software Solut, Inc, JenLab GmbH, Newport Spectra Phys, Omega Opt, Inc, Princeton Instruments, Semrock, Inc, Carl Zeiss
DE Vocal fold scarring; two-photon autofluorescence; second-harmonic
   generation; third-harmonic generation; maximum imaging depth; healthy
   porcine vocal folds, ultrafast fiber laser
ID FEMTOSECOND LASER MICROSURGERY; 2ND-HARMONIC GENERATION; FLUORESCENCE
   MICROSCOPY; EXTRACELLULAR-MATRIX; COLLAGEN; TISSUES; PROBE
AB Vocal fold scarring is one of the major causes of voice disorders and may arise from overuse or post-surgical wound healing. One promising treatment utilizes the injection of soft biomaterials aimed at restoring viscoelasticity of the outermost vibratory layer of the vocal fold, superficial lamina propria (SLP). However, the density of the tissue and the required injection pressure impair proper localization of the injected biomaterial in SLP. To enhance treatment effectiveness, we are investigating a technique to image and ablate sub-epithelial planar voids in vocal folds using ultrafast laser pulses to better localize the injected biomaterial. It is challenging to optimize the excitation wavelength to perform imaging and ablation at depths suitable for clinical use. Here, we compare maximum imaging depth using two photon autofluorescence and second harmonic generation with third-harmonic generation imaging modalities for healthy porcine vocal folds. We used a home-built inverted nonlinear scanning microscope together with a high repetition rate (2 MHz) ultrafast fiber laser (Raydiance Inc.). We acquired both two-photon autofluorescence and second harmonic generation signals using 776 nm wavelength and third harmonic generation signals using 1552 nm excitation wavelength. We observed that maximum imaging depth with 776 nm wavelength is significantly improved from 114 mu m to 205 mu m when third harmonic generation is employed using 1552 nm wavelength, without any observable damage in the tissue.
C1 [Yildirim, Murat; Ferhanoglu, Onur; Ben-Yakar, Adela] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
RP Yildirim, M (reprint author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
EM ben-yakar@mail.utexas.edu
OI Yildirim, Murat/0000-0003-0853-2557
CR Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Chu SW, 2001, OPT LETT, V26, P1909, DOI 10.1364/OL.26.001909
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Guo Y, 1996, APPL OPTICS, V35, P6810, DOI 10.1364/AO.35.006810
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Hoy CL, 2008, OPT EXPRESS, V16, P9996, DOI 10.1364/OE.16.009996
   Hoy CL, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.038002
   Hoy CL, 2011, OPT EXPRESS, V19, P10536, DOI 10.1364/OE.19.010536
   Peleg G, 1999, P NATL ACAD SCI USA, V96, P6700, DOI 10.1073/pnas.96.12.6700
   STELZER EHK, 1994, OPT COMMUN, V104, P223, DOI 10.1016/0030-4018(94)90546-0
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
NR 14
TC 0
Z9 0
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9357-6
J9 PROC SPIE
PY 2013
VL 8588
AR UNSP 858825
DI 10.1117/12.2005630
PG 6
WC Engineering, Biomedical; Microscopy; Optics
SC Engineering; Microscopy; Optics
GA BFH45
UT WOS:000319872500048
DA 2018-10-20
ER

PT J
AU Jensen, BEB
   Hosta-Rigau, L
   Spycher, PR
   Reimhult, E
   Stadler, B
   Zelikin, AN
AF Jensen, Bettina E. B.
   Hosta-Rigau, Leticia
   Spycher, Philipp R.
   Reimhult, Erik
   Stadler, Brigitte
   Zelikin, Alexander N.
TI Lipogels: surface-adherent composite hydrogels assembled from poly(vinyl
   alcohol) and liposomes
SO NANOSCALE
LA English
DT Article
ID PHYSICAL HYDROGELS; DRUG-DELIVERY; ENZYMATIC MICROREACTORS; BIOMEDICAL
   APPLICATIONS; POLYVINYL-ALCOHOL; DESIGN; RELEASE; TISSUE; BIOMATERIAL;
   ELASTICITY
AB Drug-eluting engineered surface coatings are of paramount importance for many biomedical applications from implantable devices to tissue engineering. Herein, we present the assembly of lipogels, composite physical hydrogels assembled from poly(vinyl alcohol) and liposomes using thiol-disulfide exchange between end group modified PVA and thiocholesterol containing liposomes, and the response of adhering cells to these coatings. We demonstrate the controlled loading of liposomes into the polymer matrix and the preserved mechanical properties of the lipogels. Furthermore, the lipogels are successfully rendered cell adhesive by incorporation of poly(L-lysine) into the PVA polymer matrix or by poly(dopamine) coating of the lipogels. The successful lipid uptake from the lipogels by macrophages, hepatocytes, and myoblasts was monitored by flow cytometry. Finally, the delivery of active cargo, paclitaxel, to adherent myoblasts is shown, thus illustrating the potential of the lipogels as a drug eluting interface for biomedical applications.
C1 [Jensen, Bettina E. B.; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
   [Hosta-Rigau, Leticia; Stadler, Brigitte; Zelikin, Alexander N.] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
   [Spycher, Philipp R.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.
   [Reimhult, Erik] Univ Nat Resources & Life Sci Vienna, Inst Biol Inspired Mat, Vienna, Austria.
RP Stadler, B (reprint author), Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
EM bstadler@inano.au.dk; zelikin@chem.au.dk
RI Zelikin, Alexander/J-3659-2012; Reimhult, Erik/C-6011-2013; Hosta-Rigau,
   Leticia/C-4346-2016; Stadler, Brigitte/I-2661-2013
OI Zelikin, Alexander/0000-0002-9864-321X; Reimhult,
   Erik/0000-0003-1417-5576; Hosta-Rigau, Leticia/0000-0001-8177-4806;
   Stadler, Brigitte/0000-0002-7335-3945
FU Lundbeck Foundation; Danish Council for Independent Research, Technology
   and Production Sciences, Denmark
FX This work was supported by grants from the Lundbeck Foundation and
   Sapere Aude Starting Grant from the Danish Council for Independent
   Research, Technology and Production Sciences, Denmark. The authors thank
   Thomas Hussmann (Department of Chemistry, Aarhus University) for
   synthesis of PVA, Anton A. A. Smith (Department of Chemistry, Aarhus
   University) for end modi. cation of PVA, Associate Prof. Rikke L. Meyer
   (iNANO, Aarhus University) for the use of the AFM and the CLSM, and
   Soren Kragh Moestrup laboratory, Aarhus University, for generously
   providing RAW264.7 cells.
CR Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Basile A, 2012, CARDIOVASC INTER RAD, V35, P765, DOI 10.1007/s00270-012-0423-z
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Carter S, 2009, HPB, V11, P541, DOI 10.1111/j.1477-2574.2009.00071.x
   Chong SF, 2013, SMALL, V9, P942, DOI 10.1002/smll.201201774
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fang JY, 2009, J BIOMAT SCI-POLYM E, V20, P1031, DOI 10.1163/156856209X444493
   Fejerskov B, 2013, LANGMUIR, V29, P344, DOI 10.1021/la3040903
   Fejerskov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049619
   Fejerskov B, 2012, ACS APPL MATER INTER, V4, P4981, DOI 10.1021/am3013467
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gonsalves Carin, 2008, Semin Intervent Radiol, V25, P369, DOI 10.1055/s-0028-1103001
   Gubeli RJ, 2012, MACROMOL RAPID COMM, V33, P1280, DOI 10.1002/marc.201200203
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hosta-Rigau L, 2013, NANOSCALE, V5, P89, DOI 10.1039/c2nr32923a
   Hosta-Rigau L, 2012, ADV HEALTHC MATER, V1, P791, DOI 10.1002/adhm.201200092
   Hurler J, 2012, J PHARM SCI-US, V101, P3906, DOI 10.1002/jps.23260
   Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h
   Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e
   Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lynge ME, 2013, ACS APPL MATER INTER, V5, P2967, DOI 10.1021/am4006868
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Popescu MT, 2011, BIOMACROMOLECULES, V12, P3023, DOI 10.1021/bm2006483
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h
   Suri A, 2011, SOFT MATTER, V7, P7071, DOI 10.1039/c1sm05530e
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Weaver JD, 2012, J BIOMED MATER RES B, V100B, P103, DOI 10.1002/jbm.b.31927
NR 43
TC 22
Z9 22
U1 5
U2 56
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PY 2013
VL 5
IS 15
BP 6758
EP 6766
DI 10.1039/c3nr01662e
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 181NY
UT WOS:000321675600016
PM 23685735
DA 2018-10-20
ER

PT S
AU Chen, ST
   Fan, XX
   Yan, YG
AF Chen, Shutian
   Fan, Xiaoxia
   Yan, Yonggang
BE Jiang, ZY
   Kim, YH
TI Study on biomechanical properties of quartz fiber reinforcd n-HA/PA66
   composites
SO NANOTECHNOLOGY AND PRECISION ENGINEERING, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Nanotechnology and Precision Engineering
   (ICNPE 2012)
CY DEC 26-27, 2012
CL Guilin, PEOPLES R CHINA
SP Univ Wollongong, Natl Formosa Univ, Korea Maritime Univ, Queensland Univ Technol
DE quartz fibre; nano-hydroxyapatite/polyamide 66; biomaterial;
   biomechanical properties
AB Quartz Fibre/nano-Hydroxyapatite/Polyamide 66(QF/n-HA/PA66) composite was prepared by extrusion molding method. The QF is well dispersed in the nano-hydroxyapatite/polyamide 66 matrix and some interaction and new interface formed between QF and n-HA/PA66. Tensile strength, compressive strength and flexural strength of the 38wt%QF/n-HA/PA66 composite reached 81 MPa, 190 MPa and 195 MPa, which were higher than those of human cortical bone. Mechinical properties were improved with the increasing of QF content and QF well enhanced biomechanical properties of the composite. Based on the excellent biomechanical properties of composites, the long load-bearing thigh bone substitute was fabricated for tumour infected thigh bone patient.
C1 [Chen, Shutian; Fan, Xiaoxia; Yan, Yonggang] Sichuan Univ, Coll Phys Sci & Technol, Chengdu 610065, Peoples R China.
RP Chen, ST (reprint author), Sichuan Univ, Coll Phys Sci & Technol, Chengdu 610065, Peoples R China.
EM cstian28@yahoo.com.cn; fanxiaoxia01@163.com; yan_yonggang@vip.163.com
FU National Science and Technology [2007BAE13B03]; Biological materials and
   products development of Sichuan Province Youth Science and technology
   innovation team [2011JTD0024]
FX This work was financially supported by the National Science and
   Technology support projects (2007BAE13B03) and Biological materials and
   products development of Sichuan Province Youth Science and technology
   innovation team (2011JTD0024).
CR Cui L, 2008, THESIS
   Gao Jie, 2012, CHEM ENG DESIGN, V22, P44
   Li Y. B., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393)
   Liu Yunxiang, 2004, MODERN PLASTICS PROC, V16, P55
   Yan Yonggang, 2000, CHINA PLASTICS IND, V28, P28
NR 5
TC 0
Z9 0
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-640-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 662
BP 64
EP +
DI 10.4028/www.scientific.net/AMR.662.64
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BFL12
UT WOS:000320341000013
DA 2018-10-20
ER

PT S
AU Ghosh, PK
   Sarkar, A
AF Ghosh, P. K.
   Sarkar, A.
BE Bhardwaj, S
   Shekhawat, MS
   Suthar, B
TI Biomaterial Based Sulphur di Oxide Gas Sensor
SO PROCEEDING OF INTERNATIONAL CONFERENCE ON RECENT TRENDS IN APPLIED
   PHYSICS & MATERIAL SCIENCE (RAM 2013)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Recent Trends in Applied Physics and
   Material Science (RAM)
CY FEB 01-02, 2013
CL Govt Coll Engn & Technol Bikaner, Bikaner, INDIA
SP Dept Sci & Technol (DST), New Delhi, Dept Sci & Technol (DST), Jaipur, Council Sci & Ind Res (CSIR)
HO Govt Coll Engn & Technol Bikaner
DE Gas Sensor; Response voltage; Response time; Recovery time
AB Biomaterials are getting importance in the present research field of sensors. In this present paper performance of biomaterial based gas sensor made of gum Arabica and garlic extract had been studied. Extract of garlic clove with multiple medicinal and chemical utility can be proved to be useful in sensing Sulphur di Oxide gas. On exposure to Sulphur di Oxide gas the material under observation suffers some temporary structural change, which can be observed in form of amplified potentiometric change through simple electronic circuitry. Exploiting this very property a potentiometric gas sensor of faster response and recovery time can be designed. In this work sensing property of the said material has been studied through DC conductance, FTIR spectrum etc.
C1 [Ghosh, P. K.; Sarkar, A.] BK Girls Coll, Dept Phys, Howrah 711101, W Bengal, India.
RP Ghosh, PK (reprint author), BK Girls Coll, Dept Phys, 5-3 MG Rd, Howrah 711101, W Bengal, India.
EM pkgpkgpkgpkg@gmail.com
CR French RH, 2000, J AM CERAM SOC, V83, P2117, DOI 10.1111/j.1151-2916.2000.tb01527.x
   Jaiyeola C., 1997, CHEMOTHERAPY, V40, P2286
   Sarkar A, 2011, BIOMEDICAL ENV APPL, P317
NR 3
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1160-9
J9 AIP CONF PROC
PY 2013
VL 1536
BP 1155
EP 1156
DI 10.1063/1.4810647
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BFP35
UT WOS:000320861200572
DA 2018-10-20
ER

PT S
AU Monika
   Mishra, RR
   Jaiswal, S
   Kapusetti, G
   Misra, N
AF Monika
   Mishra, R. R.
   Jaiswal, S.
   Kapusetti, G.
   Misra, N.
BE Bhardwaj, S
   Shekhawat, MS
   Suthar, B
TI Chemical Modification of Poly (vinyl chloride) Sheet with Thiourea For
   Cell Study
SO PROCEEDING OF INTERNATIONAL CONFERENCE ON RECENT TRENDS IN APPLIED
   PHYSICS & MATERIAL SCIENCE (RAM 2013)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Recent Trends in Applied Physics and
   Material Science (RAM)
CY FEB 01-02, 2013
CL Govt Coll Engn & Technol Bikaner, Bikaner, INDIA
SP Dept Sci & Technol (DST), New Delhi, Dept Sci & Technol (DST), Jaipur, Council Sci & Ind Res (CSIR)
HO Govt Coll Engn & Technol Bikaner
DE Poly (vinyl chloride); Tetra butyl ammonium hydrogen sulphate;
   Nucleophile substitution
AB Plasticized poly (vinyl chloride) has been used as biomaterial to make medical equipment. An appropriate reaction situation by temperature at 60-85 degrees C for the surface modification of PVC sheet with sodium thiourea has been investigated. Although, the use of a phase-transfer catalyst (Tetra butyl ammonium hydrogen sulphate-TBHAS) makes it feasible for the nucleophilic substitution reaction to take place, the morphology of the film is changed by the reaction, leading to a loss in both surface smoothness and transparency of the film. According to this study, the reaction with sodium thiourea occurs consistently through the sheets, and modified surface have antibacterial capacity.
C1 [Monika; Jaiswal, S.; Kapusetti, G.; Misra, N.] Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India.
   [Mishra, R. R.] Banaras Hindu Univ, Inst Microbiol, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India.
RP Monika (reprint author), Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India.
FU Department of Microbiology; Institute of Medical Science, Banaras Hindu
   University
FX This work has been supported by Department of Microbiology, Institute of
   Medical Science, Banaras Hindu University for the microbiology study.
CR Balazs D. J., 2003, EUR CELLS MATER, V6-1, P86
   Curtis J., 2008, COMP ASSESSMENT 3 CO, P1
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Kameda T, 2009, POLYM DEGRAD STABIL, V94, P107, DOI 10.1016/j.polymdegradstab.2008.10.006
   Sacristan J, 2000, POLYMER, V41, P5577, DOI 10.1016/S0032-3861(99)00784-3
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
NR 6
TC 0
Z9 0
U1 0
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1160-9
J9 AIP CONF PROC
PY 2013
VL 1536
BP 1157
EP +
DI 10.1063/1.4810648
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BFP35
UT WOS:000320861200573
DA 2018-10-20
ER

PT S
AU Dutta, A
   Sarkar, A
AF Dutta, Arup
   Sarkar, A.
BE Bhardwaj, S
   Shekhawat, MS
   Suthar, B
TI Structural Distinction Between Black And Grey Human Hair: A FTIR
   Investigation
SO PROCEEDING OF INTERNATIONAL CONFERENCE ON RECENT TRENDS IN APPLIED
   PHYSICS & MATERIAL SCIENCE (RAM 2013)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Recent Trends in Applied Physics and
   Material Science (RAM)
CY FEB 01-02, 2013
CL Govt Coll Engn & Technol Bikaner, Bikaner, INDIA
SP Dept Sci & Technol (DST), New Delhi, Dept Sci & Technol (DST), Jaipur, Council Sci & Ind Res (CSIR)
HO Govt Coll Engn & Technol Bikaner
DE Absorption spectra; Biomaterials; Proteins; Rotational levels; RNA
AB Hair is an important biomaterial primarily composed of structural protein, notably keratin. In this present work Fourier transformed infrared absorption (FTIR) spectrum of black and grey human hair is analyzed and compared from measured data of FTIR spectra. The change in characteristics bond vibration detected clearly. The obtained shift of the characteristics frequency caused due to change in molecular structure in the two types of human hair.
C1 [Dutta, Arup; Sarkar, A.] Bijoy Krishna Girls Coll, Dept Phys, Howrah 711101, WB, India.
RP Dutta, A (reprint author), Bijoy Krishna Girls Coll, Dept Phys, 5-3 MG Rd, Howrah 711101, WB, India.
EM link2ad86@gmail.com
CR Fabin H., 1999, HDB VIBRATIONAL SPEC, P3399
   Fanchon E., 2000, STRUCTURE DYNAMICS B, pCh 8
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
NR 3
TC 0
Z9 1
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1160-9
J9 AIP CONF PROC
PY 2013
VL 1536
BP 1250
EP 1251
DI 10.1063/1.4810694
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BFP35
UT WOS:000320861200619
DA 2018-10-20
ER

PT S
AU Carreon, H
   Ruiz, A
   Barriuso, S
   Gonzalez-Carrasco, JL
   Caballero, FG
   Lieblich, M
AF Carreon, H.
   Ruiz, A.
   Barriuso, S.
   Gonzalez-Carrasco, J. L.
   Caballero, F. G.
   Lieblich, M.
BE Thompson, DO
   Chimenti, DE
TI NONDESTRUCTIVE THERMOELECTRIC EVALUATION OF THE GRIT BLASTING INDUCED
   EFFECTS IN METALLIC BIOMATERIALS
SO REVIEW OF PROGRESS IN QUANTITATIVE NONDESTRUCTIVE EVALUATION, VOLS 32A
   AND 32B
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 39th Annual Review of Progress in Quantitative Nondestructive Evaluation
   (QNDE)
CY JUL 15-20, 2012
CL Denver, CO
SP QNDE Programs, AF Res Lab, Army Res Lab, Amer Soc Nondestruct Testing (ASNT), Dept Energy, AMES Lab, Fed Aviat Adm (FAA), Natl Aeronaut & Space Adm (NASA), Natl Sci Fdn (NSF), Ind/Univ Cooperat Res Ctr, Iowa State Univ, Ctr Nondestruct Evaluat
DE Grit Blasting; Thermoelectric Measurements; Residual Stress; Metallic
   Biomaterials
ID LVM STAINLESS-STEEL; MECHANICAL-PROPERTIES; PLASTIC-DEFORMATION; POWER
   MEASUREMENTS; RESIDUAL-STRESSES; MAGNETIC-FIELD; TIN INCLUSIONS; ALLOY;
   OSSEOINTEGRATION; MICROSTRUCTURE
AB Grit blasting is a surface treatment process widely used to enhance mechanical fixation of the implants through increasing their roughness. Test samples of two metallic biomaterial alloys such 316LVM and Ti6Al4V were blasted by projecting Al2O3 and ZrO2 particles which yield a coarse and a fine rough surface. Then, the blasted samples were thermally treated before and after partial stress relaxation and measured by non-destructive thermoelectric techniques (NDTT), the non-contacting and contacting thermoelectric power (TEP) measurements respectively. It has been found that the TEP measurements are associated directly with the subtle material variations such as cold work and compressive residual stresses due to plastic deformation produced by grit blasting. The TEP measurements clearly demonstrate that the non-contact NDTT technique is very sensitive to the reverse transformation of the alpha'-martensite (blasted 316LVM) and the expected relaxation of compressive residual stresses with increasing the severity of the thermal treatment (blasted 316LVM and Ti-6Al-4V), while the contact NDTT results are closely related to grain size refinement and work hardening.
C1 [Carreon, H.; Ruiz, A.] Univ Michoacana, Inst Invest Met, Nicolas Palacios Rubios 161, Morelia 58000, Michoacan, Mexico.
   [Barriuso, S.; Gonzalez-Carrasco, J. L.; Caballero, F. G.; Lieblich, M.] CSIC, CENIM, Madrid, Spain.
   [Gonzalez-Carrasco, J. L.] BBN, CIBER, Madrid, Spain.
RP Carreon, H (reprint author), Univ Michoacana, Inst Invest Met, Nicolas Palacios Rubios 161, Morelia 58000, Michoacan, Mexico.
EM memohcg@yahoo.com.mx
RI CABALLERO, FRANCISCA/A-4292-2008
OI CARREON, HECTOR/0000-0002-4803-0650
FU UMSNH (Mexico); CENIM-CSIC (Spain); CONACYT (Mexico) [CB-80883,
   MAT2009-14695-C04]
FX This work was performed at UMSNH (Mexico) and CENIM-CSIC (Spain) with a
   partial funding from CONACYT (Mexico) under project CB-80883 and
   MAT2009-14695-C04. The author H. Carreon wishes to thank CONACYT
   (Mexico) for the financial support during the sabbatical in CENIM-CSIC
CR Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6
   Aparicio C, 2004, KEY ENG MAT, V254-2, P737, DOI 10.4028/www.scientific.net/KEM.254-256.737
   Caballero FG, 2005, SCRIPTA MATER, V52, P501, DOI 10.1016/j.scriptamat.2004.11.005
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Carreon H, 2000, J APPL PHYS, V88, P6495, DOI 10.1063/1.1322591
   Carreon H, 2007, NONDESTRUCT TEST EVA, V22, P299, DOI 10.1080/10589750701546960
   Carreon H, 2006, NDT&E INT, V39, P22, DOI 10.1016/j.ndteint.2005.05.002
   Carreon H, 2012, SURF COAT TECH, V206, P2941, DOI 10.1016/j.surfcoat.2011.12.026
   Carreon H, 2002, RES NONDESTRUCT EVAL, V14, P59, DOI 10.1007/s00164-002-0001-x
   Frutos E, 2010, ACTA MATER, V58, P4191, DOI 10.1016/j.actamat.2010.04.010
   Hinken J. H., 2000, REV PROGR QUANTITATI, V19, P2085
   Hu JT, 1998, APPL PHYS LETT, V73, P467, DOI 10.1063/1.121902
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Maslov K, 2001, MATER EVAL, V59, P1081
   Multigner M, 2010, SURF COAT TECH, V205, P1830, DOI 10.1016/j.surfcoat.2010.07.126
   Multigner M, 2009, MAT SCI ENG C-BIO S, V29, P1357, DOI 10.1016/j.msec.2008.11.002
   Multigner M, 2009, REV METAL MADRID, V45, P52, DOI 10.3989/revmetalm.0803
   Nagy PB, 2000, J APPL PHYS, V87, P7481, DOI 10.1063/1.373013
   Sarasola M., 2001, REV METAL, V35, P124
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
NR 20
TC 0
Z9 0
U1 0
U2 12
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1129-6
J9 AIP CONF PROC
PY 2013
VL 1511
BP 1504
EP 1511
DI 10.1063/1.4789220
PG 8
WC Materials Science, Characterization & Testing
SC Materials Science
GA BFM02
UT WOS:000320452600194
DA 2018-10-20
ER

PT J
AU Drevet, R
   Viteaux, A
   Maurin, JC
   Benhayoune, H
AF Drevet, R.
   Viteaux, A.
   Maurin, J. C.
   Benhayoune, H.
TI Human osteoblast-like cells response to pulsed electrodeposited calcium
   phosphate coatings
SO RSC ADVANCES
LA English
DT Article
ID ELECTRON-PROBE MICROANALYSIS; IN-VIVO EVALUATION; HYDROXYAPATITE
   COATINGS; ELECTROPHORETIC DEPOSITION; TITANIUM-ALLOY; CORROSION
   BEHAVIOR; THIN-FILMS; BONE; SUBSTRATE; IMPLANTATION
AB Calcium-deficient hydroxyapatite (Ca-def HAP) coatings are synthesized by pulsed electrodeposition on titanium alloy (Ti6Al4V) substrates. Physico-chemical characterizations of the coating are carried out using Scanning Electron Microscopy (SEM) associated with Energy Dispersive X-ray Spectroscopy (EDXS) for X-ray microanalysis, and Scanning-Transmission Electron Microscopy (STEM) and X-Ray Diffraction (XRD) for structural characterization. Moreover, the biocompatibility properties of the synthesized biomaterial are studied by observing the human osteoblast-like cells' (MG-63) response, which is investigated using a proliferation study carried out with an MTS test, and a cellular morphology study performed by SEM. The analysis of gene expression is carried out using a Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). The results indicate that the pulsed electrodeposited Ca-def HAP coating doesn't produce any cytotoxic effect and enhances the gene expression of alkaline phosphatase (ALP) and osteocalcin (OC) which are the two main markers of osteoblast differentiation and bone neoformation.
C1 [Drevet, R.; Benhayoune, H.] Univ Reims, LISM EA 4695, F-51685 Reims 02, France.
   [Viteaux, A.] Univ Reims, UFR Odontol, F-51100 Reims, France.
   [Maurin, J. C.] Univ Reims, EA Biomat & Inflammat Site Osseux 4691, SFR CAP Sante, Pole Sante Med Pharm, F-51095 Reims, France.
RP Drevet, R (reprint author), Univ Reims, LISM EA 4695, 21 Rue Clement Ader,BP 138, F-51685 Reims 02, France.
EM richard.drevet@univ-reims.fr
RI DREVET, Richard/A-8878-2016
OI DREVET, Richard/0000-0002-7425-4885
CR Abdel-Aal EA, 2008, SURF COAT TECH, V202, P5895, DOI 10.1016/j.surfcoat.2008.06.139
   Abdel-Aal E. A., 2010, International Journal of Nano and Biomaterials, V3, P187, DOI 10.1504/IJNBM.2010.037804
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Lopez-Heredia MA, 2007, J MATER SCI-MATER M, V18, P381, DOI 10.1007/s10856-006-0703-8
   Benhayoune H, 2005, THIN SOLID FILMS, V493, P113, DOI 10.1016/j.tsf.2005.07.305
   Benhayoune H, 2002, J PHYS D APPL PHYS, V35, P1526, DOI 10.1088/0022-3727/35/13/312
   Benhayoune H, 2010, ADV ENG MATER, V12, pB192, DOI 10.1002/adem.200980058
   Borsari V, 2009, J BIOMED MATER RES A, V89A, P550, DOI 10.1002/jbm.a.31995
   Buyukaksoy A, 2009, ADV ENG MATER, V11, pB77, DOI 10.1002/adem.200800345
   Chen CC, 2006, J BIOMED MATER RES B, V78B, P146, DOI 10.1002/jbm.b.30465
   Corni I, 2008, J EUR CERAM SOC, V28, P1353, DOI 10.1016/j.jeurceramsoc.2007.12.011
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Di Palma F, 2004, BIOMATERIALS, V25, P2565, DOI 10.1016/j.biomaterials.2003.09-026
   Wang DG, 2008, J MATER SCI-MATER M, V19, P2281, DOI 10.1007/s10856-007-3338-5
   Drevet R, 2012, J SOLID STATE ELECTR, V16, P3069, DOI 10.1007/s10008-012-1742-3
   Drevet R, 2011, J MATER SCI-MATER M, V22, P753, DOI 10.1007/s10856-011-4251-5
   Drevet R, 2010, MATER CHARACT, V61, P786, DOI 10.1016/j.matchar.2010.04.016
   Drevet R, 2011, J BIOMATER TISS ENG, V1, P68, DOI 10.1166/jbt.2011.1007
   Drevet R, 2012, ADV ENG MATER, V14, P377, DOI 10.1002/adem.201100331
   Dumelie N, 2007, J PHYS D APPL PHYS, V40, P2124, DOI 10.1088/0022-3727/40/7/040
   Durnelie N, 2008, MATER CHARACT, V59, P129, DOI 10.1016/j.matchar.2006.11.030
   Eliaz N, 2008, CRYST GROWTH DES, V8, P3965, DOI 10.1021/cg800016h
   Eliaz N, 2007, J BIOMED MATER RES A, V80A, P621, DOI 10.1002/jbm.a.30944
   Faure J, 2012, KEY ENG MATER, V507, P135, DOI 10.4028/www.scientific.net/KEM.507.135
   Fellah BH, 2009, ACTA BIOMATER, V5, P735, DOI 10.1016/j.actbio.2008.09.005
   Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5
   Hashimoto Y, 2008, J MATER SCI-MATER M, V19, P327, DOI 10.1007/s10856-006-0107-9
   Hesse C, 2008, J MATER SCI-MATER M, V19, P3235, DOI 10.1007/s10856-008-3462-x
   Hulshoff JEG, 1996, J MATER SCI-MATER M, V7, P603, DOI 10.1007/BF00058199
   Kiewetter K., 1996, J BIOMED MATER RES, V32, P55
   Kim HK, 2004, J MATER SCI-MATER M, V15, P825, DOI 10.1023/B:JMSM.0000032824.62866.a1
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Kwok CT, 2009, APPL SURF SCI, V255, P6736, DOI 10.1016/j.apsusc.2009.02.086
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lin SJ, 2003, J BIOMED MATER RES A, V66A, P819, DOI 10.1002/jbm.a.10072
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Schouten C, 2010, ACTA BIOMATER, V6, P2227, DOI 10.1016/j.actbio.2009.11.030
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Wang SH, 2005, J EUR CERAM SOC, V25, P3287, DOI 10.1016/j.jeurceramsoc.2004.08.016
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yang YC, 2011, SURF COAT TECH, V205, P5165, DOI 10.1016/j.surfcoat.2011.05.013
   Zhang MY, 2011, ACS APPL MATER INTER, V3, P339, DOI 10.1021/am100962m
NR 45
TC 7
Z9 7
U1 1
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 28
BP 11148
EP 11154
DI 10.1039/c3ra23255g
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 169LU
UT WOS:000320782500009
DA 2018-10-20
ER

PT J
AU Huot, S
   Rohman, G
   Riffault, M
   Pinzano, A
   Grossin, L
   Migonney, V
AF Huot, Stephane
   Rohman, Geraldine
   Riffault, Mathieu
   Pinzano, Astrid
   Grossin, Laurent
   Migonney, Veronique
TI Increasing the bioactivity of elastomeric poly(epsilon-caprolactone)
   scaffolds for use in tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 7th Meeting of Lorraine Pole of Cartilage Engineering
CY OCT 18-19, 2012
CL Nancy, FRANCE
DE Tissue engineering; porous scaffolds; bioactive polymer; elastomeric
   PCL; pNaSS
AB BACKGROUND: Biodegradable polymers used in tissue engineering applications, such as poly(epsilon-caprolactone) (PCL), are hydrophobic leading to a lack of favorable cell signalization and finally to a poor cell adhesion, proliferation and differentiation. To overcome this problem, scaffolds undergo generally a surface modification.
   OBJECTIVE: Our laboratory has demonstrated that the grafting of poly(sodium styrene sulfonate) (pNaSS) onto titanium or poly(ethylene terephthalate) surfaces, leads to a more specific protein adsorption and a better control of cell proliferation. The objective of this work is to develop, through a straightforward way, bioactive elastomeric PCL scaffolds by grafting pNaSS.
   METHODS: Porous elastomeric PCL scaffolds were developed using a particulate-leaching process. pNaSS was grafted into the scaffold by a "grafting from" technique. In vitro tests were carried out to assess cell adhesion and protein expression.
   RESULTS: pNaSS was grafted homogeneously onto PCL scaffolds without degrading the biodegradable polymer or the porous structure. The in vitro studies have shown that pNaSS grafted onto PCL improves the cell response with a better expression of collagen, fibronectin and integrin alpha 1.
   CONCLUSIONS: The grafting of pNaSS onto biomaterial surfaces is a versatile method that can provide a new generation of biodegradable scaffolds which could be "biointegrable".
C1 [Huot, Stephane; Rohman, Geraldine; Migonney, Veronique] Univ Paris 13, Sorbonne Paris Cite, CSPBAT, F-93430 Villetaneuse, France.
   [Huot, Stephane; Rohman, Geraldine; Migonney, Veronique] Univ Paris 13, Ethol & Sociobiol Lab, CNRS, UMR 7244, F-93430 Villetaneuse, France.
   [Riffault, Mathieu; Pinzano, Astrid; Grossin, Laurent] Univ Lorraine, CNRS, UMR 7561, LPPIA, Vandoeuvre Les Nancy, France.
RP Rohman, G (reprint author), Univ Paris 13, LBPS, UMR7244, CSPBAT,Inst Galilee, 99 Ave Jean Baptiste Clement, F-93430 Villetaneuse, France.
EM geraldine.rohman@univ-paris13.fr
OI Riffault, Mathieu/0000-0002-1689-8199; MIGONNEY,
   VERONIQUE/0000-0002-1055-3720
FU Ministry of National Education, Research and Technology
FX The authors thank the Ministry of National Education, Research and
   Technology for the MENRT scholarship granted to Stephane Huot.
CR Baker SC, 2011, MACROMOL BIOSCI, V11, P618, DOI 10.1002/mabi.201000415
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Ciobanu M, 2006, BIOMACROMOLECULES, V7, P755, DOI 10.1021/bm050694+
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Latz C, 2003, BIOMACROMOLECULES, V4, P766, DOI 10.1021/bm025764g
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Viateau V, 2011, IRBM, V32, P118, DOI 10.1016/j.irbm.2011.01.007
   Zhou J, 2007, P ANN INT IEEE EMBS, P5115, DOI 10.1109/IEMBS.2007.4353491
NR 9
TC 6
Z9 6
U1 1
U2 18
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2013
VL 23
IS 4
BP 281
EP 288
DI 10.3233/BME-130752
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169ZP
UT WOS:000320819600005
PM 23798649
DA 2018-10-20
ER

PT J
AU Lessim, S
   Migonney, V
   Thoreux, P
   Lutomski, D
   Changotade, S
AF Lessim, Soucounda
   Migonney, Veronique
   Thoreux, Patricia
   Lutomski, Didier
   Changotade, Sylvie
TI PolyNaSS bioactivation of LARS artificial ligament promotes human
   ligament fibroblast colonisation in vitro
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 7th Meeting of Lorraine Pole of Cartilage Engineering
CY OCT 18-19, 2012
CL Nancy, FRANCE
DE Anterior cruciate ligament (ACL); fibroblast; matrix; biointegration;
   biomaterial; bioactive surface
ID ANTERIOR CRUCIATE LIGAMENT; NEW-GENERATION; RECONSTRUCTION; DECORIN;
   CELLS; ACL; MORPHOLOGY; COLLAGEN; FAILURE
AB BACKGROUND: Introduction of a new generation of artificial ligaments for ACL reconstruction, the Ligament Augmentation and Reconstruction System (LARS), gives promising clinical results [1]. The current literature supports the use of LARS from short to medium term. To go even further to improve the biocompatibility of this biomaterial, poly(sodium styrene sulfonate) (polyNaSS) was grafted onto its surface. Studies using sheep animal model showed improvement of knee functionalities with this grafted artificial ligament and a better adhesion of human cell lines.
   OBJECTIVES: To better understand this in vivo improvement of integration with the bioactivated artificial prosthesis, in vitro studies were leaded using human ligament fibroblasts.
   METHODS: Human ligament fibroblasts isolated from human ruptured ACL were amplified and seeded onto poly(NaSS) grafted and non-grafted PET scaffold (Lars ligament) under standard culture conditions. Cellularized fibers were observed under scanning electron microscopy and histological and immunohistological studies were performed.
   RESULTS: Cells are localized around the grafted PET fibers of the bioactive ligament and penetrate in the scaffold. On ungrafted fibers, cells stay around the scaffold. On grafted fibers, collagen I appears strongly organized whereas is thin and dispersed on non grafted fibers. Finally, grafting altered localization of decorin.
   CONCLUSIONS: PolyNaSS grafting enhances human ligament fibroblast organisation in vitro in contact with biomaterial and improves collagen and decorin deposits around fibers.
C1 [Lessim, Soucounda; Migonney, Veronique; Lutomski, Didier; Changotade, Sylvie] Univ Paris 13, Sorbonne Paris Cite, Lab Biomat & Polymeres Special, CSPBAT CNRS UMR 7244,UFR SMBH, F-93017 Bobigny, France.
   [Thoreux, Patricia] Univ Paris 13, UFR SMBH Bobigny, F-93017 Bobigny, France.
   [Thoreux, Patricia] Univ Paris 13, Hop Avicenne, APHP, Lab Biomecan Arts & Metiers Paris Tech, F-93017 Bobigny, France.
RP Lutomski, D (reprint author), Univ Paris 13, Sorbonne Paris Cite, UFR SMBH, 74 Rue Marcel Cachin, F-93017 Bobigny, France.
EM lutomski@smbh.univ-paris13.fr
RI Ollendorff, Christine/D-1264-2010
OI MIGONNEY, VERONIQUE/0000-0002-1055-3720
CR Brulez B., 2004, European Patent, Patent No. [FR 2850026 (A1), 2850026]
   Brulez B., 2005, European Patent, Patent No. [EP 1599238 (A1), 1599238]
   Brulez B., 2004, French Patent, Patent No. [FR 2850107 (A1), 2850107]
   Brune T, 2007, EUR CELLS MATER, V14, P78, DOI 10.22203/eCM.v014a08
   Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729
   Dericks Jr G, 1995, OPER TECHN SPORT MED, V3, P187, DOI DOI 10.1016/S1060-1872(95)80009-3
   Dhahri M, 2011, J BIOMED MATER RES A, V98A, P114, DOI 10.1002/jbm.a.33077
   Duthon VB, 2006, KNEE SURG SPORT TR A, V14, P204, DOI 10.1007/s00167-005-0679-9
   Eurasante, 2005, PERSP PLAST IND BIOM
   Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197
   Huang JM, 2010, CHINESE MED J-PEKING, V123, P160, DOI 10.3760/cma.j.issn.0366-6999.2010.02.007
   JINGRUN R, 2008, APPL SURF SCI, V255, P263
   Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200
   KLEIN W, 1992, Arthroscopy, V8, P116, DOI 10.1016/0749-8063(92)90145-2
   Kobayashi K, 2000, TISSUE ENG, V6, P29, DOI 10.1089/107632700320865
   Lavoie P, 2000, KNEE, V7, P157, DOI 10.1016/S0968-0160(00)00039-9
   Li H, 2012, ARTHROSCOPY, V28, P583, DOI 10.1016/j.arthro.2011.12.008
   MACNICOL MF, 1991, J BONE JOINT SURG BR, V73, P377
   Mulford JS, 2011, ANZ J SURG, V81, P785, DOI 10.1111/j.1445-2197.2011.05884.x
   NAGINENI CN, 1992, J ORTHOP RES, V10, P465, DOI 10.1002/jor.1100100402
   Nau T, 2002, J BONE JOINT SURG BR, V84B, P356, DOI 10.1302/0301-620X.84B3.12400
   Pavon-Djavid G, 2007, BIOMACROMOLECULES, V8, P3317, DOI 10.1021/bm070344i
   Pillai BR, 2003, CRYOBIOLOGY, V47, P242, DOI 10.1016/j.cryobiol.2003.09.004
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   RYAN WG, 1994, INJURY, V25, P443, DOI 10.1016/0020-1383(94)90270-4
   Trieb K, 2004, EUR SURG RES, V36, P148, DOI 10.1159/000077256
   Viateau V, 2011, IRBM, V32, P118, DOI 10.1016/j.irbm.2011.01.007
   Zhou J, 2007, P ANN INT IEEE EMBS, P5115, DOI 10.1109/IEMBS.2007.4353491
   Zhou J, 2009, IRBM, V30, P153, DOI 10.1016/j.irbm.2009.06.001
NR 29
TC 7
Z9 7
U1 3
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2013
VL 23
IS 4
BP 289
EP 297
DI 10.3233/BME-130753
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169ZP
UT WOS:000320819600006
PM 23798650
DA 2018-10-20
ER

PT J
AU Braune, S
   von Ruesten-Lange, M
   Mrowietz, C
   Lutzow, K
   Roch, T
   Neffe, AT
   Lendlein, A
   Jung, F
AF Braune, Steffen
   von Ruesten-Lange, Maik
   Mrowietz, Christof
   Luetzow, Karola
   Roch, Toralf
   Neffe, Axel T.
   Lendlein, Andreas
   Jung, Friedrich
TI Dynamic in vitro hemocompatibility testing of poly(ether imide)
   membranes functionalized with linear, methylated oligoglycerol and
   oligo(ethylene glycol)
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Oligoglycerol; protein resistance; hemocompatibility; surface
   functionalization; membranes; biomaterial
ID WEIGHT HYPERBRANCHED POLYGLYCEROLS; PLATELET ACTIVATION; BIOLOGICAL
   EVALUATION; ADSORBED FIBRINOGEN; MONOCLONAL-ANTIBODY; D-DIMER; BLOOD;
   COMPLEMENT; PROTEIN; SURFACE
AB Linear, side-chain methylated oligoglycerols (OGMe) were recently reported as potential surface passivating molecules for improving the protein resistance of cardiovascular application relevant poly(ether imide) (PEI) membranes. A previously reported in vitro screening under static test conditions allowed an end-point evaluation of the adhesion and activation of adherent thrombocytes performed on the material surfaces and revealed similar levels of thrombogenicity on PEI membranes, functionalized with OGMe and oligo(ethylene glycol) (OEG) of similar molecular weight (M-n = 1,300 g.mol(-1) - 1,800 g.mol(-1)). In the present study, we investigated the hemocompatibility of these materials in a dynamic closed loop system, in order to study time-dependent thrombocyte material interactions also of the circulating thrombocytes by mimicking in vivo relevant flow conditions in a dynamic test system with multiple material contacts. Activation and aggregation of circulating thrombocytes as well as complement activation and plasmatic coagulation were evaluated after 40 circulations of thrombocyte rich plasma in the closed loop system. The results of the dynamic tests revealed no differences between the OGMe and OEG functionalized PEI membranes. Furthermore, no differences were observed between the latter and a PEI membrane treated under the conditions of functionalization at pH 11 (PEI-pH11) without an oligoether being present. Blood plasma protein adsorption, as well as activation, and adherence of circulating thrombocytes occurred in a comparable, but minor manner on all investigated PEI membranes. From this we conclude that the OGMe and OEG surface functionalization did not lead to an improvement of the already good hemocompatibility of the PEI-pH11 membrane.
C1 [Braune, Steffen; von Ruesten-Lange, Maik; Mrowietz, Christof; Luetzow, Karola; Roch, Toralf; Neffe, Axel T.; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Braune, Steffen; von Ruesten-Lange, Maik; Mrowietz, Christof; Luetzow, Karola; Roch, Toralf; Neffe, Axel T.; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Luetzow, Karola; Roch, Toralf; Neffe, Axel T.; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Luetzow, Karola; Roch, Toralf; Neffe, Axel T.; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Braune, Steffen/D-2315-2015; Neffe, Axel/H-6997-2013; Roch,
   Toralf/K-9531-2013; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Jung, Friedrich/0000-0001-8098-7180;
   Lendlein, Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A]
FX The authors thank Prof. Dr. Rainer Haag and Dr. Marie Weinhart from the
   Institute of Chemistry and Biochemistry of the Freie Universitat Berlin
   for providing the linear, side-chain methylated oligoglycerol and
   oligo(ethylene glycol) used in this work. We thank the Bundesministerium
   fur Bildung und Forschung (BMBF) for funding within project number
   0315696A "Poly4bio BB".
CR ABRAMS C, 1991, THROMB HAEMOSTASIS, V65, P467
   ABRAMS CS, 1990, BLOOD, V75, P128
   American National Standard, 2009, BIOL EV 4
   Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202
   Bauer KA, 1999, BEST PRACT RES CL HA, V12, P387, DOI 10.1053/beha.1999.0032
   BERG B, 1981, REFERENCE VALUES LAB, P55
   BLACKSHEAR PL, 1971, FED PROC, V30, P1600
   Blomback M, 2010, BIOCHEM BIOPH RES CO, V396, P131, DOI 10.1016/j.bbrc.2010.03.095
   BONEU B, 1991, THROMB HAEMOSTASIS, V65, P28
   BREDDIN K, 1968, BLUT, V18, P84, DOI 10.1007/BF01632412
   BREDDIN K, 1980, THROMB RES, V19, P621, DOI 10.1016/0049-3848(80)90034-1
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   DEGAETANO G, 1985, CIRCULATION, V72, P1185, DOI 10.1161/01.CIR.72.6.1185
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Frere C, 2007, THROMB HAEMOSTASIS, V98, P838, DOI 10.1160/TH07-04-0296
   Gawaz M, 1999, CIRCULATION, V99, pE1
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordz S, 2005, CLIN HEMORHEOL MICRO, V32, P83
   Graff J, 2002, J PHARMACOL EXP THER, V300, P952, DOI 10.1124/jpet.300.3.952
   GROTEMEYER KH, 1991, THROMB RES, V61, P423, DOI 10.1016/0049-3848(91)90656-H
   Harrison P, 2011, BRIT J HAEMATOL, V155, P30, DOI 10.1111/j.1365-2141.2011.08793.x
   HSULIN SC, 1984, J BIOL CHEM, V259, P9121
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Jung F, 2003, CLIN HEMORHEOL MICRO, V28, P189
   Jung F, 2001, BIOMED TECH, V46, P200, DOI 10.1515/bmte.2001.46.7-8.200
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kainthan RK, 2007, BIOMATERIALS, V28, P4779, DOI 10.1016/j.biomaterials.2007.07.046
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   LINDON JN, 1986, BLOOD, V68, P355
   Menu P, 2013, CLIN HEMORHEOL MICRO, V53, P117, DOI 10.3233/CH-2012-1580
   NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0
   NIEUWENHUIS HK, 1987, BLOOD, V70, P838
   NIEWIAROWSKI S, 1972, J CLIN INVEST, V51, P685, DOI 10.1172/JCI106857
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720
   Papp J, 2014, CLIN HEMORHEOL MICRO, V56, P1, DOI 10.3233/CH-2012-1636
   Papp J, 2013, CLIN HEMORHEOL MICRO, V53, P81, DOI 10.3233/CH-2012-1578
   Poli D, 2008, J THROMB HAEMOST, V6, P708, DOI 10.1111/j.1538-7836.2008.02900.x
   Reinhart WH, 2013, CLIN HEMORHEOL MICRO, V53, P71, DOI 10.3233/CH-2012-1577
   Reininger A J, 2007, Hamostaseologie, V27, P247
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   RUF A, 1995, SEMIN THROMB HEMOST, V21, P146, DOI 10.1055/s-2007-1000389
   SCHMIDSCHONBEIN H, 1980, ANGIOLOGY, V31, P301, DOI 10.1177/000331978003100502
   SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107
   SHATTIL SJ, 1987, BLOOD, V70, P307
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tsai WB, 2003, J BIOMED MATER RES A, V67A, P1255, DOI 10.1002/jbm.a.20024
   Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414
   Vene N, 2003, THROMB HAEMOSTASIS, V90, P1163, DOI 10.1160/TH03-06-0363
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Weinhart M, 2010, CHEM-ASIAN J, V5, P1992, DOI 10.1002/asia.201000127
   *WORLD MED ASS GEN, 2004, J INT BIOETHIQUE, V15, P124
   WU KK, 1974, LANCET, V2, P924
   Yaseen M, 2010, BIOMATERIALS, V31, P3781, DOI 10.1016/j.biomaterials.2010.01.107
NR 67
TC 8
Z9 8
U1 0
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2013
VL 54
IS 3
BP 235
EP 248
DI 10.3233/CH-131729
PG 14
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 176TC
UT WOS:000321326700002
PM 23603330
DA 2018-10-20
ER

PT J
AU Barud, HD
   de Araujo, AM
   Saska, S
   Mestieri, LB
   Campos, JADB
   de Freitas, RM
   Ferreira, NU
   Nascimento, AP
   Miguel, FG
   Vaz, MMDLL
   Barizon, EA
   Marquele-Oliveira, F
   Gaspar, AMM
   Ribeiro, SJL
   Berretta, AA
AF Barud, Hernane da Silva
   de Araujo Junior, Adalberto Miguel
   Saska, Sybele
   Mestieri, Leticia Boldrin
   Duarte Bonini Campos, Juliana Alvares
   de Freitas, Rubens Moreno
   Ferreira, Nathalia Ursoli
   Nascimento, Andresa Piacezzi
   Miguel, Felipe Galeti
   Lima Leite Vaz, Mirela Mara de Oliveira
   Barizon, Edna Aparecida
   Marquele-Oliveira, Franciane
   Minarelli Gaspar, Ana Maria
   Lima Ribeiro, Sidney Jose
   Berretta, Andresa Aparecida
TI Antimicrobial Brazilian Propolis (EPP-AF) Containing Biocellulose
   Membranes as Promising Biomaterial for Skin Wound Healing
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID BACTERIAL CELLULOSE; THERMAL CHARACTERIZATION; SILVER SULFADIAZINE;
   GREEN PROPOLIS; IN-VIVO; BURNS; COMPOUND; EXTRACT
AB Among remarkable discoveries concerning propolis, such as antifungal, antiviral, and antioxidant activities, its anti-inflammatory, and mainly its antibacterial, properties deserve special attention when skin wound healing is concerned. Based on this and knowing the distinctive performance of bacterial (BC) membranes on wound healing, in this work it is proposed to demonstrate the potent antimicrobial activity and wound healing properties of a novel propolis containing biocellulose membrane. The obtained propolis/BCmembrane was able to adsorb propolis not only on the surface, but also in its interstices demonstrated by scanning electron microscopy, X-ray diffraction, Fourier transforminfrared (FT-IR) spectroscopy, and thermogravidimetric assays. Additionally, the polyphenolic compounds determination and the prominent antibacterial activity in the membrane are demonstrated to be dose dependent, supporting the possibility of obtaining propolis/BC membranes at the desired concentrations, taking into consideration its application and its skin residence time. Finally, it could be suggested that propolis/BC membrane may favor tissue repair in less time and more effectively in contaminated wounds.
C1 [Barud, Hernane da Silva; de Araujo Junior, Adalberto Miguel; Saska, Sybele; Lima Ribeiro, Sidney Jose] Univ Estadual Paulista UNESP, Inst Quim, BR-14800900 Araraquara, SP, Brazil.
   [Saska, Sybele; Mestieri, Leticia Boldrin; Duarte Bonini Campos, Juliana Alvares; de Freitas, Rubens Moreno; Minarelli Gaspar, Ana Maria] Univ Estadual Paulista UNESP, Fac Odontol, BR-14801903 Araraquara, SP, Brazil.
   [Ferreira, Nathalia Ursoli; Nascimento, Andresa Piacezzi; Miguel, Felipe Galeti; Lima Leite Vaz, Mirela Mara de Oliveira; Barizon, Edna Aparecida; Marquele-Oliveira, Franciane; Berretta, Andresa Aparecida] Apis Flora Ind & Comercial Ltda, Lab Pesquisa Desenvolvimento & Inovacao PD & I, BR-14020670 Ribeirao Preto, SP, Brazil.
   [Lima Leite Vaz, Mirela Mara de Oliveira; Berretta, Andresa Aparecida] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Ribeiro, SJL (reprint author), Univ Estadual Paulista UNESP, Inst Quim, CP 355, BR-14800900 Araraquara, SP, Brazil.
EM sjlribeiro@yahoo.com.br; andresaberretta@hotmail.com
RI Saska, Sybele/B-6745-2011
OI Saska, Sybele/0000-0002-0229-946X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao deAmparo a Pesquisa doEstado de Sao Paulo (FAPESP); Apis Flora
   Indl. Coml. Ltda
FX The authors would like to thank the special colleague Julia Sgarioni
   Lima Ribeiro for the important participation in the present work, which
   could justify her name as an author too. However, this is not possible
   due to sad circumstances involved. The authors also are grateful to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Fundacao deAmparo a Pesquisa doEstado de Sao Paulo (FAPESP), and Apis
   Flora Indl. Coml. Ltda. for financial support and for granting research
   fellowships, and the present coauthors are grateful to Bruno Alves
   Rocha, Paula Carolina Pires Bueno, and Alexandre Henrique Oliveira for
   suggestions of some protocols used during the experiments used.
CR Amorim Wander Lopes, 2009, Rev. Bras. Otorrinolaringol., V75, P200, DOI 10.1590/S0034-72992009000200008
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   [Anonymous], 2010, F98104 ASTM
   Barud HS, 2008, J SOL-GEL SCI TECHN, V46, P363, DOI 10.1007/s10971-007-1669-9
   Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Barud HS, 2011, J NANOMATER, DOI 10.1155/2011/721631
   Berretta AA, 2012, INT J BIOL SCI, V8, P512, DOI 10.7150/ijbs.3641
   CLSI (Clinical and Laboratory Standards Institute), 2009, M02A10 CLSI
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   de Castro PA, 2011, EUKARYOT CELL, V10, P398, DOI 10.1128/EC.00256-10
   De Salvi DTB, 2012, J SOL-GEL SCI TECHN, V63, P211, DOI 10.1007/s10971-012-2678-x
   Filho AADS, 2008, Z NATURFORSCH C, V63, P40
   Fonseca YM, 2011, EVID-BASED COMPL ALT, V2011
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   GERDING RL, 1990, ANN EMERG MED, V19, P121, DOI 10.1016/S0196-0644(05)81793-7
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   Gregory SR, 2002, J ALTERN COMPLEM MED, V8, P77, DOI 10.1089/107555302753507203
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Jorge R, 2008, PHARM BIOL, V46, P889, DOI [10.1080/13880200902370373, 10.1080/13880200802370373]
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X
   Machado JL, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/157652
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Maria LCS, 2010, POLIMEROS, V20, P72, DOI 10.1590/S0104-14282010005000001
   Marquele-Oliveira F, 2007, INT J PHARM, V342, P40, DOI 10.1016/j.ijpharm.2007.04.026
   Mayall R. C., 1990, REV BRASILEIRA CIRUR, V80, P257
   Mendes P. N., 2009, ACTA VET SCANDINAVIC, V51
   Nasser S, 2003, BURNS, V29, P229, DOI 10.1016/S0305-4179(02)00285-1
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067
   Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185
   REBELLO C, 1987, Revista Brasileira de Cirurgia, V77, P407
   Rezende G.P.S., 2006, BRAZ J ORAL SCI, V5, P967
   Rocha B. A., 2013, EVID-BASED COMPL ALT, V2013
   Rocha BA, 2012, J THERM ANAL CALORIM, V108, P87, DOI 10.1007/s10973-011-1713-4
   Rojas Y, 2012, EXPERT OPIN PHARMACO, V13, P2485, DOI 10.1517/14656566.2012.738195
   Sanchavanakit N, 2006, BIOTECHNOL PROGR, V22, P1194, DOI 10.1021/bp060035o
   Saska S, 2012, J MATER SCI-MATER M, V23, P2253, DOI 10.1007/s10856-012-4676-5
   Souza RM, 2007, Z NATURFORSCH C, V62, P801
   Trovatti E, 2012, INT J PHARMACEUT, V435, P83, DOI 10.1016/j.ijpharm.2012.01.002
   Urushisaki T., 2011, EVIDENCE BASED COMPL, V2011
   WOUK AFP, 1998, ARCH VET SCI, V3, P31
NR 44
TC 4
Z9 4
U1 0
U2 42
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2013
AR 703024
DI 10.1155/2013/703024
PG 10
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 170KT
UT WOS:000320849900001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Barradas, AMC
   Monticone, V
   Hulsman, M
   Danoux, C
   Fernandes, H
   Birgani, ZT
   Barrere-de Groot, F
   Yuan, HP
   Reinders, M
   Habibovic, P
   van Blitterswijk, C
   de Boer, J
AF Barradas, Ana M. C.
   Monticone, Veronica
   Hulsman, Marc
   Danoux, Charlene
   Fernandes, Hugo
   Birgani, Zeinab Tahmasebi
   Barrere-de Groot, Florence
   Yuan, Huipin
   Reinders, Marcel
   Habibovic, Pamela
   van Blitterswijk, Clemens
   de Boer, Jan
TI Molecular mechanisms of biomaterial-driven osteogenic differentiation in
   human mesenchymal stromal cells
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; PROTEIN-COUPLED RECEPTOR; BONE-GRAFT
   SUBSTITUTES; DNA-DAMAGE; IN-VITRO; EXPRESSION; GENE; TRANSCRIPTION;
   OSTEOBLASTS; KINASE
AB Calcium phosphate (CaP) based ceramics are used as bone graft substitutes in the treatment of bone defects. The physico-chemical properties of these materials determine their bioactivity, meaning that molecular and cellular responses in the body will be tuned accordingly. In a previous study, we compared two porous CaP ceramics, hydroxyapatite (HA) and beta-tricalcium phosphate (TCP), which, among other properties, differ in their degradation behaviour in vitro and in vivo, and we demonstrated that the more degradable beta-TCP induced more bone formation in a heterotopic model in sheep. This is correlated to in vitro data, where human bone marrow derived mesenchymal stromal cells (MSC) exhibited higher expression of osteogenic differentiation markers, such as osteopontin, osteocalcin and bone sialoprotein, when cultured in beta-TCP than in HA. More recently, we also showed that this effect could be mimicked in vitro by exposure of MSC to high concentrations of calcium ions (Ca2+). To further correlate surface physico-chemical dynamics of HA and beta-TCP ceramics with the molecular response of MSC, we followed Ca2+ release and surface changes in time as well as cell attachment and osteogenic differentiation of MSC on these ceramics. Within 24 hours, we observed differences in cell morphology, with MSC cultured in beta-TCP displaying more pronounced attachment and spreading than cells cultured in HA. In the same time frame, beta-TCP induced expression of G-protein coupled receptor (GPCR) 5A and regulator of G-protein signaling 2, revealed by DNA microarray analysis. These genes, associated with the protein kinase A and GPCR signaling pathways, may herald the earliest response of MSC to bone-inducing ceramics.
C1 [Barradas, Ana M. C.; Monticone, Veronica; Danoux, Charlene; Fernandes, Hugo; Birgani, Zeinab Tahmasebi; Yuan, Huipin; Habibovic, Pamela; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7522 NB Enschede, Netherlands.
   [Hulsman, Marc; Reinders, Marcel] Delft Univ Technol, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands.
   [Barrere-de Groot, Florence; Yuan, Huipin] Xpand Biotechnol BV, Bilthoven, Netherlands.
RP Barradas, AMC (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
EM anabarradas@me.com; vemo87@gmail.com; m.hulsman@tudelft.nl;
   c.b.s.s.danoux@utwente.nl; h.a.m.fernandes@utwente.nl;
   Z.Tahmasebi@utwente.nl; florence.de.groot@xpand-biotech.com;
   huipin.yuan@xpand-biotech.com; M.J.T.Reinders@tudelft.nl;
   p.habibovic@utwente.nl; c.a.vanblitterswijk@tnw.utwente.nl;
   j.deboer@utwente.nl
RI Fernandes, Hugo/H-6192-2014
OI Fernandes, Hugo/0000-0002-4574-7648; Barradas, Ana/0000-0003-4221-8879;
   van Blitterswijk, Clemens/0000-0003-2371-4615
FU TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs;
   Netherlands Ministry of Education, Culture and Science; BMM; STW
   Vernieuwingsimpuls Veni
FX The authors gratefully acknowledge the technical support from the
   Katholieke Universiteit Leuven and the financial support from the TeRM
   Smart Mix Program of the Netherlands Ministry of Economic Affairs and
   The Netherlands Ministry of Education, Culture and Science, BMM (ZT, AB)
   and STW Vernieuwingsimpuls Veni (PH).
CR Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573
   Bernhardt A, 2011, CLIN ORAL IMPLAN RES, V22, P651, DOI 10.1111/j.1600-0501.2010.02015.x
   Brandoff Jared F, 2008, Am J Orthop (Belle Mead NJ), V37, P410
   Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011
   Chai YC, 2010, TISSUE ENG PART A, V17, P1083
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533
   Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008
   Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Du BH, 2005, CANCER RES, V65, P5982, DOI 10.1158/0008-5472.CAN-05-0628
   EYCKMANS J, 2009, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934.2009.00807.X
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Guo YS, 2010, CHINESE MED J-PEKING, V123, P3671, DOI 10.3760/cma.j.issn.0366-6999.2010.24.029
   Hirano M, 2006, BIOCHEM BIOPH RES CO, V351, P185, DOI 10.1016/j.bbrc.2006.10.016
   Homme M, 2003, ENDOCRINOLOGY, V144, P2496, DOI 10.1210/en.2002-0160
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415
   Hulsman M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-156
   Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048
   Iwata T, 2006, EUR J CELL BIOL, V85, P423, DOI 10.1016/j.ejcb.2005.12.007
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   Mayer SI, 2008, ENDOCRINOLOGY, V149, P6311, DOI 10.1210/en.2008-0251
   Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200
   Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Tan YF, 2007, J BIOMED MATER RES A, V82A, P152, DOI 10.1002/jbm.a.31125
   Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200
   Tsingotjidou A, 2002, BONE, V30, P677, DOI 10.1016/S8756-3282(02)00698-1
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200
   Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 44
TC 41
Z9 42
U1 5
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2013
VL 5
IS 7
BP 920
EP 931
DI 10.1039/c3ib40027a
PG 12
WC Cell Biology
SC Cell Biology
GA 170TP
UT WOS:000320877100001
PM 23752904
DA 2018-10-20
ER

PT J
AU Donnelly, PE
   Jones, CM
   Bandini, SB
   Singh, S
   Schwartz, J
   Schwarzbauer, JE
AF Donnelly, Patrick E.
   Jones, Casey M.
   Bandini, Stephen B.
   Singh, Shivani
   Schwartz, Jeffrey
   Schwarzbauer, Jean E.
TI A simple nanoscale interface directs alignment of a confluent cell layer
   on oxide and polymer surfaces
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; SILICON SURFACES; SKIN SUBSTITUTES; PLASMA
   TREATMENT; ADHESION; ATTACHMENT; PROTEIN; GOLD; RGD; BIOMATERIALS
AB Templating of cell spreading and proliferation is described that yields confluent layers of cells aligned across an entire two-dimensional surface. The template is a reactive, two-component interface that is synthesized in three steps in nanometer thick, micron-scaled patterns on silicon and on several biomaterial polymers. In this method, a volatile zirconium alkoxide complex is first deposited at reduced pressure onto a surface pattern that is prepared by photolithography; the substrate is then heated to thermolyze the organic ligands to form surface-bound zirconium oxide patterns. The thickness of this oxide layer ranges from 10 to 70 nanometers, which is controlled by alkoxide complex deposition time. The oxide layer is treated with 1,4-butanediphosphonic acid to give a monolayer pattern whose composition and spatial conformity to the photolithographic mask are determined spectroscopically. NIH 3T3 fibroblasts and human bone marrow-derived mesenchymal stem cells attach and spread in alignment with the pattern without constraint by physical means or by arrays of cytophilic and cytophobic molecules. Cell alignment with the pattern is maintained as cells grow to form a confluent monolayer across the entire substrate surface.
C1 [Donnelly, Patrick E.; Jones, Casey M.; Bandini, Stephen B.; Schwartz, Jeffrey] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.
   [Singh, Shivani; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
RP Donnelly, PE (reprint author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.
EM jschwarz@princeton.edu
FU National Science Foundation [CHE-0924104]; National Institutes of Health
   [CA160611, GM059383]; New Jersey Center for Biomaterials NIBIB
   Post-doctoral Training Program [T32EB005583]
FX The authors thank the National Science Foundation (CHE-0924104), the
   National Institutes of Health (CA160611 and GM059383), and the New
   Jersey Center for Biomaterials NIBIB Post-doctoral Training Program
   (T32EB005583) for financial support. They also thank Dr Samuel Lesko
   (University of Scranton, PA, USA) for advice with statistical analyses
   and Prof. Rick Register (Princeton University, NJ, USA) for use of
   laboratory equipment.
CR Allon AA, 2012, J BIOMED MATER RES A, V100A, P2168, DOI 10.1002/jbm.a.34144
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Danahy MP, 2004, LANGMUIR, V20, P5333, DOI 10.1021/la036084h
   Dennes T. J., 2008, THESIS PRINCETON U
   Dennes TJ, 2008, SOFT MATTER, V4, P86, DOI 10.1039/b714947f
   Dennes TJ, 2007, J AM CHEM SOC, V129, P93, DOI 10.1021/ja065217t
   Dennes TJ, 2009, ACS APPL MATER INTER, V1, P2119, DOI 10.1021/am9004946
   Dennes TJ, 2009, J AM CHEM SOC, V131, P3456, DOI 10.1021/ja810075c
   Dillmore WS, 2004, LANGMUIR, V20, P7223, DOI 10.1021/la049826v
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gawalt ES, 2003, LANGMUIR, V19, P7147, DOI 10.1021/la034843q
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jing GS, 2011, ACTA BIOMATER, V7, P1094, DOI 10.1016/j.actbio.2010.09.040
   Jones CM, 2010, ACS APPL MATER INTER, V2, P2185, DOI 10.1021/am1004893
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kurtz A. M., 2007, BIOMATERIALS, V28, P4845
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   Leclair AM, 2011, BIOMATERIALS, V32, P1351, DOI 10.1016/j.biomaterials.2010.10.051
   Lenci S, 2011, APPL SURF SCI, V257, P8413, DOI 10.1016/j.apsusc.2011.04.096
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miller JS, 2006, BIOTECHNOL BIOENG, V93, P1060, DOI 10.1002/bit.20809
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pum D, 1997, COLLOID SURFACE B, V8, P157, DOI 10.1016/S0927-7765(96)01318-5
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e
   Sanchez-Cortes J, 2011, ACS CHEM BIOL, V6, P1078, DOI 10.1021/cb200186j
   Shakespeare PG, 2005, CLIN DERMATOL, V23, P413, DOI 10.1016/j.clindermatol.2004.07.015
   Shannon FJ, 2008, J BIOMED MATER RES A, V86A, P857, DOI 10.1002/jbm.a.31651
   Sorribas H., 2001, J NEUROSCI METH, V104, P131
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Thibault C, 2005, J Nanobiotechnology, V3, P7, DOI 10.1186/1477-3155-3-7
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Williams C, 2011, BIOMATERIALS, V32, P410, DOI 10.1016/j.biomaterials.2010.08.105
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
NR 47
TC 8
Z9 8
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 29
BP 3553
EP 3561
DI 10.1039/c3tb20565g
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 176NK
UT WOS:000321311200004
PM 23936630
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ventrelli, L
   Ricotti, L
   Menciassi, A
   Mazzolai, B
   Mattoli, V
AF Ventrelli, Letizia
   Ricotti, Leonardo
   Menciassi, Arianna
   Mazzolai, Barbara
   Mattoli, Virgilio
TI Nanoscaffolds for Guided Cardiac Repair: The New Therapeutic Challenge
   of Regenerative Medicine
SO JOURNAL OF NANOMATERIALS
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR
   FUNCTION; MARROW-DERIVED CELLS; BONE-MARROW; HEART-FAILURE; BIOMEDICAL
   APPLICATIONS; CELLULAR CARDIOMYOPLASTY; ISCHEMIC CARDIOMYOPATHY;
   INTRACORONARY TRANSPLANTATION
AB Cardiovascular diseases represent the leading cause of death and disability in the world. At the end-stage of heart failure, heart transplantation remains the ultimate option. Therefore, due to the numerous drawbacks associated with this procedure, new alternative strategies to repair the wounded heart are required. Cell therapy is a potential option to regenerate functional myocardial tissue. The characteristics of the ideal cardiac cell therapy include the use of the proper cell type and delivery methods as well as the choice of a suitable biomaterial acting as a cellular vehicle. Since traditional delivery methods are characterized by several counter backs, among which low cell survival, new engineered micro-and nanostructured materials are today extensively studied to provide a good cardiac therapy. In this review, we report the most recent achievements in the field of cell therapy for myocardial infarction treatment and heart regeneration, focusing on the most commonly used cell sources, the traditional approaches used to deliver cells at the damaged site, and a series of novel technologies based on recent advancements of bioengineering, highlighting the tremendous potential that nanoscaffolds have in this framework.
C1 [Ventrelli, Letizia; Mazzolai, Barbara; Mattoli, Virgilio] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, I-56025 Pontedera, Italy.
   [Ventrelli, Letizia; Ricotti, Leonardo; Menciassi, Arianna] Scuola Super Sant Anna, BioRobot Inst, I-56025 Pontedera, Italy.
RP Ventrelli, L (reprint author), Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
EM l.ventrelli@sssup.it
RI Mazzolai, Barbara/I-8876-2016; Mattoli, Virgilio/A-6744-2017; Ricotti,
   Leonardo/J-5592-2013
OI Mazzolai, Barbara/0000-0003-0722-8350; Mattoli,
   Virgilio/0000-0002-4715-8353; Ricotti, Leonardo/0000-0001-8797-3742;
   menciassi, arianna/0000-0001-6348-1081
CR Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Baker M., 2009, NATURE REPORTS STEM
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bittira B, 2003, EUR J CARDIO-THORAC, V24, P393, DOI 10.1016/S1010-7940(03)00325-7
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen CH, 2007, BIOMATERIALS, V28, P4643, DOI 10.1016/j.biomaterials.2007.07.015
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   CHIU RCJ, 1995, ANN THORAC SURG, V60, P12
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z
   Dib N, 2009, JACC-CARDIOVASC INTE, V2, P9, DOI 10.1016/j.jcin.2008.11.003
   Dierickx P, 2012, J CARDIOVASC TRANSL, V5, P566, DOI 10.1007/s12265-012-9391-6
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dvir T., 2011, NATURE NANOTECHNOLOG, Vvol. 6, ppp
   EATON LW, 1979, NEW ENGL J MED, V300, P57, DOI 10.1056/NEJM197901113000202
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0
   Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Fujie T, 2010, SOFT MATTER, V6, P4672, DOI 10.1039/c0sm00527d
   Fujii T, 2003, ANN THORAC SURG, V76, P2062, DOI 10.1016/S0003-4975(03)01013-0
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Grossman PM, 2002, CATHETER CARDIO INTE, V55, P392, DOI 10.1002/ccd.10136
   Heldman AW, 2011, J AM COLL CARDIOL, V57, P466, DOI 10.1016/j.jacc.2010.09.028
   Huang CC, 2010, BIOMATERIALS, V31, P6218, DOI 10.1016/j.biomaterials.2010.04.067
   Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307
   Iyer RK, 2006, J MOL CELL CARDIOL, V40, P877, DOI 10.1016/j.yjmcc.2006.03.322
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   KOH GY, 1993, J CLIN INVEST, V92, P1548, DOI 10.1172/JCI116734
   Kondoh H, 2007, ANN THORAC SURG, V84, P134, DOI 10.1016/j.athoracsur.2007.03.052
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Marelli D, 1992, Cell Transplant, V1, P383
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978
   Matsuura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052176
   Mattoli V, 2011, PROCEDIA COMPUT SCI, V7, P337, DOI 10.1016/j.procs.2011.09.080
   Mattoli V, 2009, PROCEDIA CHEM, V1, P28, DOI 10.1016/j.proche.2009.07.007
   Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166
   Mazhari Ramesh, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS21, DOI 10.1038/ncpcardio0770
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Menasche P, 2012, J CARDIOVASC TRANSL, V5, P555, DOI 10.1007/s12265-012-9356-9
   Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mukherjee S, 2010, J MATER CHEM, V20, P8819, DOI 10.1039/c0jm00805b
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nie SP, 2010, J ZHEJIANG UNIV-SC B, V11, P895, DOI 10.1631/jzus.B1000302
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pensabene V, 2009, 2009 9TH IEEE CONFERENCE ON NANOTECHNOLOGY (IEEE-NANO), P403
   Pensabene V, 2011, ACTA BIOMATER, V7, P2883, DOI 10.1016/j.actbio.2011.03.013
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036
   Psaltis PJ, 2010, J CARDIOVASC TRANSL, V3, P135, DOI 10.1007/s12265-009-9138-1
   PSALTIS PJ, 2008, CLIN MED CARDIOLOGY, V2, P139
   Ricotti L, 2013, IEEE T BIO-MED ENG, V60, P727, DOI 10.1109/TBME.2013.2244093
   Ricotti L, 2012, BIOMED MICRODEVICES, V14, P987, DOI 10.1007/s10544-012-9697-9
   Ricotti L, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/031001
   Ricotti L, 2010, BIOMED MICRODEVICES, V12, P809, DOI 10.1007/s10544-010-9435-0
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Ruiz-Villalba A, 2012, CURR OPIN PEDIATR, V24, P569, DOI 10.1097/MOP.0b013e328357a532
   SCUDELLARI M, 2009, NATURE REPORTS STEM
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson CA, 2005, J HEART LUNG TRANSPL, V24, P1385, DOI 10.1016/j.healun.2004.10.010
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]
   Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3
   Uosaki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046413
   Vallee JP, 2012, STEM CELL TRANSL MED, V1, P248, DOI 10.5966/sctm.2011-0028
   Wang CC, 2008, CARDIOVASC RES, V77, P515, DOI 10.1093/cvr/cvm46
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   Yeh YC, 2010, BIOMATERIALS, V31, P6444, DOI 10.1016/j.biomaterials.2010.04.069
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zhang Q, 2006, J CARDIOTHORACIC REN, V1, P3
NR 102
TC 3
Z9 3
U1 2
U2 28
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
J9 J NANOMATER
JI J. Nanomater.
PY 2013
AR 108485
DI 10.1155/2013/108485
PG 16
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 169ZT
UT WOS:000320820000001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Gociu, M
   Patroi, D
   Prejmerean, C
   Pastrav, O
   Boboia, S
   Prodan, D
   Moldovan, M
AF Gociu, M.
   Patroi, D.
   Prejmerean, Cristina
   Pastrav, O.
   Boboia, Stanca
   Prodan, Doina
   Moldovan, Marioara
TI Biology and cytotoxicity of dental materials: an in vitro study
SO ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY
LA English
DT Article
DE fibroblasts; cytotoxicity; biocompatibility; viability; animal tests
ID GINGIVAL FIBROBLASTS; ROS PRODUCTION; COMPONENTS; HEMA;
   BIOCOMPATIBILITY; COMPOSITES; APOPTOSIS; TOXICITY; SERUM; PULP
AB Objective: The purpose of the experiment was to determine the degree of biocompatibility of a sealer (RO, laboratory made product) dental material in terms of cytotoxicity and animal tests. Materials and Methods: In the present study, the biological compatibility of eight experimental composite materials was examined by in vitro methods. The bio-composites used for the cytotoxicity test were placed into direct contact with normal human fibroblasts in a cell-culture dish. After fibroblast bioassay was performed, a duplicate sample of biomaterial was placed in each well, and then the fibroblasts were incubated for 48 hours at 37 degrees C and 5% carbon dioxide. Local reactions after the implantation of the material regarding preclinical evaluation have been carried out within the Biobase Laboratory of the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. The biocompatibility was studied using the tolerance test by the subcutaneous and intramuscular implantation of the cured specimens. Results: The sealant C3 scored the highest value to the cell viability. The results of the present study showed that different dental materials had different effects on cells. The resin monomer TEGDMA, present in the sealer's composition, increased the amount of intracellular reactive oxygen species. Resin-based composites are cytotoxic before polymerization and immediately thereafter, whereas already set specimens cause almost no reaction. The test of tolerance showed that the composite materials do not contain any toxic, irritant substances or destructive ones for the living cells or tissues. Conclusions: The tests with experimental composite materials revealed that they are not cytotoxic for the living cells, in all versions of the materials used. All the samples of composite materials have maintained their integrity during the experiment, allowing the testing together with the embedded cells, which proved good viability, so they are suitable for dentistry use.
C1 [Gociu, M.; Patroi, D.] Carol Davila Univ Med & Pharm, Fac Med Dent, Bucharest, Romania.
   [Prejmerean, Cristina; Boboia, Stanca; Prodan, Doina; Moldovan, Marioara] Univ Babes Bolyai, Dept Polymer Composites, Cluj Napoca 400294, Romania.
   [Pastrav, O.] Iuliu Hatieganu Univ Med & Pharm, Fac Med Dent, Cluj Napoca, Romania.
RP Moldovan, M (reprint author), Univ Babes Bolyai, Dept Polymer Composites, 30 Fantanele St, Cluj Napoca 400294, Romania.
EM mmarioara2004@yahoo.com
RI Moldovan, Marioara/N-6387-2017
FU PNII, Parteneriate Program [165/2012]
FX This work was supported by PNII, Parteneriate Program, Project No.
   165/2012 (COSMETICDENT).
CR Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021
   Darmani H, 2007, QUINTESSENCE INT, V38, P789
   Deshpande M, 2010, HUM IMMUNOL, V71, P1089, DOI 10.1016/j.humimm.2010.08.003
   Elshahawy WM, 2009, DENT MATER, V25, P1551, DOI 10.1016/j.dental.2009.07.008
   Goldberg M, 2008, CLIN ORAL INVEST, V12, P1, DOI 10.1007/s00784-007-0162-8
   Gregson KS, 2009, DENT MATER, V25, P1358, DOI 10.1016/j.dental.2009.06.005
   Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6
   International Organization for Standardization, 2008, 7405 ISO
   International Standards Organization, 1999, ISO109935
   Langeland K, 1980, 9 FDI
   Manolea H, 2009, ROM J MORPHOL EMBRYO, V50, P207
   Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6
   Mazlyzam AL, 2008, ARCH MED RES, V39, P743, DOI 10.1016/j.arcmed.2008.09.001
   Morimoto N, 2011, J SURG RES, V171, P339, DOI 10.1016/j.jss.2009.11.724
   RUEGGEBERG FA, 1990, J DENT RES, V69, P1652, DOI 10.1177/00220345900690100501
   Schmalz G, 1997, Clin Oral Investig, V1, P154
   SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9
   Schmid-Schwap M, 2009, DENT MATER, V25, P360, DOI 10.1016/j.dental.2008.08.002
   Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022
   Spagnuolo G, 2004, J DENT RES, V83, P837, DOI 10.1177/154405910408301103
   Spahl W, 1998, J DENT, V26, P137, DOI 10.1016/S0300-5712(96)00086-3
   Toledano M, 1998, J DENT RES, V77, pP0474
   Walker D, 2004, ANN ACAD MED SINGAP, V33, P27
   Wataha JC, 2001, J PROSTHET DENT, V86, P203, DOI 10.1067/mpr.2001.117056
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Winter K, 2005, BIOMATERIALS, V26, P5321, DOI 10.1016/j.biomaterials.2005.01.068
NR 26
TC 7
Z9 7
U1 1
U2 6
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 1220-0522
J9 ROM J MORPHOL EMBRYO
JI Rom. J. Morphol. Embryol.
PY 2013
VL 54
IS 2
BP 261
EP 265
PG 5
WC Developmental Biology
SC Developmental Biology
GA 172WF
UT WOS:000321035500005
PM 23771068
DA 2018-10-20
ER

PT B
AU Fuerst, J
   Carter, M
   Huber, M
   Sears, J
   Medlin, DJ
   Vander Voort, GF
AF Fuerst, J.
   Carter, M.
   Huber, M.
   Sears, J.
   Medlin, D. J.
   Vander Voort, G. F.
GP ASM International
TI LASER Powder Deposition of Titanium-Tantalum Alloy Structured Interfaces
   for Use in Orthopedic Devices
SO MEDICAL DEVICE MATERIALS VI
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices Conference
CY AUG 08-10, 2011
CL Minneapolis, MN
ID TI-TA ALLOYS; BIOMEDICAL APPLICATIONS; POROUS TANTALUM; PERFORMANCE;
   INGROWTH; BONE
AB Tantalum has been demonstrated to have increased biocompatibility and osseointegrative properties compared to other more commonly used orthopedic grade alloys. Despite the biocompatibility of pure tantalum, there are several drawbacks to the use of it as a bulk biomaterial: low yield strength, high modulus of elasticity, high density, and high material and processing costs that make it prohibitively expensive. The use of tantalum-titanium alloys for the manufacture of orthopedic implants, in theory, could produce a device with a desired strength and low modulus of elasticity, while retaining much of the biocompatibility of tantalum. Bonding a functional tantalum coating to a titanium orthopedic device is inherently difficult because of the small difference between the melting temperature of tantalum, 3017 degrees C, and the boiling point of titanium, 3287 degrees C. LASER Powder Deposition (LPD) is a fusion operation using an Nd:YAG laser piped through a 10 mu m optical fiber to melt a small volume of substrate into which metal powder is sprayed achieving high temperature with a high solidification rate. LPD of Ti-Ta onto a Ti-6Al-4V substrate produced a structured coating with a pore size in the optimal 350 - 500 mu m range. Cell culturing of LPD produced sample coatings showed the rate of cell growth increased as the tantalum fraction of the deposition increased, indicating Ti-Ta LPD surfaces are capable of increased the osseointegrative properties of orthopedic implants.
C1 [Fuerst, J.; Carter, M.; Huber, M.; Sears, J.] South Dakota Sch Mines & Technol, Rapid City, SD USA.
RP Fuerst, J (reprint author), South Dakota Sch Mines & Technol, Rapid City, SD USA.
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Callaghan J.J., 2007, ADULT HIP, V1, P197
   Callister W.D., 2007, MAT SCI ENG INTRO, P56
   CROCHET D, 1994, CARDIOVASC INTER RAD, V17, P285, DOI 10.1007/BF00192453
   Davis J.R., 2003, HDB MAT MED DEVICES, P16
   Davis JR, 2003, HDB MAT MED DEVICES, P195
   DOBROMYSLOV AV, 2006, ARCH METALLURGY MAT, V51
   DONALD L, 1995, ENCY HDB BIOMATERI B, P806
   Harling R.J., 2002, TECHNICAL REPORT
   Jaffee Robert I., 1955, J MET, P247
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Leyens C., 2003, TITANIUM TITANIUM AL, P6
   LI CF, J METALLURGY HINDAWI, V2011
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 18
TC 0
Z9 0
U1 1
U2 7
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-1-62708-009-5
PY 2013
BP 159
EP 164
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFB40
UT WOS:000319085000032
DA 2018-10-20
ER

PT J
AU Jiang, QG
   Ao, ZM
   Jiang, Q
AF Jiang, Q. G.
   Ao, Z. M.
   Jiang, Q.
TI First principles study on the hydrophilic and conductive graphene doped
   with Al atoms
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID ELECTRIC-FIELD; FILMS; SURFACE; TRANSITION; OXIDE; WETTABILITY;
   GRAPHITE; ENERGY; ZNO
AB The effect of the Al dopant on the dissociative adsorption of a H2O molecule on graphene is investigated using first principles calculations. It is found that doping Al into graphene can facilitate the dissociative adsorption of H2O molecules. The dissociative energy barrier is reduced from 3.609 eV on pristine graphene to 0.456 eV on Al-doped graphene and the reaction releases an energy of 0.413 eV, which indicates a smooth dissociative adsorption on Al-doped graphene at room temperature. In addition, the dissociative adsorption of H2O molecules can convert the Al-doped graphene from hydrophobic to hydrophilic while obtaining conductive graphene with doping concentration higher than 5.56%. This hydrophilic and conductive graphene has potential applications in supercapacitors and biomaterial supports.
C1 [Jiang, Q. G.; Jiang, Q.] Jilin Univ, Minist Educ, Key Lab Automobile Mat, Changchun 130022, Peoples R China.
   [Jiang, Q. G.; Jiang, Q.] Jilin Univ, Sch Mat Sci & Engn, Changchun 130022, Peoples R China.
   [Ao, Z. M.] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
RP Jiang, Q (reprint author), Jilin Univ, Minist Educ, Key Lab Automobile Mat, Changchun 130022, Peoples R China.
EM jiangq@jlu.edu.cn
RI Jiang, Qing/F-4073-2012
OI Jiang, Qing/0000-0003-0660-596X
FU National Key Basic Research, Development Program [2010CB631001];
   University of New South Wales [SIR50/PS19184, RG124422]
FX We acknowledge support from National Key Basic Research, Development
   Program (Grant No. 2010CB631001) and High Performance Computing Center
   (HPCC) of Jilin University for supercomputer time. ZA acknowledges the
   financial support from the Vice-Chancellor's Postdoctoral Research
   Fellowship Program of the University of New South Wales (SIR50/PS19184),
   and the Goldstar Award of the University of New South Wales (RG124422).
CR Ao ZM, 2008, CHEM PHYS LETT, V461, P276, DOI 10.1016/j.cplett.2008.07.039
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Boukhvalov DW, 2008, J AM CHEM SOC, V130, P10697, DOI 10.1021/ja8021686
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   Dai JY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165414
   Dai JY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272008
   Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015
   Denis PA, 2010, CHEM PHYS LETT, V492, P251, DOI 10.1016/j.cplett.2010.04.038
   Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o
   Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a
   Giovambattista N, 2007, J PHYS CHEM B, V111, P9581, DOI 10.1021/jp071957s
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5
   Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224
   Jiang QG, 2012, J PHYS CHEM C, V116, P19321, DOI 10.1021/jp3050466
   Jung I, 2008, NANO LETT, V8, P4283, DOI 10.1021/nl8019938
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Leenaerts O, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125416
   Leenaerts O, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235440
   Li X, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085425
   Lin ZY, 2011, J PHYS CHEM C, V115, P7120, DOI 10.1021/jp2007073
   Lv YA, 2011, PHYS CHEM CHEM PHYS, V13, P12472, DOI 10.1039/c1cp20694j
   Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pantelic RS, 2011, NANO LETT, V11, P4319, DOI 10.1021/nl202386p
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Rafiee J, 2010, ADV MATER, V22, P2151, DOI 10.1002/adma.200903696
   Roldan A, 2009, THEOR CHEM ACC, V123, P119, DOI 10.1007/s00214-009-0540-1
   Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301
   Shang C, 2011, J AM CHEM SOC, V133, P9938, DOI 10.1021/ja203468v
   Shapovalov V, 2000, J PHYS CHEM B, V104, P9859, DOI 10.1021/jp001399g
   Song EH, 2012, J PHYS CHEM C, V116, P20342, DOI 10.1021/jp304757f
   Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y
   Sun RD, 2001, J PHYS CHEM B, V105, P1984, DOI 10.1021/jp002525j
   Wang SR, 2009, LANGMUIR, V25, P11078, DOI 10.1021/la901402f
   Xu S, 2005, J PHYS CHEM A, V109, P9563, DOI [10.1021/jp053234j, 10.1021/jp05324j]
   Zhao ZS, 2011, ACS NANO, V5, P7226, DOI 10.1021/nn202053t
   Zhou Y, 2009, CHEM MATER, V21, P2950, DOI 10.1021/cm9006603
NR 38
TC 21
Z9 21
U1 7
U2 89
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2013
VL 15
IS 26
BP 10859
EP 10865
DI 10.1039/c3cp00128h
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 163FP
UT WOS:000320321600033
PM 23698288
DA 2018-10-20
ER

PT S
AU Zhu, SL
   Xie, GQ
   Qin, FX
   Wang, XM
AF Zhu, Shengli
   Xie, Guoqiang
   Qin, Fengxiang
   Wang, Xinmin
BE Zhu, S
   Ni, B
   Ju, DY
TI Effects of minor Si addition on glass formation and thermal stability of
   Ni free Ti-based bulk metallic glass
SO ADVANCED MATERIALS SCIENCE AND TECHNOLOGY, (IFAMST-8)
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th International Forum on Advanced Materials Science and Technology
   (IFAMST-8)
CY AUG 01-04, 2012
CL Fukuoka Inst Technol, Fukuoka City, JAPAN
SP Saitama Inst Technol, Chinese Mat Res Soc Japan, Chinese Acad & Profess Assoc Japan
HO Fukuoka Inst Technol
DE bulk metallic glass; glass-forming ability; thermal stability; minor
   element addition; biomaterial
ID SUPERCOOLED LIQUID REGION; FORMING ABILITY; AMORPHOUS-ALLOYS;
   MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; ZR; CRYSTALLIZATION;
   TRANSITION
AB The effects of small amounts of Si on the glass-forming ability, thermal stability and mechanical property of a TiZrCuPdSn bulk metallic glass were investigated. The addition of Si caused the decrease of glass-forming ability and the enlarging of the supercooled liquid (SCL) region. With 2 at.% Si addition, a significant SCL region of 80 K was obtained, which indicated high thermal stability of the glassy alloy and was in favor of secondary working by viscous flow deformation. With increasing Si content, the plasticity decreased.
C1 [Zhu, Shengli; Xie, Guoqiang; Qin, Fengxiang; Wang, Xinmin] Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan.
RP Zhu, SL (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan.
EM slzhu@imr.tohoku.ac.p; xiegq@imr.tohoku.ac.jp; fxqin@imr.tohoku.ac.jp;
   jmbgwang@yahoo.co.jp
RI Xie, Guoqiang/A-8619-2011; Zhu, Shengli/D-5281-2009
OI Zhu, Shengli/0000-0002-0190-2626
CR Choi-Yim H, 1998, J APPL PHYS, V83, P7993, DOI 10.1063/1.367981
   Guo F., 2005, APPL PHYS LETT, V86
   Hasegawa M, 2004, ACTA MATER, V52, P1799, DOI 10.1016/j.actamat.2003.12.019
   INOUE A, 1994, MATER LETT, V19, P131, DOI 10.1016/0167-577X(94)90057-4
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1990, MATER T JIM, V31, P177, DOI 10.2320/matertrans1989.31.177
   Kakiuchi H., 2001, MAT T, V42, P678
   Kim YC, 2004, MAT SCI ENG A-STRUCT, V375, P127, DOI 10.1016/j.msea.2003.10.115
   Kong J, 2006, T NONFERR METAL SOC, V16, pS598, DOI 10.1016/S1003-6326(06)60263-X
   Louzguine DV, 1999, J MATER RES, V14, P4426, DOI 10.1557/JMR.1999.0599
   Ma C, 2004, MATER TRANS, V45, P3223, DOI 10.2320/matertrans.45.3223
   Men H, 2005, MATER TRANS, V46, P2218, DOI 10.2320/matertrans.46.2218
   Qin FX, 2008, INTERMETALLICS, V16, P1026, DOI 10.1016/j.intermet.2008.05.004
   Tanaka H, 2005, J NON-CRYST SOLIDS, V351, P678, DOI 10.1016/j.jnoncrysol.2005.01.070
   Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003
   Zhang QS, 2003, SCRIPTA MATER, V49, P273, DOI 10.1016/S1359-6462(03)00285-9
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhang T, 2001, MAT SCI ENG A-STRUCT, V304, P771, DOI 10.1016/S0921-5093(00)01592-6
   ZHANG T, 1991, MATER T JIM, V32, P1005, DOI 10.2320/matertrans1989.32.1005
   ZHANG T, 1994, MAT SCI ENG A-STRUCT, V182, P1423
   Zhu SL, 2008, INTERMETALLICS, V16, P1031, DOI 10.1016/j.intermet.2008.05.006
   Zhu SL, 2008, INTERMETALLICS, V16, P609, DOI 10.1016/j.intermet.2007.09.012
   Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044
   Zhu SL, 2007, MATER TRANS, V48, P163, DOI 10.2320/matertrans.48.163
   Zhu SL, 2012, MATER TRANS, V53, P500, DOI 10.2320/matertrans.M2011281
NR 25
TC 4
Z9 4
U1 1
U2 21
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 750
BP 36
EP 39
DI 10.4028/www.scientific.net/MSF.750.36
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFD20
UT WOS:000319235900009
DA 2018-10-20
ER

PT S
AU Song, X
   Wang, L
   Niinomi, M
   Nakai, M
   Liu, Y
   Zhu, MY
AF Song, Xiu
   Wang, Lei
   Niinomi, Mitsuo
   Nakai, Masaaki
   Liu, Yang
   Zhu, Miaoyong
BE Zhu, S
   Ni, B
   Ju, DY
TI Comparison of mechanical properties of a biomedical beta Titanium alloy
   added with pure rare earth and rare earth oxides
SO ADVANCED MATERIALS SCIENCE AND TECHNOLOGY, (IFAMST-8)
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th International Forum on Advanced Materials Science and Technology
   (IFAMST-8)
CY AUG 01-04, 2012
CL Fukuoka Inst Technol, Fukuoka City, JAPAN
SP Saitama Inst Technol, Chinese Mat Res Soc Japan, Chinese Acad & Profess Assoc Japan
HO Fukuoka Inst Technol
DE biomaterial; beta-type titanium alloy; fatigue strength; pure rare
   earth; rare earth oxide
ID TI-29NB-13TA-4.6ZR; MICROSTRUCTURE; YTTRIUM
AB The microstructures and mechanical properties of the TNTZ added with Y or Y2O3 have been investigated. The results indicate that TNTZ added with Y or Y2O3 are found to be composed of beta phase and the small amount of Y2O3. The grain size of TNTZ added with Y or Y2O3 is smaller than that of TNTZ. The Young's modulus of TNTZ added with Y or Y2O3 are maintained at a low level, and Young's modulus of TNTZ added with Y is smaller than that of TNTZ added with Y2O3. The mechanical properties are both improved by adding Y or Y2O3, while the tensile strength of TNTZ added with Y2O3 is slightly higher than that of TNTZ added with Y. The high cycle fatigue limit of the alloys added with Y or Y2O3 are similar, while the low cycle fatigue strength of TNTZ added with Y is higher than that of TNTZ with Y2O3. The improving of mechanical properties ascribes to the microstructure refinement and the pining effect of Y2O3 particles. On the other hand, Y elements form Y2O3 with the oxygen elements in the matrix, thus lead to the weakening of the oxygen solution effect.
C1 [Song, Xiu; Wang, Lei; Liu, Yang] Northeastern Univ, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang, Peoples R China.
   [Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi, Japan.
   [Zhu, Miaoyong] NE Univ, Sch Met & Mat, Shenyang, Peoples R China.
RP Song, X (reprint author), Northeastern Univ, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang, Peoples R China.
EM songxiu@mail.neu.edu.cn; wanglei@mail.neu.edu.cn;
   niinomi@imr.tohoku.ac.jp; nakai@imr.tohoku.ac.jp;
   liuyang@mail.neu.edu.cn; myzhu@mail.neu.edu.cn
CR Bai S, 2010, MAT SCI ENG A-STRUCT, V527, P1806, DOI 10.1016/j.msea.2009.11.011
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Nakai M, 2009, MATER TRANS, V50, P2716, DOI 10.2320/matertrans.MA200904
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Raman V, 2006, ELECTROCHEM COMMUN, V8, P1309, DOI 10.1016/j.elecom.2006.06.004
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Wang XL, 2012, J ALLOY COMPD, V522, P96, DOI 10.1016/j.jallcom.2012.01.096
   Zhang L, 2009, ACTA MATER, V57, P3671, DOI 10.1016/j.actamat.2009.04.033
   Zhou PJ, 2007, SCRIPTA MATER, V57, P643, DOI 10.1016/j.scriptamat.2007.06.003
NR 10
TC 0
Z9 0
U1 2
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 750
BP 147
EP +
DI 10.4028/www.scientific.net/MSF.750.147
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFD20
UT WOS:000319235900035
DA 2018-10-20
ER

PT S
AU Saha, N
   Vyroubal, R
   Shah, R
   Kitano, T
   Saha, P
AF Saha, Nabanita
   Vyroubal, Radek
   Shah, Rushita
   Kitano, Takeshi
   Saha, Petr
BE Zatloukal, M
TI Effect of Strain on Viscoelastic Behavior of Fresh, Swelled and
   Mineralized PVP-CMC Hydrogel
SO NOVEL TRENDS IN RHEOLOGY V
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Novel Trends in Rheology V
CY JUL 30-31, 2013
CL Tomas Bata Univ, Zlin, CZECH REPUBLIC
SP Anton Paar, Nexans, Thermo Sci, Pragolab, Tomas Bata Univ, Polymer Ctr, Ctr Polymer Syst, Czech Chemical Soc, Czech Grp Rheol, Soc Plast Engineers (SPE), Czech Grp Rheol
HO Tomas Bata Univ
DE Hydrogels; Strain; Angular frequency; Viscoelastic; Swelling;
   Mineralization
ID RHEOLOGICAL PROPERTIES; CRYSTAL-GROWTH; CACO3
AB Mineralization of calcium carbonate (CaCO3) in hydrogel matrix is one of the most interesting topics of research by material scientists for the development of bio-inspired polymeric biomaterial for biomedical applications especially for bone tissue regeneration. As per our knowledge there was no work reported about rheological properties of CaCO3 mineralized hydrogel though some works have done on mineralization of CaCO3 in various gel membranes, and also it was reported about the viscoelastic properties of Agarose, Cellulose, PVA and PVP-CMC hydrogels. This paper mainly focuses about the effect of strain on viscoelastic properties of fresh, swelled and mineralized (CaCO3) PVP-CMC hydrogel. All these three types of hydrogel sustain (or keep) strictly the elastic properties when low strain (1%) is applied, but at higher strain (10%) the viscoelastic moduli (G' and G '') show significant change, and the nature of these materials turned from elastic to viscous.
C1 [Saha, Nabanita; Vyroubal, Radek; Shah, Rushita; Kitano, Takeshi; Saha, Petr] Tomas Bata Univ Zlin, Fac Technol, Ctr Polymer, Zlin 76272, Czech Republic.
RP Saha, N (reprint author), Tomas Bata Univ Zlin, Fac Technol, Ctr Polymer, Nam T G Masaryka 275, Zlin 76272, Czech Republic.
RI Saha, Petr/F-3952-2016
OI Saha, Petr/0000-0002-1873-4163; SAHA, NABANITA/0000-0002-7549-2260
CR Antonietti M, 1998, CHEM-EUR J, V4, P2493, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
   Asenath-Smith E, 2012, ADV FUNCT MATER, V22, P2891, DOI 10.1002/adfm.201200300
   Fernandez E, 2008, J POLYM SCI POL PHYS, V46, P322, DOI 10.1002/polb.21370
   Gao HW, 2010, ACTA POLYM SIN, P542
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Grassman O, 2003, AM MINERAL, V88, P647, DOI 10.2138/am-2003-0418
   Grassmann O, 2003, CHEM-EUR J, V9, P1310, DOI 10.1002/chem.200390150
   Grassmann O, 2004, BIOMATERIALS, V25, P277, DOI 10.1016/S0142-9612(03)00526-X
   Mihranyan A, 2007, FOOD HYDROCOLLOID, V21, P267, DOI 10.1016/j.foodhyd.2006.04.003
   Rauch M. W., 2012, EUR J INORG CHEM, V32, P5192
   Roy N, 2011, AIP CONF PROC, V1375, DOI 10.1063/1.3604486
   Roy N, 2010, J APPL POLYM SCI, V117, P1703, DOI 10.1002/app.32056
   Roy N, 2009, AIP CONF PROC, V1152, P210, DOI 10.1063/1.3203272
   Saha N., 2013, AIP C P IN PRESS
   SAHA P, 2011, Patent No. 302405
   Zhao J, 2007, CHINESE SCI BULL, V52, P1796, DOI 10.1007/s11434-007-0252-7
NR 16
TC 0
Z9 0
U1 0
U2 12
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1151-7
J9 AIP CONF PROC
PY 2013
VL 1526
BP 301
EP 309
DI 10.1063/1.4802624
PG 9
WC Mechanics; Physics, Applied
SC Mechanics; Physics
GA BFG94
UT WOS:000319829500026
DA 2018-10-20
ER

PT J
AU Firdous, S
   Ahmed, A
   Nawaz, M
   Ikram, M
AF Firdous, S.
   Ahmed, A.
   Nawaz, M.
   Ikram, M.
TI Optical characterization of Chitosan for application as an engineered
   biomaterial
SO OPTIK
LA English
DT Article
DE Biomaterial; Chitosan; Polarization; Scattering; Mueller matrix
ID DEPOLARIZING MUELLER MATRICES; POLARIZED-LIGHT; POLARIMETRIC
   CHARACTERIZATION; PRODUCT DECOMPOSITIONS; LIQUID-CRYSTALS; TURBID
   MEDIUM; SCATTERING; MEDIA; PROPAGATION
AB The polarization sensitive optical imaging technique has been used to study the optical properties of Chitosan as a biomaterial suitable for orthopedic implants. The Mueller matrices of Chitosan are obtained in the wavelength range from 400 to 800 nm using polarized light, and then decomposed for the forward and reverse formulations. The decomposed images of the data are obtained for the analysis of the optical properties of the material such as retardence, depolarization, diattenuation. The optical properties prove Chitosan to be highly compatible, strong and dense scattering medium suitable for bioactive coating in favor of orthopedic implants. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Firdous, S.; Nawaz, M.] FUUAST, Dept Phys, Islamabad, Pakistan.
EM shamaraz@gmail.com
RI Firdous, Shamaraz/I-8028-2015; Ikram, Masroor/G-9117-2011
CR ALFANO RR, 1996, ADV OPTICAL IMAGING, V2
   Bychowska A., 2010, APPL SPECTROSCOPIC M
   Cameron BD, 1998, OPT LETT, V23, P485, DOI 10.1364/OL.23.000485
   CHIPMAN RA, 1989, OPT ENG, V28, P90, DOI 10.1117/12.7976914
   Collett E., 1993, POLARIZED LIGHT FIBE, P27
   De Martino A, 2003, OPT LETT, V28, P616, DOI 10.1364/OL.28.000616
   Demos SG, 1997, APPL OPTICS, V36, P150, DOI 10.1364/AO.36.000150
   Elies P, 1997, J PHYS D APPL PHYS, V30, P2520, DOI 10.1088/0022-3727/30/18/005
   Firdous S, 2005, APPL OPTICS, V44, P1171, DOI 10.1364/AO.44.001171
   Firdous S, 2011, OPT SPECTROSC+, V110, P438, DOI 10.1134/S0030400X11030064
   Firdous S, 2011, OPTIK, V122, P99, DOI 10.1016/j.ijleo.2009.10.008
   Firdous S, 2010, LASER ENG, V19, P291
   GIL JJ, 1985, OPT ACTA, V32, P259, DOI 10.1080/713821732
   Guyot S, 2003, OPTIK, V114, P289, DOI 10.1078/0030-4026-00264
   Hecht E., 2001, OPTICS, P270
   Hielscher AH, 1997, OPT EXPRESS, V1, P441, DOI 10.1364/OE.1.000441
   Jacques SL, 2000, LASER SURG MED, V26, P119, DOI 10.1002/(SICI)1096-9101(2000)26:2<119::AID-LSM3>3.3.CO;2-P
   Laude-Boulesteix B, 2004, APPL OPTICS, V43, P2824, DOI 10.1364/AO.43.002824
   Liu GL, 2002, P SOC PHOTO-OPT INS, V4617, P208, DOI 10.1117/12.472527
   Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106
   Morgan SP, 1997, APPL OPTICS, V36, P1560, DOI 10.1364/AO.36.001560
   Morio J, 2004, OPT LETT, V29, P2234, DOI 10.1364/OL.29.002234
   Ossikovski R, 2008, OPT COMMUN, V281, P2406, DOI 10.1016/j.optcom.2007.12.076
   Ossikovski R, 2007, OPT LETT, V32, P689, DOI 10.1364/OL.32.000689
   Rakovic MJ, 1999, APPL OPTICS, V38, P3399, DOI 10.1364/AO.38.003399
   SCHMITT JM, 1992, APPL OPTICS, V31, P6535, DOI 10.1364/AO.31.006535
   SHURCLIFF WA, 1962, POLARIZED LIGHT
   Smith MH, 2000, PROC SPIE, V3911, P210, DOI 10.1117/12.384904
   XING ZF, 1992, J MOD OPTIC, V39, P461, DOI 10.1080/09500349214550471
   Yao G, 2000, OPT EXPRESS, V7, P198, DOI 10.1364/OE.7.000198
NR 30
TC 6
Z9 6
U1 0
U2 11
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0030-4026
J9 OPTIK
JI Optik
PY 2013
VL 124
IS 12
BP 1297
EP 1302
DI 10.1016/j.ijleo.2012.03.069
PG 6
WC Optics
SC Optics
GA 158YO
UT WOS:000320011300049
DA 2018-10-20
ER

PT J
AU Vaseem, M
   Tripathy, N
   Khang, G
   Hahn, YB
AF Vaseem, Mohammad
   Tripathy, Nirmalya
   Khang, Gilson
   Hahn, Yoon-Bong
TI Green chemistry of glucose-capped ferromagnetic hcp-nickel nanoparticles
   and their reduced toxicity
SO RSC ADVANCES
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; METALLIC NICKEL; MAGNETIC NANOPARTICLES;
   CONTROLLABLE SYNTHESIS; CANCER-CELLS; SIZE; LUNG; STABILIZATION;
   NANOCRYSTALS; AGGREGATION
AB Well-designed multifunctional D-(+) Glucose capped nickel nanoparticles (G-Ni NPs) with reduced toxicity was synthesized via green chemistry using D-(+) Glucose and ammonia in water. Here, glucose serves as a reducing and capping agent, resulting in highly stable and well-dispersed G-Ni NPs in the solution. The temperature and field dependent magnetization (M-H) showed a typical magnetic behavior for the G-Ni NPs. In zero field cooled (ZFC) curve, the peak was observed at similar to 15 K, attributed to the blocking temperature (T-B). At room temperature, the saturation magnetization (M-s), remanent magnetization (M-r), and coercivity (H-c) were found to be 35.57 emu/g, 11.77 emu/g, and 161 Oe, respectively. Interestingly, a dosage of 50 mu g ml(-1) G-Ni NPs were found to be well-tolerated by the cells with more than 50% cell viability. Hence, these smartly designed the G-Ni NPs can be envisioned as a future potential biomaterial for various applications.
C1 [Vaseem, Mohammad; Tripathy, Nirmalya; Hahn, Yoon-Bong] Chonbuk Natl Univ, Dept BIN Fus Technol, Sch Semicond & Chem Engn, Jeonju 561756, South Korea.
   [Vaseem, Mohammad; Tripathy, Nirmalya; Hahn, Yoon-Bong] Chonbuk Natl Univ, Nanomat Proc Res Ctr, Jeonju 561756, South Korea.
   [Khang, Gilson] Chonbuk Natl Univ, Dept Polymer Nano Sci & Technol, Polymer Fus Res Ctr, Jeonju 561756, South Korea.
RP Vaseem, M (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol, Sch Semicond & Chem Engn, 567 Baekje Daero, Jeonju 561756, South Korea.
EM ybhahn@chonbuk.ac.kr
RI Khang, Gilson/B-2109-2013
OI VASEEM, MOHAMMAD/0000-0002-2953-8299
FU Priority Research Centers Program [2011-0031400]; World Class University
   program [R31-20029]; Korean government (MEST)
FX This work was supported in part by the Priority Research Centers Program
   (2011-0031400) and by the World Class University program (R31-20029)
   funded by the Korean government (MEST). YBH thanks Chonbuk National
   University for the selection of research-oriented professor in 2012.
   Authors also thank KBSI, Jeonju branch for SEM and Mr. Jong-Gyun Kang,
   Centre for University Research Facility (CURF) for taking good quality
   TEM images.
CR Agrawal M, 2010, J PHYS CHEM C, V114, P11115, DOI 10.1021/jp103003a
   Ahamed M, 2011, TOXICOL IN VITRO, V25, P930, DOI 10.1016/j.tiv.2011.02.015
   Baalousha M, 2009, SCI TOTAL ENVIRON, V407, P2093, DOI 10.1016/j.scitotenv.2008.11.022
   Bala T, 2004, J MATER CHEM, V14, P2941, DOI 10.1039/b405335b
   Barco E. D., 2001, CHEM MATER, V13, P1487
   Bardenstein D., 2009, MOL PHARM, V6, P1417
   Carenco S, 2010, CHEM MATER, V22, P1340, DOI 10.1021/cm902007g
   Chen DH, 2002, J MATER CHEM, V12, P2412, DOI 10.1039/b200603k
   Chen DH, 2000, CHEM MATER, V12, P1354, DOI 10.1021/cm991167y
   Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x
   Galvez N, 2006, J MATER CHEM, V16, P2757, DOI 10.1039/b604860a
   Geissler A, 2010, J PHYS CHEM C, V114, P89, DOI 10.1021/jp908427r
   Goodman JE, 2011, CRIT REV TOXICOL, V41, P142, DOI 10.3109/10408444.2010.531460
   Guo DD, 2008, J NANOSCI NANOTECHNO, V8, P2301, DOI 10.1166/jnn.2008.311
   Han M, 2007, ADV MATER, V19, P1096, DOI 10.1002/adma.200601460
   IPAS C, 2009, ENVIRON SCI TECHNOL, V43, P6349
   Jia FL, 2008, ADV MATER, V20, P1050, DOI 10.1002/adma.200702159
   Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Leng YH, 2007, J PHYS CHEM C, V111, P6630, DOI 10.1021/jp0676686
   Liu Juncheng, 2006, Chemistry, V12, P2131, DOI 10.1002/chem.200500925
   Maximova N, 2006, CURR OPIN COLLOID IN, V11, P246, DOI 10.1016/j.cocis.2006.06.001
   Metin O, 2010, J AM CHEM SOC, V132, P1468, DOI 10.1021/ja909243z
   Minocha S, 2012, SMALL, V8, P3289, DOI 10.1002/smll.201200478
   Mitran E, 2010, CHEM MATER, V22, P6555, DOI 10.1021/cm102030p
   Ngo AT, 2001, J APPL PHYS, V89, P3370, DOI 10.1063/1.1347001
   Palchik O, 1999, NANOSTRUCT MATER, V11, P415, DOI 10.1016/S0965-9773(99)00321-9
   Pascu O, 2010, LANGMUIR, V26, P12548, DOI 10.1021/la1011617
   Fernandez-Garcia MP, 2011, J PHYS CHEM C, V115, P5294, DOI 10.1021/jp109669t
   Pietruska JR, 2011, TOXICOL SCI, V124, P138, DOI 10.1093/toxsci/kfr206
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Reddy LH, 2012, CHEM REV, V112, P5818, DOI 10.1021/cr300068p
   Richard-Plouet M, 2007, CHEM MATER, V19, P865, DOI 10.1021/cm062521c
   Sidhaye DS, 2009, J PHYS CHEM C, V113, P3426, DOI 10.1021/jp807542w
   Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018
   Vaseem M, 2012, ACS APPL MATER INTER, V4, P3300, DOI 10.1021/am300689d
   Vaseem M, 2011, MATER CHEM PHYS, V125, P334, DOI 10.1016/j.matchemphys.2010.11.007
   Wang AL, 2009, LANGMUIR, V25, P12736, DOI 10.1021/la901815b
   Wang C, 2010, J PHYS CHEM C, V114, P3196, DOI 10.1021/jp908839r
   Wang HY, 2012, J PHYS CHEM C, V116, P26765, DOI 10.1021/jp306519t
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Zhang DQ, 2009, CRYST GROWTH DES, V9, P2812, DOI 10.1021/cg900063q
   Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23
   Zhao J., 2009, NANOBIOTECHNOL, V7, P13
   Zhou W, 2011, J AM CHEM SOC, V133, P8389, DOI 10.1021/ja201101p
NR 45
TC 10
Z9 10
U1 0
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2013
VL 3
IS 25
BP 9698
EP 9704
DI 10.1039/c3ra40462e
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 158BE
UT WOS:000319942700022
DA 2018-10-20
ER

PT S
AU Lin, JH
   Chung, HY
   Wen, SP
   Chen, WC
   Chen, YS
   Lou, CW
AF Lin, Jia-Horng
   Chung, Hsiu-Ying
   Wen, Shih-Peng
   Chen, Wen-Cheng
   Chen, Yueh-Sheng
   Lou, Ching-Wen
BE Liu, H
   Yang, Y
   Shen, S
   Zhong, Z
   Zheng, L
   Feng, P
TI Property Evaluation of Polylactic Acid Multilayer Braids Used as Bone
   Scaffolds
SO ADVANCES IN TEXTILE ENGINEERING AND MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Textile Engineering and Materials
   (ICTEM2012)
CY NOV 17-18, 2012
CL Changsha, PEOPLES R CHINA
SP Hunan Prov Text Engn Ctr
DE polylactic acid (PLA); twist per inch; bone scaffold; porosity; surface
   observation
ID PLA SCAFFOLDS; CELLS
AB Polylactic acid (PLA), which is biodegradable, is largely used as biomaterial such as bone scaffolds. This study twists PLA filaments into PLA plied yam, during which twist per inch (TPI) varies as 9, 10, 11, 12, and 13. Tensile strength and elongation of the resulting plied yam are then evaluated. The optimal TPI is 10, which results from an optimal tensile strength of 3.3 g/den and elongation of 42 %. The optimal plied yam is made into PLA braids on a 16-spindle braiding machine, with a ratio of take-up gear to braid gear of 60:60, 70:60, 80:60, 90:60, or 100:60. The braids with various gear ratios are then made into multilayer braids with a diameter of 4 mm. The resulting multilayer braids are evaluated for surface observation, porosity and water contact angle. The optimal porosity is 55-65% and the optimal water contact angle is below 30. This optimal condition indicates that the multilayer braid exhibit good hydrophilicity and a good candidate for bone tissue scaffolds.
C1 [Lin, Jia-Horng; Wen, Shih-Peng] Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
   [Lin, Jia-Horng] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan.
   [Chung, Hsiu-Ying] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 407, Taiwan.
   [Chen, Wen-Cheng] Feng Chia Univ, Dept Fiber & Composite Mat, Adv Med Devices & Composite Lab, Taichung 407, Taiwan.
   [Chen, Yueh-Sheng] China Taiwan Univ Sci & Technol, Dept Biomed Imaging & Radiolog Sci, Taichung 40402, Taiwan.
   [Lou, Ching-Wen] Cent Taiwan Univ Sci, Inst Biomed Engn & Mat Sci, Taichung 406, Taiwan.
RP Lin, JH (reprint author), Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
EM jhlin@fcu.edu.tw; yuehsc@mail.cmu.edu.tw; cwlou@ctust.edu.tw
RI Chen, wen/P-4496-2018
OI Chen, wen/0000-0002-5581-9991
FU National Science Council of the Republic of China, Taiwan [NSC
   101-2622-E-166-002-cc3]
FX This work would especially like to thank National Science Council of the
   Republic of China, Taiwan, for financially supporting this research
   under Contract NSC 101-2622-E-166-002-cc3.
CR Bao CY, 2011, ACTA BIOMATER, V7, P4037, DOI 10.1016/j.actbio.2011.06.046
   CONN RE, 1995, FOOD CHEM TOXICOL, V33, P273, DOI 10.1016/0278-6915(94)00145-E
   Lin JH, 1998, J TEXT I, V89, P266, DOI 10.1080/00405009808658615
   Lin JH, 2011, J COMPOS MATER, V45, P1945, DOI 10.1177/0021998310392413
   Lou C.W., 2011, J BIOMATERI IN PRESS
   Lou CW, 2012, APPL MECH MATER, V184-185, P1501, DOI 10.4028/www.scientific.net/AMM.184-185.1501
   Lou CW, 2012, APPL MECH MATER, V184-185, P1371, DOI 10.4028/www.scientific.net/AMM.184-185.1371
   Montjovent MO, 2008, BONE, V42, P554, DOI 10.1016/j.bone.2007.10.018
   Tsuji H, 1999, NUCL INSTRUM METH B, V148, P1136, DOI 10.1016/S0168-583X(98)00802-7
   Velasco D, 2010, J SUPERCRIT FLUID, V54, P335, DOI 10.1016/j.supflu.2010.05.012
   Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
NR 12
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-575-1
J9 ADV MATER RES-SWITZ
PY 2013
VL 627
BP 844
EP +
DI 10.4028/www.scientific.net/AMR.627.844
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Textiles
SC Materials Science
GA BFA71
UT WOS:000319022500171
DA 2018-10-20
ER

PT J
AU Turner, NJ
   Badylak, SF
AF Turner, Neill J.
   Badylak, Stephen F.
TI BIOLOGIC SCAFFOLDS FOR MUSCULOTENDINOUS TISSUE REPAIR
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Extracellular matrix; biologic scaffold; skeletal muscle; tendon;
   repair; tissue regeneration
ID ROTATOR CUFF TEARS; SMALL-INTESTINE SUBMUCOSA; HEPATOCYTE GROWTH-FACTOR;
   MUSCLE SATELLITE CELLS; EXTRACELLULAR-MATRIX SCAFFOLDS; DECELLULARIZED
   PERICARDIAL BIOMATERIAL; MULTIPOTENT PROGENITOR CELLS; MYOGENIC
   REGULATORY FACTORS; ACHILLES-TENDON RUPTURES; ACELLULAR DERMAL MATRIX
AB Traumatic injuries to the musculoskeletal system are common events and volumetric muscle loss (VML) is no longer a rare occurrence. Surgical intervention is typically the only option for restoration of partial function. Surgical intervention for VML however does not regenerate the lost tissue and typically results in alterations of both the anatomy and biomechanics at the site of injury. Non-traditional approaches to the restoration of functional musculoskeletal tissue, including those provided by tissue engineering and regenerative medicine strategies, become viable alternative therapies when the expected outcome is bleak. One such strategy involves the delivery of constructive cues and modulation of the micro-environmental niche via biologic scaffold materials. These materials ideally retain the native structure and composition of the extracellular matrix of the tissue from which they are derived. Some of the recent advances in the use of biologic scaffolds to target key stages of the musculotendinous repair process and promote the restoration of functional tissue are described herein.
C1 [Turner, Neill J.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Turner, Neill J.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
CR Aarimaa V, 2004, NEUROMUSCULAR DISORD, V14, P421, DOI 10.1016/j.nmd.2004.03.009
   Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016
   Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024
   ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Bond JL, 2008, ARTHROSCOPY, V24, P403, DOI 10.1016/j.arthro.2007.07.033
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Branch JP, 2011, J FOOT ANKLE SURG, V50, P257, DOI 10.1053/j.jfas.2010.12.015
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Chakravarthy MV, 2001, INT J SPORT NUTR EXE, V11, pS44, DOI 10.1123/ijsnem.11.s1.s44
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen JM, 2007, TISSUE ENG, V13, P1479, DOI 10.1089/ten.2006.0266
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Conti Marco, 2009, Chir Organi Mov, V93 Suppl 1, pS55, DOI 10.1007/s12306-009-0003-9
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003
   Counsel P, 2010, SEMIN MUSCULOSKEL R, V14, P162, DOI 10.1055/s-0030-1253158
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x
   Crow BD, 2007, J ORTHOP RES, V25, P396, DOI 10.1002/jor.20232
   Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333
   Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   Davis GE, 2010, J MOL CELL CARDIOL, V48, P454, DOI 10.1016/j.yjmcc.2009.09.002
   De Deyne Patrick G, 2005, Clin Podiatr Med Surg, V22, P521, DOI 10.1016/j.cpm.2005.07.006
   Deasy BM, 2004, CURR OPIN BIOTECH, V15, P419, DOI 10.1016/j.copbio.2004.08.004
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   Derwin K, 2004, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000131235.91264.d7
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Di Benedetto G., 1994, Clinical Materials, V16, P137, DOI 10.1016/0267-6605(94)90109-0
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717
   Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9
   Galatz LM, 2009, J SHOULDER ELB SURG, V18, P669, DOI 10.1016/j.jse.2009.02.016
   Galatz LM, 2001, J BONE JOINT SURG AM, V83A, P1052, DOI 10.2106/00004623-200107000-00011
   Gamba PG, 2002, PEDIATR SURG INT, V18, P327, DOI 10.1007/s00383-002-0849-5
   Garrett WE, 1996, AM J SPORT MED, V24, pS2, DOI 10.1177/036354659602406S02
   GARRETT WE, 1984, J HAND SURG-AM, V9A, P683, DOI 10.1016/S0363-5023(84)80014-3
   Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2
   Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y
   Hsu HH, 1997, BIOCHEM MOL MED, V60, P142, DOI 10.1006/bmme.1997.2570
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   Huard J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P337
   Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524
   Iannotti JP, 2008, ARTHROSCOPIC ROTATOR, P246
   Iannotti JP, 1994, J AM ACAD ORTHOP SUR, V2, P87
   ITOI E, 1995, J ORTHOPAED RES, V13, P578, DOI 10.1002/jor.1100130413
   Jackson WM, 2011, J CELL MOL MED, V15, P2377, DOI 10.1111/j.1582-4934.2010.01225.x
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Jarvinen TAH, 2000, CURR OPIN RHEUMATOL, V12, P155, DOI 10.1097/00002281-200003000-00010
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jensen LT, 1997, CARDIOVASC RES, V33, P535, DOI 10.1016/S0008-6363(96)00247-7
   Kallestad KM, 2010, J CELL PHYSIOL, V222, P676, DOI 10.1002/jcp.21989
   Kaz R, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthio.2006.07.035
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030
   Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020
   Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015
   Lee MS, 2004, ORTHOPEDICS, V27, pS151
   LEHTO MUK, 1991, ANN CHIR GYNAECOL FE, V80, P102
   Li J, 2009, EXP CELL RES, V315, P2284, DOI 10.1016/j.yexcr.2009.04.011
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Liden BA, 2009, J AM PODIAT MED ASSN, V99, P104, DOI 10.7547/0980104
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Longo UG, 2012, MED SPORT SCI, V57, P1, DOI 10.1159/000328868
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]
   Maffulli N, 2011, SPORTS MED ARTHROSC, V19, P194, DOI 10.1097/JSA.0b013e3182250cad
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Menetrey J, 1999, AM J SPORT MED, V27, P222, DOI 10.1177/03635465990270021801
   Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Metcalf M. H., 2002, OPER TECH ORTHOP, V12, P204, DOI DOI 10.1053/OTOR.2002.36298
   Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.TEA.2012.0182, 10.1089/ten.tea.2012.0182]
   Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049
   Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016
   Perry SA, 2007, J SHOULDER ELB SURG, V16, p179S, DOI 10.1016/j.jse.2007.03.009
   Ploeger DTA, 2012, IMMUNOBIOLOGY, V217, P299, DOI 10.1016/j.imbio.2011.10.007
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Quintero AJ, 2009, CLIN SPORT MED, V28, P1, DOI 10.1016/j.csm.2008.08.009
   Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rotini Roberto, 2011, Musculoskelet Surg, V95 Suppl 1, pS13, DOI 10.1007/s12306-011-0141-8
   Rowlands AS, 2007, EXPERT REV MED DEVIC, V4, P709, DOI 10.1586/17434440.4.5.709
   SCHMALBRUCH H, 1976, TISSUE CELL, V8, P673, DOI 10.1016/0040-8166(76)90039-2
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005
   Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   Snyder SJ, 2009, ARTHROSCOPY, V25, P329, DOI 10.1016/j.arthro.2008.05.023
   Soler JA, 2007, ACTA ORTHOP BELG, V73, P432
   STPIERRE BA, 1994, AM J PATHOL, V145, P1463
   Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901
   Suzuki S, 2002, BIOCHEM BIOPH RES CO, V292, P709, DOI 10.1006/bbrc.2002.6706
   Szalay K, 1997, EUR J CELL BIOL, V74, P391
   Tanaka M, 2010, UPSALA J MED SCI, V115, P193, DOI 10.3109/03009734.2010.493246
   Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062
   Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Terada N, 2001, SCAND J PLAST RECONS, V35, P233
   Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Torrente Y, 2003, CELL TRANSPLANT, V12, P91, DOI 10.3727/000000003783985115
   Tottey S, 2011, TISSUE ENG PT A, V17, P37, DOI [10.1089/ten.tea.2010.0188, 10.1089/ten.TEA.2010.0188]
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   Tsiridis E, 2008, CONNECT TISSUE RES, V49, P455, DOI 10.1080/03008200802325383
   Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029
   Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166
   Vindigni V, 2004, PLAST RECONSTR SURG, V114, P1509, DOI 10.1097/01.PRS.0000138253.96709.E5
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9
   Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje
   Wu XY, 2010, CELL TISSUE RES, V340, P549, DOI 10.1007/s00441-010-0978-4
   YAMANAKA K, 1994, CLIN ORTHOP RELAT R, P68
   Zalavras CG, 2006, J SHOULDER ELB SURG, V15, P224, DOI 10.1016/j.jse.2005.06.007
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 160
TC 31
Z9 33
U1 0
U2 31
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 130
EP 143
DI 10.22203/eCM.v025a09
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 152WM
UT WOS:000319562300005
PM 23329468
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tirkkonen, L
   Haimi, S
   Huttunen, S
   Wolff, J
   Pirhonen, E
   Sandor, GK
   Miettinen, S
AF Tirkkonen, L.
   Haimi, S.
   Huttunen, S.
   Wolff, J.
   Pirhonen, E.
   Sandor, G. K.
   Miettinen, S.
TI OSTEOGENIC MEDIUM IS SUPERIOR TO GROWTH FACTORS IN DIFFERENTIATION OF
   HUMAN ADIPOSE STEM CELLS TOWARDS BONE-FORMING CELLS IN 3D CULTURE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Adipose stem cells; mesenchymal stem cells; bone tissue engineering;
   bioactive glass; biphasic calcium phosphate; growth factors; osteogenic
   differentiation; in vitro culture; 3D scaffolds
ID MESENCHYMAL STROMAL CELLS; MORPHOGENETIC PROTEINS; IN-VITRO; BIOACTIVE
   GLASS; CALVARIAL DEFECTS; CALCIUM-PHOSPHATE; TISSUE; RECONSTRUCTION;
   SCAFFOLDS; MODEL
AB Human adipose stem cells (hASCs) have been recently used to treat bone defects in clinical practice. Yet there is a need for more optimal scaffolds and cost-effective approaches to induce osteogenic differentiation of hASCs. Therefore, we compared the efficiency of bone morphogenetic proteins (BMP-2 and BMP-7), vascular endothelial growth factor (VEGF), and osteogenic medium (OM) for the osteo-induction of hASCs in 3D culture. In addition, growth factors were tested in combination with OM. Commercially available bioactive glass scaffolds (BioRestore) and biphasic calcium phosphate granules (BoneCeramic) were evaluated as prospective carriers for hASCs. Both biomaterials supported hASC-viability, but BioRestore resulted in higher cell number than BoneCeramic, whereas BoneCeramic supported more significant collagen production. The most efficient osteo-induction was achieved with plain OM, promoting higher alkaline phosphatase activity and collagen production than growth factors. In fact, treatment with BMP-2 or VEGF did not increase osteogenic differentiation or cell number significantly more than maintenance medium with either biomaterial. Moreover, BMP-7 treatment consistently inhibited proliferation and osteogenic differentiation of hASCs. Interestingly, there was no benefit from growth factors added to OM. This is the first study to demonstrate that OM enhances hASC-differentiation towards bone-forming cells significantly more than growth factors in 3D culture.
C1 [Tirkkonen, L.; Haimi, S.; Huttunen, S.; Wolff, J.; Sandor, G. K.; Miettinen, S.] Univ Tampere, Inst Biomed Technol, FI-33014 Tampere, Finland.
   [Tirkkonen, L.; Haimi, S.; Huttunen, S.; Wolff, J.; Sandor, G. K.; Miettinen, S.] BioMediTech, FI-33520 Tampere, Finland.
   [Tirkkonen, L.; Haimi, S.; Sandor, G. K.; Miettinen, S.] Tampere Univ Hosp, Ctr Sci, FI-33521 Tampere, Finland.
   [Haimi, S.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Wolff, J.] Tampere Univ Hosp, Dept Otorhinolaryngol, Oral & Maxillofacial Unit, FI-33520 Tampere, Finland.
   [Pirhonen, E.] Onbone Oy, FI-00521 Helsinki, Finland.
   [Sandor, G. K.] Univ Oulu, Inst Dent, Dept Oral & Maxillofacial Surg, FI-90014 Oulu, Finland.
RP Haimi, S (reprint author), Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.
EM suvi.haimi@uta.fi
RI Pitkanen, Sanna/E-1211-2014; Haimi, Suvi/D-4966-2014
OI Haimi, Suvi/0000-0001-8467-0252; Sandor, George/0000-0003-3125-5172
FU Competitive Research Funding of Tampere University Hospital [9L057,
   9K117, 9L100, 9M058, 9J014]; Finnish Funding Agency for Technology and
   Innovation (TEKES); Academy of Finland; The Science Centre of Tampere
   City
FX The authors thank Ms. Anna-Maija Honkala, Ms. Miia Juntunen, Ms. Sari
   Kalliokoski, and Ms. Minna Salomaki for technical assistance with the
   hASCs. We are grateful to Straumann AG, especially to PhD Aart Molenberg
   and PhD Martin Schuler, for the delivery of Straumann (R) BoneCeramic.
   In addition, the authors thank Dr. Hannu Kuokkanen for the delivery of
   fat samples for stem cell isolation, PhD Bettina Mannerstrom for flow
   cytometric analysis, and MSc Taru Karhula for SEM images. This study has
   been financially supported by the Competitive Research Funding of
   Tampere University Hospital (grants 9L057, 9K117, 9L100, 9M058 and
   9J014), the Finnish Funding Agency for Technology and Innovation
   (TEKES), Academy of Finland, and The Science Centre of Tampere City.
CR Al-Salleeh F, 2008, ARCH ORAL BIOL, V53, P928, DOI 10.1016/j.archoralbio.2008.05.014
   Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028
   Axelrad TW, 2008, J BONE JOINT SURG BR, V90B, P1617, DOI 10.1302/0301-620X.90B12.20975
   Barr T, 2010, ORAL SURG ORAL MED O, V109, P531, DOI 10.1016/j.tripleo.2009.10.027
   Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581
   Betz RR, 2002, ORTHOPEDICS, V25, P561
   Bohnenblust ME, 2009, J CRANIOFAC SURG, V20, P340, DOI 10.1097/SCS.0b013e3181992316
   Choi HJ, 2011, J KOREAN MED SCI, V26, P482, DOI 10.3346/jkms.2011.26.4.482
   Clokie CML, 2008, J CAN DENT ASSOC, V74, P67
   Clozza E, 2012, CLIN IMPLANT DENT RE
   Clozza E, 2012, INT J ORAL MAX IMPL, V27, P770
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   D'Alimonte I, 2011, J BIOL REG HOMEOS AG, V25, P57
   de Girolamo L, 2007, J TISSUE ENG REGEN M, V1, P154, DOI 10.1002/term.12
   Di Bella C, 2008, TISSUE ENG PT A, V14, P483, DOI 10.1089/tea.2007.0137
   Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Garrido C., 2011, INT J BIOMATER, V2011, P9
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Garrison KR, 2010, COCHRANE DB SYST REV
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, piii
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Giannoudis PV, 2007, OSTEOPOROSIS INT, V18, P1565, DOI 10.1007/s00198-007-0441-x
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Giusta MS, 2010, CYTOTHERAPY, V12, P478, DOI 10.3109/14653240903580270
   Haimi S, 2009, ACTA BIOMATER, V5, P3122, DOI 10.1016/j.actbio.2009.04.006
   Haimi S, 2009, J BIOMED MATER RES A, V91A, P540, DOI 10.1002/jbm.a.32233
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Kauschke E., 2006, Folia Morphologica, V65, P37
   Kim H, 2005, BIOCHEM BIOPH RES CO, V332, P1053, DOI 10.1016/j.bbrc.2005.05.051
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636
   Lindroos B, 2010, TISSUE ENG PT A, V16, P2281, DOI [10.1089/ten.tea.2009.0621, 10.1089/ten.TEA.2009.0621]
   McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Mehrkens A, 2012, EUR CELLS MATER, V24, P308, DOI 10.22203/eCM.v024a22
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Moimas L, 2006, ACTA BIOMATER, V2, P191, DOI 10.1016/j.actbio.2005.09.006
   Mrozik KM, 2012, CLIN ORAL INVEST, V16, P867, DOI 10.1007/s00784-011-0558-3
   Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017
   Overman JR, 2013, TISSUE ENG PT A, V19, P571, DOI [10.1089/ten.tea.2012.0133, 10.1089/ten.TEA.2012.0133]
   Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710
   Peltola M, 2008, J ORAL MAXIL SURG, V66, P639, DOI 10.1016/j.joms.2007.11.019
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Pereira RC, 2000, ENDOCRINOLOGY, V141, P4558, DOI 10.1210/en.141.12.4558
   Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0
   Rokn AR, 2011, OPEN DENT J, V5, P96, DOI 10.2174/1874210601105010096
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003
   Samartzis D, 2005, J AM COLL SURGEONS, V200, P236, DOI 10.1016/j.jamcollsurg.2004.09.046
   Scherberich A, 2010, J CELL PHYSIOL, V225, P348, DOI 10.1002/jcp.22313
   Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135
   Sutherland MK, 2004, BONE, V35, P448, DOI 10.1016/j.bone.2004.04.019
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   Tirkkonen L, 2011, J R SOC INTERFACE, V8, P1736, DOI 10.1098/rsif.2011.0211
   Vincent LG, 2012, BIOMATERIALS, V33, P2482
   Wysocki RW, 2007, J HAND SURG-AM, V32A, P647, DOI 10.1016/j.jhsa.2007.03.001
   Xu LL, 2010, TISSUE ENG A, V16, P2927
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515
NR 75
TC 26
Z9 27
U1 0
U2 5
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 144
EP 158
DI 10.22203/eCM.v025a10
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 152WM
UT WOS:000319562300006
PM 23361609
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Clauss, M
   Tafin, UF
   Bizzini, A
   Trampuz, A
   Ilchmann, T
AF Clauss, Martin
   Tafin, Ulrika Furustrand
   Bizzini, Alain
   Trampuz, Andrej
   Ilchmann, Thomas
TI BIOFILM FORMATION BY STAPHYLOCOCCI ON FRESH, FRESH-FROZEN AND PROCESSED
   HUMAN AND BOVINE BONE GRAFTS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biofilms; Staphylococcus aureus; bone grafts; bacterial colonies
ID BIOMATERIAL SURFACE-CHEMISTRY; SMALL COLONY VARIANTS; IN-VITRO;
   BACTERIAL-COLONIZATION; INFECTIONS; ADHESION; ALLOGRAFTS;
   MICROCALORIMETRY; SUBSTITUTES; EPIDERMIDIS
AB Biofilm formation is a multi-step process influenced by surface properties. We investigated early and mature biofilm of Staphylococcus aureus on 4 different biological calcium phosphate (CaP) bone grafts used for filling bone defects. We investigated standardised cylinders of fresh and fresh-frozen human bone grafts were harvested from femoral heads; processed human and bovine bone grafts were obtained preformed. Biofilm formation was done in tryptic soy broth (TSB) using S. aureus (ATCC 29213) with static conditions. Biofilm density after 3 h (early biofilm) and 24 h (mature biofilm) was investigated by sonication and microcalorimetry. After 3 h, bacterial density was highest on fresh-frozen and fresh bone grafts. After 24 h, biofilm density was lowest on fresh bone grafts (p < 0.001) compared to the other 3 materials, which did not differ quantitatively (p > 0.05). The lowest increase in bacterial density was detected on fresh bone grafts (p < 0.001). Despite normal shaped colonies, we found additional small colonies on the surface of the fresh and fresh-frozen samples by sonication. This was also apparent in microcalorimetric heat-flow curves. The four investigated CaP bone grafts showed minor structural differences in architecture but marked differences concerning serum coverage and the content of bone marrow, fibrous tissue and bone cells. These variations resulted in a decreased biofilm density on fresh and fresh-frozen bone grafts after 24 h, despite an increased early biofilm formation and might also be responsible for the variations in colony morphology (small colonies). Detection of small colony variants by microcalorimetry might be a new approach to improve the understanding of biofilm formation.
C1 [Clauss, Martin; Ilchmann, Thomas] Kantonsspital Baselland Liestal, Clin Orthopaed & Trauma Surg, CH-4410 Liestal, Switzerland.
   [Clauss, Martin; Tafin, Ulrika Furustrand; Bizzini, Alain; Trampuz, Andrej] Univ Hosp Lausanne CHUV, Dept Med, Infect Dis Serv, Lausanne, Switzerland.
RP Clauss, M (reprint author), Kantonsspital Baselland Liestal, Clin Orthopaed & Trauma Surg, Rheinstr 26, CH-4410 Liestal, Switzerland.
EM martin.clauss@ksli.ch
FU RMS Foundation, Bettlach, Switzerland [E09_0001]; Swiss Society for
   Orthopaedic Surgery (SGO/SSO); Swiss National foundation
   [3200B0-112547]; Gebert Ruf Stiftung
FX We want to thank S. Gersbach (MSc) for statistical assistance analysing
   the data. This study was supported by a research grant (E09_0001) from
   the RMS Foundation, Bettlach, Switzerland and a grant from the Swiss
   Society for Orthopaedic Surgery (SGO/SSO). Additional funding was
   obtained for the microcalorimetric analysis from the Swiss National
   foundation (#3200B0-112547) and the Gebert Ruf Stiftung. We thank
   Novomedics GmbH (Zurich, Switzerland) for providing Tutoplast (TM) and
   Tutobone (TM) samples.
CR Abraham NM, 2010, MICROB PATHOGENESIS, V49, P388, DOI 10.1016/j.micpath.2010.07.005
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ARO HT, 1993, ANN MED, V25, P403, DOI 10.3109/07853899309147303
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Buchholz F, 2010, BIOTECHNOL J, V5, P1339, DOI 10.1002/biot.201000287
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Crockarell JR, 1998, J BONE JOINT SURG AM, V80A, P1306, DOI 10.2106/00004623-199809000-00009
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   de Pol GJV, 2007, J BONE JOINT SURG BR, V89B, P1225
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Kappe T, 2010, CELL TISSUE BANK, V11, P253, DOI 10.1007/s10561-009-9140-5
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Lerchner J, 2008, J MICROBIOL METH, V74, P74, DOI 10.1016/j.mimet.2008.04.004
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Monsen T, 2009, J CLIN MICROBIOL, V47, P2496, DOI 10.1128/JCM.02316-08
   Nade S, 2002, BONE CLIN ORTHOPEDIC, P379
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OSTERMANN PAW, 1994, ORTHOPEDICS, V17, P397
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Schroder A, 2006, MED MICROBIOL IMMUN, V195, P185, DOI 10.1007/s00430-006-0015-0
   Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004
   Stahli C, 2010, ACTA BIOMATER, V6, P2760, DOI 10.1016/j.actbio.2010.01.018
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trampuz Andrej, 2008, Curr Infect Dis Rep, V10, P394, DOI 10.1007/s11908-008-0064-1
   Trampuz A, 2007, TRANSFUSION, V47, P1643, DOI 10.1111/j.1537-2995.2007.01336.x
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-116
   von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 43
TC 7
Z9 7
U1 0
U2 5
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 159
EP 166
DI 10.22203/eCM.v025a11
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 152WM
UT WOS:000319562300007
PM 23361610
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Johnstone, B
   Alini, M
   Cucchiarini, M
   Dodge, GR
   Eglin, D
   Guilak, F
   Madry, H
   Mata, A
   Mauck, RL
   Semino, CE
   Stoddart, MJ
AF Johnstone, Brian
   Alini, Mauro
   Cucchiarini, Magali
   Dodge, George R.
   Eglin, David
   Guilak, Farshid
   Madry, Henning
   Mata, Alvaro
   Mauck, Robert L.
   Semino, Carlos E.
   Stoddart, Martin J.
TI TISSUE ENGINEERING FOR ARTICULAR CARTILAGE REPAIR - THE STATE OF THE ART
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Cartilage; repair; stem cells; scaffolds; gene therapy; tissue
   engineering; regenerative medicine; translational and preclinical
   research
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VITRO
   CHONDROGENESIS; BIODEGRADABLE NANOFIBROUS SCAFFOLDS; MATURE ALLOGENIC
   CHONDROCYTES; HYALURONIC-ACID NETWORKS; MARROW STROMAL CELLS; VIVO
   GENE-THERAPY; BONE-MARROW; ALGINATE BEADS
AB Adult articular cartilage exhibits little capacity for intrinsic repair, and thus even minor injuries or lesions may lead to progressive damage and osteoarthritic joint degeneration, resulting in significant pain and disability. While there have been numerous attempts to develop tissue-engineered grafts or patches to repair focal chondral and osteochondral defects, there remain significant challenges in the clinical application of cell-based therapies for cartilage repair. This paper reviews the current state of cartilage tissue engineering with respect to different cell sources and their potential genetic modification, biomaterial scaffolds and growth factors, as well as preclinical testing in various animal models. This is not intended as a systematic review, rather an opinion of where the field is moving in light of current literature. While significant advances have been made in recent years, the complexity of this problem suggests that a multidisciplinary approach - combining a clinical perspective with expertise in cell biology, biomechanics, biomaterials science and high-throughput analysis will likely be necessary to address the challenge of developing functional cartilage replacements. With this approach we are more likely to realise the clinical goal of treating both focal defects and even large-scale osteoarthritic degenerative changes in the joint.
C1 [Alini, Mauro; Eglin, David; Stoddart, Martin J.] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Cucchiarini, Magali; Madry, Henning] Univ Saarland, Med Ctr, Ctr Expt Orthopaed, Homburg, Germany.
   [Dodge, George R.; Mauck, Robert L.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA.
   [Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
   [Guilak, Farshid] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   [Johnstone, Brian] Oregon Hlth & Sci Univ, Dept Orthopaed, Portland, OR 97201 USA.
   [Madry, Henning] Univ Saarland, Med Ctr, Dept Orthopaed Surg, Homburg, Germany.
   [Mata, Alvaro] Univ London, Sch Engn & Mat Sci, London, England.
   [Semino, Carlos E.] Ramon Llull Univ URL, Sch Engn, Dept Bioengn, IQS, Barcelona, Spain.
   [Johnstone, Brian; Alini, Mauro; Cucchiarini, Magali; Dodge, George R.; Eglin, David; Guilak, Farshid; Madry, Henning; Mata, Alvaro; Mauck, Robert L.; Semino, Carlos E.; Stoddart, Martin J.] AO Fdn, Collaborat Res Partner Acute Cartilage Injury Pro, Davos, Switzerland.
RP Stoddart, MJ (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM martin.stoddart@aofoundation.org
RI Mata, Alvaro/D-6028-2015
OI Mata, Alvaro/0000-0002-6739-9111; Eglin, David/0000-0002-8500-6887;
   Guilak, Farshid/0000-0001-7380-0330; Mauck, Robert/0000-0002-9537-603X
FU Collaborative Research Centre, AO Foundation, Davos, Switzerland
FX This work was supported by the Collaborative Research Centre, AO
   Foundation, Davos, Switzerland. We wish to confirm that there are no
   known conflicts of interest associated with this publication and there
   has been no significant financial support for this work that could have
   influenced its outcome.
CR Adachi N, 2002, J RHEUMATOL, V29, P1920
   Adkisson HD, 2010, STEM CELL RES, V4, P57, DOI 10.1016/j.scr.2009.09.004
   Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   Adkisson HD, 2001, CLIN ORTHOP RELAT R, V391, P280
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008
   Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463
   Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   BANDARA G, 1992, DNA CELL BIOL, V11, P227, DOI 10.1089/dna.1992.11.227
   BANDARA G, 1993, P NATL ACAD SCI USA, V90, P10764, DOI 10.1073/pnas.90.22.10764
   Ben-Yishay A, 1995, Tissue Eng, V1, P119, DOI 10.1089/ten.1995.1.119
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Capito RM, 2009, NANOTECHNOLOGY, P385
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Che JH, 2010, KNEE SURG SPORT TR A, V18, P496, DOI 10.1007/s00167-009-0962-2
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Cucchiarini M, 2005, J GENE MED, V7, P1495, DOI 10.1002/jgm.824
   Cucchiarini M, 2012, BIO-MED MATER ENG, V22, P197, DOI 10.3233/BME-2012-0709
   Cucchiarini M, 2010, BIO-MED MATER ENG, V20, P135, DOI 10.3233/BME-2010-0625
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Davies-Tuck ML, 2008, OSTEOARTHR CARTILAGE, V16, P337, DOI 10.1016/j.joca.2007.07.005
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dhollander AAM, 2012, AM J SPORT MED, V40, P75, DOI 10.1177/0363546511423013
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Evans CH, 2005, J AM ACAD ORTHOP SUR, V13, P230, DOI 10.5435/00124635-200507000-00003
   Evans CH, 2005, P NATL ACAD SCI USA, V102, P8698, DOI 10.1073/pnas.0502854102
   EVANS CH, 1995, ANN MED, V27, P543, DOI 10.3109/07853899509002466
   Evans CH, 2011, TISSUE ENG PART B-RE, V17, P437, DOI [10.1089/ten.teb.2011.0228, 10.1089/ten.TEB.2011.0228]
   Evans CH, 2011, NAT REV RHEUMATOL, V7, P244, DOI 10.1038/nrrheum.2010.193
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Farr J, 2011, CLIN ORTHOP RELAT R, V469, P2696, DOI 10.1007/s11999-010-1764-z
   Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Gelse K, 2001, ARTHRITIS RHEUM, V44, P1943, DOI 10.1002/1529-0131(200108)44:8<1943::AID-ART332>3.0.CO;2-Z
   Gelse K, 2008, ARTHRITIS RHEUM-US, V58, P475, DOI 10.1002/art.23124
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Goodrich LR, 2007, J BONE JOINT SURG BR, V89B, P672, DOI 10.1302/0301-620X.89B5.18343
   Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Gysin R, 2002, GENE THER, V9, P991, DOI 10.1038/sj.gt.3301772
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Haleem-Smith H, 2005, MOL BIOTECHNOL, V30, P9, DOI 10.1385/MB:30:1:009
   Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Heiligenstein S, 2011, J GENE MED, V13, P230, DOI 10.1002/jgm.1557
   Hidaka C, 2003, J ORTHOPAED RES, V21, P573, DOI 10.1016/S0736-0266(02)00264-4
   Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4
   Huang AH, 2010, TISSUE ENG PT A, V16, P2699, DOI [10.1089/ten.tea.2010.0042, 10.1089/ten.TEA.2010.0042]
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135
   Hwang NS, 2011, CELL TISSUE RES, V344, P499, DOI 10.1007/s00441-011-1153-2
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   ITAY S, 1987, CLIN ORTHOP RELAT R, P284
   Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16
   Ivkovic Alan, 2011, Front Biosci (Elite Ed), V3, P923
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kaul G, 2006, J GENE MED, V8, P100, DOI 10.1002/jgm.819
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khan IM, 2009, OSTEOARTHR CARTILAGE, V17, P518, DOI 10.1016/j.joca.2008.08.002
   Khan IM, 2011, ARTHRITIS RHEUM-US, V63, P3417, DOI 10.1002/art.30543
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim M, 2011, J ORTHOP RES, V29, P1881, DOI 10.1002/jor.21467
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Koay EJ, 2009, TISSUE ENG PT A, V15, P2249, DOI 10.1089/ten.tea.2008.0320
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Kraft JJ, 2011, CARTILAGE, V2, P254, DOI 10.1177/1947603510383686
   Kupcsik L, 2009, TISSUE ENG PART A, V16, P1845
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latt LD, 2011, AM J SPORT MED, V39, P2662, DOI 10.1177/0363546511422987
   Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lefebvre V, 1996, MOL CELL BIOL, V16, P4512
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liao E, 2007, TISSUE ENG, V13, P537, DOI 10.1089/ten.2006.0117
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Madry H, 2002, HUM GENE THER, V13, P1621, DOI 10.1089/10430340260201716
   Madry H, 2011, CARTILAGE, V2, P201, DOI 10.1177/1947603510392914
   Madry H, 2011, CROAT MED J, V52, P245, DOI 10.3325/cmj.2011.52.245
   Madry H, 2010, ARCH ORTHOP TRAUM SU, V130, P1311, DOI 10.1007/s00402-010-1130-3
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P417, DOI 10.1007/s00167-010-1071-y
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   McCarthy HE, 2012, VET J, V192, P345, DOI 10.1016/j.tvjl.2011.08.036
   McCormick F, 2008, SPORTS MED ARTHROSC, V16, P217, DOI 10.1097/JSA.0b013e31818e0e4a
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mortisen D, 2010, BIOMACROMOLECULES, V11, P1261, DOI 10.1021/bm100046n
   Moskalewski S, 2002, MICROSC RES TECHNIQ, V58, P3, DOI 10.1002/jemt.10110
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Neumann AJ, 2013, MOL BIOTECHNOL, V53, P207, DOI 10.1007/s12033-012-9522-y
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Niemeyer P, 2013, Z ORTHOP UNFALLCHIR, V151, P38, DOI 10.1055/s-0032-1328207
   Novotny JE, 2006, TISSUE ENG, V12, P2755, DOI 10.1089/ten.2006.12.2755
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   Orth P, 2012, TISSUE ENG PART C-ME, V18, P329, DOI [10.1089/ten.TEC.2011.0462, 10.1089/ten.tec.2011.0462]
   Ousema PH, 2012, BIOMATERIALS, V33, P8967, DOI 10.1016/j.biomaterials.2012.08.045
   Ozbas B, 2007, J PHYS CHEM B, V111, P13901, DOI 10.1021/jp075117p
   Park J, 2006, J GENE MED, V8, P112, DOI 10.1002/jgm.826
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pena E, 2007, COMPUT BIOL MED, V37, P376, DOI 10.1016/j.compbiomed.2006.04.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Rampichova M, 2010, ASAIO J, V56, P563, DOI 10.1097/MAT.0b013e3181fcbe24
   Robbins PD, 2003, GENE THER, V10, P902, DOI 10.1038/sj.gt.3302040
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Salzmann GM, 2009, TISSUE ENG PT A, V15, P2513, DOI 10.1089/ten.tea.2008.0479
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schneider T, 2012, CLIN HEMORHEOL MICRO, V52, P325, DOI 10.3233/CH-2012-1608
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Stoddart MJ, 2006, BIOTECHNOL BIOENG, V95, P1043, DOI 10.1002/bit.21052
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827
   Symmons D, GLOBAL BURDEN OSTEOA
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Turgeman G, 2001, J GENE MED, V3, P240
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vogt S, 2009, BIOMATERIALS, V30, P2385, DOI 10.1016/j.biomaterials.2009.01.016
   Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Whitney MJ, 2009, TISSUE ENG PT A, V15, P33, DOI 10.1089/ten.tea.2007.0266
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Williams R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013246
   Woodfield TBF, 2009, CELL PROLIFERAT, V42, P485, DOI 10.1111/j.1365-2184.2009.00608.x
   Wu EC, 2012, ADV FUNCT MATER, V22, P456, DOI 10.1002/adfm.201101905
   Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhao XJ, 2007, MACROMOL BIOSCI, V7, P13, DOI 10.1002/mabi.200600230
   Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 193
TC 162
Z9 168
U1 9
U2 119
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 248
EP 267
DI 10.22203/eCM.v025a18
PG 20
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 152WM
UT WOS:000319562300014
PM 23636950
OA DOAJ Gold
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Irimia-Vladu, M
   Glowacki, ED
   Schwabegger, G
   Leonat, L
   Akpinar, HZ
   Sitter, H
   Bauer, S
   Sariciftci, NS
AF Irimia-Vladu, Mihai
   Glowacki, Eric Daniel
   Schwabegger, Guenther
   Leonat, Lucia
   Akpinar, Hava Zekiye
   Sitter, Helmut
   Bauer, Siegfried
   Sariciftci, Niyazi Serdar
TI Natural resin shellac as a substrate and a dielectric layer for organic
   field-effect transistors
SO GREEN CHEMISTRY
LA English
DT Article
ID ELECTRONICS; PAPER; INDIGO
AB Biocompatible and sustainable electronic-grade materials are integral for the development of electronics for biointegration and 'use-and-throw' applications. Herein we report the use of the natural resin shellac in organic field-effect transistors. Shellac was employed to cast robust and smooth substrates suitable for durable transistor devices. In addition shellac displays excellent insulating properties enabling its use as a high-quality dielectric layer for organic field-effect transistor (OFET) devices. We demonstrate that two common organic semiconductors, pentacene and C-60, show hysteresis-free operation in OFETs that employ shellac both as the substrate and as dielectric material. Shellac is a fully biocompatible (even edible) material that offers many advantages for OFET fabrication, including high dielectric breakdown fields, simple solution processing from ethanol solutions, and low temperature crosslinking at 50-70 degrees C. This work shows that shellac as a biomaterial can enable OFET applications where biocompatibility is necessary.
C1 [Irimia-Vladu, Mihai; Glowacki, Eric Daniel; Sariciftci, Niyazi Serdar] Johannes Kepler Univ Linz, Linz Inst Organ Solar Cells LIOS, A-4040 Linz, Austria.
   [Irimia-Vladu, Mihai; Bauer, Siegfried] Johannes Kepler Univ Linz, Dept Soft Matter Phys, A-4040 Linz, Austria.
   [Irimia-Vladu, Mihai] Joanneum Res Forsch Gesell mbH, Inst Surface Technol & Photon, A-8160 Weiz, Austria.
   [Schwabegger, Guenther; Sitter, Helmut] Johannes Kepler Univ Linz, Dept Semicond & Solid State Phys, A-4040 Linz, Austria.
   [Leonat, Lucia] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest, Romania.
   [Leonat, Lucia] IPCE CA, Natl Inst Elect Engn, Bucharest, Romania.
   [Akpinar, Hava Zekiye] Middle E Tech Univ, Dept Polymer Sci & Technol, TR-06531 Ankara, Turkey.
RP Irimia-Vladu, M (reprint author), Johannes Kepler Univ Linz, Linz Inst Organ Solar Cells LIOS, Altenberger Str 69, A-4040 Linz, Austria.
EM Mihai.Irimia-Vladu@joanneum.at
RI Leonat, Lucia/N-6868-2016; Glowacki, Eric/F-1327-2016; Sariciftci,
   Niyazi Serdar/N-3952-2017; Bauer, Siegfried/A-2354-2009
OI Leonat, Lucia/0000-0002-7120-3644; Glowacki, Eric/0000-0002-0280-8017;
   Sariciftci, Niyazi Serdar/0000-0003-4727-1193; Bauer,
   Siegfried/0000-0002-7770-9435
FU Austrian Science Funds (FWF) within the Wittgenstein award; ERC; City of
   Linz; Land Oberosterreich
FX The authors warmly thank John Anthony for fruitful discussions and
   suggestions about shellac. Work partially supported by the Austrian
   Science Funds (FWF) within the Wittgenstein award of Niyazi Serdar
   Sariciftci and the ERC Advanced Investigators Grant "SoftMap" of
   Siegfried Bauer. Mihai Irimia-Vladu gratefully acknowledges financial
   support from the City of Linz and the Land Oberosterreich.
CR Ackerlind E., 1938, T ELECTROCHEM SOC, V74, P141
   Angione MD, 2011, MATER TODAY, V14, P424, DOI 10.1016/S1369-7021(11)70187-0
   Barnes CE, 1938, IND ENG CHEM, V30, P449, DOI 10.1021/ie50340a020
   Bellan LM, 2012, ADV MATER, V24, P5187, DOI 10.1002/adma.201200810
   Eder F, 2004, APPL PHYS LETT, V84, P2673, DOI 10.1063/1.1690870
   Egginger M, 2008, ADV MATER, V20, P1018, DOI 10.1002/adma.200701479
   Electronic Waste Management in the United States Through, 2009, 530S11001 EPA OFF RE
   Farag Y, 2011, DRUG DEV IND PHARM, V37, P193, DOI 10.3109/03639045.2010.504210
   Glowacki ED, 2012, ISR J CHEM, V52, P540, DOI 10.1002/ijch.201100130
   Hamad SA, 2012, SOFT MATTER, V8, P5069, DOI 10.1039/c2sm07488e
   Hubler A, 2011, ADV ENERGY MATER, V1, P1018, DOI 10.1002/aenm.201100394
   Hulea IN, 2006, NAT MATER, V5, P982, DOI 10.1038/nmat1774
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Irimia-Vladu M, 2012, ADV MATER, V24, P375, DOI 10.1002/adma.201102619
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Irimia-Vladu M, 2010, ORG ELECTRON, V11, P1974, DOI 10.1016/j.orgel.2010.09.007
   Irimia-Vladu M, 2009, ORG ELECTRON, V10, P408, DOI 10.1016/j.orgel.2009.01.002
   Kanbur Y, 2012, ORG ELECTRON, V13, P919, DOI 10.1016/j.orgel.2012.02.006
   Leick S, 2011, PHYS CHEM CHEM PHYS, V13, P2765, DOI 10.1039/c0cp01803a
   McGuire R., 1991, J AGR FOOD CHEM, V39, P825
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Ortiz RP, 2010, CHEM REV, V110, P205, DOI 10.1021/cr9001275
   Schaeffer BB, 1938, IND ENG CHEM, V30, P333, DOI 10.1021/ie50339a024
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Thea D. Phan, 2008, J MEMBRANE SCI, V325, P277
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Veres J, 2004, CHEM MATER, V16, P4543, DOI 10.1021/cm049598q
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Zschieschang U, 2011, ADV MATER, V23, P654, DOI 10.1002/adma.201003374
NR 30
TC 31
Z9 31
U1 4
U2 48
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2013
VL 15
IS 6
BP 1473
EP 1476
DI 10.1039/c3gc40388b
PG 4
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 150QM
UT WOS:000319405900004
DA 2018-10-20
ER

PT S
AU Abudalazez, AMA
   Kasim, SR
   Ariffin, AB
   Ahmad, ZA
AF Abudalazez, Asam M. A.
   Kasim, Shah Rizal
   Ariffin, Azlan B.
   Ahmad, Zainal Arifin
BE Ahmad, ZA
   Yarmo, MA
   Aziz, FHA
   Sulaiman, MYM
   Ahmad, B
   Ismail, KN
   Abdullah, NSB
   Sulaiman, MA
   Azhar, AZA
TI Preparation and Characterization of Biphasic Calcium Phosphate Coatings
   on 316L Stainless Steel Fabricated by Electrophoretic Deposition
SO ADVANCED X-RAY CHARACTERIZATION TECHNIQUES
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on X-Ray and Related Technique in Research and
   Industry (ICXRI 2012)
CY JUL 03-05, 2012
CL Pulau Pinang, MALAYSIA
SP Malaysian XRay Appl Soc
DE Biphasic Calcium Phosphate; Electrophoretic deposition; stainless steel;
   Adhesion; Coatings
ID HYDROXYAPATITE COATINGS; CERAMICS
AB Biphasic calcium phosphate (BCP) ceramic is a synthetic biomaterial exhibiting a chemical composition similar to that of tooth mineral. Therefore, it is viably used in coating metallic implants manufactured from metals and alloys, such as titanium and stainless steel. In the present study, electrophoretic deposition (EPD) has been attempted for depositing BCP coatings on 316L Stainless Steel substrate followed by vacuum sintering at 800 degrees C for 1 h. The surface morphology, thickness, compositions and microstructure of the BCP coated 316L SS was investigated by scanning electron microscope (SEM), energy dispersive spectrometer (EDS), X-ray diffraction (XRD) and the bond strength of the coating was measured.
C1 [Abudalazez, Asam M. A.; Kasim, Shah Rizal; Ariffin, Azlan B.; Ahmad, Zainal Arifin] Univ Sci Malaysia, Sch Mat & Mineral Resources, Nibongtebal 14300, Pinang, Malaysia.
RP Abudalazez, AMA (reprint author), Univ Sci Malaysia, Sch Mat & Mineral Resources, Engn Campus, Nibongtebal 14300, Pinang, Malaysia.
EM esam_990071@yahoo.com; srshahrizal@eng.usm.my; azlan@eng.usm.my;
   zainal@eng.usm.my
RI ahmad, zainal arifin/J-1647-2017
OI ahmad, zainal arifin/0000-0003-0096-7900
CR [Anonymous], F104487 ASTM
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Ferrari B, 1998, MATER LETT, V35, P370, DOI 10.1016/S0167-577X(97)00280-2
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Hou XH, 2001, MATER LETT, V50, P103, DOI 10.1016/S0167-577X(00)00424-9
   Javidi M, 2008, MAT SCI ENG C-BIO S, V28, P1509, DOI 10.1016/j.msec.2008.04.003
   Lee BT, 2008, J MATER SCI-MATER M, V19, P2223, DOI 10.1007/s10856-007-3279-z
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Nilen RWN, 2008, J MATER SCI-MATER M, V19, P1693, DOI 10.1007/s10856-007-3252-x
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Vandeperre L., 1997, KEY ENG MATER, V567, P127
   VICTORIA EC, 2002, ARTIF ORGANS, V16, P12
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   WOLF DC, 1995, FUND APPL TOXICOL, V24, P111, DOI 10.1006/faat.1995.1013
   Yen S. K., 2002, J MAT CHEM PHYS, V77, P70
   Yildirim O.S., 2005, MED ENG PHYS, V221-224, P27
   Yildirim O.S., 2006, SPINE, V31, P215
NR 20
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-560-7
J9 ADV MATER RES-SWITZ
PY 2013
VL 620
BP 373
EP 377
DI 10.4028/www.scientific.net/AMR.620.373
PG 5
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BEZ89
UT WOS:000318958600070
DA 2018-10-20
ER

PT J
AU Hook, AL
   Scurr, DJ
   Anderson, DG
   Langer, R
   Williams, P
   Davies, M
   Alexander, M
AF Hook, Andrew L.
   Scurr, David J.
   Anderson, Daniel G.
   Langer, Robert
   Williams, Paul
   Davies, Martyn
   Alexander, Morgan
TI High throughput discovery of thermo-responsive materials using water
   contact angle measurements and time-of-flight secondary ion mass
   spectrometry
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 18th International Conferenceon Secondary Ion Mass Spectrometry (SIMS
   XVIII)
CY SEP 18-23, 2011
CL Trento, ITALY
DE thermo-responsive; stimuli; switchable; ToF-SIMS; water contact angle;
   polymer microarray
ID THERMAL RESPONSE; STEM-CELLS; POLY(N-ISOPROPYLACRYLAMIDE); SURFACE;
   BIOMATERIALS; ADSORPTION; PROTEINS; POLYMERS; DENSITY
AB Switchable materials that alter their chemical or physical properties in response to external stimuli allow for temporal control of material-biological interactions, thus, are of interest for many biomaterial applications. Our interest is the discovery of new materials suitable to the specific requirements of certain biological systems. A high throughput methodology has been developed to screen a library of polymers for thermo-responsiveness, which has resulted in the identification of novel switchable materials. To elucidate the mechanism by which the materials switch, time-of-flight secondary ion mass spectrometry has been employed to analyse the top 2 nm of the polymer samples at different temperatures. The surface enrichment of certain molecular fragments has been identified by time-of-flight secondary ion mass spectrometry analysis at different temperatures, suggesting an altered molecular conformation. In one example, a switch between an extended and collapsed conformation is inferred. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Hook, Andrew L.; Scurr, David J.; Davies, Martyn; Alexander, Morgan] Univ Nottingham, Lab Biophys & Surface Anal, Sch Pharm, Nottingham NG7 2RD, England.
   [Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Williams, Paul] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England.
RP Alexander, M (reprint author), Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
EM Morgan.Alexander@nottingham.ac.uk
RI Alexander, Morgan/C-2506-2009; Hook, Andrew/K-6924-2012; Scurr,
   David/E-8441-2012
OI Alexander, Morgan/0000-0001-5182-493X; Hook, Andrew/0000-0001-7756-8444;
   Scurr, David/0000-0003-0859-3886; Davies, Martyn/0000-0001-7695-0596;
   Williams, Paul/0000-0002-1920-5036
FU Wellcome Trust [085245/Z/08/Z]
FX Experimental assistance with material scale up by Josephine Wong Yunn
   Shyuan and Ka To Fung is kindly acknowledged. Funding from the Wellcome
   Trust (Grant number 085245/Z/08/Z) is also kindly acknowledged.
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Balamurugan S, 2003, LANGMUIR, V19, P2545, DOI 10.1021/la026787j
   Cheng XH, 2005, LANGMUIR, V21, P7833, DOI 10.1021/la050417o
   Cole MA, 2009, ANAL CHEM, V81, P6905, DOI 10.1021/ac9009337
   Cunliffe D, 2003, LANGMUIR, V19, P2888, DOI 10.1021/la026358l
   Dey S, 2011, J MATER CHEM, V21, P6883, DOI 10.1039/c0jm03993d
   Fechler N, 2009, MACROMOLECULES, V42, P33, DOI 10.1021/ma8025173
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Heinz P, 2008, LANGMUIR, V24, P6166, DOI 10.1021/la800575f
   Hook AL, 2009, ACTA BIOMATER, V5, P2350, DOI 10.1016/j.actbio.2009.03.040
   Hook AL, 2011, SOFT MATTER, V7, P7194, DOI 10.1039/c1sm06063e
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Hook AL, 2009, LANGMUIR, V25, P9173, DOI 10.1021/la900735n
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   Reihs K, 2005, LANGMUIR, V21, P10573, DOI 10.1021/la051579n
   Smith AR, 2010, CHEM MATER, V22, P294, DOI 10.1021/cm901821p
   Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Zhang R, 2009, BIOMATERIALS, V30, P6193, DOI 10.1016/j.biomaterials.2009.07.055
NR 25
TC 13
Z9 13
U1 1
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JAN
PY 2013
VL 45
IS 1
SI SI
BP 181
EP 184
DI 10.1002/sia.4910
PG 4
WC Chemistry, Physical
SC Chemistry
GA 145WB
UT WOS:000319048700048
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Celiz, AD
   Hook, AL
   Scurr, DJ
   Anderson, DG
   Langer, R
   Davies, MC
   Alexander, MR
AF Celiz, Adam D.
   Hook, Andrew L.
   Scurr, David J.
   Anderson, Daniel G.
   Langer, Robert
   Davies, Martyn C.
   Alexander, Morgan R.
TI ToF-SIMS imaging of a polymer microarray prepared using ink-jet printing
   of acrylate monomers
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 18th International Conferenceon Secondary Ion Mass Spectrometry (SIMS
   XVIII)
CY SEP 18-23, 2011
CL Trento, ITALY
DE ink-jet printing; polymer microarray; high-throughput analysis; surface
   chemical analysis; biomaterial screening
ID THROUGHPUT SURFACE CHARACTERIZATION; STEM-CELLS; BIOMATERIALS
AB Polymer microarrays are a powerful sample format for high-throughput materials discovery. We describe a polymer microarray prepared via ink-jet printing for the purpose of screening novel biomaterials. Ink-jet printing has advantages over other printing techniques including avoiding contact with the surface, preventing damage to fragile substrates, and the control of the drop volume to control the amount of material deposited. We investigate a method for ink-jet printing a library of monomer solutions, which are subsequently polymerized in-situ to form the polymer microarray. Imaging of the polymer microarray using time-of flight secondary ion mass spectrometry is employed to map specific ions characteristic of the constituent monomers and identify which chemical functionalities are present at the surface of each polymer. This is particularly important in determining the quality of the array and understanding the interactions that occur at the interface between a material and a biological organism. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Celiz, Adam D.; Hook, Andrew L.; Scurr, David J.; Davies, Martyn C.; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   [Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
RP Alexander, MR (reprint author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
EM morgan.alexander@nottingham.ac.uk
RI Hook, Andrew/K-6924-2012; Alexander, Morgan/C-2506-2009; Celiz,
   Adam/G-6841-2013; Scurr, David/E-8441-2012
OI Hook, Andrew/0000-0001-7756-8444; Alexander, Morgan/0000-0001-5182-493X;
   Celiz, Adam/0000-0003-4568-7734; Scurr, David/0000-0003-0859-3886;
   Davies, Martyn/0000-0001-7695-0596
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Davies MC, 2010, J DRUG TARGET, V18, P741, DOI 10.3109/1061186X.2010.521941
   Hook A. L., SURF INTERFACE ANAL
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Kurkuri MD, 2009, BIOMACROMOLECULES, V10, P1163, DOI 10.1021/bm801417s
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Scurr DJ, 2010, LANGMUIR, V26, P17143, DOI 10.1021/la1029933
   Tourniaire G, 2006, CHEM COMMUN, P2118, DOI 10.1039/b602009g
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
NR 10
TC 8
Z9 8
U1 1
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JAN
PY 2013
VL 45
IS 1
SI SI
BP 202
EP 205
DI 10.1002/sia.5042
PG 4
WC Chemistry, Physical
SC Chemistry
GA 145WB
UT WOS:000319048700053
OA Bronze
DA 2018-10-20
ER

PT S
AU Liu, H
   Guo, LQ
   Cheng, JM
AF Liu, Hua
   Guo, Liqiang
   Cheng, Jinming
BE Bao, YW
   Jiang, DY
   Gong, JH
TI Study on Biocompatibility of Nano-TiO2/Titanium Alloy
SO TESTING AND EVALUATION OF INORGANIC MATERIALS III
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 3rd International Conference on Testing and Evaluation of Inorganic
   Materials
CY NOV 15-18, 2012
CL Jingdezhen, PEOPLES R CHINA
SP Minist Sci & Technol China, Peoples Govt Jiangzi Prov, Chinese Ceram Soc
DE nanometer TiO2; titanium alloy; biomaterial; biocompatibility
ID TREATED TITANIUM; LAYER
AB Nanometer titanium dioxide powders were prepared by hydrolysis of titanium-tetrabutoxide with ethanol. Using the process that titanium alloys were embedded by the nanometer TiO2 powders and sintered in the high temperature furnace, the nano-TiO2/titanium alloy biomaterials was fabricated out. The particle size of TiO2 particles on the surface of Ti alloy was mainly 50-70 nm. The experimental results indicated that the films of nanocrystalline titanium oxide powders on the surface of Ti alloy were with an excellent biocompatibility. By cultivation in the simulated body fluid for 7 days, the Ca phosphates were deposited on the specimen surface, and n (Ca) / n (P) atom ratio is about 1.61:1, which is similar to that of HA and human bone. The nano-TiO2 / titanium alloy possessed favorable cell compatibility testified by the cell cultivation experiment.
C1 [Liu, Hua; Cheng, Jinming] Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Guo, Liqiang] Hebei Univ Technol, Sch Materials Sci & Engn, Tianjin 300130, Peoples R China.
RP Liu, H (reprint author), Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
EM liuhuajnu@yahoo.com.cn; time12@sohu.com; csylzh96@163.com
FU Natural Science Foundation of Guangdong Province [10451022401005182];
   Science and Technology Plan of Guangdong Province [2009B010900034];
   National Science Foundation for Post-doctoral Scientists of China
   [20100470914]
FX Supported by Natural Science Foundation of Guangdong Province (Grant No.
   10451022401005182), the Science and Technology Plan of Guangdong
   Province (Grant No. 2009B010900034) and the National Science Foundation
   for Post-doctoral Scientists of China (Grant No. 20100470914).
CR ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Donachie Jr M. J, 1988, TITANIUM TECHNICAL G
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Liu H, 2012, ADV MATER RES-SWITZ, V528, P27, DOI 10.4028/www.scientific.net/AMR.528.27
   Pham MT, 1997, THIN SOLID FILMS, V310, P251, DOI 10.1016/S0040-6090(97)00330-1
   Yousefpour M, 2007, MATER DESIGN, V28, P2154, DOI 10.1016/j.matdes.2006.06.005
NR 8
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 544
BP 384
EP +
DI 10.4028/www.scientific.net/KEM.544.384
PG 2
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BFA74
UT WOS:000319023000082
DA 2018-10-20
ER

PT S
AU Zhao, LS
   Wang, Z
   Mao, KY
   Deng, B
   Yi, YF
   Shao, LQ
   Wen, N
AF Zhao, Lisheng
   Wang, Zheng
   Mao, Keya
   Deng, Bin
   Yi, Yuanfu
   Shao, Long-quan
   Wen, Ning
BE Hu, J
   Chen, NC
   Zhang, C
TI Preparation and Properties of Porous beta-Tricalcium Phosphate Bone
   Graft
SO CHINESE CERAMICS COMMUNICATIONS III
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT Workshop on Synthesis, Characterization and Applications of Inorganic
   Powders
CY JUL 16-18, 2012
CL Guilin, PEOPLES R CHINA
SP Guilin Univ Technol, Kunming Univ Sci & Technol, Shanghai Inst Technol
DE beta-Tricalciunn phosphate; Bone graft; Porous
ID BOVINE CANCELLOUS BONE
AB The need for bone repair has increased as the population ages. However, currently, the bone grafts still have some disadvantages, such as low compressive strength and porosity, which limit their use. In order to solve these disadvantages, in this study, the porous beta-tricalcium phosphate (beta-TCP) anorganic bone graft were prepared from healthy bovine cancellous bone by cell-free, defat and twice calcinations. X-ray diffraction (XRD) was used to investigate the chemical composition of the bone graft. And the morphology, porosity and mechanical strength of the bone graft were also evaluated. The results showed that most constituent of the bone graft was beta-TCP. In addition, the bone graft scaffold exhibited the macro and micro porous structure and the porosity was 57.63%, just as the nature cancellous bone. The compressive strength was 4.47 +/- 0.63MPa. Above all, the porous beta-TCP anorganic bone graft not only has similar chemical composites as the nature cancellous bone, but also it can effectively retain the porous structure of natural cancellous bone and provides optimal channels for the in-growth of new bone and blood vessels. Therefore, the porous beta-TCP anorganic bone graft is a potential biomaterial in bone tissue engineering.
C1 [Zhao, Lisheng; Deng, Bin; Wen, Ning] Chinese PLA, Gen Hosp, Dept Prosthodont, Beijing 100853, Peoples R China.
   [Wang, Zheng; Mao, Keya] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing 100853, Peoples R China.
   [Yi, Yuanfu] Gen Hosp Chinese Peoples Armed Police Forces, Dept Stomatol, Beijing 100039, Peoples R China.
   [Shao, Long-quan] Nanfang Hosp, Dept Stomatol, Guangzhou 510515, Peoples R China.
RP Zhao, LS (reprint author), Chinese PLA, Gen Hosp, Dept Prosthodont, Beijing 100853, Peoples R China.
EM dentist_zhao@126.com; ning1972@sina.com
FU National High-tech Research and Development Program of China (863
   Program) [2011AA030107]; National Program on Key Basic Research Project
   of China (973 Program) [2012CB933900]
FX The work was supported by the National High-tech Research and
   Development Program of China (863 Program) NO.2011AA030107 and the
   National Program on Key Basic Research Project of China (973 Program)
   NO.2012CB933900.
CR Anker CJ, 2005, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000153991.94765.1b
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Cornell C.N., 1998, CLIN ORTHOP S, V355, P267
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mao KY, 2005, J BIOACT COMPAT POL, V20, P541, DOI 10.1177/0883911505059040
   Minamide A, 2001, EUR SPINE J, V10, pS185, DOI 10.1007/s005860100274
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   van Haaren EH, 2005, J BONE JOINT SURG BR, V87B, P267, DOI 10.1302/0301-620X.87B2.14749
NR 11
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-567-6
J9 ADV MATER RES-SWITZ
PY 2013
VL 624
BP 226
EP +
DI 10.4028/www.scientific.net/AMR.624.226
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA BEZ88
UT WOS:000318958100053
DA 2018-10-20
ER

PT J
AU Chen, N
   Shi, XT
   Witte, R
   Nakayama, KS
   Ohmura, K
   Wu, HK
   Takeuchi, A
   Hahn, H
   Esashi, M
   Gleiter, H
   Inoue, A
   Louzguine, DV
AF Chen, Na
   Shi, Xuetao
   Witte, Ralf
   Nakayama, Koji S.
   Ohmura, Kazuyo
   Wu, Hongkai
   Takeuchi, Akira
   Hahn, Horst
   Esashi, Masayoshi
   Gleiter, Herbert
   Inoue, Akihisa
   Louzguine, Dmitri V.
TI A novel Ti-based nanoglass composite with submicron-nanometer-sized
   hierarchical structures to modulate osteoblast behaviors
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID NANOSTRUCTURED MATERIALS; TITANIUM IMPLANTS; METALLIC-GLASS;
   CELL-ADHESION; ATOMIC-STRUCTURE; STEM-CELLS; IN-VITRO; SURFACE;
   BIOMATERIALS; OSSEOINTEGRATION
AB Owing to recent progress in nanotechnology, the ability to tune the surface properties of metals has opened an avenue for creating a new generation of biomaterials. Here we demonstrate the successful development of a novel Ti-based nanoglass composite with submicron-nanometer-sized hierarchical glassy structures. A first exploratory study was performed on the application of the unique nanostructure to modulate osteoblast behaviors. Our results show that this Ti-based nanoglass composite, relative to conventional metallic glasses, exhibits significantly improved biocompatibility. In fact, a 10 times enhancement in cell proliferation has been achieved. To a great extent, this superior bioactivity (such as enhanced cell proliferation and osteogenic phenotype) is promoted by its unique hierarchical structures combining nanoglobules and submicron button-like clusters from collective packing of these nanoglobules. This nanoglass composite could be widely applicable for surface modifications by means of coating on various materials including BMGs, crystalline metals or ceramics. Therefore, our successful experimental testing of this nanostructured metallic glass may open the way to new applications in novel biomaterial design for the purpose of bone replacement.
C1 [Chen, Na; Shi, Xuetao; Nakayama, Koji S.; Wu, Hongkai; Takeuchi, Akira; Esashi, Masayoshi; Inoue, Akihisa; Louzguine, Dmitri V.] Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan.
   [Chen, Na; Witte, Ralf; Hahn, Horst; Gleiter, Herbert] KIT, Inst Nanotechnol, D-76021 Kalsruhe, Germany.
   [Ohmura, Kazuyo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Hahn, Horst] Tech Univ Darmstadt, Joint Res Lab Nanomat, D-64287 Darmstadt, Germany.
   [Hahn, Horst; Gleiter, Herbert] Nanjing Univ Sci & Technol, Herbert Gleiter Inst Nanosci, Nanjing 210094, Jiangsu, Peoples R China.
RP Chen, N (reprint author), Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan.
EM chenn@wpi-aimr.tohoku.ac.jp; shixuetao@wpi-aimr.tohoku.ac.jp
RI Inoue, Akihisa/E-5271-2015; Takeuchi, Akira/A-3619-2010; LOUZGUINE,
   Dmitri/D-2492-2010; Chen, Na/A-4120-2010; Nakayama, Koji/E-5053-2012
OI Takeuchi, Akira/0000-0002-7246-8644; LOUZGUINE,
   Dmitri/0000-0001-5716-4987; Shi, Xuetao/0000-0001-9919-8931
CR Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   An Q, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675909
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bai CL, 2012, NANO TODAY, V7, P258, DOI 10.1016/j.nantod.2012.05.002
   Chen N, 2011, ACTA MATER, V59, P6433, DOI 10.1016/j.actamat.2011.07.007
   Chen N., 2013, NANOTECHNOLOGY, V24
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Fang JX, 2012, NANO LETT, V12, P458, DOI 10.1021/nl2038216
   Gasik M, 2012, ADV HEALTHC MATER, V1, P117, DOI 10.1002/adhm.201100006
   Ghafari M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3699228
   GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704
   GLEITER H, 1995, MATER SCI FORUM, V189-, P67, DOI 10.4028/www.scientific.net/MSF.189-190.67
   Gleiter H, 2008, ACTA MATER, V56, P5875, DOI 10.1016/j.actamat.2008.08.028
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   JING J, 1989, J NON-CRYST SOLIDS, V113, P167, DOI 10.1016/0022-3093(89)90007-0
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lee BH, 2003, BIOMATERIALS, V24, P2257, DOI 10.1016/S0142-9612(03)00034-6
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Moller B, 2012, INT J ORAL MAX SURG, V41, P638, DOI 10.1016/j.ijom.2012.02.004
   Nakayama KS, 2008, NANO LETT, V8, P516, DOI 10.1021/nl0727462
   Nakayama KS, 2012, NANO LETT, V12, P2404, DOI 10.1021/nl3003864
   Namgung S, 2011, SMALL, V7, P56, DOI 10.1002/smll.201001513
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Plecko M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-32
   Pokropivny VV, 2007, MAT SCI ENG C-BIO S, V27, P990, DOI 10.1016/j.msec.2006.09.023
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Qin CL, 2007, ACTA MATER, V55, P2057, DOI 10.1016/j.actamat.2006.10.054
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   Schroers J., 2009, JOM, V67, P21
   Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001
   Shi XT, 2012, ADV FUNCT MATER, V22, P3799, DOI 10.1002/adfm.201200914
   Shi XT, 2010, EUR J PHARM SCI, V39, P59, DOI 10.1016/j.ejps.2009.10.012
   Shi XT, 2009, BIOMATERIALS, V30, P3996, DOI 10.1016/j.biomaterials.2009.04.021
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun L, 2012, ADV HEALTHC MATER, V1, P729, DOI 10.1002/adhm.201200057
   Tiwari JN, 2012, PROG MATER SCI, V57, P724, DOI 10.1016/j.pmatsci.2011.08.003
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Yong J. Y., 2004, SURF SCI, V570, P119
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhu SL, 2007, MATER TRANS, V48, P2445, DOI 10.2320/matertrans.MRA2007086
NR 52
TC 30
Z9 33
U1 5
U2 83
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 20
BP 2568
EP 2574
DI 10.1039/c3tb20153h
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 136KN
UT WOS:000318360900002
DA 2018-10-20
ER

PT J
AU Gibly, RF
   Zhang, XM
   Lowe, WL
   Shea, LD
AF Gibly, Romie F.
   Zhang, Xiaomin
   Lowe, William L., Jr.
   Shea, Lonnie D.
TI Porous Scaffolds Support Extrahepatic Human Islet Transplantation,
   Engraftment, and Function in Mice
SO CELL TRANSPLANTATION
LA English
DT Article
DE Islets; Transplantation; Scaffold; Diabetes; Human
ID HUMAN PANCREATIC-ISLETS; SPECIES-DIFFERENCES; DIABETES-MELLITUS;
   BASEMENT-MEMBRANE; CELL FUNCTION; COMPLICATIONS; DELIVERY; MUTATION;
   ENZYMES; GRAFTS
AB Islet transplantation as a therapy or cure for type 1 diabetes has significant promise but has been limited by islet mass requirements and long-term graft failure. The intrahepatic and intravascular site may be responsible for significant loss of transplanted islets. Nonencapsulating biomaterial scaffolds provide a strategy for architecturally defining and modulating extrahepatic sites beyond the endogenous milieu to enhance islet survival and function. We utilized scaffolds to transplant human islets into the intraperitoneal fat of immunodeficient mice. A smaller human islet mass than previously reported reversed murine diabetes and restored glycemic control at human blood glucose levels. Graft function was highly dependent on the islet number transplanted and directly correlated to islet viability, as determined by the ATP-to-DNA ratio. Islets engrafted and revascularized in host tissue, and glucose tolerance testing indicated performance equivalent to healthy mice. Addition of extracellular matrix, specifically collagen IV, to scaffold surfaces improved graft function compared to serum-supplemented media. Porous scaffolds can facilitate efficient human islet transplantation and provide a platform for modulating the islet microenvironment, in ways not possible with current clinical strategies, to enhance islet engraftment and function.
C1 [Gibly, Romie F.; Lowe, William L., Jr.; Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Chicago, IL 60611 USA.
   [Gibly, Romie F.] Northwestern Univ, Integrated Grad Program, Chicago, IL 60611 USA.
   [Zhang, Xiaomin] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA.
   [Lowe, William L., Jr.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Lowe, William L., Jr.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH; NIDDK [F30 DK084649, R21 EB009502, R01 EB009910]
FX We would like to thank Samantha Holland and Ashley Goodman for histology
   development and processing. Financial support was provided by grants
   from NIH and NIDDK, including F30 DK084649, R21 EB009502, and R01
   EB009910. The authors declare no conflicts of interest.
CR Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035
   Beck J, 2007, TISSUE ENG, V13, P589, DOI 10.1089/ten.2006.0183
   Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005
   Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Contreras JL, 2008, XENOTRANSPLANTATION, V15, P99, DOI 10.1111/j.1399-3089.2008.00461.x
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Johnson D, 2007, BIOCHEM SOC T, V35, P1208, DOI 10.1042/BST03S1208
   Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009
   King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001
   Kizilel Seda, 2005, Diabetes Technol Ther, V7, P968, DOI 10.1089/dia.2005.7.968
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391
   Otonkoski T, 2008, DIABETES OBES METAB, V10, P119, DOI 10.1111/j.1463-1326.2008.00955.x
   Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423
   Pattou F, 2009, TRANSPL INT, V22, P45
   Pearson T, 2008, DIABETOLOGIA, V51, P1449, DOI 10.1007/s00125-008-1057-1
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Robertson RP, 2002, J CLIN ENDOCR METAB, V87, P5416, DOI 10.1210/jc.2002-021612
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4
   Suszynski TM, 2008, TRANSPL P, V40, P346, DOI 10.1016/j.transproceed.2008.01.061
   Ulrich AB, 2002, TOXICOL PATHOL, V30, P247, DOI 10.1080/019262302753559588
   van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515
   Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9
   Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052
   WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895
   Zawalich WS, 1996, ENDOCRINOLOGY, V137, P1664, DOI 10.1210/en.137.5.1664
NR 34
TC 14
Z9 14
U1 0
U2 17
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2013
VL 22
IS 5
BP 811
EP 819
DI 10.3727/096368912X636966
PG 9
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 139LX
UT WOS:000318585300004
PM 22507300
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hines, DJ
   Kaplan, DL
AF Hines, Daniel J.
   Kaplan, David L.
TI Poly(lactic-co-glycolic) Acid-Controlled-Release Systems: Experimental
   and Modeling Insights
SO CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
LA English
DT Review
DE PLGA; PLA; PGA; controlled release; mathematical modeling
ID CONTROLLED DRUG-RELEASE; PLGA-BASED MICROPARTICLES; CO-GLYCOLIC ACID;
   IN-VITRO; DELIVERY SYSTEMS; BIODEGRADABLE POLYMERS; PROTEIN RELEASE; PVA
   HYDROGELS; MICROSPHERES; NANOPARTICLES
AB Poly(lactic-co-glycolic acid) (PLGA) has been the most successful polymeric biomaterial used in controlled drug delivery systems. There are several different chemical and physical properties of PLGA that impact the release behavior of drugs from PLGA delivery devices. These properties must be considered and optimized in the formulation of drug release devices. Mathematical modeling is a useful tool for identifying, characterizing, and predicting mechanisms of controlled release. The advantages and limitations of poly(lactic-co-glycolic acid) for controlled release are reviewed, followed by a review of current approaches in controlled-release technology that utilize PLGA. Mathematical modeling applied toward controlled-release rates from PLGA-based devices also will be discussed to provide a complete picture of a state-of-the-art understanding of the control that can be achieved with this polymeric system, as well as the limitations.
C1 [Hines, Daniel J.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU National Institutes of Health [EB002520]
FX The authors thank the National Institutes of Health (EB002520) for
   supporting these studies.
CR Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   BRANNONPEPPAS L, 1993, ACS SYM SER, V520, P42
   Budhian A, 2008, INT J PHARM, V346, P151, DOI 10.1016/j.ijpharm.2007.06.01
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013
   Chen L, 1997, J CONTROL RELEASE, V43, P261, DOI 10.1016/S0168-3659(96)01496-4
   Chiu LK, 1995, INT J PHARM, V126, P169, DOI 10.1016/0378-5173(95)04119-2
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V32, P165, DOI 10.1016/0030-4220(71)90265-9
   Drake CF, 1989, United States patent, Patent No. [US 4866097, 4866097]
   Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4
   Faisant N, 2003, EUR J PHARM BIOPHARM, V56, P271, DOI 10.1016/S0939-6411(03)00104-8
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Friess WF, 2002, J PHARM SCI, V91, P845, DOI 10.1002/jps.10012
   Galeska I, 2005, AAPS J, V7, pE231, DOI 10.1208/aapsj070122
   Gallagher KM, 2000, J CONTROL RELEASE, V69, P261, DOI 10.1016/S0168-3659(00)00305-9
   Gasparini G, 2008, COLLOID SURFACE B, V61, P199, DOI 10.1016/j.colsurfb.2007.08.011
   GIBALDI M, 1967, J PHARM SCI, V56, P1238, DOI 10.1002/jps.2600561005
   Giteau A, 2008, INT J PHARM, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Han MJ, 2000, J APPL POLYM SCI, V75, P60, DOI 10.1002/(SICI)1097-4628(20000103)75:1<60::AID-APP7>3.0.CO;2-8
   HARLAND RS, 1988, PHARMACEUT RES, V5, P488, DOI 10.1023/A:1015913207052
   Herrera LC, 2012, DISSOLUT TECHNOL, V19, P6, DOI 10.14227/DT190212P6
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Hixson AW, 1931, IND ENG CHEM, V23, P923, DOI 10.1021/ie50260a018
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   HSU YY, 1994, J CONTROL RELEASE, V31, P223, DOI 10.1016/0168-3659(94)90003-5
   Hui HW, 1987, CONTROLLED DRUG DELI
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Joung YK, 2007, BIOMED MATER, V2, P269, DOI 10.1088/1748-6041/2/4/010
   Kawashima Y, 1999, J CONTROL RELEASE, V62, P279, DOI 10.1016/S0168-3659(99)00048-6
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   Klose D, 2008, INT J PHARMACEUT, V354, P95, DOI 10.1016/j.ijpharm.2007.10.030
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   LANGENBUCHER F, 1972, J PHARM PHARMACOL, V24, P979, DOI 10.1111/j.2042-7158.1972.tb08930.x
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   Li YP, 2001, J CONTROL RELEASE, V71, P203, DOI 10.1016/S0168-3659(01)00218-8
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1669, DOI 10.1007/s10856-009-3727-z
   Lin Y, 2001, J MED BIOL ENG, V21, P233
   Liu J, 2007, J MATER SCI-MATER M, V18, P2205, DOI 10.1007/s10856-007-3010-0
   Madene A, 2006, INT J FOOD SCI TECH, V41, P1, DOI 10.1111/j.1365-2621.2005.00980.x
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mittal G, 2007, J CONTROL RELEASE, V119, P77, DOI 10.1016/j.jconrel.2007.01.016
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Park TG, 1998, J CONTROL RELEASE, V55, P181, DOI 10.1016/S0168-3659(98)00050-9
   Paul DR, 1976, CONTROLLED RELEASE P, V33
   Pillai O, 2001, CURR OPIN CHEM BIOL, V5, P447, DOI 10.1016/S1367-5931(00)00227-1
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   RACEY GL, 1978, J ORAL SURG, V36, P766
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Rothstein SN, 2008, J MATER CHEM, V18, P1873, DOI 10.1039/b718277e
   SHAVIV A, 1993, FERT RES, V35, P1, DOI 10.1007/BF00750215
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Taluja A, 2008, INT J PHARM, V358, P50, DOI 10.1016/j.ijpharm.2008.02.010
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Varde NK, 2007, THESIS U ILLINOIS UR
   VARELAS CG, 1995, J CONTROL RELEASE, V34, P185, DOI 10.1016/0168-3659(94)00085-9
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wang YM, 1997, J CONTROL RELEASE, V49, P157, DOI 10.1016/S0168-3659(97)00082-5
   Wang ZH, 2010, BIOMATERIALS, V31, P908, DOI 10.1016/j.biomaterials.2009.09.104
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   WISE D L, 1987, Advanced Drug Delivery Reviews, V1, P19, DOI 10.1016/0169-409X(87)90067-6
   Xu QG, 2008, J CONTROL RELEASE, V127, P146, DOI 10.1016/j.jconrel.2009.01.017
NR 75
TC 62
Z9 63
U1 2
U2 73
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0743-4863
EI 2162-660X
J9 CRIT REV THER DRUG
JI Crit. Rev. Ther. Drug Carr. Syst.
PY 2013
VL 30
IS 3
BP 257
EP 276
DI 10.1615/CritRevTherDrugCarrierSyst.2013006475
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 140NO
UT WOS:000318662300003
PM 23614648
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tavakol, S
   Nikpour, MR
   Amani, A
   Soltani, M
   Rabiee, SM
   Rezayat, SM
   Chen, P
   Jahanshahi, M
AF Tavakol, S.
   Nikpour, M. R.
   Amani, A.
   Soltani, M.
   Rabiee, S. M.
   Rezayat, S. M.
   Chen, P.
   Jahanshahi, M.
TI Bone regeneration based on nano-hydroxyapatite and
   hydroxyapatite/chitosan nanocomposites: an in vitro and in vivo
   comparative study
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Nano-hydroxyapatite; Hydroxyapatite/chitosan nanocomposites; Surface
   topography; Wettability; Gene expression; Histomorphometry
ID COMPOSITE SCAFFOLDS; CALCIUM PHOSPHATE; CHITOSAN; CELLS; BIOACTIVITY;
   BIOCOMPATIBILITY; DIFFERENTIATION; IMPLANTS; COATINGS; TITANIUM
AB Surface morphology, surface wettability, and size distribution of biomaterials affect their in vitro and in vivo bone regeneration potential. Since nano-hydroxyapatite has a great chemical and structural similarity to natural bone and dental tissues, incorporated biomaterial of such products could improve bioactivity and bone bonding ability. In this research, nano-hydroxyapatite (23 +/- 0.09 nm) and its composites with variety of chitosan content [2, 4, and 6 g (45 +/- 0.19, 32 +/- 0.12, and 28 +/- 0.12 nm, respectively)] were prepared via an in situ hybridization route. Size distribution of the particles, protein adsorption, and calcium deposition of powders by the osteoblast cells, gene expression and percentage of new bone formation area were investigated. The highest degree of bone regeneration potential was observed in nano-hydroxyapatite powder, while the bone regeneration was lowest in nano-hydroxyapatite with 6 g of chitosan. Regarding these data, suitable size distribution next to size distribution of hydroxyapatite in bone, smaller size, higher wettability, lower surface roughness of the nano-hydroxyapatite particles and homogeneity in surface resulted in higher protein adsorption, cell differentiation and percentage of bone formation area. Results obtained from in vivo and in vitro tests confirmed the role of surface morphology, surface wettability, mean size and size distribution of biomaterial besides surface chemistry as a temporary bone substitute.
C1 [Tavakol, S.; Amani, A.; Rezayat, S. M.] Univ Tehran Med Sci, Dept Med Nanotechnol, Sch Adv Technol Med, Tehran, Iran.
   [Tavakol, S.] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran.
   [Nikpour, M. R.; Rabiee, S. M.; Jahanshahi, M.] Babol Univ Technol, Nanobiotechnol Res Grp, Nanotechnol Res Inst, Babol Sar, Iran.
   [Nikpour, M. R.; Jahanshahi, M.] Babol Univ Technol, Fac Chem Engn, Babol Sar, Iran.
   [Amani, A.] Univ Tehran Med Sci, Med Biomat Res Ctr, Tehran, Iran.
   [Soltani, M.; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.
   [Rabiee, S. M.] Babol Univ Technol, Fac Mech Engn, Babol Sar, Iran.
   [Rezayat, S. M.] Islamic Azad Univ IAUPS, Dept Toxicol & Pharmacol, Fac Pharm, Pharmaceut Sci Branch, Tehran, Iran.
   [Rezayat, S. M.] Univ Tehran Med Sci, Fac Med, Dept Pharmacol, Tehran, Iran.
RP Jahanshahi, M (reprint author), Babol Univ Technol, Nanobiotechnol Res Grp, Nanotechnol Res Inst, POB 484-47144, Babol Sar, Iran.
EM p4chen@uwaterloo.ca; mjahan@nit.ac.ir
OI tavakol, shima/0000-0002-8531-7650
FU Student's Scientific Research Center; Tehran University of Medical
   Sciences, Iran and Nanotechnology Research Institute in Babol University
   of Technology, Iran
FX This work was supported by grant from Student's Scientific Research
   Center, Tehran University of Medical Sciences, Iran and Nanotechnology
   Research Institute in Babol University of Technology, Iran. Authors are
   thankful to Dr. Sharmin Kharrazi for critical reading of the manuscript.
CR Ahmed R, 2011, J MECH BEHAV BIOMED, V4, P2043, DOI 10.1016/j.jmbbm.2011.07.003
   Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046
   Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Li B, 2011, MATER DESIGN, V32, P4543, DOI 10.1016/j.matdes.2011.04.039
   Chen JD, 2010, COLLOID SURFACE B, V81, P640, DOI 10.1016/j.colsurfb.2010.08.017
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/939821
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/401084
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Clarke SA, 2007, J MATER SCI-MATER M, V18, P2283, DOI 10.1007/s10856-007-3099-1
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Huang Z, 2011, CARBOHYD POLYM, V85, P261, DOI 10.1016/j.carbpol.2011.02.029
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Luo XB, 2011, APPL SURF SCI, V257, P9888, DOI 10.1016/j.apsusc.2011.06.096
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Notodihardjo FZ, 2012, J CRANIO MAXILL SURG, V40, P287, DOI 10.1016/j.jcms.2011.04.008
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   San Thian E, 2011, SURF COAT TECH, V205, P3472
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tan F, 2012, BIOTECHNOL ADV, V30, P352, DOI 10.1016/j.biotechadv.2011.07.008
   Tavakol S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1265-y
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zhao Y, 2007, J BIOMED MATER RES B, V83B, P121, DOI 10.1002/jbm.b.30774
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 39
TC 17
Z9 17
U1 2
U2 54
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JAN
PY 2013
VL 15
IS 1
AR 1373
DI 10.1007/s11051-012-1373-8
PG 16
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 138ZC
UT WOS:000318550000058
DA 2018-10-20
ER

PT J
AU Wang, LM
   Rao, RR
   Stegemann, JP
AF Wang, Limin
   Rao, Rameshwar R.
   Stegemann, Jan P.
TI Delivery of Mesenchymal Stem Cells in Chitosan/Collagen Microbeads for
   Orthopedic Tissue Repair
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Cell therapy; Chitosan; Collagen; Microencapsulation; Modular tissue
   engineering
ID REGENERATIVE MEDICINE; ALGINATE MICROSPHERES; BONE SIALOPROTEIN; LADEN
   HYDROGELS; DIFFERENTIATION; CHITOSAN; HYDROXYAPATITE; MODULATION;
   NUCLEATION; SCAFFOLDS
AB Microencapsulation and delivery of stem cells in biomaterials is a promising approach to repairing damaged tissue in a minimally invasive manner. An appropriate biomaterial niche can protect the embedded cells from the challenging environment in the host tissue, while also directing stem cell differentiation toward the desired lineage. In this study, adult human mesenchymal stem cells (MSC) were embedded in hydrogel microbeads consisting of chitosan and type I collagen using an emulsification process. Glyoxal and beta-glycerophosphate were used as chemical and physical crosslinkers to initiate copolymerization of the matrix materials. The average size and size distribution of the microbeads could be varied by controlling the emulsification conditions. Spheroidal microbeads ranging in diameter from 82 +/- 19 to 290 +/- 78 mu m were produced. Viability staining showed that MSC survived the encapsulation process (>90% viability) and spread inside the matrix over a period of 9 days in culture. Induced osteogenic differentiation using medium supplements showed that MSC increased gene expression of osterix and osteocalcin over time in culture, and also deposited calcium mineral. Bone sialoprotein and type I collagen gene expression were not affected. Delivery of microbeads through standard needles at practically relevant flow rates did not adversely affect cell viability, and microbeads could also be easily molded into prescribed geometries for delivery. Such protein-based microbeads may have utility in orthopedic tissue regeneration by allowing minimally invasive delivery of progenitor cells in microenvironments that are both protective and instructive. Copyright (c) 2013 S. Karger AG, Basel
C1 [Wang, Limin; Rao, Rameshwar R.; Stegemann, Jan P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Stegemann, JP (reprint author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM jpsteg@umich.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01-AR053231]; AO Foundation Large Bone Defect Healing Consortium;
   National Science Foundation Graduate Research Fellowship
FX This project was supported in part by the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases through grant
   R01-AR053231, by a grant from the AO Foundation Large Bone Defect
   Healing Consortium, and by a National Science Foundation Graduate
   Research Fellowship (to R.R.R.).
CR Abbah SA, 2008, J MATER SCI-MATER M, V19, P2113, DOI 10.1007/s10856-006-0013-1
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004
   Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   Caldwell DJ, 2012, ADV HEALTHCARE MAT
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chatterjea A, 2013, TISSUE ENG PART A, V3-4, P340
   Chen DY, 2013, BIOMATERIALS, V34, P1995, DOI 10.1016/j.biomaterials.2012.11.045
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331
   Dormer NH, 2012, TISSUE ENG PT A, V18, P757, DOI [10.1089/ten.tea.2011.0176, 10.1089/ten.TEA.2011.0176]
   Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102
   Giobbe GG, 2012, BIOTECHNOL BIOENG, V109, P3119, DOI 10.1002/bit.24571
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Jin GZ, 2012, J MATER SCI-MATER M, V23, P1739, DOI 10.1007/s10856-012-4646-y
   Johnson EO, 2011, MICROSURG, V31, P176, DOI 10.1002/micr.20821
   Kachouie NN, 2010, ORGANOGENESIS, V6, P234, DOI 10.4161/org.6.4.12650
   Kessler Michael W, 2008, Organogenesis, V4, P28
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]
   Lian J B, 1998, J Cell Biochem Suppl, V30-31, P62
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Man Y, 2012, BIOMATERIALS, V33, P8802, DOI 10.1016/j.biomaterials.2012.08.054
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Penolazzi L, 2010, TISSUE ENG PART C-ME, V16, P141, DOI [10.1089/ten.tec.2008.0582, 10.1089/ten.TEC.2008.0582]
   Peschel D, 2012, ACTA BIOMATER, V8, P183, DOI 10.1016/j.actbio.2011.08.012
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Wang LM, 2010, TISSUE ENG PT A, V16, P1937, DOI [10.1089/ten.tea.2009.0706, 10.1089/ten.TEA.2009.0706]
   Wang LM, 2011, ACTA BIOMATER, V7, P2410, DOI 10.1016/j.actbio.2011.02.029
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107
   Zhu YX, 2009, J MATER SCI-MATER M, V20, P799, DOI 10.1007/s10856-008-3636-6
NR 47
TC 32
Z9 32
U1 1
U2 42
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2013
VL 197
IS 5
BP 333
EP 343
DI 10.1159/000348359
PG 11
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 135YL
UT WOS:000318326500001
PM 23571151
OA Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Dai, XZ
   Wang, L
   Ma, KW
   Liu, B
   Li, H
   Pan, KJ
AF Dai, Xiaozhen
   Wang, Lan
   Ma, Kaiwang
   Liu, Bin
   Li, Hong
   Pan, Kejian
TI Characterization of a Hybridization Scaffold Based on PLGA/Acellular
   Pigskin for Nerve Regeneration
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Article
DE Poly(lactic-co-glycolic acid) (PLGA); Acellular pigskin; Nerve scaffold;
   Peripheral nerve repair
ID IN-VITRO; HYBRID SCAFFOLD; COLLAGEN; FABRICATION; CONDUIT; CELLS; PLGA;
   BIOMATERIAL; MEMBRANES; GRAFTS
AB Peripheral nerve regeneration across a long defect is a challenge in nerve reconstructive surgery. Nerve tissue engineering is a promising strategy for such regeneration. Artificial nerve scaffold design is an important part of nerve tissue engineering. In this study, a hybridization nerve scaffold was designed and fabricated with poly (lactide-co-glycolide acid) (PLGA) and acellular pigskin. Its potential as an artificial nerve scaffold is investigated in vitro. Acellular pigskin was prepared by enzymolysis and detected by hematoxylin and eosin (HE) staining, scanning electron microscopy (SEM), and examination of the DNA that remains in it. The hybridization scaffold was fabricated from PLGA and acellular pigskin using a high-pressure permeation technique. The microstructure, water absorption behavior, biodegradation, mechanical properties, and biocompatibility of the scaffold were investigated. SEM images show that the scaffold is a homogeneous three-dimensional porous structure. The maximum swelling index of the scaffold was about 124%, the thickness of the wall increased by about 56%, and the ultimate mass loss was about 9.05% in phosphate buffered saline (pH 7.4) after 8 weeks. PLGA improved the mechanical properties of acellular pigskin.The biocompatibility was evaluated by assessing the morphology and proliferation of Schwann cells (SCs) on the hybridization scaffold. Many SCs attached and adhered to the surface of the scaffold. The scaffold exhibited no cytotoxicity effects, increasing the proliferation of SCs. Therefore, the hybridization scaffold made of PLGA and acellular pigskin has suitable biodegradability, proper mechanical properties, and good biocompatibility for SCs, and thus has potential as an artificial nerve scaffold.
C1 [Dai, Xiaozhen; Wang, Lan; Li, Hong; Pan, Kejian] Chengdu Med Coll, Sch Biomed, Chengdu 610500, Peoples R China.
   [Ma, Kaiwang] Henan Univ Sci & Technol, Coll Med Technol & Engn, Luoyang 471003, Peoples R China.
   [Liu, Bin] Southwest Univ, Coll Life Sci, Chongqing 400715, Peoples R China.
RP Pan, KJ (reprint author), Chengdu Med Coll, Sch Biomed, Chengdu 610500, Peoples R China.
EM pkj6696@yahoo.com.cn
FU National Natural Science Foundation of China [81200917, 81000067,
   11172339]; Scientific Research Fund of Sichuan Provincial Education
   Department [11ZA205]
FX This project was supported in part by grants from The National Natural
   Science Foundation of China (81200917, 81000067, 11172339) and
   Scientific Research Fund of Sichuan Provincial Education Department
   (11ZA205).
CR Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Bini TB, 2006, J MATER SCI, V41, P6453, DOI 10.1007/s10853-006-0714-3
   Chen CF, 2011, J MED BIOL ENG, V31, P13, DOI 10.5405/jmbe.683
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Connolly SS, 2008, WORLD J UROL, V26, P333, DOI 10.1007/s00345-008-0283-y
   Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Feng ZH, 2005, NEUROSCIENTIST, V11, P503, DOI 10.1177/1073858405277409
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Kallenbach K, 2004, BIOMATERIALS, V25, P3613, DOI 10.1016/j.biomaterials.2003.10.040
   Khang G, 2003, ADV EXP MED BIOL, V534, P235
   KHANG G, 2004, TISSUE ENG REGEN MED, V1, P9
   Kim SH, 2006, ADV EXP MED BIOL, V585, P167
   Liu B, 2008, J MATER SCI-MATER M, V19, P1127, DOI 10.1007/s10856-007-3224-1
   Maturana LG, 2011, BRAZ J MED BIOL RES, V44, P682, DOI [10.1590/S0100-879X2011007500074, 10.1590/S0100-879X2011000700011]
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Timnak A, 2011, J MATER SCI-MATER M, V22, P1555, DOI 10.1007/s10856-011-4316-5
   Vandrovcova M, 2011, PHYSIOL RES, V60, P797
   Wang AJ, 2007, BIOTECHNOL LETT, V29, P1697, DOI 10.1007/s10529-007-9460-0
   Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Yang YM, 2004, BIOTECHNOL LETT, V26, P1793, DOI 10.1007/s10529-004-4611-z
   Yu KW, 2005, J NEUROPHYSIOL, V94, P1519, DOI 10.1152/jn.00107.2005
   Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68
   [张萌 ZHANG Meng], 2006, [功能材料, Journal of Functional Materials], V37, P277
NR 30
TC 3
Z9 3
U1 0
U2 16
PU DEPT BIOMEDICAL ENGINEERING
PI TAINAN CITY
PA NAT CHENG KUNG UNIV, NO 1 UNIVERSITY RD, TAINAN CITY, TAIWAN 701,
   PEOPLES R CHINA
SN 1609-0985
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2013
VL 33
IS 2
SI SI
BP 221
EP 227
DI 10.5405/jmbe.1082
PG 7
WC Engineering, Biomedical
SC Engineering
GA 136XK
UT WOS:000318396600014
DA 2018-10-20
ER

PT J
AU Grandfield, K
   Gustafsson, S
   Palmquist, A
AF Grandfield, Kathryn
   Gustafsson, Stefan
   Palmquist, Anders
TI Where bone meets implant: the characterization of nano-osseointegration
SO NANOSCALE
LA English
DT Article
ID TRANSMISSION ELECTRON-MICROSCOPY; FOCUSED ION-BEAM; TITANIUM
   SURFACE-FEATURES; COMPUTED-TOMOGRAPHY; STEM TOMOGRAPHY; INTERFACE;
   QUANTIFICATION; COLLAGEN; BIOLOGY
AB The recent application of electron tomography to the study of biomaterial interfaces with bone has brought about an awareness of nano-osseointegration and, to a further extent, demanded increasingly advanced characterization methodologies. In this study, nanoscale osseointegration has been studied via laser-modified titanium implants. The micro- and nano-structured implants were placed in the proximal tibia of New Zealand white rabbits for six months. High-resolution transmission electron microscopy (HRTEM), analytical microscopy, including energy dispersive X-ray spectroscopy (EDXS) and energy-filtered TEM (EFTEM), as well as electron tomography studies were used to investigate the degree of nano-osseointegration in two- and three-dimensions. HRTEM indicated the laser-modified surface encouraged the formation of crystalline hydroxyapatite in the immediate vicinity of the implant. Analytical studies suggested the presence of a functionally graded interface at the implant surface, characterized by the gradual intermixing of bone with oxide layer. Yet, the most compelling of techniques, which enabled straightforward visualization of nano-osseointegration, proved to be segmentation of electron tomographic reconstructions, where thresholding techniques identified bone penetrating into the nanoscale roughened surface features of laser-modified titanium. Combining high-resolution, analytical and three-dimensional electron microscopy techniques has proven to encourage identification and understanding of nano-osseointegration.
C1 [Grandfield, Kathryn] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden.
   [Gustafsson, Stefan] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   [Gustafsson, Stefan; Palmquist, Anders] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.
   [Palmquist, Anders] Univ Gothenburg, Dept Biomat, Gothenburg, Sweden.
RP Grandfield, K (reprint author), McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON, Canada.
EM kathryn.grandfield@gmail.com; Stefan.gustafsson@chalmers.se;
   anders.palmquist@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Grandfield, Kathryn/0000-0002-0188-9580
FU BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy,
   Gothenburg, Sweden; Natural Sciences and Engineering Research Council of
   Canada; Swedish Research Council [K2012-52X-09495-25-3]; Magnus
   Bergvalls Stiftelse Foundation; Sahlgrenska University Hospital
   Foundation
FX The authors gratefully acknowledge the financial support of BIOMATCELL
   VINN Excellence Center of Biomaterials and Cell Therapy, Gothenburg,
   Sweden. Dr. Rickard Branemark and Prof. Peter Thomsen are acknowledged
   for assistance during the study. K. G acknowledges support from the
   Natural Sciences and Engineering Research Council of Canada. A.P
   acknowledges support from the Swedish Research Council
   (K2012-52X-09495-25-3), Magnus Bergvalls Stiftelse and the Sahlgrenska
   University Hospital Foundations. Technical support is acknowledged from
   the Canadian Centre for Electron Microscopy, McMaster University,
   Canada.
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024
   Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231
   Attwood D, 2006, J BIOMED NANOTECHNOL, V2, P75, DOI 10.1166/jbn.2006.011
   Baril E, 2011, J MATER SCI-MATER M, V22, P1321, DOI 10.1007/s10856-011-4309-4
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2121, DOI 10.1007/s10439-010-0033-3
   Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043
   Giannuzzi L., 2012, P SOC PHOTO-OPT INS, V8378, P1
   Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025
   Grandfield K, 2010, J R SOC INTERFACE, V7, P1497, DOI 10.1098/rsif.2010.0213
   Grandfield K, 2012, ADV MATER SCI ENG, V2012, P841, DOI DOI 10.1155/2012/841961)
   Grandfield K, 2013, ULTRAMICROSCOPY, V127, P48, DOI 10.1016/j.ultramic.2012.07.007
   Grandfield K, 2012, PHILOS T R SOC A, V370, P1337, DOI 10.1098/rsta.2011.0253
   Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]
   Hori N, 2010, DENT MATER, V26, P275, DOI 10.1016/j.dental.2009.11.077
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Leapman RD, 2004, ULTRAMICROSCOPY, V100, P115, DOI 10.1016/j.ultramic.2004.03.002
   Liu S, 2012, J MICROSC-OXFORD, V245, P34, DOI 10.1111/j.1365-2818.2011.03541.x
   Morinaga K, 2009, CLIN IMPLANT DENT R, V11, P59, DOI 10.1111/j.1708-8208.2008.00093.x
   Palmquist A, 2008, ACTA ORTHOP, V79, P78, DOI 10.1080/17453670710014806
   Palmquist A, 2013, CLIN IMPLANT DENT R, V15, P96, DOI 10.1111/j.1708-8208.2011.00361.x
   Palmquist A, 2012, APPL SURF SCI, V258, P6485, DOI 10.1016/j.apsusc.2012.03.065
   Palmquist A, 2012, J R SOC INTERFACE, V9, P396, DOI 10.1098/rsif.2011.0420
   Palmquist A, 2011, J BIOMED MATER RES B, V97B, P289, DOI 10.1002/jbm.b.31814
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   ROSCHGER P, 1995, SCANNING MICROSCOPY, V9, P75
   Sarve H., 2011, THESIS SWEDISH AGR U
   Saunders M, 2011, MICROSC MICROANAL, V17, P220, DOI 10.1017/S1431927610094547
   Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630
   Sousa AA, 2011, J STRUCT BIOL, V174, P107, DOI 10.1016/j.jsb.2010.10.017
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006
   Ziese U, 2002, J STRUCT BIOL, V138, P58, DOI 10.1016/S1047-8477(02)00018-7
NR 39
TC 21
Z9 21
U1 2
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PY 2013
VL 5
IS 10
BP 4302
EP 4308
DI 10.1039/c3nr00826f
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 136LC
UT WOS:000318362400038
PM 23552223
DA 2018-10-20
ER

PT S
AU Mendes, MWD
   Bressiani, AHA
   Bressiani, JC
AF Mendes, M. W. D.
   Bressiani, A. H. A.
   Bressiani, J. C.
BE Vincenzini, P
   Hahn, YB
   Iannotta, S
   Lendlein, A
   Palermo, V
   Paul, S
   Sibilia, C
   Silva, SRP
   Srinivasan, G
TI Characterization of Ti-27Nb-13Zr Alloy Produced by Powder Metallurgy.
SO ADAPTIVE, ACTIVE AND MULTIFUNCTIONAL SMART MATERIALS SYSTEMS
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT Symposium A on Adaptive, Active and Multifunctional Smart Materials
   Systems of CIMTEC / 4th International Conference on Smart Materials,
   Structures and Systems
CY JUN 10-14, 2012
CL Montecatini Terme, ITALY
DE Titanium alloy; elastic modulus; hardness; powder metallurgy
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; NB ALLOY; EVOLUTION; MODULUS
AB Titanium alloy are widely used in biomedical applications due to their excellent properties such as high strength, good corrosion resistance and excellent biocompatibility. Researches are being developed with elements such as Nb and Zr that reach all criterions for excellent biocompatibility and provide titanium alloys with Young's modulus close to human bone. The aim of this work was to produce Ti-27Nb-13Zr alloy with different milling times by powder metallurgy process. The mixtures were performed by high energy milling and sintering in high vacuum furnace with temperature of 1300 degrees C / 3 h. The microstructures of samples were analyzed by SEM and XRD, while the mechanical behavior was evaluated by elastic modulus and Vickers hardness test. The diffraction results of sintering treatment indicate that the alloys are composed of alpha and beta phases. Images obtained by SEM indicate the formation of equiaxial structures. Vickers hardness measurements from sintered samples with 1300 degrees C / 3 h indicate mean values around 413, 473 and 609 HV for 2, 6 and 10 hours of milling, respectively. The values of elastic modulus enable use the alloy as biomaterial.
C1 [Mendes, M. W. D.; Bressiani, A. H. A.; Bressiani, J. C.] Inst Energet & Nucl Res IPEN, BR-05508000 Sao Paulo, Brazil.
RP Mendes, MWD (reprint author), Inst Energet & Nucl Res IPEN, Prof Lineu Prestes Ave, BR-05508000 Sao Paulo, Brazil.
EM mwdmendes@ipen.br; abressia@ipen.br; jbressia@ipen.br
RI Mendes, Marcio/D-8786-2013; Bressiani, Ana/I-1402-2012; Iannotta,
   Salvatore/O-9889-2015
OI Iannotta, Salvatore/0000-0001-7743-1317
CR Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Candioto KCG, 2006, INT J REFRACT MET H, V24, P413, DOI 10.1016/j.ijrmhm.2005.06.001
   Cui Y, 2010, MAT SCI ENG A-STRUCT, V527, P652, DOI 10.1016/j.msea.2009.08.063
   Gabriel SB, 2011, INT J REFRACT MET H, V29, P134, DOI 10.1016/j.ijrmhm.2010.09.006
   Gabriel SB, 2010, MATER RES-IBERO-AM J, V13, P333, DOI 10.1590/S1516-14392010000300009
   Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113
   He G, 2005, MAT SCI ENG C-BIO S, V25, P290, DOI 10.1016/j.msec.2005.03.001
   Henriques VAR, 2003, MAT SCI ENG A-STRUCT, V347, P315, DOI 10.1016/S0921-5093(02)00604-4
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Muller FA, 2008, DENT MATER, V24, P50, DOI 10.1016/j.dental.2007.02.005
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Nouri A, 2010, ACTA BIOMATER, V6, P1630, DOI 10.1016/j.actbio.2009.10.005
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Yakonova N.B.D., 2007, RUS METALLURGY, V1, P51
NR 15
TC 0
Z9 0
U1 0
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-63-9
J9 ADV SCI TECH
PY 2013
VL 77
BP 178
EP 183
DI 10.4028/www.scientific.net/AST.77.178
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEQ93
UT WOS:000317790300026
DA 2018-10-20
ER

PT S
AU Sakai, H
   Asaoka, T
AF Sakai, H.
   Asaoka, T.
BE Vincenzini, P
   Scilingo, EP
TI Development of biocompatible Y-stabilized ZrO2 fabricated by Spark
   Plasma Sintering
SO BIOMEDICAL APPLICATIONS OF SMART TECHNOLOGIES
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT Symposium J on Biomedical Applications of Smart Technologies of CIMTEC /
   4th International Conference on Smart Materials, Structures and Systems
CY JUN 10-14, 2012
CL Montecatini Terme, ITALY
DE zirconia; surface morfology; biomaterial; Spark Plasma Sintering
AB Due to the merits of zirconia ceramics such as high strength, toughness, abrasion resistance, and chemical stability in vivo, yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) are currently used in the femoral head of hip prostheses. However, this material has a limited applications range because it is a bioinert material that does not interact with bone tissue and thus does not easily integrate directly in the bone. Therefore, we need to add different material's layer which enables in vivo formation of bone-like apatite layer that exhibits bioactivity, composite compound bioactive ceramics, and facilitates interactions and integration in bone tissue. In addition, by developing a surface structure that enhances mechanical bonding, this material can be expected to be used as an alternative aggregate under load bearing conditions. In the present study, various method were carried out with the objective of controlling interactions between zirconia ceramics and the body such as structural design of the material surface, addition of bioactivity using reagents treatment, confirmation of formation of the apatite layer using immersion in simulated body fluid, wettability testing and develop structure with mechanical properties equal to bone strength.
C1 [Sakai, H.] Tokyo Denki Univ, Course Intelligent Mech Engn, Grad Sch Sci & Engn, Hiki, Saitama 3500394, Japan.
   [Asaoka, T.] Tokyo Denki Univ, Sch Sci & Engn, Dept Intelligent Mech Engn, Saitama 3500394, Japan.
RP Sakai, H (reprint author), Tokyo Denki Univ, Course Intelligent Mech Engn, Grad Sch Sci & Engn, Hiki, Saitama 3500394, Japan.
EM 11rmk15@ms.dendai.ac.jp; asaoka@mail.dendai.ac.jp
CR Fujisawa A., 2003, CERAMICS JAPAN, V38-1, P40
   Kokubo T., 2004, REGEN MED, V3-2, P31
   Li W., 2002, FABRICATION IN PRESS
   Suzuki J., 2005, P 49 JAP C MAT RES, P92
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Yamashita K., 2005, J JAPAN SOC POWDER P, V52-5, P347
   Yoshida M., 2004, P 8 JAP S BIOM CER, P9
NR 7
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-72-1
J9 ADV SCI TECH
PY 2013
VL 86
BP 17
EP +
DI 10.4028/www.scientific.net/AST.86.17
PG 2
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BES48
UT WOS:000317940100003
DA 2018-10-20
ER

PT J
AU Ehlert, N
   Mueller, PP
   Stieve, M
   Lenarz, T
   Behrens, P
AF Ehlert, Nina
   Mueller, Peter P.
   Stieve, Martin
   Lenarz, Thomas
   Behrens, Peter
TI Mesoporous silica films as a novel biomaterial: applications in the
   middle ear
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID OSSICULAR CHAIN; DRUG-DELIVERY; CONTROLLED-RELEASE; RABBITS; COATINGS;
   BONE; BIOCOMPATIBILITY; PROSTHESES; STABILITY; IMPLANTS
AB In this tutorial review we present the process of the development of functional implants using mesoporous silica. The different steps from chemical synthesis and physicochemical characterization followed by in vitro testing in cell culture assays to clinically relevant in vivo animal studies are examined. Since the end of the 1990s, mesoporous silicas have been considered as biomaterials. Numerous investigations have demonstrated their non-toxic and biocompatible properties. These qualities in combination with the unique properties of high surface area and pore volume, uniform and tunable pore sizes and chemical modifiability are the reasons for the great scientific interest in this field. Here we show that besides bulk materials or mesoporous silica nanoparticles, mesoporous silica films are highly promising as coatings on medical prostheses or implants. We report on the development of functionalized mesoporous silica materials specifically for middle ear applications. Middle ear prostheses are used to restore the sound transmission through this air-filled cavity when the small bones of the middle air (the ossicular chain) have been destroyed by disease or by accidents. In addition to optimal restoration of sound transmission, this technique bears several challenges, e. g. an ongoing bacterial infection or the displacement of the prosthesis due to insufficient fixation. To improve the healing process, a mesoporous silica coating was established on ceramic middle ear prostheses, which then served as a base for further functionalizations. For example, the bone growth factor BMP2 was locally attached to the coating in order to improve the fixation of the prosthesis by forming a bony connection to the remainder of the ear bones. Further, an implant-based local drug delivery system for the antibiotic ciprofloxacin was developed with the aim of fighting bacterial infections. Further possibilities using mesoporous silica nanoparticles as part of a composite on an implant are briefly discussed.
C1 [Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Inst Anorgan Chem, D-30167 Hannover, Germany.
   [Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Ctr Solid State Chem & New Mat, D-30167 Hannover, Germany.
   [Mueller, Peter P.] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
   [Stieve, Martin; Lenarz, Thomas] Hannover Med Sch, Hals Nasen Ohren Klin, D-30625 Hannover, Germany.
RP Behrens, P (reprint author), Leibniz Univ Hannover, Inst Anorgan Chem, Callinstr 9, D-30167 Hannover, Germany.
EM peter.behrens@acb.uni-hannover.de
OI Mueller, Peter/0000-0002-1209-7546
FU DFG; Collaborative Research Center (Sonderforschungsbereich) [599]
FX The scientific results presented in this paper could only be achieved
   through a close interdisciplinary collaboration. The Collaborative
   Research Center (Sonderforschungsbereich) 599 (Sustainable bioresorbable
   and permanent implants made of metallic and ceramic materials) of the
   Deutsche ForschungsGemeinschaft (DFG) has provided an ideal frame for
   this project. We thank the DFG for funding us within this center and all
   our co-workers in the work package D1 for their enthusiasm and
   willingness to cooperate; they are named in the references referring to
   our original papers. This work has profited from discussions with
   partners from the Excellence Cluster "Hearing4All" and will in part be
   continued within this measure.
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   Antunes Marcos Luiz, 2008, Braz J Otorhinolaryngol, V74, P53
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   BEHRENS P, 1993, ADV MATER, V5, P127, DOI 10.1002/adma.19930050212
   Behrens P, 1997, SOLID STATE IONICS, V101, P255, DOI 10.1016/S0167-2738(97)00366-4
   BERTANI G, 1951, J BACTERIOL, V62, P293
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I
   Dost P., 2003, MIDDLE EAR SURG RECE, P53
   Ehlert N, 2013, BIONANOMATERIALS, V14, DOI [10.1515/bnm-2012-1001, DOI 10.1515/BNM-2012-1001]
   Ehlert N, 2011, ACTA BIOMATER, V7, P1772, DOI 10.1016/j.actbio.2010.12.028
   Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g
   Ehlert N, 2010, MICROPOR MESOPOR MAT, V131, P51, DOI 10.1016/j.micromeso.2009.11.040
   Hesse D., OTOLOGY NEU IN PRESS
   Hlozanek I., 2008, BIOMATERIALIEN, V9, P199
   Hlozanek I., 2009, EUR J CELL BIOL S, VS1, P51
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Huang XL, 2010, BIOMATERIALS, V31, P6142, DOI 10.1016/j.biomaterials.2010.04.055
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   KIM JM, 1995, J PHYS CHEM-US, V99, P16742, DOI 10.1021/j100045a039
   Klein M, 2006, PLAST RECONSTR SURG, V117, P565, DOI 10.1097/01.prs.0000200770.83864.bc
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lensing R, 2013, ACTA BIOMATER, V9, P4815, DOI 10.1016/j.actbio.2012.08.016
   Manzano M, 2009, EXPERT OPIN DRUG DEL, V6, P1383, DOI 10.1517/17425240903304024
   Marschall R, 2007, MICROPOR MESOPOR MAT, V99, P190, DOI 10.1016/j.micromeso.2006.08.037
   Neumann A, 2003, MATERIALWISS WERKST, V34, P1052, DOI 10.1002/mawe.200300704
   Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t
   Scheithauer S, 2012, ORTHOPADE, V41, P6, DOI 10.1007/s00132-011-1834-2
   Schneider G, 2010, J MATER SCI-MATER M, V21, P2853, DOI 10.1007/s10856-010-4143-0
   Siebert H, 2006, ORAL MAXILLOFAC SURG, V10, P185, DOI 10.1007/s10006-006-0687-z
   Slowing II, 2010, J MATER CHEM, V20, P7924, DOI 10.1039/c0jm00554a
   Soler-Illia GJDA, 2003, CURR OPIN COLLOID IN, V8, P109, DOI 10.1016/S1359-0294(03)00002-5
   Stieve M, 2009, LAB ANIM-UK, V43, P198, DOI 10.1258/la.2008.007152
   Stieve M., 2008, MEDIZINTECHNIK LIFE, P1425
   Stieve M, 2008, LAB ANIM-UK, V42, P320, DOI 10.1258/la.2007.007080
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tang QL, 2006, J CONTROL RELEASE, V114, P41, DOI 10.1016/j.jconrel.2006.05.006
   Turck C, 2007, ACTA OTO-LARYNGOL, V127, P801, DOI 10.1080/00016480601053032
   Vallet-Regi M, 2010, J INTERN MED, V267, P22, DOI 10.1111/j.1365-2796.2009.02190.x
   Vogel B. W., 1987, ANGEW CHEM INT EDIT, V26, P527
   Vogt JC, 2008, J MATER SCI-MATER M, V19, P2629, DOI 10.1007/s10856-007-3353-6
   Vogt JC, 2009, J BIOMATER APPL, V24, P175, DOI 10.1177/0885328208095469
   Wan Y, 2007, CHEM COMMUN, P897, DOI 10.1039/b610570j
   Wendler J, 2005, J BIOTECHNOL, V119, P425, DOI 10.1016/j.jbiotec.2005.04.021
   Wu ZJ, 2007, J CONTROL RELEASE, V119, P215, DOI 10.1016/j.jconrel.2007.03.001
NR 49
TC 45
Z9 46
U1 9
U2 160
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2013
VL 42
IS 9
BP 3847
EP 3861
DI 10.1039/c3cs35359a
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA 126EU
UT WOS:000317596100015
PM 23525266
DA 2018-10-20
ER

PT J
AU Borjigin, M
   Eskridge, C
   Niamat, R
   Strouse, B
   Bialk, P
   Kmiec, EB
AF Borjigin, Mandula
   Eskridge, Chris
   Niamat, Rohina
   Strouse, Bryan
   Bialk, Pawel
   Kmiec, Eric B.
TI Electrospun fiber membranes enable proliferation of genetically modified
   cells
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanofibers; PCL-biomaterial blends; miscibility; gene editing; cell
   proliferation
ID MESENCHYMAL STEM-CELLS; ZINC-FINGER NUCLEASES; TARGETED GENE REPAIR; DNA
   OLIGONUCLEOTIDES; NANOFIBROUS SCAFFOLD; COLLAGEN NANOFIBERS; BLEND
   NANOFIBERS; CORRECTED CELLS; POLYCAPROLACTONE; LECITHIN
AB Polycaprolactone (PCL) and its blended composites (chitosan, gelatin, and lecithin) are well-established biomaterials that can enrich cell growth and enable tissue engineering. However, their application in the recovery and proliferation of genetically modified cells has not been studied. In the study reported here, we fabricated PCL-biomaterial blended fiber membranes, characterized them using physicochemical techniques, and used them as templates for the growth of genetically modified HCT116-19 colon cancer cells. Our data show that the blended polymers are highly miscible and form homogenous electrospun fiber membranes of uniform texture. The aligned PCL nanofibers support robust cell growth, yielding a 2.5-fold higher proliferation rate than cells plated on standard plastic plate surfaces. PCL-lecithin fiber membranes yielded a 2.7-fold higher rate of proliferation, while PCL-chitosan supported a more modest growth rate (1.5-fold higher). Surprisingly, PCL-gelatin did not enhance cell proliferation when compared to the rate of cell growth on plastic surfaces.
C1 [Borjigin, Mandula; Eskridge, Chris; Niamat, Rohina; Strouse, Bryan; Bialk, Pawel; Kmiec, Eric B.] Delaware State Univ, Dept Chem, Dover, DE 19901 USA.
RP Kmiec, EB (reprint author), Delaware State Univ, Dept Chem, 1200 N DuPont Highway, Dover, DE 19901 USA.
EM ekmiec@desu.edu
FU National Institutes of Health [5R01CA089325-12, R21N5053608-03]
FX This work was supported by National Institutes of Health grants
   5R01CA089325-12 and R21N5053608-03. We thank Dr Andrew Goudy, Dr Cherese
   Winstead, Dr Noureddine Melikechi, Mr Samuel Orefuwa, and Mr Adeola
   Ibikunle (Delaware State University) and Ms Debbie Powell from
   Bioimaging Center of Delaware Biotechnology Institute.
CR Aarts M, 2009, J CELL MOL MED, V14, P1657
   Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Bertoni C, 2005, HUM MOL GENET, V14, P221, DOI 10.1093/hmg/ddi020
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bonner M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.9
   Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004
   Borjigin M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.51
   Cardwell RD, J TISSUE ENG REGEN M
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119
   Ferrara L, 2006, DNA REPAIR, V5, P422, DOI 10.1016/j.dnarep.2005.11.009
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Halberstadt C, 2006, EXPERT OPIN BIOL TH, V6, P971, DOI 10.1517/14712598.6.10.971
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852
   Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46
   Kim GH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956416
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Liu CL, 2009, OLIGONUCLEOTIDES, V19, P281, DOI 10.1089/oli.2009.0191
   Lu JW, 2010, RECENT PAT NANOTECH, V4, P125, DOI 10.2174/187221010791208777
   McKee MG, 2006, SCIENCE, V311, P353, DOI 10.1126/science.1119790
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   Naglic M, 1997, IND ENG CHEM RES, V36, P5240, DOI 10.1021/ie970135m
   Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804
   Orza A, 2011, ACS NANO, V5, P4490, DOI 10.1021/nn1035312
   Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296
   Park SA, 2010, MACROMOL RES, V18, P891, DOI 10.1007/s13233-010-0909-y
   Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828
   Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   Romo-Herrera JM, 2007, NANO LETT, V7, P570, DOI 10.1021/nl0622202
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shen J, 2010, INT J ARTIF ORGANS, V33, P161
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Solanki A, 2008, NANOMEDICINE-UK, V3, P567, DOI 10.2217/17435889.3.4.567
   Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   Wang Y, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015012
   Wang YS, 2011, BIOMATERIALS, V32, P6737, DOI 10.1016/j.biomaterials.2011.05.075
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yang XC, 2009, BIOMACROMOLECULES, V10, P2772, DOI 10.1021/bm900623j
   Yeo MG, 2012, CHEM MATER, V24, P903, DOI 10.1021/cm201119q
   Zhang M, 2012, J MATER SCI-MATER M, V23, P2639, DOI 10.1007/s10856-012-4721-4
   Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136
   Zhu N, 2007, J BIOMED MATER RES A, V82A, P455, DOI 10.1002/jbm.a.31159
NR 57
TC 26
Z9 27
U1 0
U2 29
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 855
EP 864
DI 10.2147/IJN.S40117
PG 10
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 130MU
UT WOS:000317922700076
PM 23467983
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Geilich, BM
   Webster, TJ
AF Geilich, Benjamin M.
   Webster, Thomas J.
TI Reduced adhesion of Staphylococcus aureus to ZnO/PVC nanocomposites
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanomaterials; endotracheal tube; biofilm; zinc oxide; nanoparticles;
   Staphylococcus aureus
ID VENTILATOR-ASSOCIATED PNEUMONIA; CARE-ASSOCIATED INFECTIONS;
   ANTIBACTERIAL ACTIVITY; NANOPARTICLES; ZNO; EPIDERMIDIS; NANOTECHNOLOGY;
   PSEUDOMONAS; SUSPENSIONS; BIOFILMS
AB In hospitals and clinics worldwide, medical device surfaces have become a rapidly growing source of nosocomial infections. In particular, patients requiring mechanical ventilation (and, thus, intubation with an endotracheal tube) for extended lengths of time are faced with a high probability of contracting ventilator-associated pneumonia. Once inserted into the body, the endotracheal tube provides a surface to which bacteria can adhere and form a biofilm (a robust, sticky matrix that provides protection against the host immune system and antibiotic treatment). Adding to the severity of this problem is the spread of bacterial genetic tolerance to antibiotics, in part demonstrated by the recent and significant increase in the prevalence of methicillin-resistant Staphylococcus aureus. To combat these trends, different techniques in biomaterial design must be explored. Recent research has shown that nanomaterials (materials with at least one dimension less than 100 nm) may have the potential to prevent or disrupt bacterial processes that lead to infections. In this study, polyvinyl chloride (PVC) taken from a conventional endotracheal tube was embedded with varying concentrations of zinc oxide (ZnO) nanoparticles. S. aureus biofilms were then grown on these nanocomposite surfaces during a 24-hour culture. Following this, biofilms were removed from the surfaces and the number of colony forming units present was assessed. Bacterial proliferation on the samples embedded with the highest concentration of ZnO nanoparticles was 87% less when compared to the control, indicating that this technique is effective at reducing biofilm formation on PVC surfaces without the use of antibiotics.
C1 [Geilich, Benjamin M.] Northeastern Univ, Program Bioengn, Boston, MA 02115 USA.
   [Webster, Thomas J.] Northeastern Univ, Coll Engn, Dept Chem Engn, Boston, MA 02115 USA.
RP Webster, TJ (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
EM th.webster@neu.edu
FU Northeastern University, Boston, MA, USA
FX The authors would like to thank Northeastern University, Boston, MA, USA
   for their funding and support.
CR Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970
   Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557
   Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538
   Fears R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002556
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Ibrahim EH, 2001, CHEST, V120, P555, DOI 10.1378/chest.120.2.555
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Lipovsky A, 2009, J PHYS CHEM C, V113, P15997, DOI 10.1021/jp904864g
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115
   Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Seil JT, 2011, J BIOMED MATER RES B, V98B, P1, DOI 10.1002/jbm.b.31821
   Shorr AF, 2009, INFECT CONT HOSP EP, V30, P759, DOI 10.1086/599005
   Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 28
TC 18
Z9 18
U1 2
U2 44
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 1177
EP 1184
DI 10.2147/IJN.S42010
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 130MU
UT WOS:000317922700106
PM 23658484
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dong, JJ
   Cui, G
   Bi, L
   Li, J
   Lei, W
AF Dong, Jingjing
   Cui, Geng
   Bi, Long
   Li, Jie
   Lei, Wei
TI The mechanical and biological studies of calcium phosphate cement-fibrin
   glue for bone reconstruction of rabbit femoral defects
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE calcium phosphate cements; fibrin glue; bone reconstruction; micro-CT;
   biomechanical testing; histological examination
ID DONOR SITE MORBIDITY; GROWTH-FACTOR; COMPOSITES; AUGMENTATION;
   SUBSTITUTES; ADHESIVE; CHITOSAN; SEALANT; BINDING; HARVEST
AB In order to improve the mechanical and biological properties of calcium phosphate cement (CPC, nanometer-biomaterial) for bone reconstruction in the rabbit femoral defect model, fibrin glue (FG, the natural product, purified from the blood) was introduced at three different ratios. The CPC powder and the FG solution were mixed, respectively, at the powder/liquid (P/L) ratios (g/mL) of 1:1, 3:1, and 5:1 (g/mL), and pure CPC was used as a control. After being implanted into the femoral defect in rabbit, the healing process was evaluated by micro-computed tomography scan, biomechanical testing, and histological examination. By micro-computed tomography analysis, the P/L ratio of 1:1 (g/mL) group indicated the largest quantity of new bone formation at 4 weeks, 8 weeks, and 12 weeks after implantation, respectively. Bone volume per trabecular volume of the 1:1 group was highest in the four groups, which was 1.45% +/- 0.42%, 7.35% +/- 1.45%, and 29.10% +/- 1.67% at 4 weeks, 8 weeks, and 12 weeks after the operation, respectively. In the biomechanical tests, the compressive strength and the elastic modulus of the three CPC-FG groups were much higher than those of the pure CPC group at the determined time point (P < 0.05). The histological evaluation also showed the best osseointegration in the 1:1 group at 4 weeks, 8 weeks, and 12 weeks after the operation, respectively. In the 1:1 group, the bone grew into the pore of the cement in the laminar arrangement and connected with the cement tightly at the 12th week after the operation. This present study indicated that the CPC-FG composite at the P/L ratio of 1:1 (g/mL) stimulated bone regeneration better than any other designed group, which suggested that CPC-FG at the P/L ratio of 1:1 has significant potential as the bioactive material for the treatment of bone defects.
C1 [Dong, Jingjing; Bi, Long; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi, Peoples R China.
   [Cui, Geng] PLA, Gen Hosp, Inst Orthoped, Beijing, Peoples R China.
   [Li, Jie] PLA, Gen Hosp, Inst Gynecol & Obstet, Beijing, Peoples R China.
RP Lei, W (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi, Peoples R China.
EM fmmuleiwei@126.com
FU National Natural Science Foundation of China [81000790]; Science and
   Technology New Star Foundation of Beijing [031507]
FX This study was supported by the National Natural Science Foundation of
   China (81000790) and the Science and Technology New Star Foundation of
   Beijing (031507).
CR Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barinov SM, 2011, INORG MATER+, V47, P1470, DOI 10.1134/S0020168511130024
   Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215
   Catelas I, 2008, TISSUE ENG PT C-METH, V14, P119, DOI 10.1089/ten.tec.2007.0262
   CHOW LC, 1984, J DENT RES, V63, P868, DOI 10.1177/00220345840630061101
   Cui G, 2010, J BIOMED MATER RES B, V92B, P377, DOI 10.1002/jbm.b.31525
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Friedlander GE, 1999, ORTHOP CLIN N AM, V30, P583, DOI 10.1016/S0030-5898(05)70111-5
   GRECO F, 1988, ARCH ORTHOP TRAUM SU, V107, P99, DOI 10.1007/BF00454495
   Hirano M, 2003, CERAMICS, V38, P47
   Juhan-Vague I, 2003, B ACAD NAT MED PARIS, V187, P69
   Juhan-Vague I, 2003, B ACAD NATL MED, V187, P83
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P493, DOI [10.1089/ten.teb.2010.0035, 10.1089/ten.TEB.2010.0035]
   Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007
   Lopez-Heredia MA, 2013, J BIOMED MATER RES A, V101, P478, DOI 10.1002/jbm.a.34342
   Lu JX, 1999, BONE, V25, p41S, DOI 10.1016/S8756-3282(99)00131-3
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Meenach SA, 2013, INT J NANOMED, V8, P275, DOI 10.2147/IJN.S30724
   Mickiewicz RA, 2002, J BIOMED MATER RES, V61, P581, DOI 10.1002/jbm.10222
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   OBERG S, 1993, SWED DENT J, V17, P147
   Perez RA, 2011, J BIOMED MATER RES B, V97B, P156, DOI 10.1002/jbm.b.31798
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 36
TC 9
Z9 10
U1 0
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2013
VL 8
BP 1317
EP 1324
DI 10.2147/IJN.S42862
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 130MU
UT WOS:000317922700117
PM 23576869
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mikulewicz, M
   Chojnacka, K
   Kochanowska, I
   Dziewicka, A
   Janeczek, M
   Cieplik, J
   Chroszcz, A
AF Mikulewicz, Marcin
   Chojnacka, Katarzyna
   Kochanowska, Iwona
   Dziewicka, Agnieszka
   Janeczek, Maciej
   Cieplik, Jerzy
   Chroszcz, Aleksander
TI Cytotoxicity of nickel ions for human osteoblasts in the context of
   orthodontic treatment in humans and animals
SO TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES
LA English
DT Article
DE Nickel(II); cytotoxicity; osteoblasts; orthodontic appliance
ID IN-VITRO; STAINLESS-STEEL; CELL-LINES; METAL-IONS; RELEASE;
   BIOCOMPATIBILITY; APPLIANCES; CORROSION; PROLIFERATION; TITANIUM
AB In the present work, the biocompatibility of orthodontic devices was tested by the propagation of human osteoblasts. A different methodological approach was applied. Since the materials used in human and veterinary orthodontics (not in implantology) had been tested, osteoblasts were not implanted on the surface of the biomaterial, but have been cultured in the medium containing the products of corrosion. In the present work, osteoblasts were propagated in the medium spiked with Ni(II) salt versus the control. Osteoblast cells (live, dead, and total) were counted under light microscope. The statistical significance of the differences between the experimental and control groups were evaluated (P < 0.05). Based on the number of live, dead, and total cells, the viability and proliferation were determined. A slight cytotoxic effect of Ni(II) ions at the studied concentration was confirmed. The mean viability was 7% lower in the experimental versus the control group (the difference was statistically significant), while the change of proliferation was not significant.
C1 [Mikulewicz, Marcin] Med Acad Wroclaw, Dept Dentofacial Orthoped & Orthodont, PL-50425 Wroclaw, Poland.
   [Chojnacka, Katarzyna] Wroclaw Univ Technol, Inst Inorgan Technol & Mineral Fertilizers, PL-50372 Wroclaw, Poland.
   [Kochanowska, Iwona; Dziewicka, Agnieszka] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.
   [Janeczek, Maciej; Chroszcz, Aleksander] Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Fac Vet Med, PL-51631 Wroclaw, Poland.
   [Cieplik, Jerzy] Wroclaw Med Univ, Dept Organ Chem, PL-50137 Wroclaw, Poland.
RP Janeczek, M (reprint author), Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Fac Vet Med, PL-51631 Wroclaw, Poland.
EM janeczekm@poczta.onet.pl
RI Chroszcz, Aleksander/B-3840-2017
OI Mikulewicz, Marcin/0000-0001-5754-0284
FU National Centre for Research and Development in Poland [N R13 0006 10]
FX This work was financially supported by the National Centre for Research
   and Development in Poland, project Nr N R13 0006 10.
CR Antoszewska J., 2007, Medycyna Weterynaryjna, V63, P982
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V100, P151, DOI 10.1385/BTER:100:2:151
   Darabara MS, 2007, J BIOMED MATER RES B, V81B, P126, DOI 10.1002/jbm.b.30645
   DOBRESCU MV, 1994, TIERARZTL UMSCHAU, V49, P144
   Eliades T, 2002, ANGLE ORTHOD, V72, P222
   Gursoy S, 2004, ANGLE ORTHOD, V75, P92
   Hao L, 2005, J BIOMED MATER RES B, V73B, P148, DOI 10.1002/jbm.b.30194
   Hayes RB, 1997, CANCER CAUSE CONTROL, V8, P371, DOI 10.1023/A:1018457305212
   Holstrom S.E., 2004, VET DENT TECHNIQUES
   House K, 2008, AM J ORTHOD DENTOFAC, V133, P584, DOI 10.1016/j.ajodo.2007.03.021
   Hwang CJ, 2001, AM J ORTHOD DENTOFAC, V120, P383, DOI 10.1067/mod.2001.117911
   Janeczek M, 2010, POL J VET SCI, V13, P533
   Janeczek M., 2004, MAG WET, V13, P44
   Janson GRP, 1998, AM J ORTHOD DENTOFAC, V113, P655, DOI 10.1016/S0889-5406(98)70226-4
   Jodkowska K., 2004, MAGAZYN WET, V2, P25
   KEROSUO H, 1995, ANGLE ORTHOD, V65, P111
   Kolokitha O., 2008, AM J ORTHOD DENTOFAC, V134, p722e1
   Kuhta M, 2009, ANGLE ORTHOD, V79, P102, DOI 10.2319/083007-401.1
   Kusy RP, 1997, ANGLE ORTHOD, V67, P197
   Kusy RR, 2002, ANGLE ORTHOD, V72, P501
   Michiardi A, 2008, J BIOMED MATER RES A, V85A, P108, DOI 10.1002/jbm.a.31486
   Mikulewicz M, 2012, BIOL TRACE ELEM RES, V146, P272, DOI 10.1007/s12011-011-9233-4
   Mikulewicz M, 2011, BIOL TRACE ELEM RES, V139, P241, DOI 10.1007/s12011-010-8670-9
   Mikulewicz M, 2011, BIOL TRACE ELEM RES, V142, P865, DOI 10.1007/s12011-010-8798-7
   Montanaro L, 2006, J MATER SCI-MATER M, V17, P267, DOI 10.1007/s10856-006-7313-3
   Morais S, 1998, BIOMATERIALS, V19, P13, DOI 10.1016/S0142-9612(97)00149-X
   Ning J, 1999, TOXICOL IN VITRO, V13, P879, DOI 10.1016/S0887-2333(99)00075-2
   Ochsenbein A, 2008, ACTA BIOMATER, V4, P1506, DOI 10.1016/j.actbio.2008.03.012
   Oller AR, 1997, TOXICOL APPL PHARM, V143, P152, DOI 10.1006/taap.1996.8075
   RICCIO V, 1994, CLIN ORTHOP RELAT R, P73
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Tan FX, 2008, TOXICOL IN VITRO, V22, P164, DOI 10.1016/j.tiv.2007.08.020
   Torricelli P, 2003, INT J ARTIF ORGANS, V26, P952
NR 36
TC 0
Z9 0
U1 0
U2 9
PU SCIENTIFIC TECHNICAL RESEARCH COUNCIL TURKEY-TUBITAK
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKEY
SN 1300-0128
J9 TURK J VET ANIM SCI
JI Turk. J. Vet. Anim. Sci.
PY 2013
VL 37
IS 2
BP 164
EP 169
DI 10.3906/vet-1112-34
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 129ET
UT WOS:000317822400007
DA 2018-10-20
ER

PT J
AU Guerra, DL
   Silva, RAR
   Mello, I
AF Guerra, Denis L.
   Silva, Ricardo A. R.
   Mello, Ivani
TI Adsorption of mercury from aqueous solution by nontronite, Aspergillus
   niger, and hybrid material
SO WATER QUALITY RESEARCH JOURNAL OF CANADA
LA English
DT Article
DE adsorption; Aspergillus niger fungus; mercury nontronite
ID HEXAVALENT CHROMIUM; INORGANIC MERCURY; FUNGAL BIOMASS; REMOVAL;
   BIOSORPTION; COLUMN; WASTE; PHOSPHATE; SMECTITES; SURFACES
AB A natural nontronite clay sample from the Amazon region (Tocantins State, Serra da Messa Group, Brazil) was utilized for synthesis of a new biomaterial produced by a hybridization process of inorganic and organic materials. The new biomaterial was composed of an Amazon nontronite and fungal mass obtained from the Aspergillus niger fungus. The natural clay, biomass, and biomaterial samples were used in batch studies for adsorption of Hg2+ ions from aqueous solution. The effects of stirring time, adsorbent dosage, and pH on the adsorption capacity demonstrated that 70 min is sufficient to reach equilibrium at room temperature and over a pH range of 6.0-8.0. The maximum number of moles adsorbed was 9.47, 17.8, and 18.7 mmol g(-1) for natural clay, biomass, and biomaterial, respectively. From the cation/basic center interactions for each material at the solid-liquid interface, by using calorimetry, the equilibrium constant and exothermic thermal effects were calculated. By considering the net interactive number of moles for mercury ion and the equilibrium constant, the enthalpy and negative Gibbs free energy could be calculated: Delta H-int = -6.8 +/- 0.11 to -6.0 +/- 0.22 kJ mol(-1); Delta(int)G = -20.5 +/- 0.25 to -23.2 +/- 0.22 kJ mol(-1). The thermodynamic values indicated the existence of favorable conditions for interactions at the solid-liquid interface.
C1 [Guerra, Denis L.; Silva, Ricardo A. R.; Mello, Ivani] Univ Fed Mato Grosso, Dept Mineral Resources, DRM ICET UFMT, BR-78060900 Cuiaba, Mato Grosso, Brazil.
RP Guerra, DL (reprint author), Univ Fed Mato Grosso, Dept Mineral Resources, DRM ICET UFMT, BR-78060900 Cuiaba, Mato Grosso, Brazil.
EM denis@cpd.ufmt.br
FU MCT; CNPq; CAPES
FX The authors are grateful to MCT, CNPq, and CAPES for financial support
   and fellowships.
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Arpa C, 2000, TURK J CHEM, V24, P209
   Corner EJH, 1932, T BRIT MYCOL SOC, V17, P51
   Diaz U, 2007, CHEM MATER, V19, P3686, DOI 10.1021/cm070553+
   Ernest MV, 1997, IND ENG CHEM RES, V36, P212, DOI 10.1021/ie960167u
   Ford RG, 2001, ADV AGRON, V74, P41, DOI 10.1016/S0065-2113(01)74030-8
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Guerra DL, 2011, CLAY CLAY MINER, V59, P568, DOI 10.1346/CCMN.2011.0590603
   Guerra DL, 2011, J CHEM THERMODYN, V43, P69, DOI 10.1016/j.jct.2010.08.008
   Guerra DL, 2009, MATER RES BULL, V44, P485, DOI 10.1016/j.materresbull.2008.08.002
   Guerra DL, 2006, POLYHEDRON, V25, P2880, DOI 10.1016/j.poly.2006.04.015
   Han RP, 2006, J HAZARD MATER, V133, P262, DOI 10.1016/j.jhazmat.2005.10.019
   Hassan SSM, 2008, J HAZARD MATER, V154, P992, DOI 10.1016/j.jhazmat.2007.11.003
   Herrero R, 2005, WATER RES, V39, P3199, DOI 10.1016/j.watres.2005.05.041
   Kanaan N., 2005, INDIAN J CHEM TECHN, V12, P522
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Lazarin AM, 2009, J CHEM THERMODYN, V41, P21, DOI 10.1016/j.jct.2008.08.005
   Malkoc E, 2005, J HAZARD MATER, V127, P120, DOI 10.1016/j.jhazmat.2005.06.030
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Malm O., 1996, INT J ROCK MECH MIN, V33, P376
   Miretzky P, 2005, CHEMOSPHERE, V60, P1583, DOI 10.1016/j.chemosphere.2005.02.050
   NRIAGU JO, 1992, NATURE, V356, P389, DOI 10.1038/356389a0
   Padmesh TVN, 2005, J HAZARD MATER, V125, P121, DOI 10.1016/j.jhazmat.2005.05.014
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Perez-Quintanilla D, 2006, J HAZARD MATER, V134, P245, DOI 10.1016/j.jhazmat.2005.11.004
   Ramadan H, 2010, CHEM ENG J, V159, P107, DOI 10.1016/j.cej.2010.02.051
   Saglam N, 1999, PROCESS BIOCHEM, V34, P725, DOI 10.1016/S0032-9592(98)00148-4
   Sari A, 2009, J HAZARD MATER, V171, P500, DOI 10.1016/j.jhazmat.2009.06.023
   Say R, 2008, J HAZARD MATER, V150, P560, DOI 10.1016/j.jhazmat.2007.03.089
   SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004
   Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6
   SHARMA DC, 1995, BIORESOURCE TECHNOL, V52, P261, DOI 10.1016/0960-8524(95)00035-D
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Svecova L, 2006, SEP PURIF TECHNOL, V52, P142, DOI 10.1016/j.seppur.2006.03.024
   Tan ZQ, 2011, FUEL, V90, P1471, DOI 10.1016/j.fuel.2010.12.004
   Tazaki K., 1987, APPL CLAY SCI, V2, P233
   Vela G. R., 1972, J BACTERIOL, V1, P260
   Xiaohong YU, 2008, Journal of Environmental Sciences, V20, P1328
   Xu X, 2009, COLLOID SURFACE B, V70, P46, DOI 10.1016/j.colsurfb.2008.12.006
   Yardim M., 2003, CHEMOSPHERE, V52, P35
   Yeddou N, 2005, DESALINATION, V185, P499, DOI 10.1016/j.desal.2005.04.053
   Zabihi M, 2009, J HAZARD MATER, V167, P230, DOI 10.1016/j.jhazmat.2008.12.108
NR 46
TC 4
Z9 4
U1 2
U2 12
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 1201-3080
J9 WATER QUAL RES J CAN
JI Water Qual. Res. J. Canada
PY 2013
VL 48
IS 2
BP 155
EP 170
DI 10.2166/wqrjc.2013.018
PG 16
WC Water Resources
SC Water Resources
GA 130XT
UT WOS:000317954200005
DA 2018-10-20
ER

PT J
AU Sun, LG
   Xie, ZY
   Zhao, YJ
   Wei, HM
   Gu, ZZ
AF Sun, Li-Guo
   Xie, Zhuo-Ying
   Zhao, Yuan-Jin
   Wei, Hong-Mei
   Gu, Zhong-Ze
TI Optical monitoring the degradation of PLGA inverse opal film
SO CHINESE CHEMICAL LETTERS
LA English
DT Article
DE PLGA inverse opal; Degradation; Optical monitoring
ID COLLOIDAL CRYSTAL BEADS; MULTIPLEX IMMUNOASSAY; PHOTONIC CRYSTALS;
   SCAFFOLDS; SUPPORTS
AB Implantable materials have broad applications in tissue engineering and in vivo sensors. It is essential to know the detailed information of the implantable materials during their degradation. In this paper, we developed a method to monitor the degradation process of a well-used biomaterial, poly(lactide-co-glycolide) (PLGA) by taking advantage of inverse opal structure. We found that mass loss, molecular weight and glass transition temperature of PLGA during the degradation process in Hank's artificial body fluid can be in situ monitored by measuring the optical properties of PLGA inverse opal. (C) 2013 Zhong-Ze Cu. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
C1 [Sun, Li-Guo; Xie, Zhuo-Ying; Zhao, Yuan-Jin; Wei, Hong-Mei; Gu, Zhong-Ze] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Sun, Li-Guo] Heilongjiang Univ, Sch Chem & Mat, Harbin 150080, Peoples R China.
RP Gu, ZZ (reprint author), Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM gu@seu.edu.cn
RI Zhao, Yuanjin/I-1861-2013; Xie, Zhuoying/C-5450-2011
OI Xie, Zhuoying/0000-0003-3534-1924
FU National Natural Science Foundation of China [51273056, 21202091,
   5121010502, 21074031]; Innovation Fellowship Foundation of Heilongjiang
   University [Hdtd2010-11]
FX The present study has been supported in by the National Natural Science
   Foundation of China (Nos. 51273056, 21202091, 5121010502, and 21074031)
   and Innovation Fellowship Foundation of Heilongjiang University (No.
   Hdtd2010-11).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Derx K.M., 1997, J PHARM SCI, V86, P126
   Dong YM, 2011, CHINESE CHEM LETT, V22, P209, DOI 10.1016/j.cclet.2010.10.010
   Han WJ, 2011, CHINESE CHEM LETT, V22, P139, DOI 10.1016/j.cclet.2010.10.001
   Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Li C, 2006, MAT SCI ENG A-STRUCT, V438, P504, DOI 10.1016/j.msea.2006.02.185
   Loo SCJ, 2005, BIOMATERIALS, V26, P2827, DOI 10.1016/j.biomaterials.2004.08.031
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Sumioka K, 2002, ADV MATER, V14, P1284, DOI 10.1002/1521-4095(20020916)14:18<1284::AID-ADMA1284>3.0.CO;2-1
   Sumner C, 2000, ANAL CHEM, V72, P5225, DOI 10.1021/ac000411y
   Xie ZY, 2012, THIN SOLID FILMS, V520, P4063, DOI 10.1016/j.tsf.2012.01.027
   Yang Y, 2005, ANALYST, V130, P1502, DOI 10.1039/b506911d
   Zhao XW, 2006, ANGEW CHEM INT EDIT, V45, P6835, DOI 10.1002/anie.200601302
   Zhao XW, 2006, CHEM MATER, V18, P2443, DOI 10.1021/cm060283f
   Zhao YJ, 2009, ANGEW CHEM INT EDIT, V48, P7350, DOI 10.1002/anie.200903472
   Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a
   Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098
   Zhao YJ, 2009, ADV MATER, V21, P569, DOI 10.1002/adma.200802339
NR 19
TC 3
Z9 3
U1 2
U2 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1001-8417
J9 CHINESE CHEM LETT
JI Chin. Chem. Lett.
PD JAN
PY 2013
VL 24
IS 1
BP 9
EP 12
DI 10.1016/j.cclet.2013.01.012
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 125HG
UT WOS:000317530300003
DA 2018-10-20
ER

PT J
AU Son, CH
   Bae, JH
   Shin, DY
   Lee, HR
   Choi, YH
   Yang, K
   Park, YS
AF Son, Cheol-Hun
   Bae, Jae-Ho
   Shin, Dong Yeok
   Lee, Hong-Rae
   Choi, Yung Hyun
   Yang, Kwangmo
   Park, You-Soo
TI Enhanced Maturation and Function of Dendritic Cells Using Hydrogel
   Coated Plate and Antigen Electroporation
SO IMMUNOLOGICAL INVESTIGATIONS
LA English
DT Article
DE Dendritic cells; Hydrogel coated plate; Electroporation
ID CANCER VACCINES; IMMUNOTHERAPY; IMMUNITY; GENERATION; KINETICS; IMPLANT;
   SPONGES; BIOLOGY; IMPACT
AB Dendritic cells (DCs) are potent antigen-presenting cells that can be matured in vitro from immature dendritic cells (iDCs) in the presence of several biological agents such as cytokine cocktail, CD40L, TNF-a and antigen loading, which are necessary and achieved using various protocols, such as lipofection, passive pulse or electroporation. However, these DCs maturation protocols may cause with a significant loss of cells because of cellular attachment and spreading during culturing. Some biomaterials that influence adhesion and development of cells have been used in cell culture techniques, and it was thought that they might be applied on the culture of DCs. In this study, we used polyHEMA, which is a hydrogel coating biomaterial that prevents DCs from adherence, and investigated whether hydrogel coating affects the maturation of iDCs. The efficiency in the generation of mDCs was improved through hydrogel coating procedure and a dendritic cell maturation marker, CD83, was significantly increased in hydrogel-coated culture condition. The antigen-loaded mDCs from electroporation were further expressed the CD83. The mDCs generated in the hydrogel-coated culture condition showed more, longer and thicker dendrites, and produced more amounts of cytokines such as IL-12 and IFN-gamma. Therefore, it was suggested that the hydrogel-coated culture condition could improve function of mDCs.
C1 [Son, Cheol-Hun; Shin, Dong Yeok; Lee, Hong-Rae; Yang, Kwangmo; Park, You-Soo] Dongnam Inst Radiol & Med Sci, Dept Res Ctr, Pusan 619953, South Korea.
   [Son, Cheol-Hun; Bae, Jae-Ho] Pusan Natl Univ, Dept Biochem, Sch Med, Yangsan 626870, South Korea.
   [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan, South Korea.
RP Park, YS (reprint author), Dongnam Inst Radiol & Med Sci, Dept Res Ctr, Jwadong Gil 40, Pusan 619953, South Korea.
EM biotek01@hanmail.net
FU National R&D Program through the Dong-nam Institute of Radiological &
   Medical Sciences (DIRAMS); Ministry of Education, Science and Technology
   [50590-2012]
FX This research was supported by the National R&D Program through the
   Dong-nam Institute of Radiological & Medical Sciences (DIRAMS) funded by
   the Ministry of Education, Science and Technology (code: 50590-2012).
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592
   Berger TG, 2005, J IMMUNOL METHODS, V298, P61, DOI 10.1016/j.jim.2004.01.005
   Brossart P, 2001, EXP HEMATOL, V29, P1247, DOI 10.1016/S0301-472X(01)00730-5
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   Choi YS, 2012, IMMUNOL INVEST, V41, P214, DOI 10.3109/08820139.2011.619022
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245
   Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205
   Hilpert F, 2005, SCAND J IMMUNOL, V62, P399, DOI 10.1111/j.1365-3083.2005.01677.x
   Ishri RK, 2006, IMMUNOL INVEST, V35, P1, DOI 10.1080/08820130500496746
   Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kim KW, 2004, CANCER IMMUNOL IMMUN, V53, P315, DOI 10.1007/s00262-003-0448-x
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1
   Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7
   Lombello CB, 2000, J MATER SCI-MATER M, V11, P541, DOI 10.1023/A:1008915801187
   Lombello CB, 2002, J MATER SCI-MATER M, V13, P867, DOI 10.1023/A:1016552413295
   Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261
   Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x
   Milano F, 2007, J IMMUNOL METHODS, V321, P94, DOI 10.1016/j.jim.2007.01.004
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   O'Neill DW, 2004, BLOOD, V104, P2235, DOI 10.1182/blood-2003-12-4392
   Osada T, 2006, INT REV IMMUNOL, V25, P377, DOI 10.1080/08830180600992456
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peppas N. A., 1987, HYDROGELS MED PHARM
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Shen XY, 2008, IMMUNOL INVEST, V37, P798, DOI 10.1080/08820130802403358
   Slobodin G, 2008, IMMUNOL INVEST, V37, P841, DOI 10.1080/08820130802438016
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   STEINMAN RM, 1993, ADV EXP MED BIOL, V329, P1
   Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001
   van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3
   Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49
   Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806
NR 42
TC 7
Z9 8
U1 2
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0882-0139
EI 1532-4311
J9 IMMUNOL INVEST
JI Immunol. Invest.
PY 2013
VL 42
IS 4
BP 341
EP 355
DI 10.3109/08820139.2012.757234
PG 15
WC Immunology
SC Immunology
GA 124SD
UT WOS:000317485200007
PM 23509890
DA 2018-10-20
ER

PT J
AU Kour, J
   Homagai, PL
   Cagnin, M
   Masi, A
   Pokhrel, MR
   Ghimire, KN
AF Kour, Jagjit
   Homagai, Puspa Lal
   Cagnin, Massimo
   Masi, Antonio
   Pokhrel, Megh Raj
   Ghimire, Kedar Nath
TI Adsorption of Cd (II), Cu (II), and Zn (II) from Aqueous Solution onto
   Nitrogen-Functionalized Desmostachya bipinnata
SO JOURNAL OF CHEMISTRY
LA English
DT Article
ID HEAVY-METAL REMOVAL; LOW-COST ADSORBENTS; WASTE-WATER; SUGARCANE
   BAGASSE; FUNGAL BIOMASS; BIOSORPTION; IONS; SAWDUST; CU(II); PARAMETERS
AB A very simple means of nitrogen functional group grafting onto the backbone of Desmostachya bipinnata is investigated, which is a sacrificial herb in the south Asian region particular to Hindu religion. This natural biomaterial is found to be very effective for metal binding, after treatment with hydrazine monohydrate. The present study explores a comparison of amination processes by considering several options. The maximum metal loading capacities for Cd, Cu, and Zn were found to be 76.80 mg/g, 72.10 mg/g, and 58.16 mg/g, respectively. The kinetic evaluation indicated that the adsorption of Cd, Cu, and Zn onto the biomaterials followed the pseudo second-order rate equation.
C1 [Kour, Jagjit; Homagai, Puspa Lal; Pokhrel, Megh Raj; Ghimire, Kedar Nath] Tribhuvan Univ, Cent Dept Chem, Kathmandu, Nepal.
   [Cagnin, Massimo; Masi, Antonio] Univ Padua, Dept Agr Biotechnol, Legnaro, Italy.
RP Kour, J (reprint author), Tribhuvan Univ, Cent Dept Chem, POB 5506, Kathmandu, Nepal.
EM jagjit_kour@hotmail.com
OI Masi, Antonio/0000-0003-0536-5984
FU Padua University; Tribhuvan University; University Grant Commission,
   Bhaktapur, Nepal
FX One of the authors J. Kour would like to thank the cultural and
   scientific agreement program between Padua University and Tribhuvan
   University (Professor Caravello and Professor Promod. K. Jha) for
   supporting this research work. The University Grant Commission,
   Bhaktapur, Nepal, is highly acknowledged for the Ph. D. fellowship.
CR Acar FN, 2006, J HAZARD MATER, V137, P909, DOI 10.1016/j.jhazmat.2006.03.014
   Ahmed SA, 2011, CARBOHYD POLYM, V83, P1470, DOI 10.1016/j.carbpol.2010.09.051
   Alluri HK, 2007, AFR J BIOTECHNOL, V6, P2924
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h
   Blazquez G, 2005, PROCESS BIOCHEM, V40, P2649, DOI 10.1016/j.procbio.2004.11.007
   Chakraborty S, 2006, BIORESOURCE TECHNOL, V97, P2407, DOI 10.1016/j.biortech.2005.10.010
   Chen SH, 2010, J COLLOID INTERF SCI, V349, P256, DOI 10.1016/j.jcis.2010.05.057
   Chergui A, 2007, DESALINATION, V206, P179, DOI 10.1016/j.desal.2006.03.566
   Deng SB, 2005, LANGMUIR, V21, P5940, DOI 10.1021/la047349a
   Deng SB, 2003, LANGMUIR, V19, P5058, DOI 10.1021/la034061x
   Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016
   Fang L, 2003, J CHEM TECHNOL BIOT, V78, P1038, DOI 10.1002/jctb.902
   Ghimire KN, 2007, SEPAR SCI TECHNOL, V42, P2003, DOI 10.1080/15363830701313461
   Ghimire KN, 2002, SEPAR SCI TECHNOL, V37, P2785, DOI 10.1081/SS-120005466
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Homagai P. L., 2009, J NEPAL CHEM SOC, V23, P102
   Homagai PL, 2011, SEP SCI TECHNOL, V46, P330, DOI 10.1080/01496395.2010.506903
   Karnitz O, 2007, BIORESOURCE TECHNOL, V98, P1291, DOI 10.1016/j.biortech.2006.05.013
   Khoo KM, 2001, BIOCHEM ENG J, V8, P51, DOI 10.1016/S1369-703X(00)00134-0
   Kumar A, 2000, BIORESOURCE TECHNOL, V71, P133, DOI 10.1016/S0960-8524(99)00064-4
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Mahvi A. H., 2005, American Journal of Applied Sciences, V2, P372
   Memon SQ, 2007, J HAZARD MATER, V139, P116, DOI 10.1016/j.jhazmat.2006.06.013
   MORRISON RT, 1994, ORGANIC CHEM
   Moussavi G, 2010, J HAZARD MATER, V183, P724, DOI 10.1016/j.jhazmat.2010.07.086
   Sankararamakrishnan N, 2006, CARBOHYD POLYM, V66, P160, DOI 10.1016/j.carbpol.2006.02.035
   Sciban M, 2006, J HAZARD MATER, V136, P266, DOI 10.1016/j.jhazment.2005.12.009
   Shriner R. L., 1998, SYSTEMATIC IDENTIFIC
   Shukla SR, 2005, BIORESOURCE TECHNOL, V96, P1430, DOI 10.1016/j.biortech.2004.12.010
   Silverstein R. M., 1981, SPECTROMETRIC IDENTI
   Sun G, 1998, IND ENG CHEM RES, V37, P1324, DOI 10.1021/ie970468j
   Tan TW, 2003, APPL BIOCHEM BIOTECH, V104, P119, DOI 10.1385/ABAB:104:2:119
   Thirumavalavan M, 2010, J CHEM ENG DATA, V55, P1186, DOI 10.1021/je900585t
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
NR 36
TC 4
Z9 4
U1 6
U2 15
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2090-9063
EI 2090-9071
J9 J CHEM-NY
JI J. Chem.
PY 2013
AR 649142
DI 10.1155/2013/649142
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 128GK
UT WOS:000317757100001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Grumezescu, AM
   Andronescu, E
   Albu, MG
   Ficai, A
   Bleotu, C
   Dragu, D
   Lazar, V
AF Grumezescu, Alexandru Mihai
   Andronescu, Ecaterina
   Albu, Madalina Georgiana
   Ficai, Anton
   Bleotu, Coralia
   Dragu, Denisa
   Lazar, Veronica
TI Wound Dressing Based Collagen Biomaterials Containing Usnic Acid as
   Quorum Sensing Inhibitor Agent: Synthesis, Characterization and
   Bioevaluation
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Collagen biomaterial; Wound dressing; Usnic acid; Anti-biofilm
ID TISSUE REGENERATION; SKIN SUBSTITUTES; FT-IR; DEXTRAN; HYDROGELS;
   BIOFILMS; DELIVERY; CELLS
AB The aims of this research were to obtain improved wound dressings based on collagen (COLL), polysaccharides (dextran=DEX, diethylaminoethyl-cellulose= DEAEC), silica network and usnic acid, as quorum sensing inhibitor. FT-IR, SEM, interaction with eukaryotic cells and a novel protocol to evaluate the antimicrobial activity of the new wound dressing, firstly reported in literature were used for the characterization of fabricated wound dressings. The obtained wound dressings are not cytotoxic, do not influences the mesenchymal stem and exhibit good anti-biofilm properties. Taken together, these results are suggesting that the new systems can be safely used for local applications on the lesional tissues.
C1 [Grumezescu, Alexandru Mihai; Andronescu, Ecaterina; Ficai, Anton] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Sci & Engn Oxid Mat & Nanomat, Bucharest 011061, Romania.
   [Albu, Madalina Georgiana] INCDTP Leather & Footwear Res Inst, Collagen Dept, Bucharest 031215, Romania.
   [Bleotu, Coralia; Dragu, Denisa] Stefan Nicolau Inst Virol, Bucharest 030304, Romania.
   [Bleotu, Coralia; Lazar, Veronica] Univ Bucharest, Fac Biol, Dept Microbiol, Bucharest 060101, Romania.
RP Andronescu, E (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Sci & Engn Oxid Mat & Nanomat, Polizu St 1-7, Bucharest 011061, Romania.
EM ec_andronescu@yahoo.com
RI Dragu, Denisa/I-3095-2015
OI Dragu, Denisa/0000-0002-5868-2636; Ecaterina,
   Andronescu/0000-0002-7325-9115; Albu, Madalina
   Georgiana/0000-0001-9960-2244; FICAI, Anton/0000-0002-1777-0525
FU Human Resources [135/2010, 76/29.07.2010]
FX The results presented in this work were supported by the Human Resources
   135/2010 grant (Contract no. 76/29.07.2010).
CR Albu MG, 2012, J MATER RES, V27, P1086, DOI 10.1557/jmr.2012.21
   Ambrogio MW, 2011, ACCOUNTS CHEM RES, V44, P903, DOI 10.1021/ar200018x
   Andronescu E, 2012, BIOINTERFACE RES APP, V2, P332
   Andronescu E, 2011, J ELECTRON MICROSC, V60, P253, DOI 10.1093/jmicro/dfr010
   Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x
   Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc
   Butun S, 2011, CARBOHYD POLYM, V86, P636, DOI 10.1016/j.carbpol.2011.05.001
   Carlmark A., 2012, EUROPEAN POL J
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Chen FM, 2006, J CONTROL RELEASE, V114, P209, DOI 10.1016/hj.jconrel.2006.05.014
   Chifiriuc Mariana Carmen, 2009, Roum Arch Microbiol Immunol, V68, P215
   CLARK RAF, 2000, PRINCIPLES TISSUE EN, P857
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Dhanasingh S, 2011, BIOINTERFACE RES APP, V1, P48
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   Fang GY, 2011, SOL ENERG MAT SOL C, V95, P1875, DOI 10.1016/j.solmat.2011.02.010
   Fiorica C, 2011, INT J PHARMACEUT, V414, P104, DOI 10.1016/j.ijpharm.2011.05.002
   Francolini I, 2004, ANTIMICROB AGENTS CH, V48, P4360, DOI 10.1128/AAC.48.11.4360-4365.2004
   Grumezescu A.M., 2012, LETT APPL NANOBIOSCI, V1, P14
   Grumezescu AM, 2011, BIOINTERFACE RES APP, V1, P160
   Grumezescu AM, 2011, IEEE T NANOBIOSCI, V10, P269, DOI 10.1109/TNB.2011.2178263
   Holban AM, 2011, BIOINTERFACE RES APP, V1, P95
   Kim JE, 2012, ARCH TOXICOL, V86, P685, DOI 10.1007/s00204-011-0773-3
   Kinnari P, 2011, INT J PHARMACEUT, V414, P148, DOI 10.1016/j.ijpharm.2011.05.021
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kolakovic R., 2012, EUROPEAN J IN PRESS
   Lechowski Z, 2006, ENVIRON EXP BOT, V56, P239, DOI 10.1016/j.envexpbot.2005.03.001
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Medeiros SF, 2011, INT J PHARMACEUT, V403, P139, DOI 10.1016/j.ijpharm.2010.10.011
   Metreveli NO, 2010, ECOTOX ENVIRON SAFE, V73, P448, DOI 10.1016/j.ecoenv.2009.12.005
   Mihaiescu D. E., 2012, LETT APPL NANOBIOSCI, V1, P45
   Ngolfsdottir K., 2002, PHYTOCHEMISTRY, V61, P729
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Ramli NA, 2011, INT J PHARMACEUT, V403, P73, DOI 10.1016/j.ijpharm.2010.10.023
   Saviuc C, 2011, BIOINTERFACE RES APP, V1, P31
   Seth A.K., 2012, J SURG RES, P1
   Shen SC, 2011, INT J PHARMACEUT, V410, P188, DOI 10.1016/j.ijpharm.2011.03.018
   Sirbu-Boeti MP, 2009, CHIRURGIA-BUCHAREST, V104, P55
   Snelgrove RJ, 2011, TRENDS IMMUNOL, V32, P328, DOI 10.1016/j.it.2011.04.006
   Subhasree R.S., 2012, LETT APPL NANOBIOSCI, V1, P2
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
NR 44
TC 9
Z9 9
U1 1
U2 28
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PD JAN
PY 2013
VL 17
IS 2
BP 125
EP 131
PG 7
WC Chemistry, Organic
SC Chemistry
GA 121VU
UT WOS:000317273500006
DA 2018-10-20
ER

PT J
AU Szponder, T
   Mytnik, E
   Jaegermann, Z
AF Szponder, Tomasz
   Mytnik, Ewa
   Jaegermann, Zbigniew
TI USE OF CALCIUM SULFATE AS A BIOMATERIAL IN THE TREATMENT OF BONE
   FRACTURES IN RABBITS - PRELIMINARY STUDIES
SO BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY
LA English
DT Article
DE animal model; bone fracture; calcium sulfate; bone union
ID GRAFT SUBSTITUTE; DELIVERY
AB The paper presents preliminary results of the implantation of calcium sulfate type Hartform HF1 developed at the Institute of Glass and Ceramics in Warsaw. The study was conducted on 10 New Zealand White rabbits, in which after tibial osteotomy the biomaterial was implanted directly into the fracture site. The animals were divided into two groups based on the method of fracture stabilisation: intramedullary pinning using Kirschner wires in one group and acrylic external fixator in the other. After 12 weeks, bone union was observed in all animals as estimated by clinical and radiological findings. Histological tests revealed resorption of the biomaterial into the bone fracture area. It was concluded that type Hartform 1 calcium sulfate can be used as a biomaterial in veterinary orthopedics. Due to the lack of observable side effects during implantation and resorption, the material can be considered as a valuable ingredient in composite biomaterials containing calcium sulfate.
C1 [Szponder, Tomasz] Univ Life Sci, Fac Vet Med, Dept & Clin Anim Surg, PL-20950 Lublin, Poland.
   [Mytnik, Ewa] Univ Environm & Life Sci, Fac Vet Med, Dept Anim Physiol & Biostruct, PL-50375 Wroclaw, Poland.
   [Jaegermann, Zbigniew] Inst Glass & Ceram, Dept Bioceram, PL-02676 Warsaw, Poland.
RP Szponder, T (reprint author), Univ Life Sci, Fac Vet Med, Dept & Clin Anim Surg, PL-20950 Lublin, Poland.
EM tomszpon@op.pl
CR Allison D, 2011, US ONCOL HEMATOL, V7, P38
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Buhite R., 2007, J TRANSL MED, V5, P13
   Chen ZG, 2011, J BIOMED MATER RES A, V99A, P554, DOI 10.1002/jbm.a.33212
   Lee Gregory H, 2002, Iowa Orthop J, V22, P35
   Nystrom Lukas, 2008, Iowa Orthop J, V28, P81
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Parker AC, 2011, CLIN ORTHOP RELAT R, V469, P3008, DOI 10.1007/s11999-011-1911-1
   Peters C.L., 2005, WILEY INTERSCI, V10.1002, P456
   Petruskevicius J, 2002, ACTA ORTHOP SCAND, V73, P575, DOI 10.1080/000164702321022875
   Robinson D, 1999, Ann Transplant, V4, P91
   Strocchi Rita, 2002, J Oral Implantol, V28, P273, DOI 10.1563/1548-1336(2002)028<0273:BRWCSE>2.3.CO;2
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Tang ML, 2010, MAT SCI ENG C-MATER, V30, P1107, DOI 10.1016/j.msec.2010.06.006
   Thomas MV, 2008, J BIOMED MATER RES B, V88B, P597
   Turner TM, 2001, J BONE JOINT SURG AM, V83A, P8, DOI 10.2106/00004623-200100021-00003
NR 16
TC 0
Z9 0
U1 0
U2 9
PU NATL VETERINARY RESEARCH INST
PI PULAWY
PA C/O PUBICATIONS OFFICE, 24-100 PULAWY, POLAND
SN 0042-4870
J9 B VET I PULAWY
JI Bull. Vet. Inst. Pulawy
PY 2013
VL 57
IS 1
BP 119
EP 122
DI 10.2478/bvip-2013-0022
PG 4
GA 117AR
UT WOS:000316925000022
OA Other Gold
DA 2018-10-20
ER

PT J
AU Tete, S
   Vinci, R
   Zizzari, VL
   Zara, S
   La Scala, V
   Cataldi, A
   Gherlone, E
   Piattelli, A
AF Tete, S.
   Vinci, R.
   Zizzari, V. L.
   Zara, S.
   La Scala, V.
   Cataldi, A.
   Gherlone, E.
   Piattelli, A.
TI Maxillary sinus augmentation procedures through equine-derived
   biomaterial or calvaria autologous bone: immunohistochemical evaluation
   of OPG/RANKL in humans
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE osteoconduction; OPG/RANKL ratio; biomaterial resorption; integration
   bone graft; calvaria; equine-derived biomaterial
ID GROWTH-FACTOR; RECONSTRUCTION; GRAFT; OSTEOPROTEGERIN; REGENERATION;
   LIGAND
AB Autologous bone is considered the gold standard for bone regeneration, even if different heterologous bone substitutes have been proposed to overcome the limits related to its use. The aim of this study was to analyze and to compare the molecular events switched on by autologous or heterologous bone graft insertion, focusing on TGF beta 1 expression and OPG/RANKL ratio, to analyze resorption process, and estimating graft vascularization, new bone tissue deposition and its mineralization, through VEGF, BSP and SPARC expression evaluation, respectively. Patients needing pre-prosthetic rehabilitation of the posterior maxilla were treated using an equine-derived biomaterial (Group 1) or calvaria autologous bone (Group 2), according to the morphology of the bone defect. Bone graft integration was evaluated on bone samples obtained from the treated areas at the moment of dental implant insertion, by morphological and immunohistochemical analyses for TGF beta 1, OPG, RANKL, VEGF, BSP, and SPARC expression. Morphological analysis shows the presence of biomaterial residual granules in Group 1, in parallel to a good integration between graft and host tissue. Moderate TGF beta 1 expression is seen in both Group 1 and Group 2. OPG/RANKL ratio appears higher in Group 1; VEGF expression appears very strong in Group 1 and strong in Group 2, while BSP and SPARC expression results weak in Group 1 and moderate in Group 2. Our results reveal the good integration between both types of graft and the host tissue, even though autologous graft seems to produce a faster regenerative process, as evidenced by the different expression of the investigated molecules. According to these observations, the clinical use of heterologous particulate equine-derived biomaterial may ensure long-term predictability of implant-prosthetic rehabilitation, comparable to that obtained with autologous bone graft.
C1 [Tete, S.; Piattelli, A.] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Vinci, R.; Gherlone, E.] Univ Ateneo Vita Salute S Raffaele, Dept Oral Sci, Milan, Italy.
   [Zizzari, V. L.; Zara, S.; Cataldi, A.] Univ G dAnnunzio, Dept Pharm, Chieti, Italy.
RP Zara, S (reprint author), Univ G dAnnunzio, Dept Pharm, Via Vestini 31, I-66100 Chieti, CH, Italy.
EM s.zara@unich.it
RI Gherlone, Enrico/M-7376-2016
FU FIRB
FX the authors wish to thank FIRB-Accordi di Programma 2010 Project
   Processi degenerativi dei tessuti mineralizzati del cavo orale, impiego
   di biomateriali e controllo delle interazioni con i microrganismi
   dell'ambiente, Prof A. Cataldi, for the fellowship attributed to Dr. V.
   L. Zizzari.
CR Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Alvarez L, 2003, ARTHRITIS RHEUM, V48, P824, DOI 10.1002/art.10834
   Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Fonseca JE, 2005, CLIN EXP RHEUMATOL, V23, P185
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Gerber HP, 1999, NAT MED, V5, P623
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gutta R, 2009, INT J ORAL MAX IMPL, V24, P131
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jensen OT, 2006, SINUS BONE GRAFT
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Musumeci G, 2011, EUR J HISTOCHEM, V55, P162, DOI 10.4081/ejh.2011.e31
   Musumeci G, 2012, ACTA HISTOCHEM, V114, P805, DOI 10.1016/j.acthis.2012.02.001
   Perrotti V, 2009, CLIN ORAL IMPLAN RES, V20, P17, DOI 10.1111/j.1600-0501.2008.01608.x
   Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787
   Raynal C, 1996, ENDOCRINOLOGY, V137, P2347, DOI 10.1210/en.137.6.2347
   Tete S, 2009, INT J IMMUNOPATH PH, V22, P1105, DOI 10.1177/039463200902200427
   Tete S, 2011, J CRANIOFAC SURG, V22, P1702, DOI 10.1097/SCS.0b013e31822e5cbd
   Tete S, 2010, J CRANIOFAC SURG, V21, P1147, DOI 10.1097/SCS.0b013e3181e484a7
   Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153
   van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009
NR 29
TC 15
Z9 15
U1 0
U2 5
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1121-760X
EI 2038-8306
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 2013
VL 57
IS 1
BP 60
EP 65
DI 10.4081/ejh.2013.e10
PG 6
WC Cell Biology
SC Cell Biology
GA 117XO
UT WOS:000316986800011
PM 23549459
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wein, F
   Bruinink, A
AF Wein, Frederik
   Bruinink, Arie
TI Human triple cell co-culture for evaluation of bone implant materials
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; HUMAN OSTEOPROGENITORS;
   REGENERATIVE MEDICINE; OSTEOBLASTS; DIFFERENTIATION; CHONDROCYTES;
   INTERFACE; CULTURE; COMMUNICATION
AB Central to the formation of tissue at implant surfaces are the interactions between multiple cell types including fibroblasts, endothelial cells and, in the case of bone, cells of the osteoblastic lineage. To date the importance of population dynamics and interactions have been largely neglected in the in vitro evaluation of biomaterials. To fill this gap we have developed a co-culture system using 3 cell types, primary human bone marrow stromal cells (HBMC), microvascular endothelial cells (HMVEC) and abdominal dermal fibroblasts (HDF). Proliferation of each cell type separately and differentiation of HBMC were determined by flow cytometry analysis. The medium used promoted HBMC differentiation toward osteoblasts without affecting the state of differentiation of HDF and HMVEC. Furthermore, HBMC are strongly affected by HDF and HMVEC, and vice versa. When used on a titanium coated substrate the triple cell culture system identified preferential HBMC proliferation relative to HDF if HMVEC was present. This developed culture system represents a new, optimised and potentially predictive approach to evaluate biomaterial biocompatibility early in development.
C1 [Wein, Frederik; Bruinink, Arie] EMPA Mat Sci & Technol, Mat Biol Interact Lab, CH-9014 St Gallen, Switzerland.
RP Wein, F (reprint author), EMPA Mat Sci & Technol, Mat Biol Interact Lab, Lerchenfeldstr 5, CH-9014 St Gallen, Switzerland.
EM arie.bruinink@empa.ch
RI Wein, Frederik/S-7637-2017
OI Wein, Frederik/0000-0002-3762-1551
FU EC FP7 Magister project [NMP3-LA-2008-214685]
FX We would like to thank the Kantonsspital St. Gallen for providing the
   human tissue samples. We thank Dr G. Sebastien (Empa, CH) for titanium
   coating of the cell culture dishes and Prof. Dr D. Salter (Uni
   Edinburgh, UK) for critical reading of the manuscript. This work has
   been supported by EC FP7 Magister project contract no.
   NMP3-LA-2008-214685.
CR Agrawal C. M., 2011, ANN BIOMED ENG, V39, P2601
   Aguilar-Vazquez R, 2008, REV INVEST CLIN, V60, P496
   Amberg M, 2010, J ADHES SCI TECHNOL, V24, P123, DOI 10.1163/016942409X12538812479159
   ANDERSON JM, 2000, BONE ENG, P81
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Bruinink A, 2012, ADV BIOCHEM ENG BIOT, V126, P117, DOI 10.1007/10_2011_111
   Burguera EF, 2010, EUR CELLS MATER, V19, P166, DOI 10.22203/eCM.v019a17
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Finkenzeller G, 2006, TISSUE ENG, V12, P2889, DOI 10.1089/ten.2006.12.2889
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Hegemann D, 2009, MATER TECHNOL, V24, P41, DOI 10.1179/175355509X417981
   Hollinger J. O., 2006, INTRO BIOMATERIALS, V15, P63
   Ireland DC, 2004, J CELL BIOCHEM, V91, P594, DOI 10.1002/jcb.10756
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8
   KAMALIA N, 1992, J HISTOCHEM CYTOCHEM, V40, P1059, DOI 10.1177/40.7.1376742
   Kirkpatrick CJ, 2006, ARTIF ORGANS, V30, P822, DOI 10.1111/j.1525-1594.2006.00306.x
   Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Leclerc N, 2005, ARTHRITIS RHEUM, V52, P929, DOI 10.1002/art.20872
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ma JL, 2011, TISSUE ENG PART C-ME, V17, P349, DOI [10.1089/ten.tec.2010.0215, 10.1089/ten.TEC.2010.0215]
   Mair B, 2007, CLIN ORAL IMPLAN RES, V18, P370, DOI 10.1111/j.1600-0501.2006.01319.x
   Meury T, 2006, J CELL BIOCHEM, V98, P992, DOI 10.1002/jcb.20818
   NEVO Z, 1993, CELL BIOL INT, V17, P255, DOI 10.1006/cbir.1993.1062
   Oreffo ROC, 1998, CLIN SCI, V94, P549, DOI 10.1042/cs0940549
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Saleh FA, 2011, STEM CELLS DEV, V20, P391, DOI 10.1089/scd.2010.0168
   Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Scutt A. M., 2002, J CELL PHYSL, V193, P164
   Sharma C. P., 2010, BIOINTEGRATION MED I, P1
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001
   Spalazzi JP, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1256269
   Tsangari H, 2006, BONE, V39, P1226, DOI 10.1016/j.bone.2006.06.019
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475
   Zhang Y, 2010, DENT MATER, V26, P1043, DOI 10.1016/j.dental.2010.07.003
NR 46
TC 5
Z9 5
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2013
VL 5
IS 4
BP 703
EP 711
DI 10.1039/c3ib20250j
PG 9
WC Cell Biology
SC Cell Biology
GA 113TX
UT WOS:000316692700007
PM 23420382
DA 2018-10-20
ER

PT J
AU Tyliszczak, B
   Sobczak-Kupiec, AL
   Bialik-Was, K
   Kuciel, S
AF Tyliszczak, Bozena
   Sobczak-Kupiec, Agnieszka Lucyna
   Bialik-Was, Katarzyna
   Kuciel, Stanislaw
TI Dispersion and stability of tricalcium phosphate powders in polyacrylate
   dispersions
SO MICRO & NANO LETTERS
LA English
DT Article
ID CALCIUM ORTHOPHOSPHATE CEMENTS; SILVER NANOPARTICLES; TITANIA PIGMENT;
   BIOMEDICAL APPLICATION; HYDROXYAPATITE; COMPOSITES; PARTICLES;
   SUSPENSIONS; POLYMERS
AB Biomaterials is a term used to indicate materials that constitute parts of medical implants, extracorporeal devices, and disposables that have been utilised in medicine, surgery, dentistry and veterinary medicine as well as in every aspect of patient health care. Ceramics biomaterials are used as components of hip implants, dental implants, middle ear implants and heart valves. Porous or particulate calcium phosphate ceramic materials such as tricalcium phosphate (TCP) have proved successful for resorbable hard tissue replacements when low loads are applied to the material. The aim of the present work was to evaluate the biological characteristics of the biomaterial developed. Interactions of TCP with polyacrylate polymers in aqueous dispersions were characterised using X-ray diffraction, Fourier transform infrared spectroscopy, pH determination and viscosity measurements.
C1 [Tyliszczak, Bozena; Bialik-Was, Katarzyna] Cracow Univ Technol, Dept Chem & Technol Polymers, PL-31155 Krakow, Poland.
   [Sobczak-Kupiec, Agnieszka Lucyna] Cracow Univ Technol, Inst Inorgan Chem & Technol, PL-31155 Krakow, Poland.
   [Kuciel, Stanislaw] Cracow Univ Technol, Inst Mat Engn, PL-31864 Krakow, Poland.
RP Tyliszczak, B (reprint author), Cracow Univ Technol, Dept Chem & Technol Polymers, Warszawska 24, PL-31155 Krakow, Poland.
EM btyliszczak@chemia.pk.edu.pl
RI Tyliszczak, Bozena/E-3717-2014; Sobczak-Kupiec, Agieszka/N-2799-2013
OI Tyliszczak, Bozena/0000-0002-2761-6185; Kuciel,
   Stanislaw/0000-0001-9244-7499; Sobczak-Kupiec,
   Agnieszka/0000-0003-0005-6146
CR Baklouti S, 2003, J EUR CERAM SOC, V23, P905, DOI 10.1016/S0955-2219(02)00208-X
   Beruto DT, 2002, BIOMATERIALS, V23, P2509, DOI 10.1016/S0142-9612(01)00385-4
   Bialik-Was K, 2012, DIG J NANOMATER BIOS, V7, P361
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2009, MATERIALS, V2, P221, DOI 10.3390/ma2010221
   Farrokhpay S, 2005, COLLOID SURFACE A, V253, P183, DOI 10.1016/j.colsurfa.2004.11.019
   Farrokhpay S, 2009, ADV COLLOID INTERFAC, V151, P24, DOI 10.1016/j.cis.2009.07.004
   Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478
   Harzallah OA, 2003, RHEOL ACTA, V42, P10, DOI 10.1007/s00397-002-0250-2
   Huynh L, 2001, COLLOID SURFACE A, V190, P35, DOI 10.1016/S0927-7757(01)00663-X
   Ignjatovic N, 2008, ADV APPL CERAM, V107, P142, DOI 10.1179/174367608X263421
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   Krupa-Zuczek K, 2011, DIG J NANOMATER BIOS, V6, P1725
   Landsdown ABG, 2002, J WOUND CARE, V11, P125
   Leeuwenburgh SCG, 2010, ACTA BIOMATER, V6, P836, DOI 10.1016/j.actbio.2009.09.005
   Leeuwenburgh SCG, 2008, BIOMATERIALS, V29, P3047, DOI 10.1016/j.biomaterials.2008.04.032
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ratner B.D., 2004, BIOMATERIALS SCI
   Richard III J. W., 2002, J BURNS SURG WOUND C, V1, P11
   Satyavani K, 2011, DIG J NANOMATER BIOS, V6, P1019
   Sobczak-Kupiec A, 2011, MICRO NANO LETT, V6, P656, DOI 10.1049/mnl.2011.0152
   Sobczak-Kupiec A, 2010, TECH T CHEM 1, V10, P309
   Sobczak-Kupiec A, 2012, DIG J NANOMATER BIOS, V7, P459
   Taylor ML, 2003, J COLLOID INTERF SCI, V262, P81, DOI 10.1016/S0021-9797(03)00212-1
   Thamaraiselvi TV, 2004, TRENDS BIOMATER ARTI, V19, P9
   Traiphol N, 2010, CERAM INT, V36, P2147, DOI 10.1016/j.ceramint.2010.05.018
   Tyliszczak B, 2011, DIG J NANOMATER BIOS, V6, P1763
   Tyliszczak B, 2011, PRZEM CHEM, V90, P1396
NR 36
TC 0
Z9 0
U1 1
U2 21
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD JAN
PY 2013
VL 8
IS 1
BP 39
EP 42
DI 10.1049/mnl.2012.0740
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 117JX
UT WOS:000316950600011
DA 2018-10-20
ER

PT S
AU Stodolak-Zych, E
   Szumera, M
   Blazewicz, M
AF Stodolak-Zych, Ewa
   Szumera, Magdalena
   Blazewicz, Marta
BE Pinto, AMP
   Pouzada, AS
TI Osteoconductive Nanocomposite Materials for Bone Regeneration
SO ADVANCED MATERIALS FORUM VI, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Materials Symposium (MATERIALS 2011)/15th Meeting of
   SPM
CY APR 18-20, 2011
CL Univ Minho, Guimaraes, PORTUGAL
SP Portuguese Mat Soc, Univ Minho, Sch Engn, Portuguese Fdn Sci & Technol, Ctr Mech & Mat Technol, Inst Polym & Composites, 3Bs Res Grp Biomaterials Biodegradables & Biomimet, Minho Univ, Ctr Phys, Um, Sch Sci, TecMinho, Town Hall Guimaraes, Beneq, Celoplas, Filsat, Izasa, Leica MicroSystems, Mario Costa Martins & Filho Lda, Panalytical, ScienTec
HO Univ Minho
DE polymer-base nanocomposite; nanoparticles; bioactivity; osteoconductive;
   osteoinductive
ID APATITE FORMATION; BIOACTIVITY
AB Bone defect is one of the most important problem in orthopaedic therapy in which application of a biomaterial filling is necessary. Such material should be biocompatible, osteoconductive and porous as well as bioactive and compatible with the bone tissue. Subject of the work was investigations on nanocomposite membrane materials which consisted on synthetic polymer - poly-e-caprolactone (PCL) matrix and ceramic nanoparticles; tricalcium phosphate (TCP) and silica (SiO2) as a nano-filler. The nanocomposite membrane materials were produced by two-step dispersion of the nanoparticles in the biopolymer matrix. Characteristic of nanoparticles were made using transmission electron microscope (TEM), distribution of nanoparticles size (DLS) and specific surface area (BET). The morphology of nanocomposites and homogenous distribution of nanoadditives were made using scanning electron microscope with EDS analysis. Introduction of the nanofillers into the polymer matrix was monitored by thermal analysis method (TG-DCS). It was shown that the TCP nanoparticles affected stronger pore size and distribution but also the polymer structure (crystallity, physicochemical properties of the surface). Treatment of the nanocomposite samples in the simulated body fluid (SBF) induced some changes on the surface of the material containing bioactive ceramic nanoparticles. The results of the tests with SBF showed that the material is able to produce apatite structure on its surface (EDS analysis)
C1 [Stodolak-Zych, Ewa; Blazewicz, Marta] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Al Mickiewicza 30, PL-30059 Krakow, Poland.
   [Szumera, Magdalena] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Adv Ceram, PL-30059 Krakow, Poland.
RP Stodolak-Zych, E (reprint author), AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Al Mickiewicza 30, PL-30059 Krakow, Poland.
EM stodolak@agh.edu.pl; szumera@agh.edu.pl; mblazew@agh.edu.pl
OI Stodolak-Zych, Ewa/0000-0002-8935-4811
CR Asian M., 2004, J CONT DENT PRACT, V5, P1
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   KAWAKAMI T, 1992, BIOMATERIALS, V13, P759, DOI 10.1016/0142-9612(92)90014-F
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kotela I, 2009, CERAM INT, V35, P2475, DOI 10.1016/j.ceramint.2009.02.016
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Oliveira AL, 2003, KEY ENG MAT, V240-2, P111, DOI 10.4028/www.scientific.net/KEM.240-242.111
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Stodolak E, 2009, J PHYS CONF SER, V146, DOI 10.1088/1742-6596/146/1/012026
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 15
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 730-732
BP 38
EP +
DI 10.4028/www.scientific.net/MSF.730-732.38
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BDX70
UT WOS:000315545200007
DA 2018-10-20
ER

PT S
AU Gonzalez-Obeso, C
   Song, WL
   Rodriguez-Perez, MA
   Mano, JF
AF Gonzalez-Obeso, Constancio
   Song, Wenlong
   Rodriguez-Perez, Miguel A.
   Mano, Joao F.
BE Pinto, AMP
   Pouzada, AS
TI Superhydrophobic to Superhydrophylic Biomimetic Poly(3-Hydroxybutyrate)
   Surfaces Made by Phase Inversion
SO ADVANCED MATERIALS FORUM VI, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Materials Symposium (MATERIALS 2011)/15th Meeting of
   SPM
CY APR 18-20, 2011
CL Univ Minho, Guimaraes, PORTUGAL
SP Portuguese Mat Soc, Univ Minho, Sch Engn, Portuguese Fdn Sci & Technol, Ctr Mech & Mat Technol, Inst Polym & Composites, 3Bs Res Grp Biomaterials Biodegradables & Biomimet, Minho Univ, Ctr Phys, Um, Sch Sci, TecMinho, Town Hall Guimaraes, Beneq, Celoplas, Filsat, Izasa, Leica MicroSystems, Mario Costa Martins & Filho Lda, Panalytical, ScienTec
HO Univ Minho
DE Poly(3-hydroxybutyrate); superhydrophobic; superhydrophilic; phase
   inversion; biomaterial; plasma; contact angle modification
ID POLYSTYRENE
AB Biodegradable and biocompatible materials have gained increased attentions because of their applications in biomedicine and tissue engineering. Among them, poly(3-hydroxybutyrate) (PHB), a natural origin polymer, has been employed in biomedical applications as a suitable substitute of synthetic polymers for preparing scaffolds and other devices. In this context it is relevant to understand the interactions between the cells and PHB surfaces, which are governed by aspects such as surface topography and chemical composition. Both, surface topography and chemistry determine surface wettability. The aim of this work is to process PHB surfaces exhibiting extreme wettablility properties, ranging from superhydrophobic (surface contact angle higher than 150 degrees) to superhydrophilic (surface contact angle lower than 5 degrees). A simple phase inversion method was used to fabricate surperhydrophobic PHB surface. Chloroform was used as solvent, and a mixture of water and ethanol as the coagulation bath. The water contact angle was found to be 154.3 +/- 2.9 degrees. Furthermore the surface was treated by argon plasma for different times, permitting the control of wettability of the PHB surface from the superhydrophobic to superhydrophilic regime.
C1 [Gonzalez-Obeso, Constancio; Song, Wenlong; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
   [Gonzalez-Obeso, Constancio; Song, Wenlong; Mano, Joao F.] 3Bs PT Govt Associate Lab, ICVS, Braga, Portugal.
   [Gonzalez-Obeso, Constancio; Rodriguez-Perez, Miguel A.] Univ Valladolid, Fac Ciencias, Dept Condensed Matter Phys, Cellular Mat Lab CellMat, Valladolid 47011, Spain.
RP Gonzalez-Obeso, C (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM constancito@gmail.com; marrod@fmc.uva.es; jmano@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Group, 3Bs/E-4374-2012; Song,
   Wenlong/C-2799-2013
OI Mano, Joao/0000-0002-2342-3765; Group, 3Bs/0000-0002-5195-3456; 
CR Alves NM, 2009, J BIOMED MATER RES A, V91A, P480, DOI 10.1002/jbm.a.32210
   Bhushan B, 2007, ULTRAMICROSCOPY, V107, P1033, DOI 10.1016/j.ultramic.2007.05.002
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Gao LC, 2006, LANGMUIR, V22, P2966, DOI 10.1021/la0532149
   Guo ZG, 2011, J COLLOID INTERF SCI, V353, P335, DOI 10.1016/j.jcis.2010.08.047
   Guruvenket S, 2004, APPL SURF SCI, V236, P278, DOI 10.1016/j.apsusc.2004.04.033
   Neto AI, 2011, SOFT MATTER, V7, P4147, DOI 10.1039/c1sm05169e
   Oliveira NM, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.085205
   Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01
   Reverchon E, 2008, J SUPERCRIT FLUID, V47, P70, DOI 10.1016/j.supflu.2008.06.002
   Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p
   Sajadinia SH, 2010, J COLLOID INTERF SCI, V344, P575, DOI 10.1016/j.jcis.2009.12.058
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Song WL, 2010, CARBOHYD POLYM, V81, P140, DOI 10.1016/j.carbpol.2010.01.041
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   vandeWitte P, 1996, J MEMBRANE SCI, V117, P1, DOI 10.1016/0376-7388(96)00088-9
   Whyman G, 2008, CHEM PHYS LETT, V450, P355, DOI 10.1016/j.cplett.2007.11.033
   Yuan ZQ, 2007, SURF COAT TECH, V201, P7138, DOI 10.1016/j.surfcoat.2007.01.021
   Zisman W. A., 1964, ADV CHEM SER, V43, P1
NR 19
TC 2
Z9 2
U1 0
U2 19
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 730-732
BP 44
EP +
DI 10.4028/www.scientific.net/MSF.730-732.44
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BDX70
UT WOS:000315545200008
DA 2018-10-20
ER

PT J
AU Almodovar, J
   Crouzier, T
   Selimovic, S
   Boudou, T
   Khademhosseini, A
   Picart, C
AF Almodovar, Jorge
   Crouzier, Thomas
   Selimovic, Seila
   Boudou, Thomas
   Khademhosseini, Ali
   Picart, Catherine
TI Gradients of physical and biochemical cues on polyelectrolyte multilayer
   films generated via microfluidics
SO LAB ON A CHIP
LA English
DT Article
ID BY-LAYER FILMS; CELL-MIGRATION; BIOMEDICAL APPLICATIONS;
   EXTRACELLULAR-MATRIX; GROWTH-FACTORS; STEM-CELLS; ADHESION; SURFACE;
   DIFFERENTIATION; MICROENVIRONMENTS
AB The cell microenvironment is a complex and anisotropic matrix composed of a number of physical and biochemical cues that control cellular processes. A current challenge in biomaterials is the engineering of biomimetic materials which present spatially controlled physical and biochemical cues. The layer-by-layer assembly of polyelectrolyte multilayers (PEM) has been demonstrated to be a promising candidate for a biomaterial mimicking the native extracellular matrix. In this work, gradients of biochemical and physical cues were generated on PEM films composed of hyaluronan (HA) and poly(L-lysine) (PLL) using a microfluidic device. As a proof of concept, four different types of surface concentration gradients adsorbed onto the films were generated. These included surface concentration gradients of fluorescent PLL, fluorescent microbeads, a cross-linker, and one consisting of a polyelectrolyte grafted with a cell adhesive peptide. In all cases, reproducible centimeter-long linear gradients were obtained. Fluorescence microscopy, Fourier transform infrared spectroscopy and atomic force microscopy were used to characterize these gradients. Cell responses to the stiffness gradient and to the peptide gradient were studied. Pre-osteoblastic cells were found to adhere and spread more along the stiffness gradient, which varied linearly from 200 kPa-600 kPa. Myoblast cell spreading also increased throughout the length of the increasing RGD-peptide gradient. This work demonstrates a simple method to modify PEM films with concentration gradients of non-covalently bound biomolecules and with gradients in stiffness. These results highlight the potential of this technique to efficiently and quickly determine the optimal biochemical and mechanical cues necessary for specific cellular processes.
C1 [Almodovar, Jorge; Crouzier, Thomas; Boudou, Thomas; Picart, Catherine] CNRS, LMGP, UMR 5628, F-38016 Grenoble, France.
   [Almodovar, Jorge; Crouzier, Thomas; Boudou, Thomas; Picart, Catherine] MINATEC, Grenoble Inst Technol, F-38016 Grenoble, France.
   [Selimovic, Seila; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
   [Selimovic, Seila; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Picart, C (reprint author), CNRS, LMGP, UMR 5628, 3 Parvis Louis Neel, F-38016 Grenoble, France.
EM catherine.picart@grenoble-inp.fr
RI Boudou, Thomas/A-9089-2013; Khademhosseini, Ali/A-9435-2010
OI Khademhosseini, Ali/0000-0002-2692-1524; Boudou,
   Thomas/0000-0002-6821-2937; Khademhosseini, Ali/0000-0001-6322-8852;
   PICART, Catherine/0000-0002-4854-6366; PICART,
   Catherine/0000-0003-0130-1000; Crouzier, Thomas/0000-0002-1981-3736;
   Almodovar, Jorge/0000-0002-1151-3878
FU European Commission (under FP7) via an ERC starting grant (BIOMIM) [GA
   259370]; Whitaker International Fellows and Scholars Program
FX This work was supported by the European Commission (under FP7) via an
   ERC starting grant (BIOMIM, GA 259370) to CP and by the Whitaker
   International Fellows and Scholars Program by providing JA with a
   postdoctoral scholarship. The authors thank Varvara Gribova for the
   synthesis and characterization of the PGA-RGD used in this study.
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Boudou T, 2009, LANGMUIR, V25, P13809, DOI 10.1021/la9018663
   Carr LR, 2011, BIOMATERIALS, V32, P8456, DOI 10.1016/j.biomaterials.2011.07.062
   Chung BG, 2010, ELECTROPHORESIS, V31, P3014, DOI 10.1002/elps.201000137
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Han LL, 2013, BIOMATERIALS, V34, P975, DOI 10.1016/j.biomaterials.2012.10.041
   He JK, 2010, ADV FUNCT MATER, V20, P131, DOI 10.1002/adfm.200901311
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Ker EDF, 2011, BIOMATERIALS, V32, P3413, DOI 10.1016/j.biomaterials.2011.01.036
   Kipper MJ, 2007, ANAL BIOCHEM, V363, P175, DOI 10.1016/j.ab.2007.01.036
   Kirchhof K, 2011, LAB CHIP, V11, P3326, DOI 10.1039/c1lc20408d
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Miller ED, 2009, COMB CHEM HIGH T SCR, V12, P604, DOI 10.2174/138620709788681907
   Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]
   NEMOTO N, 1984, MACROMOLECULES, V17, P1731, DOI 10.1021/ma00139a017
   Nguyen EH, 2011, MACROMOL BIOSCI, V11, P483, DOI 10.1002/mabi.201000448
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Sailer M, 2012, MACROMOLECULES, V45, P5704, DOI 10.1021/ma300635n
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Seidi A, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580756
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Semenov OV, 2009, TISSUE ENG PT A, V15, P2977, DOI [10.1089/ten.tea.2008.0602, 10.1089/ten.TEA.2008.0602]
   Shen LY, 2011, BIOMACROMOLECULES, V12, P1322, DOI 10.1021/bm200070k
   Stefonek-Puccinelli TJ, 2008, ANN BIOMED ENG, V36, P2121, DOI 10.1007/s10439-008-9581-1
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e
   Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zou B, 2012, ACTA BIOMATER, V8, P1576, DOI 10.1016/j.actbio.2012.01.003
NR 55
TC 34
Z9 34
U1 0
U2 107
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2013
VL 13
IS 8
BP 1562
EP 1570
DI 10.1039/c3lc41407h
PG 9
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 108ES
UT WOS:000316275200017
PM 23440074
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Martel Fuentes, O
   Mirza Rosca, J
   Rodriguez Galindo, E
   Baltes, LS
   Tierean, MH
AF Martel Fuentes, Oscar
   Mirza Rosca, Julia
   Rodriguez Galindo, E.
   Baltes, Liana S.
   Tierean, Mircea H.
TI ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY CHARACTERIZATION OF PASSIVE FILM
   FORMED ON Ti-Ta ALLOYS
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE Ti-Ta alloy; biomaterial; corrosion resistance; osseointegration
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS
AB Titanium derives its corrosion resistance from the stable oxide film that forms on its surface, which can reform at body temperature and in physiological fluid if damaged. Increased use of titanium alloys as biomaterials is occurring due to their lower modulus, superior biocompatibility and high corrosion resistance. These attractive properties were a driving force for the early introduction of Ti and Ti-6Al-4V as implantable materials. But Ti-6Al-4V has a potential cytotoxicity and adverse tissue reactions caused by vanadium and for this reason has been required the development of new titanium alloys with non-toxic elements (Nb, Zr, Ta, Mo, Fe etc.). The studied titanium tantalum alloys were Ti-15Ta and Ti-25Ta. The influence of potential on passive film of Ti-Ta alloys under simulated physiological conditions was investigated by Electrochemical Impedance Spectroscopy (EIS). All measurements were carried out in Ringer solution at 25 degrees C and at different potentials starting at -0.4V till +2V. Analysis of the impedance spectra was done by fitting these data using the Boukamp nonlinear least square fitting procedure. The EIS spectra exhibited two-time constant system suggesting the formation of a two-layer oxide film on the alloys surface, i.e. a porous outer oxide and a barrier inner oxide. The alloy Ti-25Ta has a higher corrosion resistance than Ti-15Ta, due to the inner layer and better osseointegration ability ascribed to the inner layer.
C1 [Martel Fuentes, Oscar; Mirza Rosca, Julia; Rodriguez Galindo, E.] Las Palmas de Gran Canaria Univ, Las Palmas Gran Canaria, Spain.
   [Baltes, Liana S.; Tierean, Mircea H.] Transilvania Univ Brasov, Brasov, Romania.
RP Mirza Rosca, J (reprint author), Las Palmas de Gran Canaria Univ, Las Palmas Gran Canaria, Spain.
EM jmirza@dim.ulpgc.es
RI BALTES, Liana Sanda/E-1562-2017; TIEREAN, Mircea/D-4226-2011
OI BALTES, Liana Sanda/0000-0002-2819-210X; TIEREAN,
   Mircea/0000-0001-5185-3116
CR BOUKAMP BA, 1986, SOLID STATE IONICS, V20, P31, DOI 10.1016/0167-2738(86)90031-7
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Mareci D, 2009, ACTA BIOMATER, V5, P3625, DOI 10.1016/j.actbio.2009.05.037
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P534
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2008, MAT SCI ENG A-STRUCT, V483-84, P153, DOI 10.1016/j.msea.2006.09.173
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
   Zhou YL, 2005, MATER SCI FORUM, V475-479, P2309, DOI 10.4028/www.scientific.net/MSF.475-479.2309
NR 10
TC 0
Z9 0
U1 2
U2 19
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2013
VL 18
SI 6
BP 18
EP 22
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 102HL
UT WOS:000315835600004
DA 2018-10-20
ER

PT J
AU Donkov, N
   Zykova, A
   Safonov, V
   Luk'yanchenko, V
   Kolesnikov, D
AF Donkov, N.
   Zykova, A.
   Safonov, V.
   Luk'yanchenko, V.
   Kolesnikov, D.
TI THE SURFACE PROPERTIES OF Ta2O5 CERAMIC COATINGS AND NEXT CORRELATIONS
   WITH CELL RESPONSE IN VITRO AND IN VIVO TESTS
SO PROBLEMS OF ATOMIC SCIENCE AND TECHNOLOGY
LA English
DT Article
ID TANTALUM; BIOMATERIALS; ADHESION; ENERGY; FILMS; METAL
AB The study of e-beam evaporated Ta2O5 film structure and properties effect on cell/material response and behavior in vitro and in vivo tests was performed. The results demonstrate the good cyto compatibility of e-beam evaporated Ta2O5 coatings especially in the case of annealed films with strong stoichiometric Ta2O5 composition The possibility of controlled cell adhesion and tissue ingrowth on the biomaterial surfaces may propose novel methods of surface functionalization for next biomedical and tissue-engineering applications.
C1 [Donkov, N.] Bulgarian Acad Sci, Inst Elect, Sofia, Bulgaria.
   [Zykova, A.; Safonov, V.] NSC Kharkov Inst Phys & Technol, Kharkov, Ukraine.
   [Luk'yanchenko, V.] Inmasters Ltd, Kharkov, Ukraine.
   [Kolesnikov, D.] Belgorod State Natl Res Univ, Belgorod, Russia.
RP Donkov, N (reprint author), Bulgarian Acad Sci, Inst Elect, Sofia, Bulgaria.
FU Bulgarian-Ukrainian Academies of Science international scientific
   cooperation program
FX The research project was supported by the Bulgarian-Ukrainian Academies
   of Science international scientific cooperation program.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Busscher H. J., 1983, J BIOMED MATER RES, V17, P807
   Dhayal M, 2008, APPL SURF SCI, V254, P3331, DOI 10.1016/j.apsusc.2007.11.026
   Donkov N, 2011, PROBL ATOM SCI TECH, P131
   Donkov N, 2010, Journal of Physics: Conference Series, V223, DOI 10.1088/1742-6596/223/1/012030
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Meyer U., 2005, J EUR CELLS MAT, V9, P39
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Robertson J, 2004, EUR PHYS J-APPL PHYS, V28, P265, DOI 10.1051/epjap:2004206
NR 12
TC 3
Z9 3
U1 0
U2 5
PU KHARKOV INST PHYSICS & TECHNOLOGY
PI KHARKOV
PA NATL SCIENCE CTR, 1 AKADEMICHESKAYA ST, KHARKOV, 61108, UKRAINE
SN 1562-6016
J9 PROBL ATOM SCI TECH
JI Probl. At. Sci. Tech.
PY 2013
IS 1
BP 195
EP 197
PG 3
WC Physics, Nuclear
SC Physics
GA 099KU
UT WOS:000315620700061
DA 2018-10-20
ER

PT J
AU Oshkour, AA
   Abu Osman, NA
   Yau, YH
   Tarlochan, F
   Abas, WABW
AF Oshkour, A. A.
   Abu Osman, N. A.
   Yau, Y. H.
   Tarlochan, F.
   Abas, W. A. B. Wan
TI Design of new generation femoral prostheses using functionally graded
   materials: A finite element analysis
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE Finite element analysis; gait; functionally graded material; femoral
   prosthesis
ID TOTAL HIP-ARTHROPLASTY; FATIGUE BEHAVIOR; STEM DESIGN; OPTIMIZATION;
   REPLACEMENT; STABILITY; FEMUR; BONE; HYDROXYAPATITE; BIOMATERIAL
AB This study aimed to develop a three-dimensional finite element model of a functionally graded femoral prosthesis. The model consisted of a femoral prosthesis created from functionally graded materials (FGMs), cement, and femur. The hip prosthesis was composed of FGMs made of titanium alloy, chrome-cobalt, and hydroxyapatite at volume fraction gradient exponents of 0, 1, and 5, respectively. The stress was measured on the femoral prosthesis, cement, and femur. Stress on the neck of the femoral prosthesis was not sensitive to the properties of the constituent material. However, stress on the stem and cement decreased proportionally as the volume fraction gradient exponent of the FGM increased. Meanwhile, stress became uniform on the cement mantle layer. In addition, stress on the femur in the proximal part increased and a high surface area of the femoral part was involved in absorbing the stress. As such, the stress-shielding area decreased. The results obtained in this study are significant in the design and longevity of new prosthetic devices because FGMs offer the potential to achieve stress distribution that more closely resembles that of the natural bone in the femur.
C1 [Oshkour, A. A.; Abu Osman, N. A.; Abas, W. A. B. Wan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
   [Yau, Y. H.] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
   [Tarlochan, F.] Univ Tenaga Nas, Ctr Innovat & Design, Kajang, Malaysia.
RP Oshkour, AA (reprint author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM azim_120@yahoo.com
RI ABU OSMAN, NOOR AZUAN/B-9265-2010; Ataollahi Oshkour, Azim/A-3415-2013;
   Engineering, EE/O-1179-2016; YAU, YAT HUANG/C-1075-2010
OI ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Ataollahi Oshkour,
   Azim/0000-0001-8591-3340; 
FU UM/MOHE/HIR [D000010-16001]
FX This study was supported by UM/MOHE/HIR Project No. D000010-16001.
CR Aboudi J, 1999, COMPOS PART B-ENG, V30, P777, DOI 10.1016/S1359-8368(99)00053-0
   Bayat M, 2007, THIN WALL STRUCT, V45, P677, DOI 10.1016/j.tws.2007.05.005
   Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   Behrens BA, 2008, P I MECH ENG H, V222, P593, DOI 10.1243/09544119JEIM139
   Bennett D, 2008, MATER DESIGN, V29, P45, DOI 10.1016/j.matdes.2006.12.014
   Bougherara H, 2011, MED ENG PHYS, V33, P121, DOI 10.1016/j.medengphy.2010.09.011
   Bouxsein ML, 2005, BEST PRACT RES CL RH, V19, P897, DOI 10.1016/j.berh.2005.07.004
   Buhler DW, 1997, CLIN BIOMECH, V12, P75, DOI 10.1016/S0268-0033(96)00059-9
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Colombi P, 2002, INT J FATIGUE, V24, P739, DOI 10.1016/S0142-1123(01)00204-3
   Dopico-Gonzalez C, 2010, J BIOMECH, V43, P512, DOI 10.1016/j.jbiomech.2009.09.039
   Ebramzadeh E, 2003, BIOMATERIALS, V24, P3351, DOI 10.1016/S0142-9612(03)00187-X
   El-Sheikh HF, 2002, J MATER PROCESS TECH, V122, P309, DOI 10.1016/S0924-0136(01)01128-1
   Gross S, 2001, J BIOMECH, V34, P995, DOI 10.1016/S0021-9290(01)00072-0
   Hedia HS, 2006, J BIOMED MATER RES B, V79B, P42, DOI 10.1002/jbm.30509
   Incavo SJ, 2008, J ARTHROPLASTY, V23, P670, DOI 10.1016/j.arth.2007.05.044
   Jin G, 2005, MATER CHEM PHYS, V89, P238, DOI 10.1016/j.matchemphys.2004.03.031
   KANG YK, 1993, J BIOMED ENG, V15, P497, DOI 10.1016/0141-5425(93)90065-7
   Kayabasi O, 2007, MATER DESIGN, V28, P2269, DOI 10.1016/j.matdes.2006.08.012
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   Lin D, 2009, COMPOS PART B-ENG, V40, P668, DOI 10.1016/j.compositesb.2009.04.015
   Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5
   Mishina H, 2008, MAT SCI ENG A-STRUCT, V475, P141, DOI 10.1016/j.msea.2007.05.004
   Muller E, 2003, MAT SCI ENG A-STRUCT, V362, P17, DOI 10.1016/S0921-5093(03)00581-1
   Nie GJ, 2010, COMPOS STRUCT, V92, P265, DOI 10.1016/j.compstruct.2009.07.023
   Norman TL, 2001, J BIOMECH, V34, P1325, DOI 10.1016/S0021-9290(01)00085-9
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pedersen DR, 1997, J BIOMECH, V30, P959, DOI 10.1016/S0021-9290(97)00041-9
   Perez MA, 2006, MED ENG PHYS, V28, P525, DOI 10.1016/j.medengphy.2005.09.007
   Perez MA, 2005, ENG FRACT MECH, V72, P1125, DOI 10.1016/j.engfracmech.2004.09.002
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Sabatini AL, 2008, MATER DESIGN, V29, P1438, DOI 10.1016/j.matdes.2007.09.002
   Sakai R, 2009, J ORTHOP SCI, V14, P85, DOI 10.1007/s00776-008-1293-8
   Shen HS, 2009, FUNCTIONALLY GRADED
   Simoes JA, 2005, MATER DESIGN, V26, P391, DOI 10.1016/j.matdes.2004.07.024
   Simpson DJ, 2009, CLIN BIOMECH, V24, P274, DOI 10.1016/j.clinbiomech.2008.12.010
   Speirs AD, 2000, CLIN BIOMECH, V15, P248, DOI 10.1016/S0268-0033(99)00079-0
   Yan WY, 2011, MATER DESIGN, V32, P1776, DOI 10.1016/j.matdes.2010.12.042
   Senalp AZ, 2007, MATER DESIGN, V28, P1577, DOI 10.1016/j.matdes.2006.02.015
   Zou JP, 2005, J INORG MATER, V20, P1181
NR 42
TC 14
Z9 14
U1 0
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2013
VL 227
IS H1
BP 3
EP 17
DI 10.1177/0954411912459421
PG 15
WC Engineering, Biomedical
SC Engineering
GA 113AB
UT WOS:000316636800001
PM 23516951
DA 2018-10-20
ER

PT J
AU Sakai, T
   Okamura, K
   Watazu, A
   Teraoka, K
   Kido, H
AF Sakai, Takuya
   Okamura, Kazuhiko
   Watazu, Akira
   Teraoka, Kay
   Kido, Hirofumi
TI The Effect of Implant Surfaces sputter-coated with Hydroxyapatite Target
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Implant; Bone; Osseointegration; Titanium; Hydroxyapatite
ID PLASMA-SPRAYED HYDROXYAPATITE; COMMERCIALLY PURE TITANIUM;
   CALCIUM-PHOSPHATE; BONE RESPONSE; BIOMATERIAL ASPECTS; IN-VIVO;
   ULTRASTRUCTURE; INTERFACE; COATINGS; INTEGRATION
AB The aim of this study was to develop experimental titanium implants sputter-coated from a hydroxyapatite target and to evaluate peri-implant tissue responses in an animal experiment. The experimental implants were prepared from plastic rods, each of which was 1.6 mm in diameter and 7 mm in length. A thin titanium film was deposited onto the rods by DC magnetron sputtering. The surface of each rod was subsequently sputter-coated from a hydroxyapatite target by RF magnetron sputtering. The experimental implants were placed in the tibiae of 8-week-old male SD rats. Titanium-coated implants were placed as controls using the same method. Tissue samples were obtained 3, 5, 7, 10, 14, and 28 days after implant placement. Histological evaluation was performed using a light microscope, and the bone-implant contact ratios (BICs) were measured. Microstructural observations of implant-bone interfaces were made using a transmission electron microscope (TEM). Peri-implant osteoblastic activity was evaluated using samples obtained 5, 7, and 10 days after implant placement. Immunohistochemical evaluation of type I collagen, osteopontin, and osteocalcin was performed. Uniform smoothness of experimental implant surfaces was confirmed by scanning electron microscope(SEM) images. In the calcium phosphate layer, the compositional ratio of the experimental implant surface was Ca:P:O=1.0:0.79:2.8 based on the results of X-ray photoelectron spectroscopy(XPS). In the trabecular bone region, the BIC ratio was significantly higher in the experimental group than in the control group at 5, 7, 10, and 28 days after implant placement. Type I collagen, osteopontin, and osteocalcin immunostaining revealed that the experimental group tended to show positive results earlier than the control group. The results of this study suggest that surface treatment using a hydroxyapatite target and RF magnetron sputtering can enhance new bone formation during implant osseointegration.
C1 [Sakai, Takuya] Fukuoka Dent Coll, Grad Sch, Fukuoka 8140193, Japan.
   [Okamura, Kazuhiko] Fukuoka Dent Coll, Dept Morphol Biol, Sect Pathol, Fukuoka 8140193, Japan.
   [Watazu, Akira; Teraoka, Kay] Natl Inst Adv Ind Sci & Technol, Nagoya, Aichi, Japan.
   [Kido, Hirofumi] Fukuoka Dent Coll, Dept Oral Rehabil, Sect Oral Implantol, Fukuoka 8140193, Japan.
RP Kido, H (reprint author), Fukuoka Dent Coll, Dept Oral Rehabil, Sect Oral Implantol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM hkido@college.fdcnet.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [S1001059]
FX We want to thank professor Masaro Matsuura of Oral Medical Center,
   Fukuoka Dental College. We appreciate professor Tetsuictirou Inai and
   Mr. Koichiro Morishita, section of Functional Structure, Department of
   Morphological Biology, Fukuoka Dental College, for their valuable advice
   and support. This work was partly supported by Strategic study base
   formation support business (S1001059) from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan
CR Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Albrektsson T. O., 1994, PERIODONTOLOGY, V2000, P58
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cook S D, 1992, J Oral Implantol, V18, P354
   Dohan EDM, 2011, J ORAL IMPLANTOL, V5, P525
   Goene RJ, 2007, INT J PERIODONT REST, V27, P211
   GOTTLANDER M, 1991, International Journal of Oral and Maxillofacial Implants, V6, P399
   Hayakawa T, 2000, CLIN ORAL IMPLAN RES, V11, P296, DOI 10.1034/j.1600-0501.2000.011004296.x
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Kanabe C, 2004, J BIOMED MATER RES A, V71A, P98
   KAY J F, 1992, Dental Clinics of North America, V36, P1
   Kido H, 1996, J LONG-TERM EFF MED, V6, P119
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P717, DOI 10.1002/jbm.820270604
   Meffert RM, 1987, INT J PERIODONT REST, V4, P9
   Mohammadi S, 2004, INT J ORAL MAX IMPL, V19, P498
   Mohammadi Shams, 2003, Clin Implant Dent Relat Res, V5, P241, DOI 10.1111/j.1708-8208.2003.tb00207.x
   Morinaga K, 2009, CLIN IMPLANT DENT R, V11, P59, DOI 10.1111/j.1708-8208.2008.00093.x
   Morris H F, 2000, Ann Periodontol, V5, P1, DOI 10.1902/annals.2000.5.1.1
   Morris HF, 1998, J ORAL MAXIL SURG, V56, P1303, DOI 10.1016/S0278-2391(98)90615-2
   NANCI A, 1994, CELL MATER, V4, P1
   Ogawa Takahiro, 2002, J Prosthodont, V11, P241, DOI 10.1053/jpro.2002.129772
   Okamatsu K, 2007, CLIN IMPLANT DENT R, V9, P100, DOI 10.1111/j.1708-8208.2007.00032.x
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   Ozeki K, 2003, BIO-MED MATER ENG, V13, P451
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Schwartz-Arad D, 2005, INT J ORAL MAX IMPL, V20, P238
   SENNERBY L, 1992, J MATER SCI-MATER M, V3, P262, DOI 10.1007/BF00705291
   Shankar R, 2011, J MAXILLOFAC ORAL SU, V10, P123, DOI 10.1007/s12663-011-0189-x
   Shirakata Y, 2008, J PERIODONTOL, V79, P25, DOI 10.1902/jop.2008.070141 
   Strnad Z, 2000, INT J ORAL MAX IMPL, V15, P483
   Telleman G, 2010, CLIN IMPLANT DENT R, V12, P153, DOI 10.1111/j.1708-8208.2009.00147.x
   Trisi P, 2005, INT J ORAL MAX IMPL, V20, P124
   Truhlar R S, 2000, Ann Periodontol, V5, P109, DOI 10.1902/annals.2000.5.1.109
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   Watazu A, 2006, KEY ENG MAT, V309-311, P363, DOI 10.4028/www.scientific.net/KEM.309-311.363
   Watazu A, 2006, T MRS JAP, V31, P677
   Watazu A, 2013, KEY ENG MATER, V529-530, P531, DOI 10.4028/www.scientific.net/KEM.529-530.531
   Weinlaender M, 1992, Int J Oral Maxillofac Implants, V7, P491
   Wennerberg A., 2009, INT J ORAL MAXILLOF, V24, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 51
TC 2
Z9 2
U1 0
U2 13
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD JAN
PY 2013
VL 22
IS 1
BP 67
EP 77
DI 10.2485/jhtb.22.67
PG 11
WC Engineering, Biomedical
SC Engineering
GA 098CF
UT WOS:000315521800010
OA Bronze
DA 2018-10-20
ER

PT J
AU Boreyko, JB
   Mruetusatorn, P
   Retterer, ST
   Collier, CP
AF Boreyko, Jonathan B.
   Mruetusatorn, Prachya
   Retterer, Scott T.
   Collier, C. Patrick
TI Aqueous two-phase microdroplets with reversible phase transitions
SO LAB ON A CHIP
LA English
DT Article
ID MICROFLUIDIC DEVICE; INTERFACIAL-TENSION; POLYETHYLENE-GLYCOL; GIANT
   VESICLES; MICROCOMPARTMENTATION; SEPARATION; SYSTEMS; CELLS; FLOW;
   MICROCHANNELS
AB Aqueous two-phase systems contained within microdroplets enable a bottom-up approach to mimicking the dynamic microcompartmentation of biomaterial that naturally occurs within the cytoplasm of cells. Here, we demonstrate the generation of femtolitre aqueous two-phase droplets within a microfluidic oil channel. Gated pressure pulses were used to generate individual, stationary two-phase microdroplets with a well-defined time zero for carrying out controlled and sequential phase transformations over time. Reversible phase transitions between single-phase, two-phase, and core-shell microbead states were obtained via evaporation-induced dehydration and water rehydration. In contrast to other microfluidic aqueous two-phase droplets, which require continuous flows and high-frequency droplet formation, our system enables the controlled isolation and reversible transformation of a single microdroplet and is expected to be useful for future studies in dynamic microcompartmentation and affinity partitioning.
C1 [Boreyko, Jonathan B.; Retterer, Scott T.; Collier, C. Patrick] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.
   [Mruetusatorn, Prachya] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Retterer, Scott T.] Oak Ridge Natl Lab, Biosci Div, Biol & Nanoscale Syst Grp, Oak Ridge, TN 37831 USA.
RP Collier, CP (reprint author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.
EM colliercp@ornl.gov
RI Retterer, Scott/A-5256-2011
OI Retterer, Scott/0000-0001-8534-1979; Collier, Charles
   Patrick/0000-0002-8198-793X
FU Scientific User Facilities Division, Office of Basic Energy Sciences, U.
   S. Department of Energy
FX This research was conducted at the Center for Nanophase Materials
   Sciences, which is sponsored at Oak Ridge National Laboratory by the
   Scientific User Facilities Division, Office of Basic Energy Sciences, U.
   S. Department of Energy.
CR Albertsson P. A, 1986, PARTITIONING CELL PA
   Andes-Koback M, 2011, J AM CHEM SOC, V133, P9545, DOI 10.1021/ja202406v
   Azevedo AM, 2009, TRENDS BIOTECHNOL, V27, P240, DOI 10.1016/j.tibtech.2009.01.004
   Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501
   Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046
   Dominak LM, 2007, LANGMUIR, V23, P7148, DOI 10.1021/la063687v
   Dominak LM, 2010, LANGMUIR, V26, P5697, DOI 10.1021/la903800e
   Fiddes LK, 2007, LAB CHIP, V7, P863, DOI 10.1039/b703297h
   Frampton JP, 2011, BIOMED MICRODEVICES, V13, P1043, DOI 10.1007/s10544-011-9574-y
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Ge X, 2009, J AM CHEM SOC, V131, P9094, DOI 10.1021/ja902890r
   Hahn T, 2011, SOFT MATTER, V7, P6320, DOI 10.1039/c1sm05309d
   Hansen CL, 2006, J AM CHEM SOC, V128, P3142, DOI 10.1021/ja0576637
   He MY, 2004, ANAL CHEM, V76, P1222, DOI 10.1021/ac035196a
   Helfrich MR, 2002, J AM CHEM SOC, V124, P13374, DOI 10.1021/ja028157
   Jones D.P., 1988, MICROCOMPARTMENTATIO
   Jung SY, 2010, LAB CHIP, V10, P3373, DOI [10.1039/c0lc00376j, 10.1039/c01c00376j]
   Jung SY, 2010, LAB CHIP, V10, P2688, DOI [10.1039/c0lc00120a, 10.1039/c01c00120a]
   Lai D, 2011, LAB CHIP, V11, P3551, DOI 10.1039/c1lc20560a
   Lee SHS, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3694841
   Li YH, 2008, J AM CHEM SOC, V130, P12252, DOI 10.1021/ja8048496
   Li YH, 2012, J PHYS CHEM B, V116, P1819, DOI 10.1021/jp211850t
   Li YH, 2011, P NATL ACAD SCI USA, V108, P4731, DOI 10.1073/pnas.1015892108
   Liu YG, 2012, LANGMUIR, V28, P3831, DOI 10.1021/la204757z
   Long MS, 2008, J AM CHEM SOC, V130, P756, DOI 10.1021/ja077439c
   Long MS, 2005, P NATL ACAD SCI USA, V102, P5920, DOI 10.1073/pnas.0409333102
   Ma SH, 2012, SMALL, V8, P2356, DOI 10.1002/smll.201102715
   Matosevic S, 2011, J AM CHEM SOC, V133, P2798, DOI 10.1021/ja109137s
   Meagher RJ, 2008, LAB CHIP, V8, P527, DOI 10.1039/b716462a
   Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z
   Munchow G, 2007, LAB CHIP, V7, P98, DOI 10.1039/b612669n
   Nam KH, 2005, BIOMED MICRODEVICES, V7, P189, DOI 10.1007/s10544-005-3025-6
   RYDEN J, 1971, J COLLOID INTERF SCI, V37, P219, DOI 10.1016/0021-9797(71)90283-9
   Santesson S, 2004, ANAL CHEM, V76, P303, DOI 10.1021/ac034951h
   Sauret A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3702434
   Shim JU, 2007, J AM CHEM SOC, V129, P8825, DOI 10.1021/ja071820f
   Shim JU, 2011, LAB CHIP, V11, P1132, DOI [10.1039/c0lc00615g, 10.1039/c01c00615g]
   Shum HC, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3670365
   Song Y, 2012, LANGMUIR, V28, P12054, DOI 10.1021/la3026599
   Song YS, 2007, J CHROMATOGR A, V1162, P180, DOI 10.1016/j.chroma.2007.06.032
   SooHoo JR, 2009, BIOMED MICRODEVICES, V11, P323, DOI 10.1007/s10544-008-9238-8
   Tsukamoto M, 2009, ANALYST, V134, P1994, DOI 10.1039/b909597g
   Tumarkin E, 2009, CHEM SOC REV, V38, P2161, DOI 10.1039/b809915b
   Vijayakumar K, 2010, CHEM SCI, V1, P447, DOI 10.1039/c0sc00229a
   WALTER H, 1995, FEBS LETT, V361, P135, DOI 10.1016/0014-5793(95)00159-7
   WALTER H, 1991, ANAL BIOCHEM, V197, P1, DOI 10.1016/0003-2697(91)90348-W
   Yamada M, 2004, BIOTECHNOL BIOENG, V88, P489, DOI 10.1002/bit.20276
   Ziemecka I, 2011, SOFT MATTER, V7, P9878, DOI 10.1039/c1sm06517c
   Ziemecka I, 2011, LAB CHIP, V11, P620, DOI 10.1039/c0lc00375a
NR 49
TC 14
Z9 14
U1 8
U2 111
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2013
VL 13
IS 7
BP 1295
EP 1301
DI 10.1039/c3lc41122b
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 100HI
UT WOS:000315688500011
PM 23381219
DA 2018-10-20
ER

PT J
AU Dinh, ND
   Chiang, YY
   Hardelauf, H
   Baumann, J
   Jackson, E
   Waide, S
   Sisnaiske, J
   Frimat, JP
   van Thriel, C
   Janasek, D
   Peyrin, JM
   West, J
AF Ngoc-Duy Dinh
   Chiang, Ya-Yu
   Hardelauf, Heike
   Baumann, Jenny
   Jackson, Emily
   Waide, Sarah
   Sisnaiske, Julia
   Frimat, Jean-Philippe
   van Thriel, Christoph
   Janasek, Dirk
   Peyrin, Jean-Michel
   West, Jonathan
TI Microfluidic construction of minimalistic neuronal co-cultures
SO LAB ON A CHIP
LA English
DT Article
ID POLY-L-LYSINE; MICROELECTRODE ARRAYS; CELL-CULTURE; AXONAL-TRANSPORT;
   SOFT LITHOGRAPHY; NETWORKS; PLATFORM; REGENERATION; GROWTH; INJURY
AB In this paper we present compartmentalized neuron arraying (CNA) microfluidic circuits for the preparation of neuronal networks using minimal cellular inputs (10-100-fold less than existing systems). The approach combines the benefits of microfluidics for precision single cell handling with biomaterial patterning for the long term maintenance of neuronal arrangements. A differential flow principle was used for cell metering and loading along linear arrays. An innovative water masking technique was developed for the inclusion of aligned biomaterial patterns within the microfluidic environment. For patterning primary neurons the technique involved the use of meniscus-pinning micropillars to align a water mask for plasma stencilling a poly-amine coating. The approach was extended for patterning the human SH-SY5Y neuroblastoma cell line using a poly( ethylene glycol) ( PEG) back-fill and for dopaminergic LUHMES neuronal precursors by the further addition of a fibronectin coating. The patterning efficiency E-patt was >75% during lengthy in chip culture, with similar to 85% of the outgrowth channels occupied by neurites. Neurons were also cultured in next generation circuits which enable neurite guidance into all outgrowth channels for the formation of extensive inter-compartment networks. Fluidic isolation protocols were developed for the rapid and sustained treatment of the different cellular and sub-cellular compartments. In summary, this research demonstrates widely applicable microfluidic methods for the construction of compartmentalized brain models with single cell precision. These minimalistic ex vivo tissue constructs pave the way for high throughput experimentation to gain deeper insights into pathological processes such as Alzheimer and Parkinson Diseases, as well as neuronal development and function in health.
C1 [Ngoc-Duy Dinh; Chiang, Ya-Yu; Hardelauf, Heike; Baumann, Jenny; Jackson, Emily; Waide, Sarah; Frimat, Jean-Philippe; Janasek, Dirk; West, Jonathan] Leibniz Inst Analyt Wissensch ISAS eV, D-44227 Dortmund, Germany.
   [Jackson, Emily] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Sisnaiske, Julia; van Thriel, Christoph] Univ Dortmund, IfADo, Leibniz Res Ctr Working Environm & Human Factors, D-44139 Dortmund, Germany.
   [Frimat, Jean-Philippe] Univ Twente, MESA, BIOS Lab Chip Grp, NL-7500 AE Enschede, Netherlands.
   [Peyrin, Jean-Michel] UPMC, CNRS, UMR Neurobiol Proc Adaptatifs 7102, Paris, France.
   [West, Jonathan] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England.
RP Peyrin, JM (reprint author), UPMC, CNRS, UMR Neurobiol Proc Adaptatifs 7102, Paris, France.
EM jmpeyrin@snv.jussieu.fr; J.J.West@soton.ac.uk
RI West, Jonathan/F-3512-2012; Janasek, Dirk/G-4902-2010
OI West, Jonathan/0000-0002-5709-6790; Janasek, Dirk/0000-0002-4231-1224;
   Peyrin, Jean-Michel/0000-0002-0108-1266
FU Deutsche Forschungsgemeinschaft [DFG WE3737/3-1]; Bundesministerium fur
   Bildung und Forschung grant [BMBF 0101-31P6541]; Ministerium fur
   Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen;
   International Leibniz Graduate School "Systems Biology Lab-on-a-Chip";
   ANR "PrionTraf"; Prion SensiTNF; Fondation de France
FX The authors are grateful to Ulrich Marggraf (ISAS) for SU-8 fabrication,
   Maria Becker (ISAS) for SEM imaging, Nicole Schobel (IfADo) for
   neurobiology discussions and Vanessa Hausherr (IfADo) for immunostaining
   advice. The LUHMES cells used in this research were a kind gift from
   Marcel Leist (Universitat Konstanz). The research was financially
   supported by the Deutsche Forschungsgemeinschaft (DFG WE3737/3-1), a
   Bundesministerium fur Bildung und Forschung grant (BMBF 0101-31P6541)
   and by the Ministerium fur Innovation, Wissenschaft und Forschung des
   Landes Nordrhein-Westfalen. Heike Hardelauf thanks the International
   Leibniz Graduate School "Systems Biology Lab-on-a-Chip" for financial
   support. JMP was funded by ANR "PrionTraf", "Prion SensiTNF" and
   "Fondation de France''.
CR CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9
   Chang JC, 2000, BIOMED MICRODEVICES, V2, P245, DOI 10.1023/A:1009946920296
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Frimat JP, 2011, LAB CHIP, V11, P231, DOI [10.1039/c0lc00172d, 10.1039/c01c00172d]
   Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j
   Frimat JP, 2009, ANAL BIOANAL CHEM, V395, P601, DOI 10.1007/s00216-009-2824-7
   Hardelauf H, 2011, LAB CHIP, V11, P2763, DOI 10.1039/c1lc20257j
   Haubert K, 2006, LAB CHIP, V6, P1548, DOI 10.1039/b610567j
   Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h
   Hosmane S, 2010, LAB CHIP, V10, P741, DOI 10.1039/b918640a
   Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567
   Ionescu-Zanetti C, 2005, P NATL ACAD SCI USA, V102, P9112, DOI 10.1073/pnas.0503418102
   James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614
   Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8
   Kim HJ, 2012, ACS CHEM NEUROSCI, V3, P433, DOI 10.1021/cn3000026
   Kim YT, 2009, LAB CHIP, V9, P2576, DOI 10.1039/b903720a
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Kunze A, 2011, BIOTECHNOL BIOENG, V108, P2241, DOI 10.1002/bit.23128
   LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898
   Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006
   Li L, 2012, ANAL CHEM, V84, P6444, DOI 10.1021/ac3013708
   Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007
   Liu WW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002382
   Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10
   Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020
   Park J, 2012, LAB CHIP, V12, P3296, DOI 10.1039/c2lc40303j
   Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640
   Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c
   Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012
   Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n
   Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e
   Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x
   Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518
   Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038//NMETH793
   Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v
   Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Vogt AK, 2005, BIOMATERIALS, V26, P2549, DOI 10.1016/j.biomaterials.2004.07.031
   West J, [No title captured], Patent No. [EP 09 012 960.2.7, 0901296027]
   West J., 2010, [No title captured], Patent No. [PCT/EP2010/002811, 2010002811]
   West J, 2012, [No title captured], Patent No. [2012-0065102A1, 20120065102]
   West J, 2009, [No title captured], Patent No. [DE 10 2009 021 876.9, 1020090218769]
   White F. M, 1994, FLUID MECH, P333
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wissner-Gross ZD, 2011, INTEGR BIOL-UK, V3, P65, DOI 10.1039/c0ib00058b
   Yang IH, 2012, NEUROMOL MED, V14, P112, DOI 10.1007/s12017-012-8170-5
NR 53
TC 42
Z9 42
U1 7
U2 100
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2013
VL 13
IS 7
BP 1402
EP 1412
DI 10.1039/c3lc41224e
PG 11
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 100HI
UT WOS:000315688500024
PM 23403713
DA 2018-10-20
ER

PT S
AU Gomze, LA
   Lipusz, D
   Gomze, LN
AF Goemze, Laszlo A.
   Lipusz, Dora
   Goemze, Ludmila N.
BE Berecz, T
   Majlinger, K
   Orbulov, IN
   Szabo, PJ
TI New advanced SiC ceramics based on natural biomaterials
SO MATERIALS SCIENCE, TESTING AND INFORMATICS VI
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Hungarian Conference on Materials Science
CY OCT 09-11, 2011
CL Balatonkenese, HUNGARY
SP Laser Syst Ltd, SAPA Profiles Ltd, Paks Nucl Power Plant Co, Hungarian Acad Engn, Ecotech Co
DE biomaterials; ceramics; C/SiC composites; foams; hetero-modulus; SiC
AB On the basis of several years experiments in investigation of hetero-modulus material structures and using natural biomaterials and high purity quartz powders the authors successfully developed new high porosity low density SiC ceramic cellulars and foams. For the development of new silicon-carbide and carbon-silicon-carbide (C/SiC) cellular ceramic composites and foams the author used high purity SiO2 powders mined in Fehervarcsurgo (Hungary) and a biomaterial reagents made from renewable vegetable under trade-name IG-R1. These low density high porosity silicon-carbides probably can be successfully applied in development of light weight ceramic reinforced metal alloy composites in the future. The structure and X-ray diffraction (XRD) analysis of used raw materials and the achieved by authors new SiC and C/SiC ceramic composites and foams are described and shown in present work.
C1 [Goemze, Laszlo A.; Lipusz, Dora] Univ Miskolc, Dept Ceram & Silicate Engn, H-3515 Miskolc, Hungary.
   IGREX Engn Serv Ltd, H-3459 Igrici, Hungary.
RP Gomze, LA (reprint author), Univ Miskolc, Dept Ceram & Silicate Engn, H-3515 Miskolc, Hungary.
EM femgomze@uni-miskolc.hu; igrex2009@yandex.ru
FU TAMOP [4.2.1.B-10/2/KONV-2010-0001]; Depaihnent of Ceramic and Silicate
   Engineering at the University of Miskolc (Hungary); IGREX Engineering
   Service Ltd.
FX The authors acknowledge to IGREX Engineering Service Ltd. for the IG-Rl
   bioorigin reagent powders, the developed and submitted reactive
   sintering methods, and technical, technological and financial support.
   The authors from the Depaihnent of Ceramic and Silicate Engineering at
   the University of Miskolc (Hungary) also acknowledge to TAMOP
   4.2.1.B-10/2/KONV-2010-0001 for their financial support.
CR Bolivar C. M. Vega, 2011, IOP C SERIES MAT SCI, V18, DOI [10.1088/1757-899X/18/20/202023, DOI 10.1088/1757-899X/18/20/202023]
   Cao DF, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/20/202014
   Csanyi J, 2009, EPITOANYAG, V61, P6, DOI 10.14382/epitoanyag-jsbcm.2009.2
   Ershova NI, 2009, EPITOANYAG, V61, P34, DOI 10.14382/epitoanyag-jsbcm.2009.6
   Fuessel Alexander, 2011, IOP Conference Series: Materials Science and Engineering, V18, DOI 10.1088/1757-899X/18/18/182001
   Gomze LA, 2010, EPITOANYAG, V62, P98, DOI 10.14382/epitoanyag-jsbcm.2010.18
   Gomze LA, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/8/082001
   Gomze L A, 2009, EPITOANYAG, V61/2, P38, DOI DOI 10.14382/EPIT0ANYAG-JSBCM.2009.7
   Izhevskyi V.A., 2000, MAT RES, P131
   Jiang DL, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/20/202001
   Karoly Z, 2011, POWDER TECHNOL, V214, P300, DOI 10.1016/j.powtec.2011.08.027
   Kaygorodov A, 2010, EPITOANYAG, V62, P116, DOI 10.14382/epitoanyag-jsbcm.2010.21
   Kim BN, 2007, SCRIPTA MATER, V57, P607, DOI 10.1016/j.scriptamat.2007.06.009
   Kishimoto H, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/16/162018
   Koyanagi T, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/16/162008
   Kulkov SN, 2008, EPITOANYAG, V60, P62, DOI 10.14382/epitoanyag-jsbcm.2008.10
   Lee SP, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/16/162017
   Morikawa, 2009, EPITOANYAG, V61, P2
   Nakazato N, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/20/202011
   Nogami S, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/16/162007
   Park JS, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/20/202012
   Satori K, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/16/162019
   Shabalin IL, 2009, J ALLOY COMPD, V472, P373, DOI 10.1016/j.jallcom.2008.04.067
   Wang J., 2009, CERAM INT, V35, P1467
   Zviad K, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/20/202015
NR 25
TC 1
Z9 1
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2013
VL 729
BP 350
EP +
DI 10.4028/www.scientific.net/MSF.729.350
PG 3
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BDX60
UT WOS:000315536600059
DA 2018-10-20
ER

PT J
AU Hamida, K
   Faten, K
   Soumya, E
   Saad, IK
   Hassan, L
   Moktar, H
AF Hamida, Ksontini
   Faten, Kachouri
   Soumya, El Abed
   Saad, Ibnsouda Koraichi
   Hassan, Latrache
   Moktar, Hamdi
TI Bacillus cereus adhesion: an investigation of the physicochemical
   characteristics of surface and effect of bio adhesion on the properties
   of silicone
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE adhesion; Bacillus cereus; silicone; ESEM; physicochemical properties
ID STAINLESS-STEEL; LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS;
   BIOMATERIAL SURFACES; BACTERIAL ADHESION; CANDIDA-ALBICANS;
   HYDROPHOBICITY; ATTACHMENT; SPORES; GLASS
AB The initial microorganism adhesion on substrate is an important step for biofilm formation. The surface properties of the silicone and Bacillus cereus were characterized by the sessile drop technique. Moreover, the physicochemical properties (hydrophobicity; electron donor/electron acceptor) of surface adhesion and the impact of bio adhesion on the silicone were determined at different time of contact (3, 7, and 24h). The results showed that the strain was hydrophilic (Giwi=3.37mJ/m2), whereas the silicone has hydrophobic character (Giwi=68.28mJ/m2). Silicone surface presents a weak electron-donor character ( =2.2mJ/m2) conversely to B. cereus that presents an important electron donor-parameter ( =31.6mJ/m2). The adhesion of B. cereus to silicone was investigated using environmental scanning electron microscope and image analysis was assessed with the Matlab (R) program. After 3h of contact, the data analysis, confirmed the bio adhesion with an amount of 9.6105cfu/cm2 adhered cells. After 24h, the percentage of silicone covered reached 93%. Furthermore, despite the difference in hydrophohbicity, the interaction between B. cereus and substrata was favoured by the thermodynamic model of adhesion (G adhesion <0). The real time investigation of the effect of B. cereus adhesion on the physicochemical properties of silicone has revealed that the substrata becomes hydrophilic (degrees=47.3, Giwi=23.7mJ/m2), after 7h of contact. This bio adhesion had also favoured the increase of electron donor/acceptor character of silicone ( =53.1mJ/m2 and +=5.3mJ/m2).
C1 [Hamida, Ksontini; Faten, Kachouri; Moktar, Hamdi] INSAT ESIAT, Lab Ecol & Technol Microbienne, Tunis, Tunisia.
RP Moktar, H (reprint author), INSAT ESIAT, Lab Ecol & Technol Microbienne, Tunis, Tunisia.
EM moktar.hamdi@insat.rnu.tn
OI Saad, Ibnsouda Koraichi/0000-0001-6320-7381
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bengourram J., 2009, PHYS CHEM NEWS, V47, P138
   Bernardes PC, 2010, BRAZ J MICROBIOL, V41, P984, DOI 10.1590/S1517-838220100004000017
   Blanco MT, 1997, MICROBIOS, V89, P23
   Bos R., 1999, FEMS MICROBIOL REV, V23, P79
   Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328
   Chaves LCD, 2004, THESIS DEP ENGENHARI, V156
   El abed S, 2011, MICROBIOLOGY, V80, P43
   El Abed S, 2010, ANN MICROBIOL, V60, P377, DOI 10.1007/s13213-010-0045-0
   Faille C, 2001, J APPL MICROBIOL, V90, P892, DOI 10.1046/j.1365-2672.2001.01321.x
   Hamadi F, 2005, J ADHES SCI TECHNOL, V19, P73, DOI 10.1163/1568561053066891
   Hamadi F, 2009, MAT SCI ENG C-BIO S, V29, P1302, DOI 10.1016/j.msec.2008.10.023
   Hamadi F, 2008, BRAZ J MICROBIOL, V39, P10, DOI 10.1590/S1517-83822008000100003
   Henriques M, 2004, COLLOID SURFACE B, V33, P235, DOI 10.1016/j.colsurfb.2003.10.012
   Husmark U, 1992, BIOFOULING, V5, P335
   Karine A, 2010, J ADHES SCI TECHNOL, V24, P831
   Kouider N., 2010, INT JOR P APP SCS, V4, P1
   Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012
   Mahdavi M, 2008, J BIOL SCI, V8, P502
   de Oliveira MMM, 2010, BRAZ J MICROBIOL, V41, P97, DOI 10.1590/S1517-838220100001000016
   Oliveira R, 2001, ROLE HYDROPHOBICITY, P11
   Park MR, 2008, INT J NANOMED, V3, P497
   Parkar SG, 2001, J APPL MICROBIOL, V90, P901, DOI 10.1046/j.1365-2672.2001.01323.x
   Seale RB, 2008, APPL ENVIRON MICROB, V74, P731, DOI 10.1128/AEM.01725-07
   Sousa C, 2009, INT J BIOMATER, DOI [DOI 10.1155/2009/718017, 10.1155/2009/718017]
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1995, CLAY CLAY MINER, V43, P474, DOI 10.1346/CCMN.1995.0430411
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
NR 30
TC 3
Z9 3
U1 0
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD JAN 1
PY 2013
VL 27
IS 1
BP 90
EP 101
DI 10.1080/01694243.2012.701509
PG 12
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 093JJ
UT WOS:000315187700009
DA 2018-10-20
ER

PT J
AU Chivu, AE
   Ciuca, S
   Bojin, D
   Stan, GE
   Gebert, A
   Eckert, J
AF Chivu, Adriana Elena
   Ciuca, Sorin
   Bojin, Dionezie
   Stan, George E.
   Gebert, Annett
   Eckert, Juergen
TI ELECTROCHEMICAL DEPOSITED HYDROXYAPATITE ON PRE-TREATED CP-TI SURFACES
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE Surface treatments; electrochemical deposition; Hydroxyapatite
ID TITANIUM; OSSEOINTEGRATION; STRENGTH; IMPLANTS; ALLOYS; LAYERS; FILMS
AB Commercially pure titanium (CP-Ti) offers a good corrosion resistance and tissue tolerance. The interfacial phenomena between biomaterial and biological fluids depend especially on surface chemistry, energy, roughness and topography of the implant Different methods are used to modify CP-Ti surface in order to improve its bonding properties to bone tissue. Besides the mechanical approaches, chemical etching and chemical oxidation, there are also other procedures improving the biocornpatibility. One of the most important involves the deposition of a bioceramic thin layer on the metallic surface. A bioceramics frequently used is hydroxyapatite (HA), the mineral component of the bone. In this paper. the main objective was to study the effects of different surface pretreatments on adherence of hydroxyapatite layer obtained by electrochemical method. The CP-Ti substrate was used in different treated states of the surface. The applicability of the electrochemical technique is relieved by the fact that it is a very rapid method, requires relatively low temperatures, being also very versatile. The obtained coatings were studied by scanning electron microscopy (SEM) associated with EDX (Energy dispersive X-ray spectroscopy, X-ray diffraction method (XRD). The adherence of the layers was evaluated by the "pull-out" test. The quality of the coating (morphology and adhesion properties) is decisively influenced by the electrochemical parameters and also by the surface state.
C1 [Chivu, Adriana Elena; Ciuca, Sorin; Bojin, Dionezie] Univ Politehn Bucuresti, Fac Mat Sci & Engn, Bucharest, Romania.
   [Stan, George E.] Natl Inst Mat Phys, Bucharest, Romania.
   [Gebert, Annett; Eckert, Juergen] IFW Dresden, Inst Complex Mat, Dresden, Germany.
RP Chivu, AE (reprint author), Univ Politehn Bucuresti, Fac Mat Sci & Engn, Bucharest, Romania.
RI Ciuca, Sorin/E-8786-2015; Stan, George/B-5690-2011
OI Ciuca, Sorin/0000-0002-4343-5704; Stan, George/0000-0003-0289-8988;
   Gebert, Annett/0000-0003-2748-3850
FU Sectoral Operational Programme Human Resources Development of the
   Romanian Ministry of Labour, Family and Social Protection
   [POSDRU/88/1.5/S/61178]; European Commission in the network project
   EC-ITN BioTiNet [264635]
FX The work has been funded by the Sectoral Operational Programme Human
   Resources Development 2007-2013 of the Romanian Ministry of Labour,
   Family and Social Protection through the Financial Agreement
   POSDRU/88/1.5/S/61178 and by the European Commission in the network
   project EC-ITN BioTiNet under contract no 264635.
CR Ban S, 2003, J BIOMED MATER RES A, V66A, P138, DOI 10.1002/jbm.a.10566
   Blackwood DJ, 2009, MAT SCI ENG C-BIO S, V29, P1233, DOI 10.1016/j.msec.2008.10.015
   Eliaz N, 2009, ACTA BIOMATER, V5, P3178, DOI 10.1016/j.actbio.2009.04.005
   Eliaz N, 2008, ISR J CHEM, V48, P159, DOI 10.1560/IJC.48.3-4.159
   FENG Zude, 2003, J MAT SCI TECHNOL, V9
   Hsu HC, 2010, J MATER SCI, V45, P3661, DOI 10.1007/s10853-010-4411-x
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Koch CF, 2007, MAT SCI ENG C-BIO S, V27, P484, DOI 10.1016/j.msec.2006.05.025
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lin CM, 2005, J MATER SCI-MATER M, V16, P889, DOI 10.1007/s10856-005-4423-2
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]
   Novaes Jr Arthur Belém, 2010, Braz. Dent. J., V21, P471, DOI 10.1590/S0103-64402010000600001
   Aves EP, 2009, J MATER SCI-MATER M, V20, P543, DOI 10.1007/s10856-008-3609-9
   Teixeira Ricardo Luiz Perez, 2004, Mat. Res., V7, P299, DOI 10.1590/S1516-14392004000200013
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
NR 17
TC 0
Z9 0
U1 0
U2 13
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2013
VL 18
SI 1
BP 34
EP 38
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 095XL
UT WOS:000315368200007
DA 2018-10-20
ER

PT S
AU Ito, N
   Kamitakahara, M
   Ioku, K
AF Ito, Natsuko
   Kamitakahara, Masanobu
   Ioku, Koji
BE Ishikawa, K
   Iwamoto, Y
TI Observation of Transformation Behavior of Octacalcium Phosphate to
   Hydroxyapatite
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Octacalcium phosphate; Hydroxyapatite; Transformation
ID MODEL
AB Octacalcium phosphate (OCP) is regarded as a precursor of hydroxyapatite (HA) which is a main inorganic comstituent of human bones and teeth. OCP is becoming regarded as an important biomaterial. Recently, implanted OCP was found to be converted to apatitic phase in the body and support bone regeneration. Therefore, it is important to reveal the transformation mechanism of OCP to HA for revealing the mechanism of bone formation and for the development of biomedical materials for bone. In this study, we focused on the dissolution of OCP and precipitation of HA. OCP particles were immersed in distilled water at 60 degrees C. The temporal change of the immersed powders and immersing solution were examined, and the transformation mechanism of OCP to HA was discussed. As there was an unreactive period in the first stage of the transformation, HA crystals seemed to grow easily once HA nuclei were formed. It is speculated that HA nuclei formed on OCP crystals by heterogeneous nucleation, and then HA crystals grow using calcium and phosphoric ions supplied from dissolved OCP.
C1 [Ito, Natsuko; Kamitakahara, Masanobu] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aoba, Sendai, Miyagi 9808579, Japan.
   [Ioku, Koji] Keio Univ, Fac Econ, Kohoku Ku, Yokohama 2238521, Japan.
RP Ito, N (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aoba, Sendai, Miyagi 9808579, Japan.
EM itonatsu@ehtp.kankyo.tohoku.ac.jp; kamitaka@mail.kankyo.tohoku.ac.jp;
   kojiioku@a7.keio.jp
FU JSPS, KAKENHI [21300175, 234659]
FX The authors thank Prof Yoshimura of National Cheng Kung University of
   Taiwan for comments and suggestions. This research was partially
   supported by JSPS, KAKENHI (21300175 and 234659).
CR BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   Iijima M, 1997, J CRYST GROWTH, V181, P70, DOI 10.1016/S0022-0248(97)00230-3
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   Kamitakahara M, 2008, J CERAM SOC JPN, V116, P481, DOI 10.2109/jcersj2.116.481
   NELSON DGA, 1984, CALCIFIED TISSUE INT, V36, P219, DOI 10.1007/BF02405321
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
NR 8
TC 2
Z9 2
U1 1
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 11
EP +
DI 10.4028/www.scientific.net/KEM.529-530.11
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800003
DA 2018-10-20
ER

PT S
AU Zamanian, A
   Farhangdoust, S
   Yasaei, M
   Khorami, M
   Abbasabadi, M
AF Zamanian, Ali
   Farhangdoust, Sajad
   Yasaei, Mana
   Khorami, Mina
   Abbasabadi, Mohamad
BE Ishikawa, K
   Iwamoto, Y
TI The Effect of Sintering Temperature on the Microstructural and
   Mechanical Characteristics of Hydroxyapatite Macroporous Scaffolds
   Prepared via Freeze-Casting
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE scaffold; freeze-casting; hydroxyapatite; unidirectional; mechanical
   properties; sintering
AB The most important characteristic of biomaterial as bone-repairing material, in addition to biocompatibility and appropriate porosity, is providing mechanical strength complying with injured tissue. In the present work, slurry with 15 vol% HA prepared from calcinated hydroxyapatite. The prepared slurry freeze casted unidirectionally with the cooling rate of 8 degrees C/min from the ambient temperature. Then, green bodies freeze-dried for 72h following with sintering at different temperatures of 1250-1350 degrees C with intervals of 25 degrees C. The results showed that lamella space and porosity decreases with temperature while compressive strength and shrinkage goes up. Total porosity has a range of 75-83% while has a compressive strength of similar to 2-8 MPa. The sintered sample at 1350 degrees C, with 75% porosity, which has a similar to 8 MPa compressive strength, chose to be the optimum. Also, some dendritic branch like structure and bridges can be seen on the internal walls of lamellae which can improve mechanical properties. These features may improve adhesion and growth of osseous cells.
C1 [Zamanian, Ali; Farhangdoust, Sajad; Yasaei, Mana; Khorami, Mina; Abbasabadi, Mohamad] Mat & Energy Res Ctr, Nanotechnol & Adv Mat Dept, Karaj, Iran.
RP Zamanian, A (reprint author), Mat & Energy Res Ctr, Nanotechnol & Adv Mat Dept, Karaj, Iran.
EM a-zamanian@merc.ac.ir; s.farhangdoust@yahoo.com; yasaei.m@gmail.com;
   khorami_m@merc.ac.ir; abasabade@yahoo.com
CR Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Ji C., 2011, ACTA BIOMATER, V8, P570
   Prokopiev O, 2006, MAT SCI ENG A-STRUCT, V431, P218, DOI 10.1016/j.msea.2006.05.158
   Sadeghian Z, 2006, CERAM INT, V32, P331, DOI 10.1016/j.ceramint.2005.02.016
   Salerno A, 2010, COMPOS SCI TECHNOL, V70, P1838, DOI 10.1016/j.compscitech.2010.06.014
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3039, DOI 10.1007/s10856-010-4153-y
   Sin D, 2010, MAT SCI ENG C-MATER, V30, P78, DOI 10.1016/j.msec.2009.09.002
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 12
TC 3
Z9 3
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 133
EP 137
DI 10.4028/www.scientific.net/KEM.529-530.133
PG 5
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800028
DA 2018-10-20
ER

PT S
AU Inayama, T
   Konishi, H
   Aizawa, M
   Kanzawa, N
AF Inayama, Tetsuya
   Konishi, Hidenori
   Aizawa, Mamoru
   Kanzawa, Nobuyuki
BE Ishikawa, K
   Iwamoto, Y
TI Studies on the Anti-Tumor Action of Chelate-Setting Apatite Cements
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE apoptosis; chelate-setting apatite cement; IP6
ID INHIBITS GROWTH; PHYTIC ACID; CELL-LINE; HEXAPHOSPHATE; IP6;
   DIFFERENTIATION
AB Chelate-setting apatite cement is a novel biomaterial developed as a bone substitute. We previously reported a chelate-setting apatite cement, 26-HAp, which exhibits anti-tumor activity via apoptotic cell death. However, our preliminary data showed that excess 26 arrests osteoblast growth. We found that a high, transient amount of IP6 was released from the cement. We therefore hypothesized that a high performance cement specific for tumor cells can be developed by controlling the release of IP6 from the cement. To validate this, we used a murine calvarial osteoblast cell line (MC3T3-E1) and a human osteosarcoma cell line (HOS). Culturing HOS or MC3T3-E1 in medium containing various concentrations of IP6 more effectively arrested the growth of HOS than that of MC3T3-E1. Although the proliferation of osteoblasts was suppressed at early growth stages in response to the release of IP6 from the cements, there was no difference in the number of cells after a prolonged culture period. In contrast, osteosarcoma cell growth remained suppressed even after a prolonged culture period. To better understand why these two cell types respond differently to 26, we investigated cell viability by measuring the ratio of living and dead cells. Our findings suggest that this novel bone graft cement will find unique uses due the different sensitivity of tumor cells and osteoblasts towards IP6.
C1 [Inayama, Tetsuya; Konishi, Hidenori; Kanzawa, Nobuyuki] Sophia Univ, Grad Sch Sci & Technol, Tokyo 102, Japan.
   [Aizawa, Mamoru] Meiji Univ, Dept Appl Chem, Kanagawa, Japan.
   [Aizawa, Mamoru] Kanagawa Acad Sci & Technol, Next Generat Bioceram project, Kanagawa, Japan.
RP Inayama, T (reprint author), Sophia Univ, Grad Sch Sci & Technol, Tokyo 102, Japan.
EM n-kanza@sophia.ac.jp
CR Aizawa M, 2003, KEY ENG MAT, V240-2, P647, DOI 10.4028/www.scientific.net/KEM.240-242.647
   BANNO Y, 1993, BIOCHEM J, V292, P401, DOI 10.1042/bj2920401
   Harland BF, 1999, NUTR RES, V19, P947, DOI 10.1016/S0271-5317(99)00055-X
   Horiguchi Y, 2008, J CERAM SOC JPN, V116, P50, DOI 10.2109/jcersj2.116.50
   Huang CS, 1997, CANCER RES, V57, P2873
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   Konishi H., 2012, KEY ENG MATER, V493-494, P678
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   RAO PS, 1991, ANN THORAC SURG, V52, P908, DOI 10.1016/0003-4975(91)91254-S
   SAKAMOTO K, 1993, CARCINOGENESIS, V14, P1815, DOI 10.1093/carcin/14.9.1815
   SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9
   SHAMSUDDIN AM, 1995, CARCINOGENESIS, V16, P1975, DOI 10.1093/carcin/16.8.1975
   THOMPSON LU, 1991, CARCINOGENESIS, V12, P2041, DOI 10.1093/carcin/12.11.2041
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Vucenik I, 2004, CARCINOGENESIS, V25, P2115, DOI 10.1093/carcin/bgh232
   Vucenik I, 1998, ANTICANCER RES, V18, P4091
   Vucenik I, 1998, ANTICANCER RES, V18, P4083
NR 17
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 178
EP +
DI 10.4028/www.scientific.net/KEM.529-530.178
PG 3
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800037
DA 2018-10-20
ER

PT S
AU Violin, KB
   Ribeiro, C
   Goia, TS
   Bressiani, JC
   Bressiani, AHD
AF Violin, Kalan Bastos
   Ribeiro, Christiane
   Goia, Tamiye Simone
   Bressiani, Jose Carlos
   de Almeida Bressiani, Ana Helena
BE Ishikawa, K
   Iwamoto, Y
TI Lectinhistochemistry Evaluation of Rabbit's Tibia Implanted with
   Macroporous Biphasic Ceramic Implants
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Lectinhistochemistry; Hydroxyapatite; Beta-Tricalcium Phosphate;
   Ceramic; Bone; Implant; Macroporous; Lectin
ID BINDING; LECTINS; DESIGN; BONE
AB Many techniques are used to assess biomaterials implants, always intending to measure osseointegration success and tissue response facing the implanted material. Calcium phosphates are widely used as biomaterial and a major component of bone. Many processing methods have been used to achieve porous materials to allow bone ingrowth with an osteoconductive scaffold for bone. To obtain the macroporous BCP implant it was processed by direct consolidation using the protein-action technique, a globular protein based consolidation with ovalbumin. The samples were sintered at 1250 degrees C for 30 minutes, after sintering samples were cut in 4mm diameter cylinders, with 73% volume of porosity and mean pore size ranging about 100 mu m. In the present work the macroporous BCP of HAp:beta-TCP is assessed after bone implantation in rabbit's tibia by lectinhistochemistry (LHC) technique. Lectins are proteins from non-imune origin which binds with strong specificity carbohydrates, LHC is a technique which mark histologically carbohydrates present in glycoproteins of cells. The macroporous BCP cylindrical samples were implanted in male rabbits tibia to the evaluation of biocompatibility and osseointegration in a period of 2 weeks to 4 weeks. After euthanasia of rabbits, tibia samples from the surgery site were taken and fixed with formalin, decalcified, dehydrated and embedded with paraffin to perform histological slides for both morphological and molecular evaluation. The morphological evaluation were performed on histological slides stained with Haematoxilin and Eosin (HE), while for molecular evaluation LHC was performed on histological slides using the lectins PNA, UEA-1, WGA, sWGA and RCA-1 (Vector Labs). All samples osseointegrated well with the bone and the neoformed bone surrounding the implant took the shape of its surface. The implants also allowed bone ingrowth inside the pores towards the center of implant, characterized by islets of round bone present in the HE stained slides.
C1 [Violin, Kalan Bastos; Goia, Tamiye Simone; Bressiani, Jose Carlos; de Almeida Bressiani, Ana Helena] Mat Sci & Technol Ctr IPEN, Av Prof Lineu Prestes,2242 Cidade Univ, Sao Paulo, Brazil.
   [Ribeiro, Christiane] UFABC, Ctr Engn, Appl Social Sci Ctr, Santo Andre sp, Brazil.
RP Violin, KB (reprint author), Mat Sci & Technol Ctr IPEN, Av Prof Lineu Prestes,2242 Cidade Univ, Sao Paulo, Brazil.
EM kbviolin@ipen.br; cribeiro@ipen.br; tsgoia@ipen.br; jbressia@ipen.br;
   abressia@ipen.br
RI Bressiani, Ana/I-1402-2012
FU "lNCT em Biofabricacao", FAPESP [2010/20698-4]; CNPq
FX The authors are thankful for the financial support "lNCT em
   Biofabricacao", FAPESP 2010/20698-4 and CNPq.
CR ALROY J, 1991, CARBOHYD RES, V213, P229, DOI 10.1016/S0008-6215(00)90611-6
   Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g
   Bilyy R, 2007, AUTOIMMUNITY, V40, P249, DOI 10.1080/08916930701358867
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Doernberg M C, 2006, BIOMATERIALS, V27, P5186
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Mahal LK, 2008, ANTI-CANCER AGENT ME, V8, P37, DOI 10.2174/187152008783330806
   NIIKAWA S, 1992, ACTA NEUROPATHOL, V83, P347, DOI 10.1007/BF00713524
   Ribeiro C., 2010, ADV SCI TECHN, V76, P66
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   Taraszewska A, 2007, FOLIA NEUROPATHOL, V45, P9
   Violin K.B., 2012, ADV SCI TEC IN PRESS
NR 15
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 331
EP +
DI 10.4028/www.scientific.net/KEM.529-530.331
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800069
DA 2018-10-20
ER

PT S
AU Keuer, H
   Ganz, C
   Xu, W
   Schubert, A
   Frerich, B
   Gerber, T
AF Keuer, H.
   Ganz, C.
   Xu, W.
   Schubert, A.
   Frerich, B.
   Gerber, Th.
BE Ishikawa, K
   Iwamoto, Y
TI Osteoinductive coating on PEEK surfaces by using nanocrystalline
   biomaterial and in vivo test
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE polyetheretherketone; biomaterial coating; synthetic hydroxyapatite; in
   vivo experiment
AB A surface coating on the polymer polyetheretherketone (PEEK) was developed to improve the osteointegration of an implantation model for cages (implant for spinal fusion). In a process of induction heating the polymer surface was coated with a synthetic biomaterial. The polymer surface melts during the coating process and crawls into the nanoporous structure of the biomaterial. After heat dissipation, a strong connection is reached between polymer and biomaterial. Finally, the model was implanted into New Zealand rabbit femur as control and coated group for 2, 4 and 6 weeks. The evaluation offers a ca. 10% higher bone-to-implant-contact value for the coated group.
C1 [Keuer, H.; Ganz, C.; Xu, W.; Gerber, Th.] Univ Rostock, Inst Phys, D-18055 Rostock, Germany.
   [Schubert, A.; Frerich, B.] Univ Rostock, Dept Oral, Maxillofacial & Plast Surg, Rostock, Germany.
RP Keuer, H (reprint author), Univ Rostock, Inst Phys, D-18055 Rostock, Germany.
EM holger.keuer@uni-rostock.de; thomas.gerber@uni-rostock.de
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   SKINNER HB, 1988, CLIN ORTHOP RELAT R, P224
   Xu WG, 2009, J BIOMED MATER RES B, V91B, P692, DOI 10.1002/jbm.b.31445
NR 6
TC 0
Z9 0
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 345
EP +
DI 10.4028/www.scientific.net/KEM.529-530.345
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800072
DA 2018-10-20
ER

PT S
AU David, M
   Guenaelle, B
   Aline, L
   Maria, Z
   Luc, M
   Stephanie, S
   Nicolas, D
   Didier, BA
   Jerome, C
AF David, Marchat
   Guenaelle, Bouet
   Aline, Lueckgen
   Maria, Zymelka
   Luc, Malaval
   Stephanie, Szenknect
   Nicolas, Dacheux
   Didier, Bernache-Assollant
   Jerome, Chevalier
BE Ishikawa, K
   Iwamoto, Y
TI Physico-chemical characterization and in vitro biological evaluation of
   pure SiHA for bone tissue engineering application
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE silicon-substituted hydroxyapatite; bioceramics; dissolution; in vitro
   biocompatibility
ID SILICON-SUBSTITUTED HYDROXYAPATITE; BIOCERAMICS
AB Studies about silicon-substituted hydroxyapatites exhibit several shortcomings that leave unanswered questions regarding the properties and subsequent biological outcomes generated by this biomaterial. Firstly, samples characterization is often incomplete, meaning that phase purity on the pellet surface is not assured. In fact, ceramic materials used in literature that are claimed to be pure are actually polluted through second phase as superficial polymerized silicate.
   In this study, we have successfully synthesized a phase-pure silicon hydroxyapatite powder Ca-10(PO4)(5.5)(SiO4)(0.5)(OH)(1.5) (Si(0.5)HA) compressed this powder into pellets, sintered them, and evaluated the biological response of osteoblast cells (C3H10 line) seeded on the pellet surface. Besides, the solubility in aqueous media of HA and Si(0.5)HA pellets were determined through "static" experiments. These tests attempt to provide a comprehensive picture of the cellular response to the SiHA material, in order to determine the mechanism by which Si evokes the improved in vitro biological outcomes described in the literature. Results revealed first an equivalent solubility of Si(0.5)HA and HA pellets, and second that cells do not react favourably to the pure SiHA surface.
C1 [David, Marchat; Aline, Lueckgen; Maria, Zymelka; Didier, Bernache-Assollant] Ecole Natl Super Mines, CIS EMSE, CNRS FRE3312, 158 Cours Fauriel, F-42023 St Etienne, France.
   [Guenaelle, Bouet; Luc, Malaval] Univ Jean Monnet, Fac Med St Etienne, LBTO, INSERM, F-42023 St Etienne, France.
   [Stephanie, Szenknect; Nicolas, Dacheux] Univ Montpellier, Inst Chinnie Separat Marcoule UMR 5257, Lab Interfaces Mat Evolut LIME, F-30207 Bagnols Sur Ceze 30207, France.
   [Jerome, Chevalier] Univ Lyon, MATEIS Lab UMR CNRS 5510, INSA Lyon, F-69621 Villeurbanne, France.
RP David, M (reprint author), Ecole Natl Super Mines, CIS EMSE, CNRS FRE3312, 158 Cours Fauriel, F-42023 St Etienne, France.
EM marchat@emse.fr
CR Best SM, 2008, KEY ENG MATER, V361-363, P985, DOI 10.4028/www.scientific.net/KEM.361-363.985
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Dacheux N, 2010, J NUCL MATER, V404, P33, DOI 10.1016/j.jnucmat.2010.06.023
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Marchat D, 2012, ACTA BIOMATERI UNPUB
   Marchat D, 2011, J HAZARDOUS MA UNPUB
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2006, J BIOMED MATER RES A, V78A, P25, DOI 10.1002/jbm.a.30690
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Zymelka M, 2012, ACTA BIOMATERI UNPUB
NR 13
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 351
EP +
DI 10.4028/www.scientific.net/KEM.529-530.351
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800073
DA 2018-10-20
ER

PT S
AU Nakamura, M
   Nagai, A
   Yamashita, K
AF Nakamura, Miho
   Nagai, Akiko
   Yamashita, Kimihiro
BE Ishikawa, K
   Iwamoto, Y
TI Surface Electric Fields of Apatite Electret Promote Osteoblastic
   Responses
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE osteoblast; differentiation; polarization; hydroxyapatite
ID HYDROXYAPATITE CERAMICS; POLARIZATION
AB The osteoblast behaviors on the biomaterial substrates are recognized to play a fundamental role in osteoconduction process. The purpose of this study was to evaluate the in vitro behaviors of osteoblasts cultured on electrically polarized hydroxyapatite (HA), having the enhanced osteobonding abilities. Osteoblasts derived from mouse bone marrow were seeded onto the polarized HA and investigated the proliferation and differentiation. The polarization had effects on the proliferation of osteoblast precursor cells based on the MTT assay. The acceleration was emerged as the early achievement to the confluence on the N-HA and P-HA. The quantitative analysis of the results of ALP and AR-S staining, the charges induced on the HA surface accelerated the differentiation from the osteoblast precursor cells to mature osteoblasts.
C1 [Nakamura, Miho; Nagai, Akiko; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM miho.bcr@tmd.ac.jp; nagai.bcr@tmd.ac.jp; yama-k.bcr@tmd.ac.jp
CR Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Itoh S, 2006, CALCIFIED TISSUE INT, V78, P133, DOI 10.1007/s00223-005-0213-6
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502
   Yamashita K, 2005, J CERAM SOC JPN, V113, P1, DOI 10.2109/jcersj.113.1
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 9
TC 4
Z9 4
U1 1
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 357
EP 360
DI 10.4028/www.scientific.net/KEM.529-530.357
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800074
DA 2018-10-20
ER

PT S
AU Miyazaki, T
   Kuramoto, A
AF Miyazaki, Toshiki
   Kuramoto, Akimasa
BE Ishikawa, K
   Iwamoto, Y
TI Fabrication of Composites from Apatite and Chemically Synthesized
   collagen
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Chemically synthesized collagen; Apatite; Organic-inorganic hybrid;
   Simulated body fluid (SBF)
AB Chemically synthesized collagen with triple helix structure similar to natural collagen has been developed as a safe biomaterial. If the chemically synthesized collagen is deposited with apatite, they are expected for novel bone substitutes having bioactivity and bioresorbability. Although apatite formation on the chemically synthesized collagen has been examined, highly supersaturated condition such as 1.5SBF with ion concentration 1.5 times those of simulated body fluid (SBF) is needed to achieve apatite formation. In the present study, we intended acceleration on the apatite formation on the chemically synthesized collagen by immobilization with polyglutamic acid (PGA). PGA is known as biodegradable and biocompatible polypeptide having excellent apatite-forming ability. We examined effects of the immobilization procedure on mineralization behavior in SBF. At first, PGA was immobilized on porous sponges of chemically synthesized collagen in aqueous solutions containing PGA and CaCl2. As a result, not only apatite but also calcite-type CaCO3 was deposited on the specimens in SBF. The calcite formation was occurred during the treatment with PGA solution. pH of the solution was adjusted to 7 by NaOH solution in order to avoid dissolution of the collagen. During this procedure, Ca(OH)(2) would be precipitated by locally increase in pH of the solution and converted into the calcite. When the PGA solution treatment was shortened so as to prevent the calcite formation, single phase of the apatite was formed in SBF. The present results indicate that crystalline phase deposited on the chemically synthesized collagen can be controlled by fabrication procedure, and provide fundamental design of composites containing apatite and chemically synthesized collagen useful for bone regeneration.
C1 [Miyazaki, Toshiki; Kuramoto, Akimasa] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
RP Miyazaki, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.
EM tmiya@life.kyutech.ac.jp
CR GIRIJA EK, 2002, CHEM LETT 0705, P702
   KAMITAKAHARA M, 2005, ARCH BIOCERAMICS RES, V5, P210
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8
NR 4
TC 2
Z9 2
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 426
EP 429
DI 10.4028/www.scientific.net/KEM.529-530.426
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800088
DA 2018-10-20
ER

PT S
AU Yoshida, Y
   Okihara, T
   Nakamura, M
   Matsumoto, T
AF Yoshida, Yasuhiro
   Okihara, Takumi
   Nakamura, Mariko
   Matsumoto, Takuya
BE Ishikawa, K
   Iwamoto, Y
TI Phosphorylated Pullulan Bioadhesive for Regeneration and Reconstruction
   of Bone and Tooth
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE phosphorylated pullulan; bioadhesive; regeneration; reconstruction;
   bone; tooth
ID PERCUTANEOUS VERTEBROPLASTY; HIP-ARTHROPLASTY; TISSUE ADHESIVE; CEMENT;
   SURGERY; INTERFACE; COLLAPSE; DENTIN; DEATH
AB A biodegradable material that bonds to hard tissues such as bones and teeth is urgently needed for medical and dental applications. However, such materials are not available in today's clinical practice of orthopedics and dentistry. Therefore, we synthesized biodegradable phosphorylated pullulan to develop a biomaterial that combines primary properties such as high biocompatibility, good bonding potential to hard tissue, high strength, biodegradability, and osteoconductivity. The pharmacopoeial polysaccharide pullulan was chemically functionalized with dihydrogen phosphate groups. Phosphorylated pullulan was formed network by adding calcium ion, making the composite less soluble in water. Adhesive force measurement revealed that adhesiveness of the pastes before setting can be controlled through optimization of additives. In addition, histological evaluation revealed that phosphorylated pullulan-based composite possesses high biocompatibility. These results indicate that phosphorylated pullulan can be used as a key material for regeneration and reconstruction of bone and tooth.
C1 [Yoshida, Yasuhiro; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
   [Okihara, Takumi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Kita Ku, Okayama 7008530, Japan.
   [Nakamura, Mariko] Kibi Int Univ Jr Coll, Dept Hlth & Welf Program, Okayama 7168508, Japan.
RP Yoshida, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM yasuhiro@md.okayama-u.ac.jp; okihara@cc.okayama-u.ac.jp;
   marin@kiui.ac.jp; tmatsu@md.okayama-u.ac.jp
CR Amar AP, 2001, NEUROSURGERY, V49, P1105, DOI 10.1097/00006123-200111000-00017
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Byrick RJ, 1997, CAN J ANAESTH, V44, P107, DOI 10.1007/BF03012996
   BYRICK RJ, 1986, ANESTHESIOLOGY, V65, P213, DOI 10.1097/00000542-198608000-00016
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chen HL, 2002, ANESTH ANALG, V95, P1060, DOI 10.1213/01.ANE.0000025591.86476.F2
   DUNCAN JAT, 1989, ANAESTHESIA, V44, P149, DOI 10.1111/j.1365-2044.1989.tb11168.x
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Inoue S, 2005, J DENT RES, V84, P1160, DOI 10.1177/154405910508401213
   Leathers TD, 2003, APPL MICROBIOL BIOT, V62, P468, DOI 10.1007/s00253-003-1386-4
   MAYER JM, 1990, POLYM MAT SCI ENG, V63, P732
   Parvizi J, 1999, CLIN ORTHOP RELAT R, P39
   Ries MD, 2006, BIOMATERIALS, V27, P256, DOI 10.1016/j.biomaterials.2005.05.103
   Singer AJ, 1998, ACAD EMERG MED, V5, P94, DOI 10.1111/j.1553-2712.1998.tb02590.x
   Stanczyk M, 2004, J BIOMECH, V37, P1803, DOI [10.1016/j.jbiomech.2004.03.002, 10.1016/j.biomech.2004.03.002]
   Vasconcelos C, 2001, J VASC INTERV RADIOL, V12, P1001, DOI 10.1016/S1051-0443(07)61584-X
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375
   Yoshihara K, 2011, ACTA BIOMATER, V7, P3187, DOI 10.1016/j.actbio.2011.04.026
   Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024
NR 24
TC 2
Z9 2
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 516
EP +
DI 10.4028/www.scientific.net/KEM.529-530.516
PG 3
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800106
DA 2018-10-20
ER

PT S
AU Yamamoto, E
   Kato, N
   Nishikawa, H
   Kusunoki, M
   Hayami, T
   Yoshikawa, K
   Hontsu, S
AF Yamamoto, E.
   Kato, N.
   Nishikawa, H.
   Kusunoki, M.
   Hayami, T.
   Yoshikawa, K.
   Hontsu, S.
BE Ishikawa, K
   Iwamoto, Y
TI Adhesive Strength between Flexible Hydroxyapatite Sheet and Tooth Enamel
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Hydroxyapatite sheet; Tricalcium phosphate; Pulsed laser deposition;
   Artificial enamel; Adhesive strength
ID BONE
AB Tooth enamel cannot be reconstructed once it is destroyed immoderately. Hydroxyapatite (HAp) thin sheet can potentially be used for a novel dental biomaterial to repair the enamel. Using a pulsed laser deposition (PLD) method, we have successfully created a flexible HAp sheet of less than a few micrometers in thickness. Due to its flexibility, the HAp sheet is tightly adhered on curved surfaces at the target site. In the present study, we newly developed double-layered sheets composed of HAp film coated with tricalcium phosphate (TCP) thin layer. The HAp/TCP sheet was adhered to the extracted human teeth using a calcium phosphate solution for 3 days. The adhesive strength between the HAp/TCP sheet and tooth enamel was evaluated by quasi-static tensile tests. Moreover, the interface structure between them was observed by a scanning electron microscopy. As a result of the mechanical evaluation, the adhesive strength was greater than approximately 2.5 MPa. The electron microscopic observation revealed that the sheet was partially fused with the enamel. These findings suggest the possibility that enamel defects are repaired using the HAp/TCP sheet for a short duration.
C1 [Yamamoto, E.; Kato, N.; Nishikawa, H.; Kusunoki, M.; Hayami, T.; Hontsu, S.] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.
   [Yoshikawa, K.] Osaka Dent Univ, Dept Operat Dent, Osaka, Japan.
RP Yamamoto, E (reprint author), Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.
EM ei@waka.kindai.ac.jp; nkato@waka.kindai.ac.jp;
   nishik32@waka.kindai.ac.jp; kusu@waka.kindai.ac.jp;
   hayami@waka.kindai.ac.jp; kazushi@cc.osaka-dent.ac.jp;
   hontsu@waka.kindai.ac.jp
OI Nishikawa, Hiroaki/0000-0001-7753-3866; Kato,
   Nobuhiro/0000-0002-8210-6305
CR Hayami T, 2011, CLIN ORAL IMPLAN RES, V22, P774, DOI 10.1111/j.1600-0501.2010.02057.x
   Hontsu S, 1998, JPN J APPL PHYS 2, V37, pL1169, DOI 10.1143/JJAP.37.L1169
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   Hontsu S., 2010, MEMORIES FACULTY BIO, V26, P87
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Nishikawa H., 2010, APPL PHYS EXPRESS, V1
   Ozeki K, 2001, BIO-MED MATER ENG, V11, P63
   Schroeder JE, 2011, INJURY, V42, P609, DOI 10.1016/j.injury.2011.03.029
NR 8
TC 0
Z9 0
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 522
EP +
DI 10.4028/www.scientific.net/KEM.529-530.522
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800107
DA 2018-10-20
ER

PT S
AU Cavalu, S
   Simon, V
   Ratiu, C
   Rus, V
   Akin, I
   Goller, G
AF Cavalu, Simona
   Simon, Viorica
   Ratiu, Cristian
   Rus, Vasile
   Akin, Ipek
   Goller, Gultekin
BE Ishikawa, K
   Iwamoto, Y
TI Titania versus Ceria alumina/zirconia composites: structural aspects and
   biological tolerance
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE alumina/zirconia composites; structure; biocompatibility
ID ZIRCONIA; CERAMICS; DENSIFICATION; BIOMATERIAL; ALUMINA; SURFACE; BONE
AB The aim of our study is to compare the structural and biological tolerance of novel Al2O3/3Y-TZP composites with ceria respectively titania addition (5 wt%). Scanning electron microscopy, X-ray diffraction, infrared spectroscopy and XPS results are reported for structural characteristics and surface modifications upon different fluoride treatments. The biocompatibility of the samples was evaluated using an animal model (rabbit). The explants were analyzed at a specific period (6 weeks).The sections of implanted bone area were subjected to histological evaluation. Upon correlating the structural properties and in vivo evaluation, we concluded that the addition of both TiO2 and CeO2 to Al2O3/3Y-TZP implies similar properties and satisfactory biological tolerance. With respect to the surface treatment, qualitative and quantitative results show that the alumina/zirconia with titania addition are more sensitive to fluoride treatment.
C1 [Cavalu, Simona; Ratiu, Cristian] Univ Oradea, Fac Med & Pharm, Oradea, Romania.
   [Simon, Viorica] Univ Babes Bolyai, Fac Phys Inst Interdisciplinary Res Bio Nano Sci, Cluj Napoca, Romania.
   [Rus, Vasile] USAMV, Fac Vet Med, Cluj Napoca, Romania.
   [Akin, Ipek; Goller, Gultekin] Istanbul Tech Univ, Dept Mat Sci, Istanbul, Turkey.
RP Cavalu, S (reprint author), Univ Oradea, Fac Med & Pharm, Oradea, Romania.
EM scavalu@rdslink.ro; viorica.simon@phys.ubbcluj.ro;
   ratiu_cristian@yahoo.com; vasilerus2002@yahoo.com; akinipe@itu.edu.tr;
   goller@itu.edu.tr
RI Akin, Ipek/B-6012-2014
OI Goller, Gultekin/0000-0003-4680-3936
FU CNCS-UEFISCDI [nr. PNE-1D-PCE 2011-3-0441]; Bilateral Cooperation
   between Romania and Turkey [2012-2013]
FX This work was accomplished in the framework of CNCS-UEFISCDI, project
   nr. PNE-1D-PCE 2011-3-0441 and Bilateral Cooperation between Romania and
   Turkey 2012-2013.
CR Akin I, 2011, CERAM INT, V37, P3273, DOI 10.1016/j.ceramint.2011.05.123
   Casellas D, 2003, J MATER PROCESS TECH, V143, P148, DOI [10.1016/S0924-0136(03)00396-0, 10.1016/S0924-0136(03)000396-0]
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Duan K, 2006, J MATER CHEM, V16, P2309, DOI 10.1039/b517634d
   HATTAB FN, 1989, J DENT, V17, P47, DOI 10.1016/0300-5712(89)90129-2
   Macauro G., 2004, J BONE JOINT SURG BR, V86, P1192
   Meng FC, 2012, J ALLOY COMPD, V512, P63, DOI 10.1016/j.jallcom.2011.09.015
   Mustafa K, 2008, CLIN ORAL IMPLAN RES, V19, P1178, DOI 10.1111/j.1600-0501.2008.01560.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Silva NRFA, 2010, MATERIALS, V3, P863, DOI 10.3390/ma3020863
   Simon V, 2007, J OPTOELECTRON ADV M, V9, P3368
   Simon V., 2011, STUDIA UBB PHYS, V1, P67
   Tsukuma K, 2000, J AM CERAM SOC, V83, P3219, DOI 10.1111/j.1151-2916.2000.tb01711.x
NR 16
TC 1
Z9 1
U1 0
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 595
EP +
DI 10.4028/www.scientific.net/KEM.529-530.595
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800121
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Agathopoulos, S
   Ozyegin, LS
   Turner, IG
   Gunduz, O
   Demirkol, N
   Bruck, S
   Ben-Nissan, B
   Samur, R
   Kayali, ES
   Aktas, C
AF Oktar, F. N.
   Agathopoulos, S.
   Ozyegin, L. S.
   Turner, I. G.
   Gunduz, O.
   Demirkol, N.
   Brueck, S.
   Ben-Nissan, B.
   Samur, R.
   Kayali, E. S.
   Aktas, C.
BE Ishikawa, K
   Iwamoto, Y
TI Nano-Bioceramic Production via Mechano-Chemical Conversion
   (Ultrasonication)
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Local sea snail; ultrasonication; natural nano-bioceramics;
   hydroxyapatite
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE COATINGS; BONE; FABRICATION;
   SCAFFOLDS; DENTIN
AB The production of nano-calcium phosphate powders, such as HA (hydroxyapatite), from synthetic chemicals can be expensive and time consuming. The skeleton or shells of sea creatures (e.g. sea urchins, shells, corals) could be an alternative source of materials to produce very fine and even nano-structured calcium phosphate biomaterial powders. Hydrothermal conversion under very high pressures or methods such as hot-plating (chemical) or ultrasonication (mechano-chemical), have been proposed to transform naturally derived CaCO3, e.g. aragonite, into apatite based materials. The aim of the present work was to prepare inexpensive nano-sized HA and TCP bioceramics powders from a local sea snail shells as a possible raw material for HA/TCP bioceramics.
   Empty shells of a local sea snail (Nassarius hinia reticulatus) from Marmara Sea, Turkey were collected from a beach near Istanbul. The collected shells were ground to a particle size <75 mu m. Thermal analyses (DTA/TGA) were performed to determine the exact CaCO3 content and thermal behavior. The raw powder was suspended in an aqueous media which was placed in an ultrasonic bath. The temperature was set at 80 degrees C for 15min. Then, an equivalent (to CaO content) amount of H3PO4 was added drop by drop very gently into the solution. The reaction continued for 8h, following which the liquid component was evaporated off in an incubator at 100 degrees C for 24h. The dried sediment was collected and heat treated at two different temperatures, 400 and 800 degrees C. The morphology of the powders produced was examined using SEM. The crystalline phases were indentified using X-ray analysis.
C1 [Oktar, F. N.] Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Med Imaging Tech, Istanbul, Turkey.
   [Gunduz, O.] Marmara Univ, Nanotechnol Biomaterials Applicat Res Ctr, Istanbul, Turkey.
   [Oktar, F. N.; Turner, I. G.] Univ Bath, Dept Mech Engn, Ctr Orthopaed Biomechan, Bath BA2 7AY, Avon, England.
   [Agathopoulos, S.] Univ Ioannina, Dept Mat Sci & Engn, Ioannina, Greece.
   [Ozyegin, L. S.] Marmara Univ, Istanbul, Turkey.
   [Gunduz, O.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Gunduz, O.; Samur, R.] Marmara Univ, Fac Tech Educ, Dept Met Educ, Istanbul, Turkey.
   [Demirkol, N.] Kocaeli Univ, Degirmendere Ali Ozbay Vocat Sch, Dept Tech Programmes, Kocaeli, Turkey.
   [Brueck, S.; Aktas, C.] Leibniz Inst New Mat, Saarbrucken, Germany.
   [Ben-Nissan, B.; Samur, R.] Univ Technol, Dept Chem, Mat & Forens Sci, Sydney, NSW, Australia.
   [Kayali, E. S.] Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
EM foktar@marmara.edu.tr; sagat@cc.uoi.gr; sevgiozyegin@yahoo.com;
   I.G.Turner@bath.ac.uk; oguzhan.gunduz.09@ucl.ac.uk;
   nermin.demirkol@kocaeli.edu.tr; Stefan.Brueck@inm-gnnbh.de;
   Besim.Ben-Nissan@uts.edu.au; rsamur@marmara.edu.tr; kayali@itu.edu.tr;
   Cenk.Aktas@inm-gmbh.de
OI Gunduz, Oguzhan/0000-0002-9427-7574
CR Adak M. D., 2011, TRENDS BIOMATER ARTI, V25, P101
   Agaogullari D, 2012, ACTA PHYS POL A, V121, P23
   Agathopoulos S., 2012, Key Engineering Materials, V493-494, P775, DOI 10.4028/www.scientific.net/KEM.493-494.775
   Akyurt N., 2011, EURO PM 2011 C BARC
   Ben-Nissan B., 2008, [US Patent, Processes for treating coral and coating an object], Patent No. [2008/0063683 A1, 20080063683]
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Carvalho Alexandre L, 2007, J Oral Implantol, V33, P267, DOI 10.1563/1548-1336(2007)33[267:EOGSOT]2.0.CO;2
   Chou J., 2007, J AUST CERAM SOC, V43, P44
   Demir Muzaffer, 2003, Turkish Journal of Zoology, V27, P101
   Demirkol Nermin, 2012, Key Engineering Materials, V493-494, P588, DOI 10.4028/www.scientific.net/KEM.493-494.588
   Demirkol N, 2010, INT J ARTIF ORGANS, V33, P468
   Goller G, 2004, MATER LETT, V58, P2599, DOI 10.1016/j.matlet.2004.03.032
   Goller G, 2002, MATER LETT, V56, P142
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   Jenis L.G., 2006, MUSCULOSKELETAL REV, P48
   Karthikeyan S, 2008, J AM CHEM SOC, V130, P14968, DOI 10.1021/ja806887k
   Kel D., 2012, Key Engineering Materials, V493-494, P287, DOI 10.4028/www.scientific.net/KEM.493-494.287
   KEL D, 2011, INT J ARTIF ORGANS, V34, P700
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Lewis K, 2006, KEY ENG MAT, V309-311, P15, DOI 10.4028/www.scientific.net/KEM.309-311.15
   Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009
   Moharamzadeh K, 2008, BRIT J ORAL MAX SURG, V46, P110, DOI 10.1016/j.bjoms.2007.07.209
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Ozyegin L. S., 2012, Key Engineering Materials, V493-494, P781, DOI 10.4028/www.scientific.net/KEM.493-494.781
   Ozyegin LS, 2004, MATER LETT, V58, P2605, DOI 10.1016/j.matlet.2004.03.033
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Skolka M., 2004, SPECII INVAZIVE MARE
   Supova M, 2011, CERAM-SILIKATY, V55, P256
   Tuyel U., 2008, THESIS
NR 30
TC 5
Z9 5
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 609
EP +
DI 10.4028/www.scientific.net/KEM.529-530.609
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800124
DA 2018-10-20
ER

PT J
AU Ciambelli, GS
   Perez, MO
   Siqueira, GV
   Candella, MA
   Motta, AC
   Duarte, MAT
   Alberto-Rincon, MD
   Duek, EAD
AF Ciambelli, Giuliano Serafino
   Perez, Mariana Ortega
   Siqueira, Guilherme Vasconcelos
   Candella, Marco Aurelio
   Motta, Adriana Cristina
   Duarte, Marcia Adriana Tomaz
   Alberto-Rincon, Maria do Carmo
   de Rezende Duek, Eliana Aparecida
TI Characterization of Poly (L-co-D,L Lactic Acid) and a Study of
   Polymer-tissue Interaction in Subcutaneous Implants in Wistar Rats
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE PLDLA; degradation in vitro; tissue
ID IN-VIVO; DEGRADATION; MORPHOLOGY; COPOLYMER; MEMBRANES; VITRO
AB Poly (L-co-D,L lactic acid) (PLDLA) is an important biomaterial because of its biocompatibility properties that promote cellular regeneration and growth. The aim of this study was to evaluate the polymer-tissue interaction of PLDLA implants in the dorsal subcutaneous tissue of male Wistar rats at various intervals (2, 7, 15, 30, 60 and 90 days) after implantation. Physical properties such as the glass transition point (Tg), degradation behavior and other mechanical properties were characterized by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), gel permeation chromatography (GPC), scanning electron microscopy (SEM) and tension tests. Analysis of the degradation of PLDLA membranes in vitro showed that the polymer became crystalline as a function of the degradation time. Mechanical tension tests showed that the polymer behaved like a ductile material: when subjected to constant tension it initially suffered deformation, then elongation and finally ruptured. TGA/MEV provided evidence of PLDLA membrane degradation. For histological analysis, samples from each group were processed in xylol/paraffin, except for the 60 - and 90 - day samples. Each of the latter samples was divided in two: one half was treated with xylol/paraffin and the other with historesin. Light microscopy showed the adhesion of cells to the biomaterial, the formation of a conjunctive capsule around the implant, the presence of epithelioid cells, the formation of foreign body giant cells and angiogenesis. During degradation, the polymer showed a 'lace' - like appearance when processed in xylol/paraffin compared to the formation of "centripetal cracks in the form of glove fingers" when embedded in historesin.
C1 [Ciambelli, Giuliano Serafino; Perez, Mariana Ortega; Siqueira, Guilherme Vasconcelos; Candella, Marco Aurelio; Motta, Adriana Cristina; Duarte, Marcia Adriana Tomaz] Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
   [Alberto-Rincon, Maria do Carmo] Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, Dept Physiol Sci, BR-18030095 Sorocaba, SP, Brazil.
   [de Rezende Duek, Eliana Aparecida] Univ Estadual Campinas, Dept Mat Engn, Fac Mech Engn, BR-13083970 Campinas, SP, Brazil.
RP Ciambelli, GS (reprint author), Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
EM eliduek@fem.unicamp.br
RI Biofabris, Inct/I-2418-2013
OI Serafino Ciambelli, Giuliano/0000-0002-3271-4185
FU PIBIC/CEPE (Programa Institucional de Bolsas de Iniciacao Cientifica -
   Conselho de Ensino Pesquisa e Extensao)
FX The authors thank. Debora Regina Machado Silva, Carolina Lucchesi,
   Grazielle dos Santos Barauna and Katia Fernanda Silva (Laboratory of
   Biomaterials, PUC-SP) for help during this work and Elizabeth Almeida
   (Laboratory of Histology, PUC-SP) for technical assistance. This work
   was supported by grants from PIBIC/CEPE (Programa Institucional de
   Bolsas de Iniciacao Cientifica - Conselho de Ensino Pesquisa e
   Extensao).
CR Alberto-Rincon MC, 2001, BRAZILIAN J MORPHOLO, V18, P7
   Barauna G, 2007, THESIS U ESTADUAL CA
   BARBANTI SH, 2002, ACTA MICROSCOPICA, V11, P85
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Duck EAR, 1999, POLYMER, V40, P6465
   Duek EAR, 2005, POLIMEROS, V15, P13
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Jiang SC, 2004, MACROMOL CHEM PHYSIC, V205, P2229, DOI 10.1002/macp.200400204
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li Suming, 1990, J MATER SCI-MATER M, V1, P198
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Marucci DD, 2002, J CRANIO MAXILL SURG, V30, P208, DOI 10.1054/jcms.2002.0289
   Middeleton JC, 2000, BIOMATERIALS, V20, P2335
   Motta Adriana C., 2006, Polímeros, V16, P26, DOI 10.1590/S0104-14282006000100008
   Motta AC, 2007, POLIMEROS, V17, P123, DOI 10.1590/S0104-14282007000200011
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   PEZZIN APT, 2001, THESIS U ESTADUAL CA
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   Rezende Camila A., 2005, Polímeros, V15, P232, DOI 10.1590/S0104-14282005000300015
   Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I
   Silva DRM, 2002, THESIS STATE U CAMPI
   SILVA DRM, 2007, THESIS U ESTADUAL CA
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 32
TC 5
Z9 5
U1 0
U2 13
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-FEB
PY 2013
VL 16
IS 1
BP 28
EP 37
DI 10.1590/S1516-14392012005000146
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 087VC
UT WOS:000314791100004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chuah, JA
   Yamada, M
   Taguchi, S
   Sudesh, K
   Doi, Y
   Numata, K
AF Chuah, Jo-Ann
   Yamada, Miwa
   Taguchi, Seiichi
   Sudesh, Kumar
   Doi, Yoshiharu
   Numata, Keiji
TI Biosynthesis and characterization of polyhydroxyalkanoate containing
   5-hydroxyvalerate units: Effects of 5HV units on biodegradability,
   cytotoxicity, mechanical and thermal properties
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Polyhydroxyalkanoate (PHA); 5-hydroxyvalerate (5HV); Biomaterial;
   Lipase-mediated degradation
ID SUBSTRATE SPECIFICITIES; COMAMONAS-ACIDOVORANS; ALCALIGENES-EUTROPHUS;
   MICROBIAL SYNTHESIS; GENETIC-ANALYSIS; BACTERIAL; ACIDS; POLYESTERS;
   COPOLYMERS; SYNTHASE
AB This study describes the biosynthesis of polyhydroxyalkanoate (PHA) containing 5-hydroxyvalerate (5HV) units. Monomer units like 5HV, with variation in length of the backbone segment of the repeat unit, are known to more greatly impact mechanical properties of polymers. Introduction of 5HV units was also aimed at enhancing biodegradability of the material, as it had been found previously that a homopolymer of 5HV could be degraded by lipase. The produced poly[(R)-3-hydroxybutyrate-co-3-hydroxypropionate-co-5-hydroxyvalerate]s [P(3HB-co-3HP-co-5HV)s] with 5HV content ranging from 1 to 32 mol% by the choice of strain, type and concentration of carbon substrate, exhibited low melting temperature (T-m), reduced crystallinity and elastomeric behavior. Enzymatic degradation test confirmed the role of 5HV unit in enabling lipase-mediated degradation of P(3HB-co-3HP-co-5HV)s, as poly[(R)-3-hydroxybutyrate] and poly[(R)-3-hydroxypropionatel films were not hydrolyzed by porcine pancreas lipase. Additionally, viability assay of human mesenchymal stem cells revealed that the P(3HB-co-3HP-co-5HV) films were less cytotoxic and supported cell proliferation, highlighting the potential of P(3HB-co-3HP-co-5HV)s as biomaterials. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Chuah, Jo-Ann; Yamada, Miwa; Numata, Keiji] RIKEN, Biomass Engn Program, Enzyme Res Team, Wako, Saitama 3510198, Japan.
   [Chuah, Jo-Ann; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
   [Taguchi, Seiichi] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   [Doi, Yoshiharu] RIKEN, RIKEN Res Cluster Innovat, Wako, Saitama 3510198, Japan.
RP Numata, K (reprint author), RIKEN, Biomass Engn Program, Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM keiji.numata@riken.jp
RI Numata, Keiji/H-9751-2012; Sudesh, Kumar/C-2942-2011
OI Numata, Keiji/0000-0003-2199-7420; Sudesh, Kumar/0000-0003-4756-9192
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [23760757]; RIKEN Biomass Engineering Program; USM fellowship scheme;
   RIKEN International Program Associate
FX The work described here was supported by a Research Fellowship for Young
   Scientists (B) (no. 23760757) (to M.Y.) from the Ministry of Education,
   Culture, Sports, Science and Technology, Japan and RIKEN Biomass
   Engineering Program. J.C. is grateful to the USM fellowship scheme and
   RIKEN International Program Associate for financial support.
CR ABE H, 1995, MACROMOLECULES, V28, P7630, DOI 10.1021/ma00127a007
   Abe H, 1999, INT J BIOL MACROMOL, V25, P177, DOI 10.1016/S0141-8130(99)00032-X
   Abe H, 1998, MACROMOLECULES, V31, P1791, DOI 10.1021/ma971559v
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   DOI Y, 1990, NATO ADV SCI I E-APP, V186, P37
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Doi Y, 1987, MAKROMOL CHEM-RAPID, V8, P631
   Doi Y., 1990, MICROBIAL POLYESTERS
   Gorenflo V, 2001, BIOMACROMOLECULES, V2, P45, DOI 10.1021/bm0000992
   HAYWOOD GW, 1991, INT J BIOL MACROMOL, V13, P83, DOI 10.1016/0141-8130(91)90053-W
   Hocking PJ, 1994, BLACKIE ACAD PROFESS, P48
   JAEGER KE, 1995, APPL ENVIRON MICROB, V61, P3113
   KUNIOKA M, 1988, POLYM COMMUN, V29, P174
   Labuzek S, 2001, J APPL MICROBIOL, V90, P353, DOI 10.1046/j.1365-2672.2001.01253.x
   MUKAI K, 1993, BIOTECHNOL LETT, V15, P601, DOI 10.1007/BF00138548
   NAKAMURA S, 1991, J MACROMOL SCI CHEM, VA28, P15, DOI 10.1080/00222339108054378
   Numata K, 2011, BIOMACROMOLECULES, V12, P2137, DOI 10.1021/bm200221u
   Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0
   Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9
   Rehm BHA, 1999, INT J BIOL MACROMOL, V25, P3, DOI 10.1016/S0141-8130(99)00010-0
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   SCHUBERT P, 1988, J BACTERIOL, V170, P5837, DOI 10.1128/jb.170.12.5837-5847.1988
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudesh K, 1998, APPL ENVIRON MICROB, V64, P3437
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Taguchi S, 2002, POLYM INT, V51, P899, DOI 10.1002/pi.878
   Taguchi S, 2002, J BIOCHEM, V131, P801, DOI 10.1093/oxfordjournals.jbchem.a003168
   Taguchi S, 2001, FEMS MICROBIOL LETT, V198, P65, DOI 10.1111/j.1574-6968.2001.tb10620.x
   Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105
   Tajima K, 2003, J BIOSCI BIOENG, V95, P77, DOI 10.1016/S1389-1723(03)80152-4
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WILLIAMS SF, 2002, BIOPOLYMERS POLYESTE, V3, P91
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
NR 39
TC 30
Z9 35
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JAN
PY 2013
VL 98
IS 1
BP 331
EP 338
DI 10.1016/j.polymdegradstab.2012.09.008
PG 8
WC Polymer Science
SC Polymer Science
GA 093DD
UT WOS:000315171000041
DA 2018-10-20
ER

PT J
AU Zheng, WF
   Zhang, W
   Jiang, XY
AF Zheng, Wenfu
   Zhang, Wei
   Jiang, Xingyu
TI Precise Control of Cell Adhesion by Combination of Surface Chemistry and
   Soft Lithography
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; CIRCULATING TUMOR-CELLS; MESENCHYMAL
   STEM-CELLS; PATTERNING MULTIPLE TYPES; EXTRACELLULAR-MATRIX; IN-VITRO;
   SUBSTRATE STIFFNESS; POLYSTYRENE SURFACES; PROTEIN ADSORPTION;
   ENDOTHELIAL-CELLS
AB The adhesion of cells on an extracellular matrix (ECM) (in vivo) or the surfaces of materials (in vitro) is a prerequisite for most cells to survive. The rapid growth of nano/microfabrication and biomaterial technologies has provided new materials with excellent surfaces with specific, desirable biological interactions with their surroundings. On one hand, the chemical and physical properties of material surfaces exert an extensive influence on cell adhesion, proliferation, migration, and differentiation. On the other hand, material surfaces are useful for fundamental cell biology research and tissue engineering. In this Review, an overview will be given of the chemical and physical properties of newly developed material surfaces and their biological effects, as well as soft lithographic techniques and their applications in cell biology research. Recent advances in the manipulation of cell adhesion by the combination of surface chemistry and soft lithography will also be highlighted.
C1 [Zheng, Wenfu; Zhang, Wei; Jiang, Xingyu] Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Jiang, XY (reprint author), Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, 11 ZhongGuanCun BeiYiTiao, Beijing 100190, Peoples R China.
EM xingyujiang@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU Ministry of Science and Technology [2009CB930001, 2011CB933201];
   National Science Foundation of China [31170905, 90813032, 20890020,
   50902025]; Chinese Academy of Sciences [KJCX2-YW-M15]
FX This research was supported by the Ministry of Science and Technology
   (grant no. 2009CB930001 and 2011CB933201), the National Science
   Foundation of China (grant no. 31170905, 90813032, 20890020, and
   50902025), and the Chinese Academy of Sciences (grant no. KJCX2-YW-M15).
CR Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Auernheimer J, 2005, J AM CHEM SOC, V127, P16107, DOI 10.1021/ja053648q
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Belizna C, 2012, STROKE, V43, P1129, DOI 10.1161/STROKEAHA.111.635383
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen ZL, 2010, LANGMUIR, V26, P17790, DOI 10.1021/la103132m
   Chen ZL, 2009, ANGEW CHEM INT EDIT, V48, P8303, DOI 10.1002/anie.200902708
   Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Corey JM, 2003, EXP NEUROL, V184, pS89, DOI 10.1016/S0014-4886(03)00392-3
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Danova M, 2011, EXPERT REV MOL DIAGN, V11, P473, DOI 10.1586/ERM.11.33
   Davidson PM, 2010, J MATER SCI-MATER M, V21, P939, DOI 10.1007/s10856-009-3950-7
   den Toonder J, 2011, LAB CHIP, V11, P375, DOI 10.1039/c0lc90100h
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j
   Douville NJ, 2011, LAB CHIP, V11, P609, DOI 10.1039/c0lc00251h
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Ehrlicher A, 2011, NAT MATER, V10, P12, DOI 10.1038/nmat2928
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Felder M, 2012, LAB CHIP, V12, P640, DOI 10.1039/c1lc20879a
   Ferber D, 1999, SCIENCE, V284, P422, DOI 10.1126/science.284.5413.422
   Ferber D, 1999, SCIENCE, V286, P2051
   Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013
   Fu JP, 2011, NAT METHODS, V8, P184, DOI 10.1038/nmeth0211-184a
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fukumori K, 2009, ACTA BIOMATER, V5, P470, DOI 10.1016/j.actbio.2008.06.018
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghassemi S, 2008, J VAC SCI TECHNOL B, V26, P2549, DOI 10.1116/1.3013424
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c
   Green JV, 2009, LAB CHIP, V9, P677, DOI 10.1039/b813516a
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a
   Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iiizumi M, 2007, MICROVASC RES, V74, P114, DOI 10.1016/j.mvr.2007.04.002
   IRIE M, 1990, ADV POLYM SCI, V94, P27
   IRIE M, 1990, PURE APPL CHEM, V62, P1495, DOI 10.1351/pac199062081495
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kaji H, 2006, ANAL CHEM, V78, P5469, DOI 10.1021/ac060304p
   Kaji H, 2009, LAB CHIP, V9, P427, DOI 10.1039/b812510d
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kawaguchi T, 2000, LANGMUIR, V16, P9830, DOI 10.1021/la000756b
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim H. N., 2012, ANN BIOMED ENG
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Kushiro K, 2010, ADV MATER, V22, P4516, DOI 10.1002/adma.201001619
   Lai T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061907
   Lamb BM, 2010, LANGMUIR, V26, P12817, DOI 10.1021/la1022642
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   le Digabel J, 2010, MED BIOL ENG COMPUT, V48, P965, DOI 10.1007/s11517-010-0619-9
   Lee CJ, 2004, LANGMUIR, V20, P4155, DOI 10.1021/la035467c
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Liu YY, 2012, SMALL, V8, P676, DOI 10.1002/smll.201101199
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGlohorn JB, 2004, TISSUE ENG, V10, P505, DOI 10.1089/107632704323061861
   McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083
   Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2009.01.004
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Oliveira SM, 2011, SOFT MATTER, V7, P8932, DOI 10.1039/c1sm05943b
   Owatverot TB, 2005, J BIOMECH ENG-T ASME, V127, P374, DOI 10.1115/1.1894180
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Pearson D, 2007, J AM CHEM SOC, V129, P14862, DOI 10.1021/ja0766674
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng XL, 2012, J BIOMECH, V45, P116, DOI 10.1016/j.jbiomech.2011.09.013
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Pulsipher A, 2011, ADV POLYM SCI, V240, P103, DOI 10.1007/12_2010_87
   Qian F, 2004, REV SCI INSTRUM, V75, P2937, DOI 10.1063/1.1781382
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Robertus J, 2010, CHEM SOC REV, V39, P354, DOI 10.1039/b906608j
   Rosenhahn A, 2010, PHYS CHEM CHEM PHYS, V12, P4275, DOI 10.1039/c001968m
   Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125
   Su WT, 2011, BIOMED MICRODEVICES, V13, P11, DOI 10.1007/s10544-010-9466-6
   Su WT, 2010, J BIOMED MATER RES A, V93A, P1463, DOI 10.1002/jbm.a.32643
   Sun K, 2011, LANGMUIR, V27, P5709, DOI 10.1021/la2012099
   Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028156
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126
   Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103
   Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Uttayarat P, 2008, AM J PHYSIOL-HEART C, V294, pH1027, DOI 10.1152/ajpheart.00816.2007
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wan PB, 2009, ADV MATER, V21, P4362, DOI 10.1002/adma.200901237
   Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202
   Wischerhoff E, 2011, ADV POLYM SCI, V240, P1, DOI 10.1007/12_2010_88
   Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571
   Xie YY, 2011, LAB CHIP, V11, P2819, DOI 10.1039/c0lc00562b
   Xing SG, 2010, ELECTROPHORESIS, V31, P3144, DOI 10.1002/elps.201000133
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
   Yuan B, 2010, ADV FUNCT MATER, V20, P3715, DOI 10.1002/adfm.201001298
   Zhao C, 2006, ANGEW CHEM INT EDIT, V45, P5469, DOI 10.1002/anie.200601151
   Zhao H, 2002, MICROVASC RES, V63, P218, DOI 10.1006/mvre.2001.2390
   Zheng XJ, 2011, LAB CHIP, V11, P3269, DOI 10.1039/c1lc20331b
NR 165
TC 49
Z9 50
U1 8
U2 210
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN
PY 2013
VL 2
IS 1
SI SI
BP 95
EP 108
DI 10.1002/adhm.201200104
PG 14
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092LC
UT WOS:000315121900007
PM 23184447
DA 2018-10-20
ER

PT J
AU Gil, ES
   Panilaitis, B
   Bellas, E
   Kaplan, DL
AF Gil, Eun Seok
   Panilaitis, Bruce
   Bellas, Evangelia
   Kaplan, David L.
TI Functionalized Silk Biomaterials for Wound Healing
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; IN-VIVO; FACTOR RECEPTOR; FIBROIN FILMS; MOUSE
   SKIN; CELL FATE; MODEL; COLLAGEN; RELEASE; OXYGEN
AB Silk protein-biomaterial wound dressings with epidermal growth factor (EGF) and silver sulfadiazine were studied with a cutaneous excisional mouse wound model. Three different material designs and two different drug incorporation techniques were studied to compare wound healing responses. Material formats included silk films, lamellar porous silk films and electrospun silk nanofibers, each studied with the silk matrix alone and with drug loading or drug coatings on the silk matrices. Changes in wound size and histological assessments of wound tissues showed that the functionalized silk biomaterial wound dressings increased wound healing rate, including reepithelialization, dermis proliferation, collagen synthesis and reduced scar formation, when compared to air-permeable Tegaderm tape (3M) (-control) and a commercial wound dressing, Tegaderm Hydrocolloid dressing (3M) (+control). All silk biomaterials were effective for wound healing, while the lamellar porous films and electrospun nanofibers and the incorporation of EGF/silver sulfadiazine, via drug loading or coating, provided the most rapid wound healing responses. This systematic approach to evaluating functionalized silk biomaterial wound dressings demonstrates a useful strategy to select formulations for further study towards new treatment options for chronic wounds.
C1 [Gil, Eun Seok; Panilaitis, Bruce; Bellas, Evangelia; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH/NIBIB via the Tissue Engineering Resource Center [EB002520]
FX This study was supported by NIH/NIBIB (EB002520) via the Tissue
   Engineering Resource Center.
CR Adelson DL, 1997, REPROD FERT DEVELOP, V9, P493, DOI 10.1071/R96118
   AFILALO M, 1992, BURNS, V18, P313, DOI 10.1016/0305-4179(92)90153-L
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   CHAPMAN RE, 1988, AUST J BIOL SCI, V41, P261, DOI 10.1071/BI9880261
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   FRANKLIN JD, 1979, PLAST RECONSTR SURG, V64, P766, DOI 10.1097/00006534-197912000-00003
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3
   HUNT TK, 1969, BRIT J SURG, V56, P705
   Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   KNAUER DJ, 1984, J BIOL CHEM, V259, P5623
   Konrad D, 2002, J EXP ANIM SCI, V42, P31, DOI 10.1016/S0939-8600(02)80004-9
   Koster MI, 2002, J INVEST DERM SYMP P, V7, P41, DOI 10.1046/j.1523-1747.2002.19639.x
   LAATO M, 1987, BIOCHEM J, V247, P385, DOI 10.1042/bj2470385
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Ligouri PA, 2009, J WOUND OSTOMY CONT, V36, pS46, DOI 10.1097/01.WON.0000352024.71082.2b
   Lim HJ, 2010, POLYM-KOREA, V34, P363, DOI 10.7317/pk.2010.34.4.363
   Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   MADDEN MR, 1989, J TRAUMA, V29, P924, DOI 10.1097/00005373-198907000-00004
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   OKEEFE E, 1982, J INVEST DERMATOL, V78, P482, DOI 10.1111/1523-1747.ep12510246
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Padol Amol R, 2011, Toxicol Int, V18, P17, DOI 10.4103/0971-6580.75847
   Panchal H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-105
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P77, DOI 10.1056/NEJM197907123010204
   Richardson GD, 2009, DEVELOPMENT, V136, P2153, DOI 10.1242/dev.031427
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Strehin IA, 2011, WOUND REPAIR REGEN, V19, pA54
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   Uppal R, 2011, J BIOMED MATER RES B, V97B, P20, DOI 10.1002/jbm.b.31776
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   WYATT D, 1990, J TRAUMA, V30, P857, DOI 10.1097/00005373-199007000-00016
NR 54
TC 104
Z9 108
U1 14
U2 194
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN
PY 2013
VL 2
IS 1
SI SI
BP 206
EP 217
DI 10.1002/adhm.201200192
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092LC
UT WOS:000315121900019
PM 23184644
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ikonen, L
   Kerkela, E
   Metselaar, G
   Stuart, MCA
   de Jong, MR
   Aalto-Setala, K
AF Ikonen, Liisa
   Kerkela, Erja
   Metselaar, Gerald
   Stuart, Marc C. A.
   de Jong, Menno R.
   Aalto-Setala, Katriina
TI 2D and 3D Self-Assembling Nanofiber Hydrogels for Cardiomyocyte Culture
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CELL-DERIVED CARDIOMYOCYTES; ACUTE MYOCARDIAL-INFARCTION; EMBRYONIC
   STEM-CELLS; CARDIAC DIFFERENTIATION; TISSUE; TRANSPLANTATION;
   BIOMATERIALS; REGENERATION; SCAFFOLDS; MYOCYTES
AB Collagen is a widely used biomaterial in cardiac tissue engineering studies. However, as a natural material, it suffers from variability between batches that can complicate the standardization of culture conditions. In contrast, synthetic materials are modifiable, have well-defined structures and more homogeneous batches can be produced. In this study, several collagen-like synthetic self-assembling nanofiber hydrogels were examined for their suitability for cardiomyocyte culture in 2D and 3D. Six different nanofiber coatings were used in the 2D format with neonatal rat cardiomyocytes (NRCs) and human embryonic stem-cell-derived cardiomyocytes (hESC-CMs). The viability, growth, and functionality of the 2D-cultured cardiomyocytes were evaluated. The best-performing nanofiber coatings were selected for 3D experiments. Hydrophilic pH-sensitive nanofiber hydrogel coassembled with hyaluronic acid performed best with both NRCs and hESC-CMs. Hydrophilic non-pH-sensitive nanofiber hydrogels supported the growth of NRCs; however, their ability to promote attachment and growth of hESC-CMs was limited. NRCs also grew on hydrophobic nanofiber hydrogels; however, the cell-supporting capacity of these hydrogels was inferior to that of the hydrophilic hydrogel materials. This is the first study demonstrating that hydrophilic self-assembling nanofiber hydrogels support the culture of both NRCs and hESC-CMs, which suggests that these biomaterials hold promise for cardiac tissue engineering.
C1 [Ikonen, Liisa; Kerkela, Erja; Aalto-Setala, Katriina] Univ Tampere, IBT, Tampere 33520, Finland.
   [Ikonen, Liisa; Aalto-Setala, Katriina] BioMediTech, Tampere 33520, Finland.
   [Kerkela, Erja] Finnish Red Cross Blood Serv, Helsinki 00310, Finland.
   [Metselaar, Gerald; Stuart, Marc C. A.; de Jong, Menno R.] Nano Fiber Matrices BV, NL-9747 AG Groningen, Netherlands.
   [Metselaar, Gerald] BASF Nederland BV, NL-8466 SN Heerenveen, Netherlands.
   [Stuart, Marc C. A.] Univ Groningen, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands.
   [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere 33521, Finland.
RP Ikonen, L (reprint author), Univ Tampere, IBT, Biokatu 12, Tampere 33520, Finland.
EM liisaikonen@hotmail.com
RI Kerkela, Erja/P-9459-2016
OI Kerkela, Erja/0000-0002-2923-5300; Stuart, Marc/0000-0003-0667-6338
FU Finnish Cultural Foundation-Pirkanmaa Regional Fund; Pirkanmaa Hospital
   District; Tekes-the Finnish Funding Agency for Technology and
   Innovation; Finnish Foundation for Cardiovascular Research; NanoNextNL;
   micro- and nanotechnology consortium of the Government of The
   Netherlands
FX This study was funded by the Finnish Cultural Foundation-Pirkanmaa
   Regional Fund, Competitive Research Funding of the Pirkanmaa Hospital
   District, Tekes-the Finnish Funding Agency for Technology and Innovation
   and Finnish Foundation for Cardiovascular Research. This work is
   supported by NanoNextNL, a micro- and nanotechnology consortium of the
   Government of The Netherlands and 130 partners. The authors would like
   to thank Ms. Henna Venalainen and Mr. Markus Haponen for technical
   assistance, and Ms. Annemarie Tuin for fruitful discussions and Ms.
   Heini Huhtala for statistical analysis. They would also like to
   acknowledge the animal facilities of the University of Tampere.
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Bettiol E, 2007, REV PHYSIOL BIOCH P, V157, P1, DOI 10.1007/s112_0508
   Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004
   Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280
   Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   deJong M. R., 2008, J CONTROL RELEASE, V132, pe19
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Ikonen L., J CLIN EXPT IN PRESS
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349
   Kusters I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020435
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li F, 2010, CHEMPHYSCHEM, V11, P1956, DOI 10.1002/cphc.200900946
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Traverse JH, 2009, AM HEART J, V158, P356, DOI 10.1016/j.ahj.2009.06.009
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   UUSIMAA PA, 1992, ENDOCRINOLOGY, V130, P2455, DOI 10.1210/en.130.5.2455
   van Bommel KJC, 2005, ORG BIOMOL CHEM, V3, P2917, DOI 10.1039/b507157g
   van Bommel KJC, 2004, ANGEW CHEM INT EDIT, V43, P1663, DOI 10.1002/anie.200352396
   Widimsky P, 2006, EUR HEART J SUPPL, V8, pH16, DOI 10.1093/eurheartj/sul067
   Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
NR 44
TC 12
Z9 12
U1 1
U2 32
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 285678
DI 10.1155/2013/285678
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 089UX
UT WOS:000314936600001
PM 23573513
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lenarz, T
   Pau, HW
   Paasche, G
AF Lenarz, Thomas
   Pau, Hans-Wilhelm
   Paasche, Gerrit
TI Cochlear Implants
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Biomaterial; cochlear implant; drug delivery; electrode-neural
   interface; inner ear; neurotrophic factor; surface pattern
ID SPIRAL-GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; DEAFENED
   GUINEA-PIG; CHRONIC ELECTRICAL-STIMULATION; DORSAL-ROOT GANGLION;
   MODIFIED ELECTRODE SURFACES; FABRICATED SPIKE STRUCTURES;
   FIBROBLAST-GROWTH-FACTOR; ROUND WINDOW MEMBRANE; DRUG-ELUTING STENTS
AB Cochlear implants have evolved to become the treatment of choice for severely hearing-impaired patients. Speech signals are picked up by a microphone, processed and then delivered to the stimulating electrodes (the current maximum number being 22) that are placed on an electrode array implanted into the scala tympani of the cochlea. The target cells of electrical stimulation, the spiral ganglion cells (SGCs), are located some distance away in the central axis of the cochlea. SGCs start to degenerate after the onset of deafness. Additionally, fibrous tissue is formed around the electrode array after implantation. If cochlear implants are to deliver sound that is closer to natural hearing, the number of independent stimulation channels has to be increased. Optimization of the interface between the electrode array and the surrounding tissue is, therefore, the focus of current research. Promising approaches relating to cells, micro- and nanosystems will be reviewed.
C1 [Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Dept Otolaryngol, D-30625 Hannover, Germany.
   [Pau, Hans-Wilhelm] Univ Rostock, Dept Otolaryngol, D-18055 Rostock, Germany.
RP Lenarz, T (reprint author), Hannover Med Sch, Dept Otolaryngol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Lenarz.Thomas@mh-hannover.de
CR Abizaid A, 2007, VASC HEALTH RISK MAN, V3, P191, DOI 10.2147/vhrm.2007.3.2.191
   Adunka O, 2004, LARYNGOSCOPE, V114, P1237, DOI 10.1097/00005537-200407000-00018
   AGNEW WF, 1977, J NEUROPATH EXP NEUR, V36, P533, DOI 10.1097/00005072-197705000-00010
   Anastasiadis S. H., 2009, APS M, P19013
   Antonelli PJ, 2004, OTOL NEUROTOL, V25, P953, DOI 10.1097/00129492-200411000-00015
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnoldner C, 2010, ADV OTO-RHINO-LARYNG, V67, P116, DOI 10.1159/000262603
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Baudonck N, 2010, INT J PEDIATR OTORHI, V74, P416, DOI 10.1016/j.ijporl.2010.01.017
   Besch D, 2008, BRIT J OPHTHALMOL, V92, P1361, DOI 10.1136/bjo.2007.131961
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   BILLINGER M, 2006, J INVASIVE CARDIOL, V18, P427
   Billinger Michael, 2006, J Invasive Cardiol, V18, P423
   Briggs Robert J S, 2006, Audiol Neurootol, V11 Suppl 1, P42, DOI 10.1159/000095613
   Bromberg LE, 2000, J CONTROL RELEASE, V68, P63, DOI 10.1016/S0168-3659(00)00233-9
   BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T
   BRUMMER SB, 1975, BIOELECTROCH BIOENER, V2, P13, DOI 10.1016/0302-4598(75)80002-X
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490
   Busby P A, 2002, Cochlear Implants Int, V3, P87, DOI 10.1179/cim.2002.3.2.87
   Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878
   Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Clark G.M., 2003, COCHLEAR IMPLANTS FU
   Cogan SF, 2004, J NEUROSCI METH, V137, P141, DOI 10.1016/j.jneumeth.2004.02.019
   Cohen LT, 2006, HEARING RES, V212, P160, DOI 10.1016/j.heares.2005.11.005
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002
   De Ceulaer G, 2003, OTOL NEUROTOL, V24, P769, DOI 10.1097/00129492-200309000-00014
   DEBOER RW, 1978, MED BIOL ENG COMPUT, V16, P1
   Dinh C, 2008, OTOL NEUROTOL, V29, P1012, DOI 10.1097/MAO.0b013e3181859a1f
   Dittrich B, 2009, BIOMATERIALIEN MUNCH, V10, P61
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   Durkaya G., 2009, APS M, pC6
   Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Emerich DF, 1996, BRAIN RES, V736, P99, DOI 10.1016/S0006-8993(96)00683-X
   Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228
   Fadeeva E, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P163
   Fadeeva E, 2009, PHYS STATUS SOLIDI A, V206, P1348, DOI 10.1002/pssa.200881063
   Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7
   Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032
   Fransson A, 2009, J NEUROSCI RES, V87, P1712, DOI 10.1002/jnr.21969
   FRANZ B, 1984, ACTA OTO-LARYNGOL, P17
   FRANZ BKH, 1987, ANN OTO RHINOL LARYN, V96, P174, DOI 10.1177/000348948709600207
   Fraysse B, 2006, OTOL NEUROTOL, V27, P624, DOI 10.1097/01.mao.0000226289.04048.0f
   Gantz BJ, 2004, ACTA OTO-LARYNGOL, V124, P344, DOI 10.1080/00016480410016423
   GANTZ BJ, 1993, ANN OTO RHINOL LARYN, V102, P909, DOI 10.1177/000348949310201201
   Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x
   Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619
   Gomez N, 2007, J R SOC INTERFACE, V4, P223, DOI 10.1098/rsif.2006.0171
   GREATBATCH W, 1969, ANN NY ACAD SCI, V167, P722, DOI 10.1111/j.1749-6632.1969.tb34133.x
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Gstoettner WG, 2009, ACTA OTO-LARYNGOL, V129, P372, DOI 10.1080/00016480802552568
   Gstoettner Wolfgang K, 2006, Audiol Neurootol, V11 Suppl 1, P49, DOI 10.1159/000095614
   Hahn A, 2010, ADV ENG MATER, V12, pB156, DOI 10.1002/adem.200980071
   Hang T, 2010, APPL SURF SCI, V256, P2400, DOI 10.1016/j.apsusc.2009.10.074
   HARTSHORN DO, 1991, OTOLARYNG HEAD NECK, V104, P311, DOI 10.1177/019459989110400305
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Herr BD, 2005, OTOLARYNG HEAD NECK, V132, P527, DOI 10.1016/j.otohns.2004.09.138
   Ho M., 2004, APS M, p9012P
   Hu ZQ, 2009, OTOL NEUROTOL, V30, P551, DOI 10.1097/MAO.0b013e31819fe70a
   Hu ZQ, 2005, NEUROBIOL DIS, V18, P184, DOI 10.1016/j.nbd.2004.09.010
   Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013
   Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336
   Huang CQ, 2000, HEARING RES, V146, P57, DOI 10.1016/S0378-5955(00)00100-3
   Hyland M., 2000, P 5 ANN C INT FUNCT
   Incesulu A, 1998, ANN OTO RHINOL LARYN, V107, P906, DOI 10.1177/000348949810701102
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368
   Johnson TA, 2007, OTOLARYNG HEAD NECK, V136, P577, DOI 10.1016/j.otohns.2006.11.006
   JOHNSSON LG, 1982, ANN OTO RHINOL LARYN, V91, P74
   Jolly C, 2010, ADV OTO-RHINO-LARYNG, V67, P28, DOI 10.1159/000262594
   Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480
   Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Lamprecht A, 2002, J CONTROL RELEASE, V84, P59, DOI 10.1016/S0168-3659(02)00258-4
   Lasala John M, 2006, J Interv Cardiol, V19, P422, DOI 10.1111/j.1540-8183.2006.00183.x
   LEAKE PA, 1991, HEARING RES, V54, P251, DOI 10.1016/0378-5955(91)90120-X
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612
   Lenarz T, 2009, AUDIOL NEURO-OTOL, V14, P22, DOI 10.1159/000206492
   Levy Y, 2009, J BIOMED MATER RES B, V91B, P441, DOI 10.1002/jbm.b.31420
   Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925
   Li PMMC, 2007, ANN OTO RHINOL LARYN, V116, P731, DOI 10.1177/000348940711601004
   LOUSTEAU RJ, 1987, LARYNGOSCOPE, V97, P836
   LUCIDIPHILLIPI CA, 1995, J COMP NEUROL, V354, P361, DOI 10.1002/cne.903540306
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Malgrange B, 1996, NEUROREPORT, V7, P2495, DOI 10.1097/00001756-199611040-00019
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Marletta G, 2010, TOP APPL PHYS, V116, P345, DOI 10.1007/978-3-540-88789-8_12
   Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616
   Maruyama J, 2007, NEUROBIOL DIS, V25, P309, DOI 10.1016/j.nbd.2006.09.012
   Marzella PL, 1997, NEUROREPORT, V8, P1641, DOI 10.1097/00001756-199705060-00017
   Marzella PL, 1999, ACTA OTO-LARYNGOL, V119, P407
   McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50
   Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7
   Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320
   Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X
   Munoz-Baell IM, 2000, J EPIDEMIOL COMMUN H, V54, P40, DOI 10.1136/jech.54.1.40
   NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602
   Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005
   Nopp P, 2010, ADV OTO-RHINO-LARYNG, V67, P88, DOI 10.1159/000262600
   Okano T, 2006, MOL THER, V14, P866, DOI 10.1016/j.ymthe.2006.06.012
   Olivius P, 2003, BRAIN RES, V979, P1, DOI 10.1016/S0006-8993(03)02802-6
   Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3
   OTTE J, 1978, LARYNGOSCOPE, V88, P1231
   Paasche G, 2006, HEARING RES, V212, P74, DOI 10.1016/j.heares.2005.10.013
   Paasche G, 2003, OTOL NEUROTOL, V24, P222, DOI 10.1097/00129492-200303000-00016
   Paasche G., 2009, TAG THUR GRENZ OB TH, P267
   Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61
   Paasche G, 2009, OTOL NEUROTOL, V30, P592, DOI 10.1097/MAO.0b013e3181ab8fba
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Parker Alan L., 2003, Expert Reviews in Molecular Medicine, V5, P1
   Pawlowski KS, 2005, OTOL NEUROTOL, V26, P972, DOI 10.1097/01.mao.0000169047.38759.8b
   Peeters S, 1998, Acta Otorhinolaryngol Belg, V52, P115
   Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057
   Pettingill LN, 2007, IEEE T BIO-MED ENG, V54, P1138, DOI 10.1109/TBME.2007.895375
   PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915
   Praetorius M, 2007, ACTA OTO-LARYNGOL, V127, P486, DOI 10.1080/00016480600895102
   Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8
   QUARANTA N, 2004, ACTA OTO-LARYNGOL, V552, P68
   Rainicek A.M., 1997, J CELL SCI, V<IT>110</IT>, P2905
   Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005
   Regala C, 2005, EXP NEUROL, V193, P326, DOI 10.1016/j.expneurol.2004.12.027
   Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084
   Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010
   Richardson RT, 2006, AUDIOL NEURO-OTOL, V11, P343, DOI 10.1159/000095896
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015
   Riggs PD, 1997, BIOMATERIALS, V18, P721, DOI 10.1016/S0142-9612(96)00195-0
   ROBBLEE LS, 1990, NEURAL PROSTHESES FU, P25
   Roehm Pamela C, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P294, DOI 10.1097/01.moo.0000180919.68812.b9
   Rohm H.W., 2009, WORLD C MED PHYS BIO
   Roland JT, 2008, OTOL NEUROTOL, V29, P482, DOI 10.1097/MAO.0b013e31816845eb
   Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0
   RUDDY HA, 1995, MED BIOL ENG COMPUT, V33, P793, DOI 10.1007/BF02523011
   Ryan AF, 2006, AUDIOL NEURO-OTOL, V11, P134, DOI 10.1159/000090686
   Salt AN, 2009, AUDIOL NEURO-OTOL, V14, P350, DOI 10.1159/000241892
   Salt AN, 2006, J NEUROSCI METH, V153, P121, DOI 10.1016/j.jneumeth.2005.10.008
   Samuel U, 2004, INT J ANTIMICROB AG, V23, pS75, DOI 10.1016/j.ijantimicag.2003.12.004
   Saoji AA, 2009, EAR HEARING, V30, P559, DOI 10.1097/AUD.0b013e3181ab2b6f
   Saunders E, 2002, EAR HEARING, V23, p28S, DOI 10.1097/00003446-200202001-00004
   Scheper V, 2009, NANOMEDICINE-UK, V4, P623, DOI [10.2217/nnm.09.41, 10.2217/NNM.09.41]
   Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964
   Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553
   Shepherd R K, 1983, Acta Otolaryngol Suppl, V399, P19
   Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564
   SHEPHERD RK, 1984, ACTA OTO-LARYNGOL, P71
   Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011
   Shoji F, 2000, HEARING RES, V142, P41, DOI 10.1016/S0378-5955(00)00007-1
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208
   Sousa JE, 2003, CIRCULATION, V107, P2274, DOI 10.1161/01.CIR.0000069330.41022.90
   SPOENDLIN H, 1984, ANN OTO RHINOL LARYN, V93, P76
   STAECKER H, 1995, NEUROREPORT, V6, P1533, DOI 10.1097/00001756-199507310-00017
   Stover T, 2007, Cochlear Implants Int, V8, P38, DOI 10.1002/cii.329
   Stover T, 2005, OTOL NEUROTOL, V26, P1161
   Stover T, 2009, Laryngorhinootologie, V88 Suppl 1, pS12, DOI 10.1055/s-0028-1119552
   Sutton D, 1983, Ann Otol Rhinol Laryngol, V92, P316
   Swan EEL, 2008, ADV DRUG DELIVER REV, V60, P1583, DOI 10.1016/j.addr.2008.08.001
   Tamura T, 2005, LARYNGOSCOPE, V115, P2000, DOI 10.1097/01.mlg.00001800174.81036.5a
   Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Tsai I., 2003, APS M, P18007
   Tykocinski M, 2005, OTOL NEUROTOL, V26, P948, DOI 10.1097/01.mao.0000185056.99888.f3
   Tykocinski M, 2000, AM J OTOL, V21, P205, DOI 10.1016/S0196-0709(00)80010-1
   Tykocinski M, 2001, HEARING RES, V159, P53, DOI 10.1016/S0378-5955(01)00320-3
   Van Weert S, 2005, ACTA OTO-LARYNGOL, V125, P725, DOI 10.1080/00016480510028492
   Vieira M, 2007, HEARING RES, V230, P17, DOI 10.1016/j.heares.2007.03.005
   Vonarbourg A, 2006, J BIOMED MATER RES A, V78A, P620, DOI 10.1002/jbm.a.30711
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7
   Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b
   WEBSTER M, 1981, BRAIN RES, V212, P17, DOI 10.1016/0006-8993(81)90028-7
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Wenzel GI, 2010, EUR ARCH OTO-RHINO-L, V267, P691, DOI 10.1007/s00405-009-1126-1
   White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849
   Wissel K, 2008, OTOL NEUROTOL, V29, P475, DOI 10.1097/MAO.0b013e318164d110
   Wright CG, 2005, LARYNGOSCOPE, V115, P2041, DOI 10.1097/01.MLG.0000181461.63392.49
   Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yang FC, 2009, MATER CHEM PHYS, V113, P474, DOI 10.1016/j.matchemphys.2008.07.126
   Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zenner H.P., 2000, PHYSL MENSCHEN, V28
   Zou J, 2008, J BIOMED MATER RES B, V87B, P10, DOI 10.1002/jbm.b.31058
NR 189
TC 20
Z9 20
U1 0
U2 28
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PD JAN
PY 2013
VL 14
IS 1
BP 112
EP 123
PG 12
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 087SW
UT WOS:000314784100014
PM 23092261
DA 2018-10-20
ER

PT J
AU Silini, A
   Parolini, O
   Huppertz, B
   Lang, I
AF Silini, Antonietta
   Parolini, Ornella
   Huppertz, Berthold
   Lang, Ingrid
TI Soluble Factors of Amnion-Derived Cells in Treatment of Inflammatory and
   Fibrotic Pathologies
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Amnion; fibrosis; inflammation; placenta; soluble factors; wound healing
ID MESENCHYMAL STEM-CELLS; TRANSFORMING-GROWTH-FACTOR; MEMBRANE STROMAL
   MATRIX; INDUCED LUNG FIBROSIS; HUMAN TERM PLACENTA; VENOUS LEG ULCERS;
   EPITHELIAL-CELLS; UMBILICAL-CORD; ENDOTHELIAL-CELLS; HEPATIC-FIBROSIS
AB Inflammation is a complex defense mechanism characterized by leukocyte migration from the vasculature into damaged tissues and subsequent deposition of extracellular matrix resulting in tissue repair. The inflammatory process is generally categorized into an acute, rapid response, and a persistent but slowly evolving chronic condition, which may progress into inflammatory diseases. An excessive deposition of extracellular matrix leads to overgrowth, hardening, and/or scarring of tissues, defined as fibrosis.
   The amnion has been used as biomaterial in medicine for over 100 years and has been proven valuable for the treatment of different pathological conditions including wound healing. In light of recent reports, this article will review the effects of the amnion and its cellular components within the inflammatory-fibrotic scenario and the factors described so far that could be involved in these immunomodulatory actions. As proof of principles, we will also discuss pre-clinical and clinical applications of the amnion where advantage has been taken of its anti-inflammatory and anti-fibrotic properties. It is conceivable that the local host environment in which the amnion is placed may have a profound role in influencing the production and function of soluble factors and the shift towards different steps in triggering healing. The healing effect depends on time, dosage, and location of cytokine/growth factor production by the amnion, together with the influence of the host microenvironment. Indeed, determining the specific cascade of events that may define the role of the amnion in a given clinical situation remains a challenge.
C1 [Silini, Antonietta; Parolini, Ornella] Fdn Poliambulanza, Ctr Ric E Menni, Brescia, Italy.
   [Huppertz, Berthold; Lang, Ingrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria.
RP Lang, I (reprint author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria.
EM ingrid.lang@medunigraz.at
RI Silini, Antonietta/K-7638-2016
OI Silini, Antonietta/0000-0001-6208-3583; Huppertz,
   Berthold/0000-0003-4814-2158
FU Fondazione Cariplo, Italy; MIUR Progetto Firb, Italy
FX Fondazione Cariplo and MIUR Progetto Firb, Italy.
CR Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   Anzalone R, 2011, STEM CELL REV REP, V7, P342, DOI 10.1007/s12015-010-9196-4
   Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299
   Apte RS, 1998, J IMMUNOL, V160, P5693
   Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Baradaran-Rafii A, 2007, J OPHTHALMIC VISION, V2, P58
   Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007
   Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930
   Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857
   Ching Yiu-Hei, 2011, Eplasty, V11, pe41
   Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Dinarello CA, 1994, CYTOKINE HDB, P31
   Escorcio-Correia M, 2010, CANCER DRUG DISCOV D, P371, DOI 10.1007/978-1-4419-6615-5_18
   FIDEL PL, 1994, AM J REPROD IMMUNOL, V32, P1
   Fortunato SJ, 1997, AM J OBSTET GYNECOL, V177, P803, DOI 10.1016/S0002-9378(97)70272-2
   Fortunato SJ, 1998, AM J OBSTET GYNECOL, V179, P794, DOI 10.1016/S0002-9378(98)70085-7
   Franz Michael G, 2008, Eplasty, V8, pe21
   Gajiwala A. Lobo, 2003, Cell and Tissue Banking, V4, P147
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881
   Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83
   Hollweck T, 2011, OPEN TISSUE ENG REGE, V4, P95
   Huang SY, 1996, CLIN CANCER RES, V2, P1969
   Huang YC, 2012, STEM CELLS DEV, V21, P2900, DOI 10.1089/scd.2012.0216
   Huppertz BKJ, 2012, DEWHURSTS TXB OBSTET
   Hurme M, 1998, ANN MED, V30, P469, DOI 10.3109/07853899809002488
   Jeschke MG, 2011, OPEN TISSUE ENG REGE, V4, P21
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Kamiya K, 2005, EXP EYE RES, V80, P671, DOI 10.1016/j.exer.2004.11.018
   Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23
   Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
   Kelekci Sefa, 2007, Archives of Gynecology and Obstetrics, V276, P355, DOI 10.1007/s00404-007-0376-7
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192
   Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223
   Koziak Andrzej, 2004, Ann Transplant, V9, P21
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   La Rocca G, 2009, SCAND J IMMUNOL, V70, P161, DOI 10.1111/j.1365-3083.2009.02283.x
   Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.013909.105812
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325
   Letendre S, 2009, ADV SKIN WOUND CARE, V22, P161, DOI 10.1097/01.ASW.0000305463.32800.32
   Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495
   Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737
   Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345
   Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63
   Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x
   Lu LL, 2006, HAEMATOL-HEMATOL J, V91, P1017
   Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314
   Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010
   Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC
   Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385
   Najar M, 2012, IMMUNOL LETT, V146, P50, DOI 10.1016/j.imlet.2012.04.017
   Najar M, 2010, CELL IMMUNOL, V264, P171, DOI 10.1016/j.cellimm.2010.06.006
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Nores JER, 1999, EUR J IMMUNOL, V29, P265, DOI 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.0.CO;2-G
   Parolini O, 2011, PLACENTA, V32, pS186, DOI 10.1016/j.placenta.2010.12.016
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Parolini O, 2010, PREG INFANTS-MED PSY, P1, DOI 10.1109/ITAB.2010.5687674
   Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404
   Payne WG, 2010, WORLD J SURG, V34, P1663, DOI 10.1007/s00268-010-0420-9
   Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727
   Petter-Puchner AH, 2011, SURG ENDOSC, V25, P2125, DOI 10.1007/s00464-010-1507-y
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   Remick DG, 2009, CRIT CARE MED, V37, P1809, DOI 10.1097/CCM.0b013e3181a1a12b
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Rossi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046956
   Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252
   Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270
   SATOH K, 1981, PROSTAG LEUKOTR ESS, V6, P359, DOI 10.1016/0161-4630(81)90067-7
   Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590
   Sippel KC, 2001, CURR OPIN OPHTHALMOL, V12, P269, DOI 10.1097/00055735-200108000-00006
   SMITH RE, 1994, J IMMUNOL, V153, P4704
   SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Solomon A, 2005, CLIN EXP ALLERGY, V35, P941, DOI 10.1111/j.1365-2222.2005.02285.x
   Steed David L, 2008, Eplasty, V8, pe18
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Uberti MG, 2010, ANN PLAST SURG, V66, P575
   WARD DJ, 1989, BRIT J PLAST SURG, V42, P463, DOI 10.1016/0007-1226(89)90015-5
   Warrier S, 2012, PLACENTA, V33, P850, DOI 10.1016/j.placenta.2012.07.001
   Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008
   Yetkin G, 2009, INT J SURG, V7, P561, DOI 10.1016/j.ijsu.2009.09.007
NR 98
TC 42
Z9 45
U1 4
U2 23
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD JAN
PY 2013
VL 8
IS 1
BP 6
EP 14
DI 10.2174/1574888X11308010003
PG 9
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA 088DO
UT WOS:000314814200003
PM 23270631
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Yang, J
AF Zhang, Yi
   Yang, Jian
TI Design strategies for fluorescent biodegradable polymeric biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SEMICONDUCTOR QUANTUM DOTS; IN-VIVO; DRUG-DELIVERY; CANCER-THERAPY;
   LIVING CELLS; POLY(LACTIDE-CO-GLYCOLIDE) NANOPARTICLES; TRANSFECTION
   EFFICIENCY; 2-PHOTON ABSORPTION; HPMA COPOLYMERS; PAMAM DENDRIMER
AB The combination of biodegradable polymer and fluorescent imaging has resulted in an important area of polymeric biomaterials: biodegradable fluorescent polymers. Researchers have made significant efforts in developing versatile fluorescent biomaterials due to their promising applications in biological/biomedical labeling, tracking, monitoring, imaging, and diagnostics, especially in drug delivery, tissue engineering, and cancer imaging. Biodegradable fluorescent polymers can function not only as implant biomaterials but also as imaging probes. Currently, there are two major classes of biodegradable polymers, which are used as fluorescent materials. The first class is the combination of non-fluorescent biodegradable polymers and fluorescent agents such as organic dyes and quantum dots. Another class of polymers shows intrinsic photoluminescence as polymers by themselves carrying integral fluorescent chemical structures in or pendent to their polymer backbone, such as Green Fluorescent protein (GFP), and the recently developed biodegradable photoluminescent polymer (BPLP). Thus there is no need to conjugate or encapsulate additional fluorescent materials for the latter. In the present review, we will review the fluorescent biodegradable polymers with emphases on material fluorescence mechanism, design criteria for fluorescence, and their cutting-edge applications in biomedical engineering. We expect that this review will provide an insightful discussion on the fluorescent biomaterial design and lead to innovations for the next generation of fluorescent biomaterials and fluorescence-based biomedical technology.
C1 [Zhang, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Zhang, Yi] Univ Texas SW Med Ctr Dallas, Joint Biomed Engn Program, Dallas, TX 75390 USA.
   [Zhang, Yi] Univ Texas Arlington, Dallas, TX 75390 USA.
   [Yang, Jian] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Bioengn, University Pk, PA 16802 USA.
RP Zhang, Y (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM jxy30@psu.edu
RI Zhang, Yi/K-3340-2016; Yang, Jian/N-1291-2014
OI Zhang, Yi/0000-0001-8667-7829; Yang, Jian/0000-0003-0695-828X
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB)
   [EB012575]; National Science Foundation (NSF) [0954109]
FX This work was supported in part by a R01 award (EB012575) from the
   National Institute of Biomedical Imaging and Bioengineering (NIBIB), and
   a National Science Foundation (NSF) CAREER award 0954109.
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bagalkot V, 2007, NANO LETT, V7, P3065, DOI 10.1021/nl071546n
   Benninger RKP, 2008, REV PHYSIOL BIOCH P, V160, P71, DOI 10.1007/112_2008_801
   Bhadra D, 2003, INT J PHARM, V257, P111, DOI 10.1016/S0378-5173(03)00132-7
   Bharali DJ, 2009, INT J NANOMED, V4, P1
   Brenier A, 1996, J LUMIN, V69, P131, DOI 10.1016/0022-2313(96)00086-5
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Cao J, 2012, J BIOMED MATER RES A, V100A, P958, DOI 10.1002/jbm.a.34043
   Chang K, 2008, J NUCL CARDIOL, V15, P417, DOI 10.1016/j.nuclcard.2008.03.001
   Cheng FY, 2008, BIOMATERIALS, V29, P2104, DOI [10.1016/j.biomaterials.2008.01.010, 10.1016/j.biomaterials.2008.01.01]
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]
   Chu CC, 2009, MACROMOL RAPID COMM, V30, P89, DOI 10.1002/marc.200800571
   Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009
   Chung L. W. K., 2004, NAT BIOTECHNOL, V22, P969
   Chung YI, 2010, J CONTROL RELEASE, V143, P374, DOI 10.1016/j.jconrel.2010.01.017
   Crouch D, 2003, PHILOS T R SOC A, V361, P297, DOI 10.1098/rsta.2002.1129
   CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4
   Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Di Corato R, 2008, J MATER CHEM, V18, P1991, DOI 10.1039/b717801h
   Donaldson L, 2011, MATER TODAY, V14, P131, DOI 10.1016/S1369-7021(11)70079-7
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Escobedo JO, 2010, CURR OPIN CHEM BIOL, V14, P64, DOI 10.1016/j.cbpa.2009.10.022
   Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q
   Finn MG, 2010, CHEM SOC REV, V39, P1231, DOI 10.1039/c003740k
   Gaylord BS, 2001, J AM CHEM SOC, V123, P6417, DOI 10.1021/ja010373f
   Ghandehari H, 2008, ADV DRUG DELIVER REV, V60, P956, DOI 10.1016/j.addr.2008.04.001
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Gong YJ, 2005, CHEM MATER, V17, P2648, DOI 10.1021/cm047932c
   Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990
   Han DW, 2008, BIOORGAN MED CHEM, V16, P9652, DOI 10.1016/j.bmc.2008.10.009
   He GS, 2008, CHEM REV, V108, P1245, DOI 10.1021/cr050054x
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Hezinger AFE, 2008, EUR J PHARM BIOPHARM, V68, P138, DOI 10.1016/j.ejpb.2007.05.013
   Hild WA, 2008, EUR J PHARM BIOPHARM, V68, P153, DOI 10.1016/j.cejpb.2007.06.009
   Hirsch A, 2000, ANGEW CHEM INT EDIT, V39, P3915, DOI 10.1002/1521-3773(20001103)39:21<3915::AID-ANIE3915>3.0.CO;2-O
   Hong J, 2012, BIOMACROMOLECULES, V13, P261, DOI 10.1021/bm201554x
   Hong X, 2004, J MAGN MAGN MATER, V269, P95, DOI 10.1016/S0304-8853(03)00566-3
   Hong YN, 2009, CHEM COMMUN, P4332, DOI 10.1039/b904665h
   Hou XD, 2009, MACROMOL BIOSCI, V9, P551, DOI 10.1002/mabi.200800312
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004
   Jensen KD, 2001, AAPS PHARMSCI, V3
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kim BYS, 2008, NANO LETT, V8, P3887, DOI 10.1021/nl802311t
   Kim JS, 2011, J COLLOID INTERF SCI, V353, P363, DOI 10.1016/j.jcis.2010.08.053
   Kim JH, 2007, PROG POLYM SCI, V32, P1031, DOI 10.1016/j.progpolymsci.2007.05.016
   Kim SH, 2005, LANGMUIR, V21, P8852, DOI 10.1021/la0502084
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Knyazhanskii K., 1975, J APPL SPECTROSC, V23, P3
   Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012
   Kogej T, 1998, CHEM PHYS LETT, V298, P1, DOI 10.1016/S0009-2614(98)01196-8
   Kumar N, 2001, ADV DRUG DELIVER REV, V53, P23, DOI 10.1016/S0169-409X(01)00219-8
   Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569
   Le Droumaguet B, 2011, INT J PHARMACEUT, V416, P453, DOI 10.1016/j.ijpharm.2011.01.015
   Lee WI, 2004, J AM CHEM SOC, V126, P8358, DOI 10.1021/ja0475914
   Lee Young-Ran, 2011, Immune Netw, V11, P163, DOI 10.4110/in.2011.11.3.163
   Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Lu ZR, 2010, ADV DRUG DELIVER REV, V62, P246, DOI 10.1016/j.addr.2009.12.007
   Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024
   Majoros IJ, 2006, BIOMACROMOLECULES, V7, P572, DOI 10.1021/bm0506142
   Martinez-Palau M, 2006, ACTA CRYSTALLOGR C, V62, pO262, DOI 10.1107/S0108270106010079
   Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011
   Melancon MP, 2007, PHARM RES-DORDR, V24, P1217, DOI 10.1007/s11095-007-9253-0
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264
   Murcia MJ, 2008, OPT COMMUN, V281, P1771, DOI 10.1016/j.optcom.2007.07.069
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013
   Nam T, 2010, BIOCONJUGATE CHEM, V21, P578, DOI 10.1021/bc900408z
   Nehilla BJ, 2008, ACS NANO, V2, P538, DOI 10.1021/nn700281b
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Paganin-Gioanni A, 2010, RADIOL ONCOL, V44, P142, DOI 10.2478/v10019-010-0031-y
   Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003
   Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669
   Qi LF, 2008, EXPERT OPIN DRUG DEL, V5, P263, DOI 10.1517/17425247.5.3.263 
   Qin A, 2012, PROG POLYM SCI, V37, P182, DOI 10.1016/j.progpolymsci.2011.08.002
   Rajeshwar K, 2001, CHEM MATER, V13, P2765, DOI 10.1021/cm010254z
   Rautio J, 2008, NAT REV DRUG DISCOV, V7, P255, DOI 10.1038/nrd2468
   Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]
   Santra S, 2011, WIRES NANOMED NANOBI, V3, P501, DOI 10.1002/wnan.134
   Schipper ML, 2009, SMALL, V5, P126, DOI 10.1002/smll.200800003
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Smyder J., 2011, MATER TODAY, V14, P16
   Sokolova V, 2010, J MATER SCI, V45, P4952, DOI 10.1007/s10853-009-4159-3
   Sumer B, 2008, NANOMEDICINE-UK, V3, P137, DOI 10.2217/17435889.3.2.137
   Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tomczak N, 2009, PROG POLYM SCI, V34, P393, DOI 10.1016/j.progpolymsci.2008.11.004
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Walling MA, 2009, INT J MOL SCI, V10, P441, DOI 10.3390/ijms10020441
   Wang DJ, 2004, J AM CHEM SOC, V126, P13204, DOI 10.1021/ja0454992
   Wang D, 2007, J COLLOID INTERF SCI, V306, P222, DOI 10.1016/j.jcis.2006.10.025
   Wang F, 2006, NANOTECHNOLOGY, V17, pR1, DOI 10.1088/0957-4484/17/1/R01
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu CL, 2009, MACROMOL BIOSCI, V9, P1185, DOI 10.1002/mabi.200900232
   Xu YL, 2007, POLYMER, V48, P1711, DOI 10.1016/j.polymer.2007.01.022
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Zanetti-Ramos BG, 2006, POLYMER, V47, P8080, DOI 10.1016/j.polymer.2006.09.057
   Zhang YJ, 2011, SENSORS-BASEL, V11, P11036, DOI 10.3390/s111211036
   Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI [10.1021/bc700333s, 10.1021/b6700333s]
NR 111
TC 67
Z9 70
U1 3
U2 139
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 2
BP 132
EP 148
DI 10.1039/c2tb00071g
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA 087TN
UT WOS:000314786200001
PM 23710326
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhou, PY
   Xia, Y
   Wang, J
   Liang, C
   Yu, L
   Tang, W
   Gu, S
   Xu, SG
AF Zhou, Panyu
   Xia, Yan
   Wang, Jing
   Liang, Chong
   Yu, Long
   Tang, Wei
   Gu, Shen
   Xu, Shuogui
TI Antibacterial properties and bioactivity of HACC- and HACC-Zein-modified
   mesoporous bioactive glass scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PROSTHETIC-JOINT INFECTIONS; IN-VITRO BIOACTIVITY;
   ANTIMICROBIAL-PROPHYLAXIS; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION;
   DELIVERY-SYSTEM; DRUG-DELIVERY; CHITOSAN; BONE; BIOMATERIALS
AB Infection and its complications are one of the greatest threats to the health of orthopedic patients. Mesoporous bioglass (MBG) scaffolds are characterized by well-ordered, three-dimensional, nanometer-sized mesoporous structures, which facilitate the adhesion of hydroxyapatite and the loading of drugs. MBG has been widely used as a new-generation biomaterial in bone tissue engineering. However, MBG is very brittle and lacks antibacterial activity. This limits its applications in the treatment of bone defects, especially large bone defects complicated by infection. In order to dispel these disadvantages, a novel hydroxypropyltrimethyl ammonium chloride chitosan (HACC) and a class of prolamine proteins found in maize, Zeins, were here used to modify the traditional MBG scaffolds. Two new types of scaffold, MBG-HACC scaffolds and MBG-HACC-Zein scaffolds, were made. Transmission electron microscopy (TEM), small angle X-ray diffraction (SAXRD), and Barrett-Joyner-Halenda (BJH) were used to analyze the surface properties of these MBG scaffolds. Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), mechanical experiments, and synchrotron radiation microcomputer tomography (SR mu CT) were used to compare the features of the traditional and modified scaffolds and to analyze the mineralization of the scaffold after being soaked in simulated body fluid (SBF). Confocal laser scanning microscopy (CLSM) was used to compare the antibacterial properties and biocompatibility of the scaffolds at various points in time. The current study demonstrates that all these prepared MBG scaffolds possessed well-ordered, three-dimensional, nanometer-sized mesoporous structures and that HACC-Zein-modified MBG scaffolds are characterized by strong bioactivity and by effective, prolonged antibacterial activity. Finally, biocompatibility was demonstrated by studying the in vitro proliferation and viability of human mesenchymal stem cells (hMSCs).
C1 [Zhou, Panyu; Xia, Yan; Xu, Shuogui] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai 200433, Peoples R China.
   [Wang, Jing; Tang, Wei; Xu, Shuogui] E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
   [Liang, Chong; Xu, Shuogui] 81 Hosp Peoples Liberat Army China, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.
   [Yu, Long; Xu, Shuogui] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710033, Peoples R China.
   [Gu, Shen; Xu, Shuogui] Second Mil Med Univ, Acad Nursing, Shanghai 200433, Peoples R China.
RP Zhou, PY (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, 168 Changhai Rd, Shanghai 200433, Peoples R China.
EM summer520m@163.com; wjbiomat@yahoo.com.cn; liangchong1984@163.com;
   Bonexu@yahoo.cn
FU Nano Project of Science and Technology Commission of Shanghai
   Municipality [1052nm03100]; Key Projects for Basic Research Shanghai
   Committee of Science and Technology [11JC1415700]; National Natural
   Science Foundation of China [81171794]
FX This work received support from the Nano Project of Science and
   Technology Commission of Shanghai Municipality (no. 1052nm03100), Key
   Projects for Basic Research Shanghai Committee of Science and Technology
   (no. 11JC1415700), and National Natural Science Foundation of China (no.
   81171794).
CR Alcantara ACS, 2010, J MATER CHEM, V20, P9495, DOI 10.1039/c0jm01211d
   Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x
   Bai J, 2003, POSTHARVEST BIOL TEC, V28, P259, DOI 10.1016/S0925-5214(02)00182-5
   Berendt T, 2004, CLIN MED, V4, P510, DOI 10.7861/clinmedicine.4-6-510
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Cataldo MA, 2010, J INFECTION, V61, P443, DOI 10.1016/j.jinf.2010.09.033
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Costa EM, 2012, ANAEROBE, V18, P305, DOI 10.1016/j.anaerobe.2012.04.009
   Duan B, 2010, ACTA BIOMATER, V6, P4495, DOI 10.1016/j.actbio.2010.06.024
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Enzler MJ, 2011, MAYO CLIN PROC, V86, P686, DOI 10.4065/mcp.2011.0012
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kim YB, 2012, J MATER CHEM, V22, P16880, DOI 10.1039/c2jm33036a
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Li XN, 2010, J COLLOID INTERF SCI, V345, P46, DOI 10.1016/j.jcis.2010.01.029
   Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935
   Lonn-Stensrud J, 2009, J ANTIMICROB CHEMOTH, V63, P309, DOI 10.1093/jac/dkn501
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   Martinez-Pastor JC, 2010, EUR J CLIN MICROBIOL, V29, P1039, DOI 10.1007/s10096-010-0950-y
   Moroni L, 2008, MATER TODAY, V11, P44, DOI 10.1016/S1369-7021(08)70089-0
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   Peng ZX, 2010, CARBOHYD POLYM, V81, P275, DOI 10.1016/j.carbpol.2010.02.008
   Steinberg JP, 2009, ANN SURG, V250, P10, DOI 10.1097/SLA.0b013e3181ad5fca
   Subramanian S, 2007, BIOMACROMOLECULES, V8, P2120, DOI 10.1021/bm0701999
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu TY, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045003
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 41
TC 19
Z9 19
U1 3
U2 97
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 5
BP 685
EP 692
DI 10.1039/c2tb00102k
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 087YF
UT WOS:000314799900012
DA 2018-10-20
ER

PT J
AU Hasebe, T
   Kobayashi, E
   Tezuka, H
   Sato, T
AF Hasebe, Tatsuya
   Kobayashi, Equo
   Tezuka, Hiroyasu
   Sato, Tatsuo
TI Effects of Sintering Conditions on Mechanical Properties of Biomedical
   Porous Ti Produced by Spark Plasma Sintering
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID BIOACTIVE TITANIUM; YOUNGS MODULUS; ALLOYS; METAL; IMPLANTS
AB Because of its excellent biocompatibility, good corrosion resistance and relatively lower Young's modulus, Ti was suitable for biomaterial. It, however, showed still bigger Young's modulus comparing to the living bone. It was necessary to decrease the Young's modulus in order to avoid adversely affect to the bone, such as stress sheilding. In this study, porous Ti were fablicated to decrease the Young's modulus by space holder method from Ti/NaCl composites sintered using spark plasma sintering (SPS) method. The sintering condition and the size of NaCl affected to the porous structure and mechanical properties. According to the scanning electron microscope (SEM) observation and the relative density measurement of specimens sintered with several sintering conditions, the desirable sintering condition was concluded as 973 K of sintering temperature and 1.2 ks of sintering time. The specimens made from NaCl powder whose size were from 106 to 214 mu m showed almost opened and connected pores. The Young's modulus was decreased with increasing the porosity. (C) 2013 The Japan Society of Applied Physics
C1 [Hasebe, Tatsuya] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.
   [Kobayashi, Equo; Tezuka, Hiroyasu] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528552, Japan.
   [Sato, Tatsuo] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Hasebe, T (reprint author), Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.
RI Sato, Tatsuo/F-4407-2014
CR Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041
   Feng HB, 2005, COMPOS PART A-APPL S, V36, P558, DOI 10.1016/j.compositesa.2004.09.003
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Hisashi S., 2007, MATER SCI FORUM, V539-543, P3201
   Li Y, 2008, POWDER METALL, V51, P231, DOI 10.1179/174329007X223965
   Majumdar P, 2008, MAT SCI ENG A-STRUCT, V489, P419, DOI 10.1016/j.msea.2007.12.029
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pattanayak DK, 2009, MAT SCI ENG C-MATER, V29, P1974, DOI 10.1016/j.msec.2009.03.014
   Rak ZS, 2006, J MATER PROCESS TECH, V175, P358, DOI 10.1016/j.jmatprotec.2005.04.006
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Velten D., 2003, Z METALLKD, V6, P667
   Watanabe Y, 2011, J MATER PROCESS TECH, V211, P1919, DOI 10.1016/j.jmatprotec.2011.05.024
   Zhu K, 2007, J MATER SCI, V42, P7348, DOI 10.1007/s10853-007-1532-y
NR 15
TC 4
Z9 4
U1 0
U2 27
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD JAN
PY 2013
VL 52
IS 1
SI SI
AR 01AE03
DI 10.7567/JJAP.52.01AE03
PN 2
PG 4
WC Physics, Applied
SC Physics
GA 083LV
UT WOS:000314466500028
DA 2018-10-20
ER

PT J
AU San Martin, S
   Alaminos, M
   Zorn, TMT
   Sanchez-Quevedo, MC
   Garzon, I
   Rodriguez, IA
   Campos, A
AF San Martin, S.
   Alaminos, M.
   Zorn, T. M. T.
   Sanchez-Quevedo, M. C.
   Garzon, I.
   Rodriguez, I. A.
   Campos, A.
TI The effects of fibrin and fibrin-agarose on the extracellular matrix
   profile of bioengineered oral mucosa
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE extracellular matrix; fibrin; agarose; constructs; tissue engineering;
   oral mucosa
ID IN-VITRO; COLLAGEN FIBRILLOGENESIS; DECORIN DEFICIENCY; SMALL
   PROTEOGLYCAN; BIGLYCAN; SKIN; RECONSTRUCTION; SUBSTITUTE; EXPRESSION;
   SCAFFOLDS
AB Several studies have developed efficient oral mucosa constructs using different types of scaffold. However, the changes in the morphology and gene and protein expression profile that could occur in these artificial constructs remain unknown. This study compared the histology and expression of several extracellular matrix molecules in human artificial oral mucosa developed using two different types of scaffolds: fibrin and fibrin-agarose. To that end, bioengineered oral mucosa stromas were constructed from biopsy samples of human oral mucosa and the substitute generated was analyzed at different periods of time in culture. Histological analysis was carried out by light and transmission electron microscopy and the expression of collagen types I, III, and VI, the proteoglycans decorin and biglycan, and the different chains of laminin, were assessed by immunoperoxidase technique. This study found that fibrin scaffolds accelerated fibroblast growth and remodeling of the scaffold, thus enhancing collagen fibrillogenesis. In the fibrin-agarose scaffold, themorphology and organization of the fibroblasts did not change during the culture period. All extracellular matrix proteins analyzed were expressed in both scaffolds. However, in fibrin scaffolds, these proteins were widely distributed and replaced the scaffold during the follow-up period. These results show that the substitutes generated showed histological and molecular similarities with native human oral mucosa stroma. In addition, it was observed that the nature of the biomaterial influenced the behaviour of the oral stromal fibroblasts, thereby modulating their growth, protein synthesis, and collagen fibrillogenesis. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [San Martin, S.] Univ Valparaiso, Biomed Res Ctr, Sch Med, Valparaiso, Chile.
   [San Martin, S.] CREAS, Valparaiso, Chile.
   [Alaminos, M.; Sanchez-Quevedo, M. C.; Garzon, I.; Rodriguez, I. A.; Campos, A.] Univ Granada, Dept Histol, Granada, Spain.
   [Zorn, T. M. T.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Rodriguez, I. A.] Natl Univ Cordoba, Fac Odontol, Histol Dept B, Cordoba, Argentina.
RP San Martin, S (reprint author), Univ Valparaiso, Dept Biomed Sci, Biomed Res Ctr, Sch Med, Calle Hontaneda 2664,Casilla 92-V, Valparaiso, Chile.
EM sebastian.sanmartin@uv.cl
RI Zorn, Telma/C-4065-2008; ALAMINOS, MIGUEL/N-9960-2016
OI ALAMINOS, MIGUEL/0000-0003-4876-2672
FU National R + D + i; Institute of Health Carlos III; Biomedical Research
   Centre at Universidad de Valparaiso, Valparaiso, Chile [05/2006]
FX This study was supported by the National R + D + i 2004-2007, the
   Institute of Health Carlos III, and the Biomedical Research Centre at
   Universidad de Valparaiso, Valparaiso, Chile; grant no 05/2006). The
   authors offer thanks to Victor Carriel, Makarena Gonzalez, and Fernanda
   Barrence for their technical assistance.
CR Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   Birk DE, 1997, DEV DYNAM, V208, P291
   BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401
   Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180
   Feinberg SE, 2005, J ORAL MAXIL SURG, V63, P1418, DOI 10.1016/j.joms.2005.07.004
   Ferdous Z, 2008, BIOMATERIALS, V29, P2740, DOI 10.1016/j.biomaterials.2008.03.018
   Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x
   Garzon I, 2009, INT J ARTIF ORGANS, V32, P711
   Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178
   Hernandez Rosa, 2009, V470, P105, DOI 10.1007/978-1-59745-204-5_10
   Ionescu AM, 2010, CORNEA, V29, P895, DOI 10.1097/ICO.0b013e3181ca3650
   Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0
   Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Llames Sara, 2006, Cell and Tissue Banking, V7, P47, DOI 10.1007/s10561-004-7253-4
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Munoz-Corcuera M, 2009, CLIN EXP DERMATOL, V34, P456, DOI 10.1111/j.1365-2230.2009.03219.x
   Nieto-Aguilar R, 2010, J BIOMATER APPL, V25, P743
   Porter SR, 2005, ALIMENT PHARM THERAP, V21, P295, DOI 10.1111/j.1365-2036.2005.02333.x
   Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0
   San Martin S, 2003, CELL MOL BIOL, V49, P673
   Sanchez-Quevedo MC, 2007, HISTOL HISTOPATHOL, V22, P631, DOI 10.14670/HH-22.631
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776
   Serrato D, 2009, HISTOL HISTOPATHOL, V24, P1531, DOI 10.14670/HH-24.1531
   SLOAN P, 1991, J DENT, V19, P107, DOI 10.1016/0300-5712(91)90100-D
   Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2
   Trelstad RL, 1981, CELL BIOL EXTRACELLU, P179
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   VOGEL KG, 1987, COLLAGEN REL RES, V7, P105
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200
NR 42
TC 10
Z9 10
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2013
VL 7
IS 1
BP 10
EP 19
DI 10.1002/term.490
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 086AZ
UT WOS:000314656700002
PM 22052862
DA 2018-10-20
ER

PT J
AU Cunha-Reis, C
   El Haj, AJ
   Yang, XB
   Yang, Y
AF Cunha-Reis, Cassilda
   El Haj, Alicia J.
   Yang, Xuebin
   Yang, Ying
TI Fluorescent labeling of chitosan for use in non-invasive monitoring of
   degradation in tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE chitosan; fluorescence; degradation; scaffold; tissue engineering;
   non-invasive monitoring
ID CHEMICALLY-MODIFIED CHITOSAN; LASER-SCANNING MICROSCOPY; IN-VITRO;
   HYDROLYTIC DEGRADATION; SURFACE MODIFICATION; SWELLING BEHAVIOR;
   CELL-ADHESION; N-ACETYLATION; QUANTIFICATION; MEMBRANE
AB The establishment of non-invasive analytical tools for assessing the in-situ use of biomaterials for surgical implants or scaffolds in tissue engineering and polymer-based therapies is fundamental. This study established a method for fluorescent tracking of the degradation of a chitosan membrane scaffold for use in vitro in bioreactors and ultimately in vivo. The basis of this tracking system is a fluorescence emitting biomaterial obtained by covalent binding of the fluorophore tetramethylrhodamine isothiocyanate (TRITC) onto the backbone of chitosan. Using confocal microscopy, this study quantitated the reductions in fluorescence intensity of the membrane and correlated these decreases with weight loss during polymer breakdown, thereby providing a technique for non-destructively assessing the extent of degradation of chitosan materials over time in vitro. Using multispectral imaging in a mouse model, the study assessed the degradation profile of the fluorophore-labeled biomaterial in vivo in real time and identified the dispersing pathway of the chitosan membrane degradation products in vivo. The results revealed that TRITC conjugated chitosan was biocompatible and supported bone cell growth. The changes in fluorescence intensity correlated well with weight loss up to 16 weeks of in vitro culture and could be monitored over two weeks in vivo. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Cunha-Reis, Cassilda; El Haj, Alicia J.; Yang, Ying] Keele Univ, Sch Med, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
   [Yang, Xuebin] Univ Leeds, Dept Oral Biol, Leeds LS2 9LU, W Yorkshire, England.
RP El Haj, AJ (reprint author), Keele Univ, Sch Med, Inst Sci & Technol Med, Thornburrow Dr, Stoke On Trent ST4 7QB, Staffs, England.
EM a.j.el.haj@bemp.keele.ac.uk
OI Cunha Reis, Cassilda/0000-0001-6886-3900; Yang, Ying/0000-0002-1362-6040
FU Marie Curie Actions; Alea Jacta; EXPERTISSUES Network of Excellence
   (NoE) [NMP3-CT-2004-500283];  [EST-MEST-CT-2004-008104]; Engineering and
   Physical Sciences Research Council [EP/H028277/1]
FX The authors would like to acknowledge Marie Curie Actions, Alea Jacta,
   EST-MEST-CT-2004-008104 and EXPERTISSUES Network of Excellence (NoE),
   NMP3-CT-2004-500283 for funding and Miss Yamuna Mohanram for technical
   support with animal experiments.
CR Agnihotri SA, 2006, J APPL POLYM SCI, V102, P3255, DOI 10.1002/app.24663
   Bingaman S, 2003, MICROCIRCULATION, V10, P221, DOI 10.1038/sj.mn.7800186
   Bohmer RM, 1996, MOL BIOL CELL, V7, P101
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Capek M, 2006, MICROSC RES TECHNIQ, V69, P624, DOI 10.1002/jemt.20330
   Cesaro SN, 1998, VIB SPECTROSC, V16, P5
   Cho HJ, 2006, BIOMATERIALS, V27, P544, DOI 10.1016/j.biomaterials.2005.06.026
   Dhanasingh S, 2010, INT J ENG APPL SCI, V6, P5
   DUNN KW, 1994, FASEB J, V8, P573
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gareau DS, 2004, J BIOMED OPT, V9, P254, DOI 10.1117/1.1645798
   Giunchedi P, 1998, J CONTROL RELEASE, V56, P53, DOI 10.1016/S0168-3659(98)00068-6
   Graves EE, 2004, CURR MOL MED, V4, P419, DOI 10.2174/1566524043360555
   Han XX, 2009, BIOMATERIALS, V30, P423, DOI 10.1016/j.biomaterials.2008.10.001
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   HEINRICHS M, 1994, ANAL QUANT CYTOL, V16, P233
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Jung C, 2006, J AM CHEM SOC, V128, P5283, DOI 10.1021/ja0588104
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Luedtke MA, 2009, SKIN RES TECHNOL, V15, P482, DOI 10.1111/j.1600-0846.2009.00394.x
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Meyer LE, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337294
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065
   Murphy CL, 2002, EXP PHYSIOL, V87, P163, DOI 10.1113/eph8702332
   MUZZARELLI RAA, 1995, ENZYME MICROB TECH, V17, P541, DOI 10.1016/0141-0229(94)00015-J
   Nagata M, 1999, MACROMOLECULES, V32, P7762, DOI 10.1021/ma990907l
   Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104
   Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101
   Ntziachristos Vasilis, 2002, Nature Medicine, V8, P757, DOI 10.1038/nm729
   Ntziachristos V, 2002, MOL IMAGING, V1, P82, DOI 10.1162/153535002320162732
   Park H, 2006, J BIOMED MATER RES A, V76A, P144, DOI 10.1002/jbm.a.30533
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Qiu YZ, 2009, J BIOMED MATER RES B, V90B, P668, DOI 10.1002/jbm.b.31333
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Renouf-Glauser AC, 2006, BIOMACROMOLECULES, V7, P612, DOI 10.1021/bm050746v
   ROMIJN HJ, 1994, BRAIN RES, V657, P245, DOI 10.1016/0006-8993(94)90974-1
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Wang JW, 2003, J MATER SCI-MATER M, V14, P1079, DOI 10.1023/B:JMSM.0000004005.52762.ea
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wolbank S, 2008, 8 WORLD BIOM C AMST
   Wolf M, 2008, PHARMAZIE, V63, P43, DOI 10.1691/ph.2008.6711
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yang Y, 2005, ANALYST, V130, P1502, DOI 10.1039/b506911d
   Zhang QQ, 2000, ARTIF CELL BLOOD SUB, V28, P255, DOI 10.3109/10731190009119356
   Zhao W., 2005, ANGEW CHEM, V117, P1705
   Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899
   Zucker RM, 2006, CYTOM PART A, V69A, P930, DOI 10.1002/cyto.a.20315
NR 56
TC 21
Z9 21
U1 2
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2013
VL 7
IS 1
BP 39
EP 50
DI 10.1002/term.494
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 086AZ
UT WOS:000314656700005
PM 22125289
DA 2018-10-20
ER

PT J
AU Kuner, R
   Brase, JC
   Sultmann, H
   Wuttig, D
AF Kuner, Ruprecht
   Brase, Jan C.
   Sueltmann, Holger
   Wuttig, Daniela
TI microRNA biomarkers in body fluids of prostate cancer patients
SO METHODS
LA English
DT Review
DE miRNA; Body fluids; Prostate cancer; Biomarker
ID MESSENGER-RNA; CIRCULATING MICRORNAS; EXPRESSION SIGNATURE; LUNG-CANCER;
   SERUM; CELLS; CARCINOMA; PROFILES; PROTEIN; METHYLATION
AB The abundance of miRNAs - small non-coding RNAs involved in posttranscriptional regulation of gene expression - in tissues and body fluids of cancer patients hold great promise to identify specific biomarkers, which may be useful for early diagnosis as well as to predict the clinical outcome and treatment response. For the extraction and quantification of miRNAs from cells and tissues, present technologies for transcriptome analyses like microarrays, quantitative real-time PCR or next generation sequencing can be applied. However, the analyses of miRNAs in body fluids like serum or urine is still a challenge with respect to the nucleic acid recovery from very limited sources of biomaterial, normalization strategies and validation using independent technologies. The presence of specific miRNA patterns in body fluids like serum of cancer patients suggests a promising role of these molecules as surrogate markers. However, the majority of miRNA studies were addressed in relatively small patient cohorts limiting the validity and the clinical application of potential miRNA biomarkers or signatures. We reflect the critical steps to translate miRNA biomarker into clinical routine diagnostics and present future aspects for the fast, robust and standardized quantification of miRNAs in body fluids. (C) 2012 Elsevier Inc. All rights reserved.
C1 German Canc Res Ctr, Unit Canc Genome Res, Div Mol Genet, D-69120 Heidelberg, Germany.
   Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany.
RP Kuner, R (reprint author), German Canc Res Ctr, Unit Canc Genome Res, Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
EM r.kuner@dkfz.de; jcbrase@gmx.de; h.sueltmann@dkfz.de; d.wuttig@dkfz.de
RI Sultmann, Holger/E-4534-2013
OI Sultmann, Holger/0000-0002-5257-8600
FU German Federal Ministry of Education and Science [FKZ: 01GS0890]
FX This review is linked to experimental studies, which were funded by the
   German Federal Ministry of Education and Science in the framework of the
   program for medical genome research (FKZ: 01GS0890). The authors thank
   Maria Falth and Stephan Gade for the stimulating discussion about miRNA
   research in cancer.
CR Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9
   Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144
   Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696
   Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108
   Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79
   Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154
   Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880
   Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306
   Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376
   Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191
   Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595
   Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370
   Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282
   Chen Z.H., 2012, PROSTATE
   Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822
   Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127
   Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023
   Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76
   Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3
   Debey-Pascher Svenja, 2012, Methods Mol Biol, V822, P307, DOI 10.1007/978-1-61779-427-8_22
   Driskell JD, 2010, CHEM COMMUN, V46, P3298, DOI 10.1039/c002059a
   Gary B, 2004, AM J PATHOL, V164, P1607, DOI 10.1016/S0002-9440(10)63719-4
   Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179
   Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241
   Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342
   Kirschner M.B., 2011, PLOS ONE, V6
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032
   Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x
   Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001
   Lodes M.J., 2009, PLOS ONE, V4, pe6229
   Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lusi EA, 2009, ANAL CHEM, V81, P2819, DOI 10.1021/ac8026788
   Mahn L.C., 2011, UROLOGY, V77
   Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304
   Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815
   McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229
   Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809
   Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726
   Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421
   Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533
   Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001
   Rani S, 2011, METHODS MOL BIOL, V784, P181, DOI 10.1007/978-1-61779-289-2_13
   Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467
   Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827
   Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084
   Selth LA, 2012, INT J CANCER, V131, P652, DOI 10.1002/ijc.26405
   Shen J., 2012, PROSTATE
   Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255
   Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715
   Streichert T, 2011, METHODS MOL BIOL, V676, P253, DOI 10.1007/978-1-60761-863-8_18
   Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036
   Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573
   Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918
   Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103
   Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276
   Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183
   Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405
   Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099
   White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173
   Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117
   Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246
NR 69
TC 29
Z9 31
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD JAN
PY 2013
VL 59
IS 1
BP 132
EP 137
DI 10.1016/j.ymeth.2012.05.004
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 084RB
UT WOS:000314555700015
PM 22652624
DA 2018-10-20
ER

PT J
AU De Rita, F
   Marchi, D
   Lucchese, G
   Barozzi, L
   Dissegna, R
   Menon, T
   Faggian, G
   Mazzucco, A
   Luciani, GB
AF De Rita, Fabrizio
   Marchi, Diego
   Lucchese, Gianluca
   Barozzi, Luca
   Dissegna, Roberta
   Menon, Tiziano
   Faggian, Giuseppe
   Mazzucco, Alessandro
   Luciani, Giovanni Battista
TI Comparison Between D901 Lilliput 1 and Kids D100 Neonatal Oxygenators:
   Toward Bypass Circuit Miniaturization
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Pediatric Mechanical Circulatory Support
   Systems and Pediatric Cardiopulmonary Perfusion
CY JUN 13-16, 2012
CL Istanbul, TURKEY
DE Oxygenators; Neonatal; Cardiopulmonary bypass; Biomaterial;
   Miniaturization
ID HYPOTHERMIC CARDIOPULMONARY BYPASS; BLOOD-TRANSFUSION; HEART-SURGERY;
   INFLAMMATORY RESPONSE; RANDOMIZED-TRIAL; PERFUSION; PRIME; INFANTS
AB Progress in biomaterial technology and improvements in surgical and perfusion strategy ameliorated morbidity and mortality in pediatric cardiac surgery. In this study, we describe our clinical experience comparing performance of two neonatal oxygenators. From January 2002 to March 2011, 159 infants with less than 5kg body weight underwent heart surgery. Ninety-four patients received a D901 Lilliput 1 oxygenator with standard bypass circuit (group A), while 65 received a D100 Kids with miniaturized bypass circuit (group B). Miniaturization consisted in shortened arterial, venous, cardioplegia, and pump-master lines. Priming composition consisted in Ringer's acetate solution with addition of albumin and blood, with target hematocrit of 24% or greater. In group B cardiopulmonary bypass (CPB) was vacuum-assisted and started with an empty venous line. Modified ultrafiltration and Cell-Saver blood infusion was routinely applied in both groups. Average+/-standard deviation (SD) age at repair was 37+/-38 days in group A and 59+/-60 days in group B (P=0.005). Average+/-SD weight, height, and body surface area were 3.5+/-0.7kg, 52+/-4cm, and 0.22+/-0.03m2, respectively, in group A, and 3.7+/-1kg, 53+/-5cm, and 0.23+/-0.02m2, respectively, in group B (P=not significant [NS]). Male sex was predominant (55 vs. 58%, P=NS). Priming volume was 524+/-67mL (group A) and 337+/-53mL (group B) (P=0.001). There were no statistical differences in hemoglobin at the start, during, and at the end of CPB, but group A required higher blood volume added to the prime (111+/-33 vs. 93+/-31mL, P=0.001). In group B, two surgical procedures were completed in total hemodilution. In group B, CPB time and aortic cross-clamp time were shorter than in group A (106+/-52 vs. 142+/-78min and 44+/-31 vs. 64+/-31min, respectively, P=0.001). There were 16 hospital deaths in group A and 4 in group B (P=0.04). Durations of mechanical ventilation and intensive care unit stay were 5.3+/-3.2 vs. 4.1+/-3.2 days (P=0.02) and 6.5+/-4.9 vs. 5.1+/-3 days (P=0.03), respectively. There were significant differences in inotropic score (1083+/-1175 vs. 682+/-938, P=0.04) and blood postoperative transfusion (153+/-226 vs. 90+/-61mL, P=0.04). Twenty-seven patients in group A and 10 in group B presented with major adverse postoperative complications (P=0.04). Use of neonatal oxygenators with low priming volume, associated with a miniaturized bypass circuit, seems to be a favorable strategy to decrease postoperative morbidity after cardiac surgery in neonates and infants.
C1 [De Rita, Fabrizio; Marchi, Diego; Lucchese, Gianluca; Barozzi, Luca; Dissegna, Roberta; Menon, Tiziano; Faggian, Giuseppe; Mazzucco, Alessandro; Luciani, Giovanni Battista] Univ Verona, Div Cardiac Surg, I-37126 Verona, Italy.
RP Luciani, GB (reprint author), Univ Verona, Div Cardiac Surg, OCM Piazzale Stefani 1, I-37126 Verona, Italy.
EM giovanni.luciani@univr.it
RI Faggian, Giuseppe/J-4590-2018
OI Faggian, Giuseppe/0000-0001-5371-5761; Luciani, Giovanni
   Battista/0000-0003-0931-018X
FU Cariverona Project
FX Supported by Institutional Funds from Cariverona Project.
CR Ando M, 2004, ANN THORAC SURG, V78, P1717, DOI 10.1016/j.athorascur.2004.05.006
   De Rita F, 2011, ARTIF ORGANS, V35, P1029, DOI 10.1111/j.1525-1594.2011.01355.x
   Durandy Y, 2007, ASAIO J, V53, P659, DOI 10.1097/MAT.0b013e31815b0cee
   Durandy Yves, 2010, Asian Cardiovasc Thorac Ann, V18, P386, DOI 10.1177/0218492310376675
   Durandy Y, 2009, ASAIO J, V55, P117, DOI 10.1097/MAT.0b013e31819142f1
   Golab HD, 2009, PERFUSION-UK, V24, P239, DOI 10.1177/0267659109348722
   GROOM RC, 1994, ANN THORAC SURG, V58, P573, DOI 10.1016/0003-4975(94)92267-5
   Hickey E, 2006, ANN THORAC SURG, V81, pS2367, DOI 10.1016/j.athoracsur.2006.02.071
   Jacobs JRP, 2005, ANN THORAC SURG, V80, P2278, DOI 10.1016/j.athoracsur.2005.05.107
   Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003
   Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027
   Lawson DS, 2008, PERFUSION-UK, V23, P39, DOI 10.1177/0267659108092470
   McElhinney DB, 2001, CURR OPIN PEDIATR, V13, P104, DOI 10.1097/00008480-200104000-00003
   Merkle F, 2004, PERFUSION-UK, V19, P229, DOI 10.1191/0267659104pf744oa
   Molicki JS, 2001, J THORAC CARDIOV SUR, V122, P449, DOI 10.1067/mtc.2001.1115422
   Napoleone CP, 2008, J CARDIOVASC MED, V9, P716, DOI 10.2459/JCM.0b013e3282f3a1ca
   Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
NR 18
TC 3
Z9 3
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2013
VL 37
IS 1
BP E24
EP E28
DI 10.1111/aor.12017
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 072XG
UT WOS:000313706400008
PM 23305583
DA 2018-10-20
ER

PT J
AU Wang, HY
   Li, Y
   Qin, LX
   Heyman, A
   Shoseyov, O
   Willner, I
   Long, YT
   Tian, H
AF Wang, Hai-Yan
   Li, Yang
   Qin, Li-Xia
   Heyman, Arnon
   Shoseyov, Oded
   Willner, Itamar
   Long, Yi-Tao
   Tian, He
TI Single-molecule DNA detection using a novel SP1 protein nanopore
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ALPHA-HEMOLYSIN NANOPORE; POLYNUCLEOTIDE MOLECULES; MEMBRANE-CHANNEL;
   DISCRIMINATION; TRANSLOCATION; PORE
AB SP1 protein as a new type of biological nanopore is described and is utilized to distinguish single-stranded DNA at the single-molecule level. Using the SP1 nanopore to investigate single molecule detection broadens the existing research areas of pore-forming biomaterials from unsymmetrical biological nanopores to symmetrical biological nanopores. This novel nanopore could provide a good candidate for single-molecule detection and characterization of biomaterial applications.
C1 [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
   [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Inst Fine Chem, Shanghai 200237, Peoples R China.
   [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China.
   [Heyman, Arnon; Shoseyov, Oded] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, Jerusalem, Israel.
   [Willner, Itamar] Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il; yitaolong@ecust.edu.cn; tianhe@ecust.edu.cn
RI Long, Yitao/P-4089-2014
OI Long, Yitao/0000-0002-4466-3119; Long, Yitao/0000-0003-2571-7457
FU National Science Fund for Distinguished Young Scholars [21125522]; 973
   Program [2013CB733700]; National Natural Science Foundation of China
   [91027035, 21105028]; Science and Technology Commission of Shanghai
   Municipality Natural Science Foundation of Shanghai [11ZR1408900];
   Fundamental Research Funds for the Central Universities [WK1013002]
FX This research was supported by the National Science Fund for
   Distinguished Young Scholars (21125522), 973 Program (2013CB733700), the
   National Natural Science Foundation of China (91027035, 21105028),
   Science and Technology Commission of Shanghai Municipality Natural
   Science Foundation of Shanghai (11ZR1408900), and the Fundamental
   Research Funds for the Central Universities (WK1013002).
CR ADLER A, 1967, P NATL ACAD SCI USA, V57, P423, DOI 10.1073/pnas.57.2.423
   Butler TZ, 2007, BIOPHYS J, V93, P3229, DOI 10.1529/biophysj.107.107003
   Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106
   Dgany O, 2004, J BIOL CHEM, V279, P51516, DOI 10.1074/jbc.M409952200
   Gao C, 2008, ANAL CHEM, V81, P80
   Henrickson SE, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3328875
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274
   Medalsy I, 2008, NANO LETT, V8, P473, DOI 10.1021/nl072455t
   Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079
   Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406
   Muthukumar M, 2001, PHYS REV LETT, V86, P3188, DOI 10.1103/PhysRevLett.86.3188
   PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0
   Pastoriza-Gallego M., 2011, J AM CHEM SOC, P663
   Qin LX, 2012, ANGEW CHEM INT EDIT, V51, P140, DOI 10.1002/anie.201106482
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106
   Wang HY, 2011, ANAL CHEM, V83, P1746, DOI 10.1021/ac1029874
   Wang WX, 2002, PLANT PHYSIOL, V130, P865, DOI 10.1104/pp.002436
   Wang Y., 2011, NAT NANOTECHNOL, V147, P1
   Ying YL, 2011, CHEM COMMUN, V47, P5690, DOI 10.1039/c0cc05787h
NR 21
TC 28
Z9 29
U1 4
U2 122
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2013
VL 49
IS 17
BP 1741
EP 1743
DI 10.1039/c3cc38939a
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 082WS
UT WOS:000314424700017
PM 23340583
DA 2018-10-20
ER

PT J
AU Mhuka, V
   Dube, S
   Nindi, MM
AF Mhuka, Vimbai
   Dube, Simiso
   Nindi, Mathew Muzi
TI Chemical, structural and thermal properties of Gonometa postica silk
   fibroin, a potential biomaterial
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Biopolymer; Fibroin; Gonometa species
ID BOMBYX-MORI SILK; SPIDER SILK; IN-VITRO; PHYSICAL-PROPERTIES;
   HEAT-TREATMENT; FIBERS; ACID; SEQUENCE; REGENERATION; CONFORMATION
AB In the present study, chemical, structural and thermal properties of fibroin from Gonometa postica, a wild silkmoth species were investigated. Silk from Gonometa rufobrunnea and Bombyx mori species were included in this study for comparison. The results indicated that G. postica and G. rufobrunnea silk exhibited similar properties whereas distinct differences were observed with B. mori silk. Amino acid analysis showed that glycine, alanine and serine accounted for more than 70% of the total amino acid content in all species. The amount of polar amino acids in Gonometa fibroin was significantly higher than for B. mori fibroin suggesting increased chemical reactivity of the former. The abundance of basic amino acids in Gonometa fibroin makes it a promising biomaterial in cell and tissue culture. Structural analysis revealed a unique beta-sheet structure of Gonometa fibroin which is comprised of both poly-alanine and poly-glycine-alanine sequences. The maximum decomposition temperatures for Gonometa and B. mori fibroin were 350 degrees C and 320 degrees C respectively. The influence of amino acid composition on structural and thermal properties of the silks is also discussed. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Mhuka, Vimbai; Dube, Simiso; Nindi, Mathew Muzi] Univ S Africa, Coll Sci Engn & Technol, Dept Chem, ZA-0003 Pretoria, South Africa.
RP Dube, S (reprint author), Univ S Africa, Coll Sci Engn & Technol, Dept Chem, POB 392, ZA-0003 Pretoria, South Africa.
EM dubes@unisa.ac.za
OI Dube, Simiso/0000-0003-1225-5812
FU National Research Foundation (NRF) [69081]; University of South Africa
   (UNISA); Organization for Women in Science for the Developing World
   (OWSD)
FX The authors gratefully acknowledge the National Research Foundation
   (NRF) (Grant number 69081) and the University of South Africa (UNISA)
   for financially supporting this project. We are also indebted to the
   Organization for Women in Science for the Developing World (OWSD) for
   awarding Ms. Mhuka with a postgraduate fellowship. We would also like to
   acknowledge Mr. J. A. Nyati, University of Pretoria (Department of
   Zoology & Entomology) and Elster Vermeulen for their assistance in
   sourcing varieties of silkworm cocoons. Special thanks to Dr. S.
   Chigome, Mr. H. Steyn, Ms. N. Baloyi and Mr. S. Radzirani for SEM
   analysis.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Chang JC, 2005, POLYMER, V46, P7909, DOI 10.1016/j.polymer.2005.06.077
   Chattopadhyay R, 2008, J TEXTILE ENG, V54, P179
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   FREDDI G, 1993, J APPL POLYM SCI, V48, P99, DOI 10.1002/app.1993.070480110
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Gheysens T, 2011, BIOMACROMOLECULES, V12, P2257, DOI 10.1021/bm2003362
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Holland C, 2012, BIOPOLYMERS, V97, P362, DOI 10.1002/bip.22011
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   IIZUKA EISAKU, 1965, BIORHEOLOGY, V3, P1
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kweon H, 2001, J APPL POLYM SCI, V82, P750, DOI 10.1002/app.1901
   Lee KH, 2005, FIBER POLYM, V6, P181, DOI 10.1007/BF02875641
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Reddy N, 2010, INT J BIOL MACROMOL, V46, P419, DOI 10.1016/j.ijbiomac.2010.02.013
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Teshome A, 2012, INT J BIOL MACROMOL, V50, P63, DOI 10.1016/j.ijbiomac.2011.09.025
   TSUKADA M, 1992, J APPL POLYM SCI, V46, P1945, DOI 10.1002/app.1992.070461107
   TSUKADA M, 1987, J POLYM SCI POL PHYS, V25, P1325, DOI 10.1002/polb.1987.090250610
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Valluzzi R, 2004, BIOMACROMOLECULES, V5, P696, DOI 10.1021/bm0343085
   Veldtman R, 2002, AFR ENTOMOL, V10, P127
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Yuan QQ, 2010, POLYMER, V51, P6278, DOI 10.1016/j.polymer.2010.10.046
   Zahou E, 2000, ANAL BIOCHEM, V281, P115, DOI 10.1006/abio.2000.4549
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 39
TC 13
Z9 13
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2013
VL 52
BP 305
EP 311
DI 10.1016/j.ijbiomac.2012.09.010
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 076CO
UT WOS:000313934300045
PM 23000253
DA 2018-10-20
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Corneal Stromal Cell Growth on Gelatin/Chondroitin Sulfate Scaffolds
   Modified at Different NHS/EDC Molar Ratios
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE gelatin; chondroitin sulfate; carbodiimide chemistry; scaffold; corneal
   keratocyte
ID TISSUE ENGINEERING APPLICATIONS; HYALURONIC-ACID HYDROGELS; LINKED
   GELATIN MEMBRANES; PIGMENT EPITHELIAL-CELLS; CHONDROITIN-SULFATE;
   CROSS-LINKING; IN-VITRO; SHEET TRANSPLANTATION; EXTRACELLULAR-MATRIX;
   CHITOSAN MATERIALS
AB A nanoscale modification strategy that can incorporate chondroitin sulfate (CS) into the cross-linked porous gelatin materials has previously been proposed to give superior performance for designed corneal keratocyte scaffolds. The purpose of this work was to further investigate the influence of carbodiimide chemistry on the characteristics and biofunctionalities of gelatin/CS scaffolds treated with varying N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC) molar ratios (0-1) at a constant EDC concentration of 10 mM. Results of Fourier transform infrared spectroscopy and dimethylmethylene blue assays consistently indicated that when the NHS to EDC molar ratio exceeds a critical level (i.e., 0.5), the efficiency of carbodiimide-mediated biomaterial modification is significantly reduced. With the optimum NHS/EDC molar ratio of 0.5, chemical treatment could achieve relatively high CS content in the gelatin scaffolds, thereby enhancing the water content, glucose permeation, and fibronectin adsorption. Live/Dead assays and interleukin-6 mRNA expression analyses demonstrated that all the test samples have good cytocompatibility without causing toxicity and inflammation. In the molar ratio range of NHS to EDC from 0 to 0.5, the cell adhesion ratio and proliferation activity on the chemically modified samples significantly increased, which is attributed to the increasing CS content. Additionally, the materials with highest CS content (0.143 +/- 0.007 nmol/10 mg scaffold) showed the greatest stimulatory effect on the biosynthetic activity of cultivated keratocytes. These findings suggest that a positive correlation is noticed between the NHS to EDC molar ratio and the CS content in the biopolymer matrices, thereby greatly affecting the corneal stromal cell growth.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]; Chang Gung Memorial Hospital [CMRPD1B0451]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China and grant CMRPD1B0451 from
   Chang Gung Memorial Hospital. The author is grateful to Ya-Ting Li
   (Institute of Biochemical and Biomedical Engineering, Chang Gung
   University) for technical assistance.
CR Bassleer CT, 1998, OSTEOARTHR CARTILAGE, V6, P196, DOI 10.1053/joca.1998.0112
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   CHAYAKUL V, 1982, GRAEF ARCH CLIN EXP, V218, P145, DOI 10.1007/BF02215652
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000
   Jayasuriya AC, 2003, J BIOMED MATER RES A, V66A, P260, DOI 10.1002/jbm.a.10536
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439
   Monti D, 2002, INT J PHARM, V232, P139, DOI 10.1016/S0378-5173(01)00907-3
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Smith SML, 2007, MATRIX BIOL, V26, P175, DOI 10.1016/j.matbio.2006.10.012
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Wang HJ, 2009, ADV ATMOS SCI, V26, P613, DOI 10.1007/s00376-009-0613-z
   Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zou XH, 2009, ACTA BIOMATER, V5, P1588, DOI 10.1016/j.actbio.2008.12.001
NR 48
TC 20
Z9 20
U1 5
U2 87
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2013
VL 14
IS 1
BP 2036
EP 2055
DI 10.3390/ijms14012036
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 077SS
UT WOS:000314048800118
PM 23337203
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, X
   He, JK
   Liu, YX
   Zhao, Q
   Wu, WQ
   Li, DC
   Jin, ZM
AF Li, Xiao
   He, Jiankang
   Liu, Yaxiong
   Zhao, Qian
   Wu, Wanquan
   Li, Dichen
   Jin, Zhongmin
TI Biomaterial Scaffolds with Biomimetic Fluidic Channels for Hepatocyte
   Culture
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE liver tissue engineering; scaffold; biomimetic vascular tree; dynamic
   culture; hepatocyte
ID 3-DIMENSIONAL SCAFFOLDS; TISSUE; FABRICATION; DESIGN
AB Biomaterial scaffolds play an important role in maintaining the viability and biological functions of highly metabolic hepatocytes in liver tissue engineering. One of the major challenges involves building a complex microchannel network inside three-dimensional (3D) scaffolds for efficient mass transportation. Here we presented a biomimetic strategy to generate a microchannel network within porous biomaterial scaffolds by mimicking the vascular tree of rat liver. The typical parameters of the blood vessels were incorporated into the biomimetic design of the microchannel network such as branching angle and diameter. Silk fibroin-gelatin scaffolds with biomimetic vascular tree were fabricated by combining micromolding, freeze drying and 3D rolling techniques. The relationship between the micro-channeled design and flow pattern was revealed by a flow experiment, which indicated that the scaffolds with biomimetic vascular tree exhibited unique capability in improving mass transportation inside the 3D scaffold. The 3D scaffolds, preseeded with primary hepatocytes, were dynamically cultured in a bioreactor system. The results confirmed that the pre-designed biomimetic microchannel network facilitated the generation and expansion of hepatocytes.
C1 [Li, Xiao; He, Jiankang; Liu, Yaxiong; Zhao, Qian; Wu, Wanquan; Li, Dichen; Jin, Zhongmin] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710054, Peoples R China.
RP Liu, YX (reprint author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710054, Peoples R China.
EM yaxiongliu@mail.xjtu.edu.cn
RI Li, Xiao/H-3014-2012
OI Li, Xiao/0000-0002-1200-8590
FU National High Technology Research and Development Program
   [2009AA043801]; Natural Science Foundation of China [51275386]
FX This work was funded by the National High Technology Research and
   Development Program (2009AA043801) and the Natural Science Foundation of
   China (51275386).
CR Bhandari RNB, 2001, TISSUE ENG, V7, P345, DOI 10.1089/10763270152044206
   Bhatia SN, 1999, BIOMED MICRODEVICES, V2, P131, DOI 10.1023/A:1009949704750
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Gibson L J, 2001, PROGR MAT SCI, V46, P273
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008
   He JK, 2007, POLYMER, V48, P4578, DOI 10.1016/j.polymer.2007.05.048
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Hoganson DM, 2010, TISSUE ENG PT A, V16, P1469, DOI [10.1089/ten.tea.2009.0118, 10.1089/ten.TEA.2009.0118]
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu YM, 1999, BIOMED CHROMATOGR, V13, P75, DOI 10.1002/(SICI)1099-0801(199902)13:1<75::AID-BMC817>3.0.CO;2-6
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Song YS, 2009, ANAL BIOANAL CHEM, V395, P185, DOI 10.1007/s00216-009-2935-1
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
NR 28
TC 4
Z9 7
U1 1
U2 67
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD JAN
PY 2013
VL 10
IS 1
BP 57
EP 64
DI 10.1016/S1672-6529(13)60199-7
PG 8
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 083AV
UT WOS:000314436000007
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Gil, ES
   Panilaitis, B
   Kaplan, DL
AF Mandal, Biman B.
   Gil, Eun Seok
   Panilaitis, Bruce
   Kaplan, David L.
TI Laminar Silk Scaffolds for Aligned Tissue Fabrication
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE alignment; freeze drying; laminar scaffolds; silk
ID FIBROIN 3D SCAFFOLDS; IN-VIVO; OPTICAL INTERFEROMETRY; BIOMATERIALS;
   FIBERS; GROWTH; REPAIR; CELLS; VITRO; ACID)
AB 3D-biomaterial scaffolds with aligned architecture are of vital importance in tissue regeneration. A generic method is demonstrated to produce aligned biomaterial scaffolds using the physics of directional ice freezing. Homogeneously aligned 3D silk scaffolds with high porosity and alignment are prepared. The method can be adapted to a wide range of polymers and is devoid of any chemical reactions, thus avoiding potential complications associated with by-products. Mechanical properties and cellular responses with chondrocytes and bone-marrow-derived hMSCs are studied, assessing survival, proliferation, and differentiation. In vivo tests suggest biocompatibility of the matrices for future tissue engineering applications, specifically in areas where high cellular alignment is needed.
C1 [Mandal, Biman B.] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, India.
   [Mandal, Biman B.; Gil, Eun Seok; Panilaitis, Bruce; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [EB002520, DE017207]; DARPA [W911NF-11-1-0079]
FX We thank the NIH (EB002520, DE017207) and DARPA (W911NF-11-1-0079) for
   support of these studies.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Butler MF, 2002, CRYST GROWTH DES, V2, P541, DOI 10.1021/cg02559le
   Butler MF, 2001, CRYST GROWTH DES, V1, P213, DOI 10.1021/cg005534q
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x
   Gutierrez MC, 2006, ADV MATER, V18, P1137, DOI 10.1002/adma.200502550
   Kenar H, 2011, BIOMATERIALS, V32, P5320, DOI 10.1016/j.biomaterials.2011.04.025
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   MAHLER W, 1980, NATURE, V285, P27, DOI 10.1038/285027a0
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   McCann JT, 2006, J AM CHEM SOC, V128, P1436, DOI 10.1021/ja056810y
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mukai SR, 2004, CHEM MATER, V16, P4987, DOI 10.1021/cm0491328
   Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028
   Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
NR 44
TC 25
Z9 27
U1 3
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JAN
PY 2013
VL 13
IS 1
BP 48
EP 58
DI 10.1002/mabi.201200230
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 075UT
UT WOS:000313913100007
PM 23161731
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hsiao, MH
   Lin, KH
   Liu, DM
AF Hsiao, Meng-Hsuan
   Lin, Kuan-Hui
   Liu, Dean-Mo
TI Improved pH-responsive amphiphilic carboxymethyl-hexanoyl
   chitosan-poly(acrylic acid) macromolecules for biomedical applications
SO SOFT MATTER
LA English
DT Article
ID SELF-ASSEMBLED NANOPARTICLES; DRUG-DELIVERY; POLY(ACRYLIC ACID);
   POLYMERIC MICELLES; CHITOSAN NANOPARTICLES; ANTITUMOR-ACTIVITY;
   BLOCK-COPOLYMER; DOXORUBICIN; CARRIERS; RELEASE
AB In this communication, we report a new type of amphiphilic carboxymethyl-hexanoyl chitosan (CHC)-poly(acrylic acid) (PAA) hybrid macromolecule, which was successfully prepared through polymerization of acrylic acid (AA) in the presence of amphiphilic CHC. The chemical structure of the hybrid was characterized by FT-IR and H-1 NMR, which confirmed a chemical linkage between the amine groups of CHC and hydroxyl groups of AA. This CHC-PAA hybrid exhibited amphiphilic property as the original CHC rendering the self-assembling capability to be tunable in terms of AA concentration. Compared with the existing pristine chitosan-PAA co-polymers, this CHC-PAA hybrid exhibited a relatively high pH-responsive volumetric change by 10-100 times compared with the existing alternatives reported in the literature. The hybrid nanoparticles showed excellent encapsulation efficiency greater than 90% for a hydrophobic anti-cancer substance, (S)-(+)-camptothecin. A pH-responsive drug release behavior was systematically evaluated. Besides, this hybrid also revealed excellent cytocompatibility towards the MCF-7 and BCE cell lines, which, associated with its structural stability, suggests this new type of CHC-PAA hybrid to be a promising biomaterial for oral drug delivery application.
C1 [Hsiao, Meng-Hsuan; Lin, Kuan-Hui; Liu, Dean-Mo] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
RP Liu, DM (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Ta Hsueh Rd, Hsinchu 300, Taiwan.
EM deanmo_liu@yahoo.ca
FU National Science Council, Taiwan, Republic of China
   [NSC-100-2622-M-009-002-CC3]
FX The authors would like to thank the National Science Council, Taiwan,
   Republic of China, for the financial support under a project contract of
   NSC-100-2622-M-009-002-CC3.
CR Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Chae SY, 2005, J CONTROL RELEASE, V109, P330, DOI 10.1016/j.jconrel.2005.09.040
   Chuang CY, 2009, J POLYM SCI POL CHEM, V47, P2798, DOI 10.1002/pola.23369
   CUROTTO E, 1993, ANAL BIOCHEM, V211, P240, DOI 10.1006/abio.1993.1263
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Fu LS, 2004, CHEM MATER, V16, P1507, DOI 10.1021/cm035028z
   Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Jin YH, 2012, COLLOID SURFACE B, V94, P184, DOI 10.1016/j.colsurfb.2012.01.032
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim K, 2010, J CONTROL RELEASE, V146, P219, DOI 10.1016/j.jconrel.2010.04.004
   Kurkuri MD, 2004, J CONTROL RELEASE, V96, P9, DOI 10.1016/j.jconrel.2003.12.025
   Lee CM, 2011, BIOCONJUGATE CHEM, V22, P186, DOI 10.1021/bc100241a
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027
   Lin CL, 2005, J COLLOID INTERF SCI, V291, P411, DOI 10.1016/j.jcis.2005.05.023
   Liu JH, 2011, POLYM ADVAN TECHNOL, V22, P627, DOI 10.1002/pat.1558
   Liu KH, 2008, MACROMOLECULES, V41, P6511, DOI 10.1021/ma8002399
   Liu TY, 2006, LANGMUIR, V22, P9740, DOI 10.1021/la061471n
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Nakanishi T, 2001, J CONTROL RELEASE, V74, P295, DOI 10.1016/S0168-3659(01)00341-8
   Nasongkla N., 2004, ANGEW CHEM, V116, P6483
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4
   Park JH, 2006, BIOMATERIALS, V27, P119, DOI 10.1016/j.biomaterials.2005.05.028
   Park JS, 2006, J CONTROL RELEASE, V115, P37, DOI 10.1016/j.jconrel.2006.07.011
   Saravanakumar G, 2009, J CONTROL RELEASE, V140, P210, DOI 10.1016/j.jconrel.2009.06.015
   Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9
   Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296
   Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066
   Wu WT, 2010, BIOMATERIALS, V31, P3023, DOI 10.1016/j.biomaterials.2010.01.011
   Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0
   Zhang SS, 2011, J APPL POLYM SCI, V121, P3359, DOI 10.1002/app.33977
   Zheng C, 2011, J COLLOID INTERF SCI, V355, P374, DOI 10.1016/j.jcis.2010.12.004
   Zheng H, 2011, CARBOHYD POLYM, V83, P1952, DOI 10.1016/j.carbpol.2010.10.069
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
   Zhu HY, 2011, CARBOHYD POLYM, V86, P1118, DOI 10.1016/j.carbpol.2011.05.061
NR 39
TC 18
Z9 20
U1 1
U2 74
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 8
BP 2458
EP 2466
DI 10.1039/c2sm27610k
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 080UE
UT WOS:000314268200015
DA 2018-10-20
ER

PT J
AU Sethi, A
   Slack, JM
   Kovaleva, ES
   Buchman, GW
   Scharf, ME
AF Sethi, Amit
   Slack, Jeffrey M.
   Kovaleva, Elena S.
   Buchman, George W.
   Scharf, Michael E.
TI Lignin-associated metagene expression in a lignocellulose-digesting
   termite
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Reticulitermes flavipes; Recombinant enzymes; Lignin; Cellulose;
   Hemicellulose; Biofuel
ID RETICULITERMES-FLAVIPES; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE;
   PROTEIN-PRODUCTION; INSECT LARVAE; GUT; ISOPTERA; PROTOZOA; HOST
AB Lignin is a component of plant biomass that presents a significant obstacle to biofuel production. It is composed of a highly stable phenylpropanoid matrix that upon degradation, releases toxic metabolites. Termites have specialized digestive systems that overcome the lignin barrier in wood lignocellulose to efficiently release fermentable simple sugars; however, how termites specifically degrade lignin and tolerate its toxic byproducts remains unknown. Here, using the termite Reticulitermes flavipes and its symbiotic (protozoan) gut fauna as a model system, we used high throughput Roche 454-titanium pyrosequencing and proteomics approaches to (i) experimentally compare the effects of diets containing varying degrees of lignin complexity on host-symbiont digestome composition, (ii) deeply sample host and symbiont lignocellulase diversity, and (iii) identify promising lignocellulase candidates for functional characterization. In addition to revealing over 9500 differentially expressed transcripts related to a wide range of physiological processes, our findings reveal two detoxification enzyme families not generally considered in connection with lignocellulose digestion: aldo-keto reductases and catalases. Recombinant versions of two host enzymes from these enzyme families, which apparently play no roles in cellulose or hemicellulose digestion, significantly enhance lignocellulose saccharification by cocktails of host and symbiont cellulases. These hypothesis-driven results provide important new insights into (i) dietary lignin as a xenobiotic challenge, (ii) the complex mechanisms used by termites to cope with their lignin-rich diets, and (iii) novel lignin-targeted enzymatic approaches to enhance biofuel and biomaterial production. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Sethi, Amit; Scharf, Michael E.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Slack, Jeffrey M.; Kovaleva, Elena S.; Buchman, George W.] Chesapeake PERL Inc, Savage, MD USA.
RP Scharf, ME (reprint author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
EM mscharf@purdue.edu
FU USDA-NIFA-AFRI [2009-05245]; Phase I and II DOE-SBIR [DE-FG02-08ER85063,
   DE-85538 S08-II]
FX We thank Philip San Miguel, Rick Westerman, and Samuel Martin of the
   Purdue University Genomics Core for pyrosequencing sequencing and
   first-pass analysis, Marjorie Chow, Carolyn Diaz and Jin Koh of the
   University of Florida ICBR Proteomics Core Facility for assistance with
   proteomics, Drion Boucias, Rhitoban Raychoudhury, Ruchira Sen and
   Zachary Karl for helpful discussions; Andres Sandoval for help with
   Genbank data submission and discussions; and Jesse Hoteling for termite
   rearing. This work was supported by USDA-NIFA-AFRI grant no. 2009-05245
   to MES, and Phase I and II DOE-SBIR grant nos. DE-FG02-08ER85063 and
   DE-85538 S08-II to Chesapeake-PERL Inc. (Savage, MD) and MES. Contig
   sequences are deposited under the accession numbers KA650619-KA659892.
CR Blumberg B., 2009, METHOD MOL BIOL, V461, P555
   BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672
   BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321
   BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Cleveland L.R., 1924, BIOL BULL, V46, P177
   Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424
   Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004
   Ford G, 2001, CHEM-BIOL INTERACT, V130, P685, DOI 10.1016/S0009-2797(00)00259-3
   Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635
   Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105
   Hamilton C., 2011, J INSECT PHYSL, V57, P259
   Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363
   Ke J, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-17
   Kovaleva ES, 2009, BIOTECHNOL LETT, V31, P381, DOI 10.1007/s10529-008-9883-2
   KUHN A, 1995, APPL ENVIRON MICROB, V61, P1580
   KUPFER D, 1972, BIOCHEM BIOPH RES CO, V47, P611, DOI 10.1016/0006-291X(72)90922-9
   Leidy J., 1881, J ACAD NAT SCI-PHILA, V8, P425
   Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1
   Liu Yi, 2007, V388, P267
   NEWSHOLME EA, 1978, BIOCHEM J, V172, P533, DOI 10.1042/bj1720533
   Nutting W.L., 1990, SOIL BIOL GUIDE, V33, P997
   O'Connell KP, 2007, MOL BIOTECHNOL, V36, P44, DOI 10.1007/s12033-007-0014-4
   Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z
   Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15
   Pettersen RC, 1984, CHEM SOLID WOOD, V207, P57, DOI DOI 10.1021/BA-1984-0207.CH002
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Raychoudhury R., 2012, INSECT MOL IN PRESS
   REID ID, 1994, APPL ENVIRON MICROB, V60, P1395
   Ritter S, 2008, PLANT BIOCH, V86, P15
   Roche Inc, 2010, 454 SEQ SYST SOFTW M
   Roche Inc, 2010, EMPCR METH MAN LIB L
   Roche Inc, 2010, RAP LIB PREP METH MA
   Roche Inc, 2010, GS FLX TIT SER
   Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709
   Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002
   Scharf ME, 2010, INSECT SCI, V17, P166, DOI 10.1111/j.1744-7917.2009.01309.x
   Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107
   Scharf Michael E., 2008, V442, P205, DOI 10.1007/978-1-59745-191-8_15
   Sethi A, 2011, COMP BIOCHEM PHYS A, V159, P261, DOI 10.1016/j.cbpa.2011.03.012
   Shim SY, 2009, FOOD CHEM TOXICOL, V47, P555, DOI 10.1016/j.fct.2008.12.012
   Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108
   Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007
   Szalanski AL, 2003, J ECON ENTOMOL, V96, P1514, DOI 10.1603/0022-0493-96.5.1514
   Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25
   Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28
   Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x
   Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260
   Wheeler MM, 2010, ARCH INSECT BIOCHEM, V73, P30, DOI 10.1002/arch.20333
   Wilson E. O., 1971, INSECT SOC
   Zhou X, 2006, INSECT MOL BIOL, V15, P749, DOI 10.1111/j.1365-2583.2006.00675.x
   Zhou XG, 2007, GENE, V395, P29, DOI 10.1016/j.gene.2007.01.004
   Zhou XG, 2010, ARCH INSECT BIOCHEM, V74, P147, DOI 10.1002/arch.20368
NR 55
TC 36
Z9 38
U1 0
U2 80
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD JAN
PY 2013
VL 43
IS 1
BP 91
EP 101
DI 10.1016/j.ibmb.2012.10.001
PG 11
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA 076CT
UT WOS:000313934800010
PM 23108206
DA 2018-10-20
ER

PT J
AU de Cogan, F
   Booth, A
   Gough, JE
   Webb, SJ
AF de Cogan, Felicity
   Booth, Andrew
   Gough, Julie E.
   Webb, Simon J.
TI Spatially controlled apoptosis induced by released nickel(II) within a
   magnetically responsive nanostructured biomaterial
SO SOFT MATTER
LA English
DT Article
ID ALGINATE HYDROGELS; HYBRIDOMA CELLS; DRUG-DELIVERY; CALCEIN-BLUE;
   LIPOSOMES; NANOPARTICLES; FIBRONECTIN; VESICLES; THERAPY; REPAIR
AB Magnetically patterned and responsive biomaterials have been shown to produce spatially controlled cell death in response to a magnetic signal. The responsive elements in these nano-structured biomaterials are magnetic nanoparticle-vesicle assemblies (MNPVs), which are thermally sensitive vesicles crosslinked by magnetic nanoparticles. MNPVs are nano-sized drug delivery platforms that are responsive to magnetic fields in two ways: they can be spatially manipulated by static magnetic fields, and upon exposure to an alternating magnetic field (AMF) they can release chemical messengers stored within the vesicles. Magnetically initiated release of nickel(II) from MNPVs immobilised in an alginate hydrogel was used to produce remotely triggered and spatially controlled apoptosis of fibroblasts cultured in the hydrogel. The ability to manipulate MNPVs with static magnetic fields was used to immobilise the MNPVs in only one region of the biomaterial; subsequent AMF-induced release of nickel(II) caused a wave of cellular apoptosis through the biomaterial as the nickel(II) slowly diffused through the hydrogel.
C1 [de Cogan, Felicity; Booth, Andrew; Webb, Simon J.] Univ Manchester, MIB, Manchester M1 7DN, Lancs, England.
   [de Cogan, Felicity; Booth, Andrew; Webb, Simon J.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England.
   [de Cogan, Felicity; Booth, Andrew; Gough, Julie E.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
RP Gough, JE (reprint author), Univ Manchester, Sch Mat, Grosvenor St, Manchester M13 9PL, Lancs, England.
EM J.Gough@manchester.ac.uk; S.Webb@manchester.ac.uk
OI Webb, Simon/0000-0001-9793-8748; Booth, Andrew/0000-0001-6210-2115
FU BBSRC; Biotechnology and Biological Sciences Research Council
   [BB/F011547/1, 996810]
FX The authors gratefully acknowledge the BBSRC for financial support and
   FdC thanks Mr M. Faulkner for ESEM.
CR Aili D, 2011, NANO LETT, V11, P1401, DOI 10.1021/nl1024062
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barbucci R, 2012, ACTA BIOMATER, V8, P4244, DOI 10.1016/j.actbio.2012.09.006
   Barton P, 2002, ANGEW CHEM INT EDIT, V41, P3878, DOI 10.1002/1521-3773(20021018)41:20<3878::AID-ANIE3878>3.0.CO;2-F
   Bealle G, 2012, LANGMUIR, V28, P11843, DOI 10.1021/la3024716
   Beaune G, 2011, SOFT MATTER, V7, P6248, DOI 10.1039/c1sm05279a
   Bhosale S, 2006, SCIENCE, V313, P84, DOI 10.1126/science.1126524
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bisby RH, 2000, BIOCHEM BIOPH RES CO, V276, P169, DOI 10.1006/bbrc.2000.3456
   Bothun GD, 2011, NANOMED-NANOTECHNOL, V7, P797, DOI 10.1016/j.nano.2011.02.007
   Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609
   Brouckaert P, 2004, INT J CANCER, V109, P442, DOI 10.1002/ijc.11703
   Brule S, 2011, ADV MATER, V23, P787, DOI 10.1002/adma.201003763
   Dally H, 1997, CARCINOGENESIS, V18, P1021, DOI 10.1093/carcin/18.5.1021
   de Cogan F, 2011, ANGEW CHEM INT EDIT, V50, P12290, DOI 10.1002/anie.201103469
   de Cogan F, 2011, J MATER SCI-MATER M, V22, P1045, DOI 10.1007/s10856-011-4271-1
   Drake P, 2007, J MATER CHEM, V17, P4914, DOI 10.1039/b711962c
   Galie PA, 2011, CARDIOVASC PATHOL, V20, P325, DOI 10.1016/j.carpath.2010.10.001
   Galloway JM, 2012, SMALL, V8, P204, DOI 10.1002/smll.201101627
   Gu HW, 2005, J AM CHEM SOC, V127, P34, DOI 10.1021/ja045220h
   Guan FQ, 2007, TOXICOL APPL PHARM, V221, P86, DOI 10.1016/j.taap.2007.01.029
   Heath MD, 2010, LANGMUIR, V26, P5304, DOI 10.1021/la100678n
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   HUITINK GM, 1974, TALANTA, V21, P1221, DOI 10.1016/0039-9140(74)80143-8
   IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001
   Kim K, 2002, TOXICOL APPL PHARM, V185, P41, DOI 10.1006/taap.2002.9513
   Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]
   Leng F., 2010, MATER RES SOC S P, V1272, P1272
   Liem KP, 2007, J AM CHEM SOC, V129, P12080, DOI 10.1021/ja075000e
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Liu XX, 2003, POLYMER, V44, P407, DOI 10.1016/S0032-3861(02)00771-1
   Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn S, 1997, ENVIRON MOL MUTAGEN, V29, P208
   Ma MM, 2009, J AM CHEM SOC, V131, P16919, DOI 10.1021/ja9072657
   Mart RJ, 2009, CHEM COMMUN, P2287, DOI 10.1039/b901472a
   Mart RJ, 2009, PHARM RES-DORD, V26, P1701, DOI 10.1007/s11095-009-9880-8
   Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v
   Mishra D, 2011, MAT SCI ENG C-MATER, V31, P1295, DOI 10.1016/j.msec.2011.04.007
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mourtas S, 2007, COLLOID SURFACE B, V55, P212, DOI 10.1016/j.colsurfb.2006.12.005
   Nappini S, 2011, J PHYS CHEM LETT, V2, P713, DOI 10.1021/jz2000936
   Noble GT, 2012, J AM CHEM SOC, V134, P13010, DOI 10.1021/ja302506t
   Ong W, 2008, J AM CHEM SOC, V130, P14739, DOI 10.1021/ja8050469
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Patel E, 2012, TOXICOL APPL PHARM, V258, P367, DOI 10.1016/j.taap.2011.11.019
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   PHILLIPS D, 1971, ANAL LETT, V4, P867
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002
   Preiss MR, 2011, EXPERT OPIN DRUG DEL, V8, P1025, DOI 10.1517/17425247.2011.584868
   Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015
   Rodriguez-Llansola F, 2011, CHEM COMMUN, V47, P4706, DOI 10.1039/c1cc10640f
   Samanta B, 2008, J MATER CHEM, V18, P1204, DOI 10.1039/b718745a
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Satarkar N. S., 2010, SOFT MATTER, V6, P2364
   SCOTT BJ, 1983, CLIN CHEM, V29, P629
   Stano P, 2011, J MATER CHEM, V21, P18887, DOI 10.1039/c1jm12298c
   Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y
   Taktak S, 2007, ANAL CHEM, V79, P8863, DOI 10.1021/ac701976p
   Tejada-Berges T, 2002, Expert Rev Anticancer Ther, V2, P143, DOI 10.1586/14737140.2.2.143
   Tian YF, 2011, SOFT MATTER, V7, P6005, DOI 10.1039/c1sm05504f
   TOONEY NM, 1983, J CELL BIOL, V97, P1686, DOI 10.1083/jcb.97.6.1686
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Webber RE, 2004, MACROMOLECULES, V37, P6153, DOI 10.1021/ma049274n
   Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a
   Wu GH, 2008, J AM CHEM SOC, V130, P8175, DOI 10.1021/ja802656d
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 74
TC 10
Z9 10
U1 0
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 7
BP 2245
EP 2253
DI 10.1039/c2sm27379a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 075OR
UT WOS:000313896900018
DA 2018-10-20
ER

PT J
AU Azagarsamy, MA
   Anseth, KS
AF Azagarsamy, Malar A.
   Anseth, Kristi S.
TI Bioorthogonal Click Chemistry: An Indispensable Tool to Create
   Multifaceted Cell Culture Scaffolds
SO ACS MACRO LETTERS
LA English
DT Article
ID 3-DIMENSIONAL HYDROGELS; PEG HYDROGELS; DESIGN; GROWTH;
   PHOTOPOLYMERIZATIONS; FUNCTIONALITY; ENCAPSULATION; SELECTIVITY;
   MOLECULES; MECHANISM
AB Over the past decade, bioorthogonal click chemistry has led the field of biomaterial science into a new era of diversity and complexity by its extremely selective, versatile, and biocompatible nature. In this viewpoint, we seek to emphasize recent endeavors of exploiting this versatile chemistry toward the development of poly(ethylene glycol) hydrogels as cell culture scaffolds. In these cell-laden materials, the orthogonality of these reactions has played an effective role in allowing the creation of diverse biochemical patterns in complex biological environments that provide new found opportunities for researchers to delineate and control cellular phenotypes more precisely than ever.
C1 [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
RP Anseth, KS (reprint author), Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, 596 UCB Boulder, Boulder, CO 80303 USA.
EM kristi.anseth@colorado.edu
FU National Science Foundation [DM 1006711D]; Howard Hughes Medical
   Institute
FX The authors would like to thank the National Science Foundation (DM
   1006711D) and the Howard Hughes Medical Institute for their financial
   support.
CR Adzima BJ, 2011, NAT CHEM, V3, P256, DOI 10.1038/NCHEM.980
   Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja0449981
   Aimetti AA, 2010, CHEM COMMUN, V46, P5781, DOI 10.1039/c0cc01292k
   Baldwin A. D., 2011, BIOCONJUGATE CHEM, V22, P1946
   Barner-Kowollik C, 2011, ANGEW CHEM INT EDIT, V50, P60, DOI 10.1002/anie.201003707
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726
   Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brantley JN, 2011, SCIENCE, V333, P1606, DOI 10.1126/science.1207934
   Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446
   Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P8995, DOI 10.1002/anie.200802516
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Golas PL, 2010, CHEM SOC REV, V39, P1338, DOI 10.1039/b901978m
   Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269
   Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE J, 1989, J AM CHEM SOC, V111, P1522, DOI 10.1021/ja00186a070
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Lowe AB, 2010, J MATER CHEM, V20, P4745, DOI 10.1039/b917102a
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Wiggins KM, 2012, ACS MACRO LETT, V1, P623, DOI 10.1021/mz300167y
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 62
TC 104
Z9 104
U1 3
U2 115
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD JAN
PY 2013
VL 2
IS 1
BP 5
EP 9
DI 10.1021/mz300585q
PG 5
WC Polymer Science
SC Polymer Science
GA 071PF
UT WOS:000313606000002
PM 23336091
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Calvie, E
   Joly-Pottuz, L
   Esnouf, C
   Douillard, T
   Gremillard, L
   Malchere, A
   Chevalier, J
   Masenelli-Varlot, K
AF Calvie, E.
   Joly-Pottuz, L.
   Esnouf, C.
   Douillard, T.
   Gremillard, L.
   Malchere, A.
   Chevalier, J.
   Masenelli-Varlot, K.
TI Evidence for the formation of distorted nanodomains involved in the
   phase transformation of stabilized zirconia by coupling convergent beam
   electron diffraction and in situ TEM nanoindentation
SO ACTA MATERIALIA
LA English
DT Article
DE Transmission electron microscopy; In situ; CBED; Zirconia
ID ARC-MELTED ZRO2-2MOL-PERCENT-Y2O3; MONOCLINIC TRANSFORMATION; CBED
   PATTERNS; SPECIMEN PREPARATION; GRAIN-BOUNDARY; SIMULATION; ZRO2-Y2O3;
   STRESS; VIEW; MG
AB The transformation of zirconia from its tetragonal to its monoclinic phase is an important feature of the zirconia system. First found to be an advantage due to its important toughening effect, it can also be very detrimental when it occurs in the framework of low-temperature degradation, particularly in the case of biomaterial applications. One way to avoid or to control this phase transformation is to understand how it initiates and more particularly the stress states that can trigger it. A new technique available inside a transmission electron microscope seems to be particularly well suited for that type of study: convergent beam electron diffraction, a well-known technique to reveal stresses, was coupled to in situ transmission electron microscopy mechanical nanoindentation. The experiments reveal the presence of sheared nanoregions at grain boundaries. These could act as embryos for tetragonal-to-monoclinic phase transformations. This is an important first step in the understanding of the earliest stage of zirconia phase transformation. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Calvie, E.; Joly-Pottuz, L.; Esnouf, C.; Douillard, T.; Gremillard, L.; Malchere, A.; Chevalier, J.; Masenelli-Varlot, K.] INSA Lyon, MATEIS UMR5510, F-69621 Villeurbanne, France.
RP Joly-Pottuz, L (reprint author), INSA Lyon, MATEIS UMR5510, 7 Ave J Capelle, F-69621 Villeurbanne, France.
EM Lucile.Joly-Pottuz@insa-lyon.fr
RI Douillard, Thierry/G-9808-2014
OI Douillard, Thierry/0000-0001-7113-889X; JOLY-POTTUZ,
   Lucile/0000-0001-8970-5960; Gremillard, Laurent/0000-0001-7258-6483
FU Region Rhone-Alpes (Cluster MACODEV); Institut Universitaire de France
FX The authors would like to acknowledge the CLYM (Centre Lyonnais de
   Microscopie, http://www.clym.fr) for the access to the JEOL 2010F and A.
   Schertel (Carl Zeiss NTS company GMBH) for the preparation of the thin
   foil by the "lift-out" technique. Financial support was provided by the
   Region Rhone-Alpes (Cluster MACODEV) and the Institut Universitaire de
   France.
CR BATEMAN CA, 1990, J MATER SCI LETT, V9, P803, DOI 10.1007/BF00720164
   Beaber A, 2010, NAT MATER, V9, P698, DOI 10.1038/nmat2840
   Boudias C., 1989, CARINE CRYSTALLOGRAP
   Calvie E, 2012, J EUR CERAM SOC
   Calvie E, UNPUB
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Chuvilin A, 2005, J ELECTRON MICROSC, V54, P515, DOI 10.1093/jmicro/dfi069
   Deneen J, 2006, J MATER SCI, V41, P4477, DOI 10.1007/s10853-006-0085-9
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Esnouf C., 2011, CARACTERISATION MICR
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   HAYAKAWA M, 1989, ACTA METALL MATER, V37, P2229, DOI 10.1016/0001-6160(89)90149-1
   HAYAKAWA M, 1989, ACTA METALL MATER, V37, P2223, DOI 10.1016/0001-6160(89)90148-X
   HIRSCH PB, 1969, ELECT MICROSCOPY THI
   Houdellier F, 2008, ULTRAMICROSCOPY, V108, P426, DOI 10.1016/j.ultramic.2007.06.002
   Houdellier F, 2008, ULTRAMICROSCOPY, V108, P295, DOI 10.1016/j.ultramic.2007.04.003
   IGAWA N, 1993, J AM CERAM SOC, V76, P2673, DOI 10.1111/j.1151-2916.1993.tb03999.x
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Lee JH, 2010, ACTA MATER, V58, P4891, DOI 10.1016/j.actamat.2010.05.027
   Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007
   Minor AM, 2006, NAT MATER, V5, P697, DOI 10.1038/NMAT1714
   Morniroli J. P., 1998, ELECT DIFFRACTION SO
   Morniroli JP, 1997, INTERFACE SCI, V4, P273
   RUHLE M, 1988, PHYSICA B & C, V150, P86, DOI 10.1016/0378-4363(88)90110-6
   Shan ZW, 2008, NAT MATER, V7, P947, DOI 10.1038/nmat2295
   SHIBATA M, 1987, J MATER SCI, V22, P1432, DOI 10.1007/BF01233144
   Soer WA, 2004, ACTA MATER, V52, P5783, DOI 10.1016/j.actamat.2004.08.032
   Stadelman P, 1987, ULTRAMICROSCOPY
NR 29
TC 2
Z9 2
U1 1
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
J9 ACTA MATER
JI Acta Mater.
PD JAN
PY 2013
VL 61
IS 1
BP 174
EP 182
DI 10.1016/j.actamat.2012.09.047
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 071OP
UT WOS:000313604400016
DA 2018-10-20
ER

PT J
AU Calcaterra, J
   Van Cott, KE
   Butler, SP
   Gil, GC
   Germano, M
   van Veen, HA
   Nelson, K
   Forsberg, EJ
   Carlson, MA
   Velander, WH
AF Calcaterra, Jennifer
   Van Cott, Kevin E.
   Butler, Stephen P.
   Gil, Geun Cheol
   Germano, Marta
   van Veen, Harrie A.
   Nelson, Kay
   Forsberg, Erik J.
   Carlson, Mark A.
   Velander, William H.
TI Recombinant Human Fibrinogen That Produces Thick Fibrin Fibers with
   Increased Wound Adhesion and Clot Density
SO BIOMACROMOLECULES
LA English
DT Article
ID V LIVER-INJURIES; HYPOTHERMIC COAGULOPATHIC SWINE; REDUCE BLOOD-LOSS;
   RESUSCITATION VOLUME; SEALANT DRESSINGS; PLASMA-FIBRINOGEN; TRANSGENIC
   MICE; MAMMARY-GLAND; GAMMA-CHAIN; FACTOR-XIII
AB Human fibrinogen is a biomaterial used in surgical tissue sealants, scaffolding for tissue engineering, and wound healing. Here we report on the post-translational structure and functionality of recombinant human FL (rFI) made at commodity levels in the milk of transgenic dairy cows. Relative to plasma-derived fibrinogen (pdFI), rFI predominately contained a simplified, neutral carbohydrate structure and >4 fold higher levels of the gamma'-chain transcriptional variant that has been reported to bind thrombin and Factor XIII. In spite of these differences, rFI and pdFI were kinetically similar with respect to the thrombin-catalyzed formation of protofibrils and Factor XIIIa-mediated formation of cross-linked fibrin polymer. However, electron microscopy showed rFI produced fibrin with much thicker fibers with less branching than pdFI. In vivo studies in a swine liver transection model showed that, relative to pdFI, rFI made a denser, more strongly wound adherent fibrin clot that more rapidly established hemostasis.
C1 [Calcaterra, Jennifer; Van Cott, Kevin E.; Gil, Geun Cheol; Velander, William H.] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
   [Butler, Stephen P.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
   [Germano, Marta; van Veen, Harrie A.; Nelson, Kay] Pharming Grp NV, NL-2300 AL Leiden, Netherlands.
   [Forsberg, Erik J.] WiCell Res Inst, Madison, WI 53707 USA.
   [Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68105 USA.
   [Carlson, Mark A.] Omaha VA Med Ctr, Omaha, NE 68105 USA.
RP Velander, WH (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
EM wvelander2@unl.edu
FU U.S.A. Medical Material Development Activity of the Army Grant
   [W81XWH-05-1-0527]; American Red Cross; Pharming Group NV
FX We are grateful to Dr. Jason Johanning and Dr. Iraklis Pipinos for their
   assistance in the surgical procedures. Thanks to Dr. Mehmet Inan for the
   production of rFXIIIa and L. Smoyer of the University of Nebraska for
   technical assistance. We would like to acknowledge Dr. Roman Drews and
   the late Dr. William Drohan and Dr. Henryk Lubon for their contributions
   while at the American Red Cross Jerome Holland Laboratory. This research
   was primarily supported by a U.S.A. Medical Material Development
   Activity of the Army Grant (W81XWH-05-1-0527) to W.H.V, the American Red
   Cross and Pharming Group NV. This study is the result of work supported
   in part with resources and the use of facilities at the Omaha VA Medical
   Center.
CR Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Adiguzel C, 2009, CLIN APPL THROMB-HEM, V15, P645, DOI 10.1177/1076029609339748
   Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685
   Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   BINGHAM EW, 1974, J BIOL CHEM, V249, P3647
   Burnouf T, 2006, VOX SANG, V91, P56, DOI 10.1111/j.1423-0410.2006.00772.x
   Butler SP, 2004, TRANSGENIC RES, V13, P437, DOI 10.1007/s11248-004-9589-8
   Butler SP, 1997, THROMB HAEMOSTASIS, V78, P537
   Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3
   Chandler W. L., 1995, SEMIN THROMB HEMO S4, V<IT>21</IT>, P1
   Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499
   CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033
   Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150
   Dainiak M. B., 2009, BIOMATERIALS, V31, P67
   de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180
   Delgado AV, 2008, J TRAUMA, V64, P75, DOI 10.1097/TA.0b013e31815b843c
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P46
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P44
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P42
   Echelard Y, 2006, BIOPHARM INT, V19, P36
   Edmunds T, 1998, BLOOD, V91, P4561
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004
   Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270
   FERRY JD, 1952, P NATL ACAD SCI USA, V38, P566, DOI 10.1073/pnas.38.7.566
   FORNACE AJ, 1984, J BIOL CHEM, V259, P2826
   Forsberg EJ, 2002, BIOL REPROD, V67, P327, DOI 10.1095/biolreprod67.1.327
   Gersh KC, 2009, THROMB RES, V124, P356, DOI 10.1016/j.thromres.2008.11.016
   Gorkun OV, 1997, BLOOD, V89, P4407
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002
   Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009
   Horowitz B, 2008, TRANSFUSION, V48, P1739, DOI 10.1111/j.1537-2995.2008.01717
   Howells G, 1999, J TRAUMA, V47, P240
   LANGER BG, 1988, J BIOL CHEM, V263, P15056
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26
   Lubon H, 1996, TRANSFUS MED REV, V10, P131, DOI 10.1016/S0887-7963(96)80089-7
   Marchi R, 2004, J THROMB HAEMOST, V2, P940, DOI 10.1111/j.1538-7836.2004.00730.x
   MARTIN SC, 1992, THROMB RES, V68, P467, DOI 10.1016/0049-3848(92)90059-J
   MCDONAGH RP, 1971, FEBS LETT, V14, P33, DOI 10.1016/0014-5793(71)80268-5
   MORCOL T, 1994, ANN NY ACAD SCI, V721, P218, DOI 10.1111/j.1749-6632.1994.tb47394.x
   MORELL AG, 1971, J BIOL CHEM, V246, P1461
   Mosesson MW, 2009, J THROMB HAEMOST, V7, P102, DOI 10.1111/j.1538-7836.2008.03213.x
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Park DS, 2002, BIOTECHNOL LETT, V24, P97, DOI 10.1023/A:1013810912609
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   PLATENBURG GJ, 1994, TRANSGENIC RES, V3, P99, DOI 10.1007/BF01974087
   Powell K, 2003, NAT BIOTECHNOL, V21, P965, DOI 10.1038/nbt0903-965
   Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913
   Prunkard D, 1996, NAT BIOTECHNOL, V14, P867, DOI 10.1038/nbt0796-867
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   SPIK G, 1994, ADV EXP MED BIOL, V357, P21
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20
   Thiel KA, 2004, NAT BIOTECHNOL, V22, P1365, DOI 10.1038/nbt1104-1365
   TOWNSEND RR, 1982, J BIOL CHEM, V257, P9704
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026
NR 63
TC 10
Z9 10
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2013
VL 14
IS 1
BP 169
EP 178
DI 10.1021/bm301579p
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 071PD
UT WOS:000313605800020
PM 23215461
DA 2018-10-20
ER

PT J
AU Saito, T
   Kuramae, R
   Wohlert, J
   Berglund, LA
   Isogai, A
AF Saito, Tsuguyuki
   Kuramae, Ryota
   Wohlert, Jakob
   Berglund, Lars A.
   Isogai, Akira
TI An Ultrastrong Nanofibrillar Biomaterial: The Strength of Single
   Cellulose Nanofibrils Revealed via Sonication-Induced Fragmentation
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; TRANSMISSION ELECTRON-MICROSCOPY;
   TEMPO-OXIDIZED CELLULOSE; ELASTIC-MODULUS; CRYSTALLINE REGIONS; CARBON
   NANOTUBES; NATIVE CELLULOSE; INDUCED SCISSION; MECHANISM; BACTERIAL
AB We report the mechanical strength of native cellulose nanofibrils. Native cellulose nanofibrils, purified from wood and sea tunicate, were fully dispersed in water via a topochemical modification of cellulose nanofibrils using 2,2,6,6-tetramethylpiperidinyl-1-oxyl (TEMPO) as a catalyst. The strength of individual nanofibrils was estimated based on a model for the sonication-induced fragmentation of filamentous nanostructures. The resulting strength parameters were then analyzed based on fracture statistics. The mean strength of the wood cellulose nanofibrils ranged from 1.6 to 3 GPa, depending on the method used to measure the nanofibril width. The highly crystalline, thick tunicate cellulose nanofibrils exhibited higher mean strength of 3-6 GPa. The strength values estimated for the cellulose nanofibrils in the present study are comparable with those of commercially available multiwalled carbon nanotubes.
C1 [Saito, Tsuguyuki; Kuramae, Ryota; Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan.
   [Saito, Tsuguyuki; Wohlert, Jakob; Berglund, Lars A.] Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
   [Berglund, Lars A.] Royal Inst Technol, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
RP Berglund, LA (reprint author), Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
EM blund@kth.se; aisogai@mail.ecc.u-tokyo.ac.jp
RI Berglund, Lars/A-6971-2010; Saito, Tsuguyuki/J-7954-2014
OI Berglund, Lars/0000-0001-5818-2378; Saito, Tsuguyuki/0000-0003-1073-6663
FU Japan Society for the Promotion of Science (JSPS) [21228007, 23688020,
   24-390]; Wallenberg Wood Science Center (WWSC)
FX This study was financially supported by Scientific Research S
   (21228007), Encouragement of Young Scientists A (23688020), and
   Postdoctoral Fellowships for Research Abroad (24-390) from the Japan
   Society for the Promotion of Science (JSPS), and the Wallenberg Wood
   Science Center (WWSC).
CR Ahir SV, 2008, POLYMER, V49, P3841, DOI 10.1016/j.polymer.2008.05.005
   Aulin C, 2010, CELLULOSE, V17, P559, DOI 10.1007/s10570-009-9393-y
   Bulota M, 2012, J MATER SCI, V47, P5517, DOI 10.1007/s10853-012-6443-x
   Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379
   Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   HANLEY SJ, 1992, POLYMER, V33, P4639, DOI 10.1016/0032-3861(92)90426-W
   Helbert W, 1998, J STRUCT BIOL, V124, P42, DOI 10.1006/jsbi.1998.4045
   Hennrich F, 2007, J PHYS CHEM B, V111, P1932, DOI 10.1021/jp065262n
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Hori R, 2005, CELLULOSE, V12, P479, DOI 10.1007/s10570-005-5967-5
   Huang YY, 2009, ADV MATER, V21, P3945, DOI 10.1002/adma.200900498
   Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e
   Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n
   Jakob HF, 1995, MACROMOLECULES, V28, P8782, DOI 10.1021/ma00130a010
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Koga H, 2010, CHEM COMMUN, V46, P8567, DOI 10.1039/c0cc02754e
   Kuijpers MWA, 2004, POLYMER, V45, P6461, DOI 10.1016/j.polymer.2004.06.051
   Lahiji RR, 2010, LANGMUIR, V26, P4480, DOI 10.1021/la903111j
   Li QQ, 2011, BIOMACROMOLECULES, V12, P650, DOI 10.1021/bm101315y
   Li X, 2007, J POLYM ENVIRON, V15, P25, DOI 10.1007/s10924-006-0042-3
   NISHINO T, 1995, J POLYM SCI POL PHYS, V33, P1647, DOI 10.1002/polb.1995.090331110
   Nishiyama Y, 2009, J WOOD SCI, V55, P241, DOI 10.1007/s10086-009-1029-1
   Nystrom G, 2009, NANO LETT, V9, P3635, DOI 10.1021/nl901852h
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Olszewska A, 2011, CELLULOSE, V18, P1213, DOI 10.1007/s10570-011-9577-0
   Quintanilla J, 1999, POLYM ENG SCI, V39, P559, DOI 10.1002/pen.11446
   Rooze J, 2011, J PHYS CHEM B, V115, P11038, DOI 10.1021/jp203780a
   Roylance D., 1996, MECH MATER, P251
   Rusli R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963491
   Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155
   Sehaqui H, 2012, ACS APPL MATER INTER, V4, P1043, DOI 10.1021/am2016766
   Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c
   Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k
   Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2
   Tanpichai S, 2012, BIOMACROMOLECULES, V13, P1340, DOI 10.1021/bm300042t
   Xie SS, 2000, J PHYS CHEM SOLIDS, V61, P1153, DOI 10.1016/S0022-3697(99)00376-5
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Young R J, 1981, INTRO POLYM, P319
NR 44
TC 185
Z9 187
U1 14
U2 239
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2013
VL 14
IS 1
BP 248
EP 253
DI 10.1021/bm301674e
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 071PD
UT WOS:000313605800030
PM 23215584
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Thalla, PK
   Contreras-Garcia, A
   Fadlallah, H
   Barrette, J
   De Crescenzo, G
   Merhi, Y
   Lerouge, S
AF Thalla, Pradeep Kumar
   Contreras-Garcia, Angel
   Fadlallah, Hicham
   Barrette, Jeremie
   De Crescenzo, Gregory
   Merhi, Yahye
   Lerouge, Sophie
TI A Versatile Star PEG Grafting Method for the Generation of Nonfouling
   and Nonthrombogenic Surfaces
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION;
   PLATELET ACTIVATION; SILICON SURFACES; RESISTANCE; STABILITY; ADHESION;
   OXIDE); THROMBOSIS
AB Polyethylene glycol (PEG) grafting has a great potential to create nonfouling and nonthrombogenic surfaces, but present techniques lack versatility and stability. The present work aimed to develop a versatile PEG grafting method applicable to most biomaterial surfaces, by taking advantage of novel primary amine-rich plasma-polymerized coatings. Star-shaped PEG covalent binding was studied using static contact angle, X-ray photoelectron spectroscopy (XPS), and quartz crystal microbalance with dissipation monitoring (QCM-D). Fluorescence and QCM-D both confirmed strong reduction of protein adsorption when compared to plasma-polymerized coatings and pristine poly(ethyleneterephthalate) (PET). Moreover, almost no platelet adhesion was observed after 15 min perfusion in whole blood. Altogether, our results suggest that primary amine-rich plasma-polymerized coatings offer a promising stable and versatile method for PEG grafting in order to create nonfouling and nonthrombogenic surfaces and micropatterns.
C1 [Thalla, Pradeep Kumar; Fadlallah, Hicham; Barrette, Jeremie; Lerouge, Sophie] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Lab Endovasc Biomat LBeV, Montreal, PQ H2L 2W5, Canada.
   [Thalla, Pradeep Kumar; Barrette, Jeremie; Lerouge, Sophie] Ecole Technol Super ETS, Dept Mech Engn, Montreal, PQ H3C 1K3, Canada.
   [Contreras-Garcia, Angel] Ecole Polytech Montreal, Dept Engn Phys, Montreal, PQ H3C 3A7, Canada.
   [Fadlallah, Hicham; Merhi, Yahye] Montreal Heart Inst, Lab Thrombosis & Haemostasis, Res Ctr, Montreal, PQ H1T 1C8, Canada.
   [De Crescenzo, Gregory] Ecole Polytech Montreal, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Lerouge, S (reprint author), Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Lab Endovasc Biomat LBeV, 2099 Alexandre de Seve, Montreal, PQ H2L 2W5, Canada.
EM sophie.lerouge@etsmtl.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR)
FX This study was jointly funded by the Natural Sciences and Engineering
   Research Council of Canada (NSERC) and the Canadian Institutes of Health
   Research (CIHR). The authors would like to thank M. Ahmed Hachem and
   Younes Zaid for human blood sampling and platelet labeling. The authors
   are grateful to Professor Michael R. Wertheimer for his expertise in
   plasma polymerization. The authors would also like to thank Marion Maire
   (CRCHUM), Suzie Poulin (Ecole Polytechnique de Montreal), and Houman
   Savoji for their help regarding SEM, XPS analysis, and plasma
   deposition, respectively.
CR Cao L, 2006, J BIOMED MATER RES A, V79A, P788, DOI 10.1002/jbm.a.30908
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   DAVIS SS, 1988, BIOMATERIALS, V9, P111, DOI 10.1016/0142-9612(88)90081-6
   Demming S, 2011, PHYS STATUS SOLIDI A, V208, P1301, DOI 10.1002/pssa.201000967
   Diener JL, 2009, J THROMB HAEMOST, V7, P1155, DOI 10.1111/j.1538-7836.2009.03459.x
   Dimitrievska S, 2011, MACROMOL BIOSCI, V11, P493, DOI 10.1002/mabi.201000390
   FUERTGES F, 1990, J CONTROL RELEASE, V11, P139, DOI 10.1016/0168-3659(90)90127-F
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRAHAM NB, 1984, BIOMATERIALS, V5, P27, DOI 10.1016/0142-9612(84)90063-2
   Groll J, 2010, METHOD ENZYMOL, V472, P1, DOI 10.1016/S0076-6879(10)72019-X
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Huang H, 2011, CHEMPHYSCHEM, V12, P3642, DOI 10.1002/cphc.201100398
   Hubbell J, 1993, CARDIOVASC PATHOL, V2, P121
   Irvine DJ, 1996, MACROMOLECULES, V29, P6037, DOI 10.1021/ma951903t
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Knetsch MLW, 2010, J BIOMED MATER RES A, V93A, P77, DOI 10.1002/jbm.a.32538
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lerouge S, 2007, BIOMATERIALS, V28, P1209, DOI 10.1016/j.biomaterials.2006.10.033
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Merhi Y, 1997, J BIOMED MATER RES, V34, P477
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Ruiz JC, 2010, PLASMA PROCESS POLYM, V7, P737, DOI 10.1002/ppap.201000042
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Shin HS, 2009, J BIOACT COMPAT POL, V24, P316, DOI 10.1177/0883911509104273
   Sofia SJ, 1997, ACS SYM SER, V680, P342
   Truica-Marasescu F., 2008, THIN SOLID FILMS, V516, P7406
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Wagner C. D., 1979, HDB XRAY ULTRAVIOLET
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zhao YH, 2007, LANGMUIR, V23, P5779, DOI 10.1021/la070139o
   Zhou GY, 2011, POLYM CHEM-UK, V2, P1409, DOI 10.1039/c1py00016k
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 44
TC 4
Z9 4
U1 1
U2 30
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 962376
DI 10.1155/2013/962376
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 072VZ
UT WOS:000313702800001
PM 23509823
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, H
   Liu, XY
   Chuah, YJ
   Goh, JCH
   Li, JL
   Xu, HY
AF Wang, Hui
   Liu, Xiang Yang
   Chuah, Yon Jin
   Goh, James C. H.
   Li, Jing Liang
   Xu, Hongyao
TI Design and engineering of silk fibroin scaffolds with biomimetic
   hierarchical structures
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID SPECTROSCOPY; BIOMATERIAL; NUCLEATION; MIGRATION
AB Silk scaffolds having biomimetic hierarchical porous structures were achieved by carefully tuning liquid-liquid separation in regenerated silk fibroin solutions. Such scaffolds show greatly enhanced cellular responses.
C1 [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Xiamen Univ, Coll Mat, Xiamen 361005, Peoples R China.
   [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore.
   [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Natl Univ Singapore, Dept Chem, Singapore 117542, Singapore.
   [Wang, Hui] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Chuah, Yon Jin; Goh, James C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Singapore 119074, Singapore.
   [Liu, Xiang Yang; Xu, Hongyao] Donghua Univ, Coll Mat Sci & Engn, Shanghai, Peoples R China.
   [Liu, Xiang Yang; Xu, Hongyao] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
RP Liu, XY (reprint author), Xiamen Univ, Coll Mat, Xiamen 361005, Peoples R China.
EM phyliuxy@nus.edu.sg
RI Zhou, Weiqian/B-8991-2011; li, jingliang/E-5075-2010; Liu,
   XY/E-5090-2010
OI li, jingliang/0000-0003-0709-2246; Chuah, Yon Jin/0000-0003-0579-6370
FU Singapore ARF Project [T206B1114]; National Natural Science Foundation
   of China [50928301, 51203108]; China MOE Chang Jiang Scholars Program
FX This work was supported by the Singapore ARF Project (Grant T206B1114),
   the National Natural Science Foundation of China (50928301, 51203108)
   and the China MOE Chang Jiang Scholars Program.
CR De Cock LJ, 2012, CHEM COMMUN, V48, P3512, DOI 10.1039/c2cc17006j
   Diao YY, 2012, ADV FUNCT MATER, V22, P1354, DOI 10.1002/adfm.201102288
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Liu XY, 2004, J BIOL CHEM, V279, P6124, DOI 10.1074/jbc.M310487200
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ning D, 2002, APPL PHYS LETT, V81, P445, DOI 10.1063/1.1492849
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Schenning APHJ, 1996, J AM CHEM SOC, V118, P8549, DOI 10.1021/ja961234e
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun W, 2007, ADV MATER, V19, P921, DOI 10.1002/adma.200600319
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhang KQ, 2004, NATURE, V429, P739, DOI 10.1038/nature02630
   Zhang TH, 2009, ANGEW CHEM INT EDIT, V48, P1308, DOI 10.1002/anie.200804743
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 24
TC 17
Z9 18
U1 4
U2 130
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2013
VL 49
IS 14
BP 1431
EP 1433
DI 10.1039/c2cc38779d
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 074II
UT WOS:000313805700019
PM 23321676
DA 2018-10-20
ER

PT J
AU Wright, B
   Mi, SL
   Connon, CJ
AF Wright, Bernice
   Mi, Shengli
   Connon, Che J.
TI Towards the use of hydrogels in the Treatment of limbal stem cell
   deficiency
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID CORNEAL EPITHELIAL-CELLS; OCULAR DRUG-DELIVERY; EX-VIVO EXPANSION;
   AMNIOTIC MEMBRANE; RABBIT CORNEA; IN-VIVO; SURFACE RECONSTRUCTION;
   EXTRACELLULAR-MATRIX; COMPRESSED COLLAGEN; CONTROLLED-RELEASE
AB Corneal blindness caused by limbal stem cell deficiency (LSCD) is a prevailing disorder worldwide. Clinical outcomes for LSCD therapy using amniotic membrane (AM) are unpredictable. Hydrogels can eliminate limitations of standard therapy for LSCD, because they present all the advantages of AM (i.e. biocompatibility, inertness and a biodegradable structure) but unlike AM, they are structurally uniform and can be easily manipulated to alter mechanical and physical properties. Hydrogels can be delivered with minimum trauma to the ocular surface and do not require extensive serological screening before clinical application. The hydrogel structure is also amenable to modifications which direct stem cell fate. In this focussed review we highlight hydrogels as biomaterial substrates which may replace and/or complement AM in the treatment of LSCD.
C1 [Wright, Bernice; Connon, Che J.] Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
   [Mi, Shengli] Tsinghua Univ, Grad Sch, Shenzhen 518057, Peoples R China.
RP Connon, CJ (reprint author), Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
EM c.j.connon@rdg.ac.uk
RI Connon, Che/B-3128-2012
OI Connon, Che/0000-0001-8264-6531
FU Medical Research Council; Medical Research Council [G0900877]
FX We would like to thank the Medical Research Council for funding and Dr
   Ricardo Gouveia for editing assistance. Dr Bernice Wright and Dr Shengli
   Mi contributed equally to compiling the manuscript.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Blackmore SJ, 2010, CONTACT LENS ANTERIO, V33, P239, DOI 10.1016/j.clae.2010.06.004
   Branch M.J., 2012, INVEST OPHTHALMOL VI
   Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071
   Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h
   CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301
   Choi JA, 2011, EYE CONTACT LENS, V37, P370, DOI 10.1097/ICL.0b013e318233c9bb
   Crawford GJ, 1996, J REFRACT SURG, V12, P525
   CRAWFORD GJ, 1993, CORNEA, V12, P348, DOI 10.1097/00003226-199307000-00012
   DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]
   Di Colo G, 2002, INT J PHARM, V248, P115, DOI 10.1016/S0378-5173(02)00421-0
   Di Girolamo N, 2007, BRIT J OPHTHALMOL, V91, P459, DOI 10.1136/bjo.2006.103895
   Du LQ, 2008, OPHTHALMIC RES, V40, P282, DOI 10.1159/000131503
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022
   Felt O, 2000, J OCUL PHARMACOL TH, V16, P261, DOI 10.1089/jop.2000.16.261
   Fiorica C, 2011, INT J PHARMACEUT, V414, P104, DOI 10.1016/j.ijpharm.2011.05.002
   Francis D, 2009, EXP EYE RES, V88, P339, DOI 10.1016/j.exer.2008.06.016
   Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2
   Gorle AP, 2010, PHARM DEV TECHNOL, V15, P46, DOI 10.3109/10837450902967947
   Gu SF, 2009, MOL VIS, V15, P99
   Hackett JM, 2011, INVEST OPHTH VIS SCI, V52, P651, DOI 10.1167/iovs.10-5224
   Higa K., 2010, J BIOMATER SCI POLYM
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292
   Jain D, 2011, DRUG DEV IND PHARM, V37, P167, DOI 10.3109/03639045.2010.502533
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   KENYON KR, 1989, OPHTHALMOLOGY, V96, P709
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325
   Lee YC, 1999, INT J PHARM, V182, P121, DOI 10.1016/S0378-5173(99)00072-1
   Lee YC, 1999, INT J PHARM, V181, P71, DOI 10.1016/S0378-5173(98)00418-9
   Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liang Y, 2011, COLLOID SURFACE B, V82, P1, DOI [10.1016/j.colsurfb.2010.07.043, 10.1016/j.colsurfb.2010.07043]
   Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Mathurm M, 2011, DRUG DELIV, V18, P54, DOI 10.3109/10717544.2010.509366
   Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109
   Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748
   Mi SL, 2011, J BIOMED MATER RES A, V99A, P1, DOI 10.1002/jbm.a.33152
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Mimura T, 2008, MOL VIS, V14, P1819
   Mundada AS, 2008, CURR EYE RES, V33, P469, DOI 10.1080/02713680802023104
   Natu MV, 2007, BIOMED MATER, V2, P241, DOI 10.1088/1748-6041/2/4/006
   Ozturk E, 2006, INT J ARTIF ORGANS, V29, P228
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Pritchard N, 2000, OPTOMETRY VISION SCI, V77, P68, DOI 10.1097/00006324-200002000-00010
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   SALL KN, 1987, ANN OPHTHALMOL, V19, P31
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Stapleton F, 2006, OCUL SURF, V4, P24, DOI 10.1016/S1542-0124(12)70262-8
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Sudha B, 2006, INDIAN J MED RES, V124, P655
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Talbot M, 2006, MOL VIS, V12, P65
   TAMPONNET C, 1990, APPL MICROBIOL BIOT, V33, P442
   TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P393
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tseng SCG, 2010, CURR MOL MED, V10, P841
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Vijayasekaran S, 2000, J BIOMAT SCI-POLYM E, V11, P599, DOI 10.1163/156856200743896
   Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008
   Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.TEA.2010.0568, 10.1089/ten.tea.2010.0568]
   Wikstrom J, 2008, BIOMATERIALS, V29, P869, DOI 10.1016/j.biomaterials.2007.10.056
   Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]
   Wu XY, 1997, J BIOMED MATER RES, V37, P166, DOI 10.1002/(SICI)1097-4636(199711)37:2<166::AID-JBM4>3.3.CO;2-2
   Xu FL, 2007, J MATER SCI-MATER M, V18, P635, DOI 10.1007/s10856-007-2313-5
   Yang CF, 2000, OPHTHALMIC RES, V32, P19, DOI 10.1159/000055582
   Yeh LK, 2009, J BIOMED MATER RES A, V90A, P18, DOI 10.1002/jbm.a.32077
   Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 83
TC 26
Z9 26
U1 0
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD JAN
PY 2013
VL 18
IS 1-2
BP 79
EP 86
DI 10.1016/j.drudis.2012.07.012
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 071QG
UT WOS:000313608700010
PM 22846850
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Perez, ER
   Cruz, DMG
   Monros, MCA
   Gomez-Pinedo, U
   Pradas, MM
   Ivirico, JLE
AF Rodriguez Perez, Eduard
   Garcia Cruz, Dunia M.
   Araque Monros, Maria C.
   Gomez-Pinedo, U.
   Monleon Pradas, Manuel
   Escobar Ivirico, Jorge L.
TI Polymer chains incorporating caprolactone and arginine-glycine-aspartic
   acid functionalities: Synthesis, characterization and biological
   response in vitro of the Schwann cell
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Itaconic acid; arginine-glycine-aspartic acid; polymeric networks;
   Schwann cells; Bungner bands
ID HYALURONIC-ACID; HYDROGELS; PEPTIDES; ADHESION; PROLIFERATION;
   REGENERATION; SCAFFOLDS; SURFACE; REPAIR; BRAIN
AB This study describes a strategy for the covalent immobilization of active adhesion peptide moieties onto polymers through the intermediacy of itaconic acid. The arginine-glycine-aspartic acid peptide was grafted to a novel poly(caprolactone 2-(methacryloyloxy) ethyl ester)-co-itaconic acid bulk biomaterial, in order to improve the cell adhesion of the polymer. First, the arginine-glycine-aspartic acid sequence was grafted onto itaconic acid via an amidation reaction using N(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide as activation complex. The itaconic acid-arginine-glycine-aspartic acid macromer was characterized by Fourier transform infrared spectroscopy and H-1-NMR, yielding a functionalization degree of 85%. In a second step, poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid-arginine-glycine-aspartic acid) (with a feed mixture of 90 wt% of caprolactone 2-(methacryloyloxy) ethyl ester and 10 wt% of itaconic acid-arginine-glycine-aspartic acid macromer) and a series of copolymers of caprolactone 2-(methacryloyloxy) ethyl ester and itaconic acid with different compositions (weight fractions of itaconic acid up to 20 wt%) were synthesized by radical copolymerization. The microstructure and network architecture of the new polymer systems were investigated. Mechanical moduli of poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid), evaluated by dynamic-mechanical analysis, increase with the itaconic acid content. In poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid-arginine-glycine-aspartic acid), the glass transition temperature and the mechanical moduli of the system are smaller than in the nonfunctionalized poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid) copolymers, and the polymer is less hydrophilic. The results indicate that arginine-glycine-aspartic acid grafting of poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid) copolymer networks can be useful for tissue engineering applications, because regenerative processes in the nervous system can be promoted and accelerated, thus, opening a possibility to generate materials with a high potential for clinical applicability.
C1 [Rodriguez Perez, Eduard; Garcia Cruz, Dunia M.; Araque Monros, Maria C.; Monleon Pradas, Manuel; Escobar Ivirico, Jorge L.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
   [Gomez-Pinedo, U.] Hosp Clin San Carlos, IdISSC, Lab Med Regenerat Neurol & Neurocirugia, Madrid, Spain.
   [Monleon Pradas, Manuel] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
RP Ivirico, JLE (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
EM joresciv@ter.upv.es
RI Rodriguez-Perez, Eduard/S-9666-2017; Escobar Ivirico, Jorge/G-9649-2012;
   Escobar ivirico, Jorge/J-1203-2016; Escobar Ivirico, Jorge
   Luis/M-1947-2013
OI Rodriguez-Perez, Eduard/0000-0002-3636-4469; Escobar ivirico,
   Jorge/0000-0002-1077-2333; Escobar Ivirico, Jorge
   Luis/0000-0002-1077-2333; , ulises.gomez-pinedo/0000-0003-3097-5557;
   MONLEON PRADAS, MANUEL/0000-0001-6457-0414
FU Spanish Science and Innovation Ministry [MAT2011-28791-C03]
FX This study was supported by the Spanish Science and Innovation Ministry
   through project MAT2011-28791-C03
CR Baron-Van Evercooren A, 1982, J CELL BIOL, V93, P211
   Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   CHI H, 1993, J NEUROSCI RES, V35, P183, DOI 10.1002/jnr.490350208
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Gugutkov D, 2011, J BIOACT COMPAT POL, V26, P375, DOI 10.1177/0883911511409020
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Kirsebom H, 2007, J BIOACT COMPAT POL, V22, P621, DOI 10.1177/0883911507084293
   Krusic MK, 2004, EUR POLYM J, V40, P793, DOI 10.1016/j.europolymj.2003.11.016
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MARK JE, 1985, ACCOUNTS CHEM RES, V18, P202, DOI 10.1021/ar00115a002
   Mei Y, 2010, BIOMATERIALS, V31, P8989, DOI 10.1016/j.biomaterials.2010.08.029
   Min SK, 2010, BIOMATERIALS, V31, P4725, DOI 10.1016/j.biomaterials.2010.02.045
   Niu XF, 2005, J MATER SCI TECHNOL, V21, P571
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Patel A, 2011, J BIOACT COMPAT POL, V26, P114, DOI 10.1177/0883911511398713
   Rao S. S., 2009, FRONT NEUROENG, V2, P1, DOI 10.3389/neuro.16.006.2009
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Hernandez JCR, 2009, MACROMOL BIOSCI, V9, P766, DOI 10.1002/mabi.200800332
   RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Willke T, 2001, APPL MICROBIOL BIOT, V56, P289, DOI 10.1007/s002530100685
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 34
TC 2
Z9 2
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2013
VL 28
IS 1
BP 50
EP 65
DI 10.1177/0883911512469710
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 071LG
UT WOS:000313593600004
DA 2018-10-20
ER

PT J
AU Rasmussen, J
   Nielsen, OW
   Lund, AM
   Kober, L
   Djurhuus, H
AF Rasmussen, Jan
   Nielsen, Olav W.
   Lund, Allan M.
   Kober, Lars
   Djurhuus, Hogni
TI Primary carnitine deficiency and pivalic acid exposure causing
   encephalopathy and fatal cardiac events
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID CEREBRAL EDEMA; FATTY-ACID; TRANSPORTER; METABOLISM; CARDIOMYOPATHY;
   PREGNANCY; PIVALOYLCARNITINE; HYPERAMMONEMIA; PIVAMPICILLIN; MUTATIONS
AB Several episodes of sudden death among young Faroese individuals have been associated with primary carnitine deficiency (PCD). Patients suffering from PCD have low carnitine levels and can present with metabolic and/or cardiac complications. Pivalic acid exposure decreases carnitine levels. The purpose of this study was to investigate and describe the association and pathophysiology of exposure to antibiotics containing pivalic acid and severe neurological and cardiac complications in six identified subjects suffering from PCD.
   Six cases of PCD were identified and studied through medical records and family interview. Stored biomaterial was analyzed for mutations causing PCD.
   Five patients (two children, three adults) died suddenly while one adult patient survived sudden cardiac arrest. Lethal cardiac arrhythmia was documented in five patients, while one patient was not monitored at time of death, but had signs of cardiac arrhythmia a few days earlier. All patients suffered encephalopathy before cardiac arrhythmia. Autopsy showed severe hepatic steatosis and signs of cerebral edema in four out of five. One subject had a dilated heart. All patients were homozygous for the c.95A > G (p.N32S) mutation in SLC22A5 causing PCD. All patients had been treated with antibiotics containing pivalic acid prior to the episode.
   Exposure to antibiotics containing pivalic acid was associated with encephalopathy and progression to lethal cardiac arrhythmia in patients suffering from PCD.
C1 [Rasmussen, Jan] Natl Hosp, Dept Internal Med, FR-100 Torshavn, Faroe Islands, Denmark.
   [Nielsen, Olav W.] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.
   [Lund, Allan M.] Univ Copenhagen Hosp, Dept Clin Genet, Rigshosp, DK-2100 Copenhagen, Denmark.
   [Kober, Lars] Univ Copenhagen Hosp, Dept Cardiol, Rigshosp, DK-2100 Copenhagen, Denmark.
   [Djurhuus, Hogni] Natl Hosp, Dept Anesthesia, FR-100 Torshavn, Faroe Islands, Denmark.
RP Rasmussen, J (reprint author), Natl Hosp, Dept Internal Med, FR-100 Torshavn, Faroe Islands, Denmark.
EM lsjanra@ls.fo
RI Nielsen, Olav/S-4390-2016
OI Nielsen, Olav/0000-0003-3532-9431
FU Department of Clinical Genetics in Rigshospitalet, Copenhagen;
   Department of Pathology in the National Hospital of the Faroe Islands;
   Faroese Research Council
FX The authors would like to thank Anne Vesterby from Retsmedicinsk
   Institute, Aarhus University, and Ulrike Steuerwald for their
   contribution. And the Department of Clinical Genetics in Rigshospitalet,
   Copenhagen, the Department of Pathology in the National Hospital of the
   Faroe Islands and the Faroese Research Council for their assistance and
   support.
CR BARGENLOCKNER C, 1981, AM J OBSTET GYNECOL, V140, P412, DOI 10.1016/0002-9378(81)90035-1
   Bjerring PN, 2009, METAB BRAIN DIS, V24, P5, DOI 10.1007/s11011-008-9116-3
   Brass EP, 2002, PHARMACOL REV, V54, P589, DOI 10.1124/pr.54.4.589
   BRODERICK TL, 1995, METABOLISM, V44, P499, DOI 10.1016/0026-0495(95)90058-6
   Calvani M, 2000, BASIC RES CARDIOL, V95, P75, DOI 10.1007/s003950050167
   Christensen E, 2000, J INHERIT METAB D S1, V23
   Chung Mina K, 2004, Cardiol Rev, V12, P73, DOI 10.1097/01.crd.0000091839.22076.f4
   El-Hattab AW, 2010, GENET MED, V12, P19, DOI [10.1097/GIM.0b013e3181c5e6f7, 10.1097/GIM.0b013c3181c5e6f7]
   ERIKSSON BO, 1988, EUR J PEDIATR, V147, P662, DOI 10.1007/BF00442488
   GENGER H, 1988, Z GEBURTSH PERINATOL, V192, P134
   Haberle J, 2011, EUR J PEDIATR, V170, P21, DOI 10.1007/s00431-010-1369-2
   Heins J, 2010, METAB BRAIN DIS, V25, P81, DOI 10.1007/s11011-010-9170-5
   HOLME E, 1989, LANCET, V2, P469
   Hou Jia-Woei, 2002, Chang Gung Med J, V25, P832
   HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452
   ITO T, 1995, TOHOKU J EXP MED, V175, P43, DOI 10.1620/tjem.175.43
   KATO M, 1992, HEPATOLOGY, V15, P1060, DOI 10.1002/hep.1840150615
   Lamhonwah AM, 2002, AM J MED GENET, V111, P271, DOI 10.1002/ajmg.10585
   Lango R, 2001, CARDIOVASC RES, V51, P21, DOI 10.1016/S0008-6363(01)00313-3
   Limketkai BN, 2008, J GEN INTERN MED, V23, P210, DOI 10.1007/s11606-007-0473-0
   LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lund AM, 2007, J INHERIT METAB DIS, V30, P341, DOI 10.1007/s10545-007-0527-9
   MELEGH B, 1987, BIOCHEM PHARMACOL, V36, P3405, DOI 10.1016/0006-2952(87)90318-2
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   Ohnishi S, 2008, DRUG METAB PHARMACOK, V23, P293, DOI 10.2133/dmpk.23.293
   Opalka JR, 2001, CLIN CHEM, V47, P2150
   Osa Elmar, 2004, Ugeskr Laeger, V166, P4612
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   REBOUCHE CJ, 1992, FASEB J, V6, P3379
   REBOUCHE CJ, 1989, J NUTR, V119, P1907
   REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6
   Rijlaarsdam RS, 2004, PACE, V27, P675, DOI 10.1111/j.1540-8159.2004.00507.x
   Scaglia F, 1998, GENET MED, V1, P34
   Schoderbeck M, 1995, J PERINAT MED, V23, P477, DOI 10.1515/jpme.1995.23.6.477
   Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911
   STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512
   Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006
   SUZUKI Y, 1982, JPN HEART J, V23, P349
   Tadros TM, 2009, CIRCULATION, V120, pS747
   Takiyama N, 1998, J AM COLL NUTR, V17, P71, DOI 10.1080/07315724.1998.10720458
   Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187
   Thumburu KK, 2012, NEUROCHEM INT, V60, P672, DOI 10.1016/j.neuint.2011.10.013
   Todesco L, 2009, CHEM-BIOL INTERACT, V180, P472, DOI 10.1016/j.cbi.2009.02.014
NR 44
TC 18
Z9 22
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN
PY 2013
VL 36
IS 1
BP 35
EP 41
DI 10.1007/s10545-012-9488-8
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 070GL
UT WOS:000313494500006
PM 22566287
DA 2018-10-20
ER

PT J
AU Hwang, JY
   Shin, US
   Jang, WC
   Hyun, JK
   Wall, IB
   Kim, HW
AF Hwang, Ji-Young
   Shin, Ueon Sang
   Jang, Won-Cheoul
   Hyun, Jung Keun
   Wall, Ivan B.
   Kim, Hae-Won
TI Biofunctionalized carbon nanotubes in neural regeneration: a mini-review
SO NANOSCALE
LA English
DT Review
ID EMBRYONIC STEM-CELLS; NEURITE OUTGROWTH; NEURONAL GROWTH; DRUG-DELIVERY;
   NERVE REGENERATION; IN-VITRO; CYTOTOXICITY; STIMULATION; POLYMER;
   DIFFERENTIATION
AB Carbon nanotubes (CNTs) have become an intriguing and promising biomaterial platform for the regeneration and functional recovery of damaged nerve tissues. The unique electrical, structural and mechanical properties, diversity of available surface chemistry and cell-penetrating ability of CNTs have made them useful implantable matrices or carriers for the delivery of therapeutic molecules. Although there are still challenges being faced in the clinical applications of CNTs mainly due to their toxicity, many studies to overcome this issue have been published. Modification of CNTs with chemical groups to ensure their dissolution in aqueous media is one possible solution. Functionalization of CNTs with biologically relevant and effective molecules (biofunctionalization) is also a promising strategy to provide better biocompatibility and selectivity for neural regeneration. Here, we review recent advances in the use of CNTs to promote neural regeneration.
C1 [Hwang, Ji-Young; Shin, Ueon Sang; Jang, Won-Cheoul; Hyun, Jung Keun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat & Engn, Cheonan 330714, South Korea.
   [Shin, Ueon Sang; Hyun, Jung Keun; Wall, Ivan B.; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Shin, Ueon Sang; Hyun, Jung Keun; Wall, Ivan B.; Kim, Hae-Won] Dankook Univ, WCU Res Ctr, Cheonan 330714, South Korea.
   [Jang, Won-Cheoul] Dankook Univ, Dept Chem, Cheonan 330714, South Korea.
   [Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1E 6BT, England.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Inst Tissue Regenerat & Engn, Cheonan 330714, South Korea.
EM kimhw@dku.edu
OI Hwang, Ji-Young/0000-0001-8044-1989; Hyun, Jung Keun/0000-0001-9254-4424
FU Priority Research Centers Program [2009-0093829]; World Class University
   (WCU) Program [R31-10069]; National Research Foundation (NRF), the
   Ministry of Education, Science and Technology
FX This work was supported by Priority Research Centers Program (Grant no.
   2009-0093829) and World Class University (WCU) Program (Grant no.
   R31-10069) funded by the National Research Foundation (NRF), the
   Ministry of Education, Science and Technology.
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Al-Jamal KT, 2010, METHODS MOL BIOL, V625, P123, DOI 10.1007/978-1-60761-579-8_11
   Ali-Boucetta H, 2011, METHODS MOL BIOL, V726, P299, DOI 10.1007/978-1-61779-052-2_19
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bhirde AA, 2010, NANOMEDICINE-UK, V5, P1535, DOI 10.2217/NNM.10.90
   Bianco Alberto, 2004, Expert Opin Drug Deliv, V1, P57, DOI 10.1517/17425247.1.1.57
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   CHIQUET M, 1987, J EXP BIOL, V132, P191
   Cho YN, 2010, J BIOMED MATER RES A, V95A, P510, DOI 10.1002/jbm.a.32841
   Coccini T, 2010, TOXICOLOGY, V269, P41, DOI 10.1016/j.tox.2010.01.005
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Detriche S, 2008, J NANOSCI NANOTECHNO, V8, P6082, DOI 10.1166/jnn.2008.SW16
   Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P183, DOI 10.1016/j.nano.2008.04.003
   Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6
   Graham BP, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S9
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Jin GZ, 2011, CELL BIOL INT, V35, P741, DOI 10.1042/CBI20100705
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kiddie G, 2005, PROG BRAIN RES, V147, P67, DOI 10.1016/S0079-6123(04)47006-X
   Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281
   Li J, 2007, ACTA NEUROCHIR SUPPL, V97, P537
   Lin CM, 2009, BIOSENS BIOELECTRON, V24, P2791, DOI 10.1016/j.bios.2009.02.005
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   Lu Y, 2010, BIOMATERIALS, V31, P5169, DOI 10.1016/j.biomaterials.2010.03.022
   Malarkey EB, 2008, NANO LETT, V8, P3538, DOI 10.1021/nl8017912
   Malarkey EB, 2010, ACTA NEUROCHIR SUPPL, V106, P337, DOI 10.1007/978-3-211-98811-4_62
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Matsumoto K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115101
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078
   Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nunes A, 2010, SMALL, V6, P2281, DOI 10.1002/smll.201000864
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pancrazio JJ, 2008, NANOMEDICINE-UK, V3, P823, DOI 10.2217/17435889.3.6.823
   Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347
   Roman JA, 2011, J NEUROTRAUM, V28, P2349, DOI 10.1089/neu.2010.1409
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shin US, 2011, J TISSUE ENG
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   SISKEN BF, 1989, BRAIN RES, V485, P309, DOI 10.1016/0006-8993(89)90575-1
   Sucapane A, 2008, J NANONEUROSCI, V1, P10
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Woolley Adam T., 2004, V283, P305
   Xu FM, 2008, COLLOID SURFACE B, V67, P67, DOI 10.1016/j.colsurfb.2008.07.016
   Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102
   Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1
   Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259
   Zhou H, 2007, INT J MOL SCI, V8, P884, DOI 10.3390/i8080884
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
NR 71
TC 32
Z9 32
U1 2
U2 94
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PY 2013
VL 5
IS 2
BP 487
EP 497
DI 10.1039/c2nr31581e
PG 11
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 069HP
UT WOS:000313426200003
PM 23223857
DA 2018-10-20
ER

PT J
AU Raimondi, MT
   Eaton, SM
   Lagana, M
   Aprile, V
   Nava, MM
   Cerullo, G
   Osellame, R
AF Raimondi, Manuela T.
   Eaton, Shane M.
   Lagana, Matteo
   Aprile, Veronica
   Nava, Michele M.
   Cerullo, Giulio
   Osellame, Roberto
TI Three-dimensional structural niches engineered via two-photon laser
   polymerization promote stem cell homing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Two-photon polymerization; Femtosecond laser; Mesenchymal stem cell;
   Niche; Scaffold
ID HIGH-THROUGHPUT; FATE
AB A strategy to modulate the behavior of stem cells in culture is to mimic structural aspects of the native cell/extracellular matrix interaction. We applied femtosecond laser two-photon polymerization (2PP) to fabricate three-dimensional (3-D) microscaffolds, or "niches", using a hybrid organic-inorganic photoresist called SZ2080. The niches, of sizes fitting in a volume of 100 x 100 x 100 mu m(3), were made by an external containment grid of horizontal parallel elements and by an internal 3-D lattice. We developed two niche heights, 20 and 80-100 mu m, and four lattice pore dimensions (10, 20, 30 mu m and graded). We used primary rat mesenchymal stem cells (MSCs) to study cell viability, migration and proliferation in the niches, up to 6 culture days. MSCs preferentially stayed on/in the structures once they ran into them through random migration from the surrounding flat surface, invaded those with a lattice pore dimension greater than 10 mu m, and adhered to the internal lattice while the cell nuclei acquired a roundish morphology. In the niches, the highest MSC density was found in those areas where proliferation was observed, corresponding to the regions where the scaffold surface density available for cell adhesion was highest. The microgeometry inducing the highest cell density was 20 mu m high with graded pores, in which cell invasion was favored in the central region of large porosity and cell adhesion was favored in the lateral regions of high scaffold surface density. Cell density in the niches, 17 +/- 6 cells/(100 x 100 mu m(2)), did not significantly differ from that of the flat surface colonies. This implies that MSCs spontaneously homed and established colonies within the 3-D niches. This study brings to light the crucial role played by the niche 3-D geometry on MSC colonization in culture, with potential implications for the design of biomaterial scaffolds for synthetic niche engineering. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Raimondi, Manuela T.; Lagana, Matteo; Aprile, Veronica; Nava, Michele M.] Politecn Milan, Dept Struct Engn, LaBS, I-20133 Milan, Italy.
   [Eaton, Shane M.; Osellame, Roberto] IFN CNR, I-20133 Milan, Italy.
   [Cerullo, Giulio] Politecn Milan, Dept Phys, I-20133 Milan, Italy.
RP Raimondi, MT (reprint author), Politecn Milan, Dept Struct Engn, LaBS, I-20133 Milan, Italy.
EM manuela.raimondi@polimi.it
RI Nava, Michele/L-8939-2017; Osellame, Roberto/E-6076-2012; Eaton,
   Shane/A-2084-2008; Raimondi, Manuela Teresa/F-6606-2013
OI Nava, Michele/0000-0001-8733-6364; Osellame,
   Roberto/0000-0002-4457-9902; Eaton, Shane/0000-0003-0805-011X; Raimondi,
   Manuela Teresa/0000-0003-2585-7206; Cerullo, Giulio/0000-0002-9534-2702
FU Politecnico di Milano [CUPD41J10000490001]; "Biosensors and Artificial
   Bio-systems" (Italian Institute of Technology- IIT, Genova); Fondazione
   Cariplo, Milano
FX We acknowledge the following funding grants: "5 per Mille Junior 2009
   CUPD41J10000490001" (Politecnico di Milano), "Biosensors and Artificial
   Bio-systems" (Italian Institute of Technology- IIT, Genova), Cariplo
   2010 "3-D Micro structuring and Functionalisation of Polymeric Materials
   for Scaffolds in Regenerative Medicine" (Fondazione Cariplo, Milano).
   The funding sources had no involvement in the study design, collection,
   analysis, interpretation of data, paper writing and in the decision to
   submit it for publication. We thank Prof. A. Remuzzi for critically
   reviewing the manuscript.
CR Amato L, 2012, LAB CHIP, V12, P1135, DOI 10.1039/c2lc21116e
   Becerra J, 2011, STEM CELL REV REP, V7, P248, DOI 10.1007/s12015-010-9195-5
   Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602
   Ovsianikov A, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014104
   Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w
   Park SH, 2009, LASER PHOTONICS REV, V3, P1, DOI 10.1002/lpor.200810027
   Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158
   Psycharakis S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045008
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Wan LQ, 2010, INTEGR BIOL-UK, V2, P346, DOI 10.1039/c0ib00016g
   Zangi L, 2006, TISSUE ENG, V12, P2343, DOI 10.1089/ten.2006.12.2343
NR 19
TC 63
Z9 64
U1 1
U2 98
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4579
EP 4584
DI 10.1016/j.actbio.2012.08.022
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900011
PM 22922332
DA 2018-10-20
ER

PT J
AU Kang, TY
   Hong, JM
   Kim, BJ
   Cha, HJ
   Cho, DW
AF Kang, Tae-Yun
   Hong, Jung Min
   Kim, Bum Jin
   Cha, Hyung Joon
   Cho, Dong-Woo
TI Enhanced endothelialization for developing artificial vascular networks
   with a natural vessel mimicking the luminal surface in scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Scaffold with artificial vascular networks; Shear
   stress precondition; Surface coating; Endothelialization
ID FLOW-CHANNEL NETWORK; CELL-ADHESION; IN-VITRO; PLATELET-ADHESION;
   SHEAR-STRESS; PERFUSION CULTURE; RGD-PEPTIDES; GRAFT; FABRICATION;
   MICROSTEREOLITHOGRAPHY
AB Large tissue regeneration remains problematic because of a lack of oxygen and nutrient supply. An attempt to meet the metabolic needs of cells has been made by preforming branched vascular networks within a scaffold to act as channels for mass transport. When constructing functional vascular networks with channel patency, emphasis should be placed on anti-thrombogenic surface issues. The aim of this study was to develop a rapid endothelialization method for creating an anti-thrombogenic surface mimicking the natural vessel wall in the artificial vascular networks. Shear stress preconditioning and scaffold surface modification were investigated as effective approaches for promoting biomaterial endothelialization. We found that a transient increase in shear stress at the appropriate time is key to enhancing endothelialization. Moreover, surface modification with bioactive materials such as collagen and recombinant mussel adhesive protein fused with arginine-glycine-aspartic acid peptide (MAP-RGD) showed a synergetic effect with shear stress preconditioning. Platelet adhesion tests demonstrated the anti-thrombogenic potential of MAP-RGD itself without endothelialization. The rapid endothelialization method established in this study can be easily applied to preformed artificial vascular networks in porous scaffolds. Development of artificial vascular networks with an anti-thrombogenic luminal surface will open up a new chapter in tissue engineering and regenerative medicine. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kang, Tae-Yun; Hong, Jung Min; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 790784, Gyungbuk, South Korea.
   [Kim, Bum Jin; Cha, Hyung Joon] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Gyungbuk, South Korea.
   [Cha, Hyung Joon] Pohang Univ Sci & Technol POSTECH, Dept Chem Engn, Pohang 790784, Gyungbuk, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, Gyungbuk, South Korea.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31 Hyoja Dong, Pohang 790784, Gyungbuk, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2012-0001235]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korea government (MEST) (No. 2012-0001235).
CR Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185
   Aldenhoff Y., 2003, EUR CELLS MATER, V5, P67
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Barber RW, 2008, MICROFLUID NANOFLUID, V4, P179, DOI 10.1007/s10404-007-0163-6
   Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Choi WS, 2009, MACROMOL RES, V17, P458, DOI 10.1007/BF03218892
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Dimitrievska S, 2011, MACROMOL BIOSCI, V11, P493, DOI 10.1002/mabi.201000390
   Farrar DJ, 2000, HEART SURG FORUM, V3, P36
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Golanski J, 2011, ARCH MED SCI, V7, P34, DOI 10.5114/aoms.2011.20601
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HARKER LA, 1994, NEW ENGL J MED, V330, P1006, DOI 10.1056/NEJM199404073301411
   Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348
   He JK, 2007, POLYMER, V48, P4578, DOI 10.1016/j.polymer.2007.05.048
   Hoganson DM, 2010, TISSUE ENG PT A, V16, P1469, DOI [10.1089/ten.tea.2009.0118, 10.1089/ten.TEA.2009.0118]
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Ishii Y, 2007, ANN THORAC SURG, V83, P517, DOI 10.1016/j.athoracsur.2006.09.053
   Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8
   Kammerer PW, 2011, EUR CELLS MATER, V21, P364
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]
   Kang HW, 2009, MICROELECTRON ENG, V86, P941, DOI 10.1016/j.mee.2008.11.054
   Kang TY, 2011, ACTA BIOMATER, V7, P3345, DOI 10.1016/j.actbio.2011.05.015
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lee JH, 2004, J MATER SCI-MATER M, V15, P155, DOI 10.1023/B:JMSM.0000011817.47636.59
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin JC, 1999, BIOMATERIALS, V20, P1439, DOI 10.1016/S0142-9612(98)00200-2
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Luo XL, 2006, MACROMOL BIOSCI, V6, P373, DOI 10.1002/mabi.200500236
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b
   Park IB, 2012, INT J PRECIS ENG MAN, V13, P291, DOI 10.1007/s12541-012-0036-0
   Phaneuf MD, 1998, ASAIO J, V44, pM653, DOI 10.1097/00002480-199809000-00071
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Rouleau L, 2010, ANN BIOMED ENG, V38, P1451, DOI 10.1007/s10439-010-9934-4
   Sakai Y, 2004, MAT SCI ENG C-BIO S, V24, P379, DOI 10.1016/j.msec.2003.12.007
   Shin HS, 2009, J BIOACT COMPAT POL, V24, P316, DOI 10.1177/0883911509104273
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Yin M, 2009, BIOMATERIALS, V30, P2764, DOI 10.1016/j.biomaterials.2009.01.039
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
NR 62
TC 19
Z9 19
U1 2
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4716
EP 4725
DI 10.1016/j.actbio.2012.08.042
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900027
PM 22947325
DA 2018-10-20
ER

PT J
AU Heinemann, S
   Heinemann, C
   Wenisch, S
   Alt, V
   Worch, H
   Hanke, T
AF Heinemann, S.
   Heinemann, C.
   Wenisch, S.
   Alt, V.
   Worch, H.
   Hanke, T.
TI Calcium phosphate phases integrated in silica/collagen nanocomposite
   xerogels enhance the bioactivity and ultimately manipulate the
   osteoblast/osteoclast ratio in a human co-culture model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Human osteoblasts; Human osteoclasts; Co-culture; Nanocomposites;
   Bioactivity
ID RESISTANT ACID-PHOSPHATASE; IN-VITRO; SUBSTITUTED HYDROXYAPATITE;
   OSTEOCLAST DIFFERENTIATION; CELL-DIFFERENTIATION; COMPOSITE XEROGELS;
   BONE-REPLACEMENT; STROMAL CELLS; OSTEOBLASTS; COLLAGEN
AB A human co-culture model of osteoblasts and osteoclasts, derived from bone marrow stromal cells and monocytes respectively, was used to characterize the influence of biomaterial modification on the bioactivity and ultimately the ratio of bone-forming to bone-resorbing cells cultivated directly on the surface. Nanocomposites of silica and collagen have been shown to function as skeletal structures in nature and were reproduced in vitro by using a sol gel approach. The resulting xerogels exhibit a number of features that make it a valuable system for the development of innovative materials for bone substitution applications. In the present study, the incorporation of different calcium phosphate phases in silica/collagen-based gels was demonstrated to enhance the bioactivity of these samples. This ability of the biomaterial to precipitate calcium phosphate on the surface when incubated in simulated body fluids or cell culture medium is generally considered to an advantageous property for bone substitution materials. By co-cultivating human osteoblasts and osteoclasts up to 42 days on the xerogels, we demonstrate that the long-term ratio of these cell types depends on the level of bioactivity of the substrate samples. Biphasic silica/collagen xerogels exhibited comparably low bioactivity but encouraged proliferation of osteoblasts in comparison to osteoclast formation. A balanced ratio of both cell types was detected for moderately bioactive triphasic xerogels with 5% calcium phosphate. However, enhancing the bioactivity of the xerogel samples by increasing the calcium phosphate phase percentage to 20% resulted in a diminished number of osteoblasts in favor of osteoclast formation. Quantitative evaluation was carried out by biochemical methods (calcium, DNA, ALP, TRAP 5b) as well as RT-PCR (ALP, BSP II, OC, RANKL, TRAP, CALCR, VTNR, CTSK), and was supported by confocal laser scanning microscopy (cell nuclei, actin, CD68, TRAP) as well as scanning electron microscopy. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Heinemann, S.; Heinemann, C.; Worch, H.; Hanke, T.] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Heinemann, S.; Heinemann, C.; Worch, H.; Hanke, T.] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Wenisch, S.] Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany.
   [Alt, V.] Univ Giessen, Dept Trauma Surg, D-35385 Giessen, Germany.
RP Heinemann, S (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM sascha.heinemann@tu-dresden.de
FU Deutsche Forschungsgemeinschaft [HA5284/2-1, TRR79-TP-M03]
FX We gratefully acknowledge the Deutsche Forschungsgemeinschaft Grants
   HA5284/2-1 and TRR79-TP-M03 for partial financial support.
CR Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024
   [Anonymous], 2010, TRACP 5B ASS
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Botelho CM, 2006, J BIOMED MATER RES A, V78A, P709, DOI 10.1002/jbm.a.30726
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Guo H, 2007, BIOMED MATER, V2, pS153, DOI 10.1088/1748-6041/2/3/S13
   Halleen JM, 2002, CALCIFIED TISSUE INT, V71, P20, DOI 10.1007/s00223-001-2122-7
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Heinemann S, 2011, COMPOS SCI TECHNOL, V71, P1873, DOI 10.1016/j.compscitech.2011.08.023
   Heinemann S, 2011, ORTHOPADE, V40, P761, DOI 10.1007/s00132-011-1748-z
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Heinemann S, 2007, ADV ENG MATER, V9, P1061, DOI 10.1002/adem.200700219
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Itoh K, 2000, J BONE MINER RES, V15, P1766, DOI 10.1359/jbmr.2000.15.9.1766
   Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788
   Karpov M, 2008, J BIOMED MATER RES A, V84A, P718, DOI 10.1002/jbm.a.31386
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1
   Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Narducci P, 2009, ANN ANAT, V191, P349, DOI 10.1016/j.aanat.2009.02.009
   Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Quarles LD, 1997, J BONE MINER RES, V12, P1971, DOI 10.1359/jbmr.1997.12.12.1971
   Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393
   REINHOLT FP, 1990, J BONE MINER RES, V5, P1055
   Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465
   Sakai H, 2010, AM J PHYSIOL-CELL PH, V299, pC570, DOI 10.1152/ajpcell.00486.2009
   Schilling AF, 2008, J CELL MOL MED, V12, P2497, DOI 10.1111/j.1582-4934.2008.00275.x
   SCHWARZ K, 1978, P207
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Thimm BW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015007
   TONG HS, 1994, J BONE MINER RES, V9, P577
   Travaglione S, 2002, TOXICOL IN VITRO, V16, P405, DOI 10.1016/S0887-2333(02)00028-0
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
   Valles G, 2008, BIOMATERIALS, V29, P2326, DOI 10.1016/j.biomaterials.2008.02.011
   Yam LT, 2003, J BONE MINER RES, V18, P1894, DOI 10.1359/jbmr.2003.18.10.1894
   Yamaguchi T, 2008, J BONE MINER METAB, V26, P301, DOI 10.1007/s00774-008-0843-7
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 58
TC 36
Z9 36
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4878
EP 4888
DI 10.1016/j.actbio.2012.10.010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900044
PM 23072829
DA 2018-10-20
ER

PT J
AU Vidal, G
   Blanchi, T
   Mieszawska, AJ
   Calabrese, R
   Rossi, C
   Vigneron, P
   Duval, JL
   Kaplan, DL
   Egles, C
AF Vidal, Guillaume
   Blanchi, Thomas
   Mieszawska, Aneta J.
   Calabrese, Rossella
   Rossi, Claire
   Vigneron, Pascale
   Duval, Jean-Luc
   Kaplan, David L.
   Egles, Christophe
TI Enhanced cellular adhesion on titanium by silk functionalized with
   titanium binding and RGD peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk protein; Titanium-binding peptide; Peptide grafting; Cell adhesion;
   Surface modification
ID QUARTZ-CRYSTAL MICROBALANCE; SURFACE; BIOMATERIALS; ADSORPTION;
   ATTACHMENT; TIO2; BONE; FIBRONECTIN; PARTICLES; RESPONSES
AB Soft tissue adhesion on titanium represents a challenge for implantable materials. In order to improve adhesion at the cell/material interface we used a new approach based on the molecular recognition of titanium by specific peptides. Silk fibroin protein was chemically grafted with titanium binding peptide (TiBP) to increase adsorption of these chimeric proteins to the metal surface. A quartz crystal microbalance was used to quantify the specific adsorption of TiBP-functionalized silk and an increase in protein deposition by more than 35% was demonstrated due to the presence of the binding peptide. A silk protein grafted with TiBP and fibronectin-derived arginine glycine aspartic acid (RGD) peptide was then prepared. The adherence of fibroblasts on the titanium surface modified with the multifunctional silk coating demonstrated an increase in the number of adhering cells by 60%. The improved adhesion was demonstrated by scanning electron microscopy and immunocytochemical staining of focal contact points. Chick embryo organotypic culture also revealed strong adhesion of endothelial cells expanding on the Multifunctional silk peptide coating. These results demonstrated that silk functionalized with TiBP and RGD represents a promising approach to modify cell biomaterial interfaces, opening new perspectives for implantable medical devices, especially when reendothelialization is required. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vidal, Guillaume; Vigneron, Pascale; Duval, Jean-Luc; Egles, Christophe] Ctr Rech Royallieu, UMR CNRS Biomecan & BioIngn 7338, F-60205 Compiegne, France.
   [Blanchi, Thomas] Tufts Univ, Sch Dent Med, Dept Periodontol, Boston, MA 02111 USA.
   [Mieszawska, Aneta J.; Calabrese, Rossella; Kaplan, David L.] Tufts Univ, Biomed Engn Sci & Technol Ctr, Medford, MA 02155 USA.
   [Rossi, Claire] Ctr Rech Royallieu, UMR CNRS Genie Enzymat & Cellulaire 6022, F-60205 Compiegne, France.
   [Egles, Christophe] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA.
RP Egles, C (reprint author), Univ Technol Compiegne, Bur G212, Ctr Rech, BP 20529,Rue Personne Roberval, F-60205 Compiegne, France.
EM christophe.egles@utc.fr
OI EGLES, Christophe/0000-0003-0982-7752
FU European Union within the CPER; NIH [EB002520, AFIRM R01NS058780-01]
FX We thank the European Union for co-funding of equipment within the CPER
   2007-2013. We thank Rajesh Naik, AFOSR, for the titanium-binding peptide
   sequence and Kader Bamouni, Fanny Chapelin and Audrey Jousse for
   technical assistance. We thank the NIH (EB002520, AFIRM R01NS058780-01)
   (DLK) for support of this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Baneyx F, 2007, CURR OPIN BIOTECH, V18, P312, DOI 10.1016/j.copbio.2007.04.008
   Becker B, 2011, J MOL RECOGNIT, V24, P754, DOI 10.1002/jmr.1117
   Chen HB, 2006, ANAL CHEM, V78, P4872, DOI 10.1021/ac0603025
   Chen HB, 2009, LANGMUIR, V25, P1588, DOI 10.1021/la8030304
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Delvat E, 2008, J MECH BEHAV BIOMED, V1, P345, DOI 10.1016/j.jmbbm.2008.01.006
   Dickerson MB, 2008, CHEM MATER, V20, P1578, DOI 10.1021/cm071515t
   do Serro APVA, 2000, J BIOMED MATER RES, V49, P345
   Duval JL, 2006, J CONTROL RELEASE, V116, pE50, DOI 10.1016/j.jconrel.2006.09.045
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kriplani K, 2005, CURR OPIN BIOTECH, V16, P470, DOI DOI 10.1016/J.COPBIO.2005.07.001
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rezania A, 1996, J BIOMED MATER RES, V37, P9
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Vockenroth IK, 2009, BIOINTERPHASES, V4, P19, DOI 10.1116/1.3122019
   Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
NR 34
TC 39
Z9 41
U1 5
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4935
EP 4943
DI 10.1016/j.actbio.2012.09.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900050
PM 22975628
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nilsson, PH
   Ekdahl, KN
   Magnusson, PU
   Qu, HC
   Iwata, H
   Ricklin, D
   Hong, J
   Lambris, JD
   Nilsson, B
   Teramura, Y
AF Nilsson, Per H.
   Ekdahl, Kristina N.
   Magnusson, Peetra U.
   Qu, Hongchang
   Iwata, Hiroo
   Ricklin, Daniel
   Hong, Jaan
   Lambris, John D.
   Nilsson, Bo
   Teramura, Yuji
TI Autoregulation of thromboinflammation on biomaterial surfaces by a
   multicomponent therapeutic coating
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; poly(ethylene glycol) (PEG); Factor H-binding
   peptide; Apyrase; Complement; Coagulation
ID INDUCED LUNG INJURY; COMPLEMENT ACTIVATION; FACTOR-H; ISLET
   TRANSPLANTATION; ALTERNATIVE PATHWAY; POLYMER SURFACE; WHOLE-BLOOD;
   ADENOSINE; MODEL; BINDING
AB Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact We have created a surface which is auto-protective to human innate immunity by combining three fundamentally different strategies, all developed by us previously, which have been shown to induce substantial, but incomplete hemocompatibility when used separately. In summary, we have conjugated a factor H-binding peptide; and an ADP-degrading enzyme; using a PEG linker on both material and cellular surfaces. When exposed to human whole blood, factor H was specifically recruited to the modified surfaces and inhibited complement attack. In addition, activation of platelets and coagulation was efficiently attenuated, by degrading ADP. Thus, by inhibiting thromboinflammation using a multicomponent approach, we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Nilsson, Per H.; Ekdahl, Kristina N.] Linnaeus Univ, Sch Nat Sci, Vaxjo, Sweden.
   [Ekdahl, Kristina N.; Magnusson, Peetra U.; Hong, Jaan; Nilsson, Bo; Teramura, Yuji] Uppsala Univ, Rudbeck Lab C5, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden.
   [Qu, Hongchang; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Iwata, Hiroo; Teramura, Yuji] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068501, Japan.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab C5, Dept Immunol Genet & Pathol, Dag Hammarskolds Vag 20, SE-75185 Uppsala, Sweden.
EM bo.nilsson@igp.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012; Ricklin,
   Daniel/F-5104-2011
OI Nilsson, Bo/0000-0003-0057-2730; Ricklin, Daniel/0000-0001-6140-0233;
   Lambris, John/0000-0002-9370-5776
FU Swedish Research Council (VR) [2009-4675, 2009-4462, 90293501, A0290401,
   A0290402]; Stem Therapy; Swedish Research Council; Swedish Research
   Council/SSF/Vinnova [60761701]; Japan Society for the Promotion of
   Science grant [442-H22]; Novo Nordisk Foundation; National Institutes of
   Health [EB003968, AI068730, GM062134, AI030040]; Linnaeus University,
   Sweden
FX This work was supported by grants from the Swedish Research Council (VR)
   2009-4675, 2009-4462, 90293501, A0290401, and A0290402 and Stem Therapy;
   the Swedish Research Council; and the Swedish Research
   Council/SSF/Vinnova contract grant number 60761701; the Japan Society
   for the Promotion of Science grant number 442-H22; the Novo Nordisk
   Foundation; National Institutes of Health grants EB003968, AI068730,
   GM062134, and AI030040; and faculty grants from the Linnaeus University,
   Sweden.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281
   Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45
   Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132
   Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   HESSING M, 1990, J IMMUNOL, V144, P204
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   JACKSON R W, 1970, Infection and Immunity, V1, P142
   Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783
   Luan N.M., 2011, BIOMATERIALS
   Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P381, DOI 10.1163/1568562053654095
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   PLATTSMI.TA, 1974, J IMMUNOL, V113, P348
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254
   Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x
   Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Teramura Y, 2011, TRANSPLANTATION, V91, P271, DOI 10.1097/TP.0b013e3182034fa4
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437
   Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
NR 42
TC 32
Z9 32
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 4
BP 985
EP 994
DI 10.1016/j.biomaterials.2012.10.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 065NS
UT WOS:000313155800014
PM 23137394
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kim, HT
   Lee, KI
   Kim, DW
   Hwang, DY
AF Kim, Hyeong-Taek
   Lee, Kang-In
   Kim, Dong-Wook
   Hwang, Dong-Youn
TI An ECM-based culture system for the generation and maintenance of
   xeno-free human iPS cells
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix protein; Vitronectin biomaterial-based culture;
   Human induced pluripotent stem cells; Human embryonic stem cells
ID EMBRYONIC STEM-CELLS; PROLONGED UNDIFFERENTIATED GROWTH; BOVINE
   APOLIPOPROTEIN B-100; NONHUMAN SIALIC-ACID; HUMAN FEEDER CELLS;
   RECOMBINANT VITRONECTIN; HUMAN FIBROBLASTS; SELF-RENEWAL; INDUCTION;
   SERUM
AB Pluripotent stem cells (PSCs) including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) have emerged as a promising source for treating incurable diseases. Problems that urgently need to be resolved before the clinical application include avoiding potential xenopathogenic transmission and immune rejection that may be caused by the exposure of PSCs to animal-derived products. In addition, an efficient feeder cell-free culture condition would be required for reducing batch-to-batch variation and facilitating scale-up. Therefore, establishing an efficient xeno-free and extracelluar matrix-based culture system is a prerequisite for the clinical application of PSCs. In this study, by blocking protein kinase C and histone deacetylase activities, we formulated a medium that, in combination with vitronectin as an extracellular matrix, not only allows the long-term culture of hESCs and iPSCs but also efficiently generates xeno-free iPSCs. This xeno-free and feeder cell-free culture system would facilitate the clinical applications of both iPSC- and ESC-based cell therapies in the future. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kim, Hyeong-Taek; Lee, Kang-In; Hwang, Dong-Youn] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 463840, South Korea.
   [Kim, Dong-Wook] Yonsei Univ, Sch Med, Dept Physiol, Seoul 120749, South Korea.
RP Hwang, DY (reprint author), CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 463840, South Korea.
EM hdy@cha.ac.kr
FU Stem Cell Research Center of the 21st Frontier Research Program and Stem
   Cell Research Program [SC5170, 2010-0020350]; MEST, Korea
FX This work is supported by grants from the Stem Cell Research Center
   (SC5170) of the 21st Frontier Research Program and Stem Cell Research
   Program (2010-0020350), funded by the MEST, Korea.
CR Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Cerdan C, 2006, NAT MED, V12, P1113, DOI 10.1038/nm1006-1113
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605
   Feng XZ, 2012, STEM CELLS, V30, P461, DOI 10.1002/stem.1018
   Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444
   Hisamatsu-Sakamoto M, 2008, STEM CELLS, V26, P72, DOI 10.1634/stemcells.2007-0744
   Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]
   Kim HT, 2012, TISSUE ENG REGEN MED, V9, P55
   Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolrepod.104.033480
   Lee JB, 2004, REPRODUCTION, V128, P727, DOI 10.1530/rep.1.00415
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546
   Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248
   Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328
   Sakamoto N, 2007, BLOOD, V110, P501, DOI 10.1182/blood-2007-07-066522
   Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106
   Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232
   Wang Q, 2005, STEM CELLS, V23, P1221, DOI 10.1634/stemcells.2004-0347
   Wang QH, 2012, PROTEIN CELL, V3, P51, DOI 10.1007/s13238-012-2002-0
   Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Yoon TM, 2010, STEM CELL REV REP, V6, P425, DOI 10.1007/s12015-010-9158-x
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
NR 33
TC 18
Z9 18
U1 4
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 4
BP 1041
EP 1050
DI 10.1016/j.biomaterials.2012.10.064
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 065NS
UT WOS:000313155800020
PM 23153417
DA 2018-10-20
ER

PT J
AU Myllymaa, K
   Levon, J
   Tiainen, VM
   Myllymaa, S
   Soininen, A
   Korhonen, H
   Kaivosoja, E
   Lappalainen, R
   Konttinen, YT
AF Myllymaa, Katja
   Levon, Jaakko
   Tiainen, Veli-Matti
   Myllymaa, Sami
   Soininen, Antti
   Korhonen, Hannu
   Kaivosoja, Emilia
   Lappalainen, Reijo
   Konttinen, Yrjo Tapio
TI Formation and retention of staphylococcal biofilms on DLC and its
   hybrids compared to metals used as biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biofilm; Staphylococci; Physical vapour deposition; Diamond-like carbon;
   Polytetrafluoroethylene
ID SURFACE FREE-ENERGY; DIAMOND-LIKE CARBON; BACTERIAL ADHESION;
   EPIDERMIDIS BIOFILMS; STAINLESS-STEEL; ROUGHNESS; CHEMISTRY; POLYMERS;
   COATINGS; COLONIZATION
AB Staphylococcus epidermidis and Staphylococcus aureus cause most of the implant-related infections.Antibiotic treatment often fails and cure requires surgical intervention. It was hypothesized that biomaterial coatings resistant to biofilms offer a preventive option. Physical vapour deposited diamond-like carbon (DLC) and its polytetrafluoroethylene (DLC-PTFE-h) and polydimethylsiloxane (DLC-PDMS-h) hybrids were compared to titanium (Ti), tantalum (Ta) and chromium (Cr) thin films on silicon wafers for their resistance against formation and/or retention of biofilms produced by S. epidermidis and S. aureus in vitro. Sample surfaces were characterized for surface topography, contact angle and zeta-potential, because such properties might affect the biofilm. Biofilm was stained using calcofluor white and analysed in fluorescence microscopy using morphometry. Sixteen hour incubation was selected in pilot tests; at this checkpoint Ti, Ta, Cr and DLC-PDMS-h were almost fully covered by biofilm, but DLC and DLC-PTFE-h were only partially biofilm coated by S. epidermidis (88 +/- 26%, p < 0.001 and 56 +/- 39%, p < 0.001, respectively) or S. aureus (81 +/- 24%, p<0.001 and 51 +/- 26%, p < 0.001, respectively). DLC and its PTFE hybrid offer a potential biofilm hostile surface coating for implants and medical devices. This ability to resist biofilm formation and attachment could not be explained by only one factor, but it seems to be related to a combination of various properties, with electrokinetic streaming potential and protein coating being particularly important for its outcome. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Myllymaa, Katja; Myllymaa, Sami; Korhonen, Hannu; Lappalainen, Reijo] Univ Kuopio, Dept Phys, FI-70211 Kuopio, Finland.
   [Myllymaa, Katja] Savonia Univ Appl Sci, Sch Engn & Technol, Microsensor Lab, FI-70201 Kuopio, Finland.
   [Levon, Jaakko] Univ Helsinki, Inst Biomed, Dept Anat, FI-00014 Hy, Finland.
   [Tiainen, Veli-Matti; Soininen, Antti; Konttinen, Yrjo Tapio] ORTON Fdn, ORTON Orthopaed Hosp, FI-00281 Helsinki, Finland.
   [Kaivosoja, Emilia; Konttinen, Yrjo Tapio] Univ Helsinki, Cent Hosp, Dept Med, Inst Clin Med, FI-00029 Helsinki, Finland.
   [Konttinen, Yrjo Tapio] COXA Hosp Joint Replacement, FI-33101 Tampere, Finland.
RP Konttinen, YT (reprint author), Univ Helsinki, Cent Hosp, Dept Med, Inst Clin Med, POB 700,Haartmaninkatu 8, FI-00029 Helsinki, Finland.
EM katja.myllymaa@uku.fi; jhlevo@utu.fi; vmt@sci.fi; sami.myllymaa@uku.fi;
   antti.soininen@invalidisaatio.fi; hannu.korhonen@uku.fi;
   emilia.kaivosoja@helsinki.fi; reijo.lappalainen@uku.fi;
   yrjo.konttinen@helsinki.fi
RI Peltola, Emilia/L-9969-2013
OI Peltola, Emilia/0000-0002-8868-9273
FU Sigrid Juselius Foundation; Finska Lakaresallskapet; evo-grants;
   Orion-Farmos Foundation; ORION Foundation; Danish Council for Strategic
   research on "Individualized Musculoskeletal Medicine"; Otto A. Maim
   Foundation; Orion-Farmos Research Foundation; PhD-programme in
   Musculoskeletal Diseases and Biomaterials (TBGS); TEKES (a Finnish
   national public funding organisation for technical research and
   development) [40270/06]
FX This research work has been supported by Sigrid Juselius Foundation,
   Finska Lakaresallskapet, evo-grants, Orion-Farmos Foundation, ORION
   Foundation, Danish Council for Strategic research on "Individualized
   Musculoskeletal Medicine", Otto A. Maim Foundation, Orion-Farmos
   Research Foundation, PhD-programme in Musculoskeletal Diseases and
   Biomaterials (TBGS) and TEKES (a Finnish national public funding
   organisation for technical research and development) project 40270/06 "A
   New Generation of Titanium Biomaterials". The authors acknowledge the
   personnel of Microsensor laboratory of Savonia University of Applied
   Sciences. Montserrat Espanol Pons and Maria-Pau Ginebra from the
   Department of Materials Science and Metallurgy, Technical University of
   Catalonia, Barcelona, Spain, are gratefully acknowledged for acting as
   hosts to Katja Myllymaa and Emilia Kaivosoja during their ESF
   Regenerative Medicine RNP-sponsored stay to learn to measure zeta
   potentials.
CR Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x
   Azeredo J, 1997, J I BREWING, V103, P359, DOI 10.1002/j.2050-0416.1997.tb00964.x
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1980, ADSORPTION MICROORGA, P59
   Baier RE, 1971, MANAGEMENT OCCLUSIVE, V147- 163
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Calzado-Martin A, 2010, ACTA BIOMATER, V6, P3325, DOI 10.1016/j.actbio.2010.02.048
   Campos E, 2008, J MICROENCAPSUL, V25, P154, DOI [10.1080/02652040701806476, 10.1080/02652040701806476 ]
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Chapin K.C., 2007, MANUAL CLIN MICROBIO, V1, P334
   COLAS A, 2004, BIOMATERIALS SCI INT, P80
   Costerton J W, 2007, BIOFILM PRIMER
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Kaivosoja E., 2011, J BIOMATER APPL
   Kaivosoja E., 2011, ANN MED
   Kaivosoja E, 2010, EUR CELLS MATER, V19, P147, DOI 10.22203/eCM.v019a15
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Konttinen YT, 2008, WOODHEAD PUBL MATER, P115, DOI 10.1533/9781845694807.2.115
   Lappalainen R, 2003, J BIOMED MATER RES B, V66B, P410, DOI 10.1002/jbm.b.10026
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Levon J, 2010, J BIOMED MATER RES A, V92A, P1606, DOI 10.1002/jbm.a.32486
   Litzler PY, 2007, J THORAC CARDIOV SUR, V134, P1025, DOI 10.1016/j.jtcvs.2007.06.013
   Lyklema J. J, 1995, FUNDAMENTALS INTERFA, V2, P1
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   MEURMAN JH, 1989, ORAL MICROBIOL IMMUN, V4, P117, DOI 10.1111/j.1399-302X.1989.tb00109.x
   Munoz OLS, 2003, ELECTROPHORESIS, V24, P390, DOI 10.1002/elps.200390049
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Nayak N, 2011, J HOSP INFECT, V77, P153, DOI 10.1016/j.jhin.2010.09.023
   Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   Quirynen M., 1995, J CLIN PERIODONTOL, V22, P1
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Amarante ES, 2008, AM J DENT, V21, P318
   Soininen A, 2009, J BIOMED MATER RES B, V90B, P882, DOI 10.1002/jbm.b.31359
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P275
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Vadyvaloo V, 2005, INT J ARTIF ORGANS, V28, P1069
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Zambon J J, 1990, Am J Dent, V3 Spec No, pS27
   Zhao Q, 2008, MED ENG PHYS, V30, P341, DOI 10.1016/j.medengphy.2007.04.004
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
NR 63
TC 16
Z9 17
U1 3
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2013
VL 101
BP 290
EP 297
DI 10.1016/j.colsurfb.2012.07.012
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 068ZS
UT WOS:000313405300044
PM 23010032
DA 2018-10-20
ER

PT J
AU Amna, T
   Hassan, MS
   Shin, WS
   Ba, HV
   Lee, HK
   Khil, MS
   Hwang, IH
AF Amna, Touseef
   Hassan, M. Shamshi
   Shin, Woon-Seob
   Ba, Hoa Van
   Lee, Hak-Kyo
   Khil, Myung-Seob
   Hwang, I. H.
TI TiO2 nanorods via one-step electrospinning technique: A novel nanomatrix
   for mouse myoblasts adhesion and propagation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE TiO2 nanorods; Cytotoxicity; Scaffolds; Myoblast cells; Electrospinning
ID ZINC-OXIDE NANORODS; THIN-FILMS; CELLS; CONVERSION; ANATASE
AB This study was aimed at the synthesis and characterization of novel Titania nanorods by sol gel electrospinning technique. The physicochemical properties of the synthesized nanorods were determined by field emission scanning electron microscopy (FE-SEM), energy dispersive X-ray spectroscopy (EDX), transmission electron microscopy (TEM), and X-ray diffraction (XRD) pattern. To examine the in vitro cytotoxicity, mouse myoblast C2C12 cells were treated with different concentrations of as prepared TiO2 nanorods and the viability of cells was analyzed by Cell Counting Kit-8 assay at regular time intervals. The morphological features of the cells attached with nanorods were examined by Bio-SEM. Cytotoxicity experiments indicated that the mouse myoblast cells could attach to the TiO2 nanorods after being cultured. We observed that TiO2 nanorods could support cell adhesion and growth and guide spreading behavior of myoblasts. We conclude that the electrospun TiO2 nanorods scaffolds with unique morphology had excellent biocompatibility. Thus, the current work demonstrates that the as-synthesized TiO2 nanorods represent a promising biomaterial to be exploited for various tissue engineering applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Amna, Touseef; Ba, Hoa Van; Hwang, I. H.] Chonbuk Natl Univ, Dept Anim Sci, Inst Rare Earth Biol Applicat, Jeonju 561756, South Korea.
   [Hassan, M. Shamshi; Khil, Myung-Seob] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Shin, Woon-Seob] Kwandong Univ, Dept Microbiol, Coll Med, Kangnung 210701, South Korea.
   [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea.
RP Lee, HK (reprint author), Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea.
EM breedlee@empas.com; inho.hwang@jbnu.ac.kr
FU Next-Generation BioGreen 21 Program [PJ008191]; Rural Development
   Administration, Republic of Korea [PJ907055]
FX This work has been conducted and partly supported by a grant from
   Next-Generation BioGreen 21 Program (No. PJ008191) and a fund for FTA
   issues (No. PJ907055), Rural Development Administration, Republic of
   Korea.
CR Brown G. L., 1979, EuropeanPatent, Patent No. 0004966
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607
   Jenkins R., 1996, INTRO XRAY POWDER DI
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Liu Y., 2000, J ELECT MAT, V29, P60
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Madhugiri S, 2003, J AM CHEM SOC, V125, P14531, DOI 10.1021/ja030326i
   Maiyalagan T, 2008, APPL CATAL A-GEN, V340, P191, DOI 10.1016/j.apcata.2008.02.016
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Moon WT, 2006, SENSOR ACTUAT B-CHEM, V115, P123, DOI 10.1016/j.snb.2005.08.024
   More AM, 2008, SENSOR ACTUAT B-CHEM, V129, P671, DOI 10.1016/j.snb.2007.09.026
   NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Pathan H.M., 2005, MATER CHEM PHYS, V97, P5
   Saito Y, 2004, SOL ENERG MAT SOL C, V83, P1, DOI 10.1016/j.solomat.2004.02.010
   Sankapal BR, 2006, CR CHIM, V9, P702, DOI 10.1016/j.crci.2005.06.035
   Sankapal BR, 2005, APPL SURF SCI, V239, P165, DOI 10.1016/j.apsusc.2004.05.142
   Shimizu K, 1999, THIN SOLID FILMS, V351, P220, DOI 10.1016/S0040-6090(99)00084-X
   Shin YJ, 2007, CURR EYE RES, V32, P1, DOI 10.1080/02713680601077061
   Sorapong P., 2005, J SOLID STATE CHEM, V178, P3110
   Yoo KC, 2012, INT J NANOMED, V7, P1203, DOI 10.2147/IJN.S28647
   Yoon YI, 2009, CARBOHYD POLYM, V5, P246
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
NR 28
TC 16
Z9 16
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2013
VL 101
BP 424
EP 429
DI 10.1016/j.colsurfb.2012.06.012
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 068ZS
UT WOS:000313405300062
PM 23010050
DA 2018-10-20
ER

PT J
AU Forni, MF
   Loureiro, RR
   Cristovam, PC
   Bonatti, JA
   Sogayar, MC
   Gomes, JAP
AF Forni, Maria Fernanda
   Loureiro, Renata Ruoco
   Cristovam, Priscila Cristina
   Bonatti, Jose Americo
   Sogayar, Mari Cleide
   Pereira Gomes, Jose Alvaro
TI Comparison Between Different Biomaterial Scaffolds for Limbal-Derived
   Stem Cells Growth and Enrichment
SO CURRENT EYE RESEARCH
LA English
DT Article
DE Biomaterial scaffolds; Collagen gel; Extracellular matrix; Fibrin glue;
   Limbal-derived corneal stem cell
ID SIDE POPULATION CELLS; OCULAR SURFACE RECONSTRUCTION; CORNEAL
   REGENERATION; EPITHELIAL-CELLS; FIBRIN; THERAPY; MARKERS; P63;
   PHENOTYPE; LOCATION
AB Purpose/Aim: Corneal epithelial stem cells have been used for the treatment of total limbal deficiency with corneal conjunctivalization and decreased vision secondary to a variety of ocular surface diseases. We set to compare the ability of different extracellular components in promoting growth and migration of these cells.
   Materials and Methods: Growth parameters were evaluated, including cell migration and proliferation (by wound healing) and mRNA gene expression (by quantitative RT-PCR).
   Results: The growth of corneal epithelial cells plated onto different matrix has shown that all treatments were efficient in supporting exponential growth, with a small increase in the puramatrix and collagen I groups when compared with fibrin treatment, which displayed the best doubling time rate and saturation density. The mRNA relative levels for c-myc, a proliferation marker, were considerably higher in the fibrin-coated group. In a smaller extent, the same could be observed for the puramatrix and collagen I groups. The same pattern could be observed for beta-1 and alpha-6-integrin mRNA relative levels. The levels of CD71 mRNA, a LESC negative marker, were decreased in all groups, with a greater decrease in the fibrin group. We also found that the relative mRNA levels of the efflux pump ABCG2 and Delta Np63 transcripts were significantly higher in the fibrin group but not for collagen and puramatrix groups. Moreover, a diminished capacity of wound repair was observed for the uncoated control while the coated biomaterial groups were able to restore the cell-covered surface at some extent.
   Conclusion: All components tested were effective in promoting growth of corneal epithelial cells and maintenance of stem cell putative markers when compared with the uncoated surface group. Fibrin was far superior than collagen I and puramatrix in promoting survival, growth and migration of these cells.
C1 [Forni, Maria Fernanda; Sogayar, Mari Cleide] Univ Sao Paulo, NUCEL, Sao Paulo, Brazil.
   [Forni, Maria Fernanda; Sogayar, Mari Cleide] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.
   [Loureiro, Renata Ruoco; Cristovam, Priscila Cristina; Pereira Gomes, Jose Alvaro] Univ Fed Sao Paulo, BR-01239010 Sao Paulo, Brazil.
   [Bonatti, Jose Americo] Univ Sao Paulo, Med Sch Ophthalm Clin, Sao Paulo, Brazil.
RP Gomes, JAP (reprint author), Univ Fed Sao Paulo, Rua Sabara 566,Conjunto 43, BR-01239010 Sao Paulo, Brazil.
EM mcsoga@iq.usp.br; japgomes@uol.com.br
RI Loureiro, Renata/I-5669-2013; CRISTOVAM, PRISCILA/E-8481-2012; Gomes,
   Jose Alvaro Pereira/P-4798-2018
OI Gomes, Jose Alvaro Pereira/0000-0001-7329-9531; Forni, Maria
   Fernanda/0000-0002-3335-9023
FU FAPESP; CNPq; FINEP; BNDES-FUNTEC; MS-DECIT; MCT
FX The excellent technical support of Zizi de Mendoncca, Sandra Regina de
   Souza, Debora Cristina da Costa, Ricardo Krett de Oliveira and Marluce
   Cunha Mantovani is deeply appreciated. This work was supported by
   FAPESP, CNPq, FINEP, BNDES-FUNTEC, MS-DECIT, MCT.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003
   Bonatti JA, 1997, ARQUIVOS BRASILEIROS, V60, P60
   Bonatti José Américo, 2007, Arq. Bras. Oftalmol., V70, P884, DOI 10.1590/S0004-27492007000500029
   Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674
   Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.1147.x
   Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355
   Cristovam PC, 2008, ARQ BRAS OFTALMOL, V71, P689, DOI 10.1590/S0004-27492008000500015
   Ricardo JRD, 2010, ARQ BRAS OFTALMOL, V73, P541, DOI 10.1590/S0004-27492010000600017
   Daniels JT, 2007, EXPERT OPIN BIOL TH, V7, P1, DOI 10.1517/14712598.7.1.1
   De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093
   Dua HS, 1996, EYE, V10, P447, DOI 10.1038/eye.1996.98
   [顾国贞 GU Guozhen], 2008, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V34, P814
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Haug K, 2012, ACTA OPHTHALMOL
   Hayashi R, 2008, BIOCHEM BIOPH RES CO, V367, P256, DOI 10.1016/j.bbrc.2007.12.077
   LAGOUTTE FM, 1989, BRIT J OPHTHALMOL, V73, P757, DOI 10.1136/bjo.73.9.757
   Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   MORANDINI W, 1992, ACTA CIR BRAS, V7, P80
   Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114
   Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769
   Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441
   Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x
   Sonmez B, 2011, CORNEA, V30, P296, DOI 10.1097/ICO.0b013e3181eeb2af
   Sun TT, 2010, NATURE, V463, pE10, DOI 10.1038/nature08805
   Takacs L, 2009, CYTOM PART A, V75A, P54, DOI 10.1002/cyto.a.20671
   Talbot M, 2006, MOL VIS, V12, P65
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010
   Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014
   Vinciguerra P, 2008, J REFRACT SURG, V24, P323
   Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064
   Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0
   Yano S, 2005, STEM CELLS, V23, P834, DOI 10.1634/stemcells.2004-0226
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028
NR 42
TC 5
Z9 6
U1 0
U2 18
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
J9 CURR EYE RES
JI Curr. Eye Res.
PD JAN-FEB
PY 2013
VL 38
IS 1
BP 27
EP 34
DI 10.3109/02713683.2012.733053
PG 8
WC Ophthalmology
SC Ophthalmology
GA 067IV
UT WOS:000313288400004
PM 23051105
DA 2018-10-20
ER

PT J
AU Huang, XD
   Li, HY
   Lin, L
   Yao, K
AF Huang, Xiao-Dan
   Li, He-Yi
   Lin, Lin
   Yao, Ke
TI Reduced Silicone Oil Adherence to Silicone Intraocular Lens by Surface
   Modification with 2-Methacryloyloxyethyl Phosphoryl-Choline
SO CURRENT EYE RESEARCH
LA English
DT Article
DE Intraocular lens; Silicone oil; Bioadhesives; Surface modification;
   Phosphoryl-choline
ID BIOCOMPATIBILITY; ADHESION
AB Purpose: to evaluate and compare the interaction of silicone oil-intraocular lens (IOLs) biomaterial in 2-methacryloyloxyethyl phosphoryl-choline (MPC) -modified IOLs and various widely used IOLs in vitro.
   Methods: Five groups of foldable IOLs, including 3-piece hydrophobic silicone IOLs, MPC-modified silicone IOLs, 3-piece hydrophilic hydrogel IOLs, one-piece hydrophilic acrylic IOLs and one-piece hydrophobic acrylic IOLs were photographed after immersion in silicone oil. The silicone oil coverage of the anterior and posterior surfaces of each IOL was measured using EPCO Image-analysis software. The hydrophilicity of the IOL surface was characterized by the water contact angle.
   Results: hydrophilic IOLs, such as MPC-modified silicone IOLs, hydrophilic acrylic IOLs and hydrogel IOLs having a lower contact angle exhibited less silicone oil adherence than hydrophobic IOLs, including both silicone IOLs and hydrophobic acrylic IOLs (p = 0.000, p < 0.05).
   Conclusions: MPC-modified hydrophilic silicone IOLs reduce silicone oil adherence, and thus may meet the need of a foldable IOL suitable for vitreoretinal patients.
C1 [Huang, Xiao-Dan; Li, He-Yi; Lin, Lin; Yao, Ke] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China.
   [Huang, Xiao-Dan; Li, He-Yi; Lin, Lin; Yao, Ke] Zhejiang Univ, Coll Med, Inst Ophthalmol, Hangzhou 310009, Zhejiang, Peoples R China.
RP Yao, K (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China.
EM xlren@zju.edu.cn
FU National Natural Science Foundation of China [81000372]; Zhejiang Key
   Innovation Team Project of China [2009R50039]; Zhejiang Key Laboratory
   Fund of China [2011E10006]
FX This work was supported by National Natural Science Foundation of China
   (grant no. 81000372), and Zhejiang Key Innovation Team Project of China
   (grant no. 2009R50039), and Zhejiang Key Laboratory Fund of China
   (No.2011E10006). Pacific Edit reviewed the manuscript prior to
   submission.
CR Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   Apple DJ, 1997, J CATARACT REFR SURG, V23, P536, DOI 10.1016/S0886-3350(97)80210-6
   Arthur SN, 2001, J CATARACT REFR SURG, V27, P1662, DOI 10.1016/S0886-3350(01)00891-4
   Arthur SN, 2001, INT OPHTHALMOL CLIN, V41, P33, DOI 10.1097/00004397-200107000-00005
   BATTERBURY M, 1994, EYE, V8, P547, DOI 10.1038/eye.1994.135
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   Drimtzias EG, 2011, AM J OPHTHALMOL, V152, P824, DOI 10.1016/j.ajo.2011.04.009
   Huang XD, 2007, CLIN EXP OPHTHALMOL, V35, P462, DOI 10.1111/j.1442-9071.2007.01516.x
   Huang XD, 2010, J CATARACT REFR SURG, V36, P290, DOI 10.1016/j.jcrs.2009.09.027
   Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   Leaming DV, 2004, J CATARACT REFR SURG, V30, P892, DOI 10.1016/j.jcrs.2004.02.064
   Little U, 2009, ACTA BIOMATER, V5, P2025, DOI 10.1016/j.actbio.2009.01.042
   Maddula S, 2011, J CATARACT REFR SURG, V37, P740, DOI 10.1016/j.jcrs.2010.10.058
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Oner FH, 2003, OPHTHALMOLOGICA, V217, P124, DOI 10.1159/000068561
   Sarra-Bournet C, 2006, J PHYS D APPL PHYS, V39, P3461, DOI 10.1088/0022-3727/39/16/S03
   Yao K, <IT>China patent</IT>, Patent No. [<IT>ZL200510050022.X</IT>, 200510050022]
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
NR 18
TC 5
Z9 5
U1 2
U2 23
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
J9 CURR EYE RES
JI Curr. Eye Res.
PD JAN-FEB
PY 2013
VL 38
IS 1
BP 91
EP 96
DI 10.3109/02713683.2012.704477
PG 6
WC Ophthalmology
SC Ophthalmology
GA 067IV
UT WOS:000313288400013
PM 22742824
DA 2018-10-20
ER

PT J
AU Guterl, CC
   See, EY
   Blanquer, SBG
   Pandit, A
   Ferguson, SJ
   Benneker, LM
   Grijpma, DW
   Sakai, D
   Eglin, D
   Alini, M
   Iatridis, JC
   Grad, S
AF Guterl, Clare C.
   See, Eugene Y.
   Blanquer, Sebastien B. G.
   Pandit, Abhay
   Ferguson, Stephen J.
   Benneker, Lorin M.
   Grijpma, Dirk W.
   Sakai, Daisuke
   Eglin, David
   Alini, Mauro
   Iatridis, James C.
   Grad, Sibylle
TI CHALLENGES AND STRATEGIES IN THE REPAIR OF RUPTURED ANNULUS FIBROSUS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Annulus fibrosus rupture; disc herniation; disc biomechanics;
   biomaterial scaffold; pre-clinical model; interdisciplinary approach;
   annulus fibrosus tissue engineering; annulus fibrosus regeneration
ID INTERVERTEBRAL DISC DEGENERATION; LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS;
   FINITE-ELEMENT-ANALYSIS; ISSLS PRIZE WINNER; NUCLEUS PULPOSUS CELLS;
   HUMAN ANULUS FIBROSUS; RESEARCH TRIAL SPORT; LUMBAR DISC; IN-VIVO
AB Lumbar discectomy is the surgical procedure most frequently performed for patients suffering from low back pain and sciatica. Disc herniation as a consequence of degenerative or traumatic processes is commonly encountered as the underlying cause for the painful condition. While discectomy provides favourable outcome in a majority of cases, there are conditions where unmet requirements exist in terms of treatment, such as large disc protrusions with minimal disc degeneration; in these cases, the high rate of recurrent disc herniation after discectomy is a prevalent problem. An effective biological annular repair could improve the surgical outcome in patients with contained disc herniations but otherwise minor degenerative changes. An attractive approach is a tissue-engineered implant that will enable/stimulate the repair of the ruptured annulus. The strategy is to develop three-dimensional scaffolds and activate them by seeding cells or by incorporating molecular signals that enable new matrix synthesis at the defect site, while the biomaterial provides immediate closure of the defect and maintains the mechanical properties of the disc. This review is structured into (1) introduction, (2) clinical problems, current treatment options and needs, (3) biomechanical demands, (4) cellular and extracellular components, (5) biomaterials for delivery, scaffolding and support, (6) pre-clinical models for evaluation of newly developed cell- and material-based therapies, and (7) conclusions. This article highlights that an interdisciplinary approach is necessary for successful development of new clinical methods for annulus fibrosus repair. This will benefit from a close collaboration between research groups with expertise in all areas addressed in this review.
C1 [Guterl, Clare C.; Iatridis, James C.] Mt Sinai Med Ctr, Dept Orthopaed, New York, NY 10029 USA.
   [See, Eugene Y.; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Blanquer, Sebastien B. G.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland.
   [Benneker, Lorin M.] Univ Bern, Dept Orthopaed Surg, Bern, Switzerland.
   [Sakai, Daisuke] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 25911, Japan.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Groningen, Netherlands.
   [Eglin, David; Alini, Mauro; Grad, Sibylle] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Guterl, Clare C.; See, Eugene Y.; Blanquer, Sebastien B. G.; Pandit, Abhay; Ferguson, Stephen J.; Benneker, Lorin M.; Grijpma, Dirk W.; Sakai, Daisuke; Eglin, David; Alini, Mauro; Iatridis, James C.; Grad, Sibylle] AO Fdn, Collaborat Res Partner Annulus Fibrosus Rupture P, Davos, Switzerland.
RP Grad, S (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM sibylle.grad@aofoundation.org
RI Pandit, Abhay/B-6187-2008; Ferguson, Stephen/A-4118-2012
OI Pandit, Abhay/0000-0002-6292-4933; Ferguson, Stephen/0000-0003-0650-5889
FU AO Exploratory Research Board; NIAMS/NIH [R01 AR057397, F32 AR062455]
FX The authors are supported by a consortium grant from AO Exploratory
   Research Board. J. C. Iatridis receives funding from NIAMS/NIH R01
   AR057397 and C. C. Guterl from NIAMS/NIH F32 AR062455. We wish to
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   this work that could have influenced its outcome.
CR Acaroglu ER, 1995, SPINE, V20, P2690, DOI 10.1097/00007632-199512150-00010
   Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Alini M, 2002, EUR SPINE J, V11, pS215, DOI 10.1007/s00586-002-0485-8
   Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   Andersson GBJ, 1996, SPINE, V21, pS10, DOI 10.1097/00007632-199612151-00003
   Aoki Y, 2006, SPINE, V31, pE774, DOI 10.1097/01.brs.0000238681.71537.41
   Atlas SJ, 1996, SPINE, V21, P2885, DOI 10.1097/00007632-199612150-00020
   Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010
   Bailey A, 2010, 10 ANN GLOB S MOT PR
   Bajanes G, 2007, ONE YEAR FOLLOW DISC, V7
   Barth M, 2008, SPINE, V33, P273, DOI 10.1097/BRS.0b013e31816201a6
   Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313
   Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665
   BERNEY J, 1990, NEUROCHIRURGIE, V36, P354
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828
   Blankenbaker DG, 2006, AM J ROENTGENOL, V186, P795, DOI 10.2214/AJR.04.1629
   Bourgeault C, 2007, BIOMECHANICAL ASSESS, V7
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231
   Bron JL, 2011, J MECH BEHAV BIOMED, V4, P1196, DOI 10.1016/j.jmbbm.2011.04.002
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Carragee E J, 2001, Spine J, V1, P364, DOI 10.1016/S1529-9430(01)00051-1
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chen IR, 2009, SPINE, V34, P1402, DOI 10.1097/BRS.0b013e31817b8fbd
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f
   Chiang YF, 2012, CLIN BIOMECH, V27, P241, DOI 10.1016/j.clinbiomech.2011.09.008
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Choi JH, 2009, TISSUE ENG REGEN MED, V6, P83
   Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   COLE TC, 1985, BIOCHIM BIOPHYS ACTA, V839, P127, DOI 10.1016/0304-4165(85)90029-7
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Coombes AGA, 2002, BIOMATERIALS, V23, P2113, DOI 10.1016/S0142-9612(01)00341-6
   Costi JJ, 2007, J BIOMECH, V40, P2457, DOI 10.1016/j.jbiomech.2006.11.006
   Cs-Szabo G, 2002, SPINE, V27, P2212, DOI 10.1097/01.BRS.0000029249.02864.5B
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   DePalma MJ, 2012, PAIN PHYSICIAN, V15, pE53
   Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508
   Ekman P, 2009, EUR SPINE J, V18, P1175, DOI 10.1007/s00586-009-0947-3
   Ercelen O, 2003, SPINE, V28, P1922, DOI 10.1097/01.BRS.0000083326.39944.73
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freeman BJC, 2005, SPINE, V30, P2369, DOI 10.1097/01.brs.0000186587.43373.f2
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de
   Grad S, 2010, CELLS BIOMATERIALS I
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Gruber HE, 2007, SPINE, V32, P1181, DOI 10.1097/BRS.0b013e318053ec89
   Gruber HE, 2007, SPINE, V32, P1287, DOI 10.1097/BRS.0b013e31805931d8
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012
   Gruber HE, 2010, SPINE J, V10, P721, DOI 10.1016/j.spinee.2010.05.014
   Guilfoyle MR, 2007, BRIT J NEUROSURG, V21, P389, DOI 10.1080/02688690701477310
   Guyot L, 2010, 10 ANN GLOB S MOT PR
   Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]
   Haughton VM, 2002, AM J NEURORADIOL, V23, P1110
   Hegewald AA, 2012, SPINE, V37, P101, DOI 10.1097/BRS.0b013e318210ed55
   Helen W, 2007, BIOMATERIALS, V28, P2010, DOI 10.1016/j.biomaterials.2007.01.011
   Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2
   Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Heuer F, 2008, J BIOMECH, V41, P1953, DOI 10.1016/j.jbiomech.2008.03.023
   Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468
   Hoppe S, 2012, EUR RADIOL, V22, P2013, DOI 10.1007/s00330-012-2448-8
   Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4
   Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3
   Iatridis JC, 1999, J ORTHOPAED RES, V17, P732, DOI 10.1002/jor.1100170517
   Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407
   Iatridis JC, 2004, J BIOMECH, V37, P1165, DOI 10.1016/j.jbiomech.2003.12.026
   Illien-Junger S, 2012, SPINE, V37, P1865, DOI 10.1097/BRS.0b013e3182544a8a
   Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019
   Jackson AR, 2008, SPINE, V33, P1, DOI 10.1097/BRS.0b013e31815e4136
   JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201
   JENSEN MC, 1994, MAGN RESON QUART, V10, P173
   Johnson WE, 2006, EUR SPINE J, V15, pS389, DOI 10.1007/s00586-006-0125-9
   Johnson WEB, 2007, SPINE, V32, P1295, DOI 10.1097/BRS.0b013e31805b835d
   Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d
   KAMBIN P, 1995, SPINE, V20, P599, DOI 10.1097/00007632-199503010-00018
   Kang CH, 2009, SKELETAL RADIOL, V38, P877, DOI 10.1007/s00256-009-0709-7
   Kim KS, 2005, SPINE, V30, P33, DOI 10.1097/01.brs.0000149191.02304.9b
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kong QQ, 2011, SPINE, V36, P1030, DOI [10.1097/BRS.0b013e3181e80507, 10.1097/BRS.0b013e3181d10401]
   Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021
   Kvarstein G, 2009, PAIN, V145, P279, DOI 10.1016/j.pain.2009.05.001
   Le Visage C, 2006, SPINE, V31, P2036, DOI 10.1097/01.brs.0000231442.05245.87
   Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Ledic D, 2007, SPINE J, V7, p123S
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   Li XD, 2004, SPINE, V29, P2229, DOI 10.1097/01.brs.0000142427.82605.fb
   Liang HX, 2010, SPINE J, V10, P32, DOI 10.1016/j.spinee.2009.10.006
   Little JP, 2007, J BIOMECH, V40, P2744, DOI 10.1016/j.jbiomech.2007.01.007
   Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Maestretti G, 2012, P 30 INT S MIN INV S
   Mahor S, 2011, CURR DRUG DELIV, V8, P354, DOI 10.2174/156720111795768031
   Malandrino A, 2012, COMPUT METH IN PRESS
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MAROUDAS A, 1975, Journal of Anatomy, V120, P113
   Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Mehra M, 2012, J MED ECON, V15, P245, DOI 10.3111/13696998.2011.642090
   Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5
   Melrose J, 2012, SPINE, V37, P18, DOI 10.1097/BRS.0b013e31820cd8d5
   Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   MOORE AJ, 1994, BRIT J NEUROSURG, V8, P319, DOI 10.3109/02688699409029620
   MOORE RJ, 1994, SPINE, V19, P2787, DOI 10.1097/00007632-199412150-00010
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Mwale F, 2011, SPINE, V36, pE131, DOI 10.1097/BRS.0b013e3181d52b9e
   NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107
   Nasto LA, 2012, SPINE, V37, P1819, DOI 10.1097/BRS.0b013e31824ee8f7
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nerurkar NL, 2011, BIOMECH MODEL MECHAN, V10, P973, DOI 10.1007/s10237-011-0288-0
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Noailly J, 2012, EUR SPINE J, V21, pS675, DOI 10.1007/s00586-011-1716-7
   O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1
   Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15
   ORTOLANI F, 1988, BASIC APPL HISTOCHEM, V32, P443
   OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005
   PANJABI M, 1988, SPINE, V13, P913, DOI 10.1097/00007632-198808000-00008
   Parker SL, 2010, J NEUROSURG-SPINE, V12, P178, DOI 10.3171/2009.9.SPINE09410
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Pauza Kevin J, 2004, Spine J, V4, P27, DOI 10.1016/j.spinee.2003.07.001
   Pope MH, 1998, CLIN ORTHOP RELAT R, P241
   Power KA, 2011, ARTHRITIS RHEUM-US, V63, P3876, DOI 10.1002/art.30607
   Rethore G, 2009, TISSUE ENG PART C-ME, V15, P605, DOI [10.1089/ten.tec.2008.0581, 10.1089/ten.TEC.2008.0581]
   Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009
   Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150
   SACHS BL, 1987, SPINE, V12, P287, DOI 10.1097/00007632-198704000-00018
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Sato M, 2003, J BIOMED MATER RES A, V64A, P249
   Schmidt H, 2006, CLIN BIOMECH, V21, P337, DOI 10.1016/j.clinbiomech.2005.12.001
   Schmidt H, 2007, CLIN BIOMECH, V22, P988, DOI 10.1016/j.clinbiomech.2007.07.008
   Schneider TO, 1999, J ORTHOPAED RES, V17, P192, DOI 10.1002/jor.1100170207
   Schoenfeld AJ, 2010, INT J GEN MED, V3, P209
   Schollum ML, 2010, J ANAT, V216, P310, DOI 10.1111/j.1469-7580.2009.01197.x
   See EYS, 2011, SPINE, V36, P1744, DOI 10.1097/BRS.0b013e31821986b3
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Sha'ban M, 2008, J BIOMAT SCI-POLYM E, V19, P1219, DOI 10.1163/156856208785540163
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   SHIRAZIADL A, 1989, SPINE, V14, P96, DOI 10.1097/00007632-198901000-00019
   Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c
   Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd
   Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b
   SPENGLER DM, 1990, J BONE JOINT SURG AM, V72A, P230, DOI 10.2106/00004623-199072020-00010
   Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651
   Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da
   Suk KS, 2001, SPINE, V26, P672, DOI 10.1097/00007632-200103150-00024
   Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4
   Thompson RE, 2000, SPINE, V25, P3026, DOI 10.1097/00007632-200012010-00010
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433
   Veres SP, 2008, SPINE, V33, P2711, DOI 10.1097/BRS.0b013e31817bb906
   Vernon-Roberts B, 2007, SPINE, V32, P2797, DOI 10.1097/BRS.0b013e31815b64d2
   Vucetic N, 1997, ACTA ORTHOP SCAND, V68, P116, DOI 10.3109/17453679709003991
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wan YQ, 2007, MACROMOL BIOSCI, V7, P1217, DOI 10.1002/mabi.200700053
   Wang YH, 2007, EUR SPINE J, V16, P1021, DOI 10.1007/s00586-007-0306-1
   Wang Z, 2005, P ANN INT IEEE EMBS, P3202
   Watanabe A, 2007, AM J ROENTGENOL, V189, P936, DOI 10.2214/AJR.07.2142
   WEBER H, 1994, SPINE, V19, P2234, DOI 10.1097/00007632-199410000-00022
   WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003
   Wei A, 2009, INT J BIOL SCI, V5, P388
   Wei AQ, 2009, J ORTHOP RES, V27, P374, DOI 10.1002/jor.20567
   Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451
   Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe
   Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007
   Wuertz K, 2012, EUR CELLS MATER, V23, P103
   Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yoon SH, 2008, J NEUROSURG-SPINE, V8, P450, DOI 10.3171/SPI/2008/8/5/450
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
   Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019
   Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x
   YU SW, 1988, AM J NEURORADIOL, V9, P367
   Yurube T, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3764
   Zhang HN, 2011, J NEUROSURG-SPINE, V15, P404, DOI 10.3171/2011.5.SPINE10811
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
   Zhang YJ, 2011, SPINE, V36, P1519, DOI 10.1097/BRS.0b013e3181f60b39
   Zhang YJ, 2009, AM J PHYS MED REHAB, V88, P455, DOI 10.1097/PHM.0b013e3181a5f0aa
   Zhang YH, 2011, APOPTOSIS, V16, P594, DOI 10.1007/s10495-011-0596-y
   Zobel BB, 2012, SPINE, V37, P1224, DOI 10.1097/BRS.0b013e31824b2450
NR 218
TC 88
Z9 92
U1 2
U2 41
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 1
EP 21
PG 21
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 069FH
UT WOS:000313420200001
PM 23283636
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tamimi, F
   Comeau, P
   Le Nihouannen, D
   Zhang, YL
   Bassett, DC
   Khalili, S
   Gbureck, U
   Tran, SD
   Komarova, S
   Barralet, JE
AF Tamimi, F.
   Comeau, P.
   Le Nihouannen, D.
   Zhang, Y. L.
   Bassett, D. C.
   Khalili, S.
   Gbureck, U.
   Tran, S. D.
   Komarova, S.
   Barralet, J. E.
TI PERFLUORODECALIN AND BONE REGENERATION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Perfluorocarbons; bone regeneration; bone marrow; bone; biomaterials;
   radiopacity
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CEMENT; IN-VIVO; BLOOD
   SUBSTITUTES; PROGENITOR CELLS; TISSUE OXYGEN; STROMAL CELLS; MARROW;
   HYPOXIA; REPAIR
AB Perfluorodecalin (PFD) is a chemically and biologically inert biomaterial and, as many perfluorocarbons, is also hydrophobic, radiopaque and has a high solute capacity for gases such as oxygen. In this article we have demonstrated, both in vitro and in vivo, that PFD may significantly enhance bone regeneration. Firstly, the potential benefit of PFD was demonstrated by prolonging the survival of bone marrow cells cultured in anaerobic conditions. These findings translated in vivo, where PFD incorporated into bone-marrow-loaded 3D-printed scaffolds substantially improved their capacity to regenerate bone. Secondly, in addition to biological applications, we have also shown that PFD improves the radiopacity of bone regeneration biomaterials, a key feature required for the visualisation of biomaterials during and after surgical implantation. Finally, we have shown how the extreme hydrophobicity of PFD enables the fabrication of highly cohesive self-setting injectable biomaterials for bone regeneration. In conclusion, perfluorocarbons would appear to be highly beneficial additives to a number of regenerative biomaterials, especially those for bone regeneration.
C1 [Tamimi, F.; Comeau, P.; Zhang, Y. L.; Bassett, D. C.; Khalili, S.; Tran, S. D.; Komarova, S.; Barralet, J. E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Le Nihouannen, D.] Univ Bordeaux, Bordeaux, France.
   [Gbureck, U.] Univ Wurzburg, D-97070 Wurzburg, Germany.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM faleh.tamimimarino@mcgill.ca
RI Bassett, David/B-2489-2009; Gbureck, Uwe/G-1430-2012; barralet,
   jake/A-5820-2008
OI Bassett, David/0000-0001-7167-2566; barralet, jake/0000-0003-3543-6042
CR Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534
   Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321
   ARO H, 1984, J SURG RES, V37, P202, DOI 10.1016/0022-4804(84)90181-1
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2006, EUR CELLS MATER, V12, P26, DOI 10.22203/eCM.v012a03
   Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   Cheema U, 2008, CELL MOL LIFE SCI, V65, P177, DOI 10.1007/s00018-007-7356-8
   Chen FP, 2010, ACTA BIOMATER, V6, P3199, DOI 10.1016/j.actbio.2010.02.049
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, P8
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gbureck U, 2007, J CONTROL RELEASE, V122, P173, DOI 10.1016/j.jconrel.2007.06.022
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571
   Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11
   Huibregtse BA, 2000, J ORTHOPAED RES, V18, P18, DOI 10.1002/jor.1100180104
   Jeng MJ, 2003, PEDIATR RES, V53, P81, DOI 10.1203/01.PDR.0000041520.50792.0A
   Jewitt N, 1999, ENZYME MICROB TECH, V25, P349, DOI 10.1016/S0141-0229(99)00052-6
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   KIVISAARI J, 1975, ACTA ORTHOP SCAND, V46, P269, DOI 10.3109/17453677508989217
   Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kruyt MC, 2009, J ORTHOP RES, V27, P1055, DOI 10.1002/jor.20830
   Kurdy NMG, 1996, INJURY, V27, P143, DOI 10.1016/0020-1383(95)00169-7
   LANE TA, 1995, TRANSFUS SCI, V16, P19, DOI 10.1016/0955-3886(94)00067-T
   Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778
   Long D M, 1975, Bull Soc Int Chir, V34, P137
   LONG D M, 1971, Surgical Forum (Chicago), V22, P207
   LOWE KC, 1991, ADV MATER, V3, P87, DOI 10.1002/adma.19910030203
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   MATTREY RF, 1987, RADIOLOGY, V163, P339, DOI 10.1148/radiology.163.2.3550878
   MCFARLAND E, 1985, J COMPUT ASSIST TOMO, V9, P8, DOI 10.1097/00004728-198501000-00002
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Otto William R, 2005, Methods Mol Biol, V289, P251
   Pilarek M, 2008, BIOCHEM ENG J, V41, P38, DOI 10.1016/j.bej.2008.03.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PUTYATINA TK, 1994, ARTIF CELL BLOOD SUB, V22, P1281, DOI 10.3109/10731199409138827
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RIESS JG, 1988, BIOMATER ARTIF CELL, V16, P421, DOI 10.3109/10731198809132592
   Riess JG, 1998, BIOMATERIALS, V19, P1529, DOI 10.1016/S0142-9612(98)00071-4
   Roser BJ, 1999, US patent, Patent No. [6'190'701, 6190701]
   Sengupta S, 2010, TISSUE ENG PT A, V16, P3623, DOI [10.1089/ten.tea.2010.0302, 10.1089/ten.TEA.2010.0302]
   Soman N, 2003, BIO-MED MATER ENG, V13, P59
   Song-Ling L, 1975, US Patent, Patent No. [3'996'355, 3996355]
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   Tan Q, 2009, TISSUE ENG PT A, V15, P2471, DOI 10.1089/ten.tea.2008.0461
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yu T, 2009, ACTA BIOMATER, V5, P2717, DOI 10.1016/j.actbio.2009.03.015
NR 60
TC 10
Z9 10
U1 0
U2 33
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 22
EP 36
DI 10.22203/eCM.v025a02
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 069FH
UT WOS:000313420200002
PM 23283637
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kramer, ER
   Morey, AM
   Staruch, M
   Suib, SL
   Jain, M
   Budnick, JI
   Wei, M
AF Kramer, Erica R.
   Morey, Aimee M.
   Staruch, Margo
   Suib, Steven L.
   Jain, Menka
   Budnick, Joseph I.
   Wei, Mei
TI Synthesis and characterization of iron-substituted hydroxyapatite via a
   simple ion-exchange procedure
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MAGNETIC NANOPARTICLES; OXIDE NANOPARTICLES
AB Hydroxyapatite (HA), the main inorganic component of natural bones, is widely studied as a biomaterial due to its excellent biocompatibility and osteoinductivity. The crystal structure of HA lends itself to a wide variety of substitutions and ion doping, which allows for tailoring of material properties. In this study, iron-doped HA was synthesized via a simple ion-exchange procedure and characterized thoroughly for crystal structure and phase purity using X-ray diffraction, energy-dispersive X-ray spectroscopy, inductively coupled plasma atomic emission spectroscopy, and Fourier transform infrared spectroscopy. Magnetic properties were studied using vibrating sample magnetometer and superconducting quantum interference device analysis. Ion-exchange was attempted using both ferric and ferrous chloride iron solutions, but a substitution was only achieved using ferric chloride solution. The results showed that after iron substitution the powder retained characteristic apatite crystal structure and functional groups, but the iron-doped samples displayed paramagnetic properties, as opposed to the diamagnetism of pure HA. The effect of soaking time on iron content was also examined, and collectively X-ray diffraction and inductively coupled plasma atomic emission spectroscopy results suggested that an increase in soaking time led to an increase in iron content in the sample powder. Iron-substituted HA nanoparticles, a biomaterial with magnetic properties, could be a promising biomaterial to be used in a variety of biomedical fields, including magnetic imaging, drug delivery, or hyperthermia-based cancer treatments.
C1 [Kramer, Erica R.; Wei, Mei] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Morey, Aimee M.; Suib, Steven L.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.
   [Staruch, Margo; Jain, Menka; Budnick, Joseph I.] Univ Connecticut, Dept Phys, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, 97 N Eagleville Rd, Storrs, CT 06269 USA.
EM m.wei@ims.uconn.edu
RI Staruch, Margo/M-9260-2015
OI Staruch, Margo/0000-0003-3088-2553; Jain, Menka/0000-0002-2264-6895
FU U.S. Department of Education Graduate Assistance In Areas of National
   Need (GAANN) Fellowship Program [P200A09315]; National Science
   Foundation [BES 0503315, CBET-1133883]; US Department of Energy Office
   of Basic Energy Sciences Division of Chemical, Geological, and
   Biological Science [DE-FG02-86ER13622.A000]
FX The authors would like to thank the U.S. Department of Education
   Graduate Assistance In Areas of National Need (GAANN) Fellowship Program
   (P200A09315) and National Science Foundation (BES 0503315 and
   CBET-1133883) for their support of the research. AM and SS thank the US
   Department of Energy Office of Basic Energy Sciences Division of
   Chemical, Geological, and Biological Science under grant
   DE-FG02-86ER13622.A000 for support of this work. They would also like to
   thank Dr. Bill Hines for his assistance with the SQUID equipment, and
   Dr. Heng Zhang for his assistance with the XPS facility.
CR Biji A., 2007, INORG CHIM ACTA, V360, P1009
   Bowden V, 2010, CHILDREN THEIR FAMIL
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157
   Ennas G, 1998, CHEM MATER, V10, P495, DOI 10.1021/cm970400u
   GOLDFARB D, 1994, J AM CHEM SOC, V116, P6344, DOI 10.1021/ja00093a039
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Li Y, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012024
   Low HR, 2008, INORG CHEM, V47, P11774, DOI 10.1021/ic801491t
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Martini F, 2006, FUNDAMENTALS ANATOMY
   Morrissey R, 2005, J MATER SCI-MATER M, V16, P387, DOI 10.1007/s10856-005-6976-5
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Patel N., 2005, Journal of the Australasian Ceramic Society, V41, P1
   Pon-On W, 2008, MATER RES BULL, V43, P2137, DOI 10.1016/j.materresbull.2007.09.004
   Prakash K. H., 2006, Molecular & Cellular Biomechanics, V3, P177
   Qu H, 2005, J MATER SCI-MATER M, V16, P447, DOI 10.1007/s10856-005-6985-4
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Wang J, 2008, J MATER SCI-MATER M, V19, P2663, DOI 10.1007/s10856-007-3365-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wu H.-C., 2007, NONOTECHNOLOGY, V18, P9
NR 28
TC 24
Z9 25
U1 1
U2 72
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2013
VL 48
IS 2
BP 665
EP 673
DI 10.1007/s10853-012-6779-2
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 062FA
UT WOS:000312903400012
DA 2018-10-20
ER

PT J
AU Nicoletti, A
   Fiorini, M
   Paolillo, J
   Dolcini, L
   Sandri, M
   Pressato, D
AF Nicoletti, A.
   Fiorini, M.
   Paolillo, J.
   Dolcini, L.
   Sandri, M.
   Pressato, D.
TI Effects of different crosslinking conditions on the chemical-physical
   properties of a novel bio-inspired composite scaffold stabilised with
   1,4-butanediol diglycidyl ether (BDDGE)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DERMAL SHEEP COLLAGEN; OSTEOCHONDRAL DEFECTS; TRICALCIUM PHOSPHATE;
   FABRICATED SCAFFOLDS; HUMAN CHONDROCYTES; CARTILAGE REPAIR;
   DRUG-DELIVERY; BONE; HYDROXYAPATITE; BIOMATERIAL
AB Serious cartilage lesions (Outerbridge III, IV) may be successfully treated with a three-layered gradient scaffold made by magnesium-doped hydroxyapatite and type I collagen, manufactured through a bio-inspired process and stabilised by a reactive bis-epoxy (1,4-butanediol diglycidyl ether, BDDGE). Each layer was analysed to elucidate the effects of crosslinking variables (concentration, temperature and pH). The chemical stabilisation led to an homogeneous and aligned collagenous matrix: the fibrous structures switched to a laminar foils-based arrangement and organic phases acquired an highly coordinated 3D-organization. These morphological features were strongly evident when crosslinking occurred in alkaline solution, with BDDGE concentration of at least 1 wt%. The optimised crosslinking conditions did not affect the apatite nano-crystals nucleated into self-assembling collagen fibres. The present work allowed to demonstrate that acting on BDDGE reaction parameters might be an useful tool to control the chemical-physical properties of bio-inspired scaffold suitable to heal wide osteochondral defects, even through arthroscopic procedure.
C1 [Nicoletti, A.; Fiorini, M.; Paolillo, J.; Dolcini, L.; Pressato, D.] Fin Ceram Faenza SpA, I-48018 Faenza, RA, Italy.
   [Sandri, M.] CNR, Inst Sci & Technol Ceram ISTEC, I-48018 Faenza, RA, Italy.
RP Nicoletti, A (reprint author), Fin Ceram Faenza SpA, Via Ravegnana 186, I-48018 Faenza, RA, Italy.
EM anicoletti@finceramica.it
OI Sandri, Monica/0000-0001-5782-3137
CR BELL LC, 1978, ARCH ORAL BIOL, V23, P329, DOI 10.1016/0003-9969(78)90089-4
   Bigi A, 2004, CHEM MATER, V16, P3740, DOI 10.1021/cm049363e
   Chang MC, 2004, J MATER SCI, V39, P5547, DOI 10.1023/B:JMSC.0000039284.70028.fa
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GARCIACASTINEIRAS S, 1983, INVEST OPHTH VIS SCI, V24, P1181
   Gavenis K, 2006, IN VITRO CELL DEV-AN, V42, P159
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Gratzer PF, 2007, J BIOMED MATER RES B, V81B, P1, DOI 10.1002/jbm.b.30629
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Iwasaki N, 2009, AM J SPORT MED, V37, P2349, DOI 10.1177/0363546509341793
   Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lowenstam A.H., 1989, BIOMINERALIZATION
   Mauli C, 2001, J BIOMED MATER RES, V55, P141
   Metsaranta M, 1996, MATRIX BIOL, V15, P39, DOI 10.1016/S0945-053X(96)90125-0
   MORGAN K, 1980, ANN RHEUM DIS, V39, P285, DOI 10.1136/ard.39.3.285
   Nebelung S, 2011, BIORHEOLOGY, V48, P247, DOI 10.3233/BIR-2012-0597
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   QUELCH KJ, 1983, ARCH ORAL BIOL, V28, P665, DOI 10.1016/0003-9969(83)90100-0
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   STEFFEN C, 1964, J IMMUNOL, V93, P656
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Tampieri A, 2008, KEY ENG MATER, V361- 363, P543
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tampieri A, 2008, KEY ENG MATER, V361-363, P927, DOI 10.4028/www.scientific.net/KEM.361-363.927
   Tang B, 1999, CLIN IMMUNOL, V92, P256, DOI 10.1006/clim.1999.4755
   Teixeira CC, 2006, TISSUE ENG, V12, P2283, DOI 10.1089/ten.2006.12.2283
   TODHUNTER RJ, 1994, AM J VET RES, V55, P425
   Vinther MU, 2003, J AM ACAD ORTHOP SUR, V11, P421
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Westman E, 2006, CLIN EXP IMMUNOL, V145, P339, DOI 10.1111/j.1365-2249.2006.03129.x
   Yao B, 2009, MATER SCI-POLAND, V27, P319
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.3.CO;2-G
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 51
TC 14
Z9 15
U1 2
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2013
VL 24
IS 1
BP 17
EP 35
DI 10.1007/s10856-012-4782-4
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068LT
UT WOS:000313368900003
PM 23053811
DA 2018-10-20
ER

PT J
AU Peng, QM
   Ma, N
   Fang, DQ
   Li, H
   Liu, RP
   Tian, YJ
AF Peng, Qiuming
   Ma, Ning
   Fang, Daqing
   Li, Hui
   Liu, Riping
   Tian, Yongjun
TI Microstructures, aging behaviour and mechanical properties in hydrogen
   and chloride media of backward extruded Mg-Y based biomaterials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Mg biomaterials; Microstructure; Age hardening behaviour; Mechanical
   properties; Hydrogen and chloride media
ID STRESS-CORROSION CRACKING; MAGNESIUM ALLOYS; ZN; PERFORMANCE; EXTRUSION;
   BONE
AB Microstructures, aging behaviour from room temperature to 300 degrees C and mechanical properties in different media of backward extruded (BE) Mg-Y based biomaterial have been investigated. The results reveal that BE-Mg-Y based alloy is mainly composed of polygon-shaped grains and fine precipitates. The results of aging response show that BE-Mg-Y based alloy exhibits remarkable age hardening behaviour when the aging temperature is 200 degrees C and higher. The high mechanical properties of aged BE-Mg-Y based alloy are mostly associated with fine microstructure, solid solution strengthening and the existence of homogeneous precipitates. The hydrogen embrittlement dependence on the aging time is confirmed in BE-Mg-Y based alloy. Additionally, the strength and elongation of BE-Mg-Y based alloy are significantly influenced by the ion concentration in media. These results offer some implications for understanding the reduced strength of Mg based implants in body environment. It is demonstrated that the temporary high mechanical strength in air of BE-Mg-Y based biomaterials is insufficient to evaluate the in vivo mechanical integrity. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Peng, Qiuming; Ma, Ning; Li, Hui; Liu, Riping; Tian, Yongjun] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
   [Fang, Daqing] Taiyuan Univ Sci & Technol, Sch Mat Sci & Engn, Taiyuan 030024, Shanxi, Peoples R China.
RP Peng, QM (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
EM pengqiuming@gmail.com
RI Tian, Yongjun/A-1693-2010
OI Tian, Yongjun/0000-0002-4594-4879
FU National Natural Science Foundation of China [51101142, 50821001]; China
   Postdoctoral Science Foundation [2012M510766]
FX This research is financially supported by the National Natural Science
   Foundation of China (Grant Nos. 51101142 and 50821001) and the China
   Postdoctoral Science Foundation funded project (Grant No. 2012M510766).
   The authors also thank Dr. Guangli Bi for stimulating discussion.
CR Abe E, 2002, ACTA MATER, V50, P3845, DOI 10.1016/S1359-6454(02)00191-X
   Abidin NIZ, 2011, CORROS SCI, V53, P3542, DOI 10.1016/j.corsci.2011.06.030
   Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   ARSENAULT RJ, 1989, METALL TRANS A, V20, P1411, DOI 10.1007/BF02665498
   Atrens A, 2006, ADV ENG MATER, V8, P749, DOI 10.1002/adem.200600050
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Berman E, 1980, TOXIC METALS THEIR A
   BUXBAUM RE, 1985, IND ENG CHEM FUND, V24, P180, DOI 10.1021/i100018a007
   Dhanapal A, 2012, J ALLOY COMPD, V523, P49, DOI 10.1016/j.jallcom.2012.01.070
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Friedman LH, 1998, PHYS REV LETT, V81, P2715, DOI 10.1103/PhysRevLett.81.2715
   Gao Y, 2009, J ALLOY COMPD, V477, P374, DOI 10.1016/j.jallcom.2008.10.003
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Honma T, 2005, MAT SCI ENG A-STRUCT, V395, P301, DOI 10.1016/j.msea.2004.12.035
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Kim YD, 2008, J MATER SCI TECHNOL, V24, P80
   KIMURA H, 1962, ACTA METALL MATER, V10, P607, DOI 10.1016/0001-6160(62)90050-0
   Koleini S, 2012, MATER DESIGN, V33, P20, DOI 10.1016/j.matdes.2011.06.063
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Nayeb-Hashemi A. A., 1988, PHASE DIAGRAMS BINAR
   Peng QM, 2008, MAT SCI ENG A-STRUCT, V477, P193, DOI 10.1016/j.msea.2007.05.081
   Peng QM, 2012, J MECH BEHAV BIOMED, V10, P128, DOI 10.1016/j.jmbbm.2012.02.024
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Qu Q, 2011, CORROS SCI, V53, P1186, DOI 10.1016/j.corsci.2010.12.014
   Raynor R, 1959, PHYS METALLURGY MAGN
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song RG, 2004, ACTA MATER, V52, P4727, DOI 10.1016/j.actamat.2004.06.023
   Wu Q, 2012, J MECH BEHAV BIOMED, V8, P1, DOI 10.1016/j.jmbbm.2011.12.011
   Yamasaki M, 2007, CORROS SCI, V49, P255, DOI 10.1016/j.corsci.2006.05.017
   Yang L, 2012, J MECH BEHAV BIOMED, V13, P36, DOI 10.1016/j.jmbbm.2012.04.007
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 38
TC 10
Z9 14
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2013
VL 17
BP 176
EP 185
DI 10.1016/j.jmbbm.2012.08.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 066OP
UT WOS:000313230400016
PM 23127631
DA 2018-10-20
ER

PT J
AU Skardal, A
   Mack, D
   Atala, A
   Soker, S
AF Skardal, Aleksander
   Mack, David
   Atala, Anthony
   Soker, Shay
TI Substrate elasticity controls cell proliferation, surface marker
   expression and motile phenotype in amniotic fluid-derived stem cells
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Elastic modulus; Amniotic fluid-derived stem cells; Biomaterial; Cell
   therapy; Cell mobility
ID IN-VIVO; REGENERATIVE MEDICINE; MIGRATION; MUSCLE; EXPANSION; ADHESION;
   TISSUES; NICHES; THY-1
AB The physical cues presented to stem cells by the substrate on or in which they exist have been shown to play a crucial role in regulation of their behavior. Until recently, most research has focused on the effects of substrate elasticity on differentiation capability rather than maintenance of long-term proliferation and plasticity. The main goal of the present study is to study the interaction of amniotic fluid-derived stem (AFS) cells with growth substrata of different elasticity, which may extend their application potentials. Here, we investigate the effects of elastic modulus (E'), on AFS cell proliferation, morphology, cell surface marker expression, and autocrine stimulation of cell migration. AFS cells cultured on substrates of different E' exhibited significant changes in proliferation and morphology. Immunohistochemistry revealed increased expression of cell surface markers associated with mesenchymal stem cells (MSCs) (CD44, CD90, CD105, and N-cadherin) in cells cultured on softer substrates. Additionally, AFS cells cultured on softer substrates induced autocrine stimulation of migration. Therefore, tailoring the elastic modulus of biomaterials to specific stiffness values is an effective method to control stem cell properties, which may modulate the effectiveness of their therapeutic applications. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Skardal, Aleksander; Mack, David; Atala, Anthony; Soker, Shay] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Soker, S (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
EM ssoker@wakehealth.edu
OI Atala, Anthony/0000-0001-8186-2160
FU NIH NIBIB Grant [R01EB008009]
FX This research was supported by an NIH NIBIB Grant (R01EB008009).
CR Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Augello A, 2010, EUR CELLS MATER, V20, P121
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Benetti A, 2008, CANCER RES, V68, P8626, DOI 10.1158/0008-5472.CAN-08-1218
   Cananzi M, 2009, REPROD BIOMED ONLINE, V18, P17, DOI 10.1016/S1472-6483(10)60111-3
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chaudhuri T, 2010, METHODS MOL BIOL, V621, P185, DOI 10.1007/978-1-60761-063-2_13
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fong CY, 2012, J CELL BIOCHEM, V113, P658, DOI 10.1002/jcb.23395
   Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Hoist J, 2010, NAT BIOTECHNOL, V28, P1123
   Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46
   Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187
   Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1
   Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008
   Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8
   Raab M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt38
   Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008
   Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev
   Valli A, 2010, ONCOGENE, V29, P966, DOI 10.1038/onc.2009.405
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
NR 30
TC 20
Z9 22
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2013
VL 17
BP 307
EP 316
DI 10.1016/j.jmbbm.2012.10.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 066OP
UT WOS:000313230400028
PM 23122714
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Polak, R
   Rodas, ACD
   Chicoma, DL
   Giudici, R
   Beppu, MM
   Higa, OZ
   Pitombo, RNM
AF Polak, Roberta
   Rodas, Andrea C. D.
   Chicoma, Dennis L.
   Giudici, Reinaldo
   Beppu, Marisa M.
   Higa, Olga Z.
   Pitombo, Ronaldo N. M.
TI Inhibition of calcification of bovine pericardium after treatment with
   biopolymers, E-beam irradiation and in vitro endothelization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bovine pericardium; Electron beam irradiation; Endothelial cell;
   Calcification; Silk fibroin; Chitosan
ID TISSUE ENGINEERING APPLICATIONS; BIOPROSTHETIC HEART-VALVES; SILK
   FIBROIN; CHITOSAN MEMBRANES; RAMAN-SPECTROSCOPY; AORTIC VALVES; CELL
   ADHESION; GLUTARALDEHYDE; MATRIX; BIOMATERIALS
AB This work has investigated the in vitro calcification of bovine pericardium (BP) treated with chitosan (C), silk fibroin (SF) and electron beam irradiation after its endothelization in vitro. For this purpose, freeze-dried BP membranes treated with mixtures of C and SF (1:3, 1:1 and 3:1) and then irradiated by electron beam irradiation were seeded with human umbilical vein endothelial cells (HUVEC) in vitro. After 3 weeks of cultivation these membranes were submitted to in vitro calcification tests using simulated body fluid as the calcifying agent. Control membranes were also studied (without endothelial cells exposure). The results have shown that the membrane compatibility with HUVECs in vitro prevent such biomaterial from calcifying, showing a potential application in biomaterial area, such as cardiac valves and repair patches. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Polak, Roberta; Pitombo, Ronaldo N. M.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, BR-05508900 Sao Paulo, Brazil.
   [Rodas, Andrea C. D.; Higa, Olga Z.] IPEN CNEN SP, Energy & Nucl Res Inst, Ctr Biotechnol, Sao Paulo, Brazil.
   [Chicoma, Dennis L.; Giudici, Reinaldo] Univ Sao Paulo, Polytech Sch, Dept Chem Engn, BR-05508900 Sao Paulo, Brazil.
   [Beppu, Marisa M.] Univ Estadual Campinas, Sch Chem Engn, Campinas, SP, Brazil.
RP Pitombo, RNM (reprint author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Av Prof Lineu Prestes 580, BR-05508900 Sao Paulo, Brazil.
EM pitombo@usp.br
RI Rodas, Andrea/E-1130-2012; Polak, Roberta/E-1479-2014; BEPPU,
   MARISA/E-1057-2012; Giudici, Reinaldo/C-3467-2012
OI Giudici, Reinaldo/0000-0001-6544-7098
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   Aimoli CG, 2006, MAT SCI ENG C-BIO S, V26, P78, DOI 10.1016/j.msec.2005.06.037
   Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Arcidiacono G, 2005, J BIOMECH, V38, P1483, DOI 10.1016/j.jbiomech.2004.07.007
   Beppu MM, 2004, KEY ENG MAT, V254-2, P311, DOI 10.4028/www.scientific.net/KEM.254-256.311
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Borgognoni CF, 2009, BRAZ ARCH BIOL TECHN, V52, P1493, DOI 10.1590/S1516-89132009000600021
   Chester AH, 2011, ASWAN HEART CTR SCI, V4
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   da Costa FDA, 2004, ARTIF ORGANS, V28, P366, DOI 10.1111/j.1525-1594.2004.47357.x
   Daar E, 2010, NUCL INSTRUM METH A, V619, P356, DOI 10.1016/j.nima.2009.11.007
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Gross J. M., 2003, J THORAC CARDIOVASC, V125, pS6
   Gulbins H, 2006, ANN THORAC SURG, V81, P1472, DOI 10.1016/j.athoracsur.2005.11.011
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hung HS, 2011, CELL TRANSPLANT, V20, P63, DOI 10.3727/096368910X532864
   Jastrzebska M, 2005, J MOL STRUCT, V744, P789, DOI 10.1016/j.molstruc.2004.11.040
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kubisz L, 2007, SPECTROCHIM ACTA A, V66, P616, DOI 10.1016/j.saa.2006.04.003
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203
   Nina Vinicius José da Silva, 2004, Braz. J. Cardiovasc. Surg., V19, P144, DOI 10.1590/S0102-76382004000200008
   Nogueira GM, 2010, BIORESOURCE TECHNOL, V101, P8446, DOI 10.1016/j.biortech.2010.06.064
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   Orefice RL, 2006, BIOMATERIAIS FUNDAME
   Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015
   Otero EU, 2004, SPECTROSC-INT J, V18, P75, DOI 10.1155/2004/975105
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Polak R, 2011, CRYOBIOLOGY, V63, P61, DOI 10.1016/j.cryobiol.2011.05.001
   Popp J., 2011, OPT PHOTONIK, V6, P24
   Rodas ACD, 2011, ARTIF ORGANS, V35, P502, DOI 10.1111/j.1525-1594.2011.01255.x
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schrader B, 1995, INFRARED RAMAN SPECT
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao JZ, 2005, J APPL POLYM SCI, V96, P1999, DOI 10.1002/app.21346
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Starr A, 2002, CLIN EXP PHARMACOL P, V29, P735, DOI 10.1046/j.1440-1681.1999.03710.x
   Trantina-Yates AE, 2001, BIOMATERIALS, V22, P1837, DOI 10.1016/S0142-9612(00)00365-3
   Unger R.E., 2010, BIOMATERIALS, V27, P959
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
NR 64
TC 4
Z9 4
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2013
VL 33
IS 1
BP 85
EP 90
DI 10.1016/j.msec.2012.08.009
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 065NP
UT WOS:000313155500013
PM 25428047
DA 2018-10-20
ER

PT J
AU Hamza, S
   Bouchemi, M
   Slimane, N
   Azari, Z
AF Hamza, Samir
   Bouchemi, Meryem
   Slimane, Noureddine
   Azari, Zitouni
TI Physical and chemical characterization of adsorbed protein onto gold
   electrode functionalized with Tunisian coral and nacre
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Electrochemical impedance spectroscopy; Protein; Adsorption
ID BOVINE SERUM-ALBUMIN; IMPEDANCE SPECTROSCOPY; ELECTROCHEMICAL IMPEDANCE;
   TITANIUM SURFACES; CALCIUM-PHOSPHATE; CELL ATTACHMENT; ADSORPTION;
   POLYPYRROLE; INTERFACE; HYDROXYAPATITE
AB Bone substitutes are more and more used in bone surgery because of their biologic safety, clinic efficiency and facility to synthesize. Bone substitutes with active osteogenic properties, associating biomaterials with organic macromolecule components of the extracellular matrix (protein, GAG) are recommended. Nevertheless, we should have a simple technique to control interactions between proteins and the material. Natural coral and nacre have been found to be impressive bone graft substitutes. In this work, we characterize nacre and coral powder using energy dispersive X-ray analysis (EDX). We used electrochemical impedance spectroscopy (EIS) and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy to evaluate bovine serum albumin (BSA) as model protein, adsorbed to these biomaterial surfaces. In order to understand the nacre/coral-protein interfacial compatibility, it is necessary to investigate the wettability. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Hamza, Samir; Slimane, Noureddine] Natl Inst MT Kassab Orthoped, Biomat & Biomech Lab, Tunis 2010, Tunisia.
   [Azari, Zitouni] Natl Sch Engineers Metz, Lab Biomech Polymer & Struct Mech, F-57078 Metz 03, France.
   [Hamza, Samir; Bouchemi, Meryem] Natl Inst Appl Sci & Technol, Ctr Urbain Nord, Tunis 1080, Tunisia.
RP Hamza, S (reprint author), Natl Inst Appl Sci & Technol, Ctr Urbain Nord, BP 676, Tunis 1080, Tunisia.
EM samir.hamza@insat.rnu.tn; bouchemimeryem@yahoo.fr;
   labiomecanique@yahoo.fr; azari@univ-metz.fr
FU French Institute of Cooperation
FX We are grateful to Professors M. Boussaid, L. Sedel, R. M'Rabet, A.
   Abdelghani, and N. Marzouki for their help. We are greatly thankful for
   the financial support from the French Institute of Cooperation.
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bren L, 2004, J ADHES SCI TECHNOL, V18, P1711, DOI 10.1163/1568561042708403
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Ehrenbeck C, 1998, ELECTROCHIM ACTA, V43, P2781, DOI 10.1016/S0013-4686(98)00019-X
   Feng B, 2002, BIOMATERIALS, V23, P2499, DOI 10.1016/S0142-9612(01)00384-2
   Freng B., 2002, BIOMATERIALS, V23, P2499
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   Hafaid I, 2010, SENSOR ACTUAT B-CHEM, V144, P323, DOI 10.1016/j.snb.2009.08.058
   Hallik A, 2006, SYNTHETIC MET, V156, P488, DOI 10.1016/j.synthmet.2006.02.004
   Hubner W, 1998, CHEM PHYS LIPIDS, V96, P99, DOI 10.1016/S0009-3084(98)00083-8
   Irigaray JL, 1996, J BIOMAT SCI-POLYM E, V7, P741, DOI 10.1163/156856296X00507
   IRIGARAY JL, 1995, J MATER SCI-MATER M, V6, P230, DOI 10.1007/BF00146861
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kania R. E., 1997, INNOVATION TECHNOLOG, V18, P233
   KELLER H, 1992, THIN SOLID FILMS, V210, P799, DOI 10.1016/0040-6090(92)90408-4
   Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, B I OCEANOGR MONACO, V143, P49
   Love C. J., 2005, CHEM REV, V105, P1103
   Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107
   McClellan SJ, 2005, COLLOID SURFACE A, V260, P265, DOI 10.1016/j.colsurfa.2005.03.017
   Meiron TS, 2004, J COLLOID INTERF SCI, V274, P637, DOI 10.1016/j.jcis.2004.02.036
   Mejri MB, 2010, BIOSENS BIOELECTRON, V26, P1261, DOI 10.1016/j.bios.2010.06.054
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   ROUX FX, 1995, ACTA NEUROCHIR, V133, P201, DOI 10.1007/BF01420075
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   Soost F, 1996, CHIRURG, V67, P1193, DOI 10.1007/s001040050125
   Tlili A, 2006, MAT SCI ENG C-BIO S, V26, P546, DOI 10.1016/j.msec.2005.10.007
   Verma D, 2006, SPECTROCHIM ACTA A, V64, P1051, DOI 10.1016/j.saa.2005.09.014
   Vermette P, 2003, COLLOID SURFACE B, V29, P285, DOI 10.1016/S0927-7765(03)00017-1
   Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5
   Yang YZ, 2003, COLLOID SURFACE B, V30, P291, DOI 10.1016/S0927-7765(03)00116-4
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 41
TC 1
Z9 2
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2013
VL 33
IS 1
BP 537
EP 542
DI 10.1016/j.msec.2012.09.028
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 065NP
UT WOS:000313155500074
PM 25428107
DA 2018-10-20
ER

PT J
AU Nakashima, Y
   Mashima, N
   Imai, H
   Mitsugi, N
   Taki, N
   Mochida, Y
   Owan, I
   Arakaki, K
   Yamamoto, T
   Mawatari, T
   Motomura, G
   Ohishi, M
   Doi, T
   Kanazawa, M
   Iwamoto, Y
AF Nakashima, Yasuharu
   Mashima, Naohiko
   Imai, Hiroshi
   Mitsugi, Naoto
   Taki, Naoya
   Mochida, Yuichi
   Owan, Ichiro
   Arakaki, Kaoru
   Yamamoto, Takuaki
   Mawatari, Taro
   Motomura, Goro
   Ohishi, Masanobu
   Doi, Toshio
   Kanazawa, Masayuki
   Iwamoto, Yukihide
TI Clinical and radiographic evaluation of total hip arthroplasties using
   porous tantalum modular acetabular components: 5-year follow-up of
   clinical trial
SO MODERN RHEUMATOLOGY
LA English
DT Article
DE Clinical trial; Loosening; Porous tantalum; Radiolucency; Total hip
   arthroplasty
ID TRABECULAR METAL IMPLANTS; POLYETHYLENE WEAR; SCREW FIXATION;
   RADIOLOGICAL EVALUATION; BONE INGROWTH; CUPS; REPLACEMENTS; MULTICENTER;
   INTERFACE; NECROSIS
AB Porous tantalum is a biomaterial newly applied for artificial joints. We present here 5-years follow-up report of a multicenter clinical trial of total hip arthroplasties (THA) with porous tantalum modular acetabular component (modular PTC).
   Study participants received 82 hips in 79 cases, with 61.2 months follow-up on average. Age at operation was 60.9 years. Clinical results were evaluated using Merle d'Aubigne Postel score. Presence of implant loosening, periacetabular radiolucency, osteolysis, and gap filling were examined for radiographic results.
   Merle d'Aubigne Postel score improved from 10.0 to 16.4 points. All PTC were radiographically stable, with no evidence of progressive radiolucencies. Average polyethylene wear rate was 0.004 mm/year, with no periacetabular osteolysis. Fifteen hips (18.3%) showed a gap > 1 mm; however, all showed bone filling within 12 months. PTC with oversized reaming was significantly less likely to have a gap. No implant failure was noted related to modularity. Resulting survival rate of modular PTC was 100% at 5 years.
   Modular PTC showed excellent results at 5-years of follow-up. Some hips showed periacetabular gaps, which were filled with bone within 1 year. Further follow-up was needed to determine long-term efficacy.
C1 [Nakashima, Yasuharu; Yamamoto, Takuaki; Mawatari, Taro; Motomura, Goro; Ohishi, Masanobu; Doi, Toshio; Kanazawa, Masayuki; Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan.
   [Mashima, Naohiko; Imai, Hiroshi] Ehime Univ, Dept Bone & Joint Surg, Shizugawa, Toon 7910295, Japan.
   [Mitsugi, Naoto; Taki, Naoya; Mochida, Yuichi] Yokohama City Univ, Med Ctr, Dept Orthopaed Surg, Minami Ku, Yokohama, Kanagawa 2320024, Japan.
   [Owan, Ichiro; Arakaki, Kaoru] Univ Ryukyus, Dept Orthoped Surg, Nishihara, Okinawa 9030215, Japan.
RP Nakashima, Y (reprint author), Kyushu Univ, Dept Orthopaed Surg, Higashi Ku, 1-3-3 Maidashi, Fukuoka 8128582, Japan.
EM yasunaka@ortho.med.kyushu-u.ac.jp
RI U-ID, Kyushu/C-5291-2016
FU Zimmer
FX Y. N. received lecture fees from Zimmer. All other authors have declared
   no conflicts of interest.
CR Archibeck MJ, 2001, J BONE JOINT SURG AM, V83A, P1666, DOI 10.2106/00004623-200111000-00008
   Baad-Hansen T, 2011, ACTA ORTHOP, V82, P155, DOI 10.3109/17453674.2011.572251
   BOBYN JD, 1988, J BONE JOINT SURG BR, V70, P302
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bono J V, 1994, J Arthroplasty, V9, P119, DOI 10.1016/0883-5403(94)90059-0
   CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15, DOI 10.2106/00004623-197961010-00004
   DAntonio JA, 1997, CLIN ORTHOP RELAT R, P124
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Ebramzadeh E, 2003, J BONE JOINT SURG AM, V85A, P2378, DOI 10.2106/00004623-200312000-00016
   Fisher D A, 1990, Semin Arthroplasty, V1, P35
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   KERBOUL M, 1974, J BONE JOINT SURG BR, VB 56, P291
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4
   Latimer HA, 1996, J BONE JOINT SURG AM, V78A, P975, DOI 10.2106/00004623-199607000-00001
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Periasamy K, 2011, J BONE JOINT SURG BR, V93B, P1033, DOI 10.1302/0301-620X.93B8.26233
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   Schmalzried T P, 1994, J Arthroplasty, V9, P235, DOI 10.1016/0883-5403(94)90077-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Shiraza-Adl A, 2003, J BIOMED MATER RES, V27, P167
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
NR 31
TC 13
Z9 15
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1439-7595
EI 1439-7609
J9 MOD RHEUMATOL
JI Mod. Rheumatol.
PD JAN
PY 2013
VL 23
IS 1
BP 112
EP 118
DI 10.1007/s10165-012-0618-9
PG 7
WC Rheumatology
SC Rheumatology
GA 068ML
UT WOS:000313370700014
PM 22395477
DA 2018-10-20
ER

PT J
AU Chang, J
   Liu, WS
   Han, BQ
   Peng, SK
   He, B
   Gu, ZW
AF Chang, Jing
   Liu, Wanshun
   Han, Baoqin
   Peng, Sikai
   He, Bin
   Gu, Zhongwei
TI Investigation of the skin repair and healing mechanism of
   N-carboxymethyl chitosan in second-degree burn wounds
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID TISSUE GROWTH-FACTOR; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS;
   HYPERTROPHIC SCARS; EXPRESSION; FIBROBLASTS; KELOIDS; KERATINOCYTES;
   SURVIVIN; DEXAMETHASONE
AB N-carboxymethyl chitosan (NCMC) was synthesized with the modification of chitosan; the substitution degree was measured by titration. The biocompatibility and degradability of the NCMC were studied in vivo and the results showed that the NCMC was nontoxic and biocompatible. The in vivo degradation rate of NCMC in musculature was faster than that in subcutaneous tissue due to the relatively high lysozyme concentration. The NCMC was used as biomaterial to heal deep second-degree burn wounds. The wound size reduction, histological examination, and the quantification of transforming growth factor-beta(1), tumor necrosis factor-alpha and interleukin-8 protein levels, and Smad3 gene expression were measured to evaluate the healing effects. The results demonstrated that the NCMC was efficient in accelerating wound healing via activating transforming growth factor-beta(1)/Smad3 signaling pathway.
C1 [Chang, Jing; He, Bin; Gu, Zhongwei] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Chang, Jing; Liu, Wanshun; Han, Baoqin; Peng, Sikai] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.
RP Gu, ZW (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM zwgu@scu.edu.cn
FU National Basic Research Program of China (National 973 Program)
   [2011CB606206]; National Science Foundation of China [31100676,
   50830105]; Natural Science Foundation of Shandong Province
   [ZR2011CQ032]; National Science and Technology Support Program
   [2012BAI17B06]; China Postdoctoral Science Foundation Funded Project
   [2012T50777, 20110491724]
FX This work was funded by National Basic Research Program of China
   (National 973 Program, No. 2011CB606206), National Science Foundation of
   China (NO. 31100676, 50830105), Natural Science Foundation of Shandong
   Province (No. ZR2011CQ032), National Science and Technology Support
   Program (No. 2012BAI17B06), China Postdoctoral Science Foundation Funded
   Project (No. 2012T50777, 20110491724). Particular thanks are extended to
   the participants of this study and to Doctor Lin Cong of the Department
   of Pathology of the Affiliated Hospital of Medical College Qingdao
   University.
CR Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440
   BERRY RB, 1985, BRIT J PLAST SURG, V38, P163, DOI 10.1016/0007-1226(85)90045-1
   Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185
   Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003
   Funayama E, 2003, J INVEST DERMATOL, V121, P1326, DOI 10.1111/j.1523-1747.2003.12572.x
   GOLLADAY ES, 1988, SOUTHERN MED J, V81, P736, DOI 10.1097/00007611-198806000-00013
   Greenstein S, 2002, CLIN CANCER RES, V8, P1681
   Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345
   Gupta BBP, 2002, CURR SCI INDIA, V83, P1103
   Hammer S, 2004, J CELL BIOCHEM, V91, P840, DOI 10.1002/jcb.10766
   He L, 2006, CHINESE J CONT PEDIA, V8, P173
   Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771
   Jiang Du-yin, 2004, Zhonghua Zheng Xing Wai Ke Za Zhi, V20, P128
   KISCHER CW, 1982, HUM PATHOL, V13, P819, DOI 10.1016/S0046-8177(82)80078-6
   Leventhal D, 2006, ARCH FACIAL PLAST S, V8, P362, DOI 10.1001/archfaci.8.6.362
   MASTURZO A, 1960, Riforma Med, V74, P633
   Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746
   Ohtsuru Akira, 2000, Endocrine Journal, V47, pS41, DOI 10.1507/endocrj.47.SupplMarch_S41
   Ottolini MG, 2002, ANTIMICROB AGENTS CH, V46, P2299, DOI 10.1128/AAC.46.7.2299-2302.2002
   RAUSCHER GE, 1986, CUTIS, V37, P67
   Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123
   Rippo MR, 2010, INT J IMMUNOPATH PH, V23, P1153, DOI 10.1177/039463201002300419
   Roques Claude, 2008, Int J Low Extrem Wounds, V7, P137, DOI 10.1177/1534734608320786
   Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456
   Scoltock AB, 2006, CELL DEATH DIFFER, V14, P840
   Shaker SA, 2011, APPL IMMUNOHISTO M M, V19, P153, DOI 10.1097/PAI.0b013e3181efa2ef
   Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x
   Sloka JS, 2005, MULT SCLER, V11, P425, DOI 10.1191/1352458505ms1190oa
   Smith J. C., 2007, J INVEST DERMATOL, V128, P1298
   Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200
   Studdiford J, 2008, J AM BOARD FAM MED, V21, P149, DOI 10.3122/jabfm.2008.02.070011
   Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x
   SYED F, 2010, BRIT J DERMATOL, V164, P83
   Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430
   VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787
   Vincent AS, 2007, J INVEST DERMATOL, V128, P702
   Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274
   Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x
   Yoshimoto H, 1999, AM J PATHOL, V154, P883, DOI 10.1016/S0002-9440(10)65335-7
   Zhu HY, 2011, HEPATOL RES, V41, P795, DOI 10.1111/j.1872-034X.2011.00830.x
NR 40
TC 13
Z9 15
U1 5
U2 51
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JAN-FEB
PY 2013
VL 21
IS 1
BP 113
EP 121
DI 10.1111/j.1524-475X.2012.00859.x
PG 9
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 068EQ
UT WOS:000313348500050
PM 23126571
DA 2018-10-20
ER

PT J
AU Filardo, G
   Kon, E
   Roffi, A
   Di Martino, A
   Marcacci, M
AF Filardo, Giuseppe
   Kon, Elizaveta
   Roffi, Alice
   Di Martino, Alessandro
   Marcacci, Maurilio
TI Scaffold-Based Repair for Cartilage Healing: A Systematic Review and
   Technical Note
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   CLINICAL SAFETY TRIAL; TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; CHONDRAL
   DEFECTS; OSTEOCHONDRAL REGENERATION; PROSPECTIVE MULTICENTER;
   KNEE-JOINT; MATRIX
AB Purpose: The aim of this systematic review was to address the treatment of chondral and osteochondral knee lesions through the use of scaffolds, by showing surgical options and results of this scaffold-based repair approach for the healing of the articular surface. Methods: All studies published in English addressing cartilage scaffold-based treatment were identified, including those that fulfilled the following criteria: (1) Levels I to IV evidence addressing the outlined areas of interest, (2) measures of functional or clinical outcome, (3) knee cartilage lesions, and (4) minimum of 2 years of follow-up. Results: The analysis showed a progressively increasing number of articles per year from 1995 to February 2012. The number of selected articles was 51, with 40 focusing on 2-step procedures and 11 focusing on 1-step procedures. The evaluation of evidence level showed 3 randomized studies, 10 comparative studies, 33 case series, and 5 case reports. Conclusions: Regenerative scaffold-based procedures are emerging as a therapeutic option for the treatment of chondral lesions, but well-designed studies are lacking. Systematic long-term evaluation of these techniques and randomized studies are necessary to confirm the potential of this treatment approach, especially compared with the available traditional treatments. Different 1-step scaffold-based strategies are emerging to simplify the procedure and reduce costs. Level of Evidence: Level IV, systematic review of Level I to IV studies.
C1 [Filardo, Giuseppe; Kon, Elizaveta; Roffi, Alice; Di Martino, Alessandro; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Biomech Lab, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977; Roffi, Alice/0000-0002-2683-3743
CR Adachi N, 2007, J BONE JOINT SURG AM, V89A, P2752, DOI 10.2106/JBJS.F00983
   Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   Bauer S, 2011, KNEE
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103
   Clar H, 2010, KNEE, V17, P255, DOI 10.1016/j.knee.2009.09.004
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   Della Villa S, 2010, AM J SPORT MED, V38, P68, DOI 10.1177/0363546509348490
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Ebert JR, 2011, AM J SPORT MED, V39, P753, DOI 10.1177/0363546510390476
   Erggelet C, 2003, ARTHROSCOPY, V19, P108, DOI 10.1053/jars.2003.50025
   Erggelet C, 2010, ARCH ORTHOP TRAUM SU, V130, P957, DOI 10.1007/s00402-009-0957-y
   Ferruzi A, 2008, J BONE JOINT SURG AM, V90A, P90, DOI 10.2106/JBJS.H.00633
   Filardo G, 2011, KNEE
   Filardo G, 2011, KNEE SURG SPORTS TRA
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Gigante A, 2009, KNEE SURG SPORT TR A, V17, P2, DOI 10.1007/s00167-008-0635-6
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023
   Gobbi Alberto, 2009, J Knee Surg, V22, P36
   Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Gross AE, 2005, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000165845.21735.05
   Kim MK, 2010, KNEE SURG SPORT TR A, V18, P528, DOI 10.1007/s00167-009-0905-y
   Kon E, 2011, EUR J RADIOL, V79, P382, DOI 10.1016/j.ejrad.2010.04.002
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P2549, DOI 10.1177/0363546511420688
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   Kreuz PC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2638
   Kusano T, 2011, KNEE SURG SPORTS TRA
   Macmull S, 2012, INT ORTHOP
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Marcacci M, 2007, AM J SPORT MED, V35, P2014, DOI 10.1177/0363546507305455
   Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Panagopoulos A, 2012, ORTHOPEDICS, V35, pE6, DOI 10.3928/01477447-20111122-07
   Panni AS, 2011, INT J IMMUNOPATH PH, V24, P149, DOI 10.1177/03946320110241S228
   Pascarella A, 2010, KNEE SURG SPORT TR A, V18, P509, DOI 10.1007/s00167-009-1007-6
   Patrascu JM, 2010, J BONE JOINT SURG BR, V92B, P1160, DOI 10.1302/0301-620X.92B8.24341
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Ronga M, 2006, ARTHROSCOPY, V22, p576e1
   Salzmanni GM, 2009, OSTEOARTHR CARTILAGE, V17, P1576, DOI 10.1016/j.joca.2009.07.010
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Ventura A, 2012, KNEE SURG SPORT TR A, V20, P121, DOI 10.1007/s00167-011-1575-0
   Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971
   Wondrasch B, 2009, AM J SPORT MED, V37, p88S, DOI 10.1177/0363546509351272
   Zeifang F, 2010, AM J SPORT MED, V38, P924, DOI 10.1177/0363546509351499
NR 68
TC 80
Z9 84
U1 1
U2 49
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
J9 ARTHROSCOPY
JI Arthroscopy
PD JAN
PY 2013
VL 29
IS 1
BP 174
EP 186
DI 10.1016/j.arthro.2012.05.891
PG 13
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 063HL
UT WOS:000312986800021
PM 23159494
DA 2018-10-20
ER

PT J
AU Kurosaki, T
   Uematsu, M
   Shimoda, K
   Suzuma, K
   Nakai, M
   Nakamura, T
   Kitahara, T
   Kitaoka, T
   Sasaki, H
AF Kurosaki, Tomoaki
   Uematsu, Masafumi
   Shimoda, Kenichiro
   Suzuma, Kiyoshi
   Nakai, Masato
   Nakamura, Tadahiro
   Kitahara, Takashi
   Kitaoka, Takashi
   Sasaki, Hitoshi
TI Ocular Gene Delivery Systems Using Ternary Complexes of Plasmid DNA,
   Polyethylenimine, and Anionic Polymers
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE non-viral gene delivery; biomaterial; gene vector; nanoparticle; DNA
ID IN-VIVO; EPITHELIAL-CELLS; CATIONIC POLYMERS; THERAPY; VECTORS; RETINA;
   SERUM; NEOVASCULARIZATION; TRANSFECTION; BARRIER
AB In this experiment, we developed anionic ternary complexes for effective and safe ocular gene delivery. Ternary complexes were constructed by coating plasmid DNA (pDNA)/polyethylenimine (PEI) complex with anionic polymers such as gamma-polyglutamic acid (gamma-PGA) and chondroitin sulfate (CS). The cationic pDNA/PEI complex showed high gene expression on the human retinal pigment epithelial cell line, ARPE-19 cells. The pDNA/PEI complexes, however, also showed high cytotoxicity on the cells and aggregated strongly in the vitreous body. On the other hand, the anionic ternary complexes showed high gene expression on ARPE-19 cells without such cytotoxicity and aggregation. After intravitreous administration of the complexes, the anionic ternary complexes showed high gene expression in the retina. These results strongly indicate that anionic ternary complexes are suitable for effective and safe ocular gene therapy.
C1 [Shimoda, Kenichiro; Nakai, Masato; Nakamura, Tadahiro; Kitahara, Takashi; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan.
   [Kurosaki, Tomoaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan.
   [Kurosaki, Tomoaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028471, Japan.
   [Sasaki, Hitoshi] Nagasaki Univ, Global COE Program, Nagasaki 8528523, Japan.
   [Uematsu, Masafumi; Suzuma, Kiyoshi; Kitaoka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Nagasaki 8528501, Japan.
RP Sasaki, H (reprint author), Nagasaki Univ Hosp, Dept Hosp Pharm, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM sasaki@nagasaki-u.ac.jp
OI Kurosaki, Tomoaki/0000-0003-4234-6934
FU Global COE Program, Nagasaki University, Japan; Ministry of Education,
   Culture, Sports, Science and Technology of Japan
FX This study was supported in part by the Global COE Program, Nagasaki
   University, Japan and a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan.
CR Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/ng0501-92
   Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006
   Bainbridge JWB, 2002, GENE THER, V9, P320, DOI 10.1038/sj/gt/3301680
   Binley K, 2012, HUM GENE THER, V23, P980, DOI 10.1089/hum.2012.008
   Bishop P, 1996, EYE, V10, P664, DOI 10.1038/eye.1996.159
   Bloquel C, 2006, ADV DRUG DELIVER REV, V58, P1224, DOI 10.1016/j.addr.2006.07.023
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012
   Campochiaro PA, 2012, GENE THER, V19, P121, DOI 10.1038/gt.2011.164
   Carrabino S, 2005, J GENE MED, V7, P1555, DOI 10.1002/jgm.799
   Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003
   Finsinger D, 2000, GENE THER, V7, P1183, DOI 10.1038/sj.gt.3301227
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Hornof M, 2008, J GENE MED, V10, P70, DOI 10.1002/jgm.1125
   Itaka K, 2004, J GENE MED, V6, P76, DOI 10.1002/jbm.470
   Kawakami S, 2004, INT J PHARM, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013
   Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173
   Kim H, 2009, PHARM RES-DORDR, V26, P329, DOI 10.1007/s11095-008-9745-6
   Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2
   Kurosaki T, 2009, BIOMATERIALS, V30, P4427, DOI 10.1016/j.biomaterials.2009.04.041
   Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055
   Lee JH, 2008, J TISSUE ENG REGEN M, V2, P288, DOI 10.1002/term.94
   Liao HW, 2007, BIOTECHNIQUES, V42, P285, DOI 10.2144/000112404
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   MARIO CF, 1998, INT J PHARMACEUT, V162, P159
   Naik R, 2009, DRUG DISCOV TODAY, V14, P306, DOI 10.1016/j.drudis.2008.09.012
   Pathak A, 2009, Nucleic Acids Symp Ser (Oxf), P57, DOI 10.1093/nass/nrp029
   Peeters L, 2007, BIOCHEM SOC T, V35, P47, DOI 10.1042/BST0350047
   Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165
   Pitkanen L, 2003, PHARMACEUT RES, V20, P576, DOI 10.1023/A:1023238530504
   Ralph GS, 2006, CLIN SCI, V110, P37, DOI 10.1042/CS20050158
   Ruponen M, 1999, BBA-BIOMEMBRANES, V1415, P331, DOI 10.1016/S0005-2736(98)00199-0
   Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638
   Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Trubetskoy VS, 2003, GENE THER, V10, P261, DOI 10.1038/sj.gt.3301888
   Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216
NR 37
TC 10
Z9 10
U1 1
U2 25
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD JAN
PY 2013
VL 36
IS 1
BP 96
EP 101
DI 10.1248/bpb.b12-00728
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 063UK
UT WOS:000313027300016
PM 23302641
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Rokstad, AM
   Brekke, OL
   Steinkjer, B
   Ryan, L
   Kollarikova, G
   Strand, BL
   Skjak-Braek, G
   Lambris, JD
   Lacik, I
   Mollnes, TE
   Espevik, T
AF Rokstad, Anne Mari
   Brekke, Ole-Lars
   Steinkjer, Bjorg
   Ryan, Liv
   Kollarikova, Gabriela
   Strand, Berit L.
   Skjak-Braek, Gudmund
   Lambris, John D.
   Lacik, Igor
   Mollnes, Tom Eirik
   Espevik, Terje
TI The induction of cytokines by polycation containing microspheres by a
   complement dependent mechanism
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Inflammation; Complement; Biocompatibility; Microspheres;
   Alginate
ID FOREIGN-BODY REACTION; HUMAN WHOLE-BLOOD; IN-VIVO; ALGINATE
   MICROCAPSULES; INFLAMMATORY RESPONSES; ANAPHYLATOXINS C5A;
   SURFACE-CHEMISTRY; ENDOTHELIAL-CELLS; GIANT-CELLS; BIOMATERIALS
AB The cytokine-inducing potential of various microspheres were evaluated in a short-time screening assay of lepirudin-anticoagulated human whole blood utilizing the Bio-Plex Human cytokine 27-plex system. The inflammatory cytokines IL-1 beta, TNF and IL-6; the anti-inflammatory mediators IL-1ra and IL-10; the chemokines IL-8, MIP-1 alpha and MCP-1; and the growth factor VEGF were induced by polycation (poly-L-lysine or poly(methylene-co-guanidine)) containing microspheres. Alginate microspheres without polycations did not induce the corresponding cytokine panel, nor did soluble alginate. By inhibiting complement C3 using compstatin analog CP20, a total inhibition of complement activation as well as the inflammatory mediators was achieved, indicating that complement activation alone was responsible for the induced cytokines. A strong deposition of C3c on the poly-L-lysine containing surface, while not on the microspheres lacking polycations, also points to the formation of C3 convertase as involved in the biomaterial-induced cytokine induction. These results show that complement is responsible for the induction of cytokines by polycation containing microspheres. We point to complement as an important initiator of inflammatory responses to biomaterials and the lepirudin anticoagulated whole blood assay as an important tool to identify the most tolerable and safe materials for implantation to humans. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Rokstad, Anne Mari; Steinkjer, Bjorg; Ryan, Liv; Strand, Berit L.; Espevik, Terje] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway.
   [Brekke, Ole-Lars; Mollnes, Tom Eirik] Nordland Hosp, Dept Lab Med, Bodo, Norway.
   [Brekke, Ole-Lars; Mollnes, Tom Eirik] Univ Tromso, N-9001 Tromso, Norway.
   [Kollarikova, Gabriela; Lacik, Igor] Slovak Acad Sci, Inst Polymer, Dept Biomat Res, Bratislava, Slovakia.
   [Strand, Berit L.; Skjak-Braek, Gudmund] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7489 Trondheim, Norway.
   [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Mollnes, Tom Eirik] Univ Oslo, Rikshosp, Dept Immunol, N-0027 Oslo, Norway.
RP Rokstad, AM (reprint author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway.
EM anne.m.rokstad@ntnu.no
RI Strand, Berit Lokensgard/O-3999-2015
OI Strand, Berit Lokensgard/0000-0002-9951-0355; Lacik,
   Igor/0000-0001-6037-3747; Lambris, John/0000-0002-9370-5776
FU Central Norway Regional Health Authority; European Commission; Slovak
   Research and Development Agency [APVV-0486-10]; EFDS New Horizons grant;
   National Institutes of Health [A1068730]; Chicago Diabetes Project
FX This work has been financially supported by grant from the Central
   Norway Regional Health Authority, grant from the European Commission
   EP-7 BetaCellTherapy, grant from the Slovak Research and Development
   Agency under the contract No. APVV-0486-10, an EFDS New Horizons grant
   and by National Institutes of Health grants A1068730. The Chicago
   Diabetes Project (hap://www.chicagodiabetesproject.org/) is acknowledged
   for grant support and discussions during this work. A specific thank to
   David Hunkeler as critical discussion partner. The confocal imaging was
   performed at the Cellular & Molecular Imaging Core Facility, Norwegian
   University of Science and Technology (NTNU) by Kine Samset Hoem and
   Pontus Orning. Dr. Hongchang Qu is thanked for the peptide synthesis. In
   addition Dorte Christiansen and Grethe Bergseth at Department of
   Laboratory Medicine, Nordland Hospital are thanked for skillful
   technical support.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233
   Bergseth G, 2011, ANN THORAC SURG, V91, P527, DOI 10.1016/j.athoracsur.2010.10.084
   Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343
   Brekke OL, 2008, MOL IMMUNOL, V45, P3804, DOI 10.1016/j.molimm.2008.05.017
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835
   Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Lacik I, 1998, J BIOMED MATER RES, V39, P52, DOI 10.1002/(SICI)1097-4636(199801)39:1<52::AID-JBM7>3.0.CO;2-H
   Lappegard KT, 2008, J BIOMED MATER RES A, V87A, P129, DOI 10.1002/jbm.a.31750
   Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962
   Le YY, 2004, CELL MOL IMMUNOL, V1, P95
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Mangsbo SM, 2009, J IMMUNOL, V183, P6724, DOI 10.4049/jimmunol.0902374
   MOLLNES TE, 1993, CLIN EXP IMMUNOL, V91, P295
   MOLLNES TE, 1984, SCAND J IMMUNOL, V20, P157, DOI 10.1111/j.1365-3083.1984.tb00989.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Pan ZXK, 1998, BBA-GENE STRUCT EXPR, V1443, P90, DOI 10.1016/S0167-4781(98)00198-5
   Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755
   Qu H., 2012, IMMUNOBIOLOGY
   Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1
   Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sokolov A, 2012, J BIOMED MATER RES A, V100A, P1142, DOI 10.1002/jbm.a.34054
   Sokolov Andrey, 2011, J Diabetes Sci Technol, V5, P1490
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Takeda Y, 2012, CLIN EXP IMMUNOL, V167, P149, DOI 10.1111/j.1365-2249.2011.04490.x
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51
   VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x
   Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636
NR 52
TC 24
Z9 25
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 3
BP 621
EP 630
DI 10.1016/j.biomaterials.2012.10.012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060ER
UT WOS:000312759800002
PM 23103159
DA 2018-10-20
ER

PT J
AU van Noort, JM
   Bsibsi, M
   Nacken, PJ
   Gerritsen, WH
   Amor, S
   Holtman, IR
   Boddeke, E
   van Ark, I
   Leusink-Muis, T
   Folkerts, G
   Hennink, WE
   Amidi, M
AF van Noort, Johannes M.
   Bsibsi, Malika
   Nacken, Peter J.
   Gerritsen, Wouter H.
   Amor, Sandra
   Holtman, Inge R.
   Boddeke, Erik
   van Ark, Ingrid
   Leusink-Muis, Thea
   Folkerts, Gert
   Hennink, Wim E.
   Amidi, Maryam
TI Activation of an immune-regulatory macrophage response and inhibition of
   lung inflammation in a mouse model of COPD using heat-shock protein
   alpha B-crystallin-loaded PLGA microparticles
SO BIOMATERIALS
LA English
DT Article
DE PLGA microparticles; Heat-shock proteins; Immunomodulation; Macrophage;
   Toll-like receptors; COPD
ID MULTIPLE-SCLEROSIS; CANDIDATE AUTOANTIGEN; DENDRITIC CELLS; MICROARRAY
   DATA; T-CELL; TOLERANCE; DIFFERENTIATION; AUTOIMMUNITY; EXPRESSION;
   APOPTOSIS
AB As an extracellular protein, the small heat-shock protein alpha B-crystallin (HSPB5) has anti-inflammatory effects in several mouse models of inflammation. Here, we show that these effects are associated with the ability of HSPB5 to activate an immune-regulatory response in macrophages via endosomal/phagosomal CD14 and Toll-like receptors 1 and 2. Humans, however, possess natural antibodies against HSPB5 that block receptor binding. To protect it from these antibodies, we encapsulated HSPB5 in porous PLGA microparticles. We document here size, morphology, protein loading and release characteristics of such microparticles. Apart from effectively protecting HSPB5 from neutralization, PLGA microparticles also strongly promoted macrophage targeting of HSPB via phagocytosis. As a result, HSPB5 in porous PLGA microparticles was more than 100-fold more effective in activating macrophages than free soluble protein. Yet, the immune-regulatory nature of the macrophage response, as documented here by microarray transcript profiling, remained the same. In mice developing cigarette smoke-induced COPD, HSPB5-loaded PLGA microparticles were selectively taken up by alveolar macrophages upon intratracheal administration, and significantly suppressed lung infiltration by lymphocytes and neutrophils. In contrast, 30-fold higher doses of free soluble HSPB5 remained ineffective. Our data indicate that porous HSPB5-PLGA microparticles hold considerable promise as an anti-inflammatory biomaterial for humans. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [van Noort, Johannes M.; Bsibsi, Malika; Nacken, Peter J.] Delta Crystallon By, NL-2333 CK Leiden, Netherlands.
   [Gerritsen, Wouter H.; Amor, Sandra] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands.
   [Amor, Sandra] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurosci & Trauma, London E1 2AT, England.
   [Holtman, Inge R.; Boddeke, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Med Physiol, NL-9713 AV Groningen, Netherlands.
   [van Ark, Ingrid; Leusink-Muis, Thea; Folkerts, Gert] Univ Utrecht, Inst Pharmaceut Sci, Div Pharmacol, NL-3508 TB Utrecht, Netherlands.
   [Hennink, Wim E.; Amidi, Maryam] Univ Utrecht, Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands.
RP van Noort, JM (reprint author), Delta Crystallon By, Zernikedreef 9, NL-2333 CK Leiden, Netherlands.
EM hans@deltacrystallon.com
RI Amor, Sandra/A-1812-2013
OI van Noort, Johannes/0000-0002-9060-5921; Holtman, Inge
   R./0000-0001-9752-4756
FU Delta Crystal Ion BV
FX We are grateful to the microarray core facility of the VUmc, Amsterdam
   for their assistance in performing the microarray experiments. This
   study was sponsored by Delta Crystal Ion BV.
CR Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108
   Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108
   Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044
   Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063
   Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854
   Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x
   Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717
   Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6
   Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669
   Kalinski P, 1997, J IMMUNOL, V159, P28
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007
   Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45
   Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825
   Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935
   Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/261
   Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002
   Sarmiento J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027967
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   van Noort JM, 2006, MULT SCLER, V12, P287, DOI 10.1191/135248506ms1271oa
   van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8
   van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c
   van Sechel AC, 1999, J IMMUNOL, V162, P129
   van Stipdonk MJB, 2000, J NEUROIMMUNOL, V103, P103, DOI 10.1016/S0165-5728(99)00171-X
   van Stipdonk MJB, 2000, CELL IMMUNOL, V204, P128, DOI 10.1006/cimm.2000.1698
   VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0
   Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072
   Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009
   Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x
   Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399
NR 41
TC 21
Z9 21
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 3
BP 831
EP 839
DI 10.1016/j.biomaterials.2012.10.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060ER
UT WOS:000312759800023
PM 23117214
DA 2018-10-20
ER

PT J
AU Barone, A
   Ricci, M
   Grassi, RF
   Nannmark, U
   Quaranta, A
   Covani, U
AF Barone, A.
   Ricci, M.
   Grassi, R. F.
   Nannmark, U.
   Quaranta, A.
   Covani, U.
TI A 6-month histological analysis on maxillary sinus augmentation with and
   without use of collagen membranes over the osteotomy window: randomized
   clinical trial
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; collagen membrane; sinus augmentation
ID HUMAN OSTEOGENIC PROTEIN-1; FLOOR ELEVATION; DEPROTEINIZED BOVINE;
   IMPLANT PLACEMENT; AUTOGENOUS BONE; FOLLOW-UP; SURVIVAL; COMBINATION;
   SUCCESS; MIXTURE
AB Introduction Over the years, several modifications have been made to the sinus augmentation technique and to the materials used. However, there is still controversy about the need for using a barrier concurrently with a graft in sinus augmentation procedures. On this basis, the aim of this randomized clinical study was to investigate the effect of resorbable collagen membrane over the osteotomy window on maxillary sinus augmentation healing. Materials and methods Patients who required maxillary sinus augmentation were evaluated and selected to enter the study. After maxillary sinus grafting, each patient was randomly assigned to control (membrane over the osteotomy window) or test (no membrane) group. After 6 months, one bone biopsy was harvested from the lateral window and sent to the histology laboratory. The MannWhitney nonparametric test was used for comparing the two groups. P-value was set at 5%. Results Eighteen patients entered the study and were randomly allocated in control (nine patients) or test group (nine patients). The histomorphometric measurements revealed that newly formed bone was 30.7% +/- 15.5% of the total volume from the membrane group (control). The average percentage of connective tissue was 50.6% +/- 18.7% and residual graft percentage was 18.4% +/- 20.3%. On the other hand, data regarding the nonmembrane group (test) showed that the percentage of newly formed bone was 28.1% +/- 19.4%. The mean percentage of connective tissues was 59.3% +/- 15.4% and 12.6% +/- 12.4% for the residual graft particles. No significant difference was detected in the histomorphometrical evaluation between the two groups. Discussion Our results showed that, compared with sites not covered, the use of the membrane did not substantially increase the amount of vital bone over a period of 6 months. On the other hand, the use of membrane seems to reduce the proliferation of the connective tissue and the graft re-absorption rate. It is plausible that blood supply of maxillary sinus can play a role in such a result. Further studies are needed to explore whether the use of membrane could really be advantageous for the sinus augmentation procedure and to evaluate what influence this method can have on the amount and quality of reconstructed bone.
C1 [Barone, A.; Ricci, M.; Covani, U.] Univ Pisa, Dept Surg, Tirrenian Stomatol Inst, Versilia Hosp, Lido Di Camaiore, Italy.
   [Grassi, R. F.] Univ Bari, Dept Surg & Dent, Bari, Italy.
   [Quaranta, A.] Univ Roma La Sapienza, Dept Dent, Rome, Italy.
   [Nannmark, U.] Gothenburg Univ, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.
RP Barone, A (reprint author), Piazza Diaz 10, I-55041 Camaiore, LU, Italy.
EM barosurg@gmail.com
RI Barone, Antonio/O-2738-2013
OI Barone, Antonio/0000-0003-1226-7565; Grassi, Felice
   Roberto/0000-0002-4427-4180; QUARANTA, ALESSANDRO/0000-0002-4225-9374
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   BOYNE P. J., 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P265, DOI 10.1016/0030-4220(62)90105-6
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Del Fabbro M, 2008, EUR J ORAL SCI, V116, P497, DOI 10.1111/j.1600-0722.2008.00571.x
   Emtiaz Shahram, 2006, Implant Dent, V15, P171, DOI 10.1097/01.id.0000220550.27164.74
   ESPOSITO M, 2008, COCHRANE DB SYST REV, V16
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Hallman M, 2005, INT J ORAL MAX SURG, V34, P273, DOI 10.1016/j.ijom.2004.09.009
   Jensen O T, 1995, Int J Oral Maxillofac Implants, V10, P335
   Maiorana C, 2006, INT J ORAL MAX IMPL, V21, P426
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch C. E., 1991, J ORAL IMPLANTOL, V8, P13
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nevins M, 1998, IMPLANT THERAPY CLIN, P171
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Scala A, 2010, CLIN ORAL IMPLAN RES, V21, P1320, DOI 10.1111/j.1600-0501.2010.01964.x
   Schlegel KA, 2002, BIOMATERIALS, V23, P2939, DOI 10.1016/S0142-9612(01)00423-9
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Soltan Muna, 2005, J Oral Implantol, V31, P85, DOI 10.1563/0-773.1
   Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P117
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   WAGNER J R, 1991, Journal of Oral Implantology, V17, P152
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
NR 34
TC 21
Z9 21
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2013
VL 24
IS 1
BP 1
EP 6
DI 10.1111/j.1600-0501.2011.02340.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 060YR
UT WOS:000312814800001
PM 22151577
DA 2018-10-20
ER

PT J
AU Johnson, TD
   Christman, KL
AF Johnson, Todd D.
   Christman, Karen L.
TI Injectable hydrogel therapies and their delivery strategies for treating
   myocardial infarction
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE cardiac repair; catheter; heart failure; hydrogel; injectable;
   myocardial infarction; naturally derived; polymer
ID TISSUE ENGINEERING APPLICATIONS; VENTRICULAR SEPTAL RUPTURE; CARDIAC
   REPAIR; HEART-DISEASE; CHITOSAN HYDROGEL; IN-SITU; INJECTION; ALGINATE;
   BIOMATERIALS; COLLAGEN
AB Introduction: Heart failure following myocardial infarction (MI) impacts millions of people each year in the US. The field of tissue engineering has developed several potential therapies for treating MI including injectable acellular hydrogels. These injectable biomaterials can either be synthetic or naturally derived, and have the potential to be delivered minimally invasively.
   Areas covered: This review covers the different methods of delivery and presents the initial work on the use of injectable biomaterial scaffolds alone to improve cardiac function post-MI. Several naturally derived materials including alginate, collagen, chitosan, decellularized tissues, fibrin, hyaluronic acid, keratin, and Matrigel, as well as a few synthetic materials have shown promise on their own without the addition of therapeutics such as cells or growth factors. These biomaterials can be potentially delivered via endocardial, epicardial, or intracoronary injections and some can even utilize current catheter technology, indicating a potential for avoiding invasive surgical procedures. Once injected into the wall of the heart, these hydrogels create a scaffold that provides biochemical and structural cues, and the ability for cellular infiltration and remodeling of the local environment.
   Expert opinion: Injectable biomaterials have several crucial challenges that should be over come to design optimal therapies for MI and heart failure, including optimizing material properties, methods of injection and understanding the mechanisms of action. But, studies in both small and large animals have shown significant improvement in important parameters including wall thickness, vascularization of the ischemic region, left ventricular volumes, and cardiac function. Thus, the application of injectable biomaterials shows promise for developing into new therapies to treat MI, potentially improving millions of lives.
C1 [Johnson, Todd D.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU NSF; NIH [DP20D004309]
FX TD Johnson receives funding from the NSF as a graduate student fellow.
   KL Christman receives funding from the NIH (DP20D004309). KLC has an
   equity interest in Ventrix, Inc., and serves on the company's board.
CR Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   BioLineRX Ltd, 2007, SAF FEAS INJ BL 1040, Patent No. NCT00557531
   Birnbaum Y, 2002, NEW ENGL J MED, V347, P1426, DOI 10.1056/NEJMra020228
   Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH1708, DOI 10.1152/ajpheart.00911.2004
   Chachques Juan C, 2007, J Interv Cardiol, V20, P188, DOI 10.1111/j.1540-8183.2007.00255.x
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   EDWARDS BS, 1984, AM J CARDIOL, V54, P1201, DOI 10.1016/S0002-9149(84)80067-3
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ikara Holdings Inc, 2010, IK 5001 PREV REM VEN, Patent No. NCT01226563
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Laham RJ, 2005, DRUG METAB DISPOS, V33, P1101, DOI 10.1124/dmd.104.002774
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005
   Menon V, 2000, J AM COLL CARDIOL, V36, P1110, DOI 10.1016/S0735-1097(00)00878-0
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   NA GC, 1986, J BIOL CHEM, V261, P2290
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   POHJOLASINTONEN S, 1989, AM HEART J, V117, P809, DOI 10.1016/0002-8703(89)90617-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 83
TC 87
Z9 89
U1 4
U2 201
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD JAN
PY 2013
VL 10
IS 1
BP 59
EP 72
DI 10.1517/17425247.2013.739156
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 059JP
UT WOS:000312701500006
PM 23140533
DA 2018-10-20
ER

PT J
AU Pathare, PB
   Opara, UL
   Al-Said, FA
AF Pathare, Pankaj B.
   Opara, Umezuruike Linus
   Al-Said, Fahad Al-Julanda
TI Colour Measurement and Analysis in Fresh and Processed Foods: A Review
SO FOOD AND BIOPROCESS TECHNOLOGY
LA English
DT Review
DE Colour; Non-destructive measurement; Colorimeter; CIELAB; Colour index;
   Browning index; Colour kinetics; Food quality
ID RESPONSE-SURFACE METHODOLOGY; THERMAL-DEGRADATION KINETICS; JUICE
   QUALITY PARAMETERS; ASTERISK-B-ASTERISK; IMAGE-ANALYSIS; POTATO-CHIPS;
   HIGH-TEMPERATURES; ORANGE JUICE; BIOLOGICAL VARIATION; COMPUTER VISION
AB Colour is an important quality attribute in the food and bioprocess industries, and it influences consumer's choice and preferences. Food colour is governed by the chemical, biochemical, microbial and physical changes which occur during growth, maturation, postharvest handling and processing. Colour measurement of food products has been used as an indirect measure of other quality attributes such as flavour and contents of pigments because it is simpler, faster and correlates well with other physicochemical properties. This review discusses the techniques and procedures for the measurement and analysis of colour in food and other biomaterial materials. It focuses on the instrumental (objective) and visual (subjective) measurements for quantifying colour attributes and highlights the range of primary and derived objective colour indices used to characterise the maturity and quality of a wide range of food products and beverages. Different approaches applied to model food colour are described, including reaction mechanisms, response surface methodology and others based on probabilistic and non-isothermal kinetics. Colour is one of the most widely measured product quality attributes in postharvest handling and in the food processing research and industry. Apart from differences in instrumentation, colour measurements are often reported based on different colour indices even for the same product, making it difficult to compare results in the literature. There is a need for standardisation to improve the traceability and transferability of measurements. The correlation between colour and other sensory quality attributes is well established, but future prospects exist in the application of objective non-destructive colour measurement in predictive modelling of the nutritional quality of fresh and processed food products.
C1 [Pathare, Pankaj B.; Opara, Umezuruike Linus] Univ Stellenbosch, S African Res Chair Postharvest Technol, Postharvest Technol Res Lab, ZA-7600 Stellenbosch, South Africa.
   [Al-Said, Fahad Al-Julanda] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Crop Sci, Muscat, Oman.
RP Opara, UL (reprint author), Univ Stellenbosch, S African Res Chair Postharvest Technol, Postharvest Technol Res Lab, ZA-7600 Stellenbosch, South Africa.
EM opara@sun.ac.za
RI Pathare, Pankaj/C-4983-2009; Opara, Umezuruike/J-3978-2013
OI Pathare, Pankaj/0000-0001-5140-0272; Opara,
   Umezuruike/0000-0001-8056-7215
FU South African Research Chairs Initiative of the Department of Science
   and Technology; National Research Foundation
FX This work is based upon research supported by the South African Research
   Chairs Initiative of the Department of Science and Technology and
   National Research Foundation.
CR Abe S., 2011, American Journal of Food Technology, V6, P63
   Adam E, 2000, NAHRUNG, V44, P32, DOI 10.1002/(SICI)1521-3803(20000101)44:1<32::AID-FOOD32>3.0.CO;2-F
   Adekunte AO, 2010, FOOD CHEM, V122, P500, DOI 10.1016/j.foodchem.2010.01.026
   Ahmed J, 2000, J FOOD ENG, V44, P239, DOI 10.1016/S0260-8774(00)00034-0
   Ahmed J, 2002, J FOOD SCI, V67, P1088, DOI 10.1111/j.1365-2621.2002.tb09457.x
   Ahmed J, 2002, J FOOD SCI, V67, P2692, DOI 10.1111/j.1365-2621.2002.tb08800.x
   Ahmed J, 2002, INT J FOOD PROP, V5, P359, DOI 10.1081/JFP-120005791
   ALMELA L, 1995, FOOD CHEM, V53, P321, DOI 10.1016/0308-8146(95)93940-S
   Ameur LA, 2006, FOOD CHEM, V98, P790, DOI 10.1016/j.foodchem.2005.07.038
   Ameur LA, 2007, FOOD CHEM, V101, P1407, DOI 10.1016/j.foodchem.2006.03.049
   Arabhosseini A, 2011, FOOD BIOPROCESS TECH, V4, P1281, DOI 10.1007/s11947-009-0305-9
   Arslan D., 2010, FOOD BIOPROD PROCESS, V89, P504
   Arzate-Vazquez I, 2011, FOOD BIOPROCESS TECH, V4, P1307, DOI 10.1007/s11947-011-0595-6
   Assawarachan Rittichai, 2010, International Journal of Agricultural and Biological Engineering, V3, P74, DOI 10.3965/j.issn.1934-6344.2010.01.074-084
   Avila IMLB, 1999, J FOOD ENG, V39, P161, DOI 10.1016/S0260-8774(98)00157-5
   Baini R, 2009, J FOOD ENG, V93, P177, DOI 10.1016/j.jfoodeng.2009.01.012
   Barreiro JA, 1997, J FOOD ENG, V33, P359, DOI 10.1016/S0260-8774(97)00035-6
   Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322
   Bayarri S, 2001, FOOD SCI TECHNOL INT, V7, P399, DOI 10.1106/JJWN-FFRQ-JBMC-LQ5R
   BeMiller J. N., 1996, FOOD CHEM, P157
   Benlloch-Tinoco M, 2012, FOOD BIOPROCESS TECH, V5, P3021, DOI 10.1007/s11947-011-0652-1
   Boudhrioua N, 2003, LEBENSM-WISS TECHNOL, V36, P633, DOI 10.1016/S0023-6438(03)00083-5
   Brandt S, 2006, J SCI FOOD AGR, V86, P568, DOI 10.1002/jsfa.2390
   Brites C, 2010, FOOD BIOPROCESS TECH, V3, P707, DOI 10.1007/s11947-008-0108-4
   Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3
   Buera M. P., 1986, FARBE, V32, P318
   BUSLIG BS, 1987, P FLA STATE HORT SOC, V100, P47
   CAMPBELL CA, 1989, HORTSCIENCE, V24, P472
   Carcel JA, 2010, LWT-FOOD SCI TECHNOL, V43, P1191, DOI 10.1016/j.lwt.2010.04.011
   CARRENO J, 1995, FOOD RES INT, V28, P373, DOI 10.1016/0963-9969(95)00008-A
   Chen HH, 1997, J FOOD SCI, V62, P985, DOI 10.1111/j.1365-2621.1997.tb15021.x
   Chutintrasri B, 2007, LWT-FOOD SCI TECHNOL, V40, P300, DOI 10.1016/j.lwt.2005.11.003
   CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614
   CLYDESDALE FM, 1978, CRC CR REV FOOD SCI, V10, P243, DOI 10.1080/10408397809527252
   Corzo O, 2006, J FOOD ENG, V75, P21, DOI 10.1016/j.jfoodeng.2005.03.046
   Costa C, 2011, FOOD BIOPROCESS TECH, V4, P673, DOI 10.1007/s11947-011-0556-0
   Crisosto CH, 2003, POSTHARVEST BIOL TEC, V28, P159, DOI 10.1016/S0925-5214(02)00173-4
   Cubero S, 2011, FOOD BIOPROCESS TECH, V4, P487, DOI 10.1007/s11947-010-0411-8
   Dadali G, 2007, DRY TECHNOL, V25, P1703, DOI 10.1080/07373930701590954
   Dadali G, 2007, DRY TECHNOL, V25, P925, DOI 10.1080/07373930701372296
   Dana W, 2008, COMPUT ELECTRON AGR, V61, P126, DOI 10.1016/j.compag.2007.10.001
   Das I, 2004, J FOOD ENG, V62, P9, DOI 10.1016/S0260-8774(03)00164-X
   Dede S, 2007, J SCI FOOD AGR, V87, P773, DOI 10.1002/jsfa.2758
   Demirhan E, 2009, DRY TECHNOL, V27, P156, DOI 10.1080/07373930802566101
   Alvarez MD, 2010, FOOD BIOPROCESS TECH, V3, P55, DOI 10.1007/s11947-007-0051-9
   Drogoudi PD, 2008, SCI HORTIC-AMSTERDAM, V115, P149, DOI 10.1016/j.scienta.2007.08.010
   Du CJ, 2004, TRENDS FOOD SCI TECH, V15, P230, DOI 10.1016/j.tifs.2003.10.006
   Ekpong A, 2006, FOOD QUAL PREFER, V17, P622, DOI 10.1016/j.foodqual.2006.06.001
   Eksteen G. J., 1987, International Journal of Refrigeration, V10, P14, DOI 10.1016/0140-7007(87)90091-0
   Emmambux NM, 2003, J SCI FOOD AGR, V83, P1065, DOI 10.1002/jsfa.1509
   Erkan N, 2011, FOOD BIOPROCESS TECH, V4, P1322, DOI 10.1007/s11947-010-0415-4
   Esti M, 2002, FOOD CHEM, V76, P399, DOI 10.1016/S0308-8146(01)00231-X
   Fathi M, 2011, FOOD BIOPROCESS TECH, V4, P1357, DOI 10.1007/s11947-009-0222-y
   Fennema OR, 1996, FOOD CHEM
   Fernandez-Artigas P, 1999, J AGR FOOD CHEM, V47, P2872, DOI 10.1021/jf9808729
   Figura L. O., 2007, FOOD PHYS PHYS PROPE
   Francis F.J., 1980, HORTSCIENCE, V15, P14
   Francis F. J., 1975, FOOD COLORIMETRY THE
   FRANCIS FJ, 1995, FOOD QUAL PREFER, V6, P149, DOI 10.1016/0950-3293(94)00026-R
   Ganjloo A, 2011, FOOD BIOPROCESS TECH, V4, P1442, DOI 10.1007/s11947-009-0245-4
   Garcia JAL, 2000, INT J FOOD SCI TECH, V35, P385
   Garza S, 1999, FOOD RES INT, V32, P335, DOI 10.1016/S0963-9969(99)00094-0
   Geel L, 2005, FOOD QUAL PREFER, V16, P237, DOI 10.1016/j.foodqual.2004.04.014
   Giannou V, 2008, FOOD BIOPROCESS TECH, V1, P276, DOI 10.1007/s11947-007-0008-z
   Gomez-Sanchis J, 2008, J FOOD ENG, V89, P80, DOI 10.1016/j.jfoodeng.2008.04.009
   Granato D, 2010, CIENCIA TECNOL ALIME, V30, P1090, DOI 10.1590/S0101-20612010000400039
   Grossman R. P., 1999, J MARK PRACT APPL MA, V5, P78, DOI DOI 10.1108/EUM0000000004565
   Hertog MLATM, 2007, POSTHARVEST BIOL TEC, V43, P183, DOI 10.1016/j.postharvbio.2006.09.014
   Hertog MLATM, 2004, POSTHARVEST BIOL TEC, V34, P271, DOI 10.1016/j.postharvbio.2004.05.014
   Hertog MLATM, 2002, POSTHARVEST BIOL TEC, V26, P253, DOI 10.1016/S0925-5214(02)00044-3
   HOBSON GE, 1987, J HORTIC SCI, V62, P55, DOI 10.1080/14620316.1987.11515748
   Hosoda H, 2005, J JPN SOC FOOD SCI, V52, P120, DOI 10.3136/nskkk.52.120
   Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0
   Hunter R. S., 1987, MEASUREMENT APPEARAN
   HunterLab, 1995, INSIGHT COLOR, V5, P1
   Hur SJ, 2008, FOOD BIOPROCESS TECH, V1, P196, DOI 10.1007/s11947-008-0061-2
   Hutchings JB, 1994, FOOD COLOUR APPEARAN
   Ibanoglu E, 2002, J FOOD ENG, V51, P209, DOI 10.1016/S0260-8774(01)00057-7
   Ibarz A, 1999, J FOOD ENG, V39, P415, DOI 10.1016/S0260-8774(99)00032-1
   IWAHORI S, 1986, SCI HORTIC-AMSTERDAM, V28, P243, DOI 10.1016/0304-4238(86)90006-3
   Jackman P, 2011, TRENDS FOOD SCI TECH, V22, P185, DOI 10.1016/j.tifs.2011.01.008
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   Jha SN, 2007, J FOOD ENG, V78, P22, DOI 10.1016/j.jfoodeng.2005.08.048
   Jimenez-Cuesta M., 1981, P INT SOC CITRICULTU
   Jin SK, 2011, FOOD BIOPROCESS TECH, V4, P1407, DOI 10.1007/s11947-010-0392-7
   Jing H, 2011, FOOD BIOPROCESS TECH, V4, P1489, DOI 10.1007/s11947-009-0279-7
   K MINOLTA., 1994, PRECISE COLOR COMMUN
   Kang KJ, 2004, FOOD SCI BIOTECHNOL, V13, P119
   Kaya A, 2011, FOOD BIOPROCESS TECH, V4, P241, DOI 10.1007/s11947-008-0169-4
   Kaymak-Ertekin F, 2005, J FOOD ENG, V68, P443, DOI 10.1016/j.jfoodeng.2004.06.022
   Kotwaliwale N, 2007, J FOOD ENG, V78, P1207, DOI 10.1016/j.jfoodeng.2005.12.033
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P68
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P70
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P66
   Krokida MK, 2001, INT J FOOD SCI TECH, V36, P53, DOI 10.1046/j.1365-2621.2001.00426.x
   Krokida MK, 1999, DRY TECHNOL, V17, P449, DOI 10.1080/07373939908917545
   Krokida MK, 2000, DRY TECHNOL, V18, P937, DOI 10.1080/07373930008917745
   Krokida MK, 1998, DRY TECHNOL, V16, P667, DOI 10.1080/07373939808917429
   Kuhn BF, 2001, FOOD QUAL PREFER, V12, P543, DOI 10.1016/S0950-3293(01)00050-7
   LaBell F., 1993, Food Processing, USA, V54, P66
   LAMBRECHT HS, 1995, ACS SYM SER, V600, P313
   Lang C, 2012, FOOD BIOPROCESS TECH, V5, P3244, DOI 10.1007/s11947-011-0694-4
   Lebesi DM, 2011, FOOD BIOPROCESS TECH, V4, P710, DOI 10.1007/s11947-009-0181-3
   Lee HS, 2000, J AGR FOOD CHEM, V48, P1507, DOI 10.1021/jf9907236
   Leemans V, 1998, COMPUT ELECTRON AGR, V20, P117, DOI 10.1016/S0168-1699(98)00012-X
   Leon K, 2006, FOOD RES INT, V39, P1084, DOI 10.1016/j.foodres.2006.03.006
   Lin LY, 2009, FOOD CHEM, V112, P987, DOI 10.1016/j.foodchem.2008.07.022
   LITTLE AC, 1975, J FOOD SCI, V40, P410, DOI 10.1111/j.1365-2621.1975.tb02213.x
   Liu YL, 2003, MEAT SCI, V63, P301, DOI 10.1016/S0309-1740(02)00086-4
   Lopez A, 1997, DRY TECHNOL, V15, P989, DOI 10.1080/07373939708917273
   Lozano JE, 1997, J FOOD ENG, V31, P365, DOI 10.1016/S0260-8774(96)00079-9
   Lu SM, 2007, FOOD CHEM, V104, P824, DOI 10.1016/j.foodchem.2006.12.050
   Lunadei L, 2011, POSTHARVEST BIOL TEC, V60, P225, DOI 10.1016/j.postharvbio.2011.02.001
   Lurie S, 2009, OPTICAL MONITORING F, P2
   Lv B, 2009, J CEREAL SCI, V50, P262, DOI 10.1016/j.jcs.2009.06.004
   MacDougall DB, 2002, COLOUR FOOD IMPROVIN
   Maharaj R, 1999, POSTHARVEST BIOL TEC, V15, P13, DOI 10.1016/S0925-5214(98)00064-7
   Mangaraj S, 2011, FOOD BIOPROCESS TECH, V4, P272, DOI 10.1007/s11947-008-0145-z
   Manickavasagan A, 2010, FOOD BIOPROCESS TECH, V3, P450, DOI 10.1007/s11947-008-0110-x
   MARQUEZ G, 1986, J FOOD SCI, V51, P157, DOI 10.1111/j.1365-2621.1986.tb10859.x
   Martins RC, 2002, INT J REFRIG, V25, P966, DOI 10.1016/S0140-7007(01)00050-0
   Maskan A, 2002, J FOOD ENG, V54, P75, DOI 10.1016/S0260-8774(01)00187-X
   Maskan M, 2001, J FOOD ENG, V48, P169, DOI 10.1016/S0260-8774(00)00154-0
   MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6
   McMinn WAM, 1997, FOOD BIOPROD PROCESS, V75, P223, DOI 10.1205/096030897531621
   MEDLICOTT AP, 1992, TROP AGR, V69, P161
   Melendez-Martinez A., 2012, J FOOD COMPOS ANAL, V26, P837
   Melendez-Martinez AJ, 2005, J SCI FOOD AGR, V85, P894, DOI 10.1002/jsfa.2115
   Mendoza F, 2004, J FOOD SCI, V69, pE471
   Mendoza F, 2006, POSTHARVEST BIOL TEC, V41, P285, DOI 10.1016/j.postharvbio.2006.04.004
   Mitcham B., 1996, PERISHABLES HANDL NE, V85, P1
   Mohapatra D, 2010, J FOOD SCI, V75, pE146, DOI 10.1111/j.1750-3841.2010.01518.x
   MOTTUR GP, 1989, CEREAL FOOD WORLD, V34, P620
   Nevares I, 2009, FOOD BIOPROCESS TECH, V2, P328, DOI 10.1007/s11947-008-0109-3
   Nieto-Sandoval JM, 1999, COLOR RES APPL, V24, P93, DOI 10.1002/(SICI)1520-6378(199904)24:2<93::AID-COL4>3.0.CO;2-W
   Nisha P, 2011, FOOD BIOPROCESS TECH, V4, P781, DOI 10.1007/s11947-009-0300-1
   North M., 2006, 27 INT HORT C IHC200, P772
   O'Leary E, 2000, LEBENSM-WISS TECHNOL, V33, P217, DOI 10.1006/fstl.2000.0645
   Obenland D, 2009, POSTHARVEST BIOL TEC, V52, P156, DOI 10.1016/j.postharvbio.2009.01.005
   Ochoa MR, 2001, J FOOD ENG, V49, P55, DOI 10.1016/S0260-8774(00)00184-9
   OLIVER JR, 1992, CEREAL CHEM, V69, P546
   Opara L. U., 2010, BRIT FOOD J, V112, P797
   Opara L. U., 2010, BRIT FOOD J, V112, P811
   Opara LU, 2009, FOOD BIOPROCESS TECH, V2, P315, DOI 10.1007/s11947-008-0095-5
   Osanai Y, 2003, J JPN SOC FOOD SCI, V50, P254
   Ozdemir M, 2000, J FOOD ENG, V44, P31, DOI 10.1016/S0260-8774(99)00162-4
   Ozdemir M, 2000, J FOOD ENG, V45, P17, DOI 10.1016/S0260-8774(00)00036-4
   Palacios VM, 2002, J FOOD ENG, V54, P95, DOI 10.1016/S0260-8774(01)00189-3
   Papadakis SE, 2000, FOOD TECHNOL-CHICAGO, V54, P48
   Park C. R., 1975, KOREAN J NUTR, V8, P33
   Parker R, 2001, INTRO FOOD SCI
   Patras A, 2011, FOOD BIOPROCESS TECH, V4, P1245, DOI 10.1007/s11947-009-0226-7
   Patras A, 2009, INNOV FOOD SCI EMERG, V10, P308, DOI 10.1016/j.ifset.2008.12.004
   Pedreschi F, 2004, J FOOD SCI, V69, pE264
   Pedreschi F, 2007, J FOOD ENG, V79, P989, DOI 10.1016/j.jfoodeng.2006.03.020
   Pedreschi F, 2012, FOOD BIOPROCESS TECH, V5, P2401, DOI 10.1007/s11947-011-0559-x
   Pek Z, 2010, HORTSCIENCE, V45, P466
   Pereira AC, 2009, IND ENG CHEM RES, V48, P988, DOI 10.1021/ie071610b
   Pott I, 2005, INNOV FOOD SCI EMERG, V6, P412, DOI 10.1016/j.ifset.2005.05.004
   Pristijono P, 2006, POSTHARVEST BIOL TEC, V42, P256, DOI 10.1016/j.postharvbio.2006.07.006
   Purlis E, 2010, J FOOD ENG, V99, P239, DOI 10.1016/j.jfoodeng.2010.03.008
   Purlis E, 2009, FOOD RES INT, V42, P865, DOI 10.1016/j.foodres.2009.03.007
   Qin PY, 2010, INT J FOOD SCI TECH, V45, P951, DOI 10.1111/j.1365-2621.2010.02231.x
   Quevedo RA, 2010, FOOD BIOPROCESS TECH, V3, P637, DOI 10.1007/s11947-008-0106-6
   Quintas MAC, 2007, J FOOD ENG, V83, P483, DOI 10.1016/j.jfoodeng.2007.03.036
   Quitao-Teixeira LJ, 2008, FOOD BIOPROCESS TECH, V1, P364, DOI 10.1007/s11947-007-0018-x
   Raju PN, 2009, FOOD BIOPROCESS TECH, V2, P101, DOI 10.1007/s11947-008-0137-z
   Ramirez-Jimenez A, 2000, J AGR FOOD CHEM, V48, P4176, DOI 10.1021/jf9907687
   Rattanathanalerk M, 2005, J FOOD ENG, V66, P259, DOI 10.1016/j.jfoodeng.2004.03.016
   Rekha MN, 2010, FOOD BIOPROCESS TECH, V3, P441, DOI 10.1007/s11947-008-0123-5
   RESMINI P, 1993, ITALIAN J FOOD SCI, V4, P341
   Rhim JW, 2011, FOOD SCI BIOTECHNOL, V20, P215, DOI 10.1007/s10068-011-0029-2
   Rhim JW, 1999, J FOOD SCI, V64, P149, DOI 10.1111/j.1365-2621.1999.tb09880.x
   RHIM JW, 1989, J FOOD SCI, V54, P776, DOI 10.1111/j.1365-2621.1989.tb04710.x
   Ribotta PD, 2010, FOOD BIOPROCESS TECH, V3, P395, DOI 10.1007/s11947-008-0080-z
   Rodriguez-Aguilera R, 2011, LWT-FOOD SCI TECHNOL, V44, P337, DOI 10.1016/j.lwt.2010.06.014
   Rosales-Juarez M, 2008, FOOD BIOPROCESS TECH, V1, P152, DOI 10.1007/s11947-007-0004-3
   Sabanis D, 2008, FOOD BIOPROCESS TECH, V1, P374, DOI 10.1007/s11947-007-0027-9
   Sabanis D, 2009, FOOD BIOPROCESS TECH, V2, P68, DOI 10.1007/s11947-007-0037-7
   Sacks EJ, 2001, J AM SOC HORTIC SCI, V126, P221
   SAHIN S., 2006, PHYS PROPERTIES FOOD
   SAPERS GM, 1987, J FOOD SCI, V52, P1258, DOI 10.1111/j.1365-2621.1987.tb14057.x
   Saricoban C., 2010, World Applied Sciences Journal, V9, P14
   Saxena A., 2010, FOOD BIOPROCESS TECH, V5, P672
   SCANLON MG, 1994, AM POTATO J, V71, P717, DOI 10.1007/BF02849210
   Schouten RE, 2004, POSTHARVEST BIOL TEC, V32, P299, DOI 10.1016/j.postharvbio.2003.12.005
   Schouten RE, 2007, POSTHARVEST BIOL TEC, V45, P298, DOI 10.1016/j.postharvbio.2007.03.011
   Sciarini LS, 2010, FOOD BIOPROCESS TECH, V3, P577, DOI 10.1007/s11947-008-0098-2
   Segnini S, 1999, FOOD SCI TECHNOL-LEB, V32, P216
   Sharma R, 2008, INT J FOOD PROP, V11, P439, DOI 10.1080/10942910701530826
   SHEWFELT RL, 1984, J FOOD SCI, V49, P1612, DOI 10.1111/j.1365-2621.1984.tb12857.x
   SHEWFELT RL, 1993, POSTHARVEST HANDLING, P99, DOI DOI 10.1016/B978-0-08-092576-9.50011-2
   SHEWFELT RL, 2003, POSTHARVEST PHYSL PA, P287
   SHEWFELT RL, 2000, FRUIT VEGETABLE QUAL, P144
   Shi J, 1999, FOOD RES INT, V32, P15, DOI 10.1016/S0963-9969(99)00059-9
   SHIN SG, 1995, J FOOD ENG, V24, P77, DOI 10.1016/0260-8774(94)P1609-2
   Silva FM, 1999, INT J FOOD SCI TECH, V34, P87, DOI 10.1046/j.1365-2621.1999.00246.x
   Sinesio F, 1997, FOOD QUAL PREFER, V8, P35, DOI 10.1016/S0950-3293(96)00005-5
   Singh KK, 2006, J FOOD ENG, V73, P112, DOI 10.1016/j.jfoodeng.2005.01.010
   SKREDE G, 1985, J FOOD SCI, V50, P514
   Soysal Y, 2004, BIOSYST ENG, V89, P167, DOI 10.1016/j.biosystemseng.2004.07.008
   STAMP JA, 1983, J FOOD SCI, V48, P543, DOI 10.1111/j.1365-2621.1983.tb10785.x
   Stewart I., 1971, P FLORIDA STATE HORT
   Suh HJ, 2003, NAHRUNG, V47, P132, DOI 10.1002/food.200390024
   Sumnu G, 2005, LWT-FOOD SCI TECHNOL, V38, P549, DOI 10.1016/j.lwt.2004.07.006
   Sun DW, 2004, J FOOD ENG, V61, P1, DOI 10.1016/S0260-8774(03)00182-1
   TAO Y, 1995, T ASAE, V38, P1555
   Tijskens L., 2005, INT C POSTH UNL DOWN, P687
   Tijskens L. M. M., 1994, Postharvest Biology and Technology, V4, P85, DOI 10.1016/0925-5214(94)90010-8
   Tijskens L. M. M., 2001, Innovative Food Science and Emerging Technologies, V2, P303, DOI 10.1016/S1466-8564(01)00045-5
   Tijskens L. M. M., 2011, Journal of Fruit and Ornamental Plant Research, V19, P113
   Tijskens LMM, 2003, POSTHARVEST BIOL TEC, V27, P15, DOI 10.1016/S0925-5214(02)00191-6
   Tiwari BK, 2008, J FOOD ENG, V88, P553, DOI 10.1016/j.jfoodeng.2008.03.021
   Tiwari BK, 2008, J AGR FOOD CHEM, V56, P2423, DOI 10.1021/jf073503y
   Tiwari BK, 2009, FOOD BIOPROCESS TECH, V2, P109, DOI 10.1007/s11947-008-0156-9
   Toivonen PMA, 2004, HORTSCIENCE, V39, P1066
   Tsami E, 2000, DRY TECHNOL, V18, P1559, DOI 10.1080/07373930008917793
   Turabi E, 2008, FOOD BIOPROCESS TECH, V1, P64, DOI 10.1007/s11947-007-0003-4
   Usenik V, 2008, FOOD CHEM, V107, P185, DOI 10.1016/j.foodchem.2007.08.004
   VAMOSVIGYAZO L, 1981, CRC CR REV FOOD SCI, V15, P49, DOI 10.1080/10408398109527312
   Van Zeebroeck M, 2007, POSTHARVEST BIOL TEC, V45, P157, DOI 10.1016/j.postharvbio.2007.01.015
   vanBoekel MAJS, 1996, J FOOD SCI, V61, P477
   Vandekinderen I, 2008, J AGR FOOD CHEM, V56, P5723, DOI 10.1021/jf800681a
   Vardin H, 2003, NAHRUNG, V47, P300, DOI 10.1002/food.200390070
   Vasquez-Caicedo AL, 2005, J AGR FOOD CHEM, V53, P4827, DOI 10.1021/jf048168h
   VoegelTurenne C, 1997, DRY TECHNOL, V15, P2587, DOI 10.1080/07373939708917379
   WALKER JRL, 1975, ENZYME TECHNOL DIG, V4, P89
   Walker P., 1990, P AUSTR SOC ANIMAL P
   Walkling-Ribeiro M, 2009, FOOD BIOPROCESS TECH, V2, P422, DOI 10.1007/s11947-007-0045-7
   Walkling-Ribeiro M, 2010, LWT-FOOD SCI TECHNOL, V43, P1067, DOI 10.1016/j.lwt.2010.02.010
   Wambura P, 2011, FOOD BIOPROCESS TECH, V4, P107, DOI 10.1007/s11947-008-0150-2
   Wand SJE, 2006, SCI HORTIC-AMSTERDAM, V107, P271, DOI 10.1016/j.scienta.2005.11.002
   WOLF G, 1984, PHYSIOL REV, V64, P873
   Yam KL, 2004, J FOOD ENG, V61, P137, DOI 10.1016/S0260-8774(03)00195-X
   Yu HL, 2003, IND ENG CHEM RES, V42, P3036, DOI 10.1021/ie020941f
   Zanoni B, 1995, FOOD SCI TECHNOL-LEB, V28, P604
   Zepka LQ, 2009, J AGR FOOD CHEM, V57, P7841, DOI 10.1021/jf900558a
NR 237
TC 177
Z9 192
U1 11
U2 225
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1935-5130
J9 FOOD BIOPROCESS TECH
JI Food Bioprocess Technol.
PD JAN
PY 2013
VL 6
IS 1
BP 36
EP 60
DI 10.1007/s11947-012-0867-9
PG 25
WC Food Science & Technology
SC Food Science & Technology
GA 061VO
UT WOS:000312878500003
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Moreira, PD
   Genari, SC
   Goissis, G
   Galembeck, F
   An, YHH
   Santos, AR
AF Moreira, Patricia da Luz
   Genari, Selma Candelaria
   Goissis, Gilberto
   Galembeck, Fernando
   An, Yuehuei H.
   Santos, Arnaldo Rodrigues, Jr.
TI Bovine osteoblasts cultured on polyanionic collagen scaffolds: An
   ultrastructural and immunocytochemical study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE anionic collagen; cell culture; osteoblasts; biomaterials; tissue
   engineering; cell differentiation
ID ANIONIC COLLAGEN; BONE REPAIR; IN-VITRO; RAT CALVARIA; ELASTIN MATRICES;
   DRUG-DELIVERY; CELL-ADHESION; MINERALIZATION; BIOMATERIALS;
   DIFFERENTIATION
AB Collagen is the most abundant protein in the body and is also the most important component of the extracellular matrix. Collagen has several advantages as a biomaterial such as lack of toxicity, biocompatibility, biodegradability, and easy reabsorption. In this study, we examined bovine osteoblasts cultured on native or anionic collagen scaffolds prepared from bovine pericardium after selective hydrolysis of glutamine and asparagine side chain amides for periods from 24 (BP24) and 48 h (BP48). The cells were cultured in control and mineralization medium at 37 degrees C in the presence of 5% CO2. Transmission and scanning electron microscopy, energy dispersive spectroscopy, and an immunocytochemical marker were used for analysis. Cells with an irregular morphology forming a confluent multilayer were observed on matrices kept in control medium. Most of these cells presented a polygonal or elongated flattened morphology. Several spherical deposits of calcium crystal associated with phosphorus were observed on the native and BP48 matrices. Similar results were observed in samples kept in control medium except with lower calcium/phosphorus ratio. Vesicles actively expelled from the cell membrane were also seen (do this vesicles corresponds to calcium/phosphorus deposits). Osteocalcin was clearly visible on matrices kept in mineralization medium and was more expression on the surface of BP48 matrices. The results showed that anionic collagen is able to support osteoblastic differentiation, regardless of the medium used. Finally, the BP48 matrix promoted better osteoblast differentiation than the native matrix. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 101B: 1827, 2013.
C1 [Santos, Arnaldo Rodrigues, Jr.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.
   [Moreira, Patricia da Luz; Genari, Selma Candelaria] Univ Estadual Campinas, Dept Biol Celular, Inst Biol, Sao Paulo, Brazil.
   [Genari, Selma Candelaria] Fac Tecnol Bauru, Ctr Estadual Educ Tecnol Paula Souza, Sao Paulo, Brazil.
   [Goissis, Gilberto] Biotech Biomed Prod Med & Odontol Ltda ME Prod, Sao Paulo, Brazil.
   [Galembeck, Fernando] Univ Estadual Campinas, Inst Quim, Dept Fis Quim, Sao Paulo, Brazil.
   [An, Yuehuei H.] Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
RP Santos, AR (reprint author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.
EM arnaldo.santos@ufabc.edu.br
RI Galembeck, Fernando/D-9509-2012; Santos, Jr, Arnaldo/I-4813-2012
OI Galembeck, Fernando/0000-0003-4778-5442; 
CR Alberts B., 2008, MOL BIOL CELL
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   Chao Edmund Y S, 2003, Eur Cell Mater, V6, P72
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Chierico A, 1999, CLIN ORAL IMPLAN RES, V10, P415, DOI 10.1034/j.1600-0501.1999.100508.x
   Cobos JA, 1998, J BIOMED MATER RES, V39, P458, DOI 10.1002/(SICI)1097-4636(19980305)39:3<458::AID-JBM16>3.3.CO;2-Q
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Gundberg CM, 2003, OSTEOPOROSIS INT, V14, pS37, DOI 10.1007/s00198-003-1471-7
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Haralson M. A., 1995, EXTRACELLULAR MATRIX, P1
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kimura M, 2000, SCAND J PLAST RECONS, V34, P289, DOI 10.1080/028443100750059057
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   KRUKOWSKI M, 1994, CLIN ORTHOP RELAT R, P266
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   Kryszewski M, 2004, ACTA PHYS POL A, V105, P389, DOI 10.12693/APhysPolA.105.389
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Moreira PL, 2004, J BIOMED MATER RES B, V71B, P229, DOI 10.1002/jbm.b.30026
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Rocha LB, 2004, J BIOMED MATER RES B, V71B, P355, DOI 10.1002/jbm.b.30102
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rocha LB, 2006, J BIOMED MATER RES A, V79A, P237, DOI 10.1002/jbm.a.30782
   Rosa FP, 2003, BIOMATERIALS, V24, P207, DOI 10.1016/S0142-9612(02)00292-2
   Santos Jr AR, 2012, TISSUE REGENERATION, P339
   SAUTIER JM, 1992, CALCIFIED TISSUE INT, V50, P527, DOI 10.1007/BF00582168
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   SINGH MP, 1995, PHARMACEUT RES, V12, P1205, DOI 10.1023/A:1016272212833
   Skinner HCW, 2005, MINERAL MAG, V69, P621, DOI 10.1180/0026461056950275
   Suh H, 2001, ARTIF ORGANS, V25, P14, DOI 10.1046/j.1525-1594.2001.025001014.x
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   WERKMEISTER J A, 1992, Clinical Materials, V9, P137
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   Zellin G, 1996, CONNECT TISSUE RES, V35, P279, DOI 10.3109/03008209609029202
NR 55
TC 3
Z9 3
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2013
VL 101B
IS 1
BP 18
EP 27
DI 10.1002/jbm.b.32804
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 057CS
UT WOS:000312540100003
PM 22987821
DA 2018-10-20
ER

PT J
AU Brown, EM
   Latona, RJ
   Taylor, MM
AF Brown, Eleanor M.
   Latona, Renee J.
   Taylor, Maryann M.
TI EFFECTS OF PRETANNING PROCESSES ON COLLAGEN STRUCTURE AND REACTIVITY
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID HIDE; MICROFIBRIL; STABILITY
AB The cattle hide, a major byproduct of the US meat industry, is the tanner's substrate, and also the source of collagen for the food and biomaterials industries. Conversion of animal hides into leather is a multistep process that continually evolves in response to economic and environmental concerns. Processing changes are generally evaluated in terms of impact on tannery costs and quality of leather produced. Because the basis for tanning and other biomaterial applications is the stabilization of the collagen matrix, changes to the molecular characteristics of hide collagen may be expected to impact these applications. In previous studies, we began the development of protocols for production and utilization of powdered hide from specific steps in beam-house processing. In this study, the effects of pretanning processes on the structure, stability and reactivity of hide collagen with tanning materials are evaluated. The results are anticipated to assist the tanner as well as the manufacturers of collagen-based biomaterials and gelatin to better understand their substrate and changes to it that may occur when beam-house processes are altered.
C1 [Brown, Eleanor M.; Latona, Renee J.; Taylor, Maryann M.] USDA ARS, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Brown, EM (reprint author), USDA ARS, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM eleanor.brown@ars.usda.gov
CR Brown EM, 2006, J AM LEATHER CHEM AS, V101, P274
   Brown EM, 2012, J AM LEATHER CHEM AS, V107, P1
   Brown EM, 2011, J AM LEATHER CHEM AS, V106, P145
   Brown EM, 2010, J AM LEATHER CHEM AS, V105, P116
   Brown EM, 2009, J AM LEATHER CHEM AS, V104, P275
   Brown EM, 2005, J AM LEATHER CHEM AS, V100, P401
   BROWN EM, 1993, J AM LEATHER CHEM AS, V88, P2
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686
   Cabeza LF, 1998, J AM LEATHER CHEM AS, V93, P83
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   Marmer WN, 2005, J AM LEATHER CHEM AS, V100, P427
   TAYLOR MM, 2004, JALCA, V99, P129
NR 13
TC 4
Z9 4
U1 0
U2 11
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA 1314 50 ST, STE 103, LUBBOCK, TX 79412 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD JAN
PY 2013
VL 108
IS 1
BP 23
EP 29
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 063TE
UT WOS:000313023400004
DA 2018-10-20
ER

PT J
AU Fornell, J
   Pellicer, E
   Van Steenberge, N
   Gonzalez, S
   Gebert, A
   Surinach, S
   Baro, MD
   Sort, J
AF Fornell, J.
   Pellicer, E.
   Van Steenberge, N.
   Gonzalez, S.
   Gebert, A.
   Surinach, S.
   Baro, M. D.
   Sort, J.
TI Improved plasticity and corrosion behavior in Ti-Zr-Cu-Pd metallic glass
   with minor additions of Nb: An alloy composition intended for biomedical
   applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Biomaterial; Corrosion; Ti-based bulk glassy alloy; Elastic properties;
   Plasticity
ID MECHANICAL-PROPERTIES; MATRIX-COMPOSITES; AMORPHOUS-ALLOYS; FORMING
   ABILITY; DEFORMATION; MEDIA
AB The effects of minor additions of Nb (2, 3 and 4 at%) to the Ti40Zr10Cu38Pd12 alloy are discussed in terms of microstructure, thermal behavior, mechanical properties and corrosion resistance. The addition of Nb promotes the formation of nanocrystals, i.e., from a completely amorphous structure (when no Nb is added) to a mainly crystalline structure (for a 4% of Nb addition). The glassy alloy exhibits large hardness, relatively low Young's modulus and excellent corrosion behavior, although the plasticity is rather limited. A significant increase in compressive plasticity (total strain over 13%) is achieved in the sample with 3% of Nb without compromising the strength. Young's modulus of the as-cast alloy (around 100 GPa, as determined from acoustic measurements) increases only slightly when disperse nanocrystallites are embedded in the amorphous matrix. Improvement of the corrosion performance, with delayed pitting corrosion, is also observed for 3% Nb addition. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Fornell, J.; Pellicer, E.; Gonzalez, S.; Surinach, S.; Baro, M. D.; Sort, J.] Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
   [Van Steenberge, N.] OCAS NV, BE-9060 Zelzate, Belgium.
   [Gebert, A.] IFW Dresden, Inst Metall Mat, D-01171 Dresden, Germany.
   [Sort, J.] Univ Autonoma Barcelona, Inst Catalana Recerca & Estudis Avancats, Bellaterra 08193, Spain.
RP Fornell, J (reprint author), Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
EM Jordinafornell@gmail.com
RI Baro, Maria Dolors/A-2096-2009; Pellicer, Eva/G-2917-2014; BAI,
   JIE/D-7448-2016; Sort, Jordi/F-6582-2014; Surinach, Santiago/A-1749-2009
OI Baro, Maria Dolors/0000-0002-8636-1063; Pellicer,
   Eva/0000-0002-8901-0998; Sort, Jordi/0000-0003-1213-3639; Surinach,
   Santiago/0000-0001-8125-0594; Gonzalez Sanchez,
   Sergio/0000-0002-0211-7822; Gebert, Annett/0000-0003-2748-3850
FU Spanish Ministry of Science and Innovation; ICREA Academia; 
   [2009-SGR-1292];  [MAT2011-27380-C02-01]; 
   [FP7-PEO-PLE-2010-ITN-264635]; ICREA
FX This work has been partially financed by the 2009-SGR-1292 and
   MAT2011-27380-C02-01 research projects and the
   FP7-PEO-PLE-2010-ITN-264635 research training network. We also thank C.
   Deroover and K. Van Brussel for their technical assistance. J. F. and S.
   G. acknowledge the PhD Fellowship and the Juan de la Cierva contract
   from the Spanish Ministry of Science and Innovation, respectively.
   M.D.B. was partially supported by an ICREA Academia award.
CR Anand L, 2005, J MECH PHYS SOLIDS, V53, P1362, DOI 10.1016/j.jmps.2004.12.006
   Choe H, 2005, MAT SCI ENG A-STRUCT, V396, P99, DOI 10.1016/j.msea.2005.01.051
   Davis J. R., CORROSION UNDERSTAND
   Donachie M.J., 2000, TITANIUM TECHNICAL G, P44073
   Egami T, 2006, INTERMETALLICS, V14, P882, DOI 10.1016/j.intermet.2006.01.004
   Fornell J, 2009, INTERMETALLICS, V17, P1090, DOI 10.1016/j.intermet.2009.05.015
   Fornell J, 2009, INT J PLASTICITY, V25, P1540, DOI 10.1016/j.ijplas.2008.11.002
   Gebert A, 2010, CORROS SCI, V52, P1711, DOI 10.1016/j.corsci.2010.01.027
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jiang WH, 2008, INT J PLASTICITY, V24, P1, DOI 10.1016/j.ijplas.2007.01.015
   Kuhn U, 2006, INTERMETALLICS, V14, P978, DOI 10.1016/j.intermet.2006.01.016
   Kusy M, 2006, INTERMETALLICS, V14, P982, DOI 10.1016/j.intermet.2006.01.017
   LAMPARTER P, 1988, J NON-CRYST SOLIDS, V106, P137, DOI 10.1016/0022-3093(88)90247-5
   LEE HP, 1986, J ELECTROCHEM SOC, V133, P2035, DOI 10.1149/1.2108335
   Oak JJ, 2009, MAT SCI ENG C-BIO S, V29, P322, DOI 10.1016/j.msec.2008.07.009
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Otmacic H, 2003, ELECTROCHIM ACTA, V48, P985, DOI 10.1016/S0013-4686(02)00811-3
   Ott RT, 2003, J NON-CRYST SOLIDS, V317, P158, DOI 10.1016/S0022-3093(02)01996-8
   Park JM, 2010, PHILOS MAG, V90, P2619, DOI 10.1080/14786431003662556
   Qin F., J MECH BEHAV BIOMED
   Qin FX, 2008, INTERMETALLICS, V16, P1026, DOI 10.1016/j.intermet.2008.05.004
   Qin FX, 2007, INTERMETALLICS, V15, P1337, DOI 10.1016/j.intermet.2007.04.005
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   Raju VR, 2002, MATER LETT, V57, P173, DOI 10.1016/S0167-577X(02)00725-5
   Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052
   Wang WH, 2000, PHYS REV B, V62, P25, DOI 10.1103/PhysRevB.62.25
   WU TW, 1990, PHILOS MAG B, V61, P739, DOI 10.1080/13642819008219307
   Zhang ZF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045505
   Zhu SL, 2008, INTERMETALLICS, V16, P1031, DOI 10.1016/j.intermet.2008.05.006
   Zhu SL, 2007, MATER TRANS, V48, P163, DOI 10.2320/matertrans.48.163
NR 32
TC 23
Z9 23
U1 4
U2 93
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 1
PY 2013
VL 559
BP 159
EP 164
DI 10.1016/j.msea.2012.08.058
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 058HB
UT WOS:000312623600019
DA 2018-10-20
ER

PT J
AU Baiguera, S
   Ribatti, D
AF Baiguera, Silvia
   Ribatti, Domenico
TI Endothelialization approaches for viable engineered tissues
SO ANGIOGENESIS
LA English
DT Review
DE Angiogenesis; Endothelial cells; Growth factors; Scaffold properties;
   Tissue engineered construct; Vascularization
ID ANGIOGENIC GROWTH-FACTORS; MESENCHYMAL STEM-CELLS; COLONY-STIMULATING
   FACTOR; BLOOD-VESSEL MATURATION; MORPHOGENESIS IN-VITRO; CAPILLARY-LIKE
   NETWORK; HUMAN PERIPHERAL-BLOOD; FLUID SHEAR-STRESS; OF-THE-ART;
   PROGENITOR CELLS
AB One of the main limitation in obtaining thick, 3-dimensional viable engineered constructs is the inability to provide a sufficient and functional blood vessel system essential for the in vitro survival and the in vivo integration of the construct. Different strategies have been proposed to simulate the ingrowth of new blood vessels into engineered tissue, such as the use of growth factors, fabrication scaffold technologies, in vivo prevascularization and cell-based strategies, and it has been demonstrated that endothelial cells play a central role in the neovascularization process and in the control of blood vessel function. In particular, different "environmental" settings (origin, presence of supporting cells, biomaterial surface, presence of hemodynamic forces) strongly influence endothelial cell function, angiogenic potential and the in vivo formation of durable vessels. This review provides an overview of the different techniques developed so far for the vascularization of tissue-engineered constructs (with their advantages and pitfalls), focusing the attention on the recent development in the cell-based vascularization strategy and the in vivo applications.
C1 [Baiguera, Silvia] Univ Hosp Careggi, BIOAIRLab, European Ctr Thorac Surg CERT, I-50134 Florence, Italy.
   [Ribatti, Domenico] Univ Bari, Dept Basic Med Sci, Sect Human Anat & Histol, Sch Med, Bari, Italy.
RP Baiguera, S (reprint author), Univ Hosp Careggi, BIOAIRLab, European Ctr Thorac Surg CERT, Largo Brambilla 3, I-50134 Florence, Italy.
EM sbaiguer@libero.it
FU European Union Seventh Framework Programme [278570]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no 278570.
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Ando J, 1999, MECH FORCES ENDOTHEL, P111
   Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361
   Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   ANTONOV AS, 1992, THROMB RES, V67, P135, DOI 10.1016/0049-3848(92)90133-U
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Black AF, 1998, FASEB J, V12, P1331
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Brey EM, 2005, LANCET, V365, P2068, DOI 10.1016/S0140-6736(05)66715-3
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Cassell OCS, 2001, ANN NY ACAD SCI, V944, P429
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024
   Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Curcio E, 2010, BIOMATERIALS, V31, P5131, DOI 10.1016/j.biomaterials.2010.03.013
   D'Amore P A, 1992, Semin Cancer Biol, V3, P49
   d'Angelo I., 2010, MOL PHARM
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4
   de Boer R, 2010, J BIOMED MATER RES A, V95A, P1067, DOI 10.1002/jbm.a.32900
   Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456
   Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/scd.2004.13.509
   Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093
   Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102
   Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004
   Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x
   Finkenzeller G, 2007, TISSUE ENG, V13, P1413, DOI 10.1089/ten.2006.0369
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gassman AA, 2011, J TISSUE ENG REGEN M, V5, P375, DOI 10.1002/term.323
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI 10.1089/ten.TEA.2010.0189
   GRABOWSKI EF, 1995, THROMB HAEMOSTASIS, V74, P123
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gulino D, 1998, J BIOL CHEM, V273, P29786, DOI 10.1074/jbc.273.45.29786
   Helm CLE, 2007, BIOTECHNOL BIOENG, V96, P167, DOI 10.1002/bit.21185
   Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102
   HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hordijk PL, 1999, J CELL SCI, V112, P1915
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Huang NF, 2010, ACTA BIOMATER, V6, P3947, DOI 10.1016/j.actbio.2010.05.020
   Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   HYAKUSOKU H, 1993, BRIT J PLAST SURG, V46, P45, DOI 10.1016/0007-1226(93)90064-I
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Ishizawa K, 2004, BIOCHEM BIOPH RES CO, V324, P276, DOI 10.1016/j.bbrc.2004.09.049
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Joung IS, 2006, MICROVASC RES, V71, P1, DOI 10.1016/j.mvr.2005.10.005
   Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Karal-Yilmaz O, 2011, J MICROENCAPSUL, V28, P46, DOI 10.3109/02652048.2010.523795
   Kelm JM, 2006, TISSUE ENG, V12, P2541, DOI 10.1089/ten.2006.12.2541
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   KO C, 1995, ARTIF CELL BLOOD SUB, V23, P143, DOI 10.3109/10731199509117934
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Korbling M, 2006, TRANSFUSION, V46, P1795, DOI 10.1111/j.1537-2995.2006.00985.x
   Kosaki K, 1998, CIRC RES, V82, P794, DOI 10.1161/01.RES.82.7.794
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5
   Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306
   Layman H, 2012, J BIOMAT SCI-POLYM E, V23, P185, DOI 10.1163/092050610X546417
   le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Ley CD, 2004, MICROVASC RES, V68, P161, DOI 10.1016/j.mvr.2004.06.002
   Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8
   Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]
   Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com
   Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   MOONEY DJ, 1994, MOL BIOL CELL, V5, P1281
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Nguyen LL, 2001, INT REV CYTOL, V204, P1, DOI 10.1016/S0074-7696(01)04002-5
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ogawa R, 2007, REGEN MED, V2, P831, DOI 10.2217/17460751.2.5.831
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Polykandriotis E, 2007, PLAST RECONSTR SURG, V120, P855, DOI 10.1097/01.prs.0000277664.89467.14
   Prokop A, 2001, Diabetes Technol Ther, V3, P245, DOI 10.1089/152091501300209624
   Raimondi Manuela Teresa, 2006, Curr Drug Discov Technol, V3, P245
   Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   SAMPATH R, 1995, ANN BIOMED ENG, V23, P247, DOI 10.1007/BF02584426
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schantz JT, 2007, TISSUE ENG, V13, P2615, DOI 10.1089/ten.2006.0438
   Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587
   Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18
   Schumann P, 2009, MICROVASC RES, V78, P180, DOI 10.1016/j.mvr.2009.06.003
   Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje
   Shi Q, 1998, BLOOD, V92, P362
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   SPEISER W, 1987, BLOOD, V69, P964
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Sweeney NV, 2005, BIOCHEM BIOPH RES CO, V329, P573, DOI 10.1016/j.bbrc.2005.02.013
   Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186
   Tavassol F, 2010, TISSUE ENG PT A, V16, P2265, DOI [10.1089/ten.tea.2008.0457, 10.1089/ten.TEA.2008.0457]
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   THOUMINE O, 1995, LAB INVEST, V73, P565
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   UNDERWOOD PA, 1993, EXP CELL RES, V205, P311, DOI 10.1006/excr.1993.1091
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Vacanti JP, 1999, LANCET, V354, pSI32
   Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje
   Verseijden F, 2012, J TISSUE ENG REGEN M, V6, P169, DOI 10.1002/term.410
   Verseijden F, 2010, CELL TRANSPLANT, V19, P1007, DOI 10.3727/09636890X492571
   Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287
   Westmuckett AD, 2000, ARTERIOSCL THROM VAS, V20, P2474, DOI 10.1161/01.ATV.20.11.2474
   Wisser D, 2003, BURNS, V29, P375, DOI 10.1016/S0305-4179(03)00013-5
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yang JF, 2007, CARDIOLOGY, V107, P17, DOI 10.1159/000093609
   YOSHIZUMI M, 1989, BIOCHEM BIOPH RES CO, V161, P859, DOI 10.1016/0006-291X(89)92679-X
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
   Zheng L, 2000, J IMMUNOL, V164, P4665, DOI 10.4049/jimmunol.164.9.4665
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 163
TC 54
Z9 54
U1 2
U2 93
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD JAN
PY 2013
VL 16
IS 1
BP 1
EP 14
DI 10.1007/s10456-012-9307-8
PG 14
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 058UA
UT WOS:000312658800001
PM 23010872
DA 2018-10-20
ER

PT J
AU Ko, YG
   Co, CC
   Ho, CC
AF Ko, Young-Gwang
   Co, Carlos C.
   Ho, Chia-Chi
TI Directing cell migration in continuous microchannels by topographical
   amplification of natural directional persistence
SO BIOMATERIALS
LA English
DT Article
DE Cell migration; Microchannel; Gelatin; Directional movement
ID MOTILITY; BIOMATERIALS; SUBSTRATUM; HYDROGELS; MOVEMENT; ADHESION;
   DEPEND
AB Discrete micropatterns on biomaterial surfaces can be used to guide the direction of mammalian cell movement by orienting cell morphology. However, guiding cell assembly in three-dimensional scaffolds remains a challenge. Here we demonstrate that the random motions of motile cells can be rectified within continuous microchannels without chemotactic gradients or fluid flow. Our results show that uniform width microchannels with an overhanging zigzag design can induce polarization of NIH3T3 fibroblasts and human umbilical vein endothelial cells by expanding the cell front at each turn. These continuous zigzag microchannels can guide the direction of cell movement even for cells with altered intracellular signals that promote random movement. This approach for directing cell migration within microchannels has important potential implications in the design of scaffolds for tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Ko, Young-Gwang; Co, Carlos C.; Ho, Chia-Chi] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45220 USA.
RP Ho, CC (reprint author), Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45220 USA.
EM hocc@ucmail.uc.edu
FU National Institutes of Health [R01EB010043]; National Science Foundation
   [CBET0928219]
FX This research was supported by the National Institutes of Health
   (R01EB010043) and the National Science Foundation (CBET0928219). We
   thank Ross Andrews for synthesizing the cell resistant poly(OEGMA-MA),
   Dr. Girish Kumar for helpful discussions, and Rebecca Moore for
   performing some preliminary studies.
CR Baran ET, 2011, J TISSUE ENG REGEN M, V5, pE108, DOI 10.1002/term.368
   Cicha K, 2011, J APPL PHYS, V110
   Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a
   De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629
   Kumar G, 2011, LANGMUIR, V27, P3803, DOI 10.1021/la2000206
   Kushiro K, 2010, ADV MATER, V22, P4516, DOI 10.1002/adma.201001619
   Leclair AM, 2011, BIOMATERIALS, V32, P1351, DOI 10.1016/j.biomaterials.2010.10.051
   Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648
   Lin XF, 2008, BIOPHYS J, V95, P3066, DOI 10.1529/biophysj.107.127761
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mader CC, 2007, SOFT MATTER, V3, P357, DOI 10.1039/b606590b
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306
   Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235
   Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152
   Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849
   Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Ware MF, 1998, J CELL SCI, V111, P2423
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 28
TC 16
Z9 16
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 353
EP 360
DI 10.1016/j.biomaterials.2012.09.071
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000004
PM 23099064
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Marsano, A
   Maidhof, R
   Luo, JW
   Fujikara, K
   Konofagou, EE
   Banfi, A
   Vunjak-Novakovic, G
AF Marsano, Anna
   Maidhof, Robert
   Luo, Jianwen
   Fujikara, Kana
   Konofagou, Efisa E.
   Banfi, Andrea
   Vunjak-Novakovic, Gordana
TI The effect of controlled expression of VEGF by transduced myoblasts in a
   cardiac patch on vascularization in a mouse model of myocardial
   infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Elastomer; Bioreactor; Cardiac ischemia;
   Angiogenesis; VEGF
ID ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; STEM-CELLS; IN-VIVO;
   HEART-MUSCLE; TISSUE; ANGIOGENESIS; TRANSPLANTATION; SCAFFOLDS; DELIVERY
AB Key requirements for cardiac tissue engineering include the maintenance of cell viability and function and the establishment of a perfusable vascular network in millimeters thick and compact cardiac constructs upon implantation. We investigated if these requirements can be met by providing an intrinsic vascularization stimulus (via sustained action of VEGF secreted at a controlled rate by transduced myoblasts) to a cardiac patch engineered under conditions of effective oxygen supply (via medium flow through channeled elastomeric scaffolds seeded with neonatal cardiomyocytes). We demonstrate that this combined approach resulted in increased viability, vascularization and functionality of the cardiac patch. After implantation in a mouse model of myocardial infarction, VEGF-expressing patches displayed significantly improved engraftment, survival and differentiation of cardiomyocytes, leading to greatly enhanced contractility as compared to controls not expressing VEGF. Controlled VEGF expression also mediated the formation of mature vascular networks, both within the engineered patches and in the underlying ischemic myocardium. We propose that this combined cell-biomaterial approach can be a promising strategy to engineer cardiac patches with intrinsic and extrinsic vascularization potential. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Marsano, Anna; Maidhof, Robert; Luo, Jianwen; Fujikara, Kana; Konofagou, Efisa E.; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
   [Marsano, Anna; Banfi, Andrea] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Marsano, Anna; Banfi, Andrea] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 622 W 168th St,VC12-234, New York, NY 10032 USA.
EM abanfi@uhbs.ch; gv2131@columbia.edu
RI Banfi, Andrea/B-8720-2008; Luo, Jianwen/D-5612-2011; vunjak-novakovic,
   gordana/J-9279-2012
OI Banfi, Andrea/0000-0001-5737-8811; Luo, Jianwen/0000-0001-9215-5568;
   Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIH [HL088913, HL076485, EB002520]; Swiss National Science Foundation
   [310030-127426]
FX The authors gratefully acknowledge funding of this research provided by
   NIH (HL088913, HL076485, and EB002520 to GVN) and the Swiss National
   Science Foundation (310030-127426 to AB), and for the technical
   assistance of T. Martens, G. Eng, and J. Shin in performing the
   experiments.
CR Banfi A, 2002, METHOD ENZYMOL, V346, P145
   Banfi A.vonDG, 2012, FASEB J
   Banfi Andrea, 2005, Curr Atheroscler Rep, V7, P227, DOI 10.1007/s11883-005-0011-7
   Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Helmrich U, 2012, TISSUE ENG PART C-ME, V18, P283, DOI [10.1089/ten.tec.2011.0413, 10.1089/ten.TEC.2011.0413]
   Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065
   Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005
   Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]
   Lee EJ, 2009, CELL TRANSPLANT, V18, P731, DOI 10.3727/096368909X470919
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Luo JW, 2008, IEEE T ULTRASON FERR, V55, P240, DOI 10.1109/TUFFC.2008.633
   Luo JW, 2007, ULTRASOUND MED BIOL, V33, P1206, DOI 10.1016/j.ultrasmedbio.2007.01.019
   Luo JW, 2010, IEEE T ULTRASON FERR, V57, P1347, DOI 10.1109/TUFFC.2010.1554
   Luo JW, 2004, IEEE T ULTRASON FERR, V51, P1119, DOI 10.1109/TUFFC.2004.1334844
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Menasche P, 2008, J CARDIOVASC TRANSL, V1, P201, DOI 10.1007/s12265-008-9017-1
   Misteli H, 2010, STEM CELLS, V28, P611, DOI 10.1002/stem.291
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Perin EC, 2010, CIRCULATION, V122
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403
   Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9
   Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182
   von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wolff T, 2012, J CELL MOL MED, V16, P107, DOI 10.1111/j.1582-4934.2011.01308.x
   Zhang CW, 2011, ANN THORAC SURG, V92, P1435, DOI 10.1016/j.athoracsur.2011.05.054
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5
NR 56
TC 37
Z9 40
U1 6
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 393
EP 401
DI 10.1016/j.biomaterials.2012.09.038
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000008
PM 23083931
OA Green Accepted
DA 2018-10-20
ER

PT J
AU An, B
   DesRochers, TM
   Qin, GK
   Xia, XX
   Thiagarajan, G
   Brodsky, B
   Kaplan, DL
AF An, Bo
   DesRochers, Teresa M.
   Qin, Guokui
   Xia, Xiaoxia
   Thiagarajan, Geetha
   Brodsky, Barbara
   Kaplan, David L.
TI The influence of specific binding of collagen-silk chimeras to silk
   biomaterials on hMSC behavior
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Silk; Stem cells; Chimera
ID TRIPLE-HELIX; I COLLAGEN; OSTEOGENIC-DIFFERENTIATION; NANOFIBROUS
   SCAFFOLDS; STREPTOCOCCAL SCL1; SELF-ASSOCIATION; FIBROIN FILMS; DRAGLINE
   SILK; SPIDER SILK; PROTEIN
AB Collagen-like proteins in the bacteria Streptococcus pyogenes adopt a triple-helix structure with a thermal stability similar to that of animal collagens, can be expressed in high yield in Escherichia coli and can be easily modified through molecular biology techniques. However, potential applications for such recombinant collagens are limited by their lack of higher order structure to achieve the physical properties needed for most biomaterials. To overcome this problem, the S. pyogenes collagen domain was fused to a repetitive Bombyx mori silk consensus sequence, as a strategy to direct specific non-covalent binding onto solid silk materials whose superior stability, mechanical and material properties have been previously established. This approach resulted in the successful binding of these new collagen silk chimeric proteins to silk films and porous scaffolds, and the binding affinity could be controlled by varying the number of repeats in the silk sequence. To explore the potential of collagen silk chimera for regulating biological activity, integrin (Int) and fibronectin (Fn) binding sequences from mammalian collagens were introduced into the bacterial collagen domain. The attachment of bioactive collagen silk chimeras to solid silk biomaterials promoted hMSC spreading and proliferation substantially in comparison to the controls. The ability to combine the biomaterial features of silk with the biological activities of collagen allowed more rapid cell interactions with silk-based biomaterials, improved regulation of stem cell growth and differentiation, as well as the formation of artificial extracellular matrices useful for tissue engineering applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [An, Bo; DesRochers, Teresa M.; Qin, Guokui; Xia, Xiaoxia; Thiagarajan, Geetha; Brodsky, Barbara; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Brodsky, B (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM Barbara.Brodsky@tufts.edu; David.Kaplan@tufts.edu
RI Qin, Guokui/B-1520-2012; An, Bo/N-3466-2014; Xia, Xiaoxia/C-6614-2013
OI Qin, Guokui/0000-0002-2212-1597; An, Bo/0000-0002-1031-3380; Xia,
   Xiaoxia/0000-0001-8375-1616
FU NIH [EB011620]
FX This work is supported by NIH (grant# EB011620 to BB and DK). The
   authors would like to thank Dr. Randolph Lewis from Utah State
   University for the spider silk proteins used in this study, and Dr.
   David Wilbur and the Tufts Chemistry Department for allowing us to use
   the MALDI-TOF MS equipment. Any opinions, findings, and conclusions or
   recommendations expressed in this publication are those of the author(s)
   and do not necessarily reflect the views of the NIH.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Canabady-Rochelle LLS, 2012, BIOMACROMOLECULES, V13, P683, DOI 10.1021/bm201555c
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Cho SY, 2011, J NANOSCI NANOTECHNO, V11, P801, DOI 10.1166/jnn.2011.3181
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Ding S, 2012, BIOMACROMOLECULES, V13, P1035, DOI 10.1021/bm2017367
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106
   Fallas JA, 2010, CHEM SOC REV, V39, P3510, DOI 10.1039/b919455j
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fraser R., 1973, CONFORMATION FIBROUS
   FRW Lisman T, 2008, BIOCH SOC T, V36, P241
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li Y, 2011, BIOPOLYMERS, V95, P94, DOI 10.1002/bip.21536
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Myllyharju J., 2009, METHODS MOL BIOL, V522
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nomura Y, 2011, BIOTECHNOL LETT, V33, P1067
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Pakkanen O, 2006, J BIOTECHNOL, V123, P248, DOI 10.1016/j.jbiotec.2005.11.012
   Papanikolopoulou K, 2005, J BIOL CHEM, V280, P2481, DOI 10.1074/jbc.M406282200
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979
   Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 63
TC 36
Z9 37
U1 2
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 402
EP 412
DI 10.1016/j.biomaterials.2012.09.085
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000009
PM 23088839
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, SS
   Huang, BJ
   Kaltz, SR
   Sur, S
   Newcomb, CJ
   Stock, SR
   Shah, RN
   Stupp, SI
AF Lee, Sungsoo S.
   Huang, Brian J.
   Kaltz, Stuart R.
   Sur, Shantanu
   Newcomb, Christina J.
   Stock, Stuart R.
   Shah, Ramille N.
   Stupp, Samuel I.
TI Bone regeneration with low dose BMP-2 amplified by biomimetic
   supramolecular nanofibers within collagen scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Peptide amphiphile; Heparin; Heparan sulfate; BMP-2 (bone morphogenetic
   protein-2); Regenerative medicine; Bone regeneration
ID PEPTIDE-AMPHIPHILE NANOFIBERS; MORPHOGENETIC PROTEIN; GROWTH-FACTOR;
   INFLAMMATORY RESPONSE; ORTHOPEDIC TRAUMA; TIBIAL FRACTURES;
   DRUG-RELEASE; DELIVERY; HEPARIN; REPAIR
AB Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive cytokine that plays a critical role during bone regeneration and repair. In the extracellular environment, sulfated polysaccharides anchored covalently to glycoproteins such as syndecan and also non-covalently to fibronectin fibers have been shown to bind BMP-2 through a heparin-binding domain and regulate its bioactivity. We report here on a synthetic biomimetic strategy that emulates biological BMP-2 signaling through the use of peptide amphiphile nanofibers designed to bind heparin. The supramolecular nanofibers, which integrate the biological role of syndecan and fibronectin, were allowed to form gel networks within the pores of an absorbable collagen scaffold by simply infiltrating dilute solutions of the peptide amphiphile, heparan sulfate, and BMP-2. The hybrid biomaterial enhanced significantly bone regeneration in a rat critical-size femoral defect model using BMP-2 amounts that are one order of magnitude lower than required for healing in this animal model. Using micro-computed tomography, we also showed that the hybrid scaffold was more effective at bridging within the gap relative to a conventional scaffold of the type used clinically based on collagen and BMP-2. Histological evaluation also revealed the presence of more mature bone in the new ossified tissue when the low dose of BMP-2 was delivered using the biomimetic supramolecular system. These results demonstrate how molecularly designed materials that mimic features of the extracellular environment can amplify the regenerative capacity of growth factors. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Sur, Shantanu; Shah, Ramille N.; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Lee, Sungsoo S.; Kaltz, Stuart R.; Newcomb, Christina J.; Shah, Ramille N.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Huang, Brian J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Stock, Stuart R.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.
   [Shah, Ramille N.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
EM s-stupp@northwestern.edu
RI Shah, Ramille/E-3737-2010; Stupp, Samuel/B-6737-2009
OI Sur, Shantanu/0000-0001-6371-5466
FU NIH/NIDCR [2R01DE015920-06]; DARPA [W911NF-09-1-0044]; Samsung
   Scholarship
FX This work was supported by NIH/NIDCR grant 2R01DE015920-06 and DARPA
   grant W911NF-09-1-0044. Sungsoo Lee acknowledges fellowship support from
   the Samsung Scholarship. Experiments made use of the following
   facilities at Northwestern University: EPIC of the NUANCE Center, Center
   for Comparative Medicine, Pathology Core Facility, Mouse Histology &
   Phenotyping Laboratory, Cell Imaging Facility, and the Peptide Synthesis
   Core and Equipment Core at the Institute for BioNanotechnology in
   Medicine. The authors thank Mark Seniw for molecular graphics, Dr.
   Melina Kibbe for help with tissue embedding, and Dr. Malcolm Snead, Dr.
   Liam Palmer, Dr. Wellington Hsu, Dr. Erin Hsu, and Dr. Matthew Webber
   for useful discussions.
CR Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsu WK, 2008, SPINE J, V8, P419, DOI 10.1016/j.spinee.2008.01.008
   Huang Z, 2010, BIOMATERIALS, V31, P9202, DOI 10.1016/j.biomaterials.2010.08.013
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Julka A, 2012, J SHOULDER ELB SURG, V21, pE12, DOI 10.1016/j.jse.2011.06.006
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacDonald KM, 2010, J PEDIATR ORTHOPED, V30, P199, DOI 10.1097/BPO.0b013e3181cec35b
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Matson JB, 2012, SOFT MATTER, V8, P3586, DOI 10.1039/c2sm07420f
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2011, CHEM COMMUN, V47, P7962, DOI 10.1039/c1cc12570b
   McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890
   Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 63
TC 123
Z9 129
U1 7
U2 197
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 452
EP 459
DI 10.1016/j.biomaterials.2012.10.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000014
PM 23099062
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Reitinger, S
   Lepperdinger, G
AF Reitinger, Stephan
   Lepperdinger, Guenter
TI Hyaluronan, a Ready Choice to Fuel Regeneration: A Mini-Review
SO GERONTOLOGY
LA English
DT Review
DE Extracellular matrix; Regeneration; Wound healing; Mesenchymal stem
   cells; Biomaterial
ID POSTSURGICAL ADHESION; DOWN-REGULATION; ACID HYDROGELS; STEM-CELLS;
   REPAIR; ACTIVATION; CARTILAGE; SYSTEM; FILM
AB Background: Hyaluronan (HA) is present in extracellular spaces and interstitia of many tissue types. As it is capable of binding high amounts of water, HA provides ideal conditions for cell migration and proliferation. Under conditions of cellular crowding, it also permits lineage-specific differentiation and thus promotes many aspects of healing and tissue remodeling. Methods: The simplicity of its structure makes it amenable to chemical modifications and/or combined formulations with other bioactive substances. Thus a wide variety of clinical applications have been proposed, several of which are currently being implemented in advanced therapies. Results: Known features of HA biology, in particular regarding synthesis and processes related to signaling and control, have been adopted to elaborate specific products in order to support progress in regenerative medicine. Purified HA, HA-based hydrogels or special HA composites have been formulated together with other well-characterized biomaterials and bioactive factors. HA is currently employed in a variety of therapeutic applications both in its pure form and in a biofunctionalized form. Conclusions: HA plays an essential role in regenerative processes. Owing to the growing scientific knowledge in this field, medicinal products based on HA have been devised and are being routinely applied in ophthalmology or in trauma and transplantation surgery. Further areas of application are contemplated, such as the use of HA composite scaffold material in tissue engineering, or refined HA hydrogels enabling controlled release of medication. Copyright (c) 2012 S. Karger AG, Basel
C1 [Reitinger, Stephan; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, AT-6020 Innsbruck, Austria.
RP Lepperdinger, G (reprint author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, AT-6020 Innsbruck, Austria.
EM guenter.lepperdinger@oeaw.ac.at
CR Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Itakura H, 2009, OPHTHALMOLOGICA, V223, P32, DOI 10.1159/000165682
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Johnsson C, 2006, J HEART LUNG TRANSPL, V25, P544, DOI 10.1016/j.healun.2005.06.029
   Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200
   Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002
   Labat-Robert J, 2012, MED LONGEVITE, V4, P3
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Matsumoto Y, 2010, J BIOMAT SCI-POLYM E, V21, P715, DOI 10.1163/156856209X435844
   Park JS, 2011, J SURG RES, V168, P49, DOI 10.1016/j.jss.2009.09.025
   Park WS, 2010, ASIAN J SURG, V33, P25, DOI 10.1016/S1015-9584(10)60005-X
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Rajapaksa S, 2005, AM J RHINOL, V19, P251, DOI 10.1177/194589240501900307
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Shirali AC, 2008, CURR OPIN ORGAN TRAN, V13, P20, DOI 10.1097/MOT.0b013e3282f3df04
   Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017
   Su WY, 2011, J BIOMAT SCI-POLYM E, V22, P1777, DOI 10.1163/092050610X522729
   Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Tsai SW, 2005, J INT MED RES, V33, P68, DOI 10.1177/147323000503300106
   Turley EA, 2012, FRONT BIOSCI-LANDMRK, V17, P1775, DOI 10.2741/4018
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656
   Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x
   Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200
   Xie Y, 2011, J CONTROL RELEASE, V153, P225, DOI 10.1016/j.jconrel.2011.03.021
   Zhao J, 2008, MACROMOL BIOSCI, V8, P836, DOI 10.1002/mabi.200700334
NR 39
TC 22
Z9 23
U1 5
U2 50
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 2013
VL 59
IS 1
BP 71
EP 76
DI 10.1159/000342200
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 057UN
UT WOS:000312589600010
PM 23006468
DA 2018-10-20
ER

PT J
AU Jiang, B
   Waller, TM
   Larson, JC
   Appel, AA
   Brey, EM
AF Jiang, Bin
   Waller, Thomas M.
   Larson, Jeffery C.
   Appel, Alyssa A.
   Brey, Eric M.
TI Fibrin-Loaded Porous Poly(Ethylene Glycol) Hydrogels as Scaffold
   Materials for Vascularized Tissue Formation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MECHANICAL-PROPERTIES; MOLECULAR-MECHANISMS; PEG HYDROGELS;
   GROWTH-FACTOR; IN-VITRO; NEOVASCULARIZATION; RELEASE; GELS
AB Vascular network formation within biomaterial scaffolds is essential for the generation of properly functioning engineered tissues. In this study, a method is described for generating composite hydrogels in which porous poly(ethylene glycol) (PEG) hydrogels serve as scaffolds for mechanical and structural support, and fibrin is loaded within the pores to induce vascularized tissue formation. Porous PEG hydrogels were generated by a salt leaching technique with 100-150-mu m pore size and thrombin (Tb) preloaded within the scaffold. Fibrinogen (Fg) was loaded into pores with varying concentrations and polymerized into fibrin due to the presence of Tb, with loading efficiencies ranging from 79.9% to 82.4%. Fibrin was distributed throughout the entire porous hydrogels, lasted for greater than 20 days, and increased hydrogel mechanical stiffness. A rodent subcutaneous implant model was used to evaluate the influence of fibrin loading on in vivo response. At weeks 1, 2, and 3, all hydrogels had significant tissue invasion, but no difference in the depth of invasion was found with the Fg concentration. Hydrogels with fibrin loading induced more vascularization, with a significantly higher vascular density at 20mg/mL (week 1) and 40mg/mL (weeks 2 and 3) Fg concentration compared to hydrogels without fibrin. In conclusion, we have developed a composite hydrogel that supports rapid vascularized tissue ingrowth, and thus holds great potential for tissue engineering applications.
C1 [Jiang, Bin; Waller, Thomas M.; Larson, Jeffery C.; Appel, Alyssa A.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Jiang, Bin; Waller, Thomas M.; Larson, Jeffery C.; Appel, Alyssa A.; Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 S Dearborn St,Wishnick Hall,Room 314, Chicago, IL 60616 USA.
EM brey@iit.edu
RI Jiang, Bin/Q-4150-2017
OI Jiang, Bin/0000-0003-2390-4312
FU Veterans Administration and National Science Foundation [IIS-1125412]
FX The authors would like to acknowledge Dr. David C. Venerus (Department
   of Chemical and Biological Engineering, Illinois Institute of
   Technology) for assistance with the compression testing. We thank Dr.
   William Wolf for providing guidance in perfusion fixation technique. We
   would also like to thank Yinghui-Lee for assistance in thrombin activity
   assay and Dr. Sanja Turturro for help in isolectin injection. This work
   was supported by grants from the Veterans Administration and National
   Science Foundation (IIS-1125412).
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   Cheng MH, 2009, PLAST RECONSTR SURG, V124, P787, DOI 10.1097/PRS.0b013e3181b17a91
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Coughlin SR, 1998, ARTERIOSCL THROM VAS, V18, P514, DOI 10.1161/01.ATV.18.4.514
   Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229
   Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jiang B, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P477
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389
   Mason MN, 2010, J BIOMED MATER RES A, V95A, P283, DOI 10.1002/jbm.a.32825
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhao HG, 2009, J MATER SCI-MATER M, V20, P135, DOI 10.1007/s10856-008-3543-x
NR 30
TC 30
Z9 30
U1 1
U2 45
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2013
VL 19
IS 1-2
BP 224
EP 234
DI 10.1089/ten.tea.2012.0120
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 057XS
UT WOS:000312598400022
PM 23003671
OA Green Published
DA 2018-10-20
ER

PT J
AU Lawrence, B
   Alagumanikumaran, N
   Prithivikumaran, N
   Jeyakumaran, N
   Ramadas, V
   Natarajan, B
AF Lawrence, B.
   Alagumanikumaran, N.
   Prithivikumaran, N.
   Jeyakumaran, N.
   Ramadas, V.
   Natarajan, B.
TI Effect of surface modification on the porous silicon infiltrated with
   biomolecules
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Nanostructured porous silicon; Chicken blood plasma; Chicken blood
   serum; Biofunctionalized porous silicon surface; Biosensor
ID FABRICATION; BIOSENSOR
AB Nanostructured porous silicon was prepared by electrochemical etching method. The porous silicon has advantages over planar platforms in biosensor development due to its increased surface area. The high surface area in the porous silicon biosensors will allow for higher biosensor sensitivity while using as a smaller device. The porous silicon optical sensing device works on the basis of changes in its physical properties especially photoluminescence or reflectance, on exposure to the surrounding environment. In the present investigation, porous silicon was bio-functionalized through the deposition of functional groups on its surface by adsorption of chicken blood plasma and serum. SEM, FTIR and photoluminescence studies were carried out for bio-functionalized porous silicon surfaces to study the possibility for utilizing porous silicon as a biomaterial for biosensor applications instead of utilizing porous silicon as a biosensor and biomaterial. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Natarajan, B.] RD Govt Arts Coll, Res Dept Phys, Sivagangai 630561, India.
   [Ramadas, V.] RD Govt Arts Coll, Dept Zool Res, Sivagangai 630561, India.
   [Alagumanikumaran, N.] VHNSN Coll, Dept Zool Res, Virudunagar 626001, India.
   [Lawrence, B.; Prithivikumaran, N.; Jeyakumaran, N.] VHNSN Coll, Res Dept Phys, Virudunagar 626001, India.
RP Natarajan, B (reprint author), RD Govt Arts Coll, Res Dept Phys, Sivagangai 630561, India.
EM b_natraj_b@rediffmail.com
FU UGC, New Delhi, India [39-463/2010 (SR)]
FX The authors also express their sincere thanks to the UGC (Major Research
   Project-[F.No.39-463/2010 (SR)], New Delhi, India.
CR Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008
   Canham L., 1997, PROPERTIES POROUS SI
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Han HM, 2011, THIN SOLID FILMS, V519, P3325, DOI 10.1016/j.tsf.2010.12.015
   Hart BR, 2003, CHEM COMMUN, P322, DOI 10.1039/b209453c
   Hiraoui M, 2011, MATER CHEM PHYS, V128, P151, DOI 10.1016/j.matchemphys.2011.02.052
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512
   Massad-Ivanir N, 2011, ANAL CHEM, V83, P3282, DOI 10.1021/ac200407w
   Meskini O, 2007, TALANTA, V71, P1430, DOI 10.1016/j.talanta.2006.05.089
   Palma R. J. M., 2009, SENSORS, V9, P5149
   Rossi AM, 2007, BIOSENS BIOELECTRON, V23, P741, DOI 10.1016/j.bios.2007.06.004
   Salcedo W. J., 1997, Brazilian Journal of Physics, V27A, P158
   Salman KA, 2012, INT J ELECTROCHEM SC, V7, P376
   Sook P.J., 2006, J MICROBIOL BIOTECHN, V16, P1968
   Stefano L D, 2006, J OPT A-PURE APPL OP, V8, P540
   Stefano L.D., 2004, APPL OPTICS, V43, P167
   Stefano L.D., 2006, BIOSENS BIOELECTRON, V21, P1664
   Theiss W, 1996, THIN SOLID FILMS, V276, P7, DOI 10.1016/0040-6090(95)08036-8
   Tsargorodskaya A, 2004, NANOTECHNOLOGY, V15, P703, DOI 10.1088/0957-4484/15/5/051
   Xue T, 2008, OPTOELECTRON LETT, V4, P328, DOI 10.1007/s11801-008-8037-z
   Yin HB, 2004, MICROELECTRON ENG, V73-4, P830, DOI 10.1016/j.mee.2004.03.060
   ZHANG XG, 1991, J ELECTROCHEM SOC, V138, P3750, DOI 10.1149/1.2085494
NR 24
TC 8
Z9 8
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 1
PY 2013
VL 264
BP 767
EP 771
DI 10.1016/j.apsusc.2012.10.118
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 049SX
UT WOS:000312004800119
DA 2018-10-20
ER

PT J
AU Noriega, S
   Hasanova, G
   Subramanian, A
AF Noriega, Sandra
   Hasanova, Gulnara
   Subramanian, Anuradha
TI The Effect of Ultrasound Stimulation on the Cytoskeletal Organization of
   Chondrocytes Seeded in Three-Dimensional Matrices
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Actin cytoskeleton; Biomaterial; Cartilage, articular; Cartilage
   research; Cell-cell and cell-matrix interactions; Cytoskeleton;
   Cytoskeleton interaction; Tissue engineering, cartilage and bone
ID LOW-INTENSITY ULTRASOUND; INTERMITTENT PHYSIOLOGICAL PRESSURE;
   GENE-EXPRESSION; ARTICULAR CHONDROCYTES; INTERMEDIATE-FILAMENTS;
   REGENERATING CARTILAGE; HYDROSTATIC-PRESSURE; SELF-ORGANIZATION; ACTIN;
   PROLIFERATION
AB The impact of low-intensity diffuse ultrasound (LIDUS) stimulation on the cytoskeletal organization of chondrocytes seeded in three-dimensional (3D) scaffolds was evaluated. Chondrocytes seeded on 3D chitosan matrices were exposed to LIDUS at 5.0 MHz (approx. 15 kPa, 51 s, 4 applications/day) in order to study the organization of actin, tubulin and vimentin. The results showed that actin presented a punctate cytosolic distribution and tubulin presented a quasiparallel organization of microtubules, whereas vimentin distribution was unaffected. Chondrocytes seeded on 3D scaffolds responded to US stimulation by the disruption of actin stress fibers and were sensitive to the presence of Rho-activated kinase (ROCK) inhibitor (Y27632). The gene expression of ROCK-I, a key element in the formation of stress fibers and mDia1, was significantly upregulated under the application of US. We conclude that the results of both the cytoskeletal analyses and gene expression support the argument that the presence of punctate actin upon US stimulation was accompanied by the upregulation of the RhoA/ROCK pathway. Copyright (C) 2012 S. Karger AG, Basel
C1 [Noriega, Sandra; Hasanova, Gulnara; Subramanian, Anuradha] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68516 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68516 USA.
EM asubramanian2@unl.edu
FU UNL-Tobacco Settlement Funds; NIH [R21EB006046]; Department of Health
   and Human Services [1R21RR024437-01A1]
FX We are especially thankful to Ms. Terry Fangman and the microscopy
   facility at the University of Nebraska, Lincoln, for their help with the
   confocal microscopy, image acquisition and processing. This research
   work was partially supported by UNL-Tobacco Settlement Funds, NIH grant
   R21EB006046, and in part by the American Recovery and Reinvestment Act
   of 2009 research grant 1R21RR024437-01A1 from the Department of Health
   and Human Services.
CR BENJAMIN M, 1994, MICROSC RES TECHNIQ, V28, P372, DOI 10.1002/jemt.1070280503
   Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x
   Campbell JJ, 2007, BIOCHEM BIOPH RES CO, V361, P329, DOI 10.1016/j.bbrc.2007.06.185
   Carver SE, 1999, BIOTECHNOL BIOENG, V62, P166, DOI 10.1002/(SICI)1097-0290(19990120)62:2<166::AID-BIT6>3.3.CO;2-B
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168
   Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x
   Fioravanti A, 2005, CLIN EXP RHEUMATOL, V23, P847
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003
   Hasanova G., 2007, EUR CELLS MATER, V14, P108
   Hasanova GI, 2011, J TISSUE ENG REGEN M, V5, P815, DOI 10.1002/term.384
   Haudenschild DR, 2008, BIORHEOLOGY, V45, P219, DOI 10.3233/BIR-2008-0499
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Idowu BD, 2000, HISTOCHEM J, V32, P165, DOI 10.1023/A:1004095207330
   Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147
   Knight MM, 2006, J BIOMECH, V39, P1547, DOI 10.1016/j.jbiomech.2005.04.006
   Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826
   Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101
   Ng L, 2007, J BIOMECH, V40, P1011, DOI 10.1016/j.jbiomech.2006.04.004
   Nishikori T, 2002, J BIOMED MATER RES, V59, P201, DOI 10.1002/jbm.1226.abs
   Noriega S, 2007, TISSUE ENG, V13, P611, DOI 10.1089/ten.2006.0130
   Papaseit C, 2000, P NATL ACAD SCI USA, V97, P8364, DOI 10.1073/pnas.140029597
   Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405
   Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Tabony J, 2002, LANGMUIR, V18, P7196, DOI 10.1021/la0255875
   Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Zhang ZJ, 2003, ULTRASOUND MED BIOL, V29, P1645, DOI 10.1016/j.ultrasmedbio.2003.08.011
   Zhang ZJ, 2002, ULTRASOUND MED BIOL, V28, P1547, DOI 10.1016/S0301-5629(02)00659-2
   Zhou S., 2004, J BIOL CHEM, V279, P54563
NR 36
TC 8
Z9 11
U1 0
U2 12
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2013
VL 197
IS 1
BP 14
EP 26
DI 10.1159/000339772
PG 13
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 055UG
UT WOS:000312442700002
PM 22987069
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Saracino, GAA
   Cigognini, D
   Silva, D
   Caprini, A
   Gelain, F
AF Saracino, Gloria A. A.
   Cigognini, Daniela
   Silva, Diego
   Caprini, Andrea
   Gelain, Fabrizio
TI Nanomaterials design and tests for neural tissue engineering
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SPINAL-CORD-INJURY; MOLECULAR-DYNAMICS SIMULATIONS; PEPTIDE NANOFIBER
   SCAFFOLD; AMYLOID FIBRIL FORMATION; ATOMIC-FORCE MICROSCOPY; EMBRYONIC
   STEM-CELLS; INTERPENETRATING POLYMER NETWORKS; TRANSMISSION
   ELECTRON-MICROSCOPY; DISSIPATIVE PARTICLE DYNAMICS; PERIPHERAL-NERVE
   REGENERATION
AB Nanostructured scaffolds recently showed great promise in tissue engineering: nanomaterials can be tailored at the molecular level and scaffold morphology may more closely resemble features of extracellular matrix components in terms of porosity, framing and biofunctionalities. As a consequence, both biomechanical properties of scaffold microenvironments and biomaterial-protein interactions can be tuned, allowing for improved transplanted cell engraftment and better controlled diffusion of drugs. Easier said than done, a nanotech-based regenerative approach encompasses different fields of know-how, ranging from in silico simulations, nanomaterial synthesis and characterization at the nano-, micro-and mesoscales to random library screening methods (e. g. phage display), in vitro cellular-based experiments and validation in animal models of the target injury. All of these steps of the "assembly line'' of nanostructured scaffolds are tightly interconnected both in their standard analysis techniques and in their most recent breakthroughs: indeed their efforts have to jointly provide the deepest possible analyses of the diverse facets of the challenging field of neural tissue engineering. The purpose of this review is therefore to provide a critical overview of the recent advances in and drawbacks and potential of each mentioned field, contributing to the realization of effective nanotech-based therapies for the regeneration of peripheral nerve transections, spinal cord injuries and brain traumatic injuries. Far from being the ultimate overview of such a number of topics, the reader will acknowledge the intrinsic complexity of the goal of nanotech tissue engineering for a conscious approach to the development of a regenerative therapy and, by deciphering the thread connecting all steps of the research, will gain the necessary view of its tremendous potential if each piece of stone is correctly placed to work synergically in this impressive mosaic.
C1 [Saracino, Gloria A. A.; Cigognini, Daniela; Silva, Diego; Caprini, Andrea; Gelain, Fabrizio] AO Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, I-20162 Milan, Italy.
   [Saracino, Gloria A. A.; Cigognini, Daniela; Silva, Diego; Caprini, Andrea] Univ Milano Bicocca, Biotechnol & Biosci Dept, I-20126 Milan, Italy.
   [Gelain, Fabrizio] IRCCS Casa Sollievo Sofferenza Opera San Pio Piet, I-71013 San Giovanni Rotondo, Italy.
RP Gelain, F (reprint author), AO Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, I-20162 Milan, Italy.
EM gelain@mit.edu
RI Gelain, Fabrizio/K-5069-2012
OI Gelain, Fabrizio/0000-0002-2624-5853
CR Abu-Rub M, 2010, DRUG DISCOV TODAY, V15, P436, DOI 10.1016/j.drudis.2010.03.008
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Ahmed I, 2007, MOL CELL BIOCHEM, V301, P241, DOI 10.1007/s11010-007-9417-6
   ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121
   Auer S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.258101
   Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001
   Bahney CS, 2011, EUR CELLS MATER, V22, P43, DOI 10.22203/eCM.v022a04
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P82, DOI 10.1021/bm1010195
   Balestrieri ML, 2007, EUR J CANCER, V43, P1242, DOI 10.1016/j.ejca.2007.02.006
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barattin R, 2008, CHEM COMMUN, P1513, DOI 10.1039/b614328h
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592
   Baumketner A, 2005, BIOPHYS J, V89, P1493, DOI 10.1529/biophysj.105.059196
   Baumketner A, 2006, J MOL BIOL, V362, P567, DOI 10.1016/j.jmb.2006.07.032
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   Bellesia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3108461
   Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651
   Bull SR, 2008, J AM CHEM SOC, V130, P2742, DOI 10.1021/ja710749q
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009
   Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653
   CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030
   Carrillo JMY, 2011, MACROMOLECULES, V44, P5798, DOI 10.1021/ma2007943
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen JP, 2011, COLLOID SURFACE B, V86, P169, DOI 10.1016/j.colsurfb.2011.03.038
   Chen L, 2010, CHEM COMMUN, V46, P4267, DOI 10.1039/c003052j
   Cheon M, 2010, PROTEINS, V78, P2950, DOI 10.1002/prot.22817
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chiessi E, 2010, J PHYS CHEM B, V114, P8301, DOI 10.1021/jp912209z
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938
   Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Cui H, 2007, SOFT MATTER, V3, P945, DOI 10.1039/b704194b
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Daidone I, 2004, PROTEINS, V57, P198, DOI 10.1002/prot.20178
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081
   De Simone A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3385470
   Derreumaux P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408414
   DIETZ MH, 1971, CANCER RES, V31, P1206
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Ding F, 2005, J BIOL CHEM, V280, P40235, DOI 10.1074/jbc.M506372200
   Dobrynin AV, 2008, CURR OPIN COLLOID IN, V13, P376, DOI 10.1016/j.cocis.2008.03.006
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015
   Edgecombe S, 2008, POLYMER, V49, P1981, DOI 10.1016/j.polymer.2008.02.018
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Escobedo FA, 1999, PHYS REP, V318, P86, DOI 10.1016/S0370-1573(99)00012-5
   Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103
   Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002
   Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574
   Fang P. A., 2011, CELLS TISSUES ORGANS
   Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839
   Feng Y, 2011, CHEM COMMUN, V47, P10455, DOI 10.1039/c1cc13943f
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Flory P. J., 1953, PRINCIPLE POLYM CHEM
   Ford MD, 2001, CLIN TOXICOLOGY
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Friedrich H, 2010, ANGEW CHEM INT EDIT, V49, P7850, DOI 10.1002/anie.201001493
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gennes PG, 1979, SCALING CONCEPTS POL
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005
   Giudice S, 2007, TOXICOL IN VITRO, V21, P240, DOI 10.1016/j.tiv.2006.09.023
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guilbaud JB, 2011, CHEM SOC REV, V40, P1200, DOI 10.1039/c0cs00105h
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong HY, 2008, J CONTROL RELEASE, V131, P167, DOI 10.1016/j.jconrel.2008.07.020
   Hoogenboom HR, 1997, TRENDS BIOTECHNOL, V15, P62, DOI 10.1016/S0167-7799(97)84205-9
   HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hou ST, 2004, J NEUROSCI METH, V138, P39, DOI 10.1016/j.jneumeth.2004.03.013
   Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101
   Hyland LL, 2012, BIOPOLYMERS, V97, P177, DOI 10.1002/bip.21722
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jejurikar A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025010
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x
   Kanki S, 2011, J MOL CELL CARDIOL, V50, P841, DOI 10.1016/j.yjmcc.2011.02.003
   Kessick R, 2004, POLYMER, V45, P2981, DOI 10.1016/j.polymer.2004.02.056
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066
   Khoe U, 2009, LANGMUIR, V25, P4111, DOI 10.1021/la8025232
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5471CAN-05-2748
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601
   LaNasa SM, 2011, J BIOMED MATER RES B, V96B, P294, DOI 10.1002/jbm.b.31765
   Leach A.R., 2001, MOL MODELLING PRINCI
   Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lee SG, 2009, BIOMATERIALS, V30, P6130, DOI 10.1016/j.biomaterials.2009.07.035
   Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2989981
   Li Song, 2003, FASEB Journal, V17, P97
   Li XM, 2010, CHEM COMMUN, V46, P5364, DOI 10.1039/c0cc00163e
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   LIESI P, 1989, FEBS LETT, V244, P141, DOI 10.1016/0014-5793(89)81180-9
   Lin EI, 2010, J PHYS CHEM B, V114, P11899, DOI 10.1021/jp104114n
   Lin SL, 2011, PHYS CHEM CHEM PHYS, V13, P17323, DOI 10.1039/c1cp20186g
   Liu JK, 2005, NEUROBIOL DIS, V19, P407, DOI 10.1016/j.nbd.2005.01.022
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Longo GS, 2012, SOFT MATTER, V8, P1344, DOI 10.1039/c1sm06708g
   Longo GS, 2011, MACROMOLECULES, V44, P147, DOI 10.1021/ma102312y
   Lowery J, 2009, NANOTECHNOL SCI TECH, P1
   Lu Y, 2009, PROTEINS, V75, P954, DOI 10.1002/prot.22305
   Lu ZY, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061807
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BA, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1882275
   Mann BAF, 2011, MACROMOL THEOR SIMUL, V20, P721, DOI 10.1002/mats.201100050
   Manoutcharian K, 2001, CURR PHARM BIOTECHNO, V2, P217, DOI [10.2174/1389201013378671, DOI 10.2174/1389201013378671]
   Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102
   Mathur AM, 1996, BIOMATERIALS, V17, P547, DOI 10.1016/0142-9612(96)88705-9
   Matsumura S, 2005, MOL BIOSYST, V1, P146, DOI 10.1039/b504516a
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Meiners S, 2007, POLYM INT, V56, P1340, DOI 10.1002/pi.2383
   Merzlyak A, 2009, NANO LETT, V9, P846, DOI 10.1021/nl8036728
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   Micklitsch CM, 2011, ANGEW CHEM INT EDIT, V50, P1577, DOI 10.1002/anie.201006652
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Mousseau N, 2008, FRONT BIOSCI-LANDMRK, V13, P4495, DOI 10.2741/3019
   Murray MM, 2009, J PHYS CHEM B, V113, P6041, DOI 10.1021/jp808384x
   Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nam HB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3415372
   Nasica-Labouze J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002051
   Negureanu L, 2009, J MOL BIOL, V389, P921, DOI 10.1016/j.jmb.2009.04.058
   Nguyen HD, 2006, J AM CHEM SOC, V128, P1890, DOI 10.1021/ja0539140
   Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r
   Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Olsen BD, 2010, MACROMOLECULES, V43, P9094, DOI 10.1021/ma101434a
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Paparcone R, 2010, J BIOMECH, V43, P1196, DOI 10.1016/j.jbiomech.2009.11.026
   Paradossi G, 2011, POLYMERS-BASEL, V3, P1805, DOI 10.3390/polym3041805
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Pellarin R, 2007, J MOL BIOL, V374, P917, DOI 10.1016/j.jmb.2007.09.090
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Phillips MJ, 2011, INVEST OPHTH VIS SCI, V52, P1439, DOI 10.1167/iovs.10-6400
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Richert L, 2002, TOXICOL IN VITRO, V16, P89, DOI 10.1016/S0887-2333(01)00099-6
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   Rockwood DN, 2004, ABSTR PAP AM CHEM S, V228, pU364
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Santini S, 2004, STRUCTURE, V12, P1245, DOI 10.1016/j.str.2004.04.018
   Saracino GAA, 2009, PROTEINS, V75, P964, DOI 10.1002/prot.22306
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schor M, 2011, PHYS CHEM CHEM PHYS, V13, P10457, DOI 10.1039/c0cp02842h
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Sharpe S, 2011, BIOMACROMOLECULES, V12, P1546, DOI 10.1021/bm101486s
   SHENOY AV, 1983, RHEOL ACTA, V22, P209, DOI 10.1007/BF01332373
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh G, 2008, BIOPHYS J, V95, P3208, DOI [10.1529/biophysj.108.136226, 10.1529/biophysj.108.13622]
   Skovstrup S, 2010, BIOMACROMOLECULES, V11, P3196, DOI 10.1021/bm100736w
   SKUBITZ APN, 1990, CANCER RES, V50, P7612
   Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106
   Stedall TP, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11005-0
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526
   Stulz E, 2011, CHEM SOC REV, V40, P5633, DOI 10.1039/c1cs90048j
   Stupp S. I., 2009, US, Patent No. [7 544 661 B2, 7544661]
   Stupp S. I., 2010, NAT MATER, V9, P594
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tang C, 2011, LANGMUIR, V27, P14438, DOI 10.1021/la202113j
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Tang QW, 2009, J COLLOID INTERF SCI, V339, P45, DOI 10.1016/j.jcis.2009.07.026
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Taraballi F, 2009, SOFT MATTER, V5, P660, DOI 10.1039/b809236b
   Taraban MB, 2011, SOFT MATTER, V7, P2624, DOI 10.1039/c0sm00919a
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013
   Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   Tran H, 2011, JOVE-J VIS EXP, DOI 10.3791/3373
   Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8
   Truong WT, 2011, CHEM-ASIAN J, V6, P30, DOI 10.1002/asia.201000592
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsonchev S, 2008, J PHYS CHEM B, V112, P441, DOI 10.1021/jp076273z
   Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ueberberg S, 2010, REGUL PEPTIDES, V160, P1, DOI 10.1016/j.regpep.2009.11.017
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
   Vegners R, 1995, J Pept Sci, V1, P371, DOI 10.1002/psc.310010604
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   VENSTROM KA, 1993, FASEB J, V7, P996
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wallmersperger T, 2011, COLLOID POLYM SCI, V289, P535, DOI 10.1007/s00396-011-2404-1
   Walter J, 2010, FLUID PHASE EQUILIBR, V296, P164, DOI 10.1016/j.fluid.2010.03.025
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wang W, 2009, J BIOMED MATER RES A, V91A, P994, DOI 10.1002/jbm.a.32329
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Whaley SR, 2000, NATURE, V405, P665
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Woolfson D. N., 2005, ANGEW CHEM INT EDIT, V44, P325
   Wu RL, 2012, MACROMOL THEOR SIMUL, V21, P250, DOI 10.1002/mats.201100088
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Young TJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/12/125703
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yucel T, 2008, MACROMOLECULES, V41, P5763, DOI 10.1021/ma702840q
   Zahid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012252
   Zhang JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050295
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   Zhang Y, 2012, LANGMUIR, V28, P3063, DOI 10.1021/la203923d
   Zhao F, 2011, LANGMUIR, V27, P1510, DOI 10.1021/la103982e
   Zhao WX, 2010, J BIOMOL SCREEN, V15, P687, DOI 10.1177/1087057110370997
   Zhong S, 2010, POLYM REV, V50, P287, DOI 10.1080/15583724.2010.493254
   Zitzmann S, 2005, CLIN CANCER RES, V11, P139
   Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299
NR 325
TC 81
Z9 88
U1 7
U2 303
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2013
VL 42
IS 1
BP 225
EP 262
DI 10.1039/c2cs35065c
PG 38
WC Chemistry, Multidisciplinary
SC Chemistry
GA 049FV
UT WOS:000311968700015
PM 22990473
DA 2018-10-20
ER

PT J
AU Ferrero-Gutierrez, A
   Menendez-Menendez, Y
   Alvarez-Viejo, M
   Meana, A
   Otero, J
AF Ferrero-Gutierrez, Amaia
   Menendez-Menendez, Yolanda
   Alvarez-Viejo, Maria
   Meana, Alvaro
   Otero, Jesus
TI New serum-derived albumin scaffold seeded with adipose-derived stem
   cells and olfactory ensheathing cells used to treat spinal cord injured
   rats
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE Spinal cord injury; Cell transplantation; Albumin scaffold;
   Adipose-derived stem cells (ADSCs); Olfactory ensheathing cells (OECs)
ID MARROW STROMAL CELLS; CHRONIC PARAPLEGIC RATS; CENTRAL-NERVOUS-SYSTEM;
   FUNCTIONAL RECOVERY; AXONAL REGENERATION; EXTRACELLULAR-MATRIX; COLLAGEN
   SCAFFOLDS; CNS REGENERATION; GLIA TRANSPLANTS; MYELIN
AB Recent advances in spinal cord injury (SCI) research and cell culture techniques and biomaterials predict promising new treatments for patients with SCI or other nerve injuries. Biomaterial scaffolds form a substrate within which cells are instructed to form a tissue in a controlled manner. This study was designed to assess axon regeneration and locomotor recovery in rats with spinal cord injury treated with a novel serum-derived albumin scaffold seeded with adipose derived stem cells (ADSCs) and olfactory ensheathing cells (OECs). OECs are considered promising candidates for the treatment of SCI, and ADSCs have the ability to differentiate into neural lineages. In vitro experiments revealed that ADSCs and OECs adhered to the scaffold, remained viable and expressed specific markers of their cell types when cultured in the scaffold. Rats treated with scaffold plus cells showed locomotor skills at several time points from 45 days post-injury that were improved over those recorded in control injured, untreated animals. Astrocytic scars and tissue regeneration, identified using histological and immunohistochemical techniques, revealed that although the scaffold itself appeared to play a significant role in reducing glial scar formation and filling of the lesion cavity with cells, the presence of ADSCs and OECs in the scaffold led to the appearance of cells expressing markers of neurons and axons at the injury site. Our findings point to the clinical feasibility of an albumin scaffold seeded with ADSCs and OECs as a treatment candidate for use in spinal cord injury repair studies.
C1 [Ferrero-Gutierrez, Amaia] HUCA, Lab Trasplantes & Terapia Celular, Transplant & Cell Therapy Unit, Oviedo 33006, Asturias, Spain.
   [Meana, Alvaro] Ctr Comunitario Sangre & Tejidos Asturias, Tissue Engn Res Unit, Oviedo, Spain.
RP Ferrero-Gutierrez, A (reprint author), HUCA, Lab Trasplantes & Terapia Celular, Transplant & Cell Therapy Unit, C Celestino Villamil S-N,Edificio Polivalente A,1, Oviedo 33006, Asturias, Spain.
EM amaya.ferrero@sespa.princast.es
RI Ferrero-Gutierrez, Amaia/H-9341-2017; Alvarez-Viejo, Maria/H-9289-2017;
   Otero, Jesus/J-1858-2017
OI Otero, Jesus/0000-0003-4097-3846
FU FICYT [PEST 08-12]; Obra Social y Cultural Cajastur
FX This work was supported by FICYT PEST 08-12 and Obra Social y Cultural
   Cajastur. The authors acknowledge the assistance of: Dra. Aurora
   Astudillo and the staff of pathology unit of the HUCA, Dr. M.
   Nieto-Sampedro and E. Martin-Lopez, Dra. Ana Martin-Villalba.
CR Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3
   BALENTINE JD, 1978, LAB INVEST, V39, P254
   Barnett SC, 2004, J ANAT, V204, P57, DOI 10.1111/j.1469-7580.2004.00257.x
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   CADELLI DS, 1992, EXP NEUROL, V115, P189, DOI 10.1016/0014-4886(92)90246-M
   Caroni P, 2008, NEURON, V60, P404, DOI 10.1016/j.neuron.2008.10.028
   Ceccatelli S, 2004, TOXICOL LETT, V149, P59, DOI 10.1016/j.toxlet.2003.12.060
   Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6
   Collazos-Castro JE, 2005, J NEUROSURG-SPINE, V3, P308, DOI 10.3171/spi.2005.3.4.0308
   Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007
   Deng YB, 2008, CYTOTHERAPY, V10, P551, DOI 10.1080/14653240802165673
   Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Gallego L., 2009, J BIOMATER APPL, V25, P367
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029
   GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0
   GudinoCabrera G, 1996, RESTOR NEUROL NEUROS, V10, P25, DOI 10.3233/RNN-1996-10104
   Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X
   Li C, 2004, BRAIN, V127, P535
   Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   McDonald JW, 2003, AM J PHYS MED REHAB, V82, pS38, DOI 10.1097/01.PHM.0000086994.53716.17
   McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6
   Meana A, 2008, Spanish patent, Patent No. [WO 2008/119855, 2008119855]
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Radtke C, 2009, BRAIN RES, V1254, P10, DOI 10.1016/j.brainres.2008.11.036
   RAISMAN G, 1985, NEUROSCIENCE, V14, P237, DOI 10.1016/0306-4522(85)90176-9
   Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576
   Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Resnick DK, 2003, J NEUROTRAUM, V20, P279, DOI 10.1089/089771503321532860
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013
   Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072
   Verdu E, 2003, GLIA, V42, P275, DOI 10.1002/glia.10217
   Verdu E, 2001, NEUROREPORT, V12, P2303, DOI 10.1097/00001756-200108080-00005
   Wang B, 2006, NEUROSCI LETT, V401, P65, DOI 10.1016/j.neulet.2006.02.085
   Wang B, 2007, NEUROSCI LETT, V421, P191, DOI 10.1016/j.neulet.2007.04.081
   Yarak S, 2010, AN BRAS DERMATOL, V85, P647, DOI 10.1590/S0365-05962010000500008
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069
   Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f
NR 50
TC 14
Z9 16
U1 0
U2 26
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD JAN
PY 2013
VL 28
IS 1
BP 89
EP 100
PG 12
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 054ZK
UT WOS:000312384000008
PM 23233062
DA 2018-10-20
ER

PT J
AU Fogaca, R
   Catalani, LH
AF Fogaca, Renata
   Catalani, Luiz H.
TI PVP Hydrogel Membranes Produced by Electrospinning for Protein Release
   Devices
SO SOFT MATERIALS
LA English
DT Article
DE Collagenase; Electrospinning; Hydrogels; Porosity; PVP
ID OXIDE)/POLY(VINYL PYRROLIDONE)-IODINE COMPLEX; BIOMEDICAL APPLICATIONS;
   CROSS-LINKING; NANOFIBERS; MORPHOLOGIES; DESIGN; BLENDS
AB Hydrogels are materials of interest in the biomedical field due to their potential application in wound dressing as well as in drug delivery devices. This work describes the production of a novel poly(N-vinyl-2-pyrrolidone) (PVP) hydrogel membrane produced by electrospinning with a gel fraction up to 90% and a high swelling degree. PVP electrospun nanofiber, cross-linking with UV-C radiation and Fenton reactions, were used to obtain a highly porous membrane. By a 23 experimental design the control of the nanofiber diameter was achieved and proven to exert significant influence on the BSA release profile. Collagenase release behavior and its enzymatic activity were also evaluated in order to estimate the ability of this biomaterial to be used as an enzymatic debriding wound dressing.
C1 [Fogaca, Renata; Catalani, Luiz H.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508900 Sao Paulo, Brazil.
RP Catalani, LH (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, CP 26077, BR-05508900 Sao Paulo, Brazil.
EM catalani@usp.br
RI Catalani, Luiz/E-2841-2010; Institute of Chemistry - USP, Dept. of
   Chemistry/B-8988-2012
OI Catalani, Luiz/0000-0003-3689-1792; 
FU FAPESP; CNPq
FX The authors would like to thank FAPESP and CNPq for financial support
   and the Laboratorio Nacional de Luz Sincroton - LNLS for the use of
   their facilities.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Barros JAG, 2006, POLYMER, V47, P8414, DOI 10.1016/j.polymer.2006.10.033
   Beachley V, 2009, MAT SCI ENG C-BIO S, V29, P663, DOI 10.1016/j.msec.2008.10.037
   Bognitzki M, 2001, POLYM ENG SCI, V41, P982, DOI 10.1002/pen.10799
   Bueno VB, 2009, COLLOID POLYM SCI, V287, P705, DOI 10.1007/s00396-009-2017-0
   Chiu CT, 2008, J MATER SCI-MATER M, V19, P2503, DOI 10.1007/s10856-008-3389-2
   Cunha F, 2004, MAT RES, V7, P539
   Fechine GJM, 2004, POLYMER, V45, P4705, DOI 10.1016/j.polymer.2004.05.006
   Forte MMD, 2003, POLYMER, V44, P1377
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Harrington DJ, 1996, INFECT IMMUN, V64, P1885
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatova M, 2008, J BIOMAT SCI-POLYM E, V19, P373, DOI 10.1163/156856208783721056
   Ignatova M, 2007, EUR POLYM J, V43, P1609, DOI 10.1016/j.eurpolymj.2007.02.020
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   MOORE S, 1948, J BIOL CHEM, V176, P367
   Moura M, 2009, MAT SCI ENG C, V29, P2319
   Ozcon C., 2002, BURNS, V28, P791
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Sajeev US, 2008, B MATER SCI, V31, P343, DOI 10.1007/s12034-008-0054-9
   Shi L., 2009, WOUND OSTOMY CONTINE, V36, P12
   Tan S, 2007, POLYM INT, V56, P1330, DOI 10.1002/pi.2354
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Xin Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236382
   Xu CY, 2007, POLYM BULL, V58, P53, DOI 10.1007/s00289-006-0597-0
   Yang QB, 2004, J POLYM SCI POL PHYS, V42, P3721, DOI 10.1002/polb.20222
NR 30
TC 9
Z9 9
U1 5
U2 92
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1539-445X
J9 SOFT MATER
JI Soft Mater.
PD JAN 1
PY 2013
VL 11
IS 1
BP 61
EP 68
DI 10.1080/1539445X.2011.580411
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 055TP
UT WOS:000312440900009
DA 2018-10-20
ER

PT J
AU Ferreira, MSV
   Schneider, RK
   Wagner, W
   Jahnen-Dechent, W
   Labude, N
   Bovi, M
   Piroth, D
   Knuchel, R
   Hieronymus, T
   Muller, AM
   Zenke, M
   Neuss, S
AF Ferreira, Monica Sofia Ventura
   Schneider, Rebekka Kramann
   Wagner, Wolfgang
   Jahnen-Dechent, Willi
   Labude, Norina
   Bovi, Manfred
   Piroth, Daniela
   Knuechel, Ruth
   Hieronymus, Thomas
   Mueller, Albrecht M.
   Zenke, Martin
   Neuss, Sabine
TI Two-Dimensional Polymer-Based Cultures Expand Cord Blood-Derived
   Hematopoietic Stem Cells and Support Engraftment of NSG Mice
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID EX-VIVO EXPANSION; PROGENITOR CELLS; BONE-MARROW; 3-DIMENSIONAL
   SCAFFOLDS; STEM/PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO;
   TRANSPLANTATION; ADHESION; MATRIX
AB Currently, ex vivo expansion of hematopoietic stem cells (HSC) is still insufficient. Traditional approaches for HSC expansion include the use of stromal cultures, growth factors, and/or bioreactors. Biomaterial-based strategies provide new perspectives. We focus on identifying promising two-dimensional (2D) polymer candidates for HSC expansion. After a 7-day culture period with cytokine supplementation, 2D fibrin, poly(D, L-lacticco-glycolic acid; Resomer (R) RG503), and Poly(epsilon-caprolactone; PCL) substrates supported expansion of cord blood (CB)-derived CD34(+) cells ex vivo. Fibrin cultures achieved the highest proliferation rates (>8700-fold increase of total nuclear cells, p < 0.001), high total colony-forming units (3.6-fold increase, p < 0.001), and highest engraftment in NSG mice (7.69-fold more donor cells compared with tissue culture polysterene, p < 0.001). In addition, the presence of multiple human hematopoietic lineages such as myeloid (CD13(+)), erythroid (GypC(+)), and lymphoid (CD20(+)/CD56(+)) in murine transplant recipients confirmed the multilineage engraftment potential of fibrin-based cultures. Filopodia development in fibrin-expanded cells was a further indicator for superior cell adhesion capacities. We propose application of fibrin, Resomer (R) RG503, and PCL for future strategies of CB-CD34(+) cell expansion. Suitable polymers for HSC expansion might also be appropriate for future drug discovery applications or for studies aimed to develop hematological therapies.
C1 [Ferreira, Monica Sofia Ventura; Schneider, Rebekka Kramann; Labude, Norina; Knuechel, Ruth; Neuss, Sabine] Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Wagner, Wolfgang] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Stem Cell Biol & Cellular Engn Grp, D-52074 Aachen, Germany.
   [Jahnen-Dechent, Willi; Neuss, Sabine] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Biointerface Grp, D-52074 Aachen, Germany.
   [Bovi, Manfred] Univ Hosp Aachen, Electron Microscop Facil, Aachen, Germany.
   [Piroth, Daniela] Rhein Westfal TH Aachen, Dept Gynecol, D-52074 Aachen, Germany.
   [Hieronymus, Thomas; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, Germany.
   [Mueller, Albrecht M.] Univ Wurzburg, Inst Med Radiat & Cell Res, Wurzburg, Germany.
RP Ferreira, MSV (reprint author), Rhein Westfal TH Aachen, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM mventuraferreira@ukaachen.de; sabine.neuss@post.rwth-aachen.de
RI Ventura Ferreira, Monica/P-5910-2017; Jahnen-Dechent, Willi/A-7608-2011
OI Ventura Ferreira, Monica/0000-0002-1437-1342; Jahnen-Dechent,
   Willi/0000-0003-1315-4407; Wagner, Wolfgang/0000-0002-1971-3217
FU Federal Ministry of Education and Research (BMBF), Germany; "Cell-based
   Regenerative Medicine" program [01GN0931]
FX We thank the financial support from the Federal Ministry of Education
   and Research (BMBF), Germany. This project (Grant-Number: 01GN0931) is
   part of the CB-HERMES consortium working on a "Cell-based Regenerative
   Medicine" program. We thank the Department of Gynecology and
   Obstetrics-University Clinics RWTH Aachen for the cooperation related to
   CB collection. We thank the DWI e.V. and Institute of Technical and
   Macromolecular Chemistry, RWTH Aachen University, Dr. Anandhan
   Dhanasingh, Dr. Jochen Salber, Dr. Xiaomin Zhu, and Mareike Hoss (IZKF
   Aachen) for the cooperation related to polymer production. We thank
   Thomas Walenda and Gudrun Walenda for sharing their expertise on CFSE
   analysis and NSG transplantation.
CR Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979
   Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Ferreira MSV, 2013, J TISSUE ENG REGEN M, V7, P944, DOI 10.1002/term.1486
   Ferreira MV, 2012, J MATER SCI-MATER M, V23, P109, DOI 10.1007/s10856-011-4483-4
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Franke K, 2007, BIOMATERIALS, V28, P836, DOI 10.1016/j.biomaterials.2006.09.031
   GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707
   Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Li Y, 2001, J HEMATOTH STEM CELL, V10, P355, DOI 10.1089/152581601750288966
   Liao YL, 2011, EXP HEMATOL, V39, P393, DOI 10.1016/j.exphem.2011.01.002
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   Mantalaris A, 1998, BIOTECHNOL PROGR, V14, P126, DOI 10.1021/bp970136+
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051
   NAUGHTON BA, 1990, PROG CLIN BIOL RES, V333, P435
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276
   Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278
   Purton LE, 2008, STEMBOOK, P1
   Rocha V, 2010, BEST PRACT RES CL HA, V23, P223, DOI 10.1016/j.beha.2010.07.005
   Rosenzweig M, 1997, GENE THER, V4, P928, DOI 10.1038/sj.gt.3300480
   Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140
   Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Singbrant S, 2011, J CELL BIOCHEM, V112, P1486, DOI 10.1002/jcb.23085
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Verfaillie CM, 1998, BLOOD, V92, P2609
   Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011
   Wang JCY, 1997, BLOOD, V89, P3919
   WANG TY, 1995, EXP HEMATOL, V23, P26
   Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119
NR 46
TC 1
Z9 1
U1 0
U2 26
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JAN
PY 2013
VL 19
IS 1
DI 10.1089/ten.tec.2011.0706
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 054MM
UT WOS:000312347900003
PM 22712684
OA Green Published
DA 2018-10-20
ER

PT J
AU Cameron, K
   Travers, P
   Chander, C
   Buckland, T
   Campion, C
   Noble, B
AF Cameron, Kate
   Travers, Paul
   Chander, Chaman
   Buckland, Tom
   Campion, Charlie
   Noble, Brendon
TI Directed osteogenic differentiation of human mesenchymal stem/precursor
   cells on silicate substituted calcium phosphate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cells; biomaterial; osteogenic differentiation; calcium
   phosphate
ID MARROW STROMAL CELLS; DENTIN MATRIX PROTEIN-1; OSTEOBLASTIC
   DIFFERENTIATION; STEM-CELLS; IN-VITRO; BIOLOGICAL RESPONSE;
   GENE-EXPRESSION; BONE; RUNX2; HYDROXYAPATITE
AB Insufficient, underactive, or inappropriate osteoblast function results in serious clinical conditions such as osteoporosis, osteogenesis imperfecta and fracture nonunion and therefore the control of osteogenesis is a medical priority. In vitro mesenchymal stem cells (MSCs) can be directed to form osteoblasts through the addition of soluble factors such as beta-glycerophosphate, ascorbic acid, and dexamethasone; however this is unlikely to be practical in the clinical setting. An alternative approach would be to use a scaffold or matrix engineered to provide cues for differentiation without the need for soluble factors. Here we describe studies using Silicate-substituted calcium phosphate (Si-CaP) and unmodified hydroxyapatite (HA) to test whether these materials are capable of promoting osteogenic differentiation of MSCs in the absence of soluble factors. Si-CaP supported attachment and proliferation of MSCs and induced osteogenesis to a greater extent than HA, as evidenced through upregulation of the osteoblast-related genes: Runx2 (1.2 fold), Col1a1 (2 fold), Pth1r (1.5 fold), and Bglap (1.7 fold) Dmp1 (1.1 fold), respectively. Osteogenic-associated proteins, alkaline phosphatase (1.4 fold), RUNX2, COL1A1, and BGLAP, were also upregulated and there was an increased production of mineralized bone matrix (1.75 fold), as detected by the Von Kossa Assay. These data indicate that inorganic substrates are capable of directing the differentiation programme of stem cells in the absence of known chemical drivers and therefore may provide the basis for bone repair in the clinical setting. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:1322, 2013.
C1 [Cameron, Kate; Travers, Paul] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.
   [Chander, Chaman; Buckland, Tom; Campion, Charlie] ApaTech Ltd, Elstree WD6 3TJ, Herts, England.
   [Noble, Brendon] Univ Campus Suffolk, Sch Sci Technol & Hlth, Ipswich IP4 1QJ, Suffolk, England.
RP Cameron, K (reprint author), Univ Edinburgh, MRC Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
EM k.r.cameron@sms.ed.ac.uk
FU Chief Scientist Office [CZB/4/656]; Medical Research Council [G0700711B]
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alonso V, 2011, J BONE MINER RES, V26, P143, DOI 10.1002/jbmr.167
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chen PY, 2007, BIOCHEM BIOPH RES CO, V360, P1, DOI 10.1016/j.bbrc.2007.04.211
   Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Gargiulo C, 2010, 3 INT C DEV BIOM ENG
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Guth K, 2006, KEY ENG MATER, V309-311, P117, DOI 10.4028/www.scientific.net/KEM.309-311.117
   Hing K, 2004, T 50 A M ORTH RES SO, V9
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303
   Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Marinucci L, 2010, ANN BIOMED ENG, V38, P640, DOI 10.1007/s10439-009-9898-4
   McCauley LK, 1996, J CELL BIOCHEM, V61, P638, DOI 10.1002/(SICI)1097-4644(19960616)61:4<638::AID-JCB18>3.3.CO;2-9
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Owen M, 1988, J CELL SCI S
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469
   Porter AE, 2006, J BIOMED MATER RES A, V78A, P25, DOI 10.1002/jbm.a.30690
   Ramaswamy Y, 2008, ACTA BIOMATER, V4, P1487, DOI 10.1016/j.actbio.2008.04.014
   Rashid N, 2004, T 7 WORLD BIOM C SYD
   Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3871, 10.1101/pdb.prot4050, 10.1101/pdb.prot4044, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4022, 10.1101/pdb.prot4455]
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   STEIN GS, 1990, FASEB J, V4, P3111
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737
   Tortelli F, 2009, TISSUE ENG PT A, V15, P2373, DOI 10.1089/ten.tea.2008.0501
   Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017
   Tremoleda FL, 2008, CLONING STEM CELLS, V10, P119, DOI [10.1089/clo.2007.OR36, 10.1089/clo.2007.0R36]
   Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 54
TC 19
Z9 22
U1 1
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 13
EP 22
DI 10.1002/jbm.a.34261
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900002
PM 22733430
DA 2018-10-20
ER

PT J
AU Uzarski, JS
   Van de Walle, AB
   McFetridge, PS
AF Uzarski, Joseph S.
   Van de Walle, Aurore B.
   McFetridge, Peter S.
TI Preimplantation processing of ex vivo-derived vascular biomaterials:
   Effects on peripheral cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE allograft; cell adhesion; decellularization; endothelialization;
   extracellular matrix
ID HUMAN UMBILICAL VEIN; EXTRACELLULAR-MATRIX; BYPASS GRAFTS;
   BLOOD-VESSELS; DECELLULARIZED MATRIX; PROSTHETIC BYPASS; SAPHENOUS-VEIN;
   SCAFFOLD; REVASCULARIZATION; THROMBOGENICITY
AB The use of ex vivo-derived scaffolds as vascular conduits has shown to be a clinically valid approach to repair or bypass occluded vessels. Implantation of allogeneic tissue grafts requires careful processing to lower immunogenicity and prevent bacterial infection. However, the mechanical/chemical treatments used to prepare biological scaffolds can result in significant alterations to the native structure and surface chemistry, which can affect in vivo performance. Of particular importance for vascular grafts are binding interactions between the implanted biomaterial and host cells from the circulation and adjacent vasculature. Here we present a comparison of four strategies used to decellularize allogeneic human umbilical vein (HUV) scaffolds: ethanol/acetone, sodium chloride, sodium dodecyl sulfate (SDS), or Triton X-100. Scanning electron microscopy revealed that all four techniques achieved removal of native cells from both the lumenal and ablumenal surfaces of HUV grafts. Platelets and promyelocytic HL-60 cells showed preferential binding on the more loosely structured ablumenal surface, although low surface coverage was observed overall by peripheral blood cells. Vascular endothelial cell adhesion was highest on HUV decellularized using ethanol/acetone, and significantly higher than on SDS-processed grafts (p = 0.016). Primary cells showed high viability on the lumenal surface regardless of decellularization technique (over 95% in all cases). These results demonstrate the critical effects of various chemical processing strategies on the adhesive properties of ex vivo-derived vascular grafts. Careful application-specific consideration is warranted when selecting a processing strategy that minimizes innate responses (e.g. thrombosis, inflammation) that are often deleterious to graft survival. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:123131, 2013.
C1 [Uzarski, Joseph S.; Van de Walle, Aurore B.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, 1275 Ctr Dr, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
RI Mcfetridge, Peter/A-2802-2010
OI Van de Walle, Aurore/0000-0003-1579-9145
FU NHLBI NIH HHS [R01 HL088207]
CR Abousleiman RI, 2008, ARTIF ORGANS, V32, P735, DOI 10.1111/j.1525-1594.2008.00598.x
   Afshar-Kharghan V, 2006, CURR OPIN HEMATOL, V13, P34, DOI 10.1097/01.moh.0000190107.54790.de
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Chan RW, 2009, TISSUE ENG PT A, V15, P3537, DOI [10.1089/ten.tea.2009.0064, 10.1089/ten.TEA.2009.0064]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Crouzier T, 2009, J BIOMED MATER RES A, V89A, P818, DOI 10.1002/jbm.a.32103
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   Dardik H, 2006, J AM COLL SURGEONS, V203, P582, DOI 10.1016/j.jamcollsurg.2006.07.003
   Eble JA, 2009, CURR PHARM DESIGN, V15, P1385, DOI 10.2174/138161209787846757
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goktas S, 2010, TISSUE ENG PT A, V16, P769, DOI [10.1089/ten.tea.2009.0101, 10.1089/ten.TEA.2009.0101]
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x
   Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061
   Issa RI, 2011, TISSUE ENG PT A, V17, P1479, DOI [10.1089/ten.tea.2010.0484, 10.1089/ten.TEA.2010.0484]
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Johnson TR, 2000, J VASC SURG, V31, P994, DOI 10.1067/mva.2000.105676
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Moriyama S, 2001, ASAIO J, V47, P202, DOI 10.1097/00002480-200105000-00007
   Neufang A, 2007, J VASC SURG, V46, P280, DOI 10.1016/j.jvs.2007.03.054
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6
   Randon C, 2010, J VASC SURG, V51, P869, DOI 10.1016/j.jvs.2009.11.062
   Roger LV, 2012, CIRCULATION, V125, P188
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Stehbens WE, 2005, FETAL PEDIATR PATHOL, V24, P297, DOI 10.1080/15227950500503660
   Tosun Z, 2011, J VASC SURG, V54, P1451, DOI 10.1016/j.jvs.2011.05.050
   Twine CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001487.pub2
   Vollmar B, 2003, MICROCIRCULATION, V10, P143, DOI 10.1038/sj.mn.7800179
   Watson SP, 2009, CURR PHARM DESIGN, V15, P1358, DOI 10.2174/138161209787846702
NR 40
TC 14
Z9 15
U1 1
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 123
EP 131
DI 10.1002/jbm.a.34308
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900013
PM 22825780
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Peng, YJ
   Lu, YT
   Liu, KS
   Liu, SJ
   Fan, L
   Huang, WC
AF Peng, Yi-Jie
   Lu, Yu-Ting
   Liu, Kuo-Sheng
   Liu, Shih-Jung
   Fan, Ling
   Huang, Wen-Cheng
TI Biodegradable balloon-expandable self-locking polycaprolactone stents as
   buckling explants for the treatment of retinal detachment: An in vitro
   and in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biodegradable balloon-expandable stents; scleral buckle;
   polycaprolactone
ID SCLERAL BUCKLE; REATTACHMENT SURGERY; EPISCLERAL IMPLANTS;
   COMPLICATIONS; SILICONE; INTRUSION; PTFE; PCL
AB The purpose of this report was to develop biodegradable balloon-expandable self-locking poly(e-caprolactone) (PCL) stents for the treatment of retinal detachment. To create the biodegradable stents, polycaprolactone components were first fabricated by a laboratory-scale microinjection molding machine. The components were then assembled into mesh-like stents of 6 and 8 mm in diameter. A special geometry of the components was designed to self-lock the assembled stents after being expanded by balloons. Characterization of the biodegradable PCL stents was carried out. PCL stents exhibited comparable mechanical properties with that of silicone sponge. Neither significant amount of collapse pressure reduction nor weight loss of the stents was observed after being submerged in phosphate buffered saline for 30 days. In addition, the stents were also implanted in the episcleral space of 10 New Zealand white rabbits. The stents were placed in radial direction and left unsutured after balloon expansion. The stents achieved an efficient buckling effect in echographic and fundus photographic examinations. The ocular pressure was significantly elevated after stent implantation and gradually normalized after the second week. The computed tomography studies verified the hypothesis of minimal migration of the PCL stents. The in vivo result suggests that balloon-expandable biodegradable stents can potentially serve as an ideal indenting biomaterial in retinal detachment surgery. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:167175, 2013.
C1 [Lu, Yu-Ting; Liu, Kuo-Sheng; Liu, Shih-Jung] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan.
   [Peng, Yi-Jie] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Taipei Branch, Taipei, Taiwan.
   [Liu, Kuo-Sheng] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Tao Yuan, Taiwan.
   [Fan, Ling; Huang, Wen-Cheng] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan.
   [Fan, Ling; Huang, Wen-Cheng] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan.
RP Liu, SJ (reprint author), Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan.
EM shihjung@mail.cgu.edu.tw
OI Liu, Shih-Jung/0000-0003-2083-4865
CR Barile GR, 1998, AM J OPHTHALMOL, V126, P379, DOI 10.1016/S0002-9394(98)00093-2
   BARR CC, 1990, RETINA-J RET VIT DIS, V10, P189, DOI 10.1097/00006982-199010030-00007
   BINDER S, 1986, RETINA-J RET VIT DIS, V6, P210, DOI 10.1097/00006982-198606040-00003
   Chen H, 2010, J MATER SCI-MATER M, V21, P2887, DOI 10.1007/s10856-010-4141-2
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   Deokule S, 2003, EYE, V17, P697, DOI 10.1038/sj.eye.6700491
   DHERMIES F, 1995, RETINA-J RET VIT DIS, V15, P62, DOI 10.1097/00006982-199515010-00012
   Doi N, 1999, JPN J OPHTHALMOL, V43, P232, DOI 10.1016/S0021-5155(99)00009-X
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   KORNBLUETH W, 1964, AM J OPHTHALMOL, V57, P261, DOI 10.1016/0002-9394(64)91831-8
   Korobelnik JF, 1999, J BIOMED MATER RES, V48, P807, DOI 10.1002/(SICI)1097-4636(1999)48:6<807::AID-JBM7>3.3.CO;2-Z
   KREISSIG I, 1989, AM J OPHTHALMOL, V107, P381, DOI 10.1016/0002-9394(89)90661-2
   Lansman SM, 2005, RETINA-J RET VIT DIS, V25, P581
   Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4
   Liu KS, 2011, J THORAC CARDIOV SUR, V141, P463, DOI 10.1016/j.jtcvs.2010.08.008
   Liu SJ, 2010, ANN BIOMED ENG, V38, P3185, DOI 10.1007/s10439-010-0075-6
   Mortemousque B, 2002, J BIOMED MATER RES, V63, P686, DOI 10.1002/jbm.10393
   Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047
   Nguyen QD, 2001, RETINA-J RET VIT DIS, V21, P214
   Roldan-Pallares M, 1999, ARCH OPHTHALMOL-CHIC, V117, P197
   RUBSAMEN PE, 1994, AM J OPHTHALMOL, V118, P299, DOI 10.1016/S0002-9394(14)72952-6
   SCHEPENS CL, 1991, SURV OPHTHALMOL, V35, P447, DOI 10.1016/0039-6257(91)90108-R
   Shami MJ, 2001, RETINA-J RET VIT DIS, V21, P195, DOI 10.1097/00006982-200104000-00027
   SMIDDY WE, 1991, RETINA-J RET VIT DIS, V11, P394, DOI 10.1097/00006982-199111040-00005
   SPENCER AF, 1993, EYE, V7, P751, DOI 10.1038/eye.1993.175
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Wu WC, 2008, INVEST OPHTH VIS SCI, V49, P2673, DOI 10.1167/iovs.07-1594
   YOSHIZUMI MO, 1980, OPHTHALMOLOGY, V87, P1150
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 30
TC 3
Z9 3
U1 2
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 167
EP 175
DI 10.1002/jbm.a.34315
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900018
PM 22829533
DA 2018-10-20
ER

PT J
AU Lee, HS
   Stachelek, SJ
   Tomczyk, N
   Finley, MJ
   Composto, RJ
   Eckmann, DM
AF Lee, Hyun-Su
   Stachelek, Stanley J.
   Tomczyk, Nancy
   Finley, Matthew J.
   Composto, Russell J.
   Eckmann, David M.
TI Correlating macrophage morphology and cytokine production resulting from
   biomaterial contact
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; biocompatibility; cell morphology; biomaterials;
   inflammation
ID TITANIUM SURFACE-TOPOGRAPHY; FOREIGN-BODY REACTION; MONOCYTE-DERIVED
   MACROPHAGES; IN-VITRO; CELLS; DIFFERENTIATION; RESPONSES;
   BIOCOMPATIBILITY; BIODEGRADATION; ATTACHMENT
AB The morphological and inflammatory responses of adherent macrophages are correlated to evaluate the biocompatibility of surfaces. Monocyte-derived macrophage (MDM), THP-1, and THP-1 cells expressing GFP-actin chimeric protein were seeded onto glass, polyurethane (PU), and glass surface modified with quaternary ammonium salt functionalized chitosan (CH-Q) and hyaluronic acid (HA). Using confocal microscopy, the surface area, volume and 3D shape factor of adherent macrophages was quantified. For comparison, functional consequences of cell-surface interactions that activate macrophages and thereby elicit secretion of a proinflammatory cytokine were evaluated. Using an enzyme linked immune sorbent assay, tumor necrosis factor-alpha (TNF-alpha) was measured. On glass, macrophages exhibited mainly an amoeboid shape, exhibited the largest surface area, volume, and 3D shape factor and produced the most TNF-alpha. On PU, macrophages displayed mainly a hemispherical shape, exhibited an intermediate volume, surface area and 3D shape factor, and produced moderate TNF-alpha. In contrast, on CH-Q and HA surfaces, macrophages were spherical, exhibited the smallest volume, surface area, and 3D shape factor, and produced the least TNF-alpha. These studies begin to validate the use of GFP-actin-modified MDM as a novel tool to correlate cell morphology with inflammatory cell response. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:203212, 2013.
C1 [Lee, Hyun-Su; Tomczyk, Nancy; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Composto, Russell J.; Eckmann, David M.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.
   [Stachelek, Stanley J.; Finley, Matthew J.] Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), 331 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.
EM David.Eckmann@uphs.upenn.edu
OI Lee, Hyun-Su/0000-0002-5245-8430
FU National Institutes of Health [R01 HL60230]; Nano/Bio Interface Center
   at the University of Pennsylvania [NSF/DMR08-32802]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: R01 HL60230; Contract grant sponsor: Nano/Bio Interface Center
   at the University of Pennsylvania; contract grant number:
   NSF/DMR08-32802
CR AMATO PA, 1983, J CELL BIOL, V96, P750, DOI 10.1083/jcb.96.3.750
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Baba T, 1992, VIRCHOWS ARCH, V61, P39
   Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47
   BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Christenson EM, 2005, J BIOMED MATER RES A, V74A, P141, DOI 10.1002/jbm.a.30317
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Endo M, 2007, MOL THER, V15, P579, DOI 10.1038/sj.mt.6300092
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Jang JY, 2004, BIOMATERIALS, V25, P3663, DOI 10.1016/j.biomaterials.2003.10.062
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Labow RS, 2005, J BIOMAT SCI-POLYM E, V16, P1167, DOI 10.1163/1568562054798563
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee H, 2011, PMSE PREPRINTS, V104, P41
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Li C, 2012, POLYMER, V53, P1138, DOI 10.1016/j.polymer.2012.01.019
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Markowicz P, 2000, AM J RESP CRIT CARE, V161, P1942, DOI 10.1164/ajrccm.161.6.9909122
   Martin DC, 2010, J ORAL MAXIL SURG, V68, P508, DOI 10.1016/j.joms.2009.09.055
   MURAO S, 1983, CANCER RES, V43, P4989
   Ombelli M, 2011, BIOFOULING, V27, P505, DOI 10.1080/08927014.2011.585711
   Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020
   Schubert MA, 1997, J BIOMED MATER RES, V34, P493, DOI 10.1002/(SICI)1097-4636(19970315)34:4<493::AID-JBM10>3.0.CO;2-E
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   Stachelek SJ, 2007, J BIOMED MATER RES A, V82A, P1004, DOI 10.1002/jbm.a.31215
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   STENDAHL OI, 1980, J CELL BIOL, V84, P215, DOI 10.1083/jcb.84.2.215
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tsai IY, 2011, SOFT MATTER, V7, P3599, DOI 10.1039/c0sm01353f
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043
   Wan LS, 2007, ACTA BIOMATER, V3, P183, DOI 10.1016/j.actbio.2006.09.007
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 50
TC 39
Z9 39
U1 3
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 203
EP 212
DI 10.1002/jbm.a.34309
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900022
PM 22847892
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Voge, CM
   Johns, J
   Raghavan, M
   Morris, MD
   Stegemann, JP
AF Voge, Christopher M.
   Johns, Jeremy
   Raghavan, Mekhala
   Morris, Michael D.
   Stegemann, Jan P.
TI Wrapping and dispersion of multiwalled carbon nanotubes improves
   electrical conductivity of protein-nanotube composite biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; composite; collagen; fibroblast; nanoparticle;
   pluronic
ID PERCOLATION-THRESHOLD; SURFACE-CHEMISTRY; IN-VITRO; SWNT;
   FUNCTIONALIZATION; NEURONS; RAMAN
AB Composites of extracellular matrix proteins reinforced with carbon nanotubes have the potential to be used as conductive biopolymers in a variety of biomaterial applications. In this study, the effect of functionalization and polymer wrapping on the dispersion of multiwalled carbon nanotubes (MWCNT) in aqueous media was examined. Carboxylated MWCNT were wrapped in either Pluronic (R) F127 or gelatin. Raman spectroscopy and X-ray photoelectron spectroscopy showed that covalent functionalization of the pristine nanotubes disrupted the carbon lattice and added carboxyl groups. Polymer and gelatin wrapping resulted in increased surface adsorbed oxygen and nitrogen, respectively. Wrapping also markedly increased the stability of MWCNT suspensions in water as measured by settling time and zeta potential, with Pluronic (R)-wrapped nanotubes showing the greatest effect. Treated MWCNT were used to make 3D collagenfibrinMWCNT composite materials. Carboxylated MWCNT resulted in a decrease in construct impedance by an order of magnitude, and wrapping with Pluronic (R) resulted in a further order of magnitude decrease. Functionalization and wrapping also were associated with maintenance of fibroblast function within proteinMWCNT materials. These data show that increased dispersion of nanotubes in proteinMWCNT composites leads to higher conductivity and improved cytocompatibility. Understanding how nanotubes interact with biological systems is important in enabling the development of new biomedical technologies. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:231238, 2013.
C1 [Voge, Christopher M.; Johns, Jeremy; Raghavan, Mekhala; Stegemann, Jan P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Raghavan, Mekhala; Morris, Michael D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48108 USA.
RP Stegemann, JP (reprint author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM jpsteg@umich.edu
CR Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340
   Bardi G, 2009, NANOMED-NANOTECHNOL, V5, P96, DOI 10.1016/j.nano.2008.06.008
   Behler K, 2006, J NANOPART RES, V8, P615, DOI 10.1007/s11051-006-9113-6
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Ciofani G, 2009, FULLER NANOTUB CAR N, V17, P11, DOI 10.1080/15363830802515840
   Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Dong H, 2009, ACS APPL MATER INTER, V1, P1599, DOI 10.1021/am900267e
   Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   George JJ, 2008, J NANOSCI NANOTECHNO, V8, P1913, DOI 10.1166/jnn.2008.024
   HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8
   Hu H, 2005, J PHYS CHEM B, V109, P11520, DOI 10.1021/jp050781w
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Li J, 2007, ADV FUNCT MATER, V17, P3207, DOI 10.1002/adfm.200700065
   Luo SC, 2009, ACS APPL MATER INTER, V1, P1414, DOI 10.1021/am900117e
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   MAGNUSSON G, 1986, TOXICOL LETT, V30, P203, DOI 10.1016/0378-4274(86)90156-6
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p
   Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j
   Musumeci AW, 2007, POLYMER, V48, P1667, DOI 10.1016/j.polymer.2007.01.027
   Nativ-Roth E, 2007, MACROMOLECULES, V40, P3676, DOI 10.1021/ma0705366
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Peng HQ, 2003, J AM CHEM SOC, V125, P15174, DOI 10.1021/ja037746s
   Quent VMC, 2010, J CELL MOL MED, V14, P1003, DOI 10.1111/j.1582-4934.2010.01013.x
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   Sangodkar H, 1996, ANAL CHEM, V68, P779, DOI 10.1021/ac950655w
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   Sinani VA, 2005, J AM CHEM SOC, V127, P3463, DOI 10.1021/ja045670+
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wenseleers W, 2004, ADV FUNCT MATER, V14, P1105, DOI 10.1002/adfm.200400130
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Zhang J, 2003, J PHYS CHEM B, V107, P3712, DOI 10.1021/jp027500u
NR 36
TC 20
Z9 20
U1 1
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 231
EP 238
DI 10.1002/jbm.a.34310
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900025
PM 22865813
DA 2018-10-20
ER

PT J
AU Shen, CC
   Yang, YC
   Liu, BS
AF Shen, Chiung-Chyi
   Yang, Yi-Chin
   Liu, Bai-Shuan
TI Effects of large-area irradiated laser phototherapy on peripheral nerve
   regeneration across a large gap in a biomaterial conduit
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE low-level laser therapy; neural regeneration; peripheral nerve injury;
   sciatic nerve
ID HE-NE-LASER; SCHWANN-CELLS; SCIATIC-NERVE; REPAIR; RAT; GROWTH; ENERGY;
   RECONSTRUCTION; PERONEAL; CULTURES
AB This paper proposes a novel biodegradable nerve conduit comprising 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) cross-linked gelatin, annexed with beta-tricalcium phosphate (TCP) ceramic particles (EDC-Gelatin-TCP, EGT). In this study, the EGT-implant site in rats was irradiated using a large-area 660 nm AlGaInP diode laser (50 mW) to investigate the feasibility of laser stimulation in the regeneration of a 15-mm transected sciatic nerve. The animals were divided into three groups: a sham-irradiated group (EGT/sham); an experimental group undergoing low-level laser (LLL) therapy (EGT/laser); a control group undergoing autologous nerve grafts (autografts). Twelve weeks after implantation, walking track analysis showed a significantly higher sciatic functional index (p < 0.05) and improved toe spreading development in the EGT/laser and autograft groups than in the EGT/sham group. In electrophysiological measurement, both the mean peak amplitude and the area under the compound muscle action potential curves in the EGT/laser and autograft groups showed significantly improved functional recovery than the EGT/sham group (p < 0.05). Compared with the EGT/sham group, the EGT/laser and autograft groups displayed a reduction in muscular atrophy. Histomorphometric assessments revealed that the EGT/laser group had undergone more rapid nerve regeneration than the EGT/sham group. The laser-treated group also presented greater neural tissue area as well as larger axon diameter and thicker myelin sheath than the tube group without the laser treatment, indicating improved nerve regeneration. Thus, these assessments demonstrate that LLL therapy can accelerate the repair of a transected peripheral nerve in rats after being bridged with EGT conduit. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:239252, 2013.
C1 [Liu, Bai-Shuan] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.
   [Shen, Chiung-Chyi] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.
   [Shen, Chiung-Chyi; Yang, Yi-Chin] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan.
RP Liu, BS (reprint author), Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.
EM bsliu@ctust.edu.tw
FU Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China
   [TCVGH-CTUST1017702]; Central Taiwan University of Science and
   Technology, Taichung, Taiwan, Republic of China [TCVGH-CTUST1017702];
   National Science Council of the Republic of China, Taiwan [NSC
   98-2320-B-166-002-MY3]
FX Contract grant sponsor: Taichung Veterans General Hospital and Central
   Taiwan University of Science and Technology, Taichung, Taiwan, Republic
   of China; contract grant number: TCVGH-CTUST1017702; Contract grant
   sponsor: National Science Council of the Republic of China, Taiwan;
   contract grant number: NSC 98-2320-B-166-002-MY3
CR ABERGEL RP, 1987, J DERMATOL SURG ONC, V13, P127, DOI 10.1111/j.1524-4725.1987.tb00510.x
   Amat A, 2006, J PHOTOCH PHOTOBIO B, V82, P152, DOI 10.1016/j.jphotobiol.2005.10.001
   Bagis S, 2002, LASER SURG MED, V30, P376, DOI 10.1002/lsm.10057
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   Dahlin LB, 2004, J AM SOC SURG HAND, V4, P143, DOI DOI 10.1016/J.JASSH.2004.06.006
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899
   Elles JT, 2003, P NATL ACAD SCI USA, V100, P3439
   Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W
   Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305
   Gulsoy M, 2006, J PHOTOCH PHOTOBIO B, V82, P199, DOI 10.1016/j.jphotobiol.2005.11.004
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z
   Joel A, 2005, PHYS MED REHABILITAT
   KARU T, 1992, Laser Therapy, V4, P5
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3
   Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Raso VVM, 2005, J NEUROSCI METH, V142, P185, DOI 10.1016/j.jneumeth.2004.08.016
   Rochkind S, 2001, LASER SURG MED, V28, P216, DOI 10.1002/lsm.1041
   ROCHKIND S, 1992, Neurological Research, V14, P2
   RODRIGUEZ FJ, 2004, DRUG DISCOV TODAY DI, V1, P177, DOI DOI 10.1016/J.DDMOD.2004.09.008
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Schwartz F, 2002, J PHOTOCH PHOTOBIO B, V66, P195, DOI 10.1016/S1011-1344(02)00267-1
   Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9
   Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098
   Sufan W, 2001, J NEUROTRAUM, V18, P329, DOI 10.1089/08977150151070991
   VANBREUGEL HHFI, 1993, J NEUROCYTOL, V22, P185, DOI 10.1007/BF01246357
   Vladimirov YA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P81, DOI 10.1023/B:BIRY.0000016356.93968.7e
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   WALKER J, 1983, NEUROSCI LETT, V43, P339, DOI 10.1016/0304-3940(83)90211-2
   Wollman Y, 1996, NEUROL RES, V18, P467
   Yang YC, 2010, J BIOMED MATER RES B, V95B, P207, DOI 10.1002/jbm.b.31705
NR 39
TC 8
Z9 8
U1 3
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 239
EP 252
DI 10.1002/jbm.a.34314
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900026
PM 22887896
DA 2018-10-20
ER

PT J
AU Wang, HY
   Zhang, YQ
AF Wang, Hai-Yan
   Zhang, Yu-Qing
TI Effect of regeneration of liquid silk fibroin on its structure and
   characterization
SO SOFT MATTER
LA English
DT Article
ID BOMBYX-MORI; L-ASPARAGINASE; IMMOBILIZATION; BIOMATERIAL; COCOON; FTIR
AB Silk derived from cocoons of the female silkworm (Bombyx mori) was made into three kinds of test material, degummed fiber, liquid fibroin and regenerated silk fibroin membrane (RSFM). The effect of the silk degumming and fiber dissolution system (SD-FDS) on the molecular structure and properties of silk fibroin were studied in detail. Degumming with Na2CO3 solution had the greatest impact on silk fibroin fiber, resulting in significant reduction of the thermal stability and crystallinity, and the fiber tensile property was only half of that degummed with urea buffer. The moderate degumming solution was urea buffer, followed by strongly alkaline electrolyzed water (SAEW). SDS-PAGE showed that the silk fibroin degummed with 8.0 M urea at 80 degrees C and dissolved in 9.3 M LiBr at 25 degrees C was similar to the natural silk fibroin in vivo, but boiling in Na2CO3 solution leads to serious breakage of the silk fibroin peptide chain. The degree of breakage of the peptide chain is positively correlated with the storage time of liquid silk fibroin. DSC showed the more nearly intact the silk fibroin peptide chain, the higher the thermal decomposition temperature. The regenerated condition of the silk protein is often overlooked during the research process, while our study showed that different silk degumming and fiber dissolution systems will have different influences. The results of this test help us gain a deeper understanding of the effect of silk degumming and fiber dissolution on the molecular structure and properties of silk fibroin and provide important experimental data for screening and using silk protein as advanced functional biomaterials, such as medical tissue engineering materials.
C1 [Wang, Hai-Yan; Zhang, Yu-Qing] Soochow Univ, Sch Biol & Basic Med Sci, Silk Biotechnol Lab, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Zhang, YQ (reprint author), Soochow Univ, Sch Biol & Basic Med Sci, Silk Biotechnol Lab, Natl Engn Lab Modern Silk, 702-2303 Room,199 Renai Rd, Suzhou 215123, Peoples R China.
EM sericult@suda.edu.cn
OI Zhang, Yu-Qing/0000-0001-7670-386X
FU earmarked fund for China Agriculture Research System (CARS); Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   P. R. China
FX The authors gratefully acknowledge the earmarked fund for China
   Agriculture Research System (CARS) and a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   P. R. China.
CR Ajisawa A., 1968, SEN-I GAKKAISHI, V24, P61
   Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fraser R. D. B., 1973, CONFORMATIONS FIBROU
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Haggag K., 2007, J NATURAL FIBERS, V4
   Karve KA, 2011, J MEMBRANE SCI, V383, P44, DOI 10.1016/j.memsci.2011.08.032
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Majibur M., 2010, BIORESOURCE TECHNOL, V101, P8439
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   Matsumoto K., 1995, Japan Patent, Patent No. [JP7173192, 7173192]
   MITA K, 1994, J MOL EVOL, V38, P583
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Shimizu Y., 1978, J SERICULT SCI JPN, V47, P417
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Takasu Y., 2006, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V75, P133
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WALTERS RH, 1934, TEXT RES J, V5, P92
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YJ, 2011, ADV MATER RES-SWITZ, V175-176, P158, DOI 10.4028/www.scientific.net/AMR.175-176.158
   Wen D. J., 2005, ACTA SERICOL SIN, V26, P110
   Wu H. Y., 1993, ACTA SERICOL SIN, V19, P105
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhang Y. Q., 1997, ACTA SERICOL SIN, V28, P75
   Zhang Y.Q., 2012, China Patent, Patent No. [201210082082.X, 201210082082, CN 201210082082 X]
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhang YQ, 2010, SCI CHINA LIFE SCI, V53, P1330, DOI 10.1007/s11427-010-4084-3
NR 35
TC 50
Z9 56
U1 4
U2 128
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 1
BP 138
EP 145
DI 10.1039/c2sm26945g
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 049EF
UT WOS:000311964200015
DA 2018-10-20
ER

PT S
AU Pavaloiu, RD
   Dobre, T
   Hlevca, C
AF Pavaloiu, Ramona-Daniela
   Dobre, Tanase
   Hlevca, Cristina
GP IEEE
TI Use of Bacterial Cellulose-Glycerol-Poly(vinyl alcohol) Composites in
   Drug Release
SO 2013 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT 4th IEEE International Conference on E-Health and Bioengineering (EHB)
CY NOV 21-23, 2013
CL Iasi, ROMANIA
SP IEEE, IEEE EMB Romania Chapter, Romanian Acad Iasi Branch, Inst Comp Sci
DE bacterial cellulose; drug release; biomaterial
ID BIOMEDICAL APPLICATIONS; CELLULOSE; NANOCOMPOSITES; MEMBRANES
AB Bacterial cellulose (BC) is a biomaterial suited for various biomedical applications, due to its unique nanostructure, that confers remarkable physical and chemical properties, such as: excellent elasticity, biocompatibility, high purity, high tensile strength and high elastic modulus. The article describes the mechanism and amoxicillin release profiles from bacterial cellulose-glycerol-poly(vinyl alcohol) composites, in the aim to use such systems in controlled drug delivery field. Obtained data from these composites were slightly smaller than BC-Glycerol, probably due to the fact that PVA layers provide an additional barrier for drug release. The presented data are of interest for the biomaterials community.
C1 [Pavaloiu, Ramona-Daniela; Dobre, Tanase] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest, Romania.
   [Hlevca, Cristina] ICCF Bucharest, Natl Inst Chem Pharmaceut Res & Dev, Bucharest, Romania.
RP Pavaloiu, RD (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest, Romania.
EM pavaloiu_daniella@yahoo.com
FU European Social Fund [POSDRU/107/1.5/S/76903]
FX We gratefully thank European Social Fund for their financial support
   (POSDRU/107/1.5/S/76903).
CR Chatri A, 2011, BIOMATTER, V1, P189
   Chiaoprakobkij N, 2011, CARBOHYD POLYM, V85, P548, DOI 10.1016/j.carbpol.2011.03.011
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071
   Gea S, 2010, MATER LETT, V64, P901, DOI 10.1016/j.matlet.2010.01.042
   Grande CJ, 2009, MAT SCI ENG C-BIO S, V29, P1098, DOI 10.1016/j.msec.2008.09.024
   Halib N, 2010, J APPL POLYM SCI, V116, P2920, DOI 10.1002/app.31857
   Kim J, 2011, J POLYM RES, V18, P739, DOI 10.1007/s10965-010-9470-9
   Kurniawan H, 2013, BIOCHEM ENG J, V78, P138, DOI 10.1016/j.bej.2013.03.021
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Pavaloiu R.D., CONTROLLED REL UNPUB
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Phisalaphong M, 2008, CARBOHYD POLYM, V74, P482, DOI 10.1016/j.carbpol.2008.04.004
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Trovatti E, 2011, BIOMACROMOLECULES, V12, P4162, DOI 10.1021/bm201303r
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Yin N, 2011, PROG NAT SCI-MATER, V21, P472, DOI 10.1016/S1002-0071(12)60085-9
NR 19
TC 0
Z9 0
U1 1
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4799-2372-4
J9 E-HEALTH BIOENG CONF
PY 2013
PG 4
WC Health Care Sciences & Services; Engineering, Biomedical; Medical
   Informatics
SC Health Care Sciences & Services; Engineering; Medical Informatics
GA BB8IU
UT WOS:000346672900080
DA 2018-10-20
ER

PT S
AU Wattanutchariya, W
AF Wattanutchariya, W.
GP IEEE
TI Relationship between Polymeric Foam Characteristics and Properties of
   Porous Bone Substitute Fabricated by Polymeric Foam Replication
SO 2013 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND
   ENGINEERING MANAGEMENT (IEEM 2013)
SE International Conference on Industrial Engineering and Engineering
   Management IEEM
LA English
DT Proceedings Paper
CT IEEE International Conference on Industrial Engineering and Engineering
   Management (IEEM)
CY DEC 10-13, 2013
CL Bangkok, THAILAND
SP IEEE, IEEE TMC Thailand Chapter, IEEE TMC Singapore Chapter, IEEE TMC Hong Kong Chapter, IEEE SMC Thailand Chapter
DE Polymeric foam replication; Porous Bone substitution; Bone scaffold;
   Trabecular bone; Biomaterial
AB Polymeric foam replication is one technique used to produce bone scaffold for porous bone substitution or bone grafting in the human body. This method provides scaffolds similar to trabecular bone, as well as producing a controllable pore size and porosity scaffold. Preliminary studies illustrated that the characteristics of polymeric foam such as pore size and porosity could affect both physical and mechanical properties of the resulting scaffold. Therefore, the objective of this study is to evaluate the relationship of polymeric foam characteristics with the properties of the porous bone scaffold. In this study, 5 different types of polymeric foam were evaluated, and the phosphate glass was implemented as the biomaterial slurry. Scaffold forming took place by immersing the foam types into the slurry and then sintering them at 750 degrees C for 3 hours. Porosity and compression testings were then used to analyze the physical and mechanical properties of the specimens. Results indicate that the optimal condition of both physical and mechanical properties was found when the polymeric foam with the highest pore density (99.5%) and approximately 300 mu m pore size range was used. However, the highest compression strength obtained was only 3.48 MPa, which is at the lower range of the trabecular bone's mechanical properties. Future study will therefore focus on producing stronger porous bone scaffold for porous bone substitution.
C1 [Wattanutchariya, W.] Chiang Mai Univ, Dept Ind Engn, Fac Engn, Design & Dev Adv Mfg Res Unit, Chiang Mai, Thailand.
RP Wattanutchariya, W (reprint author), Chiang Mai Univ, Dept Ind Engn, Fac Engn, Design & Dev Adv Mfg Res Unit, Chiang Mai, Thailand.
EM wattanwa@gmail.com
FU Thai Stimulus Package 2; Department of Industrial Engineering and the
   Biomedical Engineering Center, Faculty of Engineering, Chiang Mai
   University, Thailand
FX The authors acknowledge support from Thai Stimulus Package 2. Special
   thanks to the Department of Industrial Engineering and the Biomedical
   Engineering Center, Faculty of Engineering, Chiang Mai University,
   Thailand for facility and laboratory support.
CR Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Masoud M., 2010, APPL SURF SCI, V257, P1740
   Patrick J. P., 2004, TOPICS BIOMECHANICAL, P147
   Qiang F., 2007, PREPARATION BIOACTIV, P222
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   Wang X, 2010, FUNDAMENTAL BIOMECHA
   Wattanutchariya W., 2012, P JOINT S MECH IND E
   Yenbut P., 2013, BANGK INT C BIOL ENG
NR 9
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2157-3611
BN 978-1-4799-0986-5
J9 IN C IND ENG ENG MAN
PY 2013
BP 1072
EP 1076
PG 5
WC Engineering, Industrial; Operations Research & Management Science
SC Engineering; Operations Research & Management Science
GA BH0NG
UT WOS:000395631500213
DA 2018-10-20
ER

PT S
AU Goktas, H
   Zaghloul, M
AF Goktas, Hasan
   Zaghloul, Mona
GP IEEE
TI HIGH SENSITIVITY CMOS PORTABLE BIOSENSOR WITH FLEXIBLE MICROFLUIDIC
   INTEGRATION
SO 2013 IEEE SENSORS
SE IEEE Sensors
LA English
DT Proceedings Paper
CT 12th IEEE Sensors Conference
CY NOV 03-06, 2013
CL Baltimore, MD
SP IEEE, IEEE Sensors Council
ID QUALITY-FACTOR; AIR
AB In this work, a portable biosensor that has 60% effective surface area on the chip with 1fg sensitivity by using novel array configuration is designed, and sent for fabrication. High frequency shift, quality factor, capacitance ratio, and small response time during the AC actuation are the critical parameters for the biosensor design. By using a beam structure in contrast to the more common cantilever, the effective surface area increases from 41% to 71%. Flexible microfluidic channels are integrated with the CMOS chip to deliver the biomaterial and are used for the packaging.
C1 [Goktas, Hasan; Zaghloul, Mona] George Washington Univ, Elect & Comp Engn, Washington, DC 20052 USA.
RP Goktas, H (reprint author), George Washington Univ, Elect & Comp Engn, Washington, DC 20052 USA.
EM hgoktas.gwu@gmail.com; mona.zaghloul@gmail.com
CR Ikehara T, 2007, J MICROMECH MICROENG, V17, P2491, DOI 10.1088/0960-1317/17/12/015
   Lee JH, 2007, J MICROMECH MICROENG, V17, P139, DOI 10.1088/0960-1317/17/1/018
   Li YC, 2006, J MICROMECH MICROENG, V16, P2659, DOI 10.1088/0960-1317/16/12/019
   Liu Chan, FDN MEMS, P130
   Naeli K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3062204
   Rebeiz Gabriel M., 2003, RF MEMS THEORY DESIG, P30
   Verd J., 2007, APPL PHYS LETT, V91
   YOON JY, 2012, REV SENSORS, V12, P10713, DOI DOI 10.3390/S120810713
   Zhang BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01098
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1930-0395
BN 978-1-4673-4642-9
J9 IEEE SENSOR
PY 2013
BP 314
EP 317
PG 4
WC Engineering, Electrical & Electronic; Remote Sensing
SC Engineering; Remote Sensing
GA BF0XP
UT WOS:000379846100079
DA 2018-10-20
ER

PT S
AU Feng, NC
   Zhang, FY
AF Feng, Ningchuan
   Zhang, Fengyuan
BE Quan, X
TI Untreated Chinese ephedra residue as biosorbents for the removal of Pb2+
   ions from aqueous solutions
SO 2013 INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL SCIENCE AND TECHNOLOGY
   (2013 ISEST)
SE Procedia Environmental Sciences
LA English
DT Proceedings Paper
CT 4th International Symposium on Environmental Science and Technology
   (ISEST)
CY JUN 04-07, 2013
CL Dalian, PEOPLES R CHINA
SP Chinese Soc Environm Sci, Beijing Inst Technol, Dalian Univ Technol, Dalian Assoc Sci & Technol, ENVR Div Amer Chem Soc, Dalian Soc Environm Sci, Profess Comm Pollut Prevent & Control Heavy Metals CSES, Dalian Univ Technol, Key Lab Ind Ecol & Environm Engn, Dalian Univ Technol, Sch Environm Sci & Technol, Beijing Inst Technol, State Key Lab Explos Sci & Technol
DE Ephedria residue; Pb2+ ions; Biosorption; Isotherms; Kinetics
ID LOW-COST BIOSORBENT; HEAVY-METALS; ADSORPTION; BIOSORPTION; EQUILIBRIUM;
   KINETICS; PB(II); CARBON
AB The objective of this work was to propose an alternative use for ephedra residue (ER) as untreated biosorbents for the removal of Pb2+ ions from aqueous solutions. Biosorption studies were conducted as a function of the solution pH, contact time and initial metal ion concentration. The biosorption kinetics was determined by fitting second-order kinetic models to the experimental data, being described by the pseudo-second-order model (R-2 > 0.99). Both Langmuir and Freundlich sorption models fit the experimental sorption equilibrium data, with Langmuir providing the best fit (R-2 > 0.97). According to the Langmuir equation, the maximum uptake capacity for Pb2+ ions was 1.0 mmol/g at 298K. A comparison of the maximum sorption capacity of several untreated biomaterial-based residues showed that the ER is a suitable candidate for use as biosorbents in the removal of Pb2+ ions from aqueous solutions. (C) 2013 The Authors. Published by Elsevier B.V.
C1 [Feng, Ningchuan; Zhang, Fengyuan] Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Peoples R China.
RP Feng, NC (reprint author), Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Peoples R China.
EM ncfeng@sina.com
CR Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016
   Azouaou N, 2010, J HAZARD MATER, V184, P126, DOI 10.1016/j.jhazmat.2010.08.014
   Chen JP, 2000, SEP PURIF TECHNOL, V19, P157, DOI 10.1016/S1383-5866(99)00069-6
   Farajzadeh MA, 2004, SEP PURIF TECHNOL, V38, P197, DOI 10.1016/j.seppur.2003.11.005
   Feng NC, 2011, J HAZARD MATER, V185, P49, DOI 10.1016/j.jhazmat.2010.08.114
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Huang LH, 2011, DESALINATION, V268, P12, DOI 10.1016/j.desal.2010.09.044
   Li QZ, 2009, APPL SURF SCI, V255, P4298, DOI 10.1016/j.apsusc.2008.11.024
   Qi BC, 2008, BIORESOURCE TECHNOL, V99, P5595, DOI 10.1016/j.biortech.2007.10.042
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Sari A, 2007, BIOCHEM ENG J, V37, P151, DOI 10.1016/j.bej.2007.04.007
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yao YJ, 2010, BIORESOURCE TECHNOL, V101, P3040, DOI 10.1016/j.biortech.2009.12.042
   Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0
NR 15
TC 2
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1878-0296
J9 PROCEDIA ENVIRON SCI
PY 2013
VL 18
BP 794
EP 799
DI 10.1016/j.proenv.2013.04.107
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA BD4NK
UT WOS:000360928700105
OA Other Gold
DA 2018-10-20
ER

PT J
AU Freischmidt, A
   Muller, K
   Ludolph, AC
   Weishaupt, JH
AF Freischmidt, Axel
   Mueller, Kathrin
   Ludolph, Albert C.
   Weishaupt, Jochen H.
TI Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic
   lateral sclerosis
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
AB Background: A pathological hallmark of most amyotrophic lateral sclerosis (ALS) cases are intracellular aggregates of the protein TDP-43. The pathophysiological relevance of TDP-43 is underlined by familial ALS cases caused by TDP-43 mutations. TDP-43 is involved in processing of both coding RNAs and microRNAs, which are key epigenetic regulators of transcriptome plasticity and suspected to contribute to neurological diseases. We therefore asked whether the TDP-43 binding microRNAs recently identified in cell lines are also dysregulated in ALS patients. We compared their abundance in cerebrospinal fluid (CSF), serum and immortalized lymphoblast cell lines (LCLs) derived from ALS patients and healthy controls.
   Results: We found that expression levels of 5 out of 9 TDP-43 binding microRNAs were altered in the CSF and serum of sporadic ALS cases. The differentially regulated serum microRNAs together with a poor correlation between CSF and serum levels indicate a systemic dysregulation of microRNA abundance independent from the CSF compartment, in line with the ubiquitous expression of TDP-43. The most strongly regulated microRNAs could be confirmed in LCLs from genetically defined ALS patients. While dysregulation of miR-143-5p/3p seems to be a common feature of ALS pathology, downregulation of miR-132-5p/3p and miR-574-5p/3p was evident in sporadic, TARDBP, FUS and C9ORF72, but not SOD1 mutant patients. This parallels the TDP-43 pathology found in most ALS cases, but usually not in patients with SOD1 mutation.
   Conclusions: We thus report a systemic and genotype-dependent dysregulation of TDP-43 binding microRNAs in human biomaterial that might reflect an easily accessible biological measure of TDP-43 dysfunction. Furthermore we suggest an independent regulation of TDP-43 binding microRNAs in the serum and CSF compartment as well as a generally low transition of microRNAs across the blood-cerebrospinal fluid barrier.
C1 [Freischmidt, Axel; Mueller, Kathrin; Ludolph, Albert C.; Weishaupt, Jochen H.] Ulm Univ, Dept Neurol, Albert Einstein Allee 113, D-89081 Ulm, Germany.
RP Weishaupt, JH (reprint author), Ulm Univ, Dept Neurol, Albert Einstein Allee 113, D-89081 Ulm, Germany.
EM jochen.weishaupt@uni-ulm.de
FU German Federal Ministry of Education and Research [01GI0704]; Charcot
   Foundation for ALS Research (ACL, JHW); virtual Helmholtz Institute;
   BMBF
FX Antje Knehr is gratefully acknowledged. Work was supported whole or in
   parts by grants from the German Federal Ministry of Education and
   Research (01GI0704; network for ALS research (MND-NET)), the Charcot
   Foundation for ALS Research (ACL, JHW), the virtual Helmholtz Institute
   "RNA-Dysmetabolismus bei ALS und FTD" and the BMBF funded Swabian ALS
   Registry.
CR Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4
   Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150
   Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110
   Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x
   Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x
   Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5
   Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009
   Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012
   De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101
   Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577
   Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120
   Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0
   Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009
   Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264
   Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4
   Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106
   Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kolde G, 1996, LANCET, V347, P1226, DOI 10.1016/S0140-6736(96)90737-0
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197
   Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10
   Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147
   Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107
   Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151
   Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106
   Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107
   Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280
   Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409
   Xu JH, 2012, J MOL MED, V90, P865, DOI 10.1007/s00109-011-0840-5
NR 41
TC 59
Z9 59
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PY 2013
VL 1
AR 42
DI 10.1186/2051-5960-1-42
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA V9K2F
UT WOS:000422387200032
PM 24252274
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Goffard, R
   Sforza, T
   Clarinval, A
   Dormal, T
   Boilet, L
   Hocquet, S
   Cambier, F
AF Goffard, R.
   Sforza, T.
   Clarinval, A.
   Dormal, T.
   Boilet, L.
   Hocquet, S.
   Cambier, F.
TI Additive manufacturing of biocompatible ceramics
SO ADVANCES IN PRODUCTION ENGINEERING & MANAGEMENT
LA English
DT Article
DE Biomaterial; Ceramic; Rapid Manufacturing
AB Considering that the ageing of the population is not going to stop, the need for biocompatible materials is continuously increasing, especially in the field of bone substitutes as well as in the fabrication of surgery tools. The Optoform process is an additive manufacturing technology able to shape most of the common biocompatible ceramic materials such as hydroxyapatite (HA) and tricalcium phosphate (TCP). Those ceramic materials are largely studied to substitute bone defects or as voids fillers while stronger bioinert materials like alumina and zirconia can find applications in surgery tools or in dentistry. The Optoform process allows building a component, layer by layer, from CAD data, leading to significant advantages: 1) the manufacturing of elements with a complex geometry and with a controlled porosity that would be impossible to demold or to machine; and 2) short delays of production for customized part with the desired characteristics and design. The quality control of these parts is essential for medical use and is certified by the control of each step of the manufacturing process: synthesis of biocompatible ceramic powders, preparation of photo-curable resin based paste, shaping of the part by Optoform and subsequent thermal treatment for debinding and sintering. (C) 2013 PEI, University of Maribor. All rights reserved.
C1 [Goffard, R.] CRIG, B-4030 Angleur, Belgium.
   [Sforza, T.; Clarinval, A.; Dormal, T.] Sirris, Addit Mfg Dept, Seraing 4102, Belgium.
   [Boilet, L.; Hocquet, S.; Cambier, F.] BCRC, B-7000 Mons, Belgium.
RP Goffard, R (reprint author), CRIG, 27 Quai Condroz, B-4030 Angleur, Belgium.
EM raphael.goffard@sirris.be
FU Walloon region
FX We would like to thanks the Walloon region for its financial supports in
   the project OPTOBIO. In addition we thanks Dr. D. Nimal for the cell
   culture, the rats implanted and the STL file of a cranial flap. Thanks
   to Centis, Medsys and Dr ph. Docquier for their case studies and STL
   files.
CR Allanic A.-L., 2000, Patent, Patent No. [US6110409, 6110409]
   Becker ST, 2009, ORAL ONCOL, V45, pE181, DOI 10.1016/j.oraloncology.2009.07.004
   Benaqqa C., 2003, THESIS U LYON LYON
   Boilet L, 2013, CERAM INT, V39, P283, DOI 10.1016/j.ceramint.2012.06.023
   Charlier T., 1997, Patent, Patent No. [W00042471, 0042471]
   Clarinval A.M., 2010, P NANT MAT 2010 S NA
   DORMAL T, 2004, IND TECHNOLOGIES JUI, P64
   Greco A, 2001, J MATER SCI, V36, P99, DOI 10.1023/A:1004899027360
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Kundribskaja S., 2010, J FUNCTIONAL BIOMATE, V1, P22, DOI [10.3390/jfb1010022, DOI 10.3390/JFB1010022]
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tommasini SM, 2008, J BONE MINER RES, V23, P236, DOI 10.1359/JBMR.071014
   Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179
   YUKITOSHI K, 2000, Patent No. 0059972
NR 19
TC 3
Z9 3
U1 3
U2 21
PU UNIV MARIBOR, FAC MECHANICAL ENGINEERING
PI MARIBOR
PA SMETANOVA ULICA 17, MARIBOR, SI-2000, SLOVENIA
SN 1854-6250
EI 1855-6531
J9 ADV PROD ENG MANAG
JI Adv. Prod. Eng. Manag.
PY 2013
VL 8
IS 2
BP 96
EP 106
DI 10.14743/apem2013.2.157
PG 11
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA V41VA
UT WOS:000209572500004
OA Bronze
DA 2018-10-20
ER

PT J
AU Brown, SR
   Wadhawan, H
   Nelson, RL
AF Brown, Steven R.
   Wadhawan, Himanshu
   Nelson, Richard L.
TI Surgery for faecal incontinence in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Anal Canal [surgery]; Electric Stimulation Therapy [methods]; Fecal
   Incontinence [surgery; therapy]; Pelvic Floor [surgery]; Randomized
   Controlled Trials as Topic; Adult; Humans
ID ANAL-SPHINCTER REPAIR; PELVIC FLOOR REPAIR; RANDOMIZED-CONTROLLED-TRIAL;
   SACRAL NERVE-STIMULATION; INJECTABLE SILICONE BIOMATERIAL; ARTIFICIAL
   BOWEL SPHINCTER; DOUBLE-BLIND CROSSOVER; COMPARING 3 FORMS; TO-END
   REPAIR; CLINICAL-TRIAL
AB Background
   Faecal incontinence is a debilitating problem with significant medical, social and economic implications. Treatment options include conservative, non-operative interventions (for example pelvic floor muscle training, biofeedback, drugs) and surgical procedures. A surgical procedure may be aimed at correcting an obvious mechanical defect, or augmenting a functionally deficient but structurally intact sphincter complex.
   Objectives
   To assess the effects of surgical techniques for the treatment of faecal incontinence in adults who do not have rectal prolapse. Our aim was firstly to compare surgical management with non-surgical management and secondly, to compare the various surgical techniques.
   Search methods
   Electronic searches of the Cochrane Incontinence Group Specialised Register (searched 6 March 2013), the Cochrane Colorectal Cancer Group Specialised Register (searched 6 March 2013), CENTRAL (2013, issue 1) and EMBASE (1 January 1998 to 6 March 2013) were undertaken. The British Journal of Surgery (1 January 1995 to 6 March 2013), Colorectal Diseases (1 January 2000 to 6 March 2013) and the Diseases of the Colon and Rectum (1 January 1995 to 6 March 2013) were specifically handsearched. The proceedings of the Association of Coloproctology of Great Britain and Ireland annual meetings held from 1999 to 2012 were perused. Reference lists of all relevant articles were searched for further trials.
   Selection criteria
   All randomised or quasi-randomised trials of surgery in the management of adult faecal incontinence (other than surgery for rectal prolapse).
   Data collection and analysis
   Three review authors independently selected studies from the literature, assessed the methodological quality of eligible trials and extracted data. The three primary outcome measures were change or deterioration in incontinence, failure to achieve full continence, and the presence of faecal urgency.
   Main results
   Nine trials were included with a total sample size of 264 participants. Two trials included a group managed non-surgically. One trial compared levatorplasty with anal plug electrostimulation and one compared an artificial bowel sphincter with best supportive care. The artificial bowel sphincter resulted in significant improvements in at least one primary outcome but the numbers were small. The other trial showed no difference in the primary outcome measures.
   Seven trials compared different surgical interventions. These included anterior levatorplasty versus postanal repair, anterior levatorplasty versus total pelvic floor repair, total pelvic floor versus postanal repair, end to end versus overlap sphincter repair, overlap repair with or without a defunctioning stoma or with or without biofeedback, and total pelvic floor repair versus repair plus internal sphincter plication and neosphincter formation versus total pelvic floor repair. Sacral nerve stimulation and injectables are considered in separate Cochrane reviews. Only one comparison had more than one trial (total pelvic floor versus postanal repair, 44 participants) and no trial showed any difference in primary outcome measures.
   Authors' conclusions
   The review is striking for the lack of high quality randomised controlled trials on faecal incontinence surgery that have been carried out in the last 10 years. Those trials that have been carried out have focused on sacral neuromodulation and injectable bulking agents, both reported in separate reviews. The continued small number of relevant trials identified together with their small sample sizes and other methodological weaknesses limit the usefulness of this review for guiding practice. It was impossible to identify or refute clinically important differences between the alternative surgical procedures. Larger rigorous trials are still needed. However, it should be recognised that the optimal treatment regime may be a complex combination of various surgical and non-surgical therapies.
C1 [Brown, Steven R.] Sheffield Teaching Hosp, Sheffield S7, S Yorkshire, England.
   [Wadhawan, Himanshu] Sheffield Teaching Hosp, Dept Surg, Sheffield, S Yorkshire, England.
   [Nelson, Richard L.] No Gen Hosp, Dept Gen Surg, Sheffield S7 S5 7AU, S Yorkshire, England.
RP Brown, SR (reprint author), No Gen Hosp, Sheffield Teaching Hosp, Dept Surg, Herried Rd, Sheffield S7 S5 7AU, S Yorkshire, England.
EM stevebrown@doctors.org.uk
FU NHS National R&D Programme for People with Physical and Complex
   Disabilities, UK; Chief Scientist Office, Scottish Executive Health
   Department, UK; The National Institute for Health Research, UK; The
   National Institute for Health Research (NIHR)
FX External sources; NHS National R&D Programme for People with Physical
   and Complex Disabilities, UK.; Chief Scientist Office, Scottish
   Executive Health Department, UK.; The National Institute for Health
   Research, UK.; The National Institute for Health Research (NIHR) is the
   largest single funder of the Cochrane Incontinence Group.
CR ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233
   *BLADD BOW FDN, 2000, MAK CAS INT CONT SER
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P18
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P2
   BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204
   CARRARO PS, 1994, BRIT J SURG, V81, P140
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   COUNIHAN TC, 2005, CURRENT THERAPY COLO, P105
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de Groat W.C., 1990, CIBA F SYMP, V151
   DEEN KI, 1993, BRIT J SURG, V80, P794, DOI 10.1002/bjs.1800800648
   DEEN KI, 1995, DIS COLON RECTUM, V38, P14, DOI 10.1007/BF02053851
   DEGROAT WC, 1990, CIBA F SYMP, V151, P27
   Delhi T, 2013, SCAND J GASTROENTERO, V48, P302
   Farrell SA, 2012, OBSTET GYNECOL, V120, P803, DOI 10.1097/AOG.0b013e31826ac4bb
   Farrell SA, 2010, OBSTET GYNECOL, V116, P16, DOI 10.1097/AOG.0b013e3181e366ef
   FeltBersma RJF, 1997, DIS COLON RECTUM, V40, P811, DOI 10.1007/BF02055438
   Fernando R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002866.pub2
   Fernando R, 2004, NEUROUROL URODYNAM, V23, P411
   Fernando RJ, 2006, OBSTET GYNECOL, V107, P1261, DOI 10.1097/01.AOG.0000218693.24144.bd
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   FITZPATRICK M, 1999, COLORECTAL DIS S1, V1, P10
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA
   Horrocks E, 2011, CONTROL FAECAL INCON
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Kamm MA, 1998, BRIT MED J, V316, P528, DOI 10.1136/bmj.316.7130.528
   Keating JP, 1997, DIS COLON RECTUM, V40, P896, DOI 10.1007/BF02051195
   Lam, 1999, Colorectal Dis, V1, P197, DOI 10.1046/j.1463-1318.1999.00044.x
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   LODER PB, 1993, BRIT J SURG, V80, P1352, DOI 10.1002/bjs.1800801053
   MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089
   Michelsen HB, 2008, DIS COLON RECTUM, V51, P538, DOI 10.1007/s10350-008-9219-2
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   Nakayama H, 1997, STROKE, V28, P58, DOI 10.1161/01.STR.28.1.58
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nordenstam J, 2008, BJOG-INT J OBSTET GY, V115, P857, DOI 10.1111/j.1471-0528.2008.01726.x
   O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6
   Osterberg A, 2004, BRIT J SURG, V91, P1131, DOI 10.1002/bjs.4577
   Parellada CM, 1998, DIS COLON RECTUM, V41, P593, DOI 10.1007/BF02235265
   PARKS AG, 1975, P ROY SOC MED, V68, P681
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Pfeifer J, 1997, DIS COLON RECTUM, V40, P79, DOI 10.1007/BF02055686
   Rainey J B, 1990, J R Coll Surg Edinb, V35, P101
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rygh AB, 2010, ACTA OBSTET GYN SCAN, V89, P1256, DOI 10.3109/00016349.2010.512073
   Ryhammer AM, 1997, DIS COLON RECTUM, V40, P287, DOI 10.1007/BF02050417
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   SUN WM, 1990, GUT, V31, P1056, DOI 10.1136/gut.31.9.1056
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2
   TURNBERG L, 1995, INCONTINENCE CAUSES
   Uher EM, 1998, DIS COLON RECTUM, V41, P1165, DOI 10.1007/BF02239440
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   Vaizey CJ, 1998, BRIT J SURG, V85, P596
   van Tets WF, 1998, DIS COLON RECTUM, V41, P365, DOI 10.1007/BF02237493
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   WILLIAMS A, 2004, P INT CONT SOC UK 11, P33
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Yoshioka K, 1999, DIS COLON RECTUM, V42, P252, DOI 10.1007/BF02237137
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 77
TC 11
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2013
IS 7
AR CD001757
DI 10.1002/14651858.CD001757.pub4
PG 70
WC Medicine, General & Internal
SC General & Internal Medicine
GA 193OB
UT WOS:000322568100006
PM 23821339
OA Bronze
DA 2018-10-20
ER

PT J
AU Maeda, Y
   Laurberg, S
   Norton, C
AF Maeda, Yasuko
   Laurberg, Soren
   Norton, Christine
TI Perianal injectable bulking agents as treatment for faecal incontinence
   in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Acrylic Resins [administration & dosage]; Administration, Rectal;
   Biocompatible Materials [administration & dosage]; Collagen
   [administration & dosage]; Dimethylpolysiloxanes [administration &
   dosage]; Fecal Incontinence [therapy]; Glucans [administration &
   dosage]; Hydrogels [administration & dosage]; Palpation; Randomized
   Controlled Trials as Topic; Silicones [administration & dosage];
   Ultrasonography, Interventional; Zirconium [administration & dosage];
   Adult; Humans
ID INTERNAL ANAL-SPHINCTER; SILICONE BIOMATERIAL PTQ(TM); HYALURONIC-ACID;
   AUTOLOGOUS FAT; RISK-FACTORS; INJECTION; MANAGEMENT; IMPLANTS;
   DYSFUNCTION; DEXTRANOMER
AB Background
   Faecal incontinence is a complex and distressing condition with significant medical and social implications. Injection of perianal bulking agents has been used to treat the symptoms of passive faecal incontinence. However, various agents have been used without a standardised technique and the supposed benefit of the treatment is largely anecdotal with a limited clinical research base.
   Objectives
   To determine the effectiveness of perianal injection of bulking agents for the treatment of faecal incontinence in adults.
   Search methods
   We searched the Cochrane Incontinence Group Specialised Register of trials (25 May 2012), ZETOC (3 May 2012), clinical trials registries (3 May 2012) and the reference lists of relevant articles.
   Selection criteria
   All randomised or quasi-randomised controlled trials comparing the use of injectable bulking agents for faecal incontinence with any alternative treatments or placebo were reviewed to evaluate the therapeutic effects. Case-control and cohort studies were also reviewed to assess risks and complications associated with the treatments.
   Data collection and analysis
   Two review authors (YM and CN) assessed the methodological quality of eligible trials and independently extracted data from the included trials using a range of pre-specified outcome measures.
   Main results
   Five eligible randomised trials with a total of 382 patients were identified. Four of the trials were at an uncertain or high risk of bias.
   Most trials reported a short term benefit from injections regardless of the material used, including placebo saline injection. One study demonstrated dextranomer in stabilised hyaluronic acid (NASHA Dx) to be more effective than sham injection but with more adverse effects. Dextranomer in stabilised hyaluronic acid (NASHA Dx) was better than sham injections at six months (65/136, 48% versus 48/70, 69% participants not improved, defined as less than 50% reduction in incontinence episodes, RR 0.70, 95% CI 0.55 to 0.88; with more incontinence free days (3.1 days compared with 1.7 in the sham treatment group, MD 1.40 days, 95% CI 0.33 to 2.47). Another study comparing silicone material (PTQ (TM)) to saline injections was too small to demonstrate a clinical benefit compared to the control injection of normal saline.
   A silicone biomaterial (PTQ (TM)) was shown to provide some advantages and was safer in treating faecal incontinence than carbon-coated beads (Durasphere (R)) in the short term.
   Similarly, there were short term benefits from injections delivered under ultrasound guidance compared with digital guidance.
   No long term evidence on outcomes was available and further conclusions were not warranted from the available data. None of the studies reported patient evaluation of outcomes and thus it is difficult to gauge whether the improvement in incontinence scores matched practical symptom improvements that mattered to the patients.
   Authors' conclusions
   One large randomised controlled trial has shown that this form of treatment using dextranomer in stabilised hyaluronic acid (NASHA Dx) improves continence for a little over half of patients in the short term. However, the number of identified trials was limited and most had methodological weaknesses.
C1 [Maeda, Yasuko] St Marks Hosp, Sir Alan Parks Physiol Unit, Harrow, Middx, England.
   [Laurberg, Soren] Aarhus Univ Hosp, Dept Surg, DK-8000 Aarhus, Denmark.
   [Norton, Christine] Kings Coll London, London WC2R 2LS, England.
   [Norton, Christine] Imperial Coll Healthcare NHS Trust, London, England.
RP Maeda, Y (reprint author), St Marks Hosp, Sir Alan Parks Physiol Unit, Northwick Pk,Watford Rd, Harrow, Middx, England.
EM yazmaeda@gmail.com
RI Maeda, Yasuko/B-6123-2016
FU NIHR, UK
FX External sources; NIHR, UK.; The Cochrane Incontinence Review Group is
   supported by NIHR UK
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   [Anonymous], 2011, EUCTR201002146332AT
   [Anonymous], 2009, NCT00762047 PROSP MU
   [Anonymous], 2009, NCT00605826 RAND BLI
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub3
   Chan M., 2006, INJECTABLE SILICONE
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   da Silva GM, 2003, DIS COLON RECTUM, V46, P1492, DOI 10.1097/01.DCR.0000093642.39267.67
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Dehli T, 2009, RANDOMIZED CONTROLLE
   Dehli Trond, 2007, Tidsskr Nor Laegeforen, V127, P2934
   Deutekom M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005086.pub3
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   Draganic B, PTQ VERSUS DURASPHRE
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408
   FeltBersma RJF, 1996, DIS COLON RECTUM, V39, P878, DOI 10.1007/BF02053986
   Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379
   Frudinger A, 2010, GUT, V59, P55, DOI 10.1136/gut.2009.181347
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Gett RM, 2007, ANZ J SURG S1, V77, pA16
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Higgins JP, COCHRANE HDB SYSTEMA
   Hosker G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001310.pub2
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Kumar D, 1998, BRIT J SURG, V85, P978
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Lindsey I, 2004, DIS COLON RECTUM, V47, P1643, DOI 10.1007/s10350-004-0651-7
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   National Collaborating Centre for Acute Care and NHS National Institute for Health and Clinical Excellence (NICE), 2007, CG49 ROYAL COLL SURG
   Norderval S, 2012, BLINDED RANDOMIZED C
   Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3
   Rao SSC, 2004, GASTROENTEROLOGY, V126, pS14, DOI 10.1053/j.gastro.2003.10.013
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smart N, 2008, COLORECTAL DIS, V10, P628, DOI 10.1111/j.1463-1318.2008.01475.x
   Smart N, 2005, COLORECTAL DIS, V7, P59
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2004, P AM SOC COL RECT SU, P178
   Ullah S, 2011, JCPSP-J COLL PHYSICI, V21, P227, DOI 04.2011/JCPSP.227229
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   van Wunnik B, 2012, TECH COLOPROCTOL, V16, P395, DOI 10.1007/s10151-011-0702-8
   Weiss EG, 2002, DIS COLON RECTUM, V45, pA46
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wheeler TL, 2007, CURR OPIN OBSTET GYN, V19, P474, DOI 10.1097/GCO.0b013e3282ef4142
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
NR 66
TC 27
Z9 28
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2013
IS 2
AR CD007959
DI 10.1002/14651858.CD007959.pub3
PG 45
WC Medicine, General & Internal
SC General & Internal Medicine
GA 097GE
UT WOS:000315461200015
PM 23450581
DA 2018-10-20
ER

PT S
AU Beisembayev, K
AF Beisembayev, Kanatzhan
GP SGEM
TI IMPROVEMENT OF METHODS OF BOVINE ANAPLASMOSIS DIAGNOSTICS
SO GEOCONFERENCE ON NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE
   FUTURE
SE International Multidisciplinary Scientific GeoConference-SGEM
LA English
DT Proceedings Paper
CT 13th International Multidisciplinary Scientific Geoconference, SGEM 2013
CY JUN 16-22, 2013
CL Albena, BULGARIA
DE anaplasma; animals; specific antiserum and antigens; reaction of
   indirect immunofluorescence; Vero; D. reticulates; D. silvarum;
   hemolymph-test; biomaterial
AB Specific antigens as well as RIDIF-active rabbit sera (1: 320) used for detecting Anaplasma in biomaterial of tick-transmitters and antibodies in serum of cattle, infected with anaplasmosis, have been received.
   Obtained serum can be used as indicator and identificator of bovine anaplasmosis causative agent in RIDIF and for studding antigenic and relative properties of bovine anaplasmosis causative agent and disease pathogenesis.
   High diagnostic value of RIDIF was confirmed practically, using this method (in combination with light microscopy) 14% infected animals as well as anaplasmosis - carriers have been detected.
C1 [Beisembayev, Kanatzhan] Kokshetau State Univ Ualihanov Shokan, Kokshetau, Kazakhstan.
RP Beisembayev, K (reprint author), Kokshetau State Univ Ualihanov Shokan, Kokshetau, Kazakhstan.
CR Krasikov A.P., 2000, CURRENT ISSUES VET M, P130
   Kuttler K., 1963, J AM VET MED ASS, V143
   Ristic M., 1962, J AM VET MED ASS, V141
   Schindler R., 1966, TROPENMED PARASITO B, V17, p337 
   Stepanova N.I., 1970, METHODS ANTIGEN PREP, V38, P90
NR 5
TC 0
Z9 0
U1 0
U2 1
PU STEF92 TECHNOLOGY LTD
PI SOFIA
PA 1 ANDREY LYAPCHEV BLVD, SOFIA, 1797, BULGARIA
SN 1314-2704
BN 978-619-7105-06-3
J9 INT MULTI SCI GEOCO
PY 2013
BP 163
EP 167
PG 5
WC Geosciences, Multidisciplinary; Nanoscience & Nanotechnology
SC Geology; Science & Technology - Other Topics
GA BE0GN
UT WOS:000365991700022
DA 2018-10-20
ER

PT J
AU Bellotti, C
   Stanco, D
   Ragazzini, S
   Romagnoli, L
   Martella, E
   Lazzati, S
   Marchetti, C
   Donati, D
   Lucarelli, E
AF Bellotti, C.
   Stanco, D.
   Ragazzini, S.
   Romagnoli, L.
   Martella, E.
   Lazzati, S.
   Marchetti, C.
   Donati, D.
   Lucarelli, E.
TI ANALYSIS OF THE KARYOTYPE OF EXPANDED HUMAN ADIPOSE-DERIVED STEM CELLS
   FOR BONE RECONSTRUCTION OF THE MAXILLO-FACIAL REGION
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE adipose-derived stem cells; maxillo-facial reconstruction; bone;
   cytogenetic analysis
AB Mesenchymal stem cells (MSC) and adipose-derived stem cells (ASC) were recently proposed for bone maxillofacial reconstruction in association with biomaterials. For this application MSC must be ex-vivo expanded in order to obtain, for a given volume of implanted biomaterial, a relevant number of bone forming cells. Previously conducted pre-clinical studies suggested that a concentration of 6 x 10(8) ASC associated with 900 mg of anorganic bovine bone (ABB) could be effective for human maxillary sinus floor elevation. A keystone issue to guarantee the quality and safety of Advanced Therapy Medicinal Products containing expanded MSC and ASC is their chromosome stability in culture: this topic has been widely investigated and conflicting results have been published. Abnormal karyotype of human ex-vivo expanded MSC and ASC was found by some authors, while, at the same time, several other studies showed the MSC and ASC karyotype to be normal. It is therefore important that all the results obtained on MSC and ASC karyotype analysis be published. Given this context, the aim of this manuscript, aim of this manuscript is to verify the karyotype stability of ASC in view of their applications in clinical trials. ASC obtained from the adipose tissue of 4 donors were expanded over extended culture time. Based on previous ASC expansions we hypothesized to be able to obtain 6 x 10(8) cells by passage 7. Karyotype analysis 30 metaphases was planned to be investigated at passage 2, 7, and 15 in all the cultures. No abnormalities were found in the karyotype of two donors at all the passages tested, while a translocation was found in 2 metaphases of a donor at passage 7, but not at passage 15, and in the fourth donor in 5 metaphases a trisomy was found at passage 15. Chromosomal abnormalities were detected only after extended ASC expansion. Whether these anomalies can be related to risk for the patient's safety will have to be demonstrated by in-vivo studies.
C1 [Bellotti, C.; Martella, E.; Donati, D.; Lucarelli, E.] Rizzoli Orthopaed Inst, Osteoarticular Regenerat Lab, I-40136 Bologna, Italy.
   [Stanco, D.] IRCCS Galeazzi Orthopaed Inst, Orthopaed Biotechnol Lab, Milan, Italy.
   [Ragazzini, S.; Marchetti, C.] Univ Bologna, Biomed & Neuromotor Sci, Via San Vitale 59, I-40125 Bologna, Italy.
   [Romagnoli, L.; Lazzati, S.] Areta Int Srl, I-21040 Gerenzano, VA, Italy.
RP Lucarelli, E (reprint author), Ist Ortoped Rizzoli, Lab Patol Ortoped & Rigeneraz Tissutale Osteoarti, Via Barbiano 1-10, I-40136 Bologna, BO, Italy.
EM enrico.lucarelli@ior.it
RI Lucarelli, Enrico/G-3588-2015
OI Lucarelli, Enrico/0000-0002-6681-6374; Martella,
   Elisa/0000-0003-3923-0906; DONATI, DAVIDE MARIA/0000-0002-9170-0576
FU Progetto di Ricerca [RF_EMR_2008-1216793]; FIRB-ACCORDI DI PROGRAMMA
   Anno [RBAP10447J]
FX The authors are grateful to Dr. Panagiota Dimopoulou for editorial
   assistance. The study was funded in part by Progetto di Ricerca
   RF_EMR_2008-1216793. and FIRB-ACCORDI DI PROGRAMMA Anno 2010 -
   Protocollo: RBAP10447J
CR Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100
   Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690
   Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002
   Bochkov NP, 2007, B EXP BIOL MED+, V143, P122, DOI 10.1007/s10517-007-0031-0
   Bochkov NP, 2009, B EXP BIOL MED+, V148, P677, DOI 10.1007/s10517-010-0793-7
   Bochkov NP, 2008, B EXP BIOL MED+, V146, P344, DOI 10.1007/s10517-008-0293-1
   Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3
   Cavallo C, 2011, J CELL BIOCHEM, V112, P1418
   Choumerianou DM, 2008, CELL PROLIFERAT, V41, P909, DOI 10.1111/j.1365-2184.2008.00559.x
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Ferreira RJ, 2012, CURR STEM CELL RES T, V7, P356
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Grimes BR, 2009, STEM CELLS DEV, V18, P717, DOI 10.1089/scd.2008.0255
   Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Lucarelli E, 2012, CURR PHARM DES
   Mariani E, 2012, CURR PHARM DESIGN, V18, P1821, DOI 10.2174/138161212799859666
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nikitina VA, 2011, B EXP BIOL MED+, V151, P550, DOI 10.1007/s10517-011-1379-8
   Nikitina VA, 2011, B EXP BIOL MED, V150, P627
   Pieri F, 2010, BIOMATERIALS, V31, P3527, DOI 10.1016/j.biomaterials.2010.01.066
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Safwani WK, 2012, J TISSUE ENG REGEN M, P1
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Spiropoulos A, 2011, J CELL MOL MED, V15, P1983, DOI 10.1111/j.1582-4934.2010.01157.x
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.teb.2011.0440, 10.1089/ten.TEB.2011.0440]
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Zeng DL, 2012, TISSUE ENG PT A, V18, P871, DOI [10.1089/ten.TEA.2011.0379, 10.1089/ten.tea.2011.0379]
   Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 36
TC 5
Z9 5
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN
PY 2013
VL 26
SU 1
BP 3
EP 9
DI 10.1177/03946320130260S102
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V43ZR
UT WOS:000209719800002
PM 24046944
DA 2018-10-20
ER

PT J
AU Chlapanidas, T
   Tosca, MC
   Farago, S
   Perteghella, S
   Galuzzi, M
   Lucconi, G
   Antonioli, B
   Ciancio, F
   Rapisarda, V
   Vigo, D
   Marazzi, M
   Faustini, M
   Torre, ML
AF Chlapanidas, T.
   Tosca, M. C.
   Farago, S.
   Perteghella, S.
   Galuzzi, M.
   Lucconi, G.
   Antonioli, B.
   Ciancio, F.
   Rapisarda, V.
   Vigo, D.
   Marazzi, M.
   Faustini, M.
   Torre, M. L.
TI FORMULATION AND CHARACTERIZATION OF SILK FIBROIN FILMS AS A SCAFFOLD FOR
   ADIPOSE-DERIVED STEM CELLS IN SKIN TISSUE ENGINEERING
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Silk fibroin films; adipose-derived stem cells; bioengineered skin
AB Skin substitutes are epidermal, dermal or complete bilayered constructs, composed by natural or synthetic scaffolds and by adherent cells such as fibroblasts, keratinocytes or mesenchymal stem cells. Silk fibroin is a promising polymer to realize scaffolds, since it is biocompatible, biodegradable, and exhibits excellent mechanical properties in terms of tensile strength. Moreover, fibroin can be added of others components in order to modify the biomaterial properties for the purpose. The aim of this work is to prepare silk fibroin films for adipose-derived stem cell (ADSCs) culture as a novel feeder layer for skin tissue engineering. Pectin has been added to promote the protein conformational transition and construct strength, while glycerol as plasticizer, providing biomaterial flexibility. Eighteen formulations were prepared by casting method using fibroin, pectin (range 1-10% w/w), and glycerol (range 0-20% w/w); films were characterized by Fourier transform infrared spectroscopy and differential scanning calorimetry assay, to select the optimal composition. A stable fibroin conformation was obtained using 6% w/w pectin, and the best mechanical properties were obtained using 12% w/w glycerol. Films were sterilized, and human ADSCs were seeded and cultured for 15 days. Cells adhere to the support assuming a fibroblastic-like shape and reaching confluence. The ultrastructural analysis evidences typical active-cell features and adhesion structures that promote cell anchorage to the film, thus developing a multilayered cell structure. This construct could be advantageously employed in cutaneous wound healing or where the use of ADSCs scaffold is indicated either in human or veterinary field.
C1 [Chlapanidas, T.; Tosca, M. C.; Perteghella, S.; Galuzzi, M.; Lucconi, G.; Torre, M. L.] Univ Pavia, Dipartimento Sci Farmaco, Via Palestro 3, I-27100 Pavia, Italy.
   [Tosca, M. C.; Galuzzi, M.; Antonioli, B.; Marazzi, M.] Azienda Osped Osped Niguarda Ca Granda, Terapia Tissutale, Milan, Italy.
   [Farago, S.] Innovhub, Div Stn Sperimentale Seta, Milan, Italy.
   [Ciancio, F.] Univ Florence, Ist Chirurg Plast, Florence, Italy.
   [Rapisarda, V.] Azienda Osped Osped Niguarda Ca Granda, Chirurg Plast, Milan, Italy.
   [Rapisarda, V.] Azienda Osped Osped Niguarda Ca Granda, Ctr Grandi Ustionati, Milan, Italy.
   [Vigo, D.; Faustini, M.] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy.
RP Marazzi, M (reprint author), Azienda Osped Osped Niguarda Ca Granda, Struttura Semplice Terapia Tissutale, Piazza Osped Maggiore 3, I-20162 Milan, Italy.
EM mario.marazzi@ospedaleniguarda.it
RI faustini, massimo/K-6595-2017; Torre, Maria Luisa/N-4782-2015
OI faustini, massimo/0000-0003-2182-1003; Torre, Maria
   Luisa/0000-0001-8062-6836; Perteghella, Sara/0000-0003-1128-7636
FU Pavia University; Eurostars project FIBROSPHERE [E!5227]; Milan
   University
FX This work was supported by Pavia and Milan Universities, and Eurostars
   project E!5227 FIBROSPHERE. The authors thank Gammatom S.r.l. (Guanzate,
   Italy) for gamma sterilization and Dr Vittorio Necchi (Centro Grandi
   Strumenti, Pavia University) for the ultrastructural investigation.
CR Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962
   Einhorn-Stoll U, 2009, FOOD HYDROCOLLOID, V23, P40, DOI 10.1016/j.foodhyd.2007.11.009
   Einhorn-Stoll U, 2007, FOOD HYDROCOLLOID, V21, P1101, DOI 10.1016/j.foodhyd.2006.08.004
   Farago S, IT2010MI2010A002081
   Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI [10.1089/ten.tec.2010.0214, 10.1089/ten.TEC.2010.0214]
   George KA, 2012, MAT SCI ENG C
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Mizuno H, 2011, METHODS MOL BIOL, V702, P453, DOI 10.1007/978-1-61737-960-4_33
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Munarin F, 2012, INT J BIOL MACROMOL, V51, P681, DOI 10.1016/j.ijbiomac.2012.07.002
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Nagel MD, 2008, BBA-GEN SUBJECTS, V1780, P995, DOI 10.1016/j.bbagen.2008.04.002
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Sobajo Cassandra, 2008, Eplasty, V8, pe47
   Stacey GN, 2006, J BIOTECHNOL, V125, P583, DOI 10.1016/j.jbiotec.2006.03.011
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sugiyama H, 2008, J TISSUE ENG REGEN M, V2, P445, DOI 10.1002/term.111
   Suzuki K, 1997, J RADIAT RES, V38, P55, DOI 10.1269/jrr.38.55
   Takeuchi T, 2008, JPN J INFECT DIS, V61, P9
   Uebersax L, 2007, EUR CELLS MATER, V13, P15
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 48
TC 11
Z9 12
U1 2
U2 19
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2058-7384
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN
PY 2013
VL 26
SU 1
BP 43
EP 49
DI 10.1177/03946320130260S106
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V43ZR
UT WOS:000209719800006
PM 24046948
OA Bronze
DA 2018-10-20
ER

PT B
AU Khoda, AKMB
   Koc, B
AF Khoda, A. K. M. B.
   Koc, Bahattin
GP ASME
TI FUNCTIONALLY HETEROGENEOUS POROUS SCAFFOLD DESIGN FOR TISSUE ENGINEERING
SO INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION - 2012, VOL
   2: BIOMEDICAL AND BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 09-15, 2012
CL Houston, TX
SP ASME
DE Deposition angle; Porosity function; variational filament distance
ID BONE; DENSITY
AB Most of the current tissue scaffolds are mainly designed with homogeneous porosity which does not represent the spatial heterogeneity found in actual tissues. Therefore engineering a realistic tissue scaffolds with properly graded properties to facilitate the mimicry of the complex elegance of native tissues are critical for the successful tissue regeneration. In this work, novel bio-mimetic heterogeneous porous scaffolds have been modeled. First, the geometry of the scaffold is extracted along with its internal regional heterogeneity. Then the model has been discretized with planner slices suitable for layer based fabrication. An optimum filament deposition angle has been determined for each slice based on the contour geometry and the internal heterogeneity. The internal region has been discritized considering the homogeneity factor along the deposition direction. Finally, an area weight based approach has been used to generate the spatial porosity function that determines the filament deposition location for desired bio-mimetic porosity. The proposed methodology has been implemented and illustrative examples are provided. The effective porosity has been compared between the proposed design and the conventional homogeneous scaffolds. The result shows a significant error reduction towards achieving the bio-mimetic porosity in the scaffold design and provides better control over the desired porosity level. Moreover, sample designed structures have also been fabricated with a NC motion controlled micro-nozzle biomaterial deposition system.
C1 [Khoda, A. K. M. B.] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
   [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, FENS G013, TR-34956 Istanbul, Turkey.
RP Khoda, AKMB (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bkoc@buffalo.edu
FU Telemedicine and Advanced Technology Research Center (TATRC) at the US
   Army Medical Research; Material Command (USAMRMC) [W81XWH-05-1-0401]; EU
   FP7 Marie Curie Grant [PCIG09-GA-2011-294088]
FX The research was partially supported by the Telemedicine and Advanced
   Technology Research Center (TATRC) at the US Army Medical Research and
   Material Command (USAMRMC) through award W81XWH-05-1-0401 and by EU FP7
   Marie Curie Grant #: PCIG09-GA-2011-294088 awarded to Dr. Koc.
CR Chow HN, 2007, COMPUT AIDED DESIGN, V4, P321, DOI DOI 10.1080/16864360.2007.10738552.
   Coelho PG, 2009, J BIOMECH, V42, P830, DOI 10.1016/j.jbiomech.2009.01.020
   Fryazinov O., COMPUTER AIDED DESIG
   Geffre CP, 2009, J BIOMED MATER RES A, V91A, P795, DOI 10.1002/jbm.a.32251
   Holdstein Y., 2011, GEOMETRIC MODELING A, P91
   Hosokawa A, 2010, IEEE T ULTRASON FERR, V57, P1320, DOI 10.1109/TUFFC.2010.1552
   Khoda A., 2012, ASME T J ME IN PRESS
   Khoda A. B., 2012, CAD UNPUB
   Khoda AKM, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034106
   Kou XY, 2012, INT J COMPUT INTEG M, V25, P177, DOI 10.1080/0951192X.2011.627948
   Lal P, 2004, COMPUT AIDED DESIGN, V36, P487, DOI 10.1016/S0010-4485(03)00134-9
   Pasko A, 2011, GRAPH MODELS, V73, P165, DOI 10.1016/j.gmod.2011.03.001
   Pietruszczak S, 1999, J BIOMECH, V32, P1071, DOI 10.1016/S0021-9290(99)00096-2
   Schroeder C, 2005, COMPUT AIDED DESIGN, V37, P339, DOI 10.1016/j.cad.2004.03.008
   Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005
   Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025
NR 16
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4518-9
PY 2013
BP 579
EP +
PG 3
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA BC0XX
UT WOS:000349815500076
DA 2018-10-20
ER

PT B
AU Smith, C
   Xu, ZG
   Sankar, J
AF Smith, Christopher
   Xu, Zhigang
   Sankar, Jagannathan
GP ASME
TI THE EFFECTS OF T4 AND T6 HEAT TREATMENT ON THE CORROSION BEHAVIOR OF
   MGZNCA ALLOYS
SO INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION - 2012, VOL
   3, PTS A-C: DESIGN, MATERIALS, AND MANUFACTURING
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 09-15, 2012
CL Houston, TX
SP ASME
ID MECHANICAL-PROPERTIES; MAGNESIUM ALLOY; PURE MAGNESIUM; CHLORIDE
AB Some of the most important characteristics of a medical implant biomaterial are its corrosion resistance, cytotoxicity, mechanical property, and overall biological performance. Optimizing these characteristics is therefore vital to the success of creating effective medical biomaterials. It is well known that heat treatment processes affect the microstructure of metallic alloys which consequently can have favorable influences on the mechanical properties. The determination of the effects of heat treatment on the corrosion resistance of metallic alloys is another aspect that must be examined. That is the goal of this investigation. The corrosion characteristics of two MgZnCa alloy systems (MgZnCa-31 and MgZnCa-32) were studied to determine the correlation between T4 and T6 heat treatment and the corrosion rate on the alloys. The alloys were produced by melting and casting at 730 C and then heat treated. The corrosion performances of the alloys were examined by both immersion and electrochemical analysis, which were conduct in 0.9% NaCl physiological saline solution. In terms of the effects of the T4 heat treatment, the corrosion rate of the MgZnCa-31 decreases as the time period of the heat treatment increases, whereas the MgZnCa-32 alloys have an opposite effect meaning that the corrosion rate increases as the time period of the heat treatment increases. There was no significant change in corrosion with the introduction of T6 heat treatment to both alloy systems.
C1 [Smith, Christopher; Xu, Zhigang; Sankar, Jagannathan] N Carolina Agr & Tech State Univ, Greensboro, NC 27411 USA.
RP Smith, C (reprint author), N Carolina Agr & Tech State Univ, Greensboro, NC 27411 USA.
CR Akhter R, 2007, MAT SCI ENG A-STRUCT, V447, P192, DOI 10.1016/j.msea.2006.10.148
   [Anonymous], 2006, B661062003 ASTM, DOI [10.1520/B0661-06, DOI 10.1520/B0661-06]
   ASTM, 2010, E112 ASTM INT, P1, DOI DOI 10.1520/E0112-10
   AVEDESIAN M, 1998, MAGNESIUM MAGNESIUM
   Bajat J., CORROSION SCI, V53, P409
   DeGarmo E., 1998, MAT PROCESSES MANUFA
   Deshpande K. B., CORROSION SCI, V52, P2819
   Dezellus O., MAT SCI ENG A, V528, P2795
   Esmaeili S., 2010, TMS
   Feliu S, 2004, PROG ORG COAT, V50, P199, DOI 10.1016/j.porgcoat.2004.02.008
   Garcia KE, 2006, CORROS SCI, V48, P2813, DOI 10.1016/j.corsci.2005.09.002
   Liu M., 2011, MAT SCI E B IN PRESS
   Liu XB, 2010, T NONFERR METAL SOC, V20, P1345, DOI 10.1016/S1003-6326(09)60302-2
   Osorio WR, 2007, MATER CHEM PHYS, V106, P343, DOI 10.1016/j.matchemphys.2007.06.011
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Poorqasemi E, 2009, CORROS SCI, V51, P1043, DOI 10.1016/j.corsci.2009.03.001
   Shi Z., 2000, CORROS SCI, V52, P579
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Simbi D. J., 1997, CORROS SCI, V39, P1015
   Skar JI, 1999, MATER CORROS, V50, P2, DOI 10.1002/(SICI)1521-4176(199901)50:1<2::AID-MACO2>3.0.CO;2-N
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sudholz AD, 2011, CORROS SCI, V53, P2277, DOI 10.1016/j.corsci.2011.03.010
   Sulka G. D., INTERMETALLICS, V19, P974
   Wang Y, 2008, MATER LETT, V62, P2181, DOI 10.1016/j.matlet.2007.11.045
   Wasiur-Rahman S, 2009, INTERMETALLICS, V17, P847, DOI 10.1016/j.intermet.2009.03.014
   Xu Z., MAT SCI E B IN PRESS
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
NR 31
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4519-6
PY 2013
BP 745
EP 759
PG 15
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BC1DQ
UT WOS:000350004500094
DA 2018-10-20
ER

PT J
AU Munoz-Guerra, S
   Garcia-Alvarez, M
   Portilla-Arias, JA
AF Munoz-Guerra, Sebastian
   Garcia-Alvarez, Montserrat
   Portilla-Arias, Jose A.
TI Chemical Modification of Microbial Poly(gamma-glutamic acid): Progress
   and Perspectives
SO JOURNAL OF RENEWABLE MATERIALS
LA English
DT Article
DE Microbial poly(glutamic acid); poly(gamma glutamic acid); polyglutamates
ID DRUG-DELIVERY SYSTEM; GAMMA-GLUTAMIC ACID; POLY(GLUTAMIC ACID); IONIC
   COMPLEXES; POLY(ALPHA-ALKYL GAMMA-GLUTAMATE)S; ACID)-POLY(LACTIDE)
   NANOPARTICLES; GAMMA-POLY(GLUTAMIC ACID); BIOMEDICAL APPLICATIONS;
   ENZYMATIC DEGRADATION; CATIONIC SURFACTANTS
AB Poly(gamma-glutamic acid) (PGGA) is an edible polypeptide excreted by certain bacteria that is presently accessible on a semi-industrial scale. Chemically, it is a nylon 4 derivative bearing a carboxylic side group attached to the fourth carbon of the repeating unit. Although this biopolymer is being exploited in the food, agriculture and cosmetic sectors, its use in massive applications as packaging or coating is still unknown mainly due to its instability in wet environments and unsuitability to be processed by common techniques. Chemical modification of PGGA involving esterification or amidation of the carboxylic group is the approach explored the most to obtain materials with potential interest as fibers, films or hydrogels. Electrostatic coupling of PGGA with hydrophobic cationic species may also be profited to generate non-water-soluble stable derivatives. On the other hand, the interest of modified PGGA as a functionalized biomaterial for scaffold and drug delivery has increased incredibly in the last years. This paper summarizes the progress in the methodology available for synthesizing PGGA derivatives, the relevant features of the new materials that are synthesized, and the most outstanding advances achieved in the biomedical field when modified PGGA is used.
C1 [Munoz-Guerra, Sebastian; Garcia-Alvarez, Montserrat; Portilla-Arias, Jose A.] Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Barcelona 08028, Spain.
RP Munoz-Guerra, S (reprint author), Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Diagonal 647, Barcelona 08028, Spain.
EM sebastian.munoz@upc.edu
FU MICINN (Spain) [MAT2009-14053-CO2-01]; AGAUR (Catalonia) [2009SGR1469]
FX Financial support for this work was provided by MICINN (Spain) with
   Grant MAT2009-14053-CO2-01, and by AGAUR (Catalonia) with Grant
   2009SGR1469.
CR Akagi T, 2006, BIOMACROMOLECULES, V7, P297, DOI 10.1021/bm050657i
   Akagi T, 2012, LANGMUIR, V28, P5249, DOI 10.1021/la205093j
   Akagi T, 2011, BIOMATERIALS, V32, P4959, DOI 10.1016/j.biomaterials.2011.03.049
   Akagi T, 2010, LANGMUIR, V26, P2406, DOI 10.1021/la902868g
   Akao T, 2010, J DRUG TARGET, V18, P550, DOI 10.3109/10611861003599453
   Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047
   Block H., 1983, POLY GAMMA BENZYL L
   BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   Bruckner V., 1935, HOPPESEYL Z, V247, P281
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Chang KY, 2009, POLYMER, V50, P1755, DOI 10.1016/j.polymer.2009.01.057
   CHOI HJ, 1995, J APPL POLYM SCI, V58, P807, DOI 10.1002/app.1995.070580414
   Crescenzi V, 1996, ACS SYM SER, V627, P233
   de Ilarduya AM, 2002, BIOMACROMOLECULES, V3, P1078, DOI 10.1021/bm025568
   Fan KS, 1996, J ENVIRON POLYM DEGR, V4, P253, DOI 10.1007/BF02070694
   Fujii H., 1963, NIPPON NOGEIKAGAKU K, V37, P615
   Garcia-Alvarez M, 2005, MACROMOL BIOSCI, V5, P30, DOI 10.1002/mabi.200400146
   Gonzales D, 1996, J POLYM SCI POL CHEM, V34, P2019, DOI 10.1002/(SICI)1099-0518(19960730)34:10<2019::AID-POLA19>3.0.CO;2-K
   Gross R. A., 1998, BIOPOLYMERS RENEWABL
   Inagaki M., 1992, JP Patent, Patent No. [4298533-A, 4298533]
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367
   Kubota H, 1996, J POLYM SCI POL CHEM, V34, P1347, DOI 10.1002/(SICI)1099-0518(199605)34:7<1347::AID-POLA24>3.0.CO;2-8
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   KUBOTA H, 1995, J POLYM SCI POL CHEM, V33, P85, DOI 10.1002/pola.1995.080330110
   Kunioka M, 1996, J ENVIRON POLYM DEGR, V4, P123, DOI 10.1007/BF02074873
   Kunioka M, 1997, J APPL POLYM SCI, V65, P1889, DOI 10.1002/(SICI)1097-4628(19970906)65:10<1889::AID-APP5>3.0.CO;2-B
   Kunioka M, 1998, POLYM DEGRAD STABIL, V59, P33, DOI 10.1016/S0141-3910(97)00181-X
   Liang HF, 2005, J CONTROL RELEASE, V105, P213, DOI 10.1016/j.jconrel.2005.03.021
   Liang HF, 2006, BIOCONJUGATE CHEM, V17, P291, DOI 10.1021/bc0502107
   Liang HF, 2006, BIOMATERIALS, V27, P2051, DOI 10.1016/j.biomaterials.2005.10.027
   Manocha B, 2010, J NANOMATER, DOI 10.1155/2010/780171
   Matsusaki M, 2002, BIOCONJUGATE CHEM, V13, P23, DOI 10.1021/bc010008d
   Melis J, 2002, MACROMOLECULES, V35, P8774, DOI 10.1021/ma020728v
   Melis J, 2001, POLYMER, V42, P9319, DOI 10.1016/S0032-3861(01)00484-0
   Mi FL, 2008, BIOCONJUGATE CHEM, V19, P1248, DOI 10.1021/bc800076n
   Morillo M, 2003, POLYMER, V44, P7557, DOI 10.1016/j.polymer.2003.10.001
   Morillo M, 2003, MACROMOLECULES, V36, P7567, DOI 10.1021/ma0345201
   Morillo M, 2001, MACROMOLECULES, V34, P7868, DOI 10.1021/ma010510t
   Okamoto S, 2009, VACCINE, V27, P5896, DOI 10.1016/j.vaccine.2009.07.037
   Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0
   Pacini A, 2012, J POLYM SCI POL CHEM, V50, P4790, DOI 10.1002/pola.26363
   Peng SF, 2011, BIOMATERIALS, V32, P239, DOI 10.1016/j.biomaterials.2010.08.081
   Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
   Perez-Camero G, 2004, BIOMACROMOLECULES, V5, P144, DOI 10.1021/bm034267c
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   Perez-Camero G, 2001, J APPL POLYM SCI, V82, P2027, DOI 10.1002/app.2048
   Perez-Camero G., 1999, POLYM PREP-ACS, V40, P1142
   PFEFFER PE, 1976, J ORG CHEM, V41, P1373, DOI 10.1021/jo00870a018
   Portilla-Arias JA, 2007, POLYM DEGRAD STABIL, V92, P1916, DOI 10.1016/j.polymdegradstab.2007.06.011
   Portilla-Arias JA, 2007, MACROMOL BIOSCI, V7, P897, DOI 10.1002/mabi.200700025
   Portilla-Arias JA, 2009, J BIOMAT SCI-POLYM E, V20, P1065, DOI 10.1163/156856209X444420
   Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q
   Radu JEF, 2008, COLLOID POLYM SCI, V286, P365, DOI 10.1007/s00396-007-1776-8
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   RYDON HN, 1964, J CHEM SOC, P1328, DOI 10.1039/jr9640001328
   Shah D.T., 1993, POLYM PREP AM CHEM S, V5, P488
   Shah D. T., 1995, Pat. Number US, Patent No. [5378807, 5378807-A]
   Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042
   Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061
   Tachibana Y, 2003, BIOMACROMOLECULES, V4, P1132, DOI 10.1021/bm034123y
   Takeda H., 1995, Jpn. Kokai Tokyo Koho, Japan Patent, Patent No. [JP7138364, 7138364]
   Takeda H., 1997, Jpn. Kokai Tokyo Koho, Japan Patent, Patent No. [JP8319421, 8319421]
   Tang DW, 2010, BIOMATERIALS, V31, P9320, DOI 10.1016/j.biomaterials.2010.08.058
   Tolentino A, 2012, EUR POLYM J, V48, P1838, DOI 10.1016/j.eurpolymj.2012.08.007
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P3193, DOI 10.1002/pola.1993.080311304
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P563, DOI 10.1002/pola.1993.080310229
   Wang SG, 2012, COLLOID SURFACE B, V89, P254, DOI 10.1016/j.colsurfb.2011.09.029
   Yao B, 2009, MATER SCI-POLAND, V27, P319
   Yoshida H, 2009, MACROMOL BIOSCI, V9, P568, DOI 10.1002/mabi.200800334
   Yoshikawa T, 2008, VACCINE, V26, P1303, DOI 10.1016/j.vaccine.2007.12.037
   Zanuy D, 1998, INT J BIOL MACROMOL, V23, P175, DOI 10.1016/S0141-8130(98)00047-6
   Zanuy D, 2001, BIOMACROMOLECULES, V2, P651, DOI 10.1021/bm000122j
NR 74
TC 8
Z9 8
U1 0
U2 12
PU SCRIVENER PUBLISHING
PI BEVERLY
PA 100 CUMMINGS CENTER, SUITE 541J, BEVERLY, MA 01915-6106 USA
SN 2164-6325
EI 2164-6341
J9 J RENEW MATER
JI J. Renew. Mater.
PD JAN
PY 2013
VL 1
IS 1
BP 42
EP 60
DI 10.7569/JRM.2012.634105
PG 19
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Materials Science, Composites;
   Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA V41HB
UT WOS:000209536200004
DA 2018-10-20
ER

PT S
AU Darecki, A
   Saeid, A
   Chojnacka, K
AF Darecki, A.
   Saeid, A.
   Chojnacka, K.
BE Lekkas, TD
TI BIOSORPTION OF MICROELEMENTS BY SPIRULINA: TOWARDS TECHNOLOGY OF MINERAL
   FEED SUPPLEMENTS
SO PROCEEDINGS OF THE 13TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL
   SCIENCE AND TECHNOLOGY
SE Proceedings of the International Conference on Environmental Science and
   Technology
LA English
DT Proceedings Paper
CT 13th International Conference on Environmental Science and Technology
   (CEST)
CY SEP 05-07, 2013
CL Athens, GREECE
SP Univ Aegean, Global Network Environm Sci & Technol
DE biosorption; functional groups. Spirulina maxima; FTIR; SEM-EDX;
   ICP-OES; Cu(ll); Co(II); Mn(II); Zn(II)
ID BIOMASS
AB Surface characterization and metal ion adsorption properties of biomass of blue-green algae Spirulina sp. and Spirulina maxima has been carried out by various instrumental techniques. Ths approach is useful in elaboration of new applications of biosorption, e.g. the production of mineral feed additives for livestock from the biomass of algae enriched with microelement ions. Fourier transform infrared spectroscopy technique (FTIR) and potentiometric titration were used to determine functional groups responsible for metal ion-cells interactions and their concentration on algal biomass. In obtained FTIR spectra of Spirulina maxima grown under laboratory conditions and the cells enriched in copper ions, the characteristic peak shifting of amino, amide and carbonyl groups in Cu(ll)treated biomaterial was observed, while no presence of band corresponding to neither phosphoryl nor sulfone groups was found, proving their involvement in metal ions complexation by Spirulina. The potentiometric titration data were analyzed using three kinetic models, assuming the presence of one, two and three types of surface functional groups respectively. The best fit was obtained for three types of functional groups, where the major binding site was the carboxyl group. Comparison of the analytical results obtained by inductively coupled plasma optical emission spectroscopy (ICP-OES) and scanning electron microscopy with an energy dispersive X-ray analytical system (SEMEDX) was performed in order to investigate the mechanism of metal ions biosorption. The lyophilized Spirulina sp. was enriched with Cu(ll), Mn(II), Zn(II), and Co(II) ions via biosorption and the metal affinity relationships for single and multi-component analysis were determined. Obtained results showed that metal ion biosorption occured by replacing naturally bound ions: Na(I), K(I) or Ca(II) with a descending order of Mn(II)>Cu(II)>Zn(II)>Co(I I) for single-, and a descending order of Cu(II)>Mn(II)>Co(II)>Zn(II) for multi-compontent system respectively. The concentration of elements on the surface of natural and metal-loaded material was determined both by ICP-OES and SEM-EDX analysis, showing relatively high value of correlation coefficient between the concentration of Na(I) ions in algal biomass, confirming usefulness of SEM technique for biosorption processes analysis.
C1 [Darecki, A.; Saeid, A.; Chojnacka, K.] Wroclaw Univ Technol, Inst Inorgan Technol & Mineral Fertilizers, PL-50372 Wroclaw, Poland.
RP Darecki, A (reprint author), Wroclaw Univ Technol, Inst Inorgan Technol & Mineral Fertilizers, Smoluchowskiego 25, PL-50372 Wroclaw, Poland.
EM katarzyna.chojnacka@pwr.wroc.pl
RI Saeid, Agnieszka/F-5183-2015; Saeid, Agnieszka/A-1744-2016
OI Saeid, Agnieszka/0000-0002-1755-3002; Saeid,
   Agnieszka/0000-0002-1755-3002
CR Chojnacka K, 2006, TALANTA, V70, P966, DOI 10.1016/j.talanta.2006.05.063
   Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005
   FOUREST E, 1994, FEMS MICROBIOL REV, V14, P325
   Gupta R, 2000, CURR SCI INDIA, V78, P967
   Liu Y., 2008, SEP PURIF TECHNOL, V63, P249
   Saeid A, 2013, J APPL PHYCOL, V25, P667, DOI 10.1007/s10811-012-9901-6
   Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n
   SCHLOSSER UG, 1982, BER DEUT BOT GES, V95, P181
   Zarrouk C., 1966, THESIS U PARIS FRANC
   Zielinska A, 2009, J SCI FOOD AGR, V89, P2292, DOI 10.1002/jsfa.3723
NR 10
TC 0
Z9 0
U1 2
U2 4
PU GLOBAL NEST, SECRETARIAT
PI ATHENS
PA UNIV, AEGEAN, 30, VOULGAROKTONOU STR, ATHENS, GR 114 72, GREECE
SN 1106-5516
BN 978-960-7475-51-0
J9 PROC INT CONF ENV SC
PY 2013
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA BB7WL
UT WOS:000346067900460
DA 2018-10-20
ER

PT B
AU Yu, Y
   Ozbolat, IT
AF Yu, Yin
   Ozbolat, Ibrahim T.
GP ASME
TI BIOPRINTING INDUCED CELL DAMAGE IN CELLULAR MICRO-FLUIDIC CHANNEL
   FABRICATION
SO PROCEEDINGS OF THE ASME 8TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE - 2013, VOL 1
LA English
DT Proceedings Paper
CT 8th International Manufacturing Science and Engineering Conference
CY JUN 10-14, 2013
CL Madison, WI
SP ASME, Mfg Engn Div
ID TISSUE; SCAFFOLDS
AB Bioprinting, or layer by layer additive tissue fabrication, is a revolutionary concept recently emerged as an interdisciplinary effort to produce three-dimensional living organ for clinical application. Among many challenges, it was agreed that inclusion of vascular system is critical for maintaining the viability and functionality of relatively thick 3D bioprinted tissue constructs. Our previous research addressed the printability of novel vessel-like micro-fluidic channels with alginate hydrogel and co-axial nozzles. Here, we further investigated the influence of bioprinting parameters on cartilage progenitor cells (CPCs) survival during and post printing. The results of this study revealed that quantifiable cell death could be induced by varying dispensing pressure, co-axial nozzle geometry, biomaterial concentration. However, damaged cells were able to recover during incubation, as well as undergo proliferation to certain extend. These findings may serve as a guideline for optimizing our system as well as predict cell damage in future studies.
C1 [Yu, Yin] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
RP Yu, Y (reprint author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Xiang L, 2012, ANN PLAS SURG, V68, P229, DOI 10.1097/SAP.0b013e3182384068
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   Yu Y., 2012, IDENTIFICATION CHARA, pix
   Zhang Yahui, 2013, CHARACTERIZATION PRI
NR 15
TC 0
Z9 0
U1 1
U2 8
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5545-4
PY 2013
AR V001T01A006
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BC1BI
UT WOS:000349928300006
DA 2018-10-20
ER

PT J
AU Sutivisedsak, N
   Leathers, TD
   Price, NPJ
AF Sutivisedsak, Nongnuch
   Leathers, Timothy D.
   Price, Neil P. J.
TI Production of schizophyllan from distiller's dried grains with solubles
   by diverse strains of Schizophyllum commune
SO SPRINGERPLUS
LA English
DT Article
DE Distiller's dried grains with solubles; DDGS; Schizophyllum commune;
   Schizophyllan
AB Eleven diverse strains of Schizophyllan commune were examined for production of the biopolymer schizophyllan from agricultural biomass. Strains were grown in malt extract (ME) basal medium containing 1% (w/v) distiller's dried grains with solubles (DDGS), an abundant coproduct of fuel ethanol production by the dry grind process. Ten of 11 strains tested produced more than 2 g schizophyllan/L. Two strains, ATCC 20165 and CBS 266.60, produced more than 10 g schizophyllan/L. Schizophyllan from these strains was similar to commercial product in terms of solution viscosity, molecular weight, and surface tension properties, suggesting that they would be equivalent in biomaterial applications.
C1 [Sutivisedsak, Nongnuch; Leathers, Timothy D.; Price, Neil P. J.] ARS, Renewable Prod Technol Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA.
RP Leathers, TD (reprint author), ARS, Renewable Prod Technol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.
EM Tim.Leathers@ars.usda.gov
FU Agriculture and Food Research Initiative Competitive Grant from the USDA
   National Institute of Food and Agriculture [2010-65504-20377]
FX Expert technical assistance was provided by Erika Hertenstein, Melinda
   S. Nunnally, Suzanne Unser, and Andrew J. Thomas. The authors sincerely
   thank Christopher Dunlap for surface tension measurements. This project
   was supported by Agriculture and Food Research Initiative Competitive
   Grant no. 2010-65504-20377 from the USDA National Institute of Food and
   Agriculture. Mention of any trade names or commercial products in this
   publication is solely for the purpose of providing specific information
   and does not imply recommendation or endorsement by the US Department of
   Agriculture. USDA is an equal opportunity provider and employer.
CR Dunlap CA, 2011, J MICROBIOL, V49, P603, DOI 10.1007/s12275-011-1044-y
   [高利忠 GAO Lizhong], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P214
   Kumarl M, 2008, BIORESOURCE TECHNOL, V99, P1036, DOI 10.1016/j.biortech.2007.02.029
   Leathers TD, 2006, BIOTECHNOL LETT, V28, P623, DOI 10.1007/s10529-006-0028-1
   Leathers TD, 2010, CARBOHYD POLYM, V81, P732, DOI 10.1016/j.carbpol.2010.03.030
   Li WB, 2011, Z NATURFORSCH C, V66, P173, DOI 10.5560/ZNC.2011.66c0173
   PROKOP A, 1992, EXP MYCOL, V16, P197, DOI 10.1016/0147-5975(92)90028-P
   RAU U, 1992, J IND MICROBIOL, V9, P19, DOI 10.1007/BF01576364
   Rau U, 1999, METH BIOTEC, V10, P43
   RAU U, 1992, CHEM-ING-TECH, V64, P576, DOI 10.1002/cite.330640627
   Rau U., 2002, BIOPOLYMERS POLYSACC, V6, P61
   Rosentrater KA, 2012, DISTILLERS GRAINS: PRODUCTION, PROPERTIES, AND UTILIZATION, P73
   SANROMAN MA, 1993, AN ASOC QUIM ARGENT, V81, P15
   SCHULZ D, 1992, CARBOHYD POLYM, V18, P295, DOI 10.1016/0144-8617(92)90095-8
   Shu CH, 2011, J TAIWAN INST CHEM E, V42, P387, DOI 10.1016/j.jtice.2010.08.009
   STEINER W, 1987, BIOTECHNOL BIOENG, V30, P169, DOI 10.1002/bit.260300206
   Sutivisedsak N, 2013, J IND MICROBIOL BIOT, V40, P105, DOI 10.1007/s10295-012-1208-8
NR 17
TC 3
Z9 4
U1 0
U2 3
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2193-1801
J9 SPRINGERPLUS
JI SpringerPlus
PY 2013
VL 2
AR 476
DI 10.1186/2193-1801-2-476
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V40FS
UT WOS:000209465100048
PM 24102042
OA Green Published, Other Gold
DA 2018-10-20
ER

PT S
AU Muller, WD
   Nascimento, L
   Mele, M
AF Mueller, W. D.
   Nascimento, L.
   Mele, M.
BE Mendez, JF
   Rodriguez, TYA
   Vazquez, HV
   Marin, CFC
   Barreda, MC
   Rojas, RR
   Medina, JC
   Ruiz, SBL
TI Electrochemical Assessment of Biomaterial Surfaces Using the Mini-Cell
   System
SO 5TH LATIN AMERICAN CONGRESS ON BIOMEDICAL ENGINEERING (CLAIB 2011):
   SUSTAINABLE TECHNOLOGIES FOR THE HEALTH OF ALL, PTS 1 AND 2
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th Latin American Congress on Biomedical Engineering (CLAIB 2011)
CY MAY 16-21, 2011
CL Habana, CUBA
SP SOCBIO, CORAL, Acad Ciencias Cuba, AMECA CMA, CNSCS, Int Fed Med & Biol Engn, Minist Ciencia Tecnologia & Medio Ambiente, Minist Cultura, Minist Educ Superior, Minist Ind Ligera, Minist Informat & Commun, Minist Ind Sidero Mecan, Minist Salud Publ, Oficina Historiador Ciudad, Org Panamericana Salud, Org Mundial Salud, Sociedad Cubana Fis, Agencia Representaciones Artist Musicalia, Ctr Nacl Mus Concierto, SKAN AG, Materialise NV, Bavarian Enterprises, Bavarian Minist Econ Affairs Infrastructure Transport & Technol, Bavarian Bur Int Business Relat GmbH, AKUD Med Pharm GmbH, HAWO GmbH, HT Labor & Hospitaltechnik AG, MIPM GmbH, Nurnberger Business Club GmbH, Physiomed Elektromedizin AG, DEGA EXPOTEAM GmbH & Co
DE biomaterials; electrochemistry; corrosion; surface characterization
ID ORTHODONTIC WIRES; METALLIC BIOMATERIALS; CORROSION; ALLOYS
AB Local resolved electrochemical measurement setup, MCS, will present for demonstration of the power for a non-destructive assessment of metallic biomaterial interfaces under living near conditions. As an example the experiments on orthodontic wires are presented.
C1 [Mueller, W. D.; Nascimento, L.] Charite Univ Med Berlin, Berlin, Germany.
   [Nascimento, L.] Tech Univ Berlin, FB Mat Sci, Berlin, Germany.
   [Mele, M.] INIFTA, La Plata, Argentina.
RP Muller, WD (reprint author), Charite Univ Med Berlin, Berlin, Germany.
EM wolf-dieter.mueller@charite.de
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   Ehrensberger M T, J BIOMED MAT RES A, V94, P781
   Es-Souni Martha, 2003, J Orofac Orthop, V64, P16, DOI 10.1007/s00056-003-0235-5
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Shettlemore MG, 2001, BIOMATERIALS, V22, P2215, DOI 10.1016/S0142-9612(00)00410-5
   Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5
   Wirz Jakob, 2003, Schweiz Monatsschr Zahnmed, V113, P284
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
NR 14
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-21197-3
J9 IFMBE PROC
PY 2013
VL 33
IS 1-2
BP 180
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BCO94
UT WOS:000310929100046
DA 2018-10-20
ER

PT J
AU Gilmore, L
   Rimmer, S
   McArthur, SL
   Mittar, S
   Sun, DC
   MacNeil, S
AF Gilmore, Louisa
   Rimmer, Stephen
   McArthur, Sally L.
   Mittar, Shweta
   Sun, Dachau
   MacNeil, Sheila
TI Arginine functionalization of hydrogels for heparin bindingua
   supramolecular approach to developing a pro-angiogenic biomaterial
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE angiogenesis; heparin; hydrogels
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; COLLATERAL DEVELOPMENT; SUSTAINED
   DELIVERY; ACID) MICROGELS; CELL-SURFACE; ADHESION; RELEASE; SCAFFOLDS;
   MODEL
AB Our aim was to synthesize a biomaterial that stimulates angiogenesis for tissue engineering applications by exploiting the ability of heparin to bind and release vascular endothelial growth factor (VEGF). The approach adopted involved modification of a hydrogel with positively charged peptides (oligolysine or oligoarginine) to achieve heparin binding. Precursor hydrogels were produced from copolymerization of N-vinyl pyrolidone, diethylene glycol bis allyl carbonate and acrylic acid (PNDA) and functionalized after activation of the carboxylic acid groups with trilysine or triarginine peptides (PNDKKK and PNDRRR). Both hydrogels were shown to bind and release bioactive VEGF165 with arginine-modified hydrogel outperforming the lysine-modified hydrogel. Cytocompatibility of the hydrogels was confirmed in vitro with primary human dermal fibroblasts and human dermal microvascular endothelial cells (HUDMECs). Proliferation of HUDMECs was stimulated by triarginine-functionalized hydrogels, and to a lesser extent by lysine functionalized hydrogels once loaded with heparin and VEGF. The data suggests that heparin-binding hydrogels provide a promising approach to a pro-angiogenic biomaterial. Biotechnol. Bioeng. 2013; 110: 296317. (C) 2012 Wiley Periodicals, Inc.
C1 [Mittar, Shweta; MacNeil, Sheila] Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [Gilmore, Louisa; Rimmer, Stephen; Sun, Dachau] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
   [McArthur, Sally L.] Swinburne Univ Technol, Fac Engn & Ind Sci, IRIS, Hawthorn, Vic 3122, Australia.
RP MacNeil, S (reprint author), Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
EM s.macneil@Sheffield.ac.uk
RI McArthur, Sally/B-6848-2008
OI McArthur, Sally/0000-0002-4914-6989
FU BBSRC; BBSRC (UK)
FX Contract grant sponsor: BBSRC; We thank BBSRC (UK) for funding a Ph.D.
   studentship for Louisa Gilmore and Dr. Tracy Whittle for XPS analysis.
CR Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Chen YM, 2007, BIOMATERIALS, V28, P1752, DOI 10.1016/j.biomaterials.2006.12.005
   Christensen K, 2005, THROMB RES, V115, P245, DOI 10.1016/j,thromres.2004.08.030
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Gilmore L, 2009, CHEMBIOCHEM, V10, P2165, DOI 10.1002/cbic.200900383
   GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093
   Gu F, 2007, J CONTROL RELEASE, V117, P80, DOI 10.1016/j.jconrel.2006.09.077
   Haigh R, 2002, BIOMATERIALS, V23, P3509, DOI 10.1016/S0142-9612(02)00081-9
   Hamma-Kourbali Y, 2001, J BIOL CHEM, V276, P39748, DOI 10.1074/jbc.M101117200
   Haxhinasto KB, 2008, J MATER SCI-MATER M, V19, P1999, DOI 10.1007/s10856-007-3277-1
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   Hopkins SP, 1998, J VASC SURG, V27, P886, DOI 10.1016/S0741-5214(98)70269-1
   Jay SM, 2008, J CONTROL RELEASE, V134, P26
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Johansson C, 2007, J COLLOID INTERF SCI, V316, P350, DOI 10.1016/j.jcis.2007.07.052
   Johansson C, 2010, J COLLOID INTERF SCI, V347, P241, DOI 10.1016/j.jcis.2010.03.072
   Kanczler JM, 2007, BIOCHEM BIOPH RES CO, V352, P135, DOI 10.1016/j.bbrc.2006.10.187
   Kavanagh CA, 2005, J BIOMED MATER RES A, V72A, P25, DOI 10.1002/jbm.a.30192
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033
   Kim SW, 1996, BLOOD PURIFICAT, V14, P357
   Kipshidze N, 2000, TEX HEART I J, V27, P196
   Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M5044922200
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   Yoon JJ, 2007, J BIOMED MATER RES A, V83A, P597, DOI 10.1002/jbm.a.31271
NR 47
TC 12
Z9 12
U1 2
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2013
VL 110
IS 1
BP 296
EP 317
DI 10.1002/bit.24598
PG 22
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 041EP
UT WOS:000311380200027
PM 22753043
DA 2018-10-20
ER

PT J
AU Al-Abboodi, A
   Fu, J
   Doran, PM
   Chan, PPY
AF Al-Abboodi, Aswan
   Fu, Jing
   Doran, Pauline M.
   Chan, Peggy P. Y.
TI Three-dimensional nanocharacterization of porous hydrogel with ion and
   electron beams
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE porous hydrogel; focused ion beam (FIB); SEM; tomography; cell growth
ID CELLS; MICROSCOPY; SPECIMENS; BEHAVIOR; SYSTEM; SEM
AB Porous hydrogels provide an excellent environment for cell growth and tissue regeneration, with high permeability for oxygen, nutrients, and other water-soluble metabolites through their high water-content matrix. The ability to image three-dimensional (3D) cell growth is crucial for understanding and studying various cellular activities in 3D context, particularly for designing new tissue engineering scaffold, but it is still challenging to study cell-biomaterial interfaces with high resolution imaging. We demonstrate using focused ion beam (FIB) milling, electron imaging, and associated microanalysis techniques that novel 3D characterizations can be performed effectively on cells growing inside 3D hydrogel scaffold. With FIB-tomography, the porous microstructures were revealed at nanometer resolution, and the cells grown inside. The results provide a unique 3D measurement of hydrogel porosity, as compared with those from porosimetry, and offer crucial insights into material factors affecting cell proliferation at specific regions within the scaffold. We also proved that high throughput correlative imaging of cell growth is viable through a silicon membrane based environment. The proposed approaches, together with the protocols developed, provide a unique platform for analysis of the microstructures of novel biomaterials, and for exploration of their interactions with the cells as well. Biotechnol. Bioeng. 2013; 110: 318326. (C) 2012 Wiley Periodicals, Inc.
C1 [Fu, Jing] Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
   [Al-Abboodi, Aswan] Monash Univ, Dept Chem Engn, Clayton, Vic 3800, Australia.
   [Doran, Pauline M.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Chan, Peggy P. Y.] RMIT Univ, Sch Appl Sci, Melbourne, Vic 3000, Australia.
   [Chan, Peggy P. Y.] RMIT Univ, Micro Nanophys Res Lab, Melbourne, Vic 3000, Australia.
RP Fu, J (reprint author), Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
EM jing.fu@monash.edu; peggy.chan@rmit.edu.au
OI Fu, Jing/0000-0002-7752-5417
FU Faculty of Engineering, Monash University; Australian Research Council
   Discovery (ARC) Project Grant [DP 120102570, DP 120100583]; Commonwealth
   of Australia; Victorian Government
FX The authors would like to acknowledge support from the New Staff Member
   Research Fund from the Faculty of Engineering, Monash University.
   Funding for this work was partly provided through Australian Research
   Council Discovery (ARC) Project Grant DP 120102570 and DP 120100583.
   This work was performed in part at the Monash Centre of Electron
   Microscopy (MCEM) and the Melbourne Centre for Nanofabrication (MCN), an
   initiative partly funded by the Commonwealth of Australia and the
   Victorian Government. High performance computing was supported by
   Multi-modal Australian Sciences Imaging and Visualisation Environment
   (MASSIVE). The authors also thank Dr. Manoj Sridhar, Mr. David Vowles,
   and Monash Microimaging for experiment assistance.
CR Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591
   Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080
   da Silva J, 2010, BIOMATERIALS, V31, P2201, DOI 10.1016/j.biomaterials.2009.11.105
   Edwards HK, 2009, J MICROSC-OXFORD, V234, P16, DOI 10.1111/j.1365-2818.2009.03152.x
   Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Friedmann A, 2012, SCANNING, V34, P221, DOI 10.1002/sca.20297
   Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024
   Fu J, 2008, J VAC SCI TECHNOL A, V26, P422, DOI 10.1116/1.2902962
   Fu J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/9/095010
   Giannuzzi LA, 2005, INTRO FOCUSED ION BE, Vxiv, P357
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x
   Hayles MF, 2010, J STRUCT BIOL, V172, P180, DOI 10.1016/j.jsb.2010.07.004
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005
   Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Leser V, 2009, J MICROSC-OXFORD, V233, P309, DOI 10.1111/j.1365-2818.2009.03121.x
   Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037
   Lucille A, 2007, J ORAL MAXILLOFAC SU, V65, P737
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003
   Mcgeoch JEM, 2007, J MICROSC-OXFORD, V227, P172, DOI 10.1111/j.1365-2818.2007.01798.x
   Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   Schroeder-Reiter E, 2009, J STRUCT BIOL, V165, P97, DOI 10.1016/j.jsb.2008.10.002
   Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
NR 35
TC 21
Z9 21
U1 0
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2013
VL 110
IS 1
BP 318
EP 326
DI 10.1002/bit.24612
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 041EP
UT WOS:000311380200028
PM 22811278
DA 2018-10-20
ER

PT J
AU Rodriguez, R
   Loske, AM
   Estevez, M
   Vargas, S
   Salazar, R
   Pacheco, F
   Vazquez-Carpizo, J
   Gamboa, JM
AF Rodriguez, R.
   Loske, A. M.
   Estevez, M.
   Vargas, S.
   Salazar, R.
   Pacheco, F.
   Vazquez-Carpizo, J.
   Gamboa, J. M.
TI Bio-Packaged Transponder MEMS Implanted in Rats
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Bio-package; hybrid material; hydroxyapatite; MEMS; transponder;
   biomaterial; implant
ID POROUS HYDROXYAPATITE; BONE; POLYURETHANE; BIOMATERIALS; MATRIX
AB A novel hydroxyapatite-based hybrid material with controlled porosity was designed as a bio-package to implant micro-electro-mechanical systems (MEMS) in living organisms. The biomaterial was prepared using synthetic stoichiometric hydroxyapatite powder reacted with a chemical-active, solvent-free, alkyd-based polyurethane. This porous material has interconnected pores with sizes between 100 and 350 mu m and a pore volume fraction of 50%, fulfilling the requirements for implants. The biomaterial additionally has high wearing resistance and hydrolytic stability providing high endurance properties. The bio-package was characterized mechanically and morphologically using X-ray diffraction, scanning electron microscopy, densitometry, abrasion and mechanical tests. Twelve packaged micro-electro-mechanical systems were implanted subcutaneously into rats and tested for up to 9 months with good acceptance as revealed by the histological analysis performed on the soft tissue surrounding each implant. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Rodriguez, R.; Loske, A. M.; Estevez, M.; Vargas, S.] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Qro, Mexico.
   [Rodriguez, R.] Univ Valle Mexico, Div Ciencias Salud, Queretaro 76230, Qro, Mexico.
   [Salazar, R.; Pacheco, F.] Univ Popular Autonoma Estado Puebla, Lab MEMS & CSAT, Puebla 72160, Pue, Mexico.
   [Vazquez-Carpizo, J.] Hosp Angeles Queretaro, Queretaro 76178, Qro, Mexico.
   [Gamboa, J. M.] Lab Anat Patol & Citol Queretaro, Queretaro 76020, Qro, Mexico.
RP Rodriguez, R (reprint author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Qro, Mexico.
EM rogelior@unam.mx
RI Gamboa, Jose Manuel/D-5389-2014; Rodriguez Talavera, Jose
   Rogelio/L-1709-2018; Estevez, Miriam/F-8864-2018
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; Estevez,
   Miriam/0000-0003-4749-7715; VARGAS MUNOZ, SUSANA/0000-0001-9031-4182;
   Loske, Achim/0000-0002-9873-5165
CR Alves P, 2009, EUR POLYM J, V45, P1412, DOI 10.1016/j.eurpolymj.2009.02.011
   Barbic M, 2002, J MAGN MAGN MATER, V249, P357, DOI 10.1016/S0304-8853(02)00559-0
   BECHARD S, 1986, INT J PHARMACEUT, V32, P71, DOI 10.1016/0378-5173(86)90100-6
   Byun I, 2008, MICROELECTRON J, V39, P717, DOI 10.1016/j.mejo.2007.12.004
   Chen YC, 2004, J COLLOID INTERF SCI, V279, P370, DOI 10.1016/j.jcis.2004.06.074
   Cooley P., 2002, JALA, V7, P33, DOI 10.1016/S1535-5535(04)00214-X
   FANSKA CB, 1991, J CHROMATOGR, V537, P357, DOI 10.1016/S0021-9673(01)88908-1
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   Green JR, 1999, J ARTHROPLASTY, V14, P91, DOI 10.1016/S0883-5403(99)90208-5
   HOLMES R, 1988, J CRANIO MAXILL SURG, V16, P199, DOI 10.1016/S1010-5182(88)80047-7
   Horvath I, 2001, MICROELECTR J, V32, P1, DOI 10.1016/S0026-2692(00)00073-2
   Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x
   Ko YG, 2009, J COLLOID INTERF SCI, V330, P77, DOI 10.1016/j.jcis.2008.10.015
   Kumar P, 2010, J FOOD ENG, V100, P480, DOI 10.1016/j.jfoodeng.2010.04.035
   Laurienzo P, 2010, J FOOD ENG, V97, P491, DOI 10.1016/j.jfoodeng.2009.11.006
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   Li N., 2008, JALA, V13, P237
   Lie C., 2006, MICROELECTRON J, V37, P1347
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   Rodriguez R, 2008, J MATER SCI-MATER EL, V19, P646, DOI 10.1007/s10854-007-9413-3
   Rodriguez R., 2010, J BIOMAT SCI-POLYM E, V22, P1799
   Rozenberg I., 2006, J MAGN MAGN MATER, V305
   Seramak T, 2010, J BIOMECH, V43, pS55
   Silva Marcelo Henrique Prado da, 2003, Mat. Res., V6, P321, DOI 10.1590/S1516-14392003000300004
   Singh A, 2005, J SOUND VIB, V286, P637, DOI 10.1016/j.jsv.2004.12.010
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   Susuki S., 1999, THIN SOLID FILMS, V340, P194
   Tancret F, 2006, J EUR CERAM SOC, V26, P3647, DOI 10.1016/j.jeurceramsoc.2005.12.015
   Teissier J., 1985, J CRANIO MAXILLOFAC, V43, P1000
   Xiao SY, 2007, MICROELECTRON J, V38, P360, DOI 10.1016/j.mejo.2007.01.022
   Zhong ZW, 2006, MICROELECTRON J, V37, P295, DOI 10.1016/j.mejo.2005.05.016
NR 32
TC 0
Z9 0
U1 3
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2013
VL 24
IS 1
BP 31
EP 44
DI 10.1163/156856211X621097
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 043KW
UT WOS:000311543500003
PM 22304894
DA 2018-10-20
ER

EF